Citrus Sinensis ID: 010463
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 510 | 2.2.26 [Sep-21-2011] | |||||||
| Q2LZZ7 | 458 | Serine/threonine-protein | yes | no | 0.843 | 0.938 | 0.495 | 1e-122 | |
| Q9NBK5 | 463 | Serine/threonine-protein | yes | no | 0.878 | 0.967 | 0.484 | 1e-122 | |
| Q9Y2H1 | 464 | Serine/threonine-protein | yes | no | 0.872 | 0.959 | 0.478 | 1e-122 | |
| Q7TSE6 | 464 | Serine/threonine-protein | yes | no | 0.872 | 0.959 | 0.467 | 1e-120 | |
| A2VDV2 | 465 | Serine/threonine-protein | no | no | 0.874 | 0.959 | 0.471 | 1e-119 | |
| Q5R8M1 | 465 | Serine/threonine-protein | yes | no | 0.870 | 0.954 | 0.469 | 1e-119 | |
| Q15208 | 465 | Serine/threonine-protein | no | no | 0.870 | 0.954 | 0.469 | 1e-119 | |
| Q6TGC6 | 507 | Serine/threonine-protein | N/A | no | 0.866 | 0.871 | 0.461 | 1e-118 | |
| Q91VJ4 | 465 | Serine/threonine-protein | no | no | 0.870 | 0.954 | 0.465 | 1e-118 | |
| Q54IH8 | 542 | Probable serine/threonine | yes | no | 0.884 | 0.832 | 0.449 | 1e-114 |
| >sp|Q2LZZ7|TRC_DROPS Serine/threonine-protein kinase tricorner OS=Drosophila pseudoobscura pseudoobscura GN=trc PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 440 bits (1132), Expect = e-122, Method: Compositional matrix adjust.
Identities = 220/444 (49%), Positives = 308/444 (69%), Gaps = 14/444 (3%)
Query: 35 TRQKAAAAKQFIENHYKNYLQGLQDRKERRRALQMRAQQAAVSNEEQEEMLRNLERRETE 94
T KA AK +EN+Y N + +RK+R L+ + + +++ +++E ++ETE
Sbjct: 19 TLDKATKAKVTLENYYSNLVTQYGERKQRLAKLEAQLKDESLTESQRQEKRLQHAQKETE 78
Query: 95 YMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVR 154
Y+RL+R ++G++DFE L +IG+GAFGEVRL + K TG ++AMK L+K++ML++ QV HVR
Sbjct: 79 YLRLKRLRLGVEDFEALKVIGRGAFGEVRLVQKKDTGHVYAMKVLRKADMLEKEQVAHVR 138
Query: 155 SERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAE 214
+ER++L E D + +V+++YSFQD LYLIME+LPGGD+MTLLM++D LSE+ +FYI+E
Sbjct: 139 AERDVLVEADHQWVVKMYYSFQDQVNLYLIMEFLPGGDMMTLLMKKDTLSEEGTQFYISE 198
Query: 215 SVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQE 274
+ LAI SIH+ ++HRDIKPDNL+LD GHLKLSDFGLC L+ + + D ++Q
Sbjct: 199 TALAIDSIHKLGFIHRDIKPDNLLLDARGHLKLSDFGLCTGLKKSHRTDFYRD---LSQA 255
Query: 275 TVSEAEGQWMMP---KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLG 331
S+ G P K R + WKRNRRALAYSTVGT DY+APEV L+ GYG CDWWSLG
Sbjct: 256 KPSDFIGTCASPMDSKRRAESWKRNRRALAYSTVGTPDYIAPEVFLQTGYGPACDWWSLG 315
Query: 332 AIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLG 391
IMYEML+GYPPFCSD+P+ T RK++NW+ L FP E IS+EA++ I C+ + RLG
Sbjct: 316 VIMYEMLMGYPPFCSDNPQDTYRKVMNWRETLIFPPEIPISEEAKETIIKFCCEADRRLG 375
Query: 392 T-RGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEV--DGPPSEIPSV 448
+ RG+E+LK P+FRG+ W+ + E AA V DT NF++FP+V + P + IP
Sbjct: 376 SQRGLEDLKSVPFFRGVDWEHIRERPAAIPVEVRSIDDTSNFDEFPDVSLEIPSAPIPQG 435
Query: 449 GPWRKMLTSKDTNFIGYTFKKSDV 472
G +KD FI YT+K+ +V
Sbjct: 436 GE-----IAKDWVFINYTYKRFEV 454
|
Has an important role, with fry, in controlling cell structure and proliferation of a variety of polarized outgrowths including epidermal hairs, bristles, arista laterals, and dendrites. Affects cellular morphogenesis by regulating the expression of target genes that encode cytoskeleton-interacting proteins and not via the direct modification of the cytoskeleton. Maintains the integrity of epidermal hairs and is an essential component of the signaling pathway regulating dendritic branching of sensory neurons. Drosophila pseudoobscura pseudoobscura (taxid: 46245) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9NBK5|TRC_DROME Serine/threonine-protein kinase tricorner OS=Drosophila melanogaster GN=trc PE=1 SV=1 | Back alignment and function description |
|---|
Score = 439 bits (1129), Expect = e-122, Method: Compositional matrix adjust.
Identities = 225/464 (48%), Positives = 313/464 (67%), Gaps = 16/464 (3%)
Query: 18 AAREFDLDPDVSVSSPVTRQKAAAAKQFIENHYKNYLQGLQDRKERRRALQMRAQQAAVS 77
++R D D S T KA AK +EN+Y N + +RK+R L+ + + ++S
Sbjct: 3 SSRTQDADGASIRFSDHTLDKATKAKVTLENYYSNLVTQYGERKQRLAKLEAQLKDESLS 62
Query: 78 NEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMK 137
+++E ++ETEY+RL+R ++G++DFE L +IG+GAFGEVRL + K TG ++AMK
Sbjct: 63 EAQRQEKRLQHAQKETEYLRLKRLRLGVEDFEALKVIGRGAFGEVRLVQKKDTGHVYAMK 122
Query: 138 KLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL 197
L+K++ML++ QV HVR+ER++L E D + +V+++YSFQD LYLIME+LPGGD+MTLL
Sbjct: 123 VLRKADMLEKEQVAHVRAERDVLVEADHQWVVKMYYSFQDPVNLYLIMEFLPGGDMMTLL 182
Query: 198 MREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 257
M++D LSE+ +FYI+E+ LAI SIH+ ++HRDIKPDNL+LD GHLKLSDFGLC L+
Sbjct: 183 MKKDTLSEEGTQFYISETALAIDSIHKLGFIHRDIKPDNLLLDARGHLKLSDFGLCTGLK 242
Query: 258 DKYSSILLED------EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYM 311
+ + D D I T + M K R + WKRNRRALAYSTVGT DY+
Sbjct: 243 KSHRTDFYRDLSQAKPSDFIG--TCASLSCSPMDSKRRAESWKRNRRALAYSTVGTPDYI 300
Query: 312 APEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKI 371
APEV L+ GYG CDWWSLG IMYEML+GYPPFCSD+P+ T RK++NW+ L FP E I
Sbjct: 301 APEVFLQTGYGPACDWWSLGVIMYEMLMGYPPFCSDNPQDTYRKVMNWRETLIFPPEIPI 360
Query: 372 SDEARDLICHLLCDVETRLGT-RGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQ 430
S+EA++ I + C+ + RLG+ RG+E+LK P+FRG+ W+ + E AA V DT
Sbjct: 361 SEEAKETIINFCCEADRRLGSQRGLEDLKSVPFFRGVDWEHIRERPAAIPVEVRSIDDTS 420
Query: 431 NFEKFPEV--DGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDV 472
NF++FP+V + P + IP G +KD FI YT+K+ +V
Sbjct: 421 NFDEFPDVSLEIPSAPIPQGGE-----IAKDWVFINYTYKRFEV 459
|
Has an important role, with fry, in controlling cell structure and proliferation of a variety of polarized outgrowths including epidermal hairs, bristles, arista laterals, and dendrites. Affects cellular morphogenesis by regulating the expression of target genes that encode cytoskeleton-interacting proteins and not via the direct modification of the cytoskeleton. Maintains the integrity of epidermal hairs and is an essential component of the signaling pathway regulating dendritic branching of sensory neurons. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9Y2H1|ST38L_HUMAN Serine/threonine-protein kinase 38-like OS=Homo sapiens GN=STK38L PE=1 SV=3 | Back alignment and function description |
|---|
Score = 437 bits (1125), Expect = e-122, Method: Compositional matrix adjust.
Identities = 216/451 (47%), Positives = 305/451 (67%), Gaps = 6/451 (1%)
Query: 35 TRQKAAAAKQFIENHYKNYLQGLQDRKERRRALQMRAQQAAVSNEEQEEMLRNLERRETE 94
TR++ AK +EN Y N + ++R+ R++ L++ ++ +++EE++ R+ETE
Sbjct: 17 TRERVTVAKLTLENFYSNLILQHEERETRQKKLEVAMEEEGLADEEKKLRRSQHARKETE 76
Query: 95 YMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVR 154
++RL+R ++G+DDFE L +IG+GAFGEVRL + K TG I+AMK L+KS+ML++ QV H+R
Sbjct: 77 FLRLKRTRLGLDDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKSDMLEKEQVAHIR 136
Query: 155 SERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAE 214
+ER++L E D +V++FYSFQD LYLIME+LPGGD+MTLLM++D L+E+ +FYI+E
Sbjct: 137 AERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYISE 196
Query: 215 SVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQE 274
+VLAI +IHQ ++HRDIKPDNL+LD GH+KLSDFGLC L+ + + + +
Sbjct: 197 TVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRN---LTHN 253
Query: 275 TVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIM 334
S+ Q M K + + WK+NRR LAYSTVGT DY+APEV ++ GY CDWWSLG IM
Sbjct: 254 PPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 313
Query: 335 YEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRG 394
YEMLIGYPPFCS+ P+ T RK++NWK L FP E IS++A+DLI D E R+G G
Sbjct: 314 YEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCIDSENRIGNSG 373
Query: 395 VEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKM 454
VEE+K HP+F G+ W+ + E AA + DT NF+ FPE D + P K
Sbjct: 374 VEEIKGHPFFEGVDWEHIRERPAAIPIEIKSIDDTSNFDDFPESDILQPVPNTTEPDYK- 432
Query: 455 LTSKDTNFIGYTFKKSDVLKSLENSGTDMRS 485
SKD F+ YT+K+ + L + T M++
Sbjct: 433 --SKDWVFLNYTYKRFEGLTQRGSIPTYMKA 461
|
Involved in the regulation of structural processes in differentiating and mature neuronal cells. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7TSE6|ST38L_MOUSE Serine/threonine-protein kinase 38-like OS=Mus musculus GN=Stk38l PE=1 SV=2 | Back alignment and function description |
|---|
Score = 432 bits (1111), Expect = e-120, Method: Compositional matrix adjust.
Identities = 211/451 (46%), Positives = 304/451 (67%), Gaps = 6/451 (1%)
Query: 35 TRQKAAAAKQFIENHYKNYLQGLQDRKERRRALQMRAQQAAVSNEEQEEMLRNLERRETE 94
TR++ AK +EN Y N + ++R+ R++ L++ ++ +++EE++ R+ETE
Sbjct: 17 TRERVTVAKLTLENFYSNLILQHEERETRQKKLEVAMEEEGLADEEKKLRRSQHARKETE 76
Query: 95 YMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVR 154
++RL+R ++G+DDFE L +IG+GAFGEVRL + K TG I+AMK L+K++ML++ QV H+R
Sbjct: 77 FLRLKRTRLGLDDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIR 136
Query: 155 SERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAE 214
+ER++L E D +V++FYSFQD LYLIME+LPGGD+MTLLM++D L+E+ +FYI+E
Sbjct: 137 AERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYISE 196
Query: 215 SVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQE 274
+VLAI +IHQ ++HRD+KPDNL+LD GH+KLSDFGLC L+ + + + +
Sbjct: 197 TVLAIDAIHQLGFIHRDVKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRN---LTHN 253
Query: 275 TVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIM 334
S+ Q M K + + WK+NRR LAYSTVGT DY+APEV ++ GY CDWWSLG IM
Sbjct: 254 PPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 313
Query: 335 YEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRG 394
YEMLIG+PPFCS+ P+ T RK+++WK L FP E +S++A+DLI D E R+G G
Sbjct: 314 YEMLIGFPPFCSETPQETYRKVMSWKETLAFPPEVPVSEKAKDLILRFCTDSENRIGNGG 373
Query: 395 VEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKM 454
VEE+K HP+F G+ W + E AA + DT NF+ FPE D + P K
Sbjct: 374 VEEIKGHPFFEGVDWGHIRERPAAIPIEIRSIDDTSNFDDFPESDILQPVPNTTEPDYK- 432
Query: 455 LTSKDTNFIGYTFKKSDVLKSLENSGTDMRS 485
SKD F+ YT+K+ + L + T M++
Sbjct: 433 --SKDWVFLNYTYKRFEGLTQRGSIPTYMKA 461
|
Involved in the regulation of structural processes in differentiating and mature neuronal cells. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2VDV2|STK38_BOVIN Serine/threonine-protein kinase 38 OS=Bos taurus GN=STK38 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 430 bits (1105), Expect = e-119, Method: Compositional matrix adjust.
Identities = 212/450 (47%), Positives = 304/450 (67%), Gaps = 4/450 (0%)
Query: 26 PDVSVSSPVTRQKAAAAKQFIENHYKNYLQGLQDRKERRRALQMRAQQAAVSNEEQEEML 85
P S+SS T+++ K +EN Y N + ++R+ R++ L+ ++ + +EE+
Sbjct: 8 PCSSMSSH-TKERVTMTKVTLENFYSNLIAQHEEREMRQKKLEKVMEEEGLKDEEKRLRR 66
Query: 86 RNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML 145
R+ETE++RL+R ++G++DFE L +IG+GAFGEVRL + K TG ++AMK L+K++ML
Sbjct: 67 SAHARKETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML 126
Query: 146 KRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSE 205
++ QV H+R+ER++L E DS +V++FYSFQD LYLIME+LPGGD+MTLLM++D L+E
Sbjct: 127 EKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTE 186
Query: 206 DVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265
+ +FYIAE+VLAI SIHQ ++HRDIKPDNL+LD GH+KLSDFGLC L+ + +
Sbjct: 187 EETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 246
Query: 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMEC 325
+ +N S+ Q M K + + WKRNRR LA+STVGT DY+APEV ++ GY C
Sbjct: 247 RN---LNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLC 303
Query: 326 DWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCD 385
DWWSLG IMYEMLIGYPPFCS+ P+ T +K++NWK L FP E IS++A+DLI C+
Sbjct: 304 DWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLTFPPEVPISEKAKDLILRFCCE 363
Query: 386 VETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEI 445
E R+G GVEE+K + +F G+ W+ + E AA + DT NF++FPE D +
Sbjct: 364 WEHRIGAPGVEEIKNNSFFEGVDWEHIRERPAAISIEIKSIDDTSNFDEFPESDILKPTV 423
Query: 446 PSVGPWRKMLTSKDTNFIGYTFKKSDVLKS 475
+ +KD FI YT+K+ + L +
Sbjct: 424 ATSNHPDTDYKNKDWVFINYTYKRFEGLTA 453
|
Negative regulator of MAP3K1/2 signaling. Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5R8M1|STK38_PONAB Serine/threonine-protein kinase 38 OS=Pongo abelii GN=STK38 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 430 bits (1105), Expect = e-119, Method: Compositional matrix adjust.
Identities = 210/447 (46%), Positives = 301/447 (67%), Gaps = 3/447 (0%)
Query: 29 SVSSPVTRQKAAAAKQFIENHYKNYLQGLQDRKERRRALQMRAQQAAVSNEEQEEMLRNL 88
S S T+++ K +EN Y N + ++R+ R++ L+ ++ + +EE+
Sbjct: 10 SSMSNHTKERVTMTKVTLENFYSNLIAQHEEREMRQKKLEKVMEEEGLKDEEKRLRRSAH 69
Query: 89 ERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRG 148
R+ETE++RL+R ++G++DFE L +IG+GAFGEVRL + K TG ++AMK L+K++ML++
Sbjct: 70 ARKETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKE 129
Query: 149 QVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVA 208
QV H+R+ER++L E DS +V++FYSFQD LYLIME+LPGGD+MTLLM++D L+E+
Sbjct: 130 QVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEET 189
Query: 209 RFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDE 268
+FYIAE+VLAI SIHQ ++HRDIKPDNL+LD GH+KLSDFGLC L+ + + +
Sbjct: 190 QFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRN- 248
Query: 269 DIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWW 328
+N S+ Q M K + + WKRNRR LA+STVGT DY+APEV ++ GY CDWW
Sbjct: 249 --LNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWW 306
Query: 329 SLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVET 388
SLG IMYEMLIGYPPFCS+ P+ T +K++NWK L FP E IS++A+DLI C+ E
Sbjct: 307 SLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLTFPPEVPISEKAKDLILRFCCEWEH 366
Query: 389 RLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSV 448
R+G GVEE+K + +F G+ W+ + E AA + DT NF++FPE D + +
Sbjct: 367 RIGAPGVEEIKSNSFFEGVDWEHIRERPAAISIEIKSIDDTSNFDEFPESDILKPTVATS 426
Query: 449 GPWRKMLTSKDTNFIGYTFKKSDVLKS 475
+KD FI YT+K+ + L +
Sbjct: 427 NHPETDYKNKDWVFINYTYKRFEGLTA 453
|
Negative regulator of MAP3K1/2 signaling. Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2. Pongo abelii (taxid: 9601) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q15208|STK38_HUMAN Serine/threonine-protein kinase 38 OS=Homo sapiens GN=STK38 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 430 bits (1105), Expect = e-119, Method: Compositional matrix adjust.
Identities = 210/447 (46%), Positives = 301/447 (67%), Gaps = 3/447 (0%)
Query: 29 SVSSPVTRQKAAAAKQFIENHYKNYLQGLQDRKERRRALQMRAQQAAVSNEEQEEMLRNL 88
S S T+++ K +EN Y N + ++R+ R++ L+ ++ + +EE+
Sbjct: 10 SSMSNHTKERVTMTKVTLENFYSNLIAQHEEREMRQKKLEKVMEEEGLKDEEKRLRRSAH 69
Query: 89 ERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRG 148
R+ETE++RL+R ++G++DFE L +IG+GAFGEVRL + K TG ++AMK L+K++ML++
Sbjct: 70 ARKETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKE 129
Query: 149 QVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVA 208
QV H+R+ER++L E DS +V++FYSFQD LYLIME+LPGGD+MTLLM++D L+E+
Sbjct: 130 QVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEET 189
Query: 209 RFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDE 268
+FYIAE+VLAI SIHQ ++HRDIKPDNL+LD GH+KLSDFGLC L+ + + +
Sbjct: 190 QFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRN- 248
Query: 269 DIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWW 328
+N S+ Q M K + + WKRNRR LA+STVGT DY+APEV ++ GY CDWW
Sbjct: 249 --LNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWW 306
Query: 329 SLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVET 388
SLG IMYEMLIGYPPFCS+ P+ T +K++NWK L FP E IS++A+DLI C+ E
Sbjct: 307 SLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLTFPPEVPISEKAKDLILRFCCEWEH 366
Query: 389 RLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSV 448
R+G GVEE+K + +F G+ W+ + E AA + DT NF++FPE D + +
Sbjct: 367 RIGAPGVEEIKSNSFFEGVDWEHIRERPAAISIEIKSIDDTSNFDEFPESDILKPTVATS 426
Query: 449 GPWRKMLTSKDTNFIGYTFKKSDVLKS 475
+KD FI YT+K+ + L +
Sbjct: 427 NHPETDYKNKDWVFINYTYKRFEGLTA 453
|
Negative regulator of MAP3K1/2 signaling. Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6TGC6|CBK1_PNECA Serine/threonine-protein kinase CBK1 OS=Pneumocystis carinii GN=CBK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 426 bits (1095), Expect = e-118, Method: Compositional matrix adjust.
Identities = 213/462 (46%), Positives = 305/462 (66%), Gaps = 20/462 (4%)
Query: 27 DVSVSSPVTRQKAAAAKQFIENHYKNYLQGLQDRKERRRALQMRAQQAAVSNEEQEEMLR 86
D S + T ++AA+ K +E+ YK ++ +R +RR + + Q S E ++ L
Sbjct: 45 DASSFTKTTHERAASVKLKLEHLYKVTVEQTVERNQRRMDFEAKLAQDRGSEERKKRQLN 104
Query: 87 NLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLK 146
+L ++E++++RL+R K+ ++DF + +IGKGAFGEVRL + TG+I+AMK L KSEM K
Sbjct: 105 SLGQKESQFLRLRRTKLSLNDFHTVKVIGKGAFGEVRLVQKIDTGKIYAMKTLLKSEMFK 164
Query: 147 RGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSED 206
+ Q+ HV++ER++LAE DS +V L+YSFQDS +LYLIME+LPGGD+MT+L++ D SED
Sbjct: 165 KDQLAHVKAERDVLAESDSPWVVSLYYSFQDSQYLYLIMEFLPGGDLMTMLIKYDTFSED 224
Query: 207 VARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLC----KPLEDKYSS 262
V RFYIAE +LAI ++H+ ++HRDIKPDN+++DK GH+KLSDFGL K ++ Y
Sbjct: 225 VTRFYIAECILAIEAVHKLGFIHRDIKPDNILIDKTGHIKLSDFGLSMGFHKTHDNAYYQ 284
Query: 263 ILLEDEDIINQETVSEAEGQW-------MMPKERLQQWKRNRRALAYSTVGTLDYMAPEV 315
L E + IN T S M K+++ WK+NRR +AYSTVGT DY+APE+
Sbjct: 285 RLFESK--INTSTSSTQNSLMVDTISLTMSSKDKIATWKKNRRIMAYSTVGTPDYIAPEI 342
Query: 316 LLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEA 375
+ GYG ECDWWSLGAIM+E LIG+PPFCS++ T RKI+NW+ L FPE+ +S EA
Sbjct: 343 FTQHGYGQECDWWSLGAIMFECLIGWPPFCSENAHETYRKIINWRENLYFPEDLHLSAEA 402
Query: 376 RDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEKF 435
DLI LL + RLG G ++K HP+FRG+ WD + E+ A + P + DT FE
Sbjct: 403 EDLIRKLLTSADQRLGRYGANDIKLHPFFRGVNWDTIREINAPFIPQLKSITDTSYFE-- 460
Query: 436 PEVDGPPSEIPSVGP--WRKMLTSKDTN--FIGYTFKKSDVL 473
E+D P+ + P K+ + D N F+GYT+K+ D++
Sbjct: 461 -EIDTIPNITMNSPPVLQNKIPSDVDQNLAFVGYTYKRFDMM 501
|
Protein kinase that seems to play a role in signaling pathways necessary for cell growth and mating. Pneumocystis carinii (taxid: 4754) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q91VJ4|STK38_MOUSE Serine/threonine-protein kinase 38 OS=Mus musculus GN=Stk38 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 426 bits (1094), Expect = e-118, Method: Compositional matrix adjust.
Identities = 208/447 (46%), Positives = 300/447 (67%), Gaps = 3/447 (0%)
Query: 29 SVSSPVTRQKAAAAKQFIENHYKNYLQGLQDRKERRRALQMRAQQAAVSNEEQEEMLRNL 88
S S T+++ K +EN Y N + ++R+ R++ L+ ++ + +EE+
Sbjct: 10 SSMSNHTKERVTMTKVTLENFYSNLIAQHEEREMRQKKLEKVMEEEGLKDEEKRLRRSAH 69
Query: 89 ERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRG 148
R+ETE++RL+R ++G++DFE L +IG+GAFGEVRL + K TG ++AMK L+K++ML++
Sbjct: 70 ARKETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKE 129
Query: 149 QVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVA 208
QV H+R+ER++L E DS +V++FYSFQD LYLIME+LPGGD+MTLLM++D L+E+
Sbjct: 130 QVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEET 189
Query: 209 RFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDE 268
+FYIAE+VLAI SIHQ ++HRDIKPDNL+LD GH+KLSDFGLC L+ + + +
Sbjct: 190 QFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRN- 248
Query: 269 DIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWW 328
+N S+ Q M K + + WKRNRR LA+STVGT DY+APEV ++ GY CDWW
Sbjct: 249 --LNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWW 306
Query: 329 SLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVET 388
SLG IMYEMLIGYPPFCS+ P+ T +K++NWK L FP E +S++A+ LI C+ E
Sbjct: 307 SLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLTFPPEVPVSEKAKGLILRFCCEWEH 366
Query: 389 RLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSV 448
R+G GVEE+K + +F G+ W+ + E AA + DT NF++FPE D + +
Sbjct: 367 RIGAPGVEEIKNNLFFEGVDWEHIRERPAAISIEIKSIDDTSNFDEFPESDILKPTVTTS 426
Query: 449 GPWRKMLTSKDTNFIGYTFKKSDVLKS 475
+KD FI YT+K+ + L +
Sbjct: 427 SHPETDYKNKDWVFINYTYKRFEGLTA 453
|
Negative regulator of MAP3K1/2 signaling. Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54IH8|NDRB_DICDI Probable serine/threonine-protein kinase ndrB OS=Dictyostelium discoideum GN=ndrB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 413 bits (1061), Expect = e-114, Method: Compositional matrix adjust.
Identities = 213/474 (44%), Positives = 299/474 (63%), Gaps = 23/474 (4%)
Query: 32 SPVTRQKAAAAKQFIENHYKNYLQGLQDRKERRRALQMRAQQAAVSNEEQEEMLRNLERR 91
S T + A A K IE +Y + + L++R +RR L+ + ++ + E++ R L+++
Sbjct: 54 SKETLEAAMATKVSIEQYYTSLFKSLKERDDRRCFLEKKMEELNLREEQKSVKRRELDKK 113
Query: 92 ETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVE 151
ETEY++ +R ++ FE + +IG+GAFGEVRL + K + FAMKKL KS+M+++ Q
Sbjct: 114 ETEYIKSRRIRLTGHSFESIRIIGRGAFGEVRLVKMKKNNKFFAMKKLDKSKMIEKHQTI 173
Query: 152 HVRSERNLLAEVDS-----RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSED 206
HVRSER++LA+ ++ IV L+YSFQD++FLYLIMEY+PGGD+MT L++ D +ED
Sbjct: 174 HVRSERDILADSNNIHGSNPWIVSLYYSFQDANFLYLIMEYVPGGDMMTQLIKYDTFTED 233
Query: 207 VARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 266
RFYIAE+VLA+HSIH+ +Y+HRDIKPDNL++D+ GH+K+SDFGLC L+ L E
Sbjct: 234 ATRFYIAETVLALHSIHKLSYIHRDIKPDNLLIDQKGHIKVSDFGLCTGLQTNRVPTLAE 293
Query: 267 -------DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK 319
D +I ++ ++ R WKR RR LAYS VGT DY APEVL+K
Sbjct: 294 IYKKYEGDNNIREEDQTPQSRSA------RFDSWKRQRRVLAYSNVGTPDYTAPEVLMKD 347
Query: 320 GYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCL-KFPEEPK----ISDE 374
GY ECDWWS+G IM+EML+GYPPFCS+ R T KI+NWK L K EE K +S E
Sbjct: 348 GYSAECDWWSVGVIMFEMLVGYPPFCSESIRETYHKIMNWKQTLPKIMEEAKAEVNLSPE 407
Query: 375 ARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEK 434
A+DLI L D TR+G GVEE++ HP+F+G+ W +L E P ++ DT NF+
Sbjct: 408 AQDLIERFLTDPMTRIGFNGVEEIQSHPFFKGVDWRRLRETRPPIIPQLSSPTDTSNFDH 467
Query: 435 FPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKSLENSGTDMRSNGS 488
+ E P P R+ +TS D FIGYT++ D ++ S + GS
Sbjct: 468 YEEEQQPEPMQPVQSKSRRKITSFDIPFIGYTYRNFDAMRDAFGSVNSRDAFGS 521
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 510 | ||||||
| 224063515 | 523 | predicted protein [Populus trichocarpa] | 0.980 | 0.956 | 0.875 | 0.0 | |
| 255538292 | 522 | serine/threonine-protein kinase, putativ | 0.980 | 0.957 | 0.863 | 0.0 | |
| 449450225 | 523 | PREDICTED: serine/threonine-protein kina | 0.980 | 0.956 | 0.850 | 0.0 | |
| 356564186 | 525 | PREDICTED: serine/threonine-protein kina | 0.982 | 0.954 | 0.850 | 0.0 | |
| 356552208 | 523 | PREDICTED: serine/threonine-protein kina | 0.982 | 0.957 | 0.856 | 0.0 | |
| 224137506 | 528 | predicted protein [Populus trichocarpa] | 0.978 | 0.945 | 0.861 | 0.0 | |
| 225458621 | 525 | PREDICTED: serine/threonine-protein kina | 0.980 | 0.952 | 0.852 | 0.0 | |
| 357437805 | 520 | Serine/threonine protein kinase 38-like | 0.980 | 0.961 | 0.833 | 0.0 | |
| 297811091 | 515 | hypothetical protein ARALYDRAFT_487812 [ | 0.970 | 0.961 | 0.794 | 0.0 | |
| 18416116 | 515 | Protein kinase family protein [Arabidops | 0.970 | 0.961 | 0.790 | 0.0 |
| >gi|224063515|ref|XP_002301182.1| predicted protein [Populus trichocarpa] gi|222842908|gb|EEE80455.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 925 bits (2391), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 445/508 (87%), Positives = 472/508 (92%), Gaps = 8/508 (1%)
Query: 1 MDGRDDTVRLGALNLKPAAREFDLDPDVSVSSPVTRQKAAAAKQFIENHYKNYLQGLQDR 60
MDG D TVRLGALNLKP FD PDVSVSSPVTRQKAAAAKQFIENHYKN+LQGLQDR
Sbjct: 1 MDGGDGTVRLGALNLKPDHSGFDSGPDVSVSSPVTRQKAAAAKQFIENHYKNHLQGLQDR 60
Query: 61 KERRRALQMRAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFG 120
KERRRALQMRAQ+A VSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLT+IGKGAFG
Sbjct: 61 KERRRALQMRAQEAQVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTVIGKGAFG 120
Query: 121 EVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 180
EVRLCRAK TGEIFAMKKLKKSEML RGQVEHVRSERNLLAEVDSRCIV+LFYSFQDSDF
Sbjct: 121 EVRLCRAKDTGEIFAMKKLKKSEMLSRGQVEHVRSERNLLAEVDSRCIVKLFYSFQDSDF 180
Query: 181 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD 240
LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAES+LAI SIHQHNYVHRDIKPDNLILD
Sbjct: 181 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESILAIQSIHQHNYVHRDIKPDNLILD 240
Query: 241 KNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ-------WMMPKERLQQW 293
KNGHLKLSDFGLCKPL+DKYS+ LLE+E+ QE +E+EG W+MPKE+LQQW
Sbjct: 241 KNGHLKLSDFGLCKPLDDKYSN-LLENENFSTQEGRNESEGHSTSDRPPWLMPKEKLQQW 299
Query: 294 KRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITC 353
KRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSD+PRITC
Sbjct: 300 KRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDEPRITC 359
Query: 354 RKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLY 413
RKI+NWKTCLKFPEEPKIS EA+DLICHLLCDVETRLGTRGVEELK HPWFR QWD LY
Sbjct: 360 RKIINWKTCLKFPEEPKISSEAKDLICHLLCDVETRLGTRGVEELKVHPWFRSTQWDFLY 419
Query: 414 EMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVL 473
E+EAAYKPTVNG+LDTQNFEKFP+++GPPS IPSVGPWRKMLTSKDTNFIG+T+KKSDVL
Sbjct: 420 ELEAAYKPTVNGDLDTQNFEKFPDLEGPPSTIPSVGPWRKMLTSKDTNFIGFTYKKSDVL 479
Query: 474 KSLENSGTDMRSNGSSKVPSLISLLGMI 501
KS+++SGTDM+ N SSK PSLISLLG I
Sbjct: 480 KSMQSSGTDMKLNDSSKAPSLISLLGQI 507
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255538292|ref|XP_002510211.1| serine/threonine-protein kinase, putative [Ricinus communis] gi|223550912|gb|EEF52398.1| serine/threonine-protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 914 bits (2363), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 438/507 (86%), Positives = 469/507 (92%), Gaps = 7/507 (1%)
Query: 1 MDGRDDTVRLGALNLKPAAREFDLDPDVSVSSPVTRQKAAAAKQFIENHYKNYLQGLQDR 60
MDG D TVRLGALNL+P FD PDVSVSSPVTRQKAAAAKQFIENHYKNYLQGLQDR
Sbjct: 1 MDGGDGTVRLGALNLRPDRSGFDSGPDVSVSSPVTRQKAAAAKQFIENHYKNYLQGLQDR 60
Query: 61 KERRRALQMRAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFG 120
K+RR+ALQ RAQ+A +SNEEQEEM+RNLERRETEYMRLQRRKIGIDDFEQLT+IGKGAFG
Sbjct: 61 KDRRQALQRRAQEARISNEEQEEMMRNLERRETEYMRLQRRKIGIDDFEQLTVIGKGAFG 120
Query: 121 EVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 180
EVRLCRAK+TGEIFAMKKLKKSEML RGQVEHVRSERNLLAEVDSRCIV+LFYSFQDSDF
Sbjct: 121 EVRLCRAKSTGEIFAMKKLKKSEMLSRGQVEHVRSERNLLAEVDSRCIVKLFYSFQDSDF 180
Query: 181 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD 240
LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAES+LAI SIHQH+YVHRDIKPDNLILD
Sbjct: 181 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESILAIQSIHQHSYVHRDIKPDNLILD 240
Query: 241 KNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ------WMMPKERLQQWK 294
KNGHLKLSDFGLCKPL+DKYSSILLE+ED I+QE +EA G W MPKE LQQWK
Sbjct: 241 KNGHLKLSDFGLCKPLDDKYSSILLENED-ISQEGTNEAGGHSGSEAPWSMPKEVLQQWK 299
Query: 295 RNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCR 354
RNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI+YEML+GYPPFCSDDPRITCR
Sbjct: 300 RNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAILYEMLLGYPPFCSDDPRITCR 359
Query: 355 KIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYE 414
KI+NWKTCLKFP+EPKIS+EA+DLICHLLCDVETRLGTRGV+ELK HPWFR QWD LYE
Sbjct: 360 KIINWKTCLKFPDEPKISNEAKDLICHLLCDVETRLGTRGVDELKAHPWFRCTQWDMLYE 419
Query: 415 MEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLK 474
MEAAYKP VNG+LDTQNFEKFP+++GPPS IP VGPWRKMLTSKDTNFIG+TFKKSDV+
Sbjct: 420 MEAAYKPVVNGDLDTQNFEKFPDLEGPPSAIPRVGPWRKMLTSKDTNFIGFTFKKSDVIN 479
Query: 475 SLENSGTDMRSNGSSKVPSLISLLGMI 501
S+E+SGT +SN SSK PSLISLLG I
Sbjct: 480 SMESSGTYAKSNASSKAPSLISLLGRI 506
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449450225|ref|XP_004142864.1| PREDICTED: serine/threonine-protein kinase tricorner-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 907 bits (2344), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 432/508 (85%), Positives = 467/508 (91%), Gaps = 8/508 (1%)
Query: 1 MDGRDDTVRLGALNLKPAAREFDLDPDVSVSSPVTRQKAAAAKQFIENHYKNYLQGLQDR 60
MDG D TVRLGA+NLKP FDL PDVSVSSPVTRQKAAAAKQFIENHYKNYLQGLQDR
Sbjct: 1 MDGGDGTVRLGAVNLKPDRNAFDLGPDVSVSSPVTRQKAAAAKQFIENHYKNYLQGLQDR 60
Query: 61 KERRRALQMRAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFG 120
K+RRR LQ RAQ+A +S EEQEEMLRNLERRETE+MRLQRRK+GIDDFEQLT+IGKGAFG
Sbjct: 61 KDRRRTLQRRAQEAQMSVEEQEEMLRNLERRETEFMRLQRRKVGIDDFEQLTVIGKGAFG 120
Query: 121 EVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 180
EVRLCRAK TGEIFAMKKLKKSEML RGQVEHVRSERNLLAEVDSRCIV+LFYSFQDS+F
Sbjct: 121 EVRLCRAKGTGEIFAMKKLKKSEMLSRGQVEHVRSERNLLAEVDSRCIVKLFYSFQDSEF 180
Query: 181 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD 240
LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAES+LAIHSIHQHNY+HRDIKPDNLILD
Sbjct: 181 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESILAIHSIHQHNYIHRDIKPDNLILD 240
Query: 241 KNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ-------WMMPKERLQQW 293
KNGHLKLSDFGLCKPL+DKYS+ILL DED+ Q+ +E + Q WMMPKE++QQW
Sbjct: 241 KNGHLKLSDFGLCKPLDDKYSNILLNDEDLTAQQCKNEGQSQSDSNGSHWMMPKEQIQQW 300
Query: 294 KRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITC 353
KRNRRALA+STVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML GYPPFCSDDPR+T
Sbjct: 301 KRNRRALAFSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLAGYPPFCSDDPRMTF 360
Query: 354 RKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLY 413
RKI+NW+TCLKFPE+PKIS+EA+DLI HLLCDVETRLGTRGVEE+K HPWF+GIQWDKLY
Sbjct: 361 RKIINWRTCLKFPEDPKISEEAKDLISHLLCDVETRLGTRGVEEIKSHPWFKGIQWDKLY 420
Query: 414 EMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVL 473
EMEAAYKPTV GELDTQNFEKFPEV PPSE+P+VGPWRKMLTSKDTNFIG+TFKKS+V
Sbjct: 421 EMEAAYKPTVTGELDTQNFEKFPEVQDPPSEMPTVGPWRKMLTSKDTNFIGFTFKKSNV- 479
Query: 474 KSLENSGTDMRSNGSSKVPSLISLLGMI 501
KSLE +GTD+ SN SSK PSL+SLL I
Sbjct: 480 KSLETTGTDIHSNTSSKSPSLVSLLDRI 507
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356564186|ref|XP_003550337.1| PREDICTED: serine/threonine-protein kinase CBK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 905 bits (2339), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 433/509 (85%), Positives = 467/509 (91%), Gaps = 8/509 (1%)
Query: 1 MDGRDDTVRLGALNLK-PAAREFD---LDPDVSVSSPVTRQKAAAAKQFIENHYKNYLQG 56
MDG D TVRLGA+NLK A +FD PDVSVSSPVTRQKAAAAKQFIENHYKNYLQG
Sbjct: 1 MDGYDGTVRLGAINLKHDRAADFDSATAAPDVSVSSPVTRQKAAAAKQFIENHYKNYLQG 60
Query: 57 LQDRKERRRALQMRAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGK 116
LQDRK+RRRALQ + Q++ VS EEQEEM+RNLERRETEYMRLQRRKIGIDDFEQLT+IGK
Sbjct: 61 LQDRKDRRRALQRKVQESQVSAEEQEEMMRNLERRETEYMRLQRRKIGIDDFEQLTVIGK 120
Query: 117 GAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ 176
GAFGEVRLCRAK TGEIFAMKKLKKSEML RGQVEHVRSERNLLAEVDSRCIV+L YSFQ
Sbjct: 121 GAFGEVRLCRAKDTGEIFAMKKLKKSEMLSRGQVEHVRSERNLLAEVDSRCIVKLHYSFQ 180
Query: 177 DSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDN 236
DSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAES+LAIHSIHQHNYVHRDIKPDN
Sbjct: 181 DSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESILAIHSIHQHNYVHRDIKPDN 240
Query: 237 LILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG----QWMMPKERLQQ 292
LILDKNGHLKLSDFGLCKPL+DKYSSILLE++D+ +QE+ SE EG W+MPKE+LQQ
Sbjct: 241 LILDKNGHLKLSDFGLCKPLDDKYSSILLENDDLTSQESTSETEGYSVSPWLMPKEQLQQ 300
Query: 293 WKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRIT 352
WKRNRRALAYSTVGTLDYMAPEVLLKKGYG+ECDWWSLGAIMYEMLIGYPPFCSDDPR+
Sbjct: 301 WKRNRRALAYSTVGTLDYMAPEVLLKKGYGIECDWWSLGAIMYEMLIGYPPFCSDDPRMA 360
Query: 353 CRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKL 412
CRKIVNWKTCLKFP+EPKIS EA+DLIC LLCDV++RLGTRG+EE+K HPWF+G+QWD L
Sbjct: 361 CRKIVNWKTCLKFPDEPKISAEAKDLICRLLCDVDSRLGTRGIEEIKAHPWFKGVQWDML 420
Query: 413 YEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDV 472
YE EAAYKPTV G+LDTQNFEKFPEVDGPPS +VGPWRKMLTSKD NFIGYTFKKSD+
Sbjct: 421 YESEAAYKPTVTGDLDTQNFEKFPEVDGPPSVTATVGPWRKMLTSKDNNFIGYTFKKSDI 480
Query: 473 LKSLENSGTDMRSNGSSKVPSLISLLGMI 501
LKSLE+S D+R NGSSK PSLI+LLG I
Sbjct: 481 LKSLESSDADIRVNGSSKTPSLITLLGRI 509
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356552208|ref|XP_003544461.1| PREDICTED: serine/threonine-protein kinase CBK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 904 bits (2337), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 434/507 (85%), Positives = 464/507 (91%), Gaps = 6/507 (1%)
Query: 1 MDGRDDTVRLGALNLKPA-AREFD-LDPDVSVSSPVTRQKAAAAKQFIENHYKNYLQGLQ 58
MDG D TVRLGA+NLK A +FD PDVSVSSPVTRQKAAAAKQFIENHYKNYLQGLQ
Sbjct: 1 MDGYDATVRLGAINLKHGRAADFDSASPDVSVSSPVTRQKAAAAKQFIENHYKNYLQGLQ 60
Query: 59 DRKERRRALQMRAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGA 118
DRK+RRRALQ + Q++ +S EEQEEM+RNLERRETEYMRLQRRKIG+DDFEQLT+IGKGA
Sbjct: 61 DRKDRRRALQRKVQESQISAEEQEEMMRNLERRETEYMRLQRRKIGMDDFEQLTVIGKGA 120
Query: 119 FGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 178
FGEVRLCRAK TGEIFAMKKLKKSEML RGQVEHVRSERNLLAEVDSRCIV+L YSFQDS
Sbjct: 121 FGEVRLCRAKGTGEIFAMKKLKKSEMLSRGQVEHVRSERNLLAEVDSRCIVKLHYSFQDS 180
Query: 179 DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLI 238
DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAES+LAIHSIHQHNYVHRDIKPDNLI
Sbjct: 181 DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESILAIHSIHQHNYVHRDIKPDNLI 240
Query: 239 LDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG----QWMMPKERLQQWK 294
LDKNGHLKLSDFGLCKPL+DKYSSILLE+ED+ QE+ SE E W+MPKERLQQWK
Sbjct: 241 LDKNGHLKLSDFGLCKPLDDKYSSILLENEDLTGQESTSETEAYSVSPWLMPKERLQQWK 300
Query: 295 RNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCR 354
RNRRALAYSTVGTLDYMAPEVLLKKGYG+ECDWWSLGAIMYEMLIGYPPFCSDDPR+ CR
Sbjct: 301 RNRRALAYSTVGTLDYMAPEVLLKKGYGIECDWWSLGAIMYEMLIGYPPFCSDDPRMACR 360
Query: 355 KIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYE 414
KIVNWKTCLKFP+EPKIS EA+DLIC LLCDV++RLGTRGVEE+K HPWF+GIQWD LYE
Sbjct: 361 KIVNWKTCLKFPDEPKISAEAKDLICRLLCDVDSRLGTRGVEEIKAHPWFKGIQWDMLYE 420
Query: 415 MEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLK 474
EAAYKPTV G+LDTQNFEKFPEVDGPPS SVGPWRKMLTSKD NFIGYTFKKSD+LK
Sbjct: 421 SEAAYKPTVTGDLDTQNFEKFPEVDGPPSVTASVGPWRKMLTSKDNNFIGYTFKKSDILK 480
Query: 475 SLENSGTDMRSNGSSKVPSLISLLGMI 501
SLE+S D+R NGS K PSLI+LLG I
Sbjct: 481 SLESSDADIRVNGSLKTPSLITLLGQI 507
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224137506|ref|XP_002327143.1| predicted protein [Populus trichocarpa] gi|222835458|gb|EEE73893.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 884 bits (2283), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 443/514 (86%), Positives = 467/514 (90%), Gaps = 15/514 (2%)
Query: 1 MDGRDDTVRLGALNLKPAAREFDLDPDVSVSSPVTRQKAAAAKQFIENHYKNYLQGLQDR 60
MDG D TVRLGAL+LKP FD DVSVSSPVTRQKAAAAKQFIENHYKNYLQGLQDR
Sbjct: 1 MDGGDGTVRLGALHLKPDRSVFDSGVDVSVSSPVTRQKAAAAKQFIENHYKNYLQGLQDR 60
Query: 61 KERRRALQMRAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFG 120
K+RRRALQ RAQ+A VSNEEQEEMLRNLERRETE+MRLQRRKIGIDDFEQLT+IGKGAFG
Sbjct: 61 KDRRRALQRRAQEAQVSNEEQEEMLRNLERRETEFMRLQRRKIGIDDFEQLTVIGKGAFG 120
Query: 121 EVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 180
EVRLCRAK TGEIFAMKKLKKSEML RGQVEHVRSERNLLAEVDSRCIV+LFYSFQDSDF
Sbjct: 121 EVRLCRAKDTGEIFAMKKLKKSEMLSRGQVEHVRSERNLLAEVDSRCIVKLFYSFQDSDF 180
Query: 181 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHR------DIKP 234
LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAES+LAIHSIHQHNYVHR DIKP
Sbjct: 181 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESILAIHSIHQHNYVHRERSPCRDIKP 240
Query: 235 DNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ-------WMMPK 287
DNLILDKNGHLKLSDFGLCKPL DKYS+ LLE+EDI QE +E+ G W+MPK
Sbjct: 241 DNLILDKNGHLKLSDFGLCKPL-DKYSN-LLENEDISTQEVANESGGHSASDRPPWLMPK 298
Query: 288 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSD 347
E+LQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSD
Sbjct: 299 EKLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSD 358
Query: 348 DPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGI 407
DPRITCRKI+NWKTCLKFPE+PKIS EA DLICHLLCDVETRLGTRGVEELK HPWFR
Sbjct: 359 DPRITCRKIINWKTCLKFPEDPKISSEAEDLICHLLCDVETRLGTRGVEELKAHPWFRCT 418
Query: 408 QWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTF 467
QWD LYE+EAAYKPTV G+LDTQNFEKFP+++GPPS IPSVGPWRKMLTSKDTNFIG+T+
Sbjct: 419 QWDLLYELEAAYKPTVIGDLDTQNFEKFPDLEGPPSTIPSVGPWRKMLTSKDTNFIGFTY 478
Query: 468 KKSDVLKSLENSGTDMRSNGSSKVPSLISLLGMI 501
KKSDVLKSLE+SGTDM+ N SSK SLISLLG I
Sbjct: 479 KKSDVLKSLESSGTDMKLNESSKAASLISLLGQI 512
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225458621|ref|XP_002284758.1| PREDICTED: serine/threonine-protein kinase CBK1 [Vitis vinifera] gi|302142312|emb|CBI19515.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 882 bits (2278), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 433/508 (85%), Positives = 461/508 (90%), Gaps = 8/508 (1%)
Query: 1 MDGRDDTVRLGALNLKPAAREFDLDPDVSVSSPVTRQKAAAAKQFIENHYKNYLQGLQDR 60
MDG D TV+ G LN+K A D DV+VSSPVTRQKAAAAKQFIENHYKNYLQGLQDR
Sbjct: 1 MDGADGTVKFGPLNMK-ADPYLDCAQDVAVSSPVTRQKAAAAKQFIENHYKNYLQGLQDR 59
Query: 61 KERRRALQMRAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFG 120
KERRRALQ RAQ+A VSNEEQE+MLR+LER+ETEYMRLQR KI IDDFEQLT+IGKGAFG
Sbjct: 60 KERRRALQRRAQEAQVSNEEQEQMLRSLERKETEYMRLQRHKIRIDDFEQLTIIGKGAFG 119
Query: 121 EVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 180
EVRLCR K+TGEIFAMKKLKKSEML RGQVEHVRSERNLLAEVDSRCIV+LFYSFQDSDF
Sbjct: 120 EVRLCRGKSTGEIFAMKKLKKSEMLSRGQVEHVRSERNLLAEVDSRCIVKLFYSFQDSDF 179
Query: 181 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD 240
LYLIMEYLPGGDIMTLLMRED+LSEDVARFYIAES+LAIHSIHQH+YVHRDIKPDNLILD
Sbjct: 180 LYLIMEYLPGGDIMTLLMREDVLSEDVARFYIAESILAIHSIHQHSYVHRDIKPDNLILD 239
Query: 241 KNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG-------QWMMPKERLQQW 293
KNGHLKLSDFGLCKPL+DKYS+ILLE++ QE+ SE EG W MPKERLQQW
Sbjct: 240 KNGHLKLSDFGLCKPLDDKYSTILLENDVFNTQESTSETEGYSGYDRAPWSMPKERLQQW 299
Query: 294 KRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITC 353
KRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITC
Sbjct: 300 KRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITC 359
Query: 354 RKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLY 413
RKI+NWKTCLK PEEPKISDEA+DLICHLLCDVETRLGT GVEE+K HPWFR IQWDKLY
Sbjct: 360 RKIINWKTCLKLPEEPKISDEAKDLICHLLCDVETRLGTGGVEEIKAHPWFRCIQWDKLY 419
Query: 414 EMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVL 473
EMEAA+KPTV GELDTQNFEKF EV+GPPS IP VGPWRKMLTSKD NFIGYTFKKSD++
Sbjct: 420 EMEAAHKPTVTGELDTQNFEKFDEVEGPPSTIPRVGPWRKMLTSKDANFIGYTFKKSDIM 479
Query: 474 KSLENSGTDMRSNGSSKVPSLISLLGMI 501
KS+ SGTD+RSNGSSK PSL+SL G I
Sbjct: 480 KSIGTSGTDVRSNGSSKAPSLVSLFGQI 507
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357437805|ref|XP_003589178.1| Serine/threonine protein kinase 38-like protein [Medicago truncatula] gi|355478226|gb|AES59429.1| Serine/threonine protein kinase 38-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 879 bits (2271), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 421/505 (83%), Positives = 460/505 (91%), Gaps = 5/505 (0%)
Query: 1 MDGRDDTVRLGALNLKPAAREFDLDPDVSVSSPVTRQKAAAAKQFIENHYKNYLQGLQDR 60
MDG D TVRLGALN+K +FD DVSVSSPVT+QKAAAAKQFIENHYKNYLQGLQDR
Sbjct: 1 MDGYDGTVRLGALNMKYDRGDFDSGTDVSVSSPVTKQKAAAAKQFIENHYKNYLQGLQDR 60
Query: 61 KERRRALQMRAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFG 120
K+RRRALQ + Q++ + EEQE M+RNLER+ETEYMRLQRRKIGIDDFEQLT+IGKGAFG
Sbjct: 61 KDRRRALQRKVQESQLPAEEQEVMMRNLERKETEYMRLQRRKIGIDDFEQLTVIGKGAFG 120
Query: 121 EVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 180
EVRLCRAK+TGEIFAMKKLKKSEML RGQVEHVRSERNLLAEVDSRCIV+L YSFQDSDF
Sbjct: 121 EVRLCRAKSTGEIFAMKKLKKSEMLSRGQVEHVRSERNLLAEVDSRCIVKLHYSFQDSDF 180
Query: 181 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD 240
LYLIMEYLPGGDIMTLLMREDILSE VARFYIAES+LAIHSIHQHNYVHRDIKPDNLILD
Sbjct: 181 LYLIMEYLPGGDIMTLLMREDILSEHVARFYIAESILAIHSIHQHNYVHRDIKPDNLILD 240
Query: 241 KNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAE----GQWMMPKERLQQWKRN 296
KNGHLKLSDFGLCK L+DKYS+ILLE++D QE+ SE E W+MPKE+LQ WKRN
Sbjct: 241 KNGHLKLSDFGLCKTLDDKYSTILLENDDFNGQESTSETEYNFVSPWLMPKEQLQAWKRN 300
Query: 297 RRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKI 356
RRALAYSTVGTLDYMAPEVLLKKGYG+ECDWWSLGAI+YEML+GYPPFCSDDPR+TCRKI
Sbjct: 301 RRALAYSTVGTLDYMAPEVLLKKGYGIECDWWSLGAILYEMLVGYPPFCSDDPRMTCRKI 360
Query: 357 VNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEME 416
VNWKTCLKFPEEPKIS EA+DLIC LLCDV+TRLGTRGV+E+K HPWFRG+QWD LYE+E
Sbjct: 361 VNWKTCLKFPEEPKISAEAKDLICRLLCDVDTRLGTRGVDEIKAHPWFRGVQWDMLYELE 420
Query: 417 AAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKSL 476
AAYKPTV G+LDTQNFEKFP+V GPPS +VGPWRKMLTSKDTNFIGYTFKKSD+LKS+
Sbjct: 421 AAYKPTVIGDLDTQNFEKFPDV-GPPSVTETVGPWRKMLTSKDTNFIGYTFKKSDILKSI 479
Query: 477 ENSGTDMRSNGSSKVPSLISLLGMI 501
E++ D+R NGSSK PSLISLLG I
Sbjct: 480 ESTDEDIRVNGSSKSPSLISLLGRI 504
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297811091|ref|XP_002873429.1| hypothetical protein ARALYDRAFT_487812 [Arabidopsis lyrata subsp. lyrata] gi|297319266|gb|EFH49688.1| hypothetical protein ARALYDRAFT_487812 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 849 bits (2194), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 403/507 (79%), Positives = 454/507 (89%), Gaps = 12/507 (2%)
Query: 1 MDGRDDTVRLGALNLKPAAREFDLDPDVSVSSPVTRQKAAAAKQFIENHYKNYLQGLQDR 60
MDG D TVR+ KP R F+ + DV+VSSPVTRQKAAAAKQFIENHYKNYLQGL +R
Sbjct: 1 MDGADGTVRV-----KPG-RGFETETDVAVSSPVTRQKAAAAKQFIENHYKNYLQGLHER 54
Query: 61 KERRRALQMRAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFG 120
ERRR Q + Q+A + EEQ+EM+RNL RRETEYMRLQRRKIGIDDFE LT+IGKGAFG
Sbjct: 55 MERRREFQRKVQEAQLPVEEQDEMMRNLARRETEYMRLQRRKIGIDDFELLTVIGKGAFG 114
Query: 121 EVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 180
EVRLCR ++T E++AMKKLKK+EML RGQVEHVRSERNLLAEVDSR IV+LFYSFQDS+
Sbjct: 115 EVRLCRLRSTSEVYAMKKLKKTEMLSRGQVEHVRSERNLLAEVDSRYIVKLFYSFQDSEC 174
Query: 181 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD 240
LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAES+LAIHSIHQHNYVHRDIKPDNLILD
Sbjct: 175 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESILAIHSIHQHNYVHRDIKPDNLILD 234
Query: 241 KNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAE------GQWMMPKERLQQWK 294
K+GHLKLSDFGLCKPL+DKYSS+LLED+++++Q++ +++E W MPKE+L QWK
Sbjct: 235 KSGHLKLSDFGLCKPLDDKYSSLLLEDDEMLSQDSENQSEKSDADKAPWQMPKEQLLQWK 294
Query: 295 RNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCR 354
RNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI+YEML+GYPPFCSDDPRITCR
Sbjct: 295 RNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAILYEMLVGYPPFCSDDPRITCR 354
Query: 355 KIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYE 414
KI+NWK CLKFPEEPKISDEARDLIC LLCDV++RLGTRGVEE+K HPWF+G WDKLY+
Sbjct: 355 KIINWKVCLKFPEEPKISDEARDLICRLLCDVDSRLGTRGVEEIKSHPWFKGTPWDKLYD 414
Query: 415 MEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLK 474
MEAAY+P V+GELDTQNFEKFPEV+G PSE P VGPWRKMLTSKDTNFIG+TFKKSD+ +
Sbjct: 415 MEAAYRPIVDGELDTQNFEKFPEVEGSPSEAPQVGPWRKMLTSKDTNFIGFTFKKSDITR 474
Query: 475 SLENSGTDMRSNGSSKVPSLISLLGMI 501
S+E+SG DM+SNGS + PSLISLLG I
Sbjct: 475 SMESSGADMKSNGSGEAPSLISLLGRI 501
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18416116|ref|NP_568221.1| Protein kinase family protein [Arabidopsis thaliana] gi|14334482|gb|AAK59439.1| putative protein kinase [Arabidopsis thaliana] gi|15147869|dbj|BAB62845.1| Ndr kinase [Arabidopsis thaliana] gi|16323450|gb|AAL15219.1| putative protein kinase [Arabidopsis thaliana] gi|332004078|gb|AED91461.1| Protein kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 847 bits (2188), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 401/507 (79%), Positives = 454/507 (89%), Gaps = 12/507 (2%)
Query: 1 MDGRDDTVRLGALNLKPAAREFDLDPDVSVSSPVTRQKAAAAKQFIENHYKNYLQGLQDR 60
MDG D TVR+ KP R F+ + DV+VSSPVTRQKAAAAKQFIENHYKNYLQGL +R
Sbjct: 1 MDGADGTVRV-----KPG-RGFETETDVAVSSPVTRQKAAAAKQFIENHYKNYLQGLHER 54
Query: 61 KERRRALQMRAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFG 120
ERRR Q + Q+A + EEQ+EM+RNL RRETEYMRLQRRKIGIDDFE LT+IGKGAFG
Sbjct: 55 MERRREFQRKVQEAQLPVEEQDEMMRNLARRETEYMRLQRRKIGIDDFELLTVIGKGAFG 114
Query: 121 EVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 180
EVRLCR ++T E++AMKKLKK+EML RGQVEHVRSERNLLAEVDSR IV+LFYSFQDS+
Sbjct: 115 EVRLCRLRSTSEVYAMKKLKKTEMLSRGQVEHVRSERNLLAEVDSRYIVKLFYSFQDSEC 174
Query: 181 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD 240
LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAES+LAIHSIHQHNYVHRDIKPDNLILD
Sbjct: 175 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESILAIHSIHQHNYVHRDIKPDNLILD 234
Query: 241 KNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEA------EGQWMMPKERLQQWK 294
K+GHLKLSDFGLCKPL+DKYSS+LLED+++++Q++ +++ + W MPKE+L QWK
Sbjct: 235 KSGHLKLSDFGLCKPLDDKYSSLLLEDDEMLSQDSENQSGKSDADKAPWQMPKEQLLQWK 294
Query: 295 RNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCR 354
RNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI+YEML+GYPPFCSDDPRITCR
Sbjct: 295 RNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAILYEMLVGYPPFCSDDPRITCR 354
Query: 355 KIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYE 414
KI+NW+ CLKFPEEPKISDEARDLIC LLCDV++RLGTRGVEE+K HPWF+G WDKLY+
Sbjct: 355 KIINWRVCLKFPEEPKISDEARDLICRLLCDVDSRLGTRGVEEIKSHPWFKGTPWDKLYD 414
Query: 415 MEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLK 474
MEAAY+P V+GELDTQNFEKFPEV+G PSE P VGPWRKMLTSKDTNFIG+TFKKSD+ +
Sbjct: 415 MEAAYRPIVDGELDTQNFEKFPEVEGSPSEAPQVGPWRKMLTSKDTNFIGFTFKKSDITR 474
Query: 475 SLENSGTDMRSNGSSKVPSLISLLGMI 501
S+E+SG DM+SNGS + PSLISLLG I
Sbjct: 475 SMESSGADMKSNGSGEAPSLISLLGRI 501
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 510 | ||||||
| TAIR|locus:2178208 | 516 | AT5G09890 [Arabidopsis thalian | 0.970 | 0.959 | 0.777 | 3.5e-217 | |
| TAIR|locus:2090925 | 568 | AT3G23310 [Arabidopsis thalian | 0.907 | 0.815 | 0.632 | 1.8e-165 | |
| TAIR|locus:2129650 | 551 | AT4G14350 [Arabidopsis thalian | 0.905 | 0.838 | 0.627 | 4e-161 | |
| TAIR|locus:2024167 | 569 | AT1G03920 [Arabidopsis thalian | 0.960 | 0.861 | 0.608 | 3.7e-158 | |
| TAIR|locus:2054784 | 569 | AT2G20470 [Arabidopsis thalian | 0.935 | 0.838 | 0.597 | 8.9e-157 | |
| TAIR|locus:2125894 | 519 | AT4G33080 [Arabidopsis thalian | 0.915 | 0.899 | 0.608 | 2.1e-155 | |
| TAIR|locus:2204574 | 562 | AT1G30640 [Arabidopsis thalian | 0.917 | 0.832 | 0.583 | 7.6e-151 | |
| TAIR|locus:2047590 | 527 | AT2G19400 [Arabidopsis thalian | 0.901 | 0.872 | 0.595 | 7.6e-151 | |
| UNIPROTKB|Q2LZZ7 | 458 | trc "Serine/threonine-protein | 0.854 | 0.951 | 0.492 | 1.8e-112 | |
| FB|FBgn0003744 | 463 | trc "tricornered" [Drosophila | 0.890 | 0.980 | 0.481 | 5.9e-112 |
| TAIR|locus:2178208 AT5G09890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2098 (743.6 bits), Expect = 3.5e-217, P = 3.5e-217
Identities = 395/508 (77%), Positives = 447/508 (87%)
Query: 1 MDGRDDTVRLGALNLKPAAREFDLDPDVSVSSPVTRQKAAAAKQFIENHYKNYLQGLQDR 60
MDG D TVR+ KP R F+ + DV+VSSPVTRQKAAAAKQFIENHYKNYLQGL +R
Sbjct: 1 MDGADGTVRV-----KPG-RGFETETDVAVSSPVTRQKAAAAKQFIENHYKNYLQGLHER 54
Query: 61 KEXXXXXXXXXXXXXVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFG 120
E + EEQ+EM+RNL RRETEYMRLQRRKIGIDDFE LT+IGKGAFG
Sbjct: 55 MERRREFQRKVQEAQLPVEEQDEMMRNLARRETEYMRLQRRKIGIDDFELLTVIGKGAFG 114
Query: 121 EVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 180
EVRLCR ++T E++AMKKLKK+EML RGQVEHVRSERNLLAEVDSR IV+LFYSFQDS+
Sbjct: 115 EVRLCRLRSTSEVYAMKKLKKTEMLSRGQVEHVRSERNLLAEVDSRYIVKLFYSFQDSEC 174
Query: 181 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD 240
LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAES+LAIHSIHQHNYVHRDIKPDNLILD
Sbjct: 175 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESILAIHSIHQHNYVHRDIKPDNLILD 234
Query: 241 KNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEA------EGQWMMPKERLQQWK 294
K+GHLKLSDFGLCKPL+DKYSS+LLED+++++Q++ +++ + W MPKE+L QWK
Sbjct: 235 KSGHLKLSDFGLCKPLDDKYSSLLLEDDEMLSQDSENQSGKSDADKAPWQMPKEQLLQWK 294
Query: 295 RNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCR 354
RNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI+YEML+GYPPFCSDDPRITCR
Sbjct: 295 RNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAILYEMLVGYPPFCSDDPRITCR 354
Query: 355 KIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYE 414
KI+NW+ CLKFPEEPKISDEARDLIC LLCDV++RLGTRGVEE+K HPWF+G WDKLY+
Sbjct: 355 KIINWRVCLKFPEEPKISDEARDLICRLLCDVDSRLGTRGVEEIKSHPWFKGTPWDKLYD 414
Query: 415 MEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLK 474
MEAAY+P V+GELDTQNFEKFPEV+G PSE P VGPWRKMLTSKDTNFIG+TFKKSD+ +
Sbjct: 415 MEAAYRPIVDGELDTQNFEKFPEVEGSPSEAPQVGPWRKMLTSKDTNFIGFTFKKSDITR 474
Query: 475 SLENSGT-DMRSNGSSKVPSLISLLGMI 501
S+E+SG+ DM+SNGS + PSLISLLG I
Sbjct: 475 SMESSGSADMKSNGSGEAPSLISLLGRI 502
|
|
| TAIR|locus:2090925 AT3G23310 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1610 (571.8 bits), Expect = 1.8e-165, P = 1.8e-165
Identities = 301/476 (63%), Positives = 376/476 (78%)
Query: 32 SPVTRQKAAAAKQFIENHYKNYLQGLQDRKEXXXXXXXXXXXXXVSNEEQEEMLRNLERR 91
S VT+QKAAAAKQ+IENHYK +Q Q RKE VS EEQ+ +L++LE++
Sbjct: 44 SNVTKQKAAAAKQYIENHYKKQVQSQQQRKERRDMLENKLAAAEVSEEEQKNLLKDLEKK 103
Query: 92 ETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVE 151
ETEYMR QR K+G DDFE LT+IGKGAFGEVR+CR KTTG ++AMKKLKKSEML+RGQVE
Sbjct: 104 ETEYMRRQRHKMGTDDFEPLTMIGKGAFGEVRICREKTTGNVYAMKKLKKSEMLRRGQVE 163
Query: 152 HVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFY 211
HV++ERNLLAEVDS CIV+L+ SFQD ++LYLIMEYLPGGD+MTLLMR+D L+ED ARFY
Sbjct: 164 HVKAERNLLAEVDSNCIVKLYCSFQDEEYLYLIMEYLPGGDMMTLLMRKDTLTEDEARFY 223
Query: 212 IAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDII 271
+ E+VLAI SIH+HNY+HRDIKPDNL+LD++GH+KLSDFGLCKPL+ SIL E + ++
Sbjct: 224 VGETVLAIESIHKHNYIHRDIKPDNLLLDRSGHMKLSDFGLCKPLD---CSILQEKDFVV 280
Query: 272 --NQETVSEAEGQWMMPK------ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGM 323
N +++G+ + P+ E+LQ W+RNRR LAYSTVGT DY+APEVLLKKGYGM
Sbjct: 281 AHNLSGALQSDGRPVAPRRTRSQMEQLQNWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGM 340
Query: 324 ECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLL 383
ECDWWSLGAIMYEML+G+PPF SD+P TCRKIVNWK LKFP+E ++S EA+DLIC LL
Sbjct: 341 ECDWWSLGAIMYEMLVGFPPFYSDEPMTTCRKIVNWKNYLKFPDEVRLSPEAKDLICRLL 400
Query: 384 CDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPS 443
C+VE R+GT+G E+KEHPWF G++W+KLY+M+AA+ P VN ELDTQNFEKF E D
Sbjct: 401 CNVEQRIGTKGANEIKEHPWFSGVEWEKLYQMKAAFIPQVNDELDTQNFEKFEETDKQVP 460
Query: 444 EIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKSLENSG-TDMRSNGSS-KVPSLISL 497
+ P GPWRKML+SKD NF+GYT+K +++ + G +++ + K PS+ SL
Sbjct: 461 KTPKSGPWRKMLSSKDINFVGYTYKNVEIVNHDQLPGIAELKKKSTKPKRPSIKSL 516
|
|
| TAIR|locus:2129650 AT4G14350 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1569 (557.4 bits), Expect = 4.0e-161, P = 4.0e-161
Identities = 298/475 (62%), Positives = 371/475 (78%)
Query: 32 SPVTRQKAAAAKQFIENHYKNYLQGLQDRKEXXXXXXXXXXXXXVSNEEQEEMLRNLERR 91
S +T++KAAAAK +IENHYK +Q LQ+RKE VS EEQ +L++LE +
Sbjct: 43 SNITKEKAAAAKLYIENHYKMQMQSLQERKERRKMLEKKLAAAEVSEEEQNNLLKDLEMK 102
Query: 92 ETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVE 151
ETEYMR QR K+G DDFE LT+IGKGAFGEVR+CR K TG ++AMKKLKKSEML+RGQVE
Sbjct: 103 ETEYMRRQRHKMGADDFEPLTMIGKGAFGEVRICREKGTGNVYAMKKLKKSEMLRRGQVE 162
Query: 152 HVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFY 211
HV++ERNLLAEVDS CIV+L+ SFQD ++LYLIMEYLPGGD+MTLLMR+D L+ED ARFY
Sbjct: 163 HVKAERNLLAEVDSNCIVKLYCSFQDEEYLYLIMEYLPGGDMMTLLMRKDTLTEDEARFY 222
Query: 212 IAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDII 271
I E+VLAI SIH+HNY+HRDIKPDNL+LDK+GH+KLSDFGLCKPL+ S+ L+++D
Sbjct: 223 IGETVLAIESIHKHNYIHRDIKPDNLLLDKDGHMKLSDFGLCKPLD--CSN--LQEKDFT 278
Query: 272 NQETVS---EAEGQWMMPK----ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGME 324
VS +++G+ + + E+L W+RNRR LAYSTVGT DY+APEVLLKKGYGME
Sbjct: 279 VARNVSGALQSDGRPVATRRTQQEQLLNWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGME 338
Query: 325 CDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC 384
CDWWSLGAIMYEML+G+PPF SDDP TCRKIVNW+ LKFP+E ++S EA+DLIC LLC
Sbjct: 339 CDWWSLGAIMYEMLVGFPPFYSDDPMTTCRKIVNWRNYLKFPDEVRLSPEAKDLICRLLC 398
Query: 385 DVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSE 444
+VE RLGT+G +E+K HPWFRG +W KLY+M+AA+ P VN ELDTQNFEKF E D +
Sbjct: 399 NVEQRLGTKGADEIKGHPWFRGTEWGKLYQMKAAFIPQVNDELDTQNFEKFEETDKQVPK 458
Query: 445 IPSVGPWRKMLTSKDTNFIGYTFKKSDVLKSLENSG-TDMRSNGSS-KVPSLISL 497
GPWRKML+SKD NF+GYT+K +++ + G +++ + K PS+ SL
Sbjct: 459 SAKSGPWRKMLSSKDINFVGYTYKNVEIVNDDQIPGIAELKKKSNKPKRPSIKSL 513
|
|
| TAIR|locus:2024167 AT1G03920 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1541 (547.5 bits), Expect = 3.7e-158, P = 3.7e-158
Identities = 304/500 (60%), Positives = 372/500 (74%)
Query: 5 DDTVRLGALNLKPAAREFDLDPDVSVSSPVTRQKAAAAKQFIENHYKNYLQGLQDRKEXX 64
+ TV G + + A + L D S T+QK AAAKQ+IENHYK ++ L +RKE
Sbjct: 34 ETTVPDGGNDTETATKLPPLGGDGEALSNSTKQKVAAAKQYIENHYKEQMKNLNERKERR 93
Query: 65 XXXXXXXXXXXVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRL 124
V E+Q +++ LE++ETEYMRLQR K+G DDFE LT+IGKGAFGEVR+
Sbjct: 94 TTLEKKLADADVCEEDQTNLMKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRV 153
Query: 125 CRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184
R TG +FAMKKLKKSEML+RGQVEHVR+ERNLLAEVDS CIV+L+ SFQD+++LYLI
Sbjct: 154 VREINTGHVFAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDNEYLYLI 213
Query: 185 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH 244
MEYLPGGD+MTLLMR+D LSED A+FYIAESVLAI SIH NY+HRDIKPDNL+LD+ GH
Sbjct: 214 MEYLPGGDMMTLLMRKDTLSEDEAKFYIAESVLAIESIHNRNYIHRDIKPDNLLLDRYGH 273
Query: 245 LKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK----ERLQQWKRNRRAL 300
L+LSDFGLCKPL+ S I ED + N + +E PK E+L+ W++NRR L
Sbjct: 274 LRLSDFGLCKPLD--CSVIDGEDFTVGNAGSGGGSESVSTTPKRSQQEQLEHWQKNRRML 331
Query: 301 AYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWK 360
AYSTVGT DY+APEVLLKKGYGMECDWWSLGAIMYEML+GYPPF +DDP TCRKIVNWK
Sbjct: 332 AYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPMSTCRKIVNWK 391
Query: 361 TCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYK 420
T LKFPEE ++S ARDLI LLC V RLG+ G ++K HPWF G+QW+K+Y+MEAA+
Sbjct: 392 THLKFPEESRLSRGARDLIGKLLCSVNQRLGSTGASQIKAHPWFEGVQWEKIYQMEAAFI 451
Query: 421 PTVNGELDTQNFEKFPEVDGPPSEIPS-VGPWRKMLTSKDTNFIGYTFKKSDVLKSLENS 479
P VN +LDTQNFEKF E D ++ PS GPWRKML+SKD NF+GYT+K +++ +
Sbjct: 452 PEVNDDLDTQNFEKFDEEDNQ-TQAPSRTGPWRKMLSSKDINFVGYTYKNFEIVNDYQVP 510
Query: 480 G-TDMRSNGS-SKVPSLISL 497
G +++ S SK PS+ SL
Sbjct: 511 GIAELKKKESKSKRPSVKSL 530
|
|
| TAIR|locus:2054784 AT2G20470 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1528 (542.9 bits), Expect = 8.9e-157, P = 8.9e-157
Identities = 290/485 (59%), Positives = 365/485 (75%)
Query: 18 AAREFDLDPDVSVSSPVTRQKAAAAKQFIENHYKNYLQGLQDRKEXXXXXXXXXXXXXVS 77
+A E +++ D S T+QK AAAKQ+IENHYK ++ LQ+RKE VS
Sbjct: 34 SADEHNVETDEEAVSNTTKQKVAAAKQYIENHYKEQMKILQERKERRSMLEQKLADADVS 93
Query: 78 NEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMK 137
E+Q +L+ LE++ETEYMRLQR K+G+ DF+ LT+IGKGAFGEVR+CR KTTG+++AMK
Sbjct: 94 EEDQNNLLKFLEKKETEYMRLQRHKLGVADFDLLTMIGKGAFGEVRVCREKTTGQVYAMK 153
Query: 138 KLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL 197
KLKK+EML+RGQVEHVR+ERNLLAEVDS IV+L+ SFQD D LYL+MEYLPGGD+MTLL
Sbjct: 154 KLKKAEMLRRGQVEHVRAERNLLAEVDSNYIVKLYCSFQDDDHLYLVMEYLPGGDMMTLL 213
Query: 198 MREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 257
MR+D L+E+ A+FY+AE+VLAI SIH+HNY+HRDIKPDNL+LD+ GHL+LSDFGLCKPL+
Sbjct: 214 MRKDTLTEEEAKFYVAETVLAIESIHRHNYIHRDIKPDNLLLDRYGHLRLSDFGLCKPLD 273
Query: 258 DKYSSILLEDEDIINQETVSEAEGQWMMPK----ERLQQWKRNRRALAYSTVGTLDYMAP 313
S + E++ N +E E PK E+L+ W+RNRR LAYSTVGT DY+AP
Sbjct: 274 ---CSAIGENDFSNNSNGSTEQEAGSTAPKRTQQEQLEHWQRNRRTLAYSTVGTPDYIAP 330
Query: 314 EVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISD 373
EVLLKKGYGMECDWWSLGAIMYEML+GYPPF SDDP TCRKIVNWK+ LKFPEE +S
Sbjct: 331 EVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWKSHLKFPEEAILSR 390
Query: 374 EARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFE 433
EA+DLI LLC V RLG++G +ELK H WF + WD +++M+AA+ P VN +LDTQNFE
Sbjct: 391 EAKDLINSLLCSVRRRLGSKGADELKAHTWFETVDWDTIFDMDAAFVPEVNDDLDTQNFE 450
Query: 434 KFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKSLENSG-TDMRSNGSSKVP 492
KF E + GPWRKML+SKD NF+GYT+K +++ + G +++ S P
Sbjct: 451 KFDESESETQTSSKSGPWRKMLSSKDINFVGYTYKNFEIVNDYQVPGMAELKKKKKSTRP 510
Query: 493 SLISL 497
+ SL
Sbjct: 511 MVKSL 515
|
|
| TAIR|locus:2125894 AT4G33080 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1515 (538.4 bits), Expect = 2.1e-155, P = 2.1e-155
Identities = 294/483 (60%), Positives = 366/483 (75%)
Query: 25 DPDVSVSSPVTRQKAAAAKQFIENHYKNYLQGLQDRKEXXXXXXXXXXXXXVSNEEQEEM 84
D +V + S +T +K AAAKQ+IENHYK + +Q+RKE V EEQ M
Sbjct: 12 DEEV-LGSSLTMEKVAAAKQYIENHYKAQNKNIQERKERRWILERKLASSGVPKEEQINM 70
Query: 85 LRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEM 144
+++LER+ETE+MRL+R KI +DDFE LT+IG+GAFGEVRLCR + +G I+AMKKLKKSEM
Sbjct: 71 IKDLERKETEFMRLKRNKISVDDFELLTIIGRGAFGEVRLCRERKSGNIYAMKKLKKSEM 130
Query: 145 LKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILS 204
+ RGQVEHVR+ERNLLAEV+S IV+L+YSFQD ++LYLIMEYLPGGD+MTLLMRED L
Sbjct: 131 VMRGQVEHVRAERNLLAEVESHYIVKLYYSFQDPEYLYLIMEYLPGGDMMTLLMREDTLR 190
Query: 205 EDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264
EDVARFYIA+SVLAI SIH++NY+HRDIKPDNL+LDK+GH+KLSDFGLCKPL+ + +
Sbjct: 191 EDVARFYIAQSVLAIESIHRYNYIHRDIKPDNLLLDKDGHMKLSDFGLCKPLDCRNLPSI 250
Query: 265 LEDEDIINQETVSEA------------EGQWMMPKERLQQWKRNRRALAYSTVGTLDYMA 312
E+ + ET+SE + W P+E+LQ W+ NRR LA+STVGT DY+A
Sbjct: 251 QENR-ATDDETMSEPMDVDRCFPDTDNKRSWRSPQEQLQHWQMNRRKLAFSTVGTPDYIA 309
Query: 313 PEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKIS 372
PEVLLKKGYGMECDWWSLGAIMYEML+GYPPF +DDP TCRKIV+W+ LKFPE+ K S
Sbjct: 310 PEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPISTCRKIVHWRNHLKFPEDAKFS 369
Query: 373 DEARDLICHLLCDVETRLGTRG-VEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQN 431
EA+DLIC LLC+V+ RLGT G +++K+HPWF+ + W+KLYEMEAAYKP VN ELDTQN
Sbjct: 370 SEAKDLICRLLCNVDHRLGTGGGAQQIKDHPWFKDVVWEKLYEMEAAYKPEVNDELDTQN 429
Query: 432 FEKFPEVDGPPSEIPSVGPWRKMLTS-KDTNFIGYTFKKSDVLKSLENSGTDMRSNGSSK 490
F KF EV+ P E G RKML + KD +F+GYT+K D +K L +S R+ +
Sbjct: 430 FMKFDEVNSPAPERTRSGLSRKMLLAPKDLSFVGYTYKNFDAVKGLRHSLEMARTMSLDR 489
Query: 491 VPS 493
P+
Sbjct: 490 SPA 492
|
|
| TAIR|locus:2204574 AT1G30640 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1472 (523.2 bits), Expect = 7.6e-151, P = 7.6e-151
Identities = 282/483 (58%), Positives = 361/483 (74%)
Query: 32 SPVTRQKAAAAKQFIENHYKNYLQGLQDRKEXXXXXXXXXXXXXVSNEEQEEMLRNLERR 91
S T+QK AAAKQ+IENHYK + LQ+RKE V+ E++ ++L+N E++
Sbjct: 44 SNATKQKVAAAKQYIENHYKIQKKSLQERKERRSILEQNLADADVTVEDKMDILKNFEKK 103
Query: 92 ETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVE 151
E EYMRLQR+K+G+DDFE L++IG+GAFGEVR+C+ K+TG ++AMKKLKKSEML+RGQVE
Sbjct: 104 EMEYMRLQRQKMGVDDFELLSIIGRGAFGEVRICKEKSTGSVYAMKKLKKSEMLRRGQVE 163
Query: 152 HVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFY 211
HV++ERN+LAEVDS IV+L YSFQD + LYLIMEYLPGGD+MTLLMR+D L ED RFY
Sbjct: 164 HVKAERNVLAEVDSPFIVKLCYSFQDDEHLYLIMEYLPGGDMMTLLMRKDTLREDETRFY 223
Query: 212 IAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK-YSSILLEDEDI 270
+A+++LAI SIH+HNYVHRDIKPDNL++ +NGH+KLSDFGL K LE K + E +
Sbjct: 224 VAQTILAIESIHKHNYVHRDIKPDNLLITRNGHIKLSDFGLSKSLESKNFPDFKAE---L 280
Query: 271 INQETVSEAEGQWMM-----PK----ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY 321
+++ T AE + P+ E+L W++NRR LA+STVGT DY+APEVLLKKGY
Sbjct: 281 VDRSTKPAAEHDRLSKPPSAPRRTQQEQLLHWQQNRRTLAFSTVGTPDYIAPEVLLKKGY 340
Query: 322 GMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICH 381
GMECDWWSLGAIM+EML+G+PPF S++P TCRKIVNWKTCLKFP+E K+S E +DLI
Sbjct: 341 GMECDWWSLGAIMFEMLVGFPPFYSEEPLATCRKIVNWKTCLKFPDEAKLSIEVKDLIRR 400
Query: 382 LLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGP 441
LLC+VE RLGT+GV E+K HPWFRG++W++LYE A Y P V ELDTQNFEKF EV
Sbjct: 401 LLCNVEQRLGTKGVHEIKAHPWFRGVEWERLYESNAPYIPQVKHELDTQNFEKFDEVPST 460
Query: 442 PSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKSLENSG-TDM-RSNGSSKVPSLISLLG 499
PWRKM++SKD NF+GYTFK +++ G ++ R + ++ PSL +L
Sbjct: 461 CQTSSKSSPWRKMISSKDANFLGYTFKNLEIVDEHHIPGMAELKRKSKTANKPSLKTLFE 520
Query: 500 MIY 502
Y
Sbjct: 521 TPY 523
|
|
| TAIR|locus:2047590 AT2G19400 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1472 (523.2 bits), Expect = 7.6e-151, P = 7.6e-151
Identities = 284/477 (59%), Positives = 359/477 (75%)
Query: 27 DVSVSSPVTRQKAAAAKQFIENHYKNYLQGLQDRKEXXXXXXXXXXXXXVSNEEQEEMLR 86
D + S T +K AAAK++IENHY ++ +Q RKE VS +EQ E+L
Sbjct: 24 DEGLVSNSTLEKVAAAKKYIENHYNRRMRHIQQRKERRWVLEQKIASLDVSEKEQLELLE 83
Query: 87 NLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLK 146
+L+R+ETEY RL R ++ +DDF+ L++IG+GAFGEVRLCR K TG I+AMKKLKKSEML
Sbjct: 84 DLQRKETEYTRLMRNRLCVDDFDLLSIIGRGAFGEVRLCREKKTGNIYAMKKLKKSEMLS 143
Query: 147 RGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSED 206
RGQVEHVR+ERNLLAEV S CIV+L+YSFQD ++LYLIMEYL GGD+MTLLMRE+ L+E
Sbjct: 144 RGQVEHVRAERNLLAEVASDCIVKLYYSFQDPEYLYLIMEYLSGGDVMTLLMREETLTET 203
Query: 207 VARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 266
VARFYIA+SVLAI SIH+HNYVHRDIKPDNL+LDK GH+KLSDFGLCKPL+ + S +
Sbjct: 204 VARFYIAQSVLAIESIHKHNYVHRDIKPDNLLLDKYGHMKLSDFGLCKPLDCRNISAMNV 263
Query: 267 DEDIINQETVSEA-EG-----------QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPE 314
+E + N E ++E+ +G +W P E+LQ W+ NRR LAYSTVGT DY+APE
Sbjct: 264 NEPL-NDENINESIDGDENCSIGRRGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPE 322
Query: 315 VLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDE 374
VLLKKGYG+ECDWWSLGAIMYEML+GYPPF SDDP TCRKIV+W+T L FPE +++ E
Sbjct: 323 VLLKKGYGVECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVSWRTHLVFPEGARLTPE 382
Query: 375 ARDLICHLLCDVETRLGTRGV--EELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNF 432
ARDLIC LLCD E RLG+ G E++K H WF+ ++W+KLYEM+AA+KP VNGELDTQNF
Sbjct: 383 ARDLICRLLCDSEHRLGSHGAGAEQIKAHTWFKDVEWEKLYEMDAAFKPVVNGELDTQNF 442
Query: 433 EKFPEVDGPPSEIPSVGP-WRKMLTSKDTNFIGYTFKKSDVLKSLENSGTDMRSNGS 488
KF EV+ P GP W+ +T ++ NF+GYT++ D ++ +S D++ + S
Sbjct: 443 MKFDEVECPKPARTGSGPSWKVSITPQNINFVGYTYRNFDAVRGSRHS-LDIKGSVS 498
|
|
| UNIPROTKB|Q2LZZ7 trc "Serine/threonine-protein kinase tricorner" [Drosophila pseudoobscura pseudoobscura (taxid:46245)] | Back alignment and assigned GO terms |
|---|
Score = 1110 (395.8 bits), Expect = 1.8e-112, P = 1.8e-112
Identities = 220/447 (49%), Positives = 305/447 (68%)
Query: 35 TRQKAAAAKQFIENHYKNYLQGLQDRKEXXXXXXXXXXXXXVSNEEQEEMLRNLERRETE 94
T KA AK +EN+Y N + +RK+ ++ +++E ++ETE
Sbjct: 19 TLDKATKAKVTLENYYSNLVTQYGERKQRLAKLEAQLKDESLTESQRQEKRLQHAQKETE 78
Query: 95 YMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVR 154
Y+RL+R ++G++DFE L +IG+GAFGEVRL + K TG ++AMK L+K++ML++ QV HVR
Sbjct: 79 YLRLKRLRLGVEDFEALKVIGRGAFGEVRLVQKKDTGHVYAMKVLRKADMLEKEQVAHVR 138
Query: 155 SERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAE 214
+ER++L E D + +V+++YSFQD LYLIME+LPGGD+MTLLM++D LSE+ +FYI+E
Sbjct: 139 AERDVLVEADHQWVVKMYYSFQDQVNLYLIMEFLPGGDMMTLLMKKDTLSEEGTQFYISE 198
Query: 215 SVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQE 274
+ LAI SIH+ ++HRDIKPDNL+LD GHLKLSDFGLC L+ + + D ++Q
Sbjct: 199 TALAIDSIHKLGFIHRDIKPDNLLLDARGHLKLSDFGLCTGLKKSHRTDFYRD---LSQA 255
Query: 275 TVSEAEGQWMMP---KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLG 331
S+ G P K R + WKRNRRALAYSTVGT DY+APEV L+ GYG CDWWSLG
Sbjct: 256 KPSDFIGTCASPMDSKRRAESWKRNRRALAYSTVGTPDYIAPEVFLQTGYGPACDWWSLG 315
Query: 332 AIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLG 391
IMYEML+GYPPFCSD+P+ T RK++NW+ L FP E IS+EA++ I C+ + RLG
Sbjct: 316 VIMYEMLMGYPPFCSDNPQDTYRKVMNWRETLIFPPEIPISEEAKETIIKFCCEADRRLG 375
Query: 392 T-RGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGP 450
+ RG+E+LK P+FRG+ W+ + E AA V DT NF++FP+V EIPS
Sbjct: 376 SQRGLEDLKSVPFFRGVDWEHIRERPAAIPVEVRSIDDTSNFDEFPDVS---LEIPSAPI 432
Query: 451 WRKMLTSKDTNFIGYTFKKSDVLKSLE 477
+ +KD FI YT+K+ +V ++LE
Sbjct: 433 PQGGEIAKDWVFINYTYKRFEV-RNLE 458
|
|
| FB|FBgn0003744 trc "tricornered" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 1105 (394.0 bits), Expect = 5.9e-112, P = 5.9e-112
Identities = 225/467 (48%), Positives = 310/467 (66%)
Query: 18 AAREFDLDPDVSVSSPVTRQKAAAAKQFIENHYKNYLQGLQDRKEXXXXXXXXXXXXXVS 77
++R D D S T KA AK +EN+Y N + +RK+ +S
Sbjct: 3 SSRTQDADGASIRFSDHTLDKATKAKVTLENYYSNLVTQYGERKQRLAKLEAQLKDESLS 62
Query: 78 NEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMK 137
+++E ++ETEY+RL+R ++G++DFE L +IG+GAFGEVRL + K TG ++AMK
Sbjct: 63 EAQRQEKRLQHAQKETEYLRLKRLRLGVEDFEALKVIGRGAFGEVRLVQKKDTGHVYAMK 122
Query: 138 KLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL 197
L+K++ML++ QV HVR+ER++L E D + +V+++YSFQD LYLIME+LPGGD+MTLL
Sbjct: 123 VLRKADMLEKEQVAHVRAERDVLVEADHQWVVKMYYSFQDPVNLYLIMEFLPGGDMMTLL 182
Query: 198 MREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 257
M++D LSE+ +FYI+E+ LAI SIH+ ++HRDIKPDNL+LD GHLKLSDFGLC L+
Sbjct: 183 MKKDTLSEEGTQFYISETALAIDSIHKLGFIHRDIKPDNLLLDARGHLKLSDFGLCTGLK 242
Query: 258 DKYSSILLED------EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYM 311
+ + D D I T + M K R + WKRNRRALAYSTVGT DY+
Sbjct: 243 KSHRTDFYRDLSQAKPSDFIG--TCASLSCSPMDSKRRAESWKRNRRALAYSTVGTPDYI 300
Query: 312 APEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKI 371
APEV L+ GYG CDWWSLG IMYEML+GYPPFCSD+P+ T RK++NW+ L FP E I
Sbjct: 301 APEVFLQTGYGPACDWWSLGVIMYEMLMGYPPFCSDNPQDTYRKVMNWRETLIFPPEIPI 360
Query: 372 SDEARDLICHLLCDVETRLGT-RGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQ 430
S+EA++ I + C+ + RLG+ RG+E+LK P+FRG+ W+ + E AA V DT
Sbjct: 361 SEEAKETIINFCCEADRRLGSQRGLEDLKSVPFFRGVDWEHIRERPAAIPVEVRSIDDTS 420
Query: 431 NFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKSLE 477
NF++FP+V EIPS + +KD FI YT+K+ +V ++LE
Sbjct: 421 NFDEFPDVS---LEIPSAPIPQGGEIAKDWVFINYTYKRFEV-RNLE 463
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9Y2H1 | ST38L_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.4789 | 0.8725 | 0.9590 | yes | no |
| Q7TSE6 | ST38L_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.4678 | 0.8725 | 0.9590 | yes | no |
| Q5R8M1 | STK38_PONAB | 2, ., 7, ., 1, 1, ., 1 | 0.4697 | 0.8705 | 0.9548 | yes | no |
| Q2L6W9 | SAX1_CAEEL | 2, ., 7, ., 1, 1, ., 1 | 0.4398 | 0.8627 | 0.9243 | yes | no |
| Q2LZZ7 | TRC_DROPS | 2, ., 7, ., 1, 1, ., 1 | 0.4954 | 0.8431 | 0.9388 | yes | no |
| Q54IH8 | NDRB_DICDI | 2, ., 7, ., 1, 1, ., 1 | 0.4493 | 0.8843 | 0.8321 | yes | no |
| O13310 | ORB6_SCHPO | 2, ., 7, ., 1, 1, ., 1 | 0.4523 | 0.8764 | 0.9530 | yes | no |
| Q9NBK5 | TRC_DROME | 2, ., 7, ., 1, 1, ., 1 | 0.4849 | 0.8784 | 0.9676 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 510 | |||
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.0 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-171 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-150 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-137 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-135 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-127 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-114 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-113 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-113 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-110 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-109 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-108 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-107 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-107 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-106 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-99 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-97 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-91 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-90 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-87 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-86 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-86 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-84 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-82 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-80 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-79 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-78 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-76 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-75 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-75 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-71 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-71 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-70 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-69 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-68 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-68 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 9e-68 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-67 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-65 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-63 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-61 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-60 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-59 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-58 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-57 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-57 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-56 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-55 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-54 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-54 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-54 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-53 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-53 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-53 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-53 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-50 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-50 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-50 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-49 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-48 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-48 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-48 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-47 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-45 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-45 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-44 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-44 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-44 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-44 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-44 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-43 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-42 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-41 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-40 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-38 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-38 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-38 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-37 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-35 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-34 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-34 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-34 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-33 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-33 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-32 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-32 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-32 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-31 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-31 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-31 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-30 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-29 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-29 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-29 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-29 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-29 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-29 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-29 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-28 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-28 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-27 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-27 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-27 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-27 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-27 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-27 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-26 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-26 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-26 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 9e-26 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-25 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-25 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-25 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-25 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-25 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-25 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-25 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-25 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-25 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-24 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-24 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-24 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-24 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-24 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-23 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-23 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-23 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-23 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-22 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-22 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-22 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 9e-22 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-21 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-21 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-21 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-21 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-20 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-20 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-20 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-20 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-19 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-19 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-19 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-19 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-19 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-19 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-19 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-19 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-18 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-18 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-18 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-18 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-18 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-18 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-18 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-17 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-17 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-16 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-16 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-16 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-16 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-15 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-15 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-14 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-14 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-13 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-13 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-12 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-11 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-11 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-11 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-10 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-09 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-09 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-09 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-09 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-09 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-08 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-08 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-08 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-08 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-08 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-08 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-07 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-07 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-07 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-07 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-07 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-07 | |
| pfam00433 | 47 | pfam00433, Pkinase_C, Protein kinase C terminal do | 8e-07 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-07 | |
| smart00133 | 64 | smart00133, S_TK_X, Extension to Ser/Thr-type prot | 1e-06 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-06 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-06 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 5e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-06 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-05 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-05 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-05 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-05 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-05 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-05 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 4e-05 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-04 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-04 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-04 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-04 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-04 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-04 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-04 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-04 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.001 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.001 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 0.001 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 0.003 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.003 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 0.003 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 594 bits (1533), Expect = 0.0
Identities = 204/366 (55%), Positives = 263/366 (71%), Gaps = 2/366 (0%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
DDFE + +IG+GAFGEVRL + K TG I+AMKKL+KSEML++ QV HVR+ER++LAE D+
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 225
+V+L+YSFQD ++LYLIMEYLPGGD+MTLLM++D +E+ RFYIAE++LAI SIH+
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120
Query: 226 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 285
Y+HRDIKPDNL+LD GH+KLSDFGLC L+ + + + + M
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180
Query: 286 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345
K + + WKRNRRALAYSTVGT DY+APEV L+ GY ECDWWSLG IMYEML+GYPPFC
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240
Query: 346 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFR 405
SD+P+ T RKI+NWK L+FP+E +S EA+DLI L C+ E RLG GV E+K HP+F+
Sbjct: 241 SDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFK 300
Query: 406 GIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGY 465
G+ W+ + E A P + DT NF+ F E+D P GP R + SKD FIGY
Sbjct: 301 GVDWEHIRERPAPIIPELKSITDTSNFDDFEEIDLDVPTSP--GPPRGKIKSKDLAFIGY 358
Query: 466 TFKKSD 471
T+K+ +
Sbjct: 359 TYKRFE 364
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 486 bits (1253), Expect = e-171
Identities = 179/363 (49%), Positives = 246/363 (67%), Gaps = 13/363 (3%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
DDFE + +IG+GAFGEV L R K TG+++AMK L+KS+M+KR Q+ HVR+ER++LA+ DS
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 225
IV+L+YSFQD + LYL+MEY+PGGD+M LL+R+D+ E+ ARFYIAE VLA+ S+H+
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120
Query: 226 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 285
++HRDIKPDN+++D +GH+KL+DFGLCK + ++ + +
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRR-- 178
Query: 286 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345
+ RR A STVGT DY+APEVL YG+ECDWWSLG I+YEML G+PPF
Sbjct: 179 -------DHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFY 231
Query: 346 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFR 405
SD + T KI+NWK L+FP +P +S EA DLIC LLCD E RLG+ EE+K HP+F+
Sbjct: 232 SDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGS--FEEIKSHPFFK 289
Query: 406 GIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGY 465
GI W+ L E + + P ++ LDT NF+ F + D S+ S +K+ K F+G+
Sbjct: 290 GIDWENLRETKPPFVPELSSPLDTSNFDDFED-DKDLSDYLS-QNSKKLNKGKQLAFVGF 347
Query: 466 TFK 468
T+K
Sbjct: 348 TYK 350
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 435 bits (1119), Expect = e-150
Identities = 182/379 (48%), Positives = 253/379 (66%), Gaps = 15/379 (3%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
+DF + +IGKGAFGEVRL + K TG+I+AMK L KSEM K+ Q+ HV++ER++LAE DS
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 225
+V L+YSFQD+ +LYLIME+LPGGD+MT+L++ D SEDV RFY+AE VLAI ++H+
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120
Query: 226 NYVHRDIKPDNLILDKNGHLKLSDFGLC----KPLEDKYSSILLEDEDIINQETVSEAEG 281
++HRDIKPDN+++D+ GH+KLSDFGL K + Y LL+ + N+ +
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGK--SNKNRIDNRNS 178
Query: 282 QW-------MMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIM 334
M K+++ WK+NRR +AYSTVGT DY+APE+ L++GYG ECDWWSLGAIM
Sbjct: 179 VAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238
Query: 335 YEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRG 394
+E LIG+PPFCS++ T RKI+NW+ L FP++ +S EA DLI L+ + E RLG G
Sbjct: 239 FECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGG 298
Query: 395 VEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKM 454
E+K HP+FRG+ WD + ++ A + P + DT F P + +
Sbjct: 299 AHEIKSHPFFRGVDWDTIRQIRAPFIPQLKSITDTSYFPTDELEQVPEAPALKQAAPAQQ 358
Query: 455 LTSKDTN--FIGYTFKKSD 471
S + + FIGYT+K+ D
Sbjct: 359 EESVELDLAFIGYTYKRFD 377
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 399 bits (1026), Expect = e-137
Identities = 193/364 (53%), Positives = 254/364 (69%), Gaps = 6/364 (1%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
DDFE L +IG+GAFGEVRL + K TG I+AMK L+K++ML++ QV H+R+ER++L E D
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 225
+V++FYSFQD LYLIME+LPGGD+MTLLM++D LSE+ +FYIAE+VLAI +IHQ
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 226 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 285
++HRDIKPDNL+LD GH+KLSDFGLC L+ + + + + S+ Q M
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRN---LTHNPPSDFSFQNMN 177
Query: 286 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345
K + + WK+NRR LAYSTVGT DY+APEV ++ GY CDWWSLG IMYEMLIGYPPFC
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 346 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFR 405
S+ P+ T RK++NWK L FP E IS++A+DLI D E R+G+ GVEE+K HP+F
Sbjct: 238 SETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFE 297
Query: 406 GIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGY 465
G+ W + E AA + DT NF++FPE D ++ P K SKD F+ Y
Sbjct: 298 GVDWGHIRERPAAIPIEIKSIDDTSNFDEFPESDILQPAENTIEPDYK---SKDWVFLNY 354
Query: 466 TFKK 469
T+K+
Sbjct: 355 TYKR 358
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 395 bits (1016), Expect = e-135
Identities = 188/364 (51%), Positives = 255/364 (70%), Gaps = 3/364 (0%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
+DFE L +IG+GAFGEVRL + K TG ++AMK L+K++ML++ QV H+R+ER++L E DS
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 225
+V++FYSFQD LYLIME+LPGGD+MTLLM++D L+E+ +FYIAE+VLAI SIHQ
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 226 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 285
++HRDIKPDNL+LD GH+KLSDFGLC L+ + + + +N S+ Q M
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRN---LNHSLPSDFTFQNMN 177
Query: 286 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345
K + + WKRNRR LA+STVGT DY+APEV ++ GY CDWWSLG IMYEMLIGYPPFC
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 346 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFR 405
S+ P+ T +K++NWK L FP E IS++A+DLI C+ E R+G GVEE+K +P+F
Sbjct: 238 SETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFE 297
Query: 406 GIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGY 465
G+ W+ + E AA + DT NF++FP+ D + + +KD FI Y
Sbjct: 298 GVDWEHIRERPAAIPIEIKSIDDTSNFDEFPDSDILKPTVATSNHPETDYKNKDWVFINY 357
Query: 466 TFKK 469
T+K+
Sbjct: 358 TYKR 361
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 374 bits (961), Expect = e-127
Identities = 162/372 (43%), Positives = 231/372 (62%), Gaps = 10/372 (2%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 167
F ++ IG GAFGEV L R T ++AMK L+K+++L R Q HV++ER++LAE D+
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 168 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 227
+V+L+YSFQD D LY +M+Y+PGGD+M+LL+R I ED+ARFYIAE AI S+H+ +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122
Query: 228 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 287
+HRDIKPDN+++D++GH+KL+DFGLC + S + D Q+++ +E + +
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 288 ERLQQWKRNR-----RALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 342
RL+ +R R R LA+S VGT +Y+APEVLL+ GY CDWWS+G I+YEML+G P
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242
Query: 343 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHP 402
PF +D P T K++NW+T L P + K+S EA DLI L C E RLG G +E+K HP
Sbjct: 243 PFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHP 302
Query: 403 WFRGIQWDKLY-EMEAAYKPTVNGELDTQNFEKF----PEVDGPPSEIPSVGPWRKMLTS 457
+F+GI + L +A Y P + DT NF+ D P
Sbjct: 303 FFKGIDFASLIRRQKAPYIPKITHPTDTSNFDPVDPEKLRSDDSGESSPDRNVKPNNRKR 362
Query: 458 KDTNFIGYTFKK 469
+ F +TF++
Sbjct: 363 TEHAFYEFTFRR 374
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 339 bits (871), Expect = e-114
Identities = 162/375 (43%), Positives = 213/375 (56%), Gaps = 58/375 (15%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
DDFE L +IG+GAFGEV + + K TG+++AMK L K EMLKR + R ER++L D
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQ 224
R I L Y+FQD + LYL+M+Y GGD++TLL + ED L ED+ARFY+AE VLAI S+HQ
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 225 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 284
YVHRDIKPDN++LDKNGH++L+DFG C L D Q V+
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFGSC----------LRLLADGTVQSNVA------- 163
Query: 285 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDWWSLGAIMYEMLI 339
VGT DY++PE+L K YG ECDWWSLG MYEML
Sbjct: 164 --------------------VGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLY 203
Query: 340 GYPPFCSDDPRITCRKIVNWKTCLKFP-EEPKISDEARDLICHLLCDVETRLGTRGVEEL 398
G PF ++ T KI+N K +FP + +S+EA+DLI L+C ETRLG G+++
Sbjct: 204 GETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDF 263
Query: 399 KEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFE------KFPEVDGPPSEIPSVGPWR 452
K+HP+F GI WD + A Y P V+ DT NF+ + E P S
Sbjct: 264 KDHPFFEGIDWDNIRNSTAPYVPEVSSPTDTSNFDVDDDDLRNTESLPPSSH-------- 315
Query: 453 KMLTSKDTNFIGYTF 467
+ F+G+T+
Sbjct: 316 GAFSGNHLPFVGFTY 330
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 335 bits (862), Expect = e-113
Identities = 126/292 (43%), Positives = 177/292 (60%), Gaps = 43/292 (14%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 173
+GKG+FG+V L R K TG+++AMK LKK +++KR +VEH +ERN+L+ ++ IV+L Y
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 174 SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIK 233
+FQ + LYL++EY PGG++ + L +E SE+ ARFY AE VLA+ +H ++RD+K
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 234 PDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQW 293
P+N++LD +GH+KL+DFGL K L + S
Sbjct: 121 PENILLDADGHIKLTDFGLAKELSSEGSR------------------------------- 149
Query: 294 KRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITC 353
+ GT +Y+APEVLL KGYG DWWSLG ++YEML G PPF ++D +
Sbjct: 150 -------TNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIY 202
Query: 354 RKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404
KI+ L+FPE +S EARDLI LL D RLG+ G EE+K HP+F
Sbjct: 203 EKILKDP--LRFPE--FLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 336 bits (865), Expect = e-113
Identities = 131/335 (39%), Positives = 192/335 (57%), Gaps = 50/335 (14%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
DDFE + +G G+FG V L R K +G+ +A+K L K++++K QVEHV +E+ +L +
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 225
+V L+ SFQD LYL+MEY+PGG++ + L + E VARFY A+ VLA+ +H
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL 120
Query: 226 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 285
+ V+RD+KP+NL+LD +G++K++DFG K ++ +
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-------------------------- 154
Query: 286 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345
Y+ GT +Y+APE++L KGYG DWW+LG ++YEML GYPPF
Sbjct: 155 ---------------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFF 199
Query: 346 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLL-CDVETRLGT--RGVEELKEHP 402
D+P KI+ K ++FP S +A+DLI +LL D+ RLG GV ++K HP
Sbjct: 200 DDNPIQIYEKILEGK--VRFP--SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHP 255
Query: 403 WFRGIQWDKLYEM--EAAYKPTVNGELDTQNFEKF 435
WF GI W L + EA + P V G DT NF+ +
Sbjct: 256 WFAGIDWIALLQRKIEAPFIPKVKGPGDTSNFDDY 290
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 330 bits (848), Expect = e-110
Identities = 153/388 (39%), Positives = 224/388 (57%), Gaps = 48/388 (12%)
Query: 88 LERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR 147
L R E ++ + ++ +DF+ + +IG+GAFGEV+L R K++ +++AMK L K EM+KR
Sbjct: 25 LSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKR 84
Query: 148 GQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDV 207
ER+++A +S IVQL Y+FQD +LY++MEY+PGGD++ L+ DI E
Sbjct: 85 SDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDI-PEKW 143
Query: 208 ARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLED 267
ARFY AE VLA+ +IH ++HRD+KPDN++LDK+GHLKL+DFG C + ++
Sbjct: 144 ARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC---------MKMDA 194
Query: 268 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG----YGM 323
++ +T VGT DY++PEVL +G YG
Sbjct: 195 NGMVRCDT----------------------------AVGTPDYISPEVLKSQGGDGYYGR 226
Query: 324 ECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLL 383
ECDWWS+G +YEML+G PF +D T KI++ K L FP++ +IS +A+DLIC L
Sbjct: 227 ECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFL 286
Query: 384 CDVETRLGTRGVEELKEHPWFRGIQW--DKLYEMEAAYKPTVNGELDTQNFEKFPEVDGP 441
D E RLG GV+E+K HP+F+ QW D + E A P ++ ++DT NF+ + D
Sbjct: 287 TDREVRLGRNGVDEIKSHPFFKNDQWTFDNIRETVAPVVPELSSDIDTSNFDDIEDDDKN 346
Query: 442 PSEIPSVGPWRKMLTSKDTNFIGYTFKK 469
P K FIG+T+ K
Sbjct: 347 EETFPL----PKAFAGNQLPFIGFTYSK 370
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 326 bits (838), Expect = e-109
Identities = 150/369 (40%), Positives = 208/369 (56%), Gaps = 47/369 (12%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
DF+ +L+G+G FGEV++ R K TG+I+AMK +KKS +L + V ER++L+ +S
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQ 224
I QL Y+FQD D LYL+MEY PGGD+++LL R ED ED+A+FY+AE VLAIHS+HQ
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 225 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 284
YVHRDIKP+N+++D+ GH+KL+DFG L
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLT--------------------------- 153
Query: 285 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL------KKGYGMECDWWSLGAIMYEML 338
N+ + VGT DY+APEVL K YG+ECDWWSLG I YEM+
Sbjct: 154 ----------ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMI 203
Query: 339 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEEL 398
G PF T I+N++ LKFPE+PK+S + DLI LLC + RLG G L
Sbjct: 204 YGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLCGQKERLGYEG---L 260
Query: 399 KEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSK 458
HP+F I W+ + + PT+ + DT NF++ + S+ + + K
Sbjct: 261 CCHPFFSKIDWNNIRNSLPPFVPTLKSDDDTSNFDEPEKNSTRRSQSSTTQLKPNGFSGK 320
Query: 459 DTNFIGYTF 467
D F+G++F
Sbjct: 321 DLPFVGFSF 329
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 323 bits (829), Expect = e-108
Identities = 134/297 (45%), Positives = 190/297 (63%), Gaps = 33/297 (11%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 173
I KGA+G V L + K+TG+I+A+K +KK++M+++ QV+ V +ER++L++ S +V+L+Y
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 174 SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIK 233
SFQ LYL+MEYLPGGD+ +LL L EDVAR YIAE VLA+ +H + +HRD+K
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 234 PDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQW 293
PDN+++D NGHLKL+DFGL S + L IN
Sbjct: 121 PDNILIDSNGHLKLTDFGL--------SKVGLVRR-QINLNDDE---------------- 155
Query: 294 KRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITC 353
K ++R VGT DY+APEV+L +G+ DWWSLG I+YE L+G PPF + P
Sbjct: 156 KEDKR-----IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF 210
Query: 354 RKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQW 409
+ I+N K +++PE+ ++SDEA DLI LL D E RLG + +EE+K HP+F+GI W
Sbjct: 211 QNILNGK--IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 323 bits (831), Expect = e-107
Identities = 141/376 (37%), Positives = 208/376 (55%), Gaps = 57/376 (15%)
Query: 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR 166
DF+ LT +G+G +G+V L + K TGEI A+K++KKS + K +V HV +ER++L S
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 167 CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHN 226
+V+L Y+FQD ++LYL MEY+PGGD TLL +LSED ARFY+AE A+ ++H+
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121
Query: 227 YVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMP 286
Y+HRD+KP+N ++D +GH+KL+DFGL K V+
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSK-------------------GIVT--------- 153
Query: 287 KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCS 346
A S VG+ DYMAPEVL KGY D+WSLG ++YE L G+PPF
Sbjct: 154 -------------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG 200
Query: 347 DDPRITCRKIVNWKTCLKFP--EEPK--ISDEARDLICHLLCDVETRLGTRGVEELKEHP 402
P T + WK L+ P ++P+ +SDEA DLI L+ D R G +E++K HP
Sbjct: 201 STPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFG--SLEDIKNHP 258
Query: 403 WFRGIQWDKLYEMEAAYKPTVNGELDTQNFE---------KFPEVDGPPSEIPSVGPWRK 453
+F+ + W++L E++ + P + E+DT F+ K+ +V G +
Sbjct: 259 FFKEVDWNELRELKPPFVPELESEIDTGYFDDFENEDDMAKYKDVHEKKKAAGKGGANGR 318
Query: 454 MLTSKDTNFIGYTFKK 469
F+G+TF+
Sbjct: 319 D-PGNRRKFVGFTFRH 333
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 325 bits (833), Expect = e-107
Identities = 154/379 (40%), Positives = 236/379 (62%), Gaps = 19/379 (5%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 167
F ++ +G GAFGEV L T ++AMK L+K ++L R QV HV++ER++LAE D+
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 168 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 227
+V+L+YSFQD D LY +M+Y+PGGD+M+LL+R ++ E +ARFYIAE LAI S+H+ +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122
Query: 228 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAE------- 280
+HRDIKPDN+++D +GH+KL+DFGLC ++S + I Q+++ ++
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 281 ---GQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337
G + E+ K+++R LA+S VGT +Y+APEVLL+KGY CDWWS+G I++EM
Sbjct: 183 CRCGDRLKTLEQRAT-KQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241
Query: 338 LIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEE 397
L+G PPF + P T K++NW+ L P + K+S EA DLI L C E RLG G ++
Sbjct: 242 LVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADD 301
Query: 398 LKEHPWFRGIQWDK-LYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIP--SVGPWRKM 454
+K HP+F + + + A Y P ++ +DT NF+ E + P ++ S W +
Sbjct: 302 IKAHPFFSEVDFSSDIRTQPAPYVPKISHPMDTSNFDPVEE-ESPWNDASGDSTRTWDTL 360
Query: 455 LTSKDTN----FIGYTFKK 469
+ + F +TF++
Sbjct: 361 CSPNGKHPEHAFYEFTFRR 379
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 321 bits (824), Expect = e-106
Identities = 153/337 (45%), Positives = 222/337 (65%), Gaps = 12/337 (3%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 167
F ++ +G GAFGEV L R T ++AMK L+K ++L R QV HV++ER++LAE D+
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 168 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 227
+V+L+YSFQD D LY +M+Y+PGGD+M+LL+R I ED+ARFYIAE A+ S+H+ +
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122
Query: 228 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 287
+HRDIKPDN+++D++GH+KL+DFGLC + S + D + Q+++ + +W P
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSM-DFSNEWGDPA 181
Query: 288 -----ERLQQWKR-----NRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337
+RL+ +R ++R LA+S VGT +Y+APEVLL+ GY CDWWS+G I+YEM
Sbjct: 182 NCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 241
Query: 338 LIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEE 397
L+G PPF + P T K++NW+T L P + K+S EA DLI L E RLG G +E
Sbjct: 242 LVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADE 301
Query: 398 LKEHPWFRGIQWDK-LYEMEAAYKPTVNGELDTQNFE 433
+K HP+F+ I + L + A Y P + DT NF+
Sbjct: 302 IKAHPFFKTIDFSSDLRQQSAPYIPKITHPTDTSNFD 338
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 299 bits (768), Expect = 3e-99
Identities = 118/299 (39%), Positives = 162/299 (54%), Gaps = 47/299 (15%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 167
+E L +G+G+FG+V L R K TG++ A+K +KK ++ K E + E +L ++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKK--DRERILREIKILKKLKHPN 58
Query: 168 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 227
IV+L+ F+D D LYL+MEY GGD+ LL + LSED ARFY+ + + A+ +H
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 228 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 287
VHRD+KP+N++LD++GH+KL+DFGL + L+
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGE--------------------------- 151
Query: 288 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSD 347
+ VGT +YMAPEVLL KGYG D WSLG I+YE+L G PPF D
Sbjct: 152 ------------KLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGD 199
Query: 348 D-PRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404
D +KI K P E IS EA+DLI LL D E RL EE +HP+F
Sbjct: 200 DQLLELFKKIGKPKPPF-PPPEWDISPEAKDLIRKLLVKDPEKRL---TAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 298 bits (763), Expect = 1e-97
Identities = 161/369 (43%), Positives = 217/369 (58%), Gaps = 46/369 (12%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
DDFE + +IG+GAFGEV + + K T I+AMK L K EMLKR + R ERN+L D
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQ 224
+ I L Y+FQD ++LYL+M+Y GGD++TLL + ED L ED+ARFYIAE VLAIHSIHQ
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 225 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 284
+YVHRDIKPDN++LD NGH++L+DFG C L ++D Q +V+
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFGSC----------LKMNQDGTVQSSVA------- 163
Query: 285 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVL--LKKG---YGMECDWWSLGAIMYEMLI 339
VGT DY++PE+L ++ G YG ECDWWSLG MYEML
Sbjct: 164 --------------------VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLY 203
Query: 340 GYPPFCSDDPRITCRKIVNWKTCLKFPEE-PKISDEARDLICHLLCDVETRLGTRGVEEL 398
G PF ++ T KI+N + +FP +S+EA+DLI L+C E RLG G+E+
Sbjct: 204 GETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDF 263
Query: 399 KEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSK 458
K+H +F GI W+ + +EA Y P V+ DT NF+ +V P P +
Sbjct: 264 KKHAFFEGIDWENIRNLEAPYIPDVSSPSDTSNFDVDDDVLRNPEIAPPSS--HTGFSGL 321
Query: 459 DTNFIGYTF 467
F+G+T+
Sbjct: 322 HLPFVGFTY 330
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 282 bits (723), Expect = 4e-91
Identities = 152/386 (39%), Positives = 222/386 (57%), Gaps = 48/386 (12%)
Query: 88 LERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR 147
L R + +++ ++ +D+E + +IG+GAFGEV+L R K+T +++AMK L K EM+KR
Sbjct: 25 LNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR 84
Query: 148 GQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDV 207
ER+++A +S +VQLFY+FQD +LY++MEY+PGGD++ L+ D+ E
Sbjct: 85 SDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV-PEKW 143
Query: 208 ARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLED 267
ARFY AE VLA+ +IH ++HRD+KPDN++LDK+GHLKL+DFG C +
Sbjct: 144 ARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM----------- 192
Query: 268 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG----YGM 323
N+E + + + VGT DY++PEVL +G YG
Sbjct: 193 ----NKEGMVRCD----------------------TAVGTPDYISPEVLKSQGGDGYYGR 226
Query: 324 ECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLL 383
ECDWWS+G +YEML+G PF +D T KI+N K L FP++ IS EA++LIC L
Sbjct: 227 ECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFL 286
Query: 384 CDVETRLGTRGVEELKEHPWFRGIQ--WDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGP 441
D E RLG GVEE+K H +F+ Q W+ L + A P ++ ++DT NF+ E G
Sbjct: 287 TDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDIEEDKGE 346
Query: 442 PSEIPSVGPWRKMLTSKDTNFIGYTF 467
P K F+G+T+
Sbjct: 347 EETFPI----PKAFVGNQLPFVGFTY 368
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 279 bits (714), Expect = 2e-90
Identities = 156/369 (42%), Positives = 216/369 (58%), Gaps = 46/369 (12%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
+DFE L +IG+GAFGEV + + K ++FAMK L K EMLKR + R ER++L D+
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQ 224
+ I L Y+FQD + LYL+M+Y GGD++TLL + ED L ED+ARFY+AE V+AI S+HQ
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 225 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 284
+YVHRDIKPDN+++D NGH++L+DFG C L+ED + Q +V+
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFGSCLK--------LMEDGTV--QSSVA------- 163
Query: 285 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDWWSLGAIMYEMLI 339
VGT DY++PE+L K YG ECDWWSLG MYEML
Sbjct: 164 --------------------VGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLY 203
Query: 340 GYPPFCSDDPRITCRKIVNWKTCLKFPEE-PKISDEARDLICHLLCDVETRLGTRGVEEL 398
G PF ++ T KI+N K +FP + +S++A+DLI L+C E RLG G+E+
Sbjct: 204 GETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDF 263
Query: 399 KEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSK 458
K+HP+F GI WD + EA Y P V+ DT NF+ + +P P +
Sbjct: 264 KQHPFFTGIDWDNIRNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETMPP--PSHTAFSGH 321
Query: 459 DTNFIGYTF 467
F+G+T+
Sbjct: 322 HLPFVGFTY 330
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 273 bits (699), Expect = 2e-87
Identities = 147/388 (37%), Positives = 225/388 (57%), Gaps = 48/388 (12%)
Query: 88 LERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR 147
L R E ++++ ++ +D++ + +IG+GAFGEV+L R K++ +++AMK L K EM+KR
Sbjct: 25 LNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKR 84
Query: 148 GQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDV 207
ER+++A +S +VQLF +FQD +LY++MEY+PGGD++ L+ D+ E
Sbjct: 85 SDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV-PEKW 143
Query: 208 ARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLED 267
A+FY AE VLA+ +IH +HRD+KPDN++LDK+GHLKL+DFG C + +++
Sbjct: 144 AKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC---------MKMDE 194
Query: 268 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG----YGM 323
++ +T VGT DY++PEVL +G YG
Sbjct: 195 TGMVRCDT----------------------------AVGTPDYISPEVLKSQGGDGYYGR 226
Query: 324 ECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLL 383
ECDWWS+G ++EML+G PF +D T KI++ K L FPE+ +IS A++LIC L
Sbjct: 227 ECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFL 286
Query: 384 CDVETRLGTRGVEELKEHPWFRGIQ--WDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGP 441
D E RLG GVEE+K+HP+F+ Q WD + E A P ++ ++D+ NF+ + G
Sbjct: 287 TDREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDIDSSNFDDIEDDKGD 346
Query: 442 PSEIPSVGPWRKMLTSKDTNFIGYTFKK 469
P K FIG+T+ +
Sbjct: 347 VETFPI----PKAFVGNQLPFIGFTYYR 370
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 266 bits (681), Expect = 3e-86
Identities = 108/303 (35%), Positives = 160/303 (52%), Gaps = 46/303 (15%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 173
+G G FG V L + K+ FA+K +KK +++ GQ EH+ SE+ +L E + IV+L+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 174 SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIK 233
+F+D ++Y++MEY GG++ T+L + E ARFYIA VLA +H ++RD+K
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 234 PDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQW 293
P+NL+LD NG++KL DFG K L+
Sbjct: 121 PENLLLDSNGYVKLVDFGFAKKLK------------------------------------ 144
Query: 294 KRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSD--DPRI 351
++ GT +Y+APE++L KGY D+WSLG ++YE+L G PPF D DP
Sbjct: 145 ---SGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME 201
Query: 352 TCRKIVNWKTCLKFPEEPKISDEARDLICHLLCD-VETRLGTR--GVEELKEHPWFRGIQ 408
I+ L+FP I A+DLI LL E RLG G++++K+H WF G
Sbjct: 202 IYNDILKGNGKLEFP--NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFD 259
Query: 409 WDK 411
W+
Sbjct: 260 WEG 262
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 265 bits (678), Expect = 8e-86
Identities = 129/306 (42%), Positives = 174/306 (56%), Gaps = 58/306 (18%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSER-NLLAEVDSRCIVQLF 172
I KGAFG V L + ++TG+ FA+K LKKS+M+ + QV +V++ER ++ + +S + +L+
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 173 YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDI 232
YSFQ D+LYL+MEYL GGD +L+ L ED A+ YIAE VL + +HQ +HRDI
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDI 123
Query: 233 KPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQ 292
KP+NL++D+ GHLKL+DFGL S LE++
Sbjct: 124 KPENLLIDQTGHLKLTDFGL--------SRNGLENKKF---------------------- 153
Query: 293 WKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDP--- 349
VGT DY+APE +L G DWWSLG +++E L GYPPF ++ P
Sbjct: 154 ------------VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV 201
Query: 350 --RITCRKIVNWKTCLKFPEEPK--ISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404
I R+I NW PEE K S EA DLI LLC D RLG G +E+K HP+F
Sbjct: 202 FDNILSRRI-NW------PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254
Query: 405 RGIQWD 410
+ I WD
Sbjct: 255 KSINWD 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 263 bits (675), Expect = 1e-84
Identities = 128/332 (38%), Positives = 184/332 (55%), Gaps = 31/332 (9%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
F+++ L+GKG G V L R K TG++FA+K L K EM+KR +V+ V +E+ +LA +D
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR--EDILSEDVARFYIAESVLAIHSIH 223
+ L+ SFQ +L L+M+Y PGG++ LL R LSE+VARFY AE +LA+ +H
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120
Query: 224 QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK-----YSSILLEDEDIINQ---ET 275
V+RD+KP+N++L ++GH+ LSDF L K + + + +N ET
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET 180
Query: 276 VSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 335
SE P R + S VGT +Y+APEV+ G+G DWW+LG ++Y
Sbjct: 181 FSEE------PSFR-----------SNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLY 223
Query: 336 EMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT-R 393
EML G PF + T I+ K + FP P +S ARDLI LL D RLG+ R
Sbjct: 224 EMLYGTTPFKGSNRDETFSNIL--KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKR 281
Query: 394 GVEELKEHPWFRGIQWDKLYEMEAAYKPTVNG 425
G E+K+HP+FRG+ W + P +
Sbjct: 282 GAAEIKQHPFFRGVNWALIRHTTPPIIPRPDD 313
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 256 bits (656), Expect = 9e-82
Identities = 138/369 (37%), Positives = 202/369 (54%), Gaps = 61/369 (16%)
Query: 111 LTLIGKGAFGEVRLCRAKT---TGEIFAMKKLKKSEMLKRGQVE--HVRSERNLLAEVDS 165
L ++GKG +G+V R T TG+IFAMK LKK+ + R Q + H ++ERN+L V
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKA-TIVRNQKDTAHTKAERNILEAVKH 59
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 225
IV L Y+FQ LYLI+EYL GG++ L RE I ED A FY++E LA+ +HQ
Sbjct: 60 PFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ 119
Query: 226 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 285
++RD+KP+N++LD GH+KL+DFGLCK E++ E
Sbjct: 120 GIIYRDLKPENILLDAQGHVKLTDFGLCK-------------------ESIHEGT----- 155
Query: 286 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345
+ ++ GT++YMAPE+L++ G+G DWWSLGA+MY+ML G PPF
Sbjct: 156 --------------VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFT 201
Query: 346 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHP 402
+++ + T KI+ K L P P ++ EARDL+ LL + +RLG E++ HP
Sbjct: 202 AENRKKTIDKILKGK--LNLP--PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP 257
Query: 403 WFRGIQWDKLY--EMEAAYKPTVNGELDTQNFE-KFPEVDGPPSEIPSVGPWRKMLTSKD 459
+FR + WD L ++E +KP + E D F+ KF + P P L+
Sbjct: 258 FFRHVNWDDLLARKVEPPFKPLLQSEEDVSQFDSKFTR------QTPVDSPDDSTLSESA 311
Query: 460 TN-FIGYTF 467
F+G+T+
Sbjct: 312 NQIFLGFTY 320
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 253 bits (649), Expect = 1e-80
Identities = 130/356 (36%), Positives = 187/356 (52%), Gaps = 57/356 (16%)
Query: 87 NLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLK 146
+ +T +L DFE +G G+FG VR+ + K TGE +A+K LKK E+LK
Sbjct: 6 MFTKPDTSSWKLS-------DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILK 58
Query: 147 RGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSED 206
QV+HV E+++L E+ IV + SFQD + +Y ++E++ GG++ T L + D
Sbjct: 59 MKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPND 118
Query: 207 VARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 266
VA+FY AE VLA +H + ++RD+KP+NL+LD GH+K++DFG K + D+
Sbjct: 119 VAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR------- 171
Query: 267 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECD 326
++ GT +Y+APEV+ KG+G D
Sbjct: 172 ----------------------------------TFTLCGTPEYLAPEVIQSKGHGKAVD 197
Query: 327 WWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLL-CD 385
WW++G ++YE + GYPPF D P KI+ + LKFP ARDL+ LL D
Sbjct: 198 WWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR--LKFPNW--FDGRARDLVKGLLQTD 253
Query: 386 VETRLGT--RGVEELKEHPWFRGIQWDKLYE--MEAAYKPTVNGELDTQNFEKFPE 437
RLGT GV ++K HP+F G WDKLY A V DT NFEK+P+
Sbjct: 254 HTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAPIPVRVKSPGDTSNFEKYPD 309
|
Length = 329 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 248 bits (635), Expect = 5e-79
Identities = 115/336 (34%), Positives = 178/336 (52%), Gaps = 50/336 (14%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
DD E++ +G G FG V L R + + +A+K + E+++ Q +HV +E+ +L EV
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 225
I++LF++ D FLY++MEY+PGG++ + L S FY +E V A+ +H
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 226 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 285
V+RD+KP+N++LDK GH+KL+DFG K L D+
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-------------------------- 154
Query: 286 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345
++ GT +Y+APEV+ KG+ DWW+LG ++YEML+GYPPF
Sbjct: 155 ---------------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFF 199
Query: 346 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLL-CDVETRLGT--RGVEELKEHP 402
D+P KI+ K L+FP + A+DLI LL D RLG G +++K H
Sbjct: 200 DDNPFGIYEKILAGK--LEFPRHLDLY--AKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255
Query: 403 WFRGIQWDKLYEM--EAAYKPTVNGELDTQNFEKFP 436
WF+ + WD + + + P V+ + DT NF+ +P
Sbjct: 256 WFKSVDWDDVPQRKLKPPIVPKVSHDGDTSNFDDYP 291
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 247 bits (633), Expect = 1e-78
Identities = 108/302 (35%), Positives = 174/302 (57%), Gaps = 25/302 (8%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD- 164
DDF+ +IG+G+F V L + K T + +A+K L K +++K +V++V+ E+ +L ++
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 165 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ 224
I++L+Y+FQD + LY ++EY P G+++ + + L E RFY AE +LA+ +H
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120
Query: 225 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 284
+HRD+KP+N++LDK+ H+K++DFG ++ +L+
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFG---------TAKVLDPNSSPESNKGDA------ 165
Query: 285 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 344
Q ++NRR A S VGT +Y++PE+L +K G D W+LG I+Y+ML G PPF
Sbjct: 166 --TNIDSQIEKNRRRFA-SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF 222
Query: 345 CSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR-GVEELKEHP 402
+ +T +KI+ K FP P +A+DLI LL D + RLG G +ELK HP
Sbjct: 223 RGSNEYLTFQKIL--KLEYSFP--PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHP 278
Query: 403 WF 404
+F
Sbjct: 279 FF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 241 bits (616), Expect = 2e-76
Identities = 106/302 (35%), Positives = 148/302 (49%), Gaps = 47/302 (15%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 167
+E L +G G+FG V + K TG+I A+K LKK K + + R E +L +
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSE-KSKKDQTARREIRILRRLSHPN 59
Query: 168 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 227
IV+L +F+D D LYL+MEY GGD+ L R LSED A+ + + + +H +
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 228 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 287
+HRD+KP+N++LD+NG +K++DFGL K L SS
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSS------------------------- 154
Query: 288 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYPPFCS 346
+ VGT YMAPEVLL GYG + D WSLG I+YE+L G PPF
Sbjct: 155 -------------LTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSG 201
Query: 347 DDPRITCRKIVNWKTC---LKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHP 402
++ + I P+ S+EA+DLI L D R EE+ +HP
Sbjct: 202 ENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRP---TAEEILQHP 258
Query: 403 WF 404
WF
Sbjct: 259 WF 260
|
Length = 260 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 240 bits (614), Expect = 2e-75
Identities = 131/364 (35%), Positives = 189/364 (51%), Gaps = 50/364 (13%)
Query: 112 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN-LLAEVDSRCIVQ 170
+IGKG+FG+V L + K G+ +A+K L+K +LK+ + +H+ +ERN LL V +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 171 LFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHR 230
L YSFQ +D LY +++Y+ GG++ L RE E ARFY AE A+ +H N ++R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 231 DIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERL 290
D+KP+N++LD GH+ L+DFGLCK E I + +T S
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK-------------EGIEHSKTTS------------- 154
Query: 291 QQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPR 350
+ GT +Y+APEVL K+ Y DWW LGA++YEML G PPF S D
Sbjct: 155 ------------TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA 202
Query: 351 ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRG-VEELKEHPWFRGIQ 408
I+N LK P IS AR L+ LL D RLG + E+K H +F I
Sbjct: 203 EMYDNILNKPLRLK----PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSIN 258
Query: 409 WDKLY--EMEAAYKPTVNGELDTQNFEK-FPEVDGPPSEIPSVGP--WRKMLTSKDTNFI 463
WD L ++ + P V+G +D ++F+ F E P S S + D F+
Sbjct: 259 WDDLVNKKITPPFNPNVSGPMDLKHFDPEFTEEPVPNSVGKSPDSVLVSASVKEADDAFL 318
Query: 464 GYTF 467
G+++
Sbjct: 319 GFSY 322
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 238 bits (609), Expect = 6e-75
Identities = 122/330 (36%), Positives = 187/330 (56%), Gaps = 27/330 (8%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
+DFE + LI GA+G V L R K T + FAMKK+ K ++ R Q++ V ER++L ++
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 225
+V +F SF+ L ++MEY+ GGD TLL L D+AR Y AE+VLA+ +H +
Sbjct: 61 PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120
Query: 226 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 285
VHRD+KPDNL++ GH+KL+DFGL K ++ L E E + + +
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHI--------EKDTREFL 172
Query: 286 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345
K+ GT +Y+APEV+L++GYG DWW++G I+YE L+G PF
Sbjct: 173 DKQ---------------VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 217
Query: 346 SDDPRITCRKIVNWKTCLKFPE-EPKISDEARDLICHLL-CDVETRLGTRGVEELKEHPW 403
D P ++++ +++PE + + +A+DLI LL + RLGT G E+K+H +
Sbjct: 218 GDTPEELFGQVISDD--IEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF 275
Query: 404 FRGIQWDKLYEMEAAYKPTVNGELDTQNFE 433
F G+ W+ L +A + P + E DT F+
Sbjct: 276 FLGLDWNGLLRQKAEFIPQLESEDDTSYFD 305
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 229 bits (586), Expect = 3e-71
Identities = 135/373 (36%), Positives = 192/373 (51%), Gaps = 62/373 (16%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLL---AEVDSRCIVQ 170
IGKG FG+V R K T I+AMK L K E++ + +V H ERN+L +S IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 171 LFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHR 230
L +SFQ LYL+ +Y+ GG++ L +E SED A+FYIAE VLA+ +H+++ V+R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 231 DIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERL 290
D+KP+N++LD GH+ L DFGL K L D N
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKA--------NLTDNKTTN------------------ 154
Query: 291 QQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEMLIGYPPFCSDDP 349
+ GT +Y+APEVLL +KGY D+WSLG +++EM G+ PF ++D
Sbjct: 155 ------------TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT 202
Query: 350 RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLG-TRGVEELKEHPWFRGI 407
+ R I K ++FP+ +SDE R + LL + + RLG R ELKEHP+F I
Sbjct: 203 QQMYRNIAFGK--VRFPKN-VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI 259
Query: 408 QWDKLYE--MEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKML---------- 455
WD L + + +KP V+ + D NF+ PE + PW +
Sbjct: 260 DWDLLSKKQITPPFKPIVDSDEDVSNFD--PEFTNSSLLNAGIVPWEDVPGLPGANSTPL 317
Query: 456 -TSKDTNFIGYTF 467
+S NF G+TF
Sbjct: 318 SSSVQENFRGFTF 330
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 228 bits (582), Expect = 4e-71
Identities = 123/326 (37%), Positives = 176/326 (53%), Gaps = 49/326 (15%)
Query: 107 DFEQLTLIGKGAFGEVRLCR---AKTTGEIFAMKKLKKSEML-KRGQVEHVRSERNLLAE 162
+FE L ++G GA+G+V L R G+++AMK LKK+ ++ K EH R+ER +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 163 VDSRC--IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIH 220
V RC +V L Y+FQ L+LI++Y+ GG++ T L + + +E R YIAE VLA+
Sbjct: 61 V-RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALD 119
Query: 221 SIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAE 280
+HQ ++RDIK +N++LD GH+ L+DFGL S L +E
Sbjct: 120 HLHQLGIIYRDIKLENILLDSEGHVVLTDFGL--------SKEFLAEE------------ 159
Query: 281 GQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK--GYGMECDWWSLGAIMYEML 338
+ER AYS GT++YMAPEV+ G+ DWWSLG + +E+L
Sbjct: 160 ------EER-----------AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELL 202
Query: 339 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEE 397
G PF D + + +I K P +S EARD I LL D + RLG G +E
Sbjct: 203 TGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADE 262
Query: 398 LKEHPWFRGIQWDKLYE--MEAAYKP 421
+K HP+F+GI WD L + A +KP
Sbjct: 263 IKNHPFFQGIDWDDLAAKRIPAPFKP 288
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 225 bits (576), Expect = 7e-70
Identities = 116/330 (35%), Positives = 171/330 (51%), Gaps = 50/330 (15%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR-CIVQL 171
++GKG+FG+V L K T E++A+K LKK +L+ VE +E+ +LA + QL
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 172 FYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRD 231
FQ D L+ +MEY+ GGD+M + R E ARFY AE VL + +H+ ++RD
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRD 121
Query: 232 IKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 291
+K DN++LD GH+K++DFG+CK E I+ T S
Sbjct: 122 LKLDNVLLDSEGHIKIADFGMCK-------------EGILGGVTTS-------------- 154
Query: 292 QWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI 351
+ GT DY+APE+L + YG DWW+LG ++YEML G PF DD
Sbjct: 155 -----------TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE 203
Query: 352 TCRKIVNWKTCLKFPEEPK-ISDEARDLICHLLC-DVETRLG--TRGVEELKEHPWFRGI 407
+ I+ P+ +S EA+ ++ L + E RLG G +++K HP+FR I
Sbjct: 204 LFQSILE-----DEVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258
Query: 408 QWDKL--YEMEAAYKPTVNGELDTQNFEKF 435
WDKL E++ +KP + G D NF+
Sbjct: 259 DWDKLERKEIKPPFKPKIKGRFDVSNFDDE 288
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 224 bits (571), Expect = 3e-69
Identities = 117/324 (36%), Positives = 183/324 (56%), Gaps = 45/324 (13%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 173
IGKG+FG+V R + T I+A+K ++K+ ++ R +V H +ER +LA+V+ IV L +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 174 SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIK 233
SFQ + LYL++ ++ GG++ L RE ARFY AE + A+ ++H+ N ++RD+K
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 234 PDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQW 293
P+N++LD GH+ L DFGLCK + ++D+D N
Sbjct: 121 PENILLDYQGHIALCDFGLCK--------LNMKDDDKTN--------------------- 151
Query: 294 KRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITC 353
+ GT +Y+APE+LL GY DWW+LG ++YEML G PPF ++
Sbjct: 152 ---------TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMY 202
Query: 354 RKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKL 412
RKI+ + L+FP+ +A+DL+ LL D RLG G +E+K HP+F + W KL
Sbjct: 203 RKIL--QEPLRFPD--GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKL 258
Query: 413 Y--EMEAAYKPTVNGELDTQNFEK 434
++ +KP V+ +DT NF++
Sbjct: 259 LMKGIQPPFKPAVSSAIDTSNFDE 282
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 222 bits (567), Expect = 2e-68
Identities = 122/338 (36%), Positives = 174/338 (51%), Gaps = 49/338 (14%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLF 172
L+GKG FG+V L R K TG+ +AMK LKK ++ + +V H +E +L + L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 173 YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDI 232
YSFQ D L +MEY GG++ L RE + SED ARFY AE V A+ +H + V+RD+
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDL 121
Query: 233 KPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQ 292
K +NL+LDK+GH+K++DFGLCK E I + T+
Sbjct: 122 KLENLMLDKDGHIKITDFGLCK-------------EGISDGATMK--------------- 153
Query: 293 WKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRIT 352
+ GT +Y+APEVL YG DWW LG +MYEM+ G PF + D
Sbjct: 154 ----------TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 203
Query: 353 CRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRL--GTRGVEELKEHPWFRGIQW 409
I+ + ++FP +S EA+ L+ LL D + RL G +E+ EH +F I W
Sbjct: 204 FELILMEE--IRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINW 259
Query: 410 DKLY--EMEAAYKPTVNGELDTQNFEKFPEVDGPPSEI 445
+ ++E +KP V E DT+ F++ E I
Sbjct: 260 QDVVQKKLEPPFKPQVTSETDTRYFDE--EFTAQSITI 295
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 219 bits (561), Expect = 2e-68
Identities = 104/302 (34%), Positives = 160/302 (52%), Gaps = 50/302 (16%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 167
FE L +IGKGAFG+V + + + T ++FAMK + K + +++G V +V +ER +L E++
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 168 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 227
+V L+YSFQD + +YL+++ L GGD+ L ++ SE+ +F+I E VLA+ +H
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 228 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 287
+HRDIKPDN++LD+ GH+ ++DF + + + + +
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNI---------ATKVTPDTLTT--------------- 157
Query: 288 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSD 347
ST GT YMAPEVL ++GY + DWWSLG YE L G P+
Sbjct: 158 ---------------STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPY--- 199
Query: 348 DPRITCRKIVNWKTCLKFPEEPKI----SDEARDLICHLL-CDVETRLGTRGVEELKEHP 402
R R I + + + S EA D I LL D + RLG +++LK HP
Sbjct: 200 --RGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDN-LKDLKNHP 256
Query: 403 WF 404
+F
Sbjct: 257 YF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 220 bits (563), Expect = 9e-68
Identities = 135/376 (35%), Positives = 202/376 (53%), Gaps = 62/376 (16%)
Query: 107 DFEQLTLIGKGAFGEVRLCRAKT---TGEIFAMKKLKKSEMLKRGQ-VEHVRSERNLLAE 162
+FE L ++G GA+G+V L R T TG+++AMK L+K+ ++++ + VEH R+ERN+L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 163 V-DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHS 221
V S +V L Y+FQ L+LI++Y+ GG++ T L + D SED RFY E +LA+
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 222 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 281
+H+ V+RDIK +N++LD GH+ L+DFGL K L +E
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF--------LSEE------------- 159
Query: 282 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEMLIG 340
KER YS GT++YMAPE++ K G+G DWWSLG +++E+L G
Sbjct: 160 -----KER-----------TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
Query: 341 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEE 397
PF + R T ++ P I EA+DL+ LL D + RLG +G E
Sbjct: 204 ASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASE 263
Query: 398 LKEHPWFRGIQWDKLYE--MEAAYKPTVNGELDTQNF-EKFPEVD---GPPSEIPSVGPW 451
+KEHP+F+G+ W+ L + ++P++ ELD NF E+F ++ P PS
Sbjct: 264 IKEHPFFKGLDWEALALRKVNPPFRPSIRNELDVGNFAEEFTNLEPVYSPAGTPPSGARV 323
Query: 452 RKMLTSKDTNFIGYTF 467
F GY+F
Sbjct: 324 ----------FQGYSF 329
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 218 bits (558), Expect = 4e-67
Identities = 117/340 (34%), Positives = 176/340 (51%), Gaps = 61/340 (17%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR- 166
F L ++G+G FG+V L K TGE++A+K LKK +++ R +VE + E+ + +S
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 167 --CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ 224
+V LF FQ D + +MEY GGD+M + + D+ SE A FY A VL + +H+
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLM-MHIHTDVFSEPRAVFYAACVVLGLQYLHE 119
Query: 225 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 284
+ V+RD+K DNL+LD G +K++DFGLCK EG
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLCK-------------------------EGMG- 153
Query: 285 MPKERLQQWKRNRRALAYST-VGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 343
+R ST GT +++APEVL + Y DWW LG ++YEML+G P
Sbjct: 154 -FGDRT------------STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
Query: 344 FCSDDPRITCRKIVNWKTCLKFPEEPK----ISDEARDLICHLLC-DVETRLGT--RGVE 396
F DD IVN +E + +S EA ++ LL + E RLG+ + E
Sbjct: 201 FPGDDEEEVFDSIVN--------DEVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAE 252
Query: 397 ELKEHPWFRGIQWDKLY--EMEAAYKPTVNGELDTQNFEK 434
++K+ P+FR I WD L +++ + PT+ G D NF++
Sbjct: 253 DVKKQPFFRDINWDDLLARKIKPPFVPTIKGPEDVSNFDE 292
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 213 bits (543), Expect = 5e-65
Identities = 130/349 (37%), Positives = 194/349 (55%), Gaps = 54/349 (15%)
Query: 111 LTLIGKGAFGEVRLCRAKT---TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 167
L ++G+G+FG+V L R T G+++AMK LKK+ + R +V + ER++LAEV+
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVR-TKMERDILAEVNHPF 59
Query: 168 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 227
IV+L Y+FQ LYLI+++L GGD+ T L +E + +E+ +FY+AE LA+ +H
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 119
Query: 228 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 287
++RD+KP+N++LD+ GH+KL+DFGL K
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLS---------------------------------K 146
Query: 288 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSD 347
E + K+ AYS GT++YMAPEV+ ++G+ DWWS G +M+EML G PF
Sbjct: 147 ESIDHEKK-----AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK 201
Query: 348 DPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWF 404
D + T I+ K L P+ +S EA+ L+ L + RLG GVEE+K HP+F
Sbjct: 202 DRKETMTMILKAK--LGMPQ--FLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFF 257
Query: 405 RGIQWDKLY--EMEAAYKPTVNGELDTQNFEKFPEVDG-PPSEIPSVGP 450
I W+KLY E++ +KP V DT F+ PE P + P + P
Sbjct: 258 STIDWNKLYRREIKPPFKPAVGRPDDTFYFD--PEFTSRTPKDSPGIPP 304
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 208 bits (530), Expect = 4e-63
Identities = 124/364 (34%), Positives = 184/364 (50%), Gaps = 61/364 (16%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC--IVQ 170
++GKG+FG+V L K T E FA+K LKK +L+ VE ER +LA + +
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLA-LAWEHPFLTH 60
Query: 171 LFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHR 230
LF +FQ + L+ +MEYL GGD+M + E ARFY AE + + +H+ ++R
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120
Query: 231 DIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERL 290
D+K DN++LDK+GH+K++DFG+CK E++
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCK-------------ENM-------------------- 147
Query: 291 QQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPR 350
N A + GT DY+APE+L + Y DWWS G ++YEMLIG PF +D
Sbjct: 148 -----NGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED-- 200
Query: 351 ITCRKIVNWKTCLKFPEEPK-ISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 408
+ P P+ IS EA+D + L D RLG G ++++HP+FRGI
Sbjct: 201 ---EDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRLGVDG--DIRQHPFFRGID 255
Query: 409 WDKL--YEMEAAYKPTVNGELDTQNFEK-FPEVDGPPSEIPSVGPW-RKMLTSKDTN-FI 463
W++L E+ +KP V D NF++ F +E + P +K+L S D F
Sbjct: 256 WERLEKREIPPPFKPKVKSPSDASNFDREF------TNEKVRLSPVDKKLLASMDQEQFR 309
Query: 464 GYTF 467
G++F
Sbjct: 310 GFSF 313
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 203 bits (518), Expect = 2e-61
Identities = 124/360 (34%), Positives = 183/360 (50%), Gaps = 47/360 (13%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN-LLAEVDSRCIVQL 171
+IGKG+FG+V L + K+ G +A+K L+K +LK+ + H+ +ERN LL + +V L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 172 FYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRD 231
YSFQ ++ LY +++Y+ GG++ L RE E ARFY AE AI +H N ++RD
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRD 121
Query: 232 IKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 291
+KP+N++LD GH+ L+DFGLCK E + +ET S
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCK-------------EGVEPEETTS-------------- 154
Query: 292 QWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI 351
+ GT +Y+APEVL K+ Y DWW LGA++YEML G PPF S D
Sbjct: 155 -----------TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ 203
Query: 352 TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRG-VEELKEHPWFRGIQW 409
I++ L+ P + A DL+ LL D RLG + E+K H +F I W
Sbjct: 204 MYDNILHKP--LQLP--GGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINW 259
Query: 410 DKLYEMEAA--YKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTF 467
D LY Y P V G D ++F+ + S + +S + F+G+++
Sbjct: 260 DDLYHKRITPPYNPNVAGPADLRHFDPEFTQEAVSSSVGQTPDLTASSSSASSAFLGFSY 319
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 200 bits (511), Expect = 5e-60
Identities = 114/345 (33%), Positives = 182/345 (52%), Gaps = 51/345 (14%)
Query: 99 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTG-EIFAMKKLKKSEMLKRGQVEHVRSER 157
++ K+ +DF + +G G+FG V L K A+K+ +KS+++K+ QV+HV SER
Sbjct: 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSER 82
Query: 158 NLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVL 217
+L ++ V L+ SF+D +LYL++E++ GG+ T L R DV FY A+ VL
Sbjct: 83 KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL 142
Query: 218 AIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVS 277
+ N V+RD+KP+NL+LDK+G +K++DFG K ++ +
Sbjct: 143 IFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR------------------ 184
Query: 278 EAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337
Y+ GT +Y+APE+LL G+G DWW+LG +YE+
Sbjct: 185 -----------------------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEI 221
Query: 338 LIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RG 394
L+G PPF +++P + +KI+ + + FP+ + + + L+ LL D+ R G +G
Sbjct: 222 LVGCPPFYANEPLLIYQKIL--EGIIYFPK--FLDNNCKHLMKKLLSHDLTKRYGNLKKG 277
Query: 395 VEELKEHPWFRGIQWDKLYE--MEAAYKPTVNGELDTQNFEKFPE 437
+ +KEHPWF I W L +E YKP D+ NFE+ E
Sbjct: 278 AQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKNVFDSSNFERVQE 322
|
Length = 340 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 198 bits (504), Expect = 3e-59
Identities = 132/367 (35%), Positives = 193/367 (52%), Gaps = 58/367 (15%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN-LLAEVDSRCIVQL 171
+IGKG+FG+V L R K + +A+K L+K +LK+ + +H+ SERN LL V +V L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 172 FYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRD 231
+SFQ +D LY +++Y+ GG++ L RE E ARFY AE A+ +H N V+RD
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRD 121
Query: 232 IKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 291
+KP+N++LD GH+ L+DFGLCK E+I + T S
Sbjct: 122 LKPENILLDSQGHIVLTDFGLCK-------------ENIEHNGTTS-------------- 154
Query: 292 QWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI 351
+ GT +Y+APEVL K+ Y DWW LGA++YEML G PPF S +
Sbjct: 155 -----------TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 203
Query: 352 TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLG-TRGVEELKEHPWFRGIQW 409
I+N LK P I++ AR L+ LL D RLG E+K H +F I W
Sbjct: 204 MYDNILNKPLQLK----PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINW 259
Query: 410 DKLY--EMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIP-SVG--PWRKMLTSKDTN--- 461
D L ++ + P V+G D ++F+ PE P +P S+G P ++T+
Sbjct: 260 DDLINKKITPPFNPNVSGPNDLRHFD--PEFTEEP--VPNSIGQSPDSILVTASVKEAAE 315
Query: 462 -FIGYTF 467
F+G+++
Sbjct: 316 AFLGFSY 322
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 7e-58
Identities = 119/368 (32%), Positives = 176/368 (47%), Gaps = 53/368 (14%)
Query: 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS- 165
DF L ++GKG+FG+V L K T E++A+K LKK +++ VE E+ +LA
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 225
+ QL FQ D LY +MEY+ GGD+M + + E A FY AE + + +H
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 226 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 285
++RD+K DN++LD GH+K++DFG+CK E+I +T
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCK-------------ENIFGGKTTR-------- 159
Query: 286 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345
+ GT DY+APE++ + YG DWW+ G ++YEML G PPF
Sbjct: 160 -----------------TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
Query: 346 SDDPRITCRKIVNWKTCLKFPEEPK-ISDEARDLICHLLCDVET-RLGT--RGVEELKEH 401
+D + I+ PK +S EA + LL RLG G +++EH
Sbjct: 203 GEDEDELFQSIME-----HNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257
Query: 402 PWFRGIQWDKLYEME--AAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKD 459
+FR I W+KL E +KP V G +NF+KF PP P +
Sbjct: 258 AFFRRIDWEKLERREIQPPFKPKVKGRRSAENFDKF-FTREPPVLTPP--DKLVIANIDQ 314
Query: 460 TNFIGYTF 467
+ F G++F
Sbjct: 315 SEFQGFSF 322
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 193 bits (492), Expect = 2e-57
Identities = 116/326 (35%), Positives = 170/326 (52%), Gaps = 47/326 (14%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLF 172
L+GKG FG+V L R K TG +AMK L+K ++ + +V H +E +L + L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 173 YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDI 232
Y+FQ D L +MEY GG++ L RE + +E+ ARFY AE V A+ +H + V+RDI
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 121
Query: 233 KPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQ 292
K +NL+LDK+GH+K++DFGLCK E I + T+
Sbjct: 122 KLENLMLDKDGHIKITDFGLCK-------------EGISDGATMK--------------- 153
Query: 293 WKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRIT 352
+ GT +Y+APEVL YG DWW LG +MYEM+ G PF + D
Sbjct: 154 ----------TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 203
Query: 353 CRKIVNWKTCLKFPEEPKISDEARDLICHLL-CDVETRL--GTRGVEELKEHPWFRGIQW 409
I+ + ++FP +S EA+ L+ LL D + RL G +E+ EH +F I W
Sbjct: 204 FELILMEE--IRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 259
Query: 410 DKLYE--MEAAYKPTVNGELDTQNFE 433
+ + + +KP V E+DT+ F+
Sbjct: 260 QDVVQKKLLPPFKPQVTSEVDTRYFD 285
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 193 bits (492), Expect = 2e-57
Identities = 122/363 (33%), Positives = 183/363 (50%), Gaps = 50/363 (13%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN-LLAEVDSRCIVQL 171
+IGKG+FG+V L + K G+ +A+K L+K +L R + +H+ +ERN LL V +V L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 172 FYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRD 231
YSFQ ++ LY +++++ GG++ L RE E ARFY AE A+ +H N V+RD
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRD 121
Query: 232 IKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 291
+KP+N++LD GH+ L+DFGLCK E I +T +
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCK-------------EGIAQSDTTT-------------- 154
Query: 292 QWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI 351
+ GT +Y+APEV+ K+ Y DWW LGA++YEML G PPF D
Sbjct: 155 -----------TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE 203
Query: 352 TCRKIVNWKTCLKFPEEPKISDEARDLICHLL-CDVETRLGTR-GVEELKEHPWFRGIQW 409
I++ L+ P S A ++ LL D + RLG + E++EHP+F + W
Sbjct: 204 MYDNILHKPLVLR----PGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSW 259
Query: 410 DKLYE--MEAAYKPTVNGELDTQNFE-KFPEVDGPPSEIPSVGPW--RKMLTSKDTNFIG 464
L + + + P V G D NF+ F E P S S + D F+G
Sbjct: 260 TDLEQKKIPPPFNPNVEGPDDISNFDAVFTEETVPYSVCFSSDYSIVNASVLEADDAFVG 319
Query: 465 YTF 467
+++
Sbjct: 320 FSY 322
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 188 bits (480), Expect = 2e-56
Identities = 87/296 (29%), Positives = 139/296 (46%), Gaps = 46/296 (15%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLF 172
L+G+G+FG V L K TGE+ A+K ++ S + ++E + E +L+ + IV+ +
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEE-ELEALEREIRILSSLQHPNIVRYY 65
Query: 173 YSFQDS--DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHR 230
S +D + L + +EY+ GG + +LL + L E V R Y + + + +H + VHR
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHR 125
Query: 231 DIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERL 290
DIK N+++D +G +KL+DFG K L D +
Sbjct: 126 DIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT------------------------- 160
Query: 291 QQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC-SDDP 349
S GT +MAPEV+ + YG D WSLG + EM G PP+ +P
Sbjct: 161 -----------GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP 209
Query: 350 RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404
KI + + PE +S+EA+D + L D + R +EL +HP+
Sbjct: 210 MAALYKIGSSGEPPEIPEH--LSEEAKDFLRKCLRRDPKKRP---TADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 8e-55
Identities = 109/337 (32%), Positives = 172/337 (51%), Gaps = 64/337 (18%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA-EVDSRCIVQL 171
++GKG+FG+V L K T E++A+K LKK +L+ V+ +E+ +LA + L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 172 FYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRD 231
FQ D L+ +MEY+ GGD+M + R E +RFY AE LA+ +H+H ++RD
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRD 121
Query: 232 IKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 291
+K DN++LD GH KL+DFG+CK E I+N T +
Sbjct: 122 LKLDNILLDAEGHCKLADFGMCK-------------EGILNGVTTT-------------- 154
Query: 292 QWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI 351
+ GT DY+APE+L + YG DWW+LG +MYEM+ G PPF +D+
Sbjct: 155 -----------TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD 203
Query: 352 TCRKIVN-------WKTCLKFPEEPKISDEARDLICHLLC-DVETRLG---TRGVEE-LK 399
I++ W +S EA ++ + + RLG ++G E+ +K
Sbjct: 204 LFESILHDDVLYPVW-----------LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIK 252
Query: 400 EHPWFRGIQWDKL--YEMEAAYKPTVNGELDTQNFEK 434
+HP+F+ I W L +++ +KP + + D NF++
Sbjct: 253 QHPFFKEIDWVLLEQRKIKPPFKPKIKTKRDVNNFDQ 289
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 1e-54
Identities = 103/307 (33%), Positives = 158/307 (51%), Gaps = 50/307 (16%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 173
+GKG FGEV C+ K TG+++A KKL K + KR + +E+ +L +V SR IV L Y
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 174 SFQDSDFLYLIMEYLPGGDIMTLL--MREDILSEDVARFYIAESVLAIHSIHQHNYVHRD 231
+F+ D L L+M + GGD+ + + E E A FY A+ + + +HQ V+RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 232 IKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 291
+KP+N++LD +G++++SD GL L+ K R
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAVELKGGKK------------------------IKGR-- 154
Query: 292 QWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI 351
GT YMAPEVL + Y DW++LG +YEM+ G PF ++
Sbjct: 155 -------------AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV 201
Query: 352 TCRKIVNWKTC---LKFPEEPKISDEARDLICHLLC-DVETRLGTRG--VEELKEHPWFR 405
++ + +T +++P+ K S EA+DL LL D E RLG RG +E++EHP F+
Sbjct: 202 E-KEELKRRTLEMAVEYPD--KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFK 258
Query: 406 GIQWDKL 412
+ W +L
Sbjct: 259 DLNWRRL 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 185 bits (470), Expect = 3e-54
Identities = 121/328 (36%), Positives = 173/328 (52%), Gaps = 48/328 (14%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLF 172
L+GKG FG+V L + K TG +AMK LKK ++ + +V H +E +L + L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 173 YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIH-QHNYVHRD 231
YSFQ D L +MEY GG++ L RE + SED ARFY AE V A+ +H + N V+RD
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 121
Query: 232 IKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 291
+K +NL+LDK+GH+K++DFGLCK E I + T+
Sbjct: 122 LKLENLMLDKDGHIKITDFGLCK-------------EGIKDGATMK-------------- 154
Query: 292 QWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI 351
+ GT +Y+APEVL YG DWW LG +MYEM+ G PF + D
Sbjct: 155 -----------TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 203
Query: 352 TCRKIVNWKTCLKFPEEPKISDEARDLICHLL-CDVETRL--GTRGVEELKEHPWFRGIQ 408
I+ + ++FP +S EA+ L+ LL D + RL G +E+ +H +F GI
Sbjct: 204 LFELILMEE--IRFPR--TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIV 259
Query: 409 WDKLYE--MEAAYKPTVNGELDTQNFEK 434
W +YE + +KP V E DT+ F++
Sbjct: 260 WQDVYEKKLVPPFKPQVTSETDTRYFDE 287
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 4e-54
Identities = 117/327 (35%), Positives = 170/327 (51%), Gaps = 47/327 (14%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLF 172
L+GKG FG+V L R K +G+ +AMK LKK ++ + +V H +E +L + L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 173 YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDI 232
YSFQ D L +MEY+ GG++ L RE + SED RFY AE V A+ +H V+RD+
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDL 121
Query: 233 KPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQ 292
K +NL+LDK+GH+K++DFGLCK E +++A
Sbjct: 122 KLENLMLDKDGHIKITDFGLCK-------------------EGITDA------------- 149
Query: 293 WKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRIT 352
A + GT +Y+APEVL YG DWW LG +MYEM+ G PF + D
Sbjct: 150 ------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 203
Query: 353 CRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRL--GTRGVEELKEHPWFRGIQW 409
I+ +KFP +S +A+ L+ LL D RL G +E+ H +F G+ W
Sbjct: 204 FELIL--MEDIKFPR--TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNW 259
Query: 410 DKLYE--MEAAYKPTVNGELDTQNFEK 434
+Y+ + +KP V E DT+ F++
Sbjct: 260 QDVYDKKLVPPFKPQVTSETDTRYFDE 286
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 1e-53
Identities = 107/327 (32%), Positives = 165/327 (50%), Gaps = 50/327 (15%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQL 171
++GKG+FG+V L K T + FA+K LKK +L VE E+ +L+ + + L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 172 FYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRD 231
+ +FQ + L+ +MEYL GGD+M + A FY AE + + +H V+RD
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRD 121
Query: 232 IKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 291
+K DN++LD +GH+K++DFG+CK E+++
Sbjct: 122 LKLDNILLDTDGHIKIADFGMCK-------------ENMLGDAKTC-------------- 154
Query: 292 QWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI 351
+ GT DY+APE+LL + Y DWWS G ++YEMLIG PF D
Sbjct: 155 -----------TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE 203
Query: 352 TCRKIVNWKTCLKFPEEPK-ISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQW 409
+ I + P P+ ++ EA+D++ L + E RLG +G ++++HP+FR I W
Sbjct: 204 LFQSIR-----MDNPCYPRWLTREAKDILVKLFVREPERRLGVKG--DIRQHPFFREIDW 256
Query: 410 DKL--YEMEAAYKPTVNGELDTQNFEK 434
L E+E +KP V D NF+K
Sbjct: 257 SALEEREIEPPFKPKVKSANDCSNFDK 283
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 178 bits (455), Expect = 2e-53
Identities = 84/257 (32%), Positives = 123/257 (47%), Gaps = 56/257 (21%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 173
+G+G FG V L R K TG+ A+K +KK + +E + E +L +++ IV+L+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSL--LEELLREIEILKKLNHPNIVKLYG 58
Query: 174 SFQDSDFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDI 232
F+D + LYL+MEY GG + LL E LSED + + + + +H + +HRD+
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 233 KPDNLILDK-NGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 291
KP+N++LD NG +KL+DFGL K L S
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTSDKS------------------------------ 148
Query: 292 QWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEMLIGYPPF------ 344
L + VGT YMAPEVLL K Y + D WSLG I+YE+ P
Sbjct: 149 --------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----PELKDLIRK 196
Query: 345 -CSDDP--RITCRKIVN 358
DP R + ++I+
Sbjct: 197 MLQKDPEKRPSAKEILE 213
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 182 bits (463), Expect = 3e-53
Identities = 105/328 (32%), Positives = 172/328 (52%), Gaps = 49/328 (14%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR-CIVQL 171
++GKG+FG+V L R K +G ++A+K LKK +L+ VE +E+ +L+ + + QL
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 172 FYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRD 231
+ FQ D L+ +ME++ GGD+M + + E ARFY AE A+ +H ++RD
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRD 121
Query: 232 IKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 291
+K DN++LD GH KL+DFG+CK E I N +T S
Sbjct: 122 LKLDNVLLDHEGHCKLADFGMCK-------------EGIFNGKTTS-------------- 154
Query: 292 QWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI 351
+ GT DY+APE+L + YG DWW++G ++YEML G+ PF +++
Sbjct: 155 -----------TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD 203
Query: 352 TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR---GVEELKEHPWFRGI 407
I+N + +P +S +A D++ + + RLG+ G E + HP+F+ +
Sbjct: 204 LFEAILNDEVV--YPTW--LSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL 259
Query: 408 QWDKLY--EMEAAYKPTVNGELDTQNFE 433
W+KL ++E ++P + D NF+
Sbjct: 260 DWEKLNRRQIEPPFRPRIKSREDVSNFD 287
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 181 bits (460), Expect = 3e-53
Identities = 114/329 (34%), Positives = 180/329 (54%), Gaps = 53/329 (16%)
Query: 107 DFEQLTLIGKGAFGEVRLCR---AKTTGEIFAMKKLKKSEMLKRGQV-EHVRSERNLLAE 162
+FE L ++G GA+G+V L R +G+++AMK LKK+ ++++ + EH R+ER +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 163 V-DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHS 221
+ S +V L Y+FQ L+LI++Y+ GG++ T L + + E + Y E VLA+
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120
Query: 222 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 281
+H+ ++RDIK +N++LD NGH+ L+DFGL K EDE
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE--------FHEDEV------------ 160
Query: 282 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL--KKGYGMECDWWSLGAIMYEMLI 339
ER AYS GT++YMAP+++ G+ DWWS+G +MYE+L
Sbjct: 161 ------ER-----------AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLT 203
Query: 340 GYPPFCSDDPRITCRKIVN--WKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RG 394
G PF D + + +I K+ +P+E +S A+D+I LL D + RLG
Sbjct: 204 GASPFTVDGEKNSQAEISRRILKSEPPYPQE--MSALAKDIIQRLLMKDPKKRLGCGPSD 261
Query: 395 VEELKEHPWFRGIQWDKLY--EMEAAYKP 421
+E+K+HP+F+ I WD L ++ A +KP
Sbjct: 262 ADEIKKHPFFQKINWDDLAAKKVPAPFKP 290
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 2e-50
Identities = 110/335 (32%), Positives = 173/335 (51%), Gaps = 49/335 (14%)
Query: 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR 166
DF L ++GKG+FG+V L K T E++A+K LKK +++ VE E+ +LA D
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 167 -CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 225
+ QL FQ D LY +MEY+ GGD+M + + E A FY AE + + +H+
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120
Query: 226 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 285
++RD+K DN++LD GH+K++DFG+CK E +++ T
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCK-------------EHMVDGVTTR-------- 159
Query: 286 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345
+ GT DY+APE++ + YG DWW+ G ++YEML G PPF
Sbjct: 160 -----------------TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
Query: 346 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETR---LGTRGVEELKEHP 402
+D + I+ + +P+ +S EA + L+ ++ G G +++EH
Sbjct: 203 GEDEDELFQSIMEHN--VSYPKS--LSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHA 258
Query: 403 WFRGIQWDKL--YEMEAAYKPTVNGELDTQNFEKF 435
+FR I WDKL E++ +KP V G+ +NF+KF
Sbjct: 259 FFRRIDWDKLENREIQPPFKPKVCGK-GAENFDKF 292
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 2e-50
Identities = 78/282 (27%), Positives = 128/282 (45%), Gaps = 48/282 (17%)
Query: 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR 166
+E + IGKG+FG+V L R K+ G+++ +K++ S M + E +E +L +++
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHP 59
Query: 167 CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL----MREDILSEDVARFYIAESVLAIHSI 222
I++ + SF++ L ++MEY GGD+ + E+ + + LA+ +
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 223 HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 282
H +HRDIKP N+ L NG +KL DFG+ K L
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV---------------------- 157
Query: 283 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 342
LA + VGT Y++PE+ K Y + D WSLG ++YE+
Sbjct: 158 ----------------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKH 201
Query: 343 PFCSDDPRITCRKIVNWKTCLKFPEEPKI-SDEARDLICHLL 383
PF ++ KI+ ++P P S E R+L+ LL
Sbjct: 202 PFEGENLLELALKILK----GQYPPIPSQYSSELRNLVSSLL 239
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 7e-50
Identities = 85/301 (28%), Positives = 130/301 (43%), Gaps = 52/301 (17%)
Query: 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR 166
FE L IGKG FGEV R K TG+ A+K +K K+ E + +E +L +
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKK---EKIINEIQILKKCKHP 57
Query: 167 CIVQLFYSFQDSDFLYLIMEYLPGG---DIMTLLMREDILSEDVARFYIAESVLAIHSIH 223
IV+ + S+ D L+++ME+ GG D++ + L+E + E + + +H
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT--LTESQIAYVCKELLKGLEYLH 115
Query: 224 QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQW 283
+ +HRDIK N++L +G +KL DFGL L D +
Sbjct: 116 SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN-------------------- 155
Query: 284 MMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 343
+ VGT +MAPEV+ K Y + D WSLG E+ G PP
Sbjct: 156 -------------------TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPP 196
Query: 344 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHP 402
+ S+ P + + K SDE +D + L + E R E+L +HP
Sbjct: 197 Y-SELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRP---TAEQLLKHP 252
Query: 403 W 403
+
Sbjct: 253 F 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 7e-49
Identities = 117/349 (33%), Positives = 174/349 (49%), Gaps = 55/349 (15%)
Query: 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA-EVDS 165
DF L ++GKG+FG+V L K T E++A+K LKK +++ VE E+ +LA
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 225
+ QL FQ D LY +MEY+ GGD+M + + E A FY AE + + +H
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 226 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 285
++RD+K DN++LD GH+K++DFG+CK E++ + T
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCK-------------ENMWDGVTTK-------- 159
Query: 286 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345
+ GT DY+APE++ + YG DWW+ G ++YEML G PF
Sbjct: 160 -----------------TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
Query: 346 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVE--TRLGT--RGVEELKEH 401
+D + I+ + +P+ +S EA IC L RLG G ++KEH
Sbjct: 203 GEDEDELFQSIMEHN--VAYPKS--MSKEAV-AICKGLMTKHPGKRLGCGPEGERDIKEH 257
Query: 402 PWFRGIQWDKL--YEMEAAYKPTVNGELDTQNFEKF----PEVDGPPSE 444
+FR I W+KL E++ YKP G D +NF+KF P V PP +
Sbjct: 258 AFFRYIDWEKLERKEVQPPYKPKACGR-DAENFDKFFTRHPPVLTPPDQ 305
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 1e-48
Identities = 108/327 (33%), Positives = 164/327 (50%), Gaps = 50/327 (15%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA-EVDSRCIVQL 171
++GKG+FG+V L K GE FA+K LKK +L VE E+ +LA ++ + L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 172 FYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRD 231
+ +FQ + L+ +ME+L GGD+M + + A FY AE V + +H ++RD
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRD 121
Query: 232 IKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 291
+K DN++LD++GH+K++DFG+CK E++
Sbjct: 122 LKLDNVMLDRDGHIKIADFGMCK-------------ENVFGD------------------ 150
Query: 292 QWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI 351
NR A + GT DY+APE+L Y DWWS G ++YEMLIG PF DD
Sbjct: 151 ----NR---ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE 203
Query: 352 TCRKIVNWKTCLKFPEEPK-ISDEARDLICHLL-CDVETRLGTRGVEELKEHPWFRGIQW 409
I + P P+ I+ E++D++ L D RLG G ++ HP+F+ I W
Sbjct: 204 LFESIR-----VDTPHYPRWITKESKDILEKLFERDPTRRLGVVG--NIRGHPFFKTINW 256
Query: 410 DKL--YEMEAAYKPTVNGELDTQNFEK 434
L E++ +KP V D NF++
Sbjct: 257 TALEKRELDPPFKPKVKSPSDYSNFDR 283
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 2e-48
Identities = 104/312 (33%), Positives = 158/312 (50%), Gaps = 48/312 (15%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 167
F ++GKG FGEV C+ + TG+++A KKL+K + KR +E+ +L +V+SR
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 168 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLL--MREDILSEDVARFYIAESVLAIHSIHQH 225
+V L Y+++ D L L++ + GGD+ + M E+ A FY AE + +H+
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 226 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 285
V+RD+KP+N++LD GH+++SD GL V EG+ +
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGL----------------------AVEIPEGETI- 158
Query: 286 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345
R R VGT+ YMAPEV+ + Y DWW LG ++YEM+ G PF
Sbjct: 159 ---------RGR-------VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFR 202
Query: 346 SDDPRITCRKIVNWKTCLKFPEE--PKISDEARDLICHLLC-DVETRLGTR--GVEELKE 400
++ R+ V + + EE K S+ AR + LL D RLG R G EE+K
Sbjct: 203 QRKEKVK-REEVE-RRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260
Query: 401 HPWFRGIQWDKL 412
HP+FR + +L
Sbjct: 261 HPFFRTANFKRL 272
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 168 bits (426), Expect = 2e-48
Identities = 109/323 (33%), Positives = 166/323 (51%), Gaps = 50/323 (15%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 167
F Q ++GKG FGEV C+ + TG+++A KKL+K + KR +E+ +L +V+SR
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 168 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLL--MREDILSEDVARFYIAESVLAIHSIHQH 225
+V L Y+++ D L L++ + GGD+ + M E E A FY AE + +HQ
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 226 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 285
V+RD+KP+N++LD +GH+++SD GL V EGQ +
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGL----------------------AVHVPEGQTIK 159
Query: 286 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345
+ VGT+ YMAPEV+ + Y DWW+LG ++YEM+ G PF
Sbjct: 160 GR-----------------VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ 202
Query: 346 SDDPRITCRKIVNWKTCLKFPEE--PKISDEARDLICHLLC-DVETRLGTRG--VEELKE 400
+I ++ + + EE K S +AR L LLC D + RLG +G E+KE
Sbjct: 203 QRKKKIKREEVE--RLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260
Query: 401 HPWFRGIQWDKLYE--MEAAYKP 421
HP F+ I + +L +E +KP
Sbjct: 261 HPLFKQINFKRLEAGMLEPPFKP 283
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 2e-47
Identities = 104/338 (30%), Positives = 172/338 (50%), Gaps = 56/338 (16%)
Query: 112 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR-CIVQ 170
+IG+G++ +V L K T I+AMK +KK + ++ V++E+++ + +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 171 LFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHR 230
L FQ L+ ++E++ GGD+M + R+ L E+ ARFY AE LA++ +H+ ++R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 231 DIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERL 290
D+K DN++LD GH+KL+D+G+CK E I +T S
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCK-------------EGIRPGDTTS------------- 154
Query: 291 QQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF----CS 346
+ GT +Y+APE+L + YG DWW+LG +M+EM+ G PF S
Sbjct: 155 ------------TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMS 202
Query: 347 DDPRITCR----KIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR---GVEEL 398
D+P +++ K ++ P +S +A ++ L D + RLG G ++
Sbjct: 203 DNPDQNTEDYLFQVILEKQ-IRIPRS--LSVKASSVLKGFLNKDPKERLGCHPQTGFRDI 259
Query: 399 KEHPWFRGIQWDKLYEMEAA--YKPTVNGELDTQNFEK 434
K HP+FR I WD L + + YKP + + D NF+
Sbjct: 260 KSHPFFRNIDWDLLEQKQVLPPYKPNIESDRDLDNFDP 297
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 1e-45
Identities = 101/313 (32%), Positives = 167/313 (53%), Gaps = 50/313 (15%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 167
F Q ++GKG FGEV C+ + TG+++A K+L+K + KR +E+ +L +V+S+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 168 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLL--MREDILSEDVARFYIAESVLAIHSIHQH 225
+V L Y+++ D L L++ + GGD+ + M E+ A FY AE + + +H+
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 226 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 285
N V+RD+KP+N++LD GH+++SD GL ++ + + + I
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGL---------AVKIPEGESI-------------- 158
Query: 286 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345
R R VGT+ YMAPEVL + Y + D+W LG ++YEM+ G PF
Sbjct: 159 ---------RGR-------VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFR 202
Query: 346 SDDPRITCRKIVNWKTCLKFPE--EPKISDEARDLICHLLC--DVETRLGTR--GVEELK 399
++ R+ V+ + L+ E K S+EA+ IC +L D + RLG + G E+K
Sbjct: 203 GRKEKVK-REEVD-RRVLETEEVYSAKFSEEAKS-ICKMLLTKDPKQRLGCQEEGAGEVK 259
Query: 400 EHPWFRGIQWDKL 412
HP+FR + + +L
Sbjct: 260 RHPFFRNMNFKRL 272
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 4e-45
Identities = 102/332 (30%), Positives = 179/332 (53%), Gaps = 50/332 (15%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR-CIVQL 171
+IG+G++ +V L R K +I+AMK +KK + ++ V++E+++ + S +V L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 172 FYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRD 231
FQ + L+L++EY+ GGD+M + R+ L E+ ARFY AE +A++ +H+ ++RD
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRD 121
Query: 232 IKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 291
+K DN++LD +GH+KL+D+G+CK E + +T S
Sbjct: 122 LKLDNVLLDADGHIKLTDYGMCK-------------EGLGPGDTTS-------------- 154
Query: 292 QWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF--CSDDP 349
+ GT +Y+APE+L + YG DWW+LG +M+EM+ G PF +D+P
Sbjct: 155 -----------TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNP 203
Query: 350 RITCRKIVNWKTCLKFP-EEPK-ISDEARDLICHLLC-DVETRLGTR---GVEELKEHPW 403
+ + ++ L+ P P+ +S +A ++ L D + RLG + G ++K H +
Sbjct: 204 DMNTEDYL-FQVILEKPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTF 262
Query: 404 FRGIQWDKLYEMEAA--YKPTVNGELDTQNFE 433
FR I WD L + + +KP + + +NF+
Sbjct: 263 FRSIDWDLLEKKQVTPPFKPQITDDYGLENFD 294
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 1e-44
Identities = 102/334 (30%), Positives = 170/334 (50%), Gaps = 52/334 (15%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR-CIVQL 171
+IG+G++ +V L R K T I+AMK +KK + ++ V++E+++ + + +V L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 172 FYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRD 231
FQ L+ ++EY+ GGD+M + R+ L E+ ARFY AE LA++ +H+ ++RD
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRD 121
Query: 232 IKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 291
+K DN++LD GH+KL+D+G+CK EG + P +
Sbjct: 122 LKLDNVLLDSEGHIKLTDYGMCK-------------------------EG--LRPGDTTS 154
Query: 292 QWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF----CSD 347
+ GT +Y+APE+L + YG DWW+LG +M+EM+ G PF SD
Sbjct: 155 TF-----------CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 203
Query: 348 DPRITCRKI---VNWKTCLKFPEEPKISDEARDLICHLLCDVETRLG---TRGVEELKEH 401
+P V + ++ P + A L L D + RLG G +++ H
Sbjct: 204 NPDQNTEDYLFQVILEKQIRIPRSLSVK-AASVLKSFLNKDPKERLGCHPQTGFADIQGH 262
Query: 402 PWFRGIQWDKLYEMEAA--YKPTVNGELDTQNFE 433
P+FR + WD + + + +KP ++GE NF+
Sbjct: 263 PFFRNVDWDLMEQKQVVPPFKPNISGEFGLDNFD 296
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 2e-44
Identities = 94/308 (30%), Positives = 150/308 (48%), Gaps = 49/308 (15%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 173
+GKG FGEV C+ + TG+++A KKL K + KR E E+ +LA+V SR IV L Y
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 174 SFQDSDFLYLIMEYLPGGDIMTLLMREDI----LSEDVARFYIAESVLAIHSIHQHNYVH 229
+FQ L L+M + GGD+ + D E A FY A+ + + +HQ ++
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 230 RDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKER 289
RD+KP+N++LD +G++++SD GL L+D S
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQS---------------------------- 152
Query: 290 LQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDP 349
+ Y+ GT +MAPE+L + Y D+++LG +YEM+ PF +
Sbjct: 153 --------KTKGYA--GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 202
Query: 350 RITCRKIVN--WKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR--GVEELKEHPWF 404
++ +++ + +P+ K S ++ LL D E RLG R + L+ HP F
Sbjct: 203 KVENKELKQRILNDSVTYPD--KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLF 260
Query: 405 RGIQWDKL 412
R + W +L
Sbjct: 261 RDLNWRQL 268
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 165 bits (418), Expect = 4e-44
Identities = 65/150 (43%), Positives = 102/150 (68%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 164
I++F + I +GAFG+V L R K +++A+K +KK++M+ + V V++ER+ LA
Sbjct: 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK 62
Query: 165 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ 224
S IV L+YS Q ++ +YL+MEYL GGD+ +LL E++A YI+E LA+ +H+
Sbjct: 63 SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHR 122
Query: 225 HNYVHRDIKPDNLILDKNGHLKLSDFGLCK 254
H +HRD+KPDN+++ GH+KL+DFGL K
Sbjct: 123 HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 159 bits (402), Expect = 5e-44
Identities = 116/416 (27%), Positives = 167/416 (40%), Gaps = 61/416 (14%)
Query: 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS- 165
+ L +G+G+FGEV L R + ++ A+K L K K +VE E +LA ++
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL---MREDILSEDVARFYIAESVLAIHSI 222
IV+L+ FQD LYL+MEY+ GG + LL R+ LSE A F +A+ + A+ +
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 223 HQHNYVHRDIKPDNLILDKNGH-LKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 281
H +HRDIKP+N++LD++G +KL DFGL K L D S+
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST------------------- 158
Query: 282 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG---YGMECDWWSLGAIMYEML 338
+ AL ++VGT YMAPEVLL D WSLG +YE+L
Sbjct: 159 -------------SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELL 205
Query: 339 IGYPPFCSDDPRITCRKIVNWKTCLKFPE---------EPKISDEARDLICHLL-CDVET 388
G PPF + + + L P IS A DL+ LL D +
Sbjct: 206 TGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKN 265
Query: 389 RLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSV 448
RL + H L E+ + + P +
Sbjct: 266 RLSSS---SDLSHDLLA-----HLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNS 317
Query: 449 GPWRKMLTSKDTNFIGYTFKKSDVLKSLENSGTDMRSNGSSKVPSLISLLGMIYYI 504
D + + V S NS + + S SSK SL +
Sbjct: 318 LAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSLLLSTASSKRSSLPKISARSSPS 373
|
Length = 384 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 156 bits (395), Expect = 7e-44
Identities = 99/311 (31%), Positives = 156/311 (50%), Gaps = 46/311 (14%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 167
F ++GKG FGEV C+ + TG+++A KKL+K + KR +E+ +L +V+SR
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 168 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLL--MREDILSEDVARFYIAESVLAIHSIHQH 225
+V L Y+++ D L L++ + GGD+ + M E A FY AE + + +
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 226 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 285
V+RD+KP+N++LD GH+++SD GL V EG+ +
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGL----------------------AVQIPEGETV- 158
Query: 286 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345
R R VGT+ YMAPEV+ + Y DWW LG ++YEM+ G PF
Sbjct: 159 ---------RGR-------VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFR 202
Query: 346 SDDPRITCRKIVNWKTCLKFPE-EPKISDEARDLICHLLC-DVETRLGTR--GVEELKEH 401
R+ R+ V+ + E K S++A+ + LL + + RLG R G +K+H
Sbjct: 203 KRKERVK-REEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261
Query: 402 PWFRGIQWDKL 412
P F+ I + +L
Sbjct: 262 PIFKNINFKRL 272
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 155 bits (392), Expect = 1e-43
Identities = 101/311 (32%), Positives = 151/311 (48%), Gaps = 54/311 (17%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV---DSRCIV 169
+IG+G FGEV CR TG+++AMK L K + + +ER +L+ V D IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 170 QLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVH 229
+ Y+F D L I++ + GGD+ L + + SE RFY AE +L + +H V+
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 230 RDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKER 289
RD+KP N++LD++GH+++SD GL K
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKP---------------------------- 152
Query: 290 LQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEMLIGYPPF--CS 346
+++VGT YMAPEVL K Y DW+SLG +++++L G+ PF
Sbjct: 153 ------------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200
Query: 347 DDPRITCRKIVNWKTCLKFPEEP-KISDEARDLICHLLC-DVETRLG--TRGVEELKEHP 402
+ ++ T E P S E R L+ LL DV RLG RG +E+KEHP
Sbjct: 201 TKDKHEIDRM----TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHP 256
Query: 403 WFRGIQWDKLY 413
+FR + W ++
Sbjct: 257 FFRSLDWQMVF 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 6e-42
Identities = 81/310 (26%), Positives = 132/310 (42%), Gaps = 54/310 (17%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLK-KSEMLKRGQVEHVRSERNLLAEVD 164
D E++ ++G+G+ G V R K TG+I+A+KK+ + R Q+ E L +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQL---LRELKTLRSCE 57
Query: 165 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVL-AIHSIH 223
S +V+ + +F + +++EY+ GG + LL + + E V YIA +L + +H
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA-YIARQILKGLDYLH 116
Query: 224 Q-HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 282
+ +HRDIKP NL+++ G +K++DFG+ K LE
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLE------------------------- 151
Query: 283 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 342
N + VGT+ YM+PE + + Y D WSLG + E +G
Sbjct: 152 -------------NTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKF 198
Query: 343 PFCSD---DPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEEL 398
PF + I + + S E RD I L D + R EL
Sbjct: 199 PFLPPGQPSFFELMQAICD--GPPPSLPAEEFSPEFRDFISACLQKDPKKR---PSAAEL 253
Query: 399 KEHPWFRGIQ 408
+HP+ +
Sbjct: 254 LQHPFIKKAD 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 5e-41
Identities = 79/293 (26%), Positives = 128/293 (43%), Gaps = 46/293 (15%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLF 172
LIG+GAFG V TG+ A+K++ + +K ++ + E +LL + IV+
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEK-IKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 173 YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDI 232
S + SD LY+I+EY G + ++ + E + Y+ + + + +H+ +HRDI
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDI 125
Query: 233 KPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQ 292
K N++ K+G +KL+DFG+ ++ L +
Sbjct: 126 KAANILTTKDGVVKLADFGV--------ATKLNDVSKDDA-------------------- 157
Query: 293 WKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRIT 352
S VGT +MAPEV+ G D WSLG + E+L G PP+ +P
Sbjct: 158 ----------SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA 207
Query: 353 CRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404
+IV PE IS E +D + D R + +L +HPW
Sbjct: 208 LFRIVQ-DDHPPLPEG--ISPELKDFLMQCFQKDPNLRPTAK---QLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 4e-40
Identities = 102/310 (32%), Positives = 157/310 (50%), Gaps = 52/310 (16%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEM-LKRGQVEHVRSERNLLAEV---DSRCI 168
+IG+G FGEV CR TG+++AMK L K + +K+G+ + +ER +L+ V D I
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLAL-NERIMLSLVSTGDCPFI 59
Query: 169 VQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYV 228
V + Y+F D L I++ + GGD+ L + + SE RFY E +L + +H V
Sbjct: 60 VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVV 119
Query: 229 HRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKE 288
+RD+KP N++LD++GH+++SD GL K
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDFSKKKP--------------------------- 152
Query: 289 RLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYPPFCSD 347
+++VGT YMAPEVL K Y DW+SLG +++++L G+ PF
Sbjct: 153 -------------HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF--R 197
Query: 348 DPRITCRKIVNWKTCLKFPEEP-KISDEARDLICHLLC-DVETRLGT--RGVEELKEHPW 403
+ + ++ T E P S E + L+ LL DV RLG RG +E+KEH +
Sbjct: 198 QHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVF 257
Query: 404 FRGIQWDKLY 413
F+GI W ++Y
Sbjct: 258 FKGIDWQQVY 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 1e-38
Identities = 84/300 (28%), Positives = 127/300 (42%), Gaps = 44/300 (14%)
Query: 109 EQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCI 168
++ IG G FG+V TGE+ A+K+++ + ++ + E +L + +
Sbjct: 3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQD-NDPKTIKEIADEMKVLELLKHPNL 61
Query: 169 VQLFYSFQ-DSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 227
V+ +Y + + +Y+ MEY GG + LL IL E V R Y + + + +H H
Sbjct: 62 VK-YYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGI 120
Query: 228 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 287
VHRDIKP N+ LD NG +KL DFG + T + E
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAV---------------KLKNNTTTMGEEV----- 160
Query: 288 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLK---KGYGMECDWWSLGAIMYEMLIGYPPF 344
S GT YMAPEV+ KG+G D WSLG ++ EM G P+
Sbjct: 161 --------------QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPW 206
Query: 345 CSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICH-LLCDVETRLGTRGVEELKEHPW 403
D V P+ ++S E +D + L D + R EL +HP+
Sbjct: 207 SELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTA---SELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 1e-38
Identities = 92/297 (30%), Positives = 138/297 (46%), Gaps = 54/297 (18%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRS---ERNLLAEVDSRCIV 169
L+G G+FG V G+ FA+K++ ++ + GQ E V+ E LL+++ IV
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQ-EAVKQLEQEIALLSKLQHPNIV 65
Query: 170 QLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVH 229
Q + ++ D LY+ +E +PGG + LL + E V R Y + +L + +H N VH
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVH 125
Query: 230 RDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKER 289
RDIK N+++D NG +KL+DFG+ K + +
Sbjct: 126 RDIKGANILVDTNGVVKLADFGMAKQVVEF------------------------------ 155
Query: 290 LQQWKRNRRALAYSTVGTLDYMAPEVLLKKG-YGMECDWWSLGAIMYEMLIGYPPFCSDD 348
+ A S G+ +MAPEV+ ++G YG+ D WSLG + EM G PP+ +
Sbjct: 156 ---------SFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206
Query: 349 PRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC---DVETRLGTRGVEELKEHP 402
KI K P+ +SDEA+D I L C D R EL EHP
Sbjct: 207 GVAAVFKIGRSKELPPIPDH--LSDEAKDFI--LKCLQRDPSLRP---TAAELLEHP 256
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 3e-38
Identities = 93/307 (30%), Positives = 141/307 (45%), Gaps = 63/307 (20%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
+ E+ IG+GA GEV + TG+ A+KK++ L++ E + +E ++ +
Sbjct: 22 KNLEK---IGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKELIINEILIMKDCKH 74
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGG---DIMT---LLMREDILSEDVARFYIAESVL-A 218
IV + S+ D L+++MEY+ GG DI+T + M E ++ Y+ VL
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIA------YVCREVLQG 128
Query: 219 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 278
+ +H N +HRDIK DN++L K+G +KL+DFG + +E
Sbjct: 129 LEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAA---------------QLTKE---- 169
Query: 279 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338
+ KRN S VGT +MAPEV+ +K YG + D WSLG + EM
Sbjct: 170 -------------KSKRN------SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMA 210
Query: 339 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEE 397
G PP+ + P I K K S E +D + L D E R EE
Sbjct: 211 EGEPPYLREPPLRALFLITT-KGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSA---EE 266
Query: 398 LKEHPWF 404
L +HP+
Sbjct: 267 LLQHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 1e-37
Identities = 75/249 (30%), Positives = 114/249 (45%), Gaps = 50/249 (20%)
Query: 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR 166
D+E L IGKG+FG VR R K+ G+I K++ M + + + SE N+L E+
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHP 59
Query: 167 CIVQLFYSFQD--SDFLYLIMEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIH 220
IV+ + D + LY++MEY GGD+ L+ + + E+ + + +LA++
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 221 SIH-----QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQET 275
H + +HRD+KP N+ LD N ++KL DFGL K L
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH----------------- 162
Query: 276 VSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 335
+ A + VGT YM+PE L Y + D WSLG ++Y
Sbjct: 163 ---------------------DSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIY 201
Query: 336 EMLIGYPPF 344
E+ PPF
Sbjct: 202 ELCALSPPF 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 1e-35
Identities = 85/294 (28%), Positives = 126/294 (42%), Gaps = 41/294 (13%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLK--KSEMLKRGQVEHVRSERNLLAEVDSRCIVQ 170
L+G+GAFG V LC TG A+K++ + +V + E LL + IVQ
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 171 LFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHR 230
+ +D + L + MEY+PGG + L L+E V R Y + + + +H + VHR
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHR 128
Query: 231 DIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERL 290
DIK N++ D G++KL DFG K L+ SS
Sbjct: 129 DIKGANILRDSAGNVKLGDFGASKRLQTICSSG--------------------------- 161
Query: 291 QQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPR 350
S GT +M+PEV+ +GYG + D WS+G + EML PP+ +
Sbjct: 162 --------TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM 213
Query: 351 ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWF 404
KI T + P +S +AR+ + VE EEL H +
Sbjct: 214 AAIFKIATQPTNPQLPSH--VSPDARNFLR--RTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 1e-34
Identities = 76/246 (30%), Positives = 114/246 (46%), Gaps = 45/246 (18%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKK--LKKSEMLKRGQVEHVRSERNLLAEV 163
+ F L IGKG+FGEV K T ++ A+K L+++E ++E ++ E L++
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE----DEIEDIQQEIQFLSQC 56
Query: 164 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIH 223
S I + + SF L++IMEY GG + LL + L E F + E +L + +H
Sbjct: 57 RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLH 115
Query: 224 QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQW 283
+ +HRDIK N++L + G +KL+DFG+ L S
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS---------------------- 153
Query: 284 MMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 343
KRN + VGT +MAPEV+ + GY + D WSLG E+ G PP
Sbjct: 154 ----------KRN------TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
Query: 344 FCSDDP 349
P
Sbjct: 198 LSDLHP 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 3e-34
Identities = 90/307 (29%), Positives = 151/307 (49%), Gaps = 50/307 (16%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 173
+GKG FGEV + K TG+++A KKL K + K+ + E+ +L +V+S IV L Y
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 174 SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVAR--FYIAESVLAIHSIHQHNYVHRD 231
+F+ L L+M + GGD+ + ++ R Y A+ I +H + V+RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 232 IKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 291
+KP+N++LD G+ +LSD GL ++ L+D I Q
Sbjct: 121 MKPENVLLDDQGNCRLSDLGL---------AVELKDGKTITQRA---------------- 155
Query: 292 QWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI 351
GT YMAPE+L ++ Y DW+++G +YEM+ G PF ++
Sbjct: 156 --------------GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV 201
Query: 352 TCRKIVNWKTC---LKFPEEPKISDEARDLICHLLC--DVETRLGTRGV-EELKEHPWFR 405
++ + +T +KF E ++E++D IC L E RLG+R ++ ++H +F+
Sbjct: 202 A-KEELKRRTLEDEVKF-EHQNFTEESKD-ICRLFLAKKPEDRLGSREKNDDPRKHEFFK 258
Query: 406 GIQWDKL 412
I + +L
Sbjct: 259 TINFPRL 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 7e-34
Identities = 80/254 (31%), Positives = 123/254 (48%), Gaps = 43/254 (16%)
Query: 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR 166
DFE L IGKG+FG V K ++AMK++ S+M +R + E + R +LA++DS
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEAR-VLAKLDSS 59
Query: 167 CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL--MREDILSED-VARFYIAESVLAIHSIH 223
I++ + SF D L ++MEY GD+ LL R L ED V RF+I + +L + +H
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI-QILLGLAHLH 118
Query: 224 QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQW 283
+HRDIK NL LD ++K+ D G+ K +++ T
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAK---------------LLSDNTN------- 156
Query: 284 MMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 343
A + VGT Y++PE+ K Y + D W+LG ++YE G P
Sbjct: 157 ----------------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHP 200
Query: 344 FCSDDPRITCRKIV 357
F +++ KI+
Sbjct: 201 FDANNQGALILKII 214
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 4e-33
Identities = 81/301 (26%), Positives = 141/301 (46%), Gaps = 49/301 (16%)
Query: 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR 166
+ IG+G+ G V + K+TG A+KK+ ++ K+ + E + +E ++ +
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKM---DLRKQQRRELLFNEVVIMRDYQHP 76
Query: 167 CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVL-AIHSIHQH 225
IV+++ S+ D L+++ME+L GG + ++ + E +A + +VL A+ +H
Sbjct: 77 NIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--TVCLAVLKALSFLHAQ 134
Query: 226 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 285
+HRDIK D+++L +G +KLSDFG C + + +
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE-------------------------V 169
Query: 286 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345
P+ + S VGT +MAPEV+ + YG E D WSLG ++ EM+ G PP+
Sbjct: 170 PRRK-------------SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYF 216
Query: 346 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404
++ P ++I + K K+S R + +L D R EL HP+
Sbjct: 217 NEPPLQAMKRIRDNLP-PKLKNLHKVSPRLRSFLDRMLVRDPAQRATA---AELLNHPFL 272
Query: 405 R 405
Sbjct: 273 A 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 7e-33
Identities = 84/304 (27%), Positives = 143/304 (47%), Gaps = 53/304 (17%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLK-------KSEMLKRGQVEHVRSERNLLAEVDS 165
LIGKG +G V L TTGE+ A+K+++ + + ++ V+ +RSE L ++D
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 225
IVQ ++L + +EY+PGG I + L E + RF+ + + + +H
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK 127
Query: 226 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 285
+HRD+K DNL++D +G K+SDFG+ K +D Y + D+++
Sbjct: 128 GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDN----DQNM--------------- 168
Query: 286 PKERLQQWKRNRRALAYSTVGTLDYMAPEV--LLKKGYGMECDWWSLGAIMYEMLIGYPP 343
S G++ +MAPEV +GY + D WSLG ++ EM G P
Sbjct: 169 -----------------SMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
Query: 344 FCSDDPRITCRKIVNWKTCLKFPEE--PKISDEARDLI--CHLLCDVETRLGTRGVEELK 399
+ ++ K+ N ++ P + +S A D + C + + + R R EL
Sbjct: 212 WSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTI-NPDNRPTAR---ELL 267
Query: 400 EHPW 403
+HP+
Sbjct: 268 QHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 3e-32
Identities = 101/331 (30%), Positives = 141/331 (42%), Gaps = 79/331 (23%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKS---EMLKRGQVEHVRSERNLLAEVD 164
+E L ++G+GA+G V CR K TGEI A+KK K+S E +K+ + V+ R L E
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE-- 60
Query: 165 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ 224
IV L +F+ LYL+ EY+ + L L D R YI + + AI H
Sbjct: 61 --NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS 118
Query: 225 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 284
HN +HRDIKP+N+++ ++G LKL DFG + L
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARAL---------------------------- 150
Query: 285 MPKERLQQWKRNRRALAYST-VGTLDYMAPEVLLKKG-YGMECDWWSLGAIMYEMLIGYP 342
R R A + V T Y APE+L+ YG D W++G IM E+L G P
Sbjct: 151 ----------RARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEP 200
Query: 343 PFCSD----------------DPRITCRKIVNWK-TCLKFPE-----------EPKISDE 374
F D P N + + FPE K+S
Sbjct: 201 LFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSP 260
Query: 375 ARDLICHLLC-DVETRLGTRGVEELKEHPWF 404
A D + L D + RL +EL +HP+F
Sbjct: 261 ALDFLKACLRMDPKERLTC---DELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 3e-32
Identities = 90/328 (27%), Positives = 141/328 (42%), Gaps = 77/328 (23%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRG-QVEHVRSERNLLAEVDSR 166
+E+L +G+G +G V R K TGEI A+KK++ + + G +R E +LL E+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRL-DNEEEGIPSTALR-EISLLKELKHP 58
Query: 167 CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL-MREDILSEDVARFYIAESVLAIHSIHQH 225
IV+L LYL+ EY D+ L R LS ++ + + + + + H H
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH 117
Query: 226 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 285
+HRD+KP N++++++G LKL+DFGL + +
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLARAF---------------------------GI 150
Query: 286 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYPPF 344
P V TL Y APE+LL K Y D WS+G I EM+ G P F
Sbjct: 151 PLRTYTHE-----------VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLF 199
Query: 345 CSDD--------------------PRITCRKIVNWKTCL-KFPEE------PKISDEARD 377
D P +T K+ ++K KFP + P++ E D
Sbjct: 200 PGDSEIDQLFKIFQILGTPTEESWPGVT--KLPDYKPTFPKFPPKDLEKVLPRLDPEGID 257
Query: 378 LICHLLC-DVETRLGTRGVEELKEHPWF 404
L+ +L + R+ +E +HP+F
Sbjct: 258 LLSKMLQYNPAKRI---SAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 7e-32
Identities = 83/331 (25%), Positives = 139/331 (41%), Gaps = 78/331 (23%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 167
+E++ IG+G +G+V R K TGE+ A+KK++ + + +R E LL ++
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR-EIKLLQKLRHPN 59
Query: 168 IVQL---FYSFQDSDFLYLIMEYLPGGDIMTLLMREDI-LSEDVARFYIAESVLAIHSIH 223
IV+L S Y++ EY+ D+ LL ++ +E + Y+ + + + +H
Sbjct: 60 IVRLKEIVTSKGKGSI-YMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH 117
Query: 224 QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQW 283
+ +HRDIK N++++ +G LKL+DFGL +P
Sbjct: 118 SNGILHRDIKGSNILINNDGVLKLADFGLARPYT-------------------------- 151
Query: 284 MMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEMLIGYP 342
KRN + TL Y PE+LL YG E D WS+G I+ E+ +G P
Sbjct: 152 ----------KRNSADYTNRVI-TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKP 200
Query: 343 PFCSDDP-----RIT-------------CRKIVNWKTCLKFPEEPK----------ISDE 374
F +I K+ ++ LK + K I
Sbjct: 201 IFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN-LKPKKPYKRRLREFFKHLIDPS 259
Query: 375 ARDLICHLLC-DVETRLGTRGVEELKEHPWF 404
A DL+ LL D + R+ ++ +H +F
Sbjct: 260 ALDLLDKLLTLDPKKRI---SADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 3e-31
Identities = 65/242 (26%), Positives = 114/242 (47%), Gaps = 48/242 (19%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
+ F+ L +G+G++G V K TG++ A+K + + ++ + E ++L + DS
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV---PV--EEDLQEIIKEISILKQCDS 57
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGG---DIMTLLMREDILSEDVARFYIAESVLAIHSI 222
IV+ + S+ + L+++MEY G DIM + L+E+ + +++ + +
Sbjct: 58 PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMK--ITNKTLTEEEIAAILYQTLKGLEYL 115
Query: 223 HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 282
H + +HRDIK N++L++ G KL+DFG+ L D + + TV
Sbjct: 116 HSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK----------RNTV------ 159
Query: 283 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 342
+GT +MAPEV+ + GY + D WSLG EM G P
Sbjct: 160 ----------------------IGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKP 197
Query: 343 PF 344
P+
Sbjct: 198 PY 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 3e-31
Identities = 70/241 (29%), Positives = 107/241 (44%), Gaps = 46/241 (19%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN--LLAEVDS 165
+++L IG+G +G V R K TGEI A+KK+K + + R LL E++
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRF---ESEGIPKTALREIKLLKELNH 57
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL-MREDILSEDVARFYIAESVLAIHSIHQ 224
I++L F+ LYL+ E++ D+ L+ R+ L E + + Y+ + + + H
Sbjct: 58 PNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS 116
Query: 225 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 284
H +HRD+KP+NL+++ G LKL+DFGL +
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGLARSFGSP----------------------VRP 154
Query: 285 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYPP 343
V T Y APE+LL KGY D WS+G I E+L P
Sbjct: 155 YTHY----------------VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPL 198
Query: 344 F 344
F
Sbjct: 199 F 199
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 4e-31
Identities = 73/241 (30%), Positives = 108/241 (44%), Gaps = 56/241 (23%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKK-----SEMLKRGQVEHVRSERNLLAEVDSRCI 168
+G G FG V L R K TGE+ A+KK+KK E + + V+S R L I
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECM---NLREVKSLRKLNEH---PNI 60
Query: 169 VQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI--LSEDVARFYIAESVLAIHSIHQHN 226
V+L F+++D LY + EY+ G ++ L+ SE V R I + + + IH+H
Sbjct: 61 VKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG 119
Query: 227 YVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMP 286
+ HRD+KP+NL++ +K++DFGL + +
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAREI------------------------------ 149
Query: 287 KERLQQWKRNRRAL-AYSTVGTLDYMAPEVLLKKG-YGMECDWWSLGAIMYEMLIGYPPF 344
R+R Y V T Y APE+LL+ Y D W+LG IM E+ P F
Sbjct: 150 --------RSRPPYTDY--VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLF 199
Query: 345 C 345
Sbjct: 200 P 200
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 8e-30
Identities = 83/274 (30%), Positives = 132/274 (48%), Gaps = 43/274 (15%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLK------KSEMLKRGQVEHVRSERNLLAEVDSR 166
LIG G+FG V L ++GE+ A+K+++ S+ KR ++ + E LL E+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 167 CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHN 226
IVQ S D+D L + +EY+PGG + LL E + R ++ + + ++ +H
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG 126
Query: 227 YVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMP 286
+HRDIK N+++D G +K+SDFG+ K LE + ++ +T
Sbjct: 127 IIHRDIKGANILVDNKGGIKISDFGISKKLE----------ANSLSTKT----------- 165
Query: 287 KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCS 346
R +L G++ +MAPEV+ + Y + D WSLG ++ EML G PF
Sbjct: 166 -------NGARPSLQ----GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF-- 212
Query: 347 DDPRITCRKIVNWKTCLKFPEEPK-ISDEARDLI 379
P T + + PE P IS EA D +
Sbjct: 213 --PDCTQLQAIFKIGENASPEIPSNISSEAIDFL 244
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 87/323 (26%), Positives = 125/323 (38%), Gaps = 77/323 (23%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR--GQVEH-VRSERNLLAEVDSRCIVQ 170
IG+GA G V + + TGE A+KK+ L+R G + + E L +V+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKV----ALRRLEGGIPNQALREIKALQACQHPYVVK 63
Query: 171 LFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHR 230
L F L+MEY+P L E L E + Y+ + + +H + +HR
Sbjct: 64 LLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHR 123
Query: 231 DIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERL 290
D+KP NL++ +G LK++DFGL + + + RL
Sbjct: 124 DLKPANLLISADGVLKIADFGLARLFSE---------------------------EEPRL 156
Query: 291 QQWKRNRRALAYS-TVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEMLIGYPPFCSD- 347
YS V T Y APE+L + Y D W++G I E+L G P F +
Sbjct: 157 -----------YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN 205
Query: 348 DPRITCRKI-----VNWKTC-----------LKFPEE---------PKISDEARDLICHL 382
D N +T + FPE P S EA DL+ L
Sbjct: 206 DIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGL 265
Query: 383 L-CDVETRLGTRGVEELKEHPWF 404
L D RL E HP+F
Sbjct: 266 LVYDPSKRLSA---AEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 87/334 (26%), Positives = 136/334 (40%), Gaps = 93/334 (27%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLK---KSEMLKRGQVEHVRSERNLLAE 162
DD E L +G G G V + TG+I A+K ++ + K+ + E ++L +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQ-----ILRELDILHK 55
Query: 163 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR------EDILSEDVARFYIAESV 216
+S IV + +F ++ + + MEY+ GG + +L E IL + IA +V
Sbjct: 56 CNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK------IAVAV 109
Query: 217 LA--IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQE 274
L + +H +HRD+KP N++++ G +KL DFG+ L +
Sbjct: 110 LKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN---------------- 153
Query: 275 TVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIM 334
+LA + VGT YMAPE + Y ++ D WSLG +
Sbjct: 154 ------------------------SLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSL 189
Query: 335 YEMLIG---YPPFCSDDPRIT----CRKIVNWKTCLKFPEEP------KISDEARDLICH 381
E+ G YPP +DP + IVN E P K S + +D +
Sbjct: 190 IELATGRFPYPP--ENDPPDGIFELLQYIVN--------EPPPRLPSGKFSPDFQDFVNL 239
Query: 382 LLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEM 415
L +EL EHP+ K YE
Sbjct: 240 CLIKDPRE--RPSYKELLEHPFI------KKYES 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 83/279 (29%), Positives = 130/279 (46%), Gaps = 45/279 (16%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 167
+E + IG+G+FG++ L +AK+ E +K++ ++M + + E + E LLA++
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVK-EKEASKKEVILLAKMKHPN 60
Query: 168 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQH 225
IV F SFQ++ L+++MEY GGD+M + R+ + SED + + L + IH
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 226 NYVHRDIKPDNLILDKNGHL-KLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 284
+HRDIK N+ L KNG + KL DFG+ + L D
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME----------------------- 157
Query: 285 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 344
LAY+ VGT Y++PE+ + Y + D WSLG ++YE+ PF
Sbjct: 158 ---------------LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPF 202
Query: 345 CSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLL 383
++ KI P P S + R LI L
Sbjct: 203 EGNNLHQLVLKICQGYFA---PISPNFSRDLRSLISQLF 238
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 3e-29
Identities = 66/243 (27%), Positives = 109/243 (44%), Gaps = 40/243 (16%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
DD+E + +IG GA V E A+K++ + + V+ +R E +++ +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC--QTSVDELRKEVQAMSQCNH 58
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGG---DIMTLLMREDILSEDVARFYIAESVLAIHSI 222
+V+ + SF D L+L+M YL GG DIM L E + + E + + +
Sbjct: 59 PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 223 HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 282
H + +HRDIK N++L ++G +K++DFG+ S+ L + D
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFGV--------SASLADGGD------------- 157
Query: 283 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL-LKKGYGMECDWWSLGAIMYEMLIGY 341
R R+ + VGT +MAPEV+ GY + D WS G E+ G
Sbjct: 158 ------------RTRKVR-KTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGA 204
Query: 342 PPF 344
P+
Sbjct: 205 APY 207
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 3e-29
Identities = 63/234 (26%), Positives = 113/234 (48%), Gaps = 43/234 (18%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 167
+E++ ++G+GAFG V LCR K ++ +K++ +M K + ++E +L +
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKD-ERLAAQNECQVLKLLSHPN 60
Query: 168 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM--REDILSEDVARFYIAESVLAIHSIHQH 225
I++ + +F + L ++MEY PGG + + +L ED + + +LA+H +H
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 226 NYVHRDIKPDNLILDKNGH-LKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 284
+HRD+K N++LDK+ +K+ DFG+ K L K
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK------------------------- 155
Query: 285 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338
+ AY+ VGT Y++PE+ K Y + D W+LG ++YE+
Sbjct: 156 --------------SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELA 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 3e-29
Identities = 77/298 (25%), Positives = 126/298 (42%), Gaps = 41/298 (13%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ---VEHVRSERNLLAEVDSRCIV 169
+G GAF R TG + A+K++ Q VE +R E L+A ++ I+
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 170 QLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVH 229
++ + + L +E++ GG + LL + E V Y + + + +H++ +H
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIH 126
Query: 230 RDIKPDNLILDKNGH-LKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKE 288
RD+K NL++D G L+++DFG L K + E +GQ
Sbjct: 127 RDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG-------------AGEFQGQL----- 168
Query: 289 RLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDD 348
+GT+ +MAPEVL + YG CD WS+G ++ EM PP+ ++
Sbjct: 169 ----------------LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212
Query: 349 PRITCRKIVNWKTCLKFPEEPK-ISDEARDLICHLLCDVETRLGTRGVEELKEHPWFR 405
I + P P+ +S RD+ L C EL +HP FR
Sbjct: 213 HSNHLALIFKIASATTAPSIPEHLSPGLRDVT--LRCLELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 8e-29
Identities = 64/243 (26%), Positives = 116/243 (47%), Gaps = 47/243 (19%)
Query: 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR 166
DF+ L +GKG++G V + + + +A+K++ M ++ + + V +E +LA V+
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV-NEIRILASVNHP 59
Query: 167 CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL-----MREDILSEDVARFYIAESVLAIHS 221
I+ +F D + L ++MEY P GD+ + R+ I +++ R +I + + + +
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI-QLLRGLQA 118
Query: 222 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 281
+H+ +HRD+K N++L N +K+ D G+ K L
Sbjct: 119 LHEQKILHRDLKSANILLVANDLVKIGDLGISKVL------------------------- 153
Query: 282 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341
++ +A + +GT YMAPEV + Y + D WSLG ++YEM
Sbjct: 154 ---------------KKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198
Query: 342 PPF 344
PPF
Sbjct: 199 PPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 1e-28
Identities = 89/295 (30%), Positives = 131/295 (44%), Gaps = 48/295 (16%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLK----KSEMLKRGQVEHVRSERNLLAEVDSRCI 168
L+G+GAFG V LC TG A+K+++ E K +V + E LL + I
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSK--EVNALECEIQLLKNLLHERI 66
Query: 169 VQLFYSFQDS--DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHN 226
VQ + +D L + ME++PGG I L L+E+V R Y + + + +H +
Sbjct: 67 VQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM 126
Query: 227 YVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMP 286
VHRDIK N++ D G++KL DFG K L+ +I L G M
Sbjct: 127 IVHRDIKGANILRDSVGNVKLGDFGASKRLQ----TICL--------------SGTGMK- 167
Query: 287 KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCS 346
S GT +M+PEV+ +GYG + D WS+G + EML PP+
Sbjct: 168 ----------------SVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211
Query: 347 DDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEH 401
+ KI T P P +SD RD + + + + R +EL H
Sbjct: 212 FEAMAAIFKIATQPTNPVLP--PHVSDHCRDFLKRIFVEAKLR---PSADELLRH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 72/244 (29%), Positives = 110/244 (45%), Gaps = 49/244 (20%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
+D+E + IG G +G+V R TGE+ A+K +K E ++ E ++L E
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRH 59
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGG---DIMTLLMREDILSEDVARFYIAESVLAIHSI 222
IV F S+ D L+++MEY GG DI + LSE + E++ + +
Sbjct: 60 PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP--LSELQIAYVCRETLKGLAYL 117
Query: 223 HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 282
H+ +HRDIK N++L ++G +KL+DFG+ L T++
Sbjct: 118 HETGKIHRDIKGANILLTEDGDVKLADFGVSAQLT----------------ATIA----- 156
Query: 283 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL---LKKGYGMECDWWSLGAIMYEMLI 339
KR S +GT +MAPEV K GY +CD W+LG E+
Sbjct: 157 -----------KRK------SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAE 199
Query: 340 GYPP 343
PP
Sbjct: 200 LQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 79/316 (25%), Positives = 129/316 (40%), Gaps = 78/316 (24%)
Query: 106 DDFEQLTLIGK-----GAFGEVRLCRAKTTGEIFAMKKLKKS-----EMLKRGQVEHVRS 155
+ ++ K G FG+V + + K T ++F K +K E + V +
Sbjct: 11 QFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPM----VHQLMK 66
Query: 156 ERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAES 215
D+ ++L+YS LIM+Y+ GD+ LL +E LSE + I +
Sbjct: 67 --------DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQL 118
Query: 216 VLAIHSIHQHNYVHRDIKPDNLILD-KNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQE 274
V A++ +H+HN +H DIK +N++ D + L D+GLCK II
Sbjct: 119 VEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK---------------IIGTP 163
Query: 275 TVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIM 334
+ + GTLDY +PE + Y + DWW++G +
Sbjct: 164 SCYD---------------------------GTLDYFSPEKIKGHNYDVSFDWWAVGVLT 196
Query: 335 YEMLIGYPPFCSD-----DPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVET 388
YE+L G PF D D ++ K P +S A D + +L ++
Sbjct: 197 YELLTGKHPFKEDEDEELDLESLLKRQQK-----KLPFIKNVSKNANDFVQSMLKYNINY 251
Query: 389 RLGTRGVEELKEHPWF 404
RL E+ +HP+
Sbjct: 252 RLTN--YNEIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 1e-27
Identities = 73/278 (26%), Positives = 122/278 (43%), Gaps = 44/278 (15%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 167
+ + ++GKGAFGE L R + K++ + + ++ + +E +L+ +
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKER-RDALNEIVILSLLQHPN 60
Query: 168 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQH 225
I+ + F D + L + MEY GG + ++R+ + E++ +Y+ + V A+ IH+
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 226 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 285
+HRDIK N+ L K G +KL DFG+ K L +YS
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS------------------------ 156
Query: 286 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345
+A + VGT YM+PE+ Y + D W+LG ++YE+L F
Sbjct: 157 --------------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFD 202
Query: 346 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLL 383
+ +P KIV P S E L+ LL
Sbjct: 203 ATNPLNLVVKIV---QGNYTPVVSVYSSELISLVHSLL 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 88/316 (27%), Positives = 134/316 (42%), Gaps = 65/316 (20%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
FE + +IG+G +G+V R K TG++ A+K + E + E ++ E N+L + +
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE----EEIKEEYNILRKYSN 61
Query: 166 RCIVQLFY-------SFQDSDFLYLIMEYLPGGDIM----TLLMREDILSEDVARFYIAE 214
+ FY + D L+L+ME GG + L + L E+ + + E
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 215 SVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQE 274
++ + +H++ +HRDIK N++L KN +KL DFG+ L
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL----------------DS 165
Query: 275 TVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL-----LKKGYGMECDWWS 329
T+ +RN + +GT +MAPEV+ Y D WS
Sbjct: 166 TLG----------------RRN------TFIGTPYWMAPEVIACDEQPDASYDARSDVWS 203
Query: 330 LGAIMYEMLIGYPPFCSDDPRITCRKIV-NWKTCLKFPEEPKISDEARDLICHLLC-DVE 387
LG E+ G PP C P KI N LK PE S + D I L + E
Sbjct: 204 LGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPE--NWSKKFNDFISECLIKNYE 261
Query: 388 TRLGTRGVEELKEHPW 403
R +EEL EHP+
Sbjct: 262 QR---PFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 89/294 (30%), Positives = 139/294 (47%), Gaps = 49/294 (16%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 173
IG+GA G V TG+ A+K++ + K+ E + +E ++ E IV
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK---ELIINEILVMRENKHPNIVNYLD 83
Query: 174 SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIK 233
S+ D L+++MEYL GG +T ++ E + E E + A+ +H + +HRDIK
Sbjct: 84 SYLVGDELWVVMEYLAGGS-LTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 142
Query: 234 PDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQW 293
DN++L +G +KL+DFG C + +Q
Sbjct: 143 SDNILLGMDGSVKLTDFGFCAQITP--------------------------------EQS 170
Query: 294 KRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDP-RIT 352
KR+ + VGT +MAPEV+ +K YG + D WSLG + EM+ G PP+ +++P R
Sbjct: 171 KRS------TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 224
Query: 353 CRKIVNWKTCLKFPEEPKISDEARDLICHLL-CDVETRLGTRGVEELKEHPWFR 405
N L+ PE K+S RD + L DVE R + EL +HP+ +
Sbjct: 225 YLIATNGTPELQNPE--KLSAIFRDFLNRCLEMDVEKRGSAK---ELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 90/297 (30%), Positives = 130/297 (43%), Gaps = 48/297 (16%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLK----KSEMLKRGQVEHVRSERNLLAEVDSRCI 168
L+G+GAFG V LC TG A K+++ E K +V + E LL + I
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSK--EVSALECEIQLLKNLQHERI 66
Query: 169 VQLFYSFQD--SDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHN 226
VQ + +D L + MEY+PGG + L L+E V R Y + + + +H +
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126
Query: 227 YVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMP 286
VHRDIK N++ D G++KL DFG K L+ +I + I
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQ----TICMSGTGI---------------- 166
Query: 287 KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCS 346
S GT +M+PEV+ +GYG + D WSLG + EML PP+
Sbjct: 167 ---------------RSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211
Query: 347 DDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPW 403
+ KI T + P IS+ ARD + + + R EEL HP+
Sbjct: 212 YEAMAAIFKIATQPTNPQLPSH--ISEHARDFLGCIFVEARHR---PSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 4e-27
Identities = 72/240 (30%), Positives = 115/240 (47%), Gaps = 36/240 (15%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKK--LKKSEMLK-RGQVEHVRSERNLLAEVDSRCIV 169
++GKGA+G V C G++ A+K+ L S +L + E ++ E +LL + IV
Sbjct: 7 VLGKGAYGTV-YCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 170 QLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVH 229
Q + D + + + ME++PGG I ++L R L E V Y + + + +H + VH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVH 125
Query: 230 RDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKER 289
RDIK +N++L NG +KL DFG + L + + +++
Sbjct: 126 RDIKGNNVMLMPNGIIKLIDFGCARRL--AWVGLHGTHSNMLK----------------- 166
Query: 290 LQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDP 349
S GT +MAPEV+ + GYG + D WS+G ++EM G PP S D
Sbjct: 167 -------------SMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR 213
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 85/298 (28%), Positives = 143/298 (47%), Gaps = 47/298 (15%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 167
E IG+G+ G V + R K +G A+K + ++ K+ + E + +E ++ + +
Sbjct: 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQHQN 79
Query: 168 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVL-AIHSIHQHN 226
+V+++ S+ + L+++ME+L GG + ++ + + E +A + ESVL A+ +H
Sbjct: 80 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIAT--VCESVLQALCYLHSQG 137
Query: 227 YVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMP 286
+HRDIK D+++L +G +KLSDFG C + +P
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD-------------------------VP 172
Query: 287 KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCS 346
K + S VGT +MAPEV+ + YG E D WSLG ++ EM+ G PP+ S
Sbjct: 173 KRK-------------SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS 219
Query: 347 DDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWF 404
D P + K + K KIS RD + +L T +EL +HP+
Sbjct: 220 DSP-VQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERAT--AQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-26
Identities = 65/233 (27%), Positives = 113/233 (48%), Gaps = 41/233 (17%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 167
+ ++ IG+G+FG+ L ++K G+ + +K++ S+M + + E R E +L+ +
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPK-EREESRKEVAVLSNMKHPN 60
Query: 168 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLL--MREDILSEDVARFYIAESVLAIHSIHQH 225
IVQ SF+++ LY++M+Y GGD+ + R + ED + + LA+ +H
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR 120
Query: 226 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 285
+HRDIK N+ L K+G +KL DFG+ + L TV
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS----------------TVE-------- 156
Query: 286 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338
LA + +GT Y++PE+ + Y + D W+LG ++YEM
Sbjct: 157 --------------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMC 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 5e-26
Identities = 71/246 (28%), Positives = 111/246 (45%), Gaps = 45/246 (18%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV---D 164
+++L LIG+GA+G V + TG + A+K + V ++ E LL+++
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQ 60
Query: 165 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ 224
I + + S+ L++IMEY GG + TL M+ ++E I E ++A+ IH+
Sbjct: 61 PPNITKYYGSYLKGPRLWIIMEYAEGGSVRTL-MKAGPIAEKYISVIIREVLVALKYIHK 119
Query: 225 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 284
+HRDIK N+++ G++KL DFG+
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAA------------------------------ 149
Query: 285 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYPP 343
L Q R VGT +MAPEV+ + K Y + D WSLG +YEM G PP
Sbjct: 150 ----LLNQNSSKRSTF----VGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201
Query: 344 FCSDDP 349
+ D
Sbjct: 202 YSDVDA 207
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 9e-26
Identities = 95/320 (29%), Positives = 151/320 (47%), Gaps = 53/320 (16%)
Query: 92 ETEYMRLQRRKIGIDD----FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR 147
+ E M R + I D + + IG+GA G V TG+ A+K++ + K+
Sbjct: 1 DEEIMEKLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN---LQKQ 57
Query: 148 GQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDV 207
+ E + +E ++ E+ + IV SF D L+++MEYL GG +T ++ E + E
Sbjct: 58 PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGS-LTDVVTETCMDEAQ 116
Query: 208 ARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLED 267
E + A+ +H + +HRDIK DN++L +G +KL+DFG C +
Sbjct: 117 IAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP--------- 167
Query: 268 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDW 327
+Q KR+ + VGT +MAPEV+ +K YG + D
Sbjct: 168 -----------------------EQSKRS------TMVGTPYWMAPEVVTRKAYGPKVDI 198
Query: 328 WSLGAIMYEMLIGYPPFCSDDP-RITCRKIVNWKTCLKFPEEPKISDEARDLICHLL-CD 385
WSLG + EM+ G PP+ +++P R N L+ PE K+S RD + L D
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPE--KLSPIFRDFLNRCLEMD 256
Query: 386 VETRLGTRGVEELKEHPWFR 405
VE R + EL +HP+ +
Sbjct: 257 VEKRGSAK---ELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 74/283 (26%), Positives = 124/283 (43%), Gaps = 50/283 (17%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 164
+ +F+ IGKG F V G + A+KK++ EM+ + E +LL ++D
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 165 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM----REDILSEDVARFYIAESVLAIH 220
+++ SF +++ L +++E GD+ ++ ++ ++ E Y + A+
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 221 SIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAE 280
+H +HRDIKP N+ + G +KL D GL + K ++
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA------------------ 162
Query: 281 GQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 340
A+S VGT YM+PE + + GY + D WSLG ++YEM
Sbjct: 163 --------------------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 202
Query: 341 YPPFCSDDPRI--TCRKIVNWKTCLKFPEEPK--ISDEARDLI 379
PF D + C+KI C +P P S+E RDL+
Sbjct: 203 QSPFYGDKMNLYSLCKKIEK---C-DYPPLPADHYSEELRDLV 241
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 90/337 (26%), Positives = 146/337 (43%), Gaps = 84/337 (24%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 164
+D++E+L I +G +G V R K TGEI A+KKLK + + + +R E N+L ++
Sbjct: 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQ 62
Query: 165 SRCIVQL----FYSFQDSDFLYLIMEYLPGGDIMTLL--MREDILSEDVARFYIAESVLA 218
IV + S + D +Y++MEY+ D+ +L+ M++ L +V + + + +
Sbjct: 63 HPNIVTVKEVVVGS--NLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEV-KCLMLQLLSG 118
Query: 219 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 278
+ +H + +HRD+K NL+L+ G LK+ DFGL + +Y S
Sbjct: 119 VAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAR----EYGS---------------- 158
Query: 279 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEM 337
P + Q V TL Y APE+LL K Y D WS+G I E+
Sbjct: 159 -------PLKPYTQ-----------LVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAEL 200
Query: 338 LIGYPPFC--SDDPRITC----------------RKIVNWKTCLKFPEEP---------- 369
L P F S+ ++ ++ K F + P
Sbjct: 201 LTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKK-TFTKYPYNQLRKKFPA 259
Query: 370 -KISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404
+SD DL+ LL D R+ E+ +HP+F
Sbjct: 260 LSLSDNGFDLLNRLLTYDPAKRISA---EDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-25
Identities = 88/302 (29%), Positives = 133/302 (44%), Gaps = 48/302 (15%)
Query: 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKL----KKSEMLKRGQVEHVRSERNLLAE 162
++ L+G+GAFGEV LC TG A+K++ E K +V + E LL
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSK--EVNALECEIQLLKN 60
Query: 163 VDSRCIVQLFYSFQDSD--FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIH 220
+ IVQ + +D + L + +EY+PGG I L L+E+V R Y + + +
Sbjct: 61 LRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVS 120
Query: 221 SIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAE 280
+H + VHRDIK N++ D G++KL DFG K ++ +I + I
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ----TICMSGTGI---------- 166
Query: 281 GQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 340
S GT +M+PEV+ +GYG + D WS+ + EML
Sbjct: 167 ---------------------KSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTE 205
Query: 341 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKE 400
PP+ + KI T P+ +SD RD + + + E R T E L
Sbjct: 206 KPPWAEYEAMAAIFKIATQPTKPMLPD--GVSDACRDFLKQIFVE-EKRRPT--AEFLLR 260
Query: 401 HP 402
HP
Sbjct: 261 HP 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 89/317 (28%), Positives = 139/317 (43%), Gaps = 68/317 (21%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSE--MLKRGQVEHVRSERNLLAEV 163
+ +L+ +G+GA G V CR K TG IFA+K + L++ + E +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQK----QILRELEINKSC 56
Query: 164 DSRCIVQLFYSFQD--SDFLYLIMEYLPGGDIMTL----LMREDILSEDVARFYIAESVL 217
S IV+ + +F D S + + MEY GG + ++ R + E V IAESVL
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-KIAESVL 115
Query: 218 -AIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETV 276
+ +H +HRDIKP N++L + G +KL DFG ++ E V
Sbjct: 116 KGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFG-------------------VSGELV 156
Query: 277 SEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 336
+ +LA + GT YMAPE + K Y + D WSLG + E
Sbjct: 157 N---------------------SLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLE 195
Query: 337 MLIGYPPFCSD-DPRITCRKIVNWKTCLKFPE---EPKI----SDEARDLICHLLCDVET 388
+ PF + +P + +++++ + PE EP S+E +D I L
Sbjct: 196 VAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCL----E 251
Query: 389 RLGTR--GVEELKEHPW 403
+ TR ++ EHPW
Sbjct: 252 KDPTRRPTPWDMLEHPW 268
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-25
Identities = 73/242 (30%), Positives = 106/242 (43%), Gaps = 46/242 (19%)
Query: 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMK--KLKKSEMLKRGQVEHVRSERNLLAEVD 164
+ L ++G+G+FG L + + + +AMK +L KS VE R E LLA++
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS----SAVEDSRKEAVLLAKMK 56
Query: 165 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTL--LMREDILSEDVARFYIAESVLAIHSI 222
IV SF+ LY++MEY GGD+M L R + ED + + L + I
Sbjct: 57 HPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHI 116
Query: 223 HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 282
H+ +HRDIK N+ L +NG +KL DFG + L
Sbjct: 117 HEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT------------------------- 151
Query: 283 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 342
+ A A + VGT Y+ PE+ Y + D WSLG I+YE+
Sbjct: 152 -------------SPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKH 198
Query: 343 PF 344
PF
Sbjct: 199 PF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 87/300 (29%), Positives = 142/300 (47%), Gaps = 49/300 (16%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 167
+ + IG+GA G V TG+ A+K++ + K+ E + +E ++ E +
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK---ELIINEILVMRENKNPN 77
Query: 168 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 227
IV S+ D L+++MEYL GG +T ++ E + E E + A+ +H +
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGS-LTDVVTETCMDEGQIAAVCRECLQALDFLHSNQV 136
Query: 228 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 287
+HRDIK DN++L +G +KL+DFG C +
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITP----------------------------- 167
Query: 288 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSD 347
+Q KR+ + VGT +MAPEV+ +K YG + D WSLG + EM+ G PP+ ++
Sbjct: 168 ---EQSKRS------TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218
Query: 348 DP-RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRG-VEELKEHPWFR 405
+P R N L+ PE ++S RD + L E + RG +EL +HP+ +
Sbjct: 219 NPLRALYLIATNGTPELQNPE--RLSAVFRDFLNRCL---EMDVDRRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 5e-25
Identities = 77/294 (26%), Positives = 124/294 (42%), Gaps = 66/294 (22%)
Query: 117 GAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCI---VQLFY 173
G +V L T + F +K L+KS R ++ + C+ V L
Sbjct: 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLTII-----------PHCVPNMVCLHK 52
Query: 174 SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIK 233
D ++L++++ GG + + + + + E+ + + AE V+A+ ++H+ V RD+
Sbjct: 53 YIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLN 112
Query: 234 PDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQW 293
P+N++LD GH++L+ F +ED D + + E +
Sbjct: 113 PNNILLDDRGHIQLTYFSRWSEVEDSC------DGEAV----------------ENM--- 147
Query: 294 KRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITC 353
Y APEV CDWWSLGAI++E+L G I
Sbjct: 148 ----------------YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-- 189
Query: 354 RKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETR---LGTRGVEELKEHPWF 404
N T L PE +S+EAR L+ LL T G GVE++K HP+F
Sbjct: 190 ----NTHTTLNIPEW--VSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 87/333 (26%), Positives = 133/333 (39%), Gaps = 83/333 (24%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRS---ERNLLAEVD 164
+E+ +G+G + V R K TG I A+KK+K E K + + E LL E+
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGER-KEAKDGINFTALREIKLLQELK 60
Query: 165 SRCIVQLFYSFQDSDFLYLIMEYLPG------GDIMTLLMREDILSEDVARFYIAESVLA 218
I+ L F + L+ E++ D +L DI S Y+ ++
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKS------YMLMTLRG 114
Query: 219 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 278
+ +H + +HRD+KP+NL++ +G LKL+DFGL + + S
Sbjct: 115 LEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR----SFGS---------------- 154
Query: 279 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEM 337
P ++ V T Y APE+L + YG+ D WS+G I E+
Sbjct: 155 -------PNRKMT-----------HQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAEL 196
Query: 338 LIGYPPFCSDDPRITCRKIV---------NWK--TCL----KFPEEPKI---------SD 373
L+ P D KI NW T L +F P SD
Sbjct: 197 LLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASD 256
Query: 374 EARDLICHLLC-DVETRLGTRGVEELKEHPWFR 405
+A DL+ LL + R+ R + EHP+F
Sbjct: 257 DALDLLQRLLTLNPNKRITAR---QALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 6e-25
Identities = 83/303 (27%), Positives = 148/303 (48%), Gaps = 50/303 (16%)
Query: 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV 163
+D F + IG+G+ G V + K TG+ A+KK+ ++ K+ + E + +E ++ +
Sbjct: 23 YLDSFIK---IGEGSTGIVCIATEKHTGKQVAVKKM---DLRKQQRRELLFNEVVIMRDY 76
Query: 164 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVL-AIHSI 222
+V ++ S+ D L+++ME+L GG + ++ + E +A + SVL A+ +
Sbjct: 77 HHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT--VCLSVLRALSYL 134
Query: 223 HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 282
H +HRDIK D+++L +G +KLSDFG C + +
Sbjct: 135 HNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE----------------------- 171
Query: 283 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 342
+PK + S VGT +MAPEV+ + YG E D WSLG ++ EM+ G P
Sbjct: 172 --VPKRK-------------SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP 216
Query: 343 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHP 402
P+ ++ P R+I + + + K+S R + +L ++ T +EL +HP
Sbjct: 217 PYFNEPPLQAMRRIRD-NLPPRVKDSHKVSSVLRGFLDLMLVREPSQRAT--AQELLQHP 273
Query: 403 WFR 405
+ +
Sbjct: 274 FLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 1e-24
Identities = 76/239 (31%), Positives = 113/239 (47%), Gaps = 38/239 (15%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
+ FE L ++G+GA+G V CR K T EI A+KK K SE + + +R E +L +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR-ELKMLRTLKQ 59
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 225
IV+L +F+ LYL+ EY+ + L + + + R YI + + AIH H++
Sbjct: 60 ENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN 119
Query: 226 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 285
+ VHRDIKP+NL++ N LKL DFG + L + ++ E
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE------------------- 160
Query: 286 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 344
V T Y +PE+LL YG D WS+G I+ E+ G P F
Sbjct: 161 ------------------YVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 81/277 (29%), Positives = 127/277 (45%), Gaps = 56/277 (20%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLF 172
++GKG +G V R +T A+K++ + + V+ + E L + + R IVQ
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDS---RYVQPLHEEIALHSYLKHRNIVQYL 71
Query: 173 YSFQDSDFLYLIMEYLPGGDIMTLL------MREDILSEDVARFYIAESVLAIHSIHQHN 226
S ++ F + ME +PGG + LL ++++ E FY + + + +H +
Sbjct: 72 GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDN---EQTIIFYTKQILEGLKYLHDNQ 128
Query: 227 YVHRDIKPDNLILDK-NGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 285
VHRDIK DN++++ +G +K+SDFG K L IN T
Sbjct: 129 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG------------INPCT---------- 166
Query: 286 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK--KGYGMECDWWSLGAIMYEMLIGYPP 343
+ GTL YMAPEV+ K +GYG D WSLG + EM G PP
Sbjct: 167 ----------------ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
Query: 344 FCS-DDPRITCRKIVNWKTCLKFPEEPKISDEARDLI 379
F +P+ K+ +K + PE +S EA++ I
Sbjct: 211 FIELGEPQAAMFKVGMFKIHPEIPES--LSAEAKNFI 245
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 78/292 (26%), Positives = 145/292 (49%), Gaps = 47/292 (16%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 173
IG+G+ G V + K++G++ A+KK+ ++ K+ + E + +E ++ + +V+++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 174 SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVL-AIHSIHQHNYVHRDI 232
S+ D L+++ME+L GG + ++ + E +A + +VL A+ +H +HRDI
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA--VCLAVLKALSVLHAQGVIHRDI 142
Query: 233 KPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQ 292
K D+++L +G +KLSDFG C +++E +P+ +
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQ---------------VSKE----------VPRRK--- 174
Query: 293 WKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRIT 352
S VGT +MAPE++ + YG E D WSLG ++ EM+ G PP+ ++P +
Sbjct: 175 ----------SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY-FNEPPLK 223
Query: 353 CRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWF 404
K++ K K+S + + LL + T EL +HP+
Sbjct: 224 AMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRAT--AAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 87/300 (29%), Positives = 140/300 (46%), Gaps = 49/300 (16%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 167
+ + IG+GA G V TG+ A++++ + K+ E + +E ++ E +
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKNPN 78
Query: 168 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 227
IV S+ D L+++MEYL GG +T ++ E + E E + A+ +H +
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGS-LTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 228 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 287
+HRDIK DN++L +G +KL+DFG C +
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITP----------------------------- 168
Query: 288 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSD 347
+Q KR+ VGT +MAPEV+ +K YG + D WSLG + EM+ G PP+ ++
Sbjct: 169 ---EQSKRST------MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219
Query: 348 DP-RITCRKIVNWKTCLKFPEEPKISDEARDLICHLL-CDVETRLGTRGVEELKEHPWFR 405
+P R N L+ PE K+S RD + L DVE R + EL +H + +
Sbjct: 220 NPLRALYLIATNGTPELQNPE--KLSAIFRDFLNRCLDMDVEKRGSAK---ELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 83/339 (24%), Positives = 131/339 (38%), Gaps = 84/339 (24%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKL----KKSEMLKRGQVEHVRSERNLLAEV 163
+E L IG GA+G V K TG A+KK+ KR + E LL +
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKR-----ILREIKLLRHL 56
Query: 164 DSRCIVQL---FYSFQDSDF--LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLA 218
I+ L DF +Y++ E + D+ ++ L++D ++++ + +
Sbjct: 57 RHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRG 115
Query: 219 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 278
+ +H N +HRD+KP N++++ N LK+ DFGL + D D + ++E
Sbjct: 116 LKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLAR----------GVDPDEDEKGFLTE 165
Query: 279 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEM 337
Y V T Y APE+LL Y D WS+G I E+
Sbjct: 166 -----------------------Y--VVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAEL 200
Query: 338 L---------------------IGYPPFCSDDPRITCRKIVNWKTCLKFPEE-------P 369
L +G P D IT K N+ L + P
Sbjct: 201 LTRKPLFPGRDYIDQLNLIVEVLGTPSE-EDLKFITSEKARNYLKSLPKKPKKPLSKLFP 259
Query: 370 KISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407
S EA DL+ +L D + R+ +E HP+ +
Sbjct: 260 GASPEAIDLLEKMLVFDPKKRI---TADEALAHPYLAQL 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 6e-24
Identities = 74/242 (30%), Positives = 110/242 (45%), Gaps = 41/242 (16%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 167
F +L IGKG+FGEV T E+ A+K + E ++E ++ E +L++ DS
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPY 63
Query: 168 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 227
I + + S+ L++IMEYL GG + LL + L E + E + + +H
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLL-KPGPLEETYIATILREILKGLDYLHSERK 122
Query: 228 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 287
+HRDIK N++L + G +KL+DFG+ L D
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDT---------------------------- 154
Query: 288 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSD 347
Q KRN + VGT +MAPEV+ + Y + D WSLG E+ G PP
Sbjct: 155 ----QIKRN------TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204
Query: 348 DP 349
P
Sbjct: 205 HP 206
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 2e-23
Identities = 83/311 (26%), Positives = 130/311 (41%), Gaps = 60/311 (19%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
D+ E L +GKG +G V + TG AMK+++ L + + E ++L + S
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVS 58
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL---MREDILSEDVARFYIAESVLAIHSI 222
IV + +F +Y+ MEY+ G + L + + + EDV R V + +
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 223 -HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 281
+HN +HRD+KP N++++ NG +KL DFG+ L
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV------------------------ 154
Query: 282 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG------YGMECDWWSLGAIMY 335
+LA + +G YMAPE + G Y ++ D WSLG +
Sbjct: 155 ----------------ASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSIL 198
Query: 336 EMLIG---YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGT 392
EM +G YPP + IV+ P SD+A+D + L + R T
Sbjct: 199 EMALGRYPYPPETYANIFAQLSAIVD-GDPPTLP--SGYSDDAQDFVAKCLNKIPNRRPT 255
Query: 393 RGVEELKEHPW 403
+L EHPW
Sbjct: 256 --YAQLLEHPW 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 73/251 (29%), Positives = 110/251 (43%), Gaps = 59/251 (23%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRS----ERNLLAEV 163
++++ IG+G +G V R K TGEI A+KK++ + E V S E +LL E+
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLE-----TEDEGVPSTAIREISLLKEL 55
Query: 164 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL--MREDILSEDVARFYIAESVLAIHS 221
+ IV+L + LYL+ E+L D+ + L + + Y+ + + I
Sbjct: 56 NHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY 114
Query: 222 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCK----PLEDKYSSILLEDEDIINQETVS 277
H H +HRD+KP NL++D+ G LKL+DFGL + P+
Sbjct: 115 CHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV--------------------- 153
Query: 278 EAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYE 336
R + V TL Y APE+LL + Y D WS+G I E
Sbjct: 154 --------------------RTYTHEVV-TLWYRAPEILLGSRQYSTPVDIWSIGCIFAE 192
Query: 337 MLIGYPPFCSD 347
M+ P F D
Sbjct: 193 MVNRRPLFPGD 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 6e-23
Identities = 73/245 (29%), Positives = 115/245 (46%), Gaps = 48/245 (19%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSE---MLKRGQVEHVRSERNLLAEVD 164
+E L L+G+G++G V C+ K TG+I A+KK +SE M+K+ + +R +L ++
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIR----MLKQLR 58
Query: 165 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ 224
+V L F+ LYL+ E++ + L + L E R Y+ + + I H
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS 118
Query: 225 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 284
HN +HRDIKP+N+++ ++G +KL DFG + L
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-------------------------- 152
Query: 285 MPKERLQQWKRNRRALAYST-VGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEMLIGYP 342
P E Y+ V T Y APE+L+ YG D W++G ++ EML G P
Sbjct: 153 -PGE------------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEP 199
Query: 343 PFCSD 347
F D
Sbjct: 200 LFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 9e-23
Identities = 62/255 (24%), Positives = 115/255 (45%), Gaps = 55/255 (21%)
Query: 114 IGKGAFGEVRLCRAK----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIV 169
+G+GAFGEV + K A+K LK+ + Q+E E ++ ++D +V
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQ--QIEEFLREARIMRKLDHPNVV 64
Query: 170 QLFYSFQDSDFLYLIMEYLPGGDIMTLL--MREDILSEDVARFY--IAESVLAIHSIHQH 225
+L + + LY++MEY+ GGD+++ L R + D+ F IA + +
Sbjct: 65 KLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIAR---GMEYLESK 121
Query: 226 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 285
N++HRD+ N ++ +N +K+SDFGL + L D+D
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSR---------DLYDDDYYR------------- 159
Query: 286 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML-IGYPPF 344
KR + + +MAPE L + + + D WS G +++E+ +G P+
Sbjct: 160 --------KRGGKL-------PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPY 204
Query: 345 CSDDPRITCRKIVNW 359
P ++ +++ +
Sbjct: 205 ----PGMSNEEVLEY 215
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 68/259 (26%), Positives = 105/259 (40%), Gaps = 67/259 (25%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSE--------MLKRGQVEHVRSERNL 159
+E+L IG+GA+G V R TG A+KK++ L+ E L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR---------EIAL 51
Query: 160 LAEVDSRC---IVQLFYSFQDSDF-----LYLIMEYLPGGDIMTLLMR--EDILSEDVAR 209
L +++S IV+L L L+ E++ D+ T L + + L + +
Sbjct: 52 LKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIK 110
Query: 210 FYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDED 269
+ + + + +H H VHRD+KP N+++ +G +K++DFGL + YS
Sbjct: 111 DLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLAR----IYS-------- 158
Query: 270 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWS 329
AL S V TL Y APEVLL+ Y D WS
Sbjct: 159 --------------------------FEMALT-SVVVTLWYRAPEVLLQSSYATPVDMWS 191
Query: 330 LGAIMYEMLIGYPPFCSDD 348
+G I E+ P F
Sbjct: 192 VGCIFAELFRRRPLFRGTS 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 3e-22
Identities = 71/236 (30%), Positives = 108/236 (45%), Gaps = 41/236 (17%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 167
F +L IGKG+FGEV T ++ A+K + E ++E ++ E +L++ DS
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPY 63
Query: 168 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 227
+ + + S+ L++IMEYL GG + LL R E + E + + +H
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLL-RAGPFDEFQIATMLKEILKGLDYLHSEKK 122
Query: 228 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 287
+HRDIK N++L + G +KL+DFG+ L D
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTD----------------------------- 153
Query: 288 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 343
Q KRN + VGT +MAPEV+ + Y + D WSLG E+ G PP
Sbjct: 154 ---TQIKRN------TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 7e-22
Identities = 84/329 (25%), Positives = 137/329 (41%), Gaps = 91/329 (27%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKK---SEMLKRGQVEHVRSERNLLAEVDSRCIVQ 170
IG+G F EV +++ TG+ +A+K +KK S QV ++R + L I++
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE----QVNNLREIQALRRLSPHPNILR 62
Query: 171 LFYSFQD--SDFLYLIMEYLPGGDIMTL--LM--REDILSEDVARFYIAESVLAIHSIHQ 224
L D + L L+ E + M L L+ R+ L E + Y+ + + ++ +H+
Sbjct: 63 LIEVLFDRKTGRLALVFELMD----MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR 118
Query: 225 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK--YSSILLEDEDIINQETVSEAEGQ 282
+ HRDIKP+N IL K+ LKL+DFG C+ + K Y+ E +S
Sbjct: 119 NGIFHRDIKPEN-ILIKDDILKLADFGSCRGIYSKPPYT------------EYIS----- 160
Query: 283 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG-YGMECDWWSLGAIMYEMLIGY 341
+W Y APE LL G YG + D W++G + +E+L +
Sbjct: 161 --------TRW----------------YRAPECLLTDGYYGPKMDIWAVGCVFFEILSLF 196
Query: 342 PPF----------------CSDDPRITCRKIVNWKTCLKFPEE---------PKISDEAR 376
P F + D + + + FP + P S E
Sbjct: 197 PLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGL 256
Query: 377 DLICHLLC-DVETRLGTRGVEELKEHPWF 404
DL+ LL D + R+ + + HP+F
Sbjct: 257 DLLKKLLAYDPDERITAK---QALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 9e-22
Identities = 52/131 (39%), Positives = 75/131 (57%), Gaps = 7/131 (5%)
Query: 305 VGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLK 364
+GT DY+APE+LL K +G DWW+LG ++E L G PPF + P+ + I+N +
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRD--IP 598
Query: 365 FPE-EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPT 422
+PE E K+S A++ I LL D R G++ELK+HP F G+ W+ L + P
Sbjct: 599 WPEGEEKLSVNAQNAIEILLTMDPTKR---AGLKELKQHPLFHGVDWENLQNQTMPFIPQ 655
Query: 423 VNGELDTQNFE 433
+ E DT FE
Sbjct: 656 PDDETDTSYFE 666
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 1e-21
Identities = 70/288 (24%), Positives = 125/288 (43%), Gaps = 50/288 (17%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 164
+ +F+ IG+G F EV + A+KK++ EM+ + E +LL +++
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 165 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM----REDILSEDVARFYIAESVLAIH 220
+++ SF + + L +++E GD+ ++ ++ ++ E Y + A+
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 221 SIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAE 280
+H +HRDIKP N+ + G +KL D GL + K ++
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA------------------ 162
Query: 281 GQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 340
A+S VGT YM+PE + + GY + D WSLG ++YEM
Sbjct: 163 --------------------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 202
Query: 341 YPPFCSDDPRI--TCRKIVNWKTCLKFPEEPK--ISDEARDLICHLLC 384
PF D + C+KI + C +P P S++ R+L+ +
Sbjct: 203 QSPFYGDKMNLFSLCQKI---EQC-DYPPLPTEHYSEKLRELVSMCIY 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 2e-21
Identities = 58/239 (24%), Positives = 100/239 (41%), Gaps = 61/239 (25%)
Query: 114 IGKGAFGEVRLCRAK----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIV 169
+G+GAFGEV K A+K LK+ + Q+E E ++ ++D IV
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQ--QIEEFLREARIMRKLDHPNIV 64
Query: 170 QLFYSFQDSDFLYLIMEYLPGGDIMTLL--MREDILSE--------DVARFYIAESVLAI 219
+L + + L ++MEY+PGGD++ L R LS +AR +
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIAR--------GM 116
Query: 220 HSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEA 279
+ N++HRD+ N ++ +N +K+SDFGL + L D+D
Sbjct: 117 EYLESKNFIHRDLAARNCLVGENLVVKISDFGLSR---------DLYDDDYYK------- 160
Query: 280 EGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338
+ + + +MAPE L + + + D WS G +++E+
Sbjct: 161 --------------VKGGKL-------PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIF 198
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 3e-21
Identities = 71/242 (29%), Positives = 111/242 (45%), Gaps = 41/242 (16%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 167
F +L IGKG+FGEV T ++ A+K + E ++E ++ E +L++ DS
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPY 63
Query: 168 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 227
+ + + S+ L++IMEYL GG + LL + +A + E + + +H
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATI-LREILKGLDYLHSEKK 122
Query: 228 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 287
+HRDIK N++L ++G +KL+DFG+ L D
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTD----------------------------- 153
Query: 288 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSD 347
Q KRN + VGT +MAPEV+ + Y + D WSLG E+ G PP
Sbjct: 154 ---TQIKRN------TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL 204
Query: 348 DP 349
P
Sbjct: 205 HP 206
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 8e-21
Identities = 70/230 (30%), Positives = 102/230 (44%), Gaps = 45/230 (19%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEM--LKRGQVEHVRSERNLLAEVDSRCIVQL 171
+GKG+FG V L + K +K LK+ + L + E LL+++D IV+
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 172 FYSFQDSDFLYLIMEYLPGGD----IMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 227
SF + D +I EY G D + L LSE+ + + +L +H +HQ
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI 127
Query: 228 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 287
+HRD+K N+ L KN LK+ DFG+ S +L+ D
Sbjct: 128 LHRDLKAKNIFL-KNNLLKIGDFGV--------SRLLMGSCD------------------ 160
Query: 288 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337
LA + GT YM+PE L +GY + D WSLG I+YEM
Sbjct: 161 ------------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 2e-20
Identities = 71/278 (25%), Positives = 125/278 (44%), Gaps = 47/278 (16%)
Query: 111 LTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQ 170
+ ++GKG++GEV L R +T G+ + +KKL +R + + E LL+++ IV
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRR-ERKAAEQEAQLLSQLKHPNIVA 63
Query: 171 LFYSFQDSD-FLYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNY 227
S++ D LY++M + GGD+ L + +L E+ + + +A+ +H+ +
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHI 123
Query: 228 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 287
+HRD+K N+ L + +K+ D G+ + LE++
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD-------------------------- 157
Query: 288 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSD 347
+A + +GT YM+PE+ K Y + D W+LG +YEM F +
Sbjct: 158 ------------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK 205
Query: 348 DPRITCRKIVNWKTCLKFPEEPK-ISDEARDLICHLLC 384
D +I+ K P PK S E +LI +L
Sbjct: 206 DMNSLVYRIIEG----KLPPMPKDYSPELGELIATMLS 239
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 3e-20
Identities = 87/327 (26%), Positives = 129/327 (39%), Gaps = 74/327 (22%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLK-KSEMLKRGQVEHVRSERNLLAEVDSR 166
F+QL +G+G + V R +TTGEI A+K++ +E G E +L+ E+
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE---EGTPSTAIREISLMKELKHE 58
Query: 167 CIVQLFYSFQDSDFLYLIMEYLPGGDI---MTLLMREDILSEDVARFYIAESVLAIHSIH 223
IV+L + L L+ EY+ D+ M L + + + + + I H
Sbjct: 59 NIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117
Query: 224 QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQW 283
++ +HRD+KP NL+++K G LKL+DFGL + I T S
Sbjct: 118 ENRVLHRDLKPQNLLINKRGELKLADFGLARAFG-------------IPVNTFS------ 158
Query: 284 MMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEMLIGYP 342
+ V TL Y AP+VLL + Y D WS+G IM EM+ G P
Sbjct: 159 -------------------NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRP 199
Query: 343 PFCSDDPRITCRKIVN---------WKTCLKFPE----------------EPKISDEARD 377
F + KI W + PE P D
Sbjct: 200 LFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGID 259
Query: 378 LICHLLCDVETRLGTRGVEELKEHPWF 404
L+ LL + L + L+ HPWF
Sbjct: 260 LLHRLL-QLNPELRISAHDALQ-HPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 4e-20
Identities = 78/249 (31%), Positives = 107/249 (42%), Gaps = 52/249 (20%)
Query: 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLK-KSEMLKRGQVEHVRSERNLLAEVDS 165
D+ ++ IG+G +G V R K TG+I AMKK++ +SE + G E +LL E+
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE--EEGVPSTAIREISLLKELQH 58
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSED------VARFYIAESVLAI 219
IV L LYLI E+L M L D L + + + Y+ + + I
Sbjct: 59 PNIVCLQDVLMQESRLYLIFEFLS----MDLKKYLDSLPKGQYMDAELVKSYLYQILQGI 114
Query: 220 HSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEA 279
H +HRD+KP NL++D G +KL+DFGL + A
Sbjct: 115 LFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR------------------------A 150
Query: 280 EGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEML 338
G +P R + V TL Y APEVLL Y D WS+G I EM
Sbjct: 151 FG---IPV----------RVYTHEVV-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMA 196
Query: 339 IGYPPFCSD 347
P F D
Sbjct: 197 TKKPLFHGD 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 4e-20
Identities = 71/247 (28%), Positives = 106/247 (42%), Gaps = 69/247 (27%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRS----ERNLLAEV 163
F+++ IG+G +G V R K TGE+ A+KK++ + E V S E +LL E+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-----ETEGVPSTAIREISLLKEL 56
Query: 164 DSRCIVQLFYSFQDSDFLYLIMEYL-----------PGGDIMTLLMREDILSEDVARFYI 212
+ IV+L + LYL+ E+L P I L++ Y+
Sbjct: 57 NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKS----------YL 106
Query: 213 AESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIIN 272
+ + + H H +HRD+KP NL+++ G +KL+DFGL +
Sbjct: 107 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR------------------ 148
Query: 273 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLG 331
A G + R + V TL Y APE+LL K Y D WSLG
Sbjct: 149 ------AFGVPV-------------RTYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLG 188
Query: 332 AIMYEML 338
I EM+
Sbjct: 189 CIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 7e-20
Identities = 72/242 (29%), Positives = 109/242 (45%), Gaps = 46/242 (19%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ-VEHVRSERNLLAEVD 164
+DFE + IG G +G+V R TGE+ A+K +K L+ G+ V+ E ++ +
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK----LEPGEDFAVVQQEIIMMKDCK 64
Query: 165 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ 224
IV F S+ D L++ ME+ GG + + LSE + E++ ++ +H
Sbjct: 65 HSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHS 124
Query: 225 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 284
+HRDIK N++L NGH+KL+DFG+ Q T + A
Sbjct: 125 KGKMHRDIKGANILLTDNGHVKLADFGVSA------------------QITATIA----- 161
Query: 285 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMECDWWSLGAIMYEMLIGY 341
KR S +GT +MAPEV K GY CD W++G E+
Sbjct: 162 ---------KRK------SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQ 206
Query: 342 PP 343
PP
Sbjct: 207 PP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 73/250 (29%), Positives = 109/250 (43%), Gaps = 66/250 (26%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLK--RGQVEHVRSERNLLAEV 163
DDFE+L +G G G V + +G I A +KL E+ R Q+ +R E +L E
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMA-RKLIHLEIKPAIRNQI--IR-ELKVLHEC 56
Query: 164 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSI- 222
+S IV + +F + + ME++ GG + D + + R I E++L SI
Sbjct: 57 NSPYIVGFYGAFYSDGEISICMEHMDGGSL-------DQVLKKAGR--IPENILGKISIA 107
Query: 223 ---------HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 273
+H +HRD+KP N++++ G +KL DFG+ L D
Sbjct: 108 VLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--------------- 152
Query: 274 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 333
++A S VGT YM+PE L Y ++ D WSLG
Sbjct: 153 -------------------------SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLS 187
Query: 334 MYEMLIG-YP 342
+ EM IG YP
Sbjct: 188 LVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 1e-19
Identities = 66/248 (26%), Positives = 116/248 (46%), Gaps = 39/248 (15%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR--------GQVE-HVRSERNL--LAE 162
+G+G +G+V TG+I A+KK+K E+ G H + R L + E
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 163 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSI 222
+ I+ L + + DF+ L+M+ + D+ ++ R+ L+E + + + + ++ +
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQILNGLNVL 135
Query: 223 HQHNYVHRDIKPDNLILDKNGHLKLSDFGLC-KPLEDKYSSILLEDEDIINQETVSEAEG 281
H+ ++HRD+ P N+ ++ G K++DFGL + YS L +DE
Sbjct: 136 HKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE------------- 182
Query: 282 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEMLIG 340
M +E + S V TL Y APE+L+ + Y D WS+G I E+L G
Sbjct: 183 -TMQRREEMT-----------SKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230
Query: 341 YPPFCSDD 348
P F ++
Sbjct: 231 KPLFPGEN 238
|
Length = 335 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 88.3 bits (220), Expect = 1e-19
Identities = 62/251 (24%), Positives = 107/251 (42%), Gaps = 60/251 (23%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGE----IFAMKKLKKSEMLKRGQVEHVRSERNLLAEV 163
E +G+GAFGEV K GE A+K LK+ + + E E +++ ++
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEE--EREEFLEEASIMKKL 58
Query: 164 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR-------EDIL--SEDVARFYIAE 214
IV+L + LY++ EY+PGGD++ L + +D+L + +A+
Sbjct: 59 SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAK----- 113
Query: 215 SVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQE 274
+ + N+VHRD+ N ++ +N +K+SDFGL + DI +
Sbjct: 114 ---GMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSR--------------DIYEDD 156
Query: 275 TVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIM 334
+ G + K W MAPE L + + D WS G ++
Sbjct: 157 YYRKRGGGKLPIK-----W-----------------MAPESLKDGKFTSKSDVWSFGVLL 194
Query: 335 YEML-IGYPPF 344
+E+ +G P+
Sbjct: 195 WEIFTLGEQPY 205
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 1e-19
Identities = 50/238 (21%), Positives = 99/238 (41%), Gaps = 54/238 (22%)
Query: 114 IGKGAFGEVRLCRAKTTGEIF---AMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQ 170
+G+GAFGEV + K A+K LK+ + + + E ++ ++ +V+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVR 60
Query: 171 LF-YSFQDSDFLYLIMEYLPGGDIMTLL----------MREDILSEDVARFYIAESVLAI 219
L ++ LYL++EY+ GGD++ L + + +D+ F + +
Sbjct: 61 LLGVCTEEEP-LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSF-AIQIAKGM 118
Query: 220 HSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEA 279
+ +VHRD+ N ++ ++ +K+SDFGL + + D + +
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD-------------DDYYRKKT 165
Query: 280 EGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337
G +P + +MAPE L + + D WS G +++E+
Sbjct: 166 GG--KLP---------------------IRWMAPESLKDGIFTSKSDVWSFGVLLWEI 200
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 1e-19
Identities = 64/265 (24%), Positives = 119/265 (44%), Gaps = 53/265 (20%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGE-IFAMKKLK-KSEMLKRGQVEHVRSERNLLAEVD- 164
+ L +G GAFG V R K G+ + A+K++ + + + E +S ++++EV
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 165 ------SRCIVQLFYSFQDSDFLYLIMEYLPGGDI----MTLLMREDILSEDVARFYIAE 214
IV+ + +F ++D LY++M+ + G + +L ++ +E+ +
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 215 SVLAIHSIHQHNY-VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 273
VLA+ +H+ VHRD+ P+N++L ++ + ++DFGL K
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK------------------- 162
Query: 274 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 333
++ + S VGT+ Y PE++ + YG + D W+ G I
Sbjct: 163 --------------------QKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCI 202
Query: 334 MYEMLIGYPPFCSDDPRITCRKIVN 358
+Y+M PPF S + KIV
Sbjct: 203 LYQMCTLQPPFYSTNMLSLATKIVE 227
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 3e-19
Identities = 69/274 (25%), Positives = 119/274 (43%), Gaps = 50/274 (18%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 173
IG+G F EV G A+KK++ +++ E +LL +++ +++ +
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 174 SFQDSDFLYLIMEYLPGGDIMTLLM----REDILSEDVARFYIAESVLAIHSIHQHNYVH 229
SF + + L +++E GD+ ++ ++ ++ E Y + A+ +H +H
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMH 129
Query: 230 RDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKER 289
RDIKP N+ + G +KL D GL + K ++
Sbjct: 130 RDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--------------------------- 162
Query: 290 LQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDP 349
A+S VGT YM+PE + + GY + D WSLG ++YEM PF D
Sbjct: 163 -----------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 211
Query: 350 RI--TCRKIVNWKTCLKFPEEPK--ISDEARDLI 379
+ C+KI + C +P P S+E R L+
Sbjct: 212 NLYSLCKKI---EQC-DYPPLPSDHYSEELRQLV 241
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 4e-19
Identities = 79/248 (31%), Positives = 119/248 (47%), Gaps = 54/248 (21%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN--LLAEV-D 164
+E L +GKGA+G V + T E+ A+KK+ + R + R+ R L E+ D
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDA---FRNATDAQRTFREIMFLQELGD 65
Query: 165 SRCIVQL---FYSFQDSDFLYLIMEYLPGGDIMTLL---MREDILSEDVARFYIAESVL- 217
IV+L + D D +YL+ EY+ T L +R +IL EDV + YI +L
Sbjct: 66 HPNIVKLLNVIKAENDKD-IYLVFEYME-----TDLHAVIRANIL-EDVHKRYIMYQLLK 118
Query: 218 AIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVS 277
A+ IH N +HRD+KP N++L+ + +KL+DFGL + L S + E+ + + V+
Sbjct: 119 ALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSL----SELEENPENPVLTDYVA 174
Query: 278 EAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYE 336
+W Y APE+LL Y D WS+G I+ E
Sbjct: 175 -------------TRW----------------YRAPEILLGSTRYTKGVDMWSVGCILGE 205
Query: 337 MLIGYPPF 344
ML+G P F
Sbjct: 206 MLLGKPLF 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 65/244 (26%), Positives = 113/244 (46%), Gaps = 52/244 (21%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSE---MLKRGQVEHVRSERNLLAE 162
+ +E+L+ IG+G++G V CR + TG+I A+KK +SE ++K+ + +R +L +
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIR----MLKQ 56
Query: 163 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSI 222
+ +V L F+ L+L+ EY + L + E + + I +++ A++
Sbjct: 57 LKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFC 116
Query: 223 HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCK---PLEDKYSSILLEDEDIINQETVSEA 279
H+HN +HRD+KP+N+++ K G +KL DFG + D Y+
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDY---------------- 160
Query: 280 EGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEML 338
V T Y APE+L+ YG D W++G + E+L
Sbjct: 161 -------------------------VATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELL 195
Query: 339 IGYP 342
G P
Sbjct: 196 TGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 69/247 (27%), Positives = 111/247 (44%), Gaps = 50/247 (20%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRG-QVEHVRSERNLLAEV 163
+ +FE+L IG+G +G V R T+GEI A+KK++ + + G + +R E LL +
Sbjct: 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVR-MDNERDGIPISSLR-EITLLLNL 63
Query: 164 DSRCIVQLFYSFQDS--DFLYLIMEYLPGGDIMTLLMREDI---LSEDVARFYIAESVLA 218
IV+L D ++L+MEY D+ +LL +++ SE + + + +
Sbjct: 64 RHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLL--DNMPTPFSESQVKCLMLQLLRG 120
Query: 219 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 278
+ +H++ +HRD+K NL+L G LK++DFGL +
Sbjct: 121 LQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP---------------- 164
Query: 279 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEM 337
M PK V TL Y APE+LL Y D W++G I+ E+
Sbjct: 165 -----MTPK-----------------VVTLWYRAPELLLGCTTYTTAIDMWAVGCILAEL 202
Query: 338 LIGYPPF 344
L P
Sbjct: 203 LAHKPLL 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 71/256 (27%), Positives = 114/256 (44%), Gaps = 67/256 (26%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKK-------------LKKSEMLKRGQVEH 152
++ L+ IG+GA+G V K TG A+KK L++ ++L+R + E+
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 153 VRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYI 212
+ +++ S SF D +Y++ E + D+ L+ + LS D ++++
Sbjct: 65 IIGILDII-RPPSFE------SFND---VYIVQELMET-DLYKLI-KTQHLSNDHIQYFL 112
Query: 213 AESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCK---PLEDKYSSILLEDED 269
+ + + IH N +HRD+KP NL+L+ N LK+ DFGL + P D ++ L E
Sbjct: 113 YQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD-HTGFLTE--- 168
Query: 270 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWW 328
Y V T Y APE++L KGY D W
Sbjct: 169 --------------------------------Y--VATRWYRAPEIMLNSKGYTKAIDIW 194
Query: 329 SLGAIMYEMLIGYPPF 344
S+G I+ EML P F
Sbjct: 195 SVGCILAEMLSNRPLF 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 86/313 (27%), Positives = 128/313 (40%), Gaps = 64/313 (20%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
D +E + IGKG +G+V K G A+K L + E + +E N+L +
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID----EEIEAEYNILKALSD 73
Query: 166 RCIVQLFYSF------QDSDFLYLIMEYLPGGDIMTL----LMREDILSEDVARFYIAES 215
V FY ++ D L+L++E GG + L L R + + E + + + E+
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 216 VLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQET 275
++ + +H + +HRD+K +N++L G +KL DFG+ L
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS----------------- 176
Query: 276 VSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL-----LKKGYGMECDWWSL 330
R RR ++VGT +MAPEV+ L Y CD WSL
Sbjct: 177 ------------------TRLRRN---TSVGTPFWMAPEVIACEQQLDSTYDARCDVWSL 215
Query: 331 GAIMYEMLIGYPPFCSDDPRITCRKIV-NWKTCLKFPEEPKISDEARDLICHLLC-DVET 388
G E+ G PP P KI N L PE S+E D I L D E
Sbjct: 216 GITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPE--LWSNEFNDFIRKCLTKDYEK 273
Query: 389 RLGTRGVEELKEH 401
R V +L +H
Sbjct: 274 R---PTVSDLLQH 283
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 2e-18
Identities = 70/221 (31%), Positives = 97/221 (43%), Gaps = 41/221 (18%)
Query: 129 TTGEIFAMKKLKKSEMLK-RGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEY 187
T G K + K ML Q + RSE + LA D IV+ F F+ D L LIMEY
Sbjct: 87 TRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146
Query: 188 LPGGDIMTLL---MREDI-LSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG 243
GGD+ + ++E + E + VLA+ +H +HRD+K N+ L G
Sbjct: 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG 206
Query: 244 HLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYS 303
+KL DFG K D S+ L+ +A S
Sbjct: 207 IIKLGDFGFSKQYSD---SVSLD---------------------------------VASS 230
Query: 304 TVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 344
GT Y+APE+ +K Y + D WSLG I+YE+L + PF
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF 271
|
Length = 478 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 70/256 (27%), Positives = 110/256 (42%), Gaps = 56/256 (21%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS-R 166
FE + ++G G +G+V R TG++ A+K + +E + E ++ E N+L + R
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHR 73
Query: 167 CIVQLFYSF------QDSDFLYLIMEYLPGGDIMTLL--MREDILSEDVARFYIAESVLA 218
I + +F D L+L+ME+ G + L+ + + L ED + E +
Sbjct: 74 NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133
Query: 219 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 278
+ +H H +HRDIK N++L +N +KL DFG+ L+ TV
Sbjct: 134 LAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD----------------RTVG- 176
Query: 279 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDWWSLGAI 333
+RN + +GT +MAPEV+ Y D WSLG
Sbjct: 177 ---------------RRN------TFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGIT 215
Query: 334 MYEMLIGYPPFCSDDP 349
EM G PP C P
Sbjct: 216 AIEMAEGAPPLCDMHP 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 3e-18
Identities = 70/256 (27%), Positives = 111/256 (43%), Gaps = 56/256 (21%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS-R 166
FE + L+G G +G+V R TG++ A+K + + + E ++ E N+L + R
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 63
Query: 167 CIVQLFYSFQDS------DFLYLIMEYLPGGDIMTLL--MREDILSEDVARFYIAESVLA 218
I + +F D L+L+ME+ G + L+ + + L E+ + E +
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123
Query: 219 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 278
+ +HQH +HRDIK N++L +N +KL DFG+ L+ TV
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD----------------RTVG- 166
Query: 279 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDWWSLGAI 333
+RN + +GT +MAPEV+ Y + D WSLG
Sbjct: 167 ---------------RRN------TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGIT 205
Query: 334 MYEMLIGYPPFCSDDP 349
EM G PP C P
Sbjct: 206 AIEMAEGAPPLCDMHP 221
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 74/261 (28%), Positives = 110/261 (42%), Gaps = 70/261 (26%)
Query: 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV 163
+ +E+L IG+G FGEV R K T +I A+KK+ E K G E +L +
Sbjct: 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLM-ENEKEGFPITALREIKILQLL 68
Query: 164 DSRCIVQLF---------YSFQDSDFLYLIMEY----LPGGDIMTLLMREDILSEDVARF 210
+V L Y+ F YL+ E+ L G +LS +F
Sbjct: 69 KHENVVNLIEICRTKATPYNRYKGSF-YLVFEFCEHDLAG-----------LLSNKNVKF 116
Query: 211 YIAE--SVL-----AIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 263
++E V+ ++ IH++ +HRD+K N+++ K+G LKL+DFGL +
Sbjct: 117 TLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF------- 169
Query: 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYST-VGTLDYMAPEVLL-KKGY 321
S ++ K NR Y+ V TL Y PE+LL ++ Y
Sbjct: 170 -------------SLSKNS-----------KPNR----YTNRVVTLWYRPPELLLGERDY 201
Query: 322 GMECDWWSLGAIMYEMLIGYP 342
G D W G IM EM P
Sbjct: 202 GPPIDMWGAGCIMAEMWTRSP 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 3e-18
Identities = 60/244 (24%), Positives = 107/244 (43%), Gaps = 51/244 (20%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKL---KKSEMLKRGQVEHVRSERNLLAE 162
+D E ++ +G G G V + TG + A K + KS + K+ + E ++ E
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQ-----ILRELQIMHE 59
Query: 163 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLA--IH 220
S IV + +F + + + + ME++ G + + + + ++ IA +V+ +
Sbjct: 60 CRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-KIAVAVVEGLTY 118
Query: 221 SIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAE 280
+ H +HRDIKP N++++ G +KL DFG+ L IN
Sbjct: 119 LYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL--------------IN-------- 156
Query: 281 GQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 340
++A + VGT YM+PE + Y ++ D WSLG + E+ +G
Sbjct: 157 ------------------SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALG 198
Query: 341 YPPF 344
PF
Sbjct: 199 KFPF 202
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 66/254 (25%), Positives = 109/254 (42%), Gaps = 51/254 (20%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKK-LKKSEMLKRG-QVEHVRSERNLLAE 162
+ D+E L +G+G FGEV R TG + A+KK L +E K G + +R E +L +
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE--KDGFPITALR-EIKILKK 63
Query: 163 VDSRCIVQL---FYSFQDSDF-----LYLIMEYLPGGDIMTLLMREDI-LSEDVARFYIA 213
+ +V L D +Y++ Y+ D+ LL + L+E + Y+
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM-DHDLSGLLENPSVKLTESQIKCYML 122
Query: 214 ESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 273
+ + I+ +H+++ +HRDIK N+++D G LK++DFGL +P +
Sbjct: 123 QLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGP-------------- 168
Query: 274 ETVSEAEGQWMMPKERLQQWKR----NRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWW 328
K R + V T Y PE+LL ++ Y D W
Sbjct: 169 ----------------PPNPKGGGGGGTRKYT-NLVVTRWYRPPELLLGERRYTTAVDIW 211
Query: 329 SLGAIMYEMLIGYP 342
+G + EM P
Sbjct: 212 GIGCVFAEMFTRRP 225
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 7e-18
Identities = 66/257 (25%), Positives = 108/257 (42%), Gaps = 63/257 (24%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKK---SEMLKRGQVEHVRSERNLLAE 162
D ++ L+ +G GA+G+V TG A+KKL + S + + +R LL
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELR----LLKH 70
Query: 163 VDSRCIVQL---------FYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIA 213
+D ++ L FQD +YL+ L G D+ + ++ LS+D +F +
Sbjct: 71 MDHENVIGLLDVFTPASSLEDFQD---VYLVTH-LMGADLNNI-VKCQKLSDDHIQFLVY 125
Query: 214 ESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 273
+ + + IH +HRD+KP N+ ++++ LK+ DFGL + +D+ +
Sbjct: 126 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT------------ 173
Query: 274 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG-YGMECDWWSLGA 332
Y V T Y APE++L Y D WS+G
Sbjct: 174 ---------------------------GY--VATRWYRAPEIMLNWMHYNQTVDIWSVGC 204
Query: 333 IMYEMLIGYPPFCSDDP 349
IM E+L G F D
Sbjct: 205 IMAELLTGKTLFPGSDH 221
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 8e-18
Identities = 76/264 (28%), Positives = 119/264 (45%), Gaps = 82/264 (31%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD- 164
+D + L IG+GAFG V K +G I A+K++ R V+ + ++ LL ++D
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRI-------RSTVDE-KEQKRLLMDLDV 55
Query: 165 ----SRC--IVQLFYS--FQDSDFLYLIMEYLPGGDIMTLLMREDILSE---DVARFYIA 213
S C IV+ FY F++ D ++ ME +M + + D + +V + I
Sbjct: 56 VMRSSDCPYIVK-FYGALFREGD-CWICME------LMDISL--DKFYKYVYEVLKSVIP 105
Query: 214 ESVL---AIHSIHQHNY-------VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 263
E +L A+ ++ NY +HRD+KP N++LD+NG++KL DFG+ L D SI
Sbjct: 106 EEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD---SI 162
Query: 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKG 320
+ R A G YMAPE + + G
Sbjct: 163 ------------------------------AKTRDA------GCRPYMAPERIDPSARDG 186
Query: 321 YGMECDWWSLGAIMYEMLIGYPPF 344
Y + D WSLG +YE+ G P+
Sbjct: 187 YDVRSDVWSLGITLYEVATGKFPY 210
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 82/316 (25%), Positives = 135/316 (42%), Gaps = 70/316 (22%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMK--KLKKSEMLKRGQVEHVRSERNLLAE 162
D +E + +G GAFG+V + K TG A K +++ E ++E E ++L+E
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEE-----ELEDFMVEIDILSE 58
Query: 163 VDSRCIVQLFYSFQDSDFLYLIMEYLPGG---DIMTLLMREDILSEDVARFYIAESVLAI 219
IV L+ ++ + L++++E+ GG IM L E L+E R+ + + A+
Sbjct: 59 CKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEAL 116
Query: 220 HSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEA 279
+ +H H +HRD+K N++L +G +KL+DFG+ S +
Sbjct: 117 NFLHSHKVIHRDLKAGNILLTLDGDVKLADFGV---------SAKNKSTL---------- 157
Query: 280 EGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDWWSLGAIM 334
KR+ + +GT +MAPEV+ Y + D WSLG +
Sbjct: 158 -------------QKRD------TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITL 198
Query: 335 YEMLIGYPPFCSDDPRITCRKIVNWKTCLKFP----EEP-KISDEARDLICHLLC-DVET 388
E+ PP +P KI LK ++P K S D + L D +
Sbjct: 199 IELAQMEPPHHELNPMRVLLKI------LKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDD 252
Query: 389 RLGTRGVEELKEHPWF 404
R EL +HP+
Sbjct: 253 RPTAA---ELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 88/317 (27%), Positives = 129/317 (40%), Gaps = 64/317 (20%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
D +E + IGKG +G+V K G + A+K L E + +E N+L + +
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI----SDVDEEIEAEYNILQSLPN 77
Query: 166 RCIVQLFYS-FQDSDF-----LYLIMEYLPGGDIMTL----LMREDILSEDVARFYIAES 215
V FY F +D L+L++E GG + L L+ L E + + + +
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137
Query: 216 VLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQET 275
+L + +H + +HRD+K +N++L G +KL DFG+ L
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST---------------- 181
Query: 276 VSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL-----LKKGYGMECDWWSL 330
RL +RN ++VGT +MAPEV+ Y CD WSL
Sbjct: 182 -------------RL---RRN------TSVGTPFWMAPEVIACEQQYDYSYDARCDVWSL 219
Query: 331 GAIMYEMLIGYPPFCSDDPRITCRKIV-NWKTCLKFPEEPKISDEARDLICH-LLCDVET 388
G E+ G PP P T KI N L PE K I L+ D E
Sbjct: 220 GITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPE--KWCRSFNHFISQCLIKDFEA 277
Query: 389 RLGTRGVEELKEHPWFR 405
R V L EHP+ +
Sbjct: 278 R---PSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 4e-17
Identities = 88/340 (25%), Positives = 136/340 (40%), Gaps = 100/340 (29%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRS----ERNLLAEV 163
+E+L IG+G +G V + + T EI A+K+++ + E V S E LL E+
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-----DDEGVPSSALREICLLKEL 56
Query: 164 DSRCIVQLFYSFQDSDFLYLIMEYLP----------GGDIMTLLMREDILSEDVARFYIA 213
+ IV+L+ L L+ EY GDI ++ + ++
Sbjct: 57 KHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDI----------DPEIVKSFMF 106
Query: 214 ESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 273
+ + + H HN +HRD+KP NL+++KNG LKL+DFGL +
Sbjct: 107 QLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARA------------------ 148
Query: 274 ETVSEAEGQWMMPKERLQQWKRNRRALAYST-VGTLDYMAPEVLL-KKGYGMECDWWSLG 331
+ +P YS V TL Y P+VL K Y D WS G
Sbjct: 149 ---------FGIPVR------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAG 187
Query: 332 AIMYEML-IGYPPFCSDDPRITCRKIV---------NWKTCLKFPEE------------- 368
I E+ G P F +D ++I +W K P+
Sbjct: 188 CIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLV 247
Query: 369 ---PKISDEARDLI-CHLLCDVETRLGTRGVEELKEHPWF 404
PK++ RDL+ L+C+ R+ EE +HP+F
Sbjct: 248 NVVPKLNSTGRDLLQNLLVCNPVQRISA---EEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 6e-17
Identities = 72/252 (28%), Positives = 115/252 (45%), Gaps = 51/252 (20%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 164
+D F+ + IG+G +G+V R K TGE+ A+KK++ + + +R E +L +++
Sbjct: 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLN 64
Query: 165 SRCIVQLFYSFQDS----DFL------YLIMEYLPGGDIMTLLMREDI-LSEDVARFYIA 213
R IV L D DF YL+ EY+ D+M LL + SED + ++
Sbjct: 65 HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLESGLVHFSEDHIKSFMK 123
Query: 214 ESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 273
+ + ++ H+ N++HRDIK N++L+ G +KL+DFGL
Sbjct: 124 QLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA-------------------- 163
Query: 274 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGA 332
RL + + V TL Y PE+LL ++ YG D WS G
Sbjct: 164 ---------------RL--YNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 206
Query: 333 IMYEMLIGYPPF 344
I+ E+ P F
Sbjct: 207 ILGELFTKKPIF 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 9e-17
Identities = 78/311 (25%), Positives = 132/311 (42%), Gaps = 69/311 (22%)
Query: 92 ETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVE 151
+ + Q +K I ++G GA G V + + GE FA+K + E +
Sbjct: 23 DEATAKEQAKKYWIS-----RVLGSGATGTVLCAKRVSDGEPFAVKVVD-MEGMSEADKN 76
Query: 152 HVRSERNLLAEVDSRCIVQLFYSFQDSD--------FLYLIMEYLPGGDIMTLLMREDIL 203
++E L D IV+ F D + L+++Y GD +R++I
Sbjct: 77 RAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGD-----LRQEIK 131
Query: 204 S---------EDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCK 254
S E A + +LA+H +H + +HRDIK N++L NG +KL DFG K
Sbjct: 132 SRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK 191
Query: 255 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPE 314
Y++ TVS+ G+ + GT Y+APE
Sbjct: 192 ----MYAA------------TVSDDVGR--------------------TFCGTPYYVAPE 215
Query: 315 VLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKF-PEEPKISD 373
+ +K Y + D +SLG ++YE+L PF ++ ++++ ++ P P IS
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN----MEEVMHKTLAGRYDPLPPSISP 271
Query: 374 EARDLICHLLC 384
E ++++ LL
Sbjct: 272 EMQEIVTALLS 282
|
Length = 496 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 72/247 (29%), Positives = 109/247 (44%), Gaps = 44/247 (17%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 164
+D +E++ IG+G +G V R + T E A+KK++ E G E +LL E+
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRL-EQEDEGVPSTAIREISLLKEMQ 59
Query: 165 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSED--VARFYIAESVLAIHSI 222
IV+L LYL+ EYL D+ + +++ + + Y+ + + I
Sbjct: 60 HGNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC 118
Query: 223 HQHNYVHRDIKPDNLILDK-NGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 281
H H +HRD+KP NL++D+ LKL+DFGL + A G
Sbjct: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR------------------------AFG 154
Query: 282 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEMLIG 340
+P R + V TL Y APE+LL + Y D WS+G I EM+
Sbjct: 155 ---IPV----------RTFTHEVV-TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQ 200
Query: 341 YPPFCSD 347
P F D
Sbjct: 201 KPLFPGD 207
|
Length = 294 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 67/246 (27%), Positives = 107/246 (43%), Gaps = 43/246 (17%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
DDFE+++ +G G G V K +G I A +KL E +K + E +L E +S
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMA-RKLIHLE-IKPAIRNQIIRELQVLHECNS 62
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDV-ARFYIAESVLAIHSIHQ 224
IV + +F + + ME++ GG + +L + + E + + IA + +
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 122
Query: 225 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 284
H +HRD+KP N++++ G +KL DFG+ L D
Sbjct: 123 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-------------------------- 156
Query: 285 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 344
++A S VGT YM+PE L Y ++ D WS+G + EM IG P
Sbjct: 157 --------------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
Query: 345 CSDDPR 350
D +
Sbjct: 203 PPPDAK 208
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 66/246 (26%), Positives = 108/246 (43%), Gaps = 43/246 (17%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
DDFE+++ +G G G V + K +G I A +KL E +K + E +L E +S
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMA-RKLIHLE-IKPAIRNQIIRELQVLHECNS 62
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDV-ARFYIAESVLAIHSIHQ 224
IV + +F + + ME++ GG + +L + E++ + IA + +
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 122
Query: 225 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 284
H +HRD+KP N++++ G +KL DFG+ L D
Sbjct: 123 HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-------------------------- 156
Query: 285 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 344
++A S VGT YM+PE L Y ++ D WS+G + E+ IG P
Sbjct: 157 --------------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
Query: 345 CSDDPR 350
D +
Sbjct: 203 PPPDAK 208
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 88/327 (26%), Positives = 138/327 (42%), Gaps = 91/327 (27%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD- 164
DD E + +G+GA+G V R TG I A+K++ R V + ++ LL ++D
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRI-------RATVN-SQEQKRLLMDLDI 52
Query: 165 ---SRCIVQL--FYS--FQDSDFLYLIME-------------YLPGGDIMTLLMREDILS 204
S FY F++ D +++ ME Y G L + EDIL
Sbjct: 53 SMRSVDCPYTVTFYGALFREGD-VWICMEVMDTSLDKFYKKVYDKG-----LTIPEDILG 106
Query: 205 EDVARFYIAESVL-AIHSIH-QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 262
+ IA S++ A+ +H + + +HRD+KP N+++++NG +KL DFG+ L D
Sbjct: 107 K------IAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS--- 157
Query: 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPE----VLLK 318
+ + D G YMAPE L +
Sbjct: 158 -VAKTIDA-----------------------------------GCKPYMAPERINPELNQ 181
Query: 319 KGYGMECDWWSLGAIMYEMLIGYPPFCS-DDPRITCRKIVNWKTCLKFPEEPKISDEARD 377
KGY ++ D WSLG M E+ G P+ S P +++V + + P E K S E +D
Sbjct: 182 KGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE-EPSPQLPAE-KFSPEFQD 239
Query: 378 LICHLLCDVETRLGTRGVEELKEHPWF 404
+ L EL +HP+F
Sbjct: 240 FVNKCLKKNYKERPN--YPELLQHPFF 264
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 74/259 (28%), Positives = 109/259 (42%), Gaps = 61/259 (23%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-D 164
D +E+L IG+G +G+V R K TG++ A+KK + EM + G E +LL + +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKK-TRLEMDEEGIPPTALREISLLQMLSE 59
Query: 165 SRCIVQLF-----YSFQDSDFLYLIMEYLPGGDIMTLLMRE-----DILSEDVARFYIAE 214
S IV+L LYL+ EYL D+ + L + ++ +
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 215 SVLAIHSIHQHNYVHRDIKPDNLILDKN-GHLKLSDFGLCK----PLEDKYSSILLEDED 269
+ + H+H +HRD+KP NL++DK G LK++D GL + P++ Y+
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK-SYT-------- 169
Query: 270 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWW 328
E V TL Y APEVLL Y D W
Sbjct: 170 ---HEIV------------------------------TLWYRAPEVLLGSTHYSTPVDIW 196
Query: 329 SLGAIMYEMLIGYPPFCSD 347
S+G I EM P F D
Sbjct: 197 SVGCIFAEMSRKQPLFPGD 215
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 5e-16
Identities = 74/262 (28%), Positives = 116/262 (44%), Gaps = 67/262 (25%)
Query: 99 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKS---EMLKRGQVEHVRS 155
Q+ ++D E L IG G G+V R K TG + A+K+++++ E KR +
Sbjct: 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKR----ILMD 63
Query: 156 ERNLLAEVDSRCIVQLFYSF-QDSDFLYLIMEYLPGGDIMTLLMR------EDILSEDVA 208
+L D IV+ + F DSD +++ ME L + LL R EDIL +
Sbjct: 64 LDVVLKSHDCPYIVKCYGYFITDSD-VFICME-LMSTCLDKLLKRIQGPIPEDILGK--- 118
Query: 209 RFYIAESVL-AIHSIHQ-HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 266
+ +++ A+H + + H +HRD+KP N++LD +G++KL DFG+ L D
Sbjct: 119 ---MTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD-------- 167
Query: 267 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL----LKKGYG 322
S+A + R A G YMAPE + Y
Sbjct: 168 ----------SKA---------------KTRSA------GCAAYMAPERIDPPDPNPKYD 196
Query: 323 MECDWWSLGAIMYEMLIGYPPF 344
+ D WSLG + E+ G P+
Sbjct: 197 IRADVWSLGISLVELATGQFPY 218
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 6e-16
Identities = 104/395 (26%), Positives = 158/395 (40%), Gaps = 111/395 (28%)
Query: 108 FEQLTLIGKGAFGEVRLCRA--KTTGEIFAMKKLKK---SEML-KRGQVE-----HVRSE 156
+ L +G GA+G V C A K TGE A+KKL + SE+ KR E H++ E
Sbjct: 17 YTSLKQVGSGAYGSV--CSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74
Query: 157 RNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESV 216
N++ +D FQD YL+M Y+ D+ ++ LSED ++ + + +
Sbjct: 75 -NVIGLLDVFTSAVSGDEFQD---FYLVMPYMQT-DLQKIMGHP--LSEDKVQYLVYQML 127
Query: 217 LAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETV 276
+ IH +HRD+KP NL ++++ LK+ DFGL +
Sbjct: 128 CGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARH--------------------- 166
Query: 277 SEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMY 335
++AE M + +W Y APEV+L Y D WS+G IM
Sbjct: 167 ADAE----MTGYVVTRW----------------YRAPEVILNWMHYNQTVDIWSVGCIMA 206
Query: 336 EMLIGYPPFCSDDPRITCRKIVN---------------------WKTCLKFPEE------ 368
EML G F D +I+ K+ K+P +
Sbjct: 207 EMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLF 266
Query: 369 PKISDEARDLICHLL-CDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGEL 427
PK S +A DL+ +L DV+ RL E EHP+F D + + +
Sbjct: 267 PKASPQAVDLLEKMLELDVDKRLTA---TEALEHPYF-----DSFRDADEETEQQ----- 313
Query: 428 DTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNF 462
P D +E SV W+K + + +F
Sbjct: 314 --------PYDDSLENEKLSVDEWKKHIYKEVKSF 340
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 7e-16
Identities = 91/339 (26%), Positives = 150/339 (44%), Gaps = 57/339 (16%)
Query: 95 YMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLK-KSEMLKRGQVEHV 153
Y ++R + +E + +G GAFG+V + K TG + A K ++ KSE ++E
Sbjct: 1 YEHVRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE----EELEDY 56
Query: 154 RSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI-LSEDVARFYI 212
E +LA + IV+L +F L++++E+ PGG + +++ D L+E +
Sbjct: 57 MVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVIC 116
Query: 213 AESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIIN 272
+ + A+ +H +HRD+K N++L +G +KL+DFG+ N
Sbjct: 117 RQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAK----------------N 160
Query: 273 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDW 327
+T+ +R+ S +GT +MAPEV++ Y + D
Sbjct: 161 VKTLQ----------------RRD------SFIGTPYWMAPEVVMCETMKDTPYDYKADI 198
Query: 328 WSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWK-TCLKFPEEPKISDEARDLICHLL-CD 385
WSLG + EM PP +P KI + L P K S E RD + L
Sbjct: 199 WSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPS--KWSMEFRDFLKTALDKH 256
Query: 386 VETRLGTRGVEELKEHPWFRGIQWDK-LYEMEAAYKPTV 423
ETR +L EHP+ + ++ L E+ A K V
Sbjct: 257 PETR---PSAAQLLEHPFVSSVTSNRPLRELVAEAKAEV 292
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 7e-16
Identities = 67/241 (27%), Positives = 105/241 (43%), Gaps = 46/241 (19%)
Query: 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ-VEHVRSERNLLAEVDS 165
D+E + +G G +G+V R TGE+ A+K +K L+ G ++ E ++ E
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIK----LEPGDDFSLIQQEIFMVKECKH 65
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 225
IV F S+ + L++ MEY GG + + LSE + E++ + +H
Sbjct: 66 CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK 125
Query: 226 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 285
+HRDIK N++L NG +KL+DFG+ + T + A
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKI------------------TATIA------ 161
Query: 286 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK---GYGMECDWWSLGAIMYEMLIGYP 342
KR S +GT +MAPEV + GY CD W++G E+ P
Sbjct: 162 --------KRK------SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQP 207
Query: 343 P 343
P
Sbjct: 208 P 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 67/250 (26%), Positives = 115/250 (46%), Gaps = 49/250 (19%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKL-KKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLF 172
+G GAFG+V + K TG + A K + KSE ++E E ++LA D IV+L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSE----EELEDYMVEIDILASCDHPNIVKLL 68
Query: 173 YSFQDSDFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRD 231
+F + L++++E+ GG + +++ E L+E R +++ A++ +H++ +HRD
Sbjct: 69 DAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRD 128
Query: 232 IKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 291
+K N++ +G +KL+DFG+ N T+ +
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSAK----------------NTRTIQRRD----------- 161
Query: 292 QWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDWWSLGAIMYEMLIGYPPFCS 346
S +GT +MAPEV++ + Y + D WSLG + EM PP
Sbjct: 162 -----------SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHE 210
Query: 347 DDPRITCRKI 356
+P KI
Sbjct: 211 LNPMRVLLKI 220
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 76/253 (30%), Positives = 110/253 (43%), Gaps = 57/253 (22%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKK---SEML-KRGQVE-----HVRSE 156
D + L +G GA+G V + TG A+KKL + SE+ KR E H++ E
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 157 RNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESV 216
N++ +D F D YL+M ++ G + LM+ + LSED +F + + +
Sbjct: 75 -NVIGLLDVFTPDLSLDRFHD---FYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQML 128
Query: 217 LAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETV 276
+ IH +HRD+KP NL ++++ LK+ DFGL + +T
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------------------QTD 169
Query: 277 SEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMY 335
SE G V T Y APEV+L Y D WS+G IM
Sbjct: 170 SEMTGY----------------------VVTRWYRAPEVILNWMHYTQTVDIWSVGCIMA 207
Query: 336 EMLIGYPPFCSDD 348
EML G P F D
Sbjct: 208 EMLTGKPLFKGHD 220
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 3e-15
Identities = 78/286 (27%), Positives = 125/286 (43%), Gaps = 64/286 (22%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKK----SEMLKRGQVEHVRSERNLLAEV 163
++ + LIGKG GEV L A+KK+++ + +LK+ E + A++
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKK----RFLREAKIAADL 59
Query: 164 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM---REDILSEDVARFYIAESVLAIH 220
IV ++ D D +Y M Y+ G + +LL +++ LS+++A SV A
Sbjct: 60 IHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELA---EKTSVGAFL 116
Query: 221 SI-----------HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDED 269
SI H +HRD+KPDN++L G + + D+G LE+ED
Sbjct: 117 SIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI-------FKKLEEED 169
Query: 270 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYST-------VGTLDYMAPEVLLKKGYG 322
+++ + R + YS+ VGT DYMAPE LL
Sbjct: 170 LLDI--------------------DVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPAS 209
Query: 323 MECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEE 368
D ++LG I+Y+ML P+ R RKI ++ + P E
Sbjct: 210 ESTDIYALGVILYQMLTLSFPY----RRKKGRKIS-YRDVILSPIE 250
|
Length = 932 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 5e-15
Identities = 68/247 (27%), Positives = 115/247 (46%), Gaps = 57/247 (23%)
Query: 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKL--KKSEMLKRGQVEHVRSERNLLAEVD 164
+ E++ IG GA G V + TG ++A+K + + ++R + E +L +V+
Sbjct: 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR----QICREIEILRDVN 130
Query: 165 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIM-TLLMREDILSEDVARFYIAESVLA-IHSI 222
+V+ F + + +++E++ GG + T + E L+ DVAR +L+ I +
Sbjct: 131 HPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA-DVAR-----QILSGIAYL 184
Query: 223 HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 282
H+ + VHRDIKP NL+++ ++K++DFG+ S IL + D N
Sbjct: 185 HRRHIVHRDIKPSNLLINSAKNVKIADFGV--------SRILAQTMDPCN---------- 226
Query: 283 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL---LKKGY--GMECDWWSLGAIMYEM 337
S+VGT+ YM+PE + L G G D WSLG + E
Sbjct: 227 --------------------SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEF 266
Query: 338 LIGYPPF 344
+G PF
Sbjct: 267 YLGRFPF 273
|
Length = 353 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 8e-15
Identities = 62/243 (25%), Positives = 93/243 (38%), Gaps = 51/243 (20%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 167
F L IG G+FG V R T E+ A+KK+ S + + + E L ++
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 168 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 227
++ + +L+MEY G L + + L E ++ + +H H
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER 136
Query: 228 VHRDIKPDNLILDKNGHLKLSDFG---LCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 284
+HRDIK N++L + G +KL+DFG L P
Sbjct: 137 IHRDIKAGNILLTEPGTVKLADFGSASLVSP----------------------------- 167
Query: 285 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMECDWWSLGAIMYEMLIGY 341
A S VGT +MAPEV+L + Y + D WSLG E+
Sbjct: 168 ----------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211
Query: 342 PPF 344
PP
Sbjct: 212 PPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 9e-15
Identities = 72/256 (28%), Positives = 99/256 (38%), Gaps = 61/256 (23%)
Query: 108 FEQLTLI---GKGAFGEVRLCR----AKTTGEIFAMKKLKKSEMLKRGQVEHVRS----E 156
L I G+G FG+V LCR TGE A+K L E RS E
Sbjct: 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVK------SLNHSGEEQHRSDFERE 56
Query: 157 RNLLAEVDSRCIVQLFYSFQDSDF--LYLIMEYLPGGDIMTLL--MREDILSEDVARF-- 210
+L +D IV+ + L LIMEYLP G + L R+ I + + F
Sbjct: 57 IEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSS 116
Query: 211 YIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 270
I + + + S Y+HRD+ N++++ +K+SDFGL K +L ED+D
Sbjct: 117 QICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAK--------VLPEDKDY 165
Query: 271 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSL 330
V E P E W APE L + D WS
Sbjct: 166 Y---YVKE-------PGESPIFW-----------------YAPECLRTSKFSSASDVWSF 198
Query: 331 GAIMYEMLIGYPPFCS 346
G +YE+ P S
Sbjct: 199 GVTLYELFTYGDPSQS 214
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 78/339 (23%), Positives = 136/339 (40%), Gaps = 82/339 (24%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKL-KKSEMLKRGQVEHVRSERNL--LAE 162
++ + IG GA+G V +G+ A+KK+ ++ + R+ R L L
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAK----RTLRELKILRH 60
Query: 163 VDSRCIVQLFYSFQ--DSDF--LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLA 218
I+ + + +DF +Y++M+ L D+ ++ + L+E+ R+++ + +
Sbjct: 61 FKHDNIIAIRDILRPPGADFKDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYFLYQLLRG 119
Query: 219 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 278
+ IH N +HRD+KP NL+++++ L++ DFG+ + L S
Sbjct: 120 LKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS------------------SP 161
Query: 279 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEM 337
E ++ M V T Y APE+LL Y D WS+G I EM
Sbjct: 162 TEHKYFMT----------------EYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEM 205
Query: 338 LIGYPPFCSDDP--------------------RITCRKIVNWKTCLKFPEE--------- 368
L F + RI ++ + P +
Sbjct: 206 LGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQ--NLPRKQPVPWSKIF 263
Query: 369 PKISDEARDLICHLL-CDVETRLGTRGVEELKEHPWFRG 406
PK S EA DL+ +L D E R+ VE+ +HP+
Sbjct: 264 PKASPEALDLLSQMLQFDPEERI---TVEQALQHPFLAQ 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 67/247 (27%), Positives = 106/247 (42%), Gaps = 64/247 (25%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKK----SEMLKRGQVE-----HVRSERNLLAEVD 164
+G GAFG V R + TG+ A+KK+ K + KR E H+R E N++
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHE-NII---- 72
Query: 165 SRCIVQLFYS-FQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIH 223
+ +F S +D +Y + E L G D+ LL L + ++++ + + + +H
Sbjct: 73 --SLSDIFISPLED---IYFVTELL-GTDLHRLLTSRP-LEKQFIQYFLYQILRGLKYVH 125
Query: 224 QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQW 283
VHRD+KP N+++++N LK+ DFGL + + + +
Sbjct: 126 SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGY-------------------- 165
Query: 284 MMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYP 342
V T Y APE++L + Y +E D WS G I EML G P
Sbjct: 166 ---------------------VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKP 204
Query: 343 PFCSDDP 349
F D
Sbjct: 205 LFPGKDH 211
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 8e-14
Identities = 88/339 (25%), Positives = 135/339 (39%), Gaps = 89/339 (26%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTT----GEIFAMKKL----KKSEMLKRGQVE-----HVR 154
+E + +G+GA+G V C A+ E A+KK+ K + KR E H R
Sbjct: 2 YELIKELGQGAYGIV--CSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFR 59
Query: 155 SERNLLAEVDSRCIVQLFYSFQDSDFLYL-IMEYLPGGDIMTLLMREDILSEDVARFYIA 213
+N+ D IV F + +LY +ME D+ ++ L++ + +I
Sbjct: 60 GHKNITCLYDMD-IV--FPGNFNELYLYEELMEA----DLHQIIRSGQPLTDAHFQSFIY 112
Query: 214 ESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 273
+ + + IH N +HRD+KP NL+++ + LK+ DFGL + +S E N
Sbjct: 113 QILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR----GFSENPGE-----NA 163
Query: 274 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGA 332
++E Y V T Y APE++L + Y D WS+G
Sbjct: 164 GFMTE-----------------------Y--VATRWYRAPEIMLSFQSYTKAIDVWSVGC 198
Query: 333 IMYEMLIGYPPFCSDD--------------------PRITCRKIVNWKTCLKFPEE---- 368
I+ E+L P F D RI K N+ L +
Sbjct: 199 ILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFE 258
Query: 369 ---PKISDEARDLICHLLC-DVETRLGTRGVEELKEHPW 403
P + A DL+ LL D R+ VEE EHP+
Sbjct: 259 SIFPNANPLALDLLEKLLAFDPTKRI---SVEEALEHPY 294
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 1e-13
Identities = 63/252 (25%), Positives = 110/252 (43%), Gaps = 59/252 (23%)
Query: 113 LIGKGAFGEVRLCRAKT-----TGEI-FAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR 166
+G GAFGEV A +G I A+K L+K + + E ++ E +L++ +
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-KKEFLK-EAHLMSNFNHP 59
Query: 167 CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAI------- 219
IV+L ++ Y+IME + GGD+++ L + + E +L I
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKE-LLDICLDVAKG 118
Query: 220 -HSIHQHNYVHRDIKPDNLILDKNGH-----LKLSDFGLCKPLEDKYSSILLEDEDIINQ 273
+ Q +++HRD+ N ++ + G+ +K+ DFGL + D Y S
Sbjct: 119 CVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR---DIYKS----------- 164
Query: 274 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 333
EG+ ++P + +MAPE LL + + D WS G +
Sbjct: 165 -DYYRKEGEGLLP---------------------VRWMAPESLLDGKFTTQSDVWSFGVL 202
Query: 334 MYEML-IGYPPF 344
M+E+L +G P+
Sbjct: 203 MWEILTLGQQPY 214
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 65/248 (26%), Positives = 106/248 (42%), Gaps = 68/248 (27%)
Query: 114 IGKGAFGEVRLCRAKT--TGEIFAMKK--------------LKKSEMLKRGQVEHVRSER 157
IG+GA+G V C AK T E A+KK L++ ++L+ E+V + +
Sbjct: 13 IGRGAYGIV--CSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIK 70
Query: 158 NLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVL 217
+++ +F D +Y++ E L D+ ++ LS+D ++++ + +
Sbjct: 71 DIMPPPHRE-------AFND---VYIVYE-LMDTDLHQIIRSSQTLSDDHCQYFLYQLLR 119
Query: 218 AIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVS 277
+ IH N +HRD+KP NL+L+ N LK+ DFGL + +
Sbjct: 120 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR---------------------TT 158
Query: 278 EAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYE 336
+G +M V T Y APE+LL Y D WS+G I E
Sbjct: 159 SEKGDFMT-----------------EYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAE 201
Query: 337 MLIGYPPF 344
+L P F
Sbjct: 202 LLGRKPLF 209
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 6e-13
Identities = 58/225 (25%), Positives = 95/225 (42%), Gaps = 40/225 (17%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLF 172
IGKG FG+V K E+ A+K + L E +L + D IV+L
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEV-AVKTCR--STLPPDLKRKFLQEAEILKQYDHPNIVKLI 58
Query: 173 YSFQDSDFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRD 231
+Y++ME +PGG ++T L ++ + L+ ++ + + N +HRD
Sbjct: 59 GVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRD 118
Query: 232 IKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 291
+ N ++ +N LK+SDFG+ + E+E I TVS+ Q +P
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR-----------EEEGGI--YTVSDGLKQ--IP----- 158
Query: 292 QWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 336
+ + APE L Y E D WS G +++E
Sbjct: 159 ----------------IKWTAPEALNYGRYTSESDVWSYGILLWE 187
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 9e-13
Identities = 59/240 (24%), Positives = 101/240 (42%), Gaps = 50/240 (20%)
Query: 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMK--KLKKSEMLKRGQVEHVRSERNLLAEVD 164
D + ++G G G V T I A+K L + L++ + SE +L + D
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQK----QIMSELEILYKCD 57
Query: 165 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ 224
S I+ + +F + + + E++ GG +L + I + R +A V + +
Sbjct: 58 SPYIIGFYGAFFVENRISICTEFMDGG---SLDVYRKIPEHVLGRIAVA-VVKGLTYLWS 113
Query: 225 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 284
+HRD+KP N++++ G +KL DFG+ L +N
Sbjct: 114 LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL--------------VN------------ 147
Query: 285 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 344
++A + VGT YMAPE + + YG+ D WSLG E+ +G P+
Sbjct: 148 --------------SIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 64/241 (26%), Positives = 99/241 (41%), Gaps = 59/241 (24%)
Query: 111 LTLIGKGAFGEVRLCR----AKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR 166
+ +GKG FG V LCR TGE+ A+KKL+ S + E +L +
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHD 65
Query: 167 CIVQ---LFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARF-------YIAESV 216
IV+ + YS + L L+MEYLP G + D L + R Y ++
Sbjct: 66 NIVKYKGVCYSAGRRN-LRLVMEYLPYGSL------RDYLQKHRERLDHRKLLLYASQIC 118
Query: 217 LAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETV 276
+ + YVHRD+ N++++ +K+ DFGL K +L +D++ V
Sbjct: 119 KGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTK--------VLPQDKEYY---KV 167
Query: 277 SEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 336
E P E W APE L + + + D WS G ++YE
Sbjct: 168 RE-------PGESPIFW-----------------YAPESLTESKFSVASDVWSFGVVLYE 203
Query: 337 M 337
+
Sbjct: 204 L 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 1e-12
Identities = 60/241 (24%), Positives = 99/241 (41%), Gaps = 43/241 (17%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
D +E+L +G+G++ V ++K G++ A+K ++ E + G E +LL +
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGLKH 62
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 225
IV L + L L+ EY+ + L + + ++ + + + IHQ
Sbjct: 63 ANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR 122
Query: 226 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 285
+HRD+KP NL++ G LKL+DFGL +
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLAR------------------------------- 151
Query: 286 PKERLQQWKRNRRALAYST-VGTLDYMAPEVLLKKGYGMEC-DWWSLGAIMYEMLIGYPP 343
++ + YS V TL Y P+VLL C D W +G I EM+ G
Sbjct: 152 --------AKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAA 203
Query: 344 F 344
F
Sbjct: 204 F 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 65/253 (25%), Positives = 108/253 (42%), Gaps = 57/253 (22%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEM----LKRGQVE-----HVRSE 156
+ ++ L+ +G GA+G V TG A+KKL + KR E H++ E
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 157 RNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESV 216
N++ +D + F D +YL+ +L G D+ ++ + L++D +F I + +
Sbjct: 77 -NVIGLLDVFTPARSLEEFND---VYLVT-HLMGADLNNIVKCQK-LTDDHVQFLIYQIL 130
Query: 217 LAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETV 276
+ IH + +HRD+KP NL ++++ LK+ DFGL + +D+ +
Sbjct: 131 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY------------- 177
Query: 277 SEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMY 335
V T Y APE++L Y D WS+G IM
Sbjct: 178 ----------------------------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 209
Query: 336 EMLIGYPPFCSDD 348
E+L G F D
Sbjct: 210 ELLTGRTLFPGTD 222
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 67/248 (27%), Positives = 107/248 (43%), Gaps = 52/248 (20%)
Query: 108 FEQLTLIGKGAFGEVRLCR-AKTTGEIFAMKKLK---KSEMLKRGQVEHVRSERNLLAEV 163
+E + IG+GA+G+V R K G A+K+++ E + + V R+L
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL-ETF 61
Query: 164 DSRCIVQLF----YSFQDSDF-LYLIMEYLPGGDIMTLLMR--EDILSEDVARFYIAESV 216
+ +V+LF S D + L L+ E++ D+ T L + E + + + + + +
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 217 LAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETV 276
+ +H H VHRD+KP N+++ +G +KL+DFGL + YS
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR----IYSF-------------- 162
Query: 277 SEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 336
+ S V TL Y APEVLL+ Y D WS+G I E
Sbjct: 163 ---------------------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAE 201
Query: 337 MLIGYPPF 344
M P F
Sbjct: 202 MFRRKPLF 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 7e-12
Identities = 62/240 (25%), Positives = 93/240 (38%), Gaps = 45/240 (18%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 167
F L IG G+FG V R T E+ A+KK+ S + + + E L +
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 168 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 227
++ + +L+MEY G L + + L E ++ + +H HN
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 146
Query: 228 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 287
+HRDIK N++L + G +KL+DFG + S A
Sbjct: 147 IHRDIKAGNILLTEPGQVKLADFG--------------------SASIASPAN------- 179
Query: 288 ERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMECDWWSLGAIMYEMLIGYPPF 344
S VGT +MAPEV+L + Y + D WSLG E+ PP
Sbjct: 180 ---------------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 60/241 (24%), Positives = 101/241 (41%), Gaps = 41/241 (17%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 164
++ + +L +G+G + V R+K T + A+K+++ + G E +LL +
Sbjct: 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKNLK 61
Query: 165 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ 224
IV L L L+ EYL L +++S + ++ + + + H+
Sbjct: 62 HANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK 121
Query: 225 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 284
+HRD+KP NL++++ G LKL+DFGL + + +T S
Sbjct: 122 RKILHRDLKPQNLLINEKGELKLADFGLARAKS-------------VPTKTYS------- 161
Query: 285 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEMLIGYPP 343
+ V TL Y P+VLL Y D W +G I+YEM G P
Sbjct: 162 ------------------NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPM 203
Query: 344 F 344
F
Sbjct: 204 F 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (164), Expect = 1e-11
Identities = 74/282 (26%), Positives = 116/282 (41%), Gaps = 92/282 (32%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 164
++++E + IG G FGEV L + K T E F K + + +R + + V E N++ E+
Sbjct: 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV-IEVNVMRELK 70
Query: 165 SRCIVQLFYSF--QDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSI 222
+ IV+ F + + LY++ME+ GD LS ++ + Y + H+I
Sbjct: 71 HKNIVRYIDRFLNKANQKLYILMEFCDAGD----------LSRNIQKCYKMFGKIEEHAI 120
Query: 223 ------------HQHNY---------VHRDIKPDNLILDK---------------NGH-- 244
+ HN +HRD+KP N+ L NG
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 245 LKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYST 304
K+ DFGL K +I +E ++A+S
Sbjct: 181 AKIGDFGLSK-------NIGIE--------------------------------SMAHSC 201
Query: 305 VGTLDYMAPEVLL--KKGYGMECDWWSLGAIMYEMLIGYPPF 344
VGT Y +PE+LL K Y + D W+LG I+YE+ G PF
Sbjct: 202 VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 61/259 (23%), Positives = 98/259 (37%), Gaps = 69/259 (26%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLK--------------KSEMLKR-GQVEH 152
+E + IG GA+G V R +G A+K ++ + +LKR +H
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 153 VRSERNL----LAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVA 208
R + + D V L + D D + + P G L +
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG-----------LPAETI 110
Query: 209 RFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDE 268
+ + + + + +H + VHRD+KP+N+++ G +KL+DFGL + YS +
Sbjct: 111 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLAR----IYSCQMALTP 166
Query: 269 DIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWW 328
++ TL Y APEVLL+ Y D W
Sbjct: 167 VVV-----------------------------------TLWYRAPEVLLQSTYATPVDMW 191
Query: 329 SLGAIMYEMLIGYPPFCSD 347
S+G I EM P FC +
Sbjct: 192 SVGCIFAEMFRRKPLFCGN 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 59/241 (24%), Positives = 102/241 (42%), Gaps = 41/241 (17%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 164
++ + +L +G+G + V R+K T + A+K+++ + G E +LL ++
Sbjct: 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLK 62
Query: 165 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ 224
IV L L L+ EYL L + ++ + ++ + + ++ H+
Sbjct: 63 HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR 122
Query: 225 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 284
+HRD+KP NL++++ G LKL+DFGL + I +T S
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKS-------------IPTKTYS------- 162
Query: 285 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEMLIGYPP 343
+ V TL Y P++LL Y + D W +G I YEM G P
Sbjct: 163 ------------------NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPL 204
Query: 344 F 344
F
Sbjct: 205 F 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 1e-11
Identities = 57/237 (24%), Positives = 103/237 (43%), Gaps = 48/237 (20%)
Query: 113 LIGKGAFGEVR--LCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQ 170
L+GKG FGEV + KT + K+ E+ + SE +L + D IV+
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK-----FLSEARILKQYDHPNIVK 56
Query: 171 LFYSFQDSDFLYLIMEYLPGGDIMTLLMR--EDILSEDVARFYIAESVLAIHSIHQHNYV 228
L +Y++ME +PGGD ++ L + +++ ++ + +F + ++ + + N +
Sbjct: 57 LIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFAL-DAAAGMAYLESKNCI 115
Query: 229 HRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKE 288
HRD+ N ++ +N LK+SDFG+ + ED+ I + + + +W
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQ----------EDDGIYSSSGLKQIPIKW----- 160
Query: 289 RLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML-IGYPPF 344
APE L Y E D WS G +++E +G P+
Sbjct: 161 ----------------------TAPEALNYGRYSSESDVWSYGILLWETFSLGVCPY 195
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 55/232 (23%), Positives = 95/232 (40%), Gaps = 44/232 (18%)
Query: 114 IGKGAFGEVRLCR----AKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIV 169
+G+G FG+V LCR TGE A+K LK + ++ E +L + IV
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIV 69
Query: 170 QL--FYSFQDSDFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHN 226
+ + + + LIME+LP G + L R ++ ++ Y + + +
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129
Query: 227 YVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMP 286
YVHRD+ N++++ +K+ DFGL K +E ++D+
Sbjct: 130 YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDD------------------ 171
Query: 287 KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338
+ Y APE L++ + + D WS G +YE+L
Sbjct: 172 --------LDSPVFWY---------APECLIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 60/240 (25%), Positives = 94/240 (39%), Gaps = 45/240 (18%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 167
F L IG G+FG V T E+ A+KK+ S + + + E L ++
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 168 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 227
++ + +L+MEY G L + + L E ++ + +H HN
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 142
Query: 228 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 287
+HRDIK N++L + G +KL+DFG
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFG------------------------------------ 166
Query: 288 ERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMECDWWSLGAIMYEMLIGYPPF 344
++ + A S VGT +MAPEV+L + Y + D WSLG E+ PP
Sbjct: 167 ------SASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 59/241 (24%), Positives = 102/241 (42%), Gaps = 41/241 (17%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 164
++ + +L +G+G + V R+K T + A+K+++ + G E +LL ++
Sbjct: 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKDLK 62
Query: 165 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ 224
IV L L L+ EYL + +I+S + ++ + + + H+
Sbjct: 63 HANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR 122
Query: 225 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 284
+HRD+KP NL++++ G LKL+DFGL + + +T S
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKS-------------VPTKTYS------- 162
Query: 285 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG-YGMECDWWSLGAIMYEMLIGYPP 343
+ V TL Y P+VLL Y + D W +G I +EM G P
Sbjct: 163 ------------------NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPL 204
Query: 344 F 344
F
Sbjct: 205 F 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 62/240 (25%), Positives = 94/240 (39%), Gaps = 45/240 (18%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 167
F L IG G+FG V R E+ A+KK+ S + + + E L ++
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 168 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 227
+Q + +L+MEY G L + + L E ++ + +H HN
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 228 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 287
+HRD+K N++L + G +KL DFG +SI+
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFG--------SASIM----------------------- 165
Query: 288 ERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMECDWWSLGAIMYEMLIGYPPF 344
A A VGT +MAPEV+L + Y + D WSLG E+ PP
Sbjct: 166 -----------APANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 70/243 (28%), Positives = 104/243 (42%), Gaps = 55/243 (22%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKL------KKSEMLKRGQVEHVRSERNLLAEVDSR 166
+IG G+FG V T E A+KK+ K E+L + H+ N++ D
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHI----NIIFLKDYY 128
Query: 167 CIVQLFYSFQDSDFLYLIMEYLPGG--DIMTLLMRED-ILSEDVARFYIAESVLAIHSIH 223
+ F + + FL ++ME++P M R + L + + Y + A+ IH
Sbjct: 129 -YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH 187
Query: 224 QHNYVHRDIKPDNLILDKNGH-LKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 282
HRD+KP NL++D N H LKL DFG K L GQ
Sbjct: 188 SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL----------------------LAGQ 225
Query: 283 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEMLIGY 341
R+++Y + + Y APE++L Y D WSLG I+ EM++GY
Sbjct: 226 ---------------RSVSY--ICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGY 268
Query: 342 PPF 344
P F
Sbjct: 269 PIF 271
|
Length = 440 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 68/260 (26%), Positives = 107/260 (41%), Gaps = 76/260 (29%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKT--TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-- 163
++ +IGKG++G V C A TGE A+KK+ EHV +L E+
Sbjct: 2 YKIQEVIGKGSYGVV--CSAIDTHTGEKVAIKKI-------NDVFEHVSDATRILREIKL 52
Query: 164 -------DSRCIVQLFY--------SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVA 208
D IV++ + F+D +Y++ E L D+ ++ D L+ +
Sbjct: 53 LRLLRHPD---IVEIKHIMLPPSRREFKD---IYVVFE-LMESDLHQVIKANDDLTPEHH 105
Query: 209 RFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP-LEDKYSSILLED 267
+F++ + + A+ IH N HRD+KP N++ + + LK+ DFGL + D ++I D
Sbjct: 106 QFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 165
Query: 268 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEV---LLKKGYGME 324
V T Y APE+ K Y
Sbjct: 166 ------------------------------------YVATRWYRAPELCGSFFSK-YTPA 188
Query: 325 CDWWSLGAIMYEMLIGYPPF 344
D WS+G I E+L G P F
Sbjct: 189 IDIWSIGCIFAEVLTGKPLF 208
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 5e-11
Identities = 55/238 (23%), Positives = 99/238 (41%), Gaps = 48/238 (20%)
Query: 114 IGKGAFGEVR--LCRAKTTGEI-FAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQ 170
+G G FG V + K+ E+ A+K LK+ + G+ E +R E +++A++D CIV+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI-AAGKKEFLR-EASVMAQLDHPCIVR 60
Query: 171 LFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHR 230
L + + L L+ME P G ++ L + + + + + + + ++VHR
Sbjct: 61 LIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHR 119
Query: 231 DIKPDNLILDKNGHLKLSDFGLCKPL---EDKYSSILLEDEDIINQETVSEAEGQWMMPK 287
D+ N++L K+SDFG+ + L D Y + G+W
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR---------------ATTAGRW---- 160
Query: 288 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML-IGYPPF 344
L + APE + + + D WS G ++E G P+
Sbjct: 161 -------------------PLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 8e-11
Identities = 70/254 (27%), Positives = 103/254 (40%), Gaps = 63/254 (24%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKK----SEMLKRGQVEHVRSERNLLAEV 163
++ L IG GA G V TG+ A+KKL + KR E V L+ V
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELV-----LMKLV 72
Query: 164 DSRCIVQLFYSF--QDS--DF--LYLIMEYLPGGDIMTLLMREDI---LSEDVARFYIAE 214
+ + I+ L F Q S +F +YL+ME +M + + I L + + + +
Sbjct: 73 NHKNIIGLLNVFTPQKSLEEFQDVYLVME------LMDANLCQVIQMDLDHERMSYLLYQ 126
Query: 215 SVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQE 274
+ I +H +HRD+KP N+++ + LK+ DFGL +
Sbjct: 127 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-------------------- 166
Query: 275 TVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIM 334
A +MM V T Y APEV+L GY D WS+G IM
Sbjct: 167 ---TAGTSFMMTPY----------------VVTRYYRAPEVILGMGYKENVDIWSVGCIM 207
Query: 335 YEMLIGYPPFCSDD 348
EM+ G F D
Sbjct: 208 GEMIRGTVLFPGTD 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 68/252 (26%), Positives = 100/252 (39%), Gaps = 59/252 (23%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTT--GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
++QL IG GA G V C A T G A+KKL + + + E LL V+
Sbjct: 23 YQQLKPIGSGAQGIV--CAAFDTVLGINVAVKKLSRP-FQNQTHAKRAYRELVLLKCVNH 79
Query: 166 RCIVQL---------FYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESV 216
+ I+ L FQD +YL+ME + + M L + + + + +
Sbjct: 80 KNIISLLNVFTPQKSLEEFQD---VYLVMELMDANLCQVIHME---LDHERMSYLLYQML 133
Query: 217 LAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETV 276
I +H +HRD+KP N+++ + LK+ DFGL +
Sbjct: 134 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------------------- 171
Query: 277 SEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 336
A +MM V T Y APEV+L GY D WS+G IM E
Sbjct: 172 -TACTNFMMT----------------PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 214
Query: 337 MLIGYPPFCSDD 348
++ G F D
Sbjct: 215 LVKGSVIFQGTD 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 8e-11
Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 17/151 (11%)
Query: 114 IGKGAFGEVRLCRAKT----TGEIFAMKKLKK--SEMLKRGQVEHVRSERNLLAEVDSRC 167
+G+G FG+V L TGE+ A+K LK+ + G + E N+L +
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKK----EINILKTLYHEN 67
Query: 168 IVQL--FYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARF--YIAESVLAIHSIH 223
IV+ S Q L LIMEY+P G + L + + + F I E + +HS H
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQH 127
Query: 224 QHNYVHRDIKPDNLILDKNGHLKLSDFGLCK 254
Y+HRD+ N++LD + +K+ DFGL K
Sbjct: 128 ---YIHRDLAARNVLLDNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 59/251 (23%), Positives = 99/251 (39%), Gaps = 49/251 (19%)
Query: 111 LTLIGKGAFGE--VRLCRAKTTGEIFAMKKL----KKSEMLKRGQVEHVRSERNLLAEVD 164
LTLIGK V L + K T + A+KK+ E LK Q E + S + +
Sbjct: 3 LTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQ-----LQ 57
Query: 165 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRE---DILSEDVARFYIAESVLAIHS 221
I+ SF LY++ + G L++ + L E F + + + A+
Sbjct: 58 HPNILPYVTSFIVDSELYVVSPLMAYGS-CEDLLKTHFPEGLPELAIAFILKDVLNALDY 116
Query: 222 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 281
IH ++HR +K +++L +G + LS +I
Sbjct: 117 IHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVS--------------MIKHG------- 155
Query: 282 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK--KGYGMECDWWSLGAIMYEMLI 339
+ +R S+V L +++PEVL + +GY + D +S+G E+
Sbjct: 156 ----------KRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELAN 205
Query: 340 GYPPFCSDDPR 350
G+ PF D P
Sbjct: 206 GHVPF-KDMPA 215
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 56/243 (23%), Positives = 107/243 (44%), Gaps = 52/243 (21%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 173
+G G FGEV + + ++ A+K LK M V+ E NL+ + +V+L+
Sbjct: 14 LGAGQFGEVWMGYYNNSTKV-AVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYA 68
Query: 174 SFQDSDFLYLIMEYLPGGDIMTLLMRED----ILSEDVARFYIAESVLAIHSIHQHNYVH 229
+ +Y+I EY+ G ++ L ++ +L + + + A+ + I + NY+H
Sbjct: 69 VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLID--FSAQIAEGMAYIERKNYIH 126
Query: 230 RDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKER 289
RD++ N+++ ++ K++DFGL + +ED N+ T E P
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIED-------------NEYTAREGA---KFP--- 167
Query: 290 LQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML----IGYPPFC 345
+ + APE + + ++ D WS G ++YE++ I YP
Sbjct: 168 ------------------IKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS 209
Query: 346 SDD 348
+ D
Sbjct: 210 NSD 212
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 66/246 (26%), Positives = 99/246 (40%), Gaps = 60/246 (24%)
Query: 113 LIGKGAFGEVRLCRAKTTG--EI-FAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIV 169
+IG G FGEV R K G EI A+K LK K Q SE +++ + D I+
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEK--QRRDFLSEASIMGQFDHPNII 68
Query: 170 QLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSI------- 222
L S + ++ EY+ G + L + D +F + + V + I
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD------GQFTVIQLVGMLRGIASGMKYL 122
Query: 223 HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 282
YVHRD+ N++++ N K+SDFGL + LED EA
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD-----------------PEA--- 162
Query: 283 WMMPKERLQQWKRNRRALAYSTVG---TLDYMAPEVLLKKGYGMECDWWSLGAIMYE-ML 338
AY+T G + + APE + + + D WS G +M+E M
Sbjct: 163 ------------------AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
Query: 339 IGYPPF 344
G P+
Sbjct: 205 YGERPY 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 60/251 (23%), Positives = 104/251 (41%), Gaps = 57/251 (22%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRS---ERNLLAEVD 164
++ LT +G GA+G V + A+KKL + + H R E LL +
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ----SLIHARRTYRELRLLKHMK 72
Query: 165 SRCIVQLF------YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLA 218
++ L S ++ + +YL+ L G D+ ++ + LS++ +F I + +
Sbjct: 73 HENVIGLLDVFTPATSIENFNEVYLVTN-LMGADLNNIVKCQK-LSDEHVQFLIYQLLRG 130
Query: 219 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 278
+ IH +HRD+KP N+ ++++ L++ DFGL + +D+ +
Sbjct: 131 LKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGY--------------- 175
Query: 279 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEM 337
V T Y APE++L Y D WS+G IM E+
Sbjct: 176 --------------------------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 209
Query: 338 LIGYPPFCSDD 348
L G F +D
Sbjct: 210 LKGKALFPGND 220
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 61/232 (26%), Positives = 95/232 (40%), Gaps = 44/232 (18%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSE--MLKRGQVEHVRSERNLLAEVDSRCIVQL 171
I K F + G FA K E ++K GQ +E ++L ++ I+QL
Sbjct: 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQL 148
Query: 172 FYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVL-AIHSIHQHNYVHR 230
+F + F LI+ L + +I D+ I SVL AI +H++ +HR
Sbjct: 149 KGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAICDI--LAIERSVLRAIQYLHENRIIHR 206
Query: 231 DIKPDNLILDKNGHLKLSDFG-LCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKER 289
DIK +N+ ++ G + L DFG C P++ IN
Sbjct: 207 DIKAENIFINHPGDVCLGDFGAACFPVD-------------INA---------------- 237
Query: 290 LQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341
N+ Y GT+ APE+L + YG D WS G +++EM +
Sbjct: 238 ------NKY---YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 69/253 (27%), Positives = 108/253 (42%), Gaps = 65/253 (25%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEH--------VRSE 156
++ +++L +G+G++ V R+K TG++ A+K+++ +EH +R E
Sbjct: 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIR---------LEHEEGAPFTAIR-E 53
Query: 157 RNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAES 215
+LL ++ IV L L L+ EYL D+ + LS R ++ +
Sbjct: 54 ASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQL 112
Query: 216 VLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGL--CKPLEDK-YSSILLEDEDIIN 272
+ + HQ +HRD+KP NL++ + G LKL+DFGL K + K YS+
Sbjct: 113 LRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN---------- 162
Query: 273 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLG 331
E V TL Y P+VLL Y D W +G
Sbjct: 163 -EVV------------------------------TLWYRPPDVLLGSTEYSTSLDMWGVG 191
Query: 332 AIMYEMLIGYPPF 344
I YEM G P F
Sbjct: 192 CIFYEMATGRPLF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 55/268 (20%), Positives = 109/268 (40%), Gaps = 73/268 (27%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC----- 167
+IG+G FG+V R K G ++ + +K + R+ E++ C
Sbjct: 2 VIGEGNFGQVLKARIKKDG----LRMDAAIKRMKEYASKD--DHRDFAGELEVLCKLGHH 55
Query: 168 --IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSED--VARFYIAESVLA----- 218
I+ L + + +LYL +EY P G+++ L + +L D A S L+
Sbjct: 56 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115
Query: 219 ---------IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDED 269
+ + Q ++HRD+ N+++ +N K++DFGL + ++
Sbjct: 116 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR------------GQE 163
Query: 270 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWS 329
+ ++T+ +WM + +L+Y Y D WS
Sbjct: 164 VYVKKTMGRLPVRWM-------------------AIESLNYSV--------YTTNSDVWS 196
Query: 330 LGAIMYEML-IGYPPFCSDDPRITCRKI 356
G +++E++ +G P+C +TC ++
Sbjct: 197 YGVLLWEIVSLGGTPYCG----MTCAEL 220
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 62/291 (21%), Positives = 121/291 (41%), Gaps = 83/291 (28%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC----- 167
+IG+G FG+V K G +K +MLK E+ R+ E++ C
Sbjct: 9 VIGEGNFGQVIRAMIKKDG----LKMNAAIKMLKEFASEN--DHRDFAGELEVLCKLGHH 62
Query: 168 --IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSED--VARFYIAESVLA----- 218
I+ L + ++ +LY+ +EY P G+++ L + +L D A+ + S L
Sbjct: 63 PNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 219 ---------IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDED 269
+ + + ++HRD+ N+++ +N K++DFGL + E+
Sbjct: 123 QFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR------------GEE 170
Query: 270 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWS 329
+ ++T+ +WM + +L+Y Y + D WS
Sbjct: 171 VYVKKTMGRLPVRWM-------------------AIESLNYSV--------YTTKSDVWS 203
Query: 330 LGAIMYEML-IGYPPFCSDDPRITCRKIVNWKTCLKFP-----EEPKISDE 374
G +++E++ +G P+C +TC ++ K P E+P+ D+
Sbjct: 204 FGVLLWEIVSLGGTPYCG----MTCAELYE-----KLPQGYRMEKPRNCDD 245
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 51/244 (20%), Positives = 92/244 (37%), Gaps = 59/244 (24%)
Query: 114 IGKGAFGEV---RLCRAKTTGE--IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCI 168
+G+GAFG+V + + + A+K LK E + E LL I
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLK--ETASNDARKDFEREAELLTNFQHENI 70
Query: 169 VQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED-----ILSEDVARFYIAESVLAIHSIH 223
V+ + + D ++ EY+ GD+ L + S D + S L ++
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 224 ----------QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 273
QH +VHRD+ N ++ + +K+ DFG+ + D Y++
Sbjct: 131 IASGMVYLASQH-FVHRDLATRNCLVGYDLVVKIGDFGMSR---DVYTT----------- 175
Query: 274 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 333
G M+P + +M PE ++ + + E D WS G +
Sbjct: 176 -DYYRVGGHTMLP---------------------IRWMPPESIMYRKFTTESDVWSFGVV 213
Query: 334 MYEM 337
++E+
Sbjct: 214 LWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 57/260 (21%), Positives = 100/260 (38%), Gaps = 64/260 (24%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD--------S 165
+G+G FGEV LC A+ E + V+ +R++ A D S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 166 RC----IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSE--------DVAR---F 210
R I++L D L +I EY+ GD+ L + +I S V+
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 211 YIAESVLA-IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDED 269
Y+A + + + + N+VHRD+ N ++ + +K++DFG+ + L YS
Sbjct: 133 YMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL---YSG------- 182
Query: 270 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWS 329
+G+ ++P + +MA E +L + D W+
Sbjct: 183 -----DYYRIQGRAVLP---------------------IRWMAWESILLGKFTTASDVWA 216
Query: 330 LGAIMYEMLIGYPPFCSDDP 349
G ++EM C + P
Sbjct: 217 FGVTLWEMFT----LCKEQP 232
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 53/247 (21%), Positives = 107/247 (43%), Gaps = 61/247 (24%)
Query: 109 EQLTLIGKGAFGEVRLCRAKTTGE-----IFAMKKLKKSEMLKRGQVEHV----RSERNL 159
+++T +G+G FGEV L +AK E + +K L+K++ E++ R E ++
Sbjct: 8 QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK------DENLQSEFRRELDM 61
Query: 160 LAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM----REDILSED----VARFY 211
++ + +V+L ++++ Y+I+EY GD+ L +++ L +
Sbjct: 62 FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121
Query: 212 IAESV-LAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 270
+ + L + + +VHRD+ N ++ +K+S L K D Y+S
Sbjct: 122 LCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK---DVYNS-------- 170
Query: 271 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSL 330
++ + R AL L ++APE + + + + D WS
Sbjct: 171 ---------------------EYYKLRNALI-----PLRWLAPEAVQEDDFSTKSDVWSF 204
Query: 331 GAIMYEM 337
G +M+E+
Sbjct: 205 GVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 56/239 (23%), Positives = 94/239 (39%), Gaps = 49/239 (20%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 167
++ L IG GA G V A+KKL + + + E L+ V+ +
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKN 84
Query: 168 IVQLF------YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHS 221
I+ L S ++ +Y++ME + + M L + + + + + I
Sbjct: 85 IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQMLCGIKH 141
Query: 222 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 281
+H +HRD+KP N+++ + LK+ DFGL + A
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------------------TAGT 178
Query: 282 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 340
+MM + ++ Y APEV+L GY D WS+G IM EM+ G
Sbjct: 179 SFMMTPYVVTRY----------------YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 51/222 (22%), Positives = 93/222 (41%), Gaps = 53/222 (23%)
Query: 139 LKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS--------------DFLYLI 184
+KK + V+H E ++ +D IV+++ S + +Y++
Sbjct: 35 VKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIV 94
Query: 185 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH 244
EY+ + ++ + LSE+ AR ++ + + + IH N +HRD+KP N+ ++
Sbjct: 95 QEYMETD--LANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL 152
Query: 245 -LKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYS 303
LK+ DFGL + ++ YS + +++ V+ +W
Sbjct: 153 VLKIGDFGLARIVDPHYSH-----KGYLSEGLVT----KW-------------------- 183
Query: 304 TVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYPPF 344
Y +P +LL Y D W+ G I EML G P F
Sbjct: 184 ------YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLF 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 62/278 (22%), Positives = 118/278 (42%), Gaps = 79/278 (28%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIF--AMKKLKKSEMLKRGQVEHVRSERNLLAEV 163
+D + +IG+G FG+V R K G A+K++K+ + +H R+ E+
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDH----RDFAGEL 58
Query: 164 DSRC-------IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESV 216
+ C I+ L + + +LYL +EY P G+++ L + +L D A F IA S
Sbjct: 59 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA-FAIANST 117
Query: 217 LAIHS-----------------IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259
+ S + Q ++HRD+ N+++ +N K++DFGL +
Sbjct: 118 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR----- 172
Query: 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK 319
+++ ++T+ +WM + +L+Y
Sbjct: 173 -------GQEVYVKKTMGRLPVRWM-------------------AIESLNYSV------- 199
Query: 320 GYGMECDWWSLGAIMYEML-IGYPPFCSDDPRITCRKI 356
Y D WS G +++E++ +G P+C +TC ++
Sbjct: 200 -YTTNSDVWSYGVLLWEIVSLGGTPYCG----MTCAEL 232
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 60/237 (25%), Positives = 94/237 (39%), Gaps = 45/237 (18%)
Query: 111 LTLIGKGAFGEVRLCRAKTTGEIFAMK--KLKKSEMLKRGQVEHVRSERNLLAEVDSRCI 168
L +G+G++ V ++ G++ A+K +K E + + E +LL + I
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR----EASLLKGLKHANI 65
Query: 169 VQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYV 228
V L + L + EY+ ++ L R ++ + + + IH + +
Sbjct: 66 VLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHIL 125
Query: 229 HRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKE 288
HRD+KP NL++ G LKL+DFGL + + I +Q SE
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARA------------KSIPSQTYSSE---------- 163
Query: 289 RLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEMLIGYPPF 344
V TL Y P+VLL Y D W G I EML G P F
Sbjct: 164 ----------------VVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 4e-09
Identities = 50/234 (21%), Positives = 100/234 (42%), Gaps = 46/234 (19%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 173
+G G FG V L + + ++ A+K + + M + +E E ++ ++ +VQL+
Sbjct: 12 LGSGQFGVVHLGKWRAQIKV-AIKAINEGAMSEEDFIE----EAKVMMKLSHPKLVQLYG 66
Query: 174 SFQDSDFLYLIMEYLPGGDIMTLL-MREDILSEDVARFYIAESVLAIHSIHQHNYVHRDI 232
LY++ E++ G ++ L R+ LS+D+ + + + +++++HRD+
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDL 126
Query: 233 KPDNLILDKNGHLKLSDFGLCK-PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 291
N ++ G +K+SDFG+ + L+D+Y+S
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTRYVLDDEYTS----------------------------- 157
Query: 292 QWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPF 344
+ + + PEV Y + D WS G +M+E+ G PF
Sbjct: 158 ---------SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPF 202
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 4e-09
Identities = 57/237 (24%), Positives = 91/237 (38%), Gaps = 49/237 (20%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 167
++ L IG GA G V A+KKL + + + E L+ V+ +
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKN 77
Query: 168 IVQLFYSFQDSDFL------YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHS 221
I+ L F L YL+ME + + M L + + + + + I
Sbjct: 78 IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLCGIKH 134
Query: 222 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 281
+H +HRD+KP N+++ + LK+ DFGL + A
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------------------TAGT 171
Query: 282 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338
+MM + ++ Y APEV+L GY D WS+G IM EM+
Sbjct: 172 SFMMTPYVVTRY----------------YRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 5e-09
Identities = 60/266 (22%), Positives = 106/266 (39%), Gaps = 68/266 (25%)
Query: 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE 162
I + + IGKG FG+V L + G+ A+K LK + + + LAE
Sbjct: 3 INSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLK----------DDSTAAQAFLAE 50
Query: 163 VDSRC------IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM---REDILSEDVARFYIA 213
+VQL + LY++ EY+ G ++ L R I F +
Sbjct: 51 ASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFAL- 109
Query: 214 ESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 273
+ + + + N+VHRD+ N+++ ++ K+SDFGL K +
Sbjct: 110 DVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK------------------E 151
Query: 274 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 333
+ + G+ +P + + APE L +K + + D WS G +
Sbjct: 152 ASQGQDSGK--LP---------------------VKWTAPEALREKKFSTKSDVWSFGIL 188
Query: 334 MYEML-IGYPPFCSDDPRITCRKIVN 358
++E+ G P+ PRI + +V
Sbjct: 189 LWEIYSFGRVPY----PRIPLKDVVP 210
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 60/247 (24%), Positives = 103/247 (41%), Gaps = 63/247 (25%)
Query: 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKL--------------KKSEMLKRGQVEH 152
D E IG GAFG V G+ A+KK+ ++ +ML + ++
Sbjct: 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDN 60
Query: 153 VRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYI 212
V S ++L F++ +Y++ E L D+ +++ LS D + ++
Sbjct: 61 VLSALDILQPPHIDP-------FEE---IYVVTE-LMQSDLHKIIVSPQPLSSDHVKVFL 109
Query: 213 AESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIIN 272
+ + + +H +HRDIKP NL+++ N LK+ DFGL + E ++ +
Sbjct: 110 YQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEE-------PDESKHMT 162
Query: 273 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLG 331
QE V++ Y Y APE+L+ + Y D WS+G
Sbjct: 163 QEVVTQ-----------------------Y-------YRAPEILMGSRHYTSAVDIWSVG 192
Query: 332 AIMYEML 338
I E+L
Sbjct: 193 CIFAELL 199
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 7e-09
Identities = 40/152 (26%), Positives = 75/152 (49%), Gaps = 7/152 (4%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 173
+G G +GEV K A+K LK+ M +VE E ++ E+ +VQL
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 174 SFQDSDFLYLIMEYLPGGDIMTLLMREDILSED-VARFYIAESV-LAIHSIHQHNYVHRD 231
Y+I E++ G+++ L + + V Y+A + A+ + + N++HRD
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 129
Query: 232 IKPDNLILDKNGHLKLSDFGLCKPL-EDKYSS 262
+ N ++ +N +K++DFGL + + D Y++
Sbjct: 130 LAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 53/238 (22%), Positives = 98/238 (41%), Gaps = 61/238 (25%)
Query: 114 IGKGAFGEVR--LCRAKTTGEIFAMKKLK-------KSEMLKRGQVEHVRSERNLLAEVD 164
+G G FG V+ + + + A+K LK + EM++ ++ H ++D
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMH---------QLD 53
Query: 165 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM--REDILSEDVARFYIAESVLAIHSI 222
+ IV++ +++ L L+ME GG + L +++I +V + + + + +
Sbjct: 54 NPYIVRMI-GVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVEL-MHQVSMGMKYL 111
Query: 223 HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL--EDKYSSILLEDEDIINQETVSEAE 280
N+VHRD+ N++L + K+SDFGL K L +D Y + +
Sbjct: 112 EGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK--------------ARSA 157
Query: 281 GQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338
G+W L + APE + + + D WS G M+E
Sbjct: 158 GKW-----------------------PLKWYAPECINFRKFSSRSDVWSYGITMWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 41/150 (27%), Positives = 77/150 (51%), Gaps = 14/150 (9%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 173
+G G FGEV + ++ A+K LK+ M E +E NL+ ++ +V+L Y
Sbjct: 14 LGAGQFGEVWMGYYNGHTKV-AIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRL-Y 67
Query: 174 SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFY-----IAESVLAIHSIHQHNYV 228
+ + +Y+I EY+ G ++ L + + + + IAE + I + NY+
Sbjct: 68 AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAE---GMAFIERKNYI 124
Query: 229 HRDIKPDNLILDKNGHLKLSDFGLCKPLED 258
HRD++ N+++ + K++DFGL + +ED
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIED 154
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 54/233 (23%), Positives = 100/233 (42%), Gaps = 55/233 (23%)
Query: 114 IGKGAFGEVR--LCRAKTTGEIFAMKKLK--------KSEMLKRGQVEHVRSERNLLAEV 163
+G G FG V+ + + K + + A+K LK K E+L+ E N++ ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLR---------EANVMQQL 53
Query: 164 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIH 223
D+ IV++ +++ L+ME G + L + ++E + + + + +
Sbjct: 54 DNPYIVRMI-GICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLE 112
Query: 224 QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQW 283
+ N+VHRD+ N++L + K+SDFGL K L DE+ +T G+W
Sbjct: 113 ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALG--------ADENYYKAKT----HGKW 160
Query: 284 MMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 336
+ +W APE + + + D WS G +M+E
Sbjct: 161 PV------KW-----------------YAPECMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 54/247 (21%), Positives = 103/247 (41%), Gaps = 55/247 (22%)
Query: 107 DFEQLTLI---GKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV 163
D + LT + G G FG V+ + + ++ A+K +K+ M + +E + L E
Sbjct: 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIEEAKVMMKLSHEK 60
Query: 164 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVL-AIHSI 222
+VQL+ +Y++ EY+ G ++ L + + + V + +
Sbjct: 61 ----LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYL 116
Query: 223 HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCK-PLEDKYSSILLEDEDIINQETVSEAEG 281
++HRD+ N ++D G +K+SDFGL + L+D+Y+
Sbjct: 117 ESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-------------------- 156
Query: 282 QWMMPKERLQQWKRNRRALAYSTVGT---LDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338
S+VG+ + + PEVLL + + D W+ G +M+E+
Sbjct: 157 ---------------------SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVY 195
Query: 339 -IGYPPF 344
+G P+
Sbjct: 196 SLGKMPY 202
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 43/187 (22%), Positives = 76/187 (40%), Gaps = 41/187 (21%)
Query: 155 SERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAE 214
E ++L + R I+ L ++++ + ++M D+ T + R L + A I
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQA-ITIQR 192
Query: 215 SVL-AIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFG-LCKPLEDKYSSILLEDEDIIN 272
+L A+ +H +HRD+K +N+ LD+ + L DFG CK +
Sbjct: 193 RLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT----------- 241
Query: 273 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGA 332
P+ Y GTL+ +PE+L Y + D WS G
Sbjct: 242 -------------PQ-------------CYGWSGTLETNSPELLALDPYCAKTDIWSAGL 275
Query: 333 IMYEMLI 339
+++EM +
Sbjct: 276 VLFEMSV 282
|
Length = 392 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 45/249 (18%), Positives = 94/249 (37%), Gaps = 55/249 (22%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKT--TGEIF---AMKKLKKSEMLKRGQVEHVRSERNLL 160
+ + +G+G+FG V AK GE A+K + ++ + + +E +++
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM--RERIEFLNEASVM 63
Query: 161 AEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIH 220
E + +V+L ++ME + GD+ + L R + ++
Sbjct: 64 KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYL-RSRRPEAENNPGLGPPTLQKFI 122
Query: 221 S-----------IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDED 269
+ +VHRD+ N ++ ++ +K+ DFG+ + D
Sbjct: 123 QMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR--------------D 168
Query: 270 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWS 329
I + + G+ ++P + +MAPE L + + D WS
Sbjct: 169 IYETDYYRK-GGKGLLP---------------------VRWMAPESLKDGVFTTKSDVWS 206
Query: 330 LGAIMYEML 338
G +++EM
Sbjct: 207 FGVVLWEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 54/234 (23%), Positives = 94/234 (40%), Gaps = 46/234 (19%)
Query: 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR 166
+F +G G FGEV K + A+K LK ++LK+ + E L + +
Sbjct: 7 EFTLERKLGSGYFGEVWEGLWKNRVRV-AIKILKSDDLLKQQDFQ---KEVQALKRLRHK 62
Query: 167 CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARF-YIAESVL-AIHSIHQ 224
++ LF + +Y+I E + G ++ L + VA +A V + + +
Sbjct: 63 HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 225 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL-EDKYSSILLEDEDIINQETVSEAEGQW 283
N +HRD+ N+++ ++ K++DFGL + + ED Y S D+ I + T
Sbjct: 123 QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS---SDKKIPYKWT-------- 171
Query: 284 MMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337
APE + + D WS G ++YEM
Sbjct: 172 ----------------------------APEAASHGTFSTKSDVWSFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 51/162 (31%), Positives = 76/162 (46%), Gaps = 24/162 (14%)
Query: 113 LIGKGAFGEVRLCRAKTTG--EIFAMKKLKKSEMLKRGQVEHVR----SERNLLAEVDSR 166
+IG G FGEV R K G EIF K LK G E R SE +++ + D
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIK-----TLKSGYTEKQRRDFLSEASIMGQFDHP 65
Query: 167 CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSI---- 222
I+ L S + +I E++ G + + L + D +F + + V + I
Sbjct: 66 NIIHLEGVVTKSRPVMIITEFMENGALDSFLRQND------GQFTVIQLVGMLRGIAAGM 119
Query: 223 ---HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261
+ NYVHRD+ N++++ N K+SDFGL + LED S
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 37/147 (25%), Positives = 77/147 (52%), Gaps = 8/147 (5%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 173
+G G FGEV + ++ A+K +K M VE +E N++ + +V+L +
Sbjct: 14 LGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKL-H 67
Query: 174 SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARF--YIAESVLAIHSIHQHNYVHRD 231
+ + +Y+I E++ G ++ L ++ + + + + A+ + I Q NY+HRD
Sbjct: 68 AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 127
Query: 232 IKPDNLILDKNGHLKLSDFGLCKPLED 258
++ N+++ + K++DFGL + +ED
Sbjct: 128 LRAANILVSASLVCKIADFGLARVIED 154
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 67/281 (23%), Positives = 119/281 (42%), Gaps = 69/281 (24%)
Query: 114 IGKGAFGEVRLCRA-----KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCI 168
+G+GAFG+V L + + A+K LK + R + E LL + I
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR---KDFHREAELLTNLQHEHI 69
Query: 169 VQLFYSFQDSDFLYLIMEYLPGGDIM---------TLLMREDILSEDVAR---FYIAESV 216
V+ + + D L ++ EY+ GD+ +LM E ++ + +IA+ +
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 217 LA--IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQE 274
A ++ QH +VHRD+ N ++ +N +K+ DFG+ + D YS+
Sbjct: 130 AAGMVYLASQH-FVHRDLATRNCLVGENLLVKIGDFGMSR---DVYST------------ 173
Query: 275 TVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIM 334
G M+P + +M PE ++ + + E D WSLG ++
Sbjct: 174 DYYRVGGHTMLP---------------------IRWMPPESIMYRKFTTESDVWSLGVVL 212
Query: 335 YEMLI-GYPPF--CSDDPRITC----RKIVNWKTCLKFPEE 368
+E+ G P+ S++ I C R + +TC P+E
Sbjct: 213 WEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTC---PKE 250
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 7e-08
Identities = 62/264 (23%), Positives = 102/264 (38%), Gaps = 71/264 (26%)
Query: 114 IGKGAFGEVRLCRA----KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD----- 164
+G+G FGEV LC A K + F++ +L V+ +R + N A D
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLV--AVKMLREDANKNARNDFLKEI 70
Query: 165 ---SRC----IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR----EDILSEDVA----- 208
SR I++L SD L +I EY+ GD+ L R E DV
Sbjct: 71 KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130
Query: 209 --RFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL-EDKYSSILL 265
F + + + N+VHRD+ N ++ KN +K++DFG+ + L Y I
Sbjct: 131 TLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI-- 188
Query: 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMEC 325
+G+ ++P + +M+ E +L +
Sbjct: 189 --------------QGRAVLP---------------------IRWMSWESILLGKFTTAS 213
Query: 326 DWWSLGAIMYEMLIGYPPFCSDDP 349
D W+ G ++E+L C + P
Sbjct: 214 DVWAFGVTLWEILT----LCKEQP 233
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 61/272 (22%), Positives = 117/272 (43%), Gaps = 51/272 (18%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 173
+G+G FGEV + T + A+K LK M E E ++ ++ +VQL Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 67
Query: 174 SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARF--YIAESVLAIHSIHQHNYVHRD 231
+ + +Y++ EY+ G ++ L E + + A+ + + + NYVHRD
Sbjct: 68 AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127
Query: 232 IKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 291
++ N+++ +N K++DFGL + +ED N+ T
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIED-------------NEYTA--------------- 159
Query: 292 QWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPR 350
R+ + + + APE L + ++ D WS G ++ E+ G P+ P
Sbjct: 160 -----RQGAKFP----IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY----PG 206
Query: 351 ITCRKIVNW-KTCLKFPEEPKISDEARDLICH 381
+ R++++ + + P P+ + DL+C
Sbjct: 207 MVNREVLDQVERGYRMPCPPECPESLHDLMCQ 238
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 57/259 (22%), Positives = 107/259 (41%), Gaps = 56/259 (21%)
Query: 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE 162
+ + + + L IGKG FG+V L G A+K +K + +E +++ +
Sbjct: 3 LNMKELKLLQTIGKGEFGDVML--GDYRGNKVAVKCIKND-----ATAQAFLAEASVMTQ 55
Query: 163 VDSRCIVQLF-YSFQDSDFLYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAI 219
+ +VQL ++ LY++ EY+ G ++ L +L D + + A+
Sbjct: 56 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115
Query: 220 HSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEA 279
+ +N+VHRD+ N+++ ++ K+SDFGL K S
Sbjct: 116 EYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK--------------------EASST 155
Query: 280 EGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML- 338
+ +P + + APE L +K + + D WS G +++E+
Sbjct: 156 QDTGKLP---------------------VKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194
Query: 339 IGYPPFCSDDPRITCRKIV 357
G P+ PRI + +V
Sbjct: 195 FGRVPY----PRIPLKDVV 209
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 57/233 (24%), Positives = 93/233 (39%), Gaps = 40/233 (17%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 173
IG+G FGEV R + A+K + E L E +L + IV+L
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCR--ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 174 SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLA-IHSIHQHNYVHRDI 232
+Y++ME + GGD +T L E + + E+ A + + + +HRD+
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 233 KPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQ 292
N ++ + LK+SDFG+ + E+ED + T G +P
Sbjct: 121 AARNCLVTEKNVLKISDFGMSR-----------EEEDGVYAST----GGMKQIP------ 159
Query: 293 WKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML-IGYPPF 344
+ + APE L Y E D WS G +++E +G P+
Sbjct: 160 ---------------VKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPY 197
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 58/247 (23%), Positives = 98/247 (39%), Gaps = 62/247 (25%)
Query: 114 IGKGAFGEVRLCRAKTTGE-----IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCI 168
+G+GAFG+V L + A+K LK + R + + E LL + I
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR---KDFQREAELLTNLQHEHI 69
Query: 169 VQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED----ILSEDVAR-----------FYIA 213
V+ + D D L ++ EY+ GD+ L IL + R +IA
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 214 ESVLA--IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDII 271
+ + ++ QH +VHRD+ N ++ N +K+ DFG+ + D YS+
Sbjct: 130 SQIASGMVYLASQH-FVHRDLATRNCLVGANLLVKIGDFGMSR---DVYST--------- 176
Query: 272 NQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLG 331
G M+P + +M PE ++ + + E D WS G
Sbjct: 177 ---DYYRVGGHTMLP---------------------IRWMPPESIMYRKFTTESDVWSFG 212
Query: 332 AIMYEML 338
I++E+
Sbjct: 213 VILWEIF 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 60/243 (24%), Positives = 96/243 (39%), Gaps = 54/243 (22%)
Query: 113 LIGKGAFGEVRLCRAKTTGE---IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIV 169
+IG G FGEV K G A+K LK K Q + SE +++ + I+
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEK--QRQDFLSEASIMGQFSHHNII 69
Query: 170 QLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHS----IHQH 225
+L +I EY+ G + L D + + + + + I + +
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSDM 126
Query: 226 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 285
NYVHRD+ N++++ N K+SDFGL + LED + EG
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLED-------------------DPEG---- 163
Query: 286 PKERLQQWKRNRRALAYSTVG---TLDYMAPEVLLKKGYGMECDWWSLGAIMYE-MLIGY 341
Y+T G + + APE + + + D WS G +M+E M G
Sbjct: 164 ---------------TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGE 208
Query: 342 PPF 344
P+
Sbjct: 209 RPY 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 52/217 (23%), Positives = 80/217 (36%), Gaps = 35/217 (16%)
Query: 130 TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ-DSDFLYLIMEYL 188
TG A+K L+ + Q R E L A + IV L S + L+ + EY+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 189 PGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG---HL 245
PG + +L + L + + + A+ H VHRD+KP N+++ + G H
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121
Query: 246 KLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTV 305
K+ DFG+ ++L D E +
Sbjct: 122 KVLDFGI--------GTLLPGVRDADVATLTRTTE-----------------------VL 150
Query: 306 GTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 342
GT Y APE L + D ++ G I E L G
Sbjct: 151 GTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 37/147 (25%), Positives = 76/147 (51%), Gaps = 8/147 (5%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 173
+G+G FGEV + T ++ A+K LK M+ ++ E ++ ++ +V L Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTKV-AIKTLKPGTMMPEAFLQ----EAQIMKKLRHDKLVPL-Y 67
Query: 174 SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLA--IHSIHQHNYVHRD 231
+ + +Y++ E++ G ++ L D + + + +A + I + NY+HRD
Sbjct: 68 AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127
Query: 232 IKPDNLILDKNGHLKLSDFGLCKPLED 258
++ N+++ N K++DFGL + +ED
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIED 154
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 53/257 (20%), Positives = 91/257 (35%), Gaps = 59/257 (22%)
Query: 131 GEIFAMKKLKKSE--MLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYL 188
G +F K + + +LK GQ E LL V+ ++++ + +++ +
Sbjct: 80 GRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139
Query: 189 PGGDIMTLLMREDI-LSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKL 247
D+ T L + L D A + + + +H +HRD+K +N+ ++ + +
Sbjct: 140 -SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCI 198
Query: 248 SDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGT 307
D G Q V GT
Sbjct: 199 GDLGAA-------------------QFPVVAPA--------------------FLGLAGT 219
Query: 308 LDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPE 367
++ APEVL + Y + D WS G +++EML YP +DP T PE
Sbjct: 220 VETNAPEVLARDKYNSKADIWSAGIVLFEML-AYPSTIFEDPPST-------------PE 265
Query: 368 EPKISDEA--RDLICHL 382
E S + +I L
Sbjct: 266 EYVKSCHSHLLKIISTL 282
|
Length = 357 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 35/121 (28%), Positives = 48/121 (39%), Gaps = 37/121 (30%)
Query: 218 AIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVS 277
A+ IH +HRDIK +N+ L+ +G + L DFG P E +
Sbjct: 279 AVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKE------------------ 320
Query: 278 EAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337
R A Y VGT+ +PE+L GY D WS G I+ +M
Sbjct: 321 -------------------REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361
Query: 338 L 338
L
Sbjct: 362 L 362
|
Length = 501 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 6e-07
Identities = 38/159 (23%), Positives = 77/159 (48%), Gaps = 8/159 (5%)
Query: 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA 161
+I + + + +G G FGEV + ++ A+K LK M +E E ++
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKV-AVKTLKPGTMSPESFLE----EAQIMK 56
Query: 162 EVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARF--YIAESVLAI 219
++ +VQL Y+ + +Y++ EY+ G ++ L + + + A+ +
Sbjct: 57 KLRHDKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGM 115
Query: 220 HSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258
I + NY+HRD++ N+++ K++DFGL + +ED
Sbjct: 116 AYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIED 154
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|215917 pfam00433, Pkinase_C, Protein kinase C terminal domain | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 8e-07
Identities = 10/50 (20%), Positives = 17/50 (34%), Gaps = 3/50 (6%)
Query: 422 TVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSD 471
V DT NF+ PP S + + F G+++ +
Sbjct: 1 KVKSPTDTSNFDPE-FTSEPPKL--SPPDSEVLSSIDQLEFRGFSYVNPE 47
|
Length = 47 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 9e-07
Identities = 61/260 (23%), Positives = 103/260 (39%), Gaps = 72/260 (27%)
Query: 114 IGKGAFGEVRLCRAKTTGEIF-----------AMKKLKKSEMLKRGQVEHVRSERNLLAE 162
+G+GAFG+V GE+ A+K LK++ K + R E L+++
Sbjct: 13 LGEGAFGKV------YKGELTGPNERLSATSVAIKTLKENAEPK--VQQEFRQEAELMSD 64
Query: 163 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR----EDILSEDVAR--------- 209
+ IV L ++ EYL GD+ L+R D+ +E
Sbjct: 65 LQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCS 124
Query: 210 --FYIAESVLA-IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 266
+IA + A + + H++VHRD+ N ++ + +K+SDFGL + D YS+
Sbjct: 125 DFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSR---DIYSA---- 177
Query: 267 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECD 326
D ++ S +W M PE +L + E D
Sbjct: 178 --DYYRVQSKSLLPVRW---------------------------MPPEAILYGKFTTESD 208
Query: 327 WWSLGAIMYEML-IGYPPFC 345
WS G +++E+ G P+
Sbjct: 209 IWSFGVVLWEIFSYGLQPYY 228
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|214529 smart00133, S_TK_X, Extension to Ser/Thr-type protein kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 1e-06
Identities = 22/70 (31%), Positives = 31/70 (44%), Gaps = 13/70 (18%)
Query: 405 RGIQWDKLY--EMEAAYKPTVNGELDTQNF-EKFPE---VDGPPSEIPSVGPWRKMLTSK 458
RGI WDKL E+E + P + DT NF +F E V P S G ++
Sbjct: 1 RGIDWDKLENKEIEPPFVPKIKSPTDTSNFDPEFTEETPVLTPVDSPLSGGIQQEP---- 56
Query: 459 DTNFIGYTFK 468
F G+++
Sbjct: 57 ---FRGFSYV 63
|
Length = 64 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 61/242 (25%), Positives = 97/242 (40%), Gaps = 68/242 (28%)
Query: 114 IGKGAFGEVRLCRAKTTG--EIF-AMKKLKKSEMLKRGQVEHVR----SERNLLAEVDSR 166
IG G FGEV R K G EI A+K LK G + R +E +++ + D
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIK------TLKAGSSDKQRLDFLTEASIMGQFDHP 65
Query: 167 CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSI---- 222
I++L S + +I EY+ G + L D +F + + V + I
Sbjct: 66 NIIRLEGVVTKSRPVMIITEYMENGSLDKFLREND------GKFTVGQLVGMLRGIASGM 119
Query: 223 ---HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEA 279
+ NYVHRD+ N++++ N K+SDFGL + LED +
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA------------------ 161
Query: 280 EGQWMMPKERLQQWKRNRRALAYSTVG---TLDYMAPEVLLKKGYGMECDWWSLGAIMYE 336
Y+T G + + APE + + + D WS G +M+E
Sbjct: 162 ---------------------TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWE 200
Query: 337 ML 338
++
Sbjct: 201 VM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 46/229 (20%), Positives = 95/229 (41%), Gaps = 51/229 (22%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 173
+G G FG V L + + ++ A+K +++ M + +E + L +VQL+
Sbjct: 12 LGSGQFGVVHLGKWRGKIDV-AIKMIREGAMSEDDFIEEAKVMMKLSHPN----LVQLYG 66
Query: 174 SFQDSDFLYLIMEYLPGGDIMTLL-MREDILSEDVARFYIAESVLAIHSIHQHNYVHRDI 232
++++ EY+ G ++ L R+ L + ++ A+ + + ++HRD+
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDL 126
Query: 233 KPDNLILDKNGHLKLSDFGLCK-PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 291
N ++ ++ +K+SDFGL + L+D+Y+
Sbjct: 127 AARNCLVGEDNVVKVSDFGLARYVLDDQYT------------------------------ 156
Query: 292 QWKRNRRALAYSTVGT---LDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337
S+ GT + + PEV + + D WS G +M+E+
Sbjct: 157 -----------SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 58/248 (23%), Positives = 102/248 (41%), Gaps = 65/248 (26%)
Query: 114 IGKGAFGEVRLCRA-----KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCI 168
+G+GAFG+V L + + A+K LK++ R + + E LL + + I
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR---QDFQREAELLTVLQHQHI 69
Query: 169 VQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRE----DIL--SEDVA------------RF 210
V+ + + L ++ EY+ GD+ L IL EDVA
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 211 YIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 270
IA ++ + S+H +VHRD+ N ++ + +K+ DFG+ + D YS+
Sbjct: 130 QIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSR---DIYST-------- 175
Query: 271 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSL 330
G+ M+P + +M PE +L + + E D WS
Sbjct: 176 ----DYYRVGGRTMLP---------------------IRWMPPESILYRKFTTESDIWSF 210
Query: 331 GAIMYEML 338
G +++E+
Sbjct: 211 GVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 5e-06
Identities = 23/130 (17%), Positives = 49/130 (37%), Gaps = 11/130 (8%)
Query: 126 RAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIV--QLFYSFQDSDFLYL 183
T E + +K E + E +L + + + ++ S + + YL
Sbjct: 16 LLGTKDEDYVLKINPSRE-----KGADREREVAILQLLARKGLPVPKVLASGESDGWSYL 70
Query: 184 IMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG 243
+ME++ G L ++ +AE + +H + H D+ P N+++D
Sbjct: 71 LMEWIEG----ETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK 126
Query: 244 HLKLSDFGLC 253
L + D+
Sbjct: 127 ILGIIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 7e-06
Identities = 44/176 (25%), Positives = 73/176 (41%), Gaps = 32/176 (18%)
Query: 114 IGKGAFGEVRLCRAKTTGEI----------------FAMKKLKKSEMLKRGQVEHVRSER 157
+G+G FGEV LC A + A+K L+ E E
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEV 70
Query: 158 NLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVAR-------- 209
+L+ + I +L L +IMEY+ GD+ L + + +A
Sbjct: 71 KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFS 130
Query: 210 --FYIAESVLA-IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 262
Y+A + + + + N+VHRD+ N ++ KN +K++DFG+ + L YSS
Sbjct: 131 TLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL---YSS 183
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 8e-06
Identities = 59/261 (22%), Positives = 96/261 (36%), Gaps = 69/261 (26%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAK--TTGEIFAMKKLKKSEMLKRG-----QVEHVRSERN 158
++ E + IG+GAFG V RA E F M +K MLK Q + R E
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVK---MLKEEASADMQADFQR-EAA 60
Query: 159 LLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR------EDILSEDVARFYI 212
L+AE D IV+L + L+ EY+ GD+ L + +
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 213 AESVLAIHSIHQ----------------HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 256
+ L + Q +VHRD+ N ++ +N +K++DFGL +
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR-- 178
Query: 257 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL 316
+ YS+ +A +P + +M PE +
Sbjct: 179 -NIYSA------------DYYKASENDAIP---------------------IRWMPPESI 204
Query: 317 LKKGYGMECDWWSLGAIMYEM 337
Y E D W+ G +++E+
Sbjct: 205 FYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 62/244 (25%), Positives = 106/244 (43%), Gaps = 55/244 (22%)
Query: 114 IGKGAFGEVRLCRA----KTTGEI-FAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC- 167
+G GAFG+V A K+ + A+K LK + + E + SE +++ + +
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHEN 100
Query: 168 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR--EDILS-EDVARF--YIAESVLAIHSI 222
IV L + + +I EY GD++ L R E L+ ED+ F +A+ + + S
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS- 159
Query: 223 HQHNYVHRDIKPDNLILDKNGHL-KLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 281
N +HRD+ N++L +G + K+ DFGL + DI+N +G
Sbjct: 160 --KNCIHRDLAARNVLL-THGKIVKICDFGLAR--------------DIMNDSNYV-VKG 201
Query: 282 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML-IG 340
+P + +MAPE + Y E D WS G +++E+ +G
Sbjct: 202 NARLP---------------------VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLG 240
Query: 341 YPPF 344
P+
Sbjct: 241 SNPY 244
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 59/253 (23%), Positives = 100/253 (39%), Gaps = 50/253 (19%)
Query: 97 RLQRRKIGIDDFEQLTLIGKGAFGEVR--LCRAKTTGEI-FAMKKLKKSEMLKRGQVEHV 153
+QR I + IG+G FG+V + + +I A+K K E
Sbjct: 2 EIQREDITLGR-----CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVR--EKF 54
Query: 154 RSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDI-MTLLMREDILSEDVARFYI 212
E ++ + D IV+L ++ ++++ME P G++ L + + L Y
Sbjct: 55 LQEAYIMRQFDHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDLASLILYS 113
Query: 213 AESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIIN 272
+ A+ + +VHRDI N+++ +KL DFGL S LEDE
Sbjct: 114 YQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGL---------SRYLEDESY-- 162
Query: 273 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGA 332
+K ++ L + +MAPE + + + D W G
Sbjct: 163 --------------------YKASKGKLP------IKWMAPESINFRRFTSASDVWMFGV 196
Query: 333 IMYEMLI-GYPPF 344
M+E+L+ G PF
Sbjct: 197 CMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 59/271 (21%), Positives = 105/271 (38%), Gaps = 77/271 (28%)
Query: 114 IGKGAFGEVRLCRAKTTGEI------FAMKK----LKKSEMLKRGQVEHVRS----ERNL 159
+G+G FGEV LC ++ F ++K L ++L+ ++ R+ E +
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 160 LAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR---EDILSEDVARFYIAESV 216
L+ + I++L D D L +I EY+ GD+ L +D A +
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 217 LAI------HSIHQ----------HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE--D 258
AI H Q N+VHRD+ N ++ +N +K++DFG+ + L D
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGD 192
Query: 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK 318
Y +G+ ++P + +MA E +L
Sbjct: 193 YY-----------------RIQGRAVLP---------------------IRWMAWECILM 214
Query: 319 KGYGMECDWWSLGAIMYEMLIGYPPFCSDDP 349
+ D W+ G ++E+L+ C + P
Sbjct: 215 GKFTTASDVWAFGVTLWEILM----LCKEQP 241
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 56/239 (23%), Positives = 104/239 (43%), Gaps = 50/239 (20%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGE----IFAMKKLKKSEMLKRGQVEHVRSERNLLAEV 163
E++ ++G GAFG V GE A+K L++ + + E ++A V
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASV 66
Query: 164 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM--REDILSEDVARF--YIAESVLAI 219
D +V+L S + LI + +P G ++ + +++I S+ + + IA+ +
Sbjct: 67 DHPHVVRL-LGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAK---GM 122
Query: 220 HSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEA 279
+ + VHRD+ N+++ H+K++DFGL K L+ DE + A
Sbjct: 123 SYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD--------VDEKEYH------A 168
Query: 280 EGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338
EG +P + +MA E +L + Y + D WS G ++E++
Sbjct: 169 EGG-KVP---------------------IKWMALESILHRIYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 22/161 (13%)
Query: 109 EQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
E L L +G G FGEV + T ++ A+K LK M E E ++ ++
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKV-AVKTLKPGTM----SPEAFLQEAQIMKKLRH 60
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHS---- 221
+VQL+ + + +Y++ EY+ G +LL D L + ++ + +
Sbjct: 61 DKLVQLYAVCSEEEPIYIVTEYMSKG---SLL---DFLKSGEGKKLRLPQLVDMAAQIAE 114
Query: 222 ----IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258
+ NY+HRD+ N+++ +N K++DFGL + +ED
Sbjct: 115 GMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIED 155
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 38/156 (24%), Positives = 73/156 (46%), Gaps = 16/156 (10%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 173
+G G FGEV T + A+K LK M + +E ++ ++ ++QL+
Sbjct: 14 LGAGQFGEVWEGLWNNTTPV-AVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYA 68
Query: 174 SFQDSDFLYLIMEYLPGGDIMTLLMREDI----LSE--DVARFYIAESVLAIHSIHQHNY 227
+ +Y++ E + G ++ L L + D+A A+ + + NY
Sbjct: 69 VCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMA----AQVASGMAYLEAQNY 124
Query: 228 VHRDIKPDNLILDKNGHLKLSDFGLCKPL-EDKYSS 262
+HRD+ N+++ +N K++DFGL + + ED Y +
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 44/174 (25%), Positives = 75/174 (43%), Gaps = 47/174 (27%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFA--------MKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
IG G FG+V L GE+ + +K+L+ S V+ + L E
Sbjct: 3 IGNGWFGKVIL------GEVNSGYTPAQVVVKELRVSA--------SVQEQMKFLEEA-- 46
Query: 166 RCIVQLFYSFQDSDFL------------YLIMEYLPGGDIMTLLM---REDILSED--VA 208
Q + S Q S+ L L+ME+ P GD+ L + ++++ D
Sbjct: 47 ----QPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTL 102
Query: 209 RFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGL--CKPLEDKY 260
+ E L + +H++N++H D+ N +L + +K+ D+GL K ED Y
Sbjct: 103 QRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 61/270 (22%), Positives = 102/270 (37%), Gaps = 88/270 (32%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKT--TGEIFAMKKLKKSE---------------MLKRGQV 150
+E IG+G +G V + K G+ +A+KK K + +L+ +
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 151 EHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI-------MEYLPGGDIMTLLMREDIL 203
E+V S + E + + LF + + D +I +P + +LL + IL
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLF-DYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ--IL 118
Query: 204 SEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL----DKNGHLKLSDFGLC----KP 255
+ +H +H + +HRD+KP N+++ + G +K+ D GL P
Sbjct: 119 N-------------GVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165
Query: 256 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEV 315
L+ L D D V T+ Y APE+
Sbjct: 166 LK------PLADLD---------------------------------PVVVTIWYRAPEL 186
Query: 316 LL-KKGYGMECDWWSLGAIMYEMLIGYPPF 344
LL + Y D W++G I E+L P F
Sbjct: 187 LLGARHYTKAIDIWAIGCIFAELLTLEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 62/287 (21%), Positives = 112/287 (39%), Gaps = 62/287 (21%)
Query: 113 LIGKGAFGEVRLCRAKT---TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIV 169
++GKG FG VR + K+ + + A+K LK +++ +E E + E D ++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLK-ADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 170 QLF------YSFQDSDFLYLIMEYLPGGDIMTLLMREDI------LSEDVARFYIAESVL 217
+L + +I+ ++ GD+ T L+ I L ++ +
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 218 AIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVS 277
+ + N++HRD+ N +L++N + ++DFGL K + YS D Q S
Sbjct: 125 GMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKI---YSG------DYYRQGCAS 175
Query: 278 EAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE- 336
+ +W +A E L Y D W+ G M+E
Sbjct: 176 KLPVKW---------------------------LALESLADNVYTTHSDVWAFGVTMWEI 208
Query: 337 MLIGYPPFCSDDPRITCRKIVNWKTC---LKFPEEPKISDEARDLIC 380
M G P+ + +I N+ LK P P ++ +L+C
Sbjct: 209 MTRGQTPY----AGVENSEIYNYLIKGNRLKQP--PDCLEDVYELMC 249
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 33/119 (27%), Positives = 44/119 (36%), Gaps = 36/119 (30%)
Query: 218 AIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVS 277
AI IH +HRDIK +N++++ + L DFG
Sbjct: 272 AIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFG-----------------------AAC 308
Query: 278 EAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 336
A G W P Y GT+D APEVL Y D WS G +++E
Sbjct: 309 FARGSWSTP-------------FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 68/248 (27%), Positives = 110/248 (44%), Gaps = 50/248 (20%)
Query: 109 EQLTLIGKG--AFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR 166
E LT+IG+G V L R K TGE ++++ E V ++ E ++ +
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRIN-LEACTNEMVTFLQGELHVSKLFNHP 59
Query: 167 CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVL-AIHSIH 223
IV +F + L+++ ++ G L+ D +SE +A YI + VL A+ IH
Sbjct: 60 NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSE-LAIAYILQGVLKALDYIH 118
Query: 224 QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQW 283
YVHR +K ++++ +G + LS GL S L +IN GQ
Sbjct: 119 HMGYVHRSVKASHILISVDGKVYLS--GL--------RSNL----SMINH-------GQR 157
Query: 284 M-----MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK--KGYGMECDWWSLGAIMYE 336
+ PK YS V L +++PEVL + +GY + D +S+G E
Sbjct: 158 LRVVHDFPK--------------YS-VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACE 202
Query: 337 MLIGYPPF 344
+ G+ PF
Sbjct: 203 LANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 57/271 (21%), Positives = 99/271 (36%), Gaps = 84/271 (30%)
Query: 112 TLIGKGAFGEVRLCRAKTTGEIFAMKKLK-----KSEMLKRG--QVEH--VRSERNLLAE 162
+G+G FG+V F +K +MLK E + SE NLL +
Sbjct: 6 KTLGEGEFGKV------VKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQ 59
Query: 163 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSI 222
V+ +++L+ + L LI+EY G + + L S V Y+ S
Sbjct: 60 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLR----ESRKVGPSYLGSDGNRNSSY 115
Query: 223 HQH----------------------------NYVHRDIKPDNLILDKNGHLKLSDFGLCK 254
+ VHRD+ N+++ + +K+SDFGL +
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
Query: 255 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPE 314
D Y E++ + KR++ + + +MA E
Sbjct: 176 ---DVY-----EEDSYV----------------------KRSKGRIP------VKWMAIE 199
Query: 315 VLLKKGYGMECDWWSLGAIMYEML-IGYPPF 344
L Y + D WS G +++E++ +G P+
Sbjct: 200 SLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 230
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 46/226 (20%), Positives = 91/226 (40%), Gaps = 45/226 (19%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 173
IG G FG V L ++ A+K +++ M + E E ++ ++ +VQL+
Sbjct: 12 IGSGQFGLVWLGYWLEKRKV-AIKTIREGAMSE----EDFIEEAQVMMKLSHPKLVQLYG 66
Query: 174 SFQDSDFLYLIMEYLPGGDIMTLL-MREDILSEDVARFYIAESVLAIHSIHQHNYVHRDI 232
+ + L+ E++ G + L + S++ + + + N +HRD+
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDL 126
Query: 233 KPDNLILDKNGHLKLSDFGLCK-PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 291
N ++ +N +K+SDFG+ + L+D+Y+S
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDDQYTS----------------------------- 157
Query: 292 QWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337
+ T + + +PEV Y + D WS G +M+E+
Sbjct: 158 ---------STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 32/129 (24%), Positives = 55/129 (42%), Gaps = 39/129 (30%)
Query: 224 QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK--YSSILLEDEDIINQETVSEAEG 281
+VHRD+ N +LD++ +K++DFGL + + DK YS ++ T ++
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS---------VHNHTGAKLPV 166
Query: 282 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-G 340
+W M E LQ K + + D WS G +++E++ G
Sbjct: 167 KW-MALESLQTQK--------------------------FTTKSDVWSFGVLLWELMTRG 199
Query: 341 YPPFCSDDP 349
PP+ D
Sbjct: 200 APPYPDVDS 208
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 30/118 (25%), Positives = 53/118 (44%), Gaps = 37/118 (31%)
Query: 228 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 287
+HRD+ N++L +N +K+ DFGL + D Y +D D + + G +P
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLAR---DIY-----KDPDYVRK-------GDARLP- 244
Query: 288 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML-IGYPPF 344
L +MAPE + + Y ++ D WS G +++E+ +G P+
Sbjct: 245 --------------------LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 49/242 (20%), Positives = 103/242 (42%), Gaps = 54/242 (22%)
Query: 113 LIGKGAFGEV---RLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIV 169
++G+G FG V +L + + A+K +K ++ ++E SE + + D ++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMK-LDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 170 QLF-YSFQDSDFLYL-----IMEYLPGGDIMTLLMR-------EDILSEDVARFYIAESV 216
+L F+ S + I+ ++ GD+ + L+ E + + + +F + +
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF-MVDIA 123
Query: 217 LAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETV 276
L + + N++HRD+ N +L ++ + ++DFGL K + YS D Q +
Sbjct: 124 LGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKI---YS------GDYYRQGRI 174
Query: 277 SEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 336
++ MP + ++A E L + Y + D W+ G M+E
Sbjct: 175 AK------MP---------------------VKWIAIESLADRVYTSKSDVWAFGVTMWE 207
Query: 337 ML 338
+
Sbjct: 208 IA 209
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 57/264 (21%), Positives = 102/264 (38%), Gaps = 72/264 (27%)
Query: 106 DDFEQLTLIGKGAFGEV-----RLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLL 160
D L +G GAFGEV R A+K L E E ++
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL--PESCSEQDESDFLMEALIM 63
Query: 161 AEVDSRCIVQLF-YSFQDSDFLYLIMEYLPGGDIMTLL--------------MREDI-LS 204
++ + + IV+L SF+ ++++E + GGD+ + L M++ + +
Sbjct: 64 SKFNHQNIVRLIGVSFERLPR-FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA 122
Query: 205 EDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH---LKLSDFGLCKPLEDKYS 261
DVA + +++++HRDI N +L G K++DFG+ +
Sbjct: 123 RDVA--------KGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR------- 167
Query: 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY 321
DI + G+ M+P + +M PE L +
Sbjct: 168 -------DIYRASYYRKG-GRAMLP---------------------IKWMPPEAFLDGIF 198
Query: 322 GMECDWWSLGAIMYEML-IGYPPF 344
+ D WS G +++E+ +GY P+
Sbjct: 199 TSKTDVWSFGVLLWEIFSLGYMPY 222
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 55/259 (21%), Positives = 113/259 (43%), Gaps = 65/259 (25%)
Query: 107 DFEQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV 163
+ ++LTL IG+G FG V + + TG+ A+K +K ++ + +E E ++ ++
Sbjct: 4 NLQKLTLGEIIGEGEFGAV--LQGEYTGQKVAVKNIK-CDVTAQAFLE----ETAVMTKL 56
Query: 164 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM---REDILSEDVARF--YIAESVLA 218
+ +V+L + LY++ME + G+++ L R + + +F +AE +
Sbjct: 57 HHKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEY 115
Query: 219 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 278
+ S VHRD+ N+++ ++G K+SDFGL +
Sbjct: 116 LES---KKLVHRDLAARNILVSEDGVAKVSDFGLARV----------------------- 149
Query: 279 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338
+ S + + + APE L K + + D WS G +++E+
Sbjct: 150 -----------------GSMGVDNSKL-PVKWTAPEALKHKKFSSKSDVWSYGVLLWEVF 191
Query: 339 -IGYPPFCSDDPRITCRKI 356
G P+ P+++ +++
Sbjct: 192 SYGRAPY----PKMSLKEV 206
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 31/118 (26%), Positives = 52/118 (44%), Gaps = 37/118 (31%)
Query: 228 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 287
+HRD+ N++L +N +K+ DFGL + D Y +D D + + G +P
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLAR---DIY-----KDPDYVRK-------GSARLP- 239
Query: 288 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML-IGYPPF 344
L +MAPE + K Y + D WS G +++E+ +G P+
Sbjct: 240 --------------------LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 57/253 (22%), Positives = 106/253 (41%), Gaps = 60/253 (23%)
Query: 114 IGKGAFGEVRLCRAKTTG----EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIV 169
+G+ AFG++ G ++ A+K LK ++ Q + E +L+AE+ IV
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLK--DINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 170 QLFYSFQDSDFLYLIMEYLPGGDIMT-LLMR-----------EDIL---SEDVARF-YIA 213
L + ++ EYL GD+ L+MR ED S D F +IA
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 214 ESVLA-IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIIN 272
+ A + + H +VH+D+ N+++ + H+K+SD GL + + YS+
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREI---YSA---------- 177
Query: 273 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGA 332
+ + ++P + +M PE ++ + + D WS G
Sbjct: 178 --DYYRVQPKSLLP---------------------IRWMPPEAIMYGKFSSDSDIWSFGV 214
Query: 333 IMYEML-IGYPPF 344
+++E+ G P+
Sbjct: 215 VLWEIFSFGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 56/245 (22%), Positives = 107/245 (43%), Gaps = 47/245 (19%)
Query: 107 DFEQLTLIGKGAFGEVRLCRAKTTGE----IFAMKKLKKSEMLKRGQVEHVRSERNLLAE 162
+F+++ ++G GAFG V GE A+K+L+++ K + + E ++A
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAYVMAS 65
Query: 163 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM--REDILSEDVARFYIAESVLAIH 220
VD+ + +L S + LI + +P G ++ + +++I S+ + + + + ++
Sbjct: 66 VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV-QIAKGMN 123
Query: 221 SIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAE 280
+ + VHRD+ N+++ H+K++DFGL K L E AE
Sbjct: 124 YLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--------------ADEKEYHAE 169
Query: 281 GQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE-MLI 339
G + K +MA E +L + Y + D WS G ++E M
Sbjct: 170 GGKVPIK----------------------WMALESILHRIYTHQSDVWSYGVTVWELMTF 207
Query: 340 GYPPF 344
G P+
Sbjct: 208 GSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 60/268 (22%), Positives = 107/268 (39%), Gaps = 74/268 (27%)
Query: 109 EQLTL---IGKGAFGEVRLCRA-------KTTGEIFAMKKLKKSEMLKRGQVEHVRSERN 158
++LTL +G+G FG+V + A A+K LK K + + SE
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEME 72
Query: 159 LLAEVDS-RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDIL----SEDVARFYIA 213
++ + + I+ L + LY+I+EY G++ L S D+AR +
Sbjct: 73 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIAR--VP 130
Query: 214 ESVLAIHSIHQHNY--------------VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259
+ + + Y +HRD+ N+++ +N +K++DFGL +
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR----- 185
Query: 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTL--DYMAPEVLL 317
D+ N + +K+ +T G L +MAPE L
Sbjct: 186 ---------DVNN-----------------IDYYKK-------TTNGRLPVKWMAPEALF 212
Query: 318 KKGYGMECDWWSLGAIMYEML-IGYPPF 344
+ Y + D WS G +M+E+ +G P+
Sbjct: 213 DRVYTHQSDVWSFGVLMWEIFTLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 20/66 (30%), Positives = 38/66 (57%)
Query: 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHL 245
E++ G + M +D +V + + + + + +H+ VHRDIKP+NL++ +G +
Sbjct: 289 EFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQV 348
Query: 246 KLSDFG 251
K+ DFG
Sbjct: 349 KIIDFG 354
|
Length = 507 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 40/189 (21%), Positives = 80/189 (42%), Gaps = 40/189 (21%)
Query: 168 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR--EDILSEDVARFYIAESVLAIHSIHQH 225
I+ + F +L++I ++ G +LL + +SE + + ++ ++ +HQ+
Sbjct: 61 IMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN 120
Query: 226 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 285
Y+HR+IK ++++ +G + LS L YS + GQ
Sbjct: 121 GYIHRNIKASHILISGDGLVSLSG------LSHLYSLV---------------RNGQ--- 156
Query: 286 PKERLQQWKRNRRALAYSTVGT--LDYMAPEVLLKK--GYGMECDWWSLGAIMYEMLIGY 341
+ + + T L +++PE+L + GY ++ D +S+G E+ G
Sbjct: 157 ---------KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
Query: 342 PPFCSDDPR 350
PF D R
Sbjct: 208 VPF-QDMLR 215
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.001
Identities = 43/230 (18%), Positives = 91/230 (39%), Gaps = 43/230 (18%)
Query: 113 LIGKGAFGEVRLCRAKT-TGEIF--AMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIV 169
+G G+FG VR T G++ A+K LK ++ ++ E ++ +D ++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSD--IMDDFLKEAAIMHSLDHENLI 59
Query: 170 QLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARF--YIAESVLAIHSIHQHNY 227
+L Y + L ++ E P G ++ L ++ + ++ Y + + + +
Sbjct: 60 RL-YGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRF 118
Query: 228 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 287
+HRD+ N++L + +K+ DFGL + L ++ + +E
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRAL-------PQNEDHYVMEE------------- 158
Query: 288 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337
+ + + APE L + + D W G ++EM
Sbjct: 159 --------HLKV-------PFAWCAPESLRTRTFSHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.003
Identities = 30/134 (22%), Positives = 53/134 (39%), Gaps = 39/134 (29%)
Query: 218 AIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL-EDKYSSILLEDEDIINQETV 276
+ +H+ +H+DI N ++D+ +K++D L + L Y L D +
Sbjct: 129 GMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC--LGDNE------- 179
Query: 277 SEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 336
NR + +MA E L+ K Y D WS G +++E
Sbjct: 180 -------------------NR---------PVKWMALESLVNKEYSSASDVWSFGVLLWE 211
Query: 337 ML-IGYPPFCSDDP 349
++ +G P+ DP
Sbjct: 212 LMTLGQTPYVEIDP 225
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 52/190 (27%), Positives = 76/190 (40%), Gaps = 46/190 (24%)
Query: 97 RLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSE--MLKR----GQV 150
L R DDF +G+GAFG V K + K+ KK +LK+ G V
Sbjct: 123 GLFRPSFKKDDFVLGKKLGEGAFGVVY----KASL---VNKQSKKEGKYVLKKATEYGAV 175
Query: 151 EHVRSER--------------NLLAEVDSR-----CIV-------QLFYSFQDSDFLYLI 184
E +ER L V S+ +V L Q +F Y +
Sbjct: 176 EIWMNERVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNV 235
Query: 185 MEYLPG--GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD-K 241
YL G D+ L RE+ + + + R + + A+ +H VHRD+KP N+I
Sbjct: 236 EPYLLGKVQDLPKGLERENKIIQTIMR----QILFALDGLHSTGIVHRDVKPQNIIFSEG 291
Query: 242 NGHLKLSDFG 251
+G K+ D G
Sbjct: 292 SGSFKIIDLG 301
|
Length = 566 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 45/239 (18%), Positives = 94/239 (39%), Gaps = 53/239 (22%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMK---KLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQ 170
+G+G FG V + + +K K K + R ++E SE + E D +++
Sbjct: 7 LGEGEFGSVM--EGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 171 LF-YSFQDSD-----FLYLIMEYLPGGDIMTLLMREDI------LSEDVARFYIAESVLA 218
L Q + +I+ ++ GD+ + L+ + L + ++ +
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 219 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 278
+ + +++HRD+ N +L++N ++ ++DFGL K + + D Q +++
Sbjct: 125 MEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNG---------DYYRQGRIAK 175
Query: 279 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337
+W +A E L + Y + D WS G M+E+
Sbjct: 176 MPVKW---------------------------IAIESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.004
Identities = 31/118 (26%), Positives = 52/118 (44%), Gaps = 37/118 (31%)
Query: 228 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 287
+HRD+ N++L +N +K+ DFGL + D Y +D D + + G +P
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLAR---DIY-----KDPDYVRK-------GDARLP- 238
Query: 288 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML-IGYPPF 344
L +MAPE + K Y + D WS G +++E+ +G P+
Sbjct: 239 --------------------LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 510 | |||
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.98 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.9 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.85 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.84 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.82 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.81 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.79 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.79 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.75 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.73 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.72 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.65 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.62 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.56 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.54 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.49 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.49 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.48 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.31 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.3 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.29 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.28 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.16 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.06 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.01 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.0 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.95 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.81 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.8 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.63 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.61 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.58 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.46 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.45 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.43 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.42 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.3 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.29 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.26 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.22 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.18 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 98.17 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.0 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.95 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.91 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.84 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.79 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.73 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.66 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.63 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.52 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.5 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.46 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.45 | |
| smart00133 | 64 | S_TK_X Extension to Ser/Thr-type protein kinases. | 97.39 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.24 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.03 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.03 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.93 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.81 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.77 | |
| PLN02236 | 344 | choline kinase | 96.68 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.55 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.44 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.3 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.24 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.07 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.79 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.67 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.32 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.01 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.93 | |
| PF00433 | 48 | Pkinase_C: Protein kinase C terminal domain; Inter | 94.56 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.5 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.29 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 94.02 |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-110 Score=845.95 Aligned_cols=452 Identities=60% Similarity=0.998 Sum_probs=412.7
Q ss_pred CCCCChHHHHHHHHHHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHhcCCHHHHHHHHHHHHHhHHHHHHHhhcccCCCC
Q 010463 28 VSVSSPVTRQKAAAAKQFIENHYKNYLQGLQDRKERRRALQMRAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDD 107 (510)
Q Consensus 28 ~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 107 (510)
....++.|++++++||.+++++|.+.+...++|++|++.++...+....+++++.+.++.+..+|++++|++|.+++.+|
T Consensus 63 ~~~~s~~T~~k~~~~k~~ien~Y~~~~~~~~~R~er~~~le~~l~~~~~s~~~~~~~~~~~~~kEte~lR~~R~r~~~~D 142 (550)
T KOG0605|consen 63 EFLVSNKTKRKVAAAKQYIENHYSSQIKYLNERKERRKELEEKLASEDVSEEEQNELLKSLLSKETEYLRLRRTRLSLDD 142 (550)
T ss_pred ccccCchhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccccHHHHHHHHHHHhhHHHHHHHhccccCCccc
Confidence 34568899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEec
Q 010463 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEY 187 (510)
Q Consensus 108 f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy 187 (510)
|+++++||+||||.||+|+.++||++||||+++|+.+.+.+|++|++.|++||...++||||+||++|||.+++||||||
T Consensus 143 Fe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEy 222 (550)
T KOG0605|consen 143 FELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEY 222 (550)
T ss_pred chhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEe
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccch-
Q 010463 188 LPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE- 266 (510)
Q Consensus 188 ~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~- 266 (510)
+||||++++|++.+.|+|++++||++|+++||+.||++|||||||||+|+|||..||+||+|||||+.+..........
T Consensus 223 lPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~ 302 (550)
T KOG0605|consen 223 LPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRL 302 (550)
T ss_pred cCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcc
Confidence 9999999999999999999999999999999999999999999999999999999999999999998765543222111
Q ss_pred ---hhhhhcccccccc-----cccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHh
Q 010463 267 ---DEDIINQETVSEA-----EGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 267 ---~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml 338 (510)
...........+. ....+.++++.++|+++++.+++|+||||+||||||+.+.+|+..|||||||||+||||
T Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmL 382 (550)
T KOG0605|consen 303 DEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEML 382 (550)
T ss_pred hhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHH
Confidence 0001111111111 12334578889999999999999999999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhcCccccCCCCChHHhhcCCCcCCCCchhhhcccCC
Q 010463 339 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAA 418 (510)
Q Consensus 339 ~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~dp~~R~~~~~~~eil~HpfF~~i~~~~l~~~~~p 418 (510)
.|+|||+++++.++|++|++|+..+.+|....+|++|+|||++|||||++|+|..|++||++||||++|+|+.|++..||
T Consensus 383 vGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~ap 462 (550)
T KOG0605|consen 383 VGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLCDPENRLGSKGAEEIKKHPFFKGVDWDHLREMPAP 462 (550)
T ss_pred hCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhcCHHHhcCcccHHHHhcCCccccCCcchhhcCCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CccccCCCccCCCCCCCCCCCCCCCCCCCCCcccccCC-------CcCCcccCceeeCCcccccccCC
Q 010463 419 YKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLT-------SKDTNFIGYTFKKSDVLKSLENS 479 (510)
Q Consensus 419 ~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~f~~~~~~~~~~~~~~~~~ 479 (510)
|+|.+++++|++|||+|++...+.......++++++.. +++.+|+||||++++.++....+
T Consensus 463 fvP~v~~~~DT~yFddF~e~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~FvgfTyk~~~~~~~~~~~ 530 (550)
T KOG0605|consen 463 FVPQVNSELDTQYFDDFPEEDSMTPTADKSGPSRKMLSMVDTNNSSKDINFVGFTYKNFDGLNKANSL 530 (550)
T ss_pred CCCCCCCcccccccccCcccccCcccccccccchhhhhcccccCCcccccccceeeeccccccccccc
Confidence 99999999999999999998877777666666666544 66778999999999998766555
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-84 Score=661.90 Aligned_cols=432 Identities=40% Similarity=0.732 Sum_probs=370.0
Q ss_pred HHHHHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHhcCCHHHHHHHHHHHHHhHHHHHHHhhcccCCCCceeeeeeecCC
Q 010463 39 AAAAKQFIENHYKNYLQGLQDRKERRRALQMRAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGA 118 (510)
Q Consensus 39 ~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~IG~G~ 118 (510)
-.+-|.|+|++..+.++..+.|..|+++|++.+-...+....+.++++-+.++|..|.|+.|.++.-+-|..++.||-|+
T Consensus 562 PqafkFfMEQHVEnvlksyqqr~~Rk~QLEkEM~kagLpd~~q~qMrkmL~QKESnYiRLkRaKMdKSmFvkik~iGvGA 641 (1034)
T KOG0608|consen 562 PQAFKFFMEQHVENVLKSYQQREKRKKQLEKEMVKAGLPDIMQNQMRKMLQQKESNYIRLKRAKMDKSMFVKIKTIGVGA 641 (1034)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHHHHHHHHHHHHhhhhhHHHHHHhhccccceEEEeeecccc
Confidence 34679999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEeccCCCCHHHHHH
Q 010463 119 FGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM 198 (510)
Q Consensus 119 fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy~~gG~L~~~L~ 198 (510)
||+|.+++..+|...||||.+.|.+++.++|+.|++.|++||...+++|||+||++|||.+++|+||+|++|||++++|.
T Consensus 642 FGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLI 721 (1034)
T KOG0608|consen 642 FGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI 721 (1034)
T ss_pred cceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhhhhcccccc-
Q 010463 199 REDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVS- 277 (510)
Q Consensus 199 ~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~- 277 (510)
+.+.|.|+.|+|||+++.+|++++|++|+|||||||+|||||.+|||||+|||||+-+.....+.....++-.......
T Consensus 722 rmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep 801 (1034)
T KOG0608|consen 722 RMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEP 801 (1034)
T ss_pred HhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCC
Confidence 9999999999999999999999999999999999999999999999999999999977543322222211110000000
Q ss_pred -cccccCCChHHHHHHH--HhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCCCChhhhHH
Q 010463 278 -EAEGQWMMPKERLQQW--KRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCR 354 (510)
Q Consensus 278 -~~~~~~~~~~~~~~~~--~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~~~~~~~~~ 354 (510)
...+.....-..+..- +..+|.++.+.|||+.|+||||+...+|+..|||||.||||||||.|++||.++++.++..
T Consensus 802 ~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~ 881 (1034)
T KOG0608|consen 802 SPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQY 881 (1034)
T ss_pred chhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCccee
Confidence 0000000000000000 1234567789999999999999999999999999999999999999999999999999999
Q ss_pred HHhhccccccCCCCCCCCHHHHHHHHHhhcCccccCCCCChHHhhcCCCcCCCCchhhhcccCCCccccCCCccCCCCCC
Q 010463 355 KIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEK 434 (510)
Q Consensus 355 ~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~dp~~R~~~~~~~eil~HpfF~~i~~~~l~~~~~p~~p~~~~~~d~~~f~~ 434 (510)
+|++|...+.+|...++|.+|.+||.+|+|+++.|+|..++++++.||||++|||..|+...+||+|.++.+.||+|||.
T Consensus 882 kv~nw~~~l~~~~~~~ls~e~~~li~kLc~sad~RLGkng~d~vKaHpfFkgIDfsslRkq~ApYIP~ItHptDTSNFdp 961 (1034)
T KOG0608|consen 882 KVINWRNFLHIPYQGNLSKEALDLIQKLCCSADSRLGKNGADQVKAHPFFKGIDFSSLRKQRAPYIPRITHPTDTSNFDP 961 (1034)
T ss_pred eeeehhhccccccccccCHHHHHHHHHHhcChhhhhcccchhhhhcCccccccchHhhhhccCCcCccccCCCccccCCc
Confidence 99999999999998899999999999999999999999999999999999999999999999999999999999999998
Q ss_pred CCCCCCCCCCCCCCCcccccCCCcCCcccCceeeCC
Q 010463 435 FPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKS 470 (510)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~ 470 (510)
+.+...........+.+.........+|..|||.+|
T Consensus 962 vdpeklwnddses~~~~~~~nkhpehaFyEFTfRrF 997 (1034)
T KOG0608|consen 962 VDPEKLWNDDSESPNVRDTLNKHPEHAFYEFTFRRF 997 (1034)
T ss_pred CCccccccccccCCCcccccccCCccceeEeeeehh
Confidence 765322111111111111122223357999999987
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-81 Score=611.60 Aligned_cols=328 Identities=45% Similarity=0.808 Sum_probs=286.1
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceE
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 181 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~ 181 (510)
.++.++|+++++||+|+||+|++|+.++|++.||||+|+|..+...+++++++.|++||..++||+||+|+++||+.+.+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 56789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 182 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
|||+||++||+|+.+|.+.+.|+|..+++|+++|++||.|||++|||||||||||||||.+|||+|+|||||+......
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~- 179 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG- 179 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999543221
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~ 341 (510)
..+.++|||+.|||||++.+.+|+..||||||||++||||+|.
T Consensus 180 -------------------------------------~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~ 222 (357)
T KOG0598|consen 180 -------------------------------------DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGK 222 (357)
T ss_pred -------------------------------------CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCC
Confidence 1134689999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC-CChHHhhcCCCcCCCCchhhhc--ccC
Q 010463 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT-RGVEELKEHPWFRGIQWDKLYE--MEA 417 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~-~~~~eil~HpfF~~i~~~~l~~--~~~ 417 (510)
+||.+.+...++.+|...+ +..+. ..+|.+++|||++||. ||++|+|. .++++|++||||+++||+.+.. ..|
T Consensus 223 pPF~~~~~~~~~~~I~~~k--~~~~p-~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~P 299 (357)
T KOG0598|consen 223 PPFYAEDVKKMYDKILKGK--LPLPP-GYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSP 299 (357)
T ss_pred CCCcCccHHHHHHHHhcCc--CCCCC-ccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCC
Confidence 9999999999999999854 23332 2599999999999998 99999973 5799999999999999999985 789
Q ss_pred CCccccCCCccCCCCCC-CCCCCCCCCCC---CCCCcccccCCCcCCcccCceeeCC
Q 010463 418 AYKPTVNGELDTQNFEK-FPEVDGPPSEI---PSVGPWRKMLTSKDTNFIGYTFKKS 470 (510)
Q Consensus 418 p~~p~~~~~~d~~~f~~-~~~~~~~~~~~---~~~~~~~~~~~~~~~~f~~~~~~~~ 470 (510)
||+|.+.+..|+++||. |.......... +...............|.||||..+
T Consensus 300 pF~P~~~~~~~~~~Fd~eft~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~gft~~~~ 356 (357)
T KOG0598|consen 300 PFKPNVTGLEDTSNFDNEFTSYTVDYSPVDSSPDMSAFTAFSRTYNKIFPGFTYVAS 356 (357)
T ss_pred CeecCCCCccccccccHHHHhccccCCccccCcccccccccccccccccCCccccCC
Confidence 99999999999999996 32221111111 1100111122233456999999764
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-79 Score=578.65 Aligned_cols=292 Identities=43% Similarity=0.887 Sum_probs=278.8
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEE
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~ 182 (510)
.+++||+++++||.|+||+|.+++.+.+|..||||+++|..+.+..|++|+.+|+.||+.+.||++++|+++|+|.+++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 77899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccc
Q 010463 183 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 262 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 262 (510)
|||||++||.|+++|++.++|+|..++||++||++||+|||+++||||||||||||||.+||+||+|||+|+.+...
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--- 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--- 197 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999976542
Q ss_pred ccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCC
Q 010463 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 342 (510)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~ 342 (510)
+.+.||||+|+|||++..++|+.++|||||||++|||+.|++
T Consensus 198 --------------------------------------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~p 239 (355)
T KOG0616|consen 198 --------------------------------------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYP 239 (355)
T ss_pred --------------------------------------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCC
Confidence 457899999999999999999999999999999999999999
Q ss_pred CCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CChHHhhcCCCcCCCCchhhhc--ccC
Q 010463 343 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLYE--MEA 417 (510)
Q Consensus 343 PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~--~~~~eil~HpfF~~i~~~~l~~--~~~ 417 (510)
||.+.++..+|.+|+. ..+.||. .+|++++|||++||+ |-.+|.|. +|.++|++||||++++|..+.+ ++|
T Consensus 240 PF~~~~~~~iY~KI~~--~~v~fP~--~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~ 315 (355)
T KOG0616|consen 240 PFYDDNPIQIYEKILE--GKVKFPS--YFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEP 315 (355)
T ss_pred CCcCCChHHHHHHHHh--CcccCCc--ccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccccC
Confidence 9999999999999998 4588885 899999999999998 99999886 5899999999999999999985 789
Q ss_pred CCcc-ccCCCccCCCCCCCCCCC
Q 010463 418 AYKP-TVNGELDTQNFEKFPEVD 439 (510)
Q Consensus 418 p~~p-~~~~~~d~~~f~~~~~~~ 439 (510)
||+| .+..+.|++||+.+++..
T Consensus 316 P~~pp~~~~~gdtsnfd~y~e~~ 338 (355)
T KOG0616|consen 316 PFEPPNIHGPGDTSNFDDYEEED 338 (355)
T ss_pred CCCCccccCCccccccccccccc
Confidence 9987 889999999999887654
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-79 Score=664.00 Aligned_cols=335 Identities=48% Similarity=0.836 Sum_probs=299.9
Q ss_pred HhhcccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec
Q 010463 98 LQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 177 (510)
Q Consensus 98 ~~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 177 (510)
....++..+||+++++||+|+||.|.+|+++.|+++||||+++|-.|.++.....|+.|++||...+++|||.|+++|||
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 44556788999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCc
Q 010463 178 SDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 257 (510)
Q Consensus 178 ~~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~ 257 (510)
+.++|||||||+||||.++|.+.++++|..|+||+++|+.||..||++|+|||||||+|||||..|||||+|||.|-.+.
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998776
Q ss_pred cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-----CCCCccccccchhh
Q 010463 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-----KGYGMECDWWSLGA 332 (510)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-----~~y~~~~DiwSlGv 332 (510)
.... -.+.+.||||+|++||++.. +.||..||||||||
T Consensus 227 ~dG~-------------------------------------V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV 269 (1317)
T KOG0612|consen 227 ADGT-------------------------------------VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGV 269 (1317)
T ss_pred CCCc-------------------------------------EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHH
Confidence 3210 01235799999999999973 45899999999999
Q ss_pred HHHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhcCccccCCCCChHHhhcCCCcCCCCchhh
Q 010463 333 IMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKL 412 (510)
Q Consensus 333 ilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~dp~~R~~~~~~~eil~HpfF~~i~~~~l 412 (510)
++||||+|..||++++..+||.+|++.+..+.||....+|.+++|||++|||+|+.|+|++|+++|+.||||.|++|+.|
T Consensus 270 ~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~~~e~RLgrngiedik~HpFF~g~~W~~i 349 (1317)
T KOG0612|consen 270 FMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALLCDREVRLGRNGIEDIKNHPFFEGIDWDNI 349 (1317)
T ss_pred HHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhcChhhhcccccHHHHHhCccccCCChhhh
Confidence 99999999999999999999999999999999998888999999999999999999999999999999999999999999
Q ss_pred hcccCCCccccCCCccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCcccCceeeCCc
Q 010463 413 YEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSD 471 (510)
Q Consensus 413 ~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~ 471 (510)
++..|||+|.++++.||+|||-..+...+....+... .......+..|+||||....
T Consensus 350 R~~~pP~vPevssd~DTsnFd~~~dd~~~~e~~p~~~--~~~f~Gn~LPFIGfTy~~~~ 406 (1317)
T KOG0612|consen 350 RESVPPVVPEVSSDDDTSNFDVDEDDLRDAETFPPRI--PKAFSGNHLPFIGFTYTHES 406 (1317)
T ss_pred hhcCCCCCCcCCCCCccccccccccccchhhccCCCC--CCCCcCCcCCeeeeeeccch
Confidence 9999999999999999999964332222222222111 11234567899999999743
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-74 Score=600.79 Aligned_cols=324 Identities=37% Similarity=0.704 Sum_probs=289.3
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCc
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSD 179 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~ 179 (510)
.++++++|.++++||+|+||+|+++..+.+++.||||+++|..++.+.+++.++.|..|+... +||+++.|+.+||+.+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 478899999999999999999999999999999999999999999999999999999999877 4999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 180 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
++|+||||+.||| +.++++.+.|+|..+++|+|++++||.|||++||||||||.+|||||.+||+||+|||+|+.....
T Consensus 443 ~l~fvmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 443 HLFFVMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred eEEEEEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence 9999999999999 556667789999999999999999999999999999999999999999999999999999964321
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~ 339 (510)
...+.++||||+|||||++.+..|+.++|||||||+|||||+
T Consensus 522 --------------------------------------g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~ 563 (694)
T KOG0694|consen 522 --------------------------------------GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLV 563 (694)
T ss_pred --------------------------------------CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHc
Confidence 113557999999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CChHHhhcCCCcCCCCchhhhc--
Q 010463 340 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLYE-- 414 (510)
Q Consensus 340 G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~--~~~~eil~HpfF~~i~~~~l~~-- 414 (510)
|.+||.|++.++.+..|++ ....+|. .+|.++.+++++||. +|++|+|+ +++++|+.||||+.|||+.|.+
T Consensus 564 Gq~PF~gddEee~FdsI~~--d~~~yP~--~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~ 639 (694)
T KOG0694|consen 564 GESPFPGDDEEEVFDSIVN--DEVRYPR--FLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRR 639 (694)
T ss_pred CCCCCCCCCHHHHHHHHhc--CCCCCCC--cccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhcc
Confidence 9999999999999999998 4566774 899999999999998 99999997 5799999999999999999985
Q ss_pred ccCCCccccCCCccCCCCCCCCCCCCCCCCCCCCCcccccCC-CcCCcccCceeeCCc
Q 010463 415 MEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLT-SKDTNFIGYTFKKSD 471 (510)
Q Consensus 415 ~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~f~~~~~~~~~ 471 (510)
++|||+|.++++.|.+|||+-...+.+..+.+ ....++ ..+..|.||+|.+.+
T Consensus 640 i~PPf~P~i~~~~D~snFd~eFt~e~p~Lt~~----~~~~l~~~~q~~F~~Fs~~~~~ 693 (694)
T KOG0694|consen 640 IKPPFVPTIKGPEDVSNFDEEFTSEKPALTPS----DPRPLTEEEQEAFRDFSFVAEW 693 (694)
T ss_pred CCCCCCcccCChhhhcccchhhhcCCCccCCC----CccccchhhHHHhcCccccCCC
Confidence 88999999999999999997443333332211 112233 344689999998764
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-70 Score=540.07 Aligned_cols=324 Identities=35% Similarity=0.606 Sum_probs=273.0
Q ss_pred hhcccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC
Q 010463 99 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 178 (510)
Q Consensus 99 ~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 178 (510)
+...+++++|++++.||.|.-|+||+|+.+.++..+|||+|.|..+.+++.+.++..|++||+.++||+++.||..|+.+
T Consensus 70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~ 149 (459)
T KOG0610|consen 70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD 149 (459)
T ss_pred CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence 45668889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ceEEEEEeccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccC
Q 010463 179 DFLYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 256 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~ 256 (510)
.+.|+|||||+||||..+++++ +.|+|..++||+++++.||+|||.+|||+||||||||||.++|||.|+||.|+...
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 9999999999999999999875 67999999999999999999999999999999999999999999999999999876
Q ss_pred ccccccccchhhhh-hc---ccccc--cccc-cC--CChHH-H---HH-------HHHhhcccccccccccCCCcchHhh
Q 010463 257 EDKYSSILLEDEDI-IN---QETVS--EAEG-QW--MMPKE-R---LQ-------QWKRNRRALAYSTVGTLDYMAPEVL 316 (510)
Q Consensus 257 ~~~~~~~~~~~~~~-~~---~~~~~--~~~~-~~--~~~~~-~---~~-------~~~~~~~~~~~s~~GT~~Y~APEvl 316 (510)
... +.+...... .. .+..+ -+.- +. ...+. + .. -..........|+|||-+|+|||++
T Consensus 230 ~~~--Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI 307 (459)
T KOG0610|consen 230 PVS--PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI 307 (459)
T ss_pred CCC--CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence 321 111111000 00 00000 0000 00 00000 0 00 0001112345689999999999999
Q ss_pred ccCCCCccccccchhhHHHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC-CC
Q 010463 317 LKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT-RG 394 (510)
Q Consensus 317 ~~~~y~~~~DiwSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~-~~ 394 (510)
.+.+++.++|||+|||+|||||.|..||.|.+..+++.+|+. ..+.||..+.+|..|+|||++||. ||.+|+|. +|
T Consensus 308 ~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~--~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rG 385 (459)
T KOG0610|consen 308 RGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG--QPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRG 385 (459)
T ss_pred ecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc--CCCcCCCCCcchhHHHHHHHHHhccChhhhhccccc
Confidence 999999999999999999999999999999999999999997 679999989999999999999998 99999996 78
Q ss_pred hHHhhcCCCcCCCCchhhhcccCCCccccCCC
Q 010463 395 VEELKEHPWFRGIQWDKLYEMEAAYKPTVNGE 426 (510)
Q Consensus 395 ~~eil~HpfF~~i~~~~l~~~~~p~~p~~~~~ 426 (510)
+.||++||||++++|.-++...||++|...+.
T Consensus 386 A~eIK~HpFF~gVnWaLir~~~PP~iP~~~d~ 417 (459)
T KOG0610|consen 386 AAEIKRHPFFEGVNWALIRCARPPEIPKPVDG 417 (459)
T ss_pred hHHhhcCccccCCChhheeccCCCcCCCcccc
Confidence 99999999999999998888999999976544
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-71 Score=530.56 Aligned_cols=329 Identities=38% Similarity=0.690 Sum_probs=290.6
Q ss_pred hhcccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC
Q 010463 99 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 178 (510)
Q Consensus 99 ~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 178 (510)
.+.++..++|+.+++||+|.||+|-+|+.+.||+.||||+++|..++.+.++.|...|-.+|+.++||++..|.++||..
T Consensus 161 ~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~ 240 (516)
T KOG0690|consen 161 RKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ 240 (516)
T ss_pred ccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC
Confidence 45678899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 179 DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
+.+|+||||..||+|+.+|.+...|+|+.++||-++|+.||.|||+.+||+||||.+|+|||.+|||||+|||||+.-..
T Consensus 241 drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 241 DRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred ceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999985322
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHh
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml 338 (510)
. ...+.++||||.|+|||++....|+.++|||.+||++|||+
T Consensus 321 ~--------------------------------------g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMm 362 (516)
T KOG0690|consen 321 Y--------------------------------------GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMM 362 (516)
T ss_pred c--------------------------------------cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHH
Confidence 1 01234689999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CChHHhhcCCCcCCCCchhhhc-
Q 010463 339 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLYE- 414 (510)
Q Consensus 339 ~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~--~~~~eil~HpfF~~i~~~~l~~- 414 (510)
+|+.||+..+....+..|+. ..++||. .+|++|+.|+..||. ||.+|+|. .++.||.+|+||.+|+|.....
T Consensus 363 CGRLPFyn~dh~kLFeLIl~--ed~kFPr--~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~K 438 (516)
T KOG0690|consen 363 CGRLPFYNKDHEKLFELILM--EDLKFPR--TLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRK 438 (516)
T ss_pred hccCcccccchhHHHHHHHh--hhccCCc--cCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHh
Confidence 99999999999999999987 5688995 899999999999998 99999985 4689999999999999999874
Q ss_pred -ccCCCccccCCCccCCCCCC-CCCCCCCCCCCC-CCCcccccCCCcCCcccCceeeCC
Q 010463 415 -MEAAYKPTVNGELDTQNFEK-FPEVDGPPSEIP-SVGPWRKMLTSKDTNFIGYTFKKS 470 (510)
Q Consensus 415 -~~~p~~p~~~~~~d~~~f~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~~f~~~~~~~~ 470 (510)
+.|||+|.+.++.|+++||. |..... .-+.| ..++..........+|..|+|...
T Consensus 439 ki~PPfKPqVtSetDTryFD~EFT~q~v-~lTPP~r~~~~~~~~~e~~~~FpQFsy~~~ 496 (516)
T KOG0690|consen 439 KIEPPFKPQVTSETDTRYFDEEFTSQPV-TLTPPDRYGSTVDEDEERRPHFPQFSYSAS 496 (516)
T ss_pred ccCCCCCCCcccccchhhhhhhhhccee-EecCCCCCCcccchhhhhccCCcceeeecc
Confidence 89999999999999999996 332221 11111 111111112233457888888764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-67 Score=535.41 Aligned_cols=285 Identities=36% Similarity=0.682 Sum_probs=257.9
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCce
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDF 180 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~ 180 (510)
+.+..||.+.+.||.|+|++|++|+.+.+++.||||++.|..+++...++-+..|+++|..| .||.||+||..|||+..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 55789999999999999999999999999999999999999999999999999999999999 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccc
Q 010463 181 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 260 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~ 260 (510)
+|+|+||+++|||.++|.+.+.|+|..+++|++||+.||+|||++|||||||||||||||.|||+||+|||.|+.+....
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999887642
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhC
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 340 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G 340 (510)
...-. .+.. ......+.++|||..|++||+|.....+..+|+|+||||||.||.|
T Consensus 229 ~~~~~---------~~~~----------------~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG 283 (604)
T KOG0592|consen 229 KSQEN---------PVDP----------------NQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAG 283 (604)
T ss_pred ccccC---------ccCc----------------ccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcC
Confidence 21100 0000 0000113479999999999999999999999999999999999999
Q ss_pred CCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchhhhcccCC
Q 010463 341 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAA 418 (510)
Q Consensus 341 ~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l~~~~~p 418 (510)
.|||.+.++-.++++|+. ..+.|| +.+++.++|||++||. ||.+|+ ++++|++||||.+|||+.|.+.+||
T Consensus 284 ~PPFra~NeyliFqkI~~--l~y~fp--~~fp~~a~dLv~KLLv~dp~~Rl---t~~qIk~HpFF~~Vdw~nlw~~~PP 355 (604)
T KOG0592|consen 284 QPPFRAANEYLIFQKIQA--LDYEFP--EGFPEDARDLIKKLLVRDPSDRL---TSQQIKAHPFFEGVDWENLWQQTPP 355 (604)
T ss_pred CCCCccccHHHHHHHHHH--hcccCC--CCCCHHHHHHHHHHHccCccccc---cHHHHhhCcccccCChhhhhhcCCC
Confidence 999999999999999997 346666 4899999999999998 999999 6799999999999999999987664
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-68 Score=522.79 Aligned_cols=331 Identities=36% Similarity=0.663 Sum_probs=295.1
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCce
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDF 180 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~ 180 (510)
.+...||.++.+||+|+||+|.++..+.|.+.||||+++|..++....++....|..+|+.. +-|++++|+.+||+-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 45667999999999999999999999999999999999999999999999999999999887 56899999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccc
Q 010463 181 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 260 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~ 260 (510)
+|+||||+.||||+.+++.-+.|.|..|.||+++|+.||-+||++|||+||||.+|||||.+|||||+|||+|+.-.-.
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~- 503 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD- 503 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999853221
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhC
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 340 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G 340 (510)
+..+.++||||+|+|||++..++|+.++||||+||+|||||.|
T Consensus 504 -------------------------------------~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaG 546 (683)
T KOG0696|consen 504 -------------------------------------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 546 (683)
T ss_pred -------------------------------------CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcC
Confidence 1124578999999999999999999999999999999999999
Q ss_pred CCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CChHHhhcCCCcCCCCchhhh--cc
Q 010463 341 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLY--EM 415 (510)
Q Consensus 341 ~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~--~~~~eil~HpfF~~i~~~~l~--~~ 415 (510)
++||.+++..+.+..|.. ....+|. .+|.+|.++++.+|. .|.+|+|+ .+-.+|..||||+.|||+++. ++
T Consensus 547 QpPFdGeDE~elF~aI~e--hnvsyPK--slSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~ei 622 (683)
T KOG0696|consen 547 QPPFDGEDEDELFQAIME--HNVSYPK--SLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREI 622 (683)
T ss_pred CCCCCCCCHHHHHHHHHH--ccCcCcc--cccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccC
Confidence 999999999999999997 5577775 899999999999998 99999987 457899999999999999997 58
Q ss_pred cCCCccccCCCccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCcccCceeeCCccccccc
Q 010463 416 EAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKSLE 477 (510)
Q Consensus 416 ~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~ 477 (510)
+|||+|.++..-+.+|||++.....+..+.+. ...+.+-++..|+||+|.+++.+....
T Consensus 623 qPPfkPk~k~~r~~eNFD~~Ft~~~~~lTPpD---~~v~~nldq~eF~gFsfvNpefv~~~~ 681 (683)
T KOG0696|consen 623 QPPFKPKIKCGRDAENFDKFFTREPTDLTPPD---KLVMMNLDQSEFEGFSFVNPEFVKPIV 681 (683)
T ss_pred CCCCCCccccCCchhhhhHHHhcCCCCCCCch---HHHHhcCchhhcCceeeeChhhcCCCC
Confidence 99999999999999999986655433322221 123344456789999999998876543
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-62 Score=507.82 Aligned_cols=362 Identities=52% Similarity=0.922 Sum_probs=292.4
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++|++++.||+|+||+||+|+++.+|+.||||++.+..........++..|+.++..++||||++++++|++...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 58999999999999999999999999999999999877666667788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
||++||+|.+++.+.+.+++..++.+++|++.||+|||++||+||||||+||||+.+|++||+|||+|+.+.........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 99999999999999899999999999999999999999999999999999999999999999999999866432111000
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCC
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~ 345 (510)
... .....................|++++.....+.+||+.|+|||++.+.+|+.++|||||||++|||++|.+||.
T Consensus 161 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 161 RNL---NHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred ccc---cccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 000 00000000000001111112233344444556799999999999999999999999999999999999999999
Q ss_pred CCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhcCccccCCCCChHHhhcCCCcCCCCchhhhcccCCCccccCC
Q 010463 346 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNG 425 (510)
Q Consensus 346 ~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~dp~~R~~~~~~~eil~HpfF~~i~~~~l~~~~~p~~p~~~~ 425 (510)
+.+..+.+.+|.++...+.+|....+|+++++||.+|+++|.+|+++.+++||++||||++++|+.+....++..+.+.+
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~~~~~~~~~~~~~~~~~~ 317 (363)
T cd05628 238 SETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVDWEHIRERPAAIPIEIKS 317 (363)
T ss_pred CCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCCCHHHHHhCCCCCCccCCC
Confidence 99999999999988777888876779999999999999888888887789999999999999999998877776677888
Q ss_pred CccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCcccCceeeCC
Q 010463 426 ELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKS 470 (510)
Q Consensus 426 ~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~ 470 (510)
..|+++|+.++..............-.......+..|.||||..+
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (363)
T cd05628 318 IDDTSNFDEFPDSDILKPTVATSNHPETDYKNKDWVFINYTYKRF 362 (363)
T ss_pred cchhhccCCCCccccccccccccCCcccccCcCCcccCCceeecC
Confidence 889999998776543332222111111223345567999999854
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-62 Score=507.92 Aligned_cols=364 Identities=56% Similarity=1.004 Sum_probs=301.3
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++|++++.||+|+||+||+|+++.+|+.||||++.+..+....+...+.+|+.+|..++||||++++++|++.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 58999999999999999999999999999999998876666677788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.+.........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999999865432111000
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCC
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~ 345 (510)
...........................|...++....+.+||+.|+|||++.+.+|+.++|||||||++|||++|.+||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~ 240 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence 00000000000000001112223334555556556677899999999999999999999999999999999999999999
Q ss_pred CCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhcCccccCCCCChHHhhcCCCcCCCCchhhhcccCCCccccCC
Q 010463 346 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNG 425 (510)
Q Consensus 346 ~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~dp~~R~~~~~~~eil~HpfF~~i~~~~l~~~~~p~~p~~~~ 425 (510)
+.+....+.++.+|...+.+|....+|+++++||++||++|.+|++..++++++.||||++++|+.+....+|+.|.+.+
T Consensus 241 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~ 320 (364)
T cd05599 241 SDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFKGVDWEHIRERPAPIIPELKS 320 (364)
T ss_pred CCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhcCCCcCCCCHHHHhhcCCCCCCCCCC
Confidence 99999999999998888888877789999999999999999999976679999999999999999999889999999999
Q ss_pred CccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCcccCceeeCCc
Q 010463 426 ELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSD 471 (510)
Q Consensus 426 ~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~ 471 (510)
..|.++|+.+++........+ ........+++..|+||+|++++
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 364 (364)
T cd05599 321 ITDTSNFDDFEEIDLDVPTSP--GPPRGKIKSKDLAFIGYTYKRFE 364 (364)
T ss_pred chhhhhccccccccccccCCC--ccccccccccCCCCCCCeeeCCC
Confidence 999999998766543322222 11222345688999999999875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-64 Score=495.71 Aligned_cols=262 Identities=32% Similarity=0.565 Sum_probs=235.7
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcch----hhHHHHHHHHHHHHhcCCCCeeeEeEEeecCce
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR----GQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 180 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~----~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 180 (510)
.+.|.+.+.||+|+||.|.+|..+.||+.||||+++|...... .....+.+|++||++++|||||+++++|..++.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 4568888999999999999999999999999999998765442 233457899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCC---CceeecccCCcccCc
Q 010463 181 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN---GHLKLSDFGLCKPLE 257 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~---g~vkL~DFGla~~~~ 257 (510)
.||||||+.||+|++.+..++.+.|...+.|+.|++.||.|||++||+||||||||||+..+ .++||+|||+|+...
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g 330 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSG 330 (475)
T ss_pred eEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccc
Confidence 99999999999999999999999999999999999999999999999999999999999866 789999999999765
Q ss_pred cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCC---CccccccchhhHH
Q 010463 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY---GMECDWWSLGAIM 334 (510)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y---~~~~DiwSlGvil 334 (510)
.. ....+.||||.|.||||+.++++ ..++|+|||||+|
T Consensus 331 ~~---------------------------------------sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvL 371 (475)
T KOG0615|consen 331 EG---------------------------------------SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVL 371 (475)
T ss_pred cc---------------------------------------eehhhhcCCccccChhheecCCeecccchheeeeccceE
Confidence 32 12347899999999999998764 5588999999999
Q ss_pred HHHhhCCCCCCCCChhh-hHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCC
Q 010463 335 YEMLIGYPPFCSDDPRI-TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 408 (510)
Q Consensus 335 yEml~G~~PF~~~~~~~-~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~ 408 (510)
|-||+|++||.+..... ...+|..++..+.-|.|..+|+++.|||.+||. ||++|+ +++|+|+||||+.++
T Consensus 372 fvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~---s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 372 FVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRP---SADEALNHPWFKDAP 444 (475)
T ss_pred EEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCc---CHHHHhcChhhhccc
Confidence 99999999999887666 788898877777667788999999999999998 999999 789999999999876
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-64 Score=506.08 Aligned_cols=299 Identities=36% Similarity=0.706 Sum_probs=282.4
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceE
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 181 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~ 181 (510)
.+.+.+++.+..||-||||.|=+++.+.....+|+|+++|..+....|.+|+..|++||..+++|+||+||-.|.|+.++
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 45678999999999999999999998877777999999999999999999999999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 182 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
||.||-|-||+|++.|+..+.|++..++||++.++.|++|||++|||+|||||+|+|||.+|.+||.|||+|+.+..+.
T Consensus 496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~- 574 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR- 574 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999876542
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~ 341 (510)
.+.++||||.|.|||++.+++++.++|+||||+++||||+|.
T Consensus 575 --------------------------------------KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~ 616 (732)
T KOG0614|consen 575 --------------------------------------KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGS 616 (732)
T ss_pred --------------------------------------ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCC
Confidence 234799999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCC--CCChHHhhcCCCcCCCCchhhhc--cc
Q 010463 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLG--TRGVEELKEHPWFRGIQWDKLYE--ME 416 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~--~~~~~eil~HpfF~~i~~~~l~~--~~ 416 (510)
|||.+.++..+|..|+.+...+.+|. .++..+.+||++|.. +|.+|+| ..++.+|++|.||.++||+.|+. ++
T Consensus 617 pPFs~~dpmktYn~ILkGid~i~~Pr--~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~ 694 (732)
T KOG0614|consen 617 PPFSGVDPMKTYNLILKGIDKIEFPR--RITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLP 694 (732)
T ss_pred CCCCCCchHHHHHHHHhhhhhhhccc--ccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCC
Confidence 99999999999999999988889994 899999999999987 9999999 57899999999999999999984 89
Q ss_pred CCCccccCCCccCCCCCCCCCCCCC
Q 010463 417 AAYKPTVNGELDTQNFEKFPEVDGP 441 (510)
Q Consensus 417 ~p~~p~~~~~~d~~~f~~~~~~~~~ 441 (510)
||++|.+.++.|++|||.|+...+.
T Consensus 695 pPi~~~va~ptD~s~Fd~~p~dnd~ 719 (732)
T KOG0614|consen 695 PPIIPSVANPTDVSNFDNFPPDNDE 719 (732)
T ss_pred CCccccCCCcccchhccCCCcccCC
Confidence 9999999999999999999866543
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-60 Score=496.70 Aligned_cols=366 Identities=49% Similarity=0.914 Sum_probs=292.1
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++|.+++.||+|+||+||+|+++.+|+.||||++.+..........++.+|+.+|..++|||||+++++|++.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999998876666667788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccc--
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI-- 263 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~-- 263 (510)
||++||+|.+++...+.+++..++.++.|++.||+|||+.||+||||||+|||++.+|++||+|||+|+.+.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 999999999999988899999999999999999999999999999999999999999999999999997543211100
Q ss_pred --cchhhhhhcc-----cccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHH
Q 010463 264 --LLEDEDIINQ-----ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 336 (510)
Q Consensus 264 --~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyE 336 (510)
........+. ...................|..++.....+.+||+.|+|||++.+..|+.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence 0000000000 000000000011112223344444444456789999999999999999999999999999999
Q ss_pred HhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhcCccccCCCCChHHhhcCCCcCCCCchhhhccc
Q 010463 337 MLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEME 416 (510)
Q Consensus 337 ml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~dp~~R~~~~~~~eil~HpfF~~i~~~~l~~~~ 416 (510)
|++|.+||.+.+....+.+|..|...+.+|....+|.++++||.+||++|.+|+++.++.+++.||||++++|+.+....
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~hp~~~~~~~~~~~~~~ 320 (377)
T cd05629 241 CLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDWDTIRQIR 320 (377)
T ss_pred hhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhcCCCcCCCCHHHHccCC
Confidence 99999999999888889999988777888876789999999999999999999887799999999999999999999999
Q ss_pred CCCccccCCCccCCCCCCCCCCCCCCCCCCCCCc--ccccCCCcCCcccCceeeCCc
Q 010463 417 AAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGP--WRKMLTSKDTNFIGYTFKKSD 471 (510)
Q Consensus 417 ~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~f~~~~~~~~~ 471 (510)
+|+.|.+....++.+|........+..+.....+ ........+.+|+||||+++|
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (377)
T cd05629 321 APFIPQLKSITDTSYFPTDELEQVPEAPALKQAAPAQQEESVELDLAFIGYTYKRFD 377 (377)
T ss_pred CCcccCCCCccccccCCccccccCccccccccccccccccccccCcccccceecCCC
Confidence 9999999998898888653322222111111100 112234456799999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-61 Score=494.47 Aligned_cols=359 Identities=53% Similarity=0.940 Sum_probs=292.6
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++|++++.||+|+||.||+|+++.+|+.||||++.+..........++..|+.++..++||||++++++|++.+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999998877666777888999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
||++||+|.+++.+.+.+++..++.+++|++.||+|||++||+||||||+||||+.+|++||+|||+|+.+.........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999999866432111100
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCC
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~ 345 (510)
... ............+........|..++...+.+.+||+.|+|||++.+.+|+.++|||||||++|||++|.+||.
T Consensus 161 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 161 RNL---THNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccc---ccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 000 00000000000011111122233344445567899999999999999999999999999999999999999999
Q ss_pred CCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhcCccccCCCCChHHhhcCCCcCCCCchhhhcccCCCccccCC
Q 010463 346 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNG 425 (510)
Q Consensus 346 ~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~dp~~R~~~~~~~eil~HpfF~~i~~~~l~~~~~p~~p~~~~ 425 (510)
+.++...+.++.++...+.+|....+|+++++||.+|+.||.+|+++.+++++++||||++++|..+....++..+.+.+
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~~~~~~~~~~~~ 317 (360)
T cd05627 238 SETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEGVDWGHIRERPAAIPIEIKS 317 (360)
T ss_pred CCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhccChhhcCCCCCHHHHhcCCCCCCCCHHHHhcCCCCCCccCCC
Confidence 99999999999988777778876679999999999977799999998889999999999999999998876666667888
Q ss_pred CccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCcccCceeeCC
Q 010463 426 ELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKS 470 (510)
Q Consensus 426 ~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~ 470 (510)
..|+++|+.+++........... ..-..+++..|.+|+|+.+
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 359 (360)
T cd05627 318 IDDTSNFDEFPESDILQPAENTI---EPDYKSKDWVFLNYTYKRF 359 (360)
T ss_pred cchhhhcCCCCcccccCCCcccc---ccccCcCCcccCCceeecC
Confidence 89999999876554322222221 1224567888999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-60 Score=496.23 Aligned_cols=364 Identities=43% Similarity=0.790 Sum_probs=287.5
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
+.|++++.||+|+||+||+|+++.+++.||||++.+.......+..++.+|+.+|+.++|||||+++++|++.+.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 36999999999999999999999999999999999877766777889999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
|||+||+|.+++.+.+.+++..++.+++||+.||+|||++||+||||||+|||++.+|++||+|||+|..+.........
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999998754321110000
Q ss_pred hhhhhhccccc--ccc--------cccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHH
Q 010463 266 EDEDIINQETV--SEA--------EGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 335 (510)
Q Consensus 266 ~~~~~~~~~~~--~~~--------~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvily 335 (510)
...+....... +.. ......+..+... .........+.+||+.|+|||++.+.+|+.++|||||||+||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAA-RQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhc-cccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHH
Confidence 00000000000 000 0000000000000 001122234678999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhcCccccCCCCChHHhhcCCCcCCCCchhh-hc
Q 010463 336 EMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKL-YE 414 (510)
Q Consensus 336 Eml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~dp~~R~~~~~~~eil~HpfF~~i~~~~l-~~ 414 (510)
||++|.+||.+.++.+...++.++...+.+|....+|+++.+||.+|+.+|.+|++..++++|++||||++++|... .+
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~~ 319 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDFSSDLRQ 319 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHccCHhHcCCCCCHHHHhcCCCcCCcChHHHHhc
Confidence 99999999999999888999998888888887778999999999998779999998778999999999999999874 46
Q ss_pred ccCCCccccCCCccCCCCCCCCCCCCC---CCC---CCCCCcccccCCCcCCcccCceeeCC
Q 010463 415 MEAAYKPTVNGELDTQNFEKFPEVDGP---PSE---IPSVGPWRKMLTSKDTNFIGYTFKKS 470 (510)
Q Consensus 415 ~~~p~~p~~~~~~d~~~f~~~~~~~~~---~~~---~~~~~~~~~~~~~~~~~f~~~~~~~~ 470 (510)
..+|+.|.+..+.|+++|+.+...... ... ......|......+..+|.||||+.+
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (382)
T cd05625 320 QSAPYIPKITHPTDTSNFDPVDPDKLWSDDDKEGNVNDTLNGWYKNGKHPEHAFYEFTFRRF 381 (382)
T ss_pred CCCCccCcCCCcchhhhcCCCCccccccccccccccccccccccccccccCcccccceeccc
Confidence 788999999999999999875432210 000 00111233344556679999999853
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-61 Score=496.45 Aligned_cols=257 Identities=35% Similarity=0.591 Sum_probs=242.5
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
..|...+.||+|||+.||.+++..+|+.||+|++.|..+.+..+.+.+.+|++|.+.++|||||++|.+|+|.+++|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 45999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
|+|+.|+|+.++.+.+.++|.+|++|+.||+.||.|||+++|||||||..||+|+++.+|||+|||||..+.....
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E---- 173 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE---- 173 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccc----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999998864311
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCC
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~ 345 (510)
...+.||||.|+||||+...+++..+||||+|||||-||+|+|||.
T Consensus 174 ----------------------------------rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFe 219 (592)
T KOG0575|consen 174 ----------------------------------RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFE 219 (592)
T ss_pred ----------------------------------ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcc
Confidence 1236899999999999999999999999999999999999999999
Q ss_pred CCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc-CCC
Q 010463 346 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF-RGI 407 (510)
Q Consensus 346 ~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF-~~i 407 (510)
..+..+++.+|.. ....+|. .+|.+|+|||.+||. ||.+|| ++++|+.|+|| ++.
T Consensus 220 tk~vkety~~Ik~--~~Y~~P~--~ls~~A~dLI~~lL~~~P~~Rp---sl~~vL~h~Ff~~g~ 276 (592)
T KOG0575|consen 220 TKTVKETYNKIKL--NEYSMPS--HLSAEAKDLIRKLLRPNPSERP---SLDEVLDHPFFKSGF 276 (592)
T ss_pred cchHHHHHHHHHh--cCccccc--ccCHHHHHHHHHHhcCCcccCC---CHHHHhcCHhhhCCC
Confidence 9999999999997 4566775 899999999999998 999999 79999999999 443
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-62 Score=467.31 Aligned_cols=329 Identities=31% Similarity=0.632 Sum_probs=279.9
Q ss_pred hcccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecC
Q 010463 100 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDS 178 (510)
Q Consensus 100 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~ 178 (510)
.+.++++||+++++||+|+|++|.+++++.|.+.||||+++|.-+...+.+.-+..|..+..+. +||++|.|+.+||++
T Consensus 244 ~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte 323 (593)
T KOG0695|consen 244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE 323 (593)
T ss_pred ccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc
Confidence 3457889999999999999999999999999999999999998777778899999999998665 899999999999999
Q ss_pred ceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 179 DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
..+++|.||++||||+-++++++.++|+.|+||.++|++||+|||++|||+||||.+|+|||+.||+||+|+|+|+.-..
T Consensus 324 srlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred ceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999985322
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHh
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml 338 (510)
. ...+.++||||.|+|||++++..|+.++|||+|||+++||+
T Consensus 404 ~--------------------------------------gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemm 445 (593)
T KOG0695|consen 404 P--------------------------------------GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMM 445 (593)
T ss_pred C--------------------------------------CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHH
Confidence 1 12245789999999999999999999999999999999999
Q ss_pred hCCCCCCC---CC-----hhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC---CChHHhhcCCCcCC
Q 010463 339 IGYPPFCS---DD-----PRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT---RGVEELKEHPWFRG 406 (510)
Q Consensus 339 ~G~~PF~~---~~-----~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~---~~~~eil~HpfF~~ 406 (510)
.|+.||.- ++ ..-.+.-|+. ..+.+|. .+|-.+..+++..|+ ||.+|+|+ .++.+|+.||||+.
T Consensus 446 agrspfdivgm~n~d~ntedylfqvile--kqiripr--slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 446 AGRSPFDIVGMDNPDMNTEDYLFQVILE--KQIRIPR--SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred cCCCCcceecCCCcccchhHHHHHHHhh--hcccccc--eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 99999951 22 2223444554 4577774 789999999999998 99999997 37999999999999
Q ss_pred CCchhhhc--ccCCCccccCCCccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCcccCceeeCCccc
Q 010463 407 IQWDKLYE--MEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVL 473 (510)
Q Consensus 407 i~~~~l~~--~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~ 473 (510)
|||+.+.+ +-|||.|.+.++.+..|||.-...+.+ +.+|.... .+..-++..|.||.|.++-.+
T Consensus 522 idwd~leqk~v~ppf~p~i~~d~~l~~fd~qft~e~~-qltpdd~d--~i~ridqsefegfeyinpl~m 587 (593)
T KOG0695|consen 522 IDWDLLEQKQVLPPFQPQITDDYGLDNFDTQFTSEPV-QLTPDDED--AIKRIDQSEFEGFEYINPLLM 587 (593)
T ss_pred CCHHHHhhcccCCCCCCccccccCccccccccccCCc-ccCCCCHH--HHHhcchhhcCcceecchhhc
Confidence 99999985 679999999999999999973322222 22221110 111224468999999998443
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-62 Score=483.39 Aligned_cols=297 Identities=36% Similarity=0.675 Sum_probs=262.8
Q ss_pred HHHHhhcccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEE
Q 010463 95 YMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYS 174 (510)
Q Consensus 95 ~~~~~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 174 (510)
+-.+..+.++.+.|..-++||+||||+|+-|+.+.||+.||+|.+.|..+.++.-.....+|+.||.++++|+||.|-|+
T Consensus 174 WK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA 253 (591)
T KOG0986|consen 174 WKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA 253 (591)
T ss_pred HHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee
Confidence 33455677888999999999999999999999999999999999999888777777888999999999999999999999
Q ss_pred eecCceEEEEEeccCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCC
Q 010463 175 FQDSDFLYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGL 252 (510)
Q Consensus 175 ~~~~~~~~lVmEy~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGl 252 (510)
|++.+.++|||..|+||||..+|-+.+ .|+|..++||++||++||++||+.+||+|||||+|||||+.|||+|+|.||
T Consensus 254 feTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGL 333 (591)
T KOG0986|consen 254 FETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGL 333 (591)
T ss_pred ecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccce
Confidence 999999999999999999999997765 899999999999999999999999999999999999999999999999999
Q ss_pred cccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhh
Q 010463 253 CKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGA 332 (510)
Q Consensus 253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGv 332 (510)
|..+..+.. ..+.+||.+|||||++.++.|+.++|||||||
T Consensus 334 Avei~~g~~---------------------------------------~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGC 374 (591)
T KOG0986|consen 334 AVEIPEGKP---------------------------------------IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGC 374 (591)
T ss_pred EEecCCCCc---------------------------------------cccccCcccccCHHHHcCCcccCCccHHHHHh
Confidence 998765421 12458999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCChh----hhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC--ChHHhhcCCCcC
Q 010463 333 IMYEMLIGYPPFCSDDPR----ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR--GVEELKEHPWFR 405 (510)
Q Consensus 333 ilyEml~G~~PF~~~~~~----~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~--~~~eil~HpfF~ 405 (510)
+||||+.|+.||...... +.-+.+++ ....+|+ .+|+++++|.+.||+ ||++|+|++ +++++++||||+
T Consensus 375 llYemi~G~sPFr~~KeKvk~eEvdrr~~~--~~~ey~~--kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk 450 (591)
T KOG0986|consen 375 LLYEMIAGHSPFRQRKEKVKREEVDRRTLE--DPEEYSD--KFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFK 450 (591)
T ss_pred HHHHHHcccCchhhhhhhhhHHHHHHHHhc--chhhccc--ccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccc
Confidence 999999999999764332 33344444 4456664 899999999999999 999999974 799999999999
Q ss_pred CCCchhhhc--ccCCCcccc-----CCCccCCCCCC
Q 010463 406 GIQWDKLYE--MEAAYKPTV-----NGELDTQNFEK 434 (510)
Q Consensus 406 ~i~~~~l~~--~~~p~~p~~-----~~~~d~~~f~~ 434 (510)
++||..+.. ++|||+|.. ++.+|..+|+.
T Consensus 451 ~lnw~rleagml~PPfiPdp~aVyakDv~DIeqFs~ 486 (591)
T KOG0986|consen 451 DLNWRRLEAGMLEPPFIPDPGAVYAKDVLDIEQFST 486 (591)
T ss_pred cCCHhHHhccCCCCCCCCCccccchhhhhhhhhccc
Confidence 999999984 899999975 35566666653
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-59 Score=483.97 Aligned_cols=365 Identities=42% Similarity=0.773 Sum_probs=279.6
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
+.|++++.||+|+||+||+|+++.+++.||||++.+.......+..++.+|+.+|..++|||||+++++|.+.+.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 36999999999999999999999999999999999877767777889999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
||++||+|.+++.+.+.+++..++.+++||+.||+|||+.||+||||||+||||+.+|++||+|||+|+.+.........
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 99999999999999889999999999999999999999999999999999999999999999999998755322111000
Q ss_pred hhhhhhcccccc-----c-ccc-cCCChHHHHH--HHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHH
Q 010463 266 EDEDIINQETVS-----E-AEG-QWMMPKERLQ--QWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 336 (510)
Q Consensus 266 ~~~~~~~~~~~~-----~-~~~-~~~~~~~~~~--~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyE 336 (510)
............ . ... ........+. .........+.+.+||+.|+|||++.+.+|+.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e 240 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence 000000000000 0 000 0000000000 000011122346789999999999999999999999999999999
Q ss_pred HhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhcCccccCCCCChHHhhcCCCcCCCCchhhh-cc
Q 010463 337 MLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLY-EM 415 (510)
Q Consensus 337 ml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~dp~~R~~~~~~~eil~HpfF~~i~~~~l~-~~ 415 (510)
|++|.+||.+.+......+++.+...+.+|....+|+++++||.+||+.+.+|.++.+++++++||||.+++|.... ..
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~~~~~~~ 320 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFSSDIRTQ 320 (381)
T ss_pred HHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCChhHHhhcC
Confidence 99999999998888888888887777788876789999999999998844444444489999999999999998754 56
Q ss_pred cCCCccccCCCccCCCCCCCCCCCCCCCCCC-CCCccccc----CCCcCCcccCceeeCC
Q 010463 416 EAAYKPTVNGELDTQNFEKFPEVDGPPSEIP-SVGPWRKM----LTSKDTNFIGYTFKKS 470 (510)
Q Consensus 416 ~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~f~~~~~~~~ 470 (510)
.+|+.|.+..+.++++|+...+........+ ....+... .......|.||||+.+
T Consensus 321 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (381)
T cd05626 321 PAPYVPKISHPMDTSNFDPVEEESPWNDASGDSTRTWDTLCSPNGKHPEHAFYEFTFRRF 380 (381)
T ss_pred CCCccCcCCCcchhhhcCCCCcccccccCCccchhhhccccCcccccccccccccEeecc
Confidence 7899999999999999987543322111111 00111111 1122468999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-57 Score=468.60 Aligned_cols=350 Identities=51% Similarity=0.939 Sum_probs=286.3
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++|++++.||+|+||+||+|+++.+|+.||||++.+.......+...+..|+.+|..++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999999877666677888999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
||++||+|.+++.+.+.+++..++.++.||+.||.|||+.||+||||||+||||+.+|++||+|||++..+.........
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999999876543211000
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCC
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~ 345 (510)
..... .......... .......+.......+||+.|+|||++.+..++.++|||||||++|||++|.+||.
T Consensus 161 ~~~~~-~~~~~~~~~~--------~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~ 231 (350)
T cd05573 161 LNDSH-NLLFRDNVLV--------RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFY 231 (350)
T ss_pred ccccc-cccccccccc--------cccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCC
Confidence 00000 0000000000 00000011112335689999999999999999999999999999999999999999
Q ss_pred CCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhcCccccCCCCChHHhhcCCCcCCCCchhhhcccCCCccccCC
Q 010463 346 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNG 425 (510)
Q Consensus 346 ~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~dp~~R~~~~~~~eil~HpfF~~i~~~~l~~~~~p~~p~~~~ 425 (510)
+.+....+.++..|...+.+|....+++++.+||.+||+||.+|++ +++++++||||++++|+......+|++|.+.+
T Consensus 232 ~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~dp~~R~~--s~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~ 309 (350)
T cd05573 232 SDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLG--SFEEIKSHPFFKGIDWENLRETKPPFVPELSS 309 (350)
T ss_pred CCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHccChhhcCC--CHHHHhcCCCcCCCCHHHHhhCCCCcCCCCCC
Confidence 9998889999999888888888777899999999999999999994 28999999999999999999888999999999
Q ss_pred CccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCcccCceee
Q 010463 426 ELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFK 468 (510)
Q Consensus 426 ~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~ 468 (510)
..++.+|+...+........ .....+.......+|.||+|+
T Consensus 310 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 350 (350)
T cd05573 310 PLDTSNFDDFEDDKDLSDYL--SQNSKKLNKGKQLAFVGFTYK 350 (350)
T ss_pred chhhhhcCCCCccccccccc--ccccccccccccCccCCCccC
Confidence 99999998765544322211 111223334456789999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-57 Score=472.43 Aligned_cols=330 Identities=47% Similarity=0.871 Sum_probs=269.0
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++|++++.||+|+||.||+|+++.+|+.||+|++.+..........++.+|+.+|..++||||+++++.|++++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998876666667788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|..+.........
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999999999889999999999999999999999999999999999999999999999999998754321100000
Q ss_pred hhhhhhcccccccc------cccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh
Q 010463 266 EDEDIINQETVSEA------EGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 266 ~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~ 339 (510)
.............. ......+-... ......+....+.+||+.|||||++.+..++.++|||||||++|||++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERR-RKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhh-hhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhh
Confidence 00000000000000 00000000000 000001112235689999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhcCccccCCCCChHHhhcCCCcCCCCchhhh-cccCC
Q 010463 340 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLY-EMEAA 418 (510)
Q Consensus 340 G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~dp~~R~~~~~~~eil~HpfF~~i~~~~l~-~~~~p 418 (510)
|.+||.+.++.+...++..|...+.+|....+|+++.+||.+|+++|.+|++..+++++++||||++++|..+. ...+|
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~~~t~~ell~h~~~~~~~~~~~~~~~~~~ 319 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFFKGIDFASLIRRQKAP 319 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhCCCCcCCCCHHHHhhcCCCC
Confidence 99999999988888888888777777776789999999999987899999987789999999999999999884 57789
Q ss_pred CccccCCCccCCCCCCCC
Q 010463 419 YKPTVNGELDTQNFEKFP 436 (510)
Q Consensus 419 ~~p~~~~~~d~~~f~~~~ 436 (510)
+.|.+..+.|+++|+...
T Consensus 320 ~~~~~~~~~~~~~~~~~~ 337 (376)
T cd05598 320 YIPKITHPTDTSNFDPVD 337 (376)
T ss_pred CCCcCCCcchhhhcCCCC
Confidence 999999999999987643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-57 Score=466.36 Aligned_cols=328 Identities=43% Similarity=0.845 Sum_probs=275.2
Q ss_pred hhcccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC
Q 010463 99 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 178 (510)
Q Consensus 99 ~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 178 (510)
.+..+..++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.++||||++++++|.++
T Consensus 36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (370)
T cd05621 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD 115 (370)
T ss_pred HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 34456678999999999999999999999999999999999876665556667788999999999999999999999999
Q ss_pred ceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 179 DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
+.+|+||||++||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|..+..
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 9999999999999999998654 689999999999999999999999999999999999999999999999999986532
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCC----CCccccccchhhHH
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG----YGMECDWWSLGAIM 334 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~----y~~~~DiwSlGvil 334 (510)
... ....+.+||+.|+|||++.+.+ ++.++|||||||++
T Consensus 195 ~~~-------------------------------------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~il 237 (370)
T cd05621 195 TGM-------------------------------------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 237 (370)
T ss_pred CCc-------------------------------------eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHH
Confidence 210 0012468999999999997643 78999999999999
Q ss_pred HHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhcCccccCCCCChHHhhcCCCcCCCCc--hhh
Q 010463 335 YEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQW--DKL 412 (510)
Q Consensus 335 yEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~dp~~R~~~~~~~eil~HpfF~~i~~--~~l 412 (510)
|||++|.+||.+.+....+.+|+.....+.+|....+|..+++||.+||+++.+|+++.+++|+++||||++.+| ..+
T Consensus 238 yell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~~~~~~ 317 (370)
T cd05621 238 FEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWDNI 317 (370)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCcChHhc
Confidence 999999999999998888999987666677887678899999999999997777777668999999999998655 455
Q ss_pred hcccCCCccccCCCccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCcccCceee
Q 010463 413 YEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFK 468 (510)
Q Consensus 413 ~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~ 468 (510)
....+|+.|.+.+..|.++|+...+........+. + .....+ ...|.||+|.
T Consensus 318 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~-~~~~~~~~~~ 369 (370)
T cd05621 318 RETAAPVVPELSSDIDSSNFDDIEDDKGDVETFPI--P-KAFVGN-QLPFIGFTYY 369 (370)
T ss_pred CCCCCCcCCCCCCcchhhhcCCccccccccccCCC--C-cccccc-ccccCCCEec
Confidence 56788999999999999999865443321111111 1 111222 4789999985
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-57 Score=460.88 Aligned_cols=293 Identities=44% Similarity=0.811 Sum_probs=263.6
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCce
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 180 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 180 (510)
.....++|++.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+|..++||||+++++++.+++.
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 92 (329)
T PTZ00263 13 SSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENR 92 (329)
T ss_pred CCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCE
Confidence 34567899999999999999999999999999999999988766666677889999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccc
Q 010463 181 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 260 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~ 260 (510)
+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||+.||+||||||+||||+.+|++||+|||+++.....
T Consensus 93 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~- 171 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR- 171 (329)
T ss_pred EEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence 9999999999999999999889999999999999999999999999999999999999999999999999999865322
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhC
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 340 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G 340 (510)
..+.+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 172 ----------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg 211 (329)
T PTZ00263 172 ----------------------------------------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211 (329)
T ss_pred ----------------------------------------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcC
Confidence 1235799999999999999999999999999999999999
Q ss_pred CCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CChHHhhcCCCcCCCCchhhhc--c
Q 010463 341 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLYE--M 415 (510)
Q Consensus 341 ~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~--~~~~eil~HpfF~~i~~~~l~~--~ 415 (510)
.+||.+.+....+.+|... .+.+|. .++..+++||.+||. ||.+|+++ .++++|++||||++++|+.+.. .
T Consensus 212 ~~pf~~~~~~~~~~~i~~~--~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~~~~~ 287 (329)
T PTZ00263 212 YPPFFDDTPFRIYEKILAG--RLKFPN--WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYY 287 (329)
T ss_pred CCCCCCCCHHHHHHHHhcC--CcCCCC--CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHHHhCCC
Confidence 9999998888888888764 355554 689999999999998 99999974 4689999999999999998874 5
Q ss_pred cCCCccccCCCccCCCCCCCCCC
Q 010463 416 EAAYKPTVNGELDTQNFEKFPEV 438 (510)
Q Consensus 416 ~~p~~p~~~~~~d~~~f~~~~~~ 438 (510)
.+|+.+.+....++.+|+.+++.
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~s 310 (329)
T PTZ00263 288 PAPIPVRVKSPGDTSNFEKYPDS 310 (329)
T ss_pred CCCcCCCCCCcccchhccCCccc
Confidence 67888888888899999876543
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-56 Score=463.35 Aligned_cols=330 Identities=45% Similarity=0.847 Sum_probs=278.2
Q ss_pred HhhcccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec
Q 010463 98 LQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 177 (510)
Q Consensus 98 ~~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 177 (510)
+....+..++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.++..++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 34456677999999999999999999999999999999999987666556666778899999999999999999999999
Q ss_pred CceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCc
Q 010463 178 SDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 257 (510)
Q Consensus 178 ~~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~ 257 (510)
.+.+|+||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.+.
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 9999999999999999999865 458999999999999999999999999999999999999999999999999998654
Q ss_pred cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCC----CCccccccchhhH
Q 010463 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG----YGMECDWWSLGAI 333 (510)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~----y~~~~DiwSlGvi 333 (510)
.... ....+.+||+.|||||++.+.. ++.++|||||||+
T Consensus 194 ~~~~-------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvi 236 (371)
T cd05622 194 KEGM-------------------------------------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 236 (371)
T ss_pred cCCc-------------------------------------ccccCcccCccccCHHHHhccCCCccCCCccceeehhHH
Confidence 3210 0012468999999999997643 7899999999999
Q ss_pred HHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhcCccccCCCCChHHhhcCCCcCCCC--chh
Q 010463 334 MYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQ--WDK 411 (510)
Q Consensus 334 lyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~dp~~R~~~~~~~eil~HpfF~~i~--~~~ 411 (510)
+|||++|.+||.+.+....+.+|.+....+.+|....+|.++++||.+||.+|..|+++.++++|++||||++.+ |..
T Consensus 237 lyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~~~~~ 316 (371)
T cd05622 237 LYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWET 316 (371)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCChhHHh
Confidence 999999999999999988999998766667788777899999999999999888888877999999999999855 566
Q ss_pred hhcccCCCccccCCCccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCcccCceeeC
Q 010463 412 LYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKK 469 (510)
Q Consensus 412 l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~ 469 (510)
+....+|++|.+.+..+.++|+............+. + ..... .+..|.||+|.+
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~-~~~~~~~~~~~~ 370 (371)
T cd05622 317 LRDTVAPVVPDLSSDIDTSNFDDIEEDKGEEETFPI--P-KAFVG-NQLPFVGFTYYS 370 (371)
T ss_pred cCCCCCCCCCCCCCcchhhhcCCCcccccccccCCC--C-ccccc-cccccCCCeecC
Confidence 667889999999999999999865443321111111 1 11222 247899999863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-57 Score=458.85 Aligned_cols=323 Identities=46% Similarity=0.802 Sum_probs=276.5
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++|++.+.||+|+||+||+|+++.+|+.||||++++...........+..|+.++..++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998876555566778899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 186 EYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
||++||+|.+++.+. ..+++..++.++.||+.||+|||+.||+||||||+|||++.+|++||+|||++..+......
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-- 158 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-- 158 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce--
Confidence 999999999999876 68999999999999999999999999999999999999999999999999999865432100
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc------cCCCCccccccchhhHHHHHh
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL------KKGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~------~~~y~~~~DiwSlGvilyEml 338 (510)
.....+||+.|+|||++. ...++.++|||||||++|||+
T Consensus 159 -----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~ 203 (330)
T cd05601 159 -----------------------------------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMI 203 (330)
T ss_pred -----------------------------------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeec
Confidence 011347999999999997 456789999999999999999
Q ss_pred hCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhcCccccCCCCChHHhhcCCCcCCCCchhhhcccCC
Q 010463 339 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAA 418 (510)
Q Consensus 339 ~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~dp~~R~~~~~~~eil~HpfF~~i~~~~l~~~~~p 418 (510)
+|..||.+.+....+.+|.+....+.+|..+.+++++.+||.+||++|.+|+ +++++++||||..++|..+....||
T Consensus 204 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~~p~~R~---t~~~l~~h~~~~~~~~~~~~~~~~~ 280 (330)
T cd05601 204 YGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLCGQKERL---GYEGLCCHPFFSKIDWNNIRNSLPP 280 (330)
T ss_pred cCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccChhhCC---CHHHHhCCCCcCCCCHHHHhhCCCC
Confidence 9999999988888889998876677788777899999999999999999999 7899999999999999999988899
Q ss_pred CccccCCCccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCcccCceee
Q 010463 419 YKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFK 468 (510)
Q Consensus 419 ~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~ 468 (510)
+.|.+....|.++|+......................+.++..|+||+|.
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (330)
T cd05601 281 FVPTLKSDDDTSNFDEPEKNSTRRSQSSTTQLKPNGFSGKDLPFVGFSFI 330 (330)
T ss_pred ccCcCCCcchhhhcCCCccccccccccccccCCCcCCCCCCCCccCceeC
Confidence 99999999999999764433222111111111112235567889999873
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-56 Score=457.14 Aligned_cols=316 Identities=38% Similarity=0.653 Sum_probs=264.2
Q ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEeccCCC
Q 010463 112 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGG 191 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy~~gG 191 (510)
++||+|+||.||+|+++.+|+.||||++.+..........++.+|+.+|..++||||++++++|++.+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998876656667778889999999999999999999999999999999999999
Q ss_pred CHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhhhh
Q 010463 192 DIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDII 271 (510)
Q Consensus 192 ~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~ 271 (510)
+|..++.+.+.+++..++.++.||+.||+|||+.||+||||||+||||+.+|.+||+|||+|+......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~----------- 149 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG----------- 149 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-----------
Confidence 999999998999999999999999999999999999999999999999999999999999987532110
Q ss_pred cccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCCCChhh
Q 010463 272 NQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI 351 (510)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~~~~~~ 351 (510)
......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+...
T Consensus 150 ---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~ 202 (323)
T cd05571 150 ---------------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 202 (323)
T ss_pred ---------------------------CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH
Confidence 00124689999999999999999999999999999999999999999988887
Q ss_pred hHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CChHHhhcCCCcCCCCchhhh--cccCCCccccCCC
Q 010463 352 TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLY--EMEAAYKPTVNGE 426 (510)
Q Consensus 352 ~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~--~~~~eil~HpfF~~i~~~~l~--~~~~p~~p~~~~~ 426 (510)
....+... ...+|. .+++++.+||++||. ||++|++. .++.+|++||||.+++|..+. ...||+.|.+.+.
T Consensus 203 ~~~~~~~~--~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~~~~~~~~~~~~~~~~~ 278 (323)
T cd05571 203 LFELILME--EIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQVTSE 278 (323)
T ss_pred HHHHHHcC--CCCCCC--CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCc
Confidence 77777653 345553 799999999999998 99999964 268999999999999999987 4678999999999
Q ss_pred ccCCCCCCCCCCCCCCCCCCC-CCcccccCCCcCCcccCceeeC
Q 010463 427 LDTQNFEKFPEVDGPPSEIPS-VGPWRKMLTSKDTNFIGYTFKK 469 (510)
Q Consensus 427 ~d~~~f~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~f~~~~~~~ 469 (510)
.|+++|+............+. ..+......+....|.+|+|..
T Consensus 279 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (323)
T cd05571 279 TDTRYFDEEFTAQSITITPPDRYDSLGLLQLEERPHFPQFSYSA 322 (323)
T ss_pred chhhhcCcccccCCcccCCCCcccccccccccccccCCCCeeeC
Confidence 999999752222211111111 0000001123456788998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-56 Score=444.04 Aligned_cols=260 Identities=33% Similarity=0.591 Sum_probs=235.8
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEE
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l 183 (510)
...+|.+.+.||.|+||+||+|+++.++..||||.+.+..+ .++.++.+..|+.||+.++|||||.|++++.+++++||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 35799999999999999999999999999999999988765 55567889999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCC------CceeecccCCcccCc
Q 010463 184 IMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN------GHLKLSDFGLCKPLE 257 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~------g~vkL~DFGla~~~~ 257 (510)
|||||.||||..+|.+.+.++|..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||+|+.+.
T Consensus 87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 99999999999999999999999999999999999999999999999999999999865 468999999999886
Q ss_pred cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHH
Q 010463 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337 (510)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEm 337 (510)
.. ..+.+.||+|.|||||++..+.|+.++|+||+|+|||+|
T Consensus 167 ~~---------------------------------------~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~ 207 (429)
T KOG0595|consen 167 PG---------------------------------------SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQC 207 (429)
T ss_pred ch---------------------------------------hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHH
Confidence 53 234478999999999999999999999999999999999
Q ss_pred hhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 338 LIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 338 l~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
++|++||...+..+.+..|.........+. ..+|+...+|+..+|+ ++..|. +.++...|||...-
T Consensus 208 l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~-~~~s~~~~~Ll~~ll~~~~~~~~---~~~~~~~~~~l~~~ 274 (429)
T KOG0595|consen 208 LTGKPPFDAETPKELLLYIKKGNEIVPVLP-AELSNPLRELLISLLQRNPKDRI---SFEDFFDHPFLAAN 274 (429)
T ss_pred HhCCCCccccCHHHHHHHHhccccccCchh-hhccCchhhhhhHHHhcCccccC---chHHhhhhhhcccC
Confidence 999999999999999998887665555554 3678888899999998 999998 57888889988653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-57 Score=444.59 Aligned_cols=259 Identities=30% Similarity=0.503 Sum_probs=234.4
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCce-E
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF-L 181 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~-~ 181 (510)
+..++.+.++.||+|..|+||+|+|+.|++.||+|++.-. .+....+++.+|++||..++||+||++|++|.++.. +
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 5667899999999999999999999999999999999432 345556789999999999999999999999999994 9
Q ss_pred EEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhh-CCeEEeecCCCCeeecCCCceeecccCCcccCcccc
Q 010463 182 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 260 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~-~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~ 260 (510)
+++||||.||+|..++...++++|.....++.+++.||.|||. ++||||||||+||||++.|.|||||||.++.+...
T Consensus 154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 9999999999999999999999999999999999999999995 99999999999999999999999999999876542
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhC
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 340 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G 340 (510)
.+.+++||..|||||.+.+..|+.++||||||+.++||.+|
T Consensus 233 ---------------------------------------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~G 273 (364)
T KOG0581|consen 233 ---------------------------------------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIG 273 (364)
T ss_pred ---------------------------------------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhC
Confidence 35689999999999999999999999999999999999999
Q ss_pred CCCCCCC-----ChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCC
Q 010463 341 YPPFCSD-----DPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 408 (510)
Q Consensus 341 ~~PF~~~-----~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~ 408 (510)
+.||... +.-+.+..|++. .+..+|.. .+|+++++||..||. ||.+|+ ++.|+++|||++...
T Consensus 274 rfP~~~~~~~~~~~~~Ll~~Iv~~-ppP~lP~~-~fS~ef~~FV~~CL~Kdp~~R~---s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 274 RFPYPPPNPPYLDIFELLCAIVDE-PPPRLPEG-EFSPEFRSFVSCCLRKDPSERP---SAKQLLQHPFIKKFE 342 (364)
T ss_pred CCCCCCcCCCCCCHHHHHHHHhcC-CCCCCCcc-cCCHHHHHHHHHHhcCCcccCC---CHHHHhcCHHHhhcc
Confidence 9999875 566777788874 45666753 599999999999998 999999 789999999998643
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-56 Score=457.24 Aligned_cols=293 Identities=39% Similarity=0.791 Sum_probs=262.2
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCC-CEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTG-EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 179 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg-~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 179 (510)
..+..++|++++.||+|+||.||+|.++.++ ..||+|++.+.........+.+.+|+.+|..++|||||+++++|.+.+
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 4567789999999999999999999877665 789999998876666667788999999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 180 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
.+|+||||++||+|.+++.+...+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||+++.+...
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 99999999999999999999889999999999999999999999999999999999999999999999999999865321
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~ 339 (510)
..+.+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 185 -----------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~ 223 (340)
T PTZ00426 185 -----------------------------------------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILV 223 (340)
T ss_pred -----------------------------------------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhc
Confidence 124679999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CChHHhhcCCCcCCCCchhhhc--
Q 010463 340 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLYE-- 414 (510)
Q Consensus 340 G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~--~~~~eil~HpfF~~i~~~~l~~-- 414 (510)
|.+||.+.++...+.++... ...+|. .+++.+++||++||. ||++|++. .+++++++||||++++|..+..
T Consensus 224 G~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~ 299 (340)
T PTZ00426 224 GCPPFYANEPLLIYQKILEG--IIYFPK--FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKN 299 (340)
T ss_pred CCCCCCCCCHHHHHHHHhcC--CCCCCC--CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCC
Confidence 99999999888888888763 344553 789999999999998 99999864 4799999999999999998873
Q ss_pred ccCCCccccCCCccCCCCCCCCCC
Q 010463 415 MEAAYKPTVNGELDTQNFEKFPEV 438 (510)
Q Consensus 415 ~~~p~~p~~~~~~d~~~f~~~~~~ 438 (510)
..+|++|......+.++|+...+.
T Consensus 300 ~~~~~~p~~~~~~~~~~~~~~~~~ 323 (340)
T PTZ00426 300 VEVPYKPKYKNVFDSSNFERVQED 323 (340)
T ss_pred CCCCcCCCCCCCcchhhcCCCccc
Confidence 678999999999998898765443
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-55 Score=458.69 Aligned_cols=326 Identities=44% Similarity=0.835 Sum_probs=271.8
Q ss_pred hcccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc
Q 010463 100 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 179 (510)
Q Consensus 100 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 179 (510)
...+..++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+..|+.+++.++||||+++++++.+++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~ 116 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK 116 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 34567789999999999999999999999999999999998876655666677889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 180 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
.+|+||||++||+|.+++.. ..+++..+..++.||+.||+|||+.||+||||||+|||++.+|++||+|||++......
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999999998865 46899999999999999999999999999999999999999999999999999865322
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC----CCCccccccchhhHHH
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK----GYGMECDWWSLGAIMY 335 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~----~y~~~~DiwSlGvily 335 (510)
.. ......+||+.|+|||++.+. .++.++|||||||++|
T Consensus 196 ~~-------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvily 238 (370)
T cd05596 196 GM-------------------------------------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 238 (370)
T ss_pred Cc-------------------------------------ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHH
Confidence 00 001246799999999999754 3789999999999999
Q ss_pred HHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchh--h
Q 010463 336 EMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDK--L 412 (510)
Q Consensus 336 Eml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~--l 412 (510)
||++|.+||.+.+....+.+|......+.+|....+|.++++||++||. +| +|+++.+++++++||||++.+|.. +
T Consensus 239 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p-~r~~R~s~~ell~h~~~~~~~~~~~~~ 317 (370)
T cd05596 239 EMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDRE-VRLGRNGVDEIKSHPFFKNDQWTFDNI 317 (370)
T ss_pred HHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChh-hccCCCCHHHHhcCcccCCCChhhHHh
Confidence 9999999999999888999998876677888777899999999999998 55 444444899999999999988764 4
Q ss_pred hcccCCCccccCCCccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCcccCceee
Q 010463 413 YEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFK 468 (510)
Q Consensus 413 ~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~ 468 (510)
....+|+.|.+.+..++++|+.............. + ..... ....|+||+|.
T Consensus 318 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~-~~~~~~~~~~~ 369 (370)
T cd05596 318 RETVAPVVPELSSDIDTSNFDDIEDDDKNEETFPL--P-KAFAG-NQLPFIGFTYS 369 (370)
T ss_pred cCCCcCccCcCCCcchhhhcCCccccccccccCCC--c-ccccc-ccCccCCCeec
Confidence 45678999999999999999875544322111100 0 11112 24569999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-56 Score=453.06 Aligned_cols=289 Identities=45% Similarity=0.846 Sum_probs=261.3
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+..|+.+|..++||||+++++++++.+.+|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998876555566778999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
||++||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~------ 154 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY------ 154 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcccccc------
Confidence 99999999999998889999999999999999999999999999999999999999999999999999864321
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCC
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~ 345 (510)
..+.+||+.|+|||++.+..++.++|||||||++|||++|.+||.
T Consensus 155 -----------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~ 199 (333)
T cd05600 155 -----------------------------------ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFS 199 (333)
T ss_pred -----------------------------------cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCC
Confidence 124689999999999999999999999999999999999999999
Q ss_pred CCChhhhHHHHhhccccccCCCCC----CCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchhhhcccCCCc
Q 010463 346 SDDPRITCRKIVNWKTCLKFPEEP----KISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYK 420 (510)
Q Consensus 346 ~~~~~~~~~~I~~~~~~~~~p~~~----~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l~~~~~p~~ 420 (510)
+.+..+.+..+..+...+..|... .+|+++++||.+||. +|.+|+ +++++++||||.+++|..+....||+.
T Consensus 200 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~---s~~~ll~h~~~~~~~~~~~~~~~~~~~ 276 (333)
T cd05600 200 GSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFG---SLEDIKNHPFFKEVDWNELRELKPPFV 276 (333)
T ss_pred CCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcC---CHHHHHhCcccCCCCHHHHhhCCCCCC
Confidence 999888888888776655555432 679999999999998 788888 689999999999999999998899999
Q ss_pred cccCCCccCCCCCCCCCC
Q 010463 421 PTVNGELDTQNFEKFPEV 438 (510)
Q Consensus 421 p~~~~~~d~~~f~~~~~~ 438 (510)
|.+.+..+..+|+.+...
T Consensus 277 ~~~~~~~~~~~~~~~~~~ 294 (333)
T cd05600 277 PELESEIDTGYFDDFENE 294 (333)
T ss_pred CCCCCcchhhhccCCCCc
Confidence 999988888888765543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-55 Score=448.98 Aligned_cols=324 Identities=47% Similarity=0.856 Sum_probs=270.2
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++|++++.||+|+||.||+++.+.+++.||+|++.+.......+...+..|+.++..++||||+++++++++.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999998766656666677899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 186 EYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 186 Ey~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
||++||+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|..+.....
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~--- 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT--- 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc---
Confidence 99999999999987 46799999999999999999999999999999999999999999999999999875432100
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc-----cCCCCccccccchhhHHHHHhh
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-----~~~y~~~~DiwSlGvilyEml~ 339 (510)
......+||+.|+|||++. ...++.++|||||||++|||++
T Consensus 158 ----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~ 203 (332)
T cd05623 158 ----------------------------------VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLY 203 (332)
T ss_pred ----------------------------------ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhc
Confidence 0011357999999999996 3468999999999999999999
Q ss_pred CCCCCCCCChhhhHHHHhhccccccCCCC-CCCCHHHHHHHHHhhcCccccCCCCChHHhhcCCCcCCCCchhhhcccCC
Q 010463 340 GYPPFCSDDPRITCRKIVNWKTCLKFPEE-PKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAA 418 (510)
Q Consensus 340 G~~PF~~~~~~~~~~~I~~~~~~~~~p~~-~~~s~~~~dlI~~lL~dp~~R~~~~~~~eil~HpfF~~i~~~~l~~~~~p 418 (510)
|++||.+.+....+.+|........+|.. ..+|+++++||++||+.+.+|+++.+++++++||||.+++|+.+....+|
T Consensus 204 g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~~~~~~~~ 283 (332)
T cd05623 204 GETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNIRNCEAP 283 (332)
T ss_pred CCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHHHhhCCCC
Confidence 99999999988999998876555555543 36899999999999996677777778999999999999999999999999
Q ss_pred CccccCCCccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCcccCceee
Q 010463 419 YKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFK 468 (510)
Q Consensus 419 ~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~ 468 (510)
+.|...++.++++++...+...+....+.... .........|.||||.
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 331 (332)
T cd05623 284 YIPEVSSPTDTSNFDVDDDCLKNSETMPPPSH--TAFSGHHLPFVGFTYT 331 (332)
T ss_pred ccCCCCCCcccccCCCCcccccccCCCCCCCc--cccccCCCCcCCeeec
Confidence 99999999988887643222211111111111 1112235678899986
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-55 Score=449.19 Aligned_cols=295 Identities=51% Similarity=0.907 Sum_probs=259.3
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++|++++.||+|+||.||+|+++.+++.||+|++.+...........+..|+.++..++||||+++++++++.+.+|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999998766556666777889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 186 EYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 186 Ey~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
||++||+|.+++.+ ...+++..++.++.|++.||+|||++||+||||||+|||++.+|++||+|||+|+.+......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-- 158 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-- 158 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce--
Confidence 99999999999987 467999999999999999999999999999999999999999999999999999865432100
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-----CCCCccccccchhhHHHHHhh
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-----KGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-----~~y~~~~DiwSlGvilyEml~ 339 (510)
.....+||+.|+|||++.+ ..++.++|||||||+||||++
T Consensus 159 -----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~ 203 (331)
T cd05624 159 -----------------------------------QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLY 203 (331)
T ss_pred -----------------------------------eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhh
Confidence 0112579999999999976 568899999999999999999
Q ss_pred CCCCCCCCChhhhHHHHhhccccccCCCC-CCCCHHHHHHHHHhhcCccccCCCCChHHhhcCCCcCCCCchhhhcccCC
Q 010463 340 GYPPFCSDDPRITCRKIVNWKTCLKFPEE-PKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAA 418 (510)
Q Consensus 340 G~~PF~~~~~~~~~~~I~~~~~~~~~p~~-~~~s~~~~dlI~~lL~dp~~R~~~~~~~eil~HpfF~~i~~~~l~~~~~p 418 (510)
|++||.+.+..+.+.+|......+.+|.. ..+++++++||.+||+.+.+|++..+++++++||||++++|+.+....+|
T Consensus 204 g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~ 283 (331)
T cd05624 204 GETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENIRNLEAP 283 (331)
T ss_pred CCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHHHhhCCCC
Confidence 99999999888888888876555555542 35799999999999996667877778999999999999999999999999
Q ss_pred CccccCCCccCCCCCCCCC
Q 010463 419 YKPTVNGELDTQNFEKFPE 437 (510)
Q Consensus 419 ~~p~~~~~~d~~~f~~~~~ 437 (510)
+.|...++.+.++|+.-.+
T Consensus 284 ~~p~~~~~~~~~~~~~~~~ 302 (331)
T cd05624 284 YIPDVSSPSDTSNFDVDDD 302 (331)
T ss_pred ccCCCCCcchhhhcCCccc
Confidence 9999988888888875433
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-55 Score=446.97 Aligned_cols=293 Identities=52% Similarity=0.916 Sum_probs=258.7
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.++..++||||++++++|.+++++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 57999999999999999999999999999999998876666667788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 186 EYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 186 Ey~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
||++||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++..+......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-- 158 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV-- 158 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc--
Confidence 99999999999976 467999999999999999999999999999999999999999999999999998765332100
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-----CCCCccccccchhhHHHHHhh
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-----KGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-----~~y~~~~DiwSlGvilyEml~ 339 (510)
.....+||+.|+|||++.. ..++.++|||||||++|||++
T Consensus 159 -----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~ 203 (331)
T cd05597 159 -----------------------------------QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLY 203 (331)
T ss_pred -----------------------------------cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhh
Confidence 0112479999999999973 457889999999999999999
Q ss_pred CCCCCCCCChhhhHHHHhhccccccCCCC-CCCCHHHHHHHHHhhcCccccCCCCChHHhhcCCCcCCCCchhhhcccCC
Q 010463 340 GYPPFCSDDPRITCRKIVNWKTCLKFPEE-PKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAA 418 (510)
Q Consensus 340 G~~PF~~~~~~~~~~~I~~~~~~~~~p~~-~~~s~~~~dlI~~lL~dp~~R~~~~~~~eil~HpfF~~i~~~~l~~~~~p 418 (510)
|+.||.+.+..+.+.+|......+.+|.. ..+|+++++||++||+.|.+|+++.+++++++||||.+++|..+....+|
T Consensus 204 g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~~~~~~~~ 283 (331)
T cd05597 204 GETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDNIRNSTAP 283 (331)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHHHhhCCCC
Confidence 99999998888888888876555555542 35899999999999997778877778999999999999999999988899
Q ss_pred CccccCCCccCCCCCCC
Q 010463 419 YKPTVNGELDTQNFEKF 435 (510)
Q Consensus 419 ~~p~~~~~~d~~~f~~~ 435 (510)
+.|...+..++++|+..
T Consensus 284 ~~~~~~~~~~~~~~~~~ 300 (331)
T cd05597 284 YVPEVSSPTDTSNFDVD 300 (331)
T ss_pred ccCcCCCcchhhhcCCc
Confidence 99999999998888753
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-56 Score=444.64 Aligned_cols=285 Identities=40% Similarity=0.810 Sum_probs=257.4
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++|++++.||+|+||.||+|+++.+|+.||+|++.+.......+.+.+.+|+.+|+.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999998766555556778999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~------ 154 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR------ 154 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC------
Confidence 99999999999998889999999999999999999999999999999999999999999999999998865321
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCC
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~ 345 (510)
....+||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 155 -----------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~ 199 (291)
T cd05612 155 -----------------------------------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFF 199 (291)
T ss_pred -----------------------------------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 113579999999999999999999999999999999999999999
Q ss_pred CCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CChHHhhcCCCcCCCCchhhhc--ccCCCc
Q 010463 346 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLYE--MEAAYK 420 (510)
Q Consensus 346 ~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~--~~~~eil~HpfF~~i~~~~l~~--~~~p~~ 420 (510)
+.+....+..+... ...+|. .+++.+++||++||. ||.+|++. .++++++.||||..++|..+.. ..||..
T Consensus 200 ~~~~~~~~~~i~~~--~~~~~~--~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~ 275 (291)
T cd05612 200 DDNPFGIYEKILAG--KLEFPR--HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPPIV 275 (291)
T ss_pred CCCHHHHHHHHHhC--CcCCCc--cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHHHHhcCCCCCCEe
Confidence 99888888888764 345553 679999999999998 99999964 2599999999999999998874 678899
Q ss_pred cccCCCccCCCCCCC
Q 010463 421 PTVNGELDTQNFEKF 435 (510)
Q Consensus 421 p~~~~~~d~~~f~~~ 435 (510)
|.+....|+.||+..
T Consensus 276 p~~~~~~~~~~~~~~ 290 (291)
T cd05612 276 PKVSHDGDTSNFDDY 290 (291)
T ss_pred CCCCCccccccccCC
Confidence 999999999999865
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-55 Score=445.28 Aligned_cols=317 Identities=35% Similarity=0.653 Sum_probs=266.1
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCceEEEEE
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
+|++++.||+|+||.||+|+++.+++.||||++.+..............|..++..+ +||+|+++++++++.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 689999999999999999999999999999999887655555667778888888777 5899999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
||++||+|..++...+.+++..+..++.||+.||+|||+.||+||||||+|||++.+|++||+|||+|+......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~----- 155 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG----- 155 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-----
Confidence 999999999999888899999999999999999999999999999999999999999999999999997532210
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCC
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~ 345 (510)
......+||+.|+|||++.+..++.++|||||||++|||++|.+||.
T Consensus 156 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~ 202 (323)
T cd05616 156 ---------------------------------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202 (323)
T ss_pred ---------------------------------CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCC
Confidence 00124679999999999999999999999999999999999999999
Q ss_pred CCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CChHHhhcCCCcCCCCchhhhc--ccCCCc
Q 010463 346 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLYE--MEAAYK 420 (510)
Q Consensus 346 ~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~--~~~~eil~HpfF~~i~~~~l~~--~~~p~~ 420 (510)
+.+....+..|... ...+|. .++.++.+||.+||. ||.+|++. .+..++++||||+.++|+.+.. ..||+.
T Consensus 203 ~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~~~~~~~~ 278 (323)
T cd05616 203 GEDEDELFQSIMEH--NVAYPK--SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEVQPPYK 278 (323)
T ss_pred CCCHHHHHHHHHhC--CCCCCC--cCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcC
Confidence 99888888888763 345553 789999999999998 99999975 3478999999999999999874 678999
Q ss_pred cccCCCccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCcccCceeeC
Q 010463 421 PTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKK 469 (510)
Q Consensus 421 p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~ 469 (510)
|.... .|..+|+.+.....+ ...+. .-+.+.+.....|.||+|.+
T Consensus 279 ~~~~~-~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~~~~~~~ 323 (323)
T cd05616 279 PKACG-RDAENFDKFFTRHPP-VLTPP--DQEVIMNLDQSEFEGFSYVN 323 (323)
T ss_pred CcCCC-chhhhcCchhccCCc-cCCCC--CccccccccccccCCCcccC
Confidence 88754 777888876653221 11111 11223333446788988753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-55 Score=445.07 Aligned_cols=318 Identities=36% Similarity=0.655 Sum_probs=267.2
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC-CCeeeEeEEeecCceEEEEE
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS-RCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~~~~~~~~~lVm 185 (510)
+|++++.||+|+||.||+|+++.+++.||||++.+.........+.+..|..++..++| ++|++++++|.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 68999999999999999999999999999999988765556667788899999999976 56889999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
||++||+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~----- 155 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG----- 155 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-----
Confidence 999999999999888889999999999999999999999999999999999999999999999999987432110
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCC
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~ 345 (510)
......+||+.|+|||++.+..++.++|||||||++|||++|++||.
T Consensus 156 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~ 202 (324)
T cd05587 156 ---------------------------------KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202 (324)
T ss_pred ---------------------------------CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCC
Confidence 00124679999999999999999999999999999999999999999
Q ss_pred CCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CChHHhhcCCCcCCCCchhhhc--ccCCCc
Q 010463 346 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLYE--MEAAYK 420 (510)
Q Consensus 346 ~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~--~~~~eil~HpfF~~i~~~~l~~--~~~p~~ 420 (510)
+.+....+..+... ...+| ..++.++.+||++||. ||.+|++. ...+++++||||+.++|..+.. ..+|+.
T Consensus 203 ~~~~~~~~~~i~~~--~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~ 278 (324)
T cd05587 203 GEDEDELFQSIMEH--NVSYP--KSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQPPFK 278 (324)
T ss_pred CCCHHHHHHHHHcC--CCCCC--CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcc
Confidence 99888888888763 34455 3789999999999998 99999975 2458999999999999998864 678999
Q ss_pred cccCCCccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCcccCceeeC
Q 010463 421 PTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKK 469 (510)
Q Consensus 421 p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~ 469 (510)
|.+....+.++|+.+......... +.. ...+.+.....|.+|+|.+
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~~~~ 324 (324)
T cd05587 279 PKVKGRRSAENFDKFFTREPPVLT-PPD--KLVIANIDQSEFQGFSFVN 324 (324)
T ss_pred CcCCCcchhhhcCcccccCccccC-CCC--ccccccccccccCCCcccC
Confidence 999988899999876543322211 110 1112233445788888754
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-55 Score=443.55 Aligned_cols=279 Identities=41% Similarity=0.799 Sum_probs=251.7
Q ss_pred eecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEeccCCCCH
Q 010463 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDI 193 (510)
Q Consensus 114 IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy~~gG~L 193 (510)
||+|+||.||+|+++.+++.||+|++.+..........++..|+.+|..++||||++++++|.+.+.+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999887666666778889999999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhhhhcc
Q 010463 194 MTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 273 (510)
Q Consensus 194 ~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~ 273 (510)
.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~------------ 148 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD------------ 148 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC------------
Confidence 99999888999999999999999999999999999999999999999999999999999985422100
Q ss_pred cccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCCCChhhhH
Q 010463 274 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITC 353 (510)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~~~~~~~~ 353 (510)
.....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+....+
T Consensus 149 --------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~ 202 (312)
T cd05585 149 --------------------------KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMY 202 (312)
T ss_pred --------------------------ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHH
Confidence 012467999999999999999999999999999999999999999998888888
Q ss_pred HHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchhhh--cccCCCccccCCCccCC
Q 010463 354 RKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLY--EMEAAYKPTVNGELDTQ 430 (510)
Q Consensus 354 ~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l~--~~~~p~~p~~~~~~d~~ 430 (510)
.++... .+.+|. .+++++++||.+||. ||.+|++..++.+++.||||..++|..+. ...+|+.|.+.+..+++
T Consensus 203 ~~~~~~--~~~~~~--~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (312)
T cd05585 203 RKILQE--PLRFPD--GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTS 278 (312)
T ss_pred HHHHcC--CCCCCC--cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCccchh
Confidence 888763 455553 789999999999998 99999987789999999999999998876 36789999999999999
Q ss_pred CCCC
Q 010463 431 NFEK 434 (510)
Q Consensus 431 ~f~~ 434 (510)
+|+.
T Consensus 279 ~~~~ 282 (312)
T cd05585 279 NFDE 282 (312)
T ss_pred hcCc
Confidence 9975
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-54 Score=441.40 Aligned_cols=282 Identities=35% Similarity=0.676 Sum_probs=249.6
Q ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCceEEEEEeccCC
Q 010463 112 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLYLIMEYLPG 190 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~~lVmEy~~g 190 (510)
+.||+|+||+||+|+++.+++.||||++.+...........+..|..++..+ +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999887655556677788899998776 799999999999999999999999999
Q ss_pred CCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhhh
Q 010463 191 GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 270 (510)
Q Consensus 191 G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 270 (510)
|+|..++.+...+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~---------- 150 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG---------- 150 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC----------
Confidence 9999999988899999999999999999999999999999999999999999999999999987532110
Q ss_pred hcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCCCChh
Q 010463 271 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPR 350 (510)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~~~~~ 350 (510)
......+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..
T Consensus 151 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~ 202 (320)
T cd05590 151 ----------------------------KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED 202 (320)
T ss_pred ----------------------------CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH
Confidence 0012357999999999999999999999999999999999999999999988
Q ss_pred hhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC---ChHHhhcCCCcCCCCchhhhc--ccCCCccccC
Q 010463 351 ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR---GVEELKEHPWFRGIQWDKLYE--MEAAYKPTVN 424 (510)
Q Consensus 351 ~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~---~~~eil~HpfF~~i~~~~l~~--~~~p~~p~~~ 424 (510)
..+..|.+. ...+| ..+++++++||++||. ||.+|++.. +.+++++||||.+++|+.+.. ..|||.|.+.
T Consensus 203 ~~~~~i~~~--~~~~~--~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~ 278 (320)
T cd05590 203 DLFEAILND--EVVYP--TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRIK 278 (320)
T ss_pred HHHHHHhcC--CCCCC--CCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCC
Confidence 888888763 33444 3689999999999998 999999752 348999999999999998863 6889999999
Q ss_pred CCccCCCCCCC
Q 010463 425 GELDTQNFEKF 435 (510)
Q Consensus 425 ~~~d~~~f~~~ 435 (510)
+..|.++|+..
T Consensus 279 ~~~~~~~~~~~ 289 (320)
T cd05590 279 SREDVSNFDPD 289 (320)
T ss_pred CcchhhhcCcc
Confidence 99999999853
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-55 Score=450.89 Aligned_cols=259 Identities=37% Similarity=0.644 Sum_probs=234.9
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcch--hhHHHHHHHHHHHHhcC-CCCeeeEeEEeecCc
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR--GQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSD 179 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~--~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~ 179 (510)
.....|.+.+.||+|+||+|++|++..+|..||+|++.+...... ...+.+.+|+.+++.+. ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 456789999999999999999999999999999998877533212 34567889999999999 999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCC-CceeecccCCcccCc-
Q 010463 180 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN-GHLKLSDFGLCKPLE- 257 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~-g~vkL~DFGla~~~~- 257 (510)
.+|+||||+.||+|++++.+.+++.|..++.|+.|++.||+|||++||+||||||||||+|.+ +++||+|||++....
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~ 173 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG 173 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence 999999999999999999999999999999999999999999999999999999999999999 999999999998763
Q ss_pred cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCC-C-CccccccchhhHHH
Q 010463 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG-Y-GMECDWWSLGAIMY 335 (510)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~-y-~~~~DiwSlGvily 335 (510)
.. ....+.||||.|+|||++.+.+ | +.++|+||+||+||
T Consensus 174 ~~---------------------------------------~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy 214 (370)
T KOG0583|consen 174 ED---------------------------------------GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILY 214 (370)
T ss_pred CC---------------------------------------CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHH
Confidence 11 1234689999999999999988 8 69999999999999
Q ss_pred HHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCC-CHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 336 EMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKI-SDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 336 Eml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~-s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
-|++|+.||...+...++.+|.. ..+.+|. .+ |+++++||++||. ||.+|+ ++.+|+.||||+.-
T Consensus 215 ~ml~G~~PF~d~~~~~l~~ki~~--~~~~~p~--~~~S~~~~~Li~~mL~~~P~~R~---t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 215 VLLCGRLPFDDSNVPNLYRKIRK--GEFKIPS--YLLSPEARSLIEKMLVPDPSTRI---TLLEILEHPWFQKE 281 (370)
T ss_pred HHHhCCCCCCCccHHHHHHHHhc--CCccCCC--CcCCHHHHHHHHHHcCCCcccCC---CHHHHhhChhhccC
Confidence 99999999999999999999887 4577786 56 9999999999998 999999 78999999999863
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-54 Score=440.65 Aligned_cols=281 Identities=37% Similarity=0.689 Sum_probs=248.8
Q ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCceEEEEEeccCC
Q 010463 112 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLYLIMEYLPG 190 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~~lVmEy~~g 190 (510)
++||+|+||.||+|+++.+|+.||||++.+...........+..|..++..+ +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999887655566677788899999865 899999999999999999999999999
Q ss_pred CCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhhh
Q 010463 191 GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 270 (510)
Q Consensus 191 G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 270 (510)
|+|..++.+.+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||+|+......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~---------- 150 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG---------- 150 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC----------
Confidence 9999999888899999999999999999999999999999999999999999999999999987532210
Q ss_pred hcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCCCChh
Q 010463 271 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPR 350 (510)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~~~~~ 350 (510)
......+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..
T Consensus 151 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~ 202 (321)
T cd05591 151 ----------------------------VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED 202 (321)
T ss_pred ----------------------------ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH
Confidence 0112467999999999999999999999999999999999999999999988
Q ss_pred hhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC----ChHHhhcCCCcCCCCchhhhc--ccCCCcccc
Q 010463 351 ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR----GVEELKEHPWFRGIQWDKLYE--MEAAYKPTV 423 (510)
Q Consensus 351 ~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~----~~~eil~HpfF~~i~~~~l~~--~~~p~~p~~ 423 (510)
..+..+... ...+| ..++.++.+||.+||. ||++|++.. +++++++||||.+++|..+.. ..+||.|.+
T Consensus 203 ~~~~~i~~~--~~~~p--~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~ 278 (321)
T cd05591 203 DLFESILHD--DVLYP--VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPKI 278 (321)
T ss_pred HHHHHHHcC--CCCCC--CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCCCCCC
Confidence 888888863 34445 3689999999999998 999999753 689999999999999998864 678899998
Q ss_pred CCCccCCCCCC
Q 010463 424 NGELDTQNFEK 434 (510)
Q Consensus 424 ~~~~d~~~f~~ 434 (510)
....+..+|+.
T Consensus 279 ~~~~~~~~~~~ 289 (321)
T cd05591 279 KTKRDVNNFDQ 289 (321)
T ss_pred CCcchhhhcCC
Confidence 88888888875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-54 Score=440.86 Aligned_cols=281 Identities=41% Similarity=0.743 Sum_probs=250.2
Q ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEeccCCC
Q 010463 112 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGG 191 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy~~gG 191 (510)
+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+|+.++||||+++++++++.+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998876656667788899999999999999999999999999999999999999
Q ss_pred CHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhhhh
Q 010463 192 DIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDII 271 (510)
Q Consensus 192 ~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~ 271 (510)
+|..++.....+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++.......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~---------- 150 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA---------- 150 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc----------
Confidence 9999998888999999999999999999999999999999999999999999999999999875322100
Q ss_pred cccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCCCChhh
Q 010463 272 NQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI 351 (510)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~~~~~~ 351 (510)
.....+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+...
T Consensus 151 ----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~ 202 (328)
T cd05593 151 ----------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 202 (328)
T ss_pred ----------------------------ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH
Confidence 0124679999999999999999999999999999999999999999888877
Q ss_pred hHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CChHHhhcCCCcCCCCchhhhc--ccCCCccccCCC
Q 010463 352 TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLYE--MEAAYKPTVNGE 426 (510)
Q Consensus 352 ~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~--~~~~eil~HpfF~~i~~~~l~~--~~~p~~p~~~~~ 426 (510)
....+.. ....+|. .+++++.+||++||. ||.+|++. .++.+|++||||.+++|..+.. ..||+.|.+.++
T Consensus 203 ~~~~~~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (328)
T cd05593 203 LFELILM--EDIKFPR--TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQVTSE 278 (328)
T ss_pred HHHHhcc--CCccCCC--CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCc
Confidence 7777664 3345553 789999999999998 99999864 3799999999999999998874 578999999999
Q ss_pred ccCCCCCC
Q 010463 427 LDTQNFEK 434 (510)
Q Consensus 427 ~d~~~f~~ 434 (510)
.+..+|+.
T Consensus 279 ~~~~~~~~ 286 (328)
T cd05593 279 TDTRYFDE 286 (328)
T ss_pred chhhhcCc
Confidence 99988875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-54 Score=440.91 Aligned_cols=281 Identities=40% Similarity=0.716 Sum_probs=250.3
Q ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEeccCCC
Q 010463 112 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGG 191 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy~~gG 191 (510)
+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|..++..++||||++++++|.+.+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998876555666778889999999999999999999999999999999999999
Q ss_pred CHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhhhh
Q 010463 192 DIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDII 271 (510)
Q Consensus 192 ~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~ 271 (510)
+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~---------- 150 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---------- 150 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC----------
Confidence 9999998888999999999999999999999999999999999999999999999999999875322100
Q ss_pred cccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCCCChhh
Q 010463 272 NQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI 351 (510)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~~~~~~ 351 (510)
.....+||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+...
T Consensus 151 ----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~ 202 (323)
T cd05595 151 ----------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 202 (323)
T ss_pred ----------------------------ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH
Confidence 0123579999999999999999999999999999999999999999888887
Q ss_pred hHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CChHHhhcCCCcCCCCchhhhc--ccCCCccccCCC
Q 010463 352 TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLYE--MEAAYKPTVNGE 426 (510)
Q Consensus 352 ~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~--~~~~eil~HpfF~~i~~~~l~~--~~~p~~p~~~~~ 426 (510)
....+... ...+|. .+++++++||.+||. ||.+|++. .++.++++||||.+++|..+.. ..||+.|.+.+.
T Consensus 203 ~~~~~~~~--~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (323)
T cd05595 203 LFELILME--EIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSE 278 (323)
T ss_pred HHHHHhcC--CCCCCC--CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCh
Confidence 77777653 345553 789999999999998 99999864 3799999999999999998875 568999999999
Q ss_pred ccCCCCCC
Q 010463 427 LDTQNFEK 434 (510)
Q Consensus 427 ~d~~~f~~ 434 (510)
.+++.|+.
T Consensus 279 ~~~~~~~~ 286 (323)
T cd05595 279 VDTRYFDD 286 (323)
T ss_pred hhhhhcCc
Confidence 99999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-54 Score=439.36 Aligned_cols=316 Identities=37% Similarity=0.675 Sum_probs=263.8
Q ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHH---hcCCCCeeeEeEEeecCceEEEE
Q 010463 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA---EVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 108 f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~---~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
|++++.||+|+||.||+|+++.+|+.||||++++.......+.+.+..|+.++. .++||||++++++|.+.+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 788999999999999999999999999999998876655666777888887764 56899999999999999999999
Q ss_pred EeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 185 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
|||++||+|..++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+|+......
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~---- 155 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG---- 155 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC----
Confidence 999999999988754 579999999999999999999999999999999999999999999999999987532210
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCC
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 344 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF 344 (510)
......+||+.|+|||++.+..++.++|||||||++|||++|.+||
T Consensus 156 ----------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf 201 (324)
T cd05589 156 ----------------------------------DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPF 201 (324)
T ss_pred ----------------------------------CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCC
Confidence 0012468999999999999999999999999999999999999999
Q ss_pred CCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CChHHhhcCCCcCCCCchhhhc--ccCCC
Q 010463 345 CSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLYE--MEAAY 419 (510)
Q Consensus 345 ~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~--~~~~eil~HpfF~~i~~~~l~~--~~~p~ 419 (510)
.+.+.......+... ...+| ..+++++.+||.+||. ||.+||+. .++.++++||||++++|..+.. ..+|+
T Consensus 202 ~~~~~~~~~~~i~~~--~~~~p--~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~~~~~~~~~~~ 277 (324)
T cd05589 202 PGDDEEEVFDSIVND--EVRYP--RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPPF 277 (324)
T ss_pred CCCCHHHHHHHHHhC--CCCCC--CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHHHHhCCCCcCc
Confidence 998888888888763 33455 3789999999999998 99999975 3699999999999999998763 67899
Q ss_pred ccccCCCccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCcccCceee
Q 010463 420 KPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFK 468 (510)
Q Consensus 420 ~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~ 468 (510)
.|.+....|.++|+.-.....+....+ .+.+...+..+..|.+|+|.
T Consensus 278 ~~~~~~~~d~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 324 (324)
T cd05589 278 VPTIKGPEDVSNFDEEFTSEAPVLTPP--REPRLLTEEEQELFRGFDYV 324 (324)
T ss_pred cCCCCCcchhhhcCccccccccccCCC--ccccccchhhhcccCCcccC
Confidence 999999999999875322222222111 11222334456679999874
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-54 Score=438.38 Aligned_cols=317 Identities=36% Similarity=0.663 Sum_probs=264.1
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEeEEeecCceEEEEE
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~~~lVm 185 (510)
+|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+..|..++..+. ||+|++++++|++.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 5889999999999999999999999999999998876555566777888999998885 578889999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
||++||+|..++.+.+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||+++.......
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~---- 156 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV---- 156 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc----
Confidence 9999999999999888999999999999999999999999999999999999999999999999999875322100
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCC
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~ 345 (510)
.....+||+.|+|||++.+..++.++|||||||++|||++|.+||.
T Consensus 157 ----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~ 202 (323)
T cd05615 157 ----------------------------------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202 (323)
T ss_pred ----------------------------------cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCC
Confidence 0124579999999999999999999999999999999999999999
Q ss_pred CCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC--ChHHhhcCCCcCCCCchhhhc--ccCCCc
Q 010463 346 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR--GVEELKEHPWFRGIQWDKLYE--MEAAYK 420 (510)
Q Consensus 346 ~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~--~~~eil~HpfF~~i~~~~l~~--~~~p~~ 420 (510)
+.+....+..|... ...+|. .++.++.+||.+||. +|.+|++.. ..+++++||||.+++|..+.. ..+|+.
T Consensus 203 ~~~~~~~~~~i~~~--~~~~p~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~ 278 (323)
T cd05615 203 GEDEDELFQSIMEH--NVSYPK--SLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENREIQPPFK 278 (323)
T ss_pred CCCHHHHHHHHHhC--CCCCCc--cCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHhcCCCCcCcc
Confidence 99888888888763 344553 789999999999998 999999752 478999999999999999975 578999
Q ss_pred cccCCCccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCcccCceeeC
Q 010463 421 PTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKK 469 (510)
Q Consensus 421 p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~ 469 (510)
|..... +..+|+.+.....+....+... .+.+.....|.||+|.+
T Consensus 279 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 323 (323)
T cd05615 279 PKVCGK-GAENFDKFFTRGQPVLTPPDQL---VIANIDQADFEGFSYVN 323 (323)
T ss_pred CccCCC-chhhcCccccccCCCCCCCccc---ccccccccccCCCcccC
Confidence 876654 5788887665443322211111 11222334688888753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-54 Score=439.02 Aligned_cols=315 Identities=39% Similarity=0.709 Sum_probs=260.4
Q ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHH-HHhcCCCCeeeEeEEeecCceEEEEEeccCC
Q 010463 112 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNL-LAEVDSRCIVQLFYSFQDSDFLYLIMEYLPG 190 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~i-L~~l~hp~Iv~l~~~~~~~~~~~lVmEy~~g 190 (510)
+.||+|+||+||+|+++.+|+.||+|++.+...........+..|+.+ ++.++||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 469999999999999999999999999987765555555666677664 5789999999999999999999999999999
Q ss_pred CCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhhh
Q 010463 191 GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 270 (510)
Q Consensus 191 G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 270 (510)
|+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~---------- 150 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS---------- 150 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC----------
Confidence 9999999988899999999999999999999999999999999999999999999999999987532210
Q ss_pred hcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCCCChh
Q 010463 271 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPR 350 (510)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~~~~~ 350 (510)
......+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..
T Consensus 151 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~ 202 (323)
T cd05575 151 ----------------------------KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA 202 (323)
T ss_pred ----------------------------CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH
Confidence 0012357999999999999999999999999999999999999999998888
Q ss_pred hhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC-CChHHhhcCCCcCCCCchhhhc--ccCCCccccCCC
Q 010463 351 ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT-RGVEELKEHPWFRGIQWDKLYE--MEAAYKPTVNGE 426 (510)
Q Consensus 351 ~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~-~~~~eil~HpfF~~i~~~~l~~--~~~p~~p~~~~~ 426 (510)
+.+.++... ...++ +.+++.+.+||++||. ||.+|++. ..+.++++||||..++|..+.. ..+|+.|.+...
T Consensus 203 ~~~~~i~~~--~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (323)
T cd05575 203 EMYDNILNK--PLRLK--PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITPPFNPNVSGP 278 (323)
T ss_pred HHHHHHHcC--CCCCC--CCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHHHHhhccCCCCcCCCCCCc
Confidence 888888763 23333 4689999999999998 99999976 3568999999999999999874 678999999888
Q ss_pred ccCCCCCC-CCCCCCCCCCCC--CCCcccccCCCcCCcccCceee
Q 010463 427 LDTQNFEK-FPEVDGPPSEIP--SVGPWRKMLTSKDTNFIGYTFK 468 (510)
Q Consensus 427 ~d~~~f~~-~~~~~~~~~~~~--~~~~~~~~~~~~~~~f~~~~~~ 468 (510)
.+.+.|+. +.+...+++... ............+.+|.||+|.
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (323)
T cd05575 279 MDLKHFDPEFTEEPVPNSVGKSPDSVLVSASVKEADDAFLGFSYA 323 (323)
T ss_pred chhhhcCccccccccccccCCCcccccccccccccccccCCCccC
Confidence 88888875 222222221111 1111122234456789999873
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-54 Score=439.33 Aligned_cols=316 Identities=37% Similarity=0.669 Sum_probs=261.7
Q ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHH-HHhcCCCCeeeEeEEeecCceEEEEEeccCC
Q 010463 112 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNL-LAEVDSRCIVQLFYSFQDSDFLYLIMEYLPG 190 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~i-L~~l~hp~Iv~l~~~~~~~~~~~lVmEy~~g 190 (510)
+.||+|+||+||+|+++.+|+.||+|++.+...........+..|+.+ ++.++||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 469999999999999999999999999987655445555666677664 6779999999999999999999999999999
Q ss_pred CCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhhh
Q 010463 191 GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 270 (510)
Q Consensus 191 G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 270 (510)
|+|..++.+...+++..++.++.||+.||+|||+.||+||||||+|||++.+|++||+|||+++......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~---------- 150 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS---------- 150 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC----------
Confidence 9999999988899999999999999999999999999999999999999999999999999987532210
Q ss_pred hcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCCCChh
Q 010463 271 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPR 350 (510)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~~~~~ 350 (510)
......+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..
T Consensus 151 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~ 202 (325)
T cd05604 151 ----------------------------DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA 202 (325)
T ss_pred ----------------------------CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH
Confidence 0012467999999999999999999999999999999999999999999888
Q ss_pred hhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC-CChHHhhcCCCcCCCCchhhhc--ccCCCccccCCC
Q 010463 351 ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT-RGVEELKEHPWFRGIQWDKLYE--MEAAYKPTVNGE 426 (510)
Q Consensus 351 ~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~-~~~~eil~HpfF~~i~~~~l~~--~~~p~~p~~~~~ 426 (510)
..+.++.... +.++ +.++..+.++|++||. +|.+|++. .++.+++.||||.+++|..+.. ..+|+.|.+.+.
T Consensus 203 ~~~~~~~~~~--~~~~--~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~ 278 (325)
T cd05604 203 EMYDNILHKP--LVLR--PGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGP 278 (325)
T ss_pred HHHHHHHcCC--ccCC--CCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCc
Confidence 8888887632 3333 3689999999999998 99999986 3678999999999999998874 578999999998
Q ss_pred ccCCCCCC-CCCCCCCCCCCCCCC--cccccCCCcCCcccCceeeC
Q 010463 427 LDTQNFEK-FPEVDGPPSEIPSVG--PWRKMLTSKDTNFIGYTFKK 469 (510)
Q Consensus 427 ~d~~~f~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~f~~~~~~~ 469 (510)
.|.++|+. +.+...+.+...... .........+.+|.||+|..
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (325)
T cd05604 279 DDISNFDAVFTEETVPYSVCFSSDYSIVNASVLEADDAFVGFSYAP 324 (325)
T ss_pred chhhhcCCccccCCcccCcccccccccccccccccccccCCCEecC
Confidence 89999985 333222222111111 11122334567899999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-54 Score=437.11 Aligned_cols=311 Identities=38% Similarity=0.692 Sum_probs=258.8
Q ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHh-cCCCCeeeEeEEeecCceEEEEEeccCC
Q 010463 112 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE-VDSRCIVQLFYSFQDSDFLYLIMEYLPG 190 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~~~~~~~~~lVmEy~~g 190 (510)
+.||+|+||+||+|+++.+++.||||++++.........+....|+.++.. .+||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999987655455556667778888765 4899999999999999999999999999
Q ss_pred CCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhhh
Q 010463 191 GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 270 (510)
Q Consensus 191 G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 270 (510)
|+|..++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+|+......
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~---------- 150 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---------- 150 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC----------
Confidence 9999999888899999999999999999999999999999999999999999999999999997543210
Q ss_pred hcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCCCChh
Q 010463 271 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPR 350 (510)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~~~~~ 350 (510)
......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..
T Consensus 151 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~ 202 (316)
T cd05592 151 ----------------------------GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED 202 (316)
T ss_pred ----------------------------CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH
Confidence 0112468999999999999999999999999999999999999999998888
Q ss_pred hhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchhhhc--ccCCCccccCCCc
Q 010463 351 ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYE--MEAAYKPTVNGEL 427 (510)
Q Consensus 351 ~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l~~--~~~p~~p~~~~~~ 427 (510)
..+..+... ...+| ..++.++.+||.+||. ||.+|++. ..+++.||||..++|..+.. ..||+.|..+...
T Consensus 203 ~~~~~i~~~--~~~~~--~~~~~~~~~ll~~~l~~~P~~R~~~--~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (316)
T cd05592 203 ELFDSILND--RPHFP--RWISKEAKDCLSKLFERDPTKRLGV--DGDIRQHPFFRGIDWERLEKREIPPPFKPKVKSPS 276 (316)
T ss_pred HHHHHHHcC--CCCCC--CCCCHHHHHHHHHHccCCHHHcCCC--hHHHHcCcccCCCCHHHHHhCCCCCCcCCCCCCcc
Confidence 888777653 23344 3689999999999998 99999953 46899999999999998863 6789999999999
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcccccCCC-cCCcccCceeeCC
Q 010463 428 DTQNFEKFPEVDGPPSEIPSVGPWRKMLTS-KDTNFIGYTFKKS 470 (510)
Q Consensus 428 d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~f~~~~~~~~ 470 (510)
+.++|+.............. .....+ ....|.||.|.++
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 316 (316)
T cd05592 277 DASNFDREFTNEKVRLSPVD----KKLLASMDQEQFRGFSFTNP 316 (316)
T ss_pred hhhhcCcccccccccCCCcc----ccccccccccccCCCcccCc
Confidence 99999863332222111111 122223 3457999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-55 Score=455.90 Aligned_cols=260 Identities=31% Similarity=0.573 Sum_probs=240.2
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEE
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l 183 (510)
.+.-|++.+.||+|+-|.|.+|++..||+.+|||++.+.......+...+.+|+-||+.+.||||++||++|.+..++|+
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 45679999999999999999999999999999999998755566677789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccc
Q 010463 184 IMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 263 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 263 (510)
|.||++||.|+++|.++++++|.+++.|+.||+.|+.|||..+|+||||||+|+|||..++|||+|||+|..-..+
T Consensus 90 vlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g---- 165 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG---- 165 (786)
T ss_pred EEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999864432
Q ss_pred cchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCC-CccccccchhhHHHHHhhCCC
Q 010463 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEMLIGYP 342 (510)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiwSlGvilyEml~G~~ 342 (510)
.+..+.||+|.|.|||++.+.+| |.++||||+|||||.||+|..
T Consensus 166 -----------------------------------klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~L 210 (786)
T KOG0588|consen 166 -----------------------------------KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKL 210 (786)
T ss_pred -----------------------------------ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCC
Confidence 22346799999999999999999 899999999999999999999
Q ss_pred CCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCc
Q 010463 343 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQW 409 (510)
Q Consensus 343 PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~ 409 (510)
||.+++....+.|+..+ .+..|. .+|++|+|||++||. ||++|+ +.+||++|||+.+..-
T Consensus 211 PFdDdNir~LLlKV~~G--~f~MPs--~Is~eaQdLLr~ml~VDp~~Ri---T~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 211 PFDDDNIRVLLLKVQRG--VFEMPS--NISSEAQDLLRRMLDVDPSTRI---TTEEILKHPFLSGYTS 271 (786)
T ss_pred CCCCccHHHHHHHHHcC--cccCCC--cCCHHHHHHHHHHhccCccccc---cHHHHhhCchhhcCCC
Confidence 99999999999999874 466674 899999999999998 999999 6899999999998653
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-57 Score=418.71 Aligned_cols=260 Identities=32% Similarity=0.563 Sum_probs=238.6
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
.+.|++-.+||+|.|+.|+.+.++.||+.||+|++....+... ..+.+.+|+.|...++|||||+|..+++.....|||
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 3678888999999999999999999999999999987665444 667899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCC---CceeecccCCcccCccccc
Q 010463 185 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN---GHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~---g~vkL~DFGla~~~~~~~~ 261 (510)
+|+|.||+|..-|.....++|..+..|+.||+.||.|+|.+||||||+||+|+||.+. .-+||+|||+|..+.++
T Consensus 89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g-- 166 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG-- 166 (355)
T ss_pred EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc--
Confidence 9999999999988888889999999999999999999999999999999999999743 35999999999977632
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~ 341 (510)
..+..++|||.|||||+++..+|+..+||||.|||||-||.|+
T Consensus 167 -------------------------------------~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~ 209 (355)
T KOG0033|consen 167 -------------------------------------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGY 209 (355)
T ss_pred -------------------------------------cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCC
Confidence 1234689999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
+||++++....|..|+.+.....-|.++.+|+++++||++||. ||.+|+ ++.|+|+|||+.+-
T Consensus 210 ~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRI---ta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 210 PPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRI---TADEALKHPWICNR 273 (355)
T ss_pred CCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhc---cHHHHhCCchhcch
Confidence 9999999999999999987777777899999999999999998 999999 78999999999864
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-54 Score=437.58 Aligned_cols=281 Identities=35% Similarity=0.677 Sum_probs=241.9
Q ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCceEEEEEeccCC
Q 010463 112 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLYLIMEYLPG 190 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~~lVmEy~~g 190 (510)
++||+|+||.||+|+++.+++.||+|++++...........+..|+.++..+ +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999999999999999999887655556677889999999888 799999999999999999999999999
Q ss_pred CCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhhh
Q 010463 191 GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 270 (510)
Q Consensus 191 G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 270 (510)
|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~---------- 150 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG---------- 150 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCC----------
Confidence 9999999888899999999999999999999999999999999999999999999999999987432110
Q ss_pred hcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCCCC--
Q 010463 271 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDD-- 348 (510)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~~~-- 348 (510)
......+||+.|+|||++.+..++.++|+|||||++|||++|..||....
T Consensus 151 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~ 202 (329)
T cd05588 151 ----------------------------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMS 202 (329)
T ss_pred ----------------------------CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccc
Confidence 00124689999999999999999999999999999999999999996321
Q ss_pred -------hhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC---CChHHhhcCCCcCCCCchhhhc--c
Q 010463 349 -------PRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT---RGVEELKEHPWFRGIQWDKLYE--M 415 (510)
Q Consensus 349 -------~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~---~~~~eil~HpfF~~i~~~~l~~--~ 415 (510)
.......+.. ....+|. .++.++.+||++||+ ||.+|++. .+++++++||||..++|+.+.. .
T Consensus 203 ~~~~~~~~~~~~~~~~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~~~~~ 278 (329)
T cd05588 203 DNPDQNTEDYLFQVILE--KQIRIPR--SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQV 278 (329)
T ss_pred ccccccchHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHhCCC
Confidence 1123333443 2345553 789999999999998 99999975 2589999999999999998874 5
Q ss_pred cCCCccccCCCccCCCCCC
Q 010463 416 EAAYKPTVNGELDTQNFEK 434 (510)
Q Consensus 416 ~~p~~p~~~~~~d~~~f~~ 434 (510)
.||+.|.+....+..+|+.
T Consensus 279 ~~~~~~~~~~~~~~~~~~~ 297 (329)
T cd05588 279 LPPYKPNIESDRDLDNFDP 297 (329)
T ss_pred CCCccccCCCcchhhhcCC
Confidence 6788999888888888875
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-54 Score=436.77 Aligned_cols=282 Identities=34% Similarity=0.668 Sum_probs=243.6
Q ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCceEEEEEeccCC
Q 010463 112 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLYLIMEYLPG 190 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~~lVmEy~~g 190 (510)
+.||+|+||+||+|+.+.+++.||+|++.+...........+..|+.++..+ +||||++++++|++.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999987665566778899999999887 699999999999999999999999999
Q ss_pred CCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhhh
Q 010463 191 GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 270 (510)
Q Consensus 191 G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 270 (510)
|+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---------- 150 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG---------- 150 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC----------
Confidence 9999999888899999999999999999999999999999999999999999999999999987532110
Q ss_pred hcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCCCC--
Q 010463 271 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDD-- 348 (510)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~~~-- 348 (510)
......+||+.|+|||++.+..++.++|||||||++|||++|.+||....
T Consensus 151 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~ 202 (327)
T cd05617 151 ----------------------------DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDN 202 (327)
T ss_pred ----------------------------CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCC
Confidence 00124689999999999999999999999999999999999999996422
Q ss_pred -----hhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC---CChHHhhcCCCcCCCCchhhhc--ccC
Q 010463 349 -----PRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT---RGVEELKEHPWFRGIQWDKLYE--MEA 417 (510)
Q Consensus 349 -----~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~---~~~~eil~HpfF~~i~~~~l~~--~~~ 417 (510)
....+..+.. ....+|. .+|..+.++|++||. ||.+|++. .++++|++||||++++|+.+.. ..+
T Consensus 203 ~~~~~~~~~~~~~~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~ 278 (327)
T cd05617 203 PDMNTEDYLFQVILE--KPIRIPR--FLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTP 278 (327)
T ss_pred cccccHHHHHHHHHh--CCCCCCC--CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhCCCCC
Confidence 1223333433 2344553 789999999999998 99999975 3689999999999999998874 678
Q ss_pred CCccccCCCccCCCCCCC
Q 010463 418 AYKPTVNGELDTQNFEKF 435 (510)
Q Consensus 418 p~~p~~~~~~d~~~f~~~ 435 (510)
||.|.+.+..+.++|+..
T Consensus 279 ~~~~~~~~~~~~~~~~~~ 296 (327)
T cd05617 279 PFKPQITDDYGLENFDTQ 296 (327)
T ss_pred CccCCCCCCcchhhcCCc
Confidence 999999888888888753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-56 Score=410.16 Aligned_cols=259 Identities=38% Similarity=0.619 Sum_probs=240.6
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCce
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 180 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 180 (510)
....++||++.+.||+|-||.||+|+.+.++-.||+|++.|+++....-..++++|++|.+.++||||+++|++|.|...
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR 96 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence 34678999999999999999999999999999999999999998877777889999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHH--hccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 181 LYLIMEYLPGGDIMTLLM--REDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~--~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
+||++||.++|+|+..|. +...|+|..+..|+.|++.||.|+|..+||||||||+|+|++..|.+||+|||.+...+.
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 999999999999999998 667899999999999999999999999999999999999999999999999999875432
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHh
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml 338 (510)
+ + ..+.|||.+|.+||+..+.+++..+|+|++||+.||+|
T Consensus 177 ~-------------------------------------k---R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yefl 216 (281)
T KOG0580|consen 177 N-------------------------------------K---RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFL 216 (281)
T ss_pred C-------------------------------------C---ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHH
Confidence 2 1 12689999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 339 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 339 ~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
.|.+||.+.+..++|.+|... .+.+| ..+|.+|+|||.+||. +|.+|+ ...|++.|||...
T Consensus 217 vg~ppFes~~~~etYkrI~k~--~~~~p--~~is~~a~dlI~~ll~~~p~~r~---~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 217 VGLPPFESQSHSETYKRIRKV--DLKFP--STISGGAADLISRLLVKNPIERL---ALTEVMDHPWIVA 278 (281)
T ss_pred hcCCchhhhhhHHHHHHHHHc--cccCC--cccChhHHHHHHHHhccCccccc---cHHHHhhhHHHHh
Confidence 999999999999999999973 46677 4899999999999998 999999 6899999999854
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-53 Score=434.11 Aligned_cols=279 Identities=37% Similarity=0.681 Sum_probs=243.9
Q ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHh-cCCCCeeeEeEEeecCceEEEEEeccCC
Q 010463 112 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE-VDSRCIVQLFYSFQDSDFLYLIMEYLPG 190 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~~~~~~~~~lVmEy~~g 190 (510)
+.||+|+||.||+|+++.+|+.||+|++++..............|..++.. .+||||++++++|++.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 479999999999999999999999999987655444556677888888875 4899999999999999999999999999
Q ss_pred CCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhhh
Q 010463 191 GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 270 (510)
Q Consensus 191 G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 270 (510)
|+|..++.....+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---------- 150 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD---------- 150 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC----------
Confidence 9999999888889999999999999999999999999999999999999999999999999987432110
Q ss_pred hcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCCCChh
Q 010463 271 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPR 350 (510)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~~~~~ 350 (510)
......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..
T Consensus 151 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~ 202 (316)
T cd05620 151 ----------------------------NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED 202 (316)
T ss_pred ----------------------------CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH
Confidence 0112468999999999999999999999999999999999999999998888
Q ss_pred hhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchhhh--cccCCCccccCCCc
Q 010463 351 ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLY--EMEAAYKPTVNGEL 427 (510)
Q Consensus 351 ~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l~--~~~~p~~p~~~~~~ 427 (510)
.....+... ...+|. .++.++++||++||. ||++|++. .+++++||||++++|..+. ...+|+.|....+.
T Consensus 203 ~~~~~~~~~--~~~~~~--~~~~~~~~li~~~l~~dP~~R~~~--~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (316)
T cd05620 203 ELFESIRVD--TPHYPR--WITKESKDILEKLFERDPTRRLGV--VGNIRGHPFFKTINWTALEKRELDPPFKPKVKSPS 276 (316)
T ss_pred HHHHHHHhC--CCCCCC--CCCHHHHHHHHHHccCCHHHcCCC--hHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcc
Confidence 777777653 334453 689999999999998 99999953 4689999999999999876 36789999999888
Q ss_pred cCCCCCC
Q 010463 428 DTQNFEK 434 (510)
Q Consensus 428 d~~~f~~ 434 (510)
+.++|+.
T Consensus 277 ~~~~~~~ 283 (316)
T cd05620 277 DYSNFDR 283 (316)
T ss_pred hhhhcCc
Confidence 8888875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-53 Score=433.95 Aligned_cols=312 Identities=37% Similarity=0.678 Sum_probs=259.9
Q ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCceEEEEEeccCC
Q 010463 112 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLYLIMEYLPG 190 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~~lVmEy~~g 190 (510)
+.||+|+||+||+|+++.+++.||||++.+...........+..|..++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999987665566677788899999877 799999999999999999999999999
Q ss_pred CCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhhh
Q 010463 191 GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 270 (510)
Q Consensus 191 G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 270 (510)
|+|..++.+.+.+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---------- 150 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG---------- 150 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC----------
Confidence 9999999888899999999999999999999999999999999999999999999999999987432110
Q ss_pred hcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCCCChh
Q 010463 271 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPR 350 (510)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~~~~~ 350 (510)
......+||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+..
T Consensus 151 ----------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~ 202 (318)
T cd05570 151 ----------------------------VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED 202 (318)
T ss_pred ----------------------------CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH
Confidence 0012457999999999999999999999999999999999999999988888
Q ss_pred hhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CChHHhhcCCCcCCCCchhhhc--ccCCCccccCC
Q 010463 351 ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLYE--MEAAYKPTVNG 425 (510)
Q Consensus 351 ~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~--~~~~eil~HpfF~~i~~~~l~~--~~~p~~p~~~~ 425 (510)
..+..+... ...+| ..++.++.+||++||. ||.+|++. ....++++||||+.++|..+.. ..||+.|.++.
T Consensus 203 ~~~~~i~~~--~~~~~--~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (318)
T cd05570 203 ELFQSILED--EVRYP--RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKG 278 (318)
T ss_pred HHHHHHHcC--CCCCC--CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCCCCC
Confidence 777777763 34455 3689999999999998 99999953 1239999999999999988764 67899999999
Q ss_pred CccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCcccCceee
Q 010463 426 ELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFK 468 (510)
Q Consensus 426 ~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~ 468 (510)
..+.++|+.-.....+..+.+.. . .+..-++..|.||+|.
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~ 318 (318)
T cd05570 279 RFDVSNFDDEFTKEKPVLTPPDE-A--IIRNIDQEEFRGFSYI 318 (318)
T ss_pred cchhhhcCchhccCcccCCCCcc-c--ccccccccccCCCCCC
Confidence 99999997522222221111111 1 1223344689999983
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-55 Score=436.18 Aligned_cols=268 Identities=35% Similarity=0.629 Sum_probs=233.3
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcch-----------hhHHHHHHHHHHHHhcCCCCee
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR-----------GQVEHVRSERNLLAEVDSRCIV 169 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~-----------~~~~~~~~E~~iL~~l~hp~Iv 169 (510)
.+..+++|++++.||+|.||+|.+|++..+++.||||++.|...... ..++.+++|+.||++|+|||||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 34567899999999999999999999999999999999998765322 2357899999999999999999
Q ss_pred eEeEEeecC--ceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceee
Q 010463 170 QLFYSFQDS--DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKL 247 (510)
Q Consensus 170 ~l~~~~~~~--~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL 247 (510)
+|+.+..|+ +.+|||+|||..|.+...-....-+++.+|+.|+..+++||+|||.+|||||||||+|+||+++|+|||
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKI 251 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKI 251 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEe
Confidence 999999876 489999999999988766444444999999999999999999999999999999999999999999999
Q ss_pred cccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCC---C-Cc
Q 010463 248 SDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG---Y-GM 323 (510)
Q Consensus 248 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~---y-~~ 323 (510)
+|||.|.......... .... ....+|||.|||||.+.++. | +.
T Consensus 252 sDFGVs~~~~~~~~~~----------------------~d~~-----------L~~tvGTPAF~APE~c~~~~~~~~~g~ 298 (576)
T KOG0585|consen 252 SDFGVSNEFPQGSDEG----------------------SDDQ-----------LSRTVGTPAFFAPELCSGGNSFSYSGF 298 (576)
T ss_pred eccceeeecccCCccc----------------------cHHH-----------HhhcCCCccccchHhhcCCCCccccch
Confidence 9999998664331000 0000 11368999999999998733 3 78
Q ss_pred cccccchhhHHHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCC
Q 010463 324 ECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHP 402 (510)
Q Consensus 324 ~~DiwSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~Hp 402 (510)
+.|||||||+||.|+.|+.||.++...+++.+|++ .++.||..+.+.++++|||.+||+ ||++|+ ++.+|+.||
T Consensus 299 a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn--~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri---~l~~ik~Hp 373 (576)
T KOG0585|consen 299 ALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVN--DPLEFPENPEINEDLKDLIKRLLEKDPEQRI---TLPDIKLHP 373 (576)
T ss_pred hhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhc--CcccCCCcccccHHHHHHHHHHhhcChhhee---ehhhheecc
Confidence 99999999999999999999999999999999999 679999988999999999999999 999999 689999999
Q ss_pred CcCC
Q 010463 403 WFRG 406 (510)
Q Consensus 403 fF~~ 406 (510)
|...
T Consensus 374 wvt~ 377 (576)
T KOG0585|consen 374 WVTR 377 (576)
T ss_pred eecc
Confidence 9753
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-53 Score=432.23 Aligned_cols=310 Identities=35% Similarity=0.646 Sum_probs=256.3
Q ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHh-cCCCCeeeEeEEeecCceEEEEEeccCC
Q 010463 112 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE-VDSRCIVQLFYSFQDSDFLYLIMEYLPG 190 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~~~~~~~~~lVmEy~~g 190 (510)
+.||+|+||+||+|+++.+++.||||++++..............|..++.. ++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999987654444455667778888876 4999999999999999999999999999
Q ss_pred CCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhhh
Q 010463 191 GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 270 (510)
Q Consensus 191 G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 270 (510)
|+|..++.....+++..+..++.|++.||+|||+.||+||||||+|||++.+|.+||+|||+++.......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--------- 151 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--------- 151 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC---------
Confidence 99999998888899999999999999999999999999999999999999999999999999875321100
Q ss_pred hcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCCCChh
Q 010463 271 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPR 350 (510)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~~~~~ 350 (510)
...+.+||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+..
T Consensus 152 -----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~ 202 (316)
T cd05619 152 -----------------------------KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE 202 (316)
T ss_pred -----------------------------ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH
Confidence 012467999999999999999999999999999999999999999998888
Q ss_pred hhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchhhh--cccCCCccccCCCc
Q 010463 351 ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLY--EMEAAYKPTVNGEL 427 (510)
Q Consensus 351 ~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l~--~~~~p~~p~~~~~~ 427 (510)
+....+.... ..+|. .++.++++||.+||+ ||.+|++. .++++.||||+.++|..+. ..++|+.|.+++..
T Consensus 203 ~~~~~i~~~~--~~~~~--~~~~~~~~li~~~l~~~P~~R~~~--~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (316)
T cd05619 203 ELFQSIRMDN--PCYPR--WLTREAKDILVKLFVREPERRLGV--KGDIRQHPFFREIDWSALEEREIEPPFKPKVKSAN 276 (316)
T ss_pred HHHHHHHhCC--CCCCc--cCCHHHHHHHHHHhccCHhhcCCC--hHHHHcCcccCCCCHHHHHhCCCCCCcCCCCCCcc
Confidence 7777776532 33443 689999999999998 99999953 2589999999999999886 46799999999999
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcccccCCCcC-CcccCceeeC
Q 010463 428 DTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKD-TNFIGYTFKK 469 (510)
Q Consensus 428 d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~f~~~~~~~ 469 (510)
+.++|+.......+.... ..+....+.+ ..|.||.|.+
T Consensus 277 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 315 (316)
T cd05619 277 DCSNFDKEFLNEKPRLSV----TDRMLINSMDQNMFENFSFIN 315 (316)
T ss_pred chhhcChhhhcCCcccCC----CcccccccccccccCCCcccC
Confidence 999998633222111111 1122233444 4588887754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-53 Score=426.64 Aligned_cols=275 Identities=33% Similarity=0.650 Sum_probs=235.3
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEe
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 186 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmE 186 (510)
.|++++.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+.+|..++||||++++++|.+.+.+|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 47889999999999999999999999999999987665444455667899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 187 YLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 187 y~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
|++||+|..++... ..+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC----
Confidence 99999999887643 468999999999999999999999999999999999999999999999999998653210
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCC
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 344 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF 344 (510)
.....+||+.|+|||++.+..|+.++|||||||++|||++|.+||
T Consensus 157 -----------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf 201 (285)
T cd05631 157 -----------------------------------TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201 (285)
T ss_pred -----------------------------------eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCC
Confidence 011357999999999999999999999999999999999999999
Q ss_pred CCCChhhhHHHHhhcc--ccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CChHHhhcCCCcCCCCchhhhc--ccC
Q 010463 345 CSDDPRITCRKIVNWK--TCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLYE--MEA 417 (510)
Q Consensus 345 ~~~~~~~~~~~I~~~~--~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~--~~~~eil~HpfF~~i~~~~l~~--~~~ 417 (510)
.+.+.......+.... ....++ ..+|+++.+||++||+ ||.+|++. .+++++++||||.+++|+.+.+ .+|
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~ 279 (285)
T cd05631 202 RKRKERVKREEVDRRVKEDQEEYS--EKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEP 279 (285)
T ss_pred CCCCcchhHHHHHHHhhcccccCC--ccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhCcCCc
Confidence 8765533322222111 122333 4789999999999998 99999974 3589999999999999999986 589
Q ss_pred CCccc
Q 010463 418 AYKPT 422 (510)
Q Consensus 418 p~~p~ 422 (510)
||+|.
T Consensus 280 ~~~~~ 284 (285)
T cd05631 280 PFCPD 284 (285)
T ss_pred CCCCC
Confidence 99985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-53 Score=433.13 Aligned_cols=281 Identities=34% Similarity=0.688 Sum_probs=240.6
Q ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCceEEEEEeccCC
Q 010463 112 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLYLIMEYLPG 190 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~~lVmEy~~g 190 (510)
+.||+|+||+||+|+++.+++.||+|++.+...........+..|..++..+ +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999887655556677788999998776 899999999999999999999999999
Q ss_pred CCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhhh
Q 010463 191 GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 270 (510)
Q Consensus 191 G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 270 (510)
|+|..++.+...+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--------- 151 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--------- 151 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC---------
Confidence 99999998888999999999999999999999999999999999999999999999999999875321100
Q ss_pred hcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCCCC--
Q 010463 271 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDD-- 348 (510)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~~~-- 348 (510)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 152 -----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~ 202 (329)
T cd05618 152 -----------------------------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS 202 (329)
T ss_pred -----------------------------ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCc
Confidence 0123679999999999999999999999999999999999999995211
Q ss_pred -------hhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC---CChHHhhcCCCcCCCCchhhhc--c
Q 010463 349 -------PRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT---RGVEELKEHPWFRGIQWDKLYE--M 415 (510)
Q Consensus 349 -------~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~---~~~~eil~HpfF~~i~~~~l~~--~ 415 (510)
.......+.. ....+|. .++..+.+||++||. ||.+|++. .+++++++||||++++|+.+.. .
T Consensus 203 ~~~~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~ 278 (329)
T cd05618 203 DNPDQNTEDYLFQVILE--KQIRIPR--SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQV 278 (329)
T ss_pred CCcccccHHHHHHHHhc--CCCCCCC--CCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHcCCC
Confidence 1122333443 3345553 789999999999998 99999975 2578999999999999998864 6
Q ss_pred cCCCccccCCCccCCCCCC
Q 010463 416 EAAYKPTVNGELDTQNFEK 434 (510)
Q Consensus 416 ~~p~~p~~~~~~d~~~f~~ 434 (510)
.||+.|.+.+..+..+|+.
T Consensus 279 ~~~~~~~~~~~~~~~~~~~ 297 (329)
T cd05618 279 VPPFKPNISGEFGLDNFDA 297 (329)
T ss_pred CcCccCCCCCcccchhcCc
Confidence 7899999888877777765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-53 Score=431.29 Aligned_cols=287 Identities=42% Similarity=0.785 Sum_probs=243.4
Q ss_pred CceeeeeeecCCCeEEEEEEEc---CCCCEEEEEEeechhhcc-hhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCceE
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAK---TTGEIFAMKKLKKSEMLK-RGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFL 181 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~---~tg~~vAiK~i~k~~~~~-~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~ 181 (510)
+|++++.||+|+||.||+|++. .+|+.||+|++.+..... ....+++..|+.+|..+ +||+|++++++|.+++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999998864 578999999998765432 23456788999999999 589999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 182 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
|+||||++||+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999986432210
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC-CCCccccccchhhHHHHHhhC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEMLIG 340 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiwSlGvilyEml~G 340 (510)
......+||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 161 -------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg 203 (332)
T cd05614 161 -------------------------------------ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203 (332)
T ss_pred -------------------------------------CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcC
Confidence 012246899999999999875 479999999999999999999
Q ss_pred CCCCCCCCh----hhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC--ChHHhhcCCCcCCCCchhhh
Q 010463 341 YPPFCSDDP----RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR--GVEELKEHPWFRGIQWDKLY 413 (510)
Q Consensus 341 ~~PF~~~~~----~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~--~~~eil~HpfF~~i~~~~l~ 413 (510)
..||..... ......+... ...+| ..+++.+++||.+||. ||++|+++. +++++++||||++++|..+.
T Consensus 204 ~~pf~~~~~~~~~~~~~~~~~~~--~~~~~--~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~ 279 (332)
T cd05614 204 ASPFTLEGERNTQSEVSRRILKC--DPPFP--SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALA 279 (332)
T ss_pred CCCCCCCCCCCCHHHHHHHHhcC--CCCCC--CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence 999975432 2233334432 22333 4789999999999998 999999875 89999999999999999876
Q ss_pred c--ccCCCccccCCCccCCCCCC
Q 010463 414 E--MEAAYKPTVNGELDTQNFEK 434 (510)
Q Consensus 414 ~--~~~p~~p~~~~~~d~~~f~~ 434 (510)
. ..+|+.|......+..+|..
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~ 302 (332)
T cd05614 280 LRKVNPPFRPSIRNELDVGNFAE 302 (332)
T ss_pred hCCCCCCcCCCCCCcchhhhcCc
Confidence 4 67899999998888888864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-53 Score=430.51 Aligned_cols=281 Identities=42% Similarity=0.753 Sum_probs=244.1
Q ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHH-HHHhcCCCCeeeEeEEeecCceEEEEEeccCC
Q 010463 112 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN-LLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPG 190 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~-iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy~~g 190 (510)
+.||+|+||+||+|+++.+++.||+|++.+...........+..|.. +++.++||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999998765544444455555555 46788999999999999999999999999999
Q ss_pred CCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhhh
Q 010463 191 GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 270 (510)
Q Consensus 191 G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 270 (510)
|+|..++.+.+.+++..++.++.||+.||+|||+.||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~---------- 150 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN---------- 150 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC----------
Confidence 9999999988889999999999999999999999999999999999999999999999999997532210
Q ss_pred hcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCCCChh
Q 010463 271 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPR 350 (510)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~~~~~ 350 (510)
......+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..
T Consensus 151 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 202 (325)
T cd05602 151 ----------------------------GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA 202 (325)
T ss_pred ----------------------------CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH
Confidence 0012468999999999999999999999999999999999999999999888
Q ss_pred hhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC-ChHHhhcCCCcCCCCchhhhc--ccCCCccccCCC
Q 010463 351 ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR-GVEELKEHPWFRGIQWDKLYE--MEAAYKPTVNGE 426 (510)
Q Consensus 351 ~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~-~~~eil~HpfF~~i~~~~l~~--~~~p~~p~~~~~ 426 (510)
+.+.++... ...++ +.+++.+.+||.+||. ||.+|++.. .+.++++|+||..++|+.+.. ..+|+.|.+.++
T Consensus 203 ~~~~~i~~~--~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (325)
T cd05602 203 EMYDNILNK--PLQLK--PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINKKITPPFNPNVSGP 278 (325)
T ss_pred HHHHHHHhC--CcCCC--CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHHHHHhCCCCcCcCCCCCCc
Confidence 888888763 23333 4789999999999998 999999863 577999999999999999874 578889998888
Q ss_pred ccCCCCCC
Q 010463 427 LDTQNFEK 434 (510)
Q Consensus 427 ~d~~~f~~ 434 (510)
.+...|+.
T Consensus 279 ~~~~~~~~ 286 (325)
T cd05602 279 NDLRHFDP 286 (325)
T ss_pred chhhhcCC
Confidence 88888864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-53 Score=428.99 Aligned_cols=281 Identities=41% Similarity=0.746 Sum_probs=244.7
Q ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHH-HHHhcCCCCeeeEeEEeecCceEEEEEeccCC
Q 010463 112 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN-LLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPG 190 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~-iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy~~g 190 (510)
++||+|+||.||+|+++.+|+.||+|++.+...........+..|+. +++.++||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999998766545555556666665 57889999999999999999999999999999
Q ss_pred CCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhhh
Q 010463 191 GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 270 (510)
Q Consensus 191 G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 270 (510)
|+|..++.+...+++..++.++.||+.||.|||+.||+||||||+||||+.+|++||+|||+++......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---------- 150 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE---------- 150 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC----------
Confidence 9999999888889999999999999999999999999999999999999999999999999987532210
Q ss_pred hcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCCCChh
Q 010463 271 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPR 350 (510)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~~~~~ 350 (510)
......+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..
T Consensus 151 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 202 (321)
T cd05603 151 ----------------------------ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS 202 (321)
T ss_pred ----------------------------CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH
Confidence 0012357999999999999999999999999999999999999999998888
Q ss_pred hhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC-CChHHhhcCCCcCCCCchhhhc--ccCCCccccCCC
Q 010463 351 ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT-RGVEELKEHPWFRGIQWDKLYE--MEAAYKPTVNGE 426 (510)
Q Consensus 351 ~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~-~~~~eil~HpfF~~i~~~~l~~--~~~p~~p~~~~~ 426 (510)
..+..+... ...+| +..+.++.++|.+||. ||.+|++. .++.++++||||..++|+.+.. ..+|+.|.....
T Consensus 203 ~~~~~i~~~--~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (321)
T cd05603 203 QMYDNILHK--PLQLP--GGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYHKRITPPYNPNVAGP 278 (321)
T ss_pred HHHHHHhcC--CCCCC--CCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHHHHhcCCCCCCcCCCCCCc
Confidence 888888763 34455 3689999999999998 99999975 3678999999999999999864 678888888888
Q ss_pred ccCCCCCC
Q 010463 427 LDTQNFEK 434 (510)
Q Consensus 427 ~d~~~f~~ 434 (510)
.+...|+.
T Consensus 279 ~~~~~~~~ 286 (321)
T cd05603 279 ADLRHFDP 286 (321)
T ss_pred chhhhcCC
Confidence 88888774
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-56 Score=418.55 Aligned_cols=250 Identities=33% Similarity=0.551 Sum_probs=222.7
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeE-EeecCce
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY-SFQDSDF 180 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~-~~~~~~~ 180 (510)
..+..+|+++++||+|+||+||+|++..+|+.+|.|.+.- .+........+..|+.+|++++|||||+.|+ .|..++.
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f-~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQF-GMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE 93 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcch-hhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence 3456789999999999999999999999999999999984 4556667788999999999999999999998 6766665
Q ss_pred -EEEEEeccCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHhhhh--CC--eEEeecCCCCeeecCCCceeecccC
Q 010463 181 -LYLIMEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQ--HN--YVHRDIKPDNLILDKNGHLKLSDFG 251 (510)
Q Consensus 181 -~~lVmEy~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~lH~--~g--iiHRDLKP~NILld~~g~vkL~DFG 251 (510)
++||||||.+|||..++.. +..++|..++.|+.|++.||..+|+ .. |+||||||.||+|+.+|.|||+|||
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG 173 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG 173 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence 9999999999999999864 4679999999999999999999999 45 9999999999999999999999999
Q ss_pred CcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchh
Q 010463 252 LCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLG 331 (510)
Q Consensus 252 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlG 331 (510)
|++.+... ...+.|.||||.||+||++...+|+.++||||||
T Consensus 174 L~r~l~s~--------------------------------------~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslG 215 (375)
T KOG0591|consen 174 LGRFLSSK--------------------------------------TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLG 215 (375)
T ss_pred hHhHhcch--------------------------------------hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHH
Confidence 99987543 1235689999999999999999999999999999
Q ss_pred hHHHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC
Q 010463 332 AIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT 392 (510)
Q Consensus 332 vilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~ 392 (510)
|++|||..-.+||.|++-.+.+.+|.++. ....|. ...|.++..||..|++ ||+.||+.
T Consensus 216 CllyEMcaL~~PF~g~n~~~L~~KI~qgd-~~~~p~-~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 216 CLLYEMCALQSPFYGDNLLSLCKKIEQGD-YPPLPD-EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHHHHHhcCCCcccccHHHHHHHHHcCC-CCCCcH-HHhhhHHHHHHHHHccCCcccCCCc
Confidence 99999999999999999999999999852 222442 3789999999999999 99999963
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-53 Score=429.10 Aligned_cols=281 Identities=42% Similarity=0.739 Sum_probs=248.3
Q ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEeccCCC
Q 010463 112 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGG 191 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy~~gG 191 (510)
+.||+|+||.||+|+++.+|+.||+|++.+...........+..|..++..++||||++++++|.+.+.+|+||||++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998876555566777889999999999999999999999999999999999999
Q ss_pred CHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhh-CCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhhh
Q 010463 192 DIMTLLMREDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 270 (510)
Q Consensus 192 ~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~-~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 270 (510)
+|..++.+...+++..++.++.||+.||.|||+ .||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--------- 151 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--------- 151 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc---------
Confidence 999999888899999999999999999999997 8999999999999999999999999999875322100
Q ss_pred hcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCCCChh
Q 010463 271 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPR 350 (510)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~~~~~ 350 (510)
.....+||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+..
T Consensus 152 -----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~ 202 (325)
T cd05594 152 -----------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 202 (325)
T ss_pred -----------------------------ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH
Confidence 012357999999999999999999999999999999999999999988887
Q ss_pred hhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CChHHhhcCCCcCCCCchhhhc--ccCCCccccCC
Q 010463 351 ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLYE--MEAAYKPTVNG 425 (510)
Q Consensus 351 ~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~--~~~~eil~HpfF~~i~~~~l~~--~~~p~~p~~~~ 425 (510)
.....+.. ....+|. .+++++.+||.+||. ||.+|++. .++.++++||||.++.|..+.. ..||+.|...+
T Consensus 203 ~~~~~i~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (325)
T cd05594 203 KLFELILM--EEIRFPR--TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQVTS 278 (325)
T ss_pred HHHHHHhc--CCCCCCC--CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCC
Confidence 77777765 3345553 789999999999998 99999853 3689999999999999998874 56889998888
Q ss_pred CccCCCCCC
Q 010463 426 ELDTQNFEK 434 (510)
Q Consensus 426 ~~d~~~f~~ 434 (510)
..++.+|+.
T Consensus 279 ~~~~~~~~~ 287 (325)
T cd05594 279 ETDTRYFDE 287 (325)
T ss_pred cchhhhcCc
Confidence 888888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-52 Score=426.54 Aligned_cols=282 Identities=44% Similarity=0.835 Sum_probs=245.0
Q ss_pred eeeeecCCCeEEEEEEEc---CCCCEEEEEEeechhhcc-hhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEe
Q 010463 111 LTLIGKGAFGEVRLCRAK---TTGEIFAMKKLKKSEMLK-RGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 186 (510)
Q Consensus 111 ~~~IG~G~fG~V~~~~~~---~tg~~vAiK~i~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmE 186 (510)
++.||+|+||.||+|+.. .+++.||+|++.+..... .....++..|+.+|..++||||++++++|.+++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 468999999999999864 578999999998765432 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccch
Q 010463 187 YLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 266 (510)
Q Consensus 187 y~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~ 266 (510)
|++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~------ 154 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG------ 154 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC------
Confidence 99999999999998999999999999999999999999999999999999999999999999999987532210
Q ss_pred hhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCC
Q 010463 267 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCS 346 (510)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~ 346 (510)
......+||+.|+|||++.+..++.++|||||||++|||++|.+||.+
T Consensus 155 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~ 202 (323)
T cd05584 155 --------------------------------TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA 202 (323)
T ss_pred --------------------------------CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC
Confidence 011235799999999999999999999999999999999999999999
Q ss_pred CChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CChHHhhcCCCcCCCCchhhhc--ccCCCcc
Q 010463 347 DDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLYE--MEAAYKP 421 (510)
Q Consensus 347 ~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~--~~~~eil~HpfF~~i~~~~l~~--~~~p~~p 421 (510)
.+.......+... ...+| +.+++++.+||++||. ||++|++. .++++++.||||...+|+.+.. ..+|+.|
T Consensus 203 ~~~~~~~~~~~~~--~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~ 278 (323)
T cd05584 203 ENRKKTIDKILKG--KLNLP--PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFKP 278 (323)
T ss_pred CCHHHHHHHHHcC--CCCCC--CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCHHHHhcCCCCCCcCC
Confidence 8888888888763 34445 4789999999999998 99999953 4689999999999999998874 5678888
Q ss_pred ccCCCccCCCCCC
Q 010463 422 TVNGELDTQNFEK 434 (510)
Q Consensus 422 ~~~~~~d~~~f~~ 434 (510)
...+..+.+.|+.
T Consensus 279 ~~~~~~~~~~~~~ 291 (323)
T cd05584 279 LLQSEEDVSQFDS 291 (323)
T ss_pred CCCCcchhhhcCc
Confidence 8888888777764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-54 Score=440.56 Aligned_cols=254 Identities=33% Similarity=0.588 Sum_probs=234.1
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++|-+...||+|+||+||+|+.|.|.++||||.+.|..- ...+++.+++|++|++.++|||||.++++|++..++|+|+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 678899999999999999999999999999999988753 4557889999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
||+.| +|+.+|...+.++|+.++.++.+++.||.|||+.+|+|||+||.||||+..|++|+||||+|+.+....
T Consensus 81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t----- 154 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT----- 154 (808)
T ss_pred hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc-----
Confidence 99988 999999999999999999999999999999999999999999999999999999999999999775431
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCC
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~ 345 (510)
...+++-|||.|||||++.+++|+..+|.||||||+|||++|+|||+
T Consensus 155 ---------------------------------~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~ 201 (808)
T KOG0597|consen 155 ---------------------------------SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY 201 (808)
T ss_pred ---------------------------------eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch
Confidence 12346789999999999999999999999999999999999999999
Q ss_pred CCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 346 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 346 ~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
+.........|.. .+...|. .+|..++.|+..||. ||.+|+ +..+++.|||.++
T Consensus 202 a~si~~Lv~~I~~--d~v~~p~--~~S~~f~nfl~gLL~kdP~~Rl---tW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 202 ARSITQLVKSILK--DPVKPPS--TASSSFVNFLQGLLIKDPAQRL---TWTDLLGHPFWKG 256 (808)
T ss_pred HHHHHHHHHHHhc--CCCCCcc--cccHHHHHHHHHHhhcChhhcc---cHHHHhcChHHhh
Confidence 9998888888886 3455553 899999999999998 999999 7899999999986
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-53 Score=429.79 Aligned_cols=280 Identities=43% Similarity=0.761 Sum_probs=244.4
Q ss_pred eecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc---CCCCeeeEeEEeecCceEEEEEeccCC
Q 010463 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV---DSRCIVQLFYSFQDSDFLYLIMEYLPG 190 (510)
Q Consensus 114 IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~~~~~~~~~lVmEy~~g 190 (510)
||+|+||+||+|+++.+|+.||+|++.+..........+...|..++..+ +||||++++.+|.+.+.+|+||||++|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999877665555666677788888665 799999999999999999999999999
Q ss_pred CCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhhh
Q 010463 191 GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 270 (510)
Q Consensus 191 G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 270 (510)
|+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~---------- 150 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN---------- 150 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC----------
Confidence 9999999988899999999999999999999999999999999999999999999999999987532210
Q ss_pred hcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC-CCCccccccchhhHHHHHhhCCCCCCCCCh
Q 010463 271 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEMLIGYPPFCSDDP 349 (510)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiwSlGvilyEml~G~~PF~~~~~ 349 (510)
......+||+.|+|||++.+. .++.++|+|||||++|||++|..||.+.+.
T Consensus 151 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~ 202 (330)
T cd05586 151 ----------------------------KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT 202 (330)
T ss_pred ----------------------------CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH
Confidence 011246899999999999764 589999999999999999999999999888
Q ss_pred hhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC-CChHHhhcCCCcCCCCchhhhc--ccCCCccccCC
Q 010463 350 RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT-RGVEELKEHPWFRGIQWDKLYE--MEAAYKPTVNG 425 (510)
Q Consensus 350 ~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~-~~~~eil~HpfF~~i~~~~l~~--~~~p~~p~~~~ 425 (510)
.+.+.+|... ...+|. ..+++++++||++||+ ||.+|++. .+++++++||||..++|+.+.. +.+|+.|....
T Consensus 203 ~~~~~~i~~~--~~~~~~-~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (330)
T cd05586 203 QQMYRNIAFG--KVRFPK-NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQITPPFKPIVDS 279 (330)
T ss_pred HHHHHHHHcC--CCCCCC-ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCccCCCCC
Confidence 8888777653 344553 3689999999999998 99999975 4699999999999999998864 67899999888
Q ss_pred CccCCCCCC
Q 010463 426 ELDTQNFEK 434 (510)
Q Consensus 426 ~~d~~~f~~ 434 (510)
..+.++|+.
T Consensus 280 ~~~~~~~~~ 288 (330)
T cd05586 280 DEDVSNFDP 288 (330)
T ss_pred CcchhhcCc
Confidence 888888864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-52 Score=430.96 Aligned_cols=260 Identities=36% Similarity=0.572 Sum_probs=239.9
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEeEEeecCceEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~~~l 183 (510)
...|++.+.||+|.||.||+|+.+.||+.||+|++.|..+......+.+.+|+.||+.+. |||||.++++|.+...+|+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 357999999999999999999999999999999999987766666788999999999998 9999999999999999999
Q ss_pred EEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCC----CceeecccCCcccCccc
Q 010463 184 IMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN----GHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~----g~vkL~DFGla~~~~~~ 259 (510)
|||+|.||+|++.+.+. .++|..+..++.|++.|+.|||+.||+||||||+|+|+... +.+|++|||++......
T Consensus 114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~ 192 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG 192 (382)
T ss_pred EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC
Confidence 99999999999999887 49999999999999999999999999999999999999743 57999999999976542
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~ 339 (510)
. .....||||.|+|||++...+|+..+|+||+||++|.||+
T Consensus 193 ~---------------------------------------~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~ 233 (382)
T KOG0032|consen 193 E---------------------------------------RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLS 233 (382)
T ss_pred c---------------------------------------eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhh
Confidence 1 1235799999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 340 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 340 G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
|.+||.+.+...++.+|......+..+.++.+|..|+|||++||. ||.+|+ ++.++|+|||+++.
T Consensus 234 G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~---ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 234 GVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRL---TAAQALQHPWIKSI 299 (382)
T ss_pred CCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCC---CHHHHhcCccccCC
Confidence 999999999999999999987777778888999999999999998 999999 78999999998875
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-52 Score=422.09 Aligned_cols=281 Identities=42% Similarity=0.761 Sum_probs=243.5
Q ss_pred eeeeecCCCeEEEEEEE---cCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEec
Q 010463 111 LTLIGKGAFGEVRLCRA---KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEY 187 (510)
Q Consensus 111 ~~~IG~G~fG~V~~~~~---~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy 187 (510)
++.||+|+||.||++++ +.+|+.||+|++.+... .......+..|+.+|..++||||++++++|.+++.+|+||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 36799999999999886 46889999999987643 233445677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchh
Q 010463 188 LPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLED 267 (510)
Q Consensus 188 ~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~ 267 (510)
++||+|.+++.+...+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++......
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~------- 152 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE------- 152 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-------
Confidence 9999999999888889999999999999999999999999999999999999999999999999987643220
Q ss_pred hhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCCC
Q 010463 268 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSD 347 (510)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~~ 347 (510)
....+.+||+.|+|||++.+..++.++|+|||||++|||++|..||.+.
T Consensus 153 -------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 201 (318)
T cd05582 153 -------------------------------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK 201 (318)
T ss_pred -------------------------------CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC
Confidence 0122468999999999999999999999999999999999999999998
Q ss_pred ChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCC--hHHhhcCCCcCCCCchhhhc--ccCCCccc
Q 010463 348 DPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRG--VEELKEHPWFRGIQWDKLYE--MEAAYKPT 422 (510)
Q Consensus 348 ~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~--~~eil~HpfF~~i~~~~l~~--~~~p~~p~ 422 (510)
+.......+... ...+| ..+++++.+||++||. ||++|+++.. +++++.||||..++|..+.. ..+|+.|.
T Consensus 202 ~~~~~~~~i~~~--~~~~p--~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (318)
T cd05582 202 DRKETMTMILKA--KLGMP--QFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPFKPA 277 (318)
T ss_pred CHHHHHHHHHcC--CCCCC--CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHHHHhcCCCCCcCCC
Confidence 888888777753 34455 3689999999999998 9999997644 89999999999999998874 56788888
Q ss_pred cCCCccCCCCCC
Q 010463 423 VNGELDTQNFEK 434 (510)
Q Consensus 423 ~~~~~d~~~f~~ 434 (510)
.....+..+++.
T Consensus 278 ~~~~~~~~~~~~ 289 (318)
T cd05582 278 VGRPDDTFYFDP 289 (318)
T ss_pred CCCcchhhhcCc
Confidence 776666666654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-54 Score=405.62 Aligned_cols=262 Identities=33% Similarity=0.549 Sum_probs=237.0
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhc-----chhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCc
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML-----KRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSD 179 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~-----~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~ 179 (510)
+.|+-.++||+|..++|..|.++.||+.+|+|+|...... .....+..+.|+.||+++ .||+|++|.++|+++.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 4677778999999999999999999999999998643221 123356677899999887 7999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 180 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
.+++|+|.|+.|+|+++|...-.++|..++.++.|++.|++|||.++||||||||+|||+|++.++||+|||+|+.+..+
T Consensus 97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G 176 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPG 176 (411)
T ss_pred hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999988764
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc------CCCCccccccchhhH
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK------KGYGMECDWWSLGAI 333 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~------~~y~~~~DiwSlGvi 333 (510)
. .....||||+|+|||.+.. .+|+..+|+||+|||
T Consensus 177 e---------------------------------------kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVI 217 (411)
T KOG0599|consen 177 E---------------------------------------KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVI 217 (411)
T ss_pred h---------------------------------------hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHH
Confidence 1 1234799999999999964 579999999999999
Q ss_pred HHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCc
Q 010463 334 MYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQW 409 (510)
Q Consensus 334 lyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~ 409 (510)
||.||.|.|||+......+.+.|+.++..+.-|+|.++|..++|||++||. ||++|+ +++|+|+||||..+--
T Consensus 218 myTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ri---take~LaHpff~q~~~ 291 (411)
T KOG0599|consen 218 MYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRI---TAKEALAHPFFIQIAQ 291 (411)
T ss_pred HHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcc---cHHHHhcChHHHHHHH
Confidence 999999999999999999999999999889999999999999999999998 999999 7899999999976543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-53 Score=403.11 Aligned_cols=258 Identities=33% Similarity=0.526 Sum_probs=219.9
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
+.|+.+..+|+|+||+|++|++++||+.||||++..++- .+.-.+-..+|+.+|++++|||+|.|+.+|.....++||+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esed-d~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESED-DPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCc-cHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 568899999999999999999999999999999865431 2333456789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 186 EYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 186 Ey~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
|||.. ++.+-|.+ ...++++.++.|+.|++.|+.|+|+.++||||||||||||+.+|.+||||||+|+.+....
T Consensus 81 E~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg---- 155 (396)
T KOG0593|consen 81 EYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG---- 155 (396)
T ss_pred eecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCc----
Confidence 99987 44455544 4679999999999999999999999999999999999999999999999999999875320
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHhhCCCC
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYPP 343 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml~G~~P 343 (510)
..-+..|.|.+|.|||.+.+ ..|+..+||||+||++.||++|.|-
T Consensus 156 ----------------------------------d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL 201 (396)
T KOG0593|consen 156 ----------------------------------DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPL 201 (396)
T ss_pred ----------------------------------chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcC
Confidence 00124689999999999997 7899999999999999999999999
Q ss_pred CCCCChhhhHHHHhhccc-----------------cccCCC----------CCCCCHHHHHHHHHhhc-CccccCCCCCh
Q 010463 344 FCSDDPRITCRKIVNWKT-----------------CLKFPE----------EPKISDEARDLICHLLC-DVETRLGTRGV 395 (510)
Q Consensus 344 F~~~~~~~~~~~I~~~~~-----------------~~~~p~----------~~~~s~~~~dlI~~lL~-dp~~R~~~~~~ 395 (510)
|.|.+..++...|...-+ -+.+|. .+.+|..+.||+++||. ||.+|+ +.
T Consensus 202 ~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~---sc 278 (396)
T KOG0593|consen 202 WPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRL---SC 278 (396)
T ss_pred CCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccc---cH
Confidence 999988777766653100 112232 15789999999999998 999999 67
Q ss_pred HHhhcCCCcCC
Q 010463 396 EELKEHPWFRG 406 (510)
Q Consensus 396 ~eil~HpfF~~ 406 (510)
+|++.||||.+
T Consensus 279 ~qll~H~yFd~ 289 (396)
T KOG0593|consen 279 EQLLHHPYFDG 289 (396)
T ss_pred HHHhcChHHHH
Confidence 99999999954
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-52 Score=419.64 Aligned_cols=261 Identities=31% Similarity=0.486 Sum_probs=228.7
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC--ce
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS--DF 180 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~ 180 (510)
...+.|+.+..||+|+||.||+|++..||+.||+|++..... +........+|+.||++++||||++|.+...+. ..
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 345789999999999999999999999999999999987643 455667788999999999999999999988766 68
Q ss_pred EEEEEeccCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 181 LYLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~~-~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
+|||+|||+. ||..++...+ .|++.+++.|+.|++.||+|||++||+|||||.+|||||.+|.+||+|||||+.+...
T Consensus 193 iYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999999987 9999997754 6999999999999999999999999999999999999999999999999999976543
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml 338 (510)
.. ...++.|-|.+|.|||.+++ ..|+.++|+||+||||.||+
T Consensus 272 ~~-------------------------------------~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~ 314 (560)
T KOG0600|consen 272 GS-------------------------------------APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELF 314 (560)
T ss_pred CC-------------------------------------cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHH
Confidence 11 11235789999999999997 57999999999999999999
Q ss_pred hCCCCCCCCChhhhHHHHhh---------ccccccCCC-----------------CCCCCHHHHHHHHHhhc-CccccCC
Q 010463 339 IGYPPFCSDDPRITCRKIVN---------WKTCLKFPE-----------------EPKISDEARDLICHLLC-DVETRLG 391 (510)
Q Consensus 339 ~G~~PF~~~~~~~~~~~I~~---------~~~~~~~p~-----------------~~~~s~~~~dlI~~lL~-dp~~R~~ 391 (510)
.|+|.|.|.+..++..+|.+ |. ...+|. ...++..+.+|+..||+ ||.+|.
T Consensus 315 ~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~- 392 (560)
T KOG0600|consen 315 LGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRG- 392 (560)
T ss_pred cCCCCcCCccHHHHHHHHHHHhCCCChhccc-cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccc-
Confidence 99999999999999999875 33 223331 13678999999999999 999999
Q ss_pred CCChHHhhcCCCcCC
Q 010463 392 TRGVEELKEHPWFRG 406 (510)
Q Consensus 392 ~~~~~eil~HpfF~~ 406 (510)
+|.++|.|+||..
T Consensus 393 --tA~~aL~seyF~t 405 (560)
T KOG0600|consen 393 --TASSALQSEYFTT 405 (560)
T ss_pred --cHHHHhcCccccc
Confidence 7899999999943
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-53 Score=413.41 Aligned_cols=255 Identities=31% Similarity=0.607 Sum_probs=236.4
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
..|++.+.||+|.||+|-+|.....|+.||||.|+|+.+....++-++++|++||+.++||||+.+|.+|.+.+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 46999999999999999999999999999999999999988889999999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
||..||+|++++...+.++|.+++.++.||+.|++|||+.+++|||||.+|||||.++++||+||||+..+.+.
T Consensus 133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~------ 206 (668)
T KOG0611|consen 133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK------ 206 (668)
T ss_pred EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc------
Confidence 99999999999999999999999999999999999999999999999999999999999999999999876543
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCC-CccccccchhhHHHHHhhCCCCC
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEMLIGYPPF 344 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiwSlGvilyEml~G~~PF 344 (510)
.+..++||+|-|.+||++.+.+| +..+|.|||||+||-|+.|..||
T Consensus 207 ---------------------------------kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPF 253 (668)
T KOG0611|consen 207 ---------------------------------KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPF 253 (668)
T ss_pred ---------------------------------cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhccccc
Confidence 12346899999999999999999 89999999999999999999999
Q ss_pred CCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCch
Q 010463 345 CSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWD 410 (510)
Q Consensus 345 ~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~ 410 (510)
.|.+...+.++|.++. ..-| .-+.++.-||+.||. +|++|. ++++|-.|-|. +|.
T Consensus 254 DG~Dhk~lvrQIs~Ga--YrEP---~~PSdA~gLIRwmLmVNP~RRA---TieDiAsHWWv---Nwg 309 (668)
T KOG0611|consen 254 DGRDHKRLVRQISRGA--YREP---ETPSDASGLIRWMLMVNPERRA---TIEDIASHWWV---NWG 309 (668)
T ss_pred CCchHHHHHHHhhccc--ccCC---CCCchHHHHHHHHHhcCcccch---hHHHHhhhhee---ecc
Confidence 9999999999998743 3333 456789999999998 999998 79999999885 564
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-52 Score=425.18 Aligned_cols=255 Identities=31% Similarity=0.538 Sum_probs=225.9
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
..|.....||+|+.|.||.|+...+++.||||+|...... ..+-+.+|+.+|+..+|+|||+++.+|.-.+.+|+||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~---~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP---KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC---chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 4688889999999999999999999999999999876433 3456899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
|||+||+|.+.+.. ..++|.+++.++.+++.||+|||..||||||||.+|||++.+|.+||+|||+|..+.....
T Consensus 350 Eym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~---- 424 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS---- 424 (550)
T ss_pred eecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC----
Confidence 99999998888755 4599999999999999999999999999999999999999999999999999998765311
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCC
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~ 345 (510)
.-.+.||||+|||||++....|+.++||||||+++.||+-|+|||.
T Consensus 425 ----------------------------------KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYl 470 (550)
T KOG0578|consen 425 ----------------------------------KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYL 470 (550)
T ss_pred ----------------------------------ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCcc
Confidence 1126799999999999999999999999999999999999999999
Q ss_pred CCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 346 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 346 ~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
.+++-.....|... +.+.+.....+|++++||+.+||+ |+++|+ ++.|+|+||||+-
T Consensus 471 nE~PlrAlyLIa~n-g~P~lk~~~klS~~~kdFL~~cL~~dv~~Ra---sA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 471 NENPLRALYLIATN-GTPKLKNPEKLSPELKDFLDRCLVVDVEQRA---SAKELLEHPFLKM 528 (550)
T ss_pred CCChHHHHHHHhhc-CCCCcCCccccCHHHHHHHHHHhhcchhcCC---CHHHHhcChhhhh
Confidence 88887776666542 334444445999999999999999 999999 7899999999953
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-51 Score=405.26 Aligned_cols=266 Identities=35% Similarity=0.657 Sum_probs=226.5
Q ss_pred eecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEeccCCCCH
Q 010463 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDI 193 (510)
Q Consensus 114 IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy~~gG~L 193 (510)
||+|+||+||+|.++.+|+.||+|++.+.........+.+..|+.+|+.++||||++++++|.+...+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999999877655555567788999999999999999999999999999999999999999
Q ss_pred HHHHHh----ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhh
Q 010463 194 MTLLMR----EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDED 269 (510)
Q Consensus 194 ~~~L~~----~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~ 269 (510)
..++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++..+.....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-------- 152 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-------- 152 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--------
Confidence 888743 35699999999999999999999999999999999999999999999999999976543210
Q ss_pred hhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCCCCh
Q 010463 270 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDP 349 (510)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~~~~ 349 (510)
......||+.|+|||++.+..++.++|+|||||++|||++|+.||...+.
T Consensus 153 ------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~ 202 (280)
T cd05608 153 ------------------------------KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 202 (280)
T ss_pred ------------------------------cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCc
Confidence 01135799999999999999999999999999999999999999986543
Q ss_pred hhh----HHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CChHHhhcCCCcCCCCchhhhc--ccCCCc
Q 010463 350 RIT----CRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLYE--MEAAYK 420 (510)
Q Consensus 350 ~~~----~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~--~~~~eil~HpfF~~i~~~~l~~--~~~p~~ 420 (510)
... ...+.. ....+| ..+|+++.+|+.+||. ||++|++. .+++++++||||++++|..+.. ..+||.
T Consensus 203 ~~~~~~~~~~~~~--~~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~ 278 (280)
T cd05608 203 KVENKELKQRILN--DSVTYP--DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPPFV 278 (280)
T ss_pred chhHHHHHHhhcc--cCCCCc--ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHHhhccCCCCCC
Confidence 322 222322 223333 4689999999999998 99999975 3689999999999999998864 566776
Q ss_pred c
Q 010463 421 P 421 (510)
Q Consensus 421 p 421 (510)
|
T Consensus 279 ~ 279 (280)
T cd05608 279 P 279 (280)
T ss_pred C
Confidence 6
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-50 Score=404.24 Aligned_cols=275 Identities=35% Similarity=0.672 Sum_probs=234.8
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEe
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 186 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmE 186 (510)
.|++.+.||+|+||+||++.+..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+++.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48899999999999999999999999999999987655444444567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 187 YLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 187 y~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
|++||+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.+++++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--- 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--- 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc---
Confidence 99999999888653 4699999999999999999999999999999999999999999999999999876532200
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCC
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 344 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF 344 (510)
..+.+||+.|+|||++.+..++.++|+||+||++|||++|..||
T Consensus 158 ------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf 201 (285)
T cd05605 158 ------------------------------------IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201 (285)
T ss_pred ------------------------------------cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCC
Confidence 11357999999999999999999999999999999999999999
Q ss_pred CCCChhhhHHHHhhcc--ccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC--ChHHhhcCCCcCCCCchhhhc--ccC
Q 010463 345 CSDDPRITCRKIVNWK--TCLKFPEEPKISDEARDLICHLLC-DVETRLGTR--GVEELKEHPWFRGIQWDKLYE--MEA 417 (510)
Q Consensus 345 ~~~~~~~~~~~I~~~~--~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~--~~~eil~HpfF~~i~~~~l~~--~~~ 417 (510)
.+.+.......+.... ....+| ..+++.+.+||.+||. ||.+|++.. +++++++||||...+|..+.. ..|
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 279 (285)
T cd05605 202 RQRKEKVKREEVERRVKEDQEEYS--EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEP 279 (285)
T ss_pred CCCchhhHHHHHHHHhhhcccccC--cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhhCCCCC
Confidence 8876544433332211 122233 3689999999999998 999999875 799999999999999999974 668
Q ss_pred CCccc
Q 010463 418 AYKPT 422 (510)
Q Consensus 418 p~~p~ 422 (510)
||.|.
T Consensus 280 ~~~~~ 284 (285)
T cd05605 280 PFCPD 284 (285)
T ss_pred CCCCC
Confidence 88884
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-51 Score=406.51 Aligned_cols=260 Identities=35% Similarity=0.559 Sum_probs=220.4
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc--eEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD--FLY 182 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~--~~~ 182 (510)
..++...+.||+|+||.||++..+.+|..+|||.+.... ....+.+.+|+.+|..++|||||+.++...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc---chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 456888999999999999999999999999999987652 222677899999999999999999999755444 699
Q ss_pred EEEeccCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecC-CCceeecccCCcccCcccc
Q 010463 183 LIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK-NGHLKLSDFGLCKPLEDKY 260 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~~-~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~-~g~vkL~DFGla~~~~~~~ 260 (510)
+.|||++||+|.+++.+.+ .++|..++.|..||+.||.|||++|||||||||+||||+. +|.+||+|||+++......
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999999877 7999999999999999999999999999999999999999 7999999999998765310
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCC-CCccccccchhhHHHHHhh
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG-YGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~-y~~~~DiwSlGvilyEml~ 339 (510)
.. .....+..|||.|||||++..+. .+.++|||||||++.||+|
T Consensus 173 ~~-----------------------------------~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~T 217 (313)
T KOG0198|consen 173 TK-----------------------------------SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLT 217 (313)
T ss_pred cc-----------------------------------ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccC
Confidence 00 00123578999999999999632 2459999999999999999
Q ss_pred CCCCCCC-CChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 340 GYPPFCS-DDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 340 G~~PF~~-~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
|.+||.. ........+|......+.+|. .+|++++|||.+|+. ||++|| +|+++|.|||....
T Consensus 218 g~~PW~~~~~~~~~~~~ig~~~~~P~ip~--~ls~~a~~Fl~~C~~~~p~~Rp---ta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 218 GKPPWSEFFEEAEALLLIGREDSLPEIPD--SLSDEAKDFLRKCFKRDPEKRP---TAEELLEHPFLKQN 282 (313)
T ss_pred CCCcchhhcchHHHHHHHhccCCCCCCCc--ccCHHHHHHHHHHhhcCcccCc---CHHHHhhChhhhcc
Confidence 9999987 455555556655444456664 799999999999998 999999 79999999998763
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-50 Score=399.69 Aligned_cols=285 Identities=46% Similarity=0.883 Sum_probs=256.5
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++|++++.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+|+.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998877666667788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
||++||+|.+++.+...+++..+..++.||+.||.|||+.||+||||+|+|||++.+|.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~------ 154 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR------ 154 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC------
Confidence 99999999999998889999999999999999999999999999999999999999999999999998865432
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCC
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~ 345 (510)
....+|++.|+|||.+.+..++.++|+|||||++|+|++|.+||.
T Consensus 155 -----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 199 (290)
T cd05580 155 -----------------------------------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFF 199 (290)
T ss_pred -----------------------------------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 113579999999999998889999999999999999999999999
Q ss_pred CCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC--ChHHhhcCCCcCCCCchhhhc--ccCCCc
Q 010463 346 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR--GVEELKEHPWFRGIQWDKLYE--MEAAYK 420 (510)
Q Consensus 346 ~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~--~~~eil~HpfF~~i~~~~l~~--~~~p~~ 420 (510)
+.+......++... ...+|. .++..++++|.+||. ||.+|++.. +++|+++||||+.++|..+.. +.+|+.
T Consensus 200 ~~~~~~~~~~~~~~--~~~~~~--~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 275 (290)
T cd05580 200 DDNPIQIYEKILEG--KVRFPS--FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAPFI 275 (290)
T ss_pred CCCHHHHHHHHhcC--CccCCc--cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHHHhhccCCCCcc
Confidence 88877777777753 344553 679999999999998 999999753 799999999999999999984 678999
Q ss_pred cccCCCccCCCCCCC
Q 010463 421 PTVNGELDTQNFEKF 435 (510)
Q Consensus 421 p~~~~~~d~~~f~~~ 435 (510)
|....+.|.+.|+.+
T Consensus 276 ~~~~~~~~~~~~~~~ 290 (290)
T cd05580 276 PKVKGPGDTSNFDDY 290 (290)
T ss_pred CCCCCccccccccCC
Confidence 999888888888753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-50 Score=388.90 Aligned_cols=262 Identities=31% Similarity=0.479 Sum_probs=224.3
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEee--cCceE
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ--DSDFL 181 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~--~~~~~ 181 (510)
.+++|+.+..|++|+||.||+|+++.|+++||+|.++-.. .+..---...+|+.+|.+++|||||.+..+.. +-+.+
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 4678999999999999999999999999999999987543 12222234678999999999999999988765 34579
Q ss_pred EEEEeccCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccc
Q 010463 182 YLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 260 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~-~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~ 260 (510)
|||||||+. ||.++|..-+ +|+..+++.++.|++.||+|||.+.|+||||||+|+|++..|.+||+|||||+.+....
T Consensus 153 y~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred eeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 999999977 9999998765 89999999999999999999999999999999999999999999999999999876542
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHhh
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml~ 339 (510)
.. .+..|-|.+|.|||.+.+ ..|+.++|+||+|||+.|||+
T Consensus 232 k~--------------------------------------~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~ 273 (419)
T KOG0663|consen 232 KP--------------------------------------YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLT 273 (419)
T ss_pred cc--------------------------------------CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHh
Confidence 11 235789999999999997 569999999999999999999
Q ss_pred CCCCCCCCChhhhHHHHhh---------ccccc--------cCCCC-----------CCCCHHHHHHHHHhhc-CccccC
Q 010463 340 GYPPFCSDDPRITCRKIVN---------WKTCL--------KFPEE-----------PKISDEARDLICHLLC-DVETRL 390 (510)
Q Consensus 340 G~~PF~~~~~~~~~~~I~~---------~~~~~--------~~p~~-----------~~~s~~~~dlI~~lL~-dp~~R~ 390 (510)
+.|-|.|.+...+..+|.. |++.- .++.. ..+|+...||+..||+ ||.+|+
T Consensus 274 ~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~ 353 (419)
T KOG0663|consen 274 QKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRI 353 (419)
T ss_pred cCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccc
Confidence 9999999999999999875 22211 12211 1267999999999999 999999
Q ss_pred CCCChHHhhcCCCcCCCC
Q 010463 391 GTRGVEELKEHPWFRGIQ 408 (510)
Q Consensus 391 ~~~~~~eil~HpfF~~i~ 408 (510)
+|+|.|+|+||.+..
T Consensus 354 ---tA~~~L~h~~F~e~P 368 (419)
T KOG0663|consen 354 ---TAEDGLKHEYFRETP 368 (419)
T ss_pred ---cHHHhhcccccccCC
Confidence 789999999998754
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-51 Score=410.71 Aligned_cols=257 Identities=31% Similarity=0.524 Sum_probs=222.1
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEeEEeecCc-eEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSD-FLY 182 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~-~~~ 182 (510)
.++|.+++.||.|+||.||+|+.+.+|+.||||.|++.-. .-++.- -.+|+..|++++ |||||+|.+++.+.+ .+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~-s~ee~~-nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY-SWEECM-NLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc-cHHHHH-HHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 4679999999999999999999999999999999976532 333333 356888899998 999999999999988 999
Q ss_pred EEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 183 LIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
+|||||.. +|+.++..+ +.|+|..++.|+.||+.||+|+|.+|+.||||||||||+.....|||+|||||+.+.....
T Consensus 87 fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP 165 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP 165 (538)
T ss_pred eeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCC
Confidence 99999966 899998754 6799999999999999999999999999999999999999999999999999998754311
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC-CCCccccccchhhHHHHHhhC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEMLIG 340 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiwSlGvilyEml~G 340 (510)
-+..|.|.+|.|||++++. -|+.++|+||+|||++|+.+-
T Consensus 166 ---------------------------------------YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sL 206 (538)
T KOG0661|consen 166 ---------------------------------------YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSL 206 (538)
T ss_pred ---------------------------------------cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHh
Confidence 1247899999999999864 579999999999999999999
Q ss_pred CCCCCCCChhhhHHHHhhc---------c--------ccccCCCC---------CCCCHHHHHHHHHhhc-CccccCCCC
Q 010463 341 YPPFCSDDPRITCRKIVNW---------K--------TCLKFPEE---------PKISDEARDLICHLLC-DVETRLGTR 393 (510)
Q Consensus 341 ~~PF~~~~~~~~~~~I~~~---------~--------~~~~~p~~---------~~~s~~~~dlI~~lL~-dp~~R~~~~ 393 (510)
+|-|.|.+..++..+|..- . -.+.+|.- +..|.++.+||.+||. ||.+||
T Consensus 207 rPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRp--- 283 (538)
T KOG0661|consen 207 RPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRP--- 283 (538)
T ss_pred cccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCc---
Confidence 9999999998888888631 1 12333321 4689999999999999 999999
Q ss_pred ChHHhhcCCCcCC
Q 010463 394 GVEELKEHPWFRG 406 (510)
Q Consensus 394 ~~~eil~HpfF~~ 406 (510)
+|.|+++||||+.
T Consensus 284 TA~~al~~pffq~ 296 (538)
T KOG0661|consen 284 TASQALQHPFFQV 296 (538)
T ss_pred cHHHHhcCccccc
Confidence 7899999999985
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-49 Score=395.37 Aligned_cols=274 Identities=37% Similarity=0.710 Sum_probs=231.3
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEe
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 186 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmE 186 (510)
.|++.+.||+|+||.||+|.++.+++.||+|.+.+...........+..|+.+++.++|++|+++++.+.+.+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 47889999999999999999999999999999987655444445667889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 187 YLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 187 y~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
|++||+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--- 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--- 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc---
Confidence 99999999988653 3589999999999999999999999999999999999999999999999999875432210
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCC
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 344 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF 344 (510)
..+.+||+.|+|||++.+..++.++|+|||||++|||++|.+||
T Consensus 158 ------------------------------------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf 201 (285)
T cd05630 158 ------------------------------------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 201 (285)
T ss_pred ------------------------------------ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCC
Confidence 11357999999999999999999999999999999999999999
Q ss_pred CCCChhh---hHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC--ChHHhhcCCCcCCCCchhhhc--cc
Q 010463 345 CSDDPRI---TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR--GVEELKEHPWFRGIQWDKLYE--ME 416 (510)
Q Consensus 345 ~~~~~~~---~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~--~~~eil~HpfF~~i~~~~l~~--~~ 416 (510)
.+..... ....+... ....++ ..+++++++||.+||+ ||++|++.. +++|+++||||+.++|+.+.. ..
T Consensus 202 ~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~~~~~~ 278 (285)
T cd05630 202 QQRKKKIKREEVERLVKE-VQEEYS--EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLE 278 (285)
T ss_pred CCCCccchHHHHHhhhhh-hhhhcC--ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHHhcCCCC
Confidence 8754322 22222211 111223 3689999999999999 999999642 489999999999999998875 67
Q ss_pred CCCccc
Q 010463 417 AAYKPT 422 (510)
Q Consensus 417 ~p~~p~ 422 (510)
|||+|.
T Consensus 279 ~~~~~~ 284 (285)
T cd05630 279 PPFKPD 284 (285)
T ss_pred CCCCCC
Confidence 888885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-50 Score=376.91 Aligned_cols=259 Identities=31% Similarity=0.539 Sum_probs=224.1
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
+.|..++.||+|.||.||+|++..||+.||||+++.... +.+--....+|+..|+.++||||+.|.++|.+.+++.||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~-kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNA-KDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccc-ccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 468888999999999999999999999999999987643 2233345788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 186 EYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
|||+. ||...++.. ..++..+++.|+.+++.||+|||++.|+||||||.|+||+++|.+||+|||+|+.+......
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~-- 157 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI-- 157 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc--
Confidence 99976 999998765 56999999999999999999999999999999999999999999999999999987653111
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHhhCCCC
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYPP 343 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml~G~~P 343 (510)
....|-|.+|.|||.+.+ ..|+..+|+||.|||+.||+-|.|-
T Consensus 158 ------------------------------------~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~ 201 (318)
T KOG0659|consen 158 ------------------------------------QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPF 201 (318)
T ss_pred ------------------------------------cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCC
Confidence 112388999999999987 6799999999999999999999999
Q ss_pred CCCCChhhhHHHHhh---------ccccccCCC---------------CCCCCHHHHHHHHHhhc-CccccCCCCChHHh
Q 010463 344 FCSDDPRITCRKIVN---------WKTCLKFPE---------------EPKISDEARDLICHLLC-DVETRLGTRGVEEL 398 (510)
Q Consensus 344 F~~~~~~~~~~~I~~---------~~~~~~~p~---------------~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~ei 398 (510)
|.|++..++...|.. |+.--.+|+ -+..|+++.||+.+|+. ||.+|+ ++.|+
T Consensus 202 fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Ri---ta~qa 278 (318)
T KOG0659|consen 202 FPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRI---TASQA 278 (318)
T ss_pred CCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcc---cHHHH
Confidence 999999888888874 322222221 13568899999999999 999999 78999
Q ss_pred hcCCCcCCC
Q 010463 399 KEHPWFRGI 407 (510)
Q Consensus 399 l~HpfF~~i 407 (510)
++||||+..
T Consensus 279 L~~~yf~~~ 287 (318)
T KOG0659|consen 279 LKHPYFKSL 287 (318)
T ss_pred hcchhhhcC
Confidence 999999863
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-49 Score=393.43 Aligned_cols=266 Identities=32% Similarity=0.596 Sum_probs=223.2
Q ss_pred eecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEeccCCCCH
Q 010463 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDI 193 (510)
Q Consensus 114 IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy~~gG~L 193 (510)
||+|+||.||+|+.+.+|+.||+|++.+...........+..|+++|..++||||++++++|.+...+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999876554444445567799999999999999999999999999999999999999
Q ss_pred HHHHHhcc--CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhhhh
Q 010463 194 MTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDII 271 (510)
Q Consensus 194 ~~~L~~~~--~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~ 271 (510)
.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---------- 150 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---------- 150 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce----------
Confidence 98886543 588999999999999999999999999999999999999999999999999876543210
Q ss_pred cccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCCCChh-
Q 010463 272 NQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPR- 350 (510)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~~~~~- 350 (510)
.....||+.|+|||++.+..++.++|+|||||++|||++|.+||.+....
T Consensus 151 -----------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~ 201 (277)
T cd05607 151 -----------------------------ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV 201 (277)
T ss_pred -----------------------------eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh
Confidence 11246999999999999989999999999999999999999999765432
Q ss_pred ---hhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC-ChHHhhcCCCcCCCCchhhhc--ccCCCcc
Q 010463 351 ---ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR-GVEELKEHPWFRGIQWDKLYE--MEAAYKP 421 (510)
Q Consensus 351 ---~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~-~~~eil~HpfF~~i~~~~l~~--~~~p~~p 421 (510)
.....+.. ....++. ..+++++++||++||. ||++|+++. ..++++.||||++++|..+.. ..|||+|
T Consensus 202 ~~~~~~~~~~~--~~~~~~~-~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~ 276 (277)
T cd05607 202 AKEELKRRTLE--DEVKFEH-QNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEAGLIPPPFVP 276 (277)
T ss_pred hHHHHHHHhhc--ccccccc-ccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHHHhcCcCCCCCCC
Confidence 22233332 1222222 3689999999999998 999999652 247899999999999999984 5678776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-50 Score=406.86 Aligned_cols=258 Identities=34% Similarity=0.569 Sum_probs=234.6
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
.-|++.+.||+|-|++|.+|++.-||+.||||++.|..+ ......|+..|+..|+.++|||||+||.+..+...+|||+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKl-D~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEeccccc-chhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 458888999999999999999999999999999999865 3445678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeec-CCCceeecccCCcccCccccccc
Q 010463 186 EYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD-KNGHLKLSDFGLCKPLEDKYSSI 263 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld-~~g~vkL~DFGla~~~~~~~~~~ 263 (510)
|+=.||||+++|++. ..++|+.++.|++||+.|+.|+|++.+|||||||+|+.+- .-|-|||+|||++..+..+.
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~--- 173 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK--- 173 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc---
Confidence 999999999999886 5699999999999999999999999999999999998764 77999999999998776541
Q ss_pred cchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCC-ccccccchhhHHHHHhhCCC
Q 010463 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYG-MECDWWSLGAIMYEMLIGYP 342 (510)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~-~~~DiwSlGvilyEml~G~~ 342 (510)
...+.||+..|-|||++.+..|+ +++||||||||||.|++|++
T Consensus 174 ------------------------------------kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~ 217 (864)
T KOG4717|consen 174 ------------------------------------KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQP 217 (864)
T ss_pred ------------------------------------hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCC
Confidence 13468999999999999999995 78999999999999999999
Q ss_pred CCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCch
Q 010463 343 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWD 410 (510)
Q Consensus 343 PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~ 410 (510)
||...+..+++.+|+..+ +..|. .+|.+|+|||.+||. ||.+|. ++++|..|+|++++|-.
T Consensus 218 PFqeANDSETLTmImDCK--YtvPs--hvS~eCrdLI~sMLvRdPkkRA---slEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 218 PFQEANDSETLTMIMDCK--YTVPS--HVSKECRDLIQSMLVRDPKKRA---SLEEIVSTSWLQAGDRG 279 (864)
T ss_pred ccccccchhhhhhhhccc--ccCch--hhhHHHHHHHHHHHhcCchhhc---cHHHHhccccccCCCCC
Confidence 999999999999999844 55564 899999999999998 999999 79999999999998743
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-49 Score=393.99 Aligned_cols=269 Identities=29% Similarity=0.476 Sum_probs=230.3
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCce
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 180 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 180 (510)
..+..++|++..+||.|..++||+|+...++++||||++.-... ...++.+++|+..|+.++||||++++.+|..+..
T Consensus 21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc--~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~ 98 (516)
T KOG0582|consen 21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKC--NNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSE 98 (516)
T ss_pred CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhh--hhhHHHHHHHHHHhhhcCCCCcceEEEEEEecce
Confidence 45677899999999999999999999999999999999987654 3448889999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 181 LYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
+|+||.||.+|++.+++... ..++|..++.++.+++.||.|||.+|.||||||+.|||||++|.|||+|||.+-.+..
T Consensus 99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 99999999999999999774 5699999999999999999999999999999999999999999999999999876544
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc--CCCCccccccchhhHHHH
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK--KGYGMECDWWSLGAIMYE 336 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiwSlGvilyE 336 (510)
... |.+-.. .+++|||.|||||++.. .+|+.++||||||++..|
T Consensus 179 ~G~---------------------------------R~~~rf-~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~E 224 (516)
T KOG0582|consen 179 SGD---------------------------------RQVTRF-NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACE 224 (516)
T ss_pred cCc---------------------------------eeeEee-ccccCcccccChHHhhhcccCccchhhhhhhhHHHHH
Confidence 211 111111 46899999999999764 689999999999999999
Q ss_pred HhhCCCCCCCCChhhhHHHHhhcccc------ccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCC
Q 010463 337 MLIGYPPFCSDDPRITCRKIVNWKTC------LKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 408 (510)
Q Consensus 337 ml~G~~PF~~~~~~~~~~~I~~~~~~------~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~ 408 (510)
|.+|..||..-.+......-++...+ +........+...+.+|..||. ||.+|| +++++++|+||+...
T Consensus 225 LA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRp---tAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 225 LAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRP---TASKLLKHAFFKKAK 300 (516)
T ss_pred HhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCC---CHHHHhccHHHhhcc
Confidence 99999999887776665544443221 1112234677889999999998 999999 789999999999754
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-48 Score=391.68 Aligned_cols=303 Identities=41% Similarity=0.738 Sum_probs=254.3
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++|++++.||+|+||.||++.++.+++.||+|.+.+...........+.+|++++..++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999998765544556678889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
||++||+|.+++...+.+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+++...........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999998743211110000
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCC
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~ 345 (510)
... .. . ...........|++.|+|||.+.+..++.++|+|||||++|||++|..||.
T Consensus 161 ~~~-------~~---------~-------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~ 217 (305)
T cd05609 161 EGH-------IE---------K-------DTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 217 (305)
T ss_pred ccc-------cc---------c-------chhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 000 00 0 000000113468999999999999999999999999999999999999999
Q ss_pred CCChhhhHHHHhhccccccCCCC-CCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchhhhcccCCCcccc
Q 010463 346 SDDPRITCRKIVNWKTCLKFPEE-PKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTV 423 (510)
Q Consensus 346 ~~~~~~~~~~I~~~~~~~~~p~~-~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l~~~~~p~~p~~ 423 (510)
+.+..+....+.... ...|.. ..++.++.++|.+||. +|++||+..++.++++||||.+.+|..+.....+++|.+
T Consensus 218 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~ 295 (305)
T cd05609 218 GDTPEELFGQVISDD--IEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLRQKAEFIPQL 295 (305)
T ss_pred CCCHHHHHHHHHhcc--cCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHHHhhcCCCCCCCC
Confidence 888877777766532 223322 2689999999999998 999999887899999999999999999988888999999
Q ss_pred CCCccCCCCC
Q 010463 424 NGELDTQNFE 433 (510)
Q Consensus 424 ~~~~d~~~f~ 433 (510)
....|+++||
T Consensus 296 ~~~~~~~~~~ 305 (305)
T cd05609 296 ESEDDTSYFD 305 (305)
T ss_pred CCccccccCC
Confidence 8888888764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=390.30 Aligned_cols=258 Identities=34% Similarity=0.486 Sum_probs=216.6
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++|++++.||+|+||.||+|+++.+++.||+|++..... .....+.+.+|+.++..++||||++++++|.+++.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 479999999999999999999999999999999976532 2334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
||++++.+..+......+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+|..+......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--- 156 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA--- 156 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc---
Confidence 99999877666555567999999999999999999999999999999999999999999999999999875432100
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCC
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~ 345 (510)
.....+||+.|+|||++.+..++.++|+|||||++|||++|++||.
T Consensus 157 ----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~ 202 (287)
T cd07848 157 ----------------------------------NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFP 202 (287)
T ss_pred ----------------------------------cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCC
Confidence 0113579999999999999999999999999999999999999998
Q ss_pred CCChhhhHHHHhhccc-----------------cccCCC-----------CCCCCHHHHHHHHHhhc-CccccCCCCChH
Q 010463 346 SDDPRITCRKIVNWKT-----------------CLKFPE-----------EPKISDEARDLICHLLC-DVETRLGTRGVE 396 (510)
Q Consensus 346 ~~~~~~~~~~I~~~~~-----------------~~~~p~-----------~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~ 396 (510)
+.+.......+..... ...+|. ...+|+++.|||++||. ||++|+ +++
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~---s~~ 279 (287)
T cd07848 203 GESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRY---LTE 279 (287)
T ss_pred CCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCC---CHH
Confidence 8765554433332110 011111 02378899999999999 999999 789
Q ss_pred HhhcCCCc
Q 010463 397 ELKEHPWF 404 (510)
Q Consensus 397 eil~HpfF 404 (510)
++++||||
T Consensus 280 ~~l~hp~f 287 (287)
T cd07848 280 QCLNHPAF 287 (287)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-49 Score=392.07 Aligned_cols=257 Identities=28% Similarity=0.492 Sum_probs=215.9
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEE
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l 183 (510)
..++|++++.||.|+||.||+|+++.++..||+|+++.... ......+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL 80 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 35789999999999999999999999999999999975431 2234567789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccc
Q 010463 184 IMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 262 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 262 (510)
||||++| +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++.......
T Consensus 81 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~- 158 (288)
T cd07871 81 VFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK- 158 (288)
T ss_pred EEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence 9999975 899988764 4579999999999999999999999999999999999999999999999999975432100
Q ss_pred ccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHhhCC
Q 010463 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml~G~ 341 (510)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 159 -------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~ 201 (288)
T cd07871 159 -------------------------------------TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201 (288)
T ss_pred -------------------------------------cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCC
Confidence 0113578999999999876 56899999999999999999999
Q ss_pred CCCCCCChhhhHHHHhhccc-----------------cccCCC---------CCCCCHHHHHHHHHhhc-CccccCCCCC
Q 010463 342 PPFCSDDPRITCRKIVNWKT-----------------CLKFPE---------EPKISDEARDLICHLLC-DVETRLGTRG 394 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~-----------------~~~~p~---------~~~~s~~~~dlI~~lL~-dp~~R~~~~~ 394 (510)
+||.+.+..+....+..... ...+|. .+.++++++|||++||+ ||.+|+ +
T Consensus 202 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~---t 278 (288)
T cd07871 202 PMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRI---S 278 (288)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCC---C
Confidence 99998887766655542110 001111 13578999999999999 999999 7
Q ss_pred hHHhhcCCCc
Q 010463 395 VEELKEHPWF 404 (510)
Q Consensus 395 ~~eil~HpfF 404 (510)
++|+++||||
T Consensus 279 ~~~~l~hp~f 288 (288)
T cd07871 279 AEAALRHSYF 288 (288)
T ss_pred HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=392.97 Aligned_cols=261 Identities=27% Similarity=0.422 Sum_probs=212.4
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
.++|++++.||+|+||+||+|+++.+|+.||||++..... ......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 4789999999999999999999999999999999975432 22234577899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccc
Q 010463 185 MEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 263 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 263 (510)
|||++ |+|.+++... +.+++..++.++.||+.||+|||+.||+||||||+|||++.+|.+||+|||+++.......
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 158 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH-- 158 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc--
Confidence 99996 5788877654 5689999999999999999999999999999999999999999999999999875432100
Q ss_pred cchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHhhCCC
Q 010463 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYP 342 (510)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml~G~~ 342 (510)
...+.+||+.|+|||++.+ ..++.++|||||||++|||++|.+
T Consensus 159 ------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 202 (303)
T cd07869 159 ------------------------------------TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVA 202 (303)
T ss_pred ------------------------------------cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 0123579999999999875 458999999999999999999999
Q ss_pred CCCCCCh-hhhHHHHhhc---------ccccc------------CCC-------CCCCCHHHHHHHHHhhc-CccccCCC
Q 010463 343 PFCSDDP-RITCRKIVNW---------KTCLK------------FPE-------EPKISDEARDLICHLLC-DVETRLGT 392 (510)
Q Consensus 343 PF~~~~~-~~~~~~I~~~---------~~~~~------------~p~-------~~~~s~~~~dlI~~lL~-dp~~R~~~ 392 (510)
||.+... ......+... ..... .|. ....+++++|||++||+ ||.+|+
T Consensus 203 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~-- 280 (303)
T cd07869 203 AFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRL-- 280 (303)
T ss_pred CCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhcc--
Confidence 9987543 2222222210 00000 000 01346789999999998 999999
Q ss_pred CChHHhhcCCCcCCCCc
Q 010463 393 RGVEELKEHPWFRGIQW 409 (510)
Q Consensus 393 ~~~~eil~HpfF~~i~~ 409 (510)
+++|+++||||+++++
T Consensus 281 -s~~~~l~h~~f~~~~~ 296 (303)
T cd07869 281 -SAQAALSHEYFSDLPP 296 (303)
T ss_pred -CHHHHhcCcccccCCh
Confidence 7899999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-49 Score=386.43 Aligned_cols=261 Identities=30% Similarity=0.480 Sum_probs=222.0
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec-----Cce
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD-----SDF 180 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-----~~~ 180 (510)
..|..++.||+|+||.|+.+.++.||+.||||++... +...-..++..+|+.+|+.++|+||+.+++.+.. -+.
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 4566689999999999999999999999999998642 3345567889999999999999999999999876 346
Q ss_pred EEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccc
Q 010463 181 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 260 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~ 260 (510)
+|+|+|+| +.||...|..+..++++++++++.||+.||.|+|+.||+||||||.|+|++.+..+||+|||||+.....
T Consensus 101 vYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~- 178 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF- 178 (359)
T ss_pred eEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc-
Confidence 99999999 6699999988888999999999999999999999999999999999999999999999999999977542
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHhh
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml~ 339 (510)
.. ....+..|-|.+|.|||++.. ..|+.++||||+|||+.|||+
T Consensus 179 ~~-----------------------------------~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~ 223 (359)
T KOG0660|consen 179 FE-----------------------------------DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLT 223 (359)
T ss_pred Cc-----------------------------------ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHc
Confidence 00 011234789999999999874 789999999999999999999
Q ss_pred CCCCCCCCChhhhHHHHhhccc---------------------cccCCC------CCCCCHHHHHHHHHhhc-CccccCC
Q 010463 340 GYPPFCSDDPRITCRKIVNWKT---------------------CLKFPE------EPKISDEARDLICHLLC-DVETRLG 391 (510)
Q Consensus 340 G~~PF~~~~~~~~~~~I~~~~~---------------------~~~~p~------~~~~s~~~~dlI~~lL~-dp~~R~~ 391 (510)
|++-|.|.+.-.+...|+..-+ ....|. .+++++.|.||+.+||. ||.+|+
T Consensus 224 gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRi- 302 (359)
T KOG0660|consen 224 GKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRI- 302 (359)
T ss_pred CCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccC-
Confidence 9999999987666666653111 111111 25889999999999999 999999
Q ss_pred CCChHHhhcCCCcCCC
Q 010463 392 TRGVEELKEHPWFRGI 407 (510)
Q Consensus 392 ~~~~~eil~HpfF~~i 407 (510)
+++|+|+||||...
T Consensus 303 --ta~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 303 --TAEEALAHPYLAPY 316 (359)
T ss_pred --CHHHHhcChhhhhh
Confidence 79999999999864
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-48 Score=385.84 Aligned_cols=277 Identities=34% Similarity=0.639 Sum_probs=233.3
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEe
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 186 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmE 186 (510)
.|+..+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+|..++|++|++++++|.+++.+|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 37888999999999999999999999999999987655444445667889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 187 YLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 187 y~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
|++||+|..++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~---- 156 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---- 156 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC----
Confidence 99999999888653 369999999999999999999999999999999999999999999999999987543210
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCC
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 344 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF 344 (510)
......||+.|+|||++.+..++.++|+|||||++|||++|.+||
T Consensus 157 -----------------------------------~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~ 201 (285)
T cd05632 157 -----------------------------------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201 (285)
T ss_pred -----------------------------------cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCC
Confidence 011357999999999999999999999999999999999999999
Q ss_pred CCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC--ChHHhhcCCCcCCCCchhhhc--ccCCC
Q 010463 345 CSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR--GVEELKEHPWFRGIQWDKLYE--MEAAY 419 (510)
Q Consensus 345 ~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~--~~~eil~HpfF~~i~~~~l~~--~~~p~ 419 (510)
.+.........+..............+++++.+||.+||. ||++|++.. .+.+++.||||+.++|+.+.. ..|||
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 281 (285)
T cd05632 202 RGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPF 281 (285)
T ss_pred CCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHHhcCcCCCCC
Confidence 8876554443333211111111124689999999999998 999999642 388999999999999998763 67888
Q ss_pred ccc
Q 010463 420 KPT 422 (510)
Q Consensus 420 ~p~ 422 (510)
+|.
T Consensus 282 ~~~ 284 (285)
T cd05632 282 VPD 284 (285)
T ss_pred CCC
Confidence 875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=377.61 Aligned_cols=253 Identities=34% Similarity=0.550 Sum_probs=219.6
Q ss_pred CCCceee-eeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHH-HhcCCCCeeeEeEEee----cC
Q 010463 105 IDDFEQL-TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLL-AEVDSRCIVQLFYSFQ----DS 178 (510)
Q Consensus 105 ~~~f~~~-~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL-~~l~hp~Iv~l~~~~~----~~ 178 (510)
++||.+- ++||-|-.|+|..|.++.||+.+|+|++..+ ...++|+++- ....|||||.++++|. ..
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 4677765 5899999999999999999999999998643 2367788875 4457999999998775 45
Q ss_pred ceEEEEEeccCCCCHHHHHHhccC--CCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecC---CCceeecccCCc
Q 010463 179 DFLYLIMEYLPGGDIMTLLMREDI--LSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK---NGHLKLSDFGLC 253 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~~~--l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~---~g~vkL~DFGla 253 (510)
.++.+|||.|.||+|++.+..++. |+|.++..++.||..|+.|||+++|.||||||||+|... +..+||+|||+|
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence 689999999999999999988765 999999999999999999999999999999999999974 457999999999
Q ss_pred ccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhH
Q 010463 254 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 333 (510)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvi 333 (510)
+.-.... ...+.|-||.|.|||++..+.|+..||+||+|||
T Consensus 212 K~t~~~~---------------------------------------~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVi 252 (400)
T KOG0604|consen 212 KETQEPG---------------------------------------DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVI 252 (400)
T ss_pred cccCCCc---------------------------------------cccCCcccccccCHHHhCchhcCCCCCccchhHH
Confidence 9654321 1236799999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCC----hhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 334 MYEMLIGYPPFCSDD----PRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 334 lyEml~G~~PF~~~~----~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
+|-||+|+|||++.. +..+..+|..+...+.-|+|..+|.+++|+|+.||. +|++|+ +++++++|||..+-
T Consensus 253 mYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRl---TI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 253 MYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERL---TIEEVMDHPWINQY 328 (400)
T ss_pred HHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhhe---eHHHhhcCchhccc
Confidence 999999999998764 345678888876666666788999999999999998 999999 79999999999763
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=387.28 Aligned_cols=309 Identities=39% Similarity=0.695 Sum_probs=247.8
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++|++++.||+|+||.||+|....+++.||+|.+.+...........+..|+.+|..++||||+++++.+.+....|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999998776554456778999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccc
Q 010463 186 EYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 263 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 263 (510)
||+.||+|.+++.+. ..+++..++.++.|++.||.|||+.|++||||||+||+++.+|.++|+|||++..........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999998764 579999999999999999999999999999999999999999999999999998654321110
Q ss_pred cchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCC
Q 010463 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 343 (510)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~P 343 (510)
............. ..+ ................+||..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 161 ~~~~~~~~~~~~~-------~~~--~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~p 231 (316)
T cd05574 161 SKALRKGSRRSSV-------NSI--PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231 (316)
T ss_pred ccccccccccccc-------ccc--chhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCC
Confidence 0000000000000 000 0000000001112346899999999999999999999999999999999999999
Q ss_pred CCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC-CChHHhhcCCCcCCCCchhhhcccCCCcc
Q 010463 344 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT-RGVEELKEHPWFRGIQWDKLYEMEAAYKP 421 (510)
Q Consensus 344 F~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~-~~~~eil~HpfF~~i~~~~l~~~~~p~~p 421 (510)
|.+.+....+.++.. ....+|....+++.++++|.+||+ ||++|++. .++++++.||||++++|..+....||-.|
T Consensus 232 f~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~ 309 (316)
T cd05574 232 FKGSNRDETFSNILK--KEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTPPIIP 309 (316)
T ss_pred CCCCchHHHHHHHhc--CCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhcccCCCCCCC
Confidence 998888888877775 334455544589999999999998 99999952 33899999999999999999887777777
Q ss_pred ccCC
Q 010463 422 TVNG 425 (510)
Q Consensus 422 ~~~~ 425 (510)
.+..
T Consensus 310 ~~~~ 313 (316)
T cd05574 310 RPDD 313 (316)
T ss_pred Cccc
Confidence 6543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=389.27 Aligned_cols=260 Identities=27% Similarity=0.423 Sum_probs=221.0
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEE
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~ 182 (510)
+..++|++++.||+|+||.||+|+++.+|..||+|++.... .......+.+|+.+|..++||||+++++++.+++.+|
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 45689999999999999999999999999999999987542 2334567899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhC-CeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 183 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH-NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~-giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
+||||++||+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.+|++||+|||++..+....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 158 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (331)
T ss_pred EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence 9999999999999998888899999999999999999999986 69999999999999999999999999987653220
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~ 341 (510)
....+||+.|+|||++.+..++.++|+|||||++|||++|+
T Consensus 159 ---------------------------------------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~ 199 (331)
T cd06649 159 ---------------------------------------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199 (331)
T ss_pred ---------------------------------------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCC
Confidence 12357999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhHHHH----------------------------------------------hhccccccCCCCCCCCHHH
Q 010463 342 PPFCSDDPRITCRKI----------------------------------------------VNWKTCLKFPEEPKISDEA 375 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I----------------------------------------------~~~~~~~~~p~~~~~s~~~ 375 (510)
.||...+..+....+ .+. .....+ ...+++++
T Consensus 200 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~l 277 (331)
T cd06649 200 YPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNE-PPPKLP-NGVFTPDF 277 (331)
T ss_pred CCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhC-CCcCCC-CccccHHH
Confidence 999766544332111 000 001111 12478999
Q ss_pred HHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCc
Q 010463 376 RDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQW 409 (510)
Q Consensus 376 ~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~ 409 (510)
++||.+||. ||++|| ++++|++||||+....
T Consensus 278 ~~li~~~L~~~P~~Rp---t~~ell~h~~~~~~~~ 309 (331)
T cd06649 278 QEFVNKCLIKNPAERA---DLKMLMNHTFIKRSEV 309 (331)
T ss_pred HHHHHHHccCCcccCC---CHHHHhcChHHhhccc
Confidence 999999999 999999 7899999999986543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=390.90 Aligned_cols=263 Identities=27% Similarity=0.407 Sum_probs=213.6
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC-----ceE
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS-----DFL 181 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----~~~ 181 (510)
.|++.+.||+|+||.||+|+++.+|+.||||++.... ........+.+|+.+|+.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 4899999999999999999999999999999987532 2233445688999999999999999999987543 358
Q ss_pred EEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 182 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
|+|||||. ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++.......
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 99999995 69999998888899999999999999999999999999999999999999999999999999986432110
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc--CCCCccccccchhhHHHHHhh
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK--KGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiwSlGvilyEml~ 339 (510)
.. ......+||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 159 ~~-----------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~t 203 (338)
T cd07859 159 TA-----------------------------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 203 (338)
T ss_pred cc-----------------------------------ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHc
Confidence 00 00123579999999999976 678999999999999999999
Q ss_pred CCCCCCCCChhhhHHHHhhc--------------------------cccccCC-CCCCCCHHHHHHHHHhhc-CccccCC
Q 010463 340 GYPPFCSDDPRITCRKIVNW--------------------------KTCLKFP-EEPKISDEARDLICHLLC-DVETRLG 391 (510)
Q Consensus 340 G~~PF~~~~~~~~~~~I~~~--------------------------~~~~~~p-~~~~~s~~~~dlI~~lL~-dp~~R~~ 391 (510)
|++||.+.+.......+... .....+. ..+.+++++.+||.+||+ ||++||
T Consensus 204 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp- 282 (338)
T cd07859 204 GKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRP- 282 (338)
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCC-
Confidence 99999876644332222110 0000000 113578899999999998 999999
Q ss_pred CCChHHhhcCCCcCCCCc
Q 010463 392 TRGVEELKEHPWFRGIQW 409 (510)
Q Consensus 392 ~~~~~eil~HpfF~~i~~ 409 (510)
+++|+++||||+++..
T Consensus 283 --t~~e~l~hp~f~~~~~ 298 (338)
T cd07859 283 --TAEEALADPYFKGLAK 298 (338)
T ss_pred --CHHHHhcCchhhhcCc
Confidence 7899999999987653
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-48 Score=377.73 Aligned_cols=261 Identities=31% Similarity=0.508 Sum_probs=221.6
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCC-eeeEeEEeecCc----
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC-IVQLFYSFQDSD---- 179 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~-Iv~l~~~~~~~~---- 179 (510)
...|+.++.||+|+||+||+|+.+.+|+.||+|++.-.... ..--....+|+.+|+.++|+| ||.|++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 45688888999999999999999999999999999765321 223455789999999999999 999999999887
Q ss_pred --eEEEEEeccCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCc
Q 010463 180 --FLYLIMEYLPGGDIMTLLMRED----ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLC 253 (510)
Q Consensus 180 --~~~lVmEy~~gG~L~~~L~~~~----~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla 253 (510)
.+|+|+||+.- ||..++.... .++...++.++.||+.||+|||++||+||||||.||||+++|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 89999999965 9999997755 5788899999999999999999999999999999999999999999999999
Q ss_pred ccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC-CCCccccccchhh
Q 010463 254 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGA 332 (510)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiwSlGv 332 (510)
+...-+. ....+-++|.+|.|||++.+. .|+..+|+||+||
T Consensus 168 ra~~ip~--------------------------------------~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~Gc 209 (323)
T KOG0594|consen 168 RAFSIPM--------------------------------------RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGC 209 (323)
T ss_pred HHhcCCc--------------------------------------ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHH
Confidence 8543210 001246899999999999986 7999999999999
Q ss_pred HHHHHhhCCCCCCCCChhhhHHHHhh---------ccccccCC-------CC----------CCCCHHHHHHHHHhhc-C
Q 010463 333 IMYEMLIGYPPFCSDDPRITCRKIVN---------WKTCLKFP-------EE----------PKISDEARDLICHLLC-D 385 (510)
Q Consensus 333 ilyEml~G~~PF~~~~~~~~~~~I~~---------~~~~~~~p-------~~----------~~~s~~~~dlI~~lL~-d 385 (510)
|++||+++++-|.+.+..++...|.. |+....+| .+ +..++++.||+.+||+ +
T Consensus 210 IfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~ 289 (323)
T KOG0594|consen 210 IFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYD 289 (323)
T ss_pred HHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccC
Confidence 99999999999999998888888763 33322222 11 3445699999999999 9
Q ss_pred ccccCCCCChHHhhcCCCcCCCC
Q 010463 386 VETRLGTRGVEELKEHPWFRGIQ 408 (510)
Q Consensus 386 p~~R~~~~~~~eil~HpfF~~i~ 408 (510)
|.+|. ++..++.||||..+.
T Consensus 290 p~~R~---Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 290 PAKRI---SAKGALTHPYFSELP 309 (323)
T ss_pred cccCc---CHHHHhcChhhcccc
Confidence 99999 789999999999874
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=395.99 Aligned_cols=257 Identities=30% Similarity=0.474 Sum_probs=228.5
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
...|..+..||+|+||.||+|.+..|++.||+|++.... ...+++.+..|+.+|.+++++||.+.|++|.....++++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 346888899999999999999999999999999998664 456788899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 185 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
||||.||++.++|...+.+.|..+..++.+++.||.|||..+.+|||||+.|||+..+|.+||+|||.+-.+.....
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~--- 166 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK--- 166 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhh---
Confidence 99999999999999888889999999999999999999999999999999999999999999999999987654310
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCC
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 344 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF 344 (510)
...+++|||.||||||+.+.+|+.++||||||++.+||++|.||+
T Consensus 167 -----------------------------------rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~ 211 (467)
T KOG0201|consen 167 -----------------------------------RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPH 211 (467)
T ss_pred -----------------------------------ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCC
Confidence 114689999999999999999999999999999999999999999
Q ss_pred CCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 345 CSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 345 ~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
....+......|-+. .++.+. ...|+.+++||..||. ||+.|| +|.++++|+|++..
T Consensus 212 s~~hPmrvlflIpk~-~PP~L~--~~~S~~~kEFV~~CL~k~P~~Rp---sA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 212 SKLHPMRVLFLIPKS-APPRLD--GDFSPPFKEFVEACLDKNPEFRP---SAKELLKHKFIKRA 269 (467)
T ss_pred cccCcceEEEeccCC-CCCccc--cccCHHHHHHHHHHhhcCcccCc---CHHHHhhhHHHHhc
Confidence 988885555444432 222222 3789999999999998 999999 78999999999874
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=389.12 Aligned_cols=248 Identities=27% Similarity=0.420 Sum_probs=214.9
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcCCCCE-EEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc-
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEI-FAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD- 179 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~-vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~- 179 (510)
.+..+++.+.+.||+|+||+||.+.++ |.. ||+|++......... .+.+.+|+.+|..++|||||+++|++.++.
T Consensus 37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~ 113 (362)
T KOG0192|consen 37 EIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPG 113 (362)
T ss_pred ecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 345566777778999999999999886 555 999999876543333 778999999999999999999999999888
Q ss_pred eEEEEEeccCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHhhhhCC-eEEeecCCCCeeecCCC-ceeecccCCccc
Q 010463 180 FLYLIMEYLPGGDIMTLLMR--EDILSEDVARFYIAESVLAIHSIHQHN-YVHRDIKPDNLILDKNG-HLKLSDFGLCKP 255 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~--~~~l~e~~~~~~~~qi~~aL~~lH~~g-iiHRDLKP~NILld~~g-~vkL~DFGla~~ 255 (510)
.+++|||||++|+|..+|.+ ...++...+..++.+|+.|++|||+++ ||||||||+||||+.++ ++||+|||+++.
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 79999999999999999988 688999999999999999999999999 99999999999999998 999999999986
Q ss_pred CccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc--cCCCCccccccchhhH
Q 010463 256 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL--KKGYGMECDWWSLGAI 333 (510)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~--~~~y~~~~DiwSlGvi 333 (510)
...... ...+..||+.|||||++. ...|+.++|||||||+
T Consensus 194 ~~~~~~--------------------------------------~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIv 235 (362)
T KOG0192|consen 194 KVISKT--------------------------------------SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIV 235 (362)
T ss_pred eccccc--------------------------------------cccCCCCCccccChhhhcCCCCcCCccchhhhHHHH
Confidence 543210 011357999999999999 5699999999999999
Q ss_pred HHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC
Q 010463 334 MYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT 392 (510)
Q Consensus 334 lyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~ 392 (510)
||||+||..||.+..+......++.....+.+|. ..++.+..||..|+. ||..||+.
T Consensus 236 lWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~--~~~~~l~~l~~~CW~~dp~~RP~f 293 (362)
T KOG0192|consen 236 LWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPK--ECPPHLSSLMERCWLVDPSRRPSF 293 (362)
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCc--cCCHHHHHHHHHhCCCCCCcCCCH
Confidence 9999999999999888776777765555555664 489999999999998 99999953
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-48 Score=394.10 Aligned_cols=257 Identities=32% Similarity=0.502 Sum_probs=234.1
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCce-EEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF-LYL 183 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~-~~l 183 (510)
.++|+.++.||+|+||.+++++++..++.|++|.+.-.....+ +......|..+++++.|||||..+++|..++. ++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~-~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP-ERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch-hhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 4789999999999999999999999999999999987765444 34478899999999999999999999998887 999
Q ss_pred EEeccCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 184 IMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
||+||+||+|...|.+.+ .|+|+.+..|+.||+.||.|||+++|+|||||+.||+++.++.|||+|||+|+.+....
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~- 160 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED- 160 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch-
Confidence 999999999999997654 69999999999999999999999999999999999999999999999999999886542
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~ 341 (510)
..+.+.+|||.||.||++.+.+|+.++|+|||||++|||++=+
T Consensus 161 -------------------------------------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk 203 (426)
T KOG0589|consen 161 -------------------------------------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLK 203 (426)
T ss_pred -------------------------------------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcc
Confidence 2355789999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
++|.+.+......+|.... ..|.....|.+++.||+.||. +|+.|| ++.+++.+|....
T Consensus 204 ~aF~a~~m~~Li~ki~~~~---~~Plp~~ys~el~~lv~~~l~~~P~~RP---sa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 204 PAFKASNMSELILKINRGL---YSPLPSMYSSELRSLVKSMLRKNPEHRP---SALELLRRPHLLR 263 (426)
T ss_pred cccCccchHHHHHHHhhcc---CCCCCccccHHHHHHHHHHhhcCCccCC---CHHHHhhChhhhh
Confidence 9999999999999999753 345556899999999999998 999999 7899999998763
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-48 Score=378.68 Aligned_cols=252 Identities=31% Similarity=0.523 Sum_probs=213.7
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC-----ceE
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS-----DFL 181 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----~~~ 181 (510)
.|...++||.|+||.||.|....+++.||||+.-...- --.+|..||..++|||||+|.++|... -++
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 57888999999999999999999999999998754321 134699999999999999999988732 267
Q ss_pred EEEEeccCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCC-CceeecccCCcccC
Q 010463 182 YLIMEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN-GHLKLSDFGLCKPL 256 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~-g~vkL~DFGla~~~ 256 (510)
.+||||||. +|...++. +..++.-.++.|+.||+.||.|||+.||+||||||.|||+|.+ |.+||||||.|+.+
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 899999987 89888874 4678999999999999999999999999999999999999965 99999999999988
Q ss_pred ccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHH
Q 010463 257 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMY 335 (510)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvily 335 (510)
..+... .|..-|..|.|||.+.+ ..|+.+.||||.||++.
T Consensus 177 ~~~epn---------------------------------------iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~a 217 (364)
T KOG0658|consen 177 VKGEPN---------------------------------------ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMA 217 (364)
T ss_pred ccCCCc---------------------------------------eeEEEeccccCHHHHcCccccCceeEEhhhhHHHH
Confidence 654221 25678999999999987 67999999999999999
Q ss_pred HHhhCCCCCCCCChhhhHHHHhhccc---------------cccCCC----------CCCCCHHHHHHHHHhhc-Ccccc
Q 010463 336 EMLIGYPPFCSDDPRITCRKIVNWKT---------------CLKFPE----------EPKISDEARDLICHLLC-DVETR 389 (510)
Q Consensus 336 Eml~G~~PF~~~~~~~~~~~I~~~~~---------------~~~~p~----------~~~~s~~~~dlI~~lL~-dp~~R 389 (510)
||+-|+|-|.|++...+...|++--+ ...+|. ...+++++.||+.++|. +|.+|
T Consensus 218 ELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R 297 (364)
T KOG0658|consen 218 ELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKR 297 (364)
T ss_pred HHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhc
Confidence 99999999999998888877764100 112221 13678999999999999 99999
Q ss_pred CCCCChHHhhcCCCcCCCC
Q 010463 390 LGTRGVEELKEHPWFRGIQ 408 (510)
Q Consensus 390 ~~~~~~~eil~HpfF~~i~ 408 (510)
. ++.|++.||||....
T Consensus 298 ~---~~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 298 L---SALEALAHPFFDELR 313 (364)
T ss_pred C---CHHHHhcchhhHHhh
Confidence 9 689999999998653
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-47 Score=401.24 Aligned_cols=257 Identities=28% Similarity=0.437 Sum_probs=210.6
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC----
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS---- 178 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~---- 178 (510)
....+|++++.||+|+||.||+|.+..+++.||||++.+.. ....+|+.+|+.++|||||+++++|...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~ 135 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKK 135 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence 34568999999999999999999999999999999886432 2245699999999999999998877432
Q ss_pred ----ceEEEEEeccCCCCHHHHHH----hccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCC-ceeecc
Q 010463 179 ----DFLYLIMEYLPGGDIMTLLM----REDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG-HLKLSD 249 (510)
Q Consensus 179 ----~~~~lVmEy~~gG~L~~~L~----~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g-~vkL~D 249 (510)
..+++||||+++ +|..++. ....+++..++.|+.||+.||.|||+.|||||||||+||||+.++ .+||+|
T Consensus 136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeec
Confidence 358899999986 6666654 346799999999999999999999999999999999999999665 699999
Q ss_pred cCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCcccccc
Q 010463 250 FGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWW 328 (510)
Q Consensus 250 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~Diw 328 (510)
||+|+.+.... ...+.+||+.|+|||++.+ ..|+.++|||
T Consensus 215 FGla~~~~~~~---------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 255 (440)
T PTZ00036 215 FGSAKNLLAGQ---------------------------------------RSVSYICSRFYRAPELMLGATNYTTHIDLW 255 (440)
T ss_pred cccchhccCCC---------------------------------------CcccCCCCcCccCHHHhcCCCCCCcHHHHH
Confidence 99998654321 0124579999999999876 4699999999
Q ss_pred chhhHHHHHhhCCCCCCCCChhhhHHHHhhccc---------------cccCCC----------CCCCCHHHHHHHHHhh
Q 010463 329 SLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKT---------------CLKFPE----------EPKISDEARDLICHLL 383 (510)
Q Consensus 329 SlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~---------------~~~~p~----------~~~~s~~~~dlI~~lL 383 (510)
||||+||||++|.+||.+.+..+...+++.... .+.+|. ....|+++.+||++||
T Consensus 256 SlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L 335 (440)
T PTZ00036 256 SLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFL 335 (440)
T ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHC
Confidence 999999999999999999887766666653211 111121 1247889999999999
Q ss_pred c-CccccCCCCChHHhhcCCCcCCCCc
Q 010463 384 C-DVETRLGTRGVEELKEHPWFRGIQW 409 (510)
Q Consensus 384 ~-dp~~R~~~~~~~eil~HpfF~~i~~ 409 (510)
+ ||.+|+ ++.|+++||||.++..
T Consensus 336 ~~dP~~R~---ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 336 KYEPLKRL---NPIEALADPFFDDLRD 359 (440)
T ss_pred CCChhHCc---CHHHHhCChhHHhhhc
Confidence 9 999999 7899999999987654
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-47 Score=374.66 Aligned_cols=269 Identities=36% Similarity=0.649 Sum_probs=225.8
Q ss_pred eecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEeccCCCCH
Q 010463 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDI 193 (510)
Q Consensus 114 IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy~~gG~L 193 (510)
||+|+||+||+|.++.+|+.||+|++.+...........+..|+.+|+.++||||++++++|.+.+..|+||||++||+|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999876554444556677899999999999999999999999999999999999999
Q ss_pred HHHHHhcc--CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhhhh
Q 010463 194 MTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDII 271 (510)
Q Consensus 194 ~~~L~~~~--~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~ 271 (510)
.+++.+.. .+++..+..++.|++.||.|||+.|++||||+|+|||++.++.++|+|||++........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---------- 150 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---------- 150 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc----------
Confidence 99997765 799999999999999999999999999999999999999999999999999875432100
Q ss_pred cccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCCCChhh
Q 010463 272 NQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI 351 (510)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~~~~~~ 351 (510)
.....|+..|+|||++.+..++.++|+|||||++|+|++|..||.+.....
T Consensus 151 -----------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 201 (277)
T cd05577 151 -----------------------------IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV 201 (277)
T ss_pred -----------------------------cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc
Confidence 113468899999999998889999999999999999999999998765432
Q ss_pred hHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC-C-ChHHhhcCCCcCCCCchhhhc--ccCCCcc
Q 010463 352 TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT-R-GVEELKEHPWFRGIQWDKLYE--MEAAYKP 421 (510)
Q Consensus 352 ~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~-~-~~~eil~HpfF~~i~~~~l~~--~~~p~~p 421 (510)
....+.........+....+++.+.++|.+||. +|.+|++. . ++.+++.||||..++|..+.. .+|||.|
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~ 276 (277)
T cd05577 202 EKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEPPFIP 276 (277)
T ss_pred cHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhhhhcCCCCCCCCC
Confidence 222232211111112223679999999999998 99999975 2 688999999999999998874 5677766
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=376.62 Aligned_cols=255 Identities=28% Similarity=0.445 Sum_probs=209.9
Q ss_pred CCceeeeeeecCCCeEEEEEEEcC-CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc---CCCCeeeEeEEee-----
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKT-TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV---DSRCIVQLFYSFQ----- 176 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~-tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~~~----- 176 (510)
++|++++.||+|+||+||+|++.. +|..||+|++..... .......+.+|..++..+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccC-CCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 369999999999999999999854 578899999875432 222334566787777665 6999999999885
Q ss_pred cCceEEEEEeccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcc
Q 010463 177 DSDFLYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCK 254 (510)
Q Consensus 177 ~~~~~~lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~ 254 (510)
....+++||||++ |+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3457999999996 5899998753 458999999999999999999999999999999999999999999999999997
Q ss_pred cCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHH
Q 010463 255 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIM 334 (510)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvil 334 (510)
...... .....+||+.|+|||++.+..++.++|+|||||++
T Consensus 159 ~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il 199 (290)
T cd07862 159 IYSFQM---------------------------------------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIF 199 (290)
T ss_pred eccCCc---------------------------------------ccccccccccccChHHHhCCCCCCccchHHHHHHH
Confidence 643210 11245799999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCChhhhHHHHhhcccc---------ccCCC--------------CCCCCHHHHHHHHHhhc-CccccC
Q 010463 335 YEMLIGYPPFCSDDPRITCRKIVNWKTC---------LKFPE--------------EPKISDEARDLICHLLC-DVETRL 390 (510)
Q Consensus 335 yEml~G~~PF~~~~~~~~~~~I~~~~~~---------~~~p~--------------~~~~s~~~~dlI~~lL~-dp~~R~ 390 (510)
|||++|.+||.+.+..+...+|+..... ..++. .+.+++.+++||.+||+ ||++||
T Consensus 200 ~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 279 (290)
T cd07862 200 AEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI 279 (290)
T ss_pred HHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcC
Confidence 9999999999998887777777642110 00100 13578899999999999 999999
Q ss_pred CCCChHHhhcCCCc
Q 010463 391 GTRGVEELKEHPWF 404 (510)
Q Consensus 391 ~~~~~~eil~HpfF 404 (510)
++.|+++||||
T Consensus 280 ---s~~~~l~hp~f 290 (290)
T cd07862 280 ---SAYSALSHPYF 290 (290)
T ss_pred ---CHHHHhcCCCC
Confidence 78999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=371.96 Aligned_cols=260 Identities=31% Similarity=0.548 Sum_probs=220.5
Q ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCceEEEEEeccCC
Q 010463 112 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLYLIMEYLPG 190 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~~lVmEy~~g 190 (510)
..||+|+||.|--|....||..||||++.|. ......++.+|++++..+ .|+||++|+.+|.|+...|||||-|.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 5799999999999999999999999999876 344567899999999888 699999999999999999999999999
Q ss_pred CCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCc---eeecccCCcccCccccccccchh
Q 010463 191 GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH---LKLSDFGLCKPLEDKYSSILLED 267 (510)
Q Consensus 191 G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~---vkL~DFGla~~~~~~~~~~~~~~ 267 (510)
|.|..+|.+...|+|.+|..++.+|+.||.+||.+||.||||||+|||-.+..+ ||||||.|...+......
T Consensus 161 GplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~----- 235 (463)
T KOG0607|consen 161 GPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC----- 235 (463)
T ss_pred chHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCC-----
Confidence 999999999999999999999999999999999999999999999999976655 799999998754322110
Q ss_pred hhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc-----cCCCCccccccchhhHHHHHhhCCC
Q 010463 268 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDWWSLGAIMYEMLIGYP 342 (510)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-----~~~y~~~~DiwSlGvilyEml~G~~ 342 (510)
+ +..+ .-..+.||+..|||||++. ..-|+..||.||||||||-||+|++
T Consensus 236 ---------s----past-------------P~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYp 289 (463)
T KOG0607|consen 236 ---------S----PAST-------------PELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYP 289 (463)
T ss_pred ---------C----CCCC-------------ccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCC
Confidence 0 0000 0123579999999999974 2458999999999999999999999
Q ss_pred CCCCCC---------------hhhhHHHHhhccccccCCC--CCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 343 PFCSDD---------------PRITCRKIVNWKTCLKFPE--EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 343 PF~~~~---------------~~~~~~~I~~~~~~~~~p~--~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
||.|.- ....+..|..+. +.||+ |..+|.+++|||+.||. |+.+|+ ++.++++|||+
T Consensus 290 PFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGk--YeFPdkdWahIS~eakdlisnLlvrda~~rl---sa~~vlnhPw~ 364 (463)
T KOG0607|consen 290 PFVGHCGADCGWDRGEVCRVCQNKLFESIQEGK--YEFPDKDWAHISSEAKDLISNLLVRDAKQRL---SAAQVLNHPWV 364 (463)
T ss_pred CccCccCCcCCccCCCccHHHHHHHHHHHhccC--CcCChhhhHHhhHHHHHHHHHHHhccHHhhh---hhhhccCCccc
Confidence 996531 345666777654 56664 67899999999999998 999999 68999999999
Q ss_pred CCCCch
Q 010463 405 RGIQWD 410 (510)
Q Consensus 405 ~~i~~~ 410 (510)
+.+.-+
T Consensus 365 ~~~~~e 370 (463)
T KOG0607|consen 365 QRCAPE 370 (463)
T ss_pred cccchh
Confidence 987644
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-47 Score=392.03 Aligned_cols=261 Identities=26% Similarity=0.390 Sum_probs=218.4
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc-----eE
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD-----FL 181 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-----~~ 181 (510)
+|++++.||+|+||.||+|.+..+|+.||||++.+.. ........+.+|+.+|..++||||+++++++.+.+ .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 5889999999999999999999999999999986532 12334567889999999999999999999999877 89
Q ss_pred EEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 182 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
|+||||+. ++|...+.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++.......
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 99999996 58999988888899999999999999999999999999999999999999999999999999986432210
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC-CCCccccccchhhHHHHHhhC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEMLIG 340 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiwSlGvilyEml~G 340 (510)
. .....+||+.|+|||++.+. .|+.++|||||||++|||++|
T Consensus 159 ~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g 201 (372)
T cd07853 159 K-------------------------------------HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGR 201 (372)
T ss_pred c-------------------------------------cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcC
Confidence 0 01134789999999999874 579999999999999999999
Q ss_pred CCCCCCCChhhhHHHHhhccc---------------------cccC-------CCCCCCCHHHHHHHHHhhc-CccccCC
Q 010463 341 YPPFCSDDPRITCRKIVNWKT---------------------CLKF-------PEEPKISDEARDLICHLLC-DVETRLG 391 (510)
Q Consensus 341 ~~PF~~~~~~~~~~~I~~~~~---------------------~~~~-------p~~~~~s~~~~dlI~~lL~-dp~~R~~ 391 (510)
++||.+.++......|..... .... ......++++.+||.+||+ ||.+||
T Consensus 202 ~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~- 280 (372)
T cd07853 202 RILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRI- 280 (372)
T ss_pred CCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCc-
Confidence 999998887666655543100 0001 1113568899999999999 999999
Q ss_pred CCChHHhhcCCCcCCCCc
Q 010463 392 TRGVEELKEHPWFRGIQW 409 (510)
Q Consensus 392 ~~~~~eil~HpfF~~i~~ 409 (510)
++.|+++||||.+..+
T Consensus 281 --t~~e~l~hp~~~~~~~ 296 (372)
T cd07853 281 --SAADALAHPYLDEGRL 296 (372)
T ss_pred --CHHHHhcCHhhCCCcc
Confidence 7899999999998654
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=369.33 Aligned_cols=257 Identities=46% Similarity=0.832 Sum_probs=222.2
Q ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHH-HhcCCCCeeeEeEEeecCceEEEEEeccCC
Q 010463 112 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLL-AEVDSRCIVQLFYSFQDSDFLYLIMEYLPG 190 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL-~~l~hp~Iv~l~~~~~~~~~~~lVmEy~~g 190 (510)
+.||.|+||.||+|.++.+|+.||+|++.+...........+..|..++ ...+||||+++++++.+.+.+|+||||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999999999999999999876554444445556666655 455899999999999999999999999999
Q ss_pred CCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhhh
Q 010463 191 GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 270 (510)
Q Consensus 191 G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 270 (510)
|+|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||+++.....
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----------- 150 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN----------- 150 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceecccc-----------
Confidence 999999988888999999999999999999999999999999999999999999999999998753221
Q ss_pred hcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCCCChh
Q 010463 271 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPR 350 (510)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~~~~~ 350 (510)
....|++.|+|||.+.+..++.++|||||||++|||++|.+||.+.+..
T Consensus 151 -------------------------------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 199 (260)
T cd05611 151 -------------------------------KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD 199 (260)
T ss_pred -------------------------------ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH
Confidence 1246899999999999888999999999999999999999999988887
Q ss_pred hhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCch
Q 010463 351 ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWD 410 (510)
Q Consensus 351 ~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~ 410 (510)
..+..+..............+++++.++|.+||. +|++|+++.+++|++.||||+.++||
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~~ 260 (260)
T cd05611 200 AVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINWD 260 (260)
T ss_pred HHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCCC
Confidence 7777765532222111223689999999999998 99999998889999999999999996
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=392.96 Aligned_cols=256 Identities=25% Similarity=0.350 Sum_probs=210.9
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceE
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 181 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~ 181 (510)
.+....|++++.||+|+||.||+|+++.+++.||+|+... ..+.+|+.+|+.++|||||+++++|......
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 158 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFT 158 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCee
Confidence 3556789999999999999999999999999999997532 3467899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 182 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
++|||++. ++|..++.....+++..++.++.||+.||.|||+.|||||||||+|||++.+|.+||+|||+|+.......
T Consensus 159 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 159 CLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 99999995 69999998888899999999999999999999999999999999999999999999999999975322100
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~ 341 (510)
......+||+.|+|||++.+..|+.++|||||||++|||++|.
T Consensus 238 -------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~ 280 (391)
T PHA03212 238 -------------------------------------NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280 (391)
T ss_pred -------------------------------------cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 0112468999999999999999999999999999999999999
Q ss_pred CCCCCCC-------hhhhHHHHhhccc------------------------ccc----CCCC---CCCCHHHHHHHHHhh
Q 010463 342 PPFCSDD-------PRITCRKIVNWKT------------------------CLK----FPEE---PKISDEARDLICHLL 383 (510)
Q Consensus 342 ~PF~~~~-------~~~~~~~I~~~~~------------------------~~~----~p~~---~~~s~~~~dlI~~lL 383 (510)
.||...+ .......++.... ... .|.+ ..++.++.+||.+||
T Consensus 281 ~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL 360 (391)
T PHA03212 281 DSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKML 360 (391)
T ss_pred CCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHh
Confidence 8876432 1111222211000 000 0100 135678999999999
Q ss_pred c-CccccCCCCChHHhhcCCCcCCC
Q 010463 384 C-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 384 ~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
+ ||.+|| +++|+++||||+.+
T Consensus 361 ~~dP~~Rp---ta~elL~hp~f~~~ 382 (391)
T PHA03212 361 AFDAHHRP---SAEALLDFAAFQDI 382 (391)
T ss_pred cCChhhCC---CHHHHhcChhhccC
Confidence 9 999999 78999999999874
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=373.22 Aligned_cols=254 Identities=28% Similarity=0.471 Sum_probs=209.1
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc---CCCCeeeEeEEeec-----C
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV---DSRCIVQLFYSFQD-----S 178 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~~~~-----~ 178 (510)
+|++++.||+|+||+||+|+++.+|+.||+|.+..... .......+.+|+.+++.+ +||||+++++++.+ .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTN-EDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcC-CCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 48899999999999999999999999999999875432 122223456677777655 79999999998865 3
Q ss_pred ceEEEEEeccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccC
Q 010463 179 DFLYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 256 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~ 256 (510)
..+++||||+++ +|.+++.+. ..+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+++..
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 468999999985 898888764 34899999999999999999999999999999999999999999999999999865
Q ss_pred ccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHH
Q 010463 257 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 336 (510)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyE 336 (510)
..... ....+||+.|+|||++.+..++.++|||||||++||
T Consensus 159 ~~~~~---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ 199 (288)
T cd07863 159 SCQMA---------------------------------------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAE 199 (288)
T ss_pred cCccc---------------------------------------CCCccccccccCchHhhCCCCCCcchhhhHHHHHHH
Confidence 32210 113578999999999999999999999999999999
Q ss_pred HhhCCCCCCCCChhhhHHHHhhcc---------ccccCCC--------------CCCCCHHHHHHHHHhhc-CccccCCC
Q 010463 337 MLIGYPPFCSDDPRITCRKIVNWK---------TCLKFPE--------------EPKISDEARDLICHLLC-DVETRLGT 392 (510)
Q Consensus 337 ml~G~~PF~~~~~~~~~~~I~~~~---------~~~~~p~--------------~~~~s~~~~dlI~~lL~-dp~~R~~~ 392 (510)
|++|.+||.+.+......++.... .....+. .+.++..+.|||.+||+ ||.+||
T Consensus 200 l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-- 277 (288)
T cd07863 200 MFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRI-- 277 (288)
T ss_pred HHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCC--
Confidence 999999999887776666665321 1111110 13578899999999999 999999
Q ss_pred CChHHhhcCCCc
Q 010463 393 RGVEELKEHPWF 404 (510)
Q Consensus 393 ~~~~eil~HpfF 404 (510)
++.|++.||||
T Consensus 278 -t~~~~l~hp~f 288 (288)
T cd07863 278 -SAFRALQHPFF 288 (288)
T ss_pred -CHHHHhcCCCC
Confidence 78999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=381.41 Aligned_cols=258 Identities=28% Similarity=0.432 Sum_probs=218.0
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEE
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~ 182 (510)
+..++|++++.||+|+||.||+|.++.+|..+|+|++.... .......+.+|+.+|+.++||||++++++|.+++.+|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 45689999999999999999999999999999999987542 2334567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhC-CeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 183 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH-NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~-giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
+||||++||+|.+++.+.+.+++..+..++.+++.||.|||+. +|+||||||+|||++.+|.+||+|||++..+....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~- 158 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence 9999999999999998888899999999999999999999975 79999999999999999999999999987543210
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~ 341 (510)
....+||+.|+|||++.+..++.++|+|||||++|||++|+
T Consensus 159 ---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~ 199 (333)
T cd06650 159 ---------------------------------------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199 (333)
T ss_pred ---------------------------------------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 11357999999999999989999999999999999999999
Q ss_pred CCCCCCChhhhHHH--------------------------------------------HhhccccccCCCCCCCCHHHHH
Q 010463 342 PPFCSDDPRITCRK--------------------------------------------IVNWKTCLKFPEEPKISDEARD 377 (510)
Q Consensus 342 ~PF~~~~~~~~~~~--------------------------------------------I~~~~~~~~~p~~~~~s~~~~d 377 (510)
.||...+....... +.+. ....++. ..++.++++
T Consensus 200 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~ 277 (333)
T cd06650 200 YPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNE-PPPKLPS-GVFGAEFQD 277 (333)
T ss_pred CCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcC-CCccCCC-CCcCHHHHH
Confidence 99976544322111 1110 0111111 246789999
Q ss_pred HHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 378 LICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 378 lI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
||.+||. ||++|| +++|++.||||+..
T Consensus 278 li~~~L~~~P~~Rp---t~~ell~h~~~~~~ 305 (333)
T cd06650 278 FVNKCLIKNPAERA---DLKQLMVHAFIKRS 305 (333)
T ss_pred HHHHhccCCcccCc---CHHHHhhCHHHhcC
Confidence 9999999 999999 78999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-46 Score=370.08 Aligned_cols=258 Identities=37% Similarity=0.692 Sum_probs=211.7
Q ss_pred eeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHH---hcCCCCeeeEeEEeecCceEEEEEeccC
Q 010463 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA---EVDSRCIVQLFYSFQDSDFLYLIMEYLP 189 (510)
Q Consensus 113 ~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~---~l~hp~Iv~l~~~~~~~~~~~lVmEy~~ 189 (510)
.||+|+||.||+|.+..+|+.||+|++.+.............+|..++. ..+||+|+.+++++.+.+..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999998765433333333445554443 3479999999999999999999999999
Q ss_pred CCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhh
Q 010463 190 GGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDED 269 (510)
Q Consensus 190 gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~ 269 (510)
||+|..++...+.+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--------- 151 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--------- 151 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---------
Confidence 99999999888889999999999999999999999999999999999999999999999999987543210
Q ss_pred hhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc-cCCCCccccccchhhHHHHHhhCCCCCCCCC
Q 010463 270 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEMLIGYPPFCSDD 348 (510)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-~~~y~~~~DiwSlGvilyEml~G~~PF~~~~ 348 (510)
.....||+.|+|||++. +..++.++|+|||||++|||++|..||....
T Consensus 152 -------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 200 (279)
T cd05633 152 -------------------------------PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (279)
T ss_pred -------------------------------ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCC
Confidence 01246999999999987 4668999999999999999999999997643
Q ss_pred hhh--hHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CChHHhhcCCCcCCCCchhhh
Q 010463 349 PRI--TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLY 413 (510)
Q Consensus 349 ~~~--~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~--~~~~eil~HpfF~~i~~~~l~ 413 (510)
... ....... .....+| ..++++++++|.+||. ||.+|++. .++.++++||||++++|....
T Consensus 201 ~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~~ 267 (279)
T cd05633 201 TKDKHEIDRMTL-TVNVELP--DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVY 267 (279)
T ss_pred CcCHHHHHHHhh-cCCcCCc--cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHHh
Confidence 321 1111111 1122333 3689999999999998 99999963 368999999999999998876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=387.02 Aligned_cols=255 Identities=26% Similarity=0.416 Sum_probs=209.2
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEE
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~ 182 (510)
...++|+.++.||+|+||.||+|+++.+|+.||||++.+.. .......+.+|+.+|+.++||||++++++|.+.+.+|
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 148 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ 148 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence 34578889999999999999999999999999999986542 2334567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccc
Q 010463 183 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 262 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 262 (510)
+||||++||+|... ...++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 149 lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 149 VLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred EEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence 99999999998653 3467888889999999999999999999999999999999999999999999986543210
Q ss_pred ccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-----CCCCccccccchhhHHHHH
Q 010463 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-----KGYGMECDWWSLGAIMYEM 337 (510)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-----~~y~~~~DiwSlGvilyEm 337 (510)
.....+||+.|+|||++.. ..++.++|||||||++|||
T Consensus 224 -------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el 266 (353)
T PLN00034 224 -------------------------------------PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEF 266 (353)
T ss_pred -------------------------------------cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHH
Confidence 0123579999999999853 2346789999999999999
Q ss_pred hhCCCCCCCCChhhh---HHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 338 LIGYPPFCSDDPRIT---CRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 338 l~G~~PF~~~~~~~~---~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
++|+.||........ ...+.. ......+ ..++.++++||.+||. ||++|+ ++.|+++||||.+-
T Consensus 267 ~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~l~~li~~~l~~~P~~Rp---t~~ell~hp~~~~~ 334 (353)
T PLN00034 267 YLGRFPFGVGRQGDWASLMCAICM-SQPPEAP--ATASREFRHFISCCLQREPAKRW---SAMQLLQHPFILRA 334 (353)
T ss_pred HhCCCCCCCCCCccHHHHHHHHhc-cCCCCCC--CccCHHHHHHHHHHccCChhhCc---CHHHHhcCcccccC
Confidence 999999974332221 112211 1112222 4789999999999998 999999 78999999999873
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=385.18 Aligned_cols=256 Identities=27% Similarity=0.463 Sum_probs=212.6
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC------
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS------ 178 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~------ 178 (510)
.++|.+++.||+|+||.||+|.++.+++.||||++.+.. ........+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 578999999999999999999999999999999997543 2334456688899999999999999999988654
Q ss_pred ceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 179 DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
..+|+||||+++ +|...+.. .+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+++....
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 358999999976 67777643 488999999999999999999999999999999999999999999999999986532
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHh
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml 338 (510)
.. .....+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 179 ~~---------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 219 (364)
T cd07875 179 SF---------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219 (364)
T ss_pred CC---------------------------------------cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHH
Confidence 21 012357999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhhHHHHhhcccc----------------------------------ccCCC----CCCCCHHHHHHHH
Q 010463 339 IGYPPFCSDDPRITCRKIVNWKTC----------------------------------LKFPE----EPKISDEARDLIC 380 (510)
Q Consensus 339 ~G~~PF~~~~~~~~~~~I~~~~~~----------------------------------~~~p~----~~~~s~~~~dlI~ 380 (510)
+|..||.+.+....+.+++..... ..+|. ....+..++|||.
T Consensus 220 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~ 299 (364)
T cd07875 220 KGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLS 299 (364)
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHH
Confidence 999999988877666665431100 00010 0123568999999
Q ss_pred Hhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 381 HLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 381 ~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
+||+ ||.+|| +++|+++||||..
T Consensus 300 ~mL~~dP~~R~---t~~e~L~hp~~~~ 323 (364)
T cd07875 300 KMLVIDASKRI---SVDEALQHPYINV 323 (364)
T ss_pred HhcCcCcccCC---CHHHHhcCccccc
Confidence 9999 999999 7899999999973
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-46 Score=411.81 Aligned_cols=152 Identities=43% Similarity=0.767 Sum_probs=143.5
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
+++|.+++.||+|+||.||+|.+..+++.||||++.+...........+..|+.++..++||||+++++++.+...+|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 57899999999999999999999999999999999887666666677899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccC
Q 010463 185 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 256 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~ 256 (510)
|||++||+|..++...+.+++..++.|+.||+.||.|||+.|||||||||+||||+.+|++||+|||+++..
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~ 154 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccc
Confidence 999999999999988888999999999999999999999999999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-46 Score=364.35 Aligned_cols=256 Identities=42% Similarity=0.825 Sum_probs=227.1
Q ss_pred eecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEeccCCCCH
Q 010463 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDI 193 (510)
Q Consensus 114 IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy~~gG~L 193 (510)
||.|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++.+.+++.+|+||||++||+|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 79999999999999999999999999877655555667899999999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhhhhcc
Q 010463 194 MTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 273 (510)
Q Consensus 194 ~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~ 273 (510)
.+++.+...+++..+..++.||+.||+|||+.|++|+||||+||+++.+|.++|+|||++.......
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~------------- 147 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ------------- 147 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-------------
Confidence 9999888889999999999999999999999999999999999999999999999999998664321
Q ss_pred cccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCCCC--hhh
Q 010463 274 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDD--PRI 351 (510)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~~~--~~~ 351 (510)
.....+|++.|+|||++.+..++.++|+|||||++|+|++|.+||...+ +..
T Consensus 148 --------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 201 (262)
T cd05572 148 --------------------------KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME 201 (262)
T ss_pred --------------------------ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHH
Confidence 0123579999999999998889999999999999999999999998776 666
Q ss_pred hHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CChHHhhcCCCcCCCCch
Q 010463 352 TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWD 410 (510)
Q Consensus 352 ~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~--~~~~eil~HpfF~~i~~~ 410 (510)
.+.++........+|. .++++++++|.+||+ +|.+|++. .+++|+++||||++.+|+
T Consensus 202 ~~~~~~~~~~~~~~~~--~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 261 (262)
T cd05572 202 IYNDILKGNGKLEFPN--YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE 261 (262)
T ss_pred HHHHHhccCCCCCCCc--ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence 6777765445556664 558999999999998 99999962 348999999999999996
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=398.45 Aligned_cols=255 Identities=24% Similarity=0.414 Sum_probs=206.2
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC------CCeeeEeEEee
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS------RCIVQLFYSFQ 176 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~h------p~Iv~l~~~~~ 176 (510)
+..++|++++.||+|+||+||+|.+..+++.||||++++.. ........|+.++..+.| ++|++++++|.
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34578999999999999999999999999999999996431 122345667777776644 56899999988
Q ss_pred cC-ceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhh-CCeEEeecCCCCeeecCCC-----------
Q 010463 177 DS-DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNG----------- 243 (510)
Q Consensus 177 ~~-~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~-~giiHRDLKP~NILld~~g----------- 243 (510)
.. .++|+|||++ |++|.+++.+.+.+++..++.++.||+.||+|||+ .|||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 65 5799999998 77999999888899999999999999999999997 6999999999999998776
Q ss_pred -----ceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc
Q 010463 244 -----HLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK 318 (510)
Q Consensus 244 -----~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~ 318 (510)
.+||+|||++...... ....+||+.|+|||++.+
T Consensus 281 ~~~~~~vkl~DfG~~~~~~~~-----------------------------------------~~~~~gt~~Y~APE~~~~ 319 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDERHS-----------------------------------------RTAIVSTRHYRSPEVVLG 319 (467)
T ss_pred CCCCceEEECCCCccccCccc-----------------------------------------cccccCCccccCcHHhhc
Confidence 4999999988643211 124689999999999999
Q ss_pred CCCCccccccchhhHHHHHhhCCCCCCCCChhhhHHHHhhccccc-----------------------c---CCC-----
Q 010463 319 KGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCL-----------------------K---FPE----- 367 (510)
Q Consensus 319 ~~y~~~~DiwSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~~-----------------------~---~p~----- 367 (510)
..|+.++|||||||++|||++|++||.+.+..+....+......+ . .|.
T Consensus 320 ~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (467)
T PTZ00284 320 LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARI 399 (467)
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhh
Confidence 999999999999999999999999998877655444433211000 0 000
Q ss_pred -------CCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 368 -------EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 368 -------~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
...-++.+.|||.+||+ ||.+|+ +++|+++||||..
T Consensus 400 ~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~---ta~e~L~Hp~~~~ 443 (467)
T PTZ00284 400 ARARPVREVIRDDLLCDLIYGLLHYDRQKRL---NARQMTTHPYVLK 443 (467)
T ss_pred hcccchhhhhchHHHHHHHHHhCCcChhhCC---CHHHHhcCccccc
Confidence 00124567899999999 999999 7899999999975
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=363.06 Aligned_cols=259 Identities=32% Similarity=0.522 Sum_probs=224.9
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhc--chhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML--KRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l 183 (510)
++|++.+.||+|+||.||+|.+..+++.||+|.+...... ...+...+.+|+.+++.++||||+++++++.+++.+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5799999999999999999999999999999998754321 22345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccc
Q 010463 184 IMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 263 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 263 (510)
||||++||+|.+++...+.+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++.........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999997653211000
Q ss_pred cchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCC
Q 010463 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 343 (510)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~P 343 (510)
.......|++.|+|||++.+..++.++|+|||||++|||++|++|
T Consensus 162 -----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 206 (263)
T cd06625 162 -----------------------------------TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206 (263)
T ss_pred -----------------------------------ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCC
Confidence 000135689999999999999999999999999999999999999
Q ss_pred CCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 344 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 344 F~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
|.+.+......++........+| ..++..+.+||++||. +|.+|| ++.++++||||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---t~~~ll~~~~~ 263 (263)
T cd06625 207 WAEFEAMAAIFKIATQPTNPQLP--SHVSPDARNFLRRTFVENAKKRP---SAEELLRHFFV 263 (263)
T ss_pred ccccchHHHHHHHhccCCCCCCC--ccCCHHHHHHHHHHhhcCcccCC---CHHHHhhCCCC
Confidence 98877766666666544444455 3789999999999998 999999 78999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-46 Score=397.52 Aligned_cols=257 Identities=30% Similarity=0.425 Sum_probs=222.0
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCC-CCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTT-GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~t-g~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
..|.+.+.||+|+||.||+|....+ +..||+|.+... .......+.+|+.+|+.++|||||+++++|.+.+.+|||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 3499999999999999999998877 788999977543 334456788899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccc
Q 010463 185 MEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 260 (510)
Q Consensus 185 mEy~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~ 260 (510)
|||++||+|.++|.. ...+++..+..++.||+.||+|||+.||+||||||+||||+.+|.+||+|||+|+.+....
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999999988753 3468999999999999999999999999999999999999999999999999998654321
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhC
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 340 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G 340 (510)
.. ....+.+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 224 ~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg 267 (478)
T PTZ00267 224 SL------------------------------------DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTL 267 (478)
T ss_pred cc------------------------------------ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhC
Confidence 00 012246899999999999999999999999999999999999
Q ss_pred CCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 341 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 341 ~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
..||.+.+..+...++..... ..+| ..+++++++||.+||. ||++|| ++++++.|||++.+
T Consensus 268 ~~Pf~~~~~~~~~~~~~~~~~-~~~~--~~~s~~~~~li~~~L~~dP~~Rp---s~~~~l~~~~~~~~ 329 (478)
T PTZ00267 268 HRPFKGPSQREIMQQVLYGKY-DPFP--CPVSSGMKALLDPLLSKNPALRP---TTQQLLHTEFLKYV 329 (478)
T ss_pred CCCCCCCCHHHHHHHHHhCCC-CCCC--ccCCHHHHHHHHHHhccChhhCc---CHHHHHhCHHHHHH
Confidence 999998888877777765322 1233 4789999999999998 999999 68999999999754
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=366.30 Aligned_cols=259 Identities=37% Similarity=0.678 Sum_probs=214.4
Q ss_pred eeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHH---HHhcCCCCeeeEeEEeecCceEEEEEeccC
Q 010463 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNL---LAEVDSRCIVQLFYSFQDSDFLYLIMEYLP 189 (510)
Q Consensus 113 ~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~i---L~~l~hp~Iv~l~~~~~~~~~~~lVmEy~~ 189 (510)
+||+|+||.||+|++..+|+.||+|++.+..............|..+ +...+||+|++++++|.+.+.+|+||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999999999999999987544322222233444443 444689999999999999999999999999
Q ss_pred CCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhh
Q 010463 190 GGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDED 269 (510)
Q Consensus 190 gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~ 269 (510)
||+|..++.+.+.+++..++.++.|++.||+|||+.+|+||||||+|||++.++.+||+|||++..+....
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--------- 151 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--------- 151 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---------
Confidence 99999999888889999999999999999999999999999999999999999999999999987543210
Q ss_pred hhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC-CCCccccccchhhHHHHHhhCCCCCCCCC
Q 010463 270 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEMLIGYPPFCSDD 348 (510)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiwSlGvilyEml~G~~PF~~~~ 348 (510)
....+||+.|+|||++.+. .++.++|+||+||++|||++|..||.+..
T Consensus 152 -------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~ 200 (278)
T cd05606 152 -------------------------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (278)
T ss_pred -------------------------------CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC
Confidence 1135799999999999754 68999999999999999999999998763
Q ss_pred h---hhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC--ChHHhhcCCCcCCCCchhhhcc
Q 010463 349 P---RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR--GVEELKEHPWFRGIQWDKLYEM 415 (510)
Q Consensus 349 ~---~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~--~~~eil~HpfF~~i~~~~l~~~ 415 (510)
. ......+.. ....+| ..+|.++.++|.+||. +|.+|+... ++.++++||||++++|+.+...
T Consensus 201 ~~~~~~~~~~~~~--~~~~~~--~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~~~~ 269 (278)
T cd05606 201 TKDKHEIDRMTLT--MAVELP--DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQ 269 (278)
T ss_pred ccchHHHHHHhhc--cCCCCC--CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchHhhhc
Confidence 2 222222222 223344 3579999999999998 999999765 7999999999999999988753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=375.86 Aligned_cols=260 Identities=27% Similarity=0.483 Sum_probs=215.7
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEE
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l 183 (510)
..++|.+++.||+|+||.||+|+++.+++.||+|++..... ......+.+|+.+++.++||||+++++++.+++..|+
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 81 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL 81 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence 35789999999999999999999999999999999875432 2233457789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccc
Q 010463 184 IMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 262 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 262 (510)
||||+++ +|..++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++.......
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 82 VFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred EEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence 9999975 888887654 4589999999999999999999999999999999999999999999999999875432100
Q ss_pred ccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHhhCC
Q 010463 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml~G~ 341 (510)
.....+||+.|+|||++.+ ..++.++|+|||||++|||++|.
T Consensus 160 -------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~ 202 (309)
T cd07872 160 -------------------------------------TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202 (309)
T ss_pred -------------------------------------ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 0113468999999999875 46899999999999999999999
Q ss_pred CCCCCCChhhhHHHHhhccc-----------------cccCCC---------CCCCCHHHHHHHHHhhc-CccccCCCCC
Q 010463 342 PPFCSDDPRITCRKIVNWKT-----------------CLKFPE---------EPKISDEARDLICHLLC-DVETRLGTRG 394 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~-----------------~~~~p~---------~~~~s~~~~dlI~~lL~-dp~~R~~~~~ 394 (510)
+||.+.+..+....+..... ...+|. .+.+++++++||.+||+ ||.+|+ +
T Consensus 203 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~---t 279 (309)
T cd07872 203 PLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRI---S 279 (309)
T ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCC---C
Confidence 99998876655544432100 011111 13578999999999999 999999 7
Q ss_pred hHHhhcCCCcCCC
Q 010463 395 VEELKEHPWFRGI 407 (510)
Q Consensus 395 ~~eil~HpfF~~i 407 (510)
++|+++||||+++
T Consensus 280 ~~e~l~h~~~~~~ 292 (309)
T cd07872 280 AEEAMKHAYFRSL 292 (309)
T ss_pred HHHHhcChhhhhc
Confidence 8999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-46 Score=382.10 Aligned_cols=256 Identities=29% Similarity=0.468 Sum_probs=209.7
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc-----
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD----- 179 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~----- 179 (510)
.++|++++.||+|+||.||+|.++.+|+.||+|++.+.. ........+.+|+.+++.++||||++++++|....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 578999999999999999999999999999999997543 23344567889999999999999999999987543
Q ss_pred -eEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 180 -FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 180 -~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
.+|+||||+++ +|...+. ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++....
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 57999999976 5666653 3489999999999999999999999999999999999999999999999999975432
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHh
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml 338 (510)
.. .....+||+.|+|||++.+..++.++|+|||||++|||+
T Consensus 176 ~~---------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 216 (359)
T cd07876 176 NF---------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELV 216 (359)
T ss_pred Cc---------------------------------------cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHH
Confidence 10 012357999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhhHHHHhhccc--------------------ccc--------------CCC----CCCCCHHHHHHHH
Q 010463 339 IGYPPFCSDDPRITCRKIVNWKT--------------------CLK--------------FPE----EPKISDEARDLIC 380 (510)
Q Consensus 339 ~G~~PF~~~~~~~~~~~I~~~~~--------------------~~~--------------~p~----~~~~s~~~~dlI~ 380 (510)
+|.+||.+.+....+..+..... ... +|. ....++++++||.
T Consensus 217 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 296 (359)
T cd07876 217 KGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLS 296 (359)
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHH
Confidence 99999988765444333321100 000 010 1134678999999
Q ss_pred Hhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 381 HLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 381 ~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
+||+ ||++|| ++.|+++||||..
T Consensus 297 ~mL~~dP~~R~---t~~e~l~hp~~~~ 320 (359)
T cd07876 297 KMLVIDPDKRI---SVDEALRHPYITV 320 (359)
T ss_pred HHhccCcccCC---CHHHHhcCchhhh
Confidence 9999 999999 7899999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-46 Score=397.65 Aligned_cols=262 Identities=28% Similarity=0.446 Sum_probs=224.5
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc---
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD--- 179 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~--- 179 (510)
...++|.+.+.||+|+||+||+|+++.+|+.||||++..... .......+.+|+.+|..++|+||++++..+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 345799999999999999999999999999999999976543 3445667889999999999999999988775432
Q ss_pred -----eEEEEEeccCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeeccc
Q 010463 180 -----FLYLIMEYLPGGDIMTLLMRE----DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDF 250 (510)
Q Consensus 180 -----~~~lVmEy~~gG~L~~~L~~~----~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DF 250 (510)
.+++||||++||+|.++|... ..+++..++.++.|++.||+|||+.||+||||||+||||+.+|++||+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 478999999999999998643 46999999999999999999999999999999999999999999999999
Q ss_pred CCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccch
Q 010463 251 GLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSL 330 (510)
Q Consensus 251 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSl 330 (510)
|+++.+...... ....+.+||+.|+|||++.+..|+.++|||||
T Consensus 188 Gls~~~~~~~~~------------------------------------~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSl 231 (496)
T PTZ00283 188 GFSKMYAATVSD------------------------------------DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSL 231 (496)
T ss_pred ccCeeccccccc------------------------------------cccccccCCcceeCHHHhCCCCCCcHHHHHHH
Confidence 999865432110 01124689999999999999999999999999
Q ss_pred hhHHHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 331 GAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 331 GvilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
||++|||++|..||.+.+....+.++..... ..+| +.+++++.+||.+||+ ||.+|| ++.++++|||++..
T Consensus 232 GvilyeLltG~~Pf~~~~~~~~~~~~~~~~~-~~~~--~~~~~~l~~li~~~L~~dP~~RP---s~~ell~~p~~~~~ 303 (496)
T PTZ00283 232 GVLLYELLTLKRPFDGENMEEVMHKTLAGRY-DPLP--PSISPEMQEIVTALLSSDPKRRP---SSSKLLNMPICKLF 303 (496)
T ss_pred HHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC-CCCC--CCCCHHHHHHHHHHcccChhhCc---CHHHHHhCHHHHHh
Confidence 9999999999999999888877777775322 1233 4789999999999998 999999 68999999998754
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=387.27 Aligned_cols=258 Identities=28% Similarity=0.520 Sum_probs=234.6
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEE
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~ 182 (510)
.....|.+++.||+|.|++|.+|++..||..||||.+.|...... ...++.+|+++|..++|||||+|+.+......+|
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~-~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPS-KRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChH-HHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 456789999999999999999999999999999999998865433 3455899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccc
Q 010463 183 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 262 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 262 (510)
+||||+.||+++++|.+.+...|..++.++.|++.|++|||+++|||||||.+||||+.+.++||+|||++..+....
T Consensus 132 lV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~-- 209 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL-- 209 (596)
T ss_pred EEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccc--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999876431
Q ss_pred ccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCC-CccccccchhhHHHHHhhCC
Q 010463 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiwSlGvilyEml~G~ 341 (510)
+..+.||+|.|.|||++.+..| +..+|+|||||+||-|++|.
T Consensus 210 -------------------------------------~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~Gs 252 (596)
T KOG0586|consen 210 -------------------------------------MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGS 252 (596)
T ss_pred -------------------------------------cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecc
Confidence 1236899999999999999888 79999999999999999999
Q ss_pred CCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
.||.+.+..+.-.+.+.++ +.+|. .+|.++++||+++|. +|.+|+ ++++|++|+|...-
T Consensus 253 LPFDG~~lk~Lr~rvl~gk--~rIp~--~ms~dce~lLrk~lvl~Pskr~---~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 253 LPFDGQNLKELRPRVLRGK--YRIPF--YMSCDCEDLLRKFLVLNPSKRG---PCDQIMKDRWRNDL 312 (596)
T ss_pred cccCCcccccccchheeee--ecccc--eeechhHHHHHHhhccCccccC---CHHHhhhhcccchh
Confidence 9999999888888887754 55554 689999999999998 999999 68999999998743
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=379.94 Aligned_cols=257 Identities=34% Similarity=0.596 Sum_probs=225.2
Q ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEeccCCC
Q 010463 112 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGG 191 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy~~gG 191 (510)
++||+|-||+||-|+++.+|+.||||+|.|-.... ++...+++|+.||.+++||.||.|-.-|++.+.++.|||-+. |
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~-kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPT-KQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCC-chHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 68999999999999999999999999999877644 455889999999999999999999999999999999999995 5
Q ss_pred CHHHHHHh--ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCC---ceeecccCCcccCccccccccch
Q 010463 192 DIMTLLMR--EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG---HLKLSDFGLCKPLEDKYSSILLE 266 (510)
Q Consensus 192 ~L~~~L~~--~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g---~vkL~DFGla~~~~~~~~~~~~~ 266 (510)
|+..+|.. .++++|..++|++.||+.||.|||-+||+|.||||+||||.+.. .+||||||+|+.+.+..
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks------ 721 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS------ 721 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh------
Confidence 88777643 58899999999999999999999999999999999999997553 69999999999886531
Q ss_pred hhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCC
Q 010463 267 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCS 346 (510)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~ 346 (510)
...++||||.|+|||++++++|+.+-|+||+|||+|--|+|..||..
T Consensus 722 ---------------------------------FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE 768 (888)
T KOG4236|consen 722 ---------------------------------FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE 768 (888)
T ss_pred ---------------------------------hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence 12368999999999999999999999999999999999999999964
Q ss_pred CChhhhHHHHhhccccccCCC--CCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC-Cchhhhccc
Q 010463 347 DDPRITCRKIVNWKTCLKFPE--EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI-QWDKLYEME 416 (510)
Q Consensus 347 ~~~~~~~~~I~~~~~~~~~p~--~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i-~~~~l~~~~ 416 (510)
+ +++-.+|.+. .+-+|. |..+|++|.|||..||+ .-.+|. +++..+.|||+++. -|-+|++++
T Consensus 769 d--EdIndQIQNA--aFMyPp~PW~eis~~AidlIn~LLqVkm~kRy---svdk~lsh~Wlq~yq~w~DLRelE 835 (888)
T KOG4236|consen 769 D--EDINDQIQNA--AFMYPPNPWSEISPEAIDLINNLLQVKMRKRY---SVDKSLSHPWLQDYQTWLDLRELE 835 (888)
T ss_pred c--cchhHHhhcc--ccccCCCchhhcCHHHHHHHHHHHHHHHHHhc---chHhhccchhhhcchHHHHHHHHH
Confidence 3 3345566663 345554 56899999999999998 999999 79999999999986 588888643
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=377.39 Aligned_cols=256 Identities=23% Similarity=0.354 Sum_probs=207.4
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEE-----cCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEe
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRA-----KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSF 175 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~-----~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~ 175 (510)
.+..++|++.+.||+|+||.||+|.+ +.+++.||+|++.... .......+.+|+.+|..+ +|||||+++++|
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 45567899999999999999999975 3456789999987532 233456788999999999 899999999988
Q ss_pred ecC-ceEEEEEeccCCCCHHHHHHhc------------------------------------------------------
Q 010463 176 QDS-DFLYLIMEYLPGGDIMTLLMRE------------------------------------------------------ 200 (510)
Q Consensus 176 ~~~-~~~~lVmEy~~gG~L~~~L~~~------------------------------------------------------ 200 (510)
.+. ..+|+||||++||+|.+++...
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 764 4689999999999999998753
Q ss_pred --------cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhhhhc
Q 010463 201 --------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIIN 272 (510)
Q Consensus 201 --------~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~ 272 (510)
..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.+.......
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~--------- 231 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV--------- 231 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchh---------
Confidence 247788899999999999999999999999999999999999999999999998653221000
Q ss_pred ccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh-CCCCCCCCChhh
Q 010463 273 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRI 351 (510)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~-G~~PF~~~~~~~ 351 (510)
...+..||+.|+|||++.+..|+.++|||||||+||||++ |.+||.+.....
T Consensus 232 ---------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~ 284 (338)
T cd05102 232 ---------------------------RKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE 284 (338)
T ss_pred ---------------------------cccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH
Confidence 0112357789999999999999999999999999999997 999998866544
Q ss_pred hHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 352 TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 352 ~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
.+...+........| ..+++++.+||.+||. ||.+|| ++.+|++
T Consensus 285 ~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~RP---s~~el~~ 329 (338)
T cd05102 285 EFCQRLKDGTRMRAP--ENATPEIYRIMLACWQGDPKERP---TFSALVE 329 (338)
T ss_pred HHHHHHhcCCCCCCC--CCCCHHHHHHHHHHccCChhhCc---CHHHHHH
Confidence 444444322233333 4789999999999998 999999 5667653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=367.46 Aligned_cols=265 Identities=28% Similarity=0.449 Sum_probs=225.8
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
.+.|++++.||+|+||.||+|+++.+++.||+|++... .......+..|+.+++.++||||+++++++..++.+|+|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 35699999999999999999999999999999998754 344567788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccc
Q 010463 185 MEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 263 (510)
Q Consensus 185 mEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 263 (510)
|||++||+|..++.+ ...+++..+..++.|++.||.|||+.||+||||||+||+++.+|.+||+|||++........
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~-- 165 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ-- 165 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccc--
Confidence 999999999888765 45689999999999999999999999999999999999999999999999999875422100
Q ss_pred cchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc-----cCCCCccccccchhhHHHHHh
Q 010463 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-----~~~y~~~~DiwSlGvilyEml 338 (510)
......|++.|+|||++. ...++.++|+|||||++|||+
T Consensus 166 ------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~ 209 (292)
T cd06644 166 ------------------------------------RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA 209 (292)
T ss_pred ------------------------------------ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHh
Confidence 011356899999999985 345788999999999999999
Q ss_pred hCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchhhhc
Q 010463 339 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYE 414 (510)
Q Consensus 339 ~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l~~ 414 (510)
+|.+||...+......++..... ...+....++.++.+||++||. +|++|| +++++++||||..++|.+..+
T Consensus 210 ~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~~~~~~~~~~~ 282 (292)
T cd06644 210 QIEPPHHELNPMRVLLKIAKSEP-PTLSQPSKWSMEFRDFLKTALDKHPETRP---SAAQLLEHPFVSSVTSNRPLR 282 (292)
T ss_pred cCCCCCccccHHHHHHHHhcCCC-ccCCCCcccCHHHHHHHHHHhcCCcccCc---CHHHHhcCccccccccchhHH
Confidence 99999988777666666554321 1222234688999999999998 999999 689999999999999988664
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=361.63 Aligned_cols=255 Identities=38% Similarity=0.600 Sum_probs=214.8
Q ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEec
Q 010463 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEY 187 (510)
Q Consensus 108 f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy 187 (510)
|++++.||+|+||+||+|++..+++.||+|++........ .......|..++..++||||+++++++.+...+++||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEE-EREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHH-HHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccc-ccchhhhhhhccccccccccccccccccccccccccccc
Confidence 7889999999999999999999999999999988754332 233345599999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchh
Q 010463 188 LPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLED 267 (510)
Q Consensus 188 ~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~ 267 (510)
+++++|.+++.+...+++..+..++.||+.||.+||+.||+||||||+|||++.+|.++|+|||++.......
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~------- 152 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN------- 152 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT-------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------
Confidence 9999999999988899999999999999999999999999999999999999999999999999997541110
Q ss_pred hhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc-cCCCCccccccchhhHHHHHhhCCCCCCC
Q 010463 268 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEMLIGYPPFCS 346 (510)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-~~~y~~~~DiwSlGvilyEml~G~~PF~~ 346 (510)
......+||+.|+|||++. +..++.++|+||||+++|+|++|..||..
T Consensus 153 -------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~ 201 (260)
T PF00069_consen 153 -------------------------------ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEE 201 (260)
T ss_dssp -------------------------------SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTT
T ss_pred -------------------------------ccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 0112467999999999998 78899999999999999999999999998
Q ss_pred CC---hhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 347 DD---PRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 347 ~~---~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
.. ......+................+.++.++|.+||. ||++|| ++.++++||||
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~---~~~~l~~~~~~ 260 (260)
T PF00069_consen 202 SNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRP---SAEELLKHPWF 260 (260)
T ss_dssp SSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGST---THHHHHTSGGG
T ss_pred ccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCc---CHHHHhcCCCC
Confidence 73 333333333322222222112234899999999998 999999 78999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=368.42 Aligned_cols=261 Identities=26% Similarity=0.484 Sum_probs=216.6
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEE
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l 183 (510)
..++|++++.||.|+||.||+|+++.+++.||+|.+..... ......+.+|+.+++.++||||+++++++.+++.+|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 46789999999999999999999999999999999875432 2234457789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccc
Q 010463 184 IMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 262 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 262 (510)
||||++ ++|..++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 82 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 82 VFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred EEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence 999997 5898888654 5689999999999999999999999999999999999999999999999999875432100
Q ss_pred ccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHhhCC
Q 010463 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml~G~ 341 (510)
......+++.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 160 -------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~ 202 (301)
T cd07873 160 -------------------------------------TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202 (301)
T ss_pred -------------------------------------cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCC
Confidence 0112468999999999876 45789999999999999999999
Q ss_pred CCCCCCChhhhHHHHhhccc-----------------cccCCC---------CCCCCHHHHHHHHHhhc-CccccCCCCC
Q 010463 342 PPFCSDDPRITCRKIVNWKT-----------------CLKFPE---------EPKISDEARDLICHLLC-DVETRLGTRG 394 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~-----------------~~~~p~---------~~~~s~~~~dlI~~lL~-dp~~R~~~~~ 394 (510)
+||.+.+..+....+..... ...+|. .+.+++++++||.+||+ ||.+|+ +
T Consensus 203 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~---t 279 (301)
T cd07873 203 PLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRI---S 279 (301)
T ss_pred CCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCc---C
Confidence 99998876655544432100 011111 13578999999999999 999999 7
Q ss_pred hHHhhcCCCcCCCC
Q 010463 395 VEELKEHPWFRGIQ 408 (510)
Q Consensus 395 ~~eil~HpfF~~i~ 408 (510)
++|+++||||..+-
T Consensus 280 ~~eil~h~~f~~~~ 293 (301)
T cd07873 280 AEEAMKHPYFHCLG 293 (301)
T ss_pred HHHHhcCccccccc
Confidence 89999999998653
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=378.22 Aligned_cols=256 Identities=28% Similarity=0.456 Sum_probs=210.2
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC------
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS------ 178 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~------ 178 (510)
.++|++++.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.+++.++||||++++++|...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 5789999999999999999999999999999999875432 233456778899999999999999999998754
Q ss_pred ceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 179 DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
..+|+||||+++ +|...+.. .+++..++.++.|++.||.|||+.||+||||||+||||+.+|.+||+|||+++....
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 357999999976 66666643 489999999999999999999999999999999999999999999999999986533
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHh
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml 338 (510)
.. .....+||+.|+|||++.+..++.++|+|||||++|||+
T Consensus 172 ~~---------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 212 (355)
T cd07874 172 SF---------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212 (355)
T ss_pred cc---------------------------------------ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHH
Confidence 21 012357999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhhHHHHhhccc-------------------------ccc---------CC----CCCCCCHHHHHHHH
Q 010463 339 IGYPPFCSDDPRITCRKIVNWKT-------------------------CLK---------FP----EEPKISDEARDLIC 380 (510)
Q Consensus 339 ~G~~PF~~~~~~~~~~~I~~~~~-------------------------~~~---------~p----~~~~~s~~~~dlI~ 380 (510)
+|..||.+.+....+..++..-. .+. +| .....+.++++||.
T Consensus 213 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 292 (355)
T cd07874 213 RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS 292 (355)
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHH
Confidence 99999988775554443322100 000 00 01234678899999
Q ss_pred Hhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 381 HLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 381 ~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
+||. ||++|| +++|+++||||..
T Consensus 293 ~mL~~dP~~Rp---s~~ell~hp~~~~ 316 (355)
T cd07874 293 KMLVIDPAKRI---SVDEALQHPYINV 316 (355)
T ss_pred HHhcCCchhcC---CHHHHhcCcchhc
Confidence 9998 999999 7899999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=379.12 Aligned_cols=256 Identities=27% Similarity=0.452 Sum_probs=212.0
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC------
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS------ 178 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~------ 178 (510)
.++|++++.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.+|+.++||||++++++|.+.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 3689999999999999999999999999999999976432 223445677899999999999999999988643
Q ss_pred ceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 179 DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
...|++||++ |++|..++. ...+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++....
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD 170 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence 4579999998 779987764 45699999999999999999999999999999999999999999999999999986532
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHH
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEM 337 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEm 337 (510)
. ....+||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 171 ~-----------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 209 (343)
T cd07878 171 E-----------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 209 (343)
T ss_pred C-----------------------------------------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHH
Confidence 1 123579999999999987 5689999999999999999
Q ss_pred hhCCCCCCCCChhhhHHHHhhcccc---------------------ccCCC------CCCCCHHHHHHHHHhhc-Ccccc
Q 010463 338 LIGYPPFCSDDPRITCRKIVNWKTC---------------------LKFPE------EPKISDEARDLICHLLC-DVETR 389 (510)
Q Consensus 338 l~G~~PF~~~~~~~~~~~I~~~~~~---------------------~~~p~------~~~~s~~~~dlI~~lL~-dp~~R 389 (510)
++|.+||.+.+.......+...... ...|. ....++.+.+||.+||. ||.+|
T Consensus 210 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R 289 (343)
T cd07878 210 LKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKR 289 (343)
T ss_pred HHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhC
Confidence 9999999887665555444321100 00110 12467789999999999 99999
Q ss_pred CCCCChHHhhcCCCcCCC
Q 010463 390 LGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 390 ~~~~~~~eil~HpfF~~i 407 (510)
+ ++.|+++||||...
T Consensus 290 ~---s~~ell~hp~~~~~ 304 (343)
T cd07878 290 I---SASEALAHPYFSQY 304 (343)
T ss_pred C---CHHHHhcCcchhcc
Confidence 9 78999999999764
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=384.44 Aligned_cols=262 Identities=23% Similarity=0.360 Sum_probs=216.0
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcC--CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKT--TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~--tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~ 182 (510)
..+|++++.||+|+||.||+|.... ++..||+|.+.+.. ...+|+.+|+.++|||||+++++|.....+|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 3579999999999999999997653 56789999886532 2457999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccc
Q 010463 183 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 262 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 262 (510)
+|||++. ++|..++.....+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+++.+......
T Consensus 163 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred EEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 9999995 689999977788999999999999999999999999999999999999999999999999999865432110
Q ss_pred ccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCC
Q 010463 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 342 (510)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~ 342 (510)
......+||+.|+|||++.+..|+.++|||||||++|||++|..
T Consensus 242 ------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~ 285 (392)
T PHA03207 242 ------------------------------------PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNV 285 (392)
T ss_pred ------------------------------------ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCC
Confidence 01124679999999999999999999999999999999999999
Q ss_pred CCCCCChh---hhHHHHhhcc--ccccC-------------------------CC---CCCCCHHHHHHHHHhhc-Cccc
Q 010463 343 PFCSDDPR---ITCRKIVNWK--TCLKF-------------------------PE---EPKISDEARDLICHLLC-DVET 388 (510)
Q Consensus 343 PF~~~~~~---~~~~~I~~~~--~~~~~-------------------------p~---~~~~s~~~~dlI~~lL~-dp~~ 388 (510)
||.+.... ..+..|+... ....+ |. ...++.++.+||++||+ ||++
T Consensus 286 pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~ 365 (392)
T PHA03207 286 TLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEF 365 (392)
T ss_pred CCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhh
Confidence 99875432 2222222100 00111 10 02457789999999999 9999
Q ss_pred cCCCCChHHhhcCCCcCCCCchhhhc
Q 010463 389 RLGTRGVEELKEHPWFRGIQWDKLYE 414 (510)
Q Consensus 389 R~~~~~~~eil~HpfF~~i~~~~l~~ 414 (510)
|| ++.|++.||||...+|+.+..
T Consensus 366 Rp---sa~e~l~~p~f~~~~~~~~~~ 388 (392)
T PHA03207 366 RP---SAQDILSLPLFTKEPINLLNI 388 (392)
T ss_pred CC---CHHHHhhCchhhccchhhhcC
Confidence 99 789999999999999988864
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=358.66 Aligned_cols=264 Identities=49% Similarity=0.888 Sum_probs=228.2
Q ss_pred eecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEeccCCCCH
Q 010463 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDI 193 (510)
Q Consensus 114 IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy~~gG~L 193 (510)
||.|+||.||+|++..+|+.||+|++.+.........+.+.+|++++..++||||+++++.+.+....|+||||++||+|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 69999999999999999999999999877655556678899999999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhhhhcc
Q 010463 194 MTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 273 (510)
Q Consensus 194 ~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~ 273 (510)
.+++.+.+.+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++............
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~-------- 152 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN-------- 152 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc--------
Confidence 999988788999999999999999999999999999999999999999999999999998754322100000
Q ss_pred cccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCCCChhhhH
Q 010463 274 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITC 353 (510)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~~~~~~~~ 353 (510)
.........+|++.|+|||++.+..++.++|+|||||++|||++|..||...+....+
T Consensus 153 ----------------------~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~ 210 (265)
T cd05579 153 ----------------------DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF 210 (265)
T ss_pred ----------------------cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 0000012357899999999999888999999999999999999999999988888777
Q ss_pred HHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCc
Q 010463 354 RKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQW 409 (510)
Q Consensus 354 ~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~ 409 (510)
..+.. ....+|....+++.+.+||++||+ +|.+||+..++.++++||||++++|
T Consensus 211 ~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 211 QNILN--GKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred HHHhc--CCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 77765 234455444469999999999998 9999998777899999999999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-45 Score=366.89 Aligned_cols=255 Identities=30% Similarity=0.456 Sum_probs=216.2
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++|++.+.||+|+||.||+|++..+|..||+|.+.... .......+.+|++++..++||||++++++|.+++.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 47999999999999999999999999999999986532 2334556888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhh-CCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~-~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
||++||+|.+++.+.+.+++..++.++.|++.||.|||+ .|++||||||+|||++.+|.+||+|||++.......
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---- 154 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---- 154 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc----
Confidence 999999999999988889999999999999999999997 699999999999999999999999999987543210
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCC
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 344 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF 344 (510)
..+.+|++.|+|||++.+..++.++|+|||||++|||++|..||
T Consensus 155 ------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~ 198 (308)
T cd06615 155 ------------------------------------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198 (308)
T ss_pred ------------------------------------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCC
Confidence 12357999999999998888999999999999999999999999
Q ss_pred CCCChhhhHHHHhhcc-----------------------------------ccccCCCCCCCCHHHHHHHHHhhc-Cccc
Q 010463 345 CSDDPRITCRKIVNWK-----------------------------------TCLKFPEEPKISDEARDLICHLLC-DVET 388 (510)
Q Consensus 345 ~~~~~~~~~~~I~~~~-----------------------------------~~~~~p~~~~~s~~~~dlI~~lL~-dp~~ 388 (510)
.+.+.......+.... .....|. ..++.++++||.+||. +|++
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~ 277 (308)
T cd06615 199 PPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPS-GAFSDEFQDFVDKCLKKNPKE 277 (308)
T ss_pred CCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcC-cccCHHHHHHHHHHccCChhh
Confidence 7665433222221100 0111121 2368899999999998 9999
Q ss_pred cCCCCChHHhhcCCCcCC
Q 010463 389 RLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 389 R~~~~~~~eil~HpfF~~ 406 (510)
|| ++.++++||||.+
T Consensus 278 Rp---t~~~ll~~~~~~~ 292 (308)
T cd06615 278 RA---DLKELTKHPFIKR 292 (308)
T ss_pred Cc---CHHHHhcChhhhh
Confidence 99 7899999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-45 Score=363.37 Aligned_cols=274 Identities=42% Similarity=0.757 Sum_probs=227.4
Q ss_pred CceeeeeeecCCCeEEEEEEEc---CCCCEEEEEEeechhhcc-hhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCceE
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAK---TTGEIFAMKKLKKSEMLK-RGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFL 181 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~---~tg~~vAiK~i~k~~~~~-~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~ 181 (510)
+|++.+.||+|+||.||+|+.. .+++.||||++.+..... .....++.+|..++..+ +||||+++++.+.+...+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 5889999999999999998864 467899999998654432 23456788999999999 699999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 182 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
|+||||++||+|..++.....+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++.+.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999876533210
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCC--CCccccccchhhHHHHHhh
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG--YGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~--y~~~~DiwSlGvilyEml~ 339 (510)
. .....+|++.|+|||.+.+.. ++.++|+||||+++|||++
T Consensus 161 ~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~t 203 (288)
T cd05583 161 E-------------------------------------RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLT 203 (288)
T ss_pred c-------------------------------------ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHh
Confidence 0 012357999999999997654 7889999999999999999
Q ss_pred CCCCCCCCChh----hhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchhhhc
Q 010463 340 GYPPFCSDDPR----ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYE 414 (510)
Q Consensus 340 G~~PF~~~~~~----~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l~~ 414 (510)
|..||...+.. .....+... ..+....++.++.++|.+||. ||++||+..++.++++||||+.++|+.+..
T Consensus 204 g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~~~ 279 (288)
T cd05583 204 GASPFTVDGEQNSQSEISRRILKS----KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAA 279 (288)
T ss_pred CCCCcccCcccchHHHHHHHHHcc----CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHHhh
Confidence 99999754332 222233321 122224688999999999998 999999988899999999999999998864
Q ss_pred --ccCCCcc
Q 010463 415 --MEAAYKP 421 (510)
Q Consensus 415 --~~~p~~p 421 (510)
..+||.|
T Consensus 280 ~~~~~~~~~ 288 (288)
T cd05583 280 KRIPAPFKP 288 (288)
T ss_pred hccCCCCCC
Confidence 4556643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=356.15 Aligned_cols=260 Identities=32% Similarity=0.509 Sum_probs=219.7
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhh--cchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC--ceE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEM--LKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS--DFL 181 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~~ 181 (510)
++|++.+.||+|+||.||+|.++.+|+.||||++..... ....+...+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 689999999999999999999999999999999864321 1234567889999999999999999999998864 578
Q ss_pred EEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 182 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
|+||||++||+|.+++.+...+++..+..++.|++.||.|||+.||+|+||||+|||++.+|.++|+|||++..+.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999886532100
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~ 341 (510)
.. .......||..|+|||++.+..++.++|+|||||++|||++|.
T Consensus 162 ~~-----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~ 206 (265)
T cd06652 162 SG-----------------------------------TGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206 (265)
T ss_pred cc-----------------------------------cccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCC
Confidence 00 0011356999999999999888999999999999999999999
Q ss_pred CCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhcCccccCCCCChHHhhcCCCcC
Q 010463 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFR 405 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~dp~~R~~~~~~~eil~HpfF~ 405 (510)
+||...+......++.........| ..++..+.++|++|+.+|.+|| ++++|++|||++
T Consensus 207 ~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~p~~Rp---~~~~il~~~~~~ 265 (265)
T cd06652 207 PPWAEFEAMAAIFKIATQPTNPVLP--PHVSDHCRDFLKRIFVEAKLRP---SADELLRHTFVH 265 (265)
T ss_pred CCCCccchHHHHHHHhcCCCCCCCc--hhhCHHHHHHHHHHhcChhhCC---CHHHHhcCcccC
Confidence 9998776665555554332223333 3688999999999999999999 689999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-47 Score=388.45 Aligned_cols=262 Identities=27% Similarity=0.455 Sum_probs=230.5
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
+.|+++..||.|+||+||+|..+.++-..|-|+|... ...+++.+.-|++||+.|+||+||+|+++|.-++.+||..
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 4588999999999999999999999999999998643 5677889999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 186 EYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 186 Ey~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
|||+||-...++.. ...++|.++..++.|++.||.|||+.+|||||||..|||++-+|.|+|+|||.+......
T Consensus 109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t----- 183 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST----- 183 (1187)
T ss_pred eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhH-----
Confidence 99999998887655 467999999999999999999999999999999999999999999999999997643221
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc-----cCCCCccccccchhhHHHHHhh
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-----~~~y~~~~DiwSlGvilyEml~ 339 (510)
+....+++|||+||||||+. ..+|++++||||||++|.||..
T Consensus 184 ---------------------------------~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAq 230 (1187)
T KOG0579|consen 184 ---------------------------------RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQ 230 (1187)
T ss_pred ---------------------------------HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhc
Confidence 01123789999999999986 4689999999999999999999
Q ss_pred CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchhh
Q 010463 340 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKL 412 (510)
Q Consensus 340 G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l 412 (510)
+.||-..-++...+.+|....+ +.+-....+|....||+++||. ||..|| ++.+|++||||.+++-.+.
T Consensus 231 iEPPHhelnpMRVllKiaKSeP-PTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp---~aaqll~Hpfv~~~~SnK~ 300 (1187)
T KOG0579|consen 231 IEPPHHELNPMRVLLKIAKSEP-PTLLQPSHWSRSFSDFLKRCLVKNPRNRP---PAAQLLKHPFVQNAPSNKM 300 (1187)
T ss_pred cCCCccccchHHHHHHHhhcCC-CcccCcchhhhHHHHHHHHHHhcCCccCC---CHHHHhhCcccccCCcchH
Confidence 9999999999999989887532 3333335889999999999998 999999 6899999999998876543
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=359.37 Aligned_cols=256 Identities=29% Similarity=0.462 Sum_probs=215.5
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEE
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l 183 (510)
..++|.+.+.||+|+||.||+|++..+++.||+|+++... ......+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~l 83 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWI 83 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Confidence 3468999999999999999999999999999999987542 2334567889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccc
Q 010463 184 IMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 263 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 263 (510)
||||+++|+|.+++...+.+++..++.++.|++.||.|||+.||+||||||+||+++.+|.++|+|||++..+......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~- 162 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK- 162 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccc-
Confidence 9999999999999988889999999999999999999999999999999999999999999999999998765322100
Q ss_pred cchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc---cCCCCccccccchhhHHHHHhhC
Q 010463 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMECDWWSLGAIMYEMLIG 340 (510)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~---~~~y~~~~DiwSlGvilyEml~G 340 (510)
....+||+.|+|||++. ...++.++|+|||||++|+|++|
T Consensus 163 -------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~ 205 (267)
T cd06645 163 -------------------------------------RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAEL 205 (267)
T ss_pred -------------------------------------cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcC
Confidence 11357999999999985 45688999999999999999999
Q ss_pred CCCCCCCChhhhHHHHhhcccc-ccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCC
Q 010463 341 YPPFCSDDPRITCRKIVNWKTC-LKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPW 403 (510)
Q Consensus 341 ~~PF~~~~~~~~~~~I~~~~~~-~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~Hpf 403 (510)
.+||....+......+...... ........++..+.+||.+||. +|++|| ++++|++|||
T Consensus 206 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~---~~~~ll~~~~ 267 (267)
T cd06645 206 QPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRP---TAEKLLQHPF 267 (267)
T ss_pred CCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCc---CHHHHhcCCC
Confidence 9999776654443333221111 1111123578899999999998 999999 7899999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=363.67 Aligned_cols=249 Identities=20% Similarity=0.265 Sum_probs=213.9
Q ss_pred CCCCceee--eeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec----
Q 010463 104 GIDDFEQL--TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD---- 177 (510)
Q Consensus 104 ~~~~f~~~--~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~---- 177 (510)
..++++.. ..||+|++|.||+|.. +|+.||||++++.........+.+.+|+.+|.+++|||||++++++.+
T Consensus 16 ~~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~ 93 (283)
T PHA02988 16 ESDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93 (283)
T ss_pred CHHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccC
Confidence 34444444 6899999999999987 689999999987654344446788899999999999999999999877
Q ss_pred CceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhh-CCeEEeecCCCCeeecCCCceeecccCCcccC
Q 010463 178 SDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 256 (510)
Q Consensus 178 ~~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~-~giiHRDLKP~NILld~~g~vkL~DFGla~~~ 256 (510)
...+++||||++||+|.+++.+...+++..+..++.+++.||.|||+ .+++||||||+|||++.+|.+||+|||+++.+
T Consensus 94 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~ 173 (283)
T PHA02988 94 LPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKIL 173 (283)
T ss_pred CCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhh
Confidence 45799999999999999999988889999999999999999999998 59999999999999999999999999998865
Q ss_pred ccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc--CCCCccccccchhhHH
Q 010463 257 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK--KGYGMECDWWSLGAIM 334 (510)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiwSlGvil 334 (510)
... ....+||+.|+|||++.+ ..|+.++|||||||++
T Consensus 174 ~~~-----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil 212 (283)
T PHA02988 174 SSP-----------------------------------------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVL 212 (283)
T ss_pred ccc-----------------------------------------cccccCcccccCHHHhhhccccccchhhhhHHHHHH
Confidence 321 013479999999999976 6899999999999999
Q ss_pred HHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 335 YEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 335 yEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
|||++|..||.+.+..+.+..+......+.+| ...++++++||.+||. ||++|| ++.+++.
T Consensus 213 ~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~Rp---s~~ell~ 274 (283)
T PHA02988 213 WEIFTGKIPFENLTTKEIYDLIINKNNSLKLP--LDCPLEIKCIVEACTSHDSIKRP---NIKEILY 274 (283)
T ss_pred HHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--CcCcHHHHHHHHHHhcCCcccCc---CHHHHHH
Confidence 99999999999988888888887654444444 3689999999999998 999999 5677763
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=360.73 Aligned_cols=268 Identities=39% Similarity=0.731 Sum_probs=222.6
Q ss_pred CceeeeeeecCCCeEEEEEEEc---CCCCEEEEEEeechhhcc-hhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCceE
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAK---TTGEIFAMKKLKKSEMLK-RGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFL 181 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~---~tg~~vAiK~i~k~~~~~-~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~ 181 (510)
+|++.+.||+|+||.||+|+.. .+|+.||+|++.+..... ....+++.+|+.+|..+ +||+|++++++|+.+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 5889999999999999999875 478999999997654322 23456788999999999 689999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 182 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
|+||||++||+|.+++.....+++..+..++.|++.||.|||+.|++||||||+|||++.++++||+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999986533210
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc--CCCCccccccchhhHHHHHhh
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK--KGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiwSlGvilyEml~ 339 (510)
......+|++.|+|||++.+ ..++.++|+|||||++|+|++
T Consensus 161 -------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~ 203 (290)
T cd05613 161 -------------------------------------ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLT 203 (290)
T ss_pred -------------------------------------cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhc
Confidence 00123579999999999975 357889999999999999999
Q ss_pred CCCCCCCCChhhhHHHHhhcc--ccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CChHHhhcCCCcCCCCchhhh
Q 010463 340 GYPPFCSDDPRITCRKIVNWK--TCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLY 413 (510)
Q Consensus 340 G~~PF~~~~~~~~~~~I~~~~--~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~--~~~~eil~HpfF~~i~~~~l~ 413 (510)
|..||...........+.... ....+| ..+++.+.+|+.+||. ||.+|++. .++++++.||||..++|+.+.
T Consensus 204 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~ 280 (290)
T cd05613 204 GASPFTVDGEKNSQAEISRRILKSEPPYP--QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLA 280 (290)
T ss_pred CCCCCCcCCccccHHHHHHHhhccCCCCC--ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHHh
Confidence 999997544332222222211 112233 4689999999999998 99999864 479999999999999998875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=369.20 Aligned_cols=250 Identities=26% Similarity=0.453 Sum_probs=194.9
Q ss_pred eeeeecCCCeEEEEEEEcC--CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec--CceEEEEEe
Q 010463 111 LTLIGKGAFGEVRLCRAKT--TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD--SDFLYLIME 186 (510)
Q Consensus 111 ~~~IG~G~fG~V~~~~~~~--tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~~~lVmE 186 (510)
.+.||+|+||+||+|+++. +++.||+|.+..... ...+.+|+.+|+.++||||++++++|.+ +..+|+|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 4689999999999999764 678999999865432 2346789999999999999999999854 567999999
Q ss_pred ccCCCCHHHHHHhc---------cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeee----cCCCceeecccCCc
Q 010463 187 YLPGGDIMTLLMRE---------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL----DKNGHLKLSDFGLC 253 (510)
Q Consensus 187 y~~gG~L~~~L~~~---------~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILl----d~~g~vkL~DFGla 253 (510)
|+.+ +|..++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.+|.+||+|||+|
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 9964 888887532 258999999999999999999999999999999999999 56689999999999
Q ss_pred ccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhh
Q 010463 254 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGA 332 (510)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGv 332 (510)
+......... ......+||+.|+|||++.+ ..|+.++|||||||
T Consensus 160 ~~~~~~~~~~-----------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 204 (317)
T cd07868 160 RLFNSPLKPL-----------------------------------ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGC 204 (317)
T ss_pred eccCCCCccc-----------------------------------cccCCccccccccCCHHHcCCCCcCchhhHHHHHH
Confidence 8654321100 00124679999999999987 45899999999999
Q ss_pred HHHHHhhCCCCCCCCChh---------hhHHHHhh---------ccccccCCC-------------------------CC
Q 010463 333 IMYEMLIGYPPFCSDDPR---------ITCRKIVN---------WKTCLKFPE-------------------------EP 369 (510)
Q Consensus 333 ilyEml~G~~PF~~~~~~---------~~~~~I~~---------~~~~~~~p~-------------------------~~ 369 (510)
++|||++|.+||.+.... ....++.+ |......|. ..
T Consensus 205 il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (317)
T cd07868 205 IFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV 284 (317)
T ss_pred HHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCC
Confidence 999999999999754321 11222211 000000000 01
Q ss_pred CCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 370 KISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 370 ~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
..+.++.|||++||+ ||.+|+ +++|+++||||
T Consensus 285 ~~~~~~~dli~~mL~~dP~~R~---t~~e~l~hp~f 317 (317)
T cd07868 285 KPDSKAFHLLQKLLTMDPIKRI---TSEQAMQDPYF 317 (317)
T ss_pred CCChHHHHHHHHHhccCcccCC---CHHHHhcCCCC
Confidence 346689999999999 999999 78999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=354.96 Aligned_cols=260 Identities=33% Similarity=0.529 Sum_probs=218.2
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhh--cchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec--CceE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEM--LKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD--SDFL 181 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~~ 181 (510)
.+|+..+.||+|+||.||+|.+..+|..||+|++..... ....+...+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 579999999999999999999999999999999875432 123456678999999999999999999999876 3678
Q ss_pred EEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 182 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
+++|||++|++|.+++...+.+++...+.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++..+.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999986532110
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~ 341 (510)
.. .......|+..|+|||++.+..++.++|+|||||++|||++|+
T Consensus 162 ~~-----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~ 206 (266)
T cd06651 162 SG-----------------------------------TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206 (266)
T ss_pred cC-----------------------------------CccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCC
Confidence 00 0011346899999999999988999999999999999999999
Q ss_pred CCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhcCccccCCCCChHHhhcCCCcC
Q 010463 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFR 405 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~dp~~R~~~~~~~eil~HpfF~ 405 (510)
+||.+.+......++........+| ..+++.+++||+.|+.+|++|| +++||++||||+
T Consensus 207 ~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~~~~p~~Rp---~~~eil~hp~~~ 265 (266)
T cd06651 207 PPWAEYEAMAAIFKIATQPTNPQLP--SHISEHARDFLGCIFVEARHRP---SAEELLRHPFAQ 265 (266)
T ss_pred CCccccchHHHHHHHhcCCCCCCCc--hhcCHHHHHHHHHhcCChhhCc---CHHHHhcCcccc
Confidence 9998876666555555433333444 3678999999954334999999 789999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=359.37 Aligned_cols=252 Identities=25% Similarity=0.397 Sum_probs=212.0
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++|++++.||+|+||.||+|++..+++.||+|++.+.. .......+.+|+.+|..++||||++++++|.+.+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 47889999999999999999999999999999987642 2334466889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
||++||+|..+ ..+++..+..++.|++.||.|||+.||+|+||||+|||++.+|.++|+|||++..+....
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----- 149 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----- 149 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-----
Confidence 99999998654 357899999999999999999999999999999999999999999999999997653220
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCC
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~ 345 (510)
....+||+.|+|||++.+..++.++|+|||||++|+|++|..||.
T Consensus 150 -----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~ 194 (279)
T cd06619 150 -----------------------------------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYP 194 (279)
T ss_pred -----------------------------------ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCch
Confidence 113579999999999999999999999999999999999999997
Q ss_pred CCChh-------hhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCC
Q 010463 346 SDDPR-------ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 408 (510)
Q Consensus 346 ~~~~~-------~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~ 408 (510)
..... .....+... .....+ ....++++.+||.+||+ +|.+|| ++++++.||||...+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp---~~~eil~~~~~~~~~ 260 (279)
T cd06619 195 QIQKNQGSLMPLQLLQCIVDE-DPPVLP-VGQFSEKFVHFITQCMRKQPKERP---APENLMDHPFIVQYN 260 (279)
T ss_pred hhcccccccchHHHHHHHhcc-CCCCCC-CCcCCHHHHHHHHHHhhCChhhCC---CHHHHhcCccccccc
Confidence 53221 122222221 111222 23578999999999998 999999 789999999998654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=350.66 Aligned_cols=253 Identities=28% Similarity=0.535 Sum_probs=216.9
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec-CceEEEEE
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD-SDFLYLIM 185 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~~~~~lVm 185 (510)
.|++++.||+|+||.||+|.++.+++.||+|.+..... .....+.+..|+.+++.++||||+++++.+.. +..+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 48999999999999999999999999999999976443 33445678899999999999999999998874 45789999
Q ss_pred eccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccc
Q 010463 186 EYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 263 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 263 (510)
||++|++|.+++... ..+++..+..++.+++.||.+||+.||+||||||+||+++.++.++|+|||++..+.....
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-- 157 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD-- 157 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC--
Confidence 999999999998763 4589999999999999999999999999999999999999999999999999986532210
Q ss_pred cchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCC
Q 010463 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 343 (510)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~P 343 (510)
......|++.|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus 158 ------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~ 201 (257)
T cd08223 158 ------------------------------------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHA 201 (257)
T ss_pred ------------------------------------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCC
Confidence 01135799999999999999999999999999999999999999
Q ss_pred CCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 344 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 344 F~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
|.+.+.......+..... ...+ ..+++++.+||.+||+ +|.+|| ++.++++||||
T Consensus 202 ~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~~l~~~~~ 257 (257)
T cd08223 202 FNAKDMNSLVYRIIEGKL-PPMP--KDYSPELGELIATMLSKRPEKRP---SVKSILRQPYI 257 (257)
T ss_pred CCCCCHHHHHHHHHhcCC-CCCc--cccCHHHHHHHHHHhccCcccCC---CHHHHhcCCCC
Confidence 988776666655554221 1222 4689999999999998 999999 78999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=358.75 Aligned_cols=260 Identities=27% Similarity=0.439 Sum_probs=221.9
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
.++|++++.||.|+||.||+|.+..+++.||+|++... .....+.+..|+.+++.++||||+++++++.++..+|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 36799999999999999999999999999999998654 344567788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccc
Q 010463 185 MEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 263 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 263 (510)
|||++||+|..++.+. ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-- 158 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-- 158 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc--
Confidence 9999999999998764 5699999999999999999999999999999999999999999999999999875432100
Q ss_pred cchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc-----cCCCCccccccchhhHHHHHh
Q 010463 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-----~~~y~~~~DiwSlGvilyEml 338 (510)
......||+.|+|||++. ...++.++|+|||||++|||+
T Consensus 159 ------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~ 202 (280)
T cd06611 159 ------------------------------------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELA 202 (280)
T ss_pred ------------------------------------ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHH
Confidence 011357999999999985 345688999999999999999
Q ss_pred hCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCc
Q 010463 339 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQW 409 (510)
Q Consensus 339 ~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~ 409 (510)
+|.+||.+.+......++..... ..+.....++.++.+||.+||. +|.+|| +++++++||||.....
T Consensus 203 ~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~~~~~~~~~~ 270 (280)
T cd06611 203 QMEPPHHELNPMRVLLKILKSEP-PTLDQPSKWSSSFNDFLKSCLVKDPDDRP---TAAELLKHPFVSDQSD 270 (280)
T ss_pred hCCCCcccCCHHHHHHHHhcCCC-CCcCCcccCCHHHHHHHHHHhccChhhCc---CHHHHhcChhhcccch
Confidence 99999988877666666654321 1222234789999999999998 999999 7899999999987643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=356.14 Aligned_cols=256 Identities=27% Similarity=0.421 Sum_probs=215.1
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEE
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l 183 (510)
..++|++++.||+|+||.||+|+++.+|+.||+|++.... ......+.+|+.++..++||||+++++++.+.+.+|+
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 3468999999999999999999999999999999986542 2344568889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccc
Q 010463 184 IMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 263 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 263 (510)
||||+++|+|.+++...+.+++..+..++.|++.||.|||+.||+||||||+||+++.+|.+||+|||++..+......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~- 162 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK- 162 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccc-
Confidence 9999999999999988888999999999999999999999999999999999999999999999999999865322100
Q ss_pred cchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc---cCCCCccccccchhhHHHHHhhC
Q 010463 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMECDWWSLGAIMYEMLIG 340 (510)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~---~~~y~~~~DiwSlGvilyEml~G 340 (510)
.....|++.|+|||++. ...++.++|+|||||++|||++|
T Consensus 163 -------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g 205 (267)
T cd06646 163 -------------------------------------RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAEL 205 (267)
T ss_pred -------------------------------------cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhC
Confidence 11357999999999985 35578899999999999999999
Q ss_pred CCCCCCCChhhhHHHHhhcccc-ccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCC
Q 010463 341 YPPFCSDDPRITCRKIVNWKTC-LKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPW 403 (510)
Q Consensus 341 ~~PF~~~~~~~~~~~I~~~~~~-~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~Hpf 403 (510)
.+||...++......+...... ...+....++..+.+||++||+ +|++|| ++++|++|+|
T Consensus 206 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---~~~~il~~l~ 267 (267)
T cd06646 206 QPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRP---TAERLLTHLF 267 (267)
T ss_pred CCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCc---CHHHHhcCCC
Confidence 9999766554443333221111 1111223578999999999998 999999 7899999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=403.00 Aligned_cols=263 Identities=28% Similarity=0.422 Sum_probs=218.7
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec--C
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD--S 178 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~ 178 (510)
.....++|++++.||+|+||+||+|+++.++..||+|++..... .......+..|+.+|..++|||||+++++|.+ .
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 34567899999999999999999999999999999999976543 34456778999999999999999999999864 4
Q ss_pred ceEEEEEeccCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHhhhhC-------CeEEeecCCCCeeecC------
Q 010463 179 DFLYLIMEYLPGGDIMTLLMRE----DILSEDVARFYIAESVLAIHSIHQH-------NYVHRDIKPDNLILDK------ 241 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~----~~l~e~~~~~~~~qi~~aL~~lH~~-------giiHRDLKP~NILld~------ 241 (510)
..+||||||+++|+|..+|... ..+++..++.++.||+.||.|||+. +||||||||+||||+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 5799999999999999998752 5799999999999999999999985 4999999999999964
Q ss_pred -----------CCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCC
Q 010463 242 -----------NGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDY 310 (510)
Q Consensus 242 -----------~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y 310 (510)
.+.+||+|||++..+.... .....+||+.|
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---------------------------------------~~~s~vGTp~Y 207 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIES---------------------------------------MAHSCVGTPYY 207 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccc---------------------------------------cccccCCCccc
Confidence 3458999999998653220 11245799999
Q ss_pred cchHhhcc--CCCCccccccchhhHHHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-Ccc
Q 010463 311 MAPEVLLK--KGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVE 387 (510)
Q Consensus 311 ~APEvl~~--~~y~~~~DiwSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~ 387 (510)
+|||++.+ ..++.++||||||||||||++|.+||...+.......++... ..+|. ...+.++.+||..||. +|.
T Consensus 208 mAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~--p~lpi-~~~S~eL~dLI~~~L~~dPe 284 (1021)
T PTZ00266 208 WSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRG--PDLPI-KGKSKELNILIKNLLNLSAK 284 (1021)
T ss_pred cCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcC--CCCCc-CCCCHHHHHHHHHHhcCChh
Confidence 99999965 458999999999999999999999998766554444444322 22222 3678999999999998 999
Q ss_pred ccCCCCChHHhhcCCCcCCCCc
Q 010463 388 TRLGTRGVEELKEHPWFRGIQW 409 (510)
Q Consensus 388 ~R~~~~~~~eil~HpfF~~i~~ 409 (510)
+|| ++.|++.||||+.+..
T Consensus 285 eRP---Sa~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 285 ERP---SALQCLGYQIIKNVGP 303 (1021)
T ss_pred HCc---CHHHHhccHHHhhcCC
Confidence 999 7899999999987653
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=357.36 Aligned_cols=255 Identities=28% Similarity=0.477 Sum_probs=217.5
Q ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEec
Q 010463 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEY 187 (510)
Q Consensus 108 f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy 187 (510)
|++++.||+|+||.||+|++..++..+|+|.+... .......+.+|+.+++.++||||++++++|...+..|+||||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 57889999999999999999999999999998654 234566788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccch
Q 010463 188 LPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 266 (510)
Q Consensus 188 ~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~ 266 (510)
++||+|..++.+ ...+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++........
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~----- 158 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ----- 158 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccc-----
Confidence 999999988765 46799999999999999999999999999999999999999999999999999876432110
Q ss_pred hhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc-----cCCCCccccccchhhHHHHHhhCC
Q 010463 267 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-----~~~y~~~~DiwSlGvilyEml~G~ 341 (510)
......||+.|+|||++. +..++.++|+|||||++|||++|.
T Consensus 159 ---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~ 205 (282)
T cd06643 159 ---------------------------------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIE 205 (282)
T ss_pred ---------------------------------ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCC
Confidence 011357999999999984 355788999999999999999999
Q ss_pred CCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
+||.+.+......++..... ...+....++.++++||.+||. +|.+|| +++++++||||...
T Consensus 206 ~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~~~~ 268 (282)
T cd06643 206 PPHHELNPMRVLLKIAKSEP-PTLAQPSRWSSEFKDFLKKCLEKNVDARW---TTTQLLQHPFVTVN 268 (282)
T ss_pred CCccccCHHHHHHHHhhcCC-CCCCCccccCHHHHHHHHHHccCChhhCc---CHHHHhcCCCEecc
Confidence 99998877666666654321 1222234688999999999998 999999 68999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=358.10 Aligned_cols=255 Identities=32% Similarity=0.500 Sum_probs=209.7
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEe
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 186 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmE 186 (510)
+|++++.||.|+||.||+|+++.+|+.||||++..... .......+.+|+.++..++||||+++++++.+++.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 68999999999999999999999999999999875432 23334668889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccc
Q 010463 187 YLPGGDIMTLLMRE---DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 263 (510)
Q Consensus 187 y~~gG~L~~~L~~~---~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 263 (510)
|++ |+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++........
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-- 156 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR-- 156 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc--
Confidence 997 5888887543 5689999999999999999999999999999999999999999999999999875432100
Q ss_pred cchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHhhCCC
Q 010463 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYP 342 (510)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml~G~~ 342 (510)
......|++.|+|||++.+ ..++.++|+|||||++|||++|.+
T Consensus 157 ------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~ 200 (285)
T cd07861 157 ------------------------------------VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKP 200 (285)
T ss_pred ------------------------------------cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCC
Confidence 0113468999999999875 457899999999999999999999
Q ss_pred CCCCCChhhhHHHHhhcccc----------------ccCC---------CCCCCCHHHHHHHHHhhc-CccccCCCCChH
Q 010463 343 PFCSDDPRITCRKIVNWKTC----------------LKFP---------EEPKISDEARDLICHLLC-DVETRLGTRGVE 396 (510)
Q Consensus 343 PF~~~~~~~~~~~I~~~~~~----------------~~~p---------~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~ 396 (510)
||.+.+.......+...... ..++ ....+|+++++||++||+ ||.+|| ++.
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp---t~~ 277 (285)
T cd07861 201 LFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRI---SAK 277 (285)
T ss_pred CCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCC---CHH
Confidence 99877654333322210000 0000 113579999999999999 999999 789
Q ss_pred HhhcCCCc
Q 010463 397 ELKEHPWF 404 (510)
Q Consensus 397 eil~HpfF 404 (510)
+|+.||||
T Consensus 278 ~ll~~~~~ 285 (285)
T cd07861 278 KALNHPYF 285 (285)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-45 Score=378.54 Aligned_cols=253 Identities=27% Similarity=0.435 Sum_probs=215.4
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-C-----CCeeeEeEEeecCce
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-S-----RCIVQLFYSFQDSDF 180 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~-h-----p~Iv~l~~~~~~~~~ 180 (510)
.|++++.||+|+||.|.+|.+..|++.||||+++.. ..-..+...|+.||..++ | -|+|+++++|...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 578999999999999999999999999999999764 344556778999999986 3 489999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCC--ceeecccCCcccC
Q 010463 181 LYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG--HLKLSDFGLCKPL 256 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g--~vkL~DFGla~~~ 256 (510)
+|||+|.+. -+|+++|+.+ ..|+...++.++.||+.||.+||++||||.|||||||||..-+ .|||+|||.|...
T Consensus 263 lciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 263 LCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 999999995 4999999875 4689999999999999999999999999999999999997544 7999999999875
Q ss_pred ccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHH
Q 010463 257 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 336 (510)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyE 336 (510)
... .++.+-+..|.||||+.+.+|+.+.||||||||+.|
T Consensus 342 ~q~-----------------------------------------vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAE 380 (586)
T KOG0667|consen 342 SQR-----------------------------------------VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAE 380 (586)
T ss_pred CCc-----------------------------------------ceeeeeccccccchhhccCCCCCccceeehhhhHHh
Confidence 442 236788999999999999999999999999999999
Q ss_pred HhhCCCCCCCCChhhhHHHHhhcc--------------------------------------------------ccccCC
Q 010463 337 MLIGYPPFCSDDPRITCRKIVNWK--------------------------------------------------TCLKFP 366 (510)
Q Consensus 337 ml~G~~PF~~~~~~~~~~~I~~~~--------------------------------------------------~~~~~p 366 (510)
|++|.|.|.|+++.+++..|+.-- .....|
T Consensus 381 L~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P 460 (586)
T KOG0667|consen 381 LFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGP 460 (586)
T ss_pred HhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCC
Confidence 999999999999988888876300 000112
Q ss_pred -CC-------C-CCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCC
Q 010463 367 -EE-------P-KISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 408 (510)
Q Consensus 367 -~~-------~-~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~ 408 (510)
.. . .-.....|||++||. ||.+|+ +..++++||||.+..
T Consensus 461 ~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~---tp~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 461 PGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI---TPAQALNHPFLTGTS 509 (586)
T ss_pred CCCcccchhcccccHHHHHHHHHHHhccCchhcC---CHHHHhcCccccccc
Confidence 00 0 112456999999999 999999 678999999999754
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=353.58 Aligned_cols=255 Identities=41% Similarity=0.732 Sum_probs=221.2
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEe
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 186 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmE 186 (510)
+|++.+.||.|+||.||+|+++.+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999999999999999988766555667889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccch
Q 010463 187 YLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 266 (510)
Q Consensus 187 y~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~ 266 (510)
|+.|++|..++.....+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~----- 155 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL----- 155 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc-----
Confidence 999999999998887899999999999999999999999999999999999999999999999999886543210
Q ss_pred hhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCC
Q 010463 267 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCS 346 (510)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~ 346 (510)
.....|+..|+|||++.+..++.++|+|||||++|+|++|..||..
T Consensus 156 ----------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 201 (258)
T cd05578 156 ----------------------------------TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201 (258)
T ss_pred ----------------------------------ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCC
Confidence 1134689999999999998899999999999999999999999987
Q ss_pred CCh--hhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 347 DDP--RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 347 ~~~--~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
.+. ...+.+.... ....+| ..++..+.++|.+||. ||.+|++.. +.|+++||||
T Consensus 202 ~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~i~~~l~~~p~~R~~~~-~~~l~~~~~~ 258 (258)
T cd05578 202 HSRTIRDQIRAKQET-ADVLYP--ATWSTEAIDAINKLLERDPQKRLGDN-LKDLKNHPYF 258 (258)
T ss_pred CCccHHHHHHHHhcc-ccccCc--ccCcHHHHHHHHHHccCChhHcCCcc-HHHHhcCCCC
Confidence 764 2222222221 223334 3688999999999998 999999543 4999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-47 Score=361.26 Aligned_cols=259 Identities=28% Similarity=0.474 Sum_probs=224.0
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
+-|+++..||+|+||.||+|.++.+|.++|||.+.. ...++.+..|+.||++|++|+||++|++|.....+|+||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVM 107 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVM 107 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-----cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeeh
Confidence 348889999999999999999999999999998764 345677999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHH-hccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 186 EYLPGGDIMTLLM-REDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 186 Ey~~gG~L~~~L~-~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
|||..|+..+.++ ++.+++|.++..++...+.||+|||.+.-||||||..||||+.+|+.||+|||.|-.+.+..
T Consensus 108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM---- 183 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM---- 183 (502)
T ss_pred hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhH----
Confidence 9999999999986 45789999999999999999999999999999999999999999999999999998765421
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCC
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 344 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF 344 (510)
+...++.|||.||||||+..-+|+.++||||||+...||.-|+|||
T Consensus 184 ----------------------------------AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPY 229 (502)
T KOG0574|consen 184 ----------------------------------AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPY 229 (502)
T ss_pred ----------------------------------HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCc
Confidence 0113678999999999999999999999999999999999999999
Q ss_pred CCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchh
Q 010463 345 CSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDK 411 (510)
Q Consensus 345 ~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~ 411 (510)
.+-.+....-.|-. ..+..|......|++..|||++||. .|++|- ++.++++|||.++-.-..
T Consensus 230 sDIHPMRAIFMIPT-~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~---TA~~L~~H~FiknA~g~~ 293 (502)
T KOG0574|consen 230 SDIHPMRAIFMIPT-KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERK---TALRLCEHTFIKNAPGCD 293 (502)
T ss_pred ccccccceeEeccC-CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHH---HHHHHhhhhhhcCCCccc
Confidence 87766544433322 2233333334789999999999998 999998 789999999998755433
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=350.72 Aligned_cols=259 Identities=29% Similarity=0.476 Sum_probs=221.4
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++|++.+.||.|+||+||+|....++..+|+|++.+..... +...+.+|+.+|+.++||||+++++.+.+.+..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 47999999999999999999999999999999997654322 5678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccc
Q 010463 186 EYLPGGDIMTLLMRE---DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 262 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~---~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 262 (510)
||++|++|.+++... ..+++..++.++.|++.||.+||+.||+||||||+||++++++.++|+|||++..+......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999999999764 45899999999999999999999999999999999999999999999999999866442110
Q ss_pred ccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC-CCCccccccchhhHHHHHhhCC
Q 010463 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiwSlGvilyEml~G~ 341 (510)
. .......+|++.|+|||++... .++.++|+|||||++|||++|+
T Consensus 159 ~----------------------------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~ 204 (267)
T cd06610 159 T----------------------------------RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGA 204 (267)
T ss_pred c----------------------------------ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCC
Confidence 0 0011235799999999999876 7899999999999999999999
Q ss_pred CCCCCCChhhhHHHHhhccccccCCCC---CCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 342 PPFCSDDPRITCRKIVNWKTCLKFPEE---PKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~~~~~p~~---~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
.||...+....+.++.... ...++.. ..+++.+.+||.+||. ||++|| ++++|+.||||
T Consensus 205 ~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~ll~~p~~ 267 (267)
T cd06610 205 APYSKYPPMKVLMLTLQND-PPSLETGADYKKYSKSFRKMISLCLQKDPSKRP---TAEELLKHKFF 267 (267)
T ss_pred CCccccChhhhHHHHhcCC-CCCcCCccccccccHHHHHHHHHHcCCChhhCc---CHHHHhhCCCC
Confidence 9998877766666665432 1222221 3678999999999998 999999 79999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=359.10 Aligned_cols=254 Identities=30% Similarity=0.506 Sum_probs=214.8
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++|++++.||+|+||.||+|++..+|..||+|.+.... .......+.+|+.+|..++||||+++++++...+.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 47899999999999999999999999999999986531 3334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHhhhh-CCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 186 EYLPGGDIMTLLMRE---DILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~---~~l~e~~~~~~~~qi~~aL~~lH~-~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
||++|++|..++... ..+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++..+....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 999999999888763 378999999999999999999996 699999999999999999999999999987653221
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC------CCCccccccchhhHHH
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK------GYGMECDWWSLGAIMY 335 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~------~y~~~~DiwSlGvily 335 (510)
....+|++.|+|||++.+. .++.++|+|||||++|
T Consensus 158 ---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~ 198 (286)
T cd06622 158 ---------------------------------------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSIL 198 (286)
T ss_pred ---------------------------------------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHH
Confidence 1134689999999998643 3588999999999999
Q ss_pred HHhhCCCCCCCCChhhhHHH---HhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 336 EMLIGYPPFCSDDPRITCRK---IVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 336 Eml~G~~PF~~~~~~~~~~~---I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
||++|..||...+....... +... ....+| +.+++++.+||.+||. +|.+|| ++++++.||||...
T Consensus 199 ~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~l~~~~~~~~~ 268 (286)
T cd06622 199 EMALGRYPYPPETYANIFAQLSAIVDG-DPPTLP--SGYSDDAQDFVAKCLNKIPNRRP---TYAQLLEHPWLVKY 268 (286)
T ss_pred HHHhCCCCCCCcchhhHHHHHHHHhhc-CCCCCC--cccCHHHHHHHHHHcccCcccCC---CHHHHhcChhhhhc
Confidence 99999999987655444433 3322 122333 3589999999999998 999999 68999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=347.45 Aligned_cols=253 Identities=33% Similarity=0.505 Sum_probs=220.7
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEe
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 186 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmE 186 (510)
+|.+.+.||+|+||.||+|..+.+|+.||+|.+...... ......+..|+.+++.++||||+++++++.+.+..|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 588999999999999999999999999999999765443 4456678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 187 YLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 187 y~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
|++|++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.+++++|+|||+++.+.....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~--- 156 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--- 156 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc---
Confidence 99999999999774 5789999999999999999999999999999999999999999999999999986543210
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCC
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 344 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF 344 (510)
.....+|++.|+|||++.+..++.++|+|||||++|||++|..||
T Consensus 157 -----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 201 (256)
T cd08529 157 -----------------------------------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPF 201 (256)
T ss_pred -----------------------------------hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCC
Confidence 011357899999999999999999999999999999999999999
Q ss_pred CCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 345 CSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 345 ~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
...+......++.... ...++ ..++..+.++|.+||+ +|++|| ++.+++.|||+
T Consensus 202 ~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~i~~~l~~~p~~Rp---~~~~ll~~~~~ 256 (256)
T cd08529 202 DANNQGALILKIIRGV-FPPVS--QMYSQQLAQLIDQCLTKDYRQRP---DTFQLLRNPSL 256 (256)
T ss_pred CCCCHHHHHHHHHcCC-CCCCc--cccCHHHHHHHHHHccCCcccCc---CHHHHhhCCCC
Confidence 9888776666666532 12222 2678999999999998 999999 68999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=354.09 Aligned_cols=252 Identities=30% Similarity=0.501 Sum_probs=211.1
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecC------
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDS------ 178 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~------ 178 (510)
+.|++.+.||+|+||.||+|.++.+++.||+|++.... .....+..|+.++..+ +||||++++++|.+.
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 56888999999999999999999999999999987542 2345688899999988 799999999998753
Q ss_pred ceEEEEEeccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccC
Q 010463 179 DFLYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 256 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~ 256 (510)
..+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++...
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 4689999999999999999763 46899999999999999999999999999999999999999999999999999865
Q ss_pred ccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc-----cCCCCccccccchh
Q 010463 257 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDWWSLG 331 (510)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-----~~~y~~~~DiwSlG 331 (510)
..... ......|++.|+|||++. +..|+.++|+||||
T Consensus 162 ~~~~~--------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG 203 (272)
T cd06637 162 DRTVG--------------------------------------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG 203 (272)
T ss_pred ccccc--------------------------------------cCCcccccccccCHhHhccccCcCCCCCchhhHHHHH
Confidence 32210 012357999999999996 34688999999999
Q ss_pred hHHHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 332 AIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 332 vilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
|++|||++|.+||....+......+... .........++.++.+||.+||. +|.+|| ++.+++.||||
T Consensus 204 v~l~el~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~~il~~~~~ 272 (272)
T cd06637 204 ITAIEMAEGAPPLCDMHPMRALFLIPRN--PAPRLKSKKWSKKFQSFIESCLVKNHSQRP---TTEQLMKHPFI 272 (272)
T ss_pred HHHHHHHhCCCCccccCHHHHHHHHhcC--CCCCCCCCCcCHHHHHHHHHHcCCChhhCC---CHHHHhhCCCC
Confidence 9999999999999876655544444321 11112224678999999999998 999999 68999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=354.19 Aligned_cols=248 Identities=30% Similarity=0.547 Sum_probs=203.7
Q ss_pred CCceeeeee--ecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHh-cCCCCeeeEeEEeecCceEE
Q 010463 106 DDFEQLTLI--GKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE-VDSRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 106 ~~f~~~~~I--G~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~~~~~~~~~ 182 (510)
++|++.+.+ |+|+||.||+++.+.+|..||+|++.+..... .|..+... .+||||++++++|.+.+.+|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 456666665 99999999999999999999999987653211 12222222 27999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCC-ceeecccCCcccCccccc
Q 010463 183 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG-HLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g-~vkL~DFGla~~~~~~~~ 261 (510)
+||||++||+|.+++.....+++..++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++......
T Consensus 86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-- 163 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-- 163 (267)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--
Confidence 9999999999999998888999999999999999999999999999999999999999998 9999999998765321
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~ 341 (510)
....||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 164 ----------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~ 203 (267)
T PHA03390 164 ----------------------------------------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203 (267)
T ss_pred ----------------------------------------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCC
Confidence 1246899999999999999999999999999999999999
Q ss_pred CCCCCCChhhh-HHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 342 PPFCSDDPRIT-CRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 342 ~PF~~~~~~~~-~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
.||........ ...+... .....+....+|+.+.+||.+||+ +|.+|++ ++++|++||||+.
T Consensus 204 ~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~--~~~~~l~h~~~~~ 267 (267)
T PHA03390 204 HPFKEDEDEELDLESLLKR-QQKKLPFIKNVSKNANDFVQSMLKYNINYRLT--NYNEIIKHPFLKI 267 (267)
T ss_pred CCCCCCCcchhhHHHHHHh-hcccCCcccccCHHHHHHHHHHhccChhhCCc--hHHHHhcCCcccC
Confidence 99986544332 1112111 111122224789999999999999 9999994 3699999999963
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=365.22 Aligned_cols=264 Identities=22% Similarity=0.358 Sum_probs=209.8
Q ss_pred eeeeeecC--CCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEec
Q 010463 110 QLTLIGKG--AFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEY 187 (510)
Q Consensus 110 ~~~~IG~G--~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy 187 (510)
++++||+| +||+||+++.+.+|+.||+|++..... .......+.+|+.+++.++|||||+++++|.+++..|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56789999 789999999999999999999975432 234456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 188 LPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 188 ~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
+++|+|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||++.++.++++|||.+...........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~- 159 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR- 159 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc-
Confidence 9999999999653 4589999999999999999999999999999999999999999999999997654322100000
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc--CCCCccccccchhhHHHHHhhCCCC
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK--KGYGMECDWWSLGAIMYEMLIGYPP 343 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiwSlGvilyEml~G~~P 343 (510)
.. .......+++..|+|||++.+ .+|+.++|||||||++|||++|.+|
T Consensus 160 ---------~~---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~p 209 (327)
T cd08227 160 ---------VV---------------------HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 209 (327)
T ss_pred ---------cc---------------------ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 00 000112467888999999976 4689999999999999999999999
Q ss_pred CCCCChhhhHHHHhhcccc------------------------------------------ccCCCCCCCCHHHHHHHHH
Q 010463 344 FCSDDPRITCRKIVNWKTC------------------------------------------LKFPEEPKISDEARDLICH 381 (510)
Q Consensus 344 F~~~~~~~~~~~I~~~~~~------------------------------------------~~~p~~~~~s~~~~dlI~~ 381 (510)
|.................. ...|....+++++.+||++
T Consensus 210 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 289 (327)
T cd08227 210 FKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQ 289 (327)
T ss_pred CCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHH
Confidence 9765443333222211000 0001112467899999999
Q ss_pred hhc-CccccCCCCChHHhhcCCCcCCCC
Q 010463 382 LLC-DVETRLGTRGVEELKEHPWFRGIQ 408 (510)
Q Consensus 382 lL~-dp~~R~~~~~~~eil~HpfF~~i~ 408 (510)
||+ ||++|| +++|+++||||+.+.
T Consensus 290 ~l~~dP~~Rp---t~~ell~~p~f~~~~ 314 (327)
T cd08227 290 CLQRNPDARP---SASTLLNHSFFKQIK 314 (327)
T ss_pred HHhhCchhcC---CHHHHhcChhhhhcc
Confidence 998 999999 789999999998764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=350.61 Aligned_cols=259 Identities=33% Similarity=0.526 Sum_probs=219.0
Q ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhc------chhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceE
Q 010463 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML------KRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 181 (510)
Q Consensus 108 f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~------~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~ 181 (510)
|.+.+.||+|+||.||+|.+..+++.||+|.+...... .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 66778999999999999999999999999988654322 123456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 182 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
++||||++|++|.+++...+.+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||+++.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSL 161 (267)
T ss_pred EEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999987643211
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~ 341 (510)
... .........|++.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 162 ~~~--------------------------------~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~ 209 (267)
T cd06628 162 STK--------------------------------TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209 (267)
T ss_pred cCC--------------------------------ccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCC
Confidence 000 000011356999999999999989999999999999999999999
Q ss_pred CCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
.||.+.+......++... ....+| ..++..+.++|++||. ||.+|| ++.+|++||||
T Consensus 210 ~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~ 267 (267)
T cd06628 210 HPFPDCTQLQAIFKIGEN-ASPEIP--SNISSEAIDFLEKTFEIDHNKRP---TAAELLKHPFL 267 (267)
T ss_pred CCCCCccHHHHHHHHhcc-CCCcCC--cccCHHHHHHHHHHccCCchhCc---CHHHHhhCCCC
Confidence 999887665555555442 122333 3688999999999998 999999 78999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-44 Score=350.35 Aligned_cols=260 Identities=30% Similarity=0.460 Sum_probs=217.1
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechh---hcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEE
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSE---MLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~---~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l 183 (510)
+|.+.+.||+|+||+||+|.. .+|+.+|+|.+.... .....+...+.+|+++|+.++|+||+++++++.+.+.+|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 578889999999999999976 488999999886432 1223455778999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccc
Q 010463 184 IMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 263 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 263 (510)
||||++||+|.+++.+...+++..+..++.|++.||.|||+.||+|+||||+||+++++|.++|+|||++..........
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999988653210000
Q ss_pred cchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCC
Q 010463 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 343 (510)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~P 343 (510)
. .........||+.|+|||++.+..++.++|+|||||++|+|++|.+|
T Consensus 160 ~--------------------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 207 (265)
T cd06631 160 T--------------------------------HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207 (265)
T ss_pred c--------------------------------ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCc
Confidence 0 00011235799999999999999999999999999999999999999
Q ss_pred CCCCChhhhHHHHhhcccc-ccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 344 FCSDDPRITCRKIVNWKTC-LKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 344 F~~~~~~~~~~~I~~~~~~-~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
|...+.......+...... ...| ..++.++.+||++||. +|.+|| ++.+++.||||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~p~~Rp---~~~~~l~~~~~ 265 (265)
T cd06631 208 LASMDRLAAMFYIGAHRGLMPRLP--DSFSAAAIDFVTSCLTRDQHERP---SALQLLRHDFL 265 (265)
T ss_pred cccCChHHHHHHhhhccCCCCCCC--CCCCHHHHHHHHHHhcCCcccCC---CHHHHhcCCCC
Confidence 9876655544444432111 1223 3689999999999998 999999 78999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=358.20 Aligned_cols=255 Identities=30% Similarity=0.509 Sum_probs=208.5
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEe
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 186 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmE 186 (510)
.|++++.||+|+||.||+|+++.+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 48899999999999999999999999999999976432 22334567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 187 YLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 187 y~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
|+++ +|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++.......
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~---- 154 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR---- 154 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC----
Confidence 9975 78887765 56799999999999999999999999999999999999999999999999999986532210
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC-CCCccccccchhhHHHHHhhCCCCC
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEMLIGYPPF 344 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiwSlGvilyEml~G~~PF 344 (510)
......||+.|+|||++.+. .++.++|+|||||++|||++|..||
T Consensus 155 ----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~ 200 (284)
T cd07839 155 ----------------------------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200 (284)
T ss_pred ----------------------------------CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCC
Confidence 01134689999999998764 4799999999999999999988875
Q ss_pred -CCCChhhhHHHHhhcc---------------ccccCC----------CCCCCCHHHHHHHHHhhc-CccccCCCCChHH
Q 010463 345 -CSDDPRITCRKIVNWK---------------TCLKFP----------EEPKISDEARDLICHLLC-DVETRLGTRGVEE 397 (510)
Q Consensus 345 -~~~~~~~~~~~I~~~~---------------~~~~~p----------~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~e 397 (510)
.+.+....+..+...- ....++ ..+.+|+++++||.+||. ||.+|| ++++
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~---t~~~ 277 (284)
T cd07839 201 FPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRI---SAEE 277 (284)
T ss_pred cCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcC---CHHH
Confidence 4444444444432110 000011 013578999999999998 999999 7899
Q ss_pred hhcCCCc
Q 010463 398 LKEHPWF 404 (510)
Q Consensus 398 il~HpfF 404 (510)
++.||||
T Consensus 278 il~h~~f 284 (284)
T cd07839 278 ALQHPYF 284 (284)
T ss_pred HhcCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=353.42 Aligned_cols=257 Identities=32% Similarity=0.507 Sum_probs=222.2
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++|++++.||.|+||.||+|++..+|+.||+|++.... .......+.+|+.+++.++||||+++++++.++..+|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 46889999999999999999999999999999987653 2344567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
||++||+|.+++... .+++..++.++.|++.||.|||+.|++||||+|+||+++.+|.++|+|||+++.+.....
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~---- 153 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS---- 153 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc----
Confidence 999999999998765 789999999999999999999999999999999999999999999999999987643210
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCC
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~ 345 (510)
.....+|++.|+|||++.+..++.++|+|||||++|+|++|.+||.
T Consensus 154 ----------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~ 199 (274)
T cd06609 154 ----------------------------------KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLS 199 (274)
T ss_pred ----------------------------------ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 0113579999999999999889999999999999999999999998
Q ss_pred CCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCC
Q 010463 346 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 408 (510)
Q Consensus 346 ~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~ 408 (510)
+.++......+... .....+. ..++.++.++|.+||+ +|++|| +++++++||||....
T Consensus 200 ~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~l~~~l~~~p~~Rp---t~~~il~~~~~~~~~ 258 (274)
T cd06609 200 DLHPMRVLFLIPKN-NPPSLEG-NKFSKPFKDFVSLCLNKDPKERP---SAKELLKHKFIKKAK 258 (274)
T ss_pred cCchHHHHHHhhhc-CCCCCcc-cccCHHHHHHHHHHhhCChhhCc---CHHHHhhChhhcCCC
Confidence 87766665555542 1222222 2388999999999998 999999 789999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=353.43 Aligned_cols=257 Identities=32% Similarity=0.484 Sum_probs=214.4
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++|++++.||+|+||.||+|+++.+|+.||+|++.+... .....+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 479999999999999999999999999999999875432 2223356788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
||++++.|..++.....+++..++.++.|++.||.|||+.||+||||||+||+++.+|.++|+|||++..+.....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~---- 155 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD---- 155 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc----
Confidence 9999999988887777899999999999999999999999999999999999999999999999999987643210
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHhhCCCCC
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYPPF 344 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml~G~~PF 344 (510)
......|+..|+|||++.+ ..++.++|+|||||++|||++|.+||
T Consensus 156 ----------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~ 201 (286)
T cd07847 156 ----------------------------------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLW 201 (286)
T ss_pred ----------------------------------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCC
Confidence 0112468899999999876 55789999999999999999999999
Q ss_pred CCCChhhhHHHHhhcc-----------------ccccCCC----------CCCCCHHHHHHHHHhhc-CccccCCCCChH
Q 010463 345 CSDDPRITCRKIVNWK-----------------TCLKFPE----------EPKISDEARDLICHLLC-DVETRLGTRGVE 396 (510)
Q Consensus 345 ~~~~~~~~~~~I~~~~-----------------~~~~~p~----------~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~ 396 (510)
.+.+..+....+.... .....|. .+.++..+.+||.+||+ +|++|| ++.
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~ 278 (286)
T cd07847 202 PGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERL---SCE 278 (286)
T ss_pred CCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccC---CHH
Confidence 8776544433332100 0011111 13578899999999998 999999 789
Q ss_pred HhhcCCCc
Q 010463 397 ELKEHPWF 404 (510)
Q Consensus 397 eil~HpfF 404 (510)
|++.||||
T Consensus 279 eil~~~~f 286 (286)
T cd07847 279 ELLEHPYF 286 (286)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=356.19 Aligned_cols=256 Identities=30% Similarity=0.503 Sum_probs=218.6
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
..+|++++.||+|+||.||+|.++.+++.||+|.+..... ...+.+.+|+.+++.++||||+++++.|.+....|+|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 3689999999999999999999999999999999876532 2346688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 185 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
|||++||+|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 96 ~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--- 171 (296)
T cd06654 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--- 171 (296)
T ss_pred ecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc---
Confidence 999999999998854 5689999999999999999999999999999999999999999999999999876432100
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCC
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 344 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF 344 (510)
.....+|++.|+|||.+.+..++.++|+|||||++|+|++|++||
T Consensus 172 -----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf 216 (296)
T cd06654 172 -----------------------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216 (296)
T ss_pred -----------------------------------ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCC
Confidence 011347999999999999988999999999999999999999999
Q ss_pred CCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 345 CSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 345 ~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
...++......+.... ....+....++..+.+||.+||. +|++|| ++.+|+.||||..
T Consensus 217 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~eil~~~~~~~ 275 (296)
T cd06654 217 LNENPLRALYLIATNG-TPELQNPEKLSAIFRDFLNRCLDMDVEKRG---SAKELLQHQFLKI 275 (296)
T ss_pred CCCCHHHhHHHHhcCC-CCCCCCccccCHHHHHHHHHHCcCCcccCc---CHHHHhhChhhhc
Confidence 8877655444333211 11222234688999999999998 999999 7899999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=370.35 Aligned_cols=253 Identities=20% Similarity=0.311 Sum_probs=203.9
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEE
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~ 182 (510)
+...+|++++.||+|+||.||+|++..+++.||+|+..+.. ...|..+|+.++|||||++++++.+....|
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 133 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITC 133 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeE
Confidence 34467999999999999999999999999999999864432 346899999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 183 LIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
+||||+. |+|.+++.. ...+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++......
T Consensus 134 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 211 (357)
T PHA03209 134 MVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP- 211 (357)
T ss_pred EEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence 9999995 588888765 4679999999999999999999999999999999999999999999999999987432210
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~ 341 (510)
......||+.|+|||++.+..|+.++|||||||++|||+++.
T Consensus 212 --------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~ 253 (357)
T PHA03209 212 --------------------------------------AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYP 253 (357)
T ss_pred --------------------------------------ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcC
Confidence 012357999999999999999999999999999999999854
Q ss_pred C-CCCCCChh---------hhHHHHhhc--cccccCC----------------------------CCCCCCHHHHHHHHH
Q 010463 342 P-PFCSDDPR---------ITCRKIVNW--KTCLKFP----------------------------EEPKISDEARDLICH 381 (510)
Q Consensus 342 ~-PF~~~~~~---------~~~~~I~~~--~~~~~~p----------------------------~~~~~s~~~~dlI~~ 381 (510)
. +|...... ....+++.. .....+| ....++.++.+||.+
T Consensus 254 ~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 333 (357)
T PHA03209 254 STIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHK 333 (357)
T ss_pred CccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHH
Confidence 4 44432111 111111110 0001111 012567888999999
Q ss_pred hhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 382 LLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 382 lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
||+ ||.+|| +++|+++||||+.+
T Consensus 334 mL~~dP~~Rp---ta~e~l~hp~f~~~ 357 (357)
T PHA03209 334 MLTFDAAMRP---SAEEILNYPMFAQL 357 (357)
T ss_pred HHcCCcccCc---CHHHHhcCchhccC
Confidence 999 999999 78999999999864
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=354.37 Aligned_cols=264 Identities=19% Similarity=0.292 Sum_probs=216.6
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcC-----CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEee
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKT-----TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ 176 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~-----tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 176 (510)
.+..++|++.+.||+|+||.||+|..++ .+..||+|.+.... .......+.+|..+++.++||||+++++++.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 3566889999999999999999997653 35589999886543 2233445788999999999999999999999
Q ss_pred cCceEEEEEeccCCCCHHHHHHhc----------cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCcee
Q 010463 177 DSDFLYLIMEYLPGGDIMTLLMRE----------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLK 246 (510)
Q Consensus 177 ~~~~~~lVmEy~~gG~L~~~L~~~----------~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vk 246 (510)
+.+..|+||||++||+|.+++.+. ..++...+..++.|++.||.|||+.||+||||||+|||++.++.++
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence 999999999999999999999753 2346678889999999999999999999999999999999999999
Q ss_pred ecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCcccc
Q 010463 247 LSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECD 326 (510)
Q Consensus 247 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 326 (510)
|+|||+++......... ......++..|+|||.+.+..++.++|
T Consensus 160 L~Dfg~~~~~~~~~~~~------------------------------------~~~~~~~~~~y~~pE~~~~~~~~~~~D 203 (288)
T cd05061 160 IGDFGMTRDIYETDYYR------------------------------------KGGKGLLPVRWMAPESLKDGVFTTSSD 203 (288)
T ss_pred ECcCCcccccccccccc------------------------------------ccCCCcccccccCHHHhccCCCChHhH
Confidence 99999998653321000 001234678899999999999999999
Q ss_pred ccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc----
Q 010463 327 WWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE---- 400 (510)
Q Consensus 327 iwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~---- 400 (510)
+|||||++|||++ |.+||.+.+.......+... .....| ...++.+.++|.+||+ ||.+|| ++.++++
T Consensus 204 vwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~~ll~~l~~ 277 (288)
T cd05061 204 MWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG-GYLDQP--DNCPERVTDLMRMCWQFNPKMRP---TFLEIVNLLKD 277 (288)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcCCChhHCc---CHHHHHHHHHh
Confidence 9999999999998 89999887777666666542 222333 3568999999999998 999999 4566654
Q ss_pred --CCCcCCCCc
Q 010463 401 --HPWFRGIQW 409 (510)
Q Consensus 401 --HpfF~~i~~ 409 (510)
||||++++|
T Consensus 278 ~~~~~~~~~~~ 288 (288)
T cd05061 278 DLHPSFPEVSF 288 (288)
T ss_pred hcCCCCCCCCC
Confidence 999999998
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=371.90 Aligned_cols=256 Identities=22% Similarity=0.311 Sum_probs=209.8
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcCC-----CCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEe
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTT-----GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSF 175 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t-----g~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~ 175 (510)
.+..++|++.+.||+|+||.||+|++..+ +..||+|++.... .......+.+|+.+|+.+ +|||||+++++|
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 45567899999999999999999986544 3579999997543 233456788999999999 899999999999
Q ss_pred ecCceEEEEEeccCCCCHHHHHHhc-------------------------------------------------------
Q 010463 176 QDSDFLYLIMEYLPGGDIMTLLMRE------------------------------------------------------- 200 (510)
Q Consensus 176 ~~~~~~~lVmEy~~gG~L~~~L~~~------------------------------------------------------- 200 (510)
.+.+.+|+|||||++|+|.+++...
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 9999999999999999999998642
Q ss_pred ---------------cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 201 ---------------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 201 ---------------~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
..+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.+......
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~--- 268 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY--- 268 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce---
Confidence 24788899999999999999999999999999999999999999999999999865432100
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh-CCCCC
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPF 344 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~-G~~PF 344 (510)
.......+++.|||||++.+..|+.++|||||||++|||++ |.+||
T Consensus 269 ---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf 315 (374)
T cd05106 269 ---------------------------------VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY 315 (374)
T ss_pred ---------------------------------eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 00012346678999999999999999999999999999997 99999
Q ss_pred CCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 345 CSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 345 ~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
.+........++.........| ..++++++++|.+||+ ||.+|| ++++|.+
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~RP---s~~~l~~ 367 (374)
T cd05106 316 PGILVNSKFYKMVKRGYQMSRP--DFAPPEIYSIMKMCWNLEPTERP---TFSQISQ 367 (374)
T ss_pred ccccccHHHHHHHHcccCccCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 8876655555555433223333 3678999999999998 999999 5666653
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=349.47 Aligned_cols=259 Identities=31% Similarity=0.546 Sum_probs=217.1
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhc-------chhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML-------KRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 179 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~-------~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 179 (510)
.|.+.+.||.|+||.||+|....+|+.||+|.+...... .....+.+..|..+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 467888999999999999999999999999988642211 1123467888999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 180 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
.+++||||++||+|.+++.+.+.+++..++.++.||+.||.|||+.|++||||||+||+++.++.++|+|||+++.....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999999865432
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCC--CCccccccchhhHHHHH
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG--YGMECDWWSLGAIMYEM 337 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~--y~~~~DiwSlGvilyEm 337 (510)
... .......|+..|+|||++.... ++.++|+|||||++|||
T Consensus 162 ~~~------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l 205 (272)
T cd06629 162 YDN------------------------------------DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEM 205 (272)
T ss_pred ccc------------------------------------cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHH
Confidence 110 0012356899999999998754 89999999999999999
Q ss_pred hhCCCCCCCCChhhhHHHHhhccccccCCCC--CCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 338 LIGYPPFCSDDPRITCRKIVNWKTCLKFPEE--PKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 338 l~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~--~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
++|..||...+......++........++.. ..++.++.+||.+||. +|.+|| +++++++||||
T Consensus 206 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~~~~~ 272 (272)
T cd06629 206 FAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRP---TARELLQHPFI 272 (272)
T ss_pred HhCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCC---CHHHHhhCCCC
Confidence 9999999776655555444433233333332 3578999999999998 999999 68999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=349.61 Aligned_cols=260 Identities=28% Similarity=0.492 Sum_probs=217.0
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcc---hhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEE
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLK---RGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~---~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l 183 (510)
+|+..+.||+|+||.||+|....+++.||+|++....... ......+..|+.+|+.++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4788899999999999999999999999999997543211 2235678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCC-ceeecccCCcccCcccccc
Q 010463 184 IMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG-HLKLSDFGLCKPLEDKYSS 262 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g-~vkL~DFGla~~~~~~~~~ 262 (510)
||||++||+|.+++.+.+.+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++..+......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999999999999998888899999999999999999999999999999999999999887 4999999999876432100
Q ss_pred ccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCC
Q 010463 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 342 (510)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~ 342 (510)
. .......+||..|+|||++.+..++.++|+|||||++|+|++|.+
T Consensus 161 ~----------------------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 206 (268)
T cd06630 161 A----------------------------------GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKP 206 (268)
T ss_pred C----------------------------------CccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCC
Confidence 0 000113468999999999998899999999999999999999999
Q ss_pred CCCCCChhhhHHHHhhc---cccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcC
Q 010463 343 PFCSDDPRITCRKIVNW---KTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 405 (510)
Q Consensus 343 PF~~~~~~~~~~~I~~~---~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~ 405 (510)
||...+.......+... .....+| ..+++++.++|.+||. +|.+|| ++.++++||||+
T Consensus 207 p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~p~~R~---~~~~ll~~~~~~ 268 (268)
T cd06630 207 PWNAEKHSNHLALIFKIASATTAPSIP--EHLSPGLRDVTLRCLELQPEDRP---PSRELLKHPVFR 268 (268)
T ss_pred CCCCCCCcchHHHHHHHhccCCCCCCc--hhhCHHHHHHHHHHcCCCcccCc---CHHHHhcCcccC
Confidence 99765544333333221 1122233 3688999999999998 999999 789999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=355.35 Aligned_cols=256 Identities=32% Similarity=0.521 Sum_probs=219.7
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
.+|++++.||.|+||.||+|.+..+|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 56999999999999999999999999999999987542 234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
||++||+|..++.. ..+++..+..++.+++.||+|||+.|++||||||+||+++.+|.+||+|||++........
T Consensus 96 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~---- 170 (296)
T cd06655 96 EYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS---- 170 (296)
T ss_pred EecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc----
Confidence 99999999998865 4689999999999999999999999999999999999999999999999999886533210
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCC
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~ 345 (510)
.....+|++.|+|||.+.+..++.++|+|||||++|+|++|.+||.
T Consensus 171 ----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~ 216 (296)
T cd06655 171 ----------------------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216 (296)
T ss_pred ----------------------------------cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 0113479999999999999889999999999999999999999998
Q ss_pred CCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 346 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 346 ~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
+.++......+.... .........+++.+.+||.+||. ||.+|| ++.+|+.||||+..
T Consensus 217 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---t~~~il~~~~~~~~ 275 (296)
T cd06655 217 NENPLRALYLIATNG-TPELQNPEKLSPIFRDFLNRCLEMDVEKRG---SAKELLQHPFLKLA 275 (296)
T ss_pred CCCHHHHHHHHHhcC-CcccCCcccCCHHHHHHHHHHhhcChhhCC---CHHHHhhChHhhhc
Confidence 887665554444321 11222224789999999999998 999999 78999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=353.53 Aligned_cols=257 Identities=25% Similarity=0.420 Sum_probs=217.9
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEE
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~ 182 (510)
+..++|++++.||+|+||+||+|.+..+|+.||+|++.... .......+.+|+.++..++||||+++++++.+.+.+|
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNIC 79 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEE
Confidence 34578999999999999999999999999999999986542 2334567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhh-CCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 183 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~-~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
+||||++||+|..++.+.+.+++..+..++.+++.||.|||+ .|++||||||+||+++.++.++|+|||++.......
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred EEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 999999999999999888889999999999999999999997 699999999999999999999999999987542210
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~ 341 (510)
....+||..|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 159 ---------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~ 199 (284)
T cd06620 159 ---------------------------------------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199 (284)
T ss_pred ---------------------------------------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCC
Confidence 11357999999999999889999999999999999999999
Q ss_pred CCCCCCChh-----------hhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 342 PPFCSDDPR-----------ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 342 ~PF~~~~~~-----------~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
.||...... .....+... ....++. ..++.++.+||.+||. ||.+|| +++|+++||||..
T Consensus 200 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~li~~~l~~dp~~Rp---t~~e~~~~~~~~~ 271 (284)
T cd06620 200 FPFAFSNIDDDGQDDPMGILDLLQQIVQE-PPPRLPS-SDFPEDLRDFVDACLLKDPTERP---TPQQLCAMPPFIQ 271 (284)
T ss_pred CCCcccchhhhhhhhhhHHHHHHHHHhhc-cCCCCCc-hhcCHHHHHHHHHHhcCCcccCc---CHHHHhcCccccc
Confidence 999865542 222233321 1122222 2478899999999998 999999 7899999999954
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=343.36 Aligned_cols=253 Identities=31% Similarity=0.527 Sum_probs=221.6
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEe
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 186 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmE 186 (510)
+|++++.||.|+||.|++++...+++.+|+|.+..... .......+.+|+.+|+.++|+||+++++++.+.+.+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 58999999999999999999999999999999876543 33455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 187 YLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 187 y~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
|++||+|.+++.+. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--- 156 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--- 156 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc---
Confidence 99999999999765 5689999999999999999999999999999999999999999999999999986543210
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCC
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 344 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF 344 (510)
......||+.|+|||++.+..++.++|+|||||++|||++|..||
T Consensus 157 -----------------------------------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~ 201 (256)
T cd08221 157 -----------------------------------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTF 201 (256)
T ss_pred -----------------------------------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCC
Confidence 012357999999999999888999999999999999999999999
Q ss_pred CCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 345 CSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 345 ~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
.+.+..+....+...... +....++.++.++|.+||+ +|.+|| ++.++++|||+
T Consensus 202 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~~p~~R~---s~~~ll~~~~l 256 (256)
T cd08221 202 DATNPLNLVVKIVQGNYT---PVVSVYSSELISLVHSLLQQDPEKRP---TADEVLDQPLL 256 (256)
T ss_pred CCCCHHHHHHHHHcCCCC---CCccccCHHHHHHHHHHcccCcccCC---CHHHHhhCcCC
Confidence 988888888777653221 1124689999999999998 999999 78999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=355.61 Aligned_cols=256 Identities=30% Similarity=0.512 Sum_probs=217.1
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
.+|++++.||+|+||.||+|.++.+|+.||+|.+..... ...+.+.+|+.+++.++||||++++++|.+.+..|+||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 689999999999999999999999999999999875432 23466888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
||++||+|.+++.+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.+|.++|+|||++........
T Consensus 96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~---- 170 (297)
T cd06656 96 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---- 170 (297)
T ss_pred cccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc----
Confidence 99999999999865 5689999999999999999999999999999999999999999999999999876432210
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCC
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~ 345 (510)
......|++.|+|||.+.+..++.++|+|||||++|+|++|.+||.
T Consensus 171 ----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~ 216 (297)
T cd06656 171 ----------------------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216 (297)
T ss_pred ----------------------------------CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 0112468999999999999999999999999999999999999998
Q ss_pred CCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 346 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 346 ~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
+.++......+.... .........++..+++||.+||. +|++|| +++++++||||...
T Consensus 217 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~~~~~~~~ 275 (297)
T cd06656 217 NENPLRALYLIATNG-TPELQNPERLSAVFRDFLNRCLEMDVDRRG---SAKELLQHPFLKLA 275 (297)
T ss_pred CCCcchheeeeccCC-CCCCCCccccCHHHHHHHHHHccCChhhCc---CHHHHhcCchhccc
Confidence 776544333332211 11111224688999999999998 999999 78999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=344.69 Aligned_cols=253 Identities=30% Similarity=0.494 Sum_probs=217.6
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
.++|++.+.||+|+||.||+|.++.+++.||+|.+..... .+.+.+|+++++.++||||+++++.+.+...+|++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence 3689999999999999999999999999999999875421 56789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccc
Q 010463 185 MEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 263 (510)
Q Consensus 185 mEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 263 (510)
|||++|++|.+++.. ...+++..++.++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++........
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 154 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-- 154 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence 999999999999975 45789999999999999999999999999999999999999999999999999986643210
Q ss_pred cchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCC
Q 010463 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 343 (510)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~P 343 (510)
......|++.|+|||++.+..++.++|+|||||++|+|++|.+|
T Consensus 155 ------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p 198 (256)
T cd06612 155 ------------------------------------KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198 (256)
T ss_pred ------------------------------------ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 01134689999999999999999999999999999999999999
Q ss_pred CCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 344 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 344 F~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
|...++......+.... ...+.....++.++.++|.+||. +|.+|| ++.|++.||||
T Consensus 199 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp---s~~~il~~~~~ 256 (256)
T cd06612 199 YSDIHPMRAIFMIPNKP-PPTLSDPEKWSPEFNDFVKKCLVKDPEERP---SAIQLLQHPFI 256 (256)
T ss_pred CCCcchhhhhhhhccCC-CCCCCchhhcCHHHHHHHHHHHhcChhhCc---CHHHHhcCCCC
Confidence 98776655444443321 11222223678999999999998 999999 78999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=355.82 Aligned_cols=261 Identities=30% Similarity=0.454 Sum_probs=216.3
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC--ceE
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS--DFL 181 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~~ 181 (510)
..++|++++.||+|+||.||+|.++.+|+.||+|++..... .......+.+|+.++..++||||+++++++.+. +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC-CCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 56899999999999999999999999999999999875432 222233466799999999999999999999765 579
Q ss_pred EEEEeccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccc
Q 010463 182 YLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 260 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~ 260 (510)
|+||||+.+ +|.+++.. ...+++..++.++.||+.||.|||+.|++||||||+|||++.+|.+||+|||++.......
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 999999975 88888875 3678999999999999999999999999999999999999999999999999998654321
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHhh
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml~ 339 (510)
.. .....+++.|+|||++.+ ..++.++|+|||||++|||++
T Consensus 163 ~~--------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~ 204 (309)
T cd07845 163 KP--------------------------------------MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLA 204 (309)
T ss_pred CC--------------------------------------CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHh
Confidence 00 012356889999999875 568999999999999999999
Q ss_pred CCCCCCCCChhhhHHHHhhccc-----------------cccCCC---------CCCCCHHHHHHHHHhhc-CccccCCC
Q 010463 340 GYPPFCSDDPRITCRKIVNWKT-----------------CLKFPE---------EPKISDEARDLICHLLC-DVETRLGT 392 (510)
Q Consensus 340 G~~PF~~~~~~~~~~~I~~~~~-----------------~~~~p~---------~~~~s~~~~dlI~~lL~-dp~~R~~~ 392 (510)
|.+||.+.+....+..+.+... ....+. ...+++++.+||++||+ ||++||
T Consensus 205 g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~-- 282 (309)
T cd07845 205 HKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRA-- 282 (309)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCc--
Confidence 9999999888877776664211 011111 02368999999999999 999999
Q ss_pred CChHHhhcCCCcCCC
Q 010463 393 RGVEELKEHPWFRGI 407 (510)
Q Consensus 393 ~~~~eil~HpfF~~i 407 (510)
++++++.||||.+.
T Consensus 283 -t~~~il~h~~f~~~ 296 (309)
T cd07845 283 -TAEEALESSYFKEK 296 (309)
T ss_pred -CHHHHhcChhhccC
Confidence 78999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=344.78 Aligned_cols=254 Identities=31% Similarity=0.484 Sum_probs=217.3
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++|++.+.||.|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 68999999999999999999999999999999997653 235677899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 186 EYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
||++|++|.+++... ..+++..+..++.|++.||.|||+.||+|+||||+||+++.+|.+||+|||++..+.....
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--- 156 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA--- 156 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhh---
Confidence 999999999998776 7899999999999999999999999999999999999999999999999999876532100
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC---CCCccccccchhhHHHHHhhCC
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK---GYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~---~y~~~~DiwSlGvilyEml~G~ 341 (510)
.....+|+..|+|||++.+. .++.++|+|||||++|||++|.
T Consensus 157 -----------------------------------~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~ 201 (262)
T cd06613 157 -----------------------------------KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQ 201 (262)
T ss_pred -----------------------------------ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCC
Confidence 01135789999999999876 8899999999999999999999
Q ss_pred CCCCCCChhhhHHHHhhcccc-ccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCC
Q 010463 342 PPFCSDDPRITCRKIVNWKTC-LKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPW 403 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~~-~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~Hpf 403 (510)
+||.+.+.......+...... ........++.++.+||.+||+ +|..|| ++.+|+.|||
T Consensus 202 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~~il~~~~ 262 (262)
T cd06613 202 PPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRP---TATKLLQHPF 262 (262)
T ss_pred CCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCC---CHHHHhcCCC
Confidence 999887765555444432101 1111123567899999999998 999999 7899999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=354.38 Aligned_cols=257 Identities=32% Similarity=0.507 Sum_probs=215.5
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++|++++.||+|+||.||+|.++.+++.||+|++.+.... ....+.+.+|+.+|+.++||||++++++|.+++..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 4789999999999999999999999999999998765432 234566888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
||+++++|..+......+++..+..++.||+.||.|||+.||+||||+|+||++++++.++|+|||++..+.....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~---- 155 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---- 155 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc----
Confidence 9999999988877767799999999999999999999999999999999999999999999999999886533210
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHhhCCCCC
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYPPF 344 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml~G~~PF 344 (510)
.....+|++.|+|||++.+ ..++.++|||||||++|||++|.+||
T Consensus 156 ----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~ 201 (286)
T cd07846 156 ----------------------------------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLF 201 (286)
T ss_pred ----------------------------------ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCC
Confidence 0113468999999999976 45788999999999999999999999
Q ss_pred CCCChhhhHHHHhhcccc-----------------ccCCC----------CCCCCHHHHHHHHHhhc-CccccCCCCChH
Q 010463 345 CSDDPRITCRKIVNWKTC-----------------LKFPE----------EPKISDEARDLICHLLC-DVETRLGTRGVE 396 (510)
Q Consensus 345 ~~~~~~~~~~~I~~~~~~-----------------~~~p~----------~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~ 396 (510)
.+.+..+....+...... ...|. .+.++..+.+||++||. +|++|| ++.
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---~~~ 278 (286)
T cd07846 202 PGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRP---SSS 278 (286)
T ss_pred CCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccch---hHH
Confidence 877655544444321111 00110 23678999999999998 999999 689
Q ss_pred HhhcCCCc
Q 010463 397 ELKEHPWF 404 (510)
Q Consensus 397 eil~HpfF 404 (510)
+|++||||
T Consensus 279 ~il~~~~~ 286 (286)
T cd07846 279 QLLHHEFF 286 (286)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=348.93 Aligned_cols=258 Identities=28% Similarity=0.470 Sum_probs=209.4
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHH-HHhcCCCCeeeEeEEeecCceEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNL-LAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~i-L~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
++|++++.||+|+||.||+|+++.+|+.||+|++.+... ...+. .+..|..+ ++..+||||+++++++.+++.+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~-~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN-SQEQK-RLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC-cHHHH-HHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 589999999999999999999999999999999876432 22233 34455554 6777999999999999999999999
Q ss_pred EeccCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHhhhhC-CeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 185 MEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQH-NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 185 mEy~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~lH~~-giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
|||++ |+|.+++.. ...+++..++.++.||+.||.|||+. +++||||||+|||++.++.+||+|||++..+...
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99997 578777654 34689999999999999999999997 9999999999999999999999999998865321
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc----CCCCccccccchhhHHH
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK----KGYGMECDWWSLGAIMY 335 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~----~~y~~~~DiwSlGvily 335 (510)
.. .....|++.|+|||++.+ .+++.++|+|||||++|
T Consensus 158 ~~---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~ 198 (283)
T cd06617 158 VA---------------------------------------KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMI 198 (283)
T ss_pred cc---------------------------------------cccccCCccccChhhcCCcccccccCccccchhhHHHHH
Confidence 00 012468999999999865 56789999999999999
Q ss_pred HHhhCCCCCCCC-ChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCch
Q 010463 336 EMLIGYPPFCSD-DPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWD 410 (510)
Q Consensus 336 Eml~G~~PF~~~-~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~ 410 (510)
||++|..||... ...+....+... ....+|. ..+|.++.+||.+||. +|.+|| +++++++||||....+.
T Consensus 199 ~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rp---~~~~il~~~~~~~~~~~ 270 (283)
T cd06617 199 ELATGRFPYDSWKTPFQQLKQVVEE-PSPQLPA-EKFSPEFQDFVNKCLKKNYKERP---NYPELLQHPFFELHLSK 270 (283)
T ss_pred HHHhCCCCCCccccCHHHHHHHHhc-CCCCCCc-cccCHHHHHHHHHHccCChhhCc---CHHHHhcCchhhhcccc
Confidence 999999999653 222333344332 2233332 3588999999999998 999999 78999999999987654
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=342.17 Aligned_cols=253 Identities=28% Similarity=0.518 Sum_probs=220.2
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEe
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 186 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmE 186 (510)
+|++++.||+|+||.||+++...+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 58899999999999999999999999999999976543 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 187 YLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 187 y~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
|++||+|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+|||++.++.++|+|||++.........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-- 157 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL-- 157 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh--
Confidence 999999999987643 5799999999999999999999999999999999999999999999999999765432100
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCC
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 344 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF 344 (510)
.....|++.|+|||++.+..++.++|+|||||++|+|++|..||
T Consensus 158 ------------------------------------~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~ 201 (256)
T cd08218 158 ------------------------------------ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAF 201 (256)
T ss_pred ------------------------------------hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCc
Confidence 01246899999999999888999999999999999999999999
Q ss_pred CCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 345 CSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 345 ~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
...+.......++... ....| ..++.++.++|.+||. +|.+|| ++.++++||||
T Consensus 202 ~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~vl~~~~~ 256 (256)
T cd08218 202 EAGNMKNLVLKIIRGS-YPPVS--SHYSYDLRNLVSQLFKRNPRDRP---SVNSILEKNFI 256 (256)
T ss_pred cCCCHHHHHHHHhcCC-CCCCc--ccCCHHHHHHHHHHhhCChhhCc---CHHHHhhCcCC
Confidence 9888777777776532 12223 4689999999999998 999999 78999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=344.07 Aligned_cols=259 Identities=32% Similarity=0.504 Sum_probs=219.9
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechh--hcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC--ceE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSE--MLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS--DFL 181 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~--~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~~ 181 (510)
.+|++.+.||+|+||.||+|.++.+|+.||+|.+.... .........+.+|+.+++.++||||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57999999999999999999999999999999885432 11234567889999999999999999999998764 468
Q ss_pred EEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 182 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
++||||++|++|.+++...+.+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++.......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 99999999999999998878899999999999999999999999999999999999999999999999999986532110
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~ 341 (510)
.. .......||+.|+|||++.+..++.++|+|||||++|||++|.
T Consensus 162 ~~-----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 206 (264)
T cd06653 162 SG-----------------------------------TGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206 (264)
T ss_pred cC-----------------------------------ccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCC
Confidence 00 0011356999999999999988999999999999999999999
Q ss_pred CCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhcCccccCCCCChHHhhcCCCc
Q 010463 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~dp~~R~~~~~~~eil~HpfF 404 (510)
+||..........++........+| ..+++.+.++|.+||.+|..|| ++.+++.|||.
T Consensus 207 ~p~~~~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~~i~~~l~~~~~r~---~~~~~~~~~~~ 264 (264)
T cd06653 207 PPWAEYEAMAAIFKIATQPTKPMLP--DGVSDACRDFLKQIFVEEKRRP---TAEFLLRHPFV 264 (264)
T ss_pred CCCCccCHHHHHHHHHcCCCCCCCC--cccCHHHHHHHHHHhcCcccCc---cHHHHhcCCCC
Confidence 9998876666666655433333444 4789999999999999889999 68899999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=362.09 Aligned_cols=255 Identities=29% Similarity=0.489 Sum_probs=211.4
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC------
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS------ 178 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~------ 178 (510)
.++|++++.||+|+||.||+|+++.+|+.||+|++.+.. ........+.+|+.+++.++||||++++++|...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 468999999999999999999999999999999986542 1333455677899999999999999999998754
Q ss_pred ceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 179 DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
..+|+||||+.+ +|...+... +++..+..++.|++.||+|||+.||+||||||+|||++.+|.+||+|||+++....
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 357999999965 888887654 89999999999999999999999999999999999999999999999999986543
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHh
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml 338 (510)
... .....||+.|+|||++.+..++.++|+|||||++|+|+
T Consensus 171 ~~~---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~ 211 (353)
T cd07850 171 SFM---------------------------------------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 211 (353)
T ss_pred CCC---------------------------------------CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHH
Confidence 210 11356899999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhhHHHHhhcccc----------------------------------ccCCC-----CCCCCHHHHHHH
Q 010463 339 IGYPPFCSDDPRITCRKIVNWKTC----------------------------------LKFPE-----EPKISDEARDLI 379 (510)
Q Consensus 339 ~G~~PF~~~~~~~~~~~I~~~~~~----------------------------------~~~p~-----~~~~s~~~~dlI 379 (510)
+|..||.+.+....+.+++..-.. ..+|. ....++.+++||
T Consensus 212 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 291 (353)
T cd07850 212 RGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLL 291 (353)
T ss_pred HCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHH
Confidence 999999887765555554321000 00010 113466799999
Q ss_pred HHhhc-CccccCCCCChHHhhcCCCcC
Q 010463 380 CHLLC-DVETRLGTRGVEELKEHPWFR 405 (510)
Q Consensus 380 ~~lL~-dp~~R~~~~~~~eil~HpfF~ 405 (510)
.+||+ ||.+|| ++.|++.||||+
T Consensus 292 ~~~L~~dP~~R~---t~~eiL~~~~~~ 315 (353)
T cd07850 292 SKMLVIDPEKRI---SVDDALQHPYIN 315 (353)
T ss_pred HHHcCCChhhCc---CHHHHhcChhHh
Confidence 99999 999999 789999999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=349.12 Aligned_cols=257 Identities=30% Similarity=0.486 Sum_probs=213.8
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecC---
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDS--- 178 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~--- 178 (510)
...++|++.+.||+|+||.||+|..+.+++.||+|++.... .....+..|+.++..+ +||||++++++|...
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 34688999999999999999999999999999999986532 2234577899999888 899999999998753
Q ss_pred --ceEEEEEeccCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCC
Q 010463 179 --DFLYLIMEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGL 252 (510)
Q Consensus 179 --~~~~lVmEy~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGl 252 (510)
+.+|+||||++||+|.+++.. ...+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||+
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~ 174 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGV 174 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeeccc
Confidence 368999999999999998753 45789999999999999999999999999999999999999999999999999
Q ss_pred cccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC-----CCCccccc
Q 010463 253 CKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-----GYGMECDW 327 (510)
Q Consensus 253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-----~y~~~~Di 327 (510)
+..+..... .....+|++.|+|||++... .++.++|+
T Consensus 175 ~~~~~~~~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di 216 (291)
T cd06639 175 SAQLTSTRL--------------------------------------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDV 216 (291)
T ss_pred chhcccccc--------------------------------------cccCccCCccccChhhhcCCCCcccccCCccch
Confidence 886543210 00134689999999998643 36899999
Q ss_pred cchhhHHHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcC
Q 010463 328 WSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 405 (510)
Q Consensus 328 wSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~ 405 (510)
|||||++|||++|++||...+.......+..+.. ........++..+.+||.+||. +|++|| ++.+|++||||+
T Consensus 217 ~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~il~~~~~~ 291 (291)
T cd06639 217 WSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPP-PTLLHPEKWCRSFNHFISQCLIKDFEARP---SVTHLLEHPFIK 291 (291)
T ss_pred HHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCC-CCCCcccccCHHHHHHHHHHhhcChhhCc---CHHHHhcCcccC
Confidence 9999999999999999988776666656554321 1222223577899999999998 999999 789999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=374.13 Aligned_cols=253 Identities=23% Similarity=0.289 Sum_probs=205.6
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
...|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+.+|+.++|||||++++++...+..|+|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 3479999999999999999999999999999996422 2356799999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccc
Q 010463 185 MEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 263 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 263 (510)
||++. |+|..++... ..+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+......
T Consensus 239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~- 316 (461)
T PHA03211 239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST- 316 (461)
T ss_pred EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc-
Confidence 99995 6888888654 56999999999999999999999999999999999999999999999999999865332100
Q ss_pred cchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCC
Q 010463 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 343 (510)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~P 343 (510)
......+||+.|+|||++.+..++.++|||||||+||||++|..|
T Consensus 317 -----------------------------------~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~ 361 (461)
T PHA03211 317 -----------------------------------PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTAS 361 (461)
T ss_pred -----------------------------------ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCC
Confidence 001235799999999999999999999999999999999998876
Q ss_pred CCCCCh-------hhhHHHHhhcccc--ccCC--------------------------CC---CCCCHHHHHHHHHhhc-
Q 010463 344 FCSDDP-------RITCRKIVNWKTC--LKFP--------------------------EE---PKISDEARDLICHLLC- 384 (510)
Q Consensus 344 F~~~~~-------~~~~~~I~~~~~~--~~~p--------------------------~~---~~~s~~~~dlI~~lL~- 384 (510)
+.+... .....+++..... ..+| .+ ..++.++.+||++||.
T Consensus 362 lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~ 441 (461)
T PHA03211 362 LFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTF 441 (461)
T ss_pred cccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHccc
Confidence 543221 1222223221100 0011 01 1467799999999999
Q ss_pred CccccCCCCChHHhhcCCCcCC
Q 010463 385 DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 385 dp~~R~~~~~~~eil~HpfF~~ 406 (510)
||.+|| ++.|+|+||||+.
T Consensus 442 DP~~RP---sa~elL~hp~f~~ 460 (461)
T PHA03211 442 DGARRP---SAAELLRLPLFQS 460 (461)
T ss_pred ChhhCc---CHHHHhhCcccCC
Confidence 999999 7899999999974
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=353.73 Aligned_cols=259 Identities=30% Similarity=0.475 Sum_probs=216.0
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhc--chhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML--KRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
+|++++.||+|+||.||+|.++.+|+.||+|.+...... .......+..|+.+++.++||||+++++++.+.+.+|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 488899999999999999999999999999999866433 122345577899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccc
Q 010463 185 MEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 263 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~~-~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 263 (510)
|||+ +|+|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|||+++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-- 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR-- 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc--
Confidence 9999 999999998776 799999999999999999999999999999999999999999999999999986543210
Q ss_pred cchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHhhCCC
Q 010463 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYP 342 (510)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml~G~~ 342 (510)
......+++.|+|||++.+ ..++.++|+|||||++|||++|.+
T Consensus 158 ------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~ 201 (298)
T cd07841 158 ------------------------------------KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVP 201 (298)
T ss_pred ------------------------------------cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCc
Confidence 0112357889999999865 467899999999999999999999
Q ss_pred CCCCCChhhhHHHHhhccccc---------cC---------C------CCCCCCHHHHHHHHHhhc-CccccCCCCChHH
Q 010463 343 PFCSDDPRITCRKIVNWKTCL---------KF---------P------EEPKISDEARDLICHLLC-DVETRLGTRGVEE 397 (510)
Q Consensus 343 PF~~~~~~~~~~~I~~~~~~~---------~~---------p------~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~e 397 (510)
||.+.+....+.++....... .. + ....++.++.+||.+||. ||++|| ++.|
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~---s~~e 278 (298)
T cd07841 202 FLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRI---TARQ 278 (298)
T ss_pred cccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCc---CHHH
Confidence 998877666555554210000 00 0 013467899999999998 999999 7899
Q ss_pred hhcCCCcCCC
Q 010463 398 LKEHPWFRGI 407 (510)
Q Consensus 398 il~HpfF~~i 407 (510)
++.||||.+.
T Consensus 279 ~l~~~~~~~~ 288 (298)
T cd07841 279 ALEHPYFSND 288 (298)
T ss_pred HhhCccccCC
Confidence 9999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=339.29 Aligned_cols=262 Identities=27% Similarity=0.450 Sum_probs=224.7
Q ss_pred hcccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecC
Q 010463 100 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDS 178 (510)
Q Consensus 100 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~ 178 (510)
+....+++.+.+..||.|+.|+|++++.+.+|...|||.|.+.. ..++.+++....+++... ++|+||+.+++|..+
T Consensus 86 r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n 163 (391)
T KOG0983|consen 86 RYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN 163 (391)
T ss_pred ccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC
Confidence 34566788888999999999999999999999999999998864 566778888888887766 599999999999999
Q ss_pred ceEEEEEeccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhh-CCeEEeecCCCCeeecCCCceeecccCCcccC
Q 010463 179 DFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 256 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~-~giiHRDLKP~NILld~~g~vkL~DFGla~~~ 256 (510)
..+++.||.|.. .+..+|.+ .++++|..+-.+...++.||.||.. .||||||+||+|||+|+.|+|||||||++-.+
T Consensus 164 ~dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrl 242 (391)
T KOG0983|consen 164 TDVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRL 242 (391)
T ss_pred chHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccccccee
Confidence 999999999943 55556554 4789999999999999999999985 69999999999999999999999999999877
Q ss_pred ccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc---CCCCccccccchhhH
Q 010463 257 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK---KGYGMECDWWSLGAI 333 (510)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~---~~y~~~~DiwSlGvi 333 (510)
.+...+ ....|.+.|||||.+.- ..|+..+||||||+.
T Consensus 243 vdSkAh---------------------------------------trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGIT 283 (391)
T KOG0983|consen 243 VDSKAH---------------------------------------TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGIT 283 (391)
T ss_pred eccccc---------------------------------------ccccCCccccCccccCCCCCCccchhhhhhhhccc
Confidence 654211 12469999999999963 469999999999999
Q ss_pred HHHHhhCCCCCCCC-ChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 334 MYEMLIGYPPFCSD-DPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 334 lyEml~G~~PF~~~-~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
|+||.||+.||.+. +.-++..+|++. .+..+|....+|+..++|+..||+ |+.+|| .-.++++|||+...
T Consensus 284 lveLaTg~yPy~~c~tdFe~ltkvln~-ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP---~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 284 LVELATGQYPYKGCKTDFEVLTKVLNE-EPPLLPGHMGFSPDFQSFVKDCLTKDHRKRP---KYNKLLEHPFIKRY 355 (391)
T ss_pred hhhhhcccCCCCCCCccHHHHHHHHhc-CCCCCCcccCcCHHHHHHHHHHhhcCcccCc---chHHHhcCcceeec
Confidence 99999999999875 455677888884 446677666799999999999998 999999 57899999999753
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=367.74 Aligned_cols=256 Identities=22% Similarity=0.315 Sum_probs=208.2
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEE-----cCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEe
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRA-----KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSF 175 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~-----~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~ 175 (510)
.+..++|++.+.||+|+||.||+|.+ ..++..||+|+++... .....+.+.+|+.+|..+ +|||||+++++|
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 34456899999999999999999974 4567789999996543 223456788999999999 899999999999
Q ss_pred ecCceEEEEEeccCCCCHHHHHHhcc------------------------------------------------------
Q 010463 176 QDSDFLYLIMEYLPGGDIMTLLMRED------------------------------------------------------ 201 (510)
Q Consensus 176 ~~~~~~~lVmEy~~gG~L~~~L~~~~------------------------------------------------------ 201 (510)
.+.+..|+|||||+||+|.+++....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 99999999999999999999986432
Q ss_pred ---------------------CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccc
Q 010463 202 ---------------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 260 (510)
Q Consensus 202 ---------------------~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~ 260 (510)
.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 46788899999999999999999999999999999999999999999999998654321
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh-
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI- 339 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~- 339 (510)
.. .......+++.|+|||++.+..++.++|||||||++|||++
T Consensus 269 ~~------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~ 312 (375)
T cd05104 269 NY------------------------------------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSL 312 (375)
T ss_pred cc------------------------------------cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhc
Confidence 00 00012346778999999999999999999999999999998
Q ss_pred CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 340 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 340 G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
|.+||.+........+++........| ...+.++++||.+||+ ||++|| ++.||++
T Consensus 313 g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RP---s~~eil~ 369 (375)
T cd05104 313 GSSPYPGMPVDSKFYKMIKEGYRMLSP--ECAPSEMYDIMKSCWDADPLKRP---TFKQIVQ 369 (375)
T ss_pred CCCCCCCCCchHHHHHHHHhCccCCCC--CCCCHHHHHHHHHHccCChhHCc---CHHHHHH
Confidence 899998766554444444322222223 3578899999999998 999999 5777764
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=356.79 Aligned_cols=249 Identities=24% Similarity=0.449 Sum_probs=193.0
Q ss_pred eeeecCCCeEEEEEEEcC--CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEee--cCceEEEEEec
Q 010463 112 TLIGKGAFGEVRLCRAKT--TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ--DSDFLYLIMEY 187 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~--tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~--~~~~~~lVmEy 187 (510)
..||+|+||+||+|+.+. ++..||+|.+..... ...+.+|+.+|+.++||||+++++++. ++..+|+||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 579999999999999765 668899999875422 234778999999999999999999885 45689999999
Q ss_pred cCCCCHHHHHHhc---------cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeee----cCCCceeecccCCcc
Q 010463 188 LPGGDIMTLLMRE---------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL----DKNGHLKLSDFGLCK 254 (510)
Q Consensus 188 ~~gG~L~~~L~~~---------~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILl----d~~g~vkL~DFGla~ 254 (510)
+++ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.+|.+||+|||+|+
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 865 787776421 258899999999999999999999999999999999999 567899999999998
Q ss_pred cCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhH
Q 010463 255 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAI 333 (510)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvi 333 (510)
......... ......+||+.|+|||++.+ ..++.++|||||||+
T Consensus 161 ~~~~~~~~~-----------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~i 205 (317)
T cd07867 161 LFNSPLKPL-----------------------------------ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCI 205 (317)
T ss_pred ccCCCcccc-----------------------------------cccCcceecccccCcHHhcCCCccCcHHHHHhHHHH
Confidence 664321100 00124579999999999986 458999999999999
Q ss_pred HHHHhhCCCCCCCCChhh---------hHHHHhh---------ccc---cccC----------------------CCCCC
Q 010463 334 MYEMLIGYPPFCSDDPRI---------TCRKIVN---------WKT---CLKF----------------------PEEPK 370 (510)
Q Consensus 334 lyEml~G~~PF~~~~~~~---------~~~~I~~---------~~~---~~~~----------------------p~~~~ 370 (510)
+|||++|.+||....... ...++.. |.. ...+ .....
T Consensus 206 l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (317)
T cd07867 206 FAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVK 285 (317)
T ss_pred HHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCC
Confidence 999999999997543211 1111110 000 0000 00123
Q ss_pred CCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 371 ISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 371 ~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
.+..+.+||.+||+ ||.+|| +++|+++||||
T Consensus 286 ~~~~~~~ll~~~l~~dP~~R~---t~~e~l~hp~f 317 (317)
T cd07867 286 PDSKVFLLLQKLLTMDPTKRI---TSEQALQDPYF 317 (317)
T ss_pred CChHHHHHHHHHhccCccccc---CHHHHhcCCCC
Confidence 46778999999999 999999 78999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=348.91 Aligned_cols=254 Identities=31% Similarity=0.498 Sum_probs=211.5
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeec-----
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQD----- 177 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~----- 177 (510)
..+.|++.+.||.|+||.||+|+++.+++.||+|++.... .....+..|+.++..+ +||||++++++|..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 4578999999999999999999999999999999986542 2345678899999888 79999999999853
Q ss_pred -CceEEEEEeccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcc
Q 010463 178 -SDFLYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCK 254 (510)
Q Consensus 178 -~~~~~lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~ 254 (510)
...+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 46899999999999999998653 458899999999999999999999999999999999999999999999999987
Q ss_pred cCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc-----cCCCCccccccc
Q 010463 255 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDWWS 329 (510)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-----~~~y~~~~DiwS 329 (510)
....... .....+|++.|+|||++. +..++.++|+||
T Consensus 170 ~~~~~~~--------------------------------------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~Dvws 211 (282)
T cd06636 170 QLDRTVG--------------------------------------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWS 211 (282)
T ss_pred hhhcccc--------------------------------------CCCcccccccccCHhhcCcccCcCcCCCcccchhH
Confidence 5532100 012357999999999986 356888999999
Q ss_pred hhhHHHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 330 LGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 330 lGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
|||++|||++|.+||....+......+.... .... ....++.++.+||.+||. ||.+|| ++.||++||||
T Consensus 212 lG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~li~~cl~~~p~~Rp---~~~ell~~~~~ 282 (282)
T cd06636 212 LGITAIEMAEGAPPLCDMHPMRALFLIPRNP-PPKL-KSKKWSKKFIDFIEGCLVKNYLSRP---STEQLLKHPFI 282 (282)
T ss_pred HHHHHHHHHhCCCCccccCHHhhhhhHhhCC-CCCC-cccccCHHHHHHHHHHhCCChhhCc---CHHHHhcCCCC
Confidence 9999999999999998766555444443321 1111 123688999999999998 999999 78999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=351.25 Aligned_cols=261 Identities=31% Similarity=0.475 Sum_probs=214.1
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
.++|++.+.||+|+||.||+|.++.+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 3689999999999999999999999999999999866432 223446688899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhccC--CCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecC-CCceeecccCCcccCccccc
Q 010463 185 MEYLPGGDIMTLLMREDI--LSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK-NGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~~~--l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~-~g~vkL~DFGla~~~~~~~~ 261 (510)
|||++ ++|..++..... +++..++.++.||+.||+|||+.||+||||||+||+++. ++.+||+|||++........
T Consensus 80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 99996 588888765433 588889999999999999999999999999999999985 56799999999976432100
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHhhC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIG 340 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml~G 340 (510)
.....+|++.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 159 --------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg 200 (294)
T PLN00009 159 --------------------------------------TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQ 200 (294)
T ss_pred --------------------------------------ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 0113468999999999876 4578999999999999999999
Q ss_pred CCCCCCCChhhhHHHHhhccccc----------------cCC---------CCCCCCHHHHHHHHHhhc-CccccCCCCC
Q 010463 341 YPPFCSDDPRITCRKIVNWKTCL----------------KFP---------EEPKISDEARDLICHLLC-DVETRLGTRG 394 (510)
Q Consensus 341 ~~PF~~~~~~~~~~~I~~~~~~~----------------~~p---------~~~~~s~~~~dlI~~lL~-dp~~R~~~~~ 394 (510)
.+||.+.+......++....... .+| ..+.++++++++|.+||. +|++|| +
T Consensus 201 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp---s 277 (294)
T PLN00009 201 KPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRI---T 277 (294)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCc---C
Confidence 99999877766665554311100 000 013578999999999998 999999 6
Q ss_pred hHHhhcCCCcCCCC
Q 010463 395 VEELKEHPWFRGIQ 408 (510)
Q Consensus 395 ~~eil~HpfF~~i~ 408 (510)
+++++.||||.+++
T Consensus 278 ~~~~l~~~~~~~~~ 291 (294)
T PLN00009 278 ARAALEHEYFKDLG 291 (294)
T ss_pred HHHHhcCchHhHHh
Confidence 89999999998754
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=348.58 Aligned_cols=256 Identities=29% Similarity=0.472 Sum_probs=210.9
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEe-----e
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSF-----Q 176 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~-----~ 176 (510)
...++|++++.||+|+||.||+|.++.+++.||+|++.... .....+.+|..++..+ +||||+++++++ .
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 45689999999999999999999999999999999886432 1234577899999998 799999999987 3
Q ss_pred cCceEEEEEeccCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCC
Q 010463 177 DSDFLYLIMEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGL 252 (510)
Q Consensus 177 ~~~~~~lVmEy~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGl 252 (510)
+.+.+|+||||++||+|.+++.. ...+++..++.++.|++.||.|||+.+|+||||||+||+++.+|.+||+|||+
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~ 170 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGV 170 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCc
Confidence 45689999999999999988753 35689999999999999999999999999999999999999999999999999
Q ss_pred cccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-----CCCCccccc
Q 010463 253 CKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-----KGYGMECDW 327 (510)
Q Consensus 253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-----~~y~~~~Di 327 (510)
++.+..... .....+||+.|+|||++.. ..++.++||
T Consensus 171 ~~~~~~~~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv 212 (286)
T cd06638 171 SAQLTSTRL--------------------------------------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDV 212 (286)
T ss_pred eeecccCCC--------------------------------------ccccccCCCcccChhhhchhhhccccccchhhh
Confidence 986543210 0113469999999999853 457899999
Q ss_pred cchhhHHHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 328 WSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 328 wSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
|||||++|||++|.+||...+......++.... .........++..+.+||.+||. ||++|| ++.||++||||
T Consensus 213 ~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~ell~~~~~ 286 (286)
T cd06638 213 WSLGITAIELGDGDPPLADLHPMRALFKIPRNP-PPTLHQPELWSNEFNDFIRKCLTKDYEKRP---TVSDLLQHVFI 286 (286)
T ss_pred hhHHHHHHHHhcCCCCCCCCchhHHHhhccccC-CCcccCCCCcCHHHHHHHHHHccCCcccCC---CHHHHhhcccC
Confidence 999999999999999998776554444433221 11111223568899999999998 999999 78999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=350.03 Aligned_cols=255 Identities=22% Similarity=0.361 Sum_probs=215.2
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCC-----CEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTG-----EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 177 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg-----~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 177 (510)
+..++|++++.||+|+||.||+|.....+ ..||+|.+.... .......+.+|+.++..++||||+++++++.+
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 79 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK 79 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence 45678999999999999999999987655 689999986542 23345668899999999999999999999999
Q ss_pred CceEEEEEeccCCCCHHHHHHhc----------------cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecC
Q 010463 178 SDFLYLIMEYLPGGDIMTLLMRE----------------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK 241 (510)
Q Consensus 178 ~~~~~lVmEy~~gG~L~~~L~~~----------------~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~ 241 (510)
....|++|||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE 159 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence 99999999999999999999764 45788999999999999999999999999999999999999
Q ss_pred CCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCC
Q 010463 242 NGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY 321 (510)
Q Consensus 242 ~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y 321 (510)
++.+||+|||+++........ .......+|+.|+|||++.+..+
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~~~~~~ 203 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYY------------------------------------RVQSKSLLPVRWMPPEAILYGKF 203 (283)
T ss_pred CCcEEECCCcceeeccccccc------------------------------------cccCCCcccccccCHHHhccCcC
Confidence 999999999999865322100 00113467899999999998999
Q ss_pred CccccccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhh
Q 010463 322 GMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 399 (510)
Q Consensus 322 ~~~~DiwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil 399 (510)
+.++|||||||++|||++ |..||.+.+..+....|.... ....| ..+++++.+|+.+||. ||.+|| ++.+|+
T Consensus 204 ~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~-~~~~~--~~~~~~~~~l~~~c~~~~p~~Rp---~~~~i~ 277 (283)
T cd05048 204 TTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ-LLPCP--EDCPARVYALMIECWNEIPARRP---RFKDIH 277 (283)
T ss_pred chhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-cCCCc--ccCCHHHHHHHHHHccCChhhCc---CHHHHH
Confidence 999999999999999998 999999988877777766432 22233 4789999999999998 999999 678887
Q ss_pred cC
Q 010463 400 EH 401 (510)
Q Consensus 400 ~H 401 (510)
+|
T Consensus 278 ~~ 279 (283)
T cd05048 278 TR 279 (283)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=346.02 Aligned_cols=253 Identities=16% Similarity=0.261 Sum_probs=211.2
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEc---CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAK---TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 179 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~---~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 179 (510)
+..++|++.+.||+|+||.||+|..+ ..+..||+|+++... .......+.+|+.+|..++||||+++++++...+
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 79 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN 79 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence 44578999999999999999999875 356789999987542 2344567889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 180 FLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
.+|+||||++||+|.+++.+. ..+++..++.++.||+.||+|||+.|++||||||+|||++.++.+||+|||++.....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999999999774 5789999999999999999999999999999999999999999999999998765321
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHh
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml 338 (510)
.... ......+++.|+|||++.+..++.++|||||||++|||+
T Consensus 160 ~~~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell 202 (266)
T cd05064 160 EAIY-------------------------------------TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVM 202 (266)
T ss_pred cchh-------------------------------------cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHh
Confidence 1000 001234678899999999999999999999999999977
Q ss_pred h-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 339 I-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 339 ~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
+ |.+||.+.+.......+... ...|....++..+.+++.+|+. +|.+|| ++++|++
T Consensus 203 ~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~c~~~~p~~RP---~~~~i~~ 260 (266)
T cd05064 203 SYGERPYWDMSGQDVIKAVEDG---FRLPAPRNCPNLLHQLMLDCWQKERGERP---RFSQIHS 260 (266)
T ss_pred cCCCCCcCcCCHHHHHHHHHCC---CCCCCCCCCCHHHHHHHHHHcCCCchhCC---CHHHHHH
Confidence 5 99999988877766666543 2223335788999999999998 999999 5666653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=374.99 Aligned_cols=243 Identities=36% Similarity=0.623 Sum_probs=211.3
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCceEE
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~~ 182 (510)
..++|++...+|.|+|+.|..|.++.+++.+|+|++.+.. ....+|..++... +||||+++.+.+.+..+.|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceee
Confidence 3578899999999999999999999999999999998762 1234566666554 8999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeee-cCCCceeecccCCcccCccccc
Q 010463 183 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL-DKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILl-d~~g~vkL~DFGla~~~~~~~~ 261 (510)
+|||++.||.|.+.+.....++ ..+..|++||+.|+.|||++|||||||||+|||+ ++.|+++|+|||.++.....
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 9999999999999998877766 8888999999999999999999999999999999 69999999999999876432
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~ 341 (510)
..+.|-|..|.|||++...+|+.+||||||||+||+||+|+
T Consensus 470 ---------------------------------------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~ 510 (612)
T KOG0603|consen 470 ---------------------------------------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGR 510 (612)
T ss_pred ---------------------------------------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCC
Confidence 12457899999999999999999999999999999999999
Q ss_pred CCCCCCChh-hhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 342 PPFCSDDPR-ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 342 ~PF~~~~~~-~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
+||.+.... ++..+|.. .++. ..+|++|+|||++||+ ||.+|| ++.+|+.||||
T Consensus 511 tp~~~~P~~~ei~~~i~~----~~~s--~~vS~~AKdLl~~LL~~dP~~Rl---~~~~i~~h~w~ 566 (612)
T KOG0603|consen 511 TLFAAHPAGIEIHTRIQM----PKFS--ECVSDEAKDLLQQLLQVDPALRL---GADEIGAHPWF 566 (612)
T ss_pred CccccCCchHHHHHhhcC----Cccc--cccCHHHHHHHHHhccCChhhCc---ChhhhccCcch
Confidence 999765544 44444433 2333 4899999999999999 999999 68999999999
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=382.93 Aligned_cols=268 Identities=24% Similarity=0.374 Sum_probs=203.1
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCC-CEEEEE--------------EeechhhcchhhHHHHHHHHHHHHhcCCCCee
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTG-EIFAMK--------------KLKKSEMLKRGQVEHVRSERNLLAEVDSRCIV 169 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg-~~vAiK--------------~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv 169 (510)
.++|++++.||+|+||+||+|..+... ..++.| ++.+...........+.+|+.+|..++|||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999998865432 222222 11111111223345688999999999999999
Q ss_pred eEeEEeecCceEEEEEeccCCCCHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCc
Q 010463 170 QLFYSFQDSDFLYLIMEYLPGGDIMTLLMRE-----DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH 244 (510)
Q Consensus 170 ~l~~~~~~~~~~~lVmEy~~gG~L~~~L~~~-----~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~ 244 (510)
++++++.+.+..|+|||++. ++|..++... .......++.++.||+.||.|||++|||||||||+||||+.+|.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 99999999999999999995 5787776542 23446778889999999999999999999999999999999999
Q ss_pred eeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCcc
Q 010463 245 LKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGME 324 (510)
Q Consensus 245 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~ 324 (510)
+||+|||+++.+..... ......+||+.|+|||++.+..|+.+
T Consensus 306 vkL~DFGla~~~~~~~~-------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~ 348 (501)
T PHA03210 306 IVLGDFGTAMPFEKERE-------------------------------------AFDYGWVGTVATNSPEILAGDGYCEI 348 (501)
T ss_pred EEEEeCCCceecCcccc-------------------------------------cccccccCCcCCCCchhhcCCCCCcH
Confidence 99999999986643210 01124689999999999999999999
Q ss_pred ccccchhhHHHHHhhCCCCCCC-C--ChhhhHHHHhhccc--cccCCC--------------------------CCCCCH
Q 010463 325 CDWWSLGAIMYEMLIGYPPFCS-D--DPRITCRKIVNWKT--CLKFPE--------------------------EPKISD 373 (510)
Q Consensus 325 ~DiwSlGvilyEml~G~~PF~~-~--~~~~~~~~I~~~~~--~~~~p~--------------------------~~~~s~ 373 (510)
+|||||||++|||++|..|+.+ . ++.....+++.... ...+|. ...++.
T Consensus 349 ~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 428 (501)
T PHA03210 349 TDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPA 428 (501)
T ss_pred HHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCCh
Confidence 9999999999999998754432 2 22223333222100 001110 124667
Q ss_pred HHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchhhh
Q 010463 374 EARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLY 413 (510)
Q Consensus 374 ~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l~ 413 (510)
++.++|.+||+ ||.+|| ++.|++.||||.+.....+.
T Consensus 429 ~~~~li~kmL~~DP~~Rp---sa~elL~hp~f~~~~~~~~~ 466 (501)
T PHA03210 429 DFEYPLVKMLTFDWHLRP---GAAELLALPLFSAEEEEEIL 466 (501)
T ss_pred HHHHHHHHHhccCcccCc---CHHHHhhChhhhcCCchHHH
Confidence 88899999999 999999 78999999999998877664
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=347.91 Aligned_cols=274 Identities=39% Similarity=0.711 Sum_probs=227.3
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEeEEeecCceEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~~~lV 184 (510)
++|.+.+.||+|+||.||+|..+.+|+.||+|++.+...........+..|..++..+. ||||+++++++.+.+.+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999998866555555677889999999998 99999999999999999999
Q ss_pred EeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 185 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
|||++||+|.+++.+.+.+++..+..++.|++.||.+||+.|++|+||||+||+++.+|+++|+|||++...........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 99999999999999988999999999999999999999999999999999999999999999999999986644211100
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCC
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 344 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF 344 (510)
... ... ...... ..........+|++.|+|||++....++.++|+|||||++++|++|.+||
T Consensus 161 ~~~-~~~-----~~~~~~------------~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 222 (280)
T cd05581 161 NKG-DAT-----NIDSQI------------EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF 222 (280)
T ss_pred CCC-CCc-----cccccc------------cccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCC
Confidence 000 000 000000 00001122457899999999999888999999999999999999999999
Q ss_pred CCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCh----HHhhcCCCc
Q 010463 345 CSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGV----EELKEHPWF 404 (510)
Q Consensus 345 ~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~----~eil~HpfF 404 (510)
...+....+..+.. ....+| ..+++.+.+||.+||. +|.+|| ++ +++++||||
T Consensus 223 ~~~~~~~~~~~~~~--~~~~~~--~~~~~~~~~li~~~l~~~p~~R~---~~~~~~~~ll~~~~~ 280 (280)
T cd05581 223 RGSNEYLTFQKILK--LEYSFP--PNFPPDAKDLIEKLLVLDPQDRL---GVNEGYDELKAHPFF 280 (280)
T ss_pred CCccHHHHHHHHHh--cCCCCC--CccCHHHHHHHHHHhcCCHhhCC---CcccCHHHHhcCCCC
Confidence 98887666666654 233444 3779999999999998 999999 56 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=349.84 Aligned_cols=257 Identities=31% Similarity=0.488 Sum_probs=216.1
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEe
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 186 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmE 186 (510)
+|++.+.||.|+||.||+|.++.+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL-EGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc-cchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 58899999999999999999999999999999976543 23445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 187 YLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 187 y~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
|+ |++|.+++.. ...+++..++.++.||+.||.|||+.||+|+||||+||+++.+|.++|+|||++........
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~---- 154 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP---- 154 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC----
Confidence 99 9999999865 45799999999999999999999999999999999999999999999999999986643210
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC-CCCccccccchhhHHHHHhhCCCCC
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEMLIGYPPF 344 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiwSlGvilyEml~G~~PF 344 (510)
.......||+.|+|||++.+. .++.++|||||||++|||++|.+||
T Consensus 155 ---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~ 201 (286)
T cd07832 155 ---------------------------------RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLF 201 (286)
T ss_pred ---------------------------------CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCc
Confidence 001135799999999998754 4689999999999999999999999
Q ss_pred CCCChhhhHHHHhhccc-----------------cccCCC---------CCCCCHHHHHHHHHhhc-CccccCCCCChHH
Q 010463 345 CSDDPRITCRKIVNWKT-----------------CLKFPE---------EPKISDEARDLICHLLC-DVETRLGTRGVEE 397 (510)
Q Consensus 345 ~~~~~~~~~~~I~~~~~-----------------~~~~p~---------~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~e 397 (510)
.+.+....+..+...-. ...++. .+.++.++++||++||. +|.+|| ++++
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~---~~~~ 278 (286)
T cd07832 202 PGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRL---SAAE 278 (286)
T ss_pred CCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCC---CHHH
Confidence 88777666655543110 011111 12567999999999999 999999 7899
Q ss_pred hhcCCCcC
Q 010463 398 LKEHPWFR 405 (510)
Q Consensus 398 il~HpfF~ 405 (510)
+++||||.
T Consensus 279 ~l~h~~~~ 286 (286)
T cd07832 279 ALRHPYFT 286 (286)
T ss_pred HhhCcCcC
Confidence 99999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=341.23 Aligned_cols=248 Identities=30% Similarity=0.517 Sum_probs=214.2
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEe
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 186 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmE 186 (510)
+|++.+.||.|+||.||+++++.+++.||+|.+.... .....+.+..|..+++.++||||+++++++.+.+.+|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 5899999999999999999999999999999986542 23456678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 187 YLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 187 y~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
|++||+|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--- 155 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--- 155 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc---
Confidence 99999999988653 4689999999999999999999999999999999999999999999999999876533210
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCC
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 344 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF 344 (510)
......|++.|+|||++.+..++.++|+|||||++|+|++|.+||
T Consensus 156 -----------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~ 200 (255)
T cd08219 156 -----------------------------------YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPF 200 (255)
T ss_pred -----------------------------------ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCC
Confidence 011357999999999999989999999999999999999999999
Q ss_pred CCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 345 CSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 345 ~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
.+.+.......+.... ....| ..++..+++||.+||. ||++|| ++.+|+.
T Consensus 201 ~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~P~~Rp---~~~~il~ 251 (255)
T cd08219 201 QANSWKNLILKVCQGS-YKPLP--SHYSYELRSLIKQMFKRNPRSRP---SATTILS 251 (255)
T ss_pred CCCCHHHHHHHHhcCC-CCCCC--cccCHHHHHHHHHHHhCCcccCC---CHHHHhh
Confidence 9888777766665422 11223 3688999999999998 999999 6788875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=342.06 Aligned_cols=260 Identities=31% Similarity=0.498 Sum_probs=221.6
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEe
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 186 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmE 186 (510)
.|.+.+.||+|+||.||+|....+++.||+|++..... .......+..|+.+++.++||||+++++.+.+.+.+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN-DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc-chHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 47889999999999999999999999999999987643 24567889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccch
Q 010463 187 YLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 266 (510)
Q Consensus 187 y~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~ 266 (510)
|+++++|.+++.+...+++..++.++.+++.||.|||+.||+|+||+|+||+++.++.+||+|||++..........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~--- 156 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM--- 156 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc---
Confidence 99999999999888789999999999999999999999999999999999999999999999999998764321100
Q ss_pred hhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCC---CCccccccchhhHHHHHhhCCCC
Q 010463 267 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG---YGMECDWWSLGAIMYEMLIGYPP 343 (510)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~---y~~~~DiwSlGvilyEml~G~~P 343 (510)
........|++.|+|||++.+.. ++.++|+|||||++|||++|..|
T Consensus 157 -------------------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~p 205 (264)
T cd06626 157 -------------------------------GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205 (264)
T ss_pred -------------------------------cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCC
Confidence 00011356899999999998766 89999999999999999999999
Q ss_pred CCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 344 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 344 F~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
|.+.+........+.......+|....+++.+.+||++||. +|.+|| ++.+++.|||+
T Consensus 206 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~---~~~~i~~~~~~ 264 (264)
T cd06626 206 WSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRP---TASELLQHPFV 264 (264)
T ss_pred ccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCC---CHHHHhcCCCC
Confidence 97654333333233333445666655679999999999998 999999 68999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=349.08 Aligned_cols=256 Identities=29% Similarity=0.496 Sum_probs=207.3
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
.++|++++.||.|+||.||+|..+.+++.||||.+.... .......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEH--EEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccc--ccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 578999999999999999999999999999999987542 122234467899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccc
Q 010463 185 MEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 263 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 263 (510)
|||+++ +|.+++.+. ..+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+++.......
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-- 158 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-- 158 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc--
Confidence 999985 999988764 4689999999999999999999999999999999999999999999999999875422100
Q ss_pred cchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHhhCCC
Q 010463 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYP 342 (510)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml~G~~ 342 (510)
.....++++.|+|||++.+ ..++.++|||||||++|||++|.+
T Consensus 159 ------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~ 202 (291)
T cd07844 159 ------------------------------------TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRP 202 (291)
T ss_pred ------------------------------------cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCC
Confidence 0012357899999999876 568999999999999999999999
Q ss_pred CCCCCC-hhhhHHHHhhccc-----------------cccCC---------CCCCCC--HHHHHHHHHhhc-CccccCCC
Q 010463 343 PFCSDD-PRITCRKIVNWKT-----------------CLKFP---------EEPKIS--DEARDLICHLLC-DVETRLGT 392 (510)
Q Consensus 343 PF~~~~-~~~~~~~I~~~~~-----------------~~~~p---------~~~~~s--~~~~dlI~~lL~-dp~~R~~~ 392 (510)
||.+.+ .......+.+... ...++ ..+.++ .++.++|.+||+ +|++||
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rp-- 280 (291)
T cd07844 203 LFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRI-- 280 (291)
T ss_pred CCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCccccc--
Confidence 997665 2222222211000 00000 001344 889999999998 999999
Q ss_pred CChHHhhcCCCc
Q 010463 393 RGVEELKEHPWF 404 (510)
Q Consensus 393 ~~~~eil~HpfF 404 (510)
++.+++.||||
T Consensus 281 -s~~e~l~~~~f 291 (291)
T cd07844 281 -SAAEAMKHPYF 291 (291)
T ss_pred -CHHHHhcCCCC
Confidence 68999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=341.12 Aligned_cols=254 Identities=35% Similarity=0.570 Sum_probs=217.7
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhh--cchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEM--LKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
.|+..+.||+|+||+||+|..+.+++.||+|.+..... ......+.+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 36677899999999999999998999999999876432 1234567789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 185 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
|||++|++|.+++.+...+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---- 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc----
Confidence 9999999999999888889999999999999999999999999999999999999999999999999988653321
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCC-CCccccccchhhHHHHHhhCCCC
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG-YGMECDWWSLGAIMYEMLIGYPP 343 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~-y~~~~DiwSlGvilyEml~G~~P 343 (510)
......|++.|+|||.+.... ++.++|+|||||++|+|++|.+|
T Consensus 157 -----------------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~p 201 (258)
T cd06632 157 -----------------------------------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201 (258)
T ss_pred -----------------------------------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCC
Confidence 011356999999999998776 89999999999999999999999
Q ss_pred CCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 344 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 344 F~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
|..........++........+| ..+++++.+||++||+ +|.+|| ++.+++.|||+
T Consensus 202 f~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~~l~~~~~ 258 (258)
T cd06632 202 WSQLEGVAAVFKIGRSKELPPIP--DHLSDEAKDFILKCLQRDPSLRP---TAAELLEHPFV 258 (258)
T ss_pred cccCcHHHHHHHHHhcccCCCcC--CCcCHHHHHHHHHHhhcCcccCc---CHHHHhcCCCC
Confidence 98766555444444322223333 3689999999999998 999999 78999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=349.63 Aligned_cols=257 Identities=32% Similarity=0.499 Sum_probs=210.6
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEeEEeecCce----
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSDF---- 180 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~---- 180 (510)
++|++.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM-DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhc-cccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 47999999999999999999999999999999986542 22333456788999999995 6999999999987665
Q ss_pred -EEEEEeccCCCCHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecC-CCceeecccCCc
Q 010463 181 -LYLIMEYLPGGDIMTLLMRE-----DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK-NGHLKLSDFGLC 253 (510)
Q Consensus 181 -~~lVmEy~~gG~L~~~L~~~-----~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~-~g~vkL~DFGla 253 (510)
.|+||||+++ +|..++... ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999986 888887653 35799999999999999999999999999999999999998 899999999998
Q ss_pred ccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhh
Q 010463 254 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGA 332 (510)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGv 332 (510)
..+..... ......+++.|+|||++.+ ..++.++|+|||||
T Consensus 159 ~~~~~~~~--------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ 200 (295)
T cd07837 159 RAFSIPVK--------------------------------------SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGC 200 (295)
T ss_pred eecCCCcc--------------------------------------ccCCcccccCCCChHHhhCCCCCCchHHHHHHHH
Confidence 86532100 0112368899999999875 45799999999999
Q ss_pred HHHHHhhCCCCCCCCChhhhHHHHhhcccc---------------ccCCC---------CCCCCHHHHHHHHHhhc-Ccc
Q 010463 333 IMYEMLIGYPPFCSDDPRITCRKIVNWKTC---------------LKFPE---------EPKISDEARDLICHLLC-DVE 387 (510)
Q Consensus 333 ilyEml~G~~PF~~~~~~~~~~~I~~~~~~---------------~~~p~---------~~~~s~~~~dlI~~lL~-dp~ 387 (510)
++|+|++|.+||.+.+......++...... ..+|. .+.+++++.+||.+||. ||.
T Consensus 201 ~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~ 280 (295)
T cd07837 201 IFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPA 280 (295)
T ss_pred HHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChh
Confidence 999999999999988776665555431100 00110 13588999999999998 999
Q ss_pred ccCCCCChHHhhcCCCcC
Q 010463 388 TRLGTRGVEELKEHPWFR 405 (510)
Q Consensus 388 ~R~~~~~~~eil~HpfF~ 405 (510)
+|| +++|++.||||+
T Consensus 281 ~R~---~~~eil~~~~~~ 295 (295)
T cd07837 281 KRI---SAKAALTHPYFD 295 (295)
T ss_pred hcC---CHHHHhcCCCcC
Confidence 999 789999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=342.37 Aligned_cols=257 Identities=29% Similarity=0.515 Sum_probs=221.7
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++|++.+.||+|++|.||+|.++.+|+.||+|++..... ......+.+|+.++..++||||+++++++...+.+|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 479999999999999999999999999999999876532 144567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhh-CCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~-~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
||++|++|.+++.....+++..+..++.|++.||.|||+ .|++||||+|+||+++.+|.++|+|||++........
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~--- 155 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD--- 155 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC---
Confidence 999999999999888889999999999999999999999 9999999999999999999999999999986543211
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCC
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 344 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF 344 (510)
......|+..|+|||++.+..++.++|+||||+++|+|++|.+||
T Consensus 156 -----------------------------------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~ 200 (264)
T cd06623 156 -----------------------------------QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPF 200 (264)
T ss_pred -----------------------------------cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 011346899999999999999999999999999999999999999
Q ss_pred CCCC---hhhhHHHHhhccccccCCCCCC-CCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCC
Q 010463 345 CSDD---PRITCRKIVNWKTCLKFPEEPK-ISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 408 (510)
Q Consensus 345 ~~~~---~~~~~~~I~~~~~~~~~p~~~~-~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~ 408 (510)
.+.+ .......+... .....+ .. ++..+.++|++||. +|++|| +++++++||||+.++
T Consensus 201 ~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~l~~li~~~l~~~p~~R~---~~~~ll~~~~~~~~~ 263 (264)
T cd06623 201 LPPGQPSFFELMQAICDG-PPPSLP--AEEFSPEFRDFISACLQKDPKKRP---SAAELLQHPFIKKAD 263 (264)
T ss_pred ccccccCHHHHHHHHhcC-CCCCCC--cccCCHHHHHHHHHHccCChhhCC---CHHHHHhCHHHHhcc
Confidence 8774 33344444421 122222 24 88999999999998 999999 789999999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=351.01 Aligned_cols=255 Identities=20% Similarity=0.337 Sum_probs=204.9
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcC----------------CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCC
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKT----------------TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 167 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~----------------tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~ 167 (510)
..++|.+.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+|..++|||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCC
Confidence 45689999999999999999998643 34579999987542 2334567889999999999999
Q ss_pred eeeEeEEeecCceEEEEEeccCCCCHHHHHHhcc-------------------CCCHHHHHHHHHHHHHHHHhhhhCCeE
Q 010463 168 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED-------------------ILSEDVARFYIAESVLAIHSIHQHNYV 228 (510)
Q Consensus 168 Iv~l~~~~~~~~~~~lVmEy~~gG~L~~~L~~~~-------------------~l~e~~~~~~~~qi~~aL~~lH~~gii 228 (510)
|+++++++.+.+..|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+.||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999999999999999999999999986532 367788899999999999999999999
Q ss_pred EeecCCCCeeecCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccC
Q 010463 229 HRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTL 308 (510)
Q Consensus 229 HRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~ 308 (510)
||||||+|||++.++.+||+|||+++.+...... .......+++
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~------------------------------------~~~~~~~~~~ 204 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY------------------------------------RIQGRAVLPI 204 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCcee------------------------------------EecCcCCCCc
Confidence 9999999999999999999999999865332110 0011245788
Q ss_pred CCcchHhhccCCCCccccccchhhHHHHHhh--CCCCCCCCChhhhHHHHhhc----cccccCCCCCCCCHHHHHHHHHh
Q 010463 309 DYMAPEVLLKKGYGMECDWWSLGAIMYEMLI--GYPPFCSDDPRITCRKIVNW----KTCLKFPEEPKISDEARDLICHL 382 (510)
Q Consensus 309 ~Y~APEvl~~~~y~~~~DiwSlGvilyEml~--G~~PF~~~~~~~~~~~I~~~----~~~~~~p~~~~~s~~~~dlI~~l 382 (510)
.|+|||++.+..++.++|||||||++|||++ |..||.+.+.......+... .........+.++..+.+||.+|
T Consensus 205 ~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 284 (304)
T cd05096 205 RWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQC 284 (304)
T ss_pred cccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHH
Confidence 9999999999999999999999999999986 67888876665554443221 01111112246789999999999
Q ss_pred hc-CccccCCCCChHHhh
Q 010463 383 LC-DVETRLGTRGVEELK 399 (510)
Q Consensus 383 L~-dp~~R~~~~~~~eil 399 (510)
|. ||.+|| ++++|.
T Consensus 285 l~~~p~~RP---s~~~i~ 299 (304)
T cd05096 285 WSRDCRERP---SFSDIH 299 (304)
T ss_pred ccCCchhCc---CHHHHH
Confidence 98 999999 567773
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=339.84 Aligned_cols=252 Identities=29% Similarity=0.553 Sum_probs=219.2
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEe
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 186 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmE 186 (510)
+|++++.||+|+||.||+|..+.+++.||+|.+....+ ...+...+.+|+.+|+.++||||+++++.+...+.+++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 58999999999999999999999999999999986544 34456788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCC-ceeecccCCcccCccccccc
Q 010463 187 YLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG-HLKLSDFGLCKPLEDKYSSI 263 (510)
Q Consensus 187 y~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g-~vkL~DFGla~~~~~~~~~~ 263 (510)
|++||+|.+++... ..+++..+..++.+++.||+|||++||+||||||+||+++.++ .+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-- 157 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK-- 157 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc--
Confidence 99999999999764 3589999999999999999999999999999999999998655 579999999986543210
Q ss_pred cchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCC
Q 010463 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 343 (510)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~P 343 (510)
....+|++.|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus 158 -------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~ 200 (256)
T cd08220 158 -------------------------------------AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRA 200 (256)
T ss_pred -------------------------------------ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCC
Confidence 1124689999999999988899999999999999999999999
Q ss_pred CCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 344 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 344 F~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
|.+.+.......+.... ...++ ..++.+++++|.+||. +|.+|| ++.|+++||||
T Consensus 201 ~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rp---t~~~ll~~p~~ 256 (256)
T cd08220 201 FEAANLPALVLKIMSGT-FAPIS--DRYSPDLRQLILSMLNLDPSKRP---QLSQIMAQPIC 256 (256)
T ss_pred cccCchHHHHHHHHhcC-CCCCC--CCcCHHHHHHHHHHccCChhhCC---CHHHHhhCCCC
Confidence 99888777776666432 22233 3689999999999998 999999 78999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=350.79 Aligned_cols=255 Identities=31% Similarity=0.514 Sum_probs=211.6
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEe
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 186 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmE 186 (510)
+|++++.||.|+||.||+|+++.+|+.||||.+..... .......+.+|+++++.++||||+++++++.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 58999999999999999999999999999999865432 23334568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 187 YLPGGDIMTLLMR--EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 187 y~~gG~L~~~L~~--~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
|++ ++|..++.. ...+++..++.++.|++.||+|||+.|++||||+|+||+++.+|.+||+|||++..+.....
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~--- 155 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--- 155 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc---
Confidence 996 589888865 35689999999999999999999999999999999999999999999999999876532210
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCC-CCccccccchhhHHHHHhhCCCC
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG-YGMECDWWSLGAIMYEMLIGYPP 343 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~-y~~~~DiwSlGvilyEml~G~~P 343 (510)
......+++.|+|||++.+.. ++.++|+|||||++|||++|..|
T Consensus 156 -----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p 200 (284)
T cd07860 156 -----------------------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL 200 (284)
T ss_pred -----------------------------------ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 011246889999999987644 68899999999999999999999
Q ss_pred CCCCChhhhHHHHhhccccc----------------cCCC---------CCCCCHHHHHHHHHhhc-CccccCCCCChHH
Q 010463 344 FCSDDPRITCRKIVNWKTCL----------------KFPE---------EPKISDEARDLICHLLC-DVETRLGTRGVEE 397 (510)
Q Consensus 344 F~~~~~~~~~~~I~~~~~~~----------------~~p~---------~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~e 397 (510)
|.+.+......++....... .++. .+.++++++++|.+||+ ||.+|| ++++
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---t~~~ 277 (284)
T cd07860 201 FPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRI---SAKA 277 (284)
T ss_pred CCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCC---CHHH
Confidence 98877655554443311100 1111 13578999999999998 999999 6899
Q ss_pred hhcCCCc
Q 010463 398 LKEHPWF 404 (510)
Q Consensus 398 il~HpfF 404 (510)
+++||||
T Consensus 278 ~l~~~~f 284 (284)
T cd07860 278 ALAHPFF 284 (284)
T ss_pred HhcCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=353.75 Aligned_cols=256 Identities=29% Similarity=0.522 Sum_probs=217.0
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
+.|.....||+|+||.||++.+..++..||||.+.... ....+.+.+|+.++..++||||+++++.+.+.+..|+||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 34555678999999999999999999999999986542 334566889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
||++|++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++........
T Consensus 99 e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~---- 173 (292)
T cd06658 99 EFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP---- 173 (292)
T ss_pred eCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc----
Confidence 99999999998754 5689999999999999999999999999999999999999999999999999875432110
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCC
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~ 345 (510)
.....+||+.|+|||++.+..++.++|+|||||++|||++|..||.
T Consensus 174 ----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~ 219 (292)
T cd06658 174 ----------------------------------KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYF 219 (292)
T ss_pred ----------------------------------cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 0113579999999999998899999999999999999999999998
Q ss_pred CCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 346 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 346 ~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
+.+.......+.... ....+....++..+.+||.+||+ ||.+|| +++++++||||...
T Consensus 220 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---t~~~il~~~~~~~~ 278 (292)
T cd06658 220 NEPPLQAMRRIRDNL-PPRVKDSHKVSSVLRGFLDLMLVREPSQRA---TAQELLQHPFLKLA 278 (292)
T ss_pred CCCHHHHHHHHHhcC-CCccccccccCHHHHHHHHHHccCChhHCc---CHHHHhhChhhhcc
Confidence 877666555544321 12223334678999999999998 999999 78999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=346.30 Aligned_cols=254 Identities=29% Similarity=0.489 Sum_probs=217.0
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++|++.+.||.|+||.||+|.++.+++.||+|.+.+... ......+.+|+++++.++||||+++++.+.+.+.+|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 478899999999999999999999999999999976532 244567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhh-CCeEEeecCCCCeeecCCCceeecccCCcccCccccccc
Q 010463 186 EYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 263 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~-~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 263 (510)
||++|++|.+++... ..+++..+..++.|++.||.|||+ .|++||||||+||+++.+|.++|+|||++..+....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~--- 155 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--- 155 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH---
Confidence 999999999999876 789999999999999999999999 999999999999999999999999999987543210
Q ss_pred cchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCC
Q 010463 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 343 (510)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~P 343 (510)
.....|++.|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus 156 -------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 198 (265)
T cd06605 156 -------------------------------------AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFP 198 (265)
T ss_pred -------------------------------------hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 0125689999999999999999999999999999999999999
Q ss_pred CCCCC-----hhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 344 FCSDD-----PRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 344 F~~~~-----~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
|...+ .......+... .....|.. .+++++.++|.+||. +|++|| ++.+++.||||+.
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~li~~~l~~~p~~Rp---t~~~ll~~~~~~~ 262 (265)
T cd06605 199 YPPENDPPDGIFELLQYIVNE-PPPRLPSG-KFSPDFQDFVNLCLIKDPRERP---SYKELLEHPFIKK 262 (265)
T ss_pred CCccccccccHHHHHHHHhcC-CCCCCChh-hcCHHHHHHHHHHcCCCchhCc---CHHHHhhCchhhc
Confidence 97642 22333334332 22233321 289999999999998 999999 7899999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=351.51 Aligned_cols=253 Identities=24% Similarity=0.394 Sum_probs=210.3
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcCCCCE--EEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecC
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEI--FAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDS 178 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~--vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~ 178 (510)
.+..++|++.+.||+|+||.||+|.++.+|.. +|+|.+... ........+.+|+.++..+ +||||+++++++.+.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~ 80 (303)
T cd05088 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 80 (303)
T ss_pred ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC
Confidence 35678999999999999999999999888865 477766432 2344556788999999999 899999999999999
Q ss_pred ceEEEEEeccCCCCHHHHHHhcc----------------CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCC
Q 010463 179 DFLYLIMEYLPGGDIMTLLMRED----------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN 242 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~~----------------~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~ 242 (510)
+.+|+||||++||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 160 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence 99999999999999999997543 57899999999999999999999999999999999999999
Q ss_pred CceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCC
Q 010463 243 GHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYG 322 (510)
Q Consensus 243 g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~ 322 (510)
+.+||+|||++........ .....+++.|+|||++.+..++
T Consensus 161 ~~~kl~dfg~~~~~~~~~~---------------------------------------~~~~~~~~~y~aPE~~~~~~~~ 201 (303)
T cd05088 161 YVAKIADFGLSRGQEVYVK---------------------------------------KTMGRLPVRWMAIESLNYSVYT 201 (303)
T ss_pred CcEEeCccccCcccchhhh---------------------------------------cccCCCcccccCHHHHhccCCc
Confidence 9999999999864221100 0012356789999999888899
Q ss_pred ccccccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 323 MECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 323 ~~~DiwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
.++|||||||++|||++ |.+||.+.+..+....+... .....| ..+++++.+||.+||. +|++|| ++++++.
T Consensus 202 ~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~ 275 (303)
T cd05088 202 TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKP--LNCDDEVYDLMRQCWREKPYERP---SFAQILV 275 (303)
T ss_pred ccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC-CcCCCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 99999999999999998 99999888777666665432 112223 3678999999999998 999999 6788876
Q ss_pred C
Q 010463 401 H 401 (510)
Q Consensus 401 H 401 (510)
+
T Consensus 276 ~ 276 (303)
T cd05088 276 S 276 (303)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=340.05 Aligned_cols=253 Identities=36% Similarity=0.587 Sum_probs=217.9
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec--CceEEEE
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD--SDFLYLI 184 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~~~lV 184 (510)
+|++++.||.|+||.||+|.+..+|..||+|++..... ...+.+.+..|+.+++.++||||+++++.+.+ ...+|+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 58899999999999999999999999999999976544 34456778899999999999999999997754 4578999
Q ss_pred EeccCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHhhh-----hCCeEEeecCCCCeeecCCCceeecccCCccc
Q 010463 185 MEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIH-----QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 255 (510)
Q Consensus 185 mEy~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~lH-----~~giiHRDLKP~NILld~~g~vkL~DFGla~~ 255 (510)
|||+++|+|.+++.. ...+++..++.++.||+.||.||| +.+|+||||||+||+++.++++||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999876 367999999999999999999999 89999999999999999999999999999987
Q ss_pred CccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHH
Q 010463 256 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 335 (510)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvily 335 (510)
...... ......|++.|+|||++.+..++.++|+|||||++|
T Consensus 160 ~~~~~~--------------------------------------~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~ 201 (265)
T cd08217 160 LGHDSS--------------------------------------FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIY 201 (265)
T ss_pred ccCCcc--------------------------------------cccccccCCCccChhhhcCCCCCchhHHHHHHHHHH
Confidence 643210 011357999999999999888999999999999999
Q ss_pred HHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 336 EMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 336 Eml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
+|++|..||.+.+.......+.... ...+| ..++..+.+|+.+||. +|.+|| ++++|++|||+
T Consensus 202 ~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~l~~~~l~~~p~~Rp---~~~~il~~~~~ 265 (265)
T cd08217 202 ELCALSPPFTARNQLQLASKIKEGK-FRRIP--YRYSSELNEVIKSMLNVDPDKRP---STEELLQLPLI 265 (265)
T ss_pred HHHHCCCcccCcCHHHHHHHHhcCC-CCCCc--cccCHHHHHHHHHHccCCcccCC---CHHHHhhCCCC
Confidence 9999999999887666666665432 22233 3788999999999998 999999 78999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=362.12 Aligned_cols=248 Identities=23% Similarity=0.400 Sum_probs=212.6
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCce
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 180 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 180 (510)
+.+..+.+.+++.||+|-||+|++|.++.+ ..||+|.++...+ ..+.+.+|+.||++++|++||+|++++..++.
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p 275 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSM----SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEP 275 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEecccc----ChhHHHHHHHHHHhCcccCeEEEEEEEecCCc
Confidence 344455677789999999999999998743 3689999976533 23568899999999999999999999999889
Q ss_pred EEEEEeccCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 181 LYLIMEYLPGGDIMTLLMR--EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~--~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
+|||||||+.|+|.++|+. ...+...+...+++||+.|++||+++++|||||-..||||++++.+||+|||||+...+
T Consensus 276 iyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 276 IYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred eEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCC
Confidence 9999999999999999987 56789999999999999999999999999999999999999999999999999996655
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHh
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml 338 (510)
..+.... +.--..-|.|||.+....++.++|||||||+||||+
T Consensus 356 ~~Y~~~~-------------------------------------~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~f 398 (468)
T KOG0197|consen 356 DEYTASE-------------------------------------GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELF 398 (468)
T ss_pred CceeecC-------------------------------------CCCCCceecCHHHHhhCCcccccceeehhhhHHHHh
Confidence 4332100 011234699999999999999999999999999999
Q ss_pred h-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC
Q 010463 339 I-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR 393 (510)
Q Consensus 339 ~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~ 393 (510)
| |+.||.+.+..+....+..+ ...|....+++++-+++..|+. +|++||+..
T Consensus 399 T~G~~py~~msn~ev~~~le~G---yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~ 452 (468)
T KOG0197|consen 399 TYGRVPYPGMSNEEVLELLERG---YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFE 452 (468)
T ss_pred ccCCCCCCCCCHHHHHHHHhcc---CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHH
Confidence 8 99999999999999988865 3455556899999999999998 999999643
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=342.23 Aligned_cols=255 Identities=31% Similarity=0.508 Sum_probs=213.8
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCc---
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSD--- 179 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~--- 179 (510)
..++|++.+.||+|+||.||+|.++.+++.||+|++.... ...+.+.+|+.+++.+ +||||++++++|.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 3578999999999999999999999999999999987643 2345688999999998 7999999999997644
Q ss_pred ---eEEEEEeccCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCC
Q 010463 180 ---FLYLIMEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGL 252 (510)
Q Consensus 180 ---~~~lVmEy~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGl 252 (510)
.+|+||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 59999999999999998865 35799999999999999999999999999999999999999999999999999
Q ss_pred cccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-----CCCCccccc
Q 010463 253 CKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-----KGYGMECDW 327 (510)
Q Consensus 253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-----~~y~~~~Di 327 (510)
+........ ......||+.|+|||++.. ..++.++|+
T Consensus 160 ~~~~~~~~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv 201 (275)
T cd06608 160 SAQLDSTLG--------------------------------------RRNTFIGTPYWMAPEVIACDEQPDASYDARSDV 201 (275)
T ss_pred ceecccchh--------------------------------------hhcCccccccccCHhHhcccccccCCccccccH
Confidence 876533210 0113569999999999864 346889999
Q ss_pred cchhhHHHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 328 WSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 328 wSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
|||||++|+|++|.+||...+......++.... ....+....++.++++||.+||. ||++|| +++++++|||+
T Consensus 202 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---t~~~ll~~~~~ 275 (275)
T cd06608 202 WSLGITAIELADGKPPLCDMHPMRALFKIPRNP-PPTLKSPENWSKKFNDFISECLIKNYEQRP---FMEELLEHPFI 275 (275)
T ss_pred HHhHHHHHHHHhCCCCccccchHHHHHHhhccC-CCCCCchhhcCHHHHHHHHHHhhcChhhCc---CHHHHhcCCCC
Confidence 999999999999999998776665555555422 11222223478899999999998 999999 78999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=348.73 Aligned_cols=263 Identities=25% Similarity=0.430 Sum_probs=212.2
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEeEEeecCceEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~~~l 183 (510)
.++|+.++.||+|+||.||++.+..+|+.||+|.+.+... ......+..|+.++.++. ||||+++++++.+++..++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence 4578888999999999999999999999999999876532 234566888999999986 9999999999999999999
Q ss_pred EEeccCCCCHHHHH---H--hccCCCHHHHHHHHHHHHHHHHhhhh-CCeEEeecCCCCeeecCCCceeecccCCcccCc
Q 010463 184 IMEYLPGGDIMTLL---M--REDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 257 (510)
Q Consensus 184 VmEy~~gG~L~~~L---~--~~~~l~e~~~~~~~~qi~~aL~~lH~-~giiHRDLKP~NILld~~g~vkL~DFGla~~~~ 257 (510)
||||+.+ ++.++. . ....+++..+..++.+++.||+|||+ .||+||||||+|||++.++.+||+|||++..+.
T Consensus 81 ~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 81 CMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred EEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9999865 544432 2 23679999999999999999999997 599999999999999999999999999987543
Q ss_pred cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC---CCCccccccchhhHH
Q 010463 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK---GYGMECDWWSLGAIM 334 (510)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~---~y~~~~DiwSlGvil 334 (510)
.... .....||+.|+|||++.+. .++.++|||||||++
T Consensus 160 ~~~~---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il 200 (288)
T cd06616 160 DSIA---------------------------------------KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITL 200 (288)
T ss_pred cCCc---------------------------------------cccccCccCccCHHHhccccccCCcchhhhhHHHHHH
Confidence 2210 1124689999999999876 689999999999999
Q ss_pred HHHhhCCCCCCCCCh-hhhHHHHhhccccccCCC--CCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCch
Q 010463 335 YEMLIGYPPFCSDDP-RITCRKIVNWKTCLKFPE--EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWD 410 (510)
Q Consensus 335 yEml~G~~PF~~~~~-~~~~~~I~~~~~~~~~p~--~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~ 410 (510)
|||++|.+||..... .+...++... .....+. ...++.++.+||.+||. +|++|| ++++|++||||+...|.
T Consensus 201 ~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~i~~~~~~~~~~~~ 276 (288)
T cd06616 201 YEVATGKFPYPKWNSVFDQLTQVVKG-DPPILSNSEEREFSPSFVNFINLCLIKDESKRP---KYKELLEHPFIKDYEER 276 (288)
T ss_pred HHHHhCCCCchhcchHHHHHhhhcCC-CCCcCCCcCCCccCHHHHHHHHHHccCChhhCc---CHHHHhcChhhhchhhc
Confidence 999999999976542 1222222221 1112221 23589999999999998 999999 78999999999987776
Q ss_pred hhh
Q 010463 411 KLY 413 (510)
Q Consensus 411 ~l~ 413 (510)
+..
T Consensus 277 ~~~ 279 (288)
T cd06616 277 NVD 279 (288)
T ss_pred chh
Confidence 543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=360.76 Aligned_cols=262 Identities=31% Similarity=0.514 Sum_probs=211.7
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCce
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDF 180 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~ 180 (510)
++.-..|++++.||+||.++||+|...+ ...||+|.+.-. ......+.-+++|+.+|.++ .|.+||+||++-..+++
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~-~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~ 434 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLL-EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY 434 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHh-hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence 4555679999999999999999997654 455666655332 23455678899999999999 58999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhccCCCH-HHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 181 LYLIMEYLPGGDIMTLLMREDILSE-DVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~~~l~e-~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
+||||||= ..||..+|.+.....+ -..++|..||++|++++|..||||-||||.|+|+ -.|.+||+|||+|..+...
T Consensus 435 lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 435 LYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPD 512 (677)
T ss_pred EEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCcc
Confidence 99999976 4599999988755433 5899999999999999999999999999999999 6799999999999988665
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCC-----------CCcccccc
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG-----------YGMECDWW 328 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~-----------y~~~~Diw 328 (510)
..... ..+.|||+.||+||.+.... .++++|||
T Consensus 513 TTsI~------------------------------------kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvW 556 (677)
T KOG0596|consen 513 TTSIV------------------------------------KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVW 556 (677)
T ss_pred cccee------------------------------------eccccCcccccCHHHHhhccccccCCCcceeecCccchh
Confidence 32221 12579999999999996432 46899999
Q ss_pred chhhHHHHHhhCCCCCCCCC-hhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 329 SLGAIMYEMLIGYPPFCSDD-PRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 329 SlGvilyEml~G~~PF~~~~-~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
|||||||+|+.|++||..-- ...-+..|.+-...+.||..+. ..++.++++.||. ||.+|+ ++.++|+|||...
T Consensus 557 SLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~-~~~li~~mK~CL~rdPkkR~---si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 557 SLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPE-NDELIDVMKCCLARDPKKRW---SIPELLQHPFLQI 632 (677)
T ss_pred hhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCC-chHHHHHHHHHHhcCcccCC---CcHHHhcCccccc
Confidence 99999999999999996532 3344455555445567775322 2349999999998 999999 7899999999976
Q ss_pred C
Q 010463 407 I 407 (510)
Q Consensus 407 i 407 (510)
+
T Consensus 633 ~ 633 (677)
T KOG0596|consen 633 Q 633 (677)
T ss_pred c
Confidence 3
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=345.92 Aligned_cols=254 Identities=32% Similarity=0.526 Sum_probs=212.6
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEe
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 186 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmE 186 (510)
+|++++.||.|++|.||+|+++.+|+.||||++..... ......+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 58999999999999999999999999999999976532 2234567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccc
Q 010463 187 YLPGGDIMTLLMRE---DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 263 (510)
Q Consensus 187 y~~gG~L~~~L~~~---~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 263 (510)
|++| +|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++++|.++|+|||++........
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 155 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-- 155 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--
Confidence 9985 888887654 3689999999999999999999999999999999999999999999999999975532210
Q ss_pred cchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHhhCCC
Q 010463 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYP 342 (510)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml~G~~ 342 (510)
.....+||+.|+|||++.+ ..++.++|+|||||++|+|++|.+
T Consensus 156 ------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 199 (284)
T cd07836 156 ------------------------------------TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRP 199 (284)
T ss_pred ------------------------------------ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 0113468999999999876 457899999999999999999999
Q ss_pred CCCCCChhhhHHHHhhcccc----------------ccCCC---------CCCCCHHHHHHHHHhhc-CccccCCCCChH
Q 010463 343 PFCSDDPRITCRKIVNWKTC----------------LKFPE---------EPKISDEARDLICHLLC-DVETRLGTRGVE 396 (510)
Q Consensus 343 PF~~~~~~~~~~~I~~~~~~----------------~~~p~---------~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~ 396 (510)
||.+.+..+.+.++...... ..+|. .+.+++.++++|.+||+ ||.+|| ++.
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~---~~~ 276 (284)
T cd07836 200 LFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRI---SAH 276 (284)
T ss_pred CCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCC---CHH
Confidence 99988877666655432100 00110 12568899999999998 999999 689
Q ss_pred HhhcCCCc
Q 010463 397 ELKEHPWF 404 (510)
Q Consensus 397 eil~HpfF 404 (510)
++++||||
T Consensus 277 ~~l~~~~f 284 (284)
T cd07836 277 DALQHPWF 284 (284)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=345.11 Aligned_cols=255 Identities=30% Similarity=0.520 Sum_probs=218.3
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEe
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 186 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmE 186 (510)
.|...+.||+|++|.||++.++.+++.||+|++... .....+.+.+|+.++..++||||+++++++...+..|+|||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 455568999999999999999999999999998643 22334568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccch
Q 010463 187 YLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 266 (510)
Q Consensus 187 y~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~ 266 (510)
|++|++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.+|.++|+|||++........
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~----- 170 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP----- 170 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-----
Confidence 9999999999877 6789999999999999999999999999999999999999999999999998875432100
Q ss_pred hhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCC
Q 010463 267 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCS 346 (510)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~ 346 (510)
......|++.|+|||++.+..++.++|+|||||++|||++|..||.+
T Consensus 171 ---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~ 217 (285)
T cd06648 171 ---------------------------------RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN 217 (285)
T ss_pred ---------------------------------ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC
Confidence 01135699999999999988899999999999999999999999998
Q ss_pred CChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 347 DDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 347 ~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
.++.....++.... ....+....++..+.+||.+||. +|++|| ++.++++||||+..
T Consensus 218 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~il~~~~~~~~ 275 (285)
T cd06648 218 EPPLQAMKRIRDNL-PPKLKNLHKVSPRLRSFLDRMLVRDPAQRA---TAAELLNHPFLAKA 275 (285)
T ss_pred CCHHHHHHHHHhcC-CCCCcccccCCHHHHHHHHHHcccChhhCc---CHHHHccCcccccC
Confidence 88777776666431 12222223588999999999998 999999 68999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=370.57 Aligned_cols=249 Identities=33% Similarity=0.562 Sum_probs=218.2
Q ss_pred eeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEeccCCCC
Q 010463 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGD 192 (510)
Q Consensus 113 ~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy~~gG~ 192 (510)
+||+|.||+||-|+++.|....|||-+... ....++-+..|+.+-+.++|.|||+.+|++..++++-+.||-+|||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 799999999999999999999999998654 34456678899999999999999999999999999999999999999
Q ss_pred HHHHHHhc-cCC--CHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeec-CCCceeecccCCcccCccccccccchhh
Q 010463 193 IMTLLMRE-DIL--SEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD-KNGHLKLSDFGLCKPLEDKYSSILLEDE 268 (510)
Q Consensus 193 L~~~L~~~-~~l--~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld-~~g~vkL~DFGla~~~~~~~~~~~~~~~ 268 (510)
|.++|+.. +++ .|....||..||+.||.|||.+.|||||||-+|+||+ -.|.+||+|||-|+.+..-.
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-------- 730 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-------- 730 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCC--------
Confidence 99999865 777 8999999999999999999999999999999999997 68999999999999875321
Q ss_pred hhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc--CCCCccccccchhhHHHHHhhCCCCCCC
Q 010463 269 DIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK--KGYGMECDWWSLGAIMYEMLIGYPPFCS 346 (510)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiwSlGvilyEml~G~~PF~~ 346 (510)
..+.++.||..|||||++.. .+|+.++|||||||++.||.||+|||..
T Consensus 731 ------------------------------P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~E 780 (1226)
T KOG4279|consen 731 ------------------------------PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVE 780 (1226)
T ss_pred ------------------------------ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeee
Confidence 12346889999999999975 5799999999999999999999999975
Q ss_pred C-ChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 347 D-DPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 347 ~-~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
. ++....-++--.+.++.+|. .+|.+|+.||.+|.. ||..|| ++.++|..||++.-
T Consensus 781 lgspqAAMFkVGmyKvHP~iPe--elsaeak~FilrcFepd~~~R~---sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 781 LGSPQAAMFKVGMYKVHPPIPE--ELSAEAKNFILRCFEPDPCDRP---SAKDLLQDPFLQHN 838 (1226)
T ss_pred cCChhHhhhhhcceecCCCCcH--HHHHHHHHHHHHHcCCCcccCc---cHHHhccCcccccC
Confidence 3 34444445544556667775 799999999999998 999999 68999999999864
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=340.53 Aligned_cols=256 Identities=32% Similarity=0.521 Sum_probs=210.6
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEE
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~ 182 (510)
...+++.....||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 34556666779999999999999999999999999887542 334567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhc-cCC--CHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecC-CCceeecccCCcccCcc
Q 010463 183 LIMEYLPGGDIMTLLMRE-DIL--SEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK-NGHLKLSDFGLCKPLED 258 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~-~~l--~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~-~g~vkL~DFGla~~~~~ 258 (510)
+||||++|++|.+++... ..+ ++..+..++.||+.||.|||+.||+||||||+||+++. ++.++|+|||++.....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 999999999999999764 455 88899999999999999999999999999999999986 78999999999876532
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC--CCCccccccchhhHHHH
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK--GYGMECDWWSLGAIMYE 336 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~--~y~~~~DiwSlGvilyE 336 (510)
... ......|++.|+|||++.+. .++.++|+|||||++|+
T Consensus 162 ~~~--------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~ 203 (268)
T cd06624 162 INP--------------------------------------CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVE 203 (268)
T ss_pred CCC--------------------------------------ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHH
Confidence 100 01124689999999999764 47899999999999999
Q ss_pred HhhCCCCCCCCChh-hhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 337 MLIGYPPFCSDDPR-ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 337 ml~G~~PF~~~~~~-~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
|++|.+||...... ....++........+| ..+++++++||++||. +|.+|| ++.+++.||||
T Consensus 204 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---t~~~ll~~~~~ 268 (268)
T cd06624 204 MATGKPPFIELGEPQAAMFKVGMFKIHPEIP--ESLSAEAKNFILRCFEPDPDKRA---SAHDLLQDPFL 268 (268)
T ss_pred HHhCCCCCccccChhhhHhhhhhhccCCCCC--cccCHHHHHHHHHHcCCCchhCC---CHHHHHhCCCC
Confidence 99999999754322 2222221111222334 3688999999999998 999999 78999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=347.11 Aligned_cols=258 Identities=36% Similarity=0.550 Sum_probs=215.7
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++|++.+.||+|+||.||+|.++.+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 469999999999999999999999999999999875432 3344567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
||++++.+..++.+...+++..+..++.||+.||.|||+.|++||||+|+||+++.+|.+||+|||++........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~---- 155 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA---- 155 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc----
Confidence 9999988877777777799999999999999999999999999999999999999999999999999987644211
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC-CCCccccccchhhHHHHHhhCCCCC
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEMLIGYPPF 344 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiwSlGvilyEml~G~~PF 344 (510)
......+|++.|+|||++.+. .++.++|+|||||++|+|++|.+||
T Consensus 156 ---------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~ 202 (288)
T cd07833 156 ---------------------------------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLF 202 (288)
T ss_pred ---------------------------------ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 011235789999999999887 8899999999999999999999999
Q ss_pred CCCChhhhHHHHhhcccc-----------------ccCCC-----------CCCCCHHHHHHHHHhhc-CccccCCCCCh
Q 010463 345 CSDDPRITCRKIVNWKTC-----------------LKFPE-----------EPKISDEARDLICHLLC-DVETRLGTRGV 395 (510)
Q Consensus 345 ~~~~~~~~~~~I~~~~~~-----------------~~~p~-----------~~~~s~~~~dlI~~lL~-dp~~R~~~~~~ 395 (510)
.+.+.......+...... ..++. ...++.++.+||++||. +|++|| ++
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~ 279 (288)
T cd07833 203 PGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERL---TC 279 (288)
T ss_pred CCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcc---cH
Confidence 876654433332210000 00100 12358999999999998 999999 78
Q ss_pred HHhhcCCCc
Q 010463 396 EELKEHPWF 404 (510)
Q Consensus 396 ~eil~HpfF 404 (510)
+++++||||
T Consensus 280 ~~il~~~~f 288 (288)
T cd07833 280 DELLQHPYF 288 (288)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=349.34 Aligned_cols=254 Identities=27% Similarity=0.376 Sum_probs=215.6
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
...|++++.||+|+||.||+|.++.+|+.||+|++.............+.+|+.+++.++||||++++++|.+.+..|+|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 35699999999999999999999999999999999765444455567788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccc
Q 010463 185 MEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 263 (510)
Q Consensus 185 mEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 263 (510)
|||++| +|.+++.. ...+++..+..++.|++.||.|||+.||+||||+|+||+++.+|.++|+|||++......
T Consensus 94 ~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---- 168 (307)
T cd06607 94 MEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---- 168 (307)
T ss_pred HHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC----
Confidence 999975 67666653 467999999999999999999999999999999999999999999999999998754321
Q ss_pred cchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc---cCCCCccccccchhhHHHHHhhC
Q 010463 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMECDWWSLGAIMYEMLIG 340 (510)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~---~~~y~~~~DiwSlGvilyEml~G 340 (510)
....|++.|+|||++. ...++.++|||||||++|||++|
T Consensus 169 --------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg 210 (307)
T cd06607 169 --------------------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 210 (307)
T ss_pred --------------------------------------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcC
Confidence 1246899999999985 35688999999999999999999
Q ss_pred CCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 341 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 341 ~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
.+||.+.+.......+... .....+. ..++..+++||.+||. +|.+|| ++.+|+.||||..
T Consensus 211 ~~p~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~~~ 272 (307)
T cd06607 211 KPPLFNMNAMSALYHIAQN-DSPTLSS-NDWSDYFRNFVDSCLQKIPQDRP---SSEELLKHRFVLR 272 (307)
T ss_pred CCCCCCccHHHHHHHHhcC-CCCCCCc-hhhCHHHHHHHHHHhcCChhhCc---CHHHHhcChhhcc
Confidence 9999887766655555432 1222221 3578899999999998 999999 6899999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=345.55 Aligned_cols=256 Identities=30% Similarity=0.444 Sum_probs=218.8
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
..|+.++.||.|+||.||+|.++.++..||+|++.... .......+.+|+.+++.++||||+++++++.+....|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 35788899999999999999999999999999987543 2345677899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
||++||+|.+++.. +.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---- 156 (277)
T cd06640 82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI---- 156 (277)
T ss_pred ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc----
Confidence 99999999998865 5689999999999999999999999999999999999999999999999999876533210
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCC
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~ 345 (510)
......|+..|+|||++.+..++.++|+|||||++|||++|.+||.
T Consensus 157 ----------------------------------~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 202 (277)
T cd06640 157 ----------------------------------KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNS 202 (277)
T ss_pred ----------------------------------ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCC
Confidence 0113468999999999998889999999999999999999999998
Q ss_pred CCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCC
Q 010463 346 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 408 (510)
Q Consensus 346 ~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~ 408 (510)
..++......+.... ....+ ..++..+.++|.+||. +|++|| +++++++||||....
T Consensus 203 ~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~~~~~ 260 (277)
T cd06640 203 DMHPMRVLFLIPKNN-PPTLT--GEFSKPFKEFIDACLNKDPSFRP---TAKELLKHKFIVKNA 260 (277)
T ss_pred CcChHhHhhhhhcCC-CCCCc--hhhhHHHHHHHHHHcccCcccCc---CHHHHHhChHhhhcc
Confidence 877665554443221 12222 2578899999999998 999999 789999999997654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=350.72 Aligned_cols=255 Identities=30% Similarity=0.531 Sum_probs=215.7
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEe
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 186 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmE 186 (510)
.|+....||+|+||.||+|.++.+++.||+|++.... ....+.+.+|+.++..++||||++++++|...+..|+|||
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc---cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 3444567999999999999999999999999986543 2234568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccch
Q 010463 187 YLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 266 (510)
Q Consensus 187 y~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~ 266 (510)
|++||+|..++.. ..+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++..+.....
T Consensus 99 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~----- 172 (297)
T cd06659 99 FLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP----- 172 (297)
T ss_pred cCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-----
Confidence 9999999987754 5689999999999999999999999999999999999999999999999999875432210
Q ss_pred hhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCC
Q 010463 267 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCS 346 (510)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~ 346 (510)
.....+|++.|+|||++.+..++.++|+|||||++|||++|++||..
T Consensus 173 ---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 219 (297)
T cd06659 173 ---------------------------------KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS 219 (297)
T ss_pred ---------------------------------cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 01135799999999999998999999999999999999999999988
Q ss_pred CChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 347 DDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 347 ~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
.+.......+.... .........++..+.++|.+||+ +|.+|| +++++++||||...
T Consensus 220 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rp---s~~~ll~~~~~~~~ 277 (297)
T cd06659 220 DSPVQAMKRLRDSP-PPKLKNAHKISPVLRDFLERMLTREPQERA---TAQELLDHPFLLQT 277 (297)
T ss_pred CCHHHHHHHHhccC-CCCccccCCCCHHHHHHHHHHhcCCcccCc---CHHHHhhChhhccC
Confidence 77666655554321 11222234688999999999998 999999 78999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=349.42 Aligned_cols=259 Identities=27% Similarity=0.459 Sum_probs=207.6
Q ss_pred CceeeeeeecCCCeEEEEEEEcC--CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC--ceEE
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKT--TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS--DFLY 182 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~--tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~~~ 182 (510)
.|++++.||+|+||.||+|.++. +++.||+|.+.+...........+.+|+.++..++||||+++++++.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 38899999999999999999998 8999999999875433344456678899999999999999999999988 8899
Q ss_pred EEEeccCCCCHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecC----CCceeecccCCc
Q 010463 183 LIMEYLPGGDIMTLLMRE-----DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK----NGHLKLSDFGLC 253 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~-----~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~----~g~vkL~DFGla 253 (510)
+||||+++ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++. +|.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999975 677766432 36899999999999999999999999999999999999999 999999999999
Q ss_pred ccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhh
Q 010463 254 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGA 332 (510)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGv 332 (510)
+.+....... ......+||+.|+|||++.+ ..++.++|+|||||
T Consensus 160 ~~~~~~~~~~-----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~ 204 (316)
T cd07842 160 RLFNAPLKPL-----------------------------------ADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGC 204 (316)
T ss_pred cccCCCcccc-----------------------------------cccCCccccccccCHHHHhCCCCCCcHHHHHHHHH
Confidence 8764321100 00113578999999999876 45899999999999
Q ss_pred HHHHHhhCCCCCCCCChhh---------hHHHHhh------------------------ccccccCCC---------CCC
Q 010463 333 IMYEMLIGYPPFCSDDPRI---------TCRKIVN------------------------WKTCLKFPE---------EPK 370 (510)
Q Consensus 333 ilyEml~G~~PF~~~~~~~---------~~~~I~~------------------------~~~~~~~p~---------~~~ 370 (510)
++|+|++|.+||.+.+... ....++. ......++. ...
T Consensus 205 ~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (316)
T cd07842 205 IFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKK 284 (316)
T ss_pred HHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccC
Confidence 9999999999998655432 1111110 000011110 015
Q ss_pred CCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 371 ISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 371 ~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
.+.++.++|.+||. ||++|| ++.|++.||||
T Consensus 285 ~~~~~~~~i~~~l~~~P~~Rp---s~~eil~~~~f 316 (316)
T cd07842 285 PDSQGFDLLRKLLEYDPTKRI---TAEEALEHPYF 316 (316)
T ss_pred CCHHHHHHHHHHhcCCcccCc---CHHHHhcCCCC
Confidence 67899999999999 999999 78999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=340.22 Aligned_cols=253 Identities=28% Similarity=0.485 Sum_probs=212.0
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
.++|++.+.||+|+||.||+|+.+.+++.||||.+.............+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 36899999999999999999999999999999998765555556667788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccc
Q 010463 185 MEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 260 (510)
Q Consensus 185 mEy~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~ 260 (510)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 999999999988853 3458999999999999999999999999999999999999999999999999988654321
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhC
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 340 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G 340 (510)
. ......|++.|+|||++.+..++.++|+|||||++|||++|
T Consensus 161 ~--------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g 202 (267)
T cd08228 161 T--------------------------------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 202 (267)
T ss_pred H--------------------------------------HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcC
Confidence 0 01135699999999999998999999999999999999999
Q ss_pred CCCCCCCCh--hhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 341 YPPFCSDDP--RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 341 ~~PF~~~~~--~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
..||..... ......+... .....+. ..++..+.++|.+||+ +|++|| ++.++++
T Consensus 203 ~~p~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~li~~cl~~~p~~Rp---~~~~vl~ 260 (267)
T cd08228 203 QSPFYGDKMNLFSLCQKIEQC-DYPPLPT-EHYSEKLRELVSMCIYPDPDQRP---DIGYVHQ 260 (267)
T ss_pred CCCCccccccHHHHHHHHhcC-CCCCCCh-hhcCHHHHHHHHHHCCCCcccCc---CHHHHHH
Confidence 999976543 2333333221 1111121 2578899999999998 999999 6777775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=356.34 Aligned_cols=263 Identities=27% Similarity=0.431 Sum_probs=214.7
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEee----cCceE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ----DSDFL 181 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~----~~~~~ 181 (510)
++|++.+.||.|+||.||+|..+.+|+.||+|++.+... .......+.+|+.+|+.++||||++++++|. +...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 689999999999999999999999999999999976432 2334567788999999999999999998876 34579
Q ss_pred EEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 182 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
|+||||+. |+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++........
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 99999995 58999998888899999999999999999999999999999999999999999999999999976533210
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHhhC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIG 340 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml~G 340 (510)
.. .......+|++.|+|||++.+ ..++.++|+|||||++|||++|
T Consensus 163 ~~----------------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g 208 (334)
T cd07855 163 EH----------------------------------KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGR 208 (334)
T ss_pred CC----------------------------------CcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcC
Confidence 00 001123579999999999876 5689999999999999999999
Q ss_pred CCCCCCCChhhhHHHHhhc------------------------cccccCCC---CCCCCHHHHHHHHHhhc-CccccCCC
Q 010463 341 YPPFCSDDPRITCRKIVNW------------------------KTCLKFPE---EPKISDEARDLICHLLC-DVETRLGT 392 (510)
Q Consensus 341 ~~PF~~~~~~~~~~~I~~~------------------------~~~~~~p~---~~~~s~~~~dlI~~lL~-dp~~R~~~ 392 (510)
++||.+.+.......+... ......+. .+.++++++++|++||+ +|.+||
T Consensus 209 ~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-- 286 (334)
T cd07855 209 RQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERI-- 286 (334)
T ss_pred CCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCc--
Confidence 9999887654443333221 00000100 13578999999999998 999999
Q ss_pred CChHHhhcCCCcCCC
Q 010463 393 RGVEELKEHPWFRGI 407 (510)
Q Consensus 393 ~~~~eil~HpfF~~i 407 (510)
++++++.||||.+.
T Consensus 287 -t~~~~l~~~~~~~~ 300 (334)
T cd07855 287 -TVEQALQHPFLAQY 300 (334)
T ss_pred -CHHHHHhChhhhhc
Confidence 68999999999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=343.65 Aligned_cols=255 Identities=18% Similarity=0.340 Sum_probs=211.5
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEc----CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAK----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 178 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~----~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 178 (510)
+..++|++.+.||+|+||.||+|... .++..||+|.+.... .......+.+|..+++.++||||+++++++.+.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 35678999999999999999999853 456789999987532 234456788999999999999999999999999
Q ss_pred ceEEEEEeccCCCCHHHHHHhc-----------------cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecC
Q 010463 179 DFLYLIMEYLPGGDIMTLLMRE-----------------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK 241 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~-----------------~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~ 241 (510)
...|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~ 159 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE 159 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence 9999999999999999998532 24788899999999999999999999999999999999999
Q ss_pred CCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCC
Q 010463 242 NGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY 321 (510)
Q Consensus 242 ~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y 321 (510)
++.+||+|||+++........ ....+..++..|+|||++.+..+
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~~~~~~ 203 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYY------------------------------------RVQPKSLLPIRWMPPEAIMYGKF 203 (283)
T ss_pred CCcEEeccccccccccCCcce------------------------------------ecccCCCccceecChHHhccCCC
Confidence 999999999999865432100 00113457788999999998899
Q ss_pred CccccccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhh
Q 010463 322 GMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 399 (510)
Q Consensus 322 ~~~~DiwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil 399 (510)
+.++|+|||||++|||++ |.+||.+.+.......+... ..+..| ..+++.++++|.+||+ ||.+|| ++.+|+
T Consensus 204 ~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~cl~~~p~~Rp---~~~~i~ 277 (283)
T cd05090 204 SSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKR-QLLPCS--EDCPPRMYSLMTECWQEGPSRRP---RFKDIH 277 (283)
T ss_pred CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcCCCC--CCCCHHHHHHHHHHcccCcccCc---CHHHHH
Confidence 999999999999999998 99999887766665555542 222233 4789999999999998 999999 567776
Q ss_pred cC
Q 010463 400 EH 401 (510)
Q Consensus 400 ~H 401 (510)
++
T Consensus 278 ~~ 279 (283)
T cd05090 278 TR 279 (283)
T ss_pred HH
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=363.75 Aligned_cols=251 Identities=28% Similarity=0.393 Sum_probs=220.2
Q ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEec
Q 010463 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEY 187 (510)
Q Consensus 108 f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy 187 (510)
|.-++.||.|+||-||.|++..+.++||||+|+-+.-.....-..+..|+..|..+.|||+|.+.++|..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 56678899999999999999999999999999876655555567799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccch
Q 010463 188 LPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 266 (510)
Q Consensus 188 ~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~ 266 (510)
|-| +-.++|.- ..++.|.++..+..+.+.||.|||+.+.||||||..||||++.|.|||+|||.|.....
T Consensus 108 ClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-------- 178 (948)
T KOG0577|consen 108 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-------- 178 (948)
T ss_pred Hhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc--------
Confidence 966 66666643 46799999999999999999999999999999999999999999999999999876543
Q ss_pred hhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc---cCCCCccccccchhhHHHHHhhCCCC
Q 010463 267 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMECDWWSLGAIMYEMLIGYPP 343 (510)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~---~~~y~~~~DiwSlGvilyEml~G~~P 343 (510)
+.++||||.||||||+. .+.|+-++||||||++..||.-.+||
T Consensus 179 ----------------------------------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPP 224 (948)
T KOG0577|consen 179 ----------------------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 224 (948)
T ss_pred ----------------------------------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCC
Confidence 35799999999999997 46799999999999999999999999
Q ss_pred CCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 344 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 344 F~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
+...+....+..|... ..+.++. ..+|+..+.||..||. -|.+|| +.++++.|+|..-
T Consensus 225 lFnMNAMSALYHIAQN-esPtLqs-~eWS~~F~~Fvd~CLqKipqeRp---tse~ll~H~fv~R 283 (948)
T KOG0577|consen 225 LFNMNAMSALYHIAQN-ESPTLQS-NEWSDYFRNFVDSCLQKIPQERP---TSEELLKHRFVLR 283 (948)
T ss_pred ccCchHHHHHHHHHhc-CCCCCCC-chhHHHHHHHHHHHHhhCcccCC---cHHHHhhcchhcc
Confidence 9988888777777643 2334443 4789999999999998 899999 6799999999864
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=343.95 Aligned_cols=253 Identities=21% Similarity=0.352 Sum_probs=212.0
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcC-----CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKT-----TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 178 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~-----tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 178 (510)
..++|.+++.||+|+||.||+|.+.. +++.||+|++++.. .......+.+|+.+|+.++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 45679999999999999999998753 46789999987542 233456789999999999999999999999999
Q ss_pred ceEEEEEeccCCCCHHHHHHhcc--------------CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCc
Q 010463 179 DFLYLIMEYLPGGDIMTLLMRED--------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH 244 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~~--------------~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~ 244 (510)
..+|+||||++||+|.+++...+ .+++..+..++.||+.||.|||+.|++||||||+|||++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 99999999999999999997542 4788999999999999999999999999999999999999999
Q ss_pred eeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCcc
Q 010463 245 LKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGME 324 (510)
Q Consensus 245 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~ 324 (510)
+||+|||+++.+....... ......+++.|+|||++.+..++.+
T Consensus 161 ~kl~d~g~~~~~~~~~~~~------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~ 204 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYR------------------------------------VGGHTMLPIRWMPPESIMYRKFTTE 204 (280)
T ss_pred EEECCcccceecccCccee------------------------------------cCCCCcccceecChhhhccCCcchh
Confidence 9999999987543211000 0012457889999999999999999
Q ss_pred ccccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 325 CDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 325 ~DiwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
+|||||||++|||++ |..||.+.+.......+.... ...+ ...++..+.+||.+||. ||.+|| +++|+++
T Consensus 205 ~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~--~~~~-~~~~~~~~~~li~~~l~~~p~~Rp---~~~eil~ 276 (280)
T cd05049 205 SDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGR--LLQR-PRTCPSEVYDIMLGCWKRDPQQRI---NIKDIHE 276 (280)
T ss_pred hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--cCCC-CCCCCHHHHHHHHHHcCCCcccCC---CHHHHHH
Confidence 999999999999998 999998888777777666432 2222 23689999999999998 999999 5777764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=355.24 Aligned_cols=260 Identities=30% Similarity=0.485 Sum_probs=208.8
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC-----ce
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS-----DF 180 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----~~ 180 (510)
++|++++.||+|+||.||+|.++.+|+.||+|++.... .......+..|+.+++.++||||+++++++... ..
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 68999999999999999999999999999999986422 233455678899999999999999999887654 35
Q ss_pred EEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccc
Q 010463 181 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 260 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~ 260 (510)
+|+||||+++ +|..++. ...+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++.......
T Consensus 83 ~~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 83 VYIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred EEEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 8999999965 8888774 4579999999999999999999999999999999999999999999999999998653321
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHhh
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml~ 339 (510)
.. .......+||+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 161 ~~-----------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~ 205 (336)
T cd07849 161 DH-----------------------------------TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLS 205 (336)
T ss_pred cc-----------------------------------cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHh
Confidence 00 001123579999999999765 568999999999999999999
Q ss_pred CCCCCCCCChhhhHHHHhhccc--------------------cc----cCC---CCCCCCHHHHHHHHHhhc-CccccCC
Q 010463 340 GYPPFCSDDPRITCRKIVNWKT--------------------CL----KFP---EEPKISDEARDLICHLLC-DVETRLG 391 (510)
Q Consensus 340 G~~PF~~~~~~~~~~~I~~~~~--------------------~~----~~p---~~~~~s~~~~dlI~~lL~-dp~~R~~ 391 (510)
|++||.+.+.......+...-. .. ..+ ..+.+++++.+||.+||+ +|++||
T Consensus 206 G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp- 284 (336)
T cd07849 206 NRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRI- 284 (336)
T ss_pred CCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCc-
Confidence 9999987654433322221000 00 000 013568899999999998 999999
Q ss_pred CCChHHhhcCCCcCCC
Q 010463 392 TRGVEELKEHPWFRGI 407 (510)
Q Consensus 392 ~~~~~eil~HpfF~~i 407 (510)
++.++++||||+..
T Consensus 285 --t~~e~l~hp~~~~~ 298 (336)
T cd07849 285 --TVEEALAHPYLEQY 298 (336)
T ss_pred --CHHHHhcCcccccc
Confidence 78999999999854
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=348.06 Aligned_cols=256 Identities=32% Similarity=0.497 Sum_probs=213.0
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC--ceEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS--DFLY 182 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~~~ 182 (510)
.++|++.+.||.|+||.||+|.++.+++.||+|.++..... ......+.+|+.++..++||||+++++++.+. ..+|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 46899999999999999999999999999999999765432 23334567899999999999999999999877 8999
Q ss_pred EEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 183 LIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
+||||+++ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++........
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 99999975 999988764 4589999999999999999999999999999999999999999999999999986543210
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC-CCCccccccchhhHHHHHhhC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEMLIG 340 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiwSlGvilyEml~G 340 (510)
......|++.|+|||++.+. .++.++|+|||||++|||++|
T Consensus 162 --------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g 203 (293)
T cd07843 162 --------------------------------------PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK 203 (293)
T ss_pred --------------------------------------ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhC
Confidence 01124688999999998764 468999999999999999999
Q ss_pred CCCCCCCChhhhHHHHhhcccc-----------------------------ccCCCCCCCCHHHHHHHHHhhc-CccccC
Q 010463 341 YPPFCSDDPRITCRKIVNWKTC-----------------------------LKFPEEPKISDEARDLICHLLC-DVETRL 390 (510)
Q Consensus 341 ~~PF~~~~~~~~~~~I~~~~~~-----------------------------~~~p~~~~~s~~~~dlI~~lL~-dp~~R~ 390 (510)
.+||.+.+....+.++...-.. -.+|. ..+++.+.+||++||+ +|++||
T Consensus 204 ~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~ 282 (293)
T cd07843 204 KPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPA-LSLSDNGFDLLNRLLTYDPAKRI 282 (293)
T ss_pred CCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccc-cCCChHHHHHHHHHhccCccccC
Confidence 9999988776666555421000 00111 1158899999999999 999999
Q ss_pred CCCChHHhhcCCCc
Q 010463 391 GTRGVEELKEHPWF 404 (510)
Q Consensus 391 ~~~~~~eil~HpfF 404 (510)
++.|++.||||
T Consensus 283 ---t~~ell~~~~f 293 (293)
T cd07843 283 ---SAEDALKHPYF 293 (293)
T ss_pred ---CHHHHhcCCCC
Confidence 78999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=343.66 Aligned_cols=251 Identities=29% Similarity=0.483 Sum_probs=205.8
Q ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEeEEeecC--ceEEEE
Q 010463 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDS--DFLYLI 184 (510)
Q Consensus 108 f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~--~~~~lV 184 (510)
|++++.||+|+||.||+|..+.+++.||+|++++... ...+ .....|..++..+. ||||+++++++.+. +.+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 6789999999999999999999999999999876421 2222 23456888888884 99999999999988 899999
Q ss_pred EeccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccc
Q 010463 185 MEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 263 (510)
Q Consensus 185 mEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 263 (510)
|||++| +|.+.+.. ...+++..++.++.|++.||.|||+.|++||||||+||+++. |.+||+|||+++.+.....
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-- 154 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-- 154 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC--
Confidence 999975 78888765 457899999999999999999999999999999999999999 9999999999986543210
Q ss_pred cchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHhhCCC
Q 010463 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYP 342 (510)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml~G~~ 342 (510)
.....||+.|+|||++.. ..++.++|+|||||++|||++|.+
T Consensus 155 -------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~ 197 (282)
T cd07831 155 -------------------------------------YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFP 197 (282)
T ss_pred -------------------------------------cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCc
Confidence 012468999999998765 456899999999999999999999
Q ss_pred CCCCCChhhhHHHHhhcc----------------ccccCCC---------CCCCCHHHHHHHHHhhc-CccccCCCCChH
Q 010463 343 PFCSDDPRITCRKIVNWK----------------TCLKFPE---------EPKISDEARDLICHLLC-DVETRLGTRGVE 396 (510)
Q Consensus 343 PF~~~~~~~~~~~I~~~~----------------~~~~~p~---------~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~ 396 (510)
||.+.+..+....+.... ....+|. .+.+|.++.+||.+||. +|++|| +++
T Consensus 198 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~---~~~ 274 (282)
T cd07831 198 LFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERI---TAK 274 (282)
T ss_pred CCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCccccc---CHH
Confidence 999887766555443211 1111221 12578999999999999 999999 789
Q ss_pred HhhcCCCc
Q 010463 397 ELKEHPWF 404 (510)
Q Consensus 397 eil~HpfF 404 (510)
+++.||||
T Consensus 275 ~~l~~~~~ 282 (282)
T cd07831 275 QALRHPYF 282 (282)
T ss_pred HHhhCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=336.31 Aligned_cols=249 Identities=50% Similarity=0.897 Sum_probs=220.4
Q ss_pred eecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEeccCCCCH
Q 010463 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDI 193 (510)
Q Consensus 114 IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy~~gG~L 193 (510)
||.|+||.||+|.+..+++.||+|++.+...........+..|+.+++.++||||+++++.+.++..+|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999999999999999887766666778899999999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhhhhcc
Q 010463 194 MTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 273 (510)
Q Consensus 194 ~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~ 273 (510)
.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~------------ 148 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS------------ 148 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC------------
Confidence 99998888899999999999999999999999999999999999999999999999999886543200
Q ss_pred cccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCCCChhhhH
Q 010463 274 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITC 353 (510)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~~~~~~~~ 353 (510)
......|+..|+|||.+.+...+.++|+||||+++|+|++|..||...+.....
T Consensus 149 --------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~ 202 (250)
T cd05123 149 --------------------------RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIY 202 (250)
T ss_pred --------------------------cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 012356899999999999888999999999999999999999999888776666
Q ss_pred HHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 354 RKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 354 ~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
..+.. ..+.+| ..++..+.++|++||+ ||++||+...++++++||||
T Consensus 203 ~~~~~--~~~~~~--~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 203 EKILK--DPLRFP--EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HHHhc--CCCCCC--CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 66665 334444 3679999999999998 99999965445999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=346.67 Aligned_cols=261 Identities=29% Similarity=0.425 Sum_probs=208.1
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc-----
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD----- 179 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~----- 179 (510)
.++|++++.||+|+||.||+|.++.+++.||||++..... .......+.+|+.+++.++||||+++++++.+..
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 5689999999999999999999999999999999865432 2223345678999999999999999999987654
Q ss_pred ---eEEEEEeccCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCccc
Q 010463 180 ---FLYLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 255 (510)
Q Consensus 180 ---~~~lVmEy~~gG~L~~~L~~~~-~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~ 255 (510)
..|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||+.|++||||||+|||++.++.+||+|||++..
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 45999999965 8888876653 689999999999999999999999999999999999999999999999999986
Q ss_pred CccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC-CCCccccccchhhHH
Q 010463 256 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIM 334 (510)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiwSlGvil 334 (510)
+....... .......+|++.|+|||++.+. .++.++|+|||||++
T Consensus 169 ~~~~~~~~----------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l 214 (310)
T cd07865 169 FSLSKNSK----------------------------------PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIM 214 (310)
T ss_pred ccCCcccC----------------------------------CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHH
Confidence 64321100 0001134689999999998764 478999999999999
Q ss_pred HHHhhCCCCCCCCChhhhHHHHhhcccc-----------------ccCCCC-----------CCCCHHHHHHHHHhhc-C
Q 010463 335 YEMLIGYPPFCSDDPRITCRKIVNWKTC-----------------LKFPEE-----------PKISDEARDLICHLLC-D 385 (510)
Q Consensus 335 yEml~G~~PF~~~~~~~~~~~I~~~~~~-----------------~~~p~~-----------~~~s~~~~dlI~~lL~-d 385 (510)
|||++|.+||.+.+.......+...... ..+|.. ...++.+.+||.+||+ |
T Consensus 215 ~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~ 294 (310)
T cd07865 215 AEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLD 294 (310)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCC
Confidence 9999999999887765444333221000 011110 1236788999999999 9
Q ss_pred ccccCCCCChHHhhcCCCc
Q 010463 386 VETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 386 p~~R~~~~~~~eil~HpfF 404 (510)
|.+|| +++++++||||
T Consensus 295 P~~R~---t~~e~l~h~~f 310 (310)
T cd07865 295 PAKRI---DADTALNHDFF 310 (310)
T ss_pred hhhcc---CHHHHhcCCCC
Confidence 99999 78999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=337.40 Aligned_cols=253 Identities=34% Similarity=0.591 Sum_probs=217.2
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEe
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 186 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmE 186 (510)
+|.+.+.||+|+||.||+|..+.+|..||+|.+..... ...+.+.+.+|+.+++.++||||+++++.+.+...+|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 58899999999999999999999999999999976543 22345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCc-eeecccCCcccCccccccc
Q 010463 187 YLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH-LKLSDFGLCKPLEDKYSSI 263 (510)
Q Consensus 187 y~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~-vkL~DFGla~~~~~~~~~~ 263 (510)
|++|++|.+++.+.. .+++..+..++.|++.||.|||+.||+|+||||+||+++.++. +||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-- 157 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME-- 157 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc--
Confidence 999999999987643 5799999999999999999999999999999999999998865 69999999876543210
Q ss_pred cchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCC
Q 010463 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 343 (510)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~P 343 (510)
......|++.|+|||++.+..++.++|+|||||++|||++|..|
T Consensus 158 ------------------------------------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p 201 (257)
T cd08225 158 ------------------------------------LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201 (257)
T ss_pred ------------------------------------cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 01124699999999999988899999999999999999999999
Q ss_pred CCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 344 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 344 F~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
|.+.+.......+..... .+..+.++.+++++|.+||. +|++|| ++.++++||||
T Consensus 202 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~~p~~Rp---t~~~ll~~~~~ 257 (257)
T cd08225 202 FEGNNLHQLVLKICQGYF---APISPNFSRDLRSLISQLFKVSPRDRP---SITSILKRPFL 257 (257)
T ss_pred CCCccHHHHHHHHhcccC---CCCCCCCCHHHHHHHHHHhccChhhCc---CHHHHhhCCCC
Confidence 988777666665554221 12224678999999999998 999999 78999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=344.03 Aligned_cols=251 Identities=22% Similarity=0.387 Sum_probs=211.1
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEc-----CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAK-----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 178 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~-----~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 178 (510)
..++|.+.+.||+|+||+||+|... .++..||+|.+.+. .......+.+|+.++..++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 4568999999999999999999853 35667999998754 234456789999999999999999999999999
Q ss_pred ceEEEEEeccCCCCHHHHHHhcc-------------CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCce
Q 010463 179 DFLYLIMEYLPGGDIMTLLMRED-------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHL 245 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~~-------------~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~v 245 (510)
+.+|+||||+++|+|.+++...+ .+++..+..++.|++.||+|||+.|++||||||+|||++.++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 99999999999999999997543 48999999999999999999999999999999999999999999
Q ss_pred eecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccc
Q 010463 246 KLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMEC 325 (510)
Q Consensus 246 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 325 (510)
||+|||+++........ .......|++.|+|||++.+..++.++
T Consensus 160 kl~dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~s 203 (288)
T cd05093 160 KIGDFGMSRDVYSTDYY------------------------------------RVGGHTMLPIRWMPPESIMYRKFTTES 203 (288)
T ss_pred EeccCCccccccCCcee------------------------------------ecCCCCCccccccCHHHhccCCCCchh
Confidence 99999999865322100 001124578899999999999999999
Q ss_pred cccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhh
Q 010463 326 DWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 399 (510)
Q Consensus 326 DiwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil 399 (510)
|+|||||++|||++ |.+||.+.+.......+.... ....+ ..++.++.+||.+||. ||.+|| ++.+++
T Consensus 204 DiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rp---t~~~v~ 273 (288)
T cd05093 204 DVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR-VLQRP--RTCPKEVYDLMLGCWQREPHMRL---NIKEIH 273 (288)
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-cCCCC--CCCCHHHHHHHHHHccCChhhCC---CHHHHH
Confidence 99999999999998 999999888777777776632 12222 3688999999999998 999999 456653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=338.44 Aligned_cols=251 Identities=20% Similarity=0.338 Sum_probs=212.9
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEE
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~ 182 (510)
+...+|++.+.||+|+||.||+|..+.+++.||+|++.+.. .....+.+|+.+|..++||||+++++++..++.++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 45678999999999999999999999999999999987542 23456888999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccc
Q 010463 183 LIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 260 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~ 260 (510)
+||||+++|+|.+++... ..+++..++.++.|++.||.|||+.|++||||||+|||++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 999999999999998754 358999999999999999999999999999999999999999999999999998654321
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh-
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI- 339 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~- 339 (510)
... .....+++.|+|||++.+..++.++|||||||++|||++
T Consensus 159 ~~~-------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~ 201 (263)
T cd05052 159 YTA-------------------------------------HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 201 (263)
T ss_pred eec-------------------------------------cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcC
Confidence 100 011235678999999999999999999999999999998
Q ss_pred CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 340 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 340 G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
|.+||.+.+....+..+.... ....| ..++.++.++|.+||. +|++||+ +.++++
T Consensus 202 g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~cl~~~p~~Rp~---~~~l~~ 257 (263)
T cd05052 202 GMSPYPGIDLSQVYELLEKGY-RMERP--EGCPPKVYELMRACWQWNPSDRPS---FAEIHQ 257 (263)
T ss_pred CCCCCCCCCHHHHHHHHHCCC-CCCCC--CCCCHHHHHHHHHHccCCcccCCC---HHHHHH
Confidence 999999888777776665421 22333 4789999999999998 9999994 556543
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=347.57 Aligned_cols=257 Identities=31% Similarity=0.511 Sum_probs=218.4
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
.++|++++.||+|+||.||++....+++.||+|.+.... ....+.+.+|+.+++.++||||++++++|.+.+..|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 368999999999999999999999999999999986442 23346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 185 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
|||++||+|.+++.+ ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 95 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--- 170 (293)
T cd06647 95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--- 170 (293)
T ss_pred EecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc---
Confidence 999999999999865 4588999999999999999999999999999999999999999999999999875533210
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCC
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 344 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF 344 (510)
......|++.|+|||++.+..++.++|+|||||++|+|++|.+||
T Consensus 171 -----------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf 215 (293)
T cd06647 171 -----------------------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215 (293)
T ss_pred -----------------------------------ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 011246999999999999888999999999999999999999999
Q ss_pred CCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 345 CSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 345 ~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
.+.+.......+..+ ....++....++..+++||.+||. +|.+|| ++++++.||||+..
T Consensus 216 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---~~~~il~h~~~~~~ 275 (293)
T cd06647 216 LNENPLRALYLIATN-GTPELQNPEKLSAIFRDFLNRCLEMDVEKRG---SAKELLQHPFLKIA 275 (293)
T ss_pred CCCChhhheeehhcC-CCCCCCCccccCHHHHHHHHHHccCChhhCc---CHHHHhcCHHHhcC
Confidence 877655443333322 122333334678899999999998 999999 78999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=342.31 Aligned_cols=256 Identities=31% Similarity=0.522 Sum_probs=215.8
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC---CCCeeeEeEEeecCceEEE
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD---SRCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~---hp~Iv~l~~~~~~~~~~~l 183 (510)
.|++++.||+|+||.||+|.+..+|+.||+|.+.... .......+.+|+.+++.+. ||||+++++++.+....|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 5788899999999999999999999999999987542 3345567889999999986 9999999999999999999
Q ss_pred EEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccc
Q 010463 184 IMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 263 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 263 (510)
||||++|++|.+++.. +.+++..+..++.+++.||.|||+.||+||||+|+||+++.+|.++|+|||++.........
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~- 157 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK- 157 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc-
Confidence 9999999999999865 47899999999999999999999999999999999999999999999999999866432100
Q ss_pred cchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHhhCCC
Q 010463 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYP 342 (510)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml~G~~ 342 (510)
....+|++.|+|||.+.+ ..++.++|+|||||++|+|++|.+
T Consensus 158 -------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~ 200 (277)
T cd06917 158 -------------------------------------RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNP 200 (277)
T ss_pred -------------------------------------cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCC
Confidence 113479999999999875 456899999999999999999999
Q ss_pred CCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCC
Q 010463 343 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 408 (510)
Q Consensus 343 PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~ 408 (510)
||.+.+.......+... ....++. ..++.++.++|.+||. ||.+|| ++.+++.||||+...
T Consensus 201 p~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~---~~~~il~~~~~~~~~ 262 (277)
T cd06917 201 PYSDVDAFRAMMLIPKS-KPPRLED-NGYSKLLREFVAACLDEEPKERL---SAEELLKSKWIKAHS 262 (277)
T ss_pred CCCCCChhhhhhccccC-CCCCCCc-ccCCHHHHHHHHHHcCCCcccCc---CHHHHhhChHhhccc
Confidence 99877665544433322 1122222 2378899999999998 999999 689999999998754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=354.89 Aligned_cols=259 Identities=28% Similarity=0.436 Sum_probs=213.5
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC-----ce
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS-----DF 180 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----~~ 180 (510)
+.|.+++.||+|+||+||+|++..+|+.||||.+.+... .......+.+|+.+|+.++||||+++++++... ..
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 579999999999999999999999999999999875422 333455677899999999999999999988654 35
Q ss_pred EEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccc
Q 010463 181 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 260 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~ 260 (510)
+|+||||+. ++|.+++...+.+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 162 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence 899999995 6899999888889999999999999999999999999999999999999999999999999998653220
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHhh
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml~ 339 (510)
. .....+||..|+|||++.+ ..++.++|+|||||++|+|++
T Consensus 163 ~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~ 204 (337)
T cd07858 163 D--------------------------------------FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLG 204 (337)
T ss_pred c--------------------------------------cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHc
Confidence 0 0113568999999999875 568999999999999999999
Q ss_pred CCCCCCCCChhhhHHHHhhcccc-----------------------ccCC----CCCCCCHHHHHHHHHhhc-CccccCC
Q 010463 340 GYPPFCSDDPRITCRKIVNWKTC-----------------------LKFP----EEPKISDEARDLICHLLC-DVETRLG 391 (510)
Q Consensus 340 G~~PF~~~~~~~~~~~I~~~~~~-----------------------~~~p----~~~~~s~~~~dlI~~lL~-dp~~R~~ 391 (510)
|++||.+.+.......+...... ...+ ..+.+++++.+||++||+ +|++||
T Consensus 205 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp- 283 (337)
T cd07858 205 RKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRI- 283 (337)
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhcc-
Confidence 99999877644433333211000 0000 124689999999999999 999999
Q ss_pred CCChHHhhcCCCcCCC
Q 010463 392 TRGVEELKEHPWFRGI 407 (510)
Q Consensus 392 ~~~~~eil~HpfF~~i 407 (510)
+++++++||||..+
T Consensus 284 --s~~ell~h~~~~~~ 297 (337)
T cd07858 284 --TVEEALAHPYLASL 297 (337)
T ss_pred --CHHHHHcCcchhhh
Confidence 78999999999865
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=354.50 Aligned_cols=256 Identities=31% Similarity=0.486 Sum_probs=212.9
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc-----
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD----- 179 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~----- 179 (510)
.++|++++.||+|+||.||+|.+..+|+.||||++.+.. ........+.+|+.+|+.++||||++++++|..+.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 467999999999999999999999999999999986532 22333456889999999999999999999998654
Q ss_pred -eEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 180 -FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 180 -~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
..|+||||+ |++|..++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++.....
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence 459999999 7799888754 5799999999999999999999999999999999999999999999999999886532
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHH
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEM 337 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEm 337 (510)
. .....|++.|+|||++.+ ..++.++|+|||||++|+|
T Consensus 171 ~-----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l 209 (343)
T cd07880 171 E-----------------------------------------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEM 209 (343)
T ss_pred C-----------------------------------------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHH
Confidence 1 012468999999999976 4589999999999999999
Q ss_pred hhCCCCCCCCChhhhHHHHhhccccc------------------cCC---------CCCCCCHHHHHHHHHhhc-Ccccc
Q 010463 338 LIGYPPFCSDDPRITCRKIVNWKTCL------------------KFP---------EEPKISDEARDLICHLLC-DVETR 389 (510)
Q Consensus 338 l~G~~PF~~~~~~~~~~~I~~~~~~~------------------~~p---------~~~~~s~~~~dlI~~lL~-dp~~R 389 (510)
++|.+||.+.+....+.++....... ..| ..+.+++++.++|.+||+ ||.+|
T Consensus 210 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 289 (343)
T cd07880 210 LTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESR 289 (343)
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhC
Confidence 99999998877655555544311100 000 013678899999999999 99999
Q ss_pred CCCCChHHhhcCCCcCCC
Q 010463 390 LGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 390 ~~~~~~~eil~HpfF~~i 407 (510)
| ++.+++.||||+..
T Consensus 290 ~---t~~~~l~~~~~~~~ 304 (343)
T cd07880 290 I---TAAEALAHPYFEEF 304 (343)
T ss_pred C---CHHHHhcCccHhhh
Confidence 9 68999999999875
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=336.85 Aligned_cols=250 Identities=22% Similarity=0.387 Sum_probs=211.4
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceE
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 181 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~ 181 (510)
.+..++|++++.||+|+||.||+|... ++..||+|.+.... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPI 76 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 356789999999999999999999865 56679999886532 2356788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 182 YLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
|+||||++||+|.+++.+. ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++......
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 9999999999999998653 56889999999999999999999999999999999999999999999999999875432
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~ 339 (510)
... ......++..|+|||++.+..++.++|+|||||++|+|++
T Consensus 157 ~~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t 199 (261)
T cd05072 157 EYT-------------------------------------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVT 199 (261)
T ss_pred cee-------------------------------------ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHc
Confidence 100 0012346778999999998889999999999999999998
Q ss_pred -CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhh
Q 010463 340 -GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 399 (510)
Q Consensus 340 -G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil 399 (510)
|..||.+.+.......+.+. ...|....++.++.++|.+||. +|++||+ ++++.
T Consensus 200 ~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~i~ 255 (261)
T cd05072 200 YGKIPYPGMSNSDVMSALQRG---YRMPRMENCPDELYDIMKTCWKEKAEERPT---FDYLQ 255 (261)
T ss_pred cCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCCHHHHHHHHHHccCCcccCcC---HHHHH
Confidence 99999988777777666542 2334445789999999999998 9999995 55554
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=347.04 Aligned_cols=256 Identities=30% Similarity=0.454 Sum_probs=216.6
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEe
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 186 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmE 186 (510)
.|+.++.||+|+||.||+|.+..++..||+|++.... .....+.+.+|+.+++.++||||++++++|.+.+.+|+|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 4677888999999999999999999999999987543 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccch
Q 010463 187 YLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 266 (510)
Q Consensus 187 y~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~ 266 (510)
|++||+|.+++.. +.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+......
T Consensus 83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~---- 157 (277)
T cd06642 83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK---- 157 (277)
T ss_pred ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchh----
Confidence 9999999998854 56899999999999999999999999999999999999999999999999998765432100
Q ss_pred hhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCC
Q 010463 267 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCS 346 (510)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~ 346 (510)
.....|+..|+|||++.+..++.++|+|||||++|||++|.+||..
T Consensus 158 ----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06642 158 ----------------------------------RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred ----------------------------------hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcc
Confidence 0124689999999999999999999999999999999999999987
Q ss_pred CChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCc
Q 010463 347 DDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQW 409 (510)
Q Consensus 347 ~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~ 409 (510)
..+......+.... ....+ ..++.++.++|.+||. +|.+|| ++.++++||||....+
T Consensus 204 ~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~~~~~~ 261 (277)
T cd06642 204 LHPMRVLFLIPKNS-PPTLE--GQYSKPFKEFVEACLNKDPRFRP---TAKELLKHKFITRYTK 261 (277)
T ss_pred cchhhHHhhhhcCC-CCCCC--cccCHHHHHHHHHHccCCcccCc---CHHHHHHhHHHHHHhh
Confidence 66555444433211 11222 2578899999999998 999999 7899999999976543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=341.32 Aligned_cols=254 Identities=30% Similarity=0.452 Sum_probs=216.9
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEe
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 186 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmE 186 (510)
-|++++.||.|+||.||+|.++.+++.||+|++..... ......+.+|+.++..++||||+++++++.+....|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 37788999999999999999999999999999865432 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccch
Q 010463 187 YLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 266 (510)
Q Consensus 187 y~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~ 266 (510)
|++||+|..++.. ..+++..+..++.|++.||.+||+.|++|+||||+||+++.+|.++|+|||++..+.....
T Consensus 83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~----- 156 (277)
T cd06641 83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI----- 156 (277)
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh-----
Confidence 9999999998864 5689999999999999999999999999999999999999999999999999876533200
Q ss_pred hhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCC
Q 010463 267 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCS 346 (510)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~ 346 (510)
......|+..|+|||++.+..++.++|+|||||++|+|++|.+||..
T Consensus 157 ---------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 203 (277)
T cd06641 157 ---------------------------------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE 203 (277)
T ss_pred ---------------------------------hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCc
Confidence 01134689999999999988889999999999999999999999987
Q ss_pred CChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 347 DDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 347 ~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
.+.......+... ....++ ..++.++.++|.+||. +|.+|| ++.++++||||...
T Consensus 204 ~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~i~~~l~~~p~~Rp---~~~~~l~~~~~~~~ 259 (277)
T cd06641 204 LHPMKVLFLIPKN-NPPTLE--GNYSKPLKEFVEACLNKEPSFRP---TAKELLKHKFIVRF 259 (277)
T ss_pred cchHHHHHHHhcC-CCCCCC--cccCHHHHHHHHHHccCChhhCc---CHHHHHhCHHHhhh
Confidence 7665555554332 112222 3678999999999998 999999 68999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=382.99 Aligned_cols=272 Identities=26% Similarity=0.331 Sum_probs=209.1
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
+++|++++.||+|+||.||+|++..+|+.||||++.+.........+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 36899999999999999999999999999999999765333334456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc-----------cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCc
Q 010463 185 MEYLPGGDIMTLLMRE-----------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLC 253 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~-----------~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla 253 (510)
|||++||+|.+++... ..++...+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999999998642 23455677888999999999999999999999999999999999999999999
Q ss_pred ccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhH
Q 010463 254 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 333 (510)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvi 333 (510)
+........... ........ ..+........+||+.|||||++.+..++.++|||||||+
T Consensus 161 k~i~~~~~~~~~--------l~~~~~~s------------~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVI 220 (932)
T PRK13184 161 IFKKLEEEDLLD--------IDVDERNI------------CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVI 220 (932)
T ss_pred eecccccccccc--------cccccccc------------cccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHH
Confidence 876321100000 00000000 0000001123689999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhh
Q 010463 334 MYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 399 (510)
Q Consensus 334 lyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil 399 (510)
+|||++|.+||.+.+.......... ...........+++.+.+++.+||. ||++|++. +++++
T Consensus 221 LyELLTG~~PF~~~~~~ki~~~~~i-~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss--~eeLl 284 (932)
T PRK13184 221 LYQMLTLSFPYRRKKGRKISYRDVI-LSPIEVAPYREIPPFLSQIAMKALAVDPAERYSS--VQELK 284 (932)
T ss_pred HHHHHHCCCCCCCcchhhhhhhhhc-cChhhccccccCCHHHHHHHHHHccCChhhCcCH--HHHHH
Confidence 9999999999987554433222111 1111222234788999999999998 99999863 44444
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=361.68 Aligned_cols=246 Identities=25% Similarity=0.405 Sum_probs=212.2
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCce
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 180 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 180 (510)
+++.++...-+.-||.|+.|-||+|+.+ ++.||||+++.- + ..++.-|++|+||||+.+.++|.....
T Consensus 119 WeiPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~el---k-------ETdIKHLRkLkH~NII~FkGVCtqsPc 186 (904)
T KOG4721|consen 119 WEIPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVREL---K-------ETDIKHLRKLKHPNIITFKGVCTQSPC 186 (904)
T ss_pred ccCCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhhh---h-------hhhHHHHHhccCcceeeEeeeecCCce
Confidence 4455566666788999999999999885 789999976421 1 235566889999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccc
Q 010463 181 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 260 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~ 260 (510)
+|||||||+.|-|...|+...+++......|..+|+.|++|||...|||||||.-||||..+..|||+|||-++.+.+.
T Consensus 187 yCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~- 265 (904)
T KOG4721|consen 187 YCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK- 265 (904)
T ss_pred eEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999998865432
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhC
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 340 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G 340 (510)
....+++||..|||||++++++.+.++|||||||+|||||||
T Consensus 266 --------------------------------------STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~ 307 (904)
T KOG4721|consen 266 --------------------------------------STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTG 307 (904)
T ss_pred --------------------------------------hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhc
Confidence 112478999999999999999999999999999999999999
Q ss_pred CCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCC
Q 010463 341 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHP 402 (510)
Q Consensus 341 ~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~Hp 402 (510)
..||.+-+...+..-+-. ..+.+|....+++.++-||++||. .|.+|| ++.+|+.|-
T Consensus 308 EiPYkdVdssAIIwGVGs--NsL~LpvPstcP~GfklL~Kqcw~sKpRNRP---SFrqil~Hl 365 (904)
T KOG4721|consen 308 EIPYKDVDSSAIIWGVGS--NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRP---SFRQILLHL 365 (904)
T ss_pred CCCccccchheeEEeccC--CcccccCcccCchHHHHHHHHHHhcCCCCCc---cHHHHHHHH
Confidence 999987766554443333 345566556899999999999998 999999 678888883
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=336.49 Aligned_cols=249 Identities=22% Similarity=0.352 Sum_probs=209.9
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEE
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l 183 (510)
..++|++++.||+|+||.||+|+.+. +..+|+|.+.+... ....+..|+.+|+.++||||+++++++.+.+.+|+
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 76 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYI 76 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEE
Confidence 45789999999999999999998764 56799998865432 23457889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccc
Q 010463 184 IMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 262 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 262 (510)
||||++||+|.+++.. .+.+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++........
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 77 VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 9999999999999875 356899999999999999999999999999999999999999999999999999865322100
Q ss_pred ccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh-CC
Q 010463 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GY 341 (510)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~-G~ 341 (510)
. .....++..|+|||++.+..++.++|+|||||++|||++ |+
T Consensus 157 ~-------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~ 199 (256)
T cd05114 157 S-------------------------------------SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGK 199 (256)
T ss_pred c-------------------------------------cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCC
Confidence 0 012346678999999998899999999999999999999 99
Q ss_pred CCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
+||.+.+.......+.... ....| ...+.++.+||.+|++ +|.+|| +++++++
T Consensus 200 ~p~~~~~~~~~~~~i~~~~-~~~~~--~~~~~~~~~li~~c~~~~p~~Rp---s~~~l~~ 253 (256)
T cd05114 200 MPFEKKSNYEVVEMISRGF-RLYRP--KLASMTVYEVMYSCWHEKPEGRP---TFAELLR 253 (256)
T ss_pred CCCCCCCHHHHHHHHHCCC-CCCCC--CCCCHHHHHHHHHHccCCcccCc---CHHHHHH
Confidence 9999888877777776532 22223 3578899999999998 999999 5777764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=341.09 Aligned_cols=257 Identities=30% Similarity=0.477 Sum_probs=212.5
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC--ceEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS--DFLYL 183 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~~~l 183 (510)
++|+.++.||.|++|.||+|.++.+++.||+|.+.+... ......+.+|+++++.++||||++++++|.+. +.+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 479999999999999999999999999999999876432 23456688999999999999999999998654 47999
Q ss_pred EEeccCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 184 IMEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
||||++||+|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999888753 356899999999999999999999999999999999999999999999999998754321
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~ 339 (510)
. .....|+..|+|||.+.+..++.++|+|||||++|+|++
T Consensus 159 ~----------------------------------------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~ 198 (287)
T cd06621 159 L----------------------------------------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQ 198 (287)
T ss_pred c----------------------------------------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHh
Confidence 0 012458889999999999999999999999999999999
Q ss_pred CCCCCCCCC-----hhhhHHHHhhccccccCCC----CCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCC
Q 010463 340 GYPPFCSDD-----PRITCRKIVNWKTCLKFPE----EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 408 (510)
Q Consensus 340 G~~PF~~~~-----~~~~~~~I~~~~~~~~~p~----~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~ 408 (510)
|..||.... ..+....+.... ....+. ....++.+.+||.+||. +|.+|| ++.|++.||||....
T Consensus 199 g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~eil~~~~~~~~~ 273 (287)
T cd06621 199 NRFPFPPEGEPPLGPIELLSYIVNMP-NPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRP---TPWDMLEHPWIKAQM 273 (287)
T ss_pred CCCCCCcccCCCCChHHHHHHHhcCC-chhhccCCCCCCchHHHHHHHHHHHcCCCcccCC---CHHHHHhCccccccc
Confidence 999998652 223333333321 111111 12357889999999998 999999 789999999997643
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=343.03 Aligned_cols=256 Identities=27% Similarity=0.395 Sum_probs=205.0
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
.++|.+++.||+|+||.||+|..+.+|+.||+|++..... ......+.+|+.+|+.++|+||+++++++.+.+..|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 4689999999999999999999999999999999875432 22234567899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccc
Q 010463 185 MEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 263 (510)
Q Consensus 185 mEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 263 (510)
|||+. ++|.+.+.. ...+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+++.......
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-- 158 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ-- 158 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC--
Confidence 99996 577776654 35688999999999999999999999999999999999999999999999999875432100
Q ss_pred cchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHhhCCC
Q 010463 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYP 342 (510)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml~G~~ 342 (510)
.....++++.|+|||++.+ ..++.++|+|||||++|||++|.+
T Consensus 159 ------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 202 (291)
T cd07870 159 ------------------------------------TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQP 202 (291)
T ss_pred ------------------------------------CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 0113468999999999875 458899999999999999999999
Q ss_pred CCCCCChh-hhHHHHhhccc------------------c---ccCCC-------CCCCCHHHHHHHHHhhc-CccccCCC
Q 010463 343 PFCSDDPR-ITCRKIVNWKT------------------C---LKFPE-------EPKISDEARDLICHLLC-DVETRLGT 392 (510)
Q Consensus 343 PF~~~~~~-~~~~~I~~~~~------------------~---~~~p~-------~~~~s~~~~dlI~~lL~-dp~~R~~~ 392 (510)
||.+.+.. +...++..... . ...+. ....++++.+||.+||. ||.+||
T Consensus 203 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~-- 280 (291)
T cd07870 203 AFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRI-- 280 (291)
T ss_pred CCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCc--
Confidence 99765432 22222211000 0 00000 01236789999999998 999999
Q ss_pred CChHHhhcCCCc
Q 010463 393 RGVEELKEHPWF 404 (510)
Q Consensus 393 ~~~~eil~HpfF 404 (510)
+++|++.||||
T Consensus 281 -t~~~~l~h~~~ 291 (291)
T cd07870 281 -SAQDALLHPYF 291 (291)
T ss_pred -CHHHHhcCCCC
Confidence 78999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=361.59 Aligned_cols=258 Identities=22% Similarity=0.313 Sum_probs=208.6
Q ss_pred hcccCCCCceeeeeeecCCCeEEEEEEEcCC-----CCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEeE
Q 010463 100 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTT-----GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFY 173 (510)
Q Consensus 100 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t-----g~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~ 173 (510)
+..+..+.|++++.||+|+||.||+|.+... +..||||++.... .....+.+.+|+.+|..++ |||||++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 4556678999999999999999999987433 3569999996542 3344567899999999996 999999999
Q ss_pred EeecCceEEEEEeccCCCCHHHHHHhc-----------------------------------------------------
Q 010463 174 SFQDSDFLYLIMEYLPGGDIMTLLMRE----------------------------------------------------- 200 (510)
Q Consensus 174 ~~~~~~~~~lVmEy~~gG~L~~~L~~~----------------------------------------------------- 200 (510)
+|.+.+.+|||||||+||+|.++|.+.
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 999999999999999999999988643
Q ss_pred -------------------------------------------cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCe
Q 010463 201 -------------------------------------------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNL 237 (510)
Q Consensus 201 -------------------------------------------~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NI 237 (510)
..+++..+..++.||+.||.|||+.||+||||||+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 2377888899999999999999999999999999999
Q ss_pred eecCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc
Q 010463 238 ILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL 317 (510)
Q Consensus 238 Lld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~ 317 (510)
|++.++.+||+|||+++........ ....+..|++.|+|||++.
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~~ 312 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNY------------------------------------VSKGSTFLPVKWMAPESIF 312 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccc------------------------------------cccCCcCCCcceEChhhhc
Confidence 9999999999999999865322100 0011346889999999999
Q ss_pred cCCCCccccccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCh
Q 010463 318 KKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGV 395 (510)
Q Consensus 318 ~~~y~~~~DiwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~ 395 (510)
+..++.++|||||||++|||++ |..||.+..........+.....+ +....++.++.++|.+||. ||++||+...+
T Consensus 313 ~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l 390 (400)
T cd05105 313 DNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRM--AKPDHATQEVYDIMVKCWNSEPEKRPSFLHL 390 (400)
T ss_pred CCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCC--CCCccCCHHHHHHHHHHCccCHhHCcCHHHH
Confidence 9999999999999999999997 999998765544443333322222 2334789999999999998 99999954333
Q ss_pred HH
Q 010463 396 EE 397 (510)
Q Consensus 396 ~e 397 (510)
.+
T Consensus 391 ~~ 392 (400)
T cd05105 391 SD 392 (400)
T ss_pred HH
Confidence 33
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=347.82 Aligned_cols=254 Identities=22% Similarity=0.364 Sum_probs=209.2
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCE----EEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEI----FAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 178 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~----vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 178 (510)
+...+|++++.||+|+||.||+|++..+|+. ||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~ 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence 4567899999999999999999998777664 8999986432 233456788999999999999999999998865
Q ss_pred ceEEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCc
Q 010463 179 DFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 257 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~ 257 (510)
..++|+||+++|+|.+++... ..+++..+..++.||+.||+|||+.||+||||||+|||++.++++||+|||+++.+.
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence 578999999999999999874 468899999999999999999999999999999999999999999999999998764
Q ss_pred cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHH
Q 010463 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337 (510)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEm 337 (510)
...... ......+++.|+|||++.+..++.++|||||||++|||
T Consensus 161 ~~~~~~------------------------------------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el 204 (316)
T cd05108 161 ADEKEY------------------------------------HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 204 (316)
T ss_pred CCCcce------------------------------------eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHH
Confidence 321100 00123457789999999999999999999999999999
Q ss_pred hh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 338 LI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 338 l~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
++ |.+||.+....... .++... ...|..+..+.++.++|.+||. +|.+|| ++.+++.+
T Consensus 205 ~t~g~~p~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rp---s~~~l~~~ 264 (316)
T cd05108 205 MTFGSKPYDGIPASEIS-SILEKG--ERLPQPPICTIDVYMIMVKCWMIDADSRP---KFRELIIE 264 (316)
T ss_pred HcCCCCCCCCCCHHHHH-HHHhCC--CCCCCCCCCCHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 97 99999876655443 444322 2333335788999999999998 999999 67788765
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=354.20 Aligned_cols=257 Identities=22% Similarity=0.338 Sum_probs=207.9
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcC-----CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEe
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKT-----TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSF 175 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~-----tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~ 175 (510)
.+..++|++.+.||+|+||.||+|.... +++.||+|++.... .......+..|+.++..+ +||||+++++++
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 3445689999999999999999997543 45789999986432 233456678899999999 899999999988
Q ss_pred ec-CceEEEEEeccCCCCHHHHHHhc------------------------------------------------------
Q 010463 176 QD-SDFLYLIMEYLPGGDIMTLLMRE------------------------------------------------------ 200 (510)
Q Consensus 176 ~~-~~~~~lVmEy~~gG~L~~~L~~~------------------------------------------------------ 200 (510)
.. +..+|+||||++||+|.++|...
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 75 45799999999999999998542
Q ss_pred -------cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhhhhcc
Q 010463 201 -------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 273 (510)
Q Consensus 201 -------~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~ 273 (510)
..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.+.......
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~---------- 230 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV---------- 230 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchh----------
Confidence 257899999999999999999999999999999999999999999999999998754321000
Q ss_pred cccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh-CCCCCCCCChhhh
Q 010463 274 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRIT 352 (510)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~-G~~PF~~~~~~~~ 352 (510)
...+..|++.|+|||++.+..++.++|||||||++|||++ |.+||.+....+.
T Consensus 231 --------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~ 284 (337)
T cd05054 231 --------------------------RKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE 284 (337)
T ss_pred --------------------------hccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH
Confidence 0112457788999999999999999999999999999998 9999987655554
Q ss_pred HHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 353 CRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 353 ~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
+...+........| ...++++.+++.+||+ +|++|| +++|+++|
T Consensus 285 ~~~~~~~~~~~~~~--~~~~~~~~~l~~~cl~~~p~~RP---s~~ell~~ 329 (337)
T cd05054 285 FCRRLKEGTRMRAP--EYATPEIYSIMLDCWHNNPEDRP---TFSELVEI 329 (337)
T ss_pred HHHHHhccCCCCCC--ccCCHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 44444322223333 3678999999999998 999999 67888764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=338.99 Aligned_cols=251 Identities=28% Similarity=0.492 Sum_probs=211.3
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++|++.+.||+|+||.||+|+.+.+|+.||||.+.+...........+.+|+.+++.++||||++++++|.+++.+++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 67999999999999999999999999999999988765555556678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 186 EYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 186 Ey~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
||++||+|.+++.. ...+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 99999999998864 35689999999999999999999999999999999999999999999999999876543210
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~ 341 (510)
.....+|++.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 162 --------------------------------------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~ 203 (267)
T cd08229 162 --------------------------------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 203 (267)
T ss_pred --------------------------------------ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCC
Confidence 011357999999999999999999999999999999999999
Q ss_pred CCCCCCChh--hhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhh
Q 010463 342 PPFCSDDPR--ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 399 (510)
Q Consensus 342 ~PF~~~~~~--~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil 399 (510)
.||.+.... .....+.... ....+ ...+++.+++||.+||. ||.+|| ++.+|+
T Consensus 204 ~p~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp---t~~~i~ 259 (267)
T cd08229 204 SPFYGDKMNLYSLCKKIEQCD-YPPLP-SDHYSEELRQLVNMCINPDPEKRP---DITYVY 259 (267)
T ss_pred CCcccccchHHHHhhhhhcCC-CCCCC-cccccHHHHHHHHHhcCCCcccCC---CHHHHH
Confidence 999765432 3333333211 11112 13578999999999998 999999 566554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=343.09 Aligned_cols=254 Identities=32% Similarity=0.523 Sum_probs=211.7
Q ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEec
Q 010463 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEY 187 (510)
Q Consensus 108 f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy 187 (510)
|++++.||.|++|.||+|.++.+|..||+|++..... .......+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 6788999999999999999999999999999976532 233345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 188 LPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 188 ~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
++ ++|.+++.... .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++..+.....
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---- 154 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR---- 154 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc----
Confidence 95 68999987765 789999999999999999999999999999999999999999999999999976532100
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC-CCCccccccchhhHHHHHhhCCCCC
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEMLIGYPPF 344 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiwSlGvilyEml~G~~PF 344 (510)
......|++.|+|||++.+. .++.++|+|||||++|+|++|.+||
T Consensus 155 ----------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 200 (283)
T cd07835 155 ----------------------------------TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLF 200 (283)
T ss_pred ----------------------------------ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCC
Confidence 01124678999999998764 5789999999999999999999999
Q ss_pred CCCChhhhHHHHhhcccc----------------ccCC---------CCCCCCHHHHHHHHHhhc-CccccCCCCChHHh
Q 010463 345 CSDDPRITCRKIVNWKTC----------------LKFP---------EEPKISDEARDLICHLLC-DVETRLGTRGVEEL 398 (510)
Q Consensus 345 ~~~~~~~~~~~I~~~~~~----------------~~~p---------~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~ei 398 (510)
.+.+......++...... ..++ ..+.++..+.++|.+||+ ||.+|| +++|+
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---t~~~i 277 (283)
T cd07835 201 PGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRI---SAKAA 277 (283)
T ss_pred CCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCc---CHHHH
Confidence 887765554444331100 0011 124678999999999999 999999 68999
Q ss_pred hcCCCc
Q 010463 399 KEHPWF 404 (510)
Q Consensus 399 l~HpfF 404 (510)
+.||||
T Consensus 278 l~~~~~ 283 (283)
T cd07835 278 LQHPYF 283 (283)
T ss_pred hcCCCC
Confidence 999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=339.99 Aligned_cols=255 Identities=18% Similarity=0.256 Sum_probs=210.0
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcC-----CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKT-----TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 177 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~-----tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 177 (510)
+..++|++.+.||+|+||.||+|.++. ++..||+|++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 456789999999999999999998652 45689999986532 22344568899999999999999999999999
Q ss_pred CceEEEEEeccCCCCHHHHHHhcc----------CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceee
Q 010463 178 SDFLYLIMEYLPGGDIMTLLMRED----------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKL 247 (510)
Q Consensus 178 ~~~~~lVmEy~~gG~L~~~L~~~~----------~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL 247 (510)
....++||||+++|+|.+++.+.. .++...+..++.|++.||.|||+.|++||||||+|||++.++.++|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999999987532 3567788899999999999999999999999999999999999999
Q ss_pred cccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccc
Q 010463 248 SDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDW 327 (510)
Q Consensus 248 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 327 (510)
+|||+++.+....... ......+++.|+|||++.+..++.++|+
T Consensus 161 ~dfg~~~~~~~~~~~~------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di 204 (277)
T cd05062 161 GDFGMTRDIYETDYYR------------------------------------KGGKGLLPVRWMSPESLKDGVFTTYSDV 204 (277)
T ss_pred CCCCCccccCCcceee------------------------------------cCCCCccCHhhcChhHhhcCCcCchhHH
Confidence 9999998654321100 0012356889999999999999999999
Q ss_pred cchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 328 WSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 328 wSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
|||||++|||++ |.+||.+.+.......+.... ....| ..+++.++++|.+||+ +|++|| ++.|++++
T Consensus 205 ~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~e~l~~ 274 (277)
T cd05062 205 WSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG-LLDKP--DNCPDMLFELMRMCWQYNPKMRP---SFLEIISS 274 (277)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-cCCCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 999999999999 799998887777666665432 22233 3688999999999999 999999 67787753
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=339.26 Aligned_cols=261 Identities=32% Similarity=0.505 Sum_probs=224.7
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEE
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l 183 (510)
..+.|++.+.||+|+||.||+|.+..++..||+|++..... ....+..|++++..++||||+++++++...+..|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 45679999999999999999999998999999999976432 45668889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccc
Q 010463 184 IMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 262 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~~~-~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 262 (510)
||||++|++|.+++.... .+++..+..++.+++.||.|||+.||+|+||||+||+++.+|+++|+|||++........
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 171 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS- 171 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence 999999999999998876 899999999999999999999999999999999999999999999999999875432200
Q ss_pred ccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCC
Q 010463 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 342 (510)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~ 342 (510)
......|++.|+|||++.+..++.++|+|||||++|+|++|..
T Consensus 172 -------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~ 214 (286)
T cd06614 172 -------------------------------------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEP 214 (286)
T ss_pred -------------------------------------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCC
Confidence 0013468999999999998889999999999999999999999
Q ss_pred CCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCch
Q 010463 343 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWD 410 (510)
Q Consensus 343 PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~ 410 (510)
||...++......+... .....+....++.++++||.+||+ +|.+|| ++.+++.||||....|.
T Consensus 215 p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~il~~~~~~~~~~~ 279 (286)
T cd06614 215 PYLREPPLRALFLITTK-GIPPLKNPEKWSPEFKDFLNKCLVKDPEKRP---SAEELLQHPFLKKACPK 279 (286)
T ss_pred CCCCCCHHHHHHHHHhc-CCCCCcchhhCCHHHHHHHHHHhccChhhCc---CHHHHhhChHhhccCch
Confidence 99887776655555442 222233333588999999999998 999999 78999999999986654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=341.55 Aligned_cols=256 Identities=22% Similarity=0.355 Sum_probs=212.6
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCC----------------CEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCC
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTG----------------EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 167 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg----------------~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~ 167 (510)
...+|++++.||+|+||.||+|....++ ..||+|++.... .....+.+.+|+.++..++|||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcCCCC
Confidence 3568999999999999999999877644 568999987653 2345677899999999999999
Q ss_pred eeeEeEEeecCceEEEEEeccCCCCHHHHHHhcc-----------CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCC
Q 010463 168 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED-----------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDN 236 (510)
Q Consensus 168 Iv~l~~~~~~~~~~~lVmEy~~gG~L~~~L~~~~-----------~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~N 236 (510)
|+++++++.+++..++||||+++++|..++.+.. .+++..++.++.|++.||.|||+.||+||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999998765 68999999999999999999999999999999999
Q ss_pred eeecCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhh
Q 010463 237 LILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL 316 (510)
Q Consensus 237 ILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl 316 (510)
||++.++.++|+|||+++.+...... .......+|+.|+|||++
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~ 204 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYY------------------------------------RVQGRAPLPIRWMAWESV 204 (296)
T ss_pred eeecCCCceEEccccceeecccCcce------------------------------------eecCcCCCCceecCHHHh
Confidence 99999999999999999765332100 001134678899999999
Q ss_pred ccCCCCccccccchhhHHHHHhh--CCCCCCCCChhhhHHHHhhc----cccccCCCCCCCCHHHHHHHHHhhc-Ccccc
Q 010463 317 LKKGYGMECDWWSLGAIMYEMLI--GYPPFCSDDPRITCRKIVNW----KTCLKFPEEPKISDEARDLICHLLC-DVETR 389 (510)
Q Consensus 317 ~~~~y~~~~DiwSlGvilyEml~--G~~PF~~~~~~~~~~~I~~~----~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R 389 (510)
.+..++.++|||||||++|||++ |..||...+....+..+... ......+..+.++.++.+||.+||. ||.+|
T Consensus 205 ~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 284 (296)
T cd05051 205 LLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDR 284 (296)
T ss_pred hcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcC
Confidence 98889999999999999999998 78899877766666665532 1122223334678999999999998 99999
Q ss_pred CCCCChHHhhc
Q 010463 390 LGTRGVEELKE 400 (510)
Q Consensus 390 ~~~~~~~eil~ 400 (510)
| ++.+|++
T Consensus 285 p---t~~el~~ 292 (296)
T cd05051 285 P---TFREIHL 292 (296)
T ss_pred C---CHHHHHH
Confidence 9 5677743
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=352.30 Aligned_cols=256 Identities=32% Similarity=0.505 Sum_probs=211.0
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc------
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD------ 179 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~------ 179 (510)
++|.+.+.||+|+||.||+|+++.+|+.||+|++.+... .......+.+|+.+++.++||||++++++|....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 689999999999999999999999999999999876432 2233456888999999999999999999987543
Q ss_pred eEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 180 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
..|+||||+.+ +|..++ ...+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+++.....
T Consensus 94 ~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~ 170 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE 170 (342)
T ss_pred eEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC
Confidence 56999999964 777665 346899999999999999999999999999999999999999999999999998754321
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml 338 (510)
....+||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 171 -----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~ 209 (342)
T cd07879 171 -----------------------------------------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEML 209 (342)
T ss_pred -----------------------------------------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHH
Confidence 013468999999999976 46899999999999999999
Q ss_pred hCCCCCCCCChhhhHHHHhhcccc---------------------ccCCC------CCCCCHHHHHHHHHhhc-CccccC
Q 010463 339 IGYPPFCSDDPRITCRKIVNWKTC---------------------LKFPE------EPKISDEARDLICHLLC-DVETRL 390 (510)
Q Consensus 339 ~G~~PF~~~~~~~~~~~I~~~~~~---------------------~~~p~------~~~~s~~~~dlI~~lL~-dp~~R~ 390 (510)
+|+.||.+.+....+..+...... ...+. .+.+++++.+||.+||+ ||.+||
T Consensus 210 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~ 289 (342)
T cd07879 210 TGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRL 289 (342)
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCc
Confidence 999999987765555554431100 00110 13578899999999998 999999
Q ss_pred CCCChHHhhcCCCcCCCCc
Q 010463 391 GTRGVEELKEHPWFRGIQW 409 (510)
Q Consensus 391 ~~~~~~eil~HpfF~~i~~ 409 (510)
++++++.||||.++.+
T Consensus 290 ---~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 290 ---TATEALEHPYFDSFRD 305 (342)
T ss_pred ---CHHHHhcCcchhhccc
Confidence 6899999999988653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=337.27 Aligned_cols=254 Identities=19% Similarity=0.291 Sum_probs=212.6
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCC-----CCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTT-----GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 177 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t-----g~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 177 (510)
+..++|++++.||+|+||.||+|..+.. +..||+|.+.... ...+...+.+|+.+|..++||||+++++++.+
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 4567899999999999999999988754 4789999986543 23345678899999999999999999999999
Q ss_pred CceEEEEEeccCCCCHHHHHHhc----------cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceee
Q 010463 178 SDFLYLIMEYLPGGDIMTLLMRE----------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKL 247 (510)
Q Consensus 178 ~~~~~lVmEy~~gG~L~~~L~~~----------~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL 247 (510)
....|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 99999999999999999998653 23678889999999999999999999999999999999999999999
Q ss_pred cccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccc
Q 010463 248 SDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDW 327 (510)
Q Consensus 248 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 327 (510)
+|||+++.+...... .......||..|+|||++.+..++.++|+
T Consensus 161 ~dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 204 (277)
T cd05032 161 GDFGMTRDIYETDYY------------------------------------RKGGKGLLPVRWMAPESLKDGVFTTKSDV 204 (277)
T ss_pred CCcccchhhccCccc------------------------------------ccCCCCCccccccCHHHHhcCCCCcccch
Confidence 999999865332100 00112457889999999998889999999
Q ss_pred cchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 328 WSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 328 wSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
|||||++|||++ |.+||.+.+.......+.. .....+|. .++.++.+||.+||+ +|++|| ++.++++
T Consensus 205 ~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp---t~~~l~~ 273 (277)
T cd05032 205 WSFGVVLWEMATLAEQPYQGLSNEEVLKFVID-GGHLDLPE--NCPDKLLELMRMCWQYNPKMRP---TFLEIVS 273 (277)
T ss_pred HHHHHHHHHhhccCCCCCccCCHHHHHHHHhc-CCCCCCCC--CCCHHHHHHHHHHcCCChhhCC---CHHHHHH
Confidence 999999999998 9999998887776666653 23344453 579999999999999 999999 6777764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=344.75 Aligned_cols=253 Identities=28% Similarity=0.379 Sum_probs=216.2
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
..|+.++.||+|+||.||+|++..+|..||+|++.+...........+..|+.+++.++|||++++++++.++...|+||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34888999999999999999999999999999997654444455667889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 186 EYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 186 Ey~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
||++| +|.+++.. ...+++..+..++.+++.||.|||+.||+||||+|+||+++.++.+||+|||++......
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~----- 178 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA----- 178 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc-----
Confidence 99975 77777654 567899999999999999999999999999999999999999999999999998754321
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc---cCCCCccccccchhhHHHHHhhCC
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~---~~~y~~~~DiwSlGvilyEml~G~ 341 (510)
....|++.|+|||++. .+.++.++|+|||||++|||++|.
T Consensus 179 -------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~ 221 (317)
T cd06635 179 -------------------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 221 (317)
T ss_pred -------------------------------------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCC
Confidence 1246899999999984 456899999999999999999999
Q ss_pred CCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
+||.+.+.......+...... ......+++.+++||.+||. +|.+|| ++.++++|||+..
T Consensus 222 ~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~il~~~~~~~ 282 (317)
T cd06635 222 PPLFNMNAMSALYHIAQNESP--TLQSNEWSDYFRNFVDSCLQKIPQDRP---TSEELLKHMFVLR 282 (317)
T ss_pred CCCCCccHHHHHHHHHhccCC--CCCCccccHHHHHHHHHHccCCcccCc---CHHHHHhChhhhc
Confidence 999887776666666553221 11223678899999999998 999999 7899999999954
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=337.93 Aligned_cols=255 Identities=20% Similarity=0.320 Sum_probs=212.0
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcC-----CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKT-----TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 177 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~-----tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 177 (510)
+..++|.+.+.||+|+||.||+|.++. ++..||+|.+.... .......+..|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 345789999999999999999999987 78899999886432 23334568889999999999999999999999
Q ss_pred CceEEEEEeccCCCCHHHHHHhcc-------CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCC---ceee
Q 010463 178 SDFLYLIMEYLPGGDIMTLLMRED-------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG---HLKL 247 (510)
Q Consensus 178 ~~~~~lVmEy~~gG~L~~~L~~~~-------~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g---~vkL 247 (510)
.+..|+||||++||+|.+++...+ .+++..+..++.||+.||+|||+.|++||||||+|||++.+| .+||
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence 999999999999999999997653 489999999999999999999999999999999999998765 5999
Q ss_pred cccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccc
Q 010463 248 SDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDW 327 (510)
Q Consensus 248 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 327 (510)
+|||+++.+....... ......+++.|+|||++.+..++.++||
T Consensus 161 ~dfg~~~~~~~~~~~~------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di 204 (277)
T cd05036 161 ADFGMARDIYRASYYR------------------------------------KGGRAMLPIKWMPPEAFLDGIFTSKTDV 204 (277)
T ss_pred ccCccccccCCcccee------------------------------------cCCCCCccHhhCCHHHHhcCCcCchhHH
Confidence 9999998763221000 0011234678999999998899999999
Q ss_pred cchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 328 WSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 328 wSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
|||||++|||++ |..||.+.+.......+... .....| ..++..+.++|.+||. +|++|| ++.++++|
T Consensus 205 wslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~i~~cl~~~p~~Rp---s~~~vl~~ 274 (277)
T cd05036 205 WSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG-GRLDPP--KGCPGPVYRIMTDCWQHTPEDRP---NFATILER 274 (277)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcCCCC--CCCCHHHHHHHHHHcCCCcccCc---CHHHHHHH
Confidence 999999999997 99999988777666655542 223333 4789999999999998 999999 67888876
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=329.64 Aligned_cols=253 Identities=31% Similarity=0.543 Sum_probs=221.5
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEe
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 186 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmE 186 (510)
+|++.+.||+|++|.||+|.++.+++.||+|.+.+... .......+.+|++++..++||||+++++++.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc-CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 58899999999999999999999999999999987643 23566789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccch
Q 010463 187 YLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 266 (510)
Q Consensus 187 y~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~ 266 (510)
|++|++|.+++.....+++..+..++.|++.||.+||+.||+||||||+||+++.+|.++|+|||++.........
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~---- 155 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD---- 155 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc----
Confidence 9999999999988888999999999999999999999999999999999999999999999999999876442110
Q ss_pred hhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCC
Q 010463 267 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCS 346 (510)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~ 346 (510)
.....|++.|+|||.+.+..++.++|+||||+++|+|++|.+||.+
T Consensus 156 ----------------------------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~ 201 (254)
T cd06627 156 ----------------------------------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYD 201 (254)
T ss_pred ----------------------------------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 1134689999999999888899999999999999999999999987
Q ss_pred CChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 347 DDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 347 ~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
.+......++... ....+| ..++..+.++|.+||. +|++|| ++.+++.||||
T Consensus 202 ~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~i~~~l~~~p~~R~---~~~~~l~~~~~ 254 (254)
T cd06627 202 LNPMAALFRIVQD-DHPPLP--EGISPELKDFLMQCFQKDPNLRP---TAKQLLKHPWI 254 (254)
T ss_pred ccHHHHHHHHhcc-CCCCCC--CCCCHHHHHHHHHHHhCChhhCc---CHHHHhcCCCC
Confidence 7665555554432 222333 4789999999999998 999999 68999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=332.94 Aligned_cols=251 Identities=30% Similarity=0.506 Sum_probs=211.3
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++|++.+.||+|+||.||+|....+|+.||+|.++........+.+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999999999999999998665555566778999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 186 EYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 186 Ey~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
||++||+|..++.. ...+++..+..++.+++.||.|||+.||+||||||+||+++.+|.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 99999999999864 34589999999999999999999999999999999999999999999999999886543210
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~ 341 (510)
......|++.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 162 --------------------------------------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~ 203 (267)
T cd08224 162 --------------------------------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 203 (267)
T ss_pred --------------------------------------ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCC
Confidence 012356999999999999999999999999999999999999
Q ss_pred CCCCCCCh--hhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhh
Q 010463 342 PPFCSDDP--RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 399 (510)
Q Consensus 342 ~PF~~~~~--~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil 399 (510)
.||..... ......+... .....|. ..++..+.++|.+||. +|++|| ++.+|+
T Consensus 204 ~p~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~i~~cl~~~p~~Rp---~~~~il 259 (267)
T cd08224 204 SPFYGDKMNLYSLCKKIEKC-DYPPLPA-DHYSEELRDLVSRCINPDPEKRP---DISYVL 259 (267)
T ss_pred CCcccCCccHHHHHhhhhcC-CCCCCCh-hhcCHHHHHHHHHHcCCCcccCC---CHHHHH
Confidence 99976542 2233333321 1112221 2678899999999998 999999 556655
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=337.57 Aligned_cols=253 Identities=30% Similarity=0.484 Sum_probs=210.4
Q ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc---CCCCeeeEeEEeecCce----
Q 010463 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV---DSRCIVQLFYSFQDSDF---- 180 (510)
Q Consensus 108 f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~~~~~~~---- 180 (510)
|++++.||+|+||.||+|+++.+++.||+|++..... .......+.+|+.++..+ +||||+++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 6789999999999999999999999999999975432 222334566788877665 69999999999998877
Q ss_pred -EEEEEeccCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCc
Q 010463 181 -LYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 257 (510)
Q Consensus 181 -~~lVmEy~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~ 257 (510)
+|++|||+++ +|.+++.+.. .+++..++.++.|++.||.|||+.|++|+||+|+|||++.++++||+|||++....
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999975 8999887643 58999999999999999999999999999999999999999999999999997653
Q ss_pred cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHH
Q 010463 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337 (510)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEm 337 (510)
.... ....+|++.|+|||++.+..++.++|+|||||++|||
T Consensus 159 ~~~~---------------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l 199 (287)
T cd07838 159 FEMA---------------------------------------LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199 (287)
T ss_pred CCcc---------------------------------------cccccccccccChHHhccCCCCCcchhhhHHHHHHHH
Confidence 3210 1124689999999999999999999999999999999
Q ss_pred hhCCCCCCCCChhhhHHHHhhccc---cccCC-----------C---------CCCCCHHHHHHHHHhhc-CccccCCCC
Q 010463 338 LIGYPPFCSDDPRITCRKIVNWKT---CLKFP-----------E---------EPKISDEARDLICHLLC-DVETRLGTR 393 (510)
Q Consensus 338 l~G~~PF~~~~~~~~~~~I~~~~~---~~~~p-----------~---------~~~~s~~~~dlI~~lL~-dp~~R~~~~ 393 (510)
++|.+||.+.+..+.+.++...-. ...++ . .+.+++.+.+||.+||+ ||.+||
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp--- 276 (287)
T cd07838 200 FRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRI--- 276 (287)
T ss_pred HhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCC---
Confidence 999999999888777776653210 00000 0 12467889999999998 999999
Q ss_pred ChHHhhcCCCc
Q 010463 394 GVEELKEHPWF 404 (510)
Q Consensus 394 ~~~eil~HpfF 404 (510)
++++++.||||
T Consensus 277 ~~~~il~~~~~ 287 (287)
T cd07838 277 SAFEALQHPYF 287 (287)
T ss_pred CHHHHhcCcCC
Confidence 68999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=334.12 Aligned_cols=240 Identities=23% Similarity=0.354 Sum_probs=201.3
Q ss_pred eeecCCCeEEEEEEE--cCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEeccCC
Q 010463 113 LIGKGAFGEVRLCRA--KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPG 190 (510)
Q Consensus 113 ~IG~G~fG~V~~~~~--~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy~~g 190 (510)
.||+|+||.||+|.+ +.+++.||+|++.... ......+.+..|+.+++.++||||+++++++.+ +..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence 689999999999965 4678899999986543 233456778999999999999999999998864 567999999999
Q ss_pred CCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhhh
Q 010463 191 GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 270 (510)
Q Consensus 191 G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 270 (510)
|+|.+++.+...+++..+..++.|++.||+|||+.||+||||||.|||++.++.+||+|||++..+.......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~------- 152 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY------- 152 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee-------
Confidence 9999999888889999999999999999999999999999999999999999999999999998654321100
Q ss_pred hcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh-CCCCCCCCCh
Q 010463 271 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDP 349 (510)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~-G~~PF~~~~~ 349 (510)
.......+++.|+|||++....++.++|+|||||++|||++ |.+||.+.+.
T Consensus 153 ----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 204 (257)
T cd05116 153 ----------------------------KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG 204 (257)
T ss_pred ----------------------------eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 00012345789999999988889999999999999999998 9999998877
Q ss_pred hhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC
Q 010463 350 RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT 392 (510)
Q Consensus 350 ~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~ 392 (510)
......+.+.. ....| ..+++++++||.+||+ ||.+||+.
T Consensus 205 ~~~~~~i~~~~-~~~~~--~~~~~~l~~li~~~~~~~p~~Rp~~ 245 (257)
T cd05116 205 NEVTQMIESGE-RMECP--QRCPPEMYDLMKLCWTYGVDERPGF 245 (257)
T ss_pred HHHHHHHHCCC-CCCCC--CCCCHHHHHHHHHHhccCchhCcCH
Confidence 77777666532 23344 3789999999999998 99999954
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=337.13 Aligned_cols=253 Identities=21% Similarity=0.340 Sum_probs=209.0
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCE----EEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEI----FAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 178 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~----vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 178 (510)
+..++|++++.||+|+||+||+|++..+|+. ||+|++.... .......+.+|+.++..++||||+++++++.+.
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS 81 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC
Confidence 4568999999999999999999998877764 8999986542 233456788999999999999999999999764
Q ss_pred ceEEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCc
Q 010463 179 DFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 257 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~ 257 (510)
..+++|||+++|+|.+++... +.+++..+..++.||+.||.|||+.||+||||||+|||++.++++||+|||+++.+.
T Consensus 82 -~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 82 -TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred -CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 578999999999999999764 569999999999999999999999999999999999999999999999999998764
Q ss_pred cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHH
Q 010463 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337 (510)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEm 337 (510)
...... ......+++.|+|||++.+..++.++|||||||++|||
T Consensus 161 ~~~~~~------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el 204 (279)
T cd05109 161 IDETEY------------------------------------HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWEL 204 (279)
T ss_pred ccccee------------------------------------ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHH
Confidence 321100 00112457789999999999999999999999999999
Q ss_pred hh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 338 LI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 338 l~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
++ |.+||.+.........+... .. .+.....+.++.++|.+||. ||++|| ++.+++.
T Consensus 205 ~t~g~~p~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~li~~~l~~dp~~Rp---~~~~l~~ 263 (279)
T cd05109 205 MTFGAKPYDGIPAREIPDLLEKG-ER--LPQPPICTIDVYMIMVKCWMIDSECRP---RFRELVD 263 (279)
T ss_pred HcCCCCCCCCCCHHHHHHHHHCC-Cc--CCCCccCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 98 99999877665555544432 22 23334789999999999998 999999 5677773
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=329.23 Aligned_cols=253 Identities=32% Similarity=0.581 Sum_probs=221.0
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEe
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 186 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmE 186 (510)
+|++.+.||.|+||.||+|.+..+++.||+|++..... .......+..|+++++.++|||++++++.+.+....++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 58899999999999999999999999999999976543 23455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccc
Q 010463 187 YLPGGDIMTLLMRE----DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 262 (510)
Q Consensus 187 y~~gG~L~~~L~~~----~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 262 (510)
|++|++|.+++... ..+++..+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 99999999999764 779999999999999999999999999999999999999999999999999998654321
Q ss_pred ccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCC
Q 010463 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 342 (510)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~ 342 (510)
......+|++.|+|||.+.+..++.++|+||+|+++|+|++|..
T Consensus 158 ------------------------------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 201 (258)
T cd08215 158 ------------------------------------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKH 201 (258)
T ss_pred ------------------------------------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCC
Confidence 01123579999999999999999999999999999999999999
Q ss_pred CCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 343 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 343 PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
||...+.......+.... ....| ..++..+.++|.+||. +|++|| ++.++++||||
T Consensus 202 p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~i~~~l~~~p~~Rp---~~~~ll~~~~~ 258 (258)
T cd08215 202 PFEGENLLELALKILKGQ-YPPIP--SQYSSELRNLVSSLLQKDPEERP---SIAQILQSPFI 258 (258)
T ss_pred CCCCCcHHHHHHHHhcCC-CCCCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHhcCCCC
Confidence 998887766666665422 22333 3788999999999998 999999 78999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=326.48 Aligned_cols=251 Identities=34% Similarity=0.527 Sum_probs=217.4
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEe
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 186 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmE 186 (510)
+|+..+.||+|++|.||+|.+..+++.||+|++..... .....+.+|..+++.++||+|+++++.+.+....+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 58899999999999999999999999999999976532 356778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 187 YLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 187 y~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
|++|++|.+++... ..+++..+..++.|++.||.+||+.|++||||+|+||+++.++.++|+|||++........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---- 153 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---- 153 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc----
Confidence 99999999999776 6799999999999999999999999999999999999999999999999999986543210
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCC
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~ 345 (510)
.....|+..|+|||++.+..++.++|+|||||++|+|++|.+||.
T Consensus 154 -----------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 198 (253)
T cd05122 154 -----------------------------------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYS 198 (253)
T ss_pred -----------------------------------ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 113578999999999998889999999999999999999999998
Q ss_pred CCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCC
Q 010463 346 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPW 403 (510)
Q Consensus 346 ~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~Hpf 403 (510)
..+.......+.. ......+....++..+.++|++||. ||++|| ++.+++.|||
T Consensus 199 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~---t~~~~l~~~~ 253 (253)
T cd05122 199 ELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRP---TAEQLLKHPF 253 (253)
T ss_pred CCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHHHHccCChhhCC---CHHHHhcCCC
Confidence 7765544444433 2223334333458999999999998 999999 7899999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=342.69 Aligned_cols=253 Identities=27% Similarity=0.386 Sum_probs=214.4
Q ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEec
Q 010463 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEY 187 (510)
Q Consensus 108 f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy 187 (510)
|..++.||+|+||+||+|++..+|+.||+|++.............+..|+.+++.++|||++++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66678899999999999999999999999999765544445566788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccch
Q 010463 188 LPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 266 (510)
Q Consensus 188 ~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~ 266 (510)
+.| +|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 103 ~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~------- 174 (313)
T cd06633 103 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA------- 174 (313)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCCC-------
Confidence 964 77777755 457899999999999999999999999999999999999999999999999998642211
Q ss_pred hhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc---cCCCCccccccchhhHHHHHhhCCCC
Q 010463 267 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMECDWWSLGAIMYEMLIGYPP 343 (510)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~---~~~y~~~~DiwSlGvilyEml~G~~P 343 (510)
...+|++.|+|||++. ...++.++|+|||||++|||++|.+|
T Consensus 175 -----------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p 219 (313)
T cd06633 175 -----------------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 219 (313)
T ss_pred -----------------------------------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 1357999999999985 35688999999999999999999999
Q ss_pred CCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCC
Q 010463 344 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 408 (510)
Q Consensus 344 F~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~ 408 (510)
|.+.+......++..... ...+ ...++..+++||.+||. +|.+|| ++.+++.||||...+
T Consensus 220 ~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~l~~li~~~l~~~P~~Rp---~~~~~l~~~~~~~~~ 280 (313)
T cd06633 220 LFNMNAMSALYHIAQNDS-PTLQ-SNEWTDSFRGFVDYCLQKIPQERP---ASAELLRHDFVRRDR 280 (313)
T ss_pred CCCCChHHHHHHHHhcCC-CCCC-ccccCHHHHHHHHHHccCChhhCc---CHHHHhcCcccCCCc
Confidence 988776666555543221 1111 23578899999999998 999999 689999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=339.05 Aligned_cols=257 Identities=20% Similarity=0.334 Sum_probs=214.1
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCC-----CEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEE
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTG-----EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYS 174 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg-----~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~ 174 (510)
..+..++|++++.||+|+||.||++..+..+ ..+|+|.+.... .......+.+|+.++..+ +||||++++++
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 3466678999999999999999999987543 789999987542 233456788999999999 89999999999
Q ss_pred eecCceEEEEEeccCCCCHHHHHHhc----------------cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCee
Q 010463 175 FQDSDFLYLIMEYLPGGDIMTLLMRE----------------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLI 238 (510)
Q Consensus 175 ~~~~~~~~lVmEy~~gG~L~~~L~~~----------------~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NIL 238 (510)
+.+.+.+|+||||+++|+|..++... ..+++..+..++.|++.||.|||+.||+||||||+|||
T Consensus 85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil 164 (293)
T cd05053 85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL 164 (293)
T ss_pred EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence 99999999999999999999998642 46889999999999999999999999999999999999
Q ss_pred ecCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc
Q 010463 239 LDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK 318 (510)
Q Consensus 239 ld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~ 318 (510)
++.++.+||+|||+++.+....... ......+++.|+|||++.+
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~------------------------------------~~~~~~~~~~y~aPE~~~~ 208 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYR------------------------------------KTTNGRLPVKWMAPEALFD 208 (293)
T ss_pred EcCCCeEEeCcccccccccccccee------------------------------------ccCCCCCCccccCHHHhcc
Confidence 9999999999999998764321100 0011235678999999999
Q ss_pred CCCCccccccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChH
Q 010463 319 KGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVE 396 (510)
Q Consensus 319 ~~y~~~~DiwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~ 396 (510)
..++.++|||||||++|||++ |..||.+.+..+.+..+.... ....| ...+.++.+||.+||. ||.+|| ++.
T Consensus 209 ~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~ 282 (293)
T cd05053 209 RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGY-RMEKP--QNCTQELYHLMRDCWHEVPSQRP---TFK 282 (293)
T ss_pred CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-cCCCC--CCCCHHHHHHHHHHcccCcccCc---CHH
Confidence 999999999999999999997 999999887777776665432 22333 3678999999999998 999999 678
Q ss_pred HhhcC
Q 010463 397 ELKEH 401 (510)
Q Consensus 397 eil~H 401 (510)
+++++
T Consensus 283 eil~~ 287 (293)
T cd05053 283 QLVED 287 (293)
T ss_pred HHHHH
Confidence 88764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=338.46 Aligned_cols=252 Identities=21% Similarity=0.355 Sum_probs=211.0
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEc-----CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAK-----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 177 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~-----~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 177 (510)
+...+|.+.+.||+|+||.||+|... .++..+|+|.+.+. .......+.+|+.+++.++||||+++++++.+
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTE 78 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEec
Confidence 34568899999999999999999753 35678999988654 33445678999999999999999999999999
Q ss_pred CceEEEEEeccCCCCHHHHHHhcc---------------CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCC
Q 010463 178 SDFLYLIMEYLPGGDIMTLLMRED---------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN 242 (510)
Q Consensus 178 ~~~~~lVmEy~~gG~L~~~L~~~~---------------~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~ 242 (510)
....|+||||+++|+|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+|||++++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG 158 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC
Confidence 999999999999999999997643 48899999999999999999999999999999999999999
Q ss_pred CceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCC
Q 010463 243 GHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYG 322 (510)
Q Consensus 243 g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~ 322 (510)
+++||+|||++......... .......+++.|+|||++.+..++
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~ 202 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYY------------------------------------RVGGRTMLPIRWMPPESILYRKFT 202 (280)
T ss_pred CCEEECCCCceeEcCCCcee------------------------------------ecCCCccccccccCHHHhccCCcC
Confidence 99999999999755321100 001123568899999999999999
Q ss_pred ccccccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhh
Q 010463 323 MECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 399 (510)
Q Consensus 323 ~~~DiwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil 399 (510)
.++|+|||||++|||++ |.+||...+.......+..+. ....| ..+++.+.+||.+||+ ||.+|| ++++|+
T Consensus 203 ~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~cl~~~P~~Rp---~~~~l~ 275 (280)
T cd05092 203 TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR-ELERP--RTCPPEVYAIMQGCWQREPQQRM---VIKDIH 275 (280)
T ss_pred chhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc-cCCCC--CCCCHHHHHHHHHHccCChhhCC---CHHHHH
Confidence 99999999999999998 999998877777776666542 22333 3789999999999998 999999 566665
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=334.10 Aligned_cols=254 Identities=22% Similarity=0.322 Sum_probs=213.1
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCC---CCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCce
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTT---GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 180 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~t---g~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 180 (510)
..++|++.+.||+|+||.||+|+++.+ ...||||++.... .......+.+|+.++..++||||+++++++.+.+.
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP 79 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence 457899999999999999999998754 4579999986542 33445678889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 181 LYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
+|+||||++||+|.+++... +.+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||+++.....
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999999764 47899999999999999999999999999999999999999999999999999876421
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~ 339 (510)
.... ......+++.|+|||.+.+..++.++|+|||||++|||++
T Consensus 160 ~~~~------------------------------------~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~ 203 (266)
T cd05033 160 EATY------------------------------------TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203 (266)
T ss_pred ccce------------------------------------eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHc
Confidence 1000 0012346788999999999999999999999999999998
Q ss_pred -CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 340 -GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 340 -G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
|..||...........+... ...|....+++.+.+|+.+||. +|++|| ++++|+++
T Consensus 204 ~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~~p~~Rp---~~~ei~~~ 261 (266)
T cd05033 204 YGERPYWDMSNQDVIKAVEDG---YRLPPPMDCPSALYQLMLDCWQKDRNERP---TFSQIVST 261 (266)
T ss_pred cCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCCHHHHHHHHHHcCCCcccCc---CHHHHHHH
Confidence 99999887777666666542 2223334789999999999998 999999 57777654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=340.12 Aligned_cols=254 Identities=19% Similarity=0.317 Sum_probs=212.8
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCC-----CCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTT-----GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 177 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t-----g~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 177 (510)
+...+|++++.||+|+||.||+|....+ ++.||||+++... .....+.+..|..++..++||||+++++++.+
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~ 79 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK 79 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence 4566789999999999999999987643 5789999997542 23345678899999999999999999999999
Q ss_pred CceEEEEEeccCCCCHHHHHHhc----------------cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecC
Q 010463 178 SDFLYLIMEYLPGGDIMTLLMRE----------------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK 241 (510)
Q Consensus 178 ~~~~~lVmEy~~gG~L~~~L~~~----------------~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~ 241 (510)
...+++++||+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD 159 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence 99999999999999999998532 34788889999999999999999999999999999999999
Q ss_pred CCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCC
Q 010463 242 NGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY 321 (510)
Q Consensus 242 ~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y 321 (510)
++.+||+|||+++.+...... .......+++.|+|||++.+..+
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~~~~~~ 203 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYY------------------------------------KLMGNSLLPIRWMSPEAIMYGKF 203 (283)
T ss_pred CCceEecccccccccccchhe------------------------------------eeccCccCCccccCHHHHhcCCC
Confidence 999999999999865432100 00113457889999999998889
Q ss_pred CccccccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhh
Q 010463 322 GMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 399 (510)
Q Consensus 322 ~~~~DiwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil 399 (510)
+.++|||||||++|||++ |.+||.+.+..+....+.+.. ....| ..++..+.+||.+||. +|.+|| ++.+|+
T Consensus 204 ~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~-~~~~~--~~~~~~~~~li~~cl~~~p~~RP---~~~~i~ 277 (283)
T cd05091 204 SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQ-VLPCP--DDCPAWVYTLMLECWNEFPSRRP---RFKDIH 277 (283)
T ss_pred CcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-cCCCC--CCCCHHHHHHHHHHhCCCcccCC---CHHHHH
Confidence 999999999999999998 899999888877777776532 22233 4789999999999998 999999 677877
Q ss_pred c
Q 010463 400 E 400 (510)
Q Consensus 400 ~ 400 (510)
.
T Consensus 278 ~ 278 (283)
T cd05091 278 S 278 (283)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=333.45 Aligned_cols=250 Identities=19% Similarity=0.329 Sum_probs=208.9
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEE
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l 183 (510)
...+|++.+.||+|+||.||+|+++ ++..+|+|++.+... ....+..|+.+++.++||||+++++++.+.+..|+
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 76 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFI 76 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEE
Confidence 3457899999999999999999886 467899999875432 22457789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccc
Q 010463 184 IMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 262 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 262 (510)
||||++|++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.+|.+||+|||+++........
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 77 VTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred EEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 99999999999999763 56899999999999999999999999999999999999999999999999998765322100
Q ss_pred ccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh-CC
Q 010463 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GY 341 (510)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~-G~ 341 (510)
......++..|+|||++.+..++.++|+|||||++|||++ |.
T Consensus 157 -------------------------------------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~ 199 (256)
T cd05059 157 -------------------------------------SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199 (256)
T ss_pred -------------------------------------ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCC
Confidence 0001234567999999999999999999999999999999 89
Q ss_pred CCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
+||.+.+..+....+... ...+.....+.++.+++.+||+ +|++|| ++.++++.
T Consensus 200 ~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~~p~~Rp---t~~~~l~~ 254 (256)
T cd05059 200 MPYERFSNSEVVESVSAG---YRLYRPKLAPTEVYTIMYSCWHEKPEDRP---AFKKLLSQ 254 (256)
T ss_pred CCCCCCCHHHHHHHHHcC---CcCCCCCCCCHHHHHHHHHHhcCChhhCc---CHHHHHHH
Confidence 999887777777666542 2222224689999999999998 999999 67888753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=348.14 Aligned_cols=274 Identities=28% Similarity=0.451 Sum_probs=215.9
Q ss_pred CCcee-eeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchh-----------hHHHHHHHHHHHHhcCCCCeeeEeE
Q 010463 106 DDFEQ-LTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRG-----------QVEHVRSERNLLAEVDSRCIVQLFY 173 (510)
Q Consensus 106 ~~f~~-~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~-----------~~~~~~~E~~iL~~l~hp~Iv~l~~ 173 (510)
+.|.. .+.||.|+||+||+|.++.+|+.||+|++.+....... ....+.+|+.++..++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45654 46799999999999999999999999998765332211 0124678999999999999999999
Q ss_pred EeecCceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCc
Q 010463 174 SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLC 253 (510)
Q Consensus 174 ~~~~~~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla 253 (510)
+|...+..|+||||++ |+|.+++.....+++..+..++.|++.||+|||+.||+||||||+|||++.++.++|+|||++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence 9999999999999997 599999988888999999999999999999999999999999999999999999999999999
Q ss_pred ccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC-CCCccccccchhh
Q 010463 254 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGA 332 (510)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiwSlGv 332 (510)
................ .. ..+.......+++.|+|||++.+. .++.++|+|||||
T Consensus 167 ~~~~~~~~~~~~~~~~-----------~~-------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~ 222 (335)
T PTZ00024 167 RRYGYPPYSDTLSKDE-----------TM-------------QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGC 222 (335)
T ss_pred eecccccccccccccc-----------cc-------------cccccccccccccCCCCChhcccCCCCCcHHHHHHHHH
Confidence 8654221100000000 00 000111234689999999999764 4699999999999
Q ss_pred HHHHHhhCCCCCCCCChhhhHHHHhhccc---------cccCC----------C-----CCCCCHHHHHHHHHhhc-Ccc
Q 010463 333 IMYEMLIGYPPFCSDDPRITCRKIVNWKT---------CLKFP----------E-----EPKISDEARDLICHLLC-DVE 387 (510)
Q Consensus 333 ilyEml~G~~PF~~~~~~~~~~~I~~~~~---------~~~~p----------~-----~~~~s~~~~dlI~~lL~-dp~ 387 (510)
++|||++|.+||.+.+.......+..... ....| . .+..+.++.+||.+||. +|+
T Consensus 223 ~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 302 (335)
T PTZ00024 223 IFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPL 302 (335)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCch
Confidence 99999999999998887776666553211 00000 0 12468899999999999 999
Q ss_pred ccCCCCChHHhhcCCCcCCC
Q 010463 388 TRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 388 ~R~~~~~~~eil~HpfF~~i 407 (510)
+|| +++|++.||||++.
T Consensus 303 ~R~---s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 303 ERI---SAKEALKHEYFKSD 319 (335)
T ss_pred hcc---CHHHHhcCcccCCC
Confidence 999 78999999999864
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=350.73 Aligned_cols=262 Identities=28% Similarity=0.433 Sum_probs=220.4
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc-----eE
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD-----FL 181 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-----~~ 181 (510)
+|++.+.||.|+||.||+|++..+|+.||+|++.+.. ......+.+.+|+.+++.++||||+++++++.+.. .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 4889999999999999999999999999999987642 12344567889999999999999999999998875 89
Q ss_pred EEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 182 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
|+||||+++ +|..++.+...+++..++.++.||+.||.+||+.||+||||||+|||++.+|.++|+|||++........
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 999999974 8999998878999999999999999999999999999999999999999999999999999987543210
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC-CCCccccccchhhHHHHHhhC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEMLIG 340 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiwSlGvilyEml~G 340 (510)
. ........||+.|+|||++.+. .++.++|+|||||++|+|++|
T Consensus 159 ~-----------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g 203 (330)
T cd07834 159 E-----------------------------------KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR 203 (330)
T ss_pred c-----------------------------------cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcC
Confidence 0 0011235689999999999887 889999999999999999999
Q ss_pred CCCCCCCChhhhHHHHhhccccccC------------------C---------CCCCCCHHHHHHHHHhhc-CccccCCC
Q 010463 341 YPPFCSDDPRITCRKIVNWKTCLKF------------------P---------EEPKISDEARDLICHLLC-DVETRLGT 392 (510)
Q Consensus 341 ~~PF~~~~~~~~~~~I~~~~~~~~~------------------p---------~~~~~s~~~~dlI~~lL~-dp~~R~~~ 392 (510)
.+||.+.+..+.+..+......... + ..+.++.++.+||.+||+ +|.+||
T Consensus 204 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-- 281 (330)
T cd07834 204 KPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRI-- 281 (330)
T ss_pred CCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCC--
Confidence 9999988877766666542111000 0 013478899999999998 999999
Q ss_pred CChHHhhcCCCcCCCC
Q 010463 393 RGVEELKEHPWFRGIQ 408 (510)
Q Consensus 393 ~~~~eil~HpfF~~i~ 408 (510)
++++++.||||+++.
T Consensus 282 -t~~~ll~~~~~~~~~ 296 (330)
T cd07834 282 -TADEALAHPYLAQLH 296 (330)
T ss_pred -CHHHHHhCccHHhhc
Confidence 689999999998743
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=342.09 Aligned_cols=257 Identities=21% Similarity=0.333 Sum_probs=212.1
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEE-----cCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEE
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRA-----KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYS 174 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~-----~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~ 174 (510)
.++..++|.+.+.||+|+||.||+|.. ..++..||+|++++.. .....+.+.+|+.+++.+ +||||++++++
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 345667899999999999999999975 3456689999987542 233456789999999999 89999999999
Q ss_pred eecCceEEEEEeccCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCC
Q 010463 175 FQDSDFLYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGL 252 (510)
Q Consensus 175 ~~~~~~~~lVmEy~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGl 252 (510)
+.+.+.+|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||+
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 999999999999999999999997643 389999999999999999999999999999999999999999999999999
Q ss_pred cccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhh
Q 010463 253 CKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGA 332 (510)
Q Consensus 253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGv 332 (510)
++.+....... ......+++.|+|||++.+..++.++|||||||
T Consensus 188 ~~~~~~~~~~~------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGv 231 (302)
T cd05055 188 ARDIMNDSNYV------------------------------------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 231 (302)
T ss_pred cccccCCCcee------------------------------------ecCCCCcccccCCHhhhccCCCCcHhHHHHHHH
Confidence 98654321000 001234688999999999999999999999999
Q ss_pred HHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 333 IMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 333 ilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
++|||++ |.+||.+......+.+..... ...+....+++++.+||.+||. +|++|| ++.|++.
T Consensus 232 il~el~t~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rp---t~~ell~ 296 (302)
T cd05055 232 LLWEIFSLGSNPYPGMPVDSKFYKLIKEG--YRMAQPEHAPAEIYDIMKTCWDADPLKRP---TFKQIVQ 296 (302)
T ss_pred HHHHHHhCCCCCcCCCCchHHHHHHHHcC--CcCCCCCCCCHHHHHHHHHHcCCCchhCc---CHHHHHH
Confidence 9999998 999998877666555554422 1222224678999999999998 999999 5677764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=331.95 Aligned_cols=244 Identities=24% Similarity=0.349 Sum_probs=202.8
Q ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEeccCCC
Q 010463 112 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGG 191 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy~~gG 191 (510)
+.||+|+||.||+|+++.+|+.||+|.+.+.. .......+.+|..+|+.++||||+++++++.+...+|+||||++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 36899999999999999999999999886432 2344567899999999999999999999999999999999999999
Q ss_pred CHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhhh
Q 010463 192 DIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 270 (510)
Q Consensus 192 ~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 270 (510)
+|.+++.+. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++..........
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~------- 151 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS------- 151 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccc-------
Confidence 999999764 468999999999999999999999999999999999999999999999999987643221000
Q ss_pred hcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh-CCCCCCCCCh
Q 010463 271 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDP 349 (510)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~-G~~PF~~~~~ 349 (510)
......++..|+|||.+.+..++.++|+|||||++|||++ |.+||...+.
T Consensus 152 -----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~ 202 (252)
T cd05084 152 -----------------------------TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN 202 (252)
T ss_pred -----------------------------cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH
Confidence 0001123567999999999999999999999999999998 9999987776
Q ss_pred hhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhh
Q 010463 350 RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 399 (510)
Q Consensus 350 ~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil 399 (510)
......+... .....| ...+..+.+||.+||+ +|++|| ++.+++
T Consensus 203 ~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~~~~ 247 (252)
T cd05084 203 QQTREAIEQG-VRLPCP--ELCPDAVYRLMERCWEYDPGQRP---SFSTVH 247 (252)
T ss_pred HHHHHHHHcC-CCCCCc--ccCCHHHHHHHHHHcCCChhhCc---CHHHHH
Confidence 6655555442 122233 4678999999999998 999999 566665
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=327.81 Aligned_cols=256 Identities=34% Similarity=0.538 Sum_probs=219.7
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC--ceEEEE
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS--DFLYLI 184 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~~~lV 184 (510)
+|...+.||+|++|.||+|....+++.|++|++..... ...+.+.+.+|+.+++.++||||+++++.+.+. ..+++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD-SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 47888999999999999999999999999999976543 245677899999999999999999999999988 899999
Q ss_pred EeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 185 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
|||++|++|.+++.....+++..+..++.+++.||.|||+.|++|+||+|+||+++.+|.++|+|||.+.........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-- 157 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG-- 157 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc--
Confidence 999999999999988889999999999999999999999999999999999999999999999999999876543110
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCC
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 344 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF 344 (510)
.......|++.|+|||.+.+..++.++|+|||||++|+|++|..||
T Consensus 158 ----------------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~ 203 (260)
T cd06606 158 ----------------------------------EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPW 203 (260)
T ss_pred ----------------------------------ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 0011356999999999999888999999999999999999999999
Q ss_pred CCCC-hhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 345 CSDD-PRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 345 ~~~~-~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
...+ .......+........+| ..++..+.+||.+||. +|.+|| ++.+++.||||
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~~i~~~l~~~p~~Rp---~~~~ll~~~~~ 260 (260)
T cd06606 204 SELGNPMAALYKIGSSGEPPEIP--EHLSEEAKDFLRKCLRRDPKKRP---TADELLQHPFL 260 (260)
T ss_pred CCCCchHHHHHhccccCCCcCCC--cccCHHHHHHHHHhCcCChhhCC---CHHHHhhCCCC
Confidence 8765 233333333322333344 3679999999999998 999999 78999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=333.98 Aligned_cols=251 Identities=21% Similarity=0.323 Sum_probs=207.3
Q ss_pred ceeeeeeecCCCeEEEEEEEcCC---CCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCce----
Q 010463 108 FEQLTLIGKGAFGEVRLCRAKTT---GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF---- 180 (510)
Q Consensus 108 f~~~~~IG~G~fG~V~~~~~~~t---g~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~---- 180 (510)
|.+.+.||+|+||.||+|....+ +..||+|.++... ....+...+.+|+.+|+.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI-HTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 56789999999999999987653 4789999987543 234456789999999999999999999998765443
Q ss_pred --EEEEEeccCCCCHHHHHHhc------cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCC
Q 010463 181 --LYLIMEYLPGGDIMTLLMRE------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGL 252 (510)
Q Consensus 181 --~~lVmEy~~gG~L~~~L~~~------~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGl 252 (510)
.++||||+++|+|..++... ..+++..+..++.|++.||.|||+.||+||||||+|||+++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 89999999999999998543 3689999999999999999999999999999999999999999999999999
Q ss_pred cccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhh
Q 010463 253 CKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGA 332 (510)
Q Consensus 253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGv 332 (510)
++......... ......+++.|+|||++.+..++.++|||||||
T Consensus 160 ~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~ 203 (273)
T cd05035 160 SKKIYSGDYYR------------------------------------QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGV 203 (273)
T ss_pred eeecccccccc------------------------------------ccccccCCccccCHhhcccCCCCcccchHHHHH
Confidence 98654321000 001134577899999998889999999999999
Q ss_pred HHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 333 IMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 333 ilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
++|||++ |.+||.+.+....+..+.... ....| ..++.++.++|.+||. ||.+|| ++.|++++
T Consensus 204 il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~e~~~~ 268 (273)
T cd05035 204 TMWEIATRGQTPYPGVENHEIYDYLRHGN-RLKQP--EDCLDELYDLMYSCWRADPKDRP---TFTKLREV 268 (273)
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCC--cCCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 9999999 999998888777776666532 33334 4789999999999998 999999 57777653
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=351.39 Aligned_cols=256 Identities=29% Similarity=0.473 Sum_probs=214.7
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCce----
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF---- 180 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~---- 180 (510)
.++|++++.||+|+||.||+|++..+++.||+|++.... ........+.+|+.+++.++||||+++++++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 568999999999999999999999999999999986542 223345667889999999999999999988876654
Q ss_pred --EEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 181 --LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 181 --~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
+|+||||+ |++|.+++.. ..+++..++.++.|++.||.|||+.||+||||||+||+++.+|.++|+|||++.....
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD 170 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence 99999999 6799998865 5699999999999999999999999999999999999999999999999999986532
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHH
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEM 337 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEm 337 (510)
. ....+||+.|+|||++.+ ..++.++|+|||||++|||
T Consensus 171 ~-----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~el 209 (343)
T cd07851 171 E-----------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 209 (343)
T ss_pred c-----------------------------------------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHH
Confidence 1 113468999999999875 4678999999999999999
Q ss_pred hhCCCCCCCCChhhhHHHHhhcccccc------------------CC---------CCCCCCHHHHHHHHHhhc-Ccccc
Q 010463 338 LIGYPPFCSDDPRITCRKIVNWKTCLK------------------FP---------EEPKISDEARDLICHLLC-DVETR 389 (510)
Q Consensus 338 l~G~~PF~~~~~~~~~~~I~~~~~~~~------------------~p---------~~~~~s~~~~dlI~~lL~-dp~~R 389 (510)
++|++||.+.+....+..+.+...... .+ ....+|+++.+||.+||+ ||.+|
T Consensus 210 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~R 289 (343)
T cd07851 210 LTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKR 289 (343)
T ss_pred HhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhC
Confidence 999999998877766666554211000 00 012468999999999998 99999
Q ss_pred CCCCChHHhhcCCCcCCC
Q 010463 390 LGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 390 ~~~~~~~eil~HpfF~~i 407 (510)
| ++.+|+.||||...
T Consensus 290 p---t~~ell~h~~~~~~ 304 (343)
T cd07851 290 I---TAAEALAHPYLAEY 304 (343)
T ss_pred C---CHHHHhcCCCcccc
Confidence 9 78999999999853
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=349.68 Aligned_cols=261 Identities=21% Similarity=0.337 Sum_probs=206.4
Q ss_pred eeeecC--CCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEeccC
Q 010463 112 TLIGKG--AFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLP 189 (510)
Q Consensus 112 ~~IG~G--~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy~~ 189 (510)
..||+| +||+||+|+++.+|+.||+|++..... .....+.+.+|+.+++.++||||++++++|++.+..|+||||++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 356776 999999999999999999999875433 23456788999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchh
Q 010463 190 GGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLED 267 (510)
Q Consensus 190 gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~ 267 (510)
+|+|.+++.+. ..+++..++.++.|++.||+|||+.||+||||||+|||++.++.++++|||.+...........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~--- 159 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK--- 159 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc---
Confidence 99999998764 3589999999999999999999999999999999999999999999999987643321100000
Q ss_pred hhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc--CCCCccccccchhhHHHHHhhCCCCCC
Q 010463 268 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK--KGYGMECDWWSLGAIMYEMLIGYPPFC 345 (510)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiwSlGvilyEml~G~~PF~ 345 (510)
. . ........++..|+|||++.+ .+++.++|+|||||++|||++|.+||.
T Consensus 160 --------~-----~---------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 211 (328)
T cd08226 160 --------V-----V---------------YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQ 211 (328)
T ss_pred --------c-----c---------------ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 0 0 000001246678999999976 457899999999999999999999998
Q ss_pred CCChhhhHHHHhhcccc-------------------------------------------ccCCCCCCCCHHHHHHHHHh
Q 010463 346 SDDPRITCRKIVNWKTC-------------------------------------------LKFPEEPKISDEARDLICHL 382 (510)
Q Consensus 346 ~~~~~~~~~~I~~~~~~-------------------------------------------~~~p~~~~~s~~~~dlI~~l 382 (510)
+.........++..... +..+....+++.+.+||++|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 291 (328)
T cd08226 212 DMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELC 291 (328)
T ss_pred CcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHH
Confidence 76655444443321110 01111224678899999999
Q ss_pred hc-CccccCCCCChHHhhcCCCcCCC
Q 010463 383 LC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 383 L~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
|+ ||++|| +++|+++||||..+
T Consensus 292 l~~dP~~Rp---ta~e~l~~~~~~~~ 314 (328)
T cd08226 292 LQQDPEKRP---SASSLLSHAFFKQV 314 (328)
T ss_pred ccCCcccCC---CHHHHhhCHHHHHH
Confidence 98 999999 78999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=360.57 Aligned_cols=252 Identities=24% Similarity=0.396 Sum_probs=222.3
Q ss_pred eeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhc-chhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCce--EEEEEe
Q 010463 110 QLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML-KRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF--LYLIME 186 (510)
Q Consensus 110 ~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~-~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~--~~lVmE 186 (510)
...+||+|+|-+||+|.+..+|..||--.++-.++. ...+.+++..|+.+|+.|+|||||++|++|.+..+ +-+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 345899999999999999999999997666555443 34567899999999999999999999999998776 889999
Q ss_pred ccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhC--CeEEeecCCCCeeec-CCCceeecccCCcccCccccccc
Q 010463 187 YLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH--NYVHRDIKPDNLILD-KNGHLKLSDFGLCKPLEDKYSSI 263 (510)
Q Consensus 187 y~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~--giiHRDLKP~NILld-~~g~vkL~DFGla~~~~~~~~~~ 263 (510)
++.+|+|..|+.+.+.++...++.|+.||+.||.|||++ .|||||||-+||+|+ ..|.|||+|+|||+.+...
T Consensus 124 L~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s---- 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS---- 199 (632)
T ss_pred cccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc----
Confidence 999999999999999999999999999999999999998 599999999999998 6699999999999976432
Q ss_pred cchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCC
Q 010463 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 343 (510)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~P 343 (510)
.+.+.+|||.|||||+.. +.|+..+||||||++|+||+|+..|
T Consensus 200 ------------------------------------~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYP 242 (632)
T KOG0584|consen 200 ------------------------------------HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYP 242 (632)
T ss_pred ------------------------------------ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCC
Confidence 244689999999999996 8999999999999999999999999
Q ss_pred CC-CCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhcCccccCCCCChHHhhcCCCcCCC
Q 010463 344 FC-SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 344 F~-~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~dp~~R~~~~~~~eil~HpfF~~i 407 (510)
|. ..++.++|+++..+..+-.+.. --.+++++||.+||.-.+.|+ ++.|+|+||||..-
T Consensus 243 YsEC~n~AQIYKKV~SGiKP~sl~k--V~dPevr~fIekCl~~~~~R~---sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 243 YSECTNPAQIYKKVTSGIKPAALSK--VKDPEVREFIEKCLATKSERL---SAKELLKDPFFDED 302 (632)
T ss_pred hhhhCCHHHHHHHHHcCCCHHHhhc--cCCHHHHHHHHHHhcCchhcc---CHHHHhhChhhccc
Confidence 96 5678889999998765544432 337899999999998788999 78999999999864
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=337.46 Aligned_cols=255 Identities=31% Similarity=0.529 Sum_probs=212.9
Q ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC--ceEEEEE
Q 010463 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS--DFLYLIM 185 (510)
Q Consensus 108 f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~~~lVm 185 (510)
|++++.||.|+||.||+|....+|+.||+|++.+.. ........+.+|+.+++.++||||+++++++.+. +.+|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 678999999999999999999999999999998754 2334456688899999999999999999999988 8999999
Q ss_pred eccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 186 EYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
||+++ +|.+++... ..+++..++.++.||+.||+|||+.|++|+||||+|||++++|.+||+|||++.........
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~-- 156 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA-- 156 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc--
Confidence 99975 899888765 57999999999999999999999999999999999999999999999999999865432100
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHhhCCCC
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYPP 343 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml~G~~P 343 (510)
......+++.|+|||.+.+ ..++.++|+|||||++|||++|.+|
T Consensus 157 -----------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p 201 (287)
T cd07840 157 -----------------------------------DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPI 201 (287)
T ss_pred -----------------------------------cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCC
Confidence 0112467889999998765 4679999999999999999999999
Q ss_pred CCCCChhhhHHHHhhccccc---cCCCC-----------------------CC-CCHHHHHHHHHhhc-CccccCCCCCh
Q 010463 344 FCSDDPRITCRKIVNWKTCL---KFPEE-----------------------PK-ISDEARDLICHLLC-DVETRLGTRGV 395 (510)
Q Consensus 344 F~~~~~~~~~~~I~~~~~~~---~~p~~-----------------------~~-~s~~~~dlI~~lL~-dp~~R~~~~~~ 395 (510)
|.+.+......++....... .++.. .. +++.+.++|++||+ +|.+|| ++
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp---~~ 278 (287)
T cd07840 202 FQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRI---SA 278 (287)
T ss_pred CCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCc---CH
Confidence 99888776666655321110 00000 12 38899999999999 999999 68
Q ss_pred HHhhcCCCc
Q 010463 396 EELKEHPWF 404 (510)
Q Consensus 396 ~eil~HpfF 404 (510)
.+++.||||
T Consensus 279 ~~~l~~~~~ 287 (287)
T cd07840 279 DQALQHEYF 287 (287)
T ss_pred HHHhhCcCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=390.81 Aligned_cols=258 Identities=32% Similarity=0.502 Sum_probs=221.7
Q ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEec
Q 010463 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEY 187 (510)
Q Consensus 108 f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy 187 (510)
+.-...||.|.||.||-|...+||+..|||-+.-.... ......+.+|..+|..++|||+|+.|++=.+.+.+||.|||
T Consensus 1237 Wqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1237 WQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 44456899999999999999999999999988765443 45567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchh
Q 010463 188 LPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLED 267 (510)
Q Consensus 188 ~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~ 267 (510)
|.||+|.+++...+..+|...+.|..|++.||.|||+.|||||||||+||+|+.+|-+|++|||.|..+..+.....
T Consensus 1316 C~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~--- 1392 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP--- 1392 (1509)
T ss_pred hccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCC---
Confidence 99999999999999999999999999999999999999999999999999999999999999999998765422110
Q ss_pred hhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc---CCCCccccccchhhHHHHHhhCCCCC
Q 010463 268 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK---KGYGMECDWWSLGAIMYEMLIGYPPF 344 (510)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~---~~y~~~~DiwSlGvilyEml~G~~PF 344 (510)
.-..+.+|||.|||||++.+ ++.+.+.|||||||++.||+||+.||
T Consensus 1393 -------------------------------~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW 1441 (1509)
T KOG4645|consen 1393 -------------------------------GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPW 1441 (1509)
T ss_pred -------------------------------HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCch
Confidence 00124789999999999975 67899999999999999999999999
Q ss_pred CCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcC
Q 010463 345 CSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 405 (510)
Q Consensus 345 ~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~ 405 (510)
..-+..-...--+.....+++|. .+|++.+|||.+||. ||+.|. .+.||+.|.|=+
T Consensus 1442 ~~~dne~aIMy~V~~gh~Pq~P~--~ls~~g~dFle~Cl~~dP~~Rw---~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1442 AELDNEWAIMYHVAAGHKPQIPE--RLSSEGRDFLEHCLEQDPKMRW---TASQLLEHAFGK 1498 (1509)
T ss_pred hhccchhHHHhHHhccCCCCCch--hhhHhHHHHHHHHHhcCchhhh---HHHHHHHhhccc
Confidence 76554433222233345677886 599999999999998 999998 678999998854
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=332.52 Aligned_cols=231 Identities=32% Similarity=0.520 Sum_probs=196.4
Q ss_pred CCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEeccCCCCHHHH
Q 010463 117 GAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTL 196 (510)
Q Consensus 117 G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy~~gG~L~~~ 196 (510)
|.||.||+|+++.+|+.||+|++.+... ...|...+....||||+++++++++.+..|+||||++||+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 8999999999999999999999976531 23455555666799999999999999999999999999999999
Q ss_pred HHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhhhhccccc
Q 010463 197 LMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETV 276 (510)
Q Consensus 197 L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~ 276 (510)
+.+...+++..+..++.|++.||.|||+.||+||||||+||+++.+|.++|+|||++..+...
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----------------- 138 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----------------- 138 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----------------
Confidence 988888999999999999999999999999999999999999999999999999988654321
Q ss_pred ccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCCCChhhhHHHH
Q 010463 277 SEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKI 356 (510)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~~~~~~~~~~I 356 (510)
.....+++.|+|||++.+..++.++|+||+||++|||++|..||......
T Consensus 139 ------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------ 188 (237)
T cd05576 139 ------------------------CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------ 188 (237)
T ss_pred ------------------------cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------
Confidence 01245778899999998888999999999999999999999998643211
Q ss_pred hhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CChHHhhcCCCc
Q 010463 357 VNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWF 404 (510)
Q Consensus 357 ~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~--~~~~eil~HpfF 404 (510)
......+.+| ..+++.+++||.+||+ ||.+|+++ .+++++++||||
T Consensus 189 ~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 189 INTHTTLNIP--EWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred cccccccCCc--ccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 1111223344 3689999999999998 99999975 357999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=339.68 Aligned_cols=249 Identities=22% Similarity=0.375 Sum_probs=207.5
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCC--EEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCceEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGE--IFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~--~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~~ 182 (510)
++|++.+.||+|+||.||+|..+.++. .+|+|.++.. ......+.+.+|+.++.++ +||||+++++++.+.+.+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 689999999999999999999988775 4688887532 2333456788999999998 7999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcc----------------CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCcee
Q 010463 183 LIMEYLPGGDIMTLLMRED----------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLK 246 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~~----------------~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vk 246 (510)
+||||+++|+|.+++.+.. .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999997542 488899999999999999999999999999999999999999999
Q ss_pred ecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCcccc
Q 010463 247 LSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECD 326 (510)
Q Consensus 247 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 326 (510)
|+|||++........ .....++..|+|||++.+..++.++|
T Consensus 160 l~dfg~~~~~~~~~~---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~D 200 (297)
T cd05089 160 IADFGLSRGEEVYVK---------------------------------------KTMGRLPVRWMAIESLNYSVYTTKSD 200 (297)
T ss_pred ECCcCCCccccceec---------------------------------------cCCCCcCccccCchhhccCCCCchhh
Confidence 999999864321100 00112356799999999999999999
Q ss_pred ccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 327 WWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 327 iwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
||||||++|||++ |.+||.+.+......++.... ....| ..++.++.+||.+||. +|.+|| ++++|++.
T Consensus 201 vwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~i~~~ 271 (297)
T cd05089 201 VWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-RMEKP--RNCDDEVYELMRQCWRDRPYERP---PFAQISVQ 271 (297)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-CCCCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 9999999999997 999999988877777766421 12223 4689999999999998 999999 67777643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=334.51 Aligned_cols=248 Identities=21% Similarity=0.345 Sum_probs=212.5
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEE
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l 183 (510)
...+|++++.||.|+||.||+|..+. +..+|+|++.+.. ......+..|+.+|+.++||||+++++++.+.+..|+
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 34679999999999999999999987 8899999987653 2234568889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 184 IMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999999999763 4689999999999999999999999999999999999999999999999999986543210
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh-C
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-G 340 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~-G 340 (510)
. ..+..+++.|+|||++.+..++.++|+|||||++|+|++ |
T Consensus 160 ~--------------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g 201 (261)
T cd05148 160 L--------------------------------------SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYG 201 (261)
T ss_pred c--------------------------------------ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCC
Confidence 0 012346788999999998899999999999999999998 8
Q ss_pred CCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhh
Q 010463 341 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 399 (510)
Q Consensus 341 ~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil 399 (510)
.+||.+.+..+.+..+... ...|....+++.+.++|.+||+ ||.+||+ +.+|.
T Consensus 202 ~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt---~~~l~ 255 (261)
T cd05148 202 QVPYPGMNNHEVYDQITAG---YRMPCPAKCPQEIYKIMLECWAAEPEDRPS---FKALR 255 (261)
T ss_pred CCCCCcCCHHHHHHHHHhC---CcCCCCCCCCHHHHHHHHHHcCCCchhCcC---HHHHH
Confidence 9999988877777777642 2333345789999999999998 9999994 55554
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=348.20 Aligned_cols=255 Identities=27% Similarity=0.452 Sum_probs=210.2
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC------
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS------ 178 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~------ 178 (510)
.++|++++.||+|+||.||+|.+..+|+.||+|++.+... .....+.+.+|+.++..++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 4789999999999999999999999999999999976421 233456688899999999999999999988643
Q ss_pred ceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 179 DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
...|++++++ |++|.+++.. ..+++..++.++.|++.||.|||+.||+||||||+||+++.+|.+||+|||++.....
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~ 172 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence 3578999987 7899887754 4699999999999999999999999999999999999999999999999999875432
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHH
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEM 337 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEm 337 (510)
. .....||+.|+|||++.+ ..++.++|+|||||++|||
T Consensus 173 ~-----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el 211 (345)
T cd07877 173 E-----------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 211 (345)
T ss_pred c-----------------------------------------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHH
Confidence 1 112468999999999876 5689999999999999999
Q ss_pred hhCCCCCCCCChhhhHHHHhhcccc---------------------ccCCC------CCCCCHHHHHHHHHhhc-Ccccc
Q 010463 338 LIGYPPFCSDDPRITCRKIVNWKTC---------------------LKFPE------EPKISDEARDLICHLLC-DVETR 389 (510)
Q Consensus 338 l~G~~PF~~~~~~~~~~~I~~~~~~---------------------~~~p~------~~~~s~~~~dlI~~lL~-dp~~R 389 (510)
++|.+||.+.+.......++..... ...|. ....++++.+||.+||+ ||.+|
T Consensus 212 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 291 (345)
T cd07877 212 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 291 (345)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhc
Confidence 9999999877665554444321110 01111 11468899999999998 99999
Q ss_pred CCCCChHHhhcCCCcCC
Q 010463 390 LGTRGVEELKEHPWFRG 406 (510)
Q Consensus 390 ~~~~~~~eil~HpfF~~ 406 (510)
+ ++.+++.||||..
T Consensus 292 ~---t~~e~l~h~~f~~ 305 (345)
T cd07877 292 I---TAAQALAHAYFAQ 305 (345)
T ss_pred C---CHHHHhcChhhhh
Confidence 9 6899999999986
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=329.69 Aligned_cols=246 Identities=25% Similarity=0.372 Sum_probs=212.8
Q ss_pred eeeecCCCeEEEEEEEcCC---CCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEecc
Q 010463 112 TLIGKGAFGEVRLCRAKTT---GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYL 188 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~t---g~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy~ 188 (510)
+.||+|+||.||+|..... +..||+|++...... .....+..|+.++..++||||+++++++.+...+++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE--EERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccch--hHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4699999999999999866 899999999765432 25678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhc---------cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 189 PGGDIMTLLMRE---------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 189 ~gG~L~~~L~~~---------~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
+||+|.+++... ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999999875 78999999999999999999999999999999999999999999999999999876542
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~ 339 (510)
... .......+++.|+|||++....++.++|+|||||++|||++
T Consensus 159 ~~~------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 202 (262)
T cd00192 159 DYY------------------------------------RKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFT 202 (262)
T ss_pred ccc------------------------------------ccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHh
Confidence 100 00123568999999999998899999999999999999999
Q ss_pred -CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 340 -GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 340 -G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
|..||.+.+.......+... .....| ..+|.++.++|.+||+ +|.+|| +++++++|
T Consensus 203 ~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~~l~~~ 260 (262)
T cd00192 203 LGATPYPGLSNEEVLEYLRKG-YRLPKP--EYCPDELYELMLSCWQLDPEDRP---TFSELVER 260 (262)
T ss_pred cCCCCCCCCCHHHHHHHHHcC-CCCCCC--ccCChHHHHHHHHHccCCcccCc---CHHHHHHh
Confidence 69999988877777777652 223333 4779999999999998 999999 68888765
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=332.77 Aligned_cols=253 Identities=23% Similarity=0.338 Sum_probs=211.1
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCC---EEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCce
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGE---IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 180 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~---~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 180 (510)
...+|++.+.||+|+||.||+|+++.++. .+|+|.++... .......+..|+.+|..++||||+++++++.+++.
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP 79 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 35689999999999999999999875544 79999986542 23345678999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 181 LYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
+|+||||++||+|.+++.+. ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++..+...
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999999999765 46899999999999999999999999999999999999999999999999999876432
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~ 339 (510)
.... .......+++.|+|||++.+..++.++|+|||||++|||++
T Consensus 160 ~~~~-----------------------------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~ 204 (267)
T cd05066 160 PEAA-----------------------------------YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204 (267)
T ss_pred ccee-----------------------------------eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhc
Confidence 1100 00011234678999999998899999999999999999886
Q ss_pred -CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhh
Q 010463 340 -GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 399 (510)
Q Consensus 340 -G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil 399 (510)
|..||.+.+.......+... ...|....+++.+.+++.+||+ +|.+|| ++.+++
T Consensus 205 ~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~i~ 260 (267)
T cd05066 205 YGERPYWEMSNQDVIKAIEEG---YRLPAPMDCPAALHQLMLDCWQKDRNERP---KFEQIV 260 (267)
T ss_pred CCCCCcccCCHHHHHHHHhCC---CcCCCCCCCCHHHHHHHHHHcccCchhCC---CHHHHH
Confidence 99999887777666666643 2334445788999999999998 999999 456665
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=341.68 Aligned_cols=268 Identities=28% Similarity=0.443 Sum_probs=211.3
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC------
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS------ 178 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~------ 178 (510)
.++|++++.||.|+||.||+|.++.+++.||+|++..... .......+.+|+.+++.++||||+++++.+.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE-KDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccC-CCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 6899999999999999999999999999999999876432 222234567899999999999999999887543
Q ss_pred --ceEEEEEeccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCccc
Q 010463 179 --DFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 255 (510)
Q Consensus 179 --~~~~lVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~ 255 (510)
..+|+||||+.+ +|...+.. ...+++..++.++.|++.||.|||++||+||||||+|||++++|.++|+|||++..
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 357999999965 67777664 45799999999999999999999999999999999999999999999999999986
Q ss_pred CccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHH
Q 010463 256 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIM 334 (510)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvil 334 (510)
.......... ... .........+||+.|+|||++.+ ..++.++|||||||++
T Consensus 165 ~~~~~~~~~~-----------~~~----------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il 217 (311)
T cd07866 165 YDGPPPNPKG-----------GGG----------------GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVF 217 (311)
T ss_pred ccCCCccccc-----------CCc----------------ccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHH
Confidence 5432111000 000 00011234678999999999875 4589999999999999
Q ss_pred HHHhhCCCCCCCCChhhhHHHHhhccccc---------------------cCCC-----CCCCCHHHHHHHHHhhc-Ccc
Q 010463 335 YEMLIGYPPFCSDDPRITCRKIVNWKTCL---------------------KFPE-----EPKISDEARDLICHLLC-DVE 387 (510)
Q Consensus 335 yEml~G~~PF~~~~~~~~~~~I~~~~~~~---------------------~~p~-----~~~~s~~~~dlI~~lL~-dp~ 387 (510)
|||++|++||.+.+.......+....... ..|. ...+++.+.+||.+||. ||.
T Consensus 218 ~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 297 (311)
T cd07866 218 AEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPY 297 (311)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcc
Confidence 99999999999887766666554321110 0000 12456789999999998 999
Q ss_pred ccCCCCChHHhhcCCCc
Q 010463 388 TRLGTRGVEELKEHPWF 404 (510)
Q Consensus 388 ~R~~~~~~~eil~HpfF 404 (510)
+|| ++.+++.||||
T Consensus 298 ~R~---t~~ell~~~~f 311 (311)
T cd07866 298 KRL---TASDALEHPYF 311 (311)
T ss_pred cCc---CHHHHhcCCCC
Confidence 999 68999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=346.49 Aligned_cols=259 Identities=27% Similarity=0.442 Sum_probs=209.6
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC-------
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS------- 178 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~------- 178 (510)
.+|.+.+.||.|+||.||+|.++.+|+.||+|++.... ....+.+.+|+.+|+.++||||+++++++.+.
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~---~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC---CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 68999999999999999999999999999999986653 24557788999999999999999999776543
Q ss_pred -------ceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeec-CCCceeeccc
Q 010463 179 -------DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD-KNGHLKLSDF 250 (510)
Q Consensus 179 -------~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld-~~g~vkL~DF 250 (510)
..+|+||||++ ++|..++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence 46899999997 589888754 5689999999999999999999999999999999999998 4567899999
Q ss_pred CCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccc
Q 010463 251 GLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWS 329 (510)
Q Consensus 251 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwS 329 (510)
|+++.+....... ......+||+.|+|||++.+ ..++.++|+||
T Consensus 160 g~~~~~~~~~~~~-----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwS 204 (342)
T cd07854 160 GLARIVDPHYSHK-----------------------------------GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWA 204 (342)
T ss_pred ccceecCCccccc-----------------------------------cccccccccccccCHHHHhCccccCchhhHHH
Confidence 9997653321100 00112368999999998765 56889999999
Q ss_pred hhhHHHHHhhCCCCCCCCChhhhHHHHhhccc-----------------------cccCC---CCCCCCHHHHHHHHHhh
Q 010463 330 LGAIMYEMLIGYPPFCSDDPRITCRKIVNWKT-----------------------CLKFP---EEPKISDEARDLICHLL 383 (510)
Q Consensus 330 lGvilyEml~G~~PF~~~~~~~~~~~I~~~~~-----------------------~~~~p---~~~~~s~~~~dlI~~lL 383 (510)
|||++|||++|..||.+.+.......+..... ....| ..+.++.++.+||.+||
T Consensus 205 lGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 284 (342)
T cd07854 205 AGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQIL 284 (342)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHh
Confidence 99999999999999988776555544432100 00000 01357899999999999
Q ss_pred c-CccccCCCCChHHhhcCCCcCCC
Q 010463 384 C-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 384 ~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
+ ||.+|| ++++++.||||+.+
T Consensus 285 ~~dP~~R~---t~~ell~h~~~~~~ 306 (342)
T cd07854 285 TFNPMDRL---TAEEALMHPYMSCY 306 (342)
T ss_pred CCCchhcc---CHHHHhCCCccccc
Confidence 9 999999 78999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=339.72 Aligned_cols=254 Identities=29% Similarity=0.524 Sum_probs=213.3
Q ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEec
Q 010463 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEY 187 (510)
Q Consensus 108 f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy 187 (510)
|+....||+|+||.||++..+.+|+.||||++... .......+.+|+.+++.++||||+++++.|.+.+..|+||||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 33346799999999999999999999999987543 233456688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchh
Q 010463 188 LPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLED 267 (510)
Q Consensus 188 ~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~ 267 (510)
+++++|.+++. ...+++..++.++.|++.||.|||+.|++||||||+||+++.+|+++|+|||++..+.....
T Consensus 99 ~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~------ 171 (292)
T cd06657 99 LEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP------ 171 (292)
T ss_pred CCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc------
Confidence 99999999874 45689999999999999999999999999999999999999999999999999875432100
Q ss_pred hhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCCC
Q 010463 268 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSD 347 (510)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~~ 347 (510)
.....+||+.|+|||++.+..++.++|+||+||++|+|++|.+||.+.
T Consensus 172 --------------------------------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~ 219 (292)
T cd06657 172 --------------------------------RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 219 (292)
T ss_pred --------------------------------cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 011356899999999998888999999999999999999999999887
Q ss_pred ChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 348 DPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 348 ~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
+.......+... ....++....+++.+.++|.+||. +|.+|+ ++.+++.||||...
T Consensus 220 ~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~---~~~~ll~~~~~~~~ 276 (292)
T cd06657 220 PPLKAMKMIRDN-LPPKLKNLHKVSPSLKGFLDRLLVRDPAQRA---TAAELLKHPFLAKA 276 (292)
T ss_pred CHHHHHHHHHhh-CCcccCCcccCCHHHHHHHHHHHhCCcccCc---CHHHHhcChHHhcc
Confidence 665554444321 112222234689999999999998 999999 78999999999763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=338.33 Aligned_cols=260 Identities=28% Similarity=0.457 Sum_probs=211.3
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCc
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSD 179 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~ 179 (510)
..+..++|++.+.||+|+||.||+|.++.+|+.||||.+++... ......+..|..++..+ +||||+++++++.+..
T Consensus 10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 87 (296)
T cd06618 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDS 87 (296)
T ss_pred ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCC
Confidence 34677899999999999999999999999999999999976532 22334456677666665 5999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhh-CCeEEeecCCCCeeecCCCceeecccCCcccCc
Q 010463 180 FLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 257 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~-~giiHRDLKP~NILld~~g~vkL~DFGla~~~~ 257 (510)
.+|+||||++ ++|.+++.. ...+++..+..++.|++.||.|||+ .||+||||+|+||+++.++.+||+|||++..+.
T Consensus 88 ~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 88 DVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 9999999985 477777655 4578999999999999999999997 699999999999999999999999999987653
Q ss_pred cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCC----CCccccccchhhH
Q 010463 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG----YGMECDWWSLGAI 333 (510)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~----y~~~~DiwSlGvi 333 (510)
.... .....|++.|+|||++.+.. ++.++|+|||||+
T Consensus 167 ~~~~---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~i 207 (296)
T cd06618 167 DSKA---------------------------------------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGIS 207 (296)
T ss_pred CCCc---------------------------------------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHH
Confidence 3210 01235889999999997553 7899999999999
Q ss_pred HHHHhhCCCCCCCCCh-hhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 334 MYEMLIGYPPFCSDDP-RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 334 lyEml~G~~PF~~~~~-~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
+|||++|+.||..... .+....+.... ....+....++.++.+||.+||. ||.+|| ++++++.||||..
T Consensus 208 l~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---~~~~il~~~~~~~ 278 (296)
T cd06618 208 LVELATGQFPYKNCKTEFEVLTKILQEE-PPSLPPNEGFSPDFCSFVDLCLTKDHRKRP---KYRELLQHPFIRR 278 (296)
T ss_pred HHHHHhCCCCCCcchhHHHHHHHHhcCC-CCCCCCCCCCCHHHHHHHHHHccCChhhCC---CHHHHhcChhhhc
Confidence 9999999999976332 33444444422 22333333578999999999998 999999 6899999999974
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=330.56 Aligned_cols=249 Identities=21% Similarity=0.353 Sum_probs=209.3
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEE
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~ 182 (510)
+..++|++.+.||+|+||.||+|... +++.||+|.++.... ..+.+.+|+.+++.++||||+++++++...+.+|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 45678999999999999999999875 457899999876432 2355788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccc
Q 010463 183 LIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 260 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~ 260 (510)
+||||++||+|.+++.... .+++..+..++.|++.||.+||+.||+||||||+|||++.+|.+||+|||+++......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 9999999999999997654 68999999999999999999999999999999999999999999999999998764221
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh-
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI- 339 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~- 339 (510)
... .....++..|+|||++.+..++.++|+|||||++|||++
T Consensus 158 ~~~-------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~ 200 (261)
T cd05068 158 YEA-------------------------------------REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTY 200 (261)
T ss_pred ccc-------------------------------------cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhc
Confidence 000 001223468999999999999999999999999999999
Q ss_pred CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhh
Q 010463 340 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 399 (510)
Q Consensus 340 G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil 399 (510)
|.+||.+.+.......+... ...+....++..+.++|.+||. +|.+||+ +.+|.
T Consensus 201 g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~---~~~l~ 255 (261)
T cd05068 201 GRMPYPGMTNAEVLQQVDQG---YRMPCPPGCPKELYDIMLDCWKEDPDDRPT---FETLQ 255 (261)
T ss_pred CCCCCCCCCHHHHHHHHHcC---CCCCCCCcCCHHHHHHHHHHhhcCcccCCC---HHHHH
Confidence 99999988877777766543 2223334788999999999998 9999994 55554
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=333.28 Aligned_cols=251 Identities=21% Similarity=0.326 Sum_probs=206.1
Q ss_pred ceeeeeeecCCCeEEEEEEEcCCCC--EEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC------c
Q 010463 108 FEQLTLIGKGAFGEVRLCRAKTTGE--IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS------D 179 (510)
Q Consensus 108 f~~~~~IG~G~fG~V~~~~~~~tg~--~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~------~ 179 (510)
|.+.+.||+|+||.||+|+...++. .||+|.++... ....+.+.+..|..+|+.++||||+++++.+... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3567899999999999999988776 59999887542 2455677889999999999999999999876422 2
Q ss_pred eEEEEEeccCCCCHHHHHHh------ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCc
Q 010463 180 FLYLIMEYLPGGDIMTLLMR------EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLC 253 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~------~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla 253 (510)
..++||||+++|+|..++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 57999999999999988742 234899999999999999999999999999999999999999999999999999
Q ss_pred ccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhH
Q 010463 254 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 333 (510)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvi 333 (510)
+.+....... ......+++.|+|||++.+..++.++|||||||+
T Consensus 160 ~~~~~~~~~~------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~i 203 (272)
T cd05075 160 KKIYNGDYYR------------------------------------QGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVT 203 (272)
T ss_pred cccCccccee------------------------------------cCCcccCCcccCCHHHccCCCcChHHHHHHHHHH
Confidence 8764321000 0012346788999999999999999999999999
Q ss_pred HHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 334 MYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 334 lyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
+|||++ |.+||.+.+.......+.++. ....+ +.++..+.++|.+||+ ||++|| ++++|+++
T Consensus 204 l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~~l~~~ 267 (272)
T cd05075 204 MWEIATRGQTPYPGVENSEIYDYLRQGN-RLKQP--PDCLDGLYSLMSSCWLLNPKDRP---SFETLRCE 267 (272)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHcCC-CCCCC--CCCCHHHHHHHHHHcCCCcccCc---CHHHHHHH
Confidence 999999 899998887777777766542 22223 4788999999999998 999999 67777653
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=330.59 Aligned_cols=250 Identities=21% Similarity=0.357 Sum_probs=209.9
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEE
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l 183 (510)
..++|++++.||+|+||.||+|+.+. +..||+|.+..... ..+.+.+|..++..++||||+++++++.+...+|+
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 76 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYI 76 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEE
Confidence 45689999999999999999998764 45699999875432 23558889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccc
Q 010463 184 IMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 262 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 262 (510)
||||+++|+|.+++... ..+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++........
T Consensus 77 v~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 77 VTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 99999999999999764 46899999999999999999999999999999999999999999999999998765332100
Q ss_pred ccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh-CC
Q 010463 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GY 341 (510)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~-G~ 341 (510)
. .....|+..|+|||++.+..++.++|+|||||++|||++ |.
T Consensus 157 ~-------------------------------------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~ 199 (256)
T cd05113 157 S-------------------------------------SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGK 199 (256)
T ss_pred e-------------------------------------cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCC
Confidence 0 011246678999999998889999999999999999998 99
Q ss_pred CCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
.||...+.......+.+... ...+ ...+..+++++.+||. +|.+|| ++.+|+.+
T Consensus 200 ~p~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~li~~cl~~~p~~Rp---~~~~ll~~ 254 (256)
T cd05113 200 MPYERFNNSETVEKVSQGLR-LYRP--HLASEKVYAIMYSCWHEKAEERP---TFQQLLSS 254 (256)
T ss_pred CCcCcCCHHHHHHHHhcCCC-CCCC--CCCCHHHHHHHHHHcCCCcccCC---CHHHHHHh
Confidence 99988777777777765422 1222 3578999999999998 999999 67888754
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=330.66 Aligned_cols=255 Identities=23% Similarity=0.332 Sum_probs=212.5
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCC---EEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGE---IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 179 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~---~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 179 (510)
+..++|+..+.||+|+||.||+|+.+.++. .+|+|.+.... .......+..|+.++..++||||+++++++.+.+
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK 79 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence 456789999999999999999999887665 79999986542 2334567889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 180 FLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
..|+||||+++|+|.+++... +.+++..+..++.+++.||.|||+.|++||||||+|||++.++.+||+|||++.....
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999999999764 5789999999999999999999999999999999999999999999999999876543
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHh
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml 338 (510)
..... .......+++.|+|||++.+..++.++|||||||++|||+
T Consensus 160 ~~~~~-----------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell 204 (268)
T cd05063 160 DPEGT-----------------------------------YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVM 204 (268)
T ss_pred ccccc-----------------------------------eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHH
Confidence 21000 0000123456799999999889999999999999999999
Q ss_pred h-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 339 I-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 339 ~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
+ |..||...+.......|... ...|....++.++.+||.+||. +|.+|| ++.+|++
T Consensus 205 ~~g~~p~~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~~li~~c~~~~p~~Rp---~~~~i~~ 262 (268)
T cd05063 205 SFGERPYWDMSNHEVMKAINDG---FRLPAPMDCPSAVYQLMLQCWQQDRARRP---RFVDIVN 262 (268)
T ss_pred hCCCCCCCcCCHHHHHHHHhcC---CCCCCCCCCCHHHHHHHHHHcCCCcccCc---CHHHHHH
Confidence 7 99999888777777777642 2334434688999999999998 999999 5666653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=306.62 Aligned_cols=257 Identities=31% Similarity=0.560 Sum_probs=218.4
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEe
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 186 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmE 186 (510)
.|+..+.||+|.||+|++|+.+.|++.||+|.++..+- ...-.....+|+-+|+.++|.|||+|+++...+..+-+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 46667889999999999999999999999999876542 23344668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 187 YLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 187 y~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
||.. +|..+... ++.++.+.++.++.|++.||.++|+.++.||||||.|+||+.+|.+||+|||+++.+.-...
T Consensus 82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvr---- 156 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR---- 156 (292)
T ss_pred HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE----
Confidence 9955 78777755 57799999999999999999999999999999999999999999999999999997654311
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccc-cccccCCCcchHhhcc-CCCCccccccchhhHHHHHhh-CCC
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAY-STVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLI-GYP 342 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml~-G~~ 342 (510)
++ .-+-|.+|.+|.++.+ +-|+.+.|+||.|||+.|+.. |+|
T Consensus 157 -----------------------------------cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrp 201 (292)
T KOG0662|consen 157 -----------------------------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201 (292)
T ss_pred -----------------------------------eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCC
Confidence 11 2378999999999987 458999999999999999985 899
Q ss_pred CCCCCChhhhHHHHhh---------ccccccCCCC----------------CCCCHHHHHHHHHhhc-CccccCCCCChH
Q 010463 343 PFCSDDPRITCRKIVN---------WKTCLKFPEE----------------PKISDEARDLICHLLC-DVETRLGTRGVE 396 (510)
Q Consensus 343 PF~~~~~~~~~~~I~~---------~~~~~~~p~~----------------~~~s~~~~dlI~~lL~-dp~~R~~~~~~~ 396 (510)
.|.+.+...+..+|.. |+..-.+|+. +.++..-+||+++||. +|..|+ +++
T Consensus 202 lfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qri---sae 278 (292)
T KOG0662|consen 202 LFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRI---SAE 278 (292)
T ss_pred CCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCccccc---CHH
Confidence 9999999999888864 3322222221 4566788999999995 999999 789
Q ss_pred HhhcCCCcCCC
Q 010463 397 ELKEHPWFRGI 407 (510)
Q Consensus 397 eil~HpfF~~i 407 (510)
++++||||.+.
T Consensus 279 aalqhpyf~d~ 289 (292)
T KOG0662|consen 279 AALQHPYFSDF 289 (292)
T ss_pred HHhcCcccccc
Confidence 99999999864
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=340.14 Aligned_cols=257 Identities=20% Similarity=0.321 Sum_probs=210.3
Q ss_pred hcccCCCCceeeeeeecCCCeEEEEEEEcC-------CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeE
Q 010463 100 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKT-------TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQL 171 (510)
Q Consensus 100 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~-------tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l 171 (510)
+..+..++|.+.+.||+|+||.||+|++.. ++..||+|.+.+.. .......+..|+.++..+ +||||+++
T Consensus 12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (307)
T cd05098 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINL 89 (307)
T ss_pred cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 445556889999999999999999998643 33579999997542 233456688899999999 79999999
Q ss_pred eEEeecCceEEEEEeccCCCCHHHHHHhcc----------------CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCC
Q 010463 172 FYSFQDSDFLYLIMEYLPGGDIMTLLMRED----------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPD 235 (510)
Q Consensus 172 ~~~~~~~~~~~lVmEy~~gG~L~~~L~~~~----------------~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~ 235 (510)
++++.+.+.+|+||||+++|+|.+++.... .++...+..++.|++.||+|||+.|++||||||+
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 169 (307)
T cd05098 90 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR 169 (307)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHH
Confidence 999999999999999999999999997642 4788899999999999999999999999999999
Q ss_pred CeeecCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHh
Q 010463 236 NLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEV 315 (510)
Q Consensus 236 NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEv 315 (510)
|||++.++.+||+|||+++........ .......+++.|+|||+
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~ 213 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYY------------------------------------KKTTNGRLPVKWMAPEA 213 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchh------------------------------------hccccCCCccceeChHH
Confidence 999999999999999998765321000 00001235678999999
Q ss_pred hccCCCCccccccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC
Q 010463 316 LLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR 393 (510)
Q Consensus 316 l~~~~y~~~~DiwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~ 393 (510)
+.+..++.++|+|||||++|||++ |.+||.+.+.......+... .....| ..++.++++||.+||. +|.+||
T Consensus 214 ~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp--- 287 (307)
T cd05098 214 LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG-HRMDKP--SNCTNELYMMMRDCWHAVPSQRP--- 287 (307)
T ss_pred hccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcC-CCCCCC--CcCCHHHHHHHHHHcccChhhCc---
Confidence 999999999999999999999998 89999887766666555432 223333 4689999999999998 999999
Q ss_pred ChHHhhc
Q 010463 394 GVEELKE 400 (510)
Q Consensus 394 ~~~eil~ 400 (510)
++.++++
T Consensus 288 s~~evl~ 294 (307)
T cd05098 288 TFKQLVE 294 (307)
T ss_pred CHHHHHH
Confidence 5677765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=335.93 Aligned_cols=251 Identities=23% Similarity=0.375 Sum_probs=208.0
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcC-----CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKT-----TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 178 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~-----tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 178 (510)
...+|.+.+.||+|+||.||+|+... ++..+|+|.+.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 45679999999999999999998643 45679999886542 23345688999999999999999999999999
Q ss_pred ceEEEEEeccCCCCHHHHHHhcc----------------CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCC
Q 010463 179 DFLYLIMEYLPGGDIMTLLMRED----------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN 242 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~~----------------~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~ 242 (510)
+..++||||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 99999999999999999997543 37899999999999999999999999999999999999999
Q ss_pred CceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCC
Q 010463 243 GHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYG 322 (510)
Q Consensus 243 g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~ 322 (510)
+.++|+|||+++........ .......|++.|+|||++.+..++
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~ 203 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYY------------------------------------RVGGHTMLPIRWMPPESIMYRKFT 203 (291)
T ss_pred CcEEECCCCcccccCCCcee------------------------------------ecCCCCCcceeecChHHhccCCCC
Confidence 99999999999765332100 001134678999999999999999
Q ss_pred ccccccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhh
Q 010463 323 MECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 399 (510)
Q Consensus 323 ~~~DiwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil 399 (510)
.++|+|||||++|||++ |.+||...+.......+.... ....+ ...+..+.+||.+||. +|.+||+ +.+++
T Consensus 204 ~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~P~~Rpt---~~~v~ 276 (291)
T cd05094 204 TESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR-VLERP--RVCPKEVYDIMLGCWQREPQQRLN---IKEIY 276 (291)
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCC-CCCCC--ccCCHHHHHHHHHHcccChhhCcC---HHHHH
Confidence 99999999999999998 999998887776666655422 11222 3578999999999998 9999994 55554
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=327.59 Aligned_cols=251 Identities=28% Similarity=0.491 Sum_probs=218.3
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEe
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 186 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmE 186 (510)
+|++.+.||.|+||.||+|+++.+|+.||+|.+.+... ...+...+..|+.+++.++||||+++++++.+....|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc-cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 58899999999999999999999999999999987654 23455677889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccc
Q 010463 187 YLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 262 (510)
Q Consensus 187 y~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 262 (510)
|++|++|..++.+ ...+++..+..++.+++.||.|||+.|++||||+|+||+++.++.+||+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~-- 157 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM-- 157 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC--
Confidence 9999999999876 3568999999999999999999999999999999999999999999999999997654320
Q ss_pred ccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCC
Q 010463 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 342 (510)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~ 342 (510)
.....|++.|+|||.+.+..++.++|+||||+++|||++|++
T Consensus 158 --------------------------------------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~ 199 (256)
T cd08530 158 --------------------------------------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAP 199 (256)
T ss_pred --------------------------------------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 112468999999999999999999999999999999999999
Q ss_pred CCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 343 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 343 PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
||...+.......+.... ....+ ..++.+++++|.+||. +|.+|| ++.++++||+.
T Consensus 200 p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~~l~~p~~ 256 (256)
T cd08530 200 PFEARSMQDLRYKVQRGK-YPPIP--PIYSQDLQNFIRSMLQVKPKLRP---NCDKILASPAV 256 (256)
T ss_pred CCCCCCHHHHHHHHhcCC-CCCCc--hhhCHHHHHHHHHHcCCCcccCC---CHHHHhcCCCC
Confidence 999887766655554421 12222 3688999999999998 999999 78999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=338.06 Aligned_cols=260 Identities=33% Similarity=0.505 Sum_probs=211.9
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc---
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD--- 179 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~--- 179 (510)
...++|++.+.||+|+||.||+|.++.+|+.||+|+++.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 356789999999999999999999999999999999975432 2233456778999999999999999999987655
Q ss_pred -------eEEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccC
Q 010463 180 -------FLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFG 251 (510)
Q Consensus 180 -------~~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFG 251 (510)
.+|+||||+++ ++...+... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence 89999999986 677776653 469999999999999999999999999999999999999999999999999
Q ss_pred CcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccch
Q 010463 252 LCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSL 330 (510)
Q Consensus 252 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSl 330 (510)
++..+...... ......+++.|+|||++.+ ..++.++|||||
T Consensus 162 ~~~~~~~~~~~-------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~sl 204 (302)
T cd07864 162 LARLYNSEESR-------------------------------------PYTNKVITLWYRPPELLLGEERYGPAIDVWSC 204 (302)
T ss_pred ccccccCCccc-------------------------------------ccccceeccCccChHHhcCCCCCCchhHHHHH
Confidence 99866432100 0012357889999999875 457899999999
Q ss_pred hhHHHHHhhCCCCCCCCChhhhHHHHhhccc---cccCC-----------------------CCCCCCHHHHHHHHHhhc
Q 010463 331 GAIMYEMLIGYPPFCSDDPRITCRKIVNWKT---CLKFP-----------------------EEPKISDEARDLICHLLC 384 (510)
Q Consensus 331 GvilyEml~G~~PF~~~~~~~~~~~I~~~~~---~~~~p-----------------------~~~~~s~~~~dlI~~lL~ 384 (510)
||++|||++|++||...+.......+..... ...+| ....++..+.+||.+||.
T Consensus 205 G~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 284 (302)
T cd07864 205 GCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLT 284 (302)
T ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHcc
Confidence 9999999999999988776655555443110 00000 112478999999999999
Q ss_pred -CccccCCCCChHHhhcCCCc
Q 010463 385 -DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 385 -dp~~R~~~~~~~eil~HpfF 404 (510)
||.+|| ++++++.||||
T Consensus 285 ~~P~~Rp---~~~~il~~~~~ 302 (302)
T cd07864 285 LDPSKRC---TAEEALNSPWL 302 (302)
T ss_pred CChhhCC---CHHHHhcCCCC
Confidence 999999 68999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=338.83 Aligned_cols=254 Identities=26% Similarity=0.367 Sum_probs=213.0
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
..|+.++.||+|+||.||+|+++.+++.||+|.+.............+.+|+.+++.++|||++++++++.+....|+||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34777889999999999999999999999999987543334445567888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 186 EYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 186 Ey~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
||+. |+|.+++.. ...+++..+..++.|++.||.|||+.|++||||||+|||++.+|.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~----- 168 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----- 168 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc-----
Confidence 9997 577777653 456899999999999999999999999999999999999999999999999998754321
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc---cCCCCccccccchhhHHHHHhhCC
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~---~~~y~~~~DiwSlGvilyEml~G~ 341 (510)
....||+.|+|||++. ...++.++|||||||++|||++|.
T Consensus 169 -------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~ 211 (308)
T cd06634 169 -------------------------------------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211 (308)
T ss_pred -------------------------------------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCC
Confidence 1246899999999985 346788999999999999999999
Q ss_pred CCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
.||...+.......+..... ...+ ...++..+.+||.+||. +|.+|| +++++++||||...
T Consensus 212 ~p~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~li~~cl~~~P~~Rp---~~~~ll~~~~~~~~ 273 (308)
T cd06634 212 PPLFNMNAMSALYHIAQNES-PALQ-SGHWSEYFRNFVDSCLQKIPQDRP---TSEVLLKHRFVLRE 273 (308)
T ss_pred CCCccccHHHHHHHHhhcCC-CCcC-cccccHHHHHHHHHHhhCCcccCC---CHHHHhhCcccccc
Confidence 99987765555544443211 1111 23688999999999998 999999 68999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=338.21 Aligned_cols=255 Identities=22% Similarity=0.319 Sum_probs=210.2
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcC-------CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeE
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKT-------TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFY 173 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~-------tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~ 173 (510)
.+..++|.+.+.||+|+||.||+|++.. .+..||+|.+.+.. .......+..|+.++..+ +||||+++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 3455789999999999999999998642 34579999987532 334566788999999999 6999999999
Q ss_pred EeecCceEEEEEeccCCCCHHHHHHhc----------------cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCe
Q 010463 174 SFQDSDFLYLIMEYLPGGDIMTLLMRE----------------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNL 237 (510)
Q Consensus 174 ~~~~~~~~~lVmEy~~gG~L~~~L~~~----------------~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NI 237 (510)
++.+.+.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 165 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence 999999999999999999999999753 3478889999999999999999999999999999999
Q ss_pred eecCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc
Q 010463 238 ILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL 317 (510)
Q Consensus 238 Lld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~ 317 (510)
|++.++.+||+|||+++......... ......+++.|+|||++.
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~------------------------------------~~~~~~~~~~y~aPE~~~ 209 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYK------------------------------------KTSNGRLPVKWMAPEALF 209 (314)
T ss_pred EEcCCCcEEEcccccccccccccccc------------------------------------ccccCCCCccccCHHHHc
Confidence 99999999999999998654321000 001123557899999999
Q ss_pred cCCCCccccccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCh
Q 010463 318 KKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGV 395 (510)
Q Consensus 318 ~~~y~~~~DiwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~ 395 (510)
+..++.++|||||||++|||++ |..||.+.+....+..+.... ....| ..++.++++||.+||. +|++|| ++
T Consensus 210 ~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~cl~~~p~~Rp---s~ 283 (314)
T cd05099 210 DRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGH-RMDKP--SNCTHELYMLMRECWHAVPTQRP---TF 283 (314)
T ss_pred cCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCC--CCCCHHHHHHHHHHcCCCcccCc---CH
Confidence 9999999999999999999999 899998888777777666532 22333 3678899999999998 999999 56
Q ss_pred HHhhc
Q 010463 396 EELKE 400 (510)
Q Consensus 396 ~eil~ 400 (510)
.++++
T Consensus 284 ~~ll~ 288 (314)
T cd05099 284 KQLVE 288 (314)
T ss_pred HHHHH
Confidence 66664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=341.91 Aligned_cols=261 Identities=23% Similarity=0.342 Sum_probs=205.3
Q ss_pred eeeecC--CCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEeccC
Q 010463 112 TLIGKG--AFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLP 189 (510)
Q Consensus 112 ~~IG~G--~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy~~ 189 (510)
.+||+| ++|.|++++.+.+|+.||+|++.+... .......+..|+.+++.++||||++++++|.+.+..|++|||++
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 345554 556777778888999999999976532 44567789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchh
Q 010463 190 GGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLED 267 (510)
Q Consensus 190 gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~ 267 (510)
+|+|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||.+..+........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~--- 159 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR--- 159 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccc---
Confidence 99999999763 4689999999999999999999999999999999999999999999999999876543211000
Q ss_pred hhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc--CCCCccccccchhhHHHHHhhCCCCCC
Q 010463 268 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK--KGYGMECDWWSLGAIMYEMLIGYPPFC 345 (510)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiwSlGvilyEml~G~~PF~ 345 (510)
..........++..|+|||++.+ ..|+.++|+|||||++|||++|.+||.
T Consensus 160 ----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~ 211 (314)
T cd08216 160 ----------------------------VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFK 211 (314)
T ss_pred ----------------------------ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 00000123468889999999976 468999999999999999999999998
Q ss_pred CCChhhhH-HHHhhccc-----------------------------cccCCCCCCCCHHHHHHHHHhhc-CccccCCCCC
Q 010463 346 SDDPRITC-RKIVNWKT-----------------------------CLKFPEEPKISDEARDLICHLLC-DVETRLGTRG 394 (510)
Q Consensus 346 ~~~~~~~~-~~I~~~~~-----------------------------~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~ 394 (510)
+....... .++..... ....+....++.++.+||.+||+ ||++|| +
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---t 288 (314)
T cd08216 212 DMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRP---S 288 (314)
T ss_pred CCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCc---C
Confidence 75543322 22210000 00000112346789999999998 999999 7
Q ss_pred hHHhhcCCCcCCC
Q 010463 395 VEELKEHPWFRGI 407 (510)
Q Consensus 395 ~~eil~HpfF~~i 407 (510)
++++++||||+.+
T Consensus 289 ~~~ll~~p~~~~~ 301 (314)
T cd08216 289 ASQLLNHSFFKQC 301 (314)
T ss_pred HHHHhcCchHhhh
Confidence 8999999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=338.76 Aligned_cols=258 Identities=20% Similarity=0.339 Sum_probs=213.5
Q ss_pred hcccCCCCceeeeeeecCCCeEEEEEEEc-------CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeE
Q 010463 100 RRKIGIDDFEQLTLIGKGAFGEVRLCRAK-------TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQL 171 (510)
Q Consensus 100 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~-------~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l 171 (510)
+..+..++|.+.+.||+|+||.||+|+.. .++..||+|.+.... .......+.+|+.++..+ +||||+++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~ 86 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINL 86 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchhe
Confidence 34566789999999999999999999753 234579999986532 234557789999999999 89999999
Q ss_pred eEEeecCceEEEEEeccCCCCHHHHHHhc----------------cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCC
Q 010463 172 FYSFQDSDFLYLIMEYLPGGDIMTLLMRE----------------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPD 235 (510)
Q Consensus 172 ~~~~~~~~~~~lVmEy~~gG~L~~~L~~~----------------~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~ 235 (510)
++++.+...+|+||||+++|+|.+++.+. ..++...+..++.||+.||.|||+.||+||||||+
T Consensus 87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 166 (304)
T cd05101 87 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR 166 (304)
T ss_pred eEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccc
Confidence 99999999999999999999999999764 24677888999999999999999999999999999
Q ss_pred CeeecCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHh
Q 010463 236 NLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEV 315 (510)
Q Consensus 236 NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEv 315 (510)
|||++.++.+||+|||+++.+...... .......+++.|+|||+
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~ 210 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYY------------------------------------KKTTNGRLPVKWMAPEA 210 (304)
T ss_pred eEEEcCCCcEEECCCccceeccccccc------------------------------------ccccCCCCCceeeCchh
Confidence 999999999999999999866432100 00112356788999999
Q ss_pred hccCCCCccccccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC
Q 010463 316 LLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR 393 (510)
Q Consensus 316 l~~~~y~~~~DiwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~ 393 (510)
+.+..++.++|||||||++|||++ |..||.+.+..+....+.... ....| ..++.++++||.+||. +|.+||
T Consensus 211 ~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~cl~~~p~~Rp--- 284 (304)
T cd05101 211 LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH-RMDKP--ANCTNELYMMMRDCWHAIPSHRP--- 284 (304)
T ss_pred hccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC-cCCCC--CCCCHHHHHHHHHHcccChhhCC---
Confidence 999999999999999999999998 899999888877777765432 22233 4688999999999998 999999
Q ss_pred ChHHhhcC
Q 010463 394 GVEELKEH 401 (510)
Q Consensus 394 ~~~eil~H 401 (510)
++.++++.
T Consensus 285 s~~e~l~~ 292 (304)
T cd05101 285 TFKQLVED 292 (304)
T ss_pred CHHHHHHH
Confidence 57777653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=331.40 Aligned_cols=254 Identities=22% Similarity=0.384 Sum_probs=212.3
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCC-----CCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTT-----GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 178 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~t-----g~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 178 (510)
..++|++++.||+|+||.||+|+.+.+ .+.||+|.+.... .......+.+|+.+|+.++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 346899999999999999999997643 4679999886532 222456789999999999999999999999999
Q ss_pred ceEEEEEeccCCCCHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecc
Q 010463 179 DFLYLIMEYLPGGDIMTLLMRED---------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSD 249 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~~---------~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~D 249 (510)
+..|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++.+++++|+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence 99999999999999999998765 689999999999999999999999999999999999999999999999
Q ss_pred cCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccc
Q 010463 250 FGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWS 329 (510)
Q Consensus 250 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwS 329 (510)
||+++........ ......+++.|+|||.+.+..++.++||||
T Consensus 161 ~~~~~~~~~~~~~-------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s 203 (275)
T cd05046 161 LSLSKDVYNSEYY-------------------------------------KLRNALIPLRWLAPEAVQEDDFSTKSDVWS 203 (275)
T ss_pred cccccccCccccc-------------------------------------ccCCceeEEeecChhhhccCCCCchhhHHH
Confidence 9998754221000 011246788899999999888999999999
Q ss_pred hhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 330 LGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 330 lGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
|||++|+|++ |..||.+.........+.... ..++....++..+.++|.+||+ +|++|| ++.+++++
T Consensus 204 lG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp---~~~~~l~~ 272 (275)
T cd05046 204 FGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK--LELPVPEGCPSRLYKLMTRCWAVNPKDRP---SFSELVSA 272 (275)
T ss_pred HHHHHHHHHhCCCCCccccchHHHHHHHHcCC--cCCCCCCCCCHHHHHHHHHHcCCCcccCC---CHHHHHHH
Confidence 9999999998 889998776666666665432 2233334788999999999998 999999 67888753
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=342.18 Aligned_cols=256 Identities=29% Similarity=0.454 Sum_probs=210.6
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec-CceEE
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD-SDFLY 182 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~~~~~ 182 (510)
..++|++++.||.|+||.||+|.++.+|+.||+|++.+.. ........+..|+.++..++||||++++++|.. ....|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF-STPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 4578999999999999999999999999999999986542 233345678899999999999999999999876 56899
Q ss_pred EEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccc
Q 010463 183 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 262 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 262 (510)
+||||+ +++|..++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.+|.++|+|||++......
T Consensus 87 lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~--- 161 (328)
T cd07856 87 FVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ--- 161 (328)
T ss_pred EEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC---
Confidence 999999 5688888754 56899999999999999999999999999999999999999999999999998754321
Q ss_pred ccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHhhCC
Q 010463 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml~G~ 341 (510)
..+.+|++.|+|||++.+ ..++.++|+|||||++|+|++|.
T Consensus 162 --------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~ 203 (328)
T cd07856 162 --------------------------------------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203 (328)
T ss_pred --------------------------------------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCC
Confidence 013468999999999866 57899999999999999999999
Q ss_pred CCCCCCChhhhHHHHhhc------------------------cccccCCC---CCCCCHHHHHHHHHhhc-CccccCCCC
Q 010463 342 PPFCSDDPRITCRKIVNW------------------------KTCLKFPE---EPKISDEARDLICHLLC-DVETRLGTR 393 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~------------------------~~~~~~p~---~~~~s~~~~dlI~~lL~-dp~~R~~~~ 393 (510)
+||.+.+.......+.+. ......|. .+.+++++.++|++||+ +|++||
T Consensus 204 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~--- 280 (328)
T cd07856 204 PLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRI--- 280 (328)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCC---
Confidence 999877654333222210 00001111 13578999999999998 999999
Q ss_pred ChHHhhcCCCcCC
Q 010463 394 GVEELKEHPWFRG 406 (510)
Q Consensus 394 ~~~eil~HpfF~~ 406 (510)
++++++.||||..
T Consensus 281 t~~ell~~~~~~~ 293 (328)
T cd07856 281 SAAEALAHPYLAP 293 (328)
T ss_pred CHHHHhcCCcccc
Confidence 6899999999964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=329.62 Aligned_cols=248 Identities=25% Similarity=0.414 Sum_probs=206.2
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEE
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~ 182 (510)
+..++|++++.||+|+||.||+|++..++ .||+|++.+... ..+.+.+|+.++..++||||+++++.+.+ ...|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 76 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcE
Confidence 34567999999999999999999887664 599999976432 23467889999999999999999998754 5689
Q ss_pred EEEeccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccc
Q 010463 183 LIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 260 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~ 260 (510)
+||||+++|+|.+++.+. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.+....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 999999999999999763 458999999999999999999999999999999999999999999999999998654321
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh-
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI- 339 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~- 339 (510)
.. ......|+..|+|||++.+..++.++|+|||||++|||++
T Consensus 157 ~~-------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~ 199 (262)
T cd05071 157 YT-------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 199 (262)
T ss_pred cc-------------------------------------cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcC
Confidence 00 0012357788999999998999999999999999999999
Q ss_pred CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhh
Q 010463 340 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 399 (510)
Q Consensus 340 G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil 399 (510)
|.+||.+.+.......+.... ..+....++..+.+||.+||. +|++||+ +.+++
T Consensus 200 g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rp~---~~~~~ 254 (262)
T cd05071 200 GRVPYPGMVNREVLDQVERGY---RMPCPPECPESLHDLMCQCWRKEPEERPT---FEYLQ 254 (262)
T ss_pred CCCCCCCCChHHHHHHHhcCC---CCCCccccCHHHHHHHHHHccCCcccCCC---HHHHH
Confidence 899998887777777665421 223334789999999999998 9999994 55554
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=364.42 Aligned_cols=261 Identities=24% Similarity=0.399 Sum_probs=212.3
Q ss_pred hhcccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEeEEee-
Q 010463 99 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQ- 176 (510)
Q Consensus 99 ~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~- 176 (510)
+...++-...++.+.|.+|||+.||+|+....|..||+|++-.. .....+.+++|+++|++|. |+|||.++++..
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~ 106 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAI 106 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence 33456667788999999999999999999988899999998654 5667888999999999996 999999999422
Q ss_pred c------CceEEEEEeccCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHhhhhCC--eEEeecCCCCeeecCCCcee
Q 010463 177 D------SDFLYLIMEYLPGGDIMTLLMR--EDILSEDVARFYIAESVLAIHSIHQHN--YVHRDIKPDNLILDKNGHLK 246 (510)
Q Consensus 177 ~------~~~~~lVmEy~~gG~L~~~L~~--~~~l~e~~~~~~~~qi~~aL~~lH~~g--iiHRDLKP~NILld~~g~vk 246 (510)
. .-.++|.||||.||.|.+++.. ...|+|.++..|+++++.||.+||.+. |||||||-|||||+.+|+.|
T Consensus 107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~K 186 (738)
T KOG1989|consen 107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYK 186 (738)
T ss_pred cccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEE
Confidence 1 1368999999999999999974 356999999999999999999999997 99999999999999999999
Q ss_pred ecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc---cCCCCc
Q 010463 247 LSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGM 323 (510)
Q Consensus 247 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~---~~~y~~ 323 (510)
|||||.|+........ ...+..-..+ -...-||.|.|||++. +.+.+.
T Consensus 187 LCDFGSatt~~~~~~~------------------------~~e~~~ve~e-----I~k~TTp~YRsPEMIDlysg~pI~e 237 (738)
T KOG1989|consen 187 LCDFGSATTKILSPTS------------------------AQEVNYVEEE-----IEKYTTPQYRSPEMIDLYSGLPIGE 237 (738)
T ss_pred eCcccccccccCCCcc------------------------HHHHHHHHHH-----HHhhCCccccChHHHhhhcCCCCcc
Confidence 9999998743221100 0000000000 0124799999999985 678899
Q ss_pred cccccchhhHHHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 324 ECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 324 ~~DiwSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
|+|||||||+||-|+....||..... ..|++ ..+.||..+..|..+++||+.||. ||.+|| ++-+++.
T Consensus 238 KsDIWALGclLYkLCy~t~PFe~sg~----laIln--g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RP---nI~Qv~~ 306 (738)
T KOG1989|consen 238 KSDIWALGCLLYKLCYFTTPFEESGK----LAILN--GNYSFPPFPNYSDRLKDLIRTMLQPNPDERP---NIYQVLE 306 (738)
T ss_pred hhHHHHHHHHHHHHHHhCCCcCcCcc----eeEEe--ccccCCCCccHHHHHHHHHHHHhccCcccCC---CHHHHHH
Confidence 99999999999999999999976532 45666 457888888999999999999999 999999 5555554
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=326.77 Aligned_cols=244 Identities=24% Similarity=0.422 Sum_probs=204.7
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEe-ecCceE
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSF-QDSDFL 181 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-~~~~~~ 181 (510)
+...+|++.+.||+|+||.||++... |..||+|.+... ...+.+.+|+.+++.++||+|+++++++ .+.+.+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence 45578999999999999999998764 788999998643 2345688999999999999999999875 456789
Q ss_pred EEEEeccCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 182 YLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
|+||||+++|+|.+++.+.. .+++..+..++.|++.||.|||+.||+||||||+||+++.+|.+||+|||+++.....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999999999999997643 4889999999999999999999999999999999999999999999999998754321
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~ 339 (510)
. .+..++..|+|||++.+..++.++|||||||++|||++
T Consensus 156 ~-----------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~ 194 (256)
T cd05082 156 Q-----------------------------------------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194 (256)
T ss_pred C-----------------------------------------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHh
Confidence 0 12345678999999999999999999999999999997
Q ss_pred -CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 340 -GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 340 -G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
|.+||...+.......+.... ....+ ..+++.+.++|.+||+ +|++|| ++.++++
T Consensus 195 ~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---t~~~l~~ 251 (256)
T cd05082 195 FGRVPYPRIPLKDVVPRVEKGY-KMDAP--DGCPPVVYDVMKQCWHLDAATRP---SFLQLRE 251 (256)
T ss_pred CCCCCCCCCCHHHHHHHHhcCC-CCCCC--CCCCHHHHHHHHHHhcCChhhCc---CHHHHHH
Confidence 999998877766666665421 22222 4789999999999998 999999 5666653
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=364.10 Aligned_cols=305 Identities=37% Similarity=0.645 Sum_probs=258.1
Q ss_pred eeecCCCeEEEEEEE---cCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEeEEeecCceEEEEEecc
Q 010463 113 LIGKGAFGEVRLCRA---KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSDFLYLIMEYL 188 (510)
Q Consensus 113 ~IG~G~fG~V~~~~~---~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~~~lVmEy~ 188 (510)
++|+|+||.|++++. .+.|..||||++++.....+... +...|+.++..++ ||++|++.+.|+.+..+|++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 479999999998754 45788899999988766544444 8889999999997 999999999999999999999999
Q ss_pred CCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhh
Q 010463 189 PGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDE 268 (510)
Q Consensus 189 ~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~ 268 (510)
.||+|...+.+...+++...++|.++++.|++++|+.||+|||+|++||+++.+||+++.|||+++......
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~-------- 151 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK-------- 151 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh--------
Confidence 999999999999999999999999999999999999999999999999999999999999999998654320
Q ss_pred hhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCCCC
Q 010463 269 DIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDD 348 (510)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~~~ 348 (510)
..|||..|||||++. ++..++||||+|+++|||++|-.||.+
T Consensus 152 ----------------------------------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-- 193 (612)
T KOG0603|consen 152 ----------------------------------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-- 193 (612)
T ss_pred ----------------------------------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--
Confidence 139999999999998 889999999999999999999999987
Q ss_pred hhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CChHHhhcCCCcCCCCchhhh--cccCCCcccc
Q 010463 349 PRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLY--EMEAAYKPTV 423 (510)
Q Consensus 349 ~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~--~~~~eil~HpfF~~i~~~~l~--~~~~p~~p~~ 423 (510)
++...|.. ..+..| ..++.++++++..|+. +|.+|++. .+++||++|+||..++|+.+. +..|||+|.+
T Consensus 194 --~~~~~Il~--~~~~~p--~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~ 267 (612)
T KOG0603|consen 194 --DTMKRILK--AELEMP--RELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGS 267 (612)
T ss_pred --HHHHHHhh--hccCCc--hhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcc
Confidence 67777775 234455 4899999999999998 99999987 589999999999999999876 4789999999
Q ss_pred CCCccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCcccCceeeCCccccc
Q 010463 424 NGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKS 475 (510)
Q Consensus 424 ~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~ 475 (510)
..+.|+.+|+.......|.. .|...+ ..+...-|.||+|..+.++-+
T Consensus 268 ~~e~~~~~fd~eft~~~P~d-sp~~~~----~~s~~~if~g~sfva~~il~~ 314 (612)
T KOG0603|consen 268 ITERDVAQFDPEFTSQVPAD-SPLLSA----SGSDHTIFSGPSFVAPGVLED 314 (612)
T ss_pred cchhhhhhcCchhccCCccc-CCCCCC----CccccchhcCCCccChHHhhc
Confidence 99999999997333222211 111111 122335788888888766644
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=328.07 Aligned_cols=248 Identities=23% Similarity=0.386 Sum_probs=206.2
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEE
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~ 182 (510)
+..++|++++.||+|+||.||+|... ++..||+|.+..... ..+.+.+|+.+++.++||||+++++++. ....|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 45578999999999999999999876 566799999876432 2345889999999999999999999886 45689
Q ss_pred EEEeccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccc
Q 010463 183 LIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 260 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~ 260 (510)
+||||+++|+|.+++... ..+++..++.++.+++.||.|||+.||+||||||+|||++.++.++|+|||++..+....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 999999999999999763 458999999999999999999999999999999999999999999999999998654321
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh-
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI- 339 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~- 339 (510)
.. ......|+..|+|||++.+..++.++|+|||||++|||++
T Consensus 157 ~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~ 199 (260)
T cd05070 157 YT-------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTK 199 (260)
T ss_pred cc-------------------------------------cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhc
Confidence 00 0012346678999999998889999999999999999999
Q ss_pred CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhh
Q 010463 340 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 399 (510)
Q Consensus 340 G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil 399 (510)
|.+||.+.+..+....+... ...|.....+..+.+||.+||. +|.+||+ +.++.
T Consensus 200 g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~l~ 254 (260)
T cd05070 200 GRVPYPGMNNREVLEQVERG---YRMPCPQDCPISLHELMLQCWKKDPEERPT---FEYLQ 254 (260)
T ss_pred CCCCCCCCCHHHHHHHHHcC---CCCCCCCcCCHHHHHHHHHHcccCcccCcC---HHHHH
Confidence 99999988877777766542 2223334688999999999998 9999994 55554
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=326.14 Aligned_cols=244 Identities=22% Similarity=0.332 Sum_probs=201.7
Q ss_pred eeeecCCCeEEEEEEEcCCC---CEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEecc
Q 010463 112 TLIGKGAFGEVRLCRAKTTG---EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYL 188 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~tg---~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy~ 188 (510)
+.||+|+||.||+|....++ ..||+|.+...... ...+.+..|+.+++.++|||||++++++.. +..++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeC
Confidence 46999999999999876655 78999999866432 345678899999999999999999998864 5689999999
Q ss_pred CCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhh
Q 010463 189 PGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDE 268 (510)
Q Consensus 189 ~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~ 268 (510)
++|+|.+++.+...+++..+..++.|++.||.|||..|++||||||+|||++.++.+||+|||+++.+.......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~----- 152 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY----- 152 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccc-----
Confidence 999999999888889999999999999999999999999999999999999999999999999998654321100
Q ss_pred hhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh-CCCCCCCC
Q 010463 269 DIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSD 347 (510)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~-G~~PF~~~ 347 (510)
.......++..|+|||.+.+..++.++|+|||||++|||++ |.+||...
T Consensus 153 ------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~ 202 (257)
T cd05060 153 ------------------------------RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM 202 (257)
T ss_pred ------------------------------ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC
Confidence 00001224578999999998999999999999999999998 99999887
Q ss_pred ChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhh
Q 010463 348 DPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 399 (510)
Q Consensus 348 ~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil 399 (510)
+.......+.... ....| ..++..++++|.+||+ +|.+|| ++.+++
T Consensus 203 ~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~cl~~~p~~Rp---~~~~l~ 249 (257)
T cd05060 203 KGAEVIAMLESGE-RLPRP--EECPQEIYSIMLSCWKYRPEDRP---TFSELE 249 (257)
T ss_pred CHHHHHHHHHcCC-cCCCC--CCCCHHHHHHHHHHhcCChhhCc---CHHHHH
Confidence 7766665555432 22233 4788999999999998 999999 455554
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=328.04 Aligned_cols=256 Identities=23% Similarity=0.339 Sum_probs=211.6
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCC---EEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCce
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGE---IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 180 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~---~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 180 (510)
...+|++.+.||+|+||.||+|..+.+++ .||||++.+.. .......+..|+.+++.++||||+++++++.+...
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 79 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP 79 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc
Confidence 35679999999999999999999987765 59999987542 34456789999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 181 LYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
+++||||++||+|.+++... +.+++..++.++.|++.||.|||+.|++||||||+|||++.++.+||+|||++......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999999999998764 56899999999999999999999999999999999999999999999999998765432
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~ 339 (510)
..... ........++..|+|||++.+..++.++|+|||||++|||++
T Consensus 160 ~~~~~---------------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~ 206 (269)
T cd05065 160 TSDPT---------------------------------YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206 (269)
T ss_pred ccccc---------------------------------cccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhc
Confidence 11000 000001123467999999999999999999999999999886
Q ss_pred -CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 340 -GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 340 -G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
|.+||.+.+.......+.. ....|....++..+.+++.+||. +|.+|| ++++|+.
T Consensus 207 ~g~~p~~~~~~~~~~~~i~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~i~~ 263 (269)
T cd05065 207 YGERPYWDMSNQDVINAIEQ---DYRLPPPMDCPTALHQLMLDCWQKDRNARP---KFGQIVS 263 (269)
T ss_pred CCCCCCCCCCHHHHHHHHHc---CCcCCCcccCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 9999988777766666643 23334345788999999999998 999999 5677764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=351.57 Aligned_cols=257 Identities=23% Similarity=0.331 Sum_probs=209.4
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEc-----CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEeEE
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAK-----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYS 174 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~-----~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~ 174 (510)
..+..++|.+.+.||+|+||.||+|+++ .+++.||+|++.... .......+..|+.+|..+. |||||+++++
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 4455678889999999999999999864 355689999997542 2334457889999999997 9999999999
Q ss_pred eecCceEEEEEeccCCCCHHHHHHhcc-----------------------------------------------------
Q 010463 175 FQDSDFLYLIMEYLPGGDIMTLLMRED----------------------------------------------------- 201 (510)
Q Consensus 175 ~~~~~~~~lVmEy~~gG~L~~~L~~~~----------------------------------------------------- 201 (510)
+++.+.+|+||||++||+|.++|.+.+
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 999999999999999999999996532
Q ss_pred ---------------------------------------------CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCC
Q 010463 202 ---------------------------------------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDN 236 (510)
Q Consensus 202 ---------------------------------------------~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~N 236 (510)
.+++..+..++.||+.||.|||+.||+||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N 269 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN 269 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence 35667788899999999999999999999999999
Q ss_pred eeecCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhh
Q 010463 237 LILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL 316 (510)
Q Consensus 237 ILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl 316 (510)
||++.++.+||+|||+++........ ....+.+|++.|+|||++
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~ 313 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNY------------------------------------ISKGSTFLPLKWMAPESI 313 (401)
T ss_pred EEEeCCCEEEEEecCcceeccccccc------------------------------------ccCCCcCCCCceeChHHh
Confidence 99999999999999999865321100 001134688999999999
Q ss_pred ccCCCCccccccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCC
Q 010463 317 LKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRG 394 (510)
Q Consensus 317 ~~~~y~~~~DiwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~ 394 (510)
.+..++.++|||||||++|||++ |..||......+.....+.....+..| ..++.++.+||.+|++ +|.+|| +
T Consensus 314 ~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p--~~~~~~l~~li~~cl~~~P~~RP---s 388 (401)
T cd05107 314 FNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKP--AHASDEIYEIMQKCWEEKFEIRP---D 388 (401)
T ss_pred cCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCC--CCCCHHHHHHHHHHcCCChhHCc---C
Confidence 99899999999999999999998 899998765555544444322223333 4689999999999999 999999 5
Q ss_pred hHHhhc
Q 010463 395 VEELKE 400 (510)
Q Consensus 395 ~~eil~ 400 (510)
+.+|+.
T Consensus 389 ~~ell~ 394 (401)
T cd05107 389 FSQLVH 394 (401)
T ss_pred HHHHHH
Confidence 677764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=344.86 Aligned_cols=256 Identities=22% Similarity=0.355 Sum_probs=205.3
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEE-----cCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEee
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRA-----KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQ 176 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~-----~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~ 176 (510)
+..++|++.+.||+|+||.||+|++ ..+++.||||+++... .......+.+|+.+|..+ +||||+++++++.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 4557899999999999999999984 3567899999997542 233456788999999999 6899999999876
Q ss_pred cC-ceEEEEEeccCCCCHHHHHHhc-------------------------------------------------------
Q 010463 177 DS-DFLYLIMEYLPGGDIMTLLMRE------------------------------------------------------- 200 (510)
Q Consensus 177 ~~-~~~~lVmEy~~gG~L~~~L~~~------------------------------------------------------- 200 (510)
.. ..+++||||++||+|.+++...
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 54 5689999999999999998642
Q ss_pred ------------cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhh
Q 010463 201 ------------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDE 268 (510)
Q Consensus 201 ------------~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~ 268 (510)
..++...+..++.||+.||.|||+.||+||||||+|||++.++++||+|||++..........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~----- 236 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV----- 236 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchh-----
Confidence 236778888999999999999999999999999999999999999999999998653221000
Q ss_pred hhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh-CCCCCCCC
Q 010463 269 DIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSD 347 (510)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~-G~~PF~~~ 347 (510)
......+++.|+|||++.+..++.++|+|||||++|||++ |..||.+.
T Consensus 237 -------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 285 (343)
T cd05103 237 -------------------------------RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 285 (343)
T ss_pred -------------------------------hcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 0012346778999999999999999999999999999997 99999876
Q ss_pred ChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 348 DPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 348 ~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
.........+........| ..+++++.+++..||. ||.+|| ++.+|++|
T Consensus 286 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~cl~~~p~~Rp---s~~eil~~ 335 (343)
T cd05103 286 KIDEEFCRRLKEGTRMRAP--DYTTPEMYQTMLDCWHGEPSQRP---TFSELVEH 335 (343)
T ss_pred cccHHHHHHHhccCCCCCC--CCCCHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 5443333333222223333 3578899999999998 999999 68888875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=325.82 Aligned_cols=250 Identities=24% Similarity=0.385 Sum_probs=210.7
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceE
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 181 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~ 181 (510)
++..++|.+.+.||+|+||.||+|..+ .+..||||.+..... ..+.+.+|+.+++.++||||+++++++.+...+
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPI 76 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCce
Confidence 356689999999999999999999876 457799999876432 235688899999999999999999999998999
Q ss_pred EEEEeccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 182 YLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
|+||||++||+|.+++... ..+++..+..++.+++.||.|||+.||+|+||||+||+++.++.+||+|||+++.+...
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 9999999999999999764 36899999999999999999999999999999999999999999999999999865431
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~ 339 (510)
.... .....++..|+|||.+.+..++.++|+|||||++|||++
T Consensus 157 ~~~~-------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t 199 (261)
T cd05034 157 EYTA-------------------------------------REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVT 199 (261)
T ss_pred hhhh-------------------------------------hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHh
Confidence 0000 001235678999999999899999999999999999998
Q ss_pred -CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhh
Q 010463 340 -GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 399 (510)
Q Consensus 340 -G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil 399 (510)
|+.||.+.+......++... ...+.....+.++.+++.+||+ +|.+|| +++++.
T Consensus 200 ~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp---~~~~l~ 255 (261)
T cd05034 200 YGRVPYPGMTNREVLEQVERG---YRMPRPPNCPEELYDLMLQCWDKDPEERP---TFEYLQ 255 (261)
T ss_pred CCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCCHHHHHHHHHHcccCcccCC---CHHHHH
Confidence 99999988877777776642 2233334678999999999998 999999 456654
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=326.14 Aligned_cols=249 Identities=22% Similarity=0.377 Sum_probs=207.0
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEE
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~ 182 (510)
+..++|++++.||+|+||.||+|..+ +++.||+|.+.+... ....+.+|+.+++.++||||+++++++. .+..|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 45678999999999999999999865 577899999876432 2356888999999999999999998875 45799
Q ss_pred EEEeccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccc
Q 010463 183 LIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 260 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~ 260 (510)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 999999999999998753 468999999999999999999999999999999999999999999999999997654211
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh-
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI- 339 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~- 339 (510)
.. ......++..|+|||++....++.++|+|||||++|||++
T Consensus 157 ~~-------------------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~ 199 (260)
T cd05067 157 YT-------------------------------------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTY 199 (260)
T ss_pred cc-------------------------------------cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhC
Confidence 00 0012356788999999998999999999999999999999
Q ss_pred CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 340 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 340 G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
|.+||.+.+.......+... ...+....++.++.++|.+||+ +|++|| +++++..
T Consensus 200 g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~l~~ 255 (260)
T cd05067 200 GRIPYPGMTNPEVIQNLERG---YRMPRPDNCPEELYELMRLCWKEKPEERP---TFEYLRS 255 (260)
T ss_pred CCCCCCCCChHHHHHHHHcC---CCCCCCCCCCHHHHHHHHHHccCChhhCC---CHHHHHH
Confidence 99999888776666665432 2223334678999999999998 999999 5566653
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=332.53 Aligned_cols=253 Identities=23% Similarity=0.333 Sum_probs=209.2
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcC-----CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKT-----TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 177 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~-----tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 177 (510)
+..++|++++.||+|+||.||+|.++. ++..||+|++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~ 79 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAV 79 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 345789999999999999999998753 67899999987542 23334668889999999999999999999999
Q ss_pred CceEEEEEeccCCCCHHHHHHhcc----------------------CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCC
Q 010463 178 SDFLYLIMEYLPGGDIMTLLMRED----------------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPD 235 (510)
Q Consensus 178 ~~~~~lVmEy~~gG~L~~~L~~~~----------------------~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~ 235 (510)
...+|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+.|++||||||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ 159 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR 159 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence 999999999999999999997432 3778889999999999999999999999999999
Q ss_pred CeeecCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHh
Q 010463 236 NLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEV 315 (510)
Q Consensus 236 NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEv 315 (510)
|||++.++.++|+|||++..+....... ......+++.|+|||+
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~------------------------------------~~~~~~~~~~y~aPE~ 203 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYK------------------------------------ASENDAIPIRWMPPES 203 (288)
T ss_pred heEecCCCceEECccccceecccCcccc------------------------------------ccCCCccChhhcCHHH
Confidence 9999999999999999987543221000 0011235678999999
Q ss_pred hccCCCCccccccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC
Q 010463 316 LLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR 393 (510)
Q Consensus 316 l~~~~y~~~~DiwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~ 393 (510)
+.+..++.++|+|||||++|||++ |..||.+.+..+....+.... ....| ..++.++.+||.+||+ +|.+||+
T Consensus 204 ~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rpt-- 278 (288)
T cd05050 204 IFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGN-VLSCP--DNCPLELYNLMRLCWSKLPSDRPS-- 278 (288)
T ss_pred HhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-CCCCC--CCCCHHHHHHHHHHcccCcccCCC--
Confidence 999999999999999999999997 889998888777776666432 22223 3688999999999998 9999994
Q ss_pred ChHHhh
Q 010463 394 GVEELK 399 (510)
Q Consensus 394 ~~~eil 399 (510)
++|++
T Consensus 279 -~~el~ 283 (288)
T cd05050 279 -FASIN 283 (288)
T ss_pred -HHHHH
Confidence 56654
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=326.62 Aligned_cols=248 Identities=25% Similarity=0.332 Sum_probs=200.3
Q ss_pred eeecCCCeEEEEEEEc--CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEeccCC
Q 010463 113 LIGKGAFGEVRLCRAK--TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPG 190 (510)
Q Consensus 113 ~IG~G~fG~V~~~~~~--~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy~~g 190 (510)
.||+|+||.||+|.++ .++..||+|++.... .....+.+.+|+.+++.++||||++++++++. ...++||||++|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 3899999999999765 456679999986542 33445678899999999999999999998864 578999999999
Q ss_pred CCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhh
Q 010463 191 GDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDED 269 (510)
Q Consensus 191 G~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~ 269 (510)
|+|.+++.. ...+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||++..+.......
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~------ 152 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY------ 152 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccce------
Confidence 999999875 4578999999999999999999999999999999999999999999999999998653321100
Q ss_pred hhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh-CCCCCCCCC
Q 010463 270 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDD 348 (510)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~-G~~PF~~~~ 348 (510)
.......+++.|+|||++....++.++|+|||||++|||++ |.+||.+..
T Consensus 153 -----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 203 (257)
T cd05115 153 -----------------------------KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK 203 (257)
T ss_pred -----------------------------eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC
Confidence 00001234678999999998899999999999999999996 999998887
Q ss_pred hhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 349 PRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 349 ~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
.......+..+. ....| ...++++.++|.+||. +|++||+...+.+.++.
T Consensus 204 ~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 204 GPEVMSFIEQGK-RLDCP--AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred HHHHHHHHHCCC-CCCCC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 766666555432 23333 4679999999999998 99999954444444433
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=343.67 Aligned_cols=264 Identities=32% Similarity=0.485 Sum_probs=213.5
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecC--ceE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDS--DFL 181 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~--~~~ 181 (510)
.++|++.+.||+|+||.||+|.++.+|+.||+|++.+.. ........+..|+.+++.+ +||||++++++|... ..+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 468999999999999999999999999999999986532 2233445677899999999 999999999998653 478
Q ss_pred EEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 182 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
|+||||++ ++|..++... .+++..++.++.||+.||.|||+.||+||||||+||+++.+|.+||+|||++..+.....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~ 162 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162 (337)
T ss_pred EEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence 99999997 4999988765 789999999999999999999999999999999999999999999999999986643211
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHhhC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIG 340 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml~G 340 (510)
.. ........+||+.|+|||++.+ ..++.++|+|||||++|+|++|
T Consensus 163 ~~---------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg 209 (337)
T cd07852 163 NP---------------------------------ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG 209 (337)
T ss_pred cc---------------------------------cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhC
Confidence 00 0001123579999999998865 5678999999999999999999
Q ss_pred CCCCCCCChhhhHHHHhhcccc-----------------------ccC----CCCCCCCHHHHHHHHHhhc-CccccCCC
Q 010463 341 YPPFCSDDPRITCRKIVNWKTC-----------------------LKF----PEEPKISDEARDLICHLLC-DVETRLGT 392 (510)
Q Consensus 341 ~~PF~~~~~~~~~~~I~~~~~~-----------------------~~~----p~~~~~s~~~~dlI~~lL~-dp~~R~~~ 392 (510)
++||.+........++...... ... ...+.++.++.+||.+||. ||.+||
T Consensus 210 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-- 287 (337)
T cd07852 210 KPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRL-- 287 (337)
T ss_pred CCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCccccc--
Confidence 9999887665554444322110 000 0013478999999999998 999999
Q ss_pred CChHHhhcCCCcCCC
Q 010463 393 RGVEELKEHPWFRGI 407 (510)
Q Consensus 393 ~~~~eil~HpfF~~i 407 (510)
++.++++||||+.+
T Consensus 288 -s~~~il~~~~~~~~ 301 (337)
T cd07852 288 -TAEEALEHPYVAQF 301 (337)
T ss_pred -CHHHHhhChhhhhh
Confidence 78999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=336.22 Aligned_cols=267 Identities=30% Similarity=0.474 Sum_probs=222.7
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhh----cchhhHHHHHHHHHHHHhcCCCCeeeEeEEee-cCc
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEM----LKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ-DSD 179 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~----~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-~~~ 179 (510)
.+.|-++.+||+|||++||+|.+...+++||+|+-....- .+.+-.+|..+|.+|-+.++||-||++|++|. |.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 4578889999999999999999999999999998543221 23345688999999999999999999999997 667
Q ss_pred eEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhC--CeEEeecCCCCeeec---CCCceeecccCCcc
Q 010463 180 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH--NYVHRDIKPDNLILD---KNGHLKLSDFGLCK 254 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~--giiHRDLKP~NILld---~~g~vkL~DFGla~ 254 (510)
..|-|+|||+|.||..+|..+..++|.+|+.++.||+.||.||... .|||-||||.||||- .-|.|||+||||++
T Consensus 542 sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 8999999999999999999999999999999999999999999975 699999999999995 45789999999999
Q ss_pred cCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC----CCCccccccch
Q 010463 255 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK----GYGMECDWWSL 330 (510)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~----~y~~~~DiwSl 330 (510)
.+++....... + -.++....||.+|++||.+.-+ ..+.++||||+
T Consensus 622 IMdddSy~~vd---------------G----------------meLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSv 670 (775)
T KOG1151|consen 622 IMDDDSYNSVD---------------G----------------MELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSV 670 (775)
T ss_pred hccCCccCccc---------------c----------------eeeecccCceeeecCcceeecCCCCCccccceeeEee
Confidence 98765322100 0 0123346899999999998643 35899999999
Q ss_pred hhHHHHHhhCCCCCCCCChhh---hHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 331 GAIMYEMLIGYPPFCSDDPRI---TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 331 GvilyEml~G~~PF~~~~~~~---~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
|||+|.+|.|+.||..+.... ....|++. ....||..+.+|+++++||++||. .-+.|. ++.++-.||+|..
T Consensus 671 GVIFyQClYGrKPFGhnqsQQdILqeNTIlkA-tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~---DV~qLA~dpyllP 746 (775)
T KOG1151|consen 671 GVIFYQCLYGRKPFGHNQSQQDILQENTILKA-TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRI---DVQQLACDPYLLP 746 (775)
T ss_pred ehhhhhhhccCCCCCCchhHHHHHhhhchhcc-eeccCCCCCccCHHHHHHHHHHHHhhhhhhh---hHHHHccCccccc
Confidence 999999999999997653322 23345543 467899989999999999999998 888898 7999999999853
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=324.52 Aligned_cols=245 Identities=23% Similarity=0.378 Sum_probs=209.5
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEE
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~ 182 (510)
+..++|++.+.||.|+||.||+|... |+.||+|.+..... ..+++.+|..++..++||||+++++++.+.+..|
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence 45678999999999999999999764 88999999975532 4677899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccc
Q 010463 183 LIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 260 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~ 260 (510)
+||||+++|+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||+++.+|.+||+|||+++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 9999999999999998765 79999999999999999999999999999999999999999999999999998653210
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh-
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI- 339 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~- 339 (510)
....++..|+|||++....++.++|+|||||++|||++
T Consensus 157 -----------------------------------------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~ 195 (256)
T cd05039 157 -----------------------------------------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSF 195 (256)
T ss_pred -----------------------------------------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhc
Confidence 01235667999999998889999999999999999997
Q ss_pred CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 340 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 340 G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
|..||...+.......+... .....| ..+++.+.++|.+||. +|++|| ++.++++
T Consensus 196 g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~l~~ 251 (256)
T cd05039 196 GRVPYPRIPLKDVVPHVEKG-YRMEAP--EGCPPEVYKVMKDCWELDPAKRP---TFKQLRE 251 (256)
T ss_pred CCCCCCCCCHHHHHHHHhcC-CCCCCc--cCCCHHHHHHHHHHhccChhhCc---CHHHHHH
Confidence 99999887766655555432 122333 3678999999999998 999999 5677664
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=334.04 Aligned_cols=255 Identities=20% Similarity=0.344 Sum_probs=205.2
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCC--------------CEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCee
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTG--------------EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIV 169 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg--------------~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv 169 (510)
..++|++.+.||+|+||.||+|++..++ ..||+|+++... .......+.+|+++|..++||||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcC
Confidence 3468999999999999999999876432 359999987532 234456789999999999999999
Q ss_pred eEeEEeecCceEEEEEeccCCCCHHHHHHhcc------------CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCe
Q 010463 170 QLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNL 237 (510)
Q Consensus 170 ~l~~~~~~~~~~~lVmEy~~gG~L~~~L~~~~------------~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NI 237 (510)
++++++...+.+|+||||++||+|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 99999999999999999999999999986532 367888899999999999999999999999999999
Q ss_pred eecCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc
Q 010463 238 ILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL 317 (510)
Q Consensus 238 Lld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~ 317 (510)
|++.++.+||+|||++..+...... .......+++.|+|||++.
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~~ 204 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYY------------------------------------RIQGRAVLPIRWMAWESIL 204 (295)
T ss_pred EEcCCCcEEecccccccccccCcce------------------------------------eccCcCcCceeecChhhhc
Confidence 9999999999999999765322100 0011235678999999999
Q ss_pred cCCCCccccccchhhHHHHHhh--CCCCCCCCChhhhHHHHhhcc----ccccCCCCCCCCHHHHHHHHHhhc-CccccC
Q 010463 318 KKGYGMECDWWSLGAIMYEMLI--GYPPFCSDDPRITCRKIVNWK----TCLKFPEEPKISDEARDLICHLLC-DVETRL 390 (510)
Q Consensus 318 ~~~y~~~~DiwSlGvilyEml~--G~~PF~~~~~~~~~~~I~~~~----~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~ 390 (510)
+..++.++|+|||||++|||++ |..||...+.......+.... ........+.+++.+.+||.+||. ||++||
T Consensus 205 ~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP 284 (295)
T cd05097 205 LGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRP 284 (295)
T ss_pred cCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCc
Confidence 9999999999999999999988 778998776665554443210 111122234678999999999998 999999
Q ss_pred CCCChHHhh
Q 010463 391 GTRGVEELK 399 (510)
Q Consensus 391 ~~~~~~eil 399 (510)
++++|+
T Consensus 285 ---s~~~i~ 290 (295)
T cd05097 285 ---TFNKIH 290 (295)
T ss_pred ---CHHHHH
Confidence 566664
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=327.63 Aligned_cols=242 Identities=25% Similarity=0.408 Sum_probs=199.8
Q ss_pred eeeecCCCeEEEEEEEcCCCCE--EEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCceEEEEEecc
Q 010463 112 TLIGKGAFGEVRLCRAKTTGEI--FAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLYLIMEYL 188 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~tg~~--vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~~lVmEy~ 188 (510)
+.||+|+||.||+|+.+.+|.. +|+|.++.. ........+.+|+.++..+ +||||+++++++...+.+|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 3689999999999999888864 688887642 2334456788999999999 8999999999999999999999999
Q ss_pred CCCCHHHHHHhcc----------------CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCC
Q 010463 189 PGGDIMTLLMRED----------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGL 252 (510)
Q Consensus 189 ~gG~L~~~L~~~~----------------~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGl 252 (510)
++|+|.+++.... .+++..++.++.|++.||+|||+.|++||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999997643 478899999999999999999999999999999999999999999999999
Q ss_pred cccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhh
Q 010463 253 CKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGA 332 (510)
Q Consensus 253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGv 332 (510)
+........ .....+++.|+|||++....++.++|+|||||
T Consensus 159 ~~~~~~~~~---------------------------------------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~ 199 (270)
T cd05047 159 SRGQEVYVK---------------------------------------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGV 199 (270)
T ss_pred ccccchhhh---------------------------------------ccCCCCccccCChHHHccCCCCchhhHHHHHH
Confidence 863221100 00123467899999999999999999999999
Q ss_pred HHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 333 IMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 333 ilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
++|||++ |..||.+.+....+..+... .....+ ..++.++.+|+.+|+. +|.+|| ++.+++.
T Consensus 200 il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~ 263 (270)
T cd05047 200 LLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKP--LNCDDEVYDLMRQCWREKPYERP---SFAQILV 263 (270)
T ss_pred HHHHHHcCCCCCccccCHHHHHHHHhCC-CCCCCC--CcCCHHHHHHHHHHcccChhhCC---CHHHHHH
Confidence 9999997 99999887777666666432 122223 3678999999999998 999999 5677664
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=340.18 Aligned_cols=261 Identities=29% Similarity=0.409 Sum_probs=209.3
Q ss_pred CceeeeeeecCCCeEEEEEEEcCC--CCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEee----cCc
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTT--GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQ----DSD 179 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~t--g~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~----~~~ 179 (510)
+|++.+.||+|+||.||+|+...+ +..||+|++.... ........+.+|+.++..+ +||||+++++.+. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 488999999999999999999988 9999999986432 2223345678899999988 6999999998643 235
Q ss_pred eEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 180 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
.+|++|||+. ++|..++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||+++.+...
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 6899999996 699999988888999999999999999999999999999999999999999999999999999865432
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml 338 (510)
.... .......+||+.|+|||++.+ ..++.++|+|||||++|+|+
T Consensus 159 ~~~~----------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~ 204 (332)
T cd07857 159 PGEN----------------------------------AGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL 204 (332)
T ss_pred cccc----------------------------------cccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 1100 000123579999999998875 57899999999999999999
Q ss_pred hCCCCCCCCChhhhHHHHhhccc--------------------------cccCC-CCCCCCHHHHHHHHHhhc-CccccC
Q 010463 339 IGYPPFCSDDPRITCRKIVNWKT--------------------------CLKFP-EEPKISDEARDLICHLLC-DVETRL 390 (510)
Q Consensus 339 ~G~~PF~~~~~~~~~~~I~~~~~--------------------------~~~~p-~~~~~s~~~~dlI~~lL~-dp~~R~ 390 (510)
+|.+||.+.+.......++..-. ...++ ..+.++..+.+||.+||+ ||.+||
T Consensus 205 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 284 (332)
T cd07857 205 GRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRI 284 (332)
T ss_pred hCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCC
Confidence 99999987664444333322100 00111 123568899999999998 999999
Q ss_pred CCCChHHhhcCCCcCC
Q 010463 391 GTRGVEELKEHPWFRG 406 (510)
Q Consensus 391 ~~~~~~eil~HpfF~~ 406 (510)
++.+++.||||+.
T Consensus 285 ---t~~~ll~~~~~~~ 297 (332)
T cd07857 285 ---SVEEALEHPYLAI 297 (332)
T ss_pred ---CHHHHhcChhhhh
Confidence 7899999999964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=316.51 Aligned_cols=263 Identities=25% Similarity=0.419 Sum_probs=216.8
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc--
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD-- 179 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-- 179 (510)
.++.++|.+.+.||.|||+-|++|+.-.+++.||+|++... +.++++..++|++.-++++||||++++++...+.
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~---~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH---SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc---chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 35667899999999999999999999999999999999765 3567888999999999999999999998765443
Q ss_pred ---eEEEEEeccCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHhhhhCC--eEEeecCCCCeeecCCCceeeccc
Q 010463 180 ---FLYLIMEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQHN--YVHRDIKPDNLILDKNGHLKLSDF 250 (510)
Q Consensus 180 ---~~~lVmEy~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~lH~~g--iiHRDLKP~NILld~~g~vkL~DF 250 (510)
..|++++|...|+|.+.+.. ...++|.++..|+.+|+.||++||+.. ++||||||.|||+.++|.++|.||
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 49999999999999998864 347999999999999999999999998 999999999999999999999999
Q ss_pred CCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCC---CCccccc
Q 010463 251 GLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG---YGMECDW 327 (510)
Q Consensus 251 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~---y~~~~Di 327 (510)
|.++...-.. .......+++.|... ..|..|.|||.+.-+. .+.++||
T Consensus 174 GS~~~a~i~i---------------------~~~~~a~~lQe~a~e--------~Ct~pyRAPELf~vk~~~ti~ertDI 224 (302)
T KOG2345|consen 174 GSATQAPIQI---------------------EGSRQALRLQEWAEE--------RCTIPYRAPELFNVKSHCTITERTDI 224 (302)
T ss_pred cCccccceEe---------------------echHHHHHHHHHHHH--------hCCCcccCchheecccCcccccccch
Confidence 9998654321 112233455666432 3688899999997544 4889999
Q ss_pred cchhhHHHHHhhCCCCCCCCCh--hhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 328 WSLGAIMYEMLIGYPPFCSDDP--RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 328 wSlGvilyEml~G~~PF~~~~~--~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
|||||+||+|+.|..||.-.-. ......+.+ ..+.+|....+|..+..||+.||+ ||.+|| ++.+++.+
T Consensus 225 WSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n--~q~s~P~~~~yse~l~~lik~mlqvdP~qRP---~i~~ll~~ 296 (302)
T KOG2345|consen 225 WSLGCTLYAMMFGESPFERIYQQGGSLALAVQN--AQISIPNSSRYSEALHQLIKSMLQVDPNQRP---TIPELLSK 296 (302)
T ss_pred hhhhHHHHHHHHcCCcchHHhhcCCeEEEeeec--cccccCCCCCccHHHHHHHHHHhcCCcccCC---CHHHHHHH
Confidence 9999999999999999953211 111222333 357788878899999999999998 999999 56777753
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=331.80 Aligned_cols=254 Identities=33% Similarity=0.536 Sum_probs=213.1
Q ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEec
Q 010463 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEY 187 (510)
Q Consensus 108 f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy 187 (510)
|++.+.||+|+||.||+|+...+++.||+|++.... ......+.+..|+.+++.++||||+++++++.+.+.+|+||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 677889999999999999999999999999998754 2233446678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccch
Q 010463 188 LPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 266 (510)
Q Consensus 188 ~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~ 266 (510)
++ ++|.+++.+. ..+++..+..++.+++.||.+||+.||+||||+|+||+++.+|.++|+|||+++........
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~---- 154 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT---- 154 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc----
Confidence 98 4899999876 57999999999999999999999999999999999999999999999999999865432100
Q ss_pred hhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC-CCCccccccchhhHHHHHhhCCCCCC
Q 010463 267 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEMLIGYPPFC 345 (510)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiwSlGvilyEml~G~~PF~ 345 (510)
.....+++.|+|||++.+. .++.++|+|||||++|||++|.+||.
T Consensus 155 ----------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~ 200 (282)
T cd07829 155 ----------------------------------YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFP 200 (282)
T ss_pred ----------------------------------cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 1123578889999999876 78999999999999999999999998
Q ss_pred CCChhhhHHHHhhccc----------------cccCCC---------CCCCCHHHHHHHHHhhc-CccccCCCCChHHhh
Q 010463 346 SDDPRITCRKIVNWKT----------------CLKFPE---------EPKISDEARDLICHLLC-DVETRLGTRGVEELK 399 (510)
Q Consensus 346 ~~~~~~~~~~I~~~~~----------------~~~~p~---------~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil 399 (510)
+.+....+.++...-. ...+|. .+.++..+.++|.+||. ||++|| ++++++
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp---~~~~~l 277 (282)
T cd07829 201 GDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRI---SAKEAL 277 (282)
T ss_pred CccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCC---CHHHHh
Confidence 8876665555442100 001111 12458899999999998 999999 789999
Q ss_pred cCCCc
Q 010463 400 EHPWF 404 (510)
Q Consensus 400 ~HpfF 404 (510)
.||||
T Consensus 278 ~~p~~ 282 (282)
T cd07829 278 KHPYF 282 (282)
T ss_pred hCcCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=329.40 Aligned_cols=253 Identities=20% Similarity=0.323 Sum_probs=204.0
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCE----EEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEI----FAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 178 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~----vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 178 (510)
+..++|++++.||+|+||+||+|.+..+|+. ||+|.+... ........+..|..++..++||||+++++++..
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~- 80 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG- 80 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-
Confidence 4557899999999999999999999888875 666665422 122334567778888999999999999998764
Q ss_pred ceEEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCc
Q 010463 179 DFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 257 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~ 257 (510)
...++||||+++|+|.+++... +.+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++.+.
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 5678999999999999999764 578999999999999999999999999999999999999999999999999998653
Q ss_pred cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHH
Q 010463 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337 (510)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEm 337 (510)
..... .......|+..|+|||++.+..++.++|+|||||++|||
T Consensus 161 ~~~~~------------------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el 204 (279)
T cd05111 161 PDDKK------------------------------------YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEM 204 (279)
T ss_pred CCCcc------------------------------------cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHH
Confidence 32100 001124577889999999988999999999999999999
Q ss_pred hh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 338 LI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 338 l~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
++ |..||.+.........+.+. .....| ...+.++.+++.+|+. ||.+|| ++.|+++
T Consensus 205 ~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~c~~~~p~~Rp---s~~el~~ 263 (279)
T cd05111 205 MSYGAEPYAGMRPHEVPDLLEKG-ERLAQP--QICTIDVYMVMVKCWMIDENVRP---TFKELAN 263 (279)
T ss_pred HcCCCCCCCCCCHHHHHHHHHCC-CcCCCC--CCCCHHHHHHHHHHcCCCcccCc---CHHHHHH
Confidence 98 99999887765544444332 222222 3567889999999998 999999 5777764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=331.84 Aligned_cols=254 Identities=22% Similarity=0.377 Sum_probs=204.5
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcC----------------CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCe
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKT----------------TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCI 168 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~----------------tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~I 168 (510)
.++|++.+.||+|+||.||+|++.. ++..||+|++.... .......+.+|+.+|+.++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 3579999999999999999986543 34579999987542 23345678899999999999999
Q ss_pred eeEeEEeecCceEEEEEeccCCCCHHHHHHhcc-----------CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCe
Q 010463 169 VQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED-----------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNL 237 (510)
Q Consensus 169 v~l~~~~~~~~~~~lVmEy~~gG~L~~~L~~~~-----------~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NI 237 (510)
+++++++.+.+..|+||||++||+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 999999999999999999999999999987643 367788999999999999999999999999999999
Q ss_pred eecCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc
Q 010463 238 ILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL 317 (510)
Q Consensus 238 Lld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~ 317 (510)
|++.++.++|+|||+++.+...... .......+++.|+|||+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~~pe~~~ 205 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYY------------------------------------RIQGRAVLPIRWMSWESIL 205 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcce------------------------------------eccCcCcCccccCCHHHHh
Confidence 9999999999999999865332100 0001234578899999999
Q ss_pred cCCCCccccccchhhHHHHHhh--CCCCCCCCChhhhHHHHhhc----cccccCCCCCCCCHHHHHHHHHhhc-CccccC
Q 010463 318 KKGYGMECDWWSLGAIMYEMLI--GYPPFCSDDPRITCRKIVNW----KTCLKFPEEPKISDEARDLICHLLC-DVETRL 390 (510)
Q Consensus 318 ~~~y~~~~DiwSlGvilyEml~--G~~PF~~~~~~~~~~~I~~~----~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~ 390 (510)
+..++.++|+|||||++|||++ |..||...+..+...+.... ......|....+++.+.+||.+||. ||.+||
T Consensus 206 ~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp 285 (296)
T cd05095 206 LGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERP 285 (296)
T ss_pred cCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCC
Confidence 8899999999999999999998 78999877665544433211 1112234345678999999999998 999999
Q ss_pred CCCChHHhh
Q 010463 391 GTRGVEELK 399 (510)
Q Consensus 391 ~~~~~~eil 399 (510)
+ +.+|.
T Consensus 286 ~---~~~i~ 291 (296)
T cd05095 286 S---FQEIH 291 (296)
T ss_pred C---HHHHH
Confidence 4 55554
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=338.29 Aligned_cols=257 Identities=19% Similarity=0.311 Sum_probs=211.2
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCC-------CCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEe
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTT-------GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLF 172 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t-------g~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~ 172 (510)
..+...+|++.+.||+|+||.||+|++... +..||+|++.... .......+.+|+.++..+ +||||++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLL 84 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence 445556899999999999999999986432 2369999886432 334567789999999999 899999999
Q ss_pred EEeecCceEEEEEeccCCCCHHHHHHhcc----------------CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCC
Q 010463 173 YSFQDSDFLYLIMEYLPGGDIMTLLMRED----------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDN 236 (510)
Q Consensus 173 ~~~~~~~~~~lVmEy~~gG~L~~~L~~~~----------------~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~N 236 (510)
++|.+.+.+|+||||+++|+|.++|.+.. .++...+..++.||+.||.|||+.||+||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 164 (334)
T cd05100 85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARN 164 (334)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccce
Confidence 99999999999999999999999997532 36778888999999999999999999999999999
Q ss_pred eeecCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhh
Q 010463 237 LILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL 316 (510)
Q Consensus 237 ILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl 316 (510)
||++.++.+||+|||+++......... ......+++.|+|||++
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~------------------------------------~~~~~~~~~~y~aPE~~ 208 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYK------------------------------------KTTNGRLPVKWMAPEAL 208 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccc------------------------------------cccCCCcCceEcCHHHh
Confidence 999999999999999998654321000 00112356789999999
Q ss_pred ccCCCCccccccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCC
Q 010463 317 LKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRG 394 (510)
Q Consensus 317 ~~~~y~~~~DiwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~ 394 (510)
.+..++.++|||||||++|||++ |.+||.+.+.......+.... ....| ..++.++.+||.+||. +|.+|| +
T Consensus 209 ~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~cl~~~p~~Rp---s 282 (334)
T cd05100 209 FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGH-RMDKP--ANCTHELYMIMRECWHAVPSQRP---T 282 (334)
T ss_pred ccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCC--CCCCHHHHHHHHHHcccChhhCc---C
Confidence 99999999999999999999998 899999888777776665432 22233 3678999999999998 999999 6
Q ss_pred hHHhhcC
Q 010463 395 VEELKEH 401 (510)
Q Consensus 395 ~~eil~H 401 (510)
+.+++++
T Consensus 283 ~~ell~~ 289 (334)
T cd05100 283 FKQLVED 289 (334)
T ss_pred HHHHHHH
Confidence 7888865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=327.38 Aligned_cols=253 Identities=30% Similarity=0.459 Sum_probs=212.0
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhc--chhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML--KRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
.|.+.+.||+|+||.||+|++..++..+++|+++..... .......+..|..+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 478899999999999999999888888888877643321 223345577899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccc
Q 010463 185 MEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 260 (510)
Q Consensus 185 mEy~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~ 260 (510)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++. +.++|+|||+++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999998864 356899999999999999999999999999999999999975 679999999987653321
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhC
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 340 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G 340 (510)
. ......|++.|+|||.+.+..++.++|+||||+++|+|++|
T Consensus 160 ~--------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~ 201 (260)
T cd08222 160 D--------------------------------------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCL 201 (260)
T ss_pred c--------------------------------------cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhC
Confidence 0 01134689999999999888899999999999999999999
Q ss_pred CCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 341 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 341 ~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
..||.+.+......++.... ....| ..++.++.++|.+||. +|++|| ++++|++||||
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~ 260 (260)
T cd08222 202 AHAFEGQNFLSVVLRIVEGP-TPSLP--ETYSRQLNSIMQSMLNKDPSLRP---SAAEILRNPFI 260 (260)
T ss_pred CCCCCCccHHHHHHHHHcCC-CCCCc--chhcHHHHHHHHHHhcCChhhCc---CHHHHhhCCCC
Confidence 99998777666666665421 12222 3678999999999998 999999 78999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=321.61 Aligned_cols=248 Identities=26% Similarity=0.386 Sum_probs=211.8
Q ss_pred ceeeeeeecCCCeEEEEEEEcCCC----CEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEE
Q 010463 108 FEQLTLIGKGAFGEVRLCRAKTTG----EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 108 f~~~~~IG~G~fG~V~~~~~~~tg----~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l 183 (510)
|++++.||.|+||.||+|++..++ ..||+|++.... .......+..|+.+|..++||||+++++++.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 467889999999999999998876 899999996543 22256789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhccC--CCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 184 IMEYLPGGDIMTLLMREDI--LSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~~~~--l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
||||++||+|.+++..... +++..+..++.|++.||++||+.|++||||||+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999999977554 99999999999999999999999999999999999999999999999999986543210
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh-C
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-G 340 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~-G 340 (510)
.. .....+++.|+|||.+.+..++.++|+|||||++|+|++ |
T Consensus 159 ~~-------------------------------------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g 201 (258)
T smart00219 159 YK-------------------------------------KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLG 201 (258)
T ss_pred cc-------------------------------------cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCC
Confidence 00 001237889999999988889999999999999999998 8
Q ss_pred CCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 341 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 341 ~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
.+||.+.+.......+.... ....+ ..++.++.+++.+||+ +|++|| ++.++++
T Consensus 202 ~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~i~~~l~~~p~~Rp---t~~~ll~ 256 (258)
T smart00219 202 ESPYPGMSNEEVLEYLKKGY-RLPKP--ENCPPEIYKLMLQCWAEDPEDRP---TFSELVE 256 (258)
T ss_pred CCCCCCCCHHHHHHHHhcCC-CCCCC--CcCCHHHHHHHHHHCcCChhhCc---CHHHHHh
Confidence 99998887777777776543 22233 3589999999999999 999999 6788774
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=323.31 Aligned_cols=246 Identities=20% Similarity=0.362 Sum_probs=206.0
Q ss_pred eeeecCCCeEEEEEEEcC-CCC--EEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEecc
Q 010463 112 TLIGKGAFGEVRLCRAKT-TGE--IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYL 188 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~-tg~--~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy~ 188 (510)
+.||+|+||.||+|.+.. .++ .||+|.+...... ...+.+..|+.+++.++||||+++++.+.+ ..+++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999865 333 6999999876432 566789999999999999999999999998 8999999999
Q ss_pred CCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccch
Q 010463 189 PGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 266 (510)
Q Consensus 189 ~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~ 266 (510)
++|+|.+++.... .+++..++.++.|++.||.|||+.|++||||||+|||++.++.+||+|||+++.+.......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~--- 154 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY--- 154 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccce---
Confidence 9999999997754 68999999999999999999999999999999999999999999999999998764321100
Q ss_pred hhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh-CCCCCC
Q 010463 267 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPFC 345 (510)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~-G~~PF~ 345 (510)
.......|+..|+|||++.+..++.++|+|||||++|||++ |.+||.
T Consensus 155 --------------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 202 (257)
T cd05040 155 --------------------------------VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWA 202 (257)
T ss_pred --------------------------------ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 00012457889999999999999999999999999999998 999998
Q ss_pred CCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 346 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 346 ~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
..+..+....+.........| ..++..+.++|.+||+ +|++|| ++.++++
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~~~~~ 253 (257)
T cd05040 203 GLSGSQILKKIDKEGERLERP--EACPQDIYNVMLQCWAHNPADRP---TFAALRE 253 (257)
T ss_pred CCCHHHHHHHHHhcCCcCCCC--ccCCHHHHHHHHHHCCCCcccCC---CHHHHHH
Confidence 877777666665422223333 3678999999999998 999999 5667653
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=330.01 Aligned_cols=250 Identities=22% Similarity=0.342 Sum_probs=205.4
Q ss_pred CceeeeeeecCCCeEEEEEEEcC-----CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceE
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKT-----TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 181 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~-----tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~ 181 (510)
+|++.+.||+|+||.||+|.... ....+|+|.+.+.. .......+.+|+.+|+.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 57889999999999999998753 33579999886542 233456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhc------------------------cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCe
Q 010463 182 YLIMEYLPGGDIMTLLMRE------------------------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNL 237 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~------------------------~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NI 237 (510)
|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999998642 2478889999999999999999999999999999999
Q ss_pred eecCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc
Q 010463 238 ILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL 317 (510)
Q Consensus 238 Lld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~ 317 (510)
|+++++.+||+|||+++......... ......++..|+|||++.
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~------------------------------------~~~~~~~~~~y~apE~~~ 202 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYV------------------------------------KRSKGRIPVKWMAIESLF 202 (290)
T ss_pred EEcCCCcEEeccccccccccCccchh------------------------------------cccCCCCCccccCHHHHc
Confidence 99999999999999998653221000 001235678899999999
Q ss_pred cCCCCccccccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCh
Q 010463 318 KKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGV 395 (510)
Q Consensus 318 ~~~y~~~~DiwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~ 395 (510)
+..++.++|+|||||++|||++ |.+||.+..+......+... ...+....++.++.+||.+||. +|.+|| ++
T Consensus 203 ~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp---~~ 276 (290)
T cd05045 203 DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTG---YRMERPENCSEEMYNLMLTCWKQEPDKRP---TF 276 (290)
T ss_pred cCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC---CCCCCCCCCCHHHHHHHHHHccCCcccCC---CH
Confidence 8899999999999999999998 99999888777666554432 2222234789999999999998 999999 56
Q ss_pred HHhhc
Q 010463 396 EELKE 400 (510)
Q Consensus 396 ~eil~ 400 (510)
.++++
T Consensus 277 ~~i~~ 281 (290)
T cd05045 277 ADISK 281 (290)
T ss_pred HHHHH
Confidence 66653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=323.39 Aligned_cols=248 Identities=22% Similarity=0.360 Sum_probs=204.9
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEE
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~ 182 (510)
+..++|++...||+|+||.||+|.+..++ .+|+|.+..... ..+.+.+|+.+++.++||||+++++++. .+..|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIY 76 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcE
Confidence 34467999999999999999999887654 589998865432 2345788999999999999999998885 45689
Q ss_pred EEEeccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccc
Q 010463 183 LIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 260 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~ 260 (510)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||+++++.++|+|||+++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 999999999999999764 347899999999999999999999999999999999999999999999999997654321
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh-
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI- 339 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~- 339 (510)
.. ......++..|+|||++.+..++.++|+|||||++|||++
T Consensus 157 ~~-------------------------------------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~ 199 (260)
T cd05069 157 YT-------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTK 199 (260)
T ss_pred cc-------------------------------------ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhC
Confidence 00 0012346788999999998889999999999999999999
Q ss_pred CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhh
Q 010463 340 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 399 (510)
Q Consensus 340 G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil 399 (510)
|.+||.+.+.......+... ...+....++..++++|++||. ||.+|| ++++++
T Consensus 200 g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~i~ 254 (260)
T cd05069 200 GRVPYPGMVNREVLEQVERG---YRMPCPQGCPESLHELMKLCWKKDPDERP---TFEYIQ 254 (260)
T ss_pred CCCCCCCCCHHHHHHHHHcC---CCCCCCcccCHHHHHHHHHHccCCcccCc---CHHHHH
Confidence 99999988877777666542 2222234688999999999998 999999 456654
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=326.06 Aligned_cols=249 Identities=24% Similarity=0.327 Sum_probs=193.8
Q ss_pred eeeecCCCeEEEEEEEcC--CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEeccC
Q 010463 112 TLIGKGAFGEVRLCRAKT--TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLP 189 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~--tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy~~ 189 (510)
+.||+|+||+||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++++.+...+|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 368999999999997543 34568888775432 23334567889999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 190 GGDIMTLLMRED-----ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 190 gG~L~~~L~~~~-----~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
+|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~- 157 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI- 157 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhee-
Confidence 999999997643 34678889999999999999999999999999999999999999999999987532210000
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-------CCCCccccccchhhHHHHH
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-------KGYGMECDWWSLGAIMYEM 337 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-------~~y~~~~DiwSlGvilyEm 337 (510)
......+++.|+|||++.. ..++.++|||||||++|||
T Consensus 158 -----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el 202 (269)
T cd05042 158 -----------------------------------TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202 (269)
T ss_pred -----------------------------------ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHH
Confidence 0012457788999999853 3568899999999999999
Q ss_pred hh-CCCCCCCCChhhhHHHHhhccccccCCC---CCCCCHHHHHHHHHhhcCccccCCCCChHHhh
Q 010463 338 LI-GYPPFCSDDPRITCRKIVNWKTCLKFPE---EPKISDEARDLICHLLCDVETRLGTRGVEELK 399 (510)
Q Consensus 338 l~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~---~~~~s~~~~dlI~~lL~dp~~R~~~~~~~eil 399 (510)
++ |.+||......+...+++... ...+|. ...++....+++..|+.||++||+...+.+++
T Consensus 203 ~~~~~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 203 FTAADQPYPDLSDEQVLKQVVREQ-DIKLPKPQLDLKYSDRWYEVMQFCWLDPETRPTAEEVHELL 267 (269)
T ss_pred HhCCCCCCCcCCHHHHHHHHhhcc-CccCCCCcccccCCHHHHHHHHHHhcCcccccCHHHHHHHh
Confidence 99 889998877666665554321 222222 23678889999998888999999544344443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=327.92 Aligned_cols=253 Identities=24% Similarity=0.408 Sum_probs=202.5
Q ss_pred CceeeeeeecCCCeEEEEEEE----cCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC--ce
Q 010463 107 DFEQLTLIGKGAFGEVRLCRA----KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS--DF 180 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~----~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~ 180 (510)
-|++++.||+|+||.||+|+. +.++..||+|.++... .......+.+|+.+|+.++||||+++++++.+. ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 478899999999999999974 4678899999986442 234456789999999999999999999999875 67
Q ss_pred EEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 181 LYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
.++||||++||+|.+++.+. ..+++..+..++.||+.||+|||+.||+||||||+|||++.+|.++|+|||+++.+...
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 99999999999999999664 45899999999999999999999999999999999999999999999999999865432
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~ 339 (510)
.... .......|+..|+|||++.+..++.++|+|||||++|||++
T Consensus 163 ~~~~-----------------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt 207 (284)
T cd05079 163 KEYY-----------------------------------TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207 (284)
T ss_pred ccce-----------------------------------eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhc
Confidence 1100 00113457888999999998899999999999999999999
Q ss_pred CCCCCCCCCh--------------hhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 340 GYPPFCSDDP--------------RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 340 G~~PF~~~~~--------------~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
|..|+..... .......++. ....|....++..+.+||.+||+ +|.+|| ++++++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~~il~~ 279 (284)
T cd05079 208 YCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE--GKRLPRPPNCPEEVYQLMRKCWEFQPSKRT---TFQNLIEG 279 (284)
T ss_pred CCCCCccccchhhhhcccccccccHHHHHHHHHc--CccCCCCCCCCHHHHHHHHHHccCCcccCc---CHHHHHHH
Confidence 8877643211 0111111211 11233335789999999999998 999999 67887753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=329.54 Aligned_cols=252 Identities=33% Similarity=0.532 Sum_probs=208.3
Q ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEeEEeecCceEEEEEe
Q 010463 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSDFLYLIME 186 (510)
Q Consensus 108 f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~~~lVmE 186 (510)
|.+.+.||.|+||+||+|....+++.||||.+.+... . .......+|...+..++ ||||+++++++.+++..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~-~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY-S-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc-c-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 6788999999999999999999999999999875432 1 12223456888999998 9999999999999999999999
Q ss_pred ccCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 187 YLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 187 y~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
|+ +|+|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+++.......
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--- 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC---
Confidence 99 889999987765 789999999999999999999999999999999999999999999999999986543210
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHhhCCCC
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYPP 343 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml~G~~P 343 (510)
....+|+..|+|||++.+ ..++.++|+|||||++|||++|++|
T Consensus 155 ------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~ 198 (283)
T cd07830 155 ------------------------------------YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPL 198 (283)
T ss_pred ------------------------------------cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCc
Confidence 113468999999998854 4579999999999999999999999
Q ss_pred CCCCChhhhHHHHhhccccc-----------------cCCC---------CCCCCHHHHHHHHHhhc-CccccCCCCChH
Q 010463 344 FCSDDPRITCRKIVNWKTCL-----------------KFPE---------EPKISDEARDLICHLLC-DVETRLGTRGVE 396 (510)
Q Consensus 344 F~~~~~~~~~~~I~~~~~~~-----------------~~p~---------~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~ 396 (510)
|.+.+......++...-... .++. .+..+.++.+||++||+ +|.+|| +++
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp---t~~ 275 (283)
T cd07830 199 FPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRP---TAS 275 (283)
T ss_pred cCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCC---CHH
Confidence 98877666655544311110 0000 01346889999999998 999999 689
Q ss_pred HhhcCCCc
Q 010463 397 ELKEHPWF 404 (510)
Q Consensus 397 eil~HpfF 404 (510)
|++.||||
T Consensus 276 ei~~~~~~ 283 (283)
T cd07830 276 QALQHPYF 283 (283)
T ss_pred HHhhCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=326.59 Aligned_cols=250 Identities=23% Similarity=0.374 Sum_probs=197.1
Q ss_pred ceeeeeeecCCCeEEEEEE----EcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC--ceE
Q 010463 108 FEQLTLIGKGAFGEVRLCR----AKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS--DFL 181 (510)
Q Consensus 108 f~~~~~IG~G~fG~V~~~~----~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~~ 181 (510)
|.+++.||+|+||+||++. ...++..||+|++.... .......+.+|+++|+.++||||+++++++... ..+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 3889999999999998865 34578899999987542 223456688899999999999999999987653 468
Q ss_pred EEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 182 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
|+||||+++|+|.+++... .+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 84 ~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred EEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 9999999999999998764 599999999999999999999999999999999999999999999999999986643211
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~ 341 (510)
.. .......++..|+|||++.+..++.++|||||||++|||++|.
T Consensus 163 ~~-----------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~ 207 (283)
T cd05080 163 YY-----------------------------------RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHC 207 (283)
T ss_pred hh-----------------------------------ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCC
Confidence 00 0001134667799999999888999999999999999999999
Q ss_pred CCCCCCChhh--------------hHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 342 PPFCSDDPRI--------------TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 342 ~PF~~~~~~~--------------~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
.||....... .....+... ...|....++.++.+++.+||. +|++|| ++++++.
T Consensus 208 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rp---s~~~i~~ 276 (283)
T cd05080 208 DSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG--MRLPCPKNCPQEVYILMKNCWETEAKFRP---TFRSLIP 276 (283)
T ss_pred CCCCCCcchhhhhhcccccccchhhhhhhhhcC--CCCCCCCCCCHHHHHHHHHHhccChhhCC---CHHHHHH
Confidence 9986543211 001111111 1122224678999999999998 999999 5566653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=326.25 Aligned_cols=264 Identities=27% Similarity=0.448 Sum_probs=211.5
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCC----EEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec-Cc
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGE----IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD-SD 179 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~----~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~~ 179 (510)
...|+.++.||+|.||.||+|..+.++. .||||.++...- ...-.....+|+.+++.++||||+.|..+|.. +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 3579999999999999999996665543 699999865421 11223457889999999999999999999987 88
Q ss_pred eEEEEEeccCCCCHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCC----Cceeeccc
Q 010463 180 FLYLIMEYLPGGDIMTLLMR-----EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN----GHLKLSDF 250 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~-----~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~----g~vkL~DF 250 (510)
.++|++||.+. ||...|.- ...++...++.++.||+.|++|||+.-|+||||||.|||+..+ |.|||+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999999977 99988853 2468999999999999999999999999999999999999877 89999999
Q ss_pred CCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccc
Q 010463 251 GLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWS 329 (510)
Q Consensus 251 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwS 329 (510)
|+++.+...-.+.. ....+|-|.+|.|||.+.+ ..|+.++|+||
T Consensus 181 GlaR~~~~plkpl~-----------------------------------s~d~VVVTiWYRAPELLLGa~hYT~AiDvWA 225 (438)
T KOG0666|consen 181 GLARLFNNPLKPLA-----------------------------------SLDPVVVTIWYRAPELLLGARHYTKAIDVWA 225 (438)
T ss_pred cHHHHhhccccccc-----------------------------------cCCceEEEEEecChHHhcccccccchhhhHH
Confidence 99998765422110 0124688999999999997 56899999999
Q ss_pred hhhHHHHHhhCCCCCCCCCh---------hhhHHHHhh---------ccccccCCCC-----------------------
Q 010463 330 LGAIMYEMLIGYPPFCSDDP---------RITCRKIVN---------WKTCLKFPEE----------------------- 368 (510)
Q Consensus 330 lGvilyEml~G~~PF~~~~~---------~~~~~~I~~---------~~~~~~~p~~----------------------- 368 (510)
+|||+.|||+-.|-|.+... .....+|.+ |+..-+.|+.
T Consensus 226 iGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~ 305 (438)
T KOG0666|consen 226 IGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHK 305 (438)
T ss_pred HHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHH
Confidence 99999999999999977532 123444543 3322233322
Q ss_pred -CCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCC
Q 010463 369 -PKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 408 (510)
Q Consensus 369 -~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~ 408 (510)
..-++.+-+|+.+||+ ||.+|+ +++++++|+||...+
T Consensus 306 ~k~k~~~a~~LL~klL~yDP~kRI---ta~qAleh~yF~~d~ 344 (438)
T KOG0666|consen 306 HKVKDPSALDLLQKLLTYDPIKRI---TAEQALEHPYFTEDP 344 (438)
T ss_pred hcCCCchHHHHHHHHhccCchhhc---cHHHHhcccccccCC
Confidence 1235679999999999 999999 789999999998743
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=324.27 Aligned_cols=246 Identities=22% Similarity=0.298 Sum_probs=193.5
Q ss_pred eeeecCCCeEEEEEEEc--CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEeccC
Q 010463 112 TLIGKGAFGEVRLCRAK--TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLP 189 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~--~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy~~ 189 (510)
+.||+|+||.||+|... .++..+|+|.+.... .......+.+|+.+++.++||||+++++++.+...+|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 36899999999999865 356789999886543 12233568889999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 190 GGDIMTLLMRED-----ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 190 gG~L~~~L~~~~-----~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
||+|.+++.... ..++..++.++.|++.||+|||+.|++||||||+|||++.++++||+|||+++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~-- 156 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY-- 156 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCccee--
Confidence 999999997532 3567788889999999999999999999999999999999999999999998754321000
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC-------CCCccccccchhhHHHHH
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-------GYGMECDWWSLGAIMYEM 337 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-------~y~~~~DiwSlGvilyEm 337 (510)
.......|++.|+|||++.+. .++.++|+|||||++|||
T Consensus 157 ----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el 202 (269)
T cd05087 157 ----------------------------------VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202 (269)
T ss_pred ----------------------------------ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHH
Confidence 001124688999999998642 357899999999999999
Q ss_pred hh-CCCCCCCCChhhhHHHHhhccccccCCC---CCCCCHHHHHHHHHhhcCccccCCCCChHHhh
Q 010463 338 LI-GYPPFCSDDPRITCRKIVNWKTCLKFPE---EPKISDEARDLICHLLCDVETRLGTRGVEELK 399 (510)
Q Consensus 338 l~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~---~~~~s~~~~dlI~~lL~dp~~R~~~~~~~eil 399 (510)
++ |.+||...+..+........ ....++. ....++.+.+++.+|+.+|++|| ++++|.
T Consensus 203 ~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~c~~~P~~Rp---t~~~l~ 264 (269)
T cd05087 203 FELGSQPYRHLSDEQVLTYTVRE-QQLKLPKPRLKLPLSDRWYEVMQFCWLQPEQRP---SAEEVH 264 (269)
T ss_pred HhCCCCCCCCCChHHHHHHHhhc-ccCCCCCCccCCCCChHHHHHHHHHhcCcccCC---CHHHHH
Confidence 96 99999876655544433322 1122222 12467889999999988999999 566665
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=328.97 Aligned_cols=254 Identities=33% Similarity=0.535 Sum_probs=212.3
Q ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEec
Q 010463 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEY 187 (510)
Q Consensus 108 f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy 187 (510)
|++.+.||.|++|.||+|....+|+.+|+|.+..... .......+..|+.+|+.++||||+++++++.+.+.+|+||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 5778899999999999999999999999999876532 223456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccch
Q 010463 188 LPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 266 (510)
Q Consensus 188 ~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~ 266 (510)
+++ +|..++... ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++........
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~----- 153 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR----- 153 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-----
Confidence 976 888888764 5799999999999999999999999999999999999999999999999999876643210
Q ss_pred hhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC-CCCccccccchhhHHHHHhhCCCCCC
Q 010463 267 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEMLIGYPPFC 345 (510)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiwSlGvilyEml~G~~PF~ 345 (510)
......++..|+|||.+.+. .++.++|+|||||++|+|++|++||.
T Consensus 154 ---------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~ 200 (283)
T cd05118 154 ---------------------------------PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFP 200 (283)
T ss_pred ---------------------------------cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 00124688999999999876 78999999999999999999999998
Q ss_pred CCChhhhHHHHhhcccc-----------------ccCCC---------CCCCCHHHHHHHHHhhc-CccccCCCCChHHh
Q 010463 346 SDDPRITCRKIVNWKTC-----------------LKFPE---------EPKISDEARDLICHLLC-DVETRLGTRGVEEL 398 (510)
Q Consensus 346 ~~~~~~~~~~I~~~~~~-----------------~~~p~---------~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~ei 398 (510)
+.+..+...++...-.. ..++. .+.++.++.+||.+||. ||.+|| ++.++
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp---~~~~l 277 (283)
T cd05118 201 GKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRI---TAEQA 277 (283)
T ss_pred CCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCc---CHHHH
Confidence 87766555554321000 01110 12478899999999998 999999 78999
Q ss_pred hcCCCc
Q 010463 399 KEHPWF 404 (510)
Q Consensus 399 l~HpfF 404 (510)
+.||||
T Consensus 278 l~~~~~ 283 (283)
T cd05118 278 LAHPYF 283 (283)
T ss_pred hhCCCC
Confidence 999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=325.19 Aligned_cols=253 Identities=21% Similarity=0.311 Sum_probs=210.1
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcC----CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec-
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKT----TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD- 177 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~----tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~- 177 (510)
+..++|.+.+.||+|+||.||+|.+.. ++..||+|++... ....+...+.+|..+|+.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 456789999999999999999999876 3588999988643 245567788999999999999999999997665
Q ss_pred CceEEEEEeccCCCCHHHHHHhc--------cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecc
Q 010463 178 SDFLYLIMEYLPGGDIMTLLMRE--------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSD 249 (510)
Q Consensus 178 ~~~~~lVmEy~~gG~L~~~L~~~--------~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~D 249 (510)
....++++||+++|+|..++... ..+++..+..++.|++.||+|||+.|++||||||+|||++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 57899999999999999998653 4589999999999999999999999999999999999999999999999
Q ss_pred cCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccc
Q 010463 250 FGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWS 329 (510)
Q Consensus 250 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwS 329 (510)
||+++.+........ .....++..|+|||++.+..++.++||||
T Consensus 161 ~g~~~~~~~~~~~~~------------------------------------~~~~~~~~~y~apE~~~~~~~~~~~Di~s 204 (280)
T cd05043 161 NALSRDLFPMDYHCL------------------------------------GDNENRPVKWMALESLVNKEYSSASDVWS 204 (280)
T ss_pred CCCcccccCCceEEe------------------------------------CCCCCcchhccCHHHHhcCCCCchhhHHH
Confidence 999986543211100 01134677899999999999999999999
Q ss_pred hhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhh
Q 010463 330 LGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 399 (510)
Q Consensus 330 lGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil 399 (510)
|||++||+++ |.+||.+.++......+... ...+....+++++.+++.+||+ ||++|| ++.+++
T Consensus 205 lG~~l~el~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~~~ 270 (280)
T cd05043 205 FGVLLWELMTLGQTPYVEIDPFEMAAYLKDG---YRLAQPINCPDELFAVMACCWALDPEERP---SFSQLV 270 (280)
T ss_pred hHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC---CCCCCCCcCCHHHHHHHHHHcCCChhhCC---CHHHHH
Confidence 9999999998 99999888776665555432 2233334678999999999998 999999 566665
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=320.40 Aligned_cols=249 Identities=21% Similarity=0.364 Sum_probs=206.4
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceE
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 181 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~ 181 (510)
.+..++|.+.+.||+|+||.||+|... .+..+|+|.+.... ...+.+.+|+.+++.++|+||+++++.+.+ ...
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 75 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPI 75 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCe
Confidence 355688999999999999999999865 45679999887542 234668889999999999999999999988 788
Q ss_pred EEEEeccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 182 YLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
|+||||+++|+|.+++.+. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++..+...
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 9999999999999999763 45788889999999999999999999999999999999999999999999999765432
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~ 339 (510)
... ......++..|+|||++....++.++|+|||||++|+|++
T Consensus 156 ~~~-------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t 198 (260)
T cd05073 156 EYT-------------------------------------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 198 (260)
T ss_pred Ccc-------------------------------------cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHh
Confidence 100 0012346778999999998889999999999999999998
Q ss_pred -CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhh
Q 010463 340 -GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 399 (510)
Q Consensus 340 -G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil 399 (510)
|.+||.+.+.......+... ...+....++.++.+++.+||+ +|++||+ +.+++
T Consensus 199 ~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~---~~~l~ 254 (260)
T cd05073 199 YGRIPYPGMSNPEVIRALERG---YRMPRPENCPEELYNIMMRCWKNRPEERPT---FEYIQ 254 (260)
T ss_pred cCCCCCCCCCHHHHHHHHhCC---CCCCCcccCCHHHHHHHHHHcccCcccCcC---HHHHH
Confidence 99999987776666665542 2223334788999999999998 9999994 45543
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=324.53 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=210.0
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCC----EEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGE----IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 178 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~----~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 178 (510)
+...+|++++.||+|+||.||+|..+.+|+ .||+|.+.+.. .......+.+|+.++..++||||+++++++.+
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVDHPHVVRLLGICLS- 80 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 345789999999999999999999887765 58999887653 23455678899999999999999999999987
Q ss_pred ceEEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCc
Q 010463 179 DFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 257 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~ 257 (510)
...++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 7899999999999999999774 568999999999999999999999999999999999999999999999999998764
Q ss_pred cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHH
Q 010463 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337 (510)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEm 337 (510)
...... ......+++.|+|||.+....++.++|+|||||++|||
T Consensus 161 ~~~~~~------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el 204 (279)
T cd05057 161 VDEKEY------------------------------------HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWEL 204 (279)
T ss_pred Ccccce------------------------------------ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHH
Confidence 321100 00012246789999999888999999999999999999
Q ss_pred hh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhh
Q 010463 338 LI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 399 (510)
Q Consensus 338 l~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil 399 (510)
++ |.+||.+....+....+.... ....| ...+.++.+++.+||. +|..||+ +.+++
T Consensus 205 ~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~l~~~p~~Rp~---~~~l~ 262 (279)
T cd05057 205 MTFGAKPYEGIPAVEIPDLLEKGE-RLPQP--PICTIDVYMVLVKCWMIDAESRPT---FKELI 262 (279)
T ss_pred hcCCCCCCCCCCHHHHHHHHhCCC-CCCCC--CCCCHHHHHHHHHHcCCChhhCCC---HHHHH
Confidence 98 999999888777766666532 23333 4678999999999998 9999995 45543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=346.33 Aligned_cols=254 Identities=24% Similarity=0.370 Sum_probs=217.2
Q ss_pred hhcccCCCCceeeeeeecCCCeEEEEEEEcCCCC---E-EEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEE
Q 010463 99 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGE---I-FAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYS 174 (510)
Q Consensus 99 ~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~---~-vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 174 (510)
+.+.+.-++-.+.+.||+|+||+||+|+.+..+. . ||+|..+.+....+.++..+..|.++|++++|||||++||+
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3345556777788999999999999999876533 3 89999876555677889999999999999999999999999
Q ss_pred eecCceEEEEEeccCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCc
Q 010463 175 FQDSDFLYLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLC 253 (510)
Q Consensus 175 ~~~~~~~~lVmEy~~gG~L~~~L~~~~-~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla 253 (510)
..+...+|+|||+|+||+|.++|.+.+ .++..+...++.+.+.||+|||++++|||||-..|+|++.++.+||+||||+
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccc
Confidence 999999999999999999999999987 4999999999999999999999999999999999999999999999999998
Q ss_pred ccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhH
Q 010463 254 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 333 (510)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvi 333 (510)
+....-... .....-...|+|||.+...-|+.++|||||||+
T Consensus 310 ~~~~~~~~~--------------------------------------~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~ 351 (474)
T KOG0194|consen 310 RAGSQYVMK--------------------------------------KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVL 351 (474)
T ss_pred cCCcceeec--------------------------------------cccccCcceecChhhhccCccccccchhheeee
Confidence 864311000 000113457999999999999999999999999
Q ss_pred HHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC
Q 010463 334 MYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT 392 (510)
Q Consensus 334 lyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~ 392 (510)
+||+++ |..||.+....+...+|+........| ...+.++..++.+|+. +|++|++.
T Consensus 352 ~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~--~~~p~~~~~~~~~c~~~~p~~R~tm 410 (474)
T KOG0194|consen 352 LWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP--SKTPKELAKVMKQCWKKDPEDRPTM 410 (474)
T ss_pred EEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC--CCCHHHHHHHHHHhccCChhhccCH
Confidence 999998 899999999999999996544444455 3778889999999998 99999954
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=318.35 Aligned_cols=243 Identities=26% Similarity=0.395 Sum_probs=201.7
Q ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEeccCCC
Q 010463 112 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGG 191 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy~~gG 191 (510)
++||+|+||.||+|... ++..||+|++.... .......+.+|+.+++.++||||+++++++.+.+..++||||++||
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 36899999999999865 68899999986542 2233456889999999999999999999999999999999999999
Q ss_pred CHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhhh
Q 010463 192 DIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 270 (510)
Q Consensus 192 ~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 270 (510)
+|.+++... ..+++..+..++.+++.||.|+|+.|++||||||+||+++.++.+||+|||++..........
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~------- 150 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS------- 150 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccccc-------
Confidence 999998754 468999999999999999999999999999999999999999999999999987543221000
Q ss_pred hcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh-CCCCCCCCCh
Q 010463 271 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDP 349 (510)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~-G~~PF~~~~~ 349 (510)
.....+++.|+|||++.+..++.++|+|||||++|||++ |..||.+.+.
T Consensus 151 ------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~ 200 (250)
T cd05085 151 ------------------------------SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN 200 (250)
T ss_pred ------------------------------CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH
Confidence 001235678999999998889999999999999999998 9999988877
Q ss_pred hhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 350 RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 350 ~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
......+... .....| ..++..+.+|+.+||. +|++|| ++.++++
T Consensus 201 ~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~l~~ 246 (250)
T cd05085 201 QQAREQVEKG-YRMSCP--QKCPDDVYKVMQRCWDYKPENRP---KFSELQK 246 (250)
T ss_pred HHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcccCcccCC---CHHHHHH
Confidence 6666666542 122333 3688999999999998 999999 5677654
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=319.94 Aligned_cols=250 Identities=22% Similarity=0.309 Sum_probs=208.5
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEE
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l 183 (510)
...+|++.+.||+|+||.||+|.+. .+..+|+|.+.+... ....+..|+.+++.++||||+++++++.+....|+
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICL 76 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEE
Confidence 3568999999999999999999876 467899999875432 23457889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccc
Q 010463 184 IMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 262 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 262 (510)
||||++||+|.+++... +.++++.++.++.|++.||.+||+.|++||||||+||+++.++++||+|||++.........
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 99999999999998764 56899999999999999999999999999999999999999999999999998755322100
Q ss_pred ccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh-CC
Q 010463 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GY 341 (510)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~-G~ 341 (510)
......++..|+|||++.+..++.++|+|||||++|||++ |.
T Consensus 157 -------------------------------------~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~ 199 (256)
T cd05112 157 -------------------------------------SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGK 199 (256)
T ss_pred -------------------------------------ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCC
Confidence 0012345678999999998899999999999999999998 99
Q ss_pred CCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
+||...+.......+.... ....| ...+..+.+|+++||. +|++|| ++.+++++
T Consensus 200 ~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~l~~~~l~~~p~~Rp---~~~~~l~~ 254 (256)
T cd05112 200 TPYENRSNSEVVETINAGF-RLYKP--RLASQSVYELMQHCWKERPEDRP---SFSLLLHQ 254 (256)
T ss_pred CCCCcCCHHHHHHHHhCCC-CCCCC--CCCCHHHHHHHHHHcccChhhCC---CHHHHHHh
Confidence 9998877766666665321 11222 3578999999999998 999999 67787753
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=323.31 Aligned_cols=252 Identities=26% Similarity=0.369 Sum_probs=208.0
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCC---CCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTT---GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 179 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t---g~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 179 (510)
+..++|.+.+.||+|+||.||+|.+..+ ...||+|...... .....+.+.+|+.+++.++||||+++++++.+ +
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~ 79 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N 79 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence 4456799999999999999999987654 3469999886542 23455678999999999999999999999876 4
Q ss_pred eEEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 180 FLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
..|+||||+++|+|.+++.+. ..+++..+..++.+++.||.|||+.|++||||||+|||++.++.+||+|||+++....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 578999999999999999764 3589999999999999999999999999999999999999999999999999886543
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHh
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml 338 (510)
.... ......+++.|+|||++....++.++|+|||||++|||+
T Consensus 160 ~~~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 202 (270)
T cd05056 160 ESYY-------------------------------------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 202 (270)
T ss_pred ccce-------------------------------------ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHH
Confidence 2100 001223567899999999889999999999999999999
Q ss_pred h-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 339 I-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 339 ~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
+ |.+||.+.+..+....+.+.. ....| ..++.++.++|.+|+. +|.+|| ++.+++.
T Consensus 203 ~~g~~pf~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~P~~Rp---t~~~~~~ 260 (270)
T cd05056 203 MLGVKPFQGVKNNDVIGRIENGE-RLPMP--PNCPPTLYSLMTKCWAYDPSKRP---RFTELKA 260 (270)
T ss_pred HcCCCCCCCCCHHHHHHHHHcCC-cCCCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 6 999998887776666665432 22333 4789999999999998 999999 5667664
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=331.05 Aligned_cols=254 Identities=20% Similarity=0.336 Sum_probs=206.1
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCC----EEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGE----IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 178 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~----~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 178 (510)
+..++|+.++.||+|+||.||+|.+..+|. .||+|.+.... .......+.+|..+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~ 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence 456789999999999999999999988886 46888876542 222334578899999999999999999998764
Q ss_pred ceEEEEEeccCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCc
Q 010463 179 DFLYLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 257 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~~-~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~ 257 (510)
..++||||+++|+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.+.
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence 4789999999999999987653 68999999999999999999999999999999999999999999999999998654
Q ss_pred cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHH
Q 010463 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337 (510)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEm 337 (510)
..... .......+++.|+|||++.+..++.++|+|||||++|||
T Consensus 161 ~~~~~------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el 204 (303)
T cd05110 161 GDEKE------------------------------------YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWEL 204 (303)
T ss_pred Ccccc------------------------------------cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHH
Confidence 32100 001123567899999999999999999999999999999
Q ss_pred hh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 338 LI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 338 l~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
++ |..||.+......... +.... .+|..+..+..+.++|.+|+. +|++|| ++.++++.
T Consensus 205 ~t~g~~p~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~li~~c~~~~p~~Rp---~~~~l~~~ 264 (303)
T cd05110 205 MTFGGKPYDGIPTREIPDL-LEKGE--RLPQPPICTIDVYMVMVKCWMIDADSRP---KFKELAAE 264 (303)
T ss_pred HhCCCCCCCCCCHHHHHHH-HHCCC--CCCCCCCCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 97 9999987665544433 33222 233334678999999999998 999999 56777653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=318.49 Aligned_cols=244 Identities=25% Similarity=0.378 Sum_probs=204.6
Q ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEeccCCC
Q 010463 112 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGG 191 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy~~gG 191 (510)
+.||.|+||.||+|.+.. ++.||+|.+..... ......+..|+++++.++||||+++++++.+....|+||||++|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 469999999999999887 99999999876533 235567899999999999999999999999999999999999999
Q ss_pred CHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhhh
Q 010463 192 DIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 270 (510)
Q Consensus 192 ~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 270 (510)
+|.+++.+. ..+++..+..++.+++.||.|||+.|++||||||+|||++.++++||+|||++..........
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~------- 150 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV------- 150 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCccee-------
Confidence 999999663 568999999999999999999999999999999999999999999999999998654211000
Q ss_pred hcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh-CCCCCCCCCh
Q 010463 271 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDP 349 (510)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~-G~~PF~~~~~ 349 (510)
......++..|+|||++.+..++.++|+|||||++|||++ |..||.+.+.
T Consensus 151 -----------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~ 201 (251)
T cd05041 151 -----------------------------SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN 201 (251)
T ss_pred -----------------------------ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH
Confidence 0001234677999999998899999999999999999999 8999988877
Q ss_pred hhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 350 RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 350 ~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
......+... ...+....++.++.++|.+||+ +|.+|| +++|+++
T Consensus 202 ~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~ell~ 247 (251)
T cd05041 202 QQTRERIESG---YRMPAPQLCPEEIYRLMLQCWAYDPENRP---SFSEIYN 247 (251)
T ss_pred HHHHHHHhcC---CCCCCCccCCHHHHHHHHHHhccChhhCc---CHHHHHH
Confidence 6666665432 1222234788999999999998 999999 6788774
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=324.41 Aligned_cols=252 Identities=25% Similarity=0.435 Sum_probs=200.7
Q ss_pred CCceeeeeeecCCCeEEEEEEE----cCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec--Cc
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRA----KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD--SD 179 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~----~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~ 179 (510)
.+|++++.||+|+||.||+|.. ..+++.||+|.+... .......+.+|+.+|..++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 5799999999999999999974 457889999998654 34456678899999999999999999987643 45
Q ss_pred eEEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 180 FLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
.+|+||||++||+|.+++.+. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++++||+|||++..+..
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 799999999999999999764 4689999999999999999999999999999999999999999999999999987643
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHh
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml 338 (510)
..... .......++..|+|||++.+..++.++|+|||||++|||+
T Consensus 161 ~~~~~-----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 205 (284)
T cd05081 161 DKEYY-----------------------------------KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 205 (284)
T ss_pred CCcce-----------------------------------eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHh
Confidence 21100 0000123455699999999889999999999999999999
Q ss_pred hCCCCCCCCChhh---------------hHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 339 IGYPPFCSDDPRI---------------TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 339 ~G~~PF~~~~~~~---------------~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
+|..|+....... ....++.. ...+|....++.++.+||.+||. +|++|| ++.+|++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp---t~~ei~~ 278 (284)
T cd05081 206 TYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN--NGRLPAPPGCPAEIYAIMKECWNNDPSQRP---SFSELAL 278 (284)
T ss_pred hcCCcCCCcchhhhhhcccccccccchHHHHHHHhc--CCcCCCCCCCCHHHHHHHHHHccCChhhCC---CHHHHHH
Confidence 9987765432110 01112221 12233345788999999999998 999999 5777764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=325.81 Aligned_cols=236 Identities=18% Similarity=0.309 Sum_probs=194.0
Q ss_pred eeeecCCCeEEEEEEEcCCCCE-------EEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 112 TLIGKGAFGEVRLCRAKTTGEI-------FAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~tg~~-------vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
+.||+|+||.||+|.++.++.. ||+|.+.+.. ....+.+..|..+|+.++||||+++++++.++...++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 3689999999999998765544 8888876542 33456788899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCc--------eeecccCCccc
Q 010463 185 MEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH--------LKLSDFGLCKP 255 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~~-~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~--------vkL~DFGla~~ 255 (510)
|||+++|+|..++...+ .+++..+..++.||+.||+|||+.||+||||||+|||++.++. ++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999999997654 5899999999999999999999999999999999999988775 68999998765
Q ss_pred CccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHH
Q 010463 256 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIM 334 (510)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvil 334 (510)
.... ....|++.|+|||++.+ ..++.++|+|||||++
T Consensus 158 ~~~~------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l 195 (258)
T cd05078 158 VLPK------------------------------------------EILLERIPWVPPECIENPQNLSLAADKWSFGTTL 195 (258)
T ss_pred cCCc------------------------------------------hhccccCCccCchhccCCCCCCchhhHHHHHHHH
Confidence 4221 12468999999999986 4579999999999999
Q ss_pred HHHhhC-CCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 335 YEMLIG-YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 335 yEml~G-~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
|||++| .+||...+...... +.. ....+|. ..+.++.+||.+||. ||++|| ++++|++
T Consensus 196 ~~l~~g~~~~~~~~~~~~~~~-~~~--~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp---s~~~il~ 255 (258)
T cd05078 196 WEIFSGGDKPLSALDSQKKLQ-FYE--DRHQLPA--PKWTELANLINQCMDYEPDFRP---SFRAIIR 255 (258)
T ss_pred HHHHcCCCCChhhccHHHHHH-HHH--ccccCCC--CCcHHHHHHHHHHhccChhhCC---CHHHHHH
Confidence 999998 57776655544332 222 2234443 567899999999998 999999 6788875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=323.64 Aligned_cols=248 Identities=31% Similarity=0.475 Sum_probs=203.6
Q ss_pred eeeeeeecCCCeEEEEEEEc----CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 109 EQLTLIGKGAFGEVRLCRAK----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 109 ~~~~~IG~G~fG~V~~~~~~----~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
++.+.||.|+||.||+|..+ ..+..|+||+++.. ......+.+.+|.+++++++||||+++++++.+.+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 46789999999999999998 45678999999542 2334477899999999999999999999999988889999
Q ss_pred EeccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccc
Q 010463 185 MEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 262 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 262 (510)
|||+++|+|.++|... ..+++.....++.||+.||.|||+.+|+|+||+|+|||++.++.+||+|||++.........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999886 77999999999999999999999999999999999999999999999999999876221100
Q ss_pred ccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh-CC
Q 010463 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GY 341 (510)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~-G~ 341 (510)
.......+...|+|||++.+..++.++||||||+++|||++ |.
T Consensus 160 ------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~ 203 (259)
T PF07714_consen 160 ------------------------------------KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGK 203 (259)
T ss_dssp ------------------------------------EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSS
T ss_pred ------------------------------------cccccccccccccccccccccccccccccccccccccccccccc
Confidence 00112457788999999999999999999999999999999 78
Q ss_pred CCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
.||...+......++... .....| ..++..+.++|..||. +|++|| ++.+|++
T Consensus 204 ~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~C~~~~p~~RP---s~~~i~~ 257 (259)
T PF07714_consen 204 FPFSDYDNEEIIEKLKQG-QRLPIP--DNCPKDIYSLIQQCWSHDPEKRP---SFQEILQ 257 (259)
T ss_dssp GTTTTSCHHHHHHHHHTT-EETTSB--TTSBHHHHHHHHHHT-SSGGGS-----HHHHHH
T ss_pred cccccccccccccccccc-ccceec--cchhHHHHHHHHHHcCCChhhCc---CHHHHHh
Confidence 999988888877777543 233333 4789999999999998 999999 6777763
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=319.30 Aligned_cols=241 Identities=20% Similarity=0.350 Sum_probs=202.0
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEE
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l 183 (510)
..++|++.+.||+|+||.||++. .+++.||+|++.... ....+.+|+.++..++||||+++++++..+ ..|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 45789999999999999999875 478899999986432 235688999999999999999999998765 4799
Q ss_pred EEeccCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 184 IMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
||||++||+|.+++.... .+++..+..++.|++.||.|||+.|++||||||+|||++.+|.+||+|||++.......
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 999999999999997653 57899999999999999999999999999999999999999999999999987543210
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh-C
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-G 340 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~-G 340 (510)
....++..|+|||++.+..++.++|+|||||++|||++ |
T Consensus 155 ----------------------------------------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g 194 (254)
T cd05083 155 ----------------------------------------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYG 194 (254)
T ss_pred ----------------------------------------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCC
Confidence 01234578999999998899999999999999999997 9
Q ss_pred CCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhh
Q 010463 341 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 399 (510)
Q Consensus 341 ~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil 399 (510)
.+||.+.+.......+... ...+....+++.+.+||++||. +|.+|| ++.+++
T Consensus 195 ~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~l~ 248 (254)
T cd05083 195 RAPYPKMSLKEVKECVEKG---YRMEPPEGCPADVYVLMTSCWETEPKKRP---SFHKLR 248 (254)
T ss_pred CCCCccCCHHHHHHHHhCC---CCCCCCCcCCHHHHHHHHHHcCCChhhCc---CHHHHH
Confidence 9999988777666655432 1222224688999999999998 999999 456655
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=365.23 Aligned_cols=270 Identities=30% Similarity=0.456 Sum_probs=204.0
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec-------
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD------- 177 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~------- 177 (510)
.+||+.+..||+||||.||+|+++-+|..||||+|.... .......+.+|+.+|++++|||||++|.+|..
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 478999999999999999999999999999999997654 45566789999999999999999999844300
Q ss_pred --------------------------------------------------------------------------------
Q 010463 178 -------------------------------------------------------------------------------- 177 (510)
Q Consensus 178 -------------------------------------------------------------------------------- 177 (510)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ------------------------C--------ceEEEEEeccCCCCHHHHHHhccCC-CHHHHHHHHHHHHHHHHhhhh
Q 010463 178 ------------------------S--------DFLYLIMEYLPGGDIMTLLMREDIL-SEDVARFYIAESVLAIHSIHQ 224 (510)
Q Consensus 178 ------------------------~--------~~~~lVmEy~~gG~L~~~L~~~~~l-~e~~~~~~~~qi~~aL~~lH~ 224 (510)
+ ..+||-||||+.-.|.+++.++... ....++.+++||+.||.|+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence 0 2479999999997777777665544 478899999999999999999
Q ss_pred CCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccc
Q 010463 225 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYST 304 (510)
Q Consensus 225 ~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 304 (510)
+|||||||||.||+||++++|||+|||+|+.............. ..+...+. .....++.
T Consensus 716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~----~~~~~~g~----------------~~~~~Ts~ 775 (1351)
T KOG1035|consen 716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLS----FSTNRAGS----------------NDGDLTSQ 775 (1351)
T ss_pred CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccC----ccccccCC----------------CCcccccc
Confidence 99999999999999999999999999999874311000000000 00000000 00112467
Q ss_pred cccCCCcchHhhccCC---CCccccccchhhHHHHHhhCCCCCCCCChhhhHHHHhhccccccCCCC----CCCCHHHHH
Q 010463 305 VGTLDYMAPEVLLKKG---YGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEE----PKISDEARD 377 (510)
Q Consensus 305 ~GT~~Y~APEvl~~~~---y~~~~DiwSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~----~~~s~~~~d 377 (510)
+||.-|+|||++.+.. |+.++|+||||||+|||+. ||... .+....+.+.+ ...+|.. ..--+....
T Consensus 776 VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts--MERa~iL~~LR-~g~iP~~~~f~~~~~~~e~s 849 (1351)
T KOG1035|consen 776 VGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS--MERASILTNLR-KGSIPEPADFFDPEHPEEAS 849 (1351)
T ss_pred cceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCch--HHHHHHHHhcc-cCCCCCCcccccccchHHHH
Confidence 9999999999998755 9999999999999999975 57433 23333333222 3344432 122356788
Q ss_pred HHHHhhc-CccccCCCCChHHhhcCCCcC
Q 010463 378 LICHLLC-DVETRLGTRGVEELKEHPWFR 405 (510)
Q Consensus 378 lI~~lL~-dp~~R~~~~~~~eil~HpfF~ 405 (510)
+|+.||. ||.+|| +|.|+|++.||-
T Consensus 850 lI~~Ll~hdP~kRP---tA~eLL~s~llp 875 (1351)
T KOG1035|consen 850 LIRWLLSHDPSKRP---TATELLNSELLP 875 (1351)
T ss_pred HHHHHhcCCCccCC---CHHHHhhccCCC
Confidence 9999998 999999 789999999997
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=320.41 Aligned_cols=237 Identities=19% Similarity=0.253 Sum_probs=191.8
Q ss_pred eeeecCCCeEEEEEEEcCC------------CCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc
Q 010463 112 TLIGKGAFGEVRLCRAKTT------------GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 179 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~t------------g~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 179 (510)
+.||+|+||.||+|..... ...+|+|++.... ......+.+|..++..++||||+++++++.++.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 3689999999999985432 2358899876542 334456788999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCc-------eeecccC
Q 010463 180 FLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH-------LKLSDFG 251 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~-------vkL~DFG 251 (510)
..++||||+++|+|..++.+. ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|. ++++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999999888753 56999999999999999999999999999999999999987764 8999999
Q ss_pred CcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc-cCCCCccccccch
Q 010463 252 LCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSL 330 (510)
Q Consensus 252 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-~~~y~~~~DiwSl 330 (510)
++...... ...+||+.|+|||++. +..++.++|||||
T Consensus 158 ~~~~~~~~------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 195 (262)
T cd05077 158 IPITVLSR------------------------------------------QECVERIPWIAPECVEDSKNLSIAADKWSF 195 (262)
T ss_pred CCccccCc------------------------------------------ccccccccccChhhhcCCCCCCchhHHHHH
Confidence 98754321 1246889999999987 4678999999999
Q ss_pred hhHHHHHh-hCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 331 GAIMYEML-IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 331 GvilyEml-~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
||++|||+ .|.+||.+....+.. ++... .... ....++++.+||.+||. ||.+|| ++.+|+.+
T Consensus 196 G~~l~el~~~~~~p~~~~~~~~~~-~~~~~--~~~~--~~~~~~~~~~li~~cl~~dp~~Rp---~~~~il~~ 260 (262)
T cd05077 196 GTTLWEICYNGEIPLKDKTLAEKE-RFYEG--QCML--VTPSCKELADLMTHCMNYDPNQRP---FFRAIMRD 260 (262)
T ss_pred HHHHHHHHhCCCCCCCCcchhHHH-HHHhc--CccC--CCCChHHHHHHHHHHcCCChhhCc---CHHHHHHh
Confidence 99999998 589998776544332 22221 1111 12456889999999998 999999 67888764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=344.23 Aligned_cols=257 Identities=20% Similarity=0.281 Sum_probs=209.7
Q ss_pred hhcccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC
Q 010463 99 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 178 (510)
Q Consensus 99 ~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 178 (510)
..+.+..+++.+...||+|+||+||+|++.. .||||++.-... ...+.+.|++|+.+|++.+|-||+-+.|++..+
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCC-CHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 4456777888899999999999999999864 399999987665 455899999999999999999999999999988
Q ss_pred ceEEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCc
Q 010463 179 DFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 257 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~ 257 (510)
.. .+|+.+|.|.+|+.+|.-. ..|....++.|+.||+.|+.|||.++|||||||..||+|.+++.|||+||||+..-.
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 77 9999999999999999754 468889999999999999999999999999999999999999999999999997432
Q ss_pred cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc---CCCCccccccchhhHH
Q 010463 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK---KGYGMECDWWSLGAIM 334 (510)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~---~~y~~~~DiwSlGvil 334 (510)
.... ........|...|||||+++. .+|+..+|||||||++
T Consensus 540 ~w~g------------------------------------~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~ 583 (678)
T KOG0193|consen 540 RWSG------------------------------------EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVW 583 (678)
T ss_pred eecc------------------------------------ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHH
Confidence 1100 000112458889999999984 5789999999999999
Q ss_pred HHHhhCCCCCCCCChhhhHHHHhhccccccCC-CCCCCCHHHHHHHHHhhc-CccccCCCCChHHhh
Q 010463 335 YEMLIGYPPFCSDDPRITCRKIVNWKTCLKFP-EEPKISDEARDLICHLLC-DVETRLGTRGVEELK 399 (510)
Q Consensus 335 yEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p-~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil 399 (510)
|||++|..||...+.+.+...+-.+......- .....+.++++|+..|+. ++++|| .+.+|+
T Consensus 584 YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP---~F~~il 647 (678)
T KOG0193|consen 584 YELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERP---LFPQLL 647 (678)
T ss_pred HHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCc---cHHHHH
Confidence 99999999999766665554444331111110 113566799999999998 999999 456665
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=318.45 Aligned_cols=247 Identities=21% Similarity=0.296 Sum_probs=197.6
Q ss_pred eeeecCCCeEEEEEEEcC---CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEee-cCceEEEEEec
Q 010463 112 TLIGKGAFGEVRLCRAKT---TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ-DSDFLYLIMEY 187 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~---tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-~~~~~~lVmEy 187 (510)
+.||+|+||.||+|.+.. .+..||+|.+... ......+.+..|..+++.++||||+++++++. .++..|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998754 3457999987542 13345677889999999999999999999765 45678999999
Q ss_pred cCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccch
Q 010463 188 LPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 266 (510)
Q Consensus 188 ~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~ 266 (510)
+++|+|.+++.+. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.+........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~-- 156 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV-- 156 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceee--
Confidence 9999999999764 4467778888999999999999999999999999999999999999999999986543210000
Q ss_pred hhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh-CCCCCC
Q 010463 267 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPFC 345 (510)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~-G~~PF~ 345 (510)
.......+++.|+|||++.+..++.++|||||||++|||++ |.+||.
T Consensus 157 --------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 204 (262)
T cd05058 157 --------------------------------HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204 (262)
T ss_pred --------------------------------cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCC
Confidence 00112356789999999998999999999999999999999 577887
Q ss_pred CCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 346 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 346 ~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
..+.......+..+. ....| ..+++.+.+++.+||. +|++|| ++.+++.
T Consensus 205 ~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~cl~~~p~~Rp---~~~~il~ 254 (262)
T cd05058 205 DVDSFDITVYLLQGR-RLLQP--EYCPDPLYEVMLSCWHPKPEMRP---TFSELVS 254 (262)
T ss_pred CCCHHHHHHHHhcCC-CCCCC--CcCCHHHHHHHHHHcCCChhhCC---CHHHHHH
Confidence 777666666655432 22222 3578999999999998 999999 5677764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=321.36 Aligned_cols=245 Identities=24% Similarity=0.385 Sum_probs=201.4
Q ss_pred eeeecCCCeEEEEEEEcCCC------CEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 112 TLIGKGAFGEVRLCRAKTTG------EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~tg------~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
+.||+|+||.||+|+.+..+ +.||+|.+.+.. .......+.+|..+|+.++||||+++++++.+.+..|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36899999999999987544 789999886542 2234566888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc-------cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCC-----ceeecccCCc
Q 010463 186 EYLPGGDIMTLLMRE-------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG-----HLKLSDFGLC 253 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~-------~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g-----~vkL~DFGla 253 (510)
||++||+|.+++.+. ..+++..+..++.|++.||.|||+.|++|+||||+|||++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999999642 3478899999999999999999999999999999999999888 8999999999
Q ss_pred ccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhH
Q 010463 254 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 333 (510)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvi 333 (510)
+.+....... ......+++.|+|||++.+..++.++|+|||||+
T Consensus 159 ~~~~~~~~~~------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i 202 (269)
T cd05044 159 RDIYKSDYYR------------------------------------KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVL 202 (269)
T ss_pred cccccccccc------------------------------------cCcccCCCccccCHHHHccCCcccchhHHHHHHH
Confidence 8653221000 0012356789999999999999999999999999
Q ss_pred HHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 334 MYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 334 lyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
+|||++ |..||...+.......+... ..+..+ ..++..+.+||.+||. +|.+|| ++++|++
T Consensus 203 l~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~i~~ 265 (269)
T cd05044 203 MWEILTLGQQPYPALNNQEVLQHVTAG-GRLQKP--ENCPDKIYQLMTNCWAQDPSERP---TFDRIQE 265 (269)
T ss_pred HHHHHHcCCCCCcccCHHHHHHHHhcC-CccCCc--ccchHHHHHHHHHHcCCCcccCC---CHHHHHH
Confidence 999998 99999887776666665432 222333 4789999999999998 999999 5666653
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=318.47 Aligned_cols=250 Identities=28% Similarity=0.488 Sum_probs=207.7
Q ss_pred CceeeeeeecCCCeEEEEEEEcC-CCCEEEEEEeechhh-------cchhhHHHHHHHHHHHHh-cCCCCeeeEeEEeec
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKT-TGEIFAMKKLKKSEM-------LKRGQVEHVRSERNLLAE-VDSRCIVQLFYSFQD 177 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~-tg~~vAiK~i~k~~~-------~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~~~~ 177 (510)
+|++.+.||+|+||.||+|.++. +++.+|+|.+..... ........+..|..++.. ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999988 788999998864321 223345667788888865 799999999999999
Q ss_pred CceEEEEEeccCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHhhhh-CCeEEeecCCCCeeecCCCceeecccCC
Q 010463 178 SDFLYLIMEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGHLKLSDFGL 252 (510)
Q Consensus 178 ~~~~~lVmEy~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~lH~-~giiHRDLKP~NILld~~g~vkL~DFGl 252 (510)
.+..|+||||++|++|.+++.. ...+++..++.++.|++.||.|||+ .|++||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999988743 3568999999999999999999996 7899999999999999999999999999
Q ss_pred cccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhh
Q 010463 253 CKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGA 332 (510)
Q Consensus 253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGv 332 (510)
+....... ......|+..|+|||++.+..++.++|+|||||
T Consensus 161 ~~~~~~~~---------------------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ 201 (269)
T cd08528 161 AKQKQPES---------------------------------------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGC 201 (269)
T ss_pred eeeccccc---------------------------------------ccccccCcccCcChhhhcCCCCchHHHHHHHHH
Confidence 98654321 012356899999999999888999999999999
Q ss_pred HHHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 333 IMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 333 ilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
++|||++|.+||...+.......+..... .......+++++.++|.+||. ||++|| ++.|+..
T Consensus 202 ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~Rp---~~~e~~~ 265 (269)
T cd08528 202 ILYQMCTLQPPFYSTNMLSLATKIVEAVY--EPLPEGMYSEDVTDVITSCLTPDAEARP---DIIQVSA 265 (269)
T ss_pred HHHHHHhCCCcccccCHHHHHHHHhhccC--CcCCcccCCHHHHHHHHHHCCCCCccCC---CHHHHHH
Confidence 99999999999988777666666654321 111123678999999999998 999999 5666654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=322.52 Aligned_cols=236 Identities=19% Similarity=0.253 Sum_probs=191.7
Q ss_pred eeecCCCeEEEEEEEcCC------------------------CCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCe
Q 010463 113 LIGKGAFGEVRLCRAKTT------------------------GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCI 168 (510)
Q Consensus 113 ~IG~G~fG~V~~~~~~~t------------------------g~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~I 168 (510)
.||+|+||.||+|....+ ...||+|++.... ......+.+|..+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 699999999999875432 2358999886542 2334567889999999999999
Q ss_pred eeEeEEeecCceEEEEEeccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCC----
Q 010463 169 VQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG---- 243 (510)
Q Consensus 169 v~l~~~~~~~~~~~lVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g---- 243 (510)
+++++++.+....|+||||++||+|..++.+ .+.+++..+..++.||+.||+|||+.||+||||||+|||++..|
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999999875 46789999999999999999999999999999999999998654
Q ss_pred ---ceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-C
Q 010463 244 ---HLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-K 319 (510)
Q Consensus 244 ---~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~ 319 (510)
.+||+|||++...... ....|++.|+|||++.+ .
T Consensus 159 ~~~~~kl~d~g~~~~~~~~------------------------------------------~~~~~~~~~~aPe~~~~~~ 196 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR------------------------------------------EERVERIPWIAPECVPGGN 196 (274)
T ss_pred ccceeeecCCccccccccc------------------------------------------cccccCCcccCchhhcCCC
Confidence 4899999987643211 12358889999999875 5
Q ss_pred CCCccccccchhhHHHHHh-hCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHH
Q 010463 320 GYGMECDWWSLGAIMYEML-IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEE 397 (510)
Q Consensus 320 ~y~~~~DiwSlGvilyEml-~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~e 397 (510)
.++.++|+|||||++|||+ +|.+||.+.++..... +.. .....|. ..++.+.++|.+||+ +|++|| ++.+
T Consensus 197 ~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~--~~~~~~~--~~~~~~~~li~~cl~~~p~~Rp---s~~~ 268 (274)
T cd05076 197 SLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-FYE--KKHRLPE--PSCKELATLISQCLTYEPTQRP---SFRT 268 (274)
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-HHH--hccCCCC--CCChHHHHHHHHHcccChhhCc---CHHH
Confidence 6899999999999999995 6999998776554432 222 1223332 457789999999998 999999 6788
Q ss_pred hhcC
Q 010463 398 LKEH 401 (510)
Q Consensus 398 il~H 401 (510)
|+++
T Consensus 269 il~~ 272 (274)
T cd05076 269 ILRD 272 (274)
T ss_pred HHHh
Confidence 8764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=346.37 Aligned_cols=199 Identities=34% Similarity=0.534 Sum_probs=175.3
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc------e
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD------F 180 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~------~ 180 (510)
-+..-+.||+||||.||+++++.||+.||||.+++.. ....++...+|++||++++|||||+++++=.+.. .
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 3556678999999999999999999999999998754 4455778889999999999999999998765543 5
Q ss_pred EEEEEeccCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeec--CCCc--eeecccCCc
Q 010463 181 LYLIMEYLPGGDIMTLLMRE---DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD--KNGH--LKLSDFGLC 253 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~---~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld--~~g~--vkL~DFGla 253 (510)
..+|||||+||||+..|.+. ..++|.+...++..++.||+|||.+|||||||||+||++- .+|. -||+|||.|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 78999999999999999763 5699999999999999999999999999999999999985 4443 699999999
Q ss_pred ccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhh
Q 010463 254 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGA 332 (510)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGv 332 (510)
+.++++. ...|++||+.|++||++.+ +.|+..||.|||||
T Consensus 172 rel~d~s---------------------------------------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~Gv 212 (732)
T KOG4250|consen 172 RELDDNS---------------------------------------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGV 212 (732)
T ss_pred ccCCCCC---------------------------------------eeeeecCchhhcChHHHhhccCcCceeehhhhhh
Confidence 9887652 2457999999999999995 88999999999999
Q ss_pred HHHHHhhCCCCCCC
Q 010463 333 IMYEMLIGYPPFCS 346 (510)
Q Consensus 333 ilyEml~G~~PF~~ 346 (510)
++|++.||..||-.
T Consensus 213 tlY~caTG~lPF~p 226 (732)
T KOG4250|consen 213 TLYECATGELPFIP 226 (732)
T ss_pred HHHHHhccCCCCCc
Confidence 99999999999964
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=331.66 Aligned_cols=201 Identities=26% Similarity=0.401 Sum_probs=175.1
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc-eEE
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD-FLY 182 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-~~~ 182 (510)
.+++|.--..||+|+||.||+|...++ ..||||++....... ...+.+|+.+|..++|||+|+|+|+|.+.+ ..+
T Consensus 73 AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~ 148 (361)
T KOG1187|consen 73 ATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRL 148 (361)
T ss_pred HHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEE
Confidence 348899999999999999999988754 899999886543211 344999999999999999999999999998 599
Q ss_pred EEEeccCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHhhhhCC---eEEeecCCCCeeecCCCceeecccCCcccCc
Q 010463 183 LIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHN---YVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 257 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~lH~~g---iiHRDLKP~NILld~~g~vkL~DFGla~~~~ 257 (510)
||+|||++|+|.++|.... .+++.....|+.+++.||+|||... ||||||||+|||||++...||+|||+|+...
T Consensus 149 LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~ 228 (361)
T KOG1187|consen 149 LVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGP 228 (361)
T ss_pred EEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCC
Confidence 9999999999999998765 8999999999999999999999853 9999999999999999999999999997654
Q ss_pred c-ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccc-cccCCCcchHhhccCCCCccccccchhhHHH
Q 010463 258 D-KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYST-VGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 335 (510)
Q Consensus 258 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~-~GT~~Y~APEvl~~~~y~~~~DiwSlGvily 335 (510)
. ... ..+. .||.+|+|||++..+..+.++|||||||+|.
T Consensus 229 ~~~~~---------------------------------------~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvll 269 (361)
T KOG1187|consen 229 EGDTS---------------------------------------VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLL 269 (361)
T ss_pred ccccc---------------------------------------eeeecCCCCccCChhhhccCCcCcccccccchHHHH
Confidence 3 210 0112 7999999999999989999999999999999
Q ss_pred HHhhCCCCCCCC
Q 010463 336 EMLIGYPPFCSD 347 (510)
Q Consensus 336 Eml~G~~PF~~~ 347 (510)
||++|+.|....
T Consensus 270 Elitgr~~~d~~ 281 (361)
T KOG1187|consen 270 ELITGRKAVDQS 281 (361)
T ss_pred HHHhCCcccCCC
Confidence 999999888643
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=318.03 Aligned_cols=250 Identities=22% Similarity=0.401 Sum_probs=204.1
Q ss_pred ceeeeeeecCCCeEEEEEEEcC---CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc-----
Q 010463 108 FEQLTLIGKGAFGEVRLCRAKT---TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD----- 179 (510)
Q Consensus 108 f~~~~~IG~G~fG~V~~~~~~~---tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~----- 179 (510)
|.+.++||+|+||.||+|..+. +++.||||++.... ......+.+.+|+.+|+.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 5678899999999999998653 57899999996543 33445677889999999999999999999886532
Q ss_pred -eEEEEEeccCCCCHHHHHHhc------cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCC
Q 010463 180 -FLYLIMEYLPGGDIMTLLMRE------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGL 252 (510)
Q Consensus 180 -~~~lVmEy~~gG~L~~~L~~~------~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGl 252 (510)
..++++||+++|+|..++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 357899999999998887432 2478999999999999999999999999999999999999999999999999
Q ss_pred cccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhh
Q 010463 253 CKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGA 332 (510)
Q Consensus 253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGv 332 (510)
++......... ......+++.|++||.+....++.++|||||||
T Consensus 160 ~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~ 203 (273)
T cd05074 160 SKKIYSGDYYR------------------------------------QGCASKLPVKWLALESLADNVYTTHSDVWAFGV 203 (273)
T ss_pred cccccCCccee------------------------------------cCCCccCchhhcCHhHHhcCccchhhhhHHHHH
Confidence 98653321000 001234678899999999999999999999999
Q ss_pred HHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 333 IMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 333 ilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
++|||++ |.+||.+.+....+..+..+.. +..+ +..+..+.+++.+||. +|++|| ++.+++.
T Consensus 204 il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~l~~~~l~~~p~~Rp---s~~~~~~ 267 (273)
T cd05074 204 TMWEIMTRGQTPYAGVENSEIYNYLIKGNR-LKQP--PDCLEDVYELMCQCWSPEPKCRP---SFQHLRD 267 (273)
T ss_pred HHHHHhhCCCCCCCCCCHHHHHHHHHcCCc-CCCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 9999999 9999998887777776665422 2222 4678999999999998 999999 5677764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=318.33 Aligned_cols=253 Identities=25% Similarity=0.406 Sum_probs=204.2
Q ss_pred CCceeeeeeecCCCeEEEEEEEcC----CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec--Cc
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKT----TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD--SD 179 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~----tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~ 179 (510)
.+|++++.||+|+||.||+|+... +++.||+|++.+.... .....+.+|+.+++.++||||+++++++.+ ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 578889999999999999998653 5889999999765322 356779999999999999999999999887 56
Q ss_pred eEEEEEeccCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 180 FLYLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~~-~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
..|+||||+++|+|.+++.... .+++..+..++.|++.||+|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 8999999999999999997654 689999999999999999999999999999999999999999999999999987653
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHh
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml 338 (510)
..... .......++..|+|||.+.+..++.++|+|||||++|||+
T Consensus 162 ~~~~~-----------------------------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~ 206 (284)
T cd05038 162 DKDYY-----------------------------------YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELF 206 (284)
T ss_pred CCcce-----------------------------------eccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheee
Confidence 21100 0000124566799999999889999999999999999999
Q ss_pred hCCCCCCCCChhh--------------hHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 339 IGYPPFCSDDPRI--------------TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 339 ~G~~PF~~~~~~~--------------~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
+|..||....... ....++.. ....+....++.++.+|+.+||. +|.+|| ++.||++
T Consensus 207 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp---t~~ei~~ 278 (284)
T cd05038 207 TYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE--GERLPRPPSCPDEVYDLMKLCWEAEPQDRP---SFADLIL 278 (284)
T ss_pred ccCCCcccccchhccccccccccccHHHHHHHHHc--CCcCCCCccCCHHHHHHHHHHhccChhhCC---CHHHHHH
Confidence 9999987643221 11222221 22233334678899999999998 999999 5667654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=315.07 Aligned_cols=234 Identities=19% Similarity=0.276 Sum_probs=192.8
Q ss_pred eeeecCCCeEEEEEEEcCCC----------CEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceE
Q 010463 112 TLIGKGAFGEVRLCRAKTTG----------EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 181 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~tg----------~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~ 181 (510)
+.||+|+||.||+|.++.++ ..+|+|++..... ....+.+|..+|+.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 36899999999999998877 3478887754421 15678889999999999999999999988 778
Q ss_pred EEEEeccCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCC-------ceeecccCCc
Q 010463 182 YLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG-------HLKLSDFGLC 253 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~-~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g-------~vkL~DFGla 253 (510)
++||||+++|+|.+++.+.. .+++..+..++.||+.||.|||+.||+||||||+|||++.++ ++||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999999998766 789999999999999999999999999999999999999888 8999999998
Q ss_pred ccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC--CCCccccccchh
Q 010463 254 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK--GYGMECDWWSLG 331 (510)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~--~y~~~~DiwSlG 331 (510)
...... ...+|+..|+|||++.+. .++.++|+||||
T Consensus 156 ~~~~~~------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG 193 (259)
T cd05037 156 ITVLSR------------------------------------------EERVERIPWIAPECIRNGQASLTIAADKWSFG 193 (259)
T ss_pred cccccc------------------------------------------cccccCCCccChhhhcCCCCCcchhhHHHHHH
Confidence 864321 024578889999999876 789999999999
Q ss_pred hHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 332 AIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 332 vilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
|++|||++ |..||...+......... ... ..|. ..+..+.++|.+||. +|.+|| ++.++++
T Consensus 194 ~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~--~~~~--~~~~~~~~li~~~l~~~p~~Rp---t~~~il~ 256 (259)
T cd05037 194 TTLLEICSNGEEPLSTLSSSEKERFYQ-DQH--RLPM--PDCAELANLINQCWTYDPTKRP---SFRAILR 256 (259)
T ss_pred HHHHHHHhCCCCCcccCCchhHHHHHh-cCC--CCCC--CCchHHHHHHHHHhccChhhCC---CHHHHHH
Confidence 99999999 688887765443333222 111 1221 224799999999998 999999 5777764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=315.29 Aligned_cols=248 Identities=20% Similarity=0.274 Sum_probs=193.5
Q ss_pred eeeecCCCeEEEEEEEcCCC--CEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEeccC
Q 010463 112 TLIGKGAFGEVRLCRAKTTG--EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLP 189 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~tg--~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy~~ 189 (510)
+.||+|+||.||+|+....+ ..+++|.+.... .....+.+.+|..+++.++||||+++++.|.+....|+||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 36999999999999765433 346667665432 22345678999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 190 GGDIMTLLMRE----DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 190 gG~L~~~L~~~----~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
+|+|.+++.+. ..+++..++.++.||+.||.|||+.+|+||||||+|||++.++++||+|||++.........
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~--- 155 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI--- 155 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhh---
Confidence 99999999764 34567778899999999999999999999999999999999999999999998643211000
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-------CCCCccccccchhhHHHHHh
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-------KGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-------~~y~~~~DiwSlGvilyEml 338 (510)
......+|++.|+|||++.. ..++.++|||||||++|||+
T Consensus 156 ---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~ 202 (268)
T cd05086 156 ---------------------------------ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202 (268)
T ss_pred ---------------------------------hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHH
Confidence 00113578999999999853 24578999999999999999
Q ss_pred h-CCCCCCCCChhhhHHHHhhcccc-ccCCC-CCCCCHHHHHHHHHhhcCccccCCCCChHHhhc
Q 010463 339 I-GYPPFCSDDPRITCRKIVNWKTC-LKFPE-EPKISDEARDLICHLLCDVETRLGTRGVEELKE 400 (510)
Q Consensus 339 ~-G~~PF~~~~~~~~~~~I~~~~~~-~~~p~-~~~~s~~~~dlI~~lL~dp~~R~~~~~~~eil~ 400 (510)
+ |.+||...+..+.+.++...... +..|. ...+++.+.+++..|+.+|.+|| ++++|++
T Consensus 203 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~P~~Rp---~~~~i~~ 264 (268)
T cd05086 203 ENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCWLSPEKRA---TAEEVHR 264 (268)
T ss_pred hCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHhhCcccCC---CHHHHHH
Confidence 7 67899877777777666543211 11121 13578899999999998999999 5677653
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=319.53 Aligned_cols=258 Identities=17% Similarity=0.153 Sum_probs=191.7
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCC---CCEEEEEEeechhhcchhhH--------HHHHHHHHHHHhcCCCCeeeE
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTT---GEIFAMKKLKKSEMLKRGQV--------EHVRSERNLLAEVDSRCIVQL 171 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t---g~~vAiK~i~k~~~~~~~~~--------~~~~~E~~iL~~l~hp~Iv~l 171 (510)
+..+.|.+.+.||+|+||.||+|++..+ +..+|+|+..........+. .....+...+..++|++|+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 4456899999999999999999999887 77788886432211000000 111223334566799999999
Q ss_pred eEEeecCc----eEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceee
Q 010463 172 FYSFQDSD----FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKL 247 (510)
Q Consensus 172 ~~~~~~~~----~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL 247 (510)
++++.... ..+++||++.. ++.+.+.....+++..++.++.|++.||.|||+.||+||||||+|||++.++.++|
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence 98766543 45888998854 67777766666789999999999999999999999999999999999999999999
Q ss_pred cccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccc
Q 010463 248 SDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDW 327 (510)
Q Consensus 248 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 327 (510)
+|||+|+.+........ .........+||+.|+|||++.+..|+.++||
T Consensus 168 ~DFGla~~~~~~~~~~~-------------------------------~~~~~~~~~~gt~~y~ape~~~~~~~~~~~Di 216 (294)
T PHA02882 168 IDYGIASHFIIHGKHIE-------------------------------YSKEQKDLHRGTLYYAGLDAHNGACVTRRGDL 216 (294)
T ss_pred EEcCCceeeccCCcccc-------------------------------cccccccccCCCccccCHHHhCCCCCCcHHHH
Confidence 99999987643211000 00001123579999999999999999999999
Q ss_pred cchhhHHHHHhhCCCCCCCCChhhh---------HHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHH
Q 010463 328 WSLGAIMYEMLIGYPPFCSDDPRIT---------CRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEE 397 (510)
Q Consensus 328 wSlGvilyEml~G~~PF~~~~~~~~---------~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~e 397 (510)
|||||++|||++|.+||.+.+.... ..++.. ....+ +..++++.+++..|+. +|++|| +.++
T Consensus 217 wSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~---~~~~~~~~~~~~~~~~~~~~~rp---~~~~ 288 (294)
T PHA02882 217 ESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHE--GKIKI---KNANKFIYDFIECVTKLSYEEKP---DYDA 288 (294)
T ss_pred HHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhh--hhhcc---CCCCHHHHHHHHHHHhCCCCCCC---CHHH
Confidence 9999999999999999987643221 122221 11222 3568899999999998 999999 5677
Q ss_pred hhc
Q 010463 398 LKE 400 (510)
Q Consensus 398 il~ 400 (510)
|++
T Consensus 289 l~~ 291 (294)
T PHA02882 289 LIK 291 (294)
T ss_pred HHH
Confidence 764
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=342.12 Aligned_cols=261 Identities=31% Similarity=0.495 Sum_probs=222.1
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEee---
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQ--- 176 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~--- 176 (510)
.....+-|+++.+||+|.+|.||+++++.+|+..|+|++.... ..-+.+..|.+||+.. +|||++.+||+|.
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 3445678999999999999999999999999999999986532 2234577899999766 7999999999886
Q ss_pred --cCceEEEEEeccCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCC
Q 010463 177 --DSDFLYLIMEYLPGGDIMTLLMR--EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGL 252 (510)
Q Consensus 177 --~~~~~~lVmEy~~gG~L~~~L~~--~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGl 252 (510)
.++.+|||||||.||+.-+++.. ...+.|+.+..++.+++.||.+||...+||||||-.|||++.+|.|||+|||+
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGv 169 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGV 169 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeee
Confidence 35689999999999999999865 46789999999999999999999999999999999999999999999999999
Q ss_pred cccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC-----CCCccccc
Q 010463 253 CKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-----GYGMECDW 327 (510)
Q Consensus 253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-----~y~~~~Di 327 (510)
+..++... ....+.+|||.||||||+... .|+..+|+
T Consensus 170 SaQldsT~--------------------------------------grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~ 211 (953)
T KOG0587|consen 170 SAQLDSTV--------------------------------------GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDL 211 (953)
T ss_pred eeeeeccc--------------------------------------ccccCcCCCcccccceeeecccCCCCCcccccch
Confidence 98775431 112468999999999999753 47889999
Q ss_pred cchhhHHHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 328 WSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 328 wSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
||||++..||.-|.||+.+.-+...+-+|... +++++-.+...|.+..|||..||. |-++|| ...+++.|||...
T Consensus 212 WsLGITaIEladG~PPl~DmHPmraLF~IpRN-PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP---~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 212 WSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-PPPKLKRPKKWSKKFNDFISTCLVKDYEQRP---STEELLKHPFITE 287 (953)
T ss_pred hhccceeehhcCCCCCccCcchhhhhccCCCC-CCccccchhhHHHHHHHHHHHHHhhccccCc---chhhhccCCcccc
Confidence 99999999999999999998887777666543 233333345889999999999998 999999 6899999999984
Q ss_pred C
Q 010463 407 I 407 (510)
Q Consensus 407 i 407 (510)
-
T Consensus 288 ~ 288 (953)
T KOG0587|consen 288 Q 288 (953)
T ss_pred c
Confidence 3
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=346.20 Aligned_cols=264 Identities=20% Similarity=0.326 Sum_probs=185.0
Q ss_pred hcccCCCCceeeeeeecCCCeEEEEEEEcCC----CCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEE-
Q 010463 100 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTT----GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYS- 174 (510)
Q Consensus 100 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t----g~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~- 174 (510)
+.....++|++.+.||+|+||.||+|++..+ +..||+|++.... ..+....|+ +....+.+++.+...
T Consensus 126 ~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-----~~e~~~~e~--l~~~~~~~~~~~~~~~ 198 (566)
T PLN03225 126 RPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-----AVEIWMNER--VRRACPNSCADFVYGF 198 (566)
T ss_pred CCCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-----hhHHHHHHH--HHhhchhhHHHHHHhh
Confidence 4456788999999999999999999999998 9999999876432 111111111 111222222222222
Q ss_pred -----eecCceEEEEEeccCCCCHHHHHHhccC--------------------CCHHHHHHHHHHHHHHHHhhhhCCeEE
Q 010463 175 -----FQDSDFLYLIMEYLPGGDIMTLLMREDI--------------------LSEDVARFYIAESVLAIHSIHQHNYVH 229 (510)
Q Consensus 175 -----~~~~~~~~lVmEy~~gG~L~~~L~~~~~--------------------l~e~~~~~~~~qi~~aL~~lH~~giiH 229 (510)
..+...+++||||+++|+|.+++..... ..+..++.++.||+.||+|||+.||||
T Consensus 199 ~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiH 278 (566)
T PLN03225 199 LEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVH 278 (566)
T ss_pred hcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence 2456789999999999999999865421 123456789999999999999999999
Q ss_pred eecCCCCeeecC-CCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccC
Q 010463 230 RDIKPDNLILDK-NGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTL 308 (510)
Q Consensus 230 RDLKP~NILld~-~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~ 308 (510)
|||||+|||++. ++.+||+|||+|+.+...... .....+|||
T Consensus 279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~-------------------------------------~~~~~~~t~ 321 (566)
T PLN03225 279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINY-------------------------------------IPKEFLLDP 321 (566)
T ss_pred CcCCHHHEEEeCCCCcEEEEeCCCcccccccccc-------------------------------------CCcccccCC
Confidence 999999999995 689999999999865432110 012468999
Q ss_pred CCcchHhhccC----------------------CCCccccccchhhHHHHHhhCCCCCCCCChhhhHHHHhh--------
Q 010463 309 DYMAPEVLLKK----------------------GYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVN-------- 358 (510)
Q Consensus 309 ~Y~APEvl~~~----------------------~y~~~~DiwSlGvilyEml~G~~PF~~~~~~~~~~~I~~-------- 358 (510)
.|||||++... .++.++|||||||+||||+++..|+. +....+.+++.
T Consensus 322 ~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~--~~~~~~~~~l~~~~~~~~~ 399 (566)
T PLN03225 322 RYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSD--SNLIQFNRQLKRNDYDLVA 399 (566)
T ss_pred CccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCc--hHHHHHHHHHHhcCCcHHH
Confidence 99999976532 23456799999999999998766543 22222222221
Q ss_pred cccccc--C-CC-------CCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchhh
Q 010463 359 WKTCLK--F-PE-------EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKL 412 (510)
Q Consensus 359 ~~~~~~--~-p~-------~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l 412 (510)
|..... . +. ....+..++|||++||+ ||.+|| ++.++++||||.+.++..+
T Consensus 400 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~---ta~e~L~Hpff~~~~~~~~ 461 (566)
T PLN03225 400 WRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRI---SAKAALAHPYFDREGLLGL 461 (566)
T ss_pred HHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCC---CHHHHhCCcCcCCCCcccc
Confidence 100000 0 00 01123456799999999 999999 7899999999999877544
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=347.61 Aligned_cols=258 Identities=25% Similarity=0.380 Sum_probs=218.0
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcC-----CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEe
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKT-----TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSF 175 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~-----tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 175 (510)
..+...+.+..+.||+|+||+||+|+.-. ....||||.++... ...+...|++|+++|..++|||||+|+|+|
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC 558 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVC 558 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence 34566788889999999999999998643 33569999997653 333567899999999999999999999999
Q ss_pred ecCceEEEEEeccCCCCHHHHHHhc--------------cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecC
Q 010463 176 QDSDFLYLIMEYLPGGDIMTLLMRE--------------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK 241 (510)
Q Consensus 176 ~~~~~~~lVmEy~~gG~L~~~L~~~--------------~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~ 241 (510)
..++.+|||+|||..|||..+|+.. ..++..+...++.||+.|++||-++.+|||||-..|+||.+
T Consensus 559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGE 638 (774)
T ss_pred ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceecc
Confidence 9999999999999999999999642 23788899999999999999999999999999999999999
Q ss_pred CCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCC
Q 010463 242 NGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY 321 (510)
Q Consensus 242 ~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y 321 (510)
+-.|||+||||++.+-...+.... ....-...||+||.++.+.|
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~------------------------------------~~t~lPIRWMppEsIly~kF 682 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVR------------------------------------GNTLLPIRWMPPESILYGKF 682 (774)
T ss_pred ceEEEecccccchhhhhhhhhccc------------------------------------CCceeeeecCCHHHhhcCcc
Confidence 999999999999965432211100 01123568999999999999
Q ss_pred CccccccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhh
Q 010463 322 GMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 399 (510)
Q Consensus 322 ~~~~DiwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil 399 (510)
+.++||||+||+|||+++ |..|+++.+.++....|.++.- +.-|+ +.+.++.+|+..|+. .|.+||+..++.-+|
T Consensus 683 TteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l-L~~Pe--~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L 759 (774)
T KOG1026|consen 683 TTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL-LSCPE--NCPTEVYSLMLECWNENPKRRPSFKEIHSRL 759 (774)
T ss_pred cchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc-ccCCC--CCCHHHHHHHHHHhhcCcccCCCHHHHHHHH
Confidence 999999999999999997 9999999999999999988653 55564 899999999999998 999999654444444
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=320.24 Aligned_cols=254 Identities=26% Similarity=0.422 Sum_probs=207.8
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC--C----CeeeEeEEeecC
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS--R----CIVQLFYSFQDS 178 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~h--p----~Iv~l~~~~~~~ 178 (510)
.+.|.+++.+|+|.||.|..|.+..++..||+|+++.- ..-.+..+.|+++|.++.+ | .+|.+.++|.-.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 57899999999999999999999999999999998642 2234557789999999832 2 588899999999
Q ss_pred ceEEEEEeccCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecC---------------
Q 010463 179 DFLYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK--------------- 241 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~--------------- 241 (510)
++.|+|+|.+ |-+++++|..++ +|+-.+++.+++|++.++.+||+.+++|-||||||||+-+
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence 9999999998 679999998754 6899999999999999999999999999999999999932
Q ss_pred -----CCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhh
Q 010463 242 -----NGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL 316 (510)
Q Consensus 242 -----~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl 316 (510)
+-+|||+|||.|+...... ++.|.|..|.|||++
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~h-----------------------------------------s~iVsTRHYRAPEVi 281 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEHH-----------------------------------------STIVSTRHYRAPEVI 281 (415)
T ss_pred eccCCCcceEEEecCCcceeccCc-----------------------------------------ceeeeccccCCchhe
Confidence 3468999999998754431 257899999999999
Q ss_pred ccCCCCccccccchhhHHHHHhhCCCCCCCCChhh---hHHHHhhc----------------cccccCCCC---------
Q 010463 317 LKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI---TCRKIVNW----------------KTCLKFPEE--------- 368 (510)
Q Consensus 317 ~~~~y~~~~DiwSlGvilyEml~G~~PF~~~~~~~---~~~~I~~~----------------~~~~~~p~~--------- 368 (510)
++-+++..|||||+||||+|+.+|...|...+..+ +.++|+.- ...+..|+.
T Consensus 282 LgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v 361 (415)
T KOG0671|consen 282 LGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYV 361 (415)
T ss_pred eccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhh
Confidence 99999999999999999999999999998766444 33444320 001111110
Q ss_pred --------------CCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 369 --------------PKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 369 --------------~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
..--.++-|||++||. ||.+|+ ++.|++.||||+..
T Consensus 362 ~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri---Tl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 362 FEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI---TLREALSHPFFARL 412 (415)
T ss_pred hcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc---cHHHHhcCHHhhcC
Confidence 0112357899999999 999999 78999999999864
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=311.08 Aligned_cols=267 Identities=28% Similarity=0.472 Sum_probs=219.9
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc------
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD------ 179 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~------ 179 (510)
..|.-++.+|.|+- .|..+-+.-+++.||+|++... .......++..+|..++..++|+||++++.+|.-..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 46777888999998 7777888889999999998765 334445677889999999999999999999996443
Q ss_pred eEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 180 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
.+|+|||||.+ +|...+. -.++-+.+++++.|+++|+.|||+.||+||||||+||++..++.+||+|||+|+.....
T Consensus 95 e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred hHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc
Confidence 68999999965 7877776 34788889999999999999999999999999999999999999999999999864322
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~ 339 (510)
-..+..+.|..|.|||++.+.+|...+||||+|||+.||++
T Consensus 172 ---------------------------------------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~ 212 (369)
T KOG0665|consen 172 ---------------------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELIL 212 (369)
T ss_pred ---------------------------------------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhh
Confidence 01124789999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhhHHHHhhccc-----------------------------cccCCCC---------CCCCHHHHHHHHH
Q 010463 340 GYPPFCSDDPRITCRKIVNWKT-----------------------------CLKFPEE---------PKISDEARDLICH 381 (510)
Q Consensus 340 G~~PF~~~~~~~~~~~I~~~~~-----------------------------~~~~p~~---------~~~s~~~~dlI~~ 381 (510)
|..-|.|.+...++.+|+..-+ .-.+|+. +.-+..++||+.+
T Consensus 213 ~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~ 292 (369)
T KOG0665|consen 213 GTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSK 292 (369)
T ss_pred ceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHH
Confidence 9999999988888877763100 0111211 1234679999999
Q ss_pred hhc-CccccCCCCChHHhhcCCCcCCCCchhhhcccCCCcc
Q 010463 382 LLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKP 421 (510)
Q Consensus 382 lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l~~~~~p~~p 421 (510)
||. ||++|. +++++|+||||+ -|-...+.++|.+|
T Consensus 293 MLvi~pe~Ri---sv~daL~HPY~~--vw~~~~ev~ap~pe 328 (369)
T KOG0665|consen 293 MLVIDPEKRI---SVDDALRHPYIK--VWYDPDEVEAPPPE 328 (369)
T ss_pred hhccChhhcc---cHHHHhcCCeee--eecccccccCCCCc
Confidence 998 999999 799999999999 68666666666665
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=310.42 Aligned_cols=263 Identities=29% Similarity=0.437 Sum_probs=211.8
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec-------
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD------- 177 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~------- 177 (510)
.+.|+-+..||+|.||+||+|+.+.+|+.||+|++--.. .+..--....+|+++|..++|+|++.|+..|..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 356777889999999999999999999999998653211 122333457789999999999999999876653
Q ss_pred -CceEEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCccc
Q 010463 178 -SDFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 255 (510)
Q Consensus 178 -~~~~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~ 255 (510)
...+||||.+|+. ||..+|... -.|+..+++.++.+++.||.|+|+..|+|||+||+|+||+.+|.+||+|||+++.
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 2359999999976 999999765 5799999999999999999999999999999999999999999999999999987
Q ss_pred CccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHH
Q 010463 256 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIM 334 (510)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvil 334 (510)
+....... ++ .-+..|-|.+|.+||.+.+ ..|+.+.|+|..|||+
T Consensus 174 fs~~~n~~-----------------kp-----------------rytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCim 219 (376)
T KOG0669|consen 174 FSTSKNVV-----------------KP-----------------RYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIM 219 (376)
T ss_pred eecccccC-----------------CC-----------------CcccceeeeecCCHHHhhcccccCCcchhHhHHHHH
Confidence 64431110 00 0123578999999999987 5799999999999999
Q ss_pred HHHhhCCCCCCCCChhhhHHHHhh---------ccccccCCCC----------------------CCCCHHHHHHHHHhh
Q 010463 335 YEMLIGYPPFCSDDPRITCRKIVN---------WKTCLKFPEE----------------------PKISDEARDLICHLL 383 (510)
Q Consensus 335 yEml~G~~PF~~~~~~~~~~~I~~---------~~~~~~~p~~----------------------~~~s~~~~dlI~~lL 383 (510)
.||.+|.|-|.+.+...+...|.. |+..-.+|-+ -.-++++.||+.+||
T Consensus 220 aeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll 299 (376)
T KOG0669|consen 220 AEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLL 299 (376)
T ss_pred HHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHh
Confidence 999999999999988877766642 2221111110 012468999999999
Q ss_pred c-CccccCCCCChHHhhcCCCcCC
Q 010463 384 C-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 384 ~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
. ||.+|+ .++++++|-||..
T Consensus 300 ~~DP~kR~---~ad~alnh~~F~k 320 (376)
T KOG0669|consen 300 KLDPTKRI---DADQALNHDFFWK 320 (376)
T ss_pred ccCcccCc---chHhhhchhhhhc
Confidence 9 999999 6899999999964
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=349.49 Aligned_cols=254 Identities=25% Similarity=0.381 Sum_probs=215.6
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCC-----EEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGE-----IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 177 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~-----~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 177 (510)
+.....++++.||+|+||.||.|...+-.- .||||.+.+. .+..++..|.+|..+|+.++|||||+|+|++.+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 445678889999999999999998875332 3999998764 366778899999999999999999999999999
Q ss_pred CceEEEEEeccCCCCHHHHHHhc-------cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeeccc
Q 010463 178 SDFLYLIMEYLPGGDIMTLLMRE-------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDF 250 (510)
Q Consensus 178 ~~~~~lVmEy~~gG~L~~~L~~~-------~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DF 250 (510)
....++++|||.||||..+|++. ..++......++.+|+.|++||+++++|||||-..|+||+....|||+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 99999999999999999999875 35888899999999999999999999999999999999999999999999
Q ss_pred CCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccch
Q 010463 251 GLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSL 330 (510)
Q Consensus 251 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSl 330 (510)
|+|+.+-...+.. ..- ...-...|||||.+....++.++|||||
T Consensus 847 GlArDiy~~~yyr-------------------------------~~~-----~a~lPvkWm~PEsl~d~iFtskSDvWsF 890 (1025)
T KOG1095|consen 847 GLARDIYDKDYYR-------------------------------KHG-----EAMLPVKWMPPESLKDGIFTSKSDVWSF 890 (1025)
T ss_pred chhHhhhhchhee-------------------------------ccC-----ccccceecCCHHHHhhcccccccchhhh
Confidence 9999543321110 000 0012347999999999999999999999
Q ss_pred hhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 331 GAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 331 GvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
||+|||+++ |.+||.+.+..+...-.+.+. .+..| ..+++.+.+++..|+. +|++|| ++..|++
T Consensus 891 GVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~~P--~~CP~~ly~lM~~CW~~~pe~RP---~F~~i~~ 956 (1025)
T KOG1095|consen 891 GVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLDPP--SYCPEKLYQLMLQCWKHDPEDRP---SFRTIVE 956 (1025)
T ss_pred HHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccCCC--CCCChHHHHHHHHHccCChhhCc---cHHHHHh
Confidence 999999998 999999999988888777654 44444 5899999999999998 999999 5666665
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=310.23 Aligned_cols=259 Identities=27% Similarity=0.463 Sum_probs=209.8
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHH-HhcCCCCeeeEeEEeecCceE
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLL-AEVDSRCIVQLFYSFQDSDFL 181 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL-~~l~hp~Iv~l~~~~~~~~~~ 181 (510)
...++.+-+..||.|+||+|++..++.+|+..|||.|+.... ..+..++..|.+.. +.-+.||||++||+...++..
T Consensus 61 F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdc 138 (361)
T KOG1006|consen 61 FTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDC 138 (361)
T ss_pred cccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCce
Confidence 344566667889999999999999999999999999987643 33456677787764 556899999999999999999
Q ss_pred EEEEeccCCCCHHHHH-----HhccCCCHHHHHHHHHHHHHHHHhhhh-CCeEEeecCCCCeeecCCCceeecccCCccc
Q 010463 182 YLIMEYLPGGDIMTLL-----MREDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 255 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L-----~~~~~l~e~~~~~~~~qi~~aL~~lH~-~giiHRDLKP~NILld~~g~vkL~DFGla~~ 255 (510)
|+.||+|.- +|..+- .++..++|...-.+...++.||+||-. +.|||||+||+|||||..|.|||||||+|-.
T Consensus 139 WiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGq 217 (361)
T KOG1006|consen 139 WICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQ 217 (361)
T ss_pred eeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHh
Confidence 999999953 554433 245679999999999999999999985 6999999999999999999999999999987
Q ss_pred CccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc--cCCCCccccccchhhH
Q 010463 256 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL--KKGYGMECDWWSLGAI 333 (510)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~--~~~y~~~~DiwSlGvi 333 (510)
+.++... +.-+|...|||||.+. +.+|+.++|+||||++
T Consensus 218 Lv~SiAk---------------------------------------T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGIT 258 (361)
T KOG1006|consen 218 LVDSIAK---------------------------------------TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGIT 258 (361)
T ss_pred HHHHHHh---------------------------------------hhccCCccccChhccCCccCCcchhhhhhhhcce
Confidence 7543110 1247999999999996 4579999999999999
Q ss_pred HHHHhhCCCCCCCCCh-hhhHHHHhhcccccc-CCC-CCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 334 MYEMLIGYPPFCSDDP-RITCRKIVNWKTCLK-FPE-EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 334 lyEml~G~~PF~~~~~-~~~~~~I~~~~~~~~-~p~-~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
|||+.||..|+.+-+. -++...++.+..+.- ++. ..+.|..++.||..||. |-..|| ...+++++||++.
T Consensus 259 L~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rp---ky~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 259 LYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRP---KYDDLKKFPFYRM 332 (361)
T ss_pred EeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCc---chhhhhcCchhhh
Confidence 9999999999976443 344555555433322 222 24689999999999998 999999 5789999999874
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=295.47 Aligned_cols=253 Identities=29% Similarity=0.461 Sum_probs=208.3
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEeEEeecCc--e
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSD--F 180 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~--~ 180 (510)
..++|++++.+|+|.|++|+.|....+++.++||+++.- ..+.+.+|+.||..+. ||||++|++...|+. .
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 468999999999999999999999999999999998643 2355899999999986 999999999998865 5
Q ss_pred EEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCC-CceeecccCCcccCccc
Q 010463 181 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN-GHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~-g~vkL~DFGla~~~~~~ 259 (510)
..||+||+.+.|...+- ..++.-.+++|+.|++.||.|||++||+|||+||.|++||.. -.++|+|+|||.....+
T Consensus 110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 78999999998887765 468899999999999999999999999999999999999954 57999999999877654
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml 338 (510)
... ...|.+..|--||.+.. +.|+.+-|+|||||+|..|+
T Consensus 187 ~eY---------------------------------------nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~mi 227 (338)
T KOG0668|consen 187 KEY---------------------------------------NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 227 (338)
T ss_pred cee---------------------------------------eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHH
Confidence 221 12467888999999976 67899999999999999999
Q ss_pred hCCCCC-CCCChhhhHHHHhhc-----------cccccC---------------------CCCC-CCCHHHHHHHHHhhc
Q 010463 339 IGYPPF-CSDDPRITCRKIVNW-----------KTCLKF---------------------PEEP-KISDEARDLICHLLC 384 (510)
Q Consensus 339 ~G~~PF-~~~~~~~~~~~I~~~-----------~~~~~~---------------------p~~~-~~s~~~~dlI~~lL~ 384 (510)
..+-|| .|.+..++..+|..- +..+.+ +... -+++++.||+.+||.
T Consensus 228 FrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLr 307 (338)
T KOG0668|consen 228 FRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLR 307 (338)
T ss_pred hccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHh
Confidence 988887 466655555555320 000001 1112 356999999999999
Q ss_pred -CccccCCCCChHHhhcCCCcCCC
Q 010463 385 -DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 385 -dp~~R~~~~~~~eil~HpfF~~i 407 (510)
|-.+|+ ++.|++.||||..+
T Consensus 308 YDHqeRl---TakEam~HpyF~~~ 328 (338)
T KOG0668|consen 308 YDHQERL---TAKEAMAHPYFAPV 328 (338)
T ss_pred hcccccc---chHHHhcCchHHHH
Confidence 999999 68999999999764
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=328.80 Aligned_cols=264 Identities=20% Similarity=0.281 Sum_probs=191.6
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEc----------------CCCCEEEEEEeechhhcc-----------hhhHHHH
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAK----------------TTGEIFAMKKLKKSEMLK-----------RGQVEHV 153 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~----------------~tg~~vAiK~i~k~~~~~-----------~~~~~~~ 153 (510)
.+...++|++.++||+|+||.||+|... ..++.||||.+....... ....+..
T Consensus 140 ~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~ 219 (507)
T PLN03224 140 SRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETG 219 (507)
T ss_pred CCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchh
Confidence 3467889999999999999999998652 345679999986432100 1112233
Q ss_pred HHHHHHHHhcCCCCe-----eeEeEEeec--------CceEEEEEeccCCCCHHHHHHhc--------------------
Q 010463 154 RSERNLLAEVDSRCI-----VQLFYSFQD--------SDFLYLIMEYLPGGDIMTLLMRE-------------------- 200 (510)
Q Consensus 154 ~~E~~iL~~l~hp~I-----v~l~~~~~~--------~~~~~lVmEy~~gG~L~~~L~~~-------------------- 200 (510)
..|..++..+.|.++ ++++++|.. .+..||||||+++|+|.++|...
T Consensus 220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~ 299 (507)
T PLN03224 220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD 299 (507)
T ss_pred HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence 456777777766554 666666542 35689999999999999988642
Q ss_pred ----cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhhhhccccc
Q 010463 201 ----DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETV 276 (510)
Q Consensus 201 ----~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~ 276 (510)
..+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++..+......
T Consensus 300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-------------- 365 (507)
T PLN03224 300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-------------- 365 (507)
T ss_pred hcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc--------------
Confidence 12356778889999999999999999999999999999999999999999999754322100
Q ss_pred ccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCC--------------------CC--ccccccchhhHH
Q 010463 277 SEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG--------------------YG--MECDWWSLGAIM 334 (510)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~--------------------y~--~~~DiwSlGvil 334 (510)
......+||.|+|||++.... |+ ..+|+||+||++
T Consensus 366 -----------------------~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil 422 (507)
T PLN03224 366 -----------------------NPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLL 422 (507)
T ss_pred -----------------------CccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHH
Confidence 001124689999999986432 22 347999999999
Q ss_pred HHHhhCCC-CCCCCChh-----------hhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-Cc---cccCCCCChHHh
Q 010463 335 YEMLIGYP-PFCSDDPR-----------ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DV---ETRLGTRGVEEL 398 (510)
Q Consensus 335 yEml~G~~-PF~~~~~~-----------~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp---~~R~~~~~~~ei 398 (510)
|+|++|.. ||.+.... ..++.+. .....++....+++.++|||++||+ +| .+|+ +++|+
T Consensus 423 ~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~--~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~Rl---Sa~ea 497 (507)
T PLN03224 423 MQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK--GQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRL---SVGQA 497 (507)
T ss_pred HHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc--ccCCCcccccccChHHHHHHHHHhccCCCCcccCC---CHHHH
Confidence 99999975 77542111 1111111 1234455556789999999999997 55 5788 79999
Q ss_pred hcCCCcCC
Q 010463 399 KEHPWFRG 406 (510)
Q Consensus 399 l~HpfF~~ 406 (510)
|+||||..
T Consensus 498 L~Hp~f~~ 505 (507)
T PLN03224 498 LSHRFFLP 505 (507)
T ss_pred hCCCCcCC
Confidence 99999953
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=346.20 Aligned_cols=269 Identities=39% Similarity=0.684 Sum_probs=221.6
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCce
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 180 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 180 (510)
..-.-++|+.|+.|..|+||-||+++++.|.+.+|+| +.|..++-+ +||.....|++|
T Consensus 78 ~~p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilR----------nilt~a~npfvv----------- 135 (1205)
T KOG0606|consen 78 RAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILR----------NILTFAGNPFVV----------- 135 (1205)
T ss_pred cCCCccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhh----------ccccccCCccee-----------
Confidence 3345689999999999999999999999999999994 554433221 266777778877
Q ss_pred EEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccc
Q 010463 181 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 260 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~ 260 (510)
||-.+++..-+.++-+ ++.|++|||+.||+|||+||+|+||..-||+|++|||+++......
T Consensus 136 ----------gDc~tllk~~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ----------GDCATLLKNIGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ----------chhhhhcccCCCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 7888888776776653 3889999999999999999999999999999999999998654332
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhC
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 340 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G 340 (510)
..+..++. ..+ ..+++ .....||||.|+||||+..++|+..+|||++|+|+||.|.|
T Consensus 198 atnl~eg~----------------I~k-~t~Ef------~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVg 254 (1205)
T KOG0606|consen 198 ATNLKEGH----------------IEK-DTHEF------QDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 254 (1205)
T ss_pred cchhhhcc----------------hHH-HHHHh------hhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHhee
Confidence 22111110 000 11111 11246999999999999999999999999999999999999
Q ss_pred CCCCCCCChhhhHHHHhhccccccCCC-CCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchhhhcccCC
Q 010463 341 YPPFCSDDPRITCRKIVNWKTCLKFPE-EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAA 418 (510)
Q Consensus 341 ~~PF~~~~~~~~~~~I~~~~~~~~~p~-~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l~~~~~p 418 (510)
+.||.++++++.+..++. ....+|+ ...+.++++|+|.+||. +|..|++..++-++++|+||..+||..|...+++
T Consensus 255 cvpffGdtpeelfg~vis--d~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~llRqkae 332 (1205)
T KOG0606|consen 255 CVPFFGDTPEELFGQVIS--DDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLLRQKAE 332 (1205)
T ss_pred eeeccCCCHHHHHhhhhh--hhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhhhhhcc
Confidence 999999999999999887 3455554 34688999999999998 9999999999999999999999999999999999
Q ss_pred CccccCCCccCCCCCC
Q 010463 419 YKPTVNGELDTQNFEK 434 (510)
Q Consensus 419 ~~p~~~~~~d~~~f~~ 434 (510)
|+|.+..+.|+++|+.
T Consensus 333 fvpql~~eddtsyfdT 348 (1205)
T KOG0606|consen 333 FVPQLESEDDTSYFDT 348 (1205)
T ss_pred ccccccccccchhhcc
Confidence 9999999999999974
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=290.93 Aligned_cols=241 Identities=47% Similarity=0.773 Sum_probs=205.6
Q ss_pred CCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEeccCCCCHHHHH
Q 010463 118 AFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL 197 (510)
Q Consensus 118 ~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy~~gG~L~~~L 197 (510)
+||.||+|....+|+.+|+|++........ .+.+..|+.+++.++|+||+++++.+.+....++||||+++++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 689999999999999999999976543221 577899999999999999999999999999999999999999999999
Q ss_pred HhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhhhhcccccc
Q 010463 198 MREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVS 277 (510)
Q Consensus 198 ~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~ 277 (510)
.....+++..+..++.+++.+|.+||+.|++|+||+|.||+++.++.++|+|||++.......
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----------------- 141 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----------------- 141 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-----------------
Confidence 877668999999999999999999999999999999999999999999999999998764321
Q ss_pred cccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCC-CChhhhHHHH
Q 010463 278 EAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCS-DDPRITCRKI 356 (510)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~-~~~~~~~~~I 356 (510)
......|++.|++||.+.+..++.++|+||||+++|+|++|..||.. .+.......+
T Consensus 142 ----------------------~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~ 199 (244)
T smart00220 142 ----------------------LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKI 199 (244)
T ss_pred ----------------------ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 01235789999999999988899999999999999999999999987 4444444444
Q ss_pred hhccccccCCCC-CCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 357 VNWKTCLKFPEE-PKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 357 ~~~~~~~~~p~~-~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
.... ...+.. ..++.++.+++.+||. +|.+|| ++.++++||||
T Consensus 200 ~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp---~~~~~~~~~~~ 244 (244)
T smart00220 200 GKPK--PPFPPPEWKISPEAKDLIRKLLVKDPEKRL---TAEEALQHPFF 244 (244)
T ss_pred hccC--CCCccccccCCHHHHHHHHHHccCCchhcc---CHHHHhhCCCC
Confidence 4321 111111 1288999999999998 999999 78999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=317.69 Aligned_cols=203 Identities=33% Similarity=0.536 Sum_probs=184.7
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcch-----hhHHHHHHHHHHHHhcC---CCCeeeEeEEe
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR-----GQVEHVRSERNLLAEVD---SRCIVQLFYSF 175 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~-----~~~~~~~~E~~iL~~l~---hp~Iv~l~~~~ 175 (510)
...+|..++.+|.|+||.|++|.++.+...|+||.|.|+.+.-. ..+..+-.|+.||..++ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 35689999999999999999999999999999999999876433 33455778999999997 99999999999
Q ss_pred ecCceEEEEEecc-CCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcc
Q 010463 176 QDSDFLYLIMEYL-PGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCK 254 (510)
Q Consensus 176 ~~~~~~~lVmEy~-~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~ 254 (510)
+|++++||+||-. +|-||+++|..+..++|.+++.++.|++.|+++||+.||||||||-+|+.+|.+|.+||+|||.|.
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa 718 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAA 718 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchh
Confidence 9999999999986 678999999999999999999999999999999999999999999999999999999999999987
Q ss_pred cCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCC-CccccccchhhH
Q 010463 255 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAI 333 (510)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiwSlGvi 333 (510)
....+. ...++||.+|.|||++.+..| +..-|||+||++
T Consensus 719 ~~ksgp----------------------------------------fd~f~gtv~~aapevl~g~~y~gk~qdiwalgil 758 (772)
T KOG1152|consen 719 YTKSGP----------------------------------------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGIL 758 (772)
T ss_pred hhcCCC----------------------------------------cceeeeeccccchhhhCCCccCCCcchhhhhhhe
Confidence 654431 225799999999999999999 899999999999
Q ss_pred HHHHhhCCCCCCC
Q 010463 334 MYEMLIGYPPFCS 346 (510)
Q Consensus 334 lyEml~G~~PF~~ 346 (510)
||.++....||+.
T Consensus 759 lytivykenpyyn 771 (772)
T KOG1152|consen 759 LYTIVYKENPYYN 771 (772)
T ss_pred eeEEEeccCCCcC
Confidence 9999999999974
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=292.79 Aligned_cols=260 Identities=28% Similarity=0.453 Sum_probs=214.1
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc-----eE
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD-----FL 181 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-----~~ 181 (510)
|.+--+-||-|+||.||.+.+..+|+.||+|++..- ..+-...+.+.+|..+|...+|.||+.+++..|-.. .+
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 455567899999999999999999999999998642 223334577899999999999999999998887653 58
Q ss_pred EEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 182 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
|.|+|+|.. ||..++.....++.+.++-++.||+.||.|||+.||+||||||.|+|++++..+|||||||++..+....
T Consensus 133 YV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 133 YVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred HHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence 999999965 9999999989999999999999999999999999999999999999999999999999999997543211
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHhhC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIG 340 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml~G 340 (510)
.. .+.-+-|-.|.|||++++ ..|+.++||||+|||+.|+|..
T Consensus 212 ~h-------------------------------------MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgR 254 (449)
T KOG0664|consen 212 LN-------------------------------------MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQR 254 (449)
T ss_pred hh-------------------------------------hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhh
Confidence 10 112367889999999997 5689999999999999999999
Q ss_pred CCCCCCCChhhhHHHHhhc---------------------cccccCCCC---------CCCCHHHHHHHHHhhc-Ccccc
Q 010463 341 YPPFCSDDPRITCRKIVNW---------------------KTCLKFPEE---------PKISDEARDLICHLLC-DVETR 389 (510)
Q Consensus 341 ~~PF~~~~~~~~~~~I~~~---------------------~~~~~~p~~---------~~~s~~~~dlI~~lL~-dp~~R 389 (510)
+..|...++.+....|... +...+-|.. ..-..++.+++..||. ||.+|
T Consensus 255 rILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkr 334 (449)
T KOG0664|consen 255 KILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKR 334 (449)
T ss_pred hhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCccc
Confidence 9999999988887777531 111122211 1234578889999998 99999
Q ss_pred CCCCChHHhhcCCCcCCCC
Q 010463 390 LGTRGVEELKEHPWFRGIQ 408 (510)
Q Consensus 390 ~~~~~~~eil~HpfF~~i~ 408 (510)
. +.++++.|++.....
T Consensus 335 i---s~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 335 I---SVEEALQHRYLEEGR 350 (449)
T ss_pred c---cHhhhcccccccccc
Confidence 9 689999999987654
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=311.32 Aligned_cols=256 Identities=27% Similarity=0.445 Sum_probs=210.0
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC------CCeeeEeEEee
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS------RCIVQLFYSFQ 176 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~h------p~Iv~l~~~~~ 176 (510)
+--+.|.+....|+|-|++|..|++...|..||||+|...++..+ .=..|+.||++|+. -++++|+-.|.
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~K----tGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHK----TGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhh----hhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 334578899999999999999999999999999999987665433 34579999999843 58999999999
Q ss_pred cCceEEEEEeccCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCC-ceeecccCC
Q 010463 177 DSDFLYLIMEYLPGGDIMTLLMRED---ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG-HLKLSDFGL 252 (510)
Q Consensus 177 ~~~~~~lVmEy~~gG~L~~~L~~~~---~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g-~vkL~DFGl 252 (510)
..+++|||+|-+. -+|..+|.+.+ .|....++.|+.|++.||..|-.+||+|.||||+|||+++.. .+||||||.
T Consensus 505 hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 505 HKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred hcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcc
Confidence 9999999999884 48999998865 488899999999999999999999999999999999999654 589999999
Q ss_pred cccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhh
Q 010463 253 CKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGA 332 (510)
Q Consensus 253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGv 332 (510)
|....... .+...-+..|.|||++.+-+|+...|+||+||
T Consensus 584 A~~~~ene----------------------------------------itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgc 623 (752)
T KOG0670|consen 584 ASFASENE----------------------------------------ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGC 623 (752)
T ss_pred cccccccc----------------------------------------ccHHHHHHhccCcceeecCcccCCccceeece
Confidence 98765431 11234567899999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCChhhhHHHHhhccccc-------------------c-----------------------------
Q 010463 333 IMYEMLIGYPPFCSDDPRITCRKIVNWKTCL-------------------K----------------------------- 364 (510)
Q Consensus 333 ilyEml~G~~PF~~~~~~~~~~~I~~~~~~~-------------------~----------------------------- 364 (510)
+||||.||+..|.|.+...++...+..++.+ .
T Consensus 624 tLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s 703 (752)
T KOG0670|consen 624 TLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGS 703 (752)
T ss_pred eeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHH
Confidence 9999999999999988776665444211100 0
Q ss_pred -------CCC-CCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 365 -------FPE-EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 365 -------~p~-~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
+|. .+.+-..++||+.+||. ||++|+ ++.++|+||||.+
T Consensus 704 ~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi---t~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 704 ELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI---TVNQALKHPFITE 751 (752)
T ss_pred HHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC---CHHHHhcCCcccC
Confidence 000 01122568999999998 999999 7899999999964
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=277.85 Aligned_cols=223 Identities=27% Similarity=0.485 Sum_probs=185.0
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHH-hcCCCCeeeEeEEeecCc
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA-EVDSRCIVQLFYSFQDSD 179 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~-~l~hp~Iv~l~~~~~~~~ 179 (510)
..+..++...+..||+|+||.|-+.++..+|...|+|.+.... .....++..+|.++.. ..++|++|.+|+.+.+..
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 4455567777889999999999999999999999999997542 3444566778888864 458999999999999999
Q ss_pred eEEEEEeccCCCCHHHH----HHhccCCCHHHHHHHHHHHHHHHHhhhh-CCeEEeecCCCCeeecCCCceeecccCCcc
Q 010463 180 FLYLIMEYLPGGDIMTL----LMREDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGHLKLSDFGLCK 254 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~----L~~~~~l~e~~~~~~~~qi~~aL~~lH~-~giiHRDLKP~NILld~~g~vkL~DFGla~ 254 (510)
.+++.||.|.- +|..+ +.+.+.++|..+-.++..++.||+|||+ +.+||||+||+||||+.+|+||+||||+|-
T Consensus 119 dvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 119 DVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred cEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccce
Confidence 99999999954 66544 4456789999999999999999999997 599999999999999999999999999998
Q ss_pred cCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhccccccc-ccccCCCcchHhhcc----CCCCccccccc
Q 010463 255 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYS-TVGTLDYMAPEVLLK----KGYGMECDWWS 329 (510)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s-~~GT~~Y~APEvl~~----~~y~~~~DiwS 329 (510)
.+.++. +.+ ..|...|||||.+.. .+|+.++|+||
T Consensus 198 ~L~dSi----------------------------------------Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWS 237 (282)
T KOG0984|consen 198 YLVDSI----------------------------------------AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWS 237 (282)
T ss_pred eehhhh----------------------------------------HHHHhcCCCccCChhhcCcccCcccceeehhhhh
Confidence 775531 112 358899999999863 48999999999
Q ss_pred hhhHHHHHhhCCCCCCC-CChhhhHHHHhhccccccCCC
Q 010463 330 LGAIMYEMLIGYPPFCS-DDPRITCRKIVNWKTCLKFPE 367 (510)
Q Consensus 330 lGvilyEml~G~~PF~~-~~~~~~~~~I~~~~~~~~~p~ 367 (510)
||+.++||.+++.||.. .++-+++.+++.. ...++|.
T Consensus 238 LGItmiElA~lr~PY~~w~tpF~qLkqvVee-p~P~Lp~ 275 (282)
T KOG0984|consen 238 LGITMIEMAILRFPYESWGTPFQQLKQVVEE-PSPQLPA 275 (282)
T ss_pred hhhhhhhhhhccccccccCCHHHHHHHHhcC-CCCCCcc
Confidence 99999999999999975 5677778888763 3444554
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=319.58 Aligned_cols=246 Identities=29% Similarity=0.428 Sum_probs=195.7
Q ss_pred eeeeeecCCCeE-EEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCceEEEEEec
Q 010463 110 QLTLIGKGAFGE-VRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLYLIMEY 187 (510)
Q Consensus 110 ~~~~IG~G~fG~-V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~~lVmEy 187 (510)
--+++|.|+-|+ ||+|.. .|+.||||.+-. +....+.+|+..|... +|||||+.|+.-++..++|++.|.
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVY--EGREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred cHHHcccCCCCcEEEEEee--CCceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 346789999986 787776 588999998743 3345688999999888 699999999999999999999999
Q ss_pred cCCCCHHHHHHhc--cC--CCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecC---CC--ceeecccCCcccCcc
Q 010463 188 LPGGDIMTLLMRE--DI--LSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK---NG--HLKLSDFGLCKPLED 258 (510)
Q Consensus 188 ~~gG~L~~~L~~~--~~--l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~---~g--~vkL~DFGla~~~~~ 258 (510)
|.. +|.+++... .. ......+..+.|++.||.+||+.+||||||||.||||+. +| .++|+|||+|+.+..
T Consensus 585 C~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 585 CAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 966 999999763 11 111345778899999999999999999999999999986 34 689999999999876
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHh
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml 338 (510)
+.+.. +| ..+..||-+|+|||++....-+.++||+||||++|..+
T Consensus 664 ~~sS~------------------------------~r-----~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvl 708 (903)
T KOG1027|consen 664 GKSSF------------------------------SR-----LSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVL 708 (903)
T ss_pred Ccchh------------------------------hc-----ccCCCCcccccCHHHHhccccCcccchhhcCceEEEEe
Confidence 53221 01 23467999999999999988889999999999999999
Q ss_pred hC-CCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcC
Q 010463 339 IG-YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 405 (510)
Q Consensus 339 ~G-~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~ 405 (510)
+| ..||.+.- +.-.+|++....+.--. +....+|+|||.+||. ||..|| +|.+++.||||-
T Consensus 709 tgG~HpFGd~~--~R~~NIl~~~~~L~~L~-~~~d~eA~dLI~~ml~~dP~~RP---sa~~VL~HPlFW 771 (903)
T KOG1027|consen 709 TGGSHPFGDSL--ERQANILTGNYTLVHLE-PLPDCEAKDLISRMLNPDPQLRP---SATDVLNHPLFW 771 (903)
T ss_pred cCCccCCCchH--HhhhhhhcCccceeeec-cCchHHHHHHHHHhcCCCcccCC---CHHHHhCCCccC
Confidence 96 88996543 33456666544332111 1122299999999999 999999 789999999993
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=305.94 Aligned_cols=242 Identities=24% Similarity=0.370 Sum_probs=204.2
Q ss_pred ceeeeeeecCCCeEEEEEEEcCC----CCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEE
Q 010463 108 FEQLTLIGKGAFGEVRLCRAKTT----GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 108 f~~~~~IG~G~fG~V~~~~~~~t----g~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l 183 (510)
..+.++||.|-||.||.|..... .--||||..++.. .....+.|..|..+|++++|||||+|+|++.+ ...|+
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 34456899999999999986443 3359999987653 34447889999999999999999999999975 46899
Q ss_pred EEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccc
Q 010463 184 IMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 262 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 262 (510)
|||+++-|+|..+|..+ ..++......|+.||+.||.|||+.++|||||-..|||+.+.-.|||+||||++.+.+....
T Consensus 468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY 547 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY 547 (974)
T ss_pred EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchh
Confidence 99999999999999875 57889999999999999999999999999999999999999999999999999988764221
Q ss_pred ccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh-CC
Q 010463 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GY 341 (510)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~-G~ 341 (510)
. +....-..-|||||.+.-..++.++|||-|||++||+|. |.
T Consensus 548 k-------------------------------------aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGv 590 (974)
T KOG4257|consen 548 K-------------------------------------ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGV 590 (974)
T ss_pred h-------------------------------------ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcC
Confidence 0 001122446999999999999999999999999999987 99
Q ss_pred CCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC
Q 010463 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT 392 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~ 392 (510)
.||.+-...+..-.|-++. ..|..+++++.+..|+++|+. ||.+||..
T Consensus 591 kPfqgvkNsDVI~~iEnGe---RlP~P~nCPp~LYslmskcWayeP~kRPrf 639 (974)
T KOG4257|consen 591 KPFQGVKNSDVIGHIENGE---RLPCPPNCPPALYSLMSKCWAYEPSKRPRF 639 (974)
T ss_pred CccccccccceEEEecCCC---CCCCCCCCChHHHHHHHHHhccCcccCCcH
Confidence 9999987777777777653 344446899999999999999 99999965
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=313.79 Aligned_cols=257 Identities=25% Similarity=0.384 Sum_probs=225.3
Q ss_pred hhcccCCCCceeeeeeecCCCeEEEEEEEcCCCC---EEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEe
Q 010463 99 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGE---IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSF 175 (510)
Q Consensus 99 ~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~---~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 175 (510)
.-.++..+...+.++||.|.||+|+.|+.+..|+ .||||.++... ...+...|..|..||-+.+||||++|-++.
T Consensus 622 FakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVV 699 (996)
T KOG0196|consen 622 FAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVV 699 (996)
T ss_pred hhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEE
Confidence 3456778888899999999999999999998875 59999997653 466778899999999999999999999999
Q ss_pred ecCceEEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcc
Q 010463 176 QDSDFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCK 254 (510)
Q Consensus 176 ~~~~~~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~ 254 (510)
.....+.+|+|||++|+|..+|+.+ +.|+..+..-+++.|+.|+.||-++|+|||||-..|||++++-.+|++||||++
T Consensus 700 Tks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSR 779 (996)
T KOG0196|consen 700 TKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSR 779 (996)
T ss_pred ecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEecccccee
Confidence 9999999999999999999999876 569999999999999999999999999999999999999999999999999999
Q ss_pred cCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccc---cCCCcchHhhccCCCCccccccchh
Q 010463 255 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVG---TLDYMAPEVLLKKGYGMECDWWSLG 331 (510)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~G---T~~Y~APEvl~~~~y~~~~DiwSlG 331 (510)
.+.+.... +++..| ...|.|||.+....++.++|+||+|
T Consensus 780 vledd~~~--------------------------------------~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyG 821 (996)
T KOG0196|consen 780 VLEDDPEA--------------------------------------AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYG 821 (996)
T ss_pred ecccCCCc--------------------------------------cccccCCccceeecChhHhhhcccCchhhccccc
Confidence 87654210 122222 3579999999999999999999999
Q ss_pred hHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 332 AIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 332 vilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
|+|||.++ |.-||.+.+.++....|.. .+.+|....++..+.+|+..|++ |-..|| .+.+|.++
T Consensus 822 IVmWEVmSyGERPYWdmSNQdVIkaIe~---gyRLPpPmDCP~aL~qLMldCWqkdR~~RP---~F~qiV~~ 887 (996)
T KOG0196|consen 822 IVMWEVMSYGERPYWDMSNQDVIKAIEQ---GYRLPPPMDCPAALYQLMLDCWQKDRNRRP---KFAQIVST 887 (996)
T ss_pred eEEEEecccCCCcccccchHHHHHHHHh---ccCCCCCCCCcHHHHHHHHHHHHHHhhcCC---CHHHHHHH
Confidence 99999775 9999999999999888875 46777777999999999999998 999999 56777754
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=300.06 Aligned_cols=253 Identities=21% Similarity=0.314 Sum_probs=205.3
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
.+...+.+.||+|-||+|.+|.... +..||+|+++... .......+..|+.+|.+|+|||||.|+++|..++.+++|
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecC-ceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 3455677899999999999998753 6889999997653 344467899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccc
Q 010463 185 MEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 262 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 262 (510)
||||+.|||..+|..+ ..+.......++.||+.|+.||.+.++|||||.+.|+|+|.++++||+|||+++.+-...+.
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence 9999999999999887 33345556668999999999999999999999999999999999999999999966443222
Q ss_pred ccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHh--hC
Q 010463 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML--IG 340 (510)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml--~G 340 (510)
... ...|-...|||||.+..+.++.++|+|+|||+|||++ +.
T Consensus 694 ~vq------------------------------------gr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~ 737 (807)
T KOG1094|consen 694 RVQ------------------------------------GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCR 737 (807)
T ss_pred eee------------------------------------cceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHh
Confidence 110 0245677899999999999999999999999999986 57
Q ss_pred CCCCCCCChhhhHHHHhh---ccc-cccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhh
Q 010463 341 YPPFCSDDPRITCRKIVN---WKT-CLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 399 (510)
Q Consensus 341 ~~PF~~~~~~~~~~~I~~---~~~-~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil 399 (510)
..||...+.++...+.-. .+. ....+..+-++..+..||.+|+. |.++|| +++++-
T Consensus 738 e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RP---sFe~lh 798 (807)
T KOG1094|consen 738 EQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRP---SFEQLH 798 (807)
T ss_pred hCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCC---CHHHHH
Confidence 889987766655554432 111 11222335678899999999998 999999 577763
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=305.47 Aligned_cols=247 Identities=21% Similarity=0.338 Sum_probs=209.0
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCC-CC--EEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTT-GE--IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 181 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~t-g~--~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~ 181 (510)
.++..+.+.||+|+||.|+.|.++.. |+ .||||++...... .....|.+|..+|.+++|||+++||++..+ ..+
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence 34566678999999999999998763 33 4899999765432 267889999999999999999999999988 678
Q ss_pred EEEEeccCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 182 YLIMEYLPGGDIMTLLMR--EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~--~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
.||||++++|+|.+.|.+ ...|.-.....|+.||+.|+.||.++++|||||-..||||-..-.|||+||||.+.+...
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 999999999999999987 467888889999999999999999999999999999999999999999999999987654
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~ 339 (510)
...-.. +-..--...|+|||.++...++.++|+|++||++|||++
T Consensus 266 ed~Yvm-----------------------------------~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFt 310 (1039)
T KOG0199|consen 266 EDMYVM-----------------------------------APQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFT 310 (1039)
T ss_pred CcceEe-----------------------------------cCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhc
Confidence 221100 000113456999999999999999999999999999998
Q ss_pred -CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC
Q 010463 340 -GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT 392 (510)
Q Consensus 340 -G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~ 392 (510)
|..||.|.....++++|-. ...+.-| ..+|.++.++++.|+. +|.+|++.
T Consensus 311 yGEePW~G~~g~qIL~~iD~-~erLpRP--k~csedIY~imk~cWah~paDRptF 362 (1039)
T KOG0199|consen 311 YGEEPWVGCRGIQILKNIDA-GERLPRP--KYCSEDIYQIMKNCWAHNPADRPTF 362 (1039)
T ss_pred cCCCCCCCCCHHHHHHhccc-cccCCCC--CCChHHHHHHHHHhccCCccccccH
Confidence 8999999999999988874 3445444 5899999999999998 99999954
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=336.42 Aligned_cols=238 Identities=20% Similarity=0.256 Sum_probs=185.0
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEe
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 186 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmE 186 (510)
.|.....||+|+||.||+|+.+.+|..||+|.+..... ....|+.++++++|||||++++++.+.+..|+|||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 45667889999999999999999999999999864321 11346788999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhh---hCCeEEeecCCCCeeecCCCceeecccCCcccCccccccc
Q 010463 187 YLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIH---QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 263 (510)
Q Consensus 187 y~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH---~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 263 (510)
|++||+|.+++.. +++..+..++.||+.||+||| +.+|+||||||+|||++.++..++. ||........
T Consensus 764 y~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~---- 835 (968)
T PLN00113 764 YIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD---- 835 (968)
T ss_pred CCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----
Confidence 9999999999953 789999999999999999999 6799999999999999999888875 6654432110
Q ss_pred cchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCC
Q 010463 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 343 (510)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~P 343 (510)
....||+.|||||++.+..|+.++|||||||++|||++|+.|
T Consensus 836 --------------------------------------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p 877 (968)
T PLN00113 836 --------------------------------------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877 (968)
T ss_pred --------------------------------------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCC
Confidence 124689999999999999999999999999999999999999
Q ss_pred CCCCChh-hhHHHHhh----------cccc-c--cCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 344 FCSDDPR-ITCRKIVN----------WKTC-L--KFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 344 F~~~~~~-~~~~~I~~----------~~~~-~--~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
|...... ........ +... + ..+.......++.+++.+|+. ||++|| ++.|+++
T Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP---t~~evl~ 946 (968)
T PLN00113 878 ADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARP---CANDVLK 946 (968)
T ss_pred CCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCc---CHHHHHH
Confidence 9543211 01111000 0000 0 000001122357789999998 999999 5677764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=310.42 Aligned_cols=260 Identities=29% Similarity=0.444 Sum_probs=222.6
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEE
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l 183 (510)
..++|+++..+|.|+||.||+++++.+++..|+|+++.. ......-+..|+-+++.++|||||.+++++...+.+++
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe---p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE---PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeecc---CCccccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 457999999999999999999999999999999999754 34456668889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccc
Q 010463 184 IMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 263 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 263 (510)
+||||.||+|.+.-.-.++++|.++.+...+.+.||+|||+.|-+|||||-.|||+++.|.+||+|||.+-.+....
T Consensus 90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati--- 166 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI--- 166 (829)
T ss_pred EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhh---
Confidence 99999999999988888999999999999999999999999999999999999999999999999999987654210
Q ss_pred cchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc---cCCCCccccccchhhHHHHHhhC
Q 010463 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMECDWWSLGAIMYEMLIG 340 (510)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~---~~~y~~~~DiwSlGvilyEml~G 340 (510)
....++.|||.|||||+.. .++|+..||+|++|+...|+---
T Consensus 167 -----------------------------------~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eL 211 (829)
T KOG0576|consen 167 -----------------------------------AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGEL 211 (829)
T ss_pred -----------------------------------hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhc
Confidence 0012689999999999874 67899999999999999999888
Q ss_pred CCCCCCCChhhhHHHHhh-ccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 341 YPPFCSDDPRITCRKIVN-WKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 341 ~~PF~~~~~~~~~~~I~~-~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
++|-...-+........+ ...++...+....++.+-+|++..|. +|.+|| +++.++.|||...-
T Consensus 212 qpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRp---taeklL~h~fvs~~ 277 (829)
T KOG0576|consen 212 QPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRP---TAEKLLQHPFVSQT 277 (829)
T ss_pred CCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCC---Chhhheeceeeccc
Confidence 898776665544433322 22233333345789999999999998 999999 67889999999764
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=297.47 Aligned_cols=256 Identities=20% Similarity=0.318 Sum_probs=214.8
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceE
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 181 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~ 181 (510)
++...+......||-|-||.||.|.++.-.-.||||.++... -+++.|..|..+|+.++|||+|+|+++|..+...
T Consensus 263 EmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt----MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 263 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred hccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc----hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 344456667789999999999999999999999999997553 3678899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhccC--CCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 182 YLIMEYLPGGDIMTLLMREDI--LSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~~--l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
|||+|||..|+|.++|++.+. ++.-....++.||..|++||..+++|||||-..|.|+.++..||++||||++.+...
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD 418 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence 999999999999999987643 566666777889999999999999999999999999999999999999999988654
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~ 339 (510)
.+.... ..--..-|.|||-+.-..++.++|||+|||+|||+.|
T Consensus 419 TYTAHA-------------------------------------GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIAT 461 (1157)
T KOG4278|consen 419 TYTAHA-------------------------------------GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIAT 461 (1157)
T ss_pred ceeccc-------------------------------------CccCcccccCcccccccccccchhhHHHHHHHHHHHh
Confidence 222100 0112346999999999999999999999999999997
Q ss_pred -CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 340 -GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 340 -G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
|-.||.+-+....|..+-++ ....-|+ .+++.+..|++.|++ .|..||+...+.+.++.
T Consensus 462 YGMsPYPGidlSqVY~LLEkg-yRM~~Pe--GCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 462 YGMSPYPGIDLSQVYGLLEKG-YRMDGPE--GCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred cCCCCCCCccHHHHHHHHhcc-ccccCCC--CCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 99999999888777766543 3344554 899999999999999 99999975444444443
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=284.29 Aligned_cols=131 Identities=23% Similarity=0.410 Sum_probs=114.7
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-----C---CCeeeEeEEee
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-----S---RCIVQLFYSFQ 176 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~-----h---p~Iv~l~~~~~ 176 (510)
...|-+.+.||-|-|++||+|.+..+.+.||||+.+.... -.+....|+.+|+++. | .+||+|++.|.
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh----YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH----YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH----HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 3689999999999999999999999999999999976543 3455778999998872 3 47999999997
Q ss_pred c----CceEEEEEeccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhh-CCeEEeecCCCCeeec
Q 010463 177 D----SDFLYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILD 240 (510)
Q Consensus 177 ~----~~~~~lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~-~giiHRDLKP~NILld 240 (510)
. ..++|||+|++ |-+|..+|.+. +.++...++.|+.||+.||.|||. +||||-||||+||||.
T Consensus 153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred ecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 5 45899999999 77999999875 569999999999999999999995 6999999999999994
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=283.83 Aligned_cols=289 Identities=22% Similarity=0.364 Sum_probs=207.3
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcC---CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCce
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKT---TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDF 180 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~---tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~ 180 (510)
.+.|..+..||.|+|++||++.+.. .++.||+|.+.... ...++.+|.++|..+ .+.||+++.+++..++.
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 3678899999999999999998877 78899999886542 345689999999888 68999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeec-CCCceeecccCCcccCccc
Q 010463 181 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD-KNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld-~~g~vkL~DFGla~~~~~~ 259 (510)
+.+||||++.-+..+++.. ++-..++.|+.+++.||.++|..|||||||||.|+|.+ ..++-.|+|||||...+..
T Consensus 110 v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~ 186 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY 186 (418)
T ss_pred eEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhh
Confidence 9999999999999888854 66889999999999999999999999999999999998 5688999999999842211
Q ss_pred cccccchh----------hhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC-CCCcccccc
Q 010463 260 YSSILLED----------EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWW 328 (510)
Q Consensus 260 ~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~Diw 328 (510)
........ +.......+.....+...... -...++.......|||+|.|||++.+. ..+.++|+|
T Consensus 187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~----~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRR----CNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred hhhhhhhhhhcccCCccccCcccccccccccCCCCceec----cCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 10000000 000000000000000000000 001122233456899999999999864 469999999
Q ss_pred chhhHHHHHhhCCCCCCCCC-hhhhHHHHh-------------------hcc---------------cc----c---cCC
Q 010463 329 SLGAIMYEMLIGYPPFCSDD-PRITCRKIV-------------------NWK---------------TC----L---KFP 366 (510)
Q Consensus 329 SlGvilyEml~G~~PF~~~~-~~~~~~~I~-------------------~~~---------------~~----~---~~p 366 (510)
|.|||+.-++++..||.-.. .-.....|+ -|. .. + ..|
T Consensus 263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~ 342 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP 342 (418)
T ss_pred eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence 99999999999999985321 111111110 011 00 0 000
Q ss_pred ------CCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCC
Q 010463 367 ------EEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 408 (510)
Q Consensus 367 ------~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~ 408 (510)
.....+..+.||+.+||. ||.+|+ +++++|+||||...+
T Consensus 343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRi---tAEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 343 NTEREIGSDVFPALLLDLLDKCLELNPQKRI---TAEDALKHPFFDEAD 388 (418)
T ss_pred ceeeccccccccHHHHHHHHHHccCChhhcc---cHHHHhcCcCCcchh
Confidence 012345689999999998 999999 789999999998543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=280.76 Aligned_cols=248 Identities=24% Similarity=0.320 Sum_probs=196.4
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHh--cCCCCeeeEeEEeecCc--
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE--VDSRCIVQLFYSFQDSD-- 179 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~--l~hp~Iv~l~~~~~~~~-- 179 (510)
.....+++.+||+|.||.||+|+.. ++.||||++.- .+.+.+.+|++|.+. +.|+||++++++-....
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~ 279 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD 279 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhcc--CceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence 3566778899999999999999874 69999999864 345679999999865 58999999998766444
Q ss_pred --eEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhh---------CCeEEeecCCCCeeecCCCceeec
Q 010463 180 --FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ---------HNYVHRDIKPDNLILDKNGHLKLS 248 (510)
Q Consensus 180 --~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~---------~giiHRDLKP~NILld~~g~vkL~ 248 (510)
.++||++|.+.|+|.++|.. ..++......++..|+.||+|||+ .+|+|||||..||||.+|+++.|+
T Consensus 280 ~~eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa 358 (534)
T KOG3653|consen 280 RMEYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA 358 (534)
T ss_pred ccceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence 89999999999999999965 578999999999999999999995 259999999999999999999999
Q ss_pred ccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCC-C-----C
Q 010463 249 DFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG-Y-----G 322 (510)
Q Consensus 249 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~-y-----~ 322 (510)
|||||..+...... ..+...|||..|||||++.+.- . -
T Consensus 359 DFGLAl~~~p~~~~------------------------------------~d~~~qVGT~RYMAPEvLEgainl~d~~Af 402 (534)
T KOG3653|consen 359 DFGLALRLEPGKPQ------------------------------------GDTHGQVGTRRYMAPEVLEGAINLQDRDAF 402 (534)
T ss_pred ccceeEEecCCCCC------------------------------------cchhhhhhhhhhcCHHHHhhhcccccHHHH
Confidence 99999987643211 0122368999999999997632 2 2
Q ss_pred ccccccchhhHHHHHhhCCC------------CCC-----CCChhhhHHHHhhccccccCCCCC---CCCHHHHHHHHHh
Q 010463 323 MECDWWSLGAIMYEMLIGYP------------PFC-----SDDPRITCRKIVNWKTCLKFPEEP---KISDEARDLICHL 382 (510)
Q Consensus 323 ~~~DiwSlGvilyEml~G~~------------PF~-----~~~~~~~~~~I~~~~~~~~~p~~~---~~s~~~~dlI~~l 382 (510)
...||||+|.+||||++... ||. ..+.+++...++..+..+.+|+.. .--..+++.|..|
T Consensus 403 kr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeC 482 (534)
T KOG3653|consen 403 KRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEEC 482 (534)
T ss_pred HHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHH
Confidence 56899999999999998643 332 123456666677767777777521 1234678888999
Q ss_pred hc-CccccCCCCChH
Q 010463 383 LC-DVETRLGTRGVE 396 (510)
Q Consensus 383 L~-dp~~R~~~~~~~ 396 (510)
+. |++.|+++.-++
T Consensus 483 WDhDaeARLTA~Cv~ 497 (534)
T KOG3653|consen 483 WDHDAEARLTAGCVE 497 (534)
T ss_pred cCCchhhhhhhHHHH
Confidence 97 999999764333
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=296.50 Aligned_cols=250 Identities=27% Similarity=0.387 Sum_probs=204.7
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcC-------CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEe
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKT-------TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLF 172 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~-------tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~ 172 (510)
.++..++..+.+.||.|+||.|++|..+. ....||||.++... ...+.+.+..|+.+|+.+ .||||+.|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~--~~~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA--SSSEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEeccccc--CcHHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 34445556667799999999999987542 14469999987654 236778899999999888 699999999
Q ss_pred EEeecCceEEEEEeccCCCCHHHHHHhcc----------------CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCC
Q 010463 173 YSFQDSDFLYLIMEYLPGGDIMTLLMRED----------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDN 236 (510)
Q Consensus 173 ~~~~~~~~~~lVmEy~~gG~L~~~L~~~~----------------~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~N 236 (510)
+++...+.+++|+||+..|+|..+|+..+ .++......++.||+.|++||++.++|||||-..|
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRN 448 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARN 448 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhh
Confidence 99999999999999999999999998766 48888899999999999999999999999999999
Q ss_pred eeecCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccC--CCcchH
Q 010463 237 LILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTL--DYMAPE 314 (510)
Q Consensus 237 ILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~--~Y~APE 314 (510)
||+..+..+||+|||+|+......... .....||. .|||||
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~-------------------------------------~~~~~~~LP~kWmApE 491 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYR-------------------------------------TKSSAGTLPVKWMAPE 491 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceE-------------------------------------ecCCCCccceeecCHH
Confidence 999999999999999999654321110 00112322 499999
Q ss_pred hhccCCCCccccccchhhHHHHHhh-CCCCCCCCC-hhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCC
Q 010463 315 VLLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDD-PRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLG 391 (510)
Q Consensus 315 vl~~~~y~~~~DiwSlGvilyEml~-G~~PF~~~~-~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~ 391 (510)
.+....|+.++||||+||+||||++ |..||.+-. ..+.+..+..+ ..+..|. ..+++..++++.|+. +|+.||+
T Consensus 492 sl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G-~r~~~P~--~c~~eiY~iM~~CW~~~p~~RP~ 568 (609)
T KOG0200|consen 492 SLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEG-NRMEQPE--HCSDEIYDLMKSCWNADPEDRPT 568 (609)
T ss_pred HhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcC-CCCCCCC--CCCHHHHHHHHHHhCCCcccCCC
Confidence 9999999999999999999999998 999998854 44455545443 3455564 779999999999998 9999995
Q ss_pred C
Q 010463 392 T 392 (510)
Q Consensus 392 ~ 392 (510)
.
T Consensus 569 F 569 (609)
T KOG0200|consen 569 F 569 (609)
T ss_pred H
Confidence 4
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=256.11 Aligned_cols=213 Identities=40% Similarity=0.650 Sum_probs=184.3
Q ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEec
Q 010463 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEY 187 (510)
Q Consensus 108 f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy 187 (510)
|.+.+.||.|++|.||+|....+++.+|+|.+...... ...+.+..|+..+..++|+|++++++++......++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 56788999999999999999999999999999865322 2567888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhccC-CCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccch
Q 010463 188 LPGGDIMTLLMREDI-LSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 266 (510)
Q Consensus 188 ~~gG~L~~~L~~~~~-l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~ 266 (510)
+++++|.+++..... +++..+..++.+++.+|.+||+.|++|+||+|.||+++.++.++|+|||++.........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~---- 154 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA---- 154 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc----
Confidence 999999999988766 899999999999999999999999999999999999999999999999998876432100
Q ss_pred hhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhh-ccCCCCccccccchhhHHHHHhhCCCCCC
Q 010463 267 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL-LKKGYGMECDWWSLGAIMYEMLIGYPPFC 345 (510)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl-~~~~y~~~~DiwSlGvilyEml~G~~PF~ 345 (510)
......|+..|++||++ ....++.++|+||||+++|||++|++||.
T Consensus 155 ---------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 155 ---------------------------------LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred ---------------------------------cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 01135788999999999 66778889999999999999999999998
Q ss_pred C--CChhhhHHHHhhc
Q 010463 346 S--DDPRITCRKIVNW 359 (510)
Q Consensus 346 ~--~~~~~~~~~I~~~ 359 (510)
+ .+.......|...
T Consensus 202 ~~~~~~~~~~~~~~~~ 217 (225)
T smart00221 202 GEGEFTSLLSDVWSFG 217 (225)
T ss_pred ccchhHHHHHHHHhcC
Confidence 7 3444566666653
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=271.03 Aligned_cols=244 Identities=23% Similarity=0.324 Sum_probs=185.0
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHh--cCCCCeeeEeEEeecC----
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE--VDSRCIVQLFYSFQDS---- 178 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~--l~hp~Iv~l~~~~~~~---- 178 (510)
..+..+.+.||+|.||+||+|+++ |+.||||++... +.....+|.+|.+. ++|+||+.++++=..+
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr------dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR------DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred hheeEEEEEecCccccceeecccc--CCceEEEEeccc------chhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 457889999999999999999886 889999999643 23557788888755 5999999998775433
Q ss_pred ceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhC--------CeEEeecCCCCeeecCCCceeeccc
Q 010463 179 DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH--------NYVHRDIKPDNLILDKNGHLKLSDF 250 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~--------giiHRDLKP~NILld~~g~vkL~DF 250 (510)
..+|||++|.+.|+|+++|.+ ..++-+....++..++.||.+||.. .|.|||||..|||+.++|.+.|+|+
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 269999999999999999987 6789999999999999999999942 4999999999999999999999999
Q ss_pred CCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCC----C--Ccc
Q 010463 251 GLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG----Y--GME 324 (510)
Q Consensus 251 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~----y--~~~ 324 (510)
|||-.......... ......|||..|||||++...- + -..
T Consensus 361 GLAv~h~~~t~~id----------------------------------i~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ 406 (513)
T KOG2052|consen 361 GLAVRHDSDTDTID----------------------------------IPPNPRVGTKRYMAPEVLDETINMKHFESYKR 406 (513)
T ss_pred eeeEEecccCCccc----------------------------------CCCCCccceeeccChHHhhhhcChhhhhhhhH
Confidence 99987654311100 0012469999999999996532 2 246
Q ss_pred ccccchhhHHHHHhhC----------CCCCCCC----ChhhhHHHHhh-ccccccCCCCCCCCHHH---HHHHHHhhc-C
Q 010463 325 CDWWSLGAIMYEMLIG----------YPPFCSD----DPRITCRKIVN-WKTCLKFPEEPKISDEA---RDLICHLLC-D 385 (510)
Q Consensus 325 ~DiwSlGvilyEml~G----------~~PF~~~----~~~~~~~~I~~-~~~~~~~p~~~~~s~~~---~dlI~~lL~-d 385 (510)
+||||||.++||+... ++||++- ...+..++++- .+..+.+|....-.+.+ -.+++.|+. +
T Consensus 407 ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~N 486 (513)
T KOG2052|consen 407 ADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYAN 486 (513)
T ss_pred HHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCC
Confidence 8999999999998852 5888652 22334444432 22234444432233333 445777787 9
Q ss_pred ccccCC
Q 010463 386 VETRLG 391 (510)
Q Consensus 386 p~~R~~ 391 (510)
|.-|++
T Consensus 487 p~aRlt 492 (513)
T KOG2052|consen 487 PAARLT 492 (513)
T ss_pred chhhhH
Confidence 999994
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=244.14 Aligned_cols=211 Identities=42% Similarity=0.683 Sum_probs=186.5
Q ss_pred eecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEeccCCCCH
Q 010463 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDI 193 (510)
Q Consensus 114 IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy~~gG~L 193 (510)
||+|++|.||+|....+|+.+++|++....... ....+.+|+.++..+.|++|+++++++......++||||++|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 699999999999998889999999997653211 356789999999999999999999999999999999999999999
Q ss_pred HHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecC-CCceeecccCCcccCccccccccchhhhhh
Q 010463 194 MTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK-NGHLKLSDFGLCKPLEDKYSSILLEDEDII 271 (510)
Q Consensus 194 ~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~-~g~vkL~DFGla~~~~~~~~~~~~~~~~~~ 271 (510)
.+++... ..+++..+..++.+++.+|.+||+.|++|+||+|.||+++. +++++|+|||.+........
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---------- 148 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---------- 148 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc----------
Confidence 9999776 57899999999999999999999999999999999999999 89999999999986543210
Q ss_pred cccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC-CCCccccccchhhHHHHHhhCCCCCCCCChh
Q 010463 272 NQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEMLIGYPPFCSDDPR 350 (510)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiwSlGvilyEml~G~~PF~~~~~~ 350 (510)
......++..|++||.+... .++.+.|+||||+++++|
T Consensus 149 ----------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------- 187 (215)
T cd00180 149 ----------------------------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------- 187 (215)
T ss_pred ----------------------------hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------
Confidence 01134688999999999877 889999999999999999
Q ss_pred hhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCC
Q 010463 351 ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHP 402 (510)
Q Consensus 351 ~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~Hp 402 (510)
..+.+++.+|++ +|.+|| ++.++++|+
T Consensus 188 ----------------------~~~~~~l~~~l~~~p~~R~---~~~~l~~~~ 215 (215)
T cd00180 188 ----------------------PELKDLIRKMLQKDPEKRP---SAKEILEHL 215 (215)
T ss_pred ----------------------HHHHHHHHHHhhCCcccCc---CHHHHhhCC
Confidence 678999999998 999999 689999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=283.60 Aligned_cols=243 Identities=20% Similarity=0.287 Sum_probs=201.6
Q ss_pred ceeeeeeecCCCeEEEEEEEcCCCC----EEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEE
Q 010463 108 FEQLTLIGKGAFGEVRLCRAKTTGE----IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 108 f~~~~~IG~G~fG~V~~~~~~~tg~----~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l 183 (510)
....++||+|+||+||+|.+-..|+ +||||++..... ......+..|.-+|.+++|||+++|+++++... +-|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~--~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS--PKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC--chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 4456799999999999999876665 589999876543 333456899999999999999999999999776 889
Q ss_pred EEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccc
Q 010463 184 IMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 262 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 262 (510)
|++|||+|.|.++++.+ +.+-......|..||+.|+.|||.+++|||||-..|+|+.+-.|+||+|||+++.+......
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 99999999999999764 57888889999999999999999999999999999999999999999999999987643111
Q ss_pred ccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh-CC
Q 010463 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GY 341 (510)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~-G~ 341 (510)
-. +...--.+-|||-|.+....|+.++||||+||++||++| |.
T Consensus 855 y~------------------------------------~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa 898 (1177)
T KOG1025|consen 855 YS------------------------------------APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGA 898 (1177)
T ss_pred cc------------------------------------ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCC
Confidence 00 001123457999999999999999999999999999998 99
Q ss_pred CCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC
Q 010463 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT 392 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~ 392 (510)
.|+.+...+++-.-+..+ .. ++..+..+-++.-++.+||. |+..||+.
T Consensus 899 ~Py~gi~~~eI~dlle~g-eR--LsqPpiCtiDVy~~mvkCwmid~~~rp~f 947 (1177)
T KOG1025|consen 899 KPYDGIPAEEIPDLLEKG-ER--LSQPPICTIDVYMVMVKCWMIDADSRPTF 947 (1177)
T ss_pred CccCCCCHHHhhHHHhcc-cc--CCCCCCccHHHHHHHHHHhccCcccCccH
Confidence 999988776665544443 33 44446889999999999998 99999964
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=298.75 Aligned_cols=228 Identities=14% Similarity=0.135 Sum_probs=153.1
Q ss_pred CCeeeEeEEe-------ecCceEEEEEeccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCe
Q 010463 166 RCIVQLFYSF-------QDSDFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNL 237 (510)
Q Consensus 166 p~Iv~l~~~~-------~~~~~~~lVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NI 237 (510)
+||++++++| .....++++|||+ +++|.++|.. ...+++.+++.++.||+.||.|||++|||||||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 5777888877 2335688899988 5699999965 35699999999999999999999999999999999999
Q ss_pred eecCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHh-hcccccccccccCCCcchHhh
Q 010463 238 ILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKR-NRRALAYSTVGTLDYMAPEVL 316 (510)
Q Consensus 238 Lld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~GT~~Y~APEvl 316 (510)
||+..|.+|++|||+|............-. +. ..+.... ... ............ .........+||+.|||||++
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~-Df-G~a~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDATTKSR-EI-GSSRREE-ILS-ERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred EEcccCcEEEeeccccCcccccccCccccc-cc-ccccccc-ccc-ccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 998888888888888765432110000000 00 0000000 000 000000000000 000001125799999999999
Q ss_pred ccCCCCccccccchhhHHHHHhhCCCCCCCCChhhhHHHHhhccccccCCC-CCCCCHHHHHHHHHhhc-CccccCCCCC
Q 010463 317 LKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPE-EPKISDEARDLICHLLC-DVETRLGTRG 394 (510)
Q Consensus 317 ~~~~y~~~~DiwSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~-~~~~s~~~~dlI~~lL~-dp~~R~~~~~ 394 (510)
.+..|+.++|||||||+||||++|.+||.... .....+... .+|. ...-.+.+.+++.+||. +|.+|| +
T Consensus 188 ~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~L~~~P~~Rp---s 258 (793)
T PLN00181 188 NGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHR----VLPPQILLNWPKEASFCLWLLHPEPSCRP---S 258 (793)
T ss_pred ccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHh----hcChhhhhcCHHHHHHHHHhCCCChhhCc---C
Confidence 99999999999999999999999999986432 122222211 1111 11235677899999998 999999 7
Q ss_pred hHHhhcCCCcCCC
Q 010463 395 VEELKEHPWFRGI 407 (510)
Q Consensus 395 ~~eil~HpfF~~i 407 (510)
+.||++||||...
T Consensus 259 ~~eil~h~~~~~~ 271 (793)
T PLN00181 259 MSELLQSEFINEP 271 (793)
T ss_pred hHHHhhchhhhhh
Confidence 8999999999763
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=246.25 Aligned_cols=238 Identities=22% Similarity=0.343 Sum_probs=188.0
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeE-EeecCceEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFY-SFQDSDFLYL 183 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~-~~~~~~~~~l 183 (510)
+.|.+.+.||.|-||.+.+|+++.++..+++|.+.+... ....+.+|...--.| .|.||+.-|. .||+.+.+++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 579999999999999999999999999999999987643 235577777664444 5899998885 6899999999
Q ss_pred EEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeec--CCCceeecccCCcccCccccc
Q 010463 184 IMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD--KNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld--~~g~vkL~DFGla~~~~~~~~ 261 (510)
+|||+|-|||.+-+... .+-|...+.+++|++.||+|+|+.++||||||.+||||- +.-.|||||||+.+.......
T Consensus 100 ~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~ 178 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK 178 (378)
T ss_pred eeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceeh
Confidence 99999999999988664 478999999999999999999999999999999999994 334799999999876432100
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc---CCC--CccccccchhhHHHH
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK---KGY--GMECDWWSLGAIMYE 336 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~---~~y--~~~~DiwSlGvilyE 336 (510)
-.--+..|.+||++.. +.| .+.+|+|.||+|+|.
T Consensus 179 -----------------------------------------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~ 217 (378)
T KOG1345|consen 179 -----------------------------------------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFY 217 (378)
T ss_pred -----------------------------------------hhhhhcccCCcHHHhhccccceEecccccchheeeeeee
Confidence 0124567899998763 333 788999999999999
Q ss_pred HhhCCCCCCCCCh-hhhHHHHhhcccc--ccCCC-CCCCCHHHHHHHHHhhc-Ccccc
Q 010463 337 MLIGYPPFCSDDP-RITCRKIVNWKTC--LKFPE-EPKISDEARDLICHLLC-DVETR 389 (510)
Q Consensus 337 ml~G~~PF~~~~~-~~~~~~I~~~~~~--~~~p~-~~~~s~~~~dlI~~lL~-dp~~R 389 (510)
+|+|.+||..... ...|.+...|... ...|. ...+|+.+..+.++-|. ++++|
T Consensus 218 cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 218 CLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred eecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCccccc
Confidence 9999999974332 2234444444322 23343 23689999999999998 88777
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=279.74 Aligned_cols=323 Identities=32% Similarity=0.493 Sum_probs=266.1
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceE
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 181 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~ 181 (510)
+...++|.+.+-+-+|++|.++.+....+|...++|+..+..++...+.+..+.+..++-...+|.++.....|.-...+
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 35778999999999999999999999999999999999988888888888889999998888999999999888788899
Q ss_pred EEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 182 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
+|||+|+.||+|...|...++.+++.++.+++.++.++++||+..++|||++|.|+|+..+||.+++|||+......-..
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred chhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999996553321100
Q ss_pred cccchhhhhhcccccccccccCCC-hHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMM-PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 340 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G 340 (510)
. .+.+........... ..++...........-...+||+.|.|||.+.+...+..+|||++|++++|.|+|
T Consensus 960 ~--------~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g 1031 (1205)
T KOG0606|consen 960 T--------TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTG 1031 (1205)
T ss_pred c--------CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcC
Confidence 0 000000000000000 0000000000000112357899999999999999999999999999999999999
Q ss_pred CCCCCCCChhhhHHHHhhccccccCCCC-CCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchhhhcccCC
Q 010463 341 YPPFCSDDPRITCRKIVNWKTCLKFPEE-PKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAA 418 (510)
Q Consensus 341 ~~PF~~~~~~~~~~~I~~~~~~~~~p~~-~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l~~~~~p 418 (510)
.+||.+..+...+.+|.+.. ...|.- ...++++++++..+|. +|.+|.+..++.+.+.||||++++|+.|.....+
T Consensus 1032 ~pp~na~tpq~~f~ni~~~~--~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~~q~~~ 1109 (1205)
T KOG0606|consen 1032 IPPFNAETPQQIFENILNRD--IPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLALQKAE 1109 (1205)
T ss_pred CCCCCCcchhhhhhccccCC--CCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccccccccCc
Confidence 99999999999999998853 333332 3689999999999998 9999999988889999999999999999999999
Q ss_pred CccccCCCccCCCCCC
Q 010463 419 YKPTVNGELDTQNFEK 434 (510)
Q Consensus 419 ~~p~~~~~~d~~~f~~ 434 (510)
|+|...+..|+++|..
T Consensus 1110 ~~p~~~s~~dtS~~~~ 1125 (1205)
T KOG0606|consen 1110 FVPQPESTQDTSYFES 1125 (1205)
T ss_pred cCCCCCCCCccchhhc
Confidence 9999999999999975
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-27 Score=234.43 Aligned_cols=261 Identities=40% Similarity=0.602 Sum_probs=206.5
Q ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCC-CeeeEeEEeecCceEEEEEe
Q 010463 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR-CIVQLFYSFQDSDFLYLIME 186 (510)
Q Consensus 108 f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp-~Iv~l~~~~~~~~~~~lVmE 186 (510)
|.+.+.||.|+||.||++.+. ..+|+|.+.+...........+.+|..++..+.|+ +|++++..+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 778899999999999999887 78999999877654444577899999999999988 79999999988888999999
Q ss_pred ccCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCC-ceeecccCCcccCcccccc
Q 010463 187 YLPGGDIMTLLMRED---ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG-HLKLSDFGLCKPLEDKYSS 262 (510)
Q Consensus 187 y~~gG~L~~~L~~~~---~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g-~vkL~DFGla~~~~~~~~~ 262 (510)
|+.|+++..++.... .+++..+..++.|++.++.++|+.|++|||+||+|||++..+ .++++|||+++.+......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999997776664 799999999999999999999999999999999999999998 7999999999855432111
Q ss_pred ccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc---CCCCccccccchhhHHHHHhh
Q 010463 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK---KGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~---~~y~~~~DiwSlGvilyEml~ 339 (510)
... .......+||+.|+|||++.+ ..++...|+||+|++++++++
T Consensus 159 ~~~--------------------------------~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~ 206 (384)
T COG0515 159 SSI--------------------------------PALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLT 206 (384)
T ss_pred ccc--------------------------------cccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHh
Confidence 000 001235789999999999988 578999999999999999999
Q ss_pred CCCCCCCCCh----hhhHHHHhhcccc-ccCCCCCCC----CHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 340 GYPPFCSDDP----RITCRKIVNWKTC-LKFPEEPKI----SDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 340 G~~PF~~~~~----~~~~~~I~~~~~~-~~~p~~~~~----s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
|..||..... ......+...... ...+..... ...+.+++..++. +|..|.+ ..+...++|...
T Consensus 207 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~---~~~~~~~~~~~~ 280 (384)
T COG0515 207 GLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLS---SSSDLSHDLLAH 280 (384)
T ss_pred CCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCC---HHHHhhchHhhC
Confidence 9999887763 3444444332211 111111111 2578999999998 9999994 455555555443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=228.06 Aligned_cols=161 Identities=20% Similarity=0.196 Sum_probs=129.9
Q ss_pred CCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhh
Q 010463 191 GDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDED 269 (510)
Q Consensus 191 G~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~ 269 (510)
|+|.+++... ..+++..++.++.||+.||.|||+.+ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~---------- 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE---------- 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----------
Confidence 7899999874 56999999999999999999999999 999999999999999 9998764321
Q ss_pred hhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCCCCh
Q 010463 270 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDP 349 (510)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~~~~ 349 (510)
...||+.|||||++.+..|+.++|||||||++|||++|.+||.....
T Consensus 63 ---------------------------------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~ 109 (176)
T smart00750 63 ---------------------------------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE 109 (176)
T ss_pred ---------------------------------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch
Confidence 13689999999999999999999999999999999999999976543
Q ss_pred h-hhHHHHhhccccccC---CCCCCCCH--HHHHHHHHhhc-CccccCCCCChHHhhcCCCcC
Q 010463 350 R-ITCRKIVNWKTCLKF---PEEPKISD--EARDLICHLLC-DVETRLGTRGVEELKEHPWFR 405 (510)
Q Consensus 350 ~-~~~~~I~~~~~~~~~---p~~~~~s~--~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~ 405 (510)
. .....+......... +....++. ++++||.+||. +|.+|| ++.+++.|+|+.
T Consensus 110 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp---~~~~ll~~~~~~ 169 (176)
T smart00750 110 LSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRLPQRRE---AANHYLAHCRAL 169 (176)
T ss_pred hcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhccccccc---CHHHHHHHHHHH
Confidence 2 333344332111100 11123444 69999999998 999999 789999999974
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-29 Score=271.01 Aligned_cols=262 Identities=25% Similarity=0.400 Sum_probs=204.4
Q ss_pred eeeeeecCCCeEEEEEEEcCCCCEEEEEEeech---hhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEe
Q 010463 110 QLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKS---EMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 186 (510)
Q Consensus 110 ~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~---~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmE 186 (510)
...++|.|++|.|+.+......+.++.|..... ......-...+..|.-+-..+.|||++.....+++....+-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 457899999999998888877777777765421 11111122225566666777899999988887777776677799
Q ss_pred ccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccch
Q 010463 187 YLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 266 (510)
Q Consensus 187 y~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~ 266 (510)
||++ ||+.++...+.++...+..++.|++.||.|+|+.||.||||||+|+|+..+|.+||+|||.+..+........
T Consensus 402 ~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~-- 478 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNI-- 478 (601)
T ss_pred cccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhh--
Confidence 9999 9999999988899999999999999999999999999999999999999999999999999987654432211
Q ss_pred hhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCC-ccccccchhhHHHHHhhCCCCCC
Q 010463 267 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYG-MECDWWSLGAIMYEMLIGYPPFC 345 (510)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~-~~~DiwSlGvilyEml~G~~PF~ 345 (510)
.....++|+..|+|||++.+..|. ..+|+||.|+++..|.+|+.||.
T Consensus 479 --------------------------------~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk 526 (601)
T KOG0590|consen 479 --------------------------------HESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWK 526 (601)
T ss_pred --------------------------------hhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccc
Confidence 112357999999999999999995 67999999999999999999997
Q ss_pred CCChhhhH-HHH--hhccccc--cCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCc
Q 010463 346 SDDPRITC-RKI--VNWKTCL--KFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQW 409 (510)
Q Consensus 346 ~~~~~~~~-~~I--~~~~~~~--~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~ 409 (510)
-....... ... ..+.... ..+....++.+.+.+|.+||. ||.+|. ++++|++.+||+.++=
T Consensus 527 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~---ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 527 VAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRI---TIEQILNDEWIRSIEC 593 (601)
T ss_pred cccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhhee---cHHHHhhChHhhhcce
Confidence 54433221 111 1111111 111124678899999999999 999999 7999999999998763
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=242.87 Aligned_cols=146 Identities=16% Similarity=0.171 Sum_probs=118.1
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcC-CCCEEEEEEeechhh--cchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKT-TGEIFAMKKLKKSEM--LKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 179 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~-tg~~vAiK~i~k~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 179 (510)
.-.++|++.+.||+|+||+||+|+++. +++.||||++..... ........+.+|+.+|+.++|+||+..+..+ +
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C
Confidence 345789999999999999999999876 788899998753211 1223456689999999999999998533332 4
Q ss_pred eEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeec-CCCCeeecCCCceeecccCCcccCcc
Q 010463 180 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDI-KPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDL-KP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
..|+||||++|++|.. +.. .. ...++.+++.||.|||+.||+|||| ||+|||++.+|.+||+|||+|+.+..
T Consensus 92 ~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~ 164 (365)
T PRK09188 92 KDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR 164 (365)
T ss_pred CcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence 5899999999999963 211 11 1457889999999999999999999 99999999999999999999997643
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=233.26 Aligned_cols=255 Identities=19% Similarity=0.246 Sum_probs=209.5
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCC-----EEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEe
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGE-----IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSF 175 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~-----~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 175 (510)
..+..++++....+-+|.||.||.|.+++... .|-+|.++.. .++-|+..+..|--.|..+.|||+..+.++.
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 33445568888899999999999998775433 2445555322 3566788899999999999999999999877
Q ss_pred e-cCceEEEEEeccCCCCHHHHHHhc--------cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCcee
Q 010463 176 Q-DSDFLYLIMEYLPGGDIMTLLMRE--------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLK 246 (510)
Q Consensus 176 ~-~~~~~~lVmEy~~gG~L~~~L~~~--------~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vk 246 (510)
. +....+.++.++.-|+|..+|... ..++..+...++.|+..|++|||+.||||.||-..|.+||+.-.||
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVk 436 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVK 436 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEE
Confidence 5 456788889999999999999732 3477778888999999999999999999999999999999999999
Q ss_pred ecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCcccc
Q 010463 247 LSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECD 326 (510)
Q Consensus 247 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 326 (510)
|+|=.|++.+-...++.+.++ -.....|||||.+....|+.++|
T Consensus 437 ltDsaLSRDLFP~DYhcLGDn------------------------------------EnRPvkWMslEal~n~~yssasD 480 (563)
T KOG1024|consen 437 LTDSALSRDLFPGDYHCLGDN------------------------------------ENRPVKWMSLEALQNSHYSSASD 480 (563)
T ss_pred eccchhccccCcccccccCCC------------------------------------CCCcccccCHHHHhhhhhcchhh
Confidence 999999998766555443321 11345799999999999999999
Q ss_pred ccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhh
Q 010463 327 WWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 399 (510)
Q Consensus 327 iwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil 399 (510)
+|||||+||||+| |+.|+..-++.++...+..+. .+.-|. ++++++-.++.-|+. +|++|| +.+|+.
T Consensus 481 vWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy-RlaQP~--NCPDeLf~vMacCWallpeeRP---sf~Qlv 549 (563)
T KOG1024|consen 481 VWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY-RLAQPF--NCPDELFTVMACCWALLPEERP---SFSQLV 549 (563)
T ss_pred hHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc-eecCCC--CCcHHHHHHHHHHHhcCcccCC---CHHHHH
Confidence 9999999999998 999999999999998888753 455554 899999999999998 999999 455654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-25 Score=229.59 Aligned_cols=250 Identities=24% Similarity=0.290 Sum_probs=185.4
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCC-CEEEEEEeechhhcchhhHHHHHHHHHHHHhcC----CCCeeeEeEEe-ecCce
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTG-EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD----SRCIVQLFYSF-QDSDF 180 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg-~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~----hp~Iv~l~~~~-~~~~~ 180 (510)
.|.+.+.||+|+||.||+|.+..++ +.+|+|+......... ..+..|..+|..+. .+++..++..+ ..+.+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999988775 6899998876432211 15778999998886 36999999999 58889
Q ss_pred EEEEEeccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCC-----CceeecccCCc
Q 010463 181 LYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN-----GHLKLSDFGLC 253 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~-----g~vkL~DFGla 253 (510)
-|+||+.+ |-+|.++.... +.|+...+..++.|++.+|+++|+.|+|||||||+|+++... -.+.|.|||+|
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999998 77999988544 579999999999999999999999999999999999999865 35999999999
Q ss_pred ccCc--cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchh
Q 010463 254 KPLE--DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLG 331 (510)
Q Consensus 254 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlG 331 (510)
+... ....... +..+.....+.||..|+++.+..+...+...|+||++
T Consensus 175 r~~~~~~~~~~~~------------------------------~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~ 224 (322)
T KOG1164|consen 175 RRFKYVGDSGGNL------------------------------RPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLF 224 (322)
T ss_pred ccccccCCCCccc------------------------------ccCCCCccCCCCccccccHHHhCCCccCCchhhhhHH
Confidence 9332 2110000 0001111235699999999999999999999999999
Q ss_pred hHHHHHhhCCCCCCCCChhhhHHHHhhccccccCC-CCCCCCHHHHHHHHHhhc-CccccC
Q 010463 332 AIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFP-EEPKISDEARDLICHLLC-DVETRL 390 (510)
Q Consensus 332 vilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p-~~~~~s~~~~dlI~~lL~-dp~~R~ 390 (510)
.++.||+.|..||.+........++.........+ .....+.+..++...+-. +...+|
T Consensus 225 Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P 285 (322)
T KOG1164|consen 225 YMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKP 285 (322)
T ss_pred HHHHHHhcCCCCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCC
Confidence 99999999999997655433333333222222222 111233444444444433 555555
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=210.14 Aligned_cols=144 Identities=19% Similarity=0.188 Sum_probs=114.5
Q ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhh-----------------------HHHHHHHHHHHHhcCCCC
Q 010463 111 LTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ-----------------------VEHVRSERNLLAEVDSRC 167 (510)
Q Consensus 111 ~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~-----------------------~~~~~~E~~iL~~l~hp~ 167 (510)
...||+|+||.||+|.+. +|+.||||+++......... ......|..+|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999987 89999999997653211110 123345999999998877
Q ss_pred eeeEeEEeecCceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhh-hhCCeEEeecCCCCeeecCCCcee
Q 010463 168 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSI-HQHNYVHRDIKPDNLILDKNGHLK 246 (510)
Q Consensus 168 Iv~l~~~~~~~~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~l-H~~giiHRDLKP~NILld~~g~vk 246 (510)
+......... ..+|||||++|+++...+.....+++..+..++.|++.+|.++ |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 6443322222 2389999999988876655567899999999999999999999 799999999999999998 58999
Q ss_pred ecccCCcccCcc
Q 010463 247 LSDFGLCKPLED 258 (510)
Q Consensus 247 L~DFGla~~~~~ 258 (510)
|+|||+|.....
T Consensus 158 LiDFG~a~~~~~ 169 (190)
T cd05147 158 IIDVSQSVEHDH 169 (190)
T ss_pred EEEccccccCCC
Confidence 999999986544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-25 Score=206.91 Aligned_cols=243 Identities=21% Similarity=0.270 Sum_probs=189.2
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC-CCeeeEeEEeecCceE
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS-RCIVQLFYSFQDSDFL 181 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~~~~~~~~ 181 (510)
+....|.+++.||.|+||.+|+|....+|+.||||+-++.. .-.++.-|..+...+.+ ..|..+..++....+-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-----CCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 45678999999999999999999999999999999876432 12346778889888865 7888888899999999
Q ss_pred EEEEeccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCC---ceeecccCCcccCc
Q 010463 182 YLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG---HLKLSDFGLCKPLE 257 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g---~vkL~DFGla~~~~ 257 (510)
.|||+++ |-+|.+++.- .+.|+-..+...+-|++.-|+|+|.+++|||||||+|+|+.-+- .+-|+|||||+...
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9999999 7788888753 46799999999999999999999999999999999999997544 47899999999875
Q ss_pred cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHH
Q 010463 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337 (510)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEm 337 (510)
+....... .+++. ....||..|.+--...+...+...|+-|+|.+|..+
T Consensus 166 d~~t~~HI--------------------------pyre~-----r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYf 214 (341)
T KOG1163|consen 166 DIRTRQHI--------------------------PYRED-----RNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYF 214 (341)
T ss_pred cccccccC--------------------------ccccC-----Cccceeeeehhhhhhhhhhhhhhhhhhhhcceeeee
Confidence 53221110 01111 136799999998888888889999999999999999
Q ss_pred hhCCCCCCCC---ChhhhHHHHhhccccccCCC-CCCCCHHHHHHHHHh
Q 010463 338 LIGYPPFCSD---DPRITCRKIVNWKTCLKFPE-EPKISDEARDLICHL 382 (510)
Q Consensus 338 l~G~~PF~~~---~~~~~~~~I~~~~~~~~~p~-~~~~s~~~~dlI~~l 382 (510)
.-|..||.+- +..+-+.+|...+....... ....+.+..-.+.-|
T Consensus 215 nrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~ 263 (341)
T KOG1163|consen 215 NRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYC 263 (341)
T ss_pred ecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHH
Confidence 9999999874 44566777876432221110 124555655555444
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.9e-25 Score=213.69 Aligned_cols=216 Identities=23% Similarity=0.368 Sum_probs=181.5
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCceEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~~lV 184 (510)
-+|.+.+.||.|+||++++|...-++++||||.-.. +.+.-+++.|....+.| ..+.|...|++.+...+-.||
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-----kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-----KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccc-----cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 479999999999999999999999999999997643 23345678888888777 569999999999999999999
Q ss_pred EeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCC-----ceeecccCCcccCcc
Q 010463 185 MEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG-----HLKLSDFGLCKPLED 258 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g-----~vkL~DFGla~~~~~ 258 (510)
||++ |-+|.++..-+ +.|+...+..++.|++.-++|+|++.+|+|||||+|+||..-| .|-|+|||+|+...+
T Consensus 103 idLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred hhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 9999 77888887543 5799999999999999999999999999999999999998544 488999999998766
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHh
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml 338 (510)
....... + ++. ..|..||..||+--...+...+...|+-|||-+++..|
T Consensus 182 p~TkqHI----------------P----------YrE-----~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFL 230 (449)
T KOG1165|consen 182 PKTKQHI----------------P----------YRE-----HKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFL 230 (449)
T ss_pred ccccccC----------------c----------ccc-----ccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhc
Confidence 5332111 0 000 12567999999999999999999999999999999999
Q ss_pred hCCCCCCC---CChhhhHHHHhh
Q 010463 339 IGYPPFCS---DDPRITCRKIVN 358 (510)
Q Consensus 339 ~G~~PF~~---~~~~~~~~~I~~ 358 (510)
-|..||.| ++..+-|.+|-.
T Consensus 231 RGsLPWQGLKA~tnK~kYeKIGe 253 (449)
T KOG1165|consen 231 RGSLPWQGLKADTNKEKYEKIGE 253 (449)
T ss_pred cCCCccccccCcchHHHHHHhcc
Confidence 99999975 566777777754
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=207.29 Aligned_cols=141 Identities=19% Similarity=0.206 Sum_probs=116.4
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHH------HHHHHHHHHhcCCCCeeeEeEEeecC
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEH------VRSERNLLAEVDSRCIVQLFYSFQDS 178 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~------~~~E~~iL~~l~hp~Iv~l~~~~~~~ 178 (510)
.++|.++++||.|+||.||++.. ++..||+|++............. +.+|...+.++.||+|..+..++.+.
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 47899999999999999999655 46689999997654333333333 57899999999999999998887644
Q ss_pred --------ceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeeccc
Q 010463 179 --------DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDF 250 (510)
Q Consensus 179 --------~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DF 250 (510)
+..+|||||++|.+|.++. .+++. ...+++.+|..+|+.|++|||+||+||+++.+| ++|+||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP----EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh----hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 3589999999999998773 23443 356999999999999999999999999999999 999999
Q ss_pred CCcccC
Q 010463 251 GLCKPL 256 (510)
Q Consensus 251 Gla~~~ 256 (510)
|.++..
T Consensus 179 g~~~~~ 184 (232)
T PRK10359 179 SGKRCT 184 (232)
T ss_pred CCcccc
Confidence 988754
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-24 Score=200.85 Aligned_cols=145 Identities=19% Similarity=0.177 Sum_probs=116.2
Q ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchh-----------------------hHHHHHHHHHHHHhcCCCC
Q 010463 111 LTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRG-----------------------QVEHVRSERNLLAEVDSRC 167 (510)
Q Consensus 111 ~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~-----------------------~~~~~~~E~~iL~~l~hp~ 167 (510)
+..||+|+||.||+|.+. +|+.||||+++........ .......|...+..+.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 568999999999999987 8999999999865321000 0223467899999999998
Q ss_pred eeeEeEEeecCceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhh-CCeEEeecCCCCeeecCCCcee
Q 010463 168 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGHLK 246 (510)
Q Consensus 168 Iv~l~~~~~~~~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~-~giiHRDLKP~NILld~~g~vk 246 (510)
|.....+.... .||||||++|+++.........+++..+..++.|++.+|.++|+ .||+||||||+|||++ +|.++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 75444333222 48999999998665543445678889999999999999999999 9999999999999999 89999
Q ss_pred ecccCCcccCccc
Q 010463 247 LSDFGLCKPLEDK 259 (510)
Q Consensus 247 L~DFGla~~~~~~ 259 (510)
|+|||+|+.+...
T Consensus 158 liDFG~a~~~~~~ 170 (190)
T cd05145 158 IIDVSQAVELDHP 170 (190)
T ss_pred EEEcccceecCCC
Confidence 9999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=197.51 Aligned_cols=204 Identities=18% Similarity=0.224 Sum_probs=146.7
Q ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchh-hHHHHHHHHHHHHhcC-CCCeeeEeEEeecCceEEEEE
Q 010463 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRG-QVEHVRSERNLLAEVD-SRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 108 f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~-~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~~~lVm 185 (510)
+.+...||+|+||+|+++.. .+..++.+.+.-....... ....+.+|+++|+++. |++|++++++ +..|++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 34567899999999997655 6777887777654432221 1225789999999995 4889999886 4479999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeec-CCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDI-KPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDL-KP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
||+.|++|...+.. . ...++.|++.+|.++|+.||+|||| ||+|||++.+|+++|+|||+|........ ..
T Consensus 78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~-~~ 149 (218)
T PRK12274 78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR-WM 149 (218)
T ss_pred eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch-HH
Confidence 99999998755421 1 1346789999999999999999999 79999999999999999999985443210 00
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC-CCC-ccccccchhhHHHHHhhCCC
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYG-MECDWWSLGAIMYEMLIGYP 342 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~-~~~DiwSlGvilyEml~G~~ 342 (510)
.+. ..+.+.+--+. -...+|.|++|+.-.-- ..+ ...+|++.|+-+|.++||..
T Consensus 150 ----r~L--------------~~rDl~~llk~------~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~ 205 (218)
T PRK12274 150 ----RLL--------------AREDLRHLLKH------KRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRV 205 (218)
T ss_pred ----HHH--------------HHHHHHHHHHH------HHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccC
Confidence 000 00111111010 12378999999876432 233 67899999999999999999
Q ss_pred CCCCCCh
Q 010463 343 PFCSDDP 349 (510)
Q Consensus 343 PF~~~~~ 349 (510)
|+.+++.
T Consensus 206 ~~~~~~~ 212 (218)
T PRK12274 206 LHWEDNE 212 (218)
T ss_pred CccccCC
Confidence 9987654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=206.32 Aligned_cols=275 Identities=25% Similarity=0.333 Sum_probs=187.9
Q ss_pred hhcccCCCCceeeeeeecCCCeEEEEEEEcCCCC-----------------------------------EEEEEEeechh
Q 010463 99 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGE-----------------------------------IFAMKKLKKSE 143 (510)
Q Consensus 99 ~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~-----------------------------------~vAiK~i~k~~ 143 (510)
...+..++||++..-||+|.-..||.++....|. +.|||.|-.-+
T Consensus 150 ~dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~ 229 (598)
T KOG4158|consen 150 IDSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFE 229 (598)
T ss_pred hhcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccc
Confidence 3456788999999999999999999887654211 35677654322
Q ss_pred hcchh--hHHHHHHHH------HH-----------H-----HhcCCCCeeeEeEEeecC---------------------
Q 010463 144 MLKRG--QVEHVRSER------NL-----------L-----AEVDSRCIVQLFYSFQDS--------------------- 178 (510)
Q Consensus 144 ~~~~~--~~~~~~~E~------~i-----------L-----~~l~hp~Iv~l~~~~~~~--------------------- 178 (510)
..+.. ..+..-+|. .. + ....|||||++..+|.|.
T Consensus 230 ~~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p 309 (598)
T KOG4158|consen 230 HDSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYP 309 (598)
T ss_pred cCCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecc
Confidence 21110 011111111 00 0 013699999999888652
Q ss_pred ------ceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeec--CCC--ceeec
Q 010463 179 ------DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD--KNG--HLKLS 248 (510)
Q Consensus 179 ------~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld--~~g--~vkL~ 248 (510)
..+|+||--.+. +|..+|-.+. .+....+-+++|++.|+.|||++||.|||||.+||||. +|+ .+.|+
T Consensus 310 ~g~g~~~tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVva 387 (598)
T KOG4158|consen 310 SGAGEPKTLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVA 387 (598)
T ss_pred cccCCCceEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEc
Confidence 358999998866 8999986654 57778888999999999999999999999999999984 555 47899
Q ss_pred ccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCC--C----C
Q 010463 249 DFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG--Y----G 322 (510)
Q Consensus 249 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~--y----~ 322 (510)
|||+|---+...-...... | -.+.-|.-.-||||+....+ . -
T Consensus 388 DFGCcLAd~~hGlqlpy~S-------------------------~-------~Vd~GGNa~lmAPEi~ta~PGp~avvny 435 (598)
T KOG4158|consen 388 DFGCCLADDNHGLQLPYES-------------------------D-------EVDLGGNAKLMAPEIATAVPGPNAVVNY 435 (598)
T ss_pred ccceeeecccccccccccc-------------------------c-------cccCCCcceecchhhhhcCCCCceeecc
Confidence 9998853222100000000 0 00234777889999987432 1 2
Q ss_pred ccccccchhhHHHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 323 MECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 323 ~~~DiwSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
.++|.|+.|.+.||++....||++......-..-....+....| ..+++.+++|+..+|+ ||++|++.+-+..+++-
T Consensus 436 ~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp--~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~L 513 (598)
T KOG4158|consen 436 EKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALP--SRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNL 513 (598)
T ss_pred chhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCc--ccCChHHHHHHHHHhcCCccccCCccHHHhHHHH
Confidence 47899999999999999999999854332211112111223334 3789999999999998 99999988667777776
Q ss_pred CCcCCCCc
Q 010463 402 PWFRGIQW 409 (510)
Q Consensus 402 pfF~~i~~ 409 (510)
..|..-+|
T Consensus 514 sLw~~~~~ 521 (598)
T KOG4158|consen 514 SLWRMGED 521 (598)
T ss_pred HHhcCchH
Confidence 66655555
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.9e-23 Score=202.41 Aligned_cols=231 Identities=25% Similarity=0.371 Sum_probs=152.0
Q ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC-----------CCeeeEeEEe-
Q 010463 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS-----------RCIVQLFYSF- 175 (510)
Q Consensus 108 f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~h-----------p~Iv~l~~~~- 175 (510)
......||.|+||.||.|.+..||+.+|+|+..-.........+.+++|.-....+.+ ..++.+ +..
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~-d~~~ 92 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL-DLLR 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---S-EEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeee-EEEE
Confidence 4556789999999999999999999999999876554455567777777654444322 122221 111
Q ss_pred --------ecC---c-----eEEEEEeccCCCCHHHHHH---hccCC---CHHHHHHH-HHHHHHHHHhhhhCCeEEeec
Q 010463 176 --------QDS---D-----FLYLIMEYLPGGDIMTLLM---REDIL---SEDVARFY-IAESVLAIHSIHQHNYVHRDI 232 (510)
Q Consensus 176 --------~~~---~-----~~~lVmEy~~gG~L~~~L~---~~~~l---~e~~~~~~-~~qi~~aL~~lH~~giiHRDL 232 (510)
+-. . +.+++|+-+. +||..++. ..... ....++.+ ..|++..+++||+.|+||+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 111 1 3578888884 48877753 22222 22334343 489999999999999999999
Q ss_pred CCCCeeecCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcc
Q 010463 233 KPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMA 312 (510)
Q Consensus 233 KP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~A 312 (510)
||+|++++.+|.+.|+||+.......... ....++.|.+
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----------------------------------------~~~~~~~~~P 210 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYR-----------------------------------------CSEFPVAFTP 210 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEE-----------------------------------------GGGS-TTTS-
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceee-----------------------------------------ccCCCcccCC
Confidence 99999999999999999987765433210 0235577999
Q ss_pred hHhhccC--------CCCccccccchhhHHHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc
Q 010463 313 PEVLLKK--------GYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC 384 (510)
Q Consensus 313 PEvl~~~--------~y~~~~DiwSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~ 384 (510)
||+.... .++.+.|.|+||+++|.|.||..||....+...... .|....++++.+++||++||.
T Consensus 211 Pe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~--------~f~~C~~~Pe~v~~LI~~lL~ 282 (288)
T PF14531_consen 211 PELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW--------DFSRCRDMPEPVQFLIRGLLQ 282 (288)
T ss_dssp HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG--------GGTTSS---HHHHHHHHHHT-
T ss_pred hhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc--------cchhcCCcCHHHHHHHHHHcc
Confidence 9987543 478899999999999999999999986654433221 122223688999999999998
Q ss_pred -Ccccc
Q 010463 385 -DVETR 389 (510)
Q Consensus 385 -dp~~R 389 (510)
+|.+|
T Consensus 283 ~~~~~R 288 (288)
T PF14531_consen 283 RNPEDR 288 (288)
T ss_dssp SSGGGS
T ss_pred CCcccC
Confidence 99887
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-22 Score=190.18 Aligned_cols=137 Identities=14% Similarity=0.196 Sum_probs=110.1
Q ss_pred eeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-----CCCCeeeEeEEeecCc---eE
Q 010463 110 QLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-----DSRCIVQLFYSFQDSD---FL 181 (510)
Q Consensus 110 ~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-----~hp~Iv~l~~~~~~~~---~~ 181 (510)
-.+.||+|+||.||. +..++.. +||++.... ....+.+.+|+.++..+ +||||+++|++++++. .+
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 356899999999995 7767665 699887642 22346689999999999 6799999999999874 44
Q ss_pred E-EEEec--cCCCCHHHHHHhccCCCHHHHHHHHHHHHHHH-HhhhhCCeEEeecCCCCeeecCC----CceeecccCCc
Q 010463 182 Y-LIMEY--LPGGDIMTLLMREDILSEDVARFYIAESVLAI-HSIHQHNYVHRDIKPDNLILDKN----GHLKLSDFGLC 253 (510)
Q Consensus 182 ~-lVmEy--~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL-~~lH~~giiHRDLKP~NILld~~----g~vkL~DFGla 253 (510)
+ +|||| +++|+|.+++.+. .+++. ..++.+++.++ +|||+.+||||||||+|||++.. +.++|+||+-+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 4 78999 5689999999664 57766 35688888888 99999999999999999999743 37999995544
Q ss_pred cc
Q 010463 254 KP 255 (510)
Q Consensus 254 ~~ 255 (510)
..
T Consensus 157 ~~ 158 (210)
T PRK10345 157 ST 158 (210)
T ss_pred cc
Confidence 43
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.1e-23 Score=223.00 Aligned_cols=243 Identities=21% Similarity=0.302 Sum_probs=180.5
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechh-hcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSE-MLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~-~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++...+.||++.|=+|.+|++. .|. |+||++-+.. ...-....+-..|+. ....++||++.+.-+-..+...|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 6888899999999999998875 344 8999987654 222233333334444 66679999999988877888999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
+|+.. +|++.|..+..+..-+-++|+.|++.||..+|.+||+|+|||.|||||++-.-+.|+||..-+..--.
T Consensus 101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP------ 173 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLP------ 173 (1431)
T ss_pred HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCC------
Confidence 99966 99999998888999999999999999999999999999999999999999999999999865532100
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCC-----------CCccccccchhhHH
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG-----------YGMECDWWSLGAIM 334 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~-----------y~~~~DiwSlGvil 334 (510)
.+ ..++..-. |..++ .-..|+|||.+.... .+++.||+|+||++
T Consensus 174 -eD------NPadf~fF----------FDTSr--------RRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCVi 228 (1431)
T KOG1240|consen 174 -ED------NPADFTFF----------FDTSR--------RRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVI 228 (1431)
T ss_pred -CC------CcccceEE----------EecCC--------ceeeecChHhhhccccccccCCcccccChhhhhhhhhHHH
Confidence 00 00000000 00011 123599999986522 56889999999999
Q ss_pred HHHhh-CCCCCCC-----------CChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 335 YEMLI-GYPPFCS-----------DDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 335 yEml~-G~~PF~~-----------~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
+||++ |.|||.- .+++...++|- +...+.||..|++ ||++|+ ++++.|+-
T Consensus 229 aELf~Eg~PlF~LSQL~aYr~~~~~~~e~~Le~Ie--------------d~~~Rnlil~Mi~rdPs~Rl---SAedyL~~ 291 (1431)
T KOG1240|consen 229 AELFLEGRPLFTLSQLLAYRSGNADDPEQLLEKIE--------------DVSLRNLILSMIQRDPSKRL---SAEDYLQK 291 (1431)
T ss_pred HHHHhcCCCcccHHHHHhHhccCccCHHHHHHhCc--------------CccHHHHHHHHHccCchhcc---CHHHHHHh
Confidence 99998 8999931 11222222221 3478999999999 999999 68888875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.6e-23 Score=223.59 Aligned_cols=263 Identities=27% Similarity=0.404 Sum_probs=212.9
Q ss_pred CCCceeeeeeecCCCeEEEEEEEc-CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEeEEeecCceEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAK-TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~-~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~~~ 182 (510)
...|.+.+.||+|+|+.|-++... .+...+|+|.+.... .......++..|..+-..+. |+|++.+++...+.+..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 467888999999999999987764 345567888776543 23445667778888888886 999999999999999999
Q ss_pred EEEeccCCCCHHHHH-Hhcc-CCCHHHHHHHHHHHHHHHHhhh-hCCeEEeecCCCCeeecCCC-ceeecccCCcccCcc
Q 010463 183 LIMEYLPGGDIMTLL-MRED-ILSEDVARFYIAESVLAIHSIH-QHNYVHRDIKPDNLILDKNG-HLKLSDFGLCKPLED 258 (510)
Q Consensus 183 lVmEy~~gG~L~~~L-~~~~-~l~e~~~~~~~~qi~~aL~~lH-~~giiHRDLKP~NILld~~g-~vkL~DFGla~~~~~ 258 (510)
++++|..||+++.-+ .... ..+...+.+|+.|+..+|.|+| ..++.||||||+|.+++..| .++++|||+|..+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999998 5544 6788899999999999999999 99999999999999999999 999999999987654
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccc-cCCCcchHhhccCCC-CccccccchhhHHHH
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVG-TLDYMAPEVLLKKGY-GMECDWWSLGAIMYE 336 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~G-T~~Y~APEvl~~~~y-~~~~DiwSlGvilyE 336 (510)
... ........+| ++.|+|||...+..| +...|+||+|+++.-
T Consensus 178 ~~g-----------------------------------~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~ 222 (601)
T KOG0590|consen 178 KNG-----------------------------------AERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSA 222 (601)
T ss_pred cCC-----------------------------------cceeeecccCCCCCCCCcccccchhhcCCCcccccccccccc
Confidence 100 0011234688 999999999998655 889999999999999
Q ss_pred HhhCCCCCCCCChhhh-HHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 337 MLIGYPPFCSDDPRIT-CRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 337 ml~G~~PF~~~~~~~~-~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
|++|..|+........ +..............+..++..+.+++.++|. +|..|. +.+++..+||+..
T Consensus 223 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~---s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 223 MLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRL---SIEELKLDNWLSS 291 (601)
T ss_pred cccCCCCccccccccccceeecccccccccCccccCChhhhhcccccccCCchhcc---ccccccccccccc
Confidence 9999999975544332 22222222222344456899999999999997 999999 6789999999987
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.2e-22 Score=186.97 Aligned_cols=240 Identities=19% Similarity=0.262 Sum_probs=194.3
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEE
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~ 182 (510)
+...+..++..|...-.|+.|+|++. |..++.|++...+...+ ....|..|.--|+-..||||+.++++|+.+.++.
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~r-isrdfneefp~lrifshpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTAR-ISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV 263 (448)
T ss_pred cchhhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhcchh-hcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence 44566778888999999999999886 45567788876555333 2345788888899999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHhhhhCC-eEEe-ecCCCCeeecCCCceeec--ccCCcccC
Q 010463 183 LIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHN-YVHR-DIKPDNLILDKNGHLKLS--DFGLCKPL 256 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~lH~~g-iiHR-DLKP~NILld~~g~vkL~--DFGla~~~ 256 (510)
++..|||-|+|+..|.... .++..++..++.+|+.|+.|||++. +|-| -|....++||++-+.+|+ |--++...
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe 343 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE 343 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec
Confidence 9999999999999998753 4677889999999999999999974 5444 688889999998877764 32222110
Q ss_pred ccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCC---CccccccchhhH
Q 010463 257 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY---GMECDWWSLGAI 333 (510)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y---~~~~DiwSlGvi 333 (510)
. ...-.|.||+||.+...+- -.++|+|||.++
T Consensus 344 ~---------------------------------------------gr~y~pawmspealqrkped~n~raadmwsfail 378 (448)
T KOG0195|consen 344 V---------------------------------------------GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAIL 378 (448)
T ss_pred c---------------------------------------------ccccCcccCCHHHHhcCchhcchhhhhHHHHHHH
Confidence 0 1235789999999987665 368999999999
Q ss_pred HHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC
Q 010463 334 MYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT 392 (510)
Q Consensus 334 lyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~ 392 (510)
|||+.|...||..-.+.+.-.+|.-..-...+| +.+|.....|+.-|++ ||.+||..
T Consensus 379 lwel~trevpfadlspmecgmkialeglrv~ip--pgis~hm~klm~icmnedpgkrpkf 436 (448)
T KOG0195|consen 379 LWELNTREVPFADLSPMECGMKIALEGLRVHIP--PGISRHMNKLMNICMNEDPGKRPKF 436 (448)
T ss_pred HHHhhccccccccCCchhhhhhhhhccccccCC--CCccHHHHHHHHHHhcCCCCcCCCc
Confidence 999999999999999998888887654455666 5999999999999998 99999954
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=4e-21 Score=186.98 Aligned_cols=148 Identities=14% Similarity=0.110 Sum_probs=118.2
Q ss_pred CceeeeeeecCCCeEEEEEE-EcCCCCEEEEEEeechhhcch--------------------h-hHHHHHHHHHHHHhcC
Q 010463 107 DFEQLTLIGKGAFGEVRLCR-AKTTGEIFAMKKLKKSEMLKR--------------------G-QVEHVRSERNLLAEVD 164 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~-~~~tg~~vAiK~i~k~~~~~~--------------------~-~~~~~~~E~~iL~~l~ 164 (510)
.|.+.+.||+|+||.||+|. +..+|+.||||++........ . ....+..|..++..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 57888999999999999998 677999999999875431100 0 1134578999999997
Q ss_pred CCC--eeeEeEEeecCceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCC-eEEeecCCCCeeecC
Q 010463 165 SRC--IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHN-YVHRDIKPDNLILDK 241 (510)
Q Consensus 165 hp~--Iv~l~~~~~~~~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~g-iiHRDLKP~NILld~ 241 (510)
+.+ +.+++.. ...|+||||++|++|...+.....+.+..+..++.||+.+|.+||+.| |+||||||+|||++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 633 4455443 235899999999988776655556777778899999999999999999 99999999999999
Q ss_pred CCceeecccCCcccCccc
Q 010463 242 NGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 242 ~g~vkL~DFGla~~~~~~ 259 (510)
++.++|+|||+|......
T Consensus 184 ~~~i~LiDFg~a~~~~~~ 201 (237)
T smart00090 184 DGKVVIIDVSQSVELDHP 201 (237)
T ss_pred CCCEEEEEChhhhccCCc
Confidence 899999999999876544
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.2e-21 Score=181.10 Aligned_cols=139 Identities=23% Similarity=0.307 Sum_probs=115.9
Q ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEeechhh-----cchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 111 LTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEM-----LKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 111 ~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~-----~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++.||+|++|.||+|.. .|..+++|+...... ........+.+|..++..+.|++|+....++.+.+..++||
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 36799999999999987 677899998653221 11122356788999999999999887777777788899999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccC
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 256 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~ 256 (510)
||++|++|.+++..... ....++.+++.+|.++|+.|++|||++|+|||++ ++.++|+|||++...
T Consensus 79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 99999999999865432 7778899999999999999999999999999999 889999999998753
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.1e-21 Score=212.73 Aligned_cols=198 Identities=21% Similarity=0.321 Sum_probs=157.8
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC---CCCeeeEeEEeecC
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD---SRCIVQLFYSFQDS 178 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~---hp~Iv~l~~~~~~~ 178 (510)
++....|.|-+.||+|+||+||+|.... |+.||+|+-+...... +.--.+++.+|+ -+.|+.+..++.-.
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE------fYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE------FYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee------eeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 3556789999999999999999999887 9999999876543221 111222333333 24556666665556
Q ss_pred ceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecC-------CCceeecccC
Q 010463 179 DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK-------NGHLKLSDFG 251 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~-------~g~vkL~DFG 251 (510)
+.-+||+||.+.|+|.+++...+.++|..+.+++.|++.-|++||..+|||+||||+|+||.. .--++|+|||
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecc
Confidence 778899999999999999998899999999999999999999999999999999999999942 2358999999
Q ss_pred CcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchh
Q 010463 252 LCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLG 331 (510)
Q Consensus 252 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlG 331 (510)
.+..+.--... ......++|-.+-.+|+..+.++++.+|.|.|.
T Consensus 847 ~siDm~lfp~~------------------------------------~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlA 890 (974)
T KOG1166|consen 847 RSIDMKLFPDG------------------------------------TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLA 890 (974)
T ss_pred cceeeeEcCCC------------------------------------cEEeeeeccccchhHHHhcCCCCchhhhhHHHH
Confidence 98755321000 112346889999999999999999999999999
Q ss_pred hHHHHHhhCCC
Q 010463 332 AIMYEMLIGYP 342 (510)
Q Consensus 332 vilyEml~G~~ 342 (510)
.+++-||.|+.
T Consensus 891 a~~h~mLFG~y 901 (974)
T KOG1166|consen 891 ATVHVMLFGKY 901 (974)
T ss_pred HHHHHHHHHHH
Confidence 99999999953
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.3e-20 Score=174.59 Aligned_cols=134 Identities=25% Similarity=0.286 Sum_probs=108.5
Q ss_pred eeecCCCeEEEEEEEcCCCCEEEEEEeechhh-----cchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEec
Q 010463 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEM-----LKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEY 187 (510)
Q Consensus 113 ~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~-----~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy 187 (510)
.||+|+||.||+|.. +|..+++|+...... .......++.+|..++..+.|+++.....++.+.+..++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999984 678899998653221 1122346788899999999888765555455566678999999
Q ss_pred cCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccC
Q 010463 188 LPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 256 (510)
Q Consensus 188 ~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~ 256 (510)
++|++|.+++..... .++.+++.+|.+||+.|++|||++|+|||++ ++.++++|||++...
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999999988755321 6788999999999999999999999999999 899999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.1e-20 Score=172.66 Aligned_cols=140 Identities=16% Similarity=0.161 Sum_probs=110.5
Q ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcch-------------------hhHHHHHHHHHHHHhcCCC--
Q 010463 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR-------------------GQVEHVRSERNLLAEVDSR-- 166 (510)
Q Consensus 108 f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~-------------------~~~~~~~~E~~iL~~l~hp-- 166 (510)
|.+.+.||+|+||.||+|... +|+.||||++........ ........|..++..+.|+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 777899999999999999875 799999999765321000 0112366788899988877
Q ss_pred CeeeEeEEeecCceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCcee
Q 010463 167 CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLK 246 (510)
Q Consensus 167 ~Iv~l~~~~~~~~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vk 246 (510)
.++..+. ....++||||++|++|..+... .....++.+++.++.++|+.||+||||||+||+++.++.++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 4555543 2456899999999998765421 34567788999999999999999999999999999999999
Q ss_pred ecccCCcccCcc
Q 010463 247 LSDFGLCKPLED 258 (510)
Q Consensus 247 L~DFGla~~~~~ 258 (510)
|+|||+|.....
T Consensus 166 liDfg~~~~~~~ 177 (198)
T cd05144 166 IIDWPQMVSTDH 177 (198)
T ss_pred EEECCccccCCC
Confidence 999999976654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.9e-19 Score=167.07 Aligned_cols=141 Identities=17% Similarity=0.208 Sum_probs=102.4
Q ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHH---------------------HHHHHHHHHHhcCCCC--
Q 010463 111 LTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVE---------------------HVRSERNLLAEVDSRC-- 167 (510)
Q Consensus 111 ~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~---------------------~~~~E~~iL~~l~hp~-- 167 (510)
.+.||+|+||.||+|.+. +|+.||||++............ ....|...+..+.+.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 568999999999999876 8999999998764321111111 1135666666664443
Q ss_pred eeeEeEEeecCceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhh-CCeEEeecCCCCeeecCCCcee
Q 010463 168 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGHLK 246 (510)
Q Consensus 168 Iv~l~~~~~~~~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~-~giiHRDLKP~NILld~~g~vk 246 (510)
+.+.++. ...++||||++||.+........... ..++.++.+++.++.++|. .||+||||||+||+++ ++.++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~ 154 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVY 154 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEE
Confidence 4455443 23689999999965432211111111 6678899999999999999 9999999999999999 99999
Q ss_pred ecccCCcccCcc
Q 010463 247 LSDFGLCKPLED 258 (510)
Q Consensus 247 L~DFGla~~~~~ 258 (510)
|+|||.+.....
T Consensus 155 liDfg~a~~~~~ 166 (187)
T cd05119 155 IIDVPQAVEIDH 166 (187)
T ss_pred EEECcccccccC
Confidence 999999986654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.79 E-value=6e-19 Score=191.78 Aligned_cols=139 Identities=24% Similarity=0.287 Sum_probs=112.2
Q ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechh-----hcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEE
Q 010463 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSE-----MLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 108 f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~-----~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~ 182 (510)
|...+.||+|+||+||+|..... .+++|+..... .......+.+.+|..++..++|++|+..+.++.+....+
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 34568899999999999887543 34444332211 111223466889999999999999998887777777889
Q ss_pred EEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCc
Q 010463 183 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 257 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~ 257 (510)
+||||++|++|.+++. ....++.+++.+|.+||+.||+||||||+|||+ .++.++|+|||+|+...
T Consensus 413 lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~~ 478 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD 478 (535)
T ss_pred EEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence 9999999999999885 346688999999999999999999999999999 68899999999998754
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.1e-19 Score=183.70 Aligned_cols=181 Identities=27% Similarity=0.365 Sum_probs=134.4
Q ss_pred ceEEEEEeccCCCCHHHHHHhccC---CCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCccc
Q 010463 179 DFLYLIMEYLPGGDIMTLLMREDI---LSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 255 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~~~---l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~ 255 (510)
.++|+.|++|.-++|.++|.+... .+......++.|+..|++| +|.+|||+||.||....++.+||.|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 369999999999999999975543 4566678889999999999 9999999999999999999999999999987
Q ss_pred CccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHH
Q 010463 256 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 335 (510)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvily 335 (510)
......... +.+..+..+||+.||+||.+.++.|+.++||||||+||+
T Consensus 406 ~~~~~~~~~--------------------------------~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~ 453 (516)
T KOG1033|consen 406 QDKDETVAP--------------------------------AAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILA 453 (516)
T ss_pred cccCCcccc--------------------------------hhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHH
Confidence 654321000 000112458999999999999999999999999999999
Q ss_pred HHhh-CCCCCCCCChhhhHHHHhhccccccCCCC-CCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 336 EMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEE-PKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 336 Eml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~-~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
|+++ =..+|. ...+...|-+ ..+|.. ..=-++..+|+.+||. .|.+|| ++.+.--|+|.
T Consensus 454 EL~~~f~T~~e---r~~t~~d~r~----g~ip~~~~~d~p~e~~ll~~lls~~p~~RP---~~~~~~~~~~~ 515 (516)
T KOG1033|consen 454 ELLIQFSTQFE---RIATLTDIRD----GIIPPEFLQDYPEEYTLLQQLLSPSPEERP---SAIEVALHEFL 515 (516)
T ss_pred HHHHHhccHHH---HHHhhhhhhc----CCCChHHhhcCcHHHHHHHHhcCCCcccCc---hHHHHhhhhhc
Confidence 9997 233332 1122333332 333411 1113466789999998 999999 45666666663
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.4e-17 Score=160.73 Aligned_cols=139 Identities=19% Similarity=0.285 Sum_probs=107.8
Q ss_pred eeee-cCCCeEEEEEEEcCCCCEEEEEEeechhhc----------chhhHHHHHHHHHHHHhcCCCCe--eeEeEEeecC
Q 010463 112 TLIG-KGAFGEVRLCRAKTTGEIFAMKKLKKSEML----------KRGQVEHVRSERNLLAEVDSRCI--VQLFYSFQDS 178 (510)
Q Consensus 112 ~~IG-~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~----------~~~~~~~~~~E~~iL~~l~hp~I--v~l~~~~~~~ 178 (510)
.+|| .||.|+||.+... +..+++|.+....+. .......+.+|..++..+.|++| ++.+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4688 8889999988663 778999988653321 11234568889999999998775 6666654332
Q ss_pred -ce---EEEEEeccCC-CCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCc
Q 010463 179 -DF---LYLIMEYLPG-GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLC 253 (510)
Q Consensus 179 -~~---~~lVmEy~~g-G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla 253 (510)
.. .++||||++| ++|.+++.. ..+++.. +.+|+.+|.+||+.||+||||||+|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 22 3599999998 688888754 4566654 568999999999999999999999999999999999999999
Q ss_pred ccCc
Q 010463 254 KPLE 257 (510)
Q Consensus 254 ~~~~ 257 (510)
....
T Consensus 190 ~~~~ 193 (239)
T PRK01723 190 ELRT 193 (239)
T ss_pred ccCC
Confidence 8643
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.8e-17 Score=144.76 Aligned_cols=134 Identities=20% Similarity=0.268 Sum_probs=113.5
Q ss_pred eeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC--CCeeeEeEEeecCceEEEEEec
Q 010463 110 QLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS--RCIVQLFYSFQDSDFLYLIMEY 187 (510)
Q Consensus 110 ~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~h--p~Iv~l~~~~~~~~~~~lVmEy 187 (510)
+++.||.|+++.||++.... ..+++|+...... ...+..|..++..+.| +++++++.++...+..|++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 45789999999999998753 7899999865422 4568889999999976 5999999999888899999999
Q ss_pred cCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhC---CeEEeecCCCCeeecCCCceeecccCCcccCc
Q 010463 188 LPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH---NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 257 (510)
Q Consensus 188 ~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~---giiHRDLKP~NILld~~g~vkL~DFGla~~~~ 257 (510)
++|+.+..+ +......++.+++.+|.++|.. +++|+||+|+|||++..+.++++|||++....
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~ 140 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence 999877654 4555667788999999999985 79999999999999999999999999998654
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=6.8e-16 Score=161.69 Aligned_cols=198 Identities=23% Similarity=0.262 Sum_probs=149.9
Q ss_pred HHhcCCCCeeeEeEEeecCceEEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCe-EEeecCCCCe
Q 010463 160 LAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNY-VHRDIKPDNL 237 (510)
Q Consensus 160 L~~l~hp~Iv~l~~~~~~~~~~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~gi-iHRDLKP~NI 237 (510)
|+.+.|.|+.++++.+.+....+.|.+||+.|+|.+.+... -.++..-...++.+|+.||.|+|+-.| .|+.|++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 35678999999999999999999999999999999999773 346666677778999999999998765 9999999999
Q ss_pred eecCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc
Q 010463 238 ILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL 317 (510)
Q Consensus 238 Lld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~ 317 (510)
++|..-.+||+|||+........... ......-..-|.|||.+.
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~------------------------------------~~~~~~~~~lw~aPellr 124 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPE------------------------------------AHHPIRKALLWTAPELLR 124 (484)
T ss_pred eeeeeEEEEechhhhccccccccccc------------------------------------ccchhHHHHhccCHHHhc
Confidence 99999999999999987654200000 000011234589999998
Q ss_pred cCC-------CCccccccchhhHHHHHhhCCCCCCCCC----hhhhHHHHhhccccccCCCC---CCCCHHHHHHHHHhh
Q 010463 318 KKG-------YGMECDWWSLGAIMYEMLIGYPPFCSDD----PRITCRKIVNWKTCLKFPEE---PKISDEARDLICHLL 383 (510)
Q Consensus 318 ~~~-------y~~~~DiwSlGvilyEml~G~~PF~~~~----~~~~~~~I~~~~~~~~~p~~---~~~s~~~~dlI~~lL 383 (510)
... -+.+.|+||+|++++|+++..-||.... +.+...++.+.......|.- ..+.+++..++..|+
T Consensus 125 ~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw 204 (484)
T KOG1023|consen 125 GALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCW 204 (484)
T ss_pred ccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhc
Confidence 642 3567999999999999999999997632 23444455442222222321 145567899999999
Q ss_pred c-CccccCCCC
Q 010463 384 C-DVETRLGTR 393 (510)
Q Consensus 384 ~-dp~~R~~~~ 393 (510)
. +|..||+..
T Consensus 205 ~e~P~~rPs~~ 215 (484)
T KOG1023|consen 205 EEIPEKRPSIE 215 (484)
T ss_pred ccChhhCccHH
Confidence 8 999999643
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.5e-16 Score=167.52 Aligned_cols=145 Identities=21% Similarity=0.367 Sum_probs=101.6
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhc-------------------------------chhhHHHH
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML-------------------------------KRGQVEHV 153 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~-------------------------------~~~~~~~~ 153 (510)
..+|+. +.||+|++|.||.|+.+++|+.||||++++.... -.+..+.+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 456776 7899999999999999988999999999754100 00122345
Q ss_pred HHHHHHHHhcCCCCeeeEeEEeec-------------CceEEEEEeccCCCCHHHH--HHhcc----CCCHHHHHHHHHH
Q 010463 154 RSERNLLAEVDSRCIVQLFYSFQD-------------SDFLYLIMEYLPGGDIMTL--LMRED----ILSEDVARFYIAE 214 (510)
Q Consensus 154 ~~E~~iL~~l~hp~Iv~l~~~~~~-------------~~~~~lVmEy~~gG~L~~~--L~~~~----~l~e~~~~~~~~q 214 (510)
.+|.+++... +|+.++...|.+ ....+|||||+.|+.+.++ +...+ .+.+..+..++.|
T Consensus 198 ~~ElD~~~Ea--~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 198 HDELDLMREA--ANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred HHhhCHHHHH--HHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 5555554443 233333333332 3345699999999999764 33333 2445555555555
Q ss_pred HHHHHHhhhhCCeEEeecCCCCeeecCCC----ceeecccCCcccCccc
Q 010463 215 SVLAIHSIHQHNYVHRDIKPDNLILDKNG----HLKLSDFGLCKPLEDK 259 (510)
Q Consensus 215 i~~aL~~lH~~giiHRDLKP~NILld~~g----~vkL~DFGla~~~~~~ 259 (510)
++ ..|++|+|+||.||+++.+| .++++|||++..+...
T Consensus 276 if-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 276 VF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 54 58999999999999999988 9999999999887653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.9e-14 Score=152.19 Aligned_cols=143 Identities=17% Similarity=0.262 Sum_probs=96.6
Q ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcc-------------------------------hhhHH------HHH
Q 010463 112 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLK-------------------------------RGQVE------HVR 154 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~-------------------------------~~~~~------~~~ 154 (510)
+.||.|++|.||+|+.+ +|+.||||+.+...... ..-.. .+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999876 78999999986431000 00001 133
Q ss_pred HHHHHHHhc-----CCCCeeeEeEEeecCceEEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHH-HHHhhhhCCe
Q 010463 155 SERNLLAEV-----DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVL-AIHSIHQHNY 227 (510)
Q Consensus 155 ~E~~iL~~l-----~hp~Iv~l~~~~~~~~~~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~-aL~~lH~~gi 227 (510)
+|...+..+ ++++|.-..-+..-.+..+|||||++|++|.+++... ..++. ..++..++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~~---~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLDR---KALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCCH---HHHHHHHHHHHHHHHHhCCc
Confidence 344444443 2344332222222234578999999999998876432 12222 234444444 4788999999
Q ss_pred EEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 228 VHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 228 iHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
+|+|+||.||+++.+|.++|+|||++..+..
T Consensus 279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred eeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 9999999999999999999999999988764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=7.2e-15 Score=154.17 Aligned_cols=264 Identities=21% Similarity=0.234 Sum_probs=194.0
Q ss_pred Cceeeeeeec--CCCeEEEEEEE--cCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCceE
Q 010463 107 DFEQLTLIGK--GAFGEVRLCRA--KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFL 181 (510)
Q Consensus 107 ~f~~~~~IG~--G~fG~V~~~~~--~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~ 181 (510)
.|.+.+.+|. |.+|.||.++. ..++..+|+|.-+.. ......-.+-.+|..-...+ .|++.|+.+..+...+.+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p-~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIP-FSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCC-CCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 4667889999 99999999988 889999999973321 11112222334455555555 489999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhccC-CCHHHHHHHHHHHHH----HHHhhhhCCeEEeecCCCCeeecCC-CceeecccCCccc
Q 010463 182 YLIMEYLPGGDIMTLLMREDI-LSEDVARFYIAESVL----AIHSIHQHNYVHRDIKPDNLILDKN-GHLKLSDFGLCKP 255 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~~-l~e~~~~~~~~qi~~----aL~~lH~~giiHRDLKP~NILld~~-g~vkL~DFGla~~ 255 (510)
|+-+|+|. .+|..+...... +++..++.+..+... ||.++|+.+++|-|+||+||++..+ ..++++|||+...
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~ 272 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSK 272 (524)
T ss_pred eeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEE
Confidence 99999995 688888766544 888889999999999 9999999999999999999999999 8899999999998
Q ss_pred CccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHH
Q 010463 256 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 335 (510)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvily 335 (510)
+.......... .....-|..-|++||++ +.-++...|++|||.+..
T Consensus 273 i~~~~~~~~~~---------------------------------~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l 318 (524)
T KOG0601|consen 273 ISDGNFSSVFK---------------------------------VSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVIL 318 (524)
T ss_pred ccCCcccccee---------------------------------eeecCCCCceEeChhhh-ccccchHhhhcchhhhhH
Confidence 76542111000 00123588889999998 466899999999999999
Q ss_pred HHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchhh
Q 010463 336 EMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKL 412 (510)
Q Consensus 336 Eml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l 412 (510)
+-.+|..++...-. ..+..+-++..+.++- ...|.++...+..|+. +|..|+ +++.+++|++......-.+
T Consensus 319 ~~~l~~~~~~~g~~-~~W~~~r~~~ip~e~~--~~~s~~l~~~~~~~~d~~~~~~~---~~q~~~~l~~i~s~~~~~~ 390 (524)
T KOG0601|consen 319 EAILGSHLPSVGKN-SSWSQLRQGYIPLEFC--EGGSSSLRSVTSQMLDEDPRLRL---TAQILTALNVIHSKLFVHL 390 (524)
T ss_pred hhHhhcccccCCCC-CCccccccccCchhhh--cCcchhhhhHHHHhcCcchhhhh---HHHHHhccccccchhhhcc
Confidence 99988776643310 1122222221122222 2566677778888887 888888 6789999999986554433
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.4e-14 Score=149.20 Aligned_cols=250 Identities=24% Similarity=0.229 Sum_probs=184.5
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEc-CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCce
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAK-TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDF 180 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~-~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~ 180 (510)
....+|..+..||.|.|+.|+.+..+ .++..||+|-+.+.......++.. ..|..+...+ .|.++++.+..|.....
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~s-l~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFS-LGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcc-hhhhhHhhHhhcccccCCCCCCcccccc
Confidence 34568999999999999999988766 678899999886654433333332 3455555554 58999999999988888
Q ss_pred EEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCC-CceeecccCCcccCccc
Q 010463 181 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN-GHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~-g~vkL~DFGla~~~~~~ 259 (510)
.|+--|||.|+++...+.-...+.+...+...+|++.++.++|++.++|+|+||+||++..+ +..++.|||+++.+.-.
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee
Confidence 99999999999988777666778999999999999999999999999999999999999886 78899999998753221
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhccccccccc-ccCCC-cchHhhccCCCCccccccchhhHHHHH
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTV-GTLDY-MAPEVLLKKGYGMECDWWSLGAIMYEM 337 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~-GT~~Y-~APEvl~~~~y~~~~DiwSlGvilyEm 337 (510)
.. ... ++..| .+|.......+..+.|++|||.-+.|.
T Consensus 421 ~~-----------------------------------------~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~ 459 (524)
T KOG0601|consen 421 SG-----------------------------------------VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEA 459 (524)
T ss_pred cc-----------------------------------------cccccccccccchhhcccccccccccccccccccccc
Confidence 00 111 23334 355555677889999999999999999
Q ss_pred hhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 338 LIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 338 l~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
++|.+--...+ ....|.. ...|..+..+.++..+.+.++. ++..|+ .+.++..|+=|
T Consensus 460 ~~~~~ls~~~~---~~~~i~~----~~~p~~~~~~~~~q~~~kv~~~~~~~~~~---l~~~l~~~~~~ 517 (524)
T KOG0601|consen 460 ITGSPLSESGV---QSLTIRS----GDTPNLPGLKLQLQVLLKVMINPDRKRRP---SAVELSLHSEF 517 (524)
T ss_pred ccCcccCcccc---cceeeec----ccccCCCchHHhhhhhhhhhcCCccccch---hhhhhcccchh
Confidence 99865332211 1222322 2223333555777888888876 777777 45666666544
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.49 E-value=8.5e-14 Score=127.71 Aligned_cols=129 Identities=16% Similarity=0.230 Sum_probs=96.7
Q ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCe-eeEeEEeecCceEEEEEeccC
Q 010463 111 LTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCI-VQLFYSFQDSDFLYLIMEYLP 189 (510)
Q Consensus 111 ~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~I-v~l~~~~~~~~~~~lVmEy~~ 189 (510)
++.|+.|.++.||+++.. |..|++|+...... .......|..++..+.+.++ .++++... ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 467899999999998764 78899998764421 11235678888888865444 44554433 34589999999
Q ss_pred CCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCe-----EEeecCCCCeeecCCCceeecccCCcccC
Q 010463 190 GGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY-----VHRDIKPDNLILDKNGHLKLSDFGLCKPL 256 (510)
Q Consensus 190 gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~gi-----iHRDLKP~NILld~~g~vkL~DFGla~~~ 256 (510)
|.++... ......++.+++.+|..||+.++ +|+|++|.||+++ ++.++++|||.+...
T Consensus 75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 9887543 11123456789999999999885 9999999999999 778999999998854
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.48 E-value=4.9e-13 Score=125.57 Aligned_cols=144 Identities=14% Similarity=0.160 Sum_probs=105.7
Q ss_pred eeeeecCCCeEEEEEEEcC------CCCEEEEEEeechhh--------c-----------chhhHHHHH----HHHHHHH
Q 010463 111 LTLIGKGAFGEVRLCRAKT------TGEIFAMKKLKKSEM--------L-----------KRGQVEHVR----SERNLLA 161 (510)
Q Consensus 111 ~~~IG~G~fG~V~~~~~~~------tg~~vAiK~i~k~~~--------~-----------~~~~~~~~~----~E~~iL~ 161 (510)
...||.|--+.||.|.... .+..+|||+.+.+.. . +.+....+. +|...|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999997653 357899998753211 0 111223333 7999998
Q ss_pred hcCC--CCeeeEeEEeecCceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhh-hhCCeEEeecCCCCee
Q 010463 162 EVDS--RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSI-HQHNYVHRDIKPDNLI 238 (510)
Q Consensus 162 ~l~h--p~Iv~l~~~~~~~~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~l-H~~giiHRDLKP~NIL 238 (510)
++.. -.+.+++++ ..-+|||||+.|+++..-..+...+++..+..+..+++.+|..+ |+.||||+||+|.|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 8843 456666654 45689999998765543333344566667777889999999998 8999999999999999
Q ss_pred ecCCCceeecccCCcccCccc
Q 010463 239 LDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 239 ld~~g~vkL~DFGla~~~~~~ 259 (510)
++ +|.+.|+|||.|.....+
T Consensus 158 ~~-~~~v~iIDF~qav~~~hp 177 (197)
T cd05146 158 WH-DGKVWFIDVSQSVEPTHP 177 (197)
T ss_pred EE-CCcEEEEECCCceeCCCC
Confidence 96 578999999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.7e-11 Score=128.73 Aligned_cols=169 Identities=19% Similarity=0.254 Sum_probs=128.4
Q ss_pred EEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEeccCCCCHHHHHHhccCC
Q 010463 124 LCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDIL 203 (510)
Q Consensus 124 ~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy~~gG~L~~~L~~~~~l 203 (510)
.|..+.++.+|.|.+.+.+. ....+.+.+-..-|+.++||||++++..+..++.+|+|+|-+.- |..++.+.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~---~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~l--- 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSN---GEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKEL--- 101 (690)
T ss_pred ccceeccCCceEEEEEeCCC---chhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHHh---
Confidence 46677889999999887543 24455677788889999999999999999999999999998843 44555443
Q ss_pred CHHHHHHHHHHHHHHHHhhh-hCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhhhhccccccccccc
Q 010463 204 SEDVARFYIAESVLAIHSIH-QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 282 (510)
Q Consensus 204 ~e~~~~~~~~qi~~aL~~lH-~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (510)
+......-+.||+.||.+|| +.+++|++|.-+.|+++..|+.||++|-++.........
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~-------------------- 161 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP-------------------- 161 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc--------------------
Confidence 36667777999999999997 679999999999999999999999999988654321000
Q ss_pred CCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhC
Q 010463 283 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 340 (510)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G 340 (510)
+....---.|..|+.+.... -..|.|-|||+++|++.|
T Consensus 162 ------------------~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 162 ------------------AKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ------------------cccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 00011112355666553322 457999999999999999
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.4e-12 Score=124.77 Aligned_cols=249 Identities=18% Similarity=0.194 Sum_probs=166.6
Q ss_pred EEEEEEEcCCCCEEEEEEeechhhc-chhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc-----eEEEEEeccCCCCHH
Q 010463 121 EVRLCRAKTTGEIFAMKKLKKSEML-KRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD-----FLYLIMEYLPGGDIM 194 (510)
Q Consensus 121 ~V~~~~~~~tg~~vAiK~i~k~~~~-~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-----~~~lVmEy~~gG~L~ 194 (510)
.||++-+...|..|.--.+.-.... -+.+.+..+.-.+-|-.+.|.|||+++.++.|.. ...++.|||..|+|.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 3566666666655432222111100 1122333444455567778999999999887654 488999999999999
Q ss_pred HHHHhc----cCCCHHHHHHHHHHHHHHHHhhhhC--CeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhh
Q 010463 195 TLLMRE----DILSEDVARFYIAESVLAIHSIHQH--NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDE 268 (510)
Q Consensus 195 ~~L~~~----~~l~e~~~~~~~~qi~~aL~~lH~~--giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~ 268 (510)
.+|++- ..+.....+.|+.||+.||.|||+. -|+|+++..+-|.+..+|-||+.---.......- .
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~---~----- 232 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSV---N----- 232 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhh---h-----
Confidence 999763 3577888889999999999999987 5999999999999999999997522111110000 0
Q ss_pred hhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCC-CCCC
Q 010463 269 DIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP-FCSD 347 (510)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~P-F~~~ 347 (510)
......+ ....|-++|.|||.=.....+.++|||++|....||..|..- =.+.
T Consensus 233 --------------------~~~~~Ek------~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnse 286 (458)
T KOG1266|consen 233 --------------------STREAEK------SVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSE 286 (458)
T ss_pred --------------------hhhHhhh------hccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCc
Confidence 0000001 112477899999987667778899999999999999998764 3333
Q ss_pred ChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchhhh
Q 010463 348 DPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLY 413 (510)
Q Consensus 348 ~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l~ 413 (510)
+..+.-..|.+....+. .+.-+++|++||. .|..|| ++.+++.||-.-++.-.++.
T Consensus 287 S~~~~ee~ia~~i~~le-------n~lqr~~i~kcl~~eP~~rp---~ar~llfHpllfeVhslkll 343 (458)
T KOG1266|consen 287 SKVEVEENIANVIIGLE-------NGLQRGSITKCLEGEPNGRP---DARLLLFHPLLFEVHSLKLL 343 (458)
T ss_pred ceeehhhhhhhheeecc-------CccccCcCcccccCCCCCCc---chhhhhcCceeeecchHHHH
Confidence 33333333333211111 1234678999999 999999 67899999998777655554
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.2e-11 Score=111.32 Aligned_cols=135 Identities=24% Similarity=0.282 Sum_probs=101.8
Q ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEE-eec----hhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEe
Q 010463 112 TLIGKGAFGEVRLCRAKTTGEIFAMKK-LKK----SEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 186 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~tg~~vAiK~-i~k----~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmE 186 (510)
..|++|+-+.|+.+.+. |..+.+|. ++| ..+..+-..++..+|..+|.++.--.|.-.+-++.|+....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 45789999999998664 44466664 222 222222334667889999998876666655556677888899999
Q ss_pred ccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccC
Q 010463 187 YLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 256 (510)
Q Consensus 187 y~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~ 256 (510)
|++|-.|.+.|.... ..++..+-.-+.-||..||||+||.++||++..++ +.++||||+..-
T Consensus 80 ~I~G~~lkd~l~~~~-------~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 80 YIEGELLKDALEEAR-------PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred EeCChhHHHHHHhcc-------hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 999988888887651 34466677778889999999999999999997665 999999999853
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.8e-11 Score=116.92 Aligned_cols=141 Identities=17% Similarity=0.225 Sum_probs=104.9
Q ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC--CCeeeEeEEeecC---ceEEEEEe
Q 010463 112 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS--RCIVQLFYSFQDS---DFLYLIME 186 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~h--p~Iv~l~~~~~~~---~~~~lVmE 186 (510)
+.||.|..+.||++.... |+.|++|+....... .....+..|..++..+.+ ..+.+++.+.... +..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 568999999999998753 688999998654321 123467889999999865 4467777776654 36789999
Q ss_pred ccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhh------------------------------------------
Q 010463 187 YLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ------------------------------------------ 224 (510)
Q Consensus 187 y~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~------------------------------------------ 224 (510)
|++|+++...+.. ..+++.....++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999888765432 345666666666666666666663
Q ss_pred --------------CCeEEeecCCCCeeecC--CCceeecccCCcccC
Q 010463 225 --------------HNYVHRDIKPDNLILDK--NGHLKLSDFGLCKPL 256 (510)
Q Consensus 225 --------------~giiHRDLKP~NILld~--~g~vkL~DFGla~~~ 256 (510)
..++|+|++|.|||++. ++.+.|+||+.+...
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 34799999999999998 677899999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.16 E-value=3.3e-10 Score=103.18 Aligned_cols=144 Identities=22% Similarity=0.298 Sum_probs=107.7
Q ss_pred eeeeeecCCCeEEEEEEEcCCCCEEEEEEe-----echhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 110 QLTLIGKGAFGEVRLCRAKTTGEIFAMKKL-----KKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 110 ~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i-----~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
.+..|-+|+-+.|+.+.. .|+.+.||.= ....+..+-...+..+|..+|.++.--.|.-..-+|.|...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 677889999999998765 6888888742 222222333456788899999988655555555567777788899
Q ss_pred EeccCC-CCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCc---eeecccCCccc
Q 010463 185 MEYLPG-GDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH---LKLSDFGLCKP 255 (510)
Q Consensus 185 mEy~~g-G~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~---vkL~DFGla~~ 255 (510)
|||++| .++.+++... ..........++..|-..|.-||..+|||+||..+||+|.++|. +.|+|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999988 4677777553 22223333667888888999999999999999999999987763 58999999864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.06 E-value=3.2e-09 Score=109.99 Aligned_cols=209 Identities=16% Similarity=0.255 Sum_probs=151.4
Q ss_pred eEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEee----cCceEEEEEeccCC-CCHH
Q 010463 120 GEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ----DSDFLYLIMEYLPG-GDIM 194 (510)
Q Consensus 120 G~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~----~~~~~~lVmEy~~g-G~L~ 194 (510)
.+.|+|..+.+|..|++|.++-......+ ....-.++++++.|+|||++..+|. .+..+++|++|.|+ ++|+
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n---k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTN---KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcc---cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 56899999999999999999543332221 2334567899999999999999988 34579999999986 5777
Q ss_pred HHHH---------------hccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 195 TLLM---------------REDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 195 ~~L~---------------~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
++-- .....+|+..|.|+.|+..||.++|+.|+.-+-|.|.+||++.+..|+|+..|+...+...
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 6642 2234789999999999999999999999999999999999998889999888776554332
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~ 339 (510)
. + +| +.. -.+-|.=.||.+++-|.|
T Consensus 447 ~---------------------------------------------~-----~~--le~---~Qq~D~~~lG~ll~aLAt 471 (655)
T KOG3741|consen 447 P---------------------------------------------T-----EP--LES---QQQNDLRDLGLLLLALAT 471 (655)
T ss_pred C---------------------------------------------C-----cc--hhH---HhhhhHHHHHHHHHHHhh
Confidence 1 0 00 100 124577789999999999
Q ss_pred CCCCC-CCCChhhh-HHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 340 GYPPF-CSDDPRIT-CRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 340 G~~PF-~~~~~~~~-~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
|..-= ..+..... ...|. +..|.+++++|.-|.. .++++ ++++++.|
T Consensus 472 ~~~ns~~~d~~~~s~~~~I~-----------~~yS~D~rn~v~yl~s~~~~~k----sI~~llp~ 521 (655)
T KOG3741|consen 472 GTENSNRTDSTQSSHLTRIT-----------TTYSTDLRNVVEYLESLNFREK----SIQDLLPM 521 (655)
T ss_pred cccccccccchHHHHHHHhh-----------hhhhHHHHHHHHHHHhcCcccc----cHHHHHHH
Confidence 96432 12222222 22222 3678999999998887 55542 46777654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=3.1e-10 Score=121.19 Aligned_cols=169 Identities=22% Similarity=0.329 Sum_probs=124.0
Q ss_pred HHHHHHHhhhh-CCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHH
Q 010463 214 ESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQ 292 (510)
Q Consensus 214 qi~~aL~~lH~-~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (510)
+++.|+.++|. .++||++|-|++|.++.+|..||+.|++|..........+.+ +.
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~----------------yd-------- 162 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSE----------------YD-------- 162 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCcccccc----------------CC--------
Confidence 45589999996 599999999999999999999999999987654421100000 00
Q ss_pred HHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHh-hCCCCCCCCChhhhHHHHhhccccccCCCCCCC
Q 010463 293 WKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML-IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKI 371 (510)
Q Consensus 293 ~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml-~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~ 371 (510)
..+.-...-...|.|||++.....+.++|++||||++|-+. .|+.-|.+.+....+..-.+......+-....+
T Consensus 163 -----~~lp~~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~ 237 (700)
T KOG2137|consen 163 -----PPLPLLLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNL 237 (700)
T ss_pred -----CCCChhhccCcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccC
Confidence 00001123567899999999988899999999999999999 677777666555555443332222222222578
Q ss_pred CHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchhhhc
Q 010463 372 SDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYE 414 (510)
Q Consensus 372 s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l~~ 414 (510)
+.++++=+.++|. ++..|| ++.+++.-|||.+..-..|+.
T Consensus 238 p~el~~~l~k~l~~~~~~rp---~~~~l~~~~ff~D~~~~aLrf 278 (700)
T KOG2137|consen 238 PSELRESLKKLLNGDSAVRP---TLDLLLSIPFFSDPGLKALRF 278 (700)
T ss_pred cHHHHHHHHHHhcCCcccCc---chhhhhcccccCCchhhhhhh
Confidence 9999999999998 999999 689999999999977666654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.00 E-value=7.7e-09 Score=102.35 Aligned_cols=133 Identities=13% Similarity=0.103 Sum_probs=93.0
Q ss_pred EEEEEEEcCCCCEEEEEEeechhh---cch-----hhHHHHHHHHHHHHhcCCCC--eeeEeEEeec-----CceEEEEE
Q 010463 121 EVRLCRAKTTGEIFAMKKLKKSEM---LKR-----GQVEHVRSERNLLAEVDSRC--IVQLFYSFQD-----SDFLYLIM 185 (510)
Q Consensus 121 ~V~~~~~~~tg~~vAiK~i~k~~~---~~~-----~~~~~~~~E~~iL~~l~hp~--Iv~l~~~~~~-----~~~~~lVm 185 (510)
.|..+.. .|+.|.||....... .+. .-...+.+|...+..+..-+ ++.+.+++.. ...-++||
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 3554443 577899997643221 011 11124778888887773322 2233333332 23578999
Q ss_pred eccCCC-CHHHHHHh--ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecC-------CCceeecccCCccc
Q 010463 186 EYLPGG-DIMTLLMR--EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK-------NGHLKLSDFGLCKP 255 (510)
Q Consensus 186 Ey~~gG-~L~~~L~~--~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~-------~g~vkL~DFGla~~ 255 (510)
|+++|- +|.+++.. ....++.....++.+++..+.-||..||+|+||+|.|||++. ++.+.|+||+.+..
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 999886 78888754 345667778889999999999999999999999999999985 46799999999864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.96 E-value=5.3e-09 Score=97.89 Aligned_cols=130 Identities=21% Similarity=0.247 Sum_probs=83.3
Q ss_pred EEEEEEEcCCCCEEEEEEeechhh-----------------------cchhhHHHHHHHHHHHHhcCCC--CeeeEeEEe
Q 010463 121 EVRLCRAKTTGEIFAMKKLKKSEM-----------------------LKRGQVEHVRSERNLLAEVDSR--CIVQLFYSF 175 (510)
Q Consensus 121 ~V~~~~~~~tg~~vAiK~i~k~~~-----------------------~~~~~~~~~~~E~~iL~~l~hp--~Iv~l~~~~ 175 (510)
.||.|... .|..+|+|+.+.... ..........+|...|..+..- ++.+++++-
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 48888763 577999998754211 0011235577899999999765 466666542
Q ss_pred ecCceEEEEEeccC--CCCHHHHHHhccCCCHHHHHHHHHHHHHHHHh-hhhCCeEEeecCCCCeeecCCCceeecccCC
Q 010463 176 QDSDFLYLIMEYLP--GGDIMTLLMREDILSEDVARFYIAESVLAIHS-IHQHNYVHRDIKPDNLILDKNGHLKLSDFGL 252 (510)
Q Consensus 176 ~~~~~~~lVmEy~~--gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~-lH~~giiHRDLKP~NILld~~g~vkL~DFGl 252 (510)
.-+|||||++ |..+..+ .... ++.+....++.+++..+.. +|..||||+||.+.|||++.+ .+.|+|||.
T Consensus 80 ----~~~ivME~I~~~G~~~~~l-~~~~-~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRL-KDVD-LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCH-HHCG-GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ----CCEEEEEecCCCccchhhH-Hhcc-ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 3469999998 5555443 3322 2244456667777775555 589999999999999999877 999999999
Q ss_pred cccCcc
Q 010463 253 CKPLED 258 (510)
Q Consensus 253 a~~~~~ 258 (510)
+.....
T Consensus 153 av~~~~ 158 (188)
T PF01163_consen 153 AVDSSH 158 (188)
T ss_dssp EEETTS
T ss_pred ceecCC
Confidence 886553
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.4e-10 Score=122.43 Aligned_cols=244 Identities=20% Similarity=0.190 Sum_probs=163.5
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCC-eeeEeEEeecCceEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC-IVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~-Iv~l~~~~~~~~~~~lV 184 (510)
.-+......++|+++++++.+...+.... .+.+... ...+-++++|.+++||| .+..++.++-+.+.+++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~ 312 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP 312 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence 34666778899999999987766554444 5555332 34667899999999999 78888888888999999
Q ss_pred EeccCCC--CHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccc
Q 010463 185 MEYLPGG--DIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 262 (510)
Q Consensus 185 mEy~~gG--~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 262 (510)
|+++.+| .........-.+.+-+.......-..+|+++|+.-=+||| |||..+ +..|+.|||....+....
T Consensus 313 ~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-- 385 (829)
T KOG0576|consen 313 MRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-- 385 (829)
T ss_pred hhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc--
Confidence 9999888 2211111112233334444556667789999998778998 887755 789999999987765431
Q ss_pred ccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCC
Q 010463 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 342 (510)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~ 342 (510)
...+..||+.++|||+.....+....|.||+|+--.+|--|-+
T Consensus 386 -------------------------------------~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~p 428 (829)
T KOG0576|consen 386 -------------------------------------KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLP 428 (829)
T ss_pred -------------------------------------ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCC
Confidence 1135789999999999999999999999999998888888888
Q ss_pred CCCCCChhhhHHHHhhccccccCCCCCCCCH-HHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 343 PFCSDDPRITCRKIVNWKTCLKFPEEPKISD-EARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 343 PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~-~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
|-.+. ......+-+......+......++ .-.++...|+. .|..|. ....++.|.+|++-
T Consensus 429 Pr~~P--~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pk---v~mgacfsKvfngC 490 (829)
T KOG0576|consen 429 PRSSP--PAVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPK---VHMGACFSKVFNGC 490 (829)
T ss_pred CCCCC--ccccCCCCCCCCccccchhhhcCcccccCCcccccCCCCCCCc---chhhHHHHHHhccC
Confidence 87552 222222222111111110001111 11235566666 666665 45667778888764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.81 E-value=3.3e-08 Score=94.25 Aligned_cols=128 Identities=20% Similarity=0.224 Sum_probs=92.6
Q ss_pred CCCCEEEEEEeechh----hcchhhHHHHHHHHHHHHhcCCC--CeeeEeEEeecC----ceEEEEEeccCCC-CHHHHH
Q 010463 129 TTGEIFAMKKLKKSE----MLKRGQVEHVRSERNLLAEVDSR--CIVQLFYSFQDS----DFLYLIMEYLPGG-DIMTLL 197 (510)
Q Consensus 129 ~tg~~vAiK~i~k~~----~~~~~~~~~~~~E~~iL~~l~hp--~Iv~l~~~~~~~----~~~~lVmEy~~gG-~L~~~L 197 (510)
..++.|-+|.+.... ....-......+|...+..+..- .+.+.+++.... ...++|||+++|. +|.+++
T Consensus 30 ~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~ 109 (206)
T PF06293_consen 30 LVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLL 109 (206)
T ss_pred ccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHH
Confidence 345667676543221 11112334577788877666332 233344444332 2468999999985 799998
Q ss_pred HhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCC---ceeecccCCcccC
Q 010463 198 MREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG---HLKLSDFGLCKPL 256 (510)
Q Consensus 198 ~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g---~vkL~DFGla~~~ 256 (510)
......+......++.++...+.-||..||+|+|++|.|||++.++ .+.|+||+.++..
T Consensus 110 ~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 110 QQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 8755577888888999999999999999999999999999999887 8999999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.3e-07 Score=96.09 Aligned_cols=233 Identities=14% Similarity=0.180 Sum_probs=148.9
Q ss_pred eeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeee--------EeEEeecCce
Q 010463 110 QLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQ--------LFYSFQDSDF 180 (510)
Q Consensus 110 ~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~--------l~~~~~~~~~ 180 (510)
..+.||+|+-+.+|-.-. -+. .+-|+..+...... ...+..|... +||-+-. |++. .....
T Consensus 15 ~gr~LgqGgea~ly~l~e--~~d-~VAKIYh~Pppa~~------aqk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~ 84 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE--VRD-QVAKIYHAPPPAAQ------AQKVAELAATPDAPLLNYRVAWPQATLHGG-RRGKV 84 (637)
T ss_pred CCccccCCccceeeecch--hhc-hhheeecCCCchHH------HHHHHHhccCCCCcchhhhhcccHHHhhCC-Cccce
Confidence 346799999999995322 222 34587776532211 1123334333 5654432 1111 12233
Q ss_pred EEEEEeccCCCCHHHHH-------HhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCc
Q 010463 181 LYLIMEYLPGGDIMTLL-------MREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLC 253 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L-------~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla 253 (510)
.-+.|..++|-.=-..+ +....+.+.-+...+.+++.|...||..|.+-+|+.++|+|+++++.|.|.|=..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 78899998875322222 12234677888888999999999999999999999999999999999999864322
Q ss_pred ccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc-----cCCCCcccccc
Q 010463 254 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDWW 328 (510)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-----~~~y~~~~Diw 328 (510)
.....+ ......||.+.|.+||.-. +-+-+...|-|
T Consensus 165 qi~~ng---------------------------------------~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~F 205 (637)
T COG4248 165 QINANG---------------------------------------TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNF 205 (637)
T ss_pred eeccCC---------------------------------------ceEecccCccccCCHHHhccccccccCCCccccch
Confidence 111111 1122468999999999865 23446789999
Q ss_pred chhhHHHHHhhC-CCCCCCC-------ChhhhHHHHhhc------------cccccCCCCCCCCHHHHHHHHHhhc---C
Q 010463 329 SLGAIMYEMLIG-YPPFCSD-------DPRITCRKIVNW------------KTCLKFPEEPKISDEARDLICHLLC---D 385 (510)
Q Consensus 329 SlGvilyEml~G-~~PF~~~-------~~~~~~~~I~~~------------~~~~~~p~~~~~s~~~~dlI~~lL~---d 385 (510)
.|||++|++|.| ..||.|- ++-+ ..|..+ +....-+.+.-+++++..|..++.. .
T Consensus 206 GLavLiF~lL~ggrHPysGI~~~~~ap~p~E--~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~ 283 (637)
T COG4248 206 GLAVLIFHLLFGGRHPYSGIPLISDAPNPLE--TDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGV 283 (637)
T ss_pred hHHHHHHHHHhcCCCCCCcccccCCCCCcch--hhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCC
Confidence 999999999997 9999763 1222 122211 0111111234678999999999986 3
Q ss_pred ccccCCCC
Q 010463 386 VETRLGTR 393 (510)
Q Consensus 386 p~~R~~~~ 393 (510)
+.-||+..
T Consensus 284 ~~~RP~a~ 291 (637)
T COG4248 284 ATPRPTAK 291 (637)
T ss_pred CCCCCCHH
Confidence 55788753
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.63 E-value=4.1e-07 Score=86.40 Aligned_cols=142 Identities=18% Similarity=0.296 Sum_probs=91.9
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHH------HHHHHHHHHhc---CCCCeeeEeE
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEH------VRSERNLLAEV---DSRCIVQLFY 173 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~------~~~E~~iL~~l---~hp~Iv~l~~ 173 (510)
+...+|.+++++-......|.+..- .|+.|.+|............... ..++...+..+ .--.++.++.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 3457899999998888887876543 67889999876533211111111 12223322222 2222222222
Q ss_pred -----EeecCceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeec
Q 010463 174 -----SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLS 248 (510)
Q Consensus 174 -----~~~~~~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~ 248 (510)
.+.-....+|||||++|..|.++.. +++. +...++.++.-||+.|++|+|..|.|++++.++ ++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iI 176 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRII 176 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh----cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEE
Confidence 2222345679999999988866542 3332 345677889999999999999999999998655 9999
Q ss_pred ccCCccc
Q 010463 249 DFGLCKP 255 (510)
Q Consensus 249 DFGla~~ 255 (510)
||+..+.
T Consensus 177 D~~~k~~ 183 (229)
T PF06176_consen 177 DTQGKRM 183 (229)
T ss_pred ECccccc
Confidence 9987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=2.4e-07 Score=99.24 Aligned_cols=144 Identities=18% Similarity=0.246 Sum_probs=94.6
Q ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEeechhhc--------------------c-----------hhhHHHHHH-----
Q 010463 112 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML--------------------K-----------RGQVEHVRS----- 155 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~--------------------~-----------~~~~~~~~~----- 155 (510)
.-|+.++-|.||.|+.++ |+.||||+.+..-.. . .+-.+.+..
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 568999999999999885 999999997642100 0 001122333
Q ss_pred -HHHHHHhc-----CCCCeeeEeEEeecCceEEEEEeccCCCCHHHHH--HhccCCCHHHHHHHHHHHHHHHHhhhhCCe
Q 010463 156 -ERNLLAEV-----DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL--MREDILSEDVARFYIAESVLAIHSIHQHNY 227 (510)
Q Consensus 156 -E~~iL~~l-----~hp~Iv~l~~~~~~~~~~~lVmEy~~gG~L~~~L--~~~~~l~e~~~~~~~~qi~~aL~~lH~~gi 227 (510)
|..-+.++ +.|+|.--.-+++-.+.-.|+|||+.|--+.+.. .. ..++...+.....++ .+..+-..|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~~dgf 286 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHHhcCc
Confidence 33333333 3455433333333345678999999998888874 33 445533333222222 2333445899
Q ss_pred EEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 228 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 228 iHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
+|.|.+|.||+++.+|++.+.|||+...+...
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 99999999999999999999999999887654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=2.1e-07 Score=90.18 Aligned_cols=140 Identities=16% Similarity=0.187 Sum_probs=100.5
Q ss_pred eeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhh-----------------cc--hhhHHHHHHHHHHHHhcCCC--Ce
Q 010463 110 QLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEM-----------------LK--RGQVEHVRSERNLLAEVDSR--CI 168 (510)
Q Consensus 110 ~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~-----------------~~--~~~~~~~~~E~~iL~~l~hp--~I 168 (510)
+...||-|--+.||.|... .|..+|||.=+-... .+ .-......+|..+|..+... .|
T Consensus 95 iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 95 IGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 4468999999999999875 688999996322110 00 01234467888899988655 56
Q ss_pred eeEeEEeecCceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeec
Q 010463 169 VQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLS 248 (510)
Q Consensus 169 v~l~~~~~~~~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~ 248 (510)
.+.++. +.-.+||||+.|-.|...- ++.+.+..++..|+.-+.-+-..||||+|+.+=|||++.+|.+.++
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vI 244 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVI 244 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEE
Confidence 665543 5678999999997765442 1333444455566666665568999999999999999999999999
Q ss_pred ccCCcccCccc
Q 010463 249 DFGLCKPLEDK 259 (510)
Q Consensus 249 DFGla~~~~~~ 259 (510)
||--|.....+
T Consensus 245 DwPQ~v~~~hp 255 (304)
T COG0478 245 DWPQAVPISHP 255 (304)
T ss_pred eCcccccCCCC
Confidence 99988765543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.4e-06 Score=82.51 Aligned_cols=139 Identities=13% Similarity=0.178 Sum_probs=99.8
Q ss_pred ecCCCeEEEEEEEcCCCCEEEEEEeech---hhcchhhHHHHHHHHHHHHhcCCC--CeeeEeEEeec----CceEEEEE
Q 010463 115 GKGAFGEVRLCRAKTTGEIFAMKKLKKS---EMLKRGQVEHVRSERNLLAEVDSR--CIVQLFYSFQD----SDFLYLIM 185 (510)
Q Consensus 115 G~G~fG~V~~~~~~~tg~~vAiK~i~k~---~~~~~~~~~~~~~E~~iL~~l~hp--~Iv~l~~~~~~----~~~~~lVm 185 (510)
|+||-+-|+.... .|+.|=+|.-... .+.-+.-...+.+|...|..+..- .+.+....-.. .-.-+||+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 7789988987654 3456888875411 111022346688999999887432 24444422211 12478999
Q ss_pred eccCC-CCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCc--eeecccCCccc
Q 010463 186 EYLPG-GDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH--LKLSDFGLCKP 255 (510)
Q Consensus 186 Ey~~g-G~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~--vkL~DFGla~~ 255 (510)
|-++| -||.+++... ...++..-..++.+|..+|.-||+.|+.|+|+-+.|||++.+|. |+++||--++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98764 4888887653 34577777888999999999999999999999999999997787 99999987764
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.8e-06 Score=83.45 Aligned_cols=134 Identities=20% Similarity=0.145 Sum_probs=84.7
Q ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCC--eeeEeEEeecCceEEEEEeccC
Q 010463 112 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC--IVQLFYSFQDSDFLYLIMEYLP 189 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~--Iv~l~~~~~~~~~~~lVmEy~~ 189 (510)
..||+|..+.||++ .|..+++|...... ....+.+|.+++..+..-. +.+.+++..+.+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 56899999999973 25567889875421 2344688999998885433 4677777777888899999999
Q ss_pred CCC-HHHH--------------HH-------hc--cC--CCHHHHHHHHH----------HHHHH-HHhhh----hCCeE
Q 010463 190 GGD-IMTL--------------LM-------RE--DI--LSEDVARFYIA----------ESVLA-IHSIH----QHNYV 228 (510)
Q Consensus 190 gG~-L~~~--------------L~-------~~--~~--l~e~~~~~~~~----------qi~~a-L~~lH----~~gii 228 (510)
|.+ +... +. .- .. +.... ..+.. .+... ..+|. ...++
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~-~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYK-EKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHH-HHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 964 1111 10 00 00 11100 00000 00111 11221 12578
Q ss_pred EeecCCCCeeecCCCceeecccCCcccC
Q 010463 229 HRDIKPDNLILDKNGHLKLSDFGLCKPL 256 (510)
Q Consensus 229 HRDLKP~NILld~~g~vkL~DFGla~~~ 256 (510)
|+|+.|.||+++.+| +.|+||+.+..-
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~~G 183 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFGYG 183 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcCcC
Confidence 999999999999988 999999998754
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.43 E-value=3.1e-06 Score=80.96 Aligned_cols=139 Identities=19% Similarity=0.303 Sum_probs=82.9
Q ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCC--CeeeEeEEee---cCceEEEEE
Q 010463 111 LTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR--CIVQLFYSFQ---DSDFLYLIM 185 (510)
Q Consensus 111 ~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp--~Iv~l~~~~~---~~~~~~lVm 185 (510)
++.|+.|..+.||++.... ..|++|+.... .....+..|..++..+... -+.+++.... .....+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 5789999999999988764 48999987543 2345677888888777433 3456665332 334579999
Q ss_pred eccCCCCHHH----------------HHH---hc----cCCCHHH---H---HHH---------------HHHHHH-HHH
Q 010463 186 EYLPGGDIMT----------------LLM---RE----DILSEDV---A---RFY---------------IAESVL-AIH 220 (510)
Q Consensus 186 Ey~~gG~L~~----------------~L~---~~----~~l~e~~---~---~~~---------------~~qi~~-aL~ 220 (510)
++++|..+.. .+. .. ..+.... . ... +..+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999988777 111 11 0001000 0 000 011111 222
Q ss_pred hhh-------hCCeEEeecCCCCeeec-CCCceeecccCCcccC
Q 010463 221 SIH-------QHNYVHRDIKPDNLILD-KNGHLKLSDFGLCKPL 256 (510)
Q Consensus 221 ~lH-------~~giiHRDLKP~NILld-~~g~vkL~DFGla~~~ 256 (510)
.++ ...++|+|+.|.|||++ .+|.+-|+||+.+...
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 222 35699999999999999 6777789999988643
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.42 E-value=2.4e-06 Score=82.19 Aligned_cols=143 Identities=17% Similarity=0.165 Sum_probs=97.2
Q ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchh-------------------hH--HHHHHHHHHHHhcC--CCC
Q 010463 111 LTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRG-------------------QV--EHVRSERNLLAEVD--SRC 167 (510)
Q Consensus 111 ~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~-------------------~~--~~~~~E~~iL~~l~--hp~ 167 (510)
...|+.|--+.||+|.. .++..+|+|+.+.....-+. ++ .-...|..-|..+. +-.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 34788899999999875 46889999998654321111 11 12344555565552 334
Q ss_pred eeeEeEEeecCceEEEEEeccCCCC-HHHHHHhccCCCHHHHHHHHHHHHHHHHhhhh-CCeEEeecCCCCeeecCCCce
Q 010463 168 IVQLFYSFQDSDFLYLIMEYLPGGD-IMTLLMREDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGHL 245 (510)
Q Consensus 168 Iv~l~~~~~~~~~~~lVmEy~~gG~-L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~-~giiHRDLKP~NILld~~g~v 245 (510)
+.+-+.+.. -.|||||+.... -.-.|.. -.+..+++..+..+++..+.-|-. .|+||+||..=|||+. +|.+
T Consensus 132 vP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 132 VPEPIAFRN----NVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred CCCceeecC----CeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence 455555443 469999996531 1111222 123344678888899999888776 9999999999999999 8999
Q ss_pred eecccCCcccCcccc
Q 010463 246 KLSDFGLCKPLEDKY 260 (510)
Q Consensus 246 kL~DFGla~~~~~~~ 260 (510)
.|+|||-|.....+.
T Consensus 206 ~iID~~QaV~~~hp~ 220 (268)
T COG1718 206 YIIDVSQAVTIDHPN 220 (268)
T ss_pred EEEECccccccCCCc
Confidence 999999998776543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.30 E-value=2.5e-06 Score=96.34 Aligned_cols=204 Identities=21% Similarity=0.240 Sum_probs=148.9
Q ss_pred hhHHHHHHHHHHHHhcCCCCeeeEeEEeecCce----EEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhh
Q 010463 148 GQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF----LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIH 223 (510)
Q Consensus 148 ~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~----~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH 223 (510)
.++....-|...+.+..|+|++.++.+-..... +.+..++|++-+++.++..-+.++.+.++.+.++++.||.++|
T Consensus 224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence 344555567777888999999999877654332 3345588999999999999999999999999999999999999
Q ss_pred hCCeEEeecCCC---CeeecCCCceeec--ccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcc
Q 010463 224 QHNYVHRDIKPD---NLILDKNGHLKLS--DFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRR 298 (510)
Q Consensus 224 ~~giiHRDLKP~---NILld~~g~vkL~--DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (510)
+....|.-|--. +-..+..+++.++ ||+.++.+......
T Consensus 304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~------------------------------------ 347 (1351)
T KOG1035|consen 304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS------------------------------------ 347 (1351)
T ss_pred HhccceeEEecccccccccCccceeecchhhhcccccCCCcccc------------------------------------
Confidence 997777666555 5556677788877 99988876553211
Q ss_pred cccccccccCCCcchHhhccCCCCcc--ccccchhhHHHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCH-HH
Q 010463 299 ALAYSTVGTLDYMAPEVLLKKGYGME--CDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISD-EA 375 (510)
Q Consensus 299 ~~~~s~~GT~~Y~APEvl~~~~y~~~--~DiwSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~-~~ 375 (510)
.+..-+..+.|||......+..+ .|+|.+|..+..+..|..+-.-. .+...++ +..+. +.
T Consensus 348 ---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~---~~~~~~l-----------~~~~~~~~ 410 (1351)
T KOG1035|consen 348 ---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKS---AVPVSLL-----------DVLSTSEL 410 (1351)
T ss_pred ---hhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccc---cchhhhh-----------ccccchhh
Confidence 12345667888888877666544 69999999999999876542110 1111111 12222 67
Q ss_pred HHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 376 RDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 376 ~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
.+++.+|+. ++++|+ ++.+++.|||.+.-
T Consensus 411 ~d~~~~~~~~~~~~Rl---~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 411 LDALPKCLDEDSEERL---SALELLTHPFLRFP 440 (1351)
T ss_pred hhhhhhhcchhhhhcc---chhhhhhchhcccc
Confidence 788888886 899999 67899999998753
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.3e-05 Score=75.35 Aligned_cols=128 Identities=22% Similarity=0.317 Sum_probs=90.4
Q ss_pred CCceeeeeeecCCC-eEEEEEEEcCCCCEEEEEEeechhhc---------ch---------hhHHHHHHHHHHHHhc---
Q 010463 106 DDFEQLTLIGKGAF-GEVRLCRAKTTGEIFAMKKLKKSEML---------KR---------GQVEHVRSERNLLAEV--- 163 (510)
Q Consensus 106 ~~f~~~~~IG~G~f-G~V~~~~~~~tg~~vAiK~i~k~~~~---------~~---------~~~~~~~~E~~iL~~l--- 163 (510)
.+++.++.||.|+- |.||+++. .|+.||+|+...-... .. ....-+..|.+....+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 78999999999999 99999877 5889999993321100 00 1223466677665444
Q ss_pred CCCCe--eeEeEEeecC------------------ceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhh
Q 010463 164 DSRCI--VQLFYSFQDS------------------DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIH 223 (510)
Q Consensus 164 ~hp~I--v~l~~~~~~~------------------~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH 223 (510)
.+..+ |+.+++..-. ....||.||++... .++.. -+.+|..-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----HHHHHHHHHHHHH
Confidence 45555 9999887321 12467888887653 12222 2567888899999
Q ss_pred hCCeEEeecCCCCeeecCCCceeecccCCc
Q 010463 224 QHNYVHRDIKPDNLILDKNGHLKLSDFGLC 253 (510)
Q Consensus 224 ~~giiHRDLKP~NILld~~g~vkL~DFGla 253 (510)
..||+-+|+|+.|.. .-||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999975 3489999864
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.26 E-value=5e-06 Score=89.05 Aligned_cols=142 Identities=21% Similarity=0.319 Sum_probs=91.5
Q ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEeechhh----------------------------cchhhHHHHHHHHHHHH--
Q 010463 112 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEM----------------------------LKRGQVEHVRSERNLLA-- 161 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~----------------------------~~~~~~~~~~~E~~iL~-- 161 (510)
+.||.-+.|.|+.|+.+. |+.||||+-+..-- .-.+..+.+..|.+.+.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 568999999999999987 99999999754210 00111122333333332
Q ss_pred --------hcCCCC------eeeEeEEeecCceEEEEEeccCCCCHHHH--HHhccCCCHHHHHHHHHHHHHHHHhhhhC
Q 010463 162 --------EVDSRC------IVQLFYSFQDSDFLYLIMEYLPGGDIMTL--LMREDILSEDVARFYIAESVLAIHSIHQH 225 (510)
Q Consensus 162 --------~l~hp~------Iv~l~~~~~~~~~~~lVmEy~~gG~L~~~--L~~~~~l~e~~~~~~~~qi~~aL~~lH~~ 225 (510)
.+.|-+ |.++|..+ ...-.|+||||+|.-+.++ |.+.+ ++...+...+.++. ++-+=..
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i~~~l~~~~--~~qIf~~ 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRG-ISPHDILNKLVEAY--LEQIFKT 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcC-CCHHHHHHHHHHHH--HHHHHhc
Confidence 223433 45554443 3457899999999866554 44444 45544433333332 2333457
Q ss_pred CeEEeecCCCCeeecC----CCceeecccCCcccCccc
Q 010463 226 NYVHRDIKPDNLILDK----NGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 226 giiHRDLKP~NILld~----~g~vkL~DFGla~~~~~~ 259 (510)
|++|.|-.|.|||++. ++.+.+-|||+...+...
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 8999999999999994 668999999999877553
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.22 E-value=1e-05 Score=78.94 Aligned_cols=135 Identities=16% Similarity=0.110 Sum_probs=83.9
Q ss_pred eecCCC-eEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEeEEeecCceEEEEEeccCCC
Q 010463 114 IGKGAF-GEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSDFLYLIMEYLPGG 191 (510)
Q Consensus 114 IG~G~f-G~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~~~lVmEy~~gG 191 (510)
|-.|.. ..||++... +..+.+|...... ...+.+|..++..+. +--+.+++++..+.+..++|||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 444555 789987543 4678888875432 234667888887773 344667788877777789999999997
Q ss_pred CHHHHH----------------Hhcc-------CCCHH------HHHHH-------------------HHHHHHHHHhh-
Q 010463 192 DIMTLL----------------MRED-------ILSED------VARFY-------------------IAESVLAIHSI- 222 (510)
Q Consensus 192 ~L~~~L----------------~~~~-------~l~e~------~~~~~-------------------~~qi~~aL~~l- 222 (510)
.|.... .+-. .+... ..... ..++...|...
T Consensus 78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 157 (244)
T cd05150 78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR 157 (244)
T ss_pred cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence 765431 0000 11100 00000 11111111111
Q ss_pred ---hhCCeEEeecCCCCeeecCCCceeecccCCcccC
Q 010463 223 ---HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 256 (510)
Q Consensus 223 ---H~~giiHRDLKP~NILld~~g~vkL~DFGla~~~ 256 (510)
....++|+|+.|.|||++.++.+.|+||+.|...
T Consensus 158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~g 194 (244)
T cd05150 158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVA 194 (244)
T ss_pred CCcCceEEECCCCCCccEEEeCCcEEEEEEccccccc
Confidence 2345999999999999999888899999988753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.7e-05 Score=90.85 Aligned_cols=81 Identities=20% Similarity=0.361 Sum_probs=58.2
Q ss_pred eeeeeecCCCeEEEEEEEcCCC--CEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCe--eeEeEEeecC---ceE
Q 010463 110 QLTLIGKGAFGEVRLCRAKTTG--EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCI--VQLFYSFQDS---DFL 181 (510)
Q Consensus 110 ~~~~IG~G~fG~V~~~~~~~tg--~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~-hp~I--v~l~~~~~~~---~~~ 181 (510)
.++.|+.|.++.+|+......+ ..+++|+........ ....+.+|..+|+.+. |++| .+++.++.+. +..
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 3677899999999998765433 467788765432211 1245788999999985 6654 7888888765 468
Q ss_pred EEEEeccCCCC
Q 010463 182 YLIMEYLPGGD 192 (510)
Q Consensus 182 ~lVmEy~~gG~ 192 (510)
|+||||++|..
T Consensus 120 flVME~v~G~~ 130 (822)
T PLN02876 120 FYIMEYLEGRI 130 (822)
T ss_pred eEEEEecCCcc
Confidence 99999999864
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.1e-06 Score=101.07 Aligned_cols=256 Identities=17% Similarity=0.056 Sum_probs=164.0
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhc--chhhHHHHHHHHHHHHhcCCCCeeeEeEEeec--Cc
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML--KRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD--SD 179 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~ 179 (510)
...++++.--||.|.+++--.-+.+.. -+.+|+.+..+.. .+...+....|++-++...|++++..+.-..+ ..
T Consensus 1227 ~~e~~EV~l~i~~~~~~R~k~Lr~kid--~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ 1304 (2724)
T KOG1826|consen 1227 AMEHSEVNLGISNHFHFRNKWLRSKID--WFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSEST 1304 (2724)
T ss_pred HhhhhheeeecccceeeccchHhhhhc--eeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCCh
Confidence 346777777777777765432222222 2445555433221 22234556677887888899999877655543 34
Q ss_pred eEEEEEeccCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHhhhhCC-----eEEeecCCCCeeecCCCceeeccc
Q 010463 180 FLYLIMEYLPGGDIMTLLMRE----DILSEDVARFYIAESVLAIHSIHQHN-----YVHRDIKPDNLILDKNGHLKLSDF 250 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~----~~l~e~~~~~~~~qi~~aL~~lH~~g-----iiHRDLKP~NILld~~g~vkL~DF 250 (510)
..|.+|+|+.+|++++.|.+. ..+.+.-+.....+.+.+..-+|++. .+|++||+-|.+|..+-.+|+.++
T Consensus 1305 ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~ 1384 (2724)
T KOG1826|consen 1305 EEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKG 1384 (2724)
T ss_pred HHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccccc
Confidence 679999999999999999764 23333333333334477777777542 789999999999999999999999
Q ss_pred CCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccch
Q 010463 251 GLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSL 330 (510)
Q Consensus 251 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSl 330 (510)
|+.+..... .......+++|.|++|++...-.++.++|+|..
T Consensus 1385 gLdKIknp~--------------------------------------~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~ 1426 (2724)
T KOG1826|consen 1385 GLDKIKNPV--------------------------------------LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRR 1426 (2724)
T ss_pred ccccccCch--------------------------------------HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHH
Confidence 999832221 011224688999999999999899999999999
Q ss_pred hhHHHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcC
Q 010463 331 GAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 405 (510)
Q Consensus 331 GvilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~ 405 (510)
|+-+|+.--|.++|...........|.+ ......+. -.|.++......+|- .-..||+ ...++.-+.|.
T Consensus 1427 s~~ly~rs~~n~~fi~flq~~Lkgiidn-~tf~sIe~--l~pgdaNve~~~~Ll~K~~~rp~---q~isls~d~~a 1496 (2724)
T KOG1826|consen 1427 SLSLYLRSDGNAYFIFFLQPALKGIIDN-HTFFSIEK--LKPGDANVEALHRLLWKYMERPG---QYISLSRDHFA 1496 (2724)
T ss_pred HHHHHHHhcccHHHHHHHHHHHcCcccc-cccccccc--cCCCcccHHHHHHHHHHhhhcch---hhhhccccccc
Confidence 9999999999998854332222222222 22233331 123334444444443 5567773 45566655554
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.00 E-value=3e-05 Score=70.96 Aligned_cols=131 Identities=15% Similarity=0.207 Sum_probs=91.5
Q ss_pred eeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEecc
Q 010463 109 EQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYL 188 (510)
Q Consensus 109 ~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy~ 188 (510)
...+.||+|.+|.||+|.+. |..+|+|+-... .-...+..|..+|..+..-++..=.+.+- .-++.|||+
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~d-----s~r~~l~kEakiLeil~g~~~~p~vy~yg---~~~i~me~i 94 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRD-----SPRRNLEKEAKILEILAGEGVTPEVYFYG---EDFIRMEYI 94 (201)
T ss_pred hhhhhhhcccccEEEEeecc--CceEEEEEecCC-----cchhhHHHHHHHHHHhhhcCCCceEEEec---hhhhhhhhh
Confidence 34568999999999999885 668999986543 23466888999999998776654433332 234559999
Q ss_pred CCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecC-CCCeeecCCCceeecccCCcccC
Q 010463 189 PGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIK-PDNLILDKNGHLKLSDFGLCKPL 256 (510)
Q Consensus 189 ~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLK-P~NILld~~g~vkL~DFGla~~~ 256 (510)
.|-.|.+.-... +..+ +..++.+---|-.+||-|..|. |..++|-.++.+.|+||.-|+.-
T Consensus 95 ~G~~L~~~~~~~---~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 95 DGRPLGKLEIGG---DRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred cCcchhhhhhcc---cHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 998887765421 1222 3334444344567899999885 56566666679999999998843
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.95 E-value=5.8e-05 Score=73.28 Aligned_cols=74 Identities=12% Similarity=0.224 Sum_probs=46.2
Q ss_pred eeeeecCCCe-EEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCC---CeeeEeEEeecCc---eEEE
Q 010463 111 LTLIGKGAFG-EVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR---CIVQLFYSFQDSD---FLYL 183 (510)
Q Consensus 111 ~~~IG~G~fG-~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp---~Iv~l~~~~~~~~---~~~l 183 (510)
+..|+.|+.. .||.+ +..+.+|..+.. .....+.+|..+|..+... -+.+.++.....+ ..|+
T Consensus 2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~~-----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 2 IEPVDSGGTDNATFRL-----GDDMSVRLPSAA-----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred ceeccCCCcccceEEc-----CCceEEEcCCcc-----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 3467877776 48975 235777865432 1234688899999877531 3444444443322 4589
Q ss_pred EEeccCCCCHH
Q 010463 184 IMEYLPGGDIM 194 (510)
Q Consensus 184 VmEy~~gG~L~ 194 (510)
||++++|.++.
T Consensus 72 l~~~i~G~~l~ 82 (235)
T cd05155 72 VYRWLEGETAT 82 (235)
T ss_pred EEEeecCCCCC
Confidence 99999996653
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00018 Score=67.93 Aligned_cols=136 Identities=19% Similarity=0.248 Sum_probs=92.9
Q ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEeechhh-------------cchhhHHHHHHHHHHHHhcC------CCCeeeE
Q 010463 111 LTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEM-------------LKRGQVEHVRSERNLLAEVD------SRCIVQL 171 (510)
Q Consensus 111 ~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~-------------~~~~~~~~~~~E~~iL~~l~------hp~Iv~l 171 (510)
...||+|+.=.|| .+.. .....||++..... ..........+|..-...+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy--~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCY--QHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEE--ECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 3579999999999 4443 34467899876640 01122345666666655554 7899999
Q ss_pred eEEeecCceEEEEEeccCC--C----CHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCC--C
Q 010463 172 FYSFQDSDFLYLIMEYLPG--G----DIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN--G 243 (510)
Q Consensus 172 ~~~~~~~~~~~lVmEy~~g--G----~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~--g 243 (510)
||..+++.-+-+|+|.+-. | +|.+++.. +.+++ .... .+-.-..+|-+.+|+.+||+|.||++... |
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 9999999999999998743 2 57777744 45666 3332 23344567789999999999999999733 2
Q ss_pred --ceeecc-cCCcc
Q 010463 244 --HLKLSD-FGLCK 254 (510)
Q Consensus 244 --~vkL~D-FGla~ 254 (510)
.+.|+| ||-..
T Consensus 158 ~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 158 EFRLVLIDGLGEKE 171 (199)
T ss_pred ceEEEEEeCCCCcc
Confidence 466776 45433
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00062 Score=71.13 Aligned_cols=81 Identities=16% Similarity=0.171 Sum_probs=55.7
Q ss_pred eeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhc--c--hhhHHHHHHHHHHHHhcC---CCCeeeEeEEeecCceEE
Q 010463 110 QLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML--K--RGQVEHVRSERNLLAEVD---SRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 110 ~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~--~--~~~~~~~~~E~~iL~~l~---hp~Iv~l~~~~~~~~~~~ 182 (510)
..+.||.|.++.||.+...+.++.+.||.-....-. . ....++...|.+.|..+. ...+++++.+ +++..+
T Consensus 30 ~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~ 107 (401)
T PRK09550 30 TAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAV 107 (401)
T ss_pred eeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCE
Confidence 457899999999999988654468999974311100 0 123566778888887752 3467777666 456678
Q ss_pred EEEeccCCCC
Q 010463 183 LIMEYLPGGD 192 (510)
Q Consensus 183 lVmEy~~gG~ 192 (510)
+||||+++..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 9999998743
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00031 Score=70.88 Aligned_cols=78 Identities=10% Similarity=0.031 Sum_probs=54.7
Q ss_pred eeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC---CCeeeEeEEeecC---ceEE
Q 010463 109 EQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS---RCIVQLFYSFQDS---DFLY 182 (510)
Q Consensus 109 ~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~h---p~Iv~l~~~~~~~---~~~~ 182 (510)
.-.+.||.|..+.||.... ++..+.+|..+ .. .....+..|...|+.+.. ..|.++++++.+. +..+
T Consensus 17 ~~~~~i~~G~~~~vy~~~~--~~~~~~~k~~~-~~----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 17 SRVECISEQPYAALWALYD--SQGNPMPLMAR-SF----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred heeeecCCccceeEEEEEc--CCCCEEEEEec-cc----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 3456799999999997643 23346677743 21 112458889999988743 4678888877643 6689
Q ss_pred EEEeccCCCCH
Q 010463 183 LIMEYLPGGDI 193 (510)
Q Consensus 183 lVmEy~~gG~L 193 (510)
+|||+++|+.+
T Consensus 90 LVmE~i~G~~~ 100 (297)
T PRK10593 90 LLLERLRGVSV 100 (297)
T ss_pred EEEeccCCEec
Confidence 99999998754
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00025 Score=68.52 Aligned_cols=138 Identities=14% Similarity=0.197 Sum_probs=81.7
Q ss_pred eeeeecCCCeEEEEEEEcC-CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC-CCeeeEeEEeecCceEEEEEecc
Q 010463 111 LTLIGKGAFGEVRLCRAKT-TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS-RCIVQLFYSFQDSDFLYLIMEYL 188 (510)
Q Consensus 111 ~~~IG~G~fG~V~~~~~~~-tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~~~~~~~~~lVmEy~ 188 (510)
++.|..|-...||++.... .++.|.+|+..... .. .-...+|..++..+.. ...+++++.+.+ .+||||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~---~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT---EL-IIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCc---cc-eecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEee
Confidence 4667888889999886543 35688899765421 11 1123468888888743 334555554432 3799999
Q ss_pred CCCCHHHH--------------HHh---cc-CC----------C-HHHHHHHHHH----------------------H--
Q 010463 189 PGGDIMTL--------------LMR---ED-IL----------S-EDVARFYIAE----------------------S-- 215 (510)
Q Consensus 189 ~gG~L~~~--------------L~~---~~-~l----------~-e~~~~~~~~q----------------------i-- 215 (510)
+|-.+... |.+ .. .. . .+.+..|... +
T Consensus 75 ~G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 154 (235)
T cd05157 75 PGRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRD 154 (235)
T ss_pred CCCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHH
Confidence 98654211 110 00 01 0 1122222111 1
Q ss_pred -HHHHHh-h----hhCCeEEeecCCCCeeecC-CCceeecccCCcccC
Q 010463 216 -VLAIHS-I----HQHNYVHRDIKPDNLILDK-NGHLKLSDFGLCKPL 256 (510)
Q Consensus 216 -~~aL~~-l----H~~giiHRDLKP~NILld~-~g~vkL~DFGla~~~ 256 (510)
+..|.. + ...+++|+|+.|.|||++. ++.+.|+||-.|...
T Consensus 155 ~~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~~ 202 (235)
T cd05157 155 EISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGYN 202 (235)
T ss_pred HHHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCcC
Confidence 111111 1 2246999999999999998 688999999988753
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00017 Score=67.69 Aligned_cols=99 Identities=18% Similarity=0.221 Sum_probs=78.9
Q ss_pred HHHHHHHHhcCC-CCeeeEeEEeecCceEEEEEeccCCCCHHHH---HHhccCCCHHHHHHHHHHHHHHHHhhhh---CC
Q 010463 154 RSERNLLAEVDS-RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTL---LMREDILSEDVARFYIAESVLAIHSIHQ---HN 226 (510)
Q Consensus 154 ~~E~~iL~~l~h-p~Iv~l~~~~~~~~~~~lVmEy~~gG~L~~~---L~~~~~l~e~~~~~~~~qi~~aL~~lH~---~g 226 (510)
..|.-+|+.+.+ +++++++|+|-+ ++|.||.+.+++.+. +......++.....++.+++..+++++. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 347778888865 699999999943 678999998876532 2222346888889999999999999987 34
Q ss_pred eEEeecCCCCeeecCCCceeecccCCcccC
Q 010463 227 YVHRDIKPDNLILDKNGHLKLSDFGLCKPL 256 (510)
Q Consensus 227 iiHRDLKP~NILld~~g~vkL~DFGla~~~ 256 (510)
+.-.|++|+|+-++++|++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 666899999999999999999999977643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00019 Score=70.63 Aligned_cols=134 Identities=19% Similarity=0.226 Sum_probs=78.0
Q ss_pred eecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCe-eeEeEEeecCceEEEEEeccCCCC
Q 010463 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCI-VQLFYSFQDSDFLYLIMEYLPGGD 192 (510)
Q Consensus 114 IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~I-v~l~~~~~~~~~~~lVmEy~~gG~ 192 (510)
+..|-.+.+|++. .+|+.|++|....... .-.+ ...+|..+|+.+....+ .++++... -++||||++|..
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~--~~~~-~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~ 74 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCK--ALGV-DRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEV 74 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccc--cccC-cHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcc
Confidence 4568888999876 4577888997654311 1001 24668888888754323 44444432 368999999865
Q ss_pred HHH--------------HHHh---cc----CCC-HHHHHHHHHHH---------HHHHHhhh--------hCCeEEeecC
Q 010463 193 IMT--------------LLMR---ED----ILS-EDVARFYIAES---------VLAIHSIH--------QHNYVHRDIK 233 (510)
Q Consensus 193 L~~--------------~L~~---~~----~l~-e~~~~~~~~qi---------~~aL~~lH--------~~giiHRDLK 233 (510)
+.. .|.+ .. .++ ...+..|..++ ...+..+- ...++|+|+.
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 431 1111 11 111 11222222111 11111111 1258999999
Q ss_pred CCCeeecCCCceeecccCCcccCc
Q 010463 234 PDNLILDKNGHLKLSDFGLCKPLE 257 (510)
Q Consensus 234 P~NILld~~g~vkL~DFGla~~~~ 257 (510)
|.|||++.+| +.|+||..|....
T Consensus 155 ~~Nil~~~~~-~~lIDwE~a~~gd 177 (256)
T TIGR02721 155 AYNLVVTPQG-LKLIDWEYASDGD 177 (256)
T ss_pred cCcEEEeCCC-CEEEeccccCcCC
Confidence 9999999887 7899999987543
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0015 Score=66.42 Aligned_cols=31 Identities=19% Similarity=0.337 Sum_probs=27.0
Q ss_pred CCeEEeecCCCCeeecCCCceeecccCCccc
Q 010463 225 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 255 (510)
Q Consensus 225 ~giiHRDLKP~NILld~~g~vkL~DFGla~~ 255 (510)
.|+||+|+.|.|||++.+...-|+||+.|..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 4899999999999998665568999999875
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00055 Score=69.25 Aligned_cols=145 Identities=17% Similarity=0.190 Sum_probs=84.7
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCC--CeeeEeEEe------
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR--CIVQLFYSF------ 175 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp--~Iv~l~~~~------ 175 (510)
.++....++.++.|.-..||++.. .+| .|.+|+..... ....+..|..++..+... .+.+++...
T Consensus 20 ~~~~~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~-----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~ 92 (307)
T TIGR00938 20 DLGELLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV-----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLS 92 (307)
T ss_pred CCCCceeccccCCccccceEEEEe-CCC-cEEEEEecCCC-----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeeh
Confidence 334455677888888889998764 334 57889765421 123355667777666321 244444321
Q ss_pred ecCceEEEEEeccCCCCHH-----------HHH---Hhc-cCCC---------HHH----HH----------HHHHHHHH
Q 010463 176 QDSDFLYLIMEYLPGGDIM-----------TLL---MRE-DILS---------EDV----AR----------FYIAESVL 217 (510)
Q Consensus 176 ~~~~~~~lVmEy~~gG~L~-----------~~L---~~~-~~l~---------e~~----~~----------~~~~qi~~ 217 (510)
...+..++||+|++|..+. ..| ... ..++ ... .. .....+..
T Consensus 93 ~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~ 172 (307)
T TIGR00938 93 TLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDK 172 (307)
T ss_pred hcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHH
Confidence 2245679999999985431 111 110 0010 000 00 00111223
Q ss_pred HHHhhh-------hCCeEEeecCCCCeeecCCCceeecccCCccc
Q 010463 218 AIHSIH-------QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 255 (510)
Q Consensus 218 aL~~lH-------~~giiHRDLKP~NILld~~g~vkL~DFGla~~ 255 (510)
.++++. ..++||+|+.+.||+++.++.+.|+||+.|..
T Consensus 173 ~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 173 ELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 444443 36899999999999999988778999999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00046 Score=69.51 Aligned_cols=138 Identities=15% Similarity=0.183 Sum_probs=82.9
Q ss_pred eeeeecCCCeEEEEEEEcC------CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCC-CeeeEeEEeecCceEEE
Q 010463 111 LTLIGKGAFGEVRLCRAKT------TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR-CIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 111 ~~~IG~G~fG~V~~~~~~~------tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp-~Iv~l~~~~~~~~~~~l 183 (510)
++.|..|-...||++.... +++.|++|+..... .......+|..++..+... -..++++++.+ .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 4566677778999887543 36789999975431 1123456788888777432 24456666642 36
Q ss_pred EEeccCCCCHHHH--------------HH---hc--c-------CCC--HHHHHHH------------------------
Q 010463 184 IMEYLPGGDIMTL--------------LM---RE--D-------ILS--EDVARFY------------------------ 211 (510)
Q Consensus 184 VmEy~~gG~L~~~--------------L~---~~--~-------~l~--e~~~~~~------------------------ 211 (510)
||||++|..+... |. +. . ..+ +.....+
T Consensus 75 v~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (302)
T cd05156 75 IEEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELS 154 (302)
T ss_pred hhheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHH
Confidence 8999998765321 10 00 0 000 0011110
Q ss_pred --HHHHHHHHHhhh---------hCCeEEeecCCCCeeecCC----CceeecccCCcccC
Q 010463 212 --IAESVLAIHSIH---------QHNYVHRDIKPDNLILDKN----GHLKLSDFGLCKPL 256 (510)
Q Consensus 212 --~~qi~~aL~~lH---------~~giiHRDLKP~NILld~~----g~vkL~DFGla~~~ 256 (510)
..++...+..+- ..+++|+|+.|.|||++.+ +.+.|+||..|...
T Consensus 155 ~~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~ 214 (302)
T cd05156 155 LFLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN 214 (302)
T ss_pred HHHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence 112222233332 2468999999999999985 88999999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0013 Score=66.07 Aligned_cols=141 Identities=14% Similarity=0.125 Sum_probs=84.1
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCC--CeeeEeEE------eecC
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR--CIVQLFYS------FQDS 178 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp--~Iv~l~~~------~~~~ 178 (510)
+..-++.|..|....||++.. .+..+++|+.... ....+..|..++..+.+. .+.+++.. ....
T Consensus 15 ~~~~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~ 86 (296)
T cd05153 15 ELLSFEGISAGIENTNYFVTT--DSGRYVLTLFEKV------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELA 86 (296)
T ss_pred chhheecccCccccceEEEEe--CCCcEEEEEcCCC------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeC
Confidence 334467788888899998754 3457899987531 123466677777766322 24454432 2334
Q ss_pred ceEEEEEeccCCCCHHH----H-------H---Hhc-cCCCH--------HHHH------------HHHHHHHHHHHhhh
Q 010463 179 DFLYLIMEYLPGGDIMT----L-------L---MRE-DILSE--------DVAR------------FYIAESVLAIHSIH 223 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~----~-------L---~~~-~~l~e--------~~~~------------~~~~qi~~aL~~lH 223 (510)
+..++||+|++|..+.. . | ... ..+.. .... .....+..++.++.
T Consensus 87 ~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~ 166 (296)
T cd05153 87 GKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQD 166 (296)
T ss_pred CceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHH
Confidence 56789999999976421 1 1 000 00000 0000 00111222333333
Q ss_pred h-------CCeEEeecCCCCeeecCCCceeecccCCccc
Q 010463 224 Q-------HNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 255 (510)
Q Consensus 224 ~-------~giiHRDLKP~NILld~~g~vkL~DFGla~~ 255 (510)
. .+++|+|+.|.|||++.++.+.|+||+.|..
T Consensus 167 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 167 AFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred hhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 2 4799999999999999987789999999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >smart00133 S_TK_X Extension to Ser/Thr-type protein kinases | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.00016 Score=54.99 Aligned_cols=60 Identities=33% Similarity=0.613 Sum_probs=39.4
Q ss_pred CCCCchhhh--cccCCCccccCCCccCCCCCC-CCCCCCCCCCCCCCCcccccCCCcCCcccCceee
Q 010463 405 RGIQWDKLY--EMEAAYKPTVNGELDTQNFEK-FPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFK 468 (510)
Q Consensus 405 ~~i~~~~l~--~~~~p~~p~~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~ 468 (510)
++|||+.|. ++.|||+|.+.+..|+++|+. +.......+.... .. ........|.||+|.
T Consensus 1 ~~idW~~l~~r~~~pP~~P~~~~~~d~s~fd~~~~~~~~~~s~~~~-~~---~~~~~~~~F~gfsy~ 63 (64)
T smart00133 1 RGIDWDKLENKEIEPPFVPKIKSPTDTSNFDDEFTEETPVLTPVDS-PA---SGGSQQEPFRGFSYV 63 (64)
T ss_pred CCCCHHHHHhCCCCCCcccccCCccHHhHcCCcCCCCCCCCCCCCc-cc---cccccccccCCCccc
Confidence 479999996 588999999999999999997 5443322111110 00 001113579999985
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0034 Score=64.46 Aligned_cols=83 Identities=17% Similarity=0.146 Sum_probs=52.7
Q ss_pred eeecCCCeEEEEEEEcCCCCEEEEEEeechhhc----chhhHHHHHHHHHHHHhcC--CC-CeeeEeEEeecCceEEEEE
Q 010463 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML----KRGQVEHVRSERNLLAEVD--SR-CIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 113 ~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~----~~~~~~~~~~E~~iL~~l~--hp-~Iv~l~~~~~~~~~~~lVm 185 (510)
.||.|...-||++.....++.++||.-....-. -.-..++...|...|.... .| .+.++| .| |++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy-~~-D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF-HF-DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE-EE-ccccceehH
Confidence 579999999999997644468999974321110 1234566777888887653 35 444443 33 455667999
Q ss_pred eccCCC-CHHHHH
Q 010463 186 EYLPGG-DIMTLL 197 (510)
Q Consensus 186 Ey~~gG-~L~~~L 197 (510)
|+++.. .|...|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 999653 344444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.011 Score=59.63 Aligned_cols=30 Identities=23% Similarity=0.558 Sum_probs=26.9
Q ss_pred CCeEEeecCCCCeeecCCCceeecccCCccc
Q 010463 225 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 255 (510)
Q Consensus 225 ~giiHRDLKP~NILld~~g~vkL~DFGla~~ 255 (510)
.+++|+|+.+.|||++. +.+.|+||+.|..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 58999999999999987 6789999998764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0037 Score=63.61 Aligned_cols=146 Identities=21% Similarity=0.201 Sum_probs=95.3
Q ss_pred eeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcch----------------------hhHH-HHHHHHHHHHhcCCC
Q 010463 110 QLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR----------------------GQVE-HVRSERNLLAEVDSR 166 (510)
Q Consensus 110 ~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~----------------------~~~~-~~~~E~~iL~~l~hp 166 (510)
+-.+|..|--+.||.|.. .+|..+|||+++.+-+.-+ ..++ -...|+.-|..++.-
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 446889999999999865 4788899999865433211 1111 123355556666432
Q ss_pred CeeeEeEEeecCceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhh-hCCeEEeecCCCCeeecCCCce
Q 010463 167 CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIH-QHNYVHRDIKPDNLILDKNGHL 245 (510)
Q Consensus 167 ~Iv~l~~~~~~~~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH-~~giiHRDLKP~NILld~~g~v 245 (510)
.|.-.--.. -..-.|||+|+.+-....=..+.-.++...++.+-.+++.-+.-|- .+++||.||.-=|+|+ .+|++
T Consensus 227 GIP~PePIl--Lk~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~l 303 (520)
T KOG2270|consen 227 GIPCPEPIL--LKNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKL 303 (520)
T ss_pred CCCCCCcee--eecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEE
Confidence 221100000 0234699999964322222223445788888888888888877664 6799999999999998 67899
Q ss_pred eecccCCcccCccc
Q 010463 246 KLSDFGLCKPLEDK 259 (510)
Q Consensus 246 kL~DFGla~~~~~~ 259 (510)
.|+|-+-+.....+
T Consensus 304 yiIDVSQSVE~DHP 317 (520)
T KOG2270|consen 304 YIIDVSQSVEHDHP 317 (520)
T ss_pred EEEEccccccCCCh
Confidence 99999988766544
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0069 Score=60.42 Aligned_cols=32 Identities=25% Similarity=0.472 Sum_probs=27.2
Q ss_pred CeEEeecCCCCeeecCCCc-eeecccCCcccCc
Q 010463 226 NYVHRDIKPDNLILDKNGH-LKLSDFGLCKPLE 257 (510)
Q Consensus 226 giiHRDLKP~NILld~~g~-vkL~DFGla~~~~ 257 (510)
.++|+|+.|.|||++.+|. .-|+||+.+...+
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGD 218 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVGD 218 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccCC
Confidence 5899999999999997565 4699999988654
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.013 Score=61.19 Aligned_cols=84 Identities=15% Similarity=0.121 Sum_probs=54.8
Q ss_pred eeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcch----hhHHHHHHHHHHHHhcC---CCCeeeEeEEeecCceEE
Q 010463 110 QLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR----GQVEHVRSERNLLAEVD---SRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 110 ~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~----~~~~~~~~E~~iL~~l~---hp~Iv~l~~~~~~~~~~~ 182 (510)
..+.||.|....||++.. .+..|.||.-........ ....+...|...|..+. ...+.++|.++. +.-+
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 467889999999999876 345688997542211111 13455566777776653 247888888776 4467
Q ss_pred EEEeccCCC--CHHHHH
Q 010463 183 LIMEYLPGG--DIMTLL 197 (510)
Q Consensus 183 lVmEy~~gG--~L~~~L 197 (510)
+||||++++ .+.+-|
T Consensus 112 lvME~L~~~~~ilr~~L 128 (418)
T PLN02756 112 IGMRYLEPPHIILRKGL 128 (418)
T ss_pred EEEeecCCcceehhhhh
Confidence 889999772 344444
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.0014 Score=65.65 Aligned_cols=138 Identities=12% Similarity=0.137 Sum_probs=90.3
Q ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhc-----ch--------------hhHHHHHHHHHHHHhcC-CCC
Q 010463 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML-----KR--------------GQVEHVRSERNLLAEVD-SRC 167 (510)
Q Consensus 108 f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~-----~~--------------~~~~~~~~E~~iL~~l~-hp~ 167 (510)
+.+...||-|.-+.||++-+. .|.++++|.-...... .+ -..-...+|...|+.+. |-+
T Consensus 94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 456678999999999998764 6888899853221110 00 01112445677777663 322
Q ss_pred -eeeEeEEeecCceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCcee
Q 010463 168 -IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLK 246 (510)
Q Consensus 168 -Iv~l~~~~~~~~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vk 246 (510)
|.+.+ |.+.-++|||++.|--|...-.- .+. ..+...++.-+--|-..|+||+|..-=||+++++++++
T Consensus 173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v---~d~---~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 173 PVPKPI----DHNRHCVVMELVDGYPLRQVRHV---EDP---PTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCCcc----cccceeeHHHhhcccceeeeeec---CCh---HHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 22222 34567899999998766543211 112 22233455556667899999999999999999999999
Q ss_pred ecccCCcccC
Q 010463 247 LSDFGLCKPL 256 (510)
Q Consensus 247 L~DFGla~~~ 256 (510)
++||--+...
T Consensus 243 vIDFPQmvS~ 252 (465)
T KOG2268|consen 243 VIDFPQMVST 252 (465)
T ss_pred EeechHhhcc
Confidence 9999876544
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.012 Score=60.59 Aligned_cols=142 Identities=13% Similarity=0.186 Sum_probs=83.0
Q ss_pred CCceeeeeeecCCCeEEEEEEEcC----CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCe-eeEeEEeecCce
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKT----TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCI-VQLFYSFQDSDF 180 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~----tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~I-v~l~~~~~~~~~ 180 (510)
+..++ ..|-.|-...+|++.... +++.|.+|+..... ...+. -.+|..++..+..-++ .++++.+...
T Consensus 37 ~~~~i-~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g-- 109 (344)
T PLN02236 37 EALQV-IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG-- 109 (344)
T ss_pred CcEEE-EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc--
Confidence 34444 455558888999987532 34689999876532 22223 2568888887754333 4556666432
Q ss_pred EEEEEeccCCCCHHHH--------------HH---hcc------CCCHHHHHHHHHHH--------------------HH
Q 010463 181 LYLIMEYLPGGDIMTL--------------LM---RED------ILSEDVARFYIAES--------------------VL 217 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~--------------L~---~~~------~l~e~~~~~~~~qi--------------------~~ 217 (510)
.|++|++|-.|... |. ... ......+..++.++ +.
T Consensus 110 --~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~ 187 (344)
T PLN02236 110 --RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEIN 187 (344)
T ss_pred --eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHH
Confidence 58999987655311 11 000 01112222332211 11
Q ss_pred HHHh-----hhhCCeEEeecCCCCeeecC-CCceeecccCCcccC
Q 010463 218 AIHS-----IHQHNYVHRDIKPDNLILDK-NGHLKLSDFGLCKPL 256 (510)
Q Consensus 218 aL~~-----lH~~giiHRDLKP~NILld~-~g~vkL~DFGla~~~ 256 (510)
.|.. .+...++|+|+++.|||++. ++.+.|+||..|...
T Consensus 188 ~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 188 LLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred HHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 1111 22346899999999999986 578999999998753
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.015 Score=59.66 Aligned_cols=142 Identities=14% Similarity=0.207 Sum_probs=80.7
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCC---CCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCe-eeEeEEeecCceE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTT---GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCI-VQLFYSFQDSDFL 181 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~t---g~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~I-v~l~~~~~~~~~~ 181 (510)
+++.+.. |..|=...+|++..... +..|.+|+..... ..-+. -.+|..+++.+..-++ .++++++.. +
T Consensus 15 ~~i~i~~-l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~~~Id-R~~E~~il~~l~~~gl~P~~l~~~~~-G-- 86 (330)
T PLN02421 15 SDFSVER-ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT---DYVID-RERELQAIKYLSAAGFGAKLLGVFGN-G-- 86 (330)
T ss_pred CceEEEE-eCCcccceEEEEEecCCCCCCceEEEEEecCCc---CeEec-hHHHHHHHHHHHhcCCCCceeEEeCC-c--
Confidence 4555544 44477788998865432 3378899875431 11112 3568888888755444 456666632 2
Q ss_pred EEEEeccCCCCHHH----------HH----Hh---cc-C----C-CHHHHHHHHHHH-----------------------
Q 010463 182 YLIMEYLPGGDIMT----------LL----MR---ED-I----L-SEDVARFYIAES----------------------- 215 (510)
Q Consensus 182 ~lVmEy~~gG~L~~----------~L----~~---~~-~----l-~e~~~~~~~~qi----------------------- 215 (510)
+|.+|++|-.|.. .+ .+ .. + + ....+..|..++
T Consensus 87 -~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~ 165 (330)
T PLN02421 87 -MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELR 165 (330)
T ss_pred -EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHH
Confidence 5899998765421 11 11 01 0 1 112222332221
Q ss_pred --HHHHHhhh-hC----CeEEeecCCCCeeecC-CCceeecccCCcccC
Q 010463 216 --VLAIHSIH-QH----NYVHRDIKPDNLILDK-NGHLKLSDFGLCKPL 256 (510)
Q Consensus 216 --~~aL~~lH-~~----giiHRDLKP~NILld~-~g~vkL~DFGla~~~ 256 (510)
+..+..+. .. -++|.||-|.|||++. ++.++++||..|...
T Consensus 166 ~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 166 DEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred HHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 11111121 22 3799999999999974 578999999998754
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.04 Score=55.25 Aligned_cols=137 Identities=17% Similarity=0.219 Sum_probs=73.0
Q ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc---CCCCeeeEeEEeecCceEEEE
Q 010463 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV---DSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 108 f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~~~~~~~~~lV 184 (510)
.+-.+.||.|....+|... .+++.|-+|+-... ....+..|..-|+.+ ..-.+.+.+.+....+.-|||
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl 90 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL 90 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecChh------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence 3446778999999999765 67889999987632 123477788888777 345677888888777777999
Q ss_pred EeccCCCC--------HHHH---HHh-c--c-----------------CCCHHHHHHHHHH-------------------
Q 010463 185 MEYLPGGD--------IMTL---LMR-E--D-----------------ILSEDVARFYIAE------------------- 214 (510)
Q Consensus 185 mEy~~gG~--------L~~~---L~~-~--~-----------------~l~e~~~~~~~~q------------------- 214 (510)
|||++.+. |-.. |.+ . + .-+.....||+.+
T Consensus 91 le~l~~~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~ 170 (288)
T PF03881_consen 91 LEFLEMGSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAEL 170 (288)
T ss_dssp EE--------CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHH
T ss_pred EEeecCCCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHH
Confidence 99998761 1111 111 0 0 1122333344322
Q ss_pred --HHHHHH-hhhhC----CeEEeecCCCCeeecCCCceeecccCC
Q 010463 215 --SVLAIH-SIHQH----NYVHRDIKPDNLILDKNGHLKLSDFGL 252 (510)
Q Consensus 215 --i~~aL~-~lH~~----giiHRDLKP~NILld~~g~vkL~DFGl 252 (510)
++..|. .|+.. .+||+||-+.|++.+.+|.+.|.|=..
T Consensus 171 ~~l~~~~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa~ 215 (288)
T PF03881_consen 171 ERLVERLPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPAC 215 (288)
T ss_dssp HHHHHHHHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S---
T ss_pred HHHHHHHHHHhcCCCCCceeeEcCccccceeecCCCCceeecccc
Confidence 111111 12322 489999999999999999999988653
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.048 Score=55.18 Aligned_cols=30 Identities=13% Similarity=0.164 Sum_probs=28.3
Q ss_pred CeEEeecCCCCeeecCCCceeecccCCccc
Q 010463 226 NYVHRDIKPDNLILDKNGHLKLSDFGLCKP 255 (510)
Q Consensus 226 giiHRDLKP~NILld~~g~vkL~DFGla~~ 255 (510)
+++|+|+.++|+|++.+|.+.++||..|..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999999875
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.039 Score=55.92 Aligned_cols=149 Identities=15% Similarity=0.147 Sum_probs=86.0
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC--CCeeeEeEEeecCc--eE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS--RCIVQLFYSFQDSD--FL 181 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~h--p~Iv~l~~~~~~~~--~~ 181 (510)
.+..++..+-.|---.+|.... +++.+.+. ... ......+.....+|..+|..+.- .-+...++.+.++. ..
T Consensus 25 ~~~~~v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~p 100 (321)
T COG3173 25 AGLLIVEEISGGWSNDTFRLGD--TGQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTP 100 (321)
T ss_pred CCCceeeeccCCcccceEEEec--CCceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCc
Confidence 4455566654443344454333 47888888 332 12233445567778888887743 23344566666655 77
Q ss_pred EEEEeccCCCCHHHH------------------HHh--------------ccCCCHHHHHHHHHHH--------------
Q 010463 182 YLIMEYLPGGDIMTL------------------LMR--------------EDILSEDVARFYIAES-------------- 215 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~------------------L~~--------------~~~l~e~~~~~~~~qi-------------- 215 (510)
|.||+|+.|..+.+. |.. .+.+...+...+..+.
T Consensus 101 f~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~ 180 (321)
T COG3173 101 FYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA 180 (321)
T ss_pred eEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence 999999998432221 110 0001111222222222
Q ss_pred HHHHHhhh--------hCCeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 216 VLAIHSIH--------QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 216 ~~aL~~lH--------~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
..-..+++ .-.++|+|+.+.||+++.++-+-+.||+++..-+.
T Consensus 181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 11122333 23589999999999999999899999999987554
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.046 Score=56.95 Aligned_cols=86 Identities=19% Similarity=0.235 Sum_probs=56.2
Q ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcc---hhhHHHHHHHHHHHHhcC--CC-CeeeEeEEeecCceEEEE
Q 010463 111 LTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLK---RGQVEHVRSERNLLAEVD--SR-CIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 111 ~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~---~~~~~~~~~E~~iL~~l~--hp-~Iv~l~~~~~~~~~~~lV 184 (510)
++.||.|.-.-||++.....++.++||.-..-.-.. .-..++...|..+|+... .| .+.++|. | |++...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~-~-D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL-F-DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE-E-CcHHhhHH
Confidence 778999999999999875445678999643211111 234677888888887763 35 4555543 3 55667899
Q ss_pred EeccCCC-CHHHHHH
Q 010463 185 MEYLPGG-DIMTLLM 198 (510)
Q Consensus 185 mEy~~gG-~L~~~L~ 198 (510)
||+++.. .|...|.
T Consensus 112 MEdL~~~~ilR~~Li 126 (409)
T PRK12396 112 MEDLSDHTILRTALI 126 (409)
T ss_pred HHhCcccHHHHHHHH
Confidence 9999653 3444443
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.021 Score=58.25 Aligned_cols=72 Identities=21% Similarity=0.430 Sum_probs=51.2
Q ss_pred CceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhh-CCeEEeecCCCCeeecCCCceeecccCCccc
Q 010463 178 SDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 255 (510)
Q Consensus 178 ~~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~-~giiHRDLKP~NILld~~g~vkL~DFGla~~ 255 (510)
..++|++|++- |+.+.-. +. -...++..++.+.+..++-+.. ..+=||||.-+||||+ +|+|.|+||-+|+.
T Consensus 298 ~~y~yl~~kdh-gt~is~i--k~--~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 298 TLYLYLHFKDH-GTPISII--KA--DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred ceEEEEEEecC-Cceeeee--ec--ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 45788888876 4444221 11 2344555566666665555554 4789999999999999 99999999999994
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.67 E-value=0.071 Score=55.72 Aligned_cols=79 Identities=15% Similarity=0.170 Sum_probs=45.8
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCC-CCE-----EEEEEeechhhcchhhHHHHHHHHHHHHhcCCC-CeeeEeEEeecC
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTT-GEI-----FAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR-CIVQLFYSFQDS 178 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~t-g~~-----vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp-~Iv~l~~~~~~~ 178 (510)
+++++ +.|..|-.+.+|++..... +.. |.+.+.... ....-.-.+|..+++.+... .-.++++.|..
T Consensus 51 ~~i~i-~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~----~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~- 124 (383)
T PTZ00384 51 EFIEI-KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY----NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD- 124 (383)
T ss_pred ccEEE-EEeCCcccceEEEEEecCCCCCccccceEEEEeccCC----CceEeccHHHHHHHHHHHhCCCCCeEEEecCC-
Confidence 34444 4555588899999875433 222 333332111 11111124588888888554 44666777653
Q ss_pred ceEEEEEeccCCCCH
Q 010463 179 DFLYLIMEYLPGGDI 193 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L 193 (510)
++|.||++|-.|
T Consensus 125 ---g~l~efIeGr~l 136 (383)
T PTZ00384 125 ---FTIQEWVEGNTM 136 (383)
T ss_pred ---EEEEEEeccccC
Confidence 699999998654
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.32 E-value=0.055 Score=51.38 Aligned_cols=31 Identities=32% Similarity=0.694 Sum_probs=22.6
Q ss_pred CCeEEeecCCCCeee-cCCCceeecccCCccc
Q 010463 225 HNYVHRDIKPDNLIL-DKNGHLKLSDFGLCKP 255 (510)
Q Consensus 225 ~giiHRDLKP~NILl-d~~g~vkL~DFGla~~ 255 (510)
..++|.||.|.|||+ +.++.++|+||-.|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 468999999999999 8999999999999874
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.01 E-value=0.39 Score=49.01 Aligned_cols=30 Identities=17% Similarity=0.286 Sum_probs=25.5
Q ss_pred hCCeEEeecCCCCeeecCCCceeecccCCccc
Q 010463 224 QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 255 (510)
Q Consensus 224 ~~giiHRDLKP~NILld~~g~vkL~DFGla~~ 255 (510)
..++||+|+.|.|||++ + .+.|+||+-|..
T Consensus 195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred CccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 34799999999999995 4 578999999875
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.93 E-value=0.46 Score=56.05 Aligned_cols=31 Identities=26% Similarity=0.484 Sum_probs=27.0
Q ss_pred CCeEEeecCCCCeeecCCC--cee-ecccCCccc
Q 010463 225 HNYVHRDIKPDNLILDKNG--HLK-LSDFGLCKP 255 (510)
Q Consensus 225 ~giiHRDLKP~NILld~~g--~vk-L~DFGla~~ 255 (510)
.++||.|+.++|||++.++ ++. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 5799999999999999876 565 999999874
|
|
| >PF00433 Pkinase_C: Protein kinase C terminal domain; InterPro: IPR017892 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=94.56 E-value=0.0089 Score=42.77 Aligned_cols=45 Identities=31% Similarity=0.475 Sum_probs=23.6
Q ss_pred cCCCccCCCCCC-CCCCCCCCCCCCCCCcccccCCCcCCcccCceeeCC
Q 010463 423 VNGELDTQNFEK-FPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKS 470 (510)
Q Consensus 423 ~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~ 470 (510)
|+++.|++|||. |....... .+. .....+..+.+..|.||||.++
T Consensus 2 v~~~~DtsnFD~eFt~~~~~~--t~~-~~~~~~~~~~~~~F~GFTy~~~ 47 (48)
T PF00433_consen 2 VKSETDTSNFDPEFTEEPPVD--TPP-SDPSPLSSSMQENFQGFTYVNP 47 (48)
T ss_dssp -SSTT-GTTSCHHHHTSSSSS----S---HHHHCTSSGGGGTT-CEETC
T ss_pred CCchhhhhhcCcccccCCCCC--CCc-ccCCcccccccCcCCCCeecCC
Confidence 678999999997 44332111 111 1112223445567999999976
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This domain is found in a large variety of protein kinases with different functions and dependencies. Protein kinase C, for example, is a calcium-activated, phospholipid-dependent serine- and threonine-specific enzyme. It is activated by diacylglycerol which, in turn, phosphorylates a range of cellular proteins. This domain is most often found associated with IPR000719 from INTERPRO.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3E8D_A 1MRV_A 3E88_A 1GZO_A 1GZK_A 2JDO_A 2JDR_A 1MRY_A 1GZN_A 1O6L_A .... |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.50 E-value=0.089 Score=55.99 Aligned_cols=79 Identities=19% Similarity=0.183 Sum_probs=54.4
Q ss_pred ccccccchhhHHHHHhhCCCCCCCCChhhhHHHHhhccccccCCCC-----------CCCCHHHHHHHHHhhc-CccccC
Q 010463 323 MECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEE-----------PKISDEARDLICHLLC-DVETRL 390 (510)
Q Consensus 323 ~~~DiwSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~-----------~~~s~~~~dlI~~lL~-dp~~R~ 390 (510)
+++||||+|.++.|+..|..-+...+..+....|... ...+.. ..++....++..+|+. .|..|+
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~---~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~ 186 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKY---YTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRP 186 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHh---ccCchhHHHHHHHHHHHHhhhHhHHHHhccCCcccccccc
Confidence 3999999999999999998777665555555555431 111110 1345566777778887 888898
Q ss_pred CCCChHHhhcCCCcCCC
Q 010463 391 GTRGVEELKEHPWFRGI 407 (510)
Q Consensus 391 ~~~~~~eil~HpfF~~i 407 (510)
-..+..+|+-|..+
T Consensus 187 ---l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 187 ---LPMELSKRCSFTEV 200 (725)
T ss_pred ---chhHHhcCccHHHH
Confidence 45678888888765
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.29 E-value=0.15 Score=48.73 Aligned_cols=101 Identities=21% Similarity=0.228 Sum_probs=65.5
Q ss_pred EEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHH
Q 010463 134 FAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIA 213 (510)
Q Consensus 134 vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~ 213 (510)
..+|++...... -....+..+.+|++++. .|++|..- +.-.+-++.|+|-.-. ....-++.
T Consensus 88 L~lKKi~slp~~--~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~------------i~~~N~i~- 148 (308)
T PF07387_consen 88 LFLKKIRSLPCC--INDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK------------INFSNFIT- 148 (308)
T ss_pred hhhhhccCCCcc--cchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc------------cchhHHHH-
Confidence 455655443321 11244678888888763 67887722 3335778999984311 11111222
Q ss_pred HHHHHHHhhhh--CCeEEeecCCCCeeecCCCceeecccCCc
Q 010463 214 ESVLAIHSIHQ--HNYVHRDIKPDNLILDKNGHLKLSDFGLC 253 (510)
Q Consensus 214 qi~~aL~~lH~--~giiHRDLKP~NILld~~g~vkL~DFGla 253 (510)
--+.+|.-.|+ .+.+|+|-.|+||+-|+.|.+||.|=+..
T Consensus 149 agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 149 AGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred HhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence 22456777884 57999999999999999999999998853
|
The function of this family is unknown. |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.02 E-value=0.051 Score=54.78 Aligned_cols=35 Identities=29% Similarity=0.523 Sum_probs=25.9
Q ss_pred HHHHHHHHHHHHHHHhhh----hCCeEEeecCCCCeeec
Q 010463 206 DVARFYIAESVLAIHSIH----QHNYVHRDIKPDNLILD 240 (510)
Q Consensus 206 ~~~~~~~~qi~~aL~~lH----~~giiHRDLKP~NILld 240 (510)
+-+++++.||++-.-.+- -.+++|-||||+||||-
T Consensus 279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiF 317 (444)
T PHA03111 279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIF 317 (444)
T ss_pred HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEe
Confidence 446788888876553332 34799999999999984
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 510 | ||||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-76 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-76 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-76 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-76 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-73 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-73 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-73 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 7e-68 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-59 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-59 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-58 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-57 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-57 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-57 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-57 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-57 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-57 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 9e-57 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-56 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-56 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-56 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-56 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-56 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-56 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-56 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-56 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-56 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-56 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-56 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-56 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-56 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-55 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-55 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-55 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-55 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-55 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-55 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-55 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-55 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-55 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-55 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-55 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-55 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-55 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-55 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-55 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-55 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-55 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-55 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-55 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-55 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 9e-55 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-54 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-54 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-54 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-54 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-54 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-54 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-54 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-54 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-54 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-54 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-54 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-51 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-50 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-50 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-50 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-50 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-50 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-50 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-49 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-49 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-49 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-49 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-49 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-49 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-49 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-49 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-49 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-49 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-49 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-47 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-46 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-45 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-43 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-43 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-43 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-43 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-43 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-42 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-42 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-41 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 9e-41 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-40 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-40 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-40 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-40 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-40 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-40 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-40 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-40 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-40 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-40 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-40 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-40 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-40 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-40 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-40 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-40 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-40 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-40 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-39 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-39 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-39 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-36 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-36 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-36 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-36 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-36 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-36 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 8e-36 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-33 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-33 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-32 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-32 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-32 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-32 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-32 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-32 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-32 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-32 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-32 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-32 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-32 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-32 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-32 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-32 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-32 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-32 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-32 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-32 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-32 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-32 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-32 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-32 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-32 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-32 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-32 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-32 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-32 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-32 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-32 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-32 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-31 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-31 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-31 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-31 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-31 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-31 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-31 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-31 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-31 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-30 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-30 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-30 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-30 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-30 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-30 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-29 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-29 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-29 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-29 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-29 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-28 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-28 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-28 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-28 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-28 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-27 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-27 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-27 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-27 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-26 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-26 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-26 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-26 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-26 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-26 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-26 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-26 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-26 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-26 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-26 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-26 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-26 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-26 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-26 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-25 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-25 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-25 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-25 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-25 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-25 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-25 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-25 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-25 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-25 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 7e-25 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-25 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-25 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-25 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-25 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-24 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-24 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-24 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-24 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-24 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-24 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-24 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-24 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-24 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-24 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-24 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-24 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-24 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-24 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-24 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-24 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 9e-24 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-24 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-23 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-23 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-23 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-23 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-23 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-23 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-23 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-23 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-23 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-23 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-23 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-23 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-23 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-23 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-23 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-23 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-23 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-23 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-23 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-23 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-23 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-22 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-22 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-22 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-22 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-22 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-22 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-22 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-22 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-22 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-22 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-22 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-22 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-22 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-22 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-22 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-22 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-22 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-22 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-21 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-21 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-21 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-21 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-21 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-21 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-21 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-21 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-21 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-21 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-21 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-21 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-21 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-21 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-21 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-21 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-21 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-21 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-21 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-21 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-21 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-20 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-20 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-20 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-20 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-20 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-20 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-20 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-20 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-20 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-20 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-20 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-20 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-20 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-20 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-20 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-20 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-20 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-20 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-20 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-20 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-20 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-20 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-20 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-20 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-20 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-20 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-20 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-19 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-19 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-19 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-19 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-19 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-18 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-18 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-18 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-18 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-18 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-18 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-18 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-18 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-18 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-18 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-18 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-18 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 4e-18 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-18 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-18 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-18 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-18 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-18 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-18 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-18 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-18 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 9e-18 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-17 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-17 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-17 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-17 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-17 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-17 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-17 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-17 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-17 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-17 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-16 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-16 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-16 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-16 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-16 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-16 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-16 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-16 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-15 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-15 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-15 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 8e-15 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-15 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-14 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-14 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-14 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-14 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-14 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-14 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-14 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-14 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-13 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-13 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-13 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-13 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-13 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 9e-13 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-12 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-12 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-12 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-12 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-12 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-12 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-12 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-12 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-12 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-12 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-12 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-12 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-12 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-12 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-12 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-12 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 5e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-12 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-12 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-12 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-12 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-12 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-12 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-12 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-12 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-12 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-12 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-12 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-12 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-12 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 8e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-12 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 8e-12 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-12 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 8e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-12 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 9e-12 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 9e-12 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 9e-12 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 9e-12 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 9e-12 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-11 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-11 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-11 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-10 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-10 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-10 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-10 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-10 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-10 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-10 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-10 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 9e-10 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-09 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-09 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-09 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-08 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-08 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-08 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-08 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-08 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-08 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-08 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-08 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-08 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-08 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-08 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-08 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-08 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-08 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-08 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-08 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-08 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-08 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-08 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 9e-08 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 9e-08 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-07 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-07 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-07 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-07 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-07 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-07 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-07 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-06 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-07 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-07 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-07 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-07 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-07 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-07 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-07 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-07 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-07 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-06 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-06 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-06 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-06 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-06 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-06 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-06 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-06 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-06 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-06 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-06 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-06 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-06 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-06 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-06 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-06 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-06 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-06 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-06 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-06 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-06 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-06 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-06 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-06 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-06 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 6e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 9e-06 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-05 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-05 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-05 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-05 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-05 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-05 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-05 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-05 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-05 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-05 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-05 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-05 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 3e-05 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-05 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-05 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 4e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 5e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-05 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 6e-05 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 7e-05 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-05 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-05 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-05 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-05 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-05 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-04 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-04 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-04 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-04 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-04 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-04 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-04 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-04 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-04 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-04 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-04 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-04 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-04 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-04 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-04 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 3e-04 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-04 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-04 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-04 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-04 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-04 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-04 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-04 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-04 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-04 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 5e-04 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-04 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-04 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 6e-04 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-04 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-04 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-04 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-04 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-04 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-04 |
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 480 bits (1237), Expect = e-168
Identities = 155/448 (34%), Positives = 228/448 (50%), Gaps = 56/448 (12%)
Query: 41 AAKQFIENHYKNYLQGLQDRKERRRALQMRAQQAAVSNEEQEEMLRN-LERRETEYMRLQ 99
+ +Q + + L+ L D L Q+ S Q++ + + L+ E +RL+
Sbjct: 1 SMQQLVLDPGFLGLEPLLD------LLLGVHQELGASELAQDKYVADFLQWAEPIVVRLK 54
Query: 100 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNL 159
++ DDFE L +IG+GAF EV + + K TG+++AMK + K +MLKRG+V R ER++
Sbjct: 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDV 114
Query: 160 LAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLA 218
L D R I QL ++FQD ++LYL+MEY GGD++TLL + + + ++ARFY+AE V+A
Sbjct: 115 LVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMA 174
Query: 219 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 278
I S+H+ YVHRDIKPDN++LD+ GH++L+DFG C + + S
Sbjct: 175 IDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCL-------------KLRADGTVRS- 220
Query: 279 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG-------YGMECDWWSLG 331
VGT DY++PE+L G YG ECDWW+LG
Sbjct: 221 -----------------------LVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALG 257
Query: 332 AIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPK-ISDEARDLICHLLCDVETRL 390
YEM G PF +D T KIV++K L P + + +EARD I LLC ETRL
Sbjct: 258 VFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCPPETRL 317
Query: 391 GTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEKFPE---VDGPPSEIPS 447
G G + + HP+F G+ WD L + + P G DT NF+ +
Sbjct: 318 GRGGAGDFRTHPFFFGLDWDGLRDSVPPFTPDFEGATDTCNFDLVEDGLTAMVSGGGETL 377
Query: 448 VGPWRKMLTSKDTNFIGYTFKKSDVLKS 475
F+GY++ + S
Sbjct: 378 SDIREGAPLGVHLPFVGYSYSCMALRDS 405
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 470 bits (1210), Expect = e-163
Identities = 158/420 (37%), Positives = 228/420 (54%), Gaps = 46/420 (10%)
Query: 79 EEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKK 138
++ +L LE + ++++ ++ +DFE L +IG+GAFGEV + + K ++FAMK
Sbjct: 47 RREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKI 106
Query: 139 LKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM 198
L K EMLKR + R ER++L DS+ I L Y+FQD + LYL+M+Y GGD++TLL
Sbjct: 107 LNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLS 166
Query: 199 R-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 257
+ ED L E++ARFY+AE V+AI S+HQ +YVHRDIKPDN+++D NGH++L+DFG C
Sbjct: 167 KFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCL--- 223
Query: 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL 317
+ + + S VGT DY++PE+L
Sbjct: 224 ----------KLMEDGTVQS------------------------SVAVGTPDYISPEILQ 249
Query: 318 -----KKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEE-PKI 371
K YG ECDWWSLG MYEML G PF ++ T KI+N K +FP + +
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDV 309
Query: 372 SDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQN 431
S+ A+DLI L+C E RLG G+E+ K+HP+F GI WD + EA Y P V+ DT N
Sbjct: 310 SENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIRNCEAPYIPEVSSPTDTSN 369
Query: 432 FEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKSLENSGTDMRSNGSSKV 491
F+ + +P P + F+G+T+ S VL + +
Sbjct: 370 FDVDDDCLKNSETMPP--PTHTAFSGHHLPFVGFTYTSSCVLSDRSCLRVTAGPTSAENL 427
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 467 bits (1204), Expect = e-163
Identities = 154/426 (36%), Positives = 225/426 (52%), Gaps = 50/426 (11%)
Query: 66 ALQMRAQQAAVSNEEQEEMLRN-LERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRL 124
L + + + N L R + +++ ++ +D+E + +IG+GAFGEV+L
Sbjct: 28 GLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQL 87
Query: 125 CRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184
R K+T +++AMK L K EM+KR ER+++A +S +VQLFY+FQD +LY++
Sbjct: 88 VRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 147
Query: 185 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH 244
MEY+PGGD++ L+ D+ E ARFY AE VLA+ +IH ++HRD+KPDN++LDK+GH
Sbjct: 148 MEYMPGGDLVNLMSNYDV-PEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH 206
Query: 245 LKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYST 304
LKL+DFG C + +
Sbjct: 207 LKLADFGTCMKMNK-------------------------------------EGMVRCDTA 229
Query: 305 VGTLDYMAPEVLLKKG----YGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWK 360
VGT DY++PEVL +G YG ECDWWS+G +YEML+G PF +D T KI+N K
Sbjct: 230 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK 289
Query: 361 TCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLY--EMEAA 418
L FP++ IS EA++LIC L D E RLG GVEE+K H +F+ QW + A
Sbjct: 290 NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAP 349
Query: 419 YKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKSLEN 478
P ++ ++DT NF+ E G P K F+G+T+ + S
Sbjct: 350 VVPDLSSDIDTSNFDDLEEDKGEEETFPI----PKAFVGNQLPFVGFTYYSNRRYLS-SA 404
Query: 479 SGTDMR 484
+ D R
Sbjct: 405 NPNDNR 410
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 389 bits (1001), Expect = e-133
Identities = 123/348 (35%), Positives = 191/348 (54%), Gaps = 51/348 (14%)
Query: 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA 161
K + DF+ L +G G+FG V L R++ G +AMK LKK +++ QVEH ER +L+
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 162 EVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHS 221
V I++++ +FQD+ +++IM+Y+ GG++ +LL + VA+FY AE LA+
Sbjct: 62 IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 121
Query: 222 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 281
+H + ++RD+KP+N++LDKNGH+K++DFG K + D
Sbjct: 122 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---------------------- 159
Query: 282 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341
Y+ GT DY+APEV+ K Y DWWS G ++YEML GY
Sbjct: 160 -------------------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 200
Query: 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEEL 398
PF + T KI+N + L+FP P +++ +DL+ L+ D+ RLG G E++
Sbjct: 201 TPFYDSNTMKTYEKILNAE--LRFP--PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDV 256
Query: 399 KEHPWFRGIQWDKLY--EMEAAYKPTV-NGELDTQNFEKFPEVDGPPS 443
K HPWF+ + W+KL +E Y+P + G+ DT F+K+PE D
Sbjct: 257 KNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDKYPEEDINYG 304
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 387 bits (997), Expect = e-132
Identities = 117/378 (30%), Positives = 199/378 (52%), Gaps = 50/378 (13%)
Query: 71 AQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTT 130
A++ + +E + + E ++ + +D F+++ +G G+FG V L + K +
Sbjct: 6 AKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKES 65
Query: 131 GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPG 190
G +AMK L K +++K Q+EH +E+ +L V+ +V+L +SF+D+ LY++MEY+ G
Sbjct: 66 GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 191 GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDF 250
G++ + L R SE ARFY A+ VL +H + ++RD+KP+NL++D+ G+++++DF
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 251 GLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDY 310
G K ++ + ++ GT +
Sbjct: 186 GFAKRVKGR-----------------------------------------TWTLCGTPEA 204
Query: 311 MAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPK 370
+APE++L KGY DWW+LG ++YEM GYPPF +D P KIV+ K ++FP
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFP--SH 260
Query: 371 ISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLY--EMEAAYKPTVNG 425
S + +DL+ +LL D+ R G GV ++K H WF W +Y ++EA + P G
Sbjct: 261 FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKG 320
Query: 426 ELDTQNFEKFPEVDGPPS 443
DT NF+ + E + S
Sbjct: 321 PGDTSNFDDYEEEEIRVS 338
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 367 bits (944), Expect = e-125
Identities = 130/344 (37%), Positives = 190/344 (55%), Gaps = 51/344 (14%)
Query: 100 RRKIGIDDFEQLTLIGKGAFGEVRLCR---AKTTGEIFAMKKLKKSEMLKRG-QVEHVRS 155
KI + FE L ++GKG +G+V R TG+IFAMK LKK+ +++ H ++
Sbjct: 11 PEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA 70
Query: 156 ERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAES 215
ERN+L EV IV L Y+FQ LYLI+EYL GG++ L RE I ED A FY+AE
Sbjct: 71 ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI 130
Query: 216 VLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQET 275
+A+ +HQ ++RD+KP+N++L+ GH+KL+DFGLCK E I +
Sbjct: 131 SMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK-------------ESIHDGTV 177
Query: 276 VSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 335
++ GT++YMAPE+L++ G+ DWWSLGA+MY
Sbjct: 178 -------------------------THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMY 212
Query: 336 EMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT-- 392
+ML G PPF ++ + T KI+ K L P P ++ EARDL+ LL + +RLG
Sbjct: 213 DMLTGAPPFTGENRKKTIDKILKCK--LNLP--PYLTQEARDLLKKLLKRNAASRLGAGP 268
Query: 393 RGVEELKEHPWFRGIQWDKLY--EMEAAYKPTVNGELDTQNFEK 434
E++ HP+FR I W++L ++E +KP + E D F+
Sbjct: 269 GDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDS 312
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 366 bits (943), Expect = e-125
Identities = 125/375 (33%), Positives = 186/375 (49%), Gaps = 51/375 (13%)
Query: 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA 161
K+ ++DF+ L L+GKG FG+V L R K TG +AMK L+K ++ + +V H +E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 162 EVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHS 221
+ L Y+FQ D L +MEY GG++ L RE + +E+ ARFY AE V A+
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 222 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 281
+H + V+RDIK +NL+LDK+GH+K++DFGLCK E I + T
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK-------------EGISDGAT------ 161
Query: 282 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341
+ GT +Y+APEVL YG DWW LG +MYEM+ G
Sbjct: 162 -------------------MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
Query: 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLG--TRGVEEL 398
PF + D I+ + ++FP +S EA+ L+ LL D + RLG +E+
Sbjct: 203 LPFYNQDHERLFELILMEE--IRFP--RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV 258
Query: 399 KEHPWFRGIQWDKLY--EMEAAYKPTVNGELDTQNFEKF----PEVDGPPSEIPSVGPWR 452
EH +F I W + ++ +KP V E+DT+ F+ PP S+G
Sbjct: 259 MEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLE 318
Query: 453 KMLTSKDTNFIGYTF 467
+ F + +
Sbjct: 319 LDQREEQEMFEDFDY 333
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 365 bits (940), Expect = e-124
Identities = 97/330 (29%), Positives = 167/330 (50%), Gaps = 44/330 (13%)
Query: 92 ETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVE 151
+ Q RK +DF+ ++G+G+F V L R T +A+K L+K ++K +V
Sbjct: 16 QHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVP 75
Query: 152 HVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFY 211
+V ER++++ +D V+L+++FQD + LY + Y G+++ + + E RFY
Sbjct: 76 YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY 135
Query: 212 IAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDII 271
AE V A+ +H +HRD+KP+N++L+++ H++++DFG K L +
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE------------ 183
Query: 272 NQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLG 331
+++A A S VGT Y++PE+L +K D W+LG
Sbjct: 184 ------------------------SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALG 219
Query: 332 AIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRL 390
I+Y+++ G PPF + + + +KI+ + FP K +ARDL+ LL D RL
Sbjct: 220 CIIYQLVAGLPPFRAGNEYLIFQKIIKLE--YDFP--EKFFPKARDLVEKLLVLDATKRL 275
Query: 391 G---TRGVEELKEHPWFRGIQWDKLYEMEA 417
G G LK HP+F + W+ L++
Sbjct: 276 GCEEMEGYGPLKAHPFFESVTWENLHQQTP 305
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 366 bits (943), Expect = e-124
Identities = 128/407 (31%), Positives = 195/407 (47%), Gaps = 56/407 (13%)
Query: 75 AVSNEEQEEMLR------NLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAK 128
+S ++ E++ ++ DF L +IGKG+FG+V L R K
Sbjct: 1 GISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHK 60
Query: 129 TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE-VDSRCIVQLFYSFQDSDFLYLIMEY 187
+A+K L+K +LK+ + +H+ SERN+L + V +V L +SFQ +D LY +++Y
Sbjct: 61 AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDY 120
Query: 188 LPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKL 247
+ GG++ L RE E ARFY AE A+ +H N V+RD+KP+N++LD GH+ L
Sbjct: 121 INGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVL 180
Query: 248 SDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGT 307
+DFGLCK E+I + T + GT
Sbjct: 181 TDFGLCK-------------ENIEHNST-------------------------TSTFCGT 202
Query: 308 LDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPE 367
+Y+APEVL K+ Y DWW LGA++YEML G PPF S + I+N L+
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP--LQLK- 259
Query: 368 EPKISDEARDLICHLLC-DVETRLG-TRGVEELKEHPWFRGIQWDKLY--EMEAAYKPTV 423
P I++ AR L+ LL D RLG E+K H +F I WD L ++ + P V
Sbjct: 260 -PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPNV 318
Query: 424 NGELDTQNFEKF---PEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTF 467
+G D ++F+ V + P + F+G+++
Sbjct: 319 SGPNDLRHFDPEFTEEPVPNAIGKAPDSVLVTASVKEAAEAFLGFSY 365
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 362 bits (932), Expect = e-123
Identities = 123/350 (35%), Positives = 188/350 (53%), Gaps = 51/350 (14%)
Query: 93 TEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCR---AKTTGEIFAMKKLKKSEMLKRGQ 149
T +++ K FE L ++G+G+FG+V L + +++AMK LKK+ + R +
Sbjct: 11 THHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR 70
Query: 150 VEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVAR 209
V + ER++L EV+ IV+L Y+FQ LYLI+++L GGD+ T L +E + +E+ +
Sbjct: 71 V-RTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVK 129
Query: 210 FYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDED 269
FY+AE LA+ +H ++RD+KP+N++LD+ GH+KL+DFGL K E
Sbjct: 130 FYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK-------------ES 176
Query: 270 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWS 329
I +++ AYS GT++YMAPEV+ ++G+ DWWS
Sbjct: 177 IDHEKK-------------------------AYSFCGTVEYMAPEVVNRRGHTQSADWWS 211
Query: 330 LGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVET 388
G +M+EML G PF D + T I+ K L P +S EA+ L+ L +
Sbjct: 212 FGVLMFEMLTGTLPFQGKDRKETMTMILKAK--LGMP--QFLSPEAQSLLRMLFKRNPAN 267
Query: 389 RLG--TRGVEELKEHPWFRGIQWDKLY--EMEAAYKPTVNGELDTQNFEK 434
RLG GVEE+K H +F I W+KLY E+ +KP DT F+
Sbjct: 268 RLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKPATGRPEDTFYFDP 317
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 358 bits (922), Expect = e-121
Identities = 125/391 (31%), Positives = 200/391 (51%), Gaps = 57/391 (14%)
Query: 58 QDRKERRRALQMRAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKG 117
+E + A +A + E++L T + K+GI++FE L ++G G
Sbjct: 6 HHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTG 65
Query: 118 AFGEVRLCR---AKTTGEIFAMKKLKKSEMLKRG-QVEHVRSERNLLAEVDSRC-IVQLF 172
A+G+V L R TG+++AMK LKK+ ++++ EH R+ER +L + +V L
Sbjct: 66 AYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH 125
Query: 173 YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDI 232
Y+FQ L+LI++Y+ GG++ T L + + +E + Y+ E VLA+ +H+ ++RDI
Sbjct: 126 YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDI 185
Query: 233 KPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQ 292
K +N++LD NGH+ L+DFGL K E + ++
Sbjct: 186 KLENILLDSNGHVVLTDFGLSK-------------EFVADETER---------------- 216
Query: 293 WKRNRRALAYSTVGTLDYMAPEVLL--KKGYGMECDWWSLGAIMYEMLIGYPPFCSDD-- 348
AY GT++YMAP+++ G+ DWWSLG +MYE+L G PF D
Sbjct: 217 --------AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK 268
Query: 349 --PRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLG--TRGVEELKEHPW 403
R+I+ + +P ++S A+DLI LL D + RLG R +E+KEH +
Sbjct: 269 NSQAEISRRILKSE--PPYP--QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324
Query: 404 FRGIQWDKLY--EMEAAYKPTVNGELDTQNF 432
F+ I WD L ++ A +KP + ELD NF
Sbjct: 325 FQKINWDDLAAKKVPAPFKPVIRDELDVSNF 355
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 358 bits (920), Expect = e-121
Identities = 121/391 (30%), Positives = 188/391 (48%), Gaps = 60/391 (15%)
Query: 99 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN 158
R ++ + DF L ++GKG+FG+V L K T E++A+K LKK +++ VE E+
Sbjct: 13 NRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR 72
Query: 159 LLAEVDSRC-IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVL 217
+LA + QL FQ D LY +MEY+ GGD+M + + E A FY AE +
Sbjct: 73 VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI 132
Query: 218 AIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVS 277
+ + ++RD+K DN++LD GH+K++DFG+CK E+I + T
Sbjct: 133 GLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-------------ENIWDGVT-- 177
Query: 278 EAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337
+ GT DY+APE++ + YG DWW+ G ++YEM
Sbjct: 178 -----------------------TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 214
Query: 338 LIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RG 394
L G PF +D + I+ + +P +S EA + L+ RLG G
Sbjct: 215 LAGQAPFEGEDEDELFQSIMEHN--VAYP--KSMSKEAVAICKGLMTKHPGKRLGCGPEG 270
Query: 395 VEELKEHPWFRGIQWDKLY--EMEAAYKPTVNGELDTQNFEKF----PEVDGPPSEIPSV 448
++KEH +FR I W+KL E++ YKP G + +NF++F P V PP +
Sbjct: 271 ERDIKEHAFFRYIDWEKLERKEIQPPYKPKACGR-NAENFDRFFTRHPPVLTPPDQEV-- 327
Query: 449 GPWRKMLTSKDTNFIGYTFKKSDVLKSLENS 479
+ + F G++F S+ LK S
Sbjct: 328 -----IRNIDQSEFEGFSFVNSEFLKPEVKS 353
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 355 bits (914), Expect = e-120
Identities = 112/390 (28%), Positives = 186/390 (47%), Gaps = 60/390 (15%)
Query: 89 ERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRG 148
+ ++GID+FE + ++GKG+FG+V L R K TG+++A+K LKK +L+
Sbjct: 6 SKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDD 65
Query: 149 QVEHVRSERNLLAEVDSRC-IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDV 207
VE +E+ +L+ + + QLF FQ D L+ +ME++ GGD+M + + E
Sbjct: 66 DVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEAR 125
Query: 208 ARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLED 267
ARFY AE + A+ +H ++RD+K DN++LD GH KL+DFG+CK
Sbjct: 126 ARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK------------- 172
Query: 268 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDW 327
E I N T + GT DY+APE+L + YG DW
Sbjct: 173 EGICNGVT-------------------------TATFCGTPDYIAPEILQEMLYGPAVDW 207
Query: 328 WSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DV 386
W++G ++YEML G+ PF +++ I+N + + +P + ++A ++ + +
Sbjct: 208 WAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE--VVYP--TWLHEDATGILKSFMTKNP 263
Query: 387 ETRLG---TRGVEELKEHPWFRGIQWDKLY--EMEAAYKPTVNGELDTQNFEKF----PE 437
RLG G + HP+F+ I W +L ++E ++P + D NF+
Sbjct: 264 TMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSREDVSNFDPDFIKEEP 323
Query: 438 VDGPPSEIPSVGPWRKMLTSKDTNFIGYTF 467
V P E + F + +
Sbjct: 324 VLTPIDE-------GHLPMINQDEFRNFEY 346
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 354 bits (911), Expect = e-120
Identities = 112/378 (29%), Positives = 174/378 (46%), Gaps = 61/378 (16%)
Query: 99 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN 158
+ K+ I+DF ++GKG+FG+V L K T + FA+K LKK +L VE E+
Sbjct: 10 LQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKR 69
Query: 159 LLAEVDSRC--IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESV 216
+L+ + +F +FQ + L+ +MEYL GGD+M + A FY AE +
Sbjct: 70 VLSLA-WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEII 128
Query: 217 LAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETV 276
L + +H V+RD+K DN++LDK+GH+K++DFG+CK E+++
Sbjct: 129 LGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK-------------ENMLGDAK- 174
Query: 277 SEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 336
+ GT DY+APE+LL + Y DWWS G ++YE
Sbjct: 175 ------------------------TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYE 210
Query: 337 MLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGV 395
MLIG PF D I +P + EA+DL+ L + E RLG
Sbjct: 211 MLIGQSPFHGQDEEELFHSIRMDN--PFYP--RWLEKEAKDLLVKLFVREPEKRLG--VR 264
Query: 396 EELKEHPWFRGIQWDKLY--EMEAAYKPTVNGELDTQNFEKF----PEVDGPPSEIPSVG 449
++++HP FR I W++L E++ ++P V D NF+K
Sbjct: 265 GDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADR----- 319
Query: 450 PWRKMLTSKDTNFIGYTF 467
+ + F ++F
Sbjct: 320 --ALINSMDQNMFRNFSF 335
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 349 bits (897), Expect = e-117
Identities = 92/390 (23%), Positives = 170/390 (43%), Gaps = 58/390 (14%)
Query: 99 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN 158
+ + D FE L IGKG+FG+V + + T +++AMK + K + ++R +V +V E
Sbjct: 8 ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQ 67
Query: 159 LLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLA 218
++ ++ +V L+YSFQD + ++++++ L GGD+ L + E+ + +I E V+A
Sbjct: 68 IMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMA 127
Query: 219 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 278
+ + +HRD+KPDN++LD++GH+ ++DF + L
Sbjct: 128 LDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR-------------------- 167
Query: 279 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK---GYGMECDWWSLGAIMY 335
+ GT YMAPE+ + GY DWWSLG Y
Sbjct: 168 -------------------ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAY 208
Query: 336 EMLIGYPPF---CSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLG 391
E+L G P+ S + + +P S E L+ LL + + R
Sbjct: 209 ELLRGRRPYHIRSSTSSKEIVHTFETTV--VTYP--SAWSQEMVSLLKKLLEPNPDQRFS 264
Query: 392 TRGVEELKEHPWFRGIQWDKLY--EMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVG 449
+ +++ P+ I WD ++ + + P N + E++ E +
Sbjct: 265 --QLSDVQNFPYMNDINWDAVFQKRLIPGFIPNK----GRLNCDPTFELEEMILESKPLH 318
Query: 450 PWRKMLTSKDTNFIGYTFKKSDVLKSLENS 479
+K L K+ + ++ +L+ +S
Sbjct: 319 KKKKRLAKKEKDMRKCDSSQTCLLQEHLDS 348
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 345 bits (888), Expect = e-116
Identities = 107/388 (27%), Positives = 188/388 (48%), Gaps = 69/388 (17%)
Query: 100 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNL 159
+G+ DF+ L +IG+G++ +V L R K T I+AMK +KK + ++ V++E+++
Sbjct: 3 MDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV 62
Query: 160 LAEVDSR-CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLA 218
+ + +V L FQ L+ ++EY+ GGD+M + R+ L E+ ARFY AE LA
Sbjct: 63 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 122
Query: 219 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 278
++ +H+ ++RD+K DN++LD GH+KL+D+G+CK E + +T
Sbjct: 123 LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-------------EGLRPGDT--- 166
Query: 279 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338
+ GT +Y+APE+L + YG DWW+LG +M+EM+
Sbjct: 167 ----------------------TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 204
Query: 339 IGYPPFC---------SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVET 388
G PF + + I+ + ++ P +S +A ++ L D +
Sbjct: 205 AGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIP--RSLSVKAASVLKSFLNKDPKE 260
Query: 389 RLG---TRGVEELKEHPWFRGIQWDKLY--EMEAAYKPTVNGELDTQNF-EKF---PEVD 439
RLG G +++ HP+FR + WD + ++ +KP ++GE NF +F P
Sbjct: 261 RLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDSQFTNEPVQL 320
Query: 440 GPPSEIPSVGPWRKMLTSKDTNFIGYTF 467
P + + + F G+ +
Sbjct: 321 TPDDD-------DIVRKIDQSEFEGFEY 341
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 349 bits (897), Expect = e-116
Identities = 129/402 (32%), Positives = 201/402 (50%), Gaps = 56/402 (13%)
Query: 45 FIENHYKNYLQGLQDRKERRRALQMRAQQAAVSNEEQEEMLRNLERRETEYMRLQ----- 99
IE + +++ ++R+E A+Q A + + + ++
Sbjct: 83 VIERTF--HVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAK 140
Query: 100 -RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN 158
+ ++ +++FE L L+GKG FG+V L + K TG +AMK LKK ++ + +V H +E
Sbjct: 141 PKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR 200
Query: 159 LLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLA 218
+L + L YSFQ D L +MEY GG++ L RE + SED ARFY AE V A
Sbjct: 201 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA 260
Query: 219 IHSIH-QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVS 277
+ +H + N V+RD+K +NL+LDK+GH+K++DFGLCK E I + T
Sbjct: 261 LDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-------------EGIKDGAT-- 305
Query: 278 EAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337
+ GT +Y+APEVL YG DWW LG +MYEM
Sbjct: 306 -----------------------MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 342
Query: 338 LIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLG--TRG 394
+ G PF + D I+ + ++FP + EA+ L+ LL D + RLG +
Sbjct: 343 MCGRLPFYNQDHEKLFELILMEE--IRFP--RTLGPEAKSLLSGLLKKDPKQRLGGGSED 398
Query: 395 VEELKEHPWFRGIQWDKLY--EMEAAYKPTVNGELDTQNFEK 434
+E+ +H +F GI W +Y ++ +KP V E DT+ F++
Sbjct: 399 AKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDE 440
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 344 bits (885), Expect = e-115
Identities = 107/420 (25%), Positives = 191/420 (45%), Gaps = 69/420 (16%)
Query: 68 QMRAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRA 127
+ + E T +G+ DF+ L +IG+G++ +V L R
Sbjct: 14 IPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRL 73
Query: 128 KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR-CIVQLFYSFQDSDFLYLIME 186
K T I+AM+ +KK + ++ V++E+++ + + +V L FQ L+ ++E
Sbjct: 74 KKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE 133
Query: 187 YLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLK 246
Y+ GGD+M + R+ L E+ ARFY AE LA++ +H+ ++RD+K DN++LD GH+K
Sbjct: 134 YVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIK 193
Query: 247 LSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVG 306
L+D+G+CK E + +T + G
Sbjct: 194 LTDYGMCK-------------EGLRPGDT-------------------------TSTFCG 215
Query: 307 TLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC---------SDDPRITCRKIV 357
T +Y+APE+L + YG DWW+LG +M+EM+ G PF + + I+
Sbjct: 216 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 275
Query: 358 NWKTCLKFPEEPKISDEARDLICHLLC-DVETRLG---TRGVEELKEHPWFRGIQWDKLY 413
+ ++ P +S +A ++ L D + RLG G +++ HP+FR + WD +
Sbjct: 276 EKQ--IRIP--RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMME 331
Query: 414 --EMEAAYKPTVNGELDTQNFEKF----PEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTF 467
++ +KP ++GE NF+ P P + + + F G+ +
Sbjct: 332 QKQVVPPFKPNISGEFGLDNFDSQFTNEPVQLTPDDD-------DIVRKIDQSEFEGFEY 384
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 352 bits (905), Expect = e-115
Identities = 124/431 (28%), Positives = 200/431 (46%), Gaps = 60/431 (13%)
Query: 59 DRKERRRALQMRAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGA 118
+ E L+ + ++A + + + R ++ + DF L ++GKG+
Sbjct: 294 EGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGS 353
Query: 119 FGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR-CIVQLFYSFQD 177
FG+V L K T E++A+K LKK +++ VE E+ +LA + QL FQ
Sbjct: 354 FGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT 413
Query: 178 SDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNL 237
D LY +MEY+ GGD+M + + E A FY AE + + + ++RD+K DN+
Sbjct: 414 MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNV 473
Query: 238 ILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNR 297
+LD GH+K++DFG+CK E+I + T
Sbjct: 474 MLDSEGHIKIADFGMCK-------------ENIWDGVT---------------------- 498
Query: 298 RALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIV 357
+ GT DY+APE++ + YG DWW+ G ++YEML G PF +D + I+
Sbjct: 499 ---TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 555
Query: 358 NWKTCLKFPEEPKISDEARDLICHLLC-DVETRLG--TRGVEELKEHPWFRGIQWDKLY- 413
+ +P +S EA + L+ RLG G ++KEH +FR I W+KL
Sbjct: 556 EHN--VAYP--KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLER 611
Query: 414 -EMEAAYKPTVNGELDTQNFEKF----PEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFK 468
E++ YKP +G + +NF++F P V PP + + + F G++F
Sbjct: 612 KEIQPPYKPKASGR-NAENFDRFFTRHPPVLTPPDQEV-------IRNIDQSEFEGFSFV 663
Query: 469 KSDVLKSLENS 479
S+ LK S
Sbjct: 664 NSEFLKPEVKS 674
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 345 bits (886), Expect = e-113
Identities = 107/389 (27%), Positives = 167/389 (42%), Gaps = 69/389 (17%)
Query: 89 ERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRG 148
R ++ L+ + +G D F ++G+G FGEV C+ K TG+++A KKL K + KR
Sbjct: 168 FLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRK 227
Query: 149 QVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIM----TLLMREDILS 204
+ E+ +LA+V SR IV L Y+F+ L L+M + GGDI +
Sbjct: 228 GYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ 287
Query: 205 EDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264
E A FY A+ V + +HQ N ++RD+KP+N++LD +G++++SD GL
Sbjct: 288 EPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV---------- 337
Query: 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGME 324
E Q GT +MAPE+LL + Y
Sbjct: 338 ---ELKAGQTKTK-------------------------GYAGTPGFMAPELLLGEEYDFS 369
Query: 325 CDWWSLGAIMYEMLIGYPPFCSDDPRITC----RKIVNWKTCLKFPEEPKISDEARDLIC 380
D+++LG +YEM+ PF + ++ ++++ + +P K S ++D
Sbjct: 370 VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA--VTYP--DKFSPASKDFCE 425
Query: 381 HLLC-DVETRLGTR--GVEELKEHPWFRGIQWDKLY--EMEAAYKPTVNGELDTQNF--E 433
LL D E RLG R + L+ HP FR I W +L + + P
Sbjct: 426 ALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDSRTVYAKNIQDVG 485
Query: 434 KFPEVDGPPSEIPSVGPWRKMLTSKDTNF 462
F V G DT F
Sbjct: 486 AFSTVKGVA------------FEKADTEF 502
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 344 bits (884), Expect = e-112
Identities = 108/366 (29%), Positives = 174/366 (47%), Gaps = 56/366 (15%)
Query: 90 RRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ 149
R ++ L+R+ + + F Q ++GKG FGEV C+ + TG+++A KKL+K + KR
Sbjct: 168 NRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG 227
Query: 150 VEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL--MREDILSEDV 207
+E+ +L +V+SR +V L Y+++ D L L++ + GGD+ + M + E
Sbjct: 228 EAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEAR 287
Query: 208 ARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLED 267
A FY AE + +H+ V+RD+KP+N++LD +GH+++SD GL + +
Sbjct: 288 AVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-------- 339
Query: 268 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDW 327
VGT+ YMAPEV+ + Y DW
Sbjct: 340 -------------------------------QTIKGRVGTVGYMAPEVVKNERYTFSPDW 368
Query: 328 WSLGAIMYEMLIGYPPFCSDDPRITC----RKIVNWKTCLKFPEEPKISDEARDLICHLL 383
W+LG ++YEM+ G PF +I R + ++ + S +AR L LL
Sbjct: 369 WALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP--EEYS--ERFSPQARSLCSQLL 424
Query: 384 C-DVETRLGTR--GVEELKEHPWFRGIQWDKLY--EMEAAYKPTVNGE--LDTQNFEKFP 436
C D RLG R E+KEHP F+ + + +L +E +KP D + E+F
Sbjct: 425 CKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIYCKDVLDIEQFS 484
Query: 437 EVDGPP 442
V G
Sbjct: 485 TVKGVE 490
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 337 bits (866), Expect = e-108
Identities = 111/413 (26%), Positives = 182/413 (44%), Gaps = 74/413 (17%)
Query: 81 QEEMLRNLERRETEYMRLQR-RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKL 139
Q+ + + R ++ ++ + ++DF +IG+G FGEV CR TG+++AMK L
Sbjct: 163 QKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL 222
Query: 140 KKSEMLKRGQVEHVRSERNLLAEV---DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTL 196
K + + +ER +L+ V D IV + Y+F D L I++ + GGD+
Sbjct: 223 DKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYH 282
Query: 197 LMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 256
L + + SE RFY AE +L + +H V+RD+KP N++LD++GH+++SD GL
Sbjct: 283 LSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342
Query: 257 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL 316
K +++VGT YMAPEVL
Sbjct: 343 SKK----------------------------------------KPHASVGTHGYMAPEVL 362
Query: 317 LKK-GYGMECDWWSLGAIMYEMLIGYPPF---CSDDPRITCRKIVNWKTCLKFPEEPKIS 372
K Y DW+SLG +++++L G+ PF + D R + ++ P S
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA--VELP--DSFS 418
Query: 373 DEARDLICHLLC-DVETRLG--TRGVEELKEHPWFRGIQWDKLY--EMEAAYKPTVNG-- 425
E R L+ LL DV RLG RG +E+KE P+FR + W ++ + P
Sbjct: 419 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVN 478
Query: 426 ---ELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKS 475
D +F++ + G +L S + + S+ +
Sbjct: 479 AADAFDIGSFDEE-DTKGIK-----------LLDSDQELYRNFPLTISERWQQ 519
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 288 bits (740), Expect = 6e-95
Identities = 93/308 (30%), Positives = 143/308 (46%), Gaps = 48/308 (15%)
Query: 99 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN 158
++R+ ++DFE +GKG FG V L R K + I A+K L K+++ K G +R E
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 159 LLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLA 218
+ + + I++L+ F D+ +YLI+EY P G + L + E YI E A
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 219 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 278
+ H +HRDIKP+NL+L G LK++DFG
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-------------------- 161
Query: 279 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338
+RR GTLDY+ PE++ + + + D WSLG + YE L
Sbjct: 162 -----------------SRR---TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL 201
Query: 339 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEE 397
+G PPF ++ + T ++I + FP +++ ARDLI LL + R + E
Sbjct: 202 VGKPPFEANTYQETYKRISRVE--FTFP--DFVTEGARDLISRLLKHNPSQRP---MLRE 254
Query: 398 LKEHPWFR 405
+ EHPW
Sbjct: 255 VLEHPWIT 262
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 288 bits (739), Expect = 9e-95
Identities = 98/314 (31%), Positives = 148/314 (47%), Gaps = 48/314 (15%)
Query: 93 TEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEH 152
T + +RK IDDF+ +GKG FG V L R K I A+K L KS++ K G
Sbjct: 1 TALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 60
Query: 153 VRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYI 212
+R E + + + I++++ F D +YL++E+ P G++ L + E + ++
Sbjct: 61 LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM 120
Query: 213 AESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIIN 272
E A+H H+ +HRDIKP+NL++ G LK++DFG
Sbjct: 121 EELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV------------------ 162
Query: 273 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGA 332
P R + + GTLDY+ PE++ K + + D W G
Sbjct: 163 -----------HAPSLRRR-----------TMCGTLDYLPPEMIEGKTHDEKVDLWCAGV 200
Query: 333 IMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLG 391
+ YE L+G PPF S T R+IVN LKFP P +SD ++DLI LL RL
Sbjct: 201 LCYEFLVGMPPFDSPSHTETHRRIVNVD--LKFP--PFLSDGSKDLISKLLRYHPPQRL- 255
Query: 392 TRGVEELKEHPWFR 405
++ + EHPW +
Sbjct: 256 --PLKGVMEHPWVK 267
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 3e-80
Identities = 73/323 (22%), Positives = 136/323 (42%), Gaps = 49/323 (15%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
DFE++ ++G+GAFG+V R +A+KK++ +E ++ + SE LLA ++
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNH 61
Query: 166 RCIVQLFYSFQDSD-------------FLYLIMEYLPGGDIMTLLMREDI-LSEDVARFY 211
+ +V+ + ++ + L++ MEY G + L+ E++ D
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 212 IAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDII 271
+ + A+ IH +HRD+KP N+ +D++ ++K+ DFGL K + + L+ +++
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 272 NQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG-YGMECDWWSL 330
S +GT Y+A EVL G Y + D +SL
Sbjct: 182 GSSD------------------------NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSL 217
Query: 331 GAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETR 389
G I +EM+ YP + +K+ + + + +I L+ D R
Sbjct: 218 GIIFFEMI--YPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKR 275
Query: 390 LGTRGVEELKEHPWFRGIQWDKL 412
G L W D++
Sbjct: 276 P---GARTLLNSGWLPVKHQDEV 295
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 2e-78
Identities = 67/313 (21%), Positives = 112/313 (35%), Gaps = 51/313 (16%)
Query: 95 YMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVR 154
Y + F++L+ +G G++GEV R+K G ++A+K+ + + +
Sbjct: 46 YDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLA 105
Query: 155 SERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI-LSEDVARFYIA 213
+ C V+L ++++ LYL E G + L E Y+
Sbjct: 106 EVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLR 164
Query: 214 ESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 273
+++LA+ +H VH D+KP N+ L G KL DFGL L
Sbjct: 165 DTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL----------------- 207
Query: 274 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 333
G YMAPE+ L+ YG D +SLG
Sbjct: 208 ----------------------GTAGAGEVQEGDPRYMAPEL-LQGSYGTAADVFSLGLT 244
Query: 334 MYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT 392
+ E+ + +++ +F +S E R ++ +L D + R
Sbjct: 245 ILEVACNMELPHGGEGW---QQLRQGYLPPEFT--AGLSSELRSVLVMMLEPDPKLRA-- 297
Query: 393 RGVEELKEHPWFR 405
E L P R
Sbjct: 298 -TAEALLALPVLR 309
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 248 bits (634), Expect = 3e-78
Identities = 69/380 (18%), Positives = 137/380 (36%), Gaps = 91/380 (23%)
Query: 79 EEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKK 138
+++L N ++ + I+D+ + + +G F ++ L + + +A+KK
Sbjct: 4 GSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIIL--CEKDNKFYALKK 61
Query: 139 LKKSEMLK--------------RGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184
+KS + K + + + ++E ++ ++ + + + D +Y+I
Sbjct: 62 YEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYII 121
Query: 185 MEYLPGGDIMTLLMREDIL--------SEDVARFYIAESVLAIHSIHQHNYV-HRDIKPD 235
EY+ I+ +L V + I + + IH + HRD+KP
Sbjct: 122 YEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPS 181
Query: 236 NLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKR 295
N+++DKNG +KLSDFG + M ++++
Sbjct: 182 NILMDKNGRVKLSDFGESE-----------------------------YMVDKKIK---- 208
Query: 296 NRRALAYSTVGTLDYMAPEVLLKKG--YGMECDWWSLGAIMYEMLIGYPPFCSD-DPRIT 352
+ GT ++M PE + G + D WSLG +Y M PF
Sbjct: 209 -------GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261
Query: 353 CRKIVNWKTCLKFPEEPK-----------------ISDEARDLICHLLC-DVETRLGTRG 394
I +++P + +S+E D + L + R+
Sbjct: 262 FNNIRTKN--IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI---T 316
Query: 395 VEELKEHPWFRGIQWDKLYE 414
E+ +H W + L E
Sbjct: 317 SEDALKHEWLADTNIEDLRE 336
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 4e-78
Identities = 88/304 (28%), Positives = 151/304 (49%), Gaps = 49/304 (16%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 164
I+DF+ L+GKG+F V + TG A+K + K M K G V+ V++E + ++
Sbjct: 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 165 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM-REDILSEDVARFYIAESVLAIHSIH 223
I++L+ F+DS+++YL++E G++ L R SE+ AR ++ + + + +H
Sbjct: 70 HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129
Query: 224 QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQW 283
H +HRD+ NL+L +N ++K++DFGL + L+
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGL---------ATQLKMPH-------------- 166
Query: 284 MMPKERLQQWKRNRRALAYSTV-GTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 342
E+ T+ GT +Y++PE+ + +G+E D WSLG + Y +LIG P
Sbjct: 167 ----EKHY------------TLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRP 210
Query: 343 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401
PF +D + T K+V + P +S EA+DLI LL + RL + + +H
Sbjct: 211 PFDTDTVKNTLNKVVLAD--YEMP--SFLSIEAKDLIHQLLRRNPADRL---SLSSVLDH 263
Query: 402 PWFR 405
P+
Sbjct: 264 PFMS 267
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 2e-77
Identities = 83/311 (26%), Positives = 137/311 (44%), Gaps = 48/311 (15%)
Query: 97 RLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSE 156
+ + + +GKG F + T E+FA K + KS +LK Q E + E
Sbjct: 6 EVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME 65
Query: 157 RNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESV 216
++ + + +V F+D+DF+++++E ++ L R L+E AR+Y+ + V
Sbjct: 66 ISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV 125
Query: 217 LAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETV 276
L +H++ +HRD+K NL L+++ +K+ DFGL +
Sbjct: 126 LGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV-------------------- 165
Query: 277 SEAEGQWMMPKERLQQWKRNRRALAYSTV-GTLDYMAPEVLLKKGYGMECDWWSLGAIMY 335
ER + + GT +Y+APEVL KKG+ E D WS+G IMY
Sbjct: 166 -------EYDGERKK------------VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMY 206
Query: 336 EMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRG 394
+L+G PPF + + T +I + P I+ A LI +L D R
Sbjct: 207 TLLVGKPPFETSCLKETYLRIKKNE--YSIP--KHINPVAASLIQKMLQTDPTARP---T 259
Query: 395 VEELKEHPWFR 405
+ EL +F
Sbjct: 260 INELLNDEFFT 270
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 4e-77
Identities = 83/311 (26%), Positives = 137/311 (44%), Gaps = 48/311 (15%)
Query: 97 RLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSE 156
+ + + +GKG F + T E+FA K + KS +LK Q E + E
Sbjct: 32 EVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME 91
Query: 157 RNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESV 216
++ + + +V F+D+DF+++++E ++ L R L+E AR+Y+ + V
Sbjct: 92 ISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV 151
Query: 217 LAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETV 276
L +H++ +HRD+K NL L+++ +K+ DFGL +
Sbjct: 152 LGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV-------------------- 191
Query: 277 SEAEGQWMMPKERLQQWKRNRRALAYSTV-GTLDYMAPEVLLKKGYGMECDWWSLGAIMY 335
ER + + GT +Y+APEVL KKG+ E D WS+G IMY
Sbjct: 192 -------EYDGERKK------------VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMY 232
Query: 336 EMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRG 394
+L+G PPF + + T +I + P I+ A LI +L D R
Sbjct: 233 TLLVGKPPFETSCLKETYLRIKKNE--YSIP--KHINPVAASLIQKMLQTDPTARP---T 285
Query: 395 VEELKEHPWFR 405
+ EL +F
Sbjct: 286 INELLNDEFFT 296
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 9e-76
Identities = 76/331 (22%), Positives = 138/331 (41%), Gaps = 60/331 (18%)
Query: 90 RRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ 149
TE + Q + + L IG G +V + +I+A+K + E +
Sbjct: 12 DLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQ-T 69
Query: 150 VEHVRSERNLLAEVD--SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDV 207
++ R+E L ++ S I++L+ ++Y++ME D+ + L ++ +
Sbjct: 70 LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWE 128
Query: 208 ARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLED 267
+ Y + A+H+IHQH VH D+KP N ++ +G LKL DFG+ ++ +S++ +
Sbjct: 129 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKD- 186
Query: 268 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL---------- 317
S VGT++YM PE +
Sbjct: 187 -----------------------------------SQVGTVNYMPPEAIKDMSSSRENGK 211
Query: 318 -KKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI-TCRKIVNWKTCLKFPEEPKISDEA 375
K + D WSLG I+Y M G PF +I I++ ++FP+ +
Sbjct: 212 SKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD--IPEKDL 269
Query: 376 RDLICHLLC-DVETRLGTRGVEELKEHPWFR 405
+D++ L D + R+ + EL HP+ +
Sbjct: 270 QDVLKCCLKRDPKQRI---SIPELLAHPYVQ 297
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 4e-73
Identities = 73/319 (22%), Positives = 133/319 (41%), Gaps = 60/319 (18%)
Query: 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA 161
+ + L IG G +V + +I+A+K + E + ++ R+E L
Sbjct: 5 SVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQ-TLDSYRNEIAYLN 62
Query: 162 EVD--SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAI 219
++ S I++L+ ++Y++ME D+ + L ++ + + Y + A+
Sbjct: 63 KLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAV 121
Query: 220 HSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEA 279
H+IHQH VH D+KP N ++ +G LKL DFG+ ++ +S++ +
Sbjct: 122 HTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKD------------- 167
Query: 280 EGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----------KKGYGMECDWW 328
S VGT++YM PE + K + D W
Sbjct: 168 -----------------------SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 204
Query: 329 SLGAIMYEMLIGYPPFCSDDPRI-TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DV 386
SLG I+Y M G PF +I I++ ++FP + +D++ L D
Sbjct: 205 SLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP--DIPEKDLQDVLKCCLKRDP 262
Query: 387 ETRLGTRGVEELKEHPWFR 405
+ R+ + EL HP+ +
Sbjct: 263 KQRI---SIPELLAHPYVQ 278
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 7e-72
Identities = 80/358 (22%), Positives = 143/358 (39%), Gaps = 50/358 (13%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 164
++ + +L IG+G+FG+ L ++ G + +K++ S M + + E R E +LA +
Sbjct: 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK-EREESRREVAVLANMK 81
Query: 165 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSI 222
IVQ SF+++ LY++M+Y GGD+ + + + ED + + LA+ +
Sbjct: 82 HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 223 HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 282
H +HRDIK N+ L K+G ++L DFG+ + L
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE--------------------- 180
Query: 283 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 342
LA + +GT Y++PE+ K Y + D W+LG ++YE+
Sbjct: 181 -----------------LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKH 223
Query: 343 PFCSDDPRITCRKIVNWKTCLKFPEEP-KISDEARDLICHLLC-DVETRLGTRGVEELKE 400
F + + KI++ FP S + R L+ L + R V + E
Sbjct: 224 AFEAGSMKNLVLKIIS----GSFPPVSLHYSYDLRSLVSQLFKRNPRDRP---SVNSILE 276
Query: 401 HPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSK 458
+ L A + + + + SV P +K+
Sbjct: 277 KGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPA 334
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 230 bits (587), Expect = 7e-71
Identities = 72/319 (22%), Positives = 133/319 (41%), Gaps = 60/319 (18%)
Query: 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA 161
+ + L IG G +V + +I+A+K + E + ++ R+E L
Sbjct: 52 SVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQ-TLDSYRNEIAYLN 109
Query: 162 EVD--SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAI 219
++ S I++L+ ++Y++ME D+ + L ++ + + Y + A+
Sbjct: 110 KLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAV 168
Query: 220 HSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEA 279
H+IHQH VH D+KP N ++ +G LKL DFG+ ++ +S++ +
Sbjct: 169 HTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKD------------- 214
Query: 280 EGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----------KKGYGMECDWW 328
S VG ++YM PE + K + D W
Sbjct: 215 -----------------------SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 251
Query: 329 SLGAIMYEMLIGYPPFCSDDPRI-TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DV 386
SLG I+Y M G PF +I I++ ++FP+ + +D++ L D
Sbjct: 252 SLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD--IPEKDLQDVLKCCLKRDP 309
Query: 387 ETRLGTRGVEELKEHPWFR 405
+ R+ + EL HP+ +
Sbjct: 310 KQRI---SIPELLAHPYVQ 325
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 5e-69
Identities = 87/307 (28%), Positives = 142/307 (46%), Gaps = 54/307 (17%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
F + ++G GAF EV L + + TG++FA+K +KKS + + +E +L ++
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKS---PAFRDSSLENEIAVLKKIKH 65
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 225
IV L ++ + YL+M+ + GG++ ++ + +E A I + + A+ +H++
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 226 NYVHRDIKPDNLIL---DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 282
VHRD+KP+NL+ ++N + ++DFGL S + ++ +
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGL---------SKMEQNGIM------------ 164
Query: 283 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 342
+ GT Y+APEVL +K Y D WS+G I Y +L GYP
Sbjct: 165 -------------------STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYP 205
Query: 343 PFCSDDPRITCRKIVNWKTCLKFPEEP--KISDEARDLICHLLC-DVETRLGTRGVEELK 399
PF + KI +F IS+ A+D ICHLL D R T E+
Sbjct: 206 PFYEETESKLFEKIKEGY--YEFESPFWDDISESAKDFICHLLEKDPNERY-T--CEKAL 260
Query: 400 EHPWFRG 406
HPW G
Sbjct: 261 SHPWIDG 267
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 6e-69
Identities = 79/299 (26%), Positives = 131/299 (43%), Gaps = 51/299 (17%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 173
+GKGAF VR C KTTG FA K + ++ R + + E + ++ IV+L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHD 72
Query: 174 SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIK 233
S Q+ F YL+ + + GG++ ++ + SE A I + + +I H + VHR++K
Sbjct: 73 SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLK 132
Query: 234 PDNLIL---DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERL 290
P+NL+L K +KL+DFGL + + +
Sbjct: 133 PENLLLASKAKGAAVKLADFGLAIEVN----------------------DSEAW------ 164
Query: 291 QQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPR 350
+ GT Y++PEVL K Y D W+ G I+Y +L+GYPPF +D
Sbjct: 165 -----------HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH 213
Query: 351 ITCRKIVNWKTCLKFPEEP--KISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406
+I +P ++ EA+ LI +L + + R+ ++ + PW
Sbjct: 214 RLYAQIKAGA--YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI---TADQALKVPWICN 267
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 7e-69
Identities = 74/301 (24%), Positives = 130/301 (43%), Gaps = 56/301 (18%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 173
+G GAFG+V L +++G +K + K + +E + +E +L +D I+++F
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 174 SFQDSDFLYLIMEYLPGGD----IMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVH 229
F+D +Y++ME GG+ I++ R LSE + + + A+ H + VH
Sbjct: 88 VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVH 147
Query: 230 RDIKPDNLIL---DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMP 286
+D+KP+N++ + +K+ DFGL + L + ++
Sbjct: 148 KDLKPENILFQDTSPHSPIKIIDFGL---------AELFKSDEHSTN------------- 185
Query: 287 KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCS 346
GT YMAPEV K+ +CD WS G +MY +L G PF
Sbjct: 186 -----------------AAGTALYMAPEV-FKRDVTFKCDIWSAGVVMYFLLTGCLPFTG 227
Query: 347 DDPRITCRKIVNWKTCLKFPEEPK-ISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404
+K + + E + ++ +A DL+ +L D E R ++ H WF
Sbjct: 228 TSLEEVQQKATYKE--PNYAVECRPLTPQAVDLLKQMLTKDPERRP---SAAQVLHHEWF 282
Query: 405 R 405
+
Sbjct: 283 K 283
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 9e-69
Identities = 80/305 (26%), Positives = 129/305 (42%), Gaps = 56/305 (18%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ--VEHVRSERNLLAEVDSRCIVQL 171
IGKG F VR C + TG+ FA+K + ++ E ++ E ++ + IV+L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 172 FYSFQDSDFLYLIMEYLPGGD----IMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 227
++ LY++ E++ G D I+ + SE VA Y+ + + A+ H +N
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNI 151
Query: 228 VHRDIKPDNLIL---DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 284
+HRD+KP ++L + + +KL FG+ L + G
Sbjct: 152 IHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE---------------------SGLVA 190
Query: 285 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 344
VGT +MAPEV+ ++ YG D W G I++ +L G PF
Sbjct: 191 -----------------GGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233
Query: 345 CSDDPRITCRKIVNWKTCLKFPEEP--KISDEARDLICHLLC-DVETRLGTRGVEELKEH 401
R+ I+ K K IS+ A+DL+ +L D R+ T V E H
Sbjct: 234 YGTKERLF-EGIIKGK--YKMNPRQWSHISESAKDLVRRMLMLDPAERI-T--VYEALNH 287
Query: 402 PWFRG 406
PW +
Sbjct: 288 PWLKE 292
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 220 bits (564), Expect = 1e-68
Identities = 84/299 (28%), Positives = 136/299 (45%), Gaps = 52/299 (17%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 173
+GKG+FGEV C+ + T + +A+K + K+ + + E LL ++D I++LF
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFE 88
Query: 174 SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIK 233
+DS Y++ E GG++ +++ SE A I + I +H+HN VHRD+K
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLK 148
Query: 234 PDNLIL---DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERL 290
P+N++L +K+ +K+ DFGL + + M
Sbjct: 149 PENILLESKEKDCDIKIIDFGLSTCFQ----------------------QNTKM------ 180
Query: 291 QQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPR 350
+GT Y+APEV L+ Y +CD WS G I+Y +L G PPF +
Sbjct: 181 -----------KDRIGTAYYIAPEV-LRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEY 228
Query: 351 ITCRKIVNWKTCLKFPEEP--KISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406
+++ K F ISD+A+DLI +L R+ + EHPW +
Sbjct: 229 DILKRVETGK--YAFDLPQWRTISDDAKDLIRKMLTFHPSLRI---TATQCLEHPWIQK 282
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 2e-68
Identities = 87/322 (27%), Positives = 144/322 (44%), Gaps = 52/322 (16%)
Query: 91 RETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQV 150
R +E+M K D+++ +GKGAF VR C KTTG FA K + ++ R
Sbjct: 15 RGSEFMMNASTKFS-DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DF 72
Query: 151 EHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARF 210
+ + E + ++ IV+L S Q+ F YL+ + + GG++ ++ + SE A
Sbjct: 73 QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH 132
Query: 211 YIAESVLAIHSIHQHNYVHRDIKPDNLIL---DKNGHLKLSDFGLCKPLEDKYSSILLED 267
I + + +I H + VHR++KP+NL+L K +KL+DFGL +I + D
Sbjct: 133 CIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL---------AIEVND 183
Query: 268 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDW 327
+ + GT Y++PEVL K Y D
Sbjct: 184 SEAW------------------------------HGFAGTPGYLSPEVLKKDPYSKPVDI 213
Query: 328 WSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEP--KISDEARDLICHLLC- 384
W+ G I+Y +L+GYPPF +D +I +P ++ EA+ LI +L
Sbjct: 214 WACGVILYILLVGYPPFWDEDQHRLYAQIKAGA--YDYPSPEWDTVTPEAKSLIDSMLTV 271
Query: 385 DVETRLGTRGVEELKEHPWFRG 406
+ + R+ T ++ + PW
Sbjct: 272 NPKKRI-T--ADQALKVPWICN 290
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 2e-68
Identities = 86/318 (27%), Positives = 147/318 (46%), Gaps = 48/318 (15%)
Query: 95 YMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVR 154
+++ D ++ ++GKG+FGEV LC+ K TG+ A+K + K ++ ++ E +
Sbjct: 16 FVQHSTAIFS-DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 74
Query: 155 SERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAE 214
E LL ++D I++L+ F+D + YL+ E GG++ ++ SE A I +
Sbjct: 75 REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ 134
Query: 215 SVLAIHSIHQHNYVHRDIKPDNLIL---DKNGHLKLSDFGLCKPLEDKYSSILLEDEDII 271
+ I +H++ VHRD+KP+NL+L K+ ++++ DFGL E
Sbjct: 135 VLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE-------------- 180
Query: 272 NQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLG 331
+ M +GT Y+APEV L Y +CD WS G
Sbjct: 181 --------ASKKMK-----------------DKIGTAYYIAPEV-LHGTYDEKCDVWSTG 214
Query: 332 AIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRL 390
I+Y +L G PPF + +K+ K + P+ K+S+ A+DLI +L R+
Sbjct: 215 VILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRI 274
Query: 391 GTRGVEELKEHPWFRGIQ 408
+ +H W +
Sbjct: 275 ---SARDALDHEWIQTYT 289
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 3e-68
Identities = 93/342 (27%), Positives = 157/342 (45%), Gaps = 49/342 (14%)
Query: 69 MRAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAK 128
M S E +L+ ++ ++ + + ++++ +G GA+GEV LCR K
Sbjct: 1 MHHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLS-EMYQRVKKLGSGAYGEVLLCRDK 59
Query: 129 TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYL 188
T A+K ++K+ + + E +L +D I++L+ F+D YL+ME
Sbjct: 60 VTHVERAIKIIRKTS-VSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECY 118
Query: 189 PGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL---DKNGHL 245
GG++ ++ +E A I + + + +H+HN VHRD+KP+NL+L +K+ +
Sbjct: 119 KGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALI 178
Query: 246 KLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTV 305
K+ DFGL E + M +
Sbjct: 179 KIVDFGLSAVFE----------------------NQKKM-----------------KERL 199
Query: 306 GTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKF 365
GT Y+APEV L+K Y +CD WS+G I++ +L GYPPF + RK+ K
Sbjct: 200 GTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDS 258
Query: 366 PEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406
PE +S+ A+DLI +L D + R+ ++ EHPW +
Sbjct: 259 PEWKNVSEGAKDLIKQMLQFDSQRRI---SAQQALEHPWIKE 297
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 5e-68
Identities = 82/367 (22%), Positives = 143/367 (38%), Gaps = 84/367 (22%)
Query: 86 RNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEM- 144
+ RE Y + + IG+G++G VR+ T I A+K + K+++
Sbjct: 6 HHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIR 65
Query: 145 -LKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDI---------- 193
+ VE +++E L+ ++ I +L+ ++D ++ L+ME GG +
Sbjct: 66 QINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDD 125
Query: 194 ------------------------------MTLLMREDILSEDVARFYIAESVLAIHSIH 223
+ + E + + + A+H +H
Sbjct: 126 STGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185
Query: 224 QHNYVHRDIKPDNLIL--DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 281
HRDIKP+N + +K+ +KL DFGL K + E
Sbjct: 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKL-----------------NNGEY 228
Query: 282 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL--LKKGYGMECDWWSLGAIMYEMLI 339
M + GT ++APEVL + YG +CD WS G +++ +L+
Sbjct: 229 YGMT-----------------TKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLM 271
Query: 340 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEEL 398
G PF + T +++N K C + P +S ARDL+ +LL +V+ R
Sbjct: 272 GAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERF---DAMRA 328
Query: 399 KEHPWFR 405
+HPW
Sbjct: 329 LQHPWIS 335
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 1e-67
Identities = 84/307 (27%), Positives = 141/307 (45%), Gaps = 48/307 (15%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
+ + + ++GKG+FGEV C+ + T + +A+K + K+ + + E LL ++D
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDH 80
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 225
I++LF +DS Y++ E GG++ +++ SE A I + I +H+H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 226 NYVHRDIKPDNLIL---DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 282
N VHRD+KP+N++L +K+ +K+ DFGL + +
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ----------------------QNT 178
Query: 283 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 342
M +GT Y+APEV L+ Y +CD WS G I+Y +L G P
Sbjct: 179 KM-----------------KDRIGTAYYIAPEV-LRGTYDEKCDVWSAGVILYILLSGTP 220
Query: 343 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401
PF + +++ K P+ ISD+A+DLI +L R+ + EH
Sbjct: 221 PFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRI---TATQCLEH 277
Query: 402 PWFRGIQ 408
PW +
Sbjct: 278 PWIQKYS 284
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 2e-67
Identities = 80/315 (25%), Positives = 131/315 (41%), Gaps = 60/315 (19%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-------SR 166
+G+G VR C K T + +A+K + + E L EVD
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 167 CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHN 226
I+QL +++ + F +L+ + + G++ L + LSE R + + I ++H+ N
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN 144
Query: 227 YVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMP 286
VHRD+KP+N++LD + ++KL+DFG L+ G+ +
Sbjct: 145 IVHRDLKPENILLDDDMNIKLTDFGFSCQLD----------------------PGEKLR- 181
Query: 287 KERLQQWKRNRRALAYSTVGTLDYMAPEVL------LKKGYGMECDWWSLGAIMYEMLIG 340
GT Y+APE++ GYG E D WS G IMY +L G
Sbjct: 182 ----------------EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
Query: 341 YPPFCSDDPRITCRKIVNWKTCLKFPEEP--KISDEARDLICHLLC-DVETRLGTRGVEE 397
PPF + R I++ +F SD +DL+ L + R EE
Sbjct: 226 SPPFWHRKQMLMLRMIMSGN--YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY---TAEE 280
Query: 398 LKEHPWFRGIQWDKL 412
HP+F+ +++
Sbjct: 281 ALAHPFFQQYVVEEV 295
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 2e-67
Identities = 80/303 (26%), Positives = 132/303 (43%), Gaps = 54/303 (17%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ---VEHVRSERNLLAEVDSRCIVQ 170
+G G F VR CR K TG+ +A K +KK + + E + E N+L E+ I+
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 171 LFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHR 230
L F++ + LI+E + GG++ L ++ L+ED A ++ + + +H +H H
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHF 132
Query: 231 DIKPDNLIL----DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMP 286
D+KP+N++L N +KL DFG+ +E
Sbjct: 133 DLKPENIMLLDKNVPNPRIKLIDFGIAHKIE----------------------------A 164
Query: 287 KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCS 346
+ GT +++APE++ + G+E D WS+G I Y +L G PF
Sbjct: 165 GNEFKN-----------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 213
Query: 347 DDPRITCRKIVNWKTCLKFPEEP--KISDEARDLICHLLC-DVETRLGTRGVEELKEHPW 403
+ + T I F EE S+ A+D I LL D + R+ + + EH W
Sbjct: 214 ETKQETLTNISAVN--YDFDEEYFSNTSELAKDFIRRLLVKDPKRRM---TIAQSLEHSW 268
Query: 404 FRG 406
+
Sbjct: 269 IKA 271
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 5e-67
Identities = 80/311 (25%), Positives = 136/311 (43%), Gaps = 54/311 (17%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ---VEHVRSERNLLAE 162
D ++ +G G F V+ CR K+TG +A K +KK + + E + E ++L +
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 163 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSI 222
V ++ L +++ + LI+E + GG++ L +++ LSE+ A +I + + ++ +
Sbjct: 72 VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 223 HQHNYVHRDIKPDNLIL----DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 278
H H D+KP+N++L H+KL DFGL +E
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--------------------- 170
Query: 279 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338
+ GT +++APE++ + G+E D WS+G I Y +L
Sbjct: 171 -------DGVEFKN-----------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 212
Query: 339 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEP--KISDEARDLICHLLC-DVETRLGTRGV 395
G PF D + T I + F EE S+ A+D I LL + RL +
Sbjct: 213 SGASPFLGDTKQETLANITSVS--YDFDEEFFSHTSELAKDFIRKLLVKETRKRL---TI 267
Query: 396 EELKEHPWFRG 406
+E HPW
Sbjct: 268 QEALRHPWITP 278
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 2e-66
Identities = 82/299 (27%), Positives = 134/299 (44%), Gaps = 54/299 (18%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 173
IG+G++GEV++ K T A KK+ K + V+ + E ++ +D I++L+
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPNIIRLYE 73
Query: 174 SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIK 233
+F+D+ +YL+ME GG++ ++ + + E A + + + A+ H+ N HRD+K
Sbjct: 74 TFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLK 133
Query: 234 PDNLIL---DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERL 290
P+N + + LKL DFGL + + ++
Sbjct: 134 PENFLFLTDSPDSPLKLIDFGL---------AARFKPGKMMRT----------------- 167
Query: 291 QQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPR 350
VGT Y++P+V L+ YG ECD WS G +MY +L GYPPF +
Sbjct: 168 -------------KVGTPYYVSPQV-LEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDS 213
Query: 351 ITCRKIVNWKTCLKFPEEP--KISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406
KI FPE+ +S +A LI LL + R+ + EH WF
Sbjct: 214 EVMLKIREGT--FTFPEKDWLNVSPQAESLIRRLLTKSPKQRI---TSLQALEHEWFEK 267
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 2e-66
Identities = 84/307 (27%), Positives = 133/307 (43%), Gaps = 50/307 (16%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
++++ +GKGAF VR C G+ +A + L + + E + +
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTK-KLSARDHQKLEREARICRLLKH 69
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 225
IV+L S + YLI + + GG++ ++ + SE A I + + A+ HQ
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 226 NYVHRDIKPDNLIL---DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 282
VHR++KP+NL+L K +KL+DFGL +I +E E Q
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGL---------AIEVEG------------EQQ 168
Query: 283 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 342
+ GT Y++PEVL K YG D W+ G I+Y +L+GYP
Sbjct: 169 AW-----------------FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYP 211
Query: 343 PFCSDDPRITCRKIVNWKTCLKFPEEP--KISDEARDLICHLLC-DVETRLGTRGVEELK 399
PF +D ++I FP ++ EA+DLI +L + R+ T E
Sbjct: 212 PFWDEDQHRLYQQIKAGA--YDFPSPEWDTVTPEAKDLINKMLTINPSKRI-T--AAEAL 266
Query: 400 EHPWFRG 406
+HPW
Sbjct: 267 KHPWISH 273
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 3e-66
Identities = 96/349 (27%), Positives = 153/349 (43%), Gaps = 58/349 (16%)
Query: 72 QQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTG 131
S+ + + + Y+R + KIG + + ++ +G GA+GEV LC+ K
Sbjct: 3 HHHHHSSGRENLYFQGIAINPGMYVRKKEGKIG-ESYFKVRKLGSGAYGEVLLCKEKNGH 61
Query: 132 EIFAMKKLKKSEM----------LKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 181
A+K +KKS+ E + +E +LL +D I++LF F+D +
Sbjct: 62 SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYF 121
Query: 182 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL-- 239
YL+ E+ GG++ ++ E A + + + I +H+HN VHRDIKP+N++L
Sbjct: 122 YLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLEN 181
Query: 240 -DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRR 298
+ ++K+ DFGL + +
Sbjct: 182 KNSLLNIKIVDFGLSSFFS----------------------KDYKL-------------- 205
Query: 299 ALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVN 358
+GT Y+APEV LKK Y +CD WS G IMY +L GYPPF + + +K+
Sbjct: 206 ---RDRLGTAYYIAPEV-LKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK 261
Query: 359 WKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406
K F + ISDEA++LI +L D R EE W +
Sbjct: 262 GKYYFDFNDWKNISDEAKELIKLMLTYDYNKRC---TAEEALNSRWIKK 307
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 3e-66
Identities = 81/311 (26%), Positives = 136/311 (43%), Gaps = 54/311 (17%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ---VEHVRSERNLLAE 162
D ++ +G G F V+ CR K+TG +A K +KK + + E + E ++L +
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 163 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSI 222
V I+ L +++ + LI+E + GG++ L +++ LSE+ A +I + + ++ +
Sbjct: 72 VLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 223 HQHNYVHRDIKPDNLIL----DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 278
H H D+KP+N++L H+KL DFGL +E
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--------------------- 170
Query: 279 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338
+ GT +++APE++ + G+E D WS+G I Y +L
Sbjct: 171 -------DGVEFKN-----------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 212
Query: 339 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEP--KISDEARDLICHLLC-DVETRLGTRGV 395
G PF D + T I F EE + S+ A+D I LL + RL +
Sbjct: 213 SGASPFLGDTKQETLANITAVS--YDFDEEFFSQTSELAKDFIRKLLVKETRKRL---TI 267
Query: 396 EELKEHPWFRG 406
+E HPW
Sbjct: 268 QEALRHPWITP 278
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 4e-66
Identities = 86/314 (27%), Positives = 138/314 (43%), Gaps = 59/314 (18%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 164
+D+E L IG G++G + R K+ G+I K+L M + + + + SE NLL E+
Sbjct: 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEVNLLRELK 63
Query: 165 SRCIVQLFYSFQD--SDFLYLIMEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLA 218
IV+ + D + LY++MEY GGD+ +++ + L E+ + + LA
Sbjct: 64 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 219 IHSIHQHNY-----VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 273
+ H+ + +HRD+KP N+ LD ++KL DFGL + L
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN---------------- 167
Query: 274 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 333
+ + A + VGT YM+PE + + Y + D WSLG +
Sbjct: 168 ----------------------HDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCL 205
Query: 334 MYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKI-SDEARDLICHLLC-DVETRLG 391
+YE+ PPF + + KI KF P SDE ++I +L R
Sbjct: 206 LYELCALMPPFTAFSQKELAGKIRE----GKFRRIPYRYSDELNEIITRMLNLKDYHRP- 260
Query: 392 TRGVEELKEHPWFR 405
VEE+ E+P
Sbjct: 261 --SVEEILENPLIL 272
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 7e-66
Identities = 86/307 (28%), Positives = 131/307 (42%), Gaps = 63/307 (20%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS-RCIVQLF 172
+G+G+F R C K + + FA+K + K + + E L + IV+L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLH 72
Query: 173 YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDI 232
F D +L+ME L GG++ + ++ SE A + + + V A+ +H VHRD+
Sbjct: 73 EVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDL 132
Query: 233 KPDNLIL---DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKER 289
KP+NL+ + N +K+ DFG + + + Q +
Sbjct: 133 KPENLLFTDENDNLEIKIIDFGFAR---------------------LKPPDNQPLK---- 167
Query: 290 LQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDP 349
+ TL Y APE+L + GY CD WSLG I+Y ML G PF S D
Sbjct: 168 -------------TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDR 214
Query: 350 RITC-------RKIVNWKTCLKFPEEP--KISDEARDLICHLLC-DVETRLGTRGVEELK 399
+TC +KI F E +S EA+DLI LL D RL + L+
Sbjct: 215 SLTCTSAVEIMKKIKKGD--FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRL-K--MSGLR 269
Query: 400 EHPWFRG 406
+ W +
Sbjct: 270 YNEWLQD 276
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 1e-65
Identities = 72/311 (23%), Positives = 135/311 (43%), Gaps = 54/311 (17%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ---VEHVRSERNLLAE 162
D ++ +G G F V+ CR K+TG +A K +KK + E + E ++L E
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 163 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSI 222
+ ++ L +++ + LI+E + GG++ L ++ L+E+ A ++ + + ++ +
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 223 HQHNYVHRDIKPDNLIL----DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 278
H H D+KP+N++L +K+ DFGL ++
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--------------------- 169
Query: 279 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338
+ GT +++APE++ + G+E D WS+G I Y +L
Sbjct: 170 -------FGNEFKN-----------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 211
Query: 339 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEP--KISDEARDLICHLLC-DVETRLGTRGV 395
G PF D + T + +F +E S A+D I LL D + R+ +
Sbjct: 212 SGASPFLGDTKQETLANVSAVN--YEFEDEYFSNTSALAKDFIRRLLVKDPKKRM---TI 266
Query: 396 EELKEHPWFRG 406
++ +HPW +
Sbjct: 267 QDSLQHPWIKP 277
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 1e-65
Identities = 77/301 (25%), Positives = 129/301 (42%), Gaps = 54/301 (17%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR-CIVQLF 172
+G+G F VR C +K+TG+ +A K LKK + + E +L S ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRR-RGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 173 YSFQDSDFLYLIMEYLPGGDIMTLLMREDI--LSEDVARFYIAESVLAIHSIHQHNYVHR 230
++++ + LI+EY GG+I +L + E +SE+ I + + ++ +HQ+N VH
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHL 155
Query: 231 DIKPDNLIL---DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 287
D+KP N++L G +K+ DFG+ + +
Sbjct: 156 DLKPQNILLSSIYPLGDIKIVDFGMSRKIG----------------------------HA 187
Query: 288 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSD 347
L++ +GT +Y+APE+L D W++G I Y +L PF +
Sbjct: 188 CELRE-----------IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE 236
Query: 348 DPRITCRKIVNWKTCLKFPEEP--KISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404
D + T I + + EE +S A D I LL + E R E H W
Sbjct: 237 DNQETYLNISQVN--VDYSEETFSSVSQLATDFIQSLLVKNPEKRP---TAEICLSHSWL 291
Query: 405 R 405
+
Sbjct: 292 Q 292
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 2e-65
Identities = 82/359 (22%), Positives = 156/359 (43%), Gaps = 55/359 (15%)
Query: 54 LQGLQDRKERRRALQMRAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTL 113
++G ++ + +++ ++ ++ ++ ++ D ++ L
Sbjct: 1 MRGSHHHHHHGSKVRGKYDGPKINDYDKFY--EDIWKKYVPQPVEVKQGSVYDYYDILEE 58
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 173
+G GAFG V C K TG +F K + V++E +++ ++ ++ L
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTP---YPLDKYTVKNEISIMNQLHHPKLINLHD 115
Query: 174 SFQDSDFLYLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDI 232
+F+D + LI+E+L GG++ + ED +SE Y+ ++ + +H+H+ VH DI
Sbjct: 116 AFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDI 175
Query: 233 KPDNLIL--DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERL 290
KP+N++ K +K+ DFGL L P E +
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATKLN----------------------------PDEIV 207
Query: 291 QQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPR 350
+ T T ++ APE++ ++ G D W++G + Y +L G PF +D
Sbjct: 208 KV-----------TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL 256
Query: 351 ITCRKIVNWKTCLKFPEE--PKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406
T + + +F E+ +S EA+D I +LL + RL V + EHPW +G
Sbjct: 257 ETLQNVKRCD--WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL---TVHDALEHPWLKG 310
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 9e-65
Identities = 79/306 (25%), Positives = 137/306 (44%), Gaps = 56/306 (18%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMK-----KLKKSEMLKRGQVEHVRSERNLLAEVDSRCI 168
+G GA GEV+L + T + A++ K + +V +E +L +++ CI
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 169 VQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYV 228
+++ F D Y+++E + GG++ ++ L E + Y + +LA+ +H++ +
Sbjct: 203 IKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGII 261
Query: 229 HRDIKPDNLIL---DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 285
HRD+KP+N++L +++ +K++DFG K L E M
Sbjct: 262 HRDLKPENVLLSSQEEDCLIKITDFGHSKILG----------------------ETSLM- 298
Query: 286 PKERLQQWKRNRRALAYSTVGTLDYMAPEVL---LKKGYGMECDWWSLGAIMYEMLIGYP 342
+ GT Y+APEVL GY D WSLG I++ L GYP
Sbjct: 299 ----------------RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 342
Query: 343 PFCSDDPRITC-RKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400
PF +++ +I + K ++S++A DL+ LL D + R EE
Sbjct: 343 PFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARF---TTEEALR 399
Query: 401 HPWFRG 406
HPW +
Sbjct: 400 HPWLQD 405
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 213 bits (543), Expect = 2e-64
Identities = 75/306 (24%), Positives = 136/306 (44%), Gaps = 53/306 (17%)
Query: 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR 166
+ ++G G FG+V C TG A K +K E V++E +++ ++D
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR---GMKDKEEVKNEISVMNQLDHA 146
Query: 167 CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQH 225
++QL+ +F+ + + L+MEY+ GG++ ++ E L+E ++ + I +HQ
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM 206
Query: 226 NYVHRDIKPDNLIL-DKNGH-LKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQW 283
+H D+KP+N++ +++ +K+ DFGL + +
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARRYK-------------------------- 240
Query: 284 MMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 343
P+E+L+ GT +++APEV+ D WS+G I Y +L G P
Sbjct: 241 --PREKLKV-----------NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
Query: 344 FCSDDPRITCRKIVNWKTCLKFPEE--PKISDEARDLICHLLC-DVETRLGTRGVEELKE 400
F D+ T I+ + +E IS+EA++ I LL + R+ E +
Sbjct: 288 FLGDNDAETLNNILACR--WDLEDEEFQDISEEAKEFISKLLIKEKSWRI---SASEALK 342
Query: 401 HPWFRG 406
HPW
Sbjct: 343 HPWLSD 348
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 2e-64
Identities = 89/362 (24%), Positives = 147/362 (40%), Gaps = 60/362 (16%)
Query: 58 QDRKERRRALQMRAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKG 117
+ + + A + +++ + ++ ++ +IG+G
Sbjct: 47 DPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFY-QKYDPKDVIGRG 105
Query: 118 AFGEVRLCRAKTTGEIFAMK-----KLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQL 171
VR C + TG FA+K + S E R E ++L +V I+ L
Sbjct: 106 VSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165
Query: 172 FYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRD 231
S++ S F++L+ + + G++ L + LSE R + + A+ +H +N VHRD
Sbjct: 166 IDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRD 225
Query: 232 IKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 291
+KP+N++LD N ++LSDFG LE G+ +
Sbjct: 226 LKPENILLDDNMQIRLSDFGFSCHLE----------------------PGEKL------- 256
Query: 292 QWKRNRRALAYSTVGTLDYMAPEVL------LKKGYGMECDWWSLGAIMYEMLIGYPPFC 345
GT Y+APE+L GYG E D W+ G I++ +L G PPF
Sbjct: 257 ----------RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFW 306
Query: 346 SDDPRITCRKIVNWKTCLKFPEEP--KISDEARDLICHLLC-DVETRLGTRGVEELKEHP 402
+ R I+ + +F S +DLI LL D E RL T E+ +HP
Sbjct: 307 HRRQILMLRMIMEGQ--YQFSSPEWDDRSSTVKDLISRLLQVDPEARL-T--AEQALQHP 361
Query: 403 WF 404
+F
Sbjct: 362 FF 363
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 2e-64
Identities = 84/353 (23%), Positives = 149/353 (42%), Gaps = 54/353 (15%)
Query: 60 RKERRRALQMRAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAF 119
+ ++ + VS+ + ++ + + ++ + D ++ +G GAF
Sbjct: 112 GYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVL-DHYDIHEELGTGAF 170
Query: 120 GEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 179
G V + TG FA K + E VR E ++ + +V L +F+D +
Sbjct: 171 GVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 227
Query: 180 FLYLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLI 238
+ +I E++ GG++ + E +SED A Y+ + + +H++NYVH D+KP+N++
Sbjct: 228 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIM 287
Query: 239 L--DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRN 296
++ LKL DFGL L+ PK+ ++
Sbjct: 288 FTTKRSNELKLIDFGLTAHLD----------------------------PKQSVKV---- 315
Query: 297 RRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKI 356
T GT ++ APEV K G D WS+G + Y +L G PF ++ T R +
Sbjct: 316 -------TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV 368
Query: 357 VNWKTCLKFPEE--PKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406
+ + IS++ +D I LL D TR+ + + EHPW
Sbjct: 369 KSCD--WNMDDSAFSGISEDGKDFIRKLLLADPNTRM---TIHQALEHPWLTP 416
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 210 bits (538), Expect = 2e-64
Identities = 73/307 (23%), Positives = 126/307 (41%), Gaps = 54/307 (17%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
+ + +G+G FG V C ++ + + K +K K V+ E ++L
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARH 60
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIM-TLLMREDILSEDVARFYIAESVLAIHSIHQ 224
R I+ L SF+ + L +I E++ G DI + L+E Y+ + A+ +H
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 225 HNYVHRDIKPDNLIL--DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 282
HN H DI+P+N+I ++ +K+ +FG + L+
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK------------------------- 155
Query: 283 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 342
P + + +Y APEV D WSLG ++Y +L G
Sbjct: 156 ---PGDNFRL-----------LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN 201
Query: 343 PFCSDDPRITCRKIVNWKTCLKFPEEP--KISDEARDLICHLLC-DVETRLGTRGVEELK 399
PF ++ + I+N + F EE +IS EA D + LL + ++R+ E
Sbjct: 202 PFLAETNQQIIENIMNAE--YTFDEEAFKEISIEAMDFVDRLLVKERKSRM---TASEAL 256
Query: 400 EHPWFRG 406
+HPW +
Sbjct: 257 QHPWLKQ 263
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 2e-64
Identities = 81/301 (26%), Positives = 140/301 (46%), Gaps = 56/301 (18%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLF 172
+G+GA V C+ K T + +A+K LKK+ + VR+E +L + I++L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLK 114
Query: 173 YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDI 232
F+ + L++E + GG++ ++ + SE A + + + A+ +H++ VHRD+
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDL 174
Query: 233 KPDNLIL---DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKER 289
KP+NL+ + LK++DFGL S ++E + ++
Sbjct: 175 KPENLLYATPAPDAPLKIADFGL---------SKIVEHQVLM------------------ 207
Query: 290 LQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSD-D 348
+ GT Y APE+L YG E D WS+G I Y +L G+ PF +
Sbjct: 208 ------------KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG 255
Query: 349 PRITCRKIVNWKTCLKFPEEP--KISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 405
+ R+I+N + F ++S A+DL+ L+ D + RL T + +HPW
Sbjct: 256 DQFMFRRILNCE--YYFISPWWDEVSLNAKDLVRKLIVLDPKKRL-T--TFQALQHPWVT 310
Query: 406 G 406
G
Sbjct: 311 G 311
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 3e-64
Identities = 82/313 (26%), Positives = 138/313 (44%), Gaps = 60/313 (19%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMK-----KLKKSEMLKRGQVEHVRSERNLLAEVDSRCI 168
+G GA GEV+L + T + A+K K + +V +E +L +++ CI
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 169 VQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYV 228
+++ F D+ Y+++E + GG++ ++ L E + Y + +LA+ +H++ +
Sbjct: 78 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGII 136
Query: 229 HRDIKPDNLIL---DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 285
HRD+KP+N++L +++ +K++DFG K L E M
Sbjct: 137 HRDLKPENVLLSSQEEDCLIKITDFGHSKILG----------------------ETSLM- 173
Query: 286 PKERLQQWKRNRRALAYSTVGTLDYMAPEVL---LKKGYGMECDWWSLGAIMYEMLIGYP 342
+ GT Y+APEVL GY D WSLG I++ L GYP
Sbjct: 174 ----------------RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217
Query: 343 PFCSD-DPRITCRKIVNWKTCLKFPEEP--KISDEARDLICHLLC-DVETRLGTRGVEEL 398
PF +I + K F E ++S++A DL+ LL D + R EE
Sbjct: 218 PFSEHRTQVSLKDQITSGK--YNFIPEVWAEVSEKALDLVKKLLVVDPKARF---TTEEA 272
Query: 399 KEHPWFRGIQWDK 411
HPW + +
Sbjct: 273 LRHPWLQDEDMKR 285
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 2e-63
Identities = 82/311 (26%), Positives = 132/311 (42%), Gaps = 59/311 (18%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
D +E IG G++ + C K T FA+K + KS+ ++E LL
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI------LLRYGQH 75
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 225
I+ L + D ++Y++ E + GG+++ ++R+ SE A + + +H
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ 135
Query: 226 NYVHRDIKPDNLIL-DKNGH---LKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 281
VHRD+KP N++ D++G+ +++ DFG K L AE
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL---------------------RAEN 174
Query: 282 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341
+M + T +++APEVL ++GY CD WSLG ++Y ML GY
Sbjct: 175 GLLM-----------------TPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGY 217
Query: 342 PPF---CSDDPRITCRKIVNWKTCLKFPEEP--KISDEARDLICHLLC-DVETRLGTRGV 395
PF D P +I + K +SD A+DL+ +L D RL
Sbjct: 218 TPFANGPDDTPEEILARIGSGK--FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRL---TA 272
Query: 396 EELKEHPWFRG 406
+ HPW
Sbjct: 273 ALVLRHPWIVH 283
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 2e-63
Identities = 73/308 (23%), Positives = 126/308 (40%), Gaps = 54/308 (17%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 164
+ +F IG+G F EV G A+KK++ +++ E +LL +++
Sbjct: 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90
Query: 165 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL----MREDILSEDVARFYIAESVLAIH 220
+++ + SF + + L +++E GD+ ++ ++ ++ E Y + A+
Sbjct: 91 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 221 SIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAE 280
+H +HRDIKP N+ + G +KL D GL + K +
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT------------------- 191
Query: 281 GQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 340
A+S VGT YM+PE + + GY + D WSLG ++YEM
Sbjct: 192 -------------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 232
Query: 341 YPPFCSDDPRIT--CRKIVNWKTCLKFPEEPK--ISDEARDLICHLLC-DVETRLGTRGV 395
PF D + C+KI +P P S+E R L+ + D E R V
Sbjct: 233 QSPFYGDKMNLYSLCKKIEQ----CDYPPLPSDHYSEELRQLVNMCINPDPEKR---PDV 285
Query: 396 EELKEHPW 403
+ +
Sbjct: 286 TYVYDVAK 293
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 2e-63
Identities = 65/320 (20%), Positives = 112/320 (35%), Gaps = 78/320 (24%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
DF+++ LIG G FG+V + + G+ + +K++K + E E LA++D
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDH 63
Query: 166 RCIVQLFYSFQDSD----------------FLYLIMEYLPGGDIMTLL--MREDILSEDV 207
IV + D L++ ME+ G + + R + L + +
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 208 ARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLED 267
A + + IH ++RD+KP N+ L +K+ DFGL L++
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND-------- 175
Query: 268 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDW 327
+ GTL YM+PE + + YG E D
Sbjct: 176 -------------------------------GKRTRSKGTLRYMSPEQISSQDYGKEVDL 204
Query: 328 WSLGAIMYEML-IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-D 385
++LG I+ E+L + F + R + + L+ LL
Sbjct: 205 YALGLILAELLHVCDTAFETSKFFTDLRDG-------IIS--DIFDKKEKTLLQKLLSKK 255
Query: 386 VETRLGTRGVEELKEHPWFR 405
E R E+
Sbjct: 256 PEDRP---NTSEILRTLTVW 272
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 208 bits (530), Expect = 3e-63
Identities = 69/350 (19%), Positives = 121/350 (34%), Gaps = 87/350 (24%)
Query: 98 LQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSER 157
+ + + ++G+GA V R K TG++FA+K L+ V+ E
Sbjct: 1 MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREF 58
Query: 158 NLLAEVDSRCIVQLFYSFQD--SDFLYLIMEYLPGGDIMTLLM---REDILSEDVARFYI 212
+L +++ + IV+LF ++ + LIME+ P G + T+L L E +
Sbjct: 59 EVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118
Query: 213 AESVLAIHSIHQHNYVHRDIKPDNLIL----DKNGHLKLSDFGLCKPLEDKYSSILLEDE 268
+ V ++ + ++ VHR+IKP N++ D KL+DFG + LED
Sbjct: 119 RDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--------- 169
Query: 269 DIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL--------LKKG 320
S GT +Y+ P++ +K
Sbjct: 170 ------------------------------EQFVSLYGTEEYLHPDMYERAVLRKDHQKK 199
Query: 321 YGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVN---------------------W 359
YG D WS+G Y G PF + ++++
Sbjct: 200 YGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPI 259
Query: 360 KTCLKFPEEPKISDEARDLICHLL-----CDVETRLGTRGVEELKEHPWF 404
P +S + L+ +L D E G ++
Sbjct: 260 DWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW---GFDQFFAETSD 306
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 209 bits (532), Expect = 6e-63
Identities = 45/398 (11%), Positives = 106/398 (26%), Gaps = 110/398 (27%)
Query: 56 GLQDRKERRRALQMRAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIG 115
++ E ++ ++ N Q + + + ++G
Sbjct: 35 NVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGT------------VLG 82
Query: 116 KGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSER------------------ 157
+ + TGE F + +E ++ ++ E
Sbjct: 83 QEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 142
Query: 158 -------NLLAEVDSRCIVQLFYSFQDSDFL--YLIME------YLPGGDIMTLLMREDI 202
+L+ + + ++++ +D L + + G +++
Sbjct: 143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS 202
Query: 203 LSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 262
L + + + S+H + VH ++P +++LD+ G + L+ F +
Sbjct: 203 LVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR--- 259
Query: 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL----- 317
+ + + PE+
Sbjct: 260 ---------------------------------------VVSSVSRGFEPPELEARRATI 280
Query: 318 ------KKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKI 371
+ D W+LG ++Y + P D I F I
Sbjct: 281 SYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI--------FRSCKNI 332
Query: 372 SDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 408
R L+ L E RL + E P + ++
Sbjct: 333 PQPVRALLEGFLRYPKEDRL---LPLQAMETPEYEQLR 367
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 1e-62
Identities = 78/319 (24%), Positives = 133/319 (41%), Gaps = 62/319 (19%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQL 171
++G+GA V+ C T + +A+K ++K R V E +L + R +++L
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR---SRVFREVEMLYQCQGHRNVLEL 76
Query: 172 FYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRD 231
F++ D YL+ E + GG I++ + + +E A + + A+ +H HRD
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRD 136
Query: 232 IKPDNLIL---DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKE 288
+KP+N++ ++ +K+ DF L ++ S ++
Sbjct: 137 LKPENILCEHPNQVSPVKICDFDLGSGIKL--------------NGDCSPISTPELL--- 179
Query: 289 RLQQWKRNRRALAYSTVGTLDYMAPEVLLK-----KGYGMECDWWSLGAIMYEMLIGYPP 343
+ G+ +YMAPEV+ Y CD WSLG I+Y +L GYPP
Sbjct: 180 --------------TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
Query: 344 FCSD-DPRITCRKIVNWKTC------------LKFPEEP--KISDEARDLICHLLC-DVE 387
F + C +FP++ IS A+DLI LL D +
Sbjct: 226 FVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAK 285
Query: 388 TRLGTRGVEELKEHPWFRG 406
RL ++ +HPW +G
Sbjct: 286 QRL---SAAQVLQHPWVQG 301
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 2e-62
Identities = 90/339 (26%), Positives = 139/339 (41%), Gaps = 76/339 (22%)
Query: 89 ERRETEYMRLQRRKIGIDDFEQLT--LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLK 146
E + + +K + D QL+ ++G G G+V C + TG+ A+K L S +
Sbjct: 10 SGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKAR 69
Query: 147 RGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD----FLYLIMEYLPGGDIMTLLMR--- 199
+ +V+H IV + +++ L +IME + GG+ L R
Sbjct: 70 Q-EVDH------HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGE---LFSRIQE 119
Query: 200 --EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL---DKNGHLKLSDFGLCK 254
+ +E A + + AI +H HN HRD+KP+NL+ +K+ LKL+DFG K
Sbjct: 120 RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179
Query: 255 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPE 314
+ P T Y+APE
Sbjct: 180 ETT----------------------QNALQTP------------------CYTPYYVAPE 199
Query: 315 VLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITC----RKIVNWKTCLKFPEEP- 369
VL + Y CD WSLG IMY +L G+PPF S+ + R+I + FP
Sbjct: 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ--YGFPNPEW 257
Query: 370 -KISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406
++S++A+ LI LL D RL + + HPW
Sbjct: 258 SEVSEDAKQLIRLLLKTDPTERL---TITQFMNHPWINQ 293
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 8e-62
Identities = 90/324 (27%), Positives = 142/324 (43%), Gaps = 77/324 (23%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC----- 167
IGKG++G V+L + +AMK L K +++++ R
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 168 ------------------IVQLF--YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDV 207
+V+L + D LY++ E + G +M + LSED
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQ 138
Query: 208 ARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLED 267
ARFY + + I +H +HRDIKP NL++ ++GH+K++DFG+ S +
Sbjct: 139 ARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGV---------SNEFKG 189
Query: 268 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL--LKKGY-GME 324
D AL +TVGT +MAPE L +K + G
Sbjct: 190 SD-----------------------------ALLSNTVGTPAFMAPESLSETRKIFSGKA 220
Query: 325 CDWWSLGAIMYEMLIGYPPFCSDDPRITC--RKIVNWKTCLKFPEEPKISDEARDLICHL 382
D W++G +Y + G PF D RI C KI + L+FP++P I+++ +DLI +
Sbjct: 221 LDVWAMGVTLYCFVFGQCPF--MDERIMCLHSKIKSQA--LEFPDQPDIAEDLKDLITRM 276
Query: 383 LC-DVETRLGTRGVEELKEHPWFR 405
L + E+R+ V E+K HPW
Sbjct: 277 LDKNPESRI---VVPEIKLHPWVT 297
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 1e-61
Identities = 67/321 (20%), Positives = 121/321 (37%), Gaps = 54/321 (16%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 164
+ DFE + +G+G FG V + K +A+K+++ E V E LA+++
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNREL--AREKVMREVKALAKLE 61
Query: 165 SRCIVQLFYSFQDSD------------FLYLIMEYLPGGDIMTLLMR---EDILSEDVAR 209
IV+ F ++ + + +LY+ M+ ++ + + V
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 210 FYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDED 269
+ A+ +H +HRD+KP N+ + +K+ DFGL + D+D
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM----------DQD 171
Query: 270 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWS 329
Q ++ A VGT YM+PE + Y + D +S
Sbjct: 172 EEEQTVLTPMPAY----------------ARHTGQVGTKLYMSPEQIHGNSYSHKVDIFS 215
Query: 330 LGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEP-KISDEARDLICHLLC-DVE 387
LG I++E+L YP + T + N LKFP + ++ +L
Sbjct: 216 LGLILFELL--YPFSTQMERVRTLTDVRN----LKFPPLFTQKYPCEYVMVQDMLSPSPM 269
Query: 388 TRLGTRGVEELKEHPWFRGIQ 408
R + E+ F +
Sbjct: 270 ERP---EAINIIENAVFEDLD 287
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 2e-61
Identities = 69/306 (22%), Positives = 130/306 (42%), Gaps = 50/306 (16%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 164
++D++ + +G+GA+GEV+L + T E A+K + + E+++ E + ++
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 63
Query: 165 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ 224
+V+ + ++ + YL +EY GG++ + + + E A+ + + + + +H
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 225 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 284
HRDIKP+NL+LD+ +LK+SDFGL LL
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN------------------ 165
Query: 285 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEMLIGYPP 343
GTL Y+APE+L ++ + D WS G ++ ML G P
Sbjct: 166 ------------------KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
Query: 344 FCSDDPRITC---RKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 399
+ D P +C + KI L+ +L + R+ + ++K
Sbjct: 208 W--DQPSDSCQEYSDWK--EKKTYLNPWKKIDSAPLALLHKILVENPSARI---TIPDIK 260
Query: 400 EHPWFR 405
+ W+
Sbjct: 261 KDRWYN 266
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 1e-60
Identities = 77/309 (24%), Positives = 128/309 (41%), Gaps = 60/309 (19%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVE-----HVRSERNL 159
+ ++ +G GAFG V K + +K +KK ++L+ +E V E +
Sbjct: 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 160 LAEVDSRCIVQLFYSFQDSDFLYLIME-YLPGGDIMTLLMREDILSEDVARFYIAESVLA 218
L+ V+ I+++ F++ F L+ME + G D+ + R L E +A + + V A
Sbjct: 83 LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSA 142
Query: 219 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 278
+ + + +HRDIK +N+++ ++ +KL DFG LE
Sbjct: 143 VGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER-------------------- 182
Query: 279 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEM 337
L Y+ GT++Y APEVL+ Y G E + WSLG +Y +
Sbjct: 183 -------------------GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTL 223
Query: 338 LIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVE 396
+ PFC + V + P +S E L+ LL E R +E
Sbjct: 224 VFEENPFCEL------EETVEAA--IHPP--YLVSKELMSLVSGLLQPVPERRT---TLE 270
Query: 397 ELKEHPWFR 405
+L PW
Sbjct: 271 KLVTDPWVT 279
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 3e-60
Identities = 78/319 (24%), Positives = 127/319 (39%), Gaps = 66/319 (20%)
Query: 99 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVE---HVRS 155
+ R+ ++ L+GKG FG V T A+K + ++ +L +
Sbjct: 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL 83
Query: 156 ERNLLAEVDSRC----IVQLFYSFQDSDFLYLIMEY-LPGGDIMTLLMREDILSEDVARF 210
E LL +V + +++L F+ + L++E LP D+ + + L E +R
Sbjct: 84 EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRC 143
Query: 211 YIAESVLAIHSIHQHNYVHRDIKPDNLILD-KNGHLKLSDFGLCKPLEDKYSSILLEDED 269
+ + V AI H VHRDIK +N+++D + G KL DFG LL DE
Sbjct: 144 FFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS---------GALLHDE- 193
Query: 270 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYST-VGTLDYMAPEVLLKKGY-GMECDW 327
Y+ GT Y PE + + Y +
Sbjct: 194 -------------------------------PYTDFDGTRVYSPPEWISRHQYHALPATV 222
Query: 328 WSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DV 386
WSLG ++Y+M+ G PF D ++I+ + L FP +S + LI L
Sbjct: 223 WSLGILLYDMVCGDIPFERD------QEILEAE--LHFP--AHVSPDCCALIRRCLAPKP 272
Query: 387 ETRLGTRGVEELKEHPWFR 405
+R +EE+ PW +
Sbjct: 273 SSRP---SLEEILLDPWMQ 288
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 3e-60
Identities = 84/312 (26%), Positives = 122/312 (39%), Gaps = 73/312 (23%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC--IVQL 171
+G G G+V K T E FA+K L+ +R E L S+C IV++
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRA-SQCPHIVRI 120
Query: 172 FYSFQDS----DFLYLIMEYLPGGDIMTLLMR-----EDILSEDVARFYIAESVLAIHSI 222
+++ L ++ME L GG+ L R + +E A + AI +
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGE---LFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 177
Query: 223 HQHNYVHRDIKPDNLIL---DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEA 279
H N HRD+KP+NL+ N LKL+DFG K
Sbjct: 178 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---------------------- 215
Query: 280 EGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 339
+ + T Y+APEVL + Y CD WSLG IMY +L
Sbjct: 216 SHNSLT-----------------TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 258
Query: 340 GYPPFCSDDPRITCRKIVN--WKTCLKFPEEP--KISDEARDLICHLLC-DVETRLGTRG 394
GYPPF S+ + +FP ++S+E + LI +LL + R+
Sbjct: 259 GYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM---T 315
Query: 395 VEELKEHPWFRG 406
+ E HPW
Sbjct: 316 ITEFMNHPWIMQ 327
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 4e-60
Identities = 71/352 (20%), Positives = 143/352 (40%), Gaps = 51/352 (14%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 164
++D++ + +G+GA+GEV+L + T E A+K + + E+++ E + ++
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 63
Query: 165 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ 224
+V+ + ++ + YL +EY GG++ + + + E A+ + + + + +H
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 225 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 284
HRDIKP+NL+LD+ +LK+SDFGL LL
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN------------------ 165
Query: 285 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEMLIGYPP 343
GTL Y+APE+L ++ + D WS G ++ ML G P
Sbjct: 166 ------------------KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
Query: 344 FCSDDPRITC---RKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 399
+ D P +C + KI L+ +L + R+ + ++K
Sbjct: 208 W--DQPSDSCQEYSDWK--EKKTYLNPWKKIDSAPLALLHKILVENPSARI---TIPDIK 260
Query: 400 EHPWFR-GIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGP 450
+ W+ ++ + + + +++ + + S + G
Sbjct: 261 KDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASRTPGS 312
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 7e-60
Identities = 69/349 (19%), Positives = 121/349 (34%), Gaps = 87/349 (24%)
Query: 98 LQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSER 157
+ + + ++G+GA V R K TG++FA+K L+ V+ E
Sbjct: 1 MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREF 58
Query: 158 NLLAEVDSRCIVQLFYSFQD--SDFLYLIMEYLPGGDIMTLLM---REDILSEDVARFYI 212
+L +++ + IV+LF ++ + LIME+ P G + T+L L E +
Sbjct: 59 EVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118
Query: 213 AESVLAIHSIHQHNYVHRDIKPDNLIL----DKNGHLKLSDFGLCKPLEDKYSSILLEDE 268
+ V ++ + ++ VHR+IKP N++ D KL+DFG + LED
Sbjct: 119 RDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--------- 169
Query: 269 DIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL--------LKKG 320
S GT +Y+ P++ +K
Sbjct: 170 ------------------------------EQFVSLYGTEEYLHPDMYERAVLRKDHQKK 199
Query: 321 YGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVN---------------------W 359
YG D WS+G Y G PF + ++++
Sbjct: 200 YGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPI 259
Query: 360 KTCLKFPEEPKISDEARDLICHLL-----CDVETRLGTRGVEELKEHPW 403
P +S + L+ +L D E G ++
Sbjct: 260 DWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW---GFDQFFAETS 305
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 1e-59
Identities = 75/309 (24%), Positives = 132/309 (42%), Gaps = 48/309 (15%)
Query: 99 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN 158
++ I + +G G FG+V++ + TG A+K L + ++ V ++ E
Sbjct: 4 HDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQ 63
Query: 159 LLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLA 218
L I++L+ +++MEY+ GG++ + + + E AR + + A
Sbjct: 64 NLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA 123
Query: 219 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 278
+ H+H VHRD+KP+N++LD + + K++DFGL
Sbjct: 124 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS------------------------- 158
Query: 279 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEM 337
M E L+ G+ +Y APEV+ + Y G E D WS G I+Y +
Sbjct: 159 ---NMMSDGEFLRTS-----------CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYAL 204
Query: 338 LIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVE 396
L G PF + +KI F ++ L+ H+L D R ++
Sbjct: 205 LCGTLPFDDEHVPTLFKKIRG----GVFYIPEYLNRSVATLLMHMLQVDPLKRA---TIK 257
Query: 397 ELKEHPWFR 405
+++EH WF+
Sbjct: 258 DIREHEWFK 266
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 6e-59
Identities = 62/328 (18%), Positives = 109/328 (33%), Gaps = 52/328 (15%)
Query: 91 RETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQV 150
RE Y + I + + +G+G F V L G +A+K++ E R
Sbjct: 14 RENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDR--- 70
Query: 151 EHVRSERNLLAEVDSRCIVQLFYSFQDSDF----LYLIMEYLPGGD----IMTLLMREDI 202
E + E ++ + I++L +L++ + G I L + +
Sbjct: 71 EEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF 130
Query: 203 LSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 262
L+ED + + + +IH Y HRD+KP N++L G L D G
Sbjct: 131 LTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190
Query: 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY- 321
+ + T+ Y APE+ + +
Sbjct: 191 -----------------------------SRQALTLQDWAAQRCTISYRAPELFSVQSHC 221
Query: 322 --GMECDWWSLGAIMYEMLIGYPPFCSDDPRI--TCRKIVNWKTCLKFPEEPKISDEARD 377
D WSLG ++Y M+ G P+ + + N L P+ P+ S
Sbjct: 222 VIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN---QLSIPQSPRHSSALWQ 278
Query: 378 LICHLLC-DVETRLGTRGVEELKEHPWF 404
L+ ++ D R + L
Sbjct: 279 LLNSMMTVDPHQRP---HIPLLLSQLEA 303
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 1e-58
Identities = 80/348 (22%), Positives = 134/348 (38%), Gaps = 62/348 (17%)
Query: 68 QMRAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRA 127
++ M + T+ + ++ ++ L+G G FG V
Sbjct: 5 HHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIR 64
Query: 128 KTTGEIFAMKKLKKSEMLKRGQVEH---VRSERNLLAEVDSRC--IVQLFYSFQDSDFLY 182
+ A+K ++K + G++ + V E LL +V S +++L F+ D
Sbjct: 65 VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 124
Query: 183 LIMEY-LPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK 241
LI+E P D+ + L E++AR + + + A+ H +HRDIK +N+++D
Sbjct: 125 LILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL 184
Query: 242 N-GHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRAL 300
N G LKL DFG L+D + D
Sbjct: 185 NRGELKLIDFGSGALLKDT----VYTD--------------------------------- 207
Query: 301 AYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNW 359
GT Y PE + Y G WSLG ++Y+M+ G PF D +I+
Sbjct: 208 ---FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRG 258
Query: 360 KTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406
+ + F ++S E + LI L R EE++ HPW +
Sbjct: 259 Q--VFFR--QRVSSECQHLIRWCLALRPSDRP---TFEEIQNHPWMQD 299
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 2e-58
Identities = 71/359 (19%), Positives = 125/359 (34%), Gaps = 57/359 (15%)
Query: 60 RKERRRALQMRAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAF 119
+ + +++ + E + L+ + EY + + +G+G+F
Sbjct: 18 KTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEY------REEVHWMTHQPRVGRGSF 71
Query: 120 GEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 179
GEV + K TG A+KK++ E A + S IV L+ + ++
Sbjct: 72 GEVHRMKDKQTGFQCAVKKVRLEVFRVE--------ELVACAGLSSPRIVPLYGAVREGP 123
Query: 180 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL 239
++ + ME L GG + L+ + L ED A +Y+ +++ + +H +H D+K DN++L
Sbjct: 124 WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLL 183
Query: 240 DKNG-HLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRR 298
+G L DFG L+
Sbjct: 184 SSDGSRAALCDFGHALCLQPDGLG---------------------------------KSL 210
Query: 299 ALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVN 358
GT +MAPEV++ K + D WS +M ML G P+ C KI +
Sbjct: 211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS 270
Query: 359 WKTCLKFPEEPKISDEARDLICHLLC---DVETRLGTRGVEELKEHPWFRGIQWDKLYE 414
+ P + I + R EL+ + L
Sbjct: 271 -EPPPIREIPPSCAPLTAQAI--QEGLRKEPVHRA---SAMELRRKVGKALQEVGGLKS 323
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 3e-58
Identities = 78/303 (25%), Positives = 130/303 (42%), Gaps = 49/303 (16%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 164
I ++ L IGKG F +V+L R TG A+K + K++ L ++ + E ++ ++
Sbjct: 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ-LNPTSLQKLFREVRIMKILN 72
Query: 165 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ 224
IV+LF + LYLIMEY GG++ L+ + E AR + V A+ HQ
Sbjct: 73 HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 132
Query: 225 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 284
VHRD+K +NL+LD + ++K++DFG
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFS----------------------------NEF 164
Query: 285 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEMLIGYPP 343
+L + G Y APE+ K Y G E D WSLG I+Y ++ G P
Sbjct: 165 TVGGKLDAF-----------CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213
Query: 344 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHP 402
F + + +++ K+ +S + +L+ L + R +E++ +
Sbjct: 214 FDGQNLKELRERVLR----GKYRIPFYMSTDCENLLKRFLVLNPIKRG---TLEQIMKDR 266
Query: 403 WFR 405
W
Sbjct: 267 WIN 269
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 3e-58
Identities = 96/360 (26%), Positives = 145/360 (40%), Gaps = 63/360 (17%)
Query: 84 MLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSE 143
M R M + D ++ + IG G FG RL R K T E+ A+K +++
Sbjct: 1 MDRAPVTTGPLDMPIMHD---SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA 57
Query: 144 MLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDIL 203
+ E+V+ E + IV+ L +IMEY GG++ +
Sbjct: 58 AID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRF 113
Query: 204 SEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN--GHLKLSDFGLCKPLEDKYS 261
SED ARF+ + + + H HRD+K +N +LD + LK+ DFG K
Sbjct: 114 SEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK------- 166
Query: 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY 321
+ + + STVGT Y+APEVLL++ Y
Sbjct: 167 ---------------------SSVLHSQPK-----------STVGTPAYIAPEVLLRQEY 194
Query: 322 -GMECDWWSLGAIMYEMLIGYPPFCSDDP------RITCRKIVNWKTCLKFPEEPKISDE 374
G D WS G +Y ML+G PF +DP R T ++I++ K P++ +IS E
Sbjct: 195 DGKIADVWSCGVTLYVMLVGAYPF--EDPEEPRDYRKTIQRILSVK--YSIPDDIRISPE 250
Query: 375 ARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFE 433
LI + D TR+ + E+K H WF L E Q+ +
Sbjct: 251 CCHLISRIFVADPATRI---SIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLD 307
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 194 bits (493), Expect = 2e-57
Identities = 57/391 (14%), Positives = 96/391 (24%), Gaps = 96/391 (24%)
Query: 58 QDRKERRRALQMRAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKG 117
++ + A + A A V + E + +L + ++L + G
Sbjct: 26 REEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVE------------PLRVG 73
Query: 118 AFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLF----- 172
V L R E FA+K R ++E + A + +
Sbjct: 74 DRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRL 133
Query: 173 ---------------------YSFQDSDFLYLIMEYLPG--GDIMTLLMREDI----LSE 205
L+M + + L +
Sbjct: 134 LLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGI 193
Query: 206 DVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265
A+ + ++ VH PDNL + +G L L D + + +
Sbjct: 194 LALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPAS-- 251
Query: 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG--YGM 323
+ Y E L +
Sbjct: 252 ---------------------------------------SVPVTYAPREFLNASTATFTH 272
Query: 324 ECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTC-----LKFPEEPKISDEARDL 378
+ W LG +Y + + PF P I L F + D + L
Sbjct: 273 ALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTL 332
Query: 379 ICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 408
I L D RL E E P F +Q
Sbjct: 333 IGRFLNFDRRRRL---LPLEAMETPEFLQLQ 360
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 6e-57
Identities = 79/312 (25%), Positives = 140/312 (44%), Gaps = 51/312 (16%)
Query: 96 MRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRS 155
M + +R IG + +G+G+FG+V+L T + A+K + + + K V
Sbjct: 1 MAISKRHIG--PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER 58
Query: 156 ERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAES 215
E + L + I++L+ + +++EY GG++ ++ + ++ED R + +
Sbjct: 59 EISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQI 117
Query: 216 VLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQET 275
+ AI H+H VHRD+KP+NL+LD N ++K++DFGL
Sbjct: 118 ICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSN--------------------- 156
Query: 276 VSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIM 334
M L+ G+ +Y APEV+ K Y G E D WS G ++
Sbjct: 157 -------IMTDGNFLKTS-----------CGSPNYAAPEVINGKLYAGPEVDVWSCGIVL 198
Query: 335 YEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR 393
Y ML+G PF + +K+ + + +S A+ LI ++ D R+
Sbjct: 199 YVMLVGRLPFDDEFIPNLFKKVNSC----VYVMPDFLSPGAQSLIRRMIVADPMQRI--- 251
Query: 394 GVEELKEHPWFR 405
++E++ PWF
Sbjct: 252 TIQEIRRDPWFN 263
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 7e-56
Identities = 53/428 (12%), Positives = 113/428 (26%), Gaps = 104/428 (24%)
Query: 56 GLQDRKERRRALQMRAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIG 115
++ E ++ ++ N Q + + L R ++G
Sbjct: 40 NVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGER--PRTLVRGT----------VLG 87
Query: 116 KGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSER------------------ 157
+ + TGE F + +E ++ ++ E
Sbjct: 88 QEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 147
Query: 158 -------NLLAEVDSRCIVQLFYSFQDSDFL--YLIMEYLPG-----GDIMTLLMREDIL 203
+L+ + + ++++ +D L + + + G+++
Sbjct: 148 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS 207
Query: 204 SEDVARFYIAESVL-AIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 262
AR + V+ + S+H + VH ++P +++LD+ G + L+ F
Sbjct: 208 LVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--- 264
Query: 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL----- 317
+ + A +L
Sbjct: 265 ----------------------------------AVSPIGRGFAPPETTAERMLPFGQHH 290
Query: 318 KKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARD 377
D W+LG +Y + P D I F I R
Sbjct: 291 PTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI--------FRSCKNIPQPVRA 342
Query: 378 LICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEKFP 436
L+ L E RL + E P + +L +A P + + P
Sbjct: 343 LLEGFLRYPKEDRLLP---LQAMETPEYE-----QLRTELSAALPLYQTDGEPTREGGAP 394
Query: 437 EVDGPPSE 444
+
Sbjct: 395 PSGTSQPD 402
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 9e-56
Identities = 76/309 (24%), Positives = 134/309 (43%), Gaps = 48/309 (15%)
Query: 99 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN 158
++ I + +G G FG+V++ + + TG A+K L + ++ V +R E
Sbjct: 9 HDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQ 68
Query: 159 LLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLA 218
L I++L+ ++++MEY+ GG++ + + L E +R + +
Sbjct: 69 NLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSG 128
Query: 219 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 278
+ H+H VHRD+KP+N++LD + + K++DFGL
Sbjct: 129 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS------------------------- 163
Query: 279 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEM 337
M E L+ G+ +Y APEV+ + Y G E D WS G I+Y +
Sbjct: 164 ---NMMSDGEFLRTS-----------CGSPNYAAPEVISGRLYAGPEVDIWSSGVILYAL 209
Query: 338 LIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVE 396
L G PF D +KI + F ++ L+ H+L D R ++
Sbjct: 210 LCGTLPFDDDHVPTLFKKICDG----IFYTPQYLNPSVISLLKHMLQVDPMKRA---TIK 262
Query: 397 ELKEHPWFR 405
+++EH WF+
Sbjct: 263 DIREHEWFK 271
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 1e-55
Identities = 53/345 (15%), Positives = 106/345 (30%), Gaps = 75/345 (21%)
Query: 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKT-----TGEIFAMKKLKKSEMLKRGQVEHVRSE 156
++G L+G+GAF +V + F +K K + +
Sbjct: 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIGTQL 117
Query: 157 RNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR-----EDILSEDVARFY 211
L ++ + + + L+ E G ++ + E ++ + + +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 212 IAESVLAIHSIHQHNYVHRDIKPDNLIL-----------DKNGHLKLSDFGLCKPLEDKY 260
+ I +H +H DIKPDN IL D + L L D G ++
Sbjct: 178 AMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK--- 234
Query: 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG 320
+ PK + + T + E+L K
Sbjct: 235 -----------------------LFPKGT----------IFTAKCETSGFQCVEMLSNKP 261
Query: 321 YGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIV--------NWK----TCLKFPEE 368
+ + D++ + A +Y ML G ++ + + W L P+
Sbjct: 262 WNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDC 321
Query: 369 PKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLY 413
+ + DL+ L V + T + L+ + + K
Sbjct: 322 HHLP--SLDLLRQKLKKVFQQHYTNKIRALR-NRLIVLLLECKRS 363
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 3e-54
Identities = 64/322 (19%), Positives = 113/322 (35%), Gaps = 63/322 (19%)
Query: 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLL 160
+G F ++G GA G + + R A+K++ E LL
Sbjct: 19 VIVGKISFCPKDVLGHGAEGTI-VYRGMFDNRDVAVKRILPE------CFSFADREVQLL 71
Query: 161 AEVDS-RCIVQLFYSFQDSDFLYLIMEYLPGG--DIMTLLMREDILSEDVARFYIAESVL 217
E D +++ F + +D F Y+ +E + + ++ + ++
Sbjct: 72 RESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYV--EQKDFAHLGLEPITLLQQTTS 129
Query: 218 AIHSIHQHNYVHRDIKPDNLILDKNGH-----LKLSDFGLCKPLEDKYSSILLEDEDIIN 272
+ +H N VHRD+KP N+++ +SDFGLCK L S
Sbjct: 130 GLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSF--------- 180
Query: 273 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL---LKKGYGMECDWWS 329
+ GT ++APE+L K+ D +S
Sbjct: 181 --------------------------SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFS 214
Query: 330 LGAIMYEML-IGYPPFCSDDPRITCRKIVNWKTCLKFPE-EPKISDEARDLICHLLC-DV 386
G + Y ++ G PF R I+ L E AR+LI ++ D
Sbjct: 215 AGCVFYYVISEGSHPFGKSLQRQA--NILLGACSLDCLHPEKHEDVIARELIEKMIAMDP 272
Query: 387 ETRLGTRGVEELKEHPWFRGIQ 408
+ R + + +HP+F ++
Sbjct: 273 QKRP---SAKHVLKHPFFWSLE 291
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 6e-54
Identities = 68/337 (20%), Positives = 113/337 (33%), Gaps = 77/337 (22%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 164
+E +G G FG V + TGE A+K+ ++ L E E ++ +++
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLN 70
Query: 165 SRCIVQLF------YSFQDSDFLYLIMEYLPGGDIMTLLM---REDILSEDVARFYIAES 215
+V +D L MEY GGD+ L L E R +++
Sbjct: 71 HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130
Query: 216 VLAIHSIHQHNYVHRDIKPDNLILDKNGH---LKLSDFGLCKPLEDKYSSILLEDEDIIN 272
A+ +H++ +HRD+KP+N++L K+ D G K L+
Sbjct: 131 SSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG------------- 177
Query: 273 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGA 332
L VGTL Y+APE+L +K Y + D+WS G
Sbjct: 178 --------------------------ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGT 211
Query: 333 IMYEMLIGYPPFCSDDPRITCRKIV----------------NWKTCLKFPEEPKISDEAR 376
+ +E + G+ PF + + V K P +S
Sbjct: 212 LAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILA 271
Query: 377 DLICHLL-----CDVETRLGTRGVEELKEHPWFRGIQ 408
+ L R + F+ +
Sbjct: 272 GKLERWLQCMLMWHQRQRG---TDPQNPNVGCFQALD 305
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 1e-52
Identities = 67/327 (20%), Positives = 115/327 (35%), Gaps = 80/327 (24%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS-RCIVQL 171
++G G+ G V G A+K++ + E LL E D +++
Sbjct: 22 ILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFC------DIALMEIKLLTESDDHPNVIRY 74
Query: 172 FYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAES-------VLAIHSIHQ 224
+ S FLY+ +E ++ L+ +++ E++ + +H
Sbjct: 75 YCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 225 HNYVHRDIKPDNLILD-------------KNGHLKLSDFGLCKPLEDKYSSILLEDEDII 271
+HRD+KP N+++ +N + +SDFGLCK L+ SS
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF-------- 185
Query: 272 NQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-------KKGYGME 324
R + GT + APE+L K+
Sbjct: 186 --------------------------RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRS 219
Query: 325 CDWWSLGAIMYEML-IGYPPFCSDDPRITCRKIVNWKTCL---KFPEEPKISDEARDLIC 380
D +S+G + Y +L G PF R + I+ L K + + EA DLI
Sbjct: 220 IDIFSMGCVFYYILSKGKHPFGDKYSRES--NIIRGIFSLDEMKCLHDRSLIAEATDLIS 277
Query: 381 HLLC-DVETRLGTRGVEELKEHPWFRG 406
++ D R ++ HP F
Sbjct: 278 QMIDHDPLKRP---TAMKVLRHPLFWP 301
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 1e-52
Identities = 87/346 (25%), Positives = 139/346 (40%), Gaps = 72/346 (20%)
Query: 75 AVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIF 134
++ + E+ + +L + EY R ++GKG +G V R +
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRV----------VLGKGTYGIVYAGRDLSNQVRI 50
Query: 135 AMK--KLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGD 192
A+K + S + + E L + + IVQ SF ++ F+ + ME +PGG
Sbjct: 51 AIKEIPERDSRY-----SQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGS 105
Query: 193 IMTLLMRED---ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD-KNGHLKLS 248
+ LL + +E FY + + + +H + VHRDIK DN++++ +G LK+S
Sbjct: 106 LSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKIS 165
Query: 249 DFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTL 308
DFG K L + GTL
Sbjct: 166 DFGTSKRLAGINPC--------------------------------------TETFTGTL 187
Query: 309 DYMAPEVLLK--KGYGMECDWWSLGAIMYEMLIGYPPFCS-DDPRITCRKIVNWKTCLKF 365
YMAPE++ K +GYG D WSLG + EM G PPF +P+ K+ +K +
Sbjct: 188 QYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEI 247
Query: 366 PEEPKISDEARDLICHLLC---DVETRLGTRGVEELKEHPWFRGIQ 408
PE +S EA+ I L C D + R +L + +
Sbjct: 248 PES--MSAEAKAFI--LKCFEPDPDKRA---CANDLLVDEFLKVSS 286
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 2e-52
Identities = 54/308 (17%), Positives = 102/308 (33%), Gaps = 42/308 (13%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
+F +L IG G FG V C + G I+A+K+ KK + +R
Sbjct: 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL----MREDILSEDVARFYIAESVLAIHS 221
+V+ F ++ + D + + EY GG + + E + + + +
Sbjct: 71 SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130
Query: 222 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL-LEDEDIINQETVSEAE 280
IH + VH DIKP N+ + + + + + + D + + +
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS----- 185
Query: 281 GQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEMLI 339
G ++A EVL + + D ++L +
Sbjct: 186 -------------------SPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAG 226
Query: 340 GYPPFCSDDPRITCRKIVNWKTCLKFPEEP-KISDEARDLICHLLC-DVETRLGTRGVEE 397
P + D +I + P P +S E +L+ ++ D E R
Sbjct: 227 AEPLPRNGDQW---HEIRQ----GRLPRIPQVLSQEFTELLKVMIHPDPERRP---SAMA 276
Query: 398 LKEHPWFR 405
L +H
Sbjct: 277 LVKHSVLL 284
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 178 bits (455), Expect = 2e-52
Identities = 66/300 (22%), Positives = 117/300 (39%), Gaps = 50/300 (16%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVE-HVRSERNLLAEVDSRCIVQL 171
L+G+G++G+V+ T A+K LKK ++ + E +V+ E LL + + ++QL
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 172 F--YSFQDSDFLYLIMEYLPGGDI-MTLLMREDILSEDVARFYIAESVLAIHSIHQHNYV 228
++ +Y++MEY G M + E A Y + + + +H V
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIV 131
Query: 229 HRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKE 288
H+DIKP NL+L G LK+S G+ + L +
Sbjct: 132 HKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR---------------------- 169
Query: 289 RLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGY-GMECDWWSLGAIMYEMLIGYPPFCS 346
++ G+ + PE+ + G + D WS G +Y + G PF
Sbjct: 170 --------------TSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215
Query: 347 DDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 405
D+ I P + DL+ +L + R + ++++H WFR
Sbjct: 216 DNIYKLFENIGKGS--YAIPGD--CGPPLSDLLKGMLEYEPAKRF---SIRQIRQHSWFR 268
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 5e-46
Identities = 64/319 (20%), Positives = 111/319 (34%), Gaps = 55/319 (17%)
Query: 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA 161
++G ++ +G F V + +G +A+K+L +E K + E +
Sbjct: 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN---RAIIQEVCFMK 80
Query: 162 EV-DSRCIVQLFYSF-------QDSDFLYLIMEYLPGGDIMTLLMR---EDILSEDVARF 210
++ IVQ + +L++ L G ++ L + LS D
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 211 YIAESVLAIHSIHQHN--YVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDE 268
++ A+ +H+ +HRD+K +NL+L G +KL DFG +
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHY--------- 191
Query: 269 DIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL---LKKGYGMEC 325
P +R + T Y PE++ G +
Sbjct: 192 -----------------PDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQ 234
Query: 326 DWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC- 384
D W+LG I+Y + PF +D +IVN K P LI +L
Sbjct: 235 DIWALGCILYLLCFRQHPF--EDGAK--LRIVNGK--YSIPPHDTQYTVFHSLIRAMLQV 288
Query: 385 DVETRLGTRGVEELKEHPW 403
+ E RL + E+
Sbjct: 289 NPEERL---SIAEVVHQLQ 304
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-45
Identities = 84/340 (24%), Positives = 148/340 (43%), Gaps = 53/340 (15%)
Query: 72 QQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDD----FEQLTLIGKGAFGEVRLCRA 127
+ V + ++ ++ R + D + IG+G+ G V L R
Sbjct: 7 HSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLARE 66
Query: 128 KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEY 187
K +G A+K + + +R E + +E ++ + +V+++ S+ + L+++ME+
Sbjct: 67 KHSGRQVAVKMMDLRKQQRR---ELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123
Query: 188 LPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKL 247
L GG + T ++ + L+E+ + A+ +H +HRDIK D+++L +G +KL
Sbjct: 124 LQGGAL-TDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKL 182
Query: 248 SDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGT 307
SDFG C + KR S VGT
Sbjct: 183 SDFGFCAQISKDVP--------------------------------KRK------SLVGT 204
Query: 308 LDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKT-CLKFP 366
+MAPEV+ + Y E D WSLG ++ EM+ G PP+ SD P +++ + LK
Sbjct: 205 PYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNS 264
Query: 367 EEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 405
K+S RD + +L D + R +EL +HP+
Sbjct: 265 H--KVSPVLRDFLERMLVRDPQERATA---QELLDHPFLL 299
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-45
Identities = 89/306 (29%), Positives = 143/306 (46%), Gaps = 57/306 (18%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
+ + IG+GA G V TG+ A++++ + K+ E + +E ++ E +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKN 76
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIA----ESVLAIHS 221
IV S+ D L+++MEYL GG + T ++ E + E IA E + A+
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEG----QIAAVCRECLQALEF 131
Query: 222 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 281
+H + +HRDIK DN++L +G +KL+DFG C + + S
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-------------------- 171
Query: 282 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341
KR+ + VGT +MAPEV+ +K YG + D WSLG + EM+ G
Sbjct: 172 ------------KRS------TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
Query: 342 PPFCSDDPRITCRKIVNWKT-CLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 399
PP+ +++P I T L+ PE K+S RD + L DVE R +EL
Sbjct: 214 PPYLNENPLRALYLIATNGTPELQNPE--KLSAIFRDFLNRCLEMDVEKRGSA---KELL 268
Query: 400 EHPWFR 405
+H + +
Sbjct: 269 QHQFLK 274
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 3e-45
Identities = 58/363 (15%), Positives = 111/363 (30%), Gaps = 97/363 (26%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTG----------------------EIFAMKKLK--- 140
DFE + +G+G FG V + K E+ A+ KL+
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 141 ------------------------------KSEMLKRGQVEHVRSERNLLAEVDSRCIVQ 170
+ ++ + + ++ V
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 171 LFYSFQDSDFLYLIMEYLPGGDIMTLLMR---EDILSEDVARFYIAESVLAIHSIHQHNY 227
+LY+ M+ ++ + R + V + A+ +H
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 228 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 287
+HRD+KP N+ + +K+ DFGL ++ + +
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQ--------- 236
Query: 288 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSD 347
VGT YM+PE + Y + D +SLG I++E+L F +
Sbjct: 237 -----------------VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY---SFSTQ 276
Query: 348 DPRI-TCRKIVNWKTCLKFPEEP-KISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404
R+ + N LKFP + + ++ +L R ++ E+ F
Sbjct: 277 MERVRIITDVRN----LKFPLLFTQKYPQEHMMVQDMLSPSPTERPEA---TDIIENAIF 329
Query: 405 RGI 407
+
Sbjct: 330 ENL 332
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 7e-45
Identities = 79/304 (25%), Positives = 127/304 (41%), Gaps = 54/304 (17%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ--VEHVRSERNLLAEV 163
+ F +L IGKG+FGEV T ++ A+K + L+ + +E ++ E +L++
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID----LEEAEDEIEDIQQEITVLSQC 77
Query: 164 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIH 223
DS + + + S+ L++IMEYL GG + L + L E + E + + +H
Sbjct: 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDL-LEPGPLDETQIATILREILKGLDYLH 136
Query: 224 QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQW 283
+HRDIK N++L ++G +KL+DFG+ L D
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI---------------------- 174
Query: 284 MMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 343
KRN + VGT +MAPEV+ + Y + D WSLG E+ G PP
Sbjct: 175 ----------KRN------TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218
Query: 344 FCSDDPRITCRKIVNWKTCLKFPE-EPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401
P I P E S ++ + L + R +EL +H
Sbjct: 219 HSELHPMKVLFLIPKNNP----PTLEGNYSKPLKEFVEACLNKEPSFRPTA---KELLKH 271
Query: 402 PWFR 405
+
Sbjct: 272 KFIL 275
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 9e-45
Identities = 55/301 (18%), Positives = 112/301 (37%), Gaps = 54/301 (17%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLF 172
IG+G+F V T A +L+ ++ K + + + E +L + IV+ +
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 173 YSFQDS----DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY- 227
S++ + + L+ E + G + T L R ++ V R + + + + +H
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 151
Query: 228 -VHRDIKPDNLILD-KNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 285
+HRD+K DN+ + G +K+ D GL +
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF------------------------- 186
Query: 286 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345
A + +GT ++MAPE+ ++ Y D ++ G M EM P+
Sbjct: 187 ---------------AKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPYS 230
Query: 346 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404
+ V ++ E +++I + + + R + +L H +F
Sbjct: 231 ECQNAAQIYRRVTSGVKPASFDK-VAIPEVKEIIEGCIRQNKDERYSIK---DLLNHAFF 286
Query: 405 R 405
+
Sbjct: 287 Q 287
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-44
Identities = 72/321 (22%), Positives = 129/321 (40%), Gaps = 65/321 (20%)
Query: 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLK---KSEMLKRGQVEHVRSERN 158
+D + L IG+GA+G V K +G+I A+K+++ + K+ ++
Sbjct: 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDL----DV 73
Query: 159 LLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGG--DIMTLLM--REDILSEDVARFYIAE 214
++ D IVQ + + ++ ME + + +D++ E++ I
Sbjct: 74 VMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG-KITL 132
Query: 215 SVL-AIHSIH-QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIIN 272
+ + A++ + +HRDIKP N++LD++G++KL DFG+ L D +
Sbjct: 133 ATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA----------- 181
Query: 273 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL----LKKGYGMECDWW 328
K G YMAPE + ++GY + D W
Sbjct: 182 ---------------------KTR-------DAGCRPYMAPERIDPSASRQGYDVRSDVW 213
Query: 329 SLGAIMYEMLIGYPPFCSDDPRITC-RKIVNWKT-CLKFPEEPKISDEARDLI--CHLLC 384
SLG +YE+ G P+ + ++V L EE + S + + C L
Sbjct: 214 SLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLC-LTK 272
Query: 385 DVETRLGTRGVEELKEHPWFR 405
D R + EL +HP+
Sbjct: 273 DESKRPKYK---ELLKHPFIL 290
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 6e-44
Identities = 73/333 (21%), Positives = 131/333 (39%), Gaps = 62/333 (18%)
Query: 86 RNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLK---KS 142
+ ++ + QR + I+D E L +G G G+V R + TG + A+K+++
Sbjct: 5 SSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK 64
Query: 143 EMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI 202
E KR ++ +L D IVQ F +F + +++ ME + +
Sbjct: 65 EENKRILMDL----DVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGP 120
Query: 203 LSEDVARFYIAESVL-AIHSIH-QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 260
+ E + + +++ A++ + +H +HRD+KP N++LD+ G +KL DFG+ L D
Sbjct: 121 IPERILG-KMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179
Query: 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL---- 316
+ K + G YMAPE +
Sbjct: 180 A--------------------------------KDR-------SAGCAAYMAPERIDPPD 200
Query: 317 -LKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI-TCRKIVNWKTCLKFPEEPKISDE 374
K Y + D WSLG + E+ G P+ + K++ + P S +
Sbjct: 201 PTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ-EEPPLLPGHMGFSGD 259
Query: 375 ARDLI--CHLLCDVETRLGTRGVEELKEHPWFR 405
+ + C L D R +L EH + +
Sbjct: 260 FQSFVKDC-LTKDHRKRPKYN---KLLEHSFIK 288
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 7e-44
Identities = 71/318 (22%), Positives = 125/318 (39%), Gaps = 58/318 (18%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ--VEHVRSERNLLAEV 163
DD+E +IG GA V+ E A+K++ L++ Q ++ + E +++
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN----LEKCQTSMDELLKEIQAMSQC 70
Query: 164 DSRCIVQLFYSFQDSDFLYLIMEYLPGG---DIMTLLMRED-----ILSEDVARFYIAES 215
IV + SF D L+L+M+ L GG DI+ ++ + +L E + E
Sbjct: 71 HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 216 VLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQET 275
+ + +H++ +HRD+K N++L ++G ++++DFG+
Sbjct: 131 LEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS---------------------- 168
Query: 276 VSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIM 334
+ + R + VGT +MAPEV+ + +GY + D WS G
Sbjct: 169 -----AFLATGGDITRNKVRK------TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITA 217
Query: 335 YEMLIGYPPFCSDDPRITCRKIVNWKT------CLKFPEEPKISDEARDLICHLLC-DVE 387
E+ G P+ P + K R +I L D E
Sbjct: 218 IELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPE 277
Query: 388 TRLGTRGVEELKEHPWFR 405
R EL H +F+
Sbjct: 278 KRPTA---AELLRHKFFQ 292
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-43
Identities = 82/305 (26%), Positives = 132/305 (43%), Gaps = 55/305 (18%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
+ F+ L +G+G++G V K TG+I A+K++ ++ + E +++ + DS
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDS 83
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGG---DIMTLLMREDILSEDVARFYIAESVLAIHSI 222
+V+ + S+ + L+++MEY G DI+ L R L+ED + ++ + +
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYL 141
Query: 223 HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 282
H +HRDIK N++L+ GH KL+DFG+ L D +
Sbjct: 142 HFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA--------------------- 180
Query: 283 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 342
KRN + +GT +MAPEV+ + GY D WSLG EM G P
Sbjct: 181 -----------KRN------TVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKP 223
Query: 343 PFCSDDPRITCRKIVNWKT-CLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400
P+ P I + PE SD D + L E R +L +
Sbjct: 224 PYADIHPMRAIFMIPTNPPPTFRKPE--LWSDNFTDFVKQCLVKSPEQRATA---TQLLQ 278
Query: 401 HPWFR 405
HP+ R
Sbjct: 279 HPFVR 283
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 3e-42
Identities = 71/309 (22%), Positives = 124/309 (40%), Gaps = 59/309 (19%)
Query: 83 EMLRNLERRETEYMRL--------QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIF 134
+ L LE E + RL + ++ DDFE+++ +G G G V K +G +
Sbjct: 2 KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVM 61
Query: 135 AMKKLK---KSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGG 191
A K + K + + + E +L E +S IV + +F + + ME++ GG
Sbjct: 62 ARKLIHLEIKPAIRNQ-----IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 116
Query: 192 DIMTLLMREDILSEDVARFYIAESVL-AIHSIH-QHNYVHRDIKPDNLILDKNGHLKLSD 249
+ +L + + E + ++ +V+ + + +H +HRD+KP N++++ G +KL D
Sbjct: 117 SLDQVLKKAGRIPEQILG-KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCD 175
Query: 250 FGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLD 309
FG+ L D ++A S VGT
Sbjct: 176 FGVSGQLID----------------------------------------SMANSFVGTRS 195
Query: 310 YMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEP 369
YM+PE L Y ++ D WS+G + EM +G P D + P
Sbjct: 196 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 255
Query: 370 KISDEARDL 378
+ R L
Sbjct: 256 RPRTPGRPL 264
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 6e-42
Identities = 76/320 (23%), Positives = 135/320 (42%), Gaps = 67/320 (20%)
Query: 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLK---KSEMLKRGQVEHVRSERN 158
++ DD E + +G+GA+G V R +G+I A+K+++ S+ KR ++
Sbjct: 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDL----DI 58
Query: 159 LLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGG---DIMTLLMREDILSEDVARFYIAES 215
+ VD V + + +++ ME + ++ + + ED+ IA S
Sbjct: 59 SMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILG-KIAVS 117
Query: 216 VL-AIHSIH-QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 273
++ A+ +H + + +HRD+KP N++++ G +K+ DFG+ L D
Sbjct: 118 IVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD-------------- 163
Query: 274 ETVSEAEGQWMMPKERLQQWKRNRRALAYST-VGTLDYMAPEVLL----KKGYGMECDWW 328
+A G YMAPE + +KGY ++ D W
Sbjct: 164 --------------------------VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIW 197
Query: 329 SLGAIMYEMLIGYPPFCSDD-PRITCRKIVNWKTCLKFPEEPKISDEARDLI--CHLLCD 385
SLG M E+ I P+ S P +++V + + P + K S E D C L +
Sbjct: 198 SLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS-PQLPAD-KFSAEFVDFTSQC-LKKN 254
Query: 386 VETRLGTRGVEELKEHPWFR 405
+ R EL +HP+F
Sbjct: 255 SKERPTYP---ELMQHPFFT 271
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 7e-42
Identities = 75/340 (22%), Positives = 124/340 (36%), Gaps = 57/340 (16%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
F L IG G+FG V R E+ A+KK+ S + + + E L ++
Sbjct: 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 225
+Q + +L+MEY G L + + L E ++ + +H H
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173
Query: 226 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 285
N +HRD+K N++L + G +KL DFG
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSAS------------------------------- 202
Query: 286 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMECDWWSLGAIMYEMLIGYP 342
N S VGT +MAPEV+L + Y + D WSLG E+ P
Sbjct: 203 -----IMAPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 251
Query: 343 PFCSDDPRITCRKIVNWKTCLKFP--EEPKISDEARDLICHLLC-DVETRLGTRGVEELK 399
P + + I ++ P + S+ R+ + L + R + E L
Sbjct: 252 PLFNMNAMSALYHIAQNES----PALQSGHWSEYFRNFVDSCLQKIPQDRPTS---EVLL 304
Query: 400 EHPWFRGIQWDK-LYEMEAAYKPTVNGELDTQNFEKFPEV 438
+H + + + ++ K V ELD + K ++
Sbjct: 305 KHRFVLRERPPTVIMDLIQRTKDAVR-ELDNLQYRKMKKI 343
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 4e-41
Identities = 81/310 (26%), Positives = 129/310 (41%), Gaps = 58/310 (18%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
+ +E + +G GAFG+V + K TG + A K ++ + +E E +LA D
Sbjct: 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYIVEIEILATCDH 75
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGG---DIMTLLMREDILSEDVARFYIAESVLAIHSI 222
IV+L ++ L++++E+ PGG IM L R L+E + + + A++ +
Sbjct: 76 PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR--GLTEPQIQVVCRQMLEALNFL 133
Query: 223 HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 282
H +HRD+K N+++ G ++L+DFG+
Sbjct: 134 HSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ--------------------- 172
Query: 283 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDWWSLGAIMYEM 337
KR+ S +GT +MAPEV++ Y + D WSLG + EM
Sbjct: 173 -----------KRD------SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 215
Query: 338 LIGYPPFCSDDPRITCRKIVNWKT-CLKFPEEPKISDEARDLICHLLC-DVETRLGTRGV 395
PP +P KI L P K S E RD + L + ETR
Sbjct: 216 AQIEPPHHELNPMRVLLKIAKSDPPTLLTPS--KWSVEFRDFLKIALDKNPETRPSA--- 270
Query: 396 EELKEHPWFR 405
+L EHP+
Sbjct: 271 AQLLEHPFVS 280
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-41
Identities = 53/251 (21%), Positives = 98/251 (39%), Gaps = 40/251 (15%)
Query: 106 DDFEQLTLIGKGA--FGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV 163
+E LT+IGKG V L R K TGE ++++ E V ++ E ++
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN-LEACSNEMVTFLQGELHVSKLF 83
Query: 164 DSRCIVQLFYSFQDSDFLYLIMEYLPGG---DIMTLLMREDILSEDVARFYIAESVLAIH 220
+ IV +F + L+++ ++ G D++ D ++E + + + A+
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALD 142
Query: 221 SIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAE 280
IH YVHR +K ++++ +G + LS +
Sbjct: 143 YIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH--------------------- 181
Query: 281 GQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL--LKKGYGMECDWWSLGAIMYEML 338
Q +R +V L +++PEVL +GY + D +S+G E+
Sbjct: 182 ----------GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELA 231
Query: 339 IGYPPFCSDDP 349
G+ PF
Sbjct: 232 NGHVPFKDMPA 242
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-39
Identities = 84/339 (24%), Positives = 136/339 (40%), Gaps = 66/339 (19%)
Query: 84 MLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSE 143
M + R + + L + FE + L+G G +G+V R TG++ A+K +
Sbjct: 2 MASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD--- 58
Query: 144 MLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSF------QDSDFLYLIMEYLPGGDIMTL 196
+ + E ++ E N+L + R I + +F D L+L+ME+ G + L
Sbjct: 59 -VTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL 117
Query: 197 LM--REDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCK 254
+ + + L E+ + E + + +HQH +HRDIK N++L +N +KL DFG+
Sbjct: 118 IKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177
Query: 255 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPE 314
L+ +RN + +GT +MAPE
Sbjct: 178 QLDRTVG--------------------------------RRN------TFIGTPYWMAPE 199
Query: 315 VLLKK-----GYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFP--E 367
V+ Y + D WSLG EM G PP C P I P +
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA----PRLK 255
Query: 368 EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 405
K S + + I L + R T E+L +HP+ R
Sbjct: 256 SKKWSKKFQSFIESCLVKNHSQRPAT---EQLMKHPFIR 291
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 9e-38
Identities = 81/340 (23%), Positives = 138/340 (40%), Gaps = 87/340 (25%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRS----ERNLLA 161
+ +E++ IG+G++G V CR + TG+I A+KK +SE ++ E +L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-----DDPVIKKIALREIRMLK 57
Query: 162 EVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL-MREDILSEDVARFYIAESVLAIH 220
++ +V L F+ L+L+ EY ++ L + + E + + +++ A++
Sbjct: 58 QLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVN 116
Query: 221 SIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL---EDKYSSILLEDEDIINQETVS 277
H+HN +HRD+KP+N+++ K+ +KL DFG + L D Y DE
Sbjct: 117 FCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD-----DE--------- 162
Query: 278 EAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYE 336
V T Y +PE+L+ YG D W++G + E
Sbjct: 163 ---------------------------VATRWYRSPELLVGDTQYGPPVDVWAIGCVFAE 195
Query: 337 MLIGYP--------------------------PFCSDDPRITCRKIVNWKTCLKFPEE-P 369
+L G P S + + KI + + + P
Sbjct: 196 LLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFP 255
Query: 370 KISDEARDLICHLL-CDVETRLGTRGVEELKEHPWFRGIQ 408
IS A L+ L D RL E+L HP+F I+
Sbjct: 256 NISYPALGLLKGCLHMDPTERL---TCEQLLHHPYFENIR 292
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-37
Identities = 88/357 (24%), Positives = 142/357 (39%), Gaps = 92/357 (25%)
Query: 90 RRETEYMRLQRRKIG---IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLK 146
+ + L + ++ +E L L+G+G++G V CR K TG I A+KK +S+
Sbjct: 6 HHHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD--- 62
Query: 147 RGQVEHVRS----ERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL-MRED 201
+ V+ E LL ++ +V L + YL+ E++ I+ L + +
Sbjct: 63 --DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPN 119
Query: 202 ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL---ED 258
L V + Y+ + + I H HN +HRDIKP+N+++ ++G +KL DFG + L +
Sbjct: 120 GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179
Query: 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL- 317
Y DE V T Y APE+L+
Sbjct: 180 VYD-----DE------------------------------------VATRWYRAPELLVG 198
Query: 318 KKGYGMECDWWSLGAIMYEMLIGYPPFCSD----------------DPRI--TCRKIVNW 359
YG D W++G ++ EM +G P F D PR K +
Sbjct: 199 DVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258
Query: 360 KTCLKFPEE----------PKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 405
++ PE PK+S+ DL L D + R EL H +F+
Sbjct: 259 AG-VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRP---FCAELLHHDFFQ 311
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-34
Identities = 71/341 (20%), Positives = 121/341 (35%), Gaps = 87/341 (25%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEH----VRSERNLL 160
+E + IG GA+G V R +G A+K ++ G VR E LL
Sbjct: 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV-PNGGGGGGGLPISTVR-EVALL 65
Query: 161 AEVDSRC---IVQLF-----YSFQDSDFLYLIMEYLPGGDIMTLL--MREDILSEDVARF 210
+++ +V+L + L+ E++ D+ T L L + +
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKD 124
Query: 211 YIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP--LEDKYSSILLEDE 268
+ + + + +H + VHRD+KP+N+++ G +KL+DFGL + + + +
Sbjct: 125 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPV----- 179
Query: 269 DIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWW 328
V TL Y APEVLL+ Y D W
Sbjct: 180 ------------------------------------VVTLWYRAPEVLLQSTYATPVDMW 203
Query: 329 SLGAIMYEMLIGYPPFCSDDPRITCRKIV---------NWKTCLKFPEE----------- 368
S+G I EM P FC + KI +W + P
Sbjct: 204 SVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQ 263
Query: 369 ---PKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 405
P++ + L+ +L + R+ L+ H +
Sbjct: 264 SVVPEMEESGAQLLLEMLTFNPHKRISAF--RALQ-HSYLH 301
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 61/256 (23%), Positives = 101/256 (39%), Gaps = 71/256 (27%)
Query: 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE 162
I + E ++G+GAFG V C+AK + A+K+++ K E L+
Sbjct: 5 IDYKEIEVEEVVGRGAFGVV--CKAKWRAKDVAIKQIESESERK-----AFIVELRQLSR 57
Query: 163 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSE-----------DVAR-- 209
V+ IV+L+ + + + L+MEY GG + +L + L ++
Sbjct: 58 VNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 210 FYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG-HLKLSDFGLCKPLEDKYSSILLEDE 268
Y+ HS+ +HRD+KP NL+L G LK+ DFG ++
Sbjct: 116 AYL-------HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--------- 159
Query: 269 DIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWW 328
M + G+ +MAPEV Y +CD +
Sbjct: 160 ---------------MT-----------------NNKGSAAWMAPEVFEGSNYSEKCDVF 187
Query: 329 SLGAIMYEMLIGYPPF 344
S G I++E++ PF
Sbjct: 188 SWGIILWEVITRRKPF 203
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 7e-34
Identities = 81/348 (23%), Positives = 138/348 (39%), Gaps = 92/348 (26%)
Query: 96 MRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEH--- 152
+ ++ R +E+L +G+G F V R K T +I A+KK+K + R + +
Sbjct: 3 LDVKSR---AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIK---LGHRSEAKDGIN 56
Query: 153 ---VRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI-LSEDVA 208
+R E LL E+ I+ L +F + L+ +++ D+ ++ + L+
Sbjct: 57 RTALR-EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHI 114
Query: 209 RFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED---KYSSILL 265
+ Y+ ++ + +HQH +HRD+KP+NL+LD+NG LKL+DFGL K Y+
Sbjct: 115 KAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT---- 170
Query: 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGME 324
V T Y APE+L + YG+
Sbjct: 171 -------------------------------------HQVVTRWYRAPELLFGARMYGVG 193
Query: 325 CDWWSLGAIMYEMLIGYPPFCSDD--------------------PRITCRKIVNWKTCLK 364
D W++G I+ E+L+ P D P + + ++ T
Sbjct: 194 VDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC--SLPDYVTFKS 251
Query: 365 FPEE------PKISDEARDLICHLL-CDVETRLGTRGVEELKEHPWFR 405
FP D+ DLI L + R+ + LK +F
Sbjct: 252 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITAT--QALK-MKYFS 296
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 8e-34
Identities = 77/342 (22%), Positives = 133/342 (38%), Gaps = 97/342 (28%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEH--------VRSE 156
++ + +L +G+G + V ++K T + A+K+++ +EH +R E
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR---------LEHEEGAPCTAIR-E 50
Query: 157 RNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL-MREDILSEDVARFYIAES 215
+LL ++ IV L L L+ EYL D+ L +I++ + ++ +
Sbjct: 51 VSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQL 109
Query: 216 VLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQET 275
+ + H+ +HRD+KP NL++++ G LKL+DFGL + S
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARA----KSI------------- 152
Query: 276 VSEAEGQWMMPKERLQQWKRNRRALAYST-VGTLDYMAPEVLL-KKGYGMECDWWSLGAI 333
P + Y V TL Y P++LL Y + D W +G I
Sbjct: 153 ----------PTKT------------YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCI 190
Query: 334 MYEMLIGYPPFCSDD--------------------PRITCRKIVNWKTCLKFPEE----- 368
YEM G P F P I +KT +P+
Sbjct: 191 FYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL--SNEEFKT-YNYPKYRAEAL 247
Query: 369 ----PKISDEARDLICHLL-CDVETRLGTRGVEELKEHPWFR 405
P++ + DL+ LL + R+ E+ +HP+F
Sbjct: 248 LSHAPRLDSDGADLLTKLLQFEGRNRISA---EDAMKHPFFL 286
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 9e-34
Identities = 77/351 (21%), Positives = 130/351 (37%), Gaps = 106/351 (30%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEH--------VRSE 156
F+QL +G G + V KTTG A+K++K ++ +R E
Sbjct: 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK---------LDSEEGTPSTAIR-E 53
Query: 157 RNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL------MREDILSEDVARF 210
+L+ E+ IV+L+ + L L+ E++ D+ + L ++ ++
Sbjct: 54 ISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKY 112
Query: 211 YIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGL----CKPLEDKYSSILLE 266
+ + + + H++ +HRD+KP NL+++K G LKL DFGL P+ +S
Sbjct: 113 FQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN-TFS----- 166
Query: 267 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMEC 325
E V TL Y AP+VL+ + Y
Sbjct: 167 ------SEVV------------------------------TLWYRAPDVLMGSRTYSTSI 190
Query: 326 DWWSLGAIMYEMLIGYPPFCSDD------------------------------PRITCRK 355
D WS G I+ EM+ G P F + P I R
Sbjct: 191 DIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRP 250
Query: 356 IVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 405
+ + L+ + + D + LL + + RL ++ HPWF
Sbjct: 251 PRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRL---SAKQALHHPWFA 298
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-33
Identities = 83/334 (24%), Positives = 133/334 (39%), Gaps = 82/334 (24%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ-VEHVRSERNLLAEV 163
++ + L IG+G +G V + GE FA+KK++ E G +R E ++L E+
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIR-LEKEDEGIPSTTIR-EISILKEL 57
Query: 164 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL-MREDILSEDVARFYIAESVLAIHSI 222
IV+L+ L L+ E+L D+ LL + E L A+ ++ + + I
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 223 HQHNYVHRDIKPDNLILDKNGHLKLSDFGL----CKPLEDKYSSILLEDEDIINQETVSE 278
H +HRD+KP NL++++ G LK++DFGL P+ KY+ E V
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYT-----------HEIV-- 162
Query: 279 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEM 337
TL Y AP+VL+ K Y D WS+G I EM
Sbjct: 163 ----------------------------TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEM 194
Query: 338 LIGYPPFCSDDPRITCRKI---------VNWKTCLKFPE----------------EPKIS 372
+ G P F +I NW + P+ +
Sbjct: 195 VNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLD 254
Query: 373 DEARDLICHLL-CDVETRLGTRGVEELKEHPWFR 405
+ DL+ +L D R+ ++ EH +F+
Sbjct: 255 ESGIDLLSKMLKLDPNQRITA---KQALEHAYFK 285
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-33
Identities = 60/247 (24%), Positives = 97/247 (39%), Gaps = 51/247 (20%)
Query: 107 DFEQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV 163
+ L + IG G+FG V RA+ G A+K L + + +V E ++ +
Sbjct: 35 PWCDLNIKEKIGAGSFGTV--HRAEWHGSDVAVKILMEQDFHAE-RVNEFLREVAIMKRL 91
Query: 164 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI---LSEDVARFYIAESV-LAI 219
IV + L ++ EYL G + LL + L E R +A V +
Sbjct: 92 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERR-RLSMAYDVAKGM 150
Query: 220 HSIHQHNY--VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVS 277
+ +H N VHR++K NL++DK +K+ DFGL + + S
Sbjct: 151 NYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--------------- 195
Query: 278 EAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337
S GT ++MAPEVL + + D +S G I++E+
Sbjct: 196 ------SK-----------------SAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWEL 232
Query: 338 LIGYPPF 344
P+
Sbjct: 233 ATLQQPW 239
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-33
Identities = 79/363 (21%), Positives = 138/363 (38%), Gaps = 85/363 (23%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCR-AKTTGEIFAMKKLKKSEMLKRGQ-VEHVRSERNLLAE 162
+E + IG+GA+G+V R K G A+K+++ + + G + +R E +L
Sbjct: 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR-VQTGEEGMPLSTIR-EVAVLRH 67
Query: 163 VDSRC---IVQLF-----YSFQDSDFLYLIMEYLPGGDIMTLL--MREDILSEDVARFYI 212
+++ +V+LF L L+ E++ D+ T L + E + + + +
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126
Query: 213 AESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP--LEDKYSSILLEDEDI 270
+ + + +H H VHRD+KP N+++ +G +KL+DFGL + + +S+
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV------- 179
Query: 271 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSL 330
V TL Y APEVLL+ Y D WS+
Sbjct: 180 ----------------------------------VVTLWYRAPEVLLQSSYATPVDLWSV 205
Query: 331 GAIMYEMLIGYPPFCSDDPRITCRKIV---------NWKTCLKFPEE------------- 368
G I EM P F KI+ +W + P +
Sbjct: 206 GCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKF 265
Query: 369 -PKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGE 426
I + +DL+ L + R+ HP+F+ ++ K E
Sbjct: 266 VTDIDELGKDLLLKCLTFNPAKRI---SAYSALSHPYFQDLERCKENLDSHLPPSQNTSE 322
Query: 427 LDT 429
L+T
Sbjct: 323 LNT 325
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-33
Identities = 82/339 (24%), Positives = 136/339 (40%), Gaps = 91/339 (26%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCRAK-TTGEIFAMKKLKKSEMLKRGQ-VEHVRSERNLLAE 162
++ +++L +G+G +G V +AK + G I A+K+++ + G +R E +LL E
Sbjct: 20 MEKYQKLEKVGEGTYGVV--YKAKDSQGRIVALKRIR-LDAEDEGIPSTAIR-EISLLKE 75
Query: 163 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL-MREDILSEDVARFYIAESVLAIHS 221
+ IV L L L+ E++ D+ +L + L + + Y+ + + +
Sbjct: 76 LHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAH 134
Query: 222 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGL----CKPLEDKYSSILLEDEDIINQETVS 277
HQH +HRD+KP NL+++ +G LKL+DFGL P+ Y+ E V
Sbjct: 135 CHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-SYT-----------HEVV- 181
Query: 278 EAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYE 336
TL Y AP+VL+ K Y D WS+G I E
Sbjct: 182 -----------------------------TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAE 212
Query: 337 MLIGYPPFCSDD--------------------PRITCRKIVNWKTCLKFPEE-------- 368
M+ G P F P++ ++ WK F
Sbjct: 213 MITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ--ELPLWKQ-RTFQVFEKKPWSSI 269
Query: 369 -PKISDEARDLICHLL-CDVETRLGTRGVEELKEHPWFR 405
P E DL+ ++L D R+ + HP+F+
Sbjct: 270 IPGFCQEGIDLLSNMLCFDPNKRISA---RDAMNHPYFK 305
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-33
Identities = 85/337 (25%), Positives = 137/337 (40%), Gaps = 86/337 (25%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ-VEHVRSERNLLAEV 163
+ +E+L IG+G +G V + + T EI A+K+++ + G +R E LL E+
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-LDDDDEGVPSSALR-EICLLKEL 58
Query: 164 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL-MREDILSEDVARFYIAESVLAIHSI 222
+ IV+L L L+ E+ D+ L ++ + ++ + + +
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 223 HQHNYVHRDIKPDNLILDKNGHLKLSDFGL----CKPLEDKYSSILLEDEDIINQETVSE 278
H N +HRD+KP NL++++NG LKL++FGL P+ YS E V
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYS-----------AEVV-- 163
Query: 279 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEM 337
TL Y P+VL K Y D WS G I E+
Sbjct: 164 ----------------------------TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 195
Query: 338 L-IGYPPFCSDD--------------------PRITCRKIVNWKTCLKFPEE-------P 369
G P F +D P +T K+ ++K +P P
Sbjct: 196 ANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT--KLPDYKPYPMYPATTSLVNVVP 253
Query: 370 KISDEARDLICHLL-CDVETRLGTRGVEELKEHPWFR 405
K++ RDL+ +LL C+ R+ E L+ HP+F
Sbjct: 254 KLNATGRDLLQNLLKCNPVQRISAE--EALQ-HPYFS 287
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 80/339 (23%), Positives = 130/339 (38%), Gaps = 86/339 (25%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ-VEHVRSERNLLAEV 163
ID + ++T +G+G +GEV T E A+K++ + E + G +R E +LL E+
Sbjct: 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAIR-EVSLLKEL 90
Query: 164 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIH 223
R I++L + L+LI EY D+ + + +S V + ++ + + ++ H
Sbjct: 91 QHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH 149
Query: 224 QHNYVHRDIKPDNLILDKN-----GHLKLSDFGL----CKPLEDKYSSILLEDEDIINQE 274
+HRD+KP NL+L + LK+ DFGL P+ +++ E
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR-QFT-----------HE 197
Query: 275 TVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAI 333
+ TL Y PE+LL + Y D WS+ I
Sbjct: 198 II------------------------------TLWYRPPEILLGSRHYSTSVDIWSIACI 227
Query: 334 MYEMLIGYPPFCSDDPRITCRKI---------VNWKTCLKFPE----------------- 367
EML+ P F D KI W P+
Sbjct: 228 WAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVL 287
Query: 368 EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 405
+ DE DL+ +L D R+ + EHP+F
Sbjct: 288 GALLDDEGLDLLTAMLEMDPVKRISA---KNALEHPYFS 323
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-32
Identities = 56/257 (21%), Positives = 103/257 (40%), Gaps = 49/257 (19%)
Query: 107 DFEQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKK-SEMLKRGQVEHVRSERNLLAE 162
L +GKG FG+ + TGE+ MK+L + E +R E ++
Sbjct: 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQR----TFLKEVKVMRC 63
Query: 163 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI---------LSEDVARFYIA 213
++ +++ L I EY+ GG + ++ D ++D+A
Sbjct: 64 LEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIAS---- 119
Query: 214 ESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 273
+ +H N +HRD+ N ++ +N ++ ++DFGL + L+ DE
Sbjct: 120 ----GMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGL---------ARLMVDEK---- 162
Query: 274 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 333
E L+ K+ R Y+ VG +MAPE++ + Y + D +S G +
Sbjct: 163 -----------TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIV 211
Query: 334 MYEMLIGYPPFCSDDPR 350
+ E++ PR
Sbjct: 212 LCEIIGRVNADPDYLPR 228
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-32
Identities = 81/338 (23%), Positives = 126/338 (37%), Gaps = 94/338 (27%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 167
+ +IG G+FG V + +GE+ A+KK+ + + K R E ++ ++D
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK------NR-ELQIMRKLDHCN 108
Query: 168 IVQLFYSF------QDSDFLYLIMEYLPGGDIMTL--LMRE-----DILSEDVARFYIAE 214
IV+L Y F +D +L L+++Y+P T+ + R L + Y+ +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQ 164
Query: 215 SVLAIHSIHQHNYVHRDIKPDNLILDKN-GHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 273
++ IH HRDIKP NL+LD + LKL DFG K L +
Sbjct: 165 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-------------GE 211
Query: 274 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGA 332
VS + + Y APE++ Y D WS G
Sbjct: 212 PNVSY--------------------------ICSRYYRAPELIFGATDYTSSIDVWSAGC 245
Query: 333 IMYEMLIGYPPFCSDDPRITCRKIVN---------WKTCL------KFPE---------- 367
++ E+L+G P F D +I+ + KFP+
Sbjct: 246 VLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVF 305
Query: 368 EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404
P+ EA L LL RL E H +F
Sbjct: 306 RPRTPPEAIALCSRLLEYTPTARL---TPLEACAHSFF 340
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-31
Identities = 65/260 (25%), Positives = 100/260 (38%), Gaps = 72/260 (27%)
Query: 107 DFEQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ-VEHVRSERNLLAE 162
DF +LTL IG G FG+V RA G+ A+K + Q +E+VR E L A
Sbjct: 5 DFAELTLEEIIGIGGFGKV--YRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAM 62
Query: 163 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI-------LSEDVARFYIAES 215
+ I+ L L L+ME+ GG + +L + I + +AR
Sbjct: 63 LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIAR------ 116
Query: 216 VLAIHSIHQHNY---VHRDIKPDNLILDK--------NGHLKLSDFGLCKPLEDKYSSIL 264
++ +H +HRD+K N+++ + N LK++DFGL +
Sbjct: 117 --GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---- 170
Query: 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGME 324
M S G +MAPEV+ +
Sbjct: 171 -------------------KM-----------------SAAGAYAWMAPEVIRASMFSKG 194
Query: 325 CDWWSLGAIMYEMLIGYPPF 344
D WS G +++E+L G PF
Sbjct: 195 SDVWSYGVLLWELLTGEVPF 214
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 81/339 (23%), Positives = 124/339 (36%), Gaps = 97/339 (28%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLK-RGQVEHVRSERNLLAEVDSR 166
+ +IG G+FG V + + E+ A+KK+ + + K R E ++ V
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEV-AIKKVLQDKRFKNR--------ELQIMRIVKHP 92
Query: 167 CIVQLFYSF------QDSDFLYLIMEYLPGGDIMTL--LMR-----EDILSEDVARFYIA 213
+V L F +D FL L++EY+P T+ R + + + + Y+
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYVP----ETVYRASRHYAKLKQTMPMLLIKLYMY 148
Query: 214 ESVLAIHSIHQHNYVHRDIKPDNLILDKN-GHLKLSDFGLCKPLEDKYSSILLEDEDIIN 272
+ + ++ IH HRDIKP NL+LD G LKL DFG K L
Sbjct: 149 QLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA-------------G 195
Query: 273 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLG 331
+ VS + + Y APE++ Y D WS G
Sbjct: 196 EPNVSY--------------------------ICSRYYRAPELIFGATNYTTNIDIWSTG 229
Query: 332 AIMYEMLIGYPPFCSDD---------------PRITCRKIVNWKTCLKFPE--------- 367
+M E++ G P F + R + + KFP+
Sbjct: 230 CVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKV 289
Query: 368 -EPKISDEARDLICHLL-CDVETRLGTRGVEELKEHPWF 404
P+ +A DLI LL RL E HP+F
Sbjct: 290 FRPRTPPDAIDLISRLLEYTPSARL---TAIEALCHPFF 325
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 77/346 (22%), Positives = 126/346 (36%), Gaps = 90/346 (26%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRS----ERNLL 160
+ +E+L IG+G FGEV R + TG+ A+KK+ E K G E +L
Sbjct: 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL-MENEKEG----FPITALREIKIL 70
Query: 161 AEVDSRCIVQLF--------YSFQDSDFLYLIMEYLPGGDIMTLLMREDI-LSEDVARFY 211
+ +V L + +YL+ ++ D+ LL + + +
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV 129
Query: 212 IAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDII 271
+ + ++ IH++ +HRD+K N+++ ++G LKL+DFGL
Sbjct: 130 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL------------------- 170
Query: 272 NQETVSEAEGQWMMPKERLQQWKRNRRALAY-STVGTLDYMAPEVLL-KKGYGMECDWWS 329
A R +N + Y + V TL Y PE+LL ++ YG D W
Sbjct: 171 -------A---------RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWG 214
Query: 330 LGAIMYEMLIGYPPFCSDD-----PRI-------------TCRKIVNWKTCLKFPEEPK- 370
G IM EM P + I ++ L+ + K
Sbjct: 215 AGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEK-LELVKGQKR 273
Query: 371 ----------ISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 405
A DLI LL D R+ ++ H +F
Sbjct: 274 KVKDRLKAYVRDPYALDLIDKLLVLDPAQRI---DSDDALNHDFFW 316
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-30
Identities = 51/251 (20%), Positives = 93/251 (37%), Gaps = 51/251 (20%)
Query: 107 DFEQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV 163
FEQL + IGKG FG+V + GE+ A++ + + Q++ + E +
Sbjct: 31 PFEQLEIGELIGKGRFGQV--YHGRWHGEV-AIRLIDIERDNED-QLKAFKREVMAYRQT 86
Query: 164 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESV-LAIHSI 222
+V + L +I G + +++ I+ + IA+ + + +
Sbjct: 87 RHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 223 HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 282
H +H+D+K N+ D NG + ++DFGL I E +
Sbjct: 147 HAKGILHKDLKSKNVFYD-NGKVVITDFGLFS---------------ISGVLQAGRREDK 190
Query: 283 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL---------LKKGYGMECDWWSLGAI 333
+ G L ++APE++ K + D ++LG I
Sbjct: 191 LRIQ------------------NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTI 232
Query: 334 MYEMLIGYPPF 344
YE+ PF
Sbjct: 233 WYELHAREWPF 243
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-29
Identities = 52/256 (20%), Positives = 94/256 (36%), Gaps = 62/256 (24%)
Query: 107 DFEQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKK----SEMLKRGQVEHVRSERNL 159
++ IGKG FG V R + A+K L E + + + E +
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 160 LAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI-LSEDVARFYIAESV-L 217
++ ++ IV+L+ + ++ME++P GD+ L+ + + V + + + L
Sbjct: 77 MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSV-KLRLMLDIAL 133
Query: 218 AIHSIHQHNY--VHRDIKPDNLILDKNG-----HLKLSDFGLCKPLEDKYSSILLEDEDI 270
I + N VHRD++ N+ L K++DFGL
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL------------------ 175
Query: 271 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG--YGMECDWW 328
S+ + +G +MAPE + + Y + D +
Sbjct: 176 ------SQQSVHSVS-----------------GLLGNFQWMAPETIGAEEESYTEKADTY 212
Query: 329 SLGAIMYEMLIGYPPF 344
S I+Y +L G PF
Sbjct: 213 SFAMILYTILTGEGPF 228
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 9e-29
Identities = 80/364 (21%), Positives = 133/364 (36%), Gaps = 98/364 (26%)
Query: 89 ERRETEYMRLQRRKIG---IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML 145
R EY + + DD++ + +G+G + EV T E +K LK
Sbjct: 16 THRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---- 71
Query: 146 KRGQVEHVRSER--NLLAEV-DSRCIVQLFYSFQD--SDFLYLIMEYLPGGDIMTLLMRE 200
V+ + +R +L + I+ L +D S L+ E++ D L
Sbjct: 72 ----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--- 124
Query: 201 DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD-KNGHLKLSDFGLCKPLEDK 259
L++ RFY+ E + A+ H +HRD+KP N+++D ++ L+L D+GL
Sbjct: 125 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL------- 177
Query: 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK- 318
AE P + N R V + + PE+L+
Sbjct: 178 -------------------AEFY--HPGQEY-----NVR------VASRYFKGPELLVDY 205
Query: 319 KGYGMECDWWSLGAIMYEMLIGYPPFC-----------------SDDPRITCRKI----- 356
+ Y D WSLG ++ M+ PF ++D K
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265
Query: 357 ------------VNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPW 403
W+ + + +S EA D + LL D ++RL T E EHP+
Sbjct: 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL-T--AREAMEHPY 322
Query: 404 FRGI 407
F +
Sbjct: 323 FYTV 326
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 9e-29
Identities = 49/245 (20%), Positives = 101/245 (41%), Gaps = 48/245 (19%)
Query: 107 DFEQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV 163
Q+T+ IG G+FG V + K G++ A+K L + + Q++ ++E +L +
Sbjct: 22 PDGQITVGQRIGSGSFGTV--YKGKWHGDV-AVKMLNVTAPTPQ-QLQAFKNEVGVLRKT 77
Query: 164 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESV-LAIHSI 222
I+ F + + L ++ ++ G + L + E IA + +
Sbjct: 78 RHVNILL-FMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL 136
Query: 223 HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 282
H + +HRD+K +N+ L ++ +K+ DFGL + + + +
Sbjct: 137 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLAT----------EKSRWSGSHQFEQLS--- 183
Query: 283 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG---YGMECDWWSLGAIMYEMLI 339
G++ +MAPEV+ + Y + D ++ G ++YE++
Sbjct: 184 -----------------------GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMT 220
Query: 340 GYPPF 344
G P+
Sbjct: 221 GQLPY 225
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 81/346 (23%), Positives = 131/346 (37%), Gaps = 97/346 (28%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAK--TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV 163
D F+ + G+G FG V K +TG A+KK+ + + +++ ++ LA +
Sbjct: 23 DRFQVERMAGQGTFGTV--QLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQ----DLAVL 76
Query: 164 DSRCIVQL---FYSFQDSDF----LYLIMEYLPGGD----IMTLLMREDILSEDVARFY- 211
IVQL FY+ + D L ++MEY+P R+ + + +
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 212 --IAESVLAIHSIHQHNYVHRDIKPDNLILDK-NGHLKLSDFGLCKPLEDKYSSILLEDE 268
+ S+ +H N HRDIKP N+++++ +G LKL DFG K L
Sbjct: 136 FQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP---------- 184
Query: 269 DIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDW 327
++ V+ + + Y APE++ + Y D
Sbjct: 185 ---SEPNVAY--------------------------ICSRYYRAPELIFGNQHYTTAVDI 215
Query: 328 WSLGAIMYEMLIGYPPFCSDDP-----RIT----------CRKIVNWKTCLKFP------ 366
WS+G I EM++G P F D+ I RK+ T +
Sbjct: 216 WSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIP 275
Query: 367 -------EEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404
K + EA DL+ LL E R+ E HP+F
Sbjct: 276 WSNVFSDHSLKDAKEAYDLLSALLQYLPEERM---KPYEALCHPYF 318
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 50/172 (29%), Positives = 75/172 (43%), Gaps = 26/172 (15%)
Query: 105 IDDFEQL-TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV 163
IDD++ ++G G G+V K T E FA+K L+ +R E L
Sbjct: 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRA 67
Query: 164 -DSRCIVQLFYSFQDS----DFLYLIMEYLPGGDIMTLLMR-----EDILSEDVARFYIA 213
IV++ +++ L ++ME L GG+ L R + +E A +
Sbjct: 68 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGE---LFSRIQDRGDQAFTEREASEIMK 124
Query: 214 ESVLAIHSIHQHNYVHRDIKPDNLIL---DKNGHLKLSDFGLCKP-LEDKYS 261
AI +H N HRD+KP+NL+ N LKL+DFG K +KY
Sbjct: 125 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEKYD 176
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 5e-22
Identities = 33/100 (33%), Positives = 46/100 (46%), Gaps = 9/100 (9%)
Query: 312 APEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVN--WKTCLKFPEEP 369
A E + Y CD WSLG IMY +L GYPPF S+ + +FP
Sbjct: 167 AKETT-GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 225
Query: 370 --KISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406
++S+E + LI +LL + R+ T + E HPW
Sbjct: 226 WSEVSEEVKMLIRNLLKTEPTQRM-T--ITEFMNHPWIMQ 262
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 35/251 (13%), Positives = 74/251 (29%), Gaps = 60/251 (23%)
Query: 107 DFEQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV 163
DF+QL + + GE+ + + G +K LK + R + E L
Sbjct: 8 DFKQLNFLTKLNENHSGEL--WKGRWQGNDIVVKVLKVRDWSTR-KSRDFNEECPRLRIF 64
Query: 164 DSRCIVQLFY---SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVA-RFYIAESV-LA 218
++ + LI ++P G + +L D + A +
Sbjct: 65 SHPNVLP-VLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARG 123
Query: 219 IHSIHQHNY--VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETV 276
+ +H + ++++D++ ++S + +
Sbjct: 124 MAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP----------------- 166
Query: 277 SEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGME---CDWWSLGAI 333
+ ++APE L KK D WS +
Sbjct: 167 --------------------------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVL 200
Query: 334 MYEMLIGYPPF 344
++E++ PF
Sbjct: 201 LWELVTREVPF 211
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 60/288 (20%), Positives = 116/288 (40%), Gaps = 28/288 (9%)
Query: 62 ERRRALQMRAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDD-FEQLTLIGKGAFG 120
++ + S +E ++ ++ + T M I D +E LIG G++G
Sbjct: 8 AAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYG 67
Query: 121 EVRLCRAKTTGEIFAMKKLKK---SEML-KRGQVEHVRSERNLLAEVDSRCIVQL---FY 173
V K + A+KK+ + + KR +R E +L ++ +V++
Sbjct: 68 HVCEAYDKLEKRVVAIKKILRVFEDLIDCKRI----LR-EIAILNRLNHDHVVKVLDIVI 122
Query: 174 SFQDSDF--LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRD 231
F LY+++E D L L+E + + ++ + +H +HRD
Sbjct: 123 PKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRD 181
Query: 232 IKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 291
+KP N +++++ +K+ DFGL + ++ + + K +L
Sbjct: 182 LKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLT 241
Query: 292 QWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEML 338
+ V T Y APE++L ++ Y D WS+G I E+L
Sbjct: 242 G---------H--VVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 53/240 (22%), Positives = 93/240 (38%), Gaps = 39/240 (16%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLF 172
L+G+G G+V I A+K + ++ ++ E + +V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 173 YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVL-AIHSIHQHNYVHRD 231
+ LY+ M + G D+ +L R+ L+ A I + A+ + H HRD
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRA-VAIVRQIGSALDAAHAAGATHRD 159
Query: 232 IKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 291
+KP+N+++ + L DFG+ D E +++
Sbjct: 160 VKPENILVSADDFAYLVDFGIASATTD---------------EKLTQLG----------- 193
Query: 292 QWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI 351
+TVGTL YMAPE + D ++L ++YE L G PP+ D +
Sbjct: 194 -----------NTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV 242
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-27
Identities = 69/362 (19%), Positives = 122/362 (33%), Gaps = 110/362 (30%)
Query: 108 FEQLTLIGKGAFGEVRLCRAK--TTGEIFAMKKL-------------------------- 139
+ +G G+FG V C +G+ FA+KK+
Sbjct: 9 YSLGKTLGTGSFGIV--CEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLV 66
Query: 140 -----KKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGD-- 192
E K Q ++ + + + + +L +IMEY+P
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLH 125
Query: 193 --IMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD-KNGHLKLSD 249
+ + + + ++ YI + A+ IH HRDIKP NL+++ K+ LKL D
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCD 185
Query: 250 FGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLD 309
FG K L ++ +V+ + +
Sbjct: 186 FGSAKKLIP-------------SEPSVAY--------------------------ICSRF 206
Query: 310 YMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYPPFCSDD---------------PRITC 353
Y APE++L Y D WS+G + E+++G P F + +
Sbjct: 207 YRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQM 266
Query: 354 RKIVNWKTCLKFPEEPKIS----------DEARDLICHLLC-DVETRLGTRGVEELKEHP 402
++ T ++FP A DL+ +L + + R+ E HP
Sbjct: 267 IRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI---NPYEAMAHP 323
Query: 403 WF 404
+F
Sbjct: 324 FF 325
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 55/242 (22%), Positives = 100/242 (41%), Gaps = 37/242 (15%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 167
++ + +G G V L A+K + K ++ E + +++ +
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 168 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 227
IV + ++ D YL+MEY+ G + + LS D A + + + I H
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRI 132
Query: 228 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 287
VHRDIKP N+++D N LK+ DFG+ K +++ ++++
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAK---------------ALSETSLTQTN------- 170
Query: 288 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSD 347
+GT+ Y +PE + D +S+G ++YEML+G PPF +
Sbjct: 171 ---------------HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE 215
Query: 348 DP 349
Sbjct: 216 TA 217
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 57/241 (23%), Positives = 99/241 (41%), Gaps = 39/241 (16%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLF 172
++G G EV L R A+K L+ R E A ++ IV ++
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 173 ----YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYV 228
Y++MEY+ G + ++ E ++ A IA++ A++ HQ+ +
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGII 138
Query: 229 HRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKE 288
HRD+KP N+++ +K+ DFG+ + + D +S+ T +
Sbjct: 139 HRDVKPANIMISATNAVKVMDFGIARAIADSGNSV-----------TQTA---------- 177
Query: 289 RLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDD 348
+ +GT Y++PE D +SLG ++YE+L G PPF D
Sbjct: 178 --------------AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223
Query: 349 P 349
P
Sbjct: 224 P 224
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 60/255 (23%), Positives = 110/255 (43%), Gaps = 32/255 (12%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKL----KKSEMLKRGQVEHVRSERNLLA 161
D++ LIG+G++G V L K T + A+KK+ + KR +R E +L
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRI----LR-EITILN 80
Query: 162 EVDSRCIVQL---FYSFQDSDF--LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESV 216
+ S I++L F LY+++E D+ L L+E+ + + +
Sbjct: 81 RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLL 139
Query: 217 LAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETV 276
L + IH+ +HRD+KP N +L+++ +K+ DFGL + + + + ++ D + +
Sbjct: 140 LGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP 199
Query: 277 SEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMY 335
+ + + +W Y APE++L + Y D WS G I
Sbjct: 200 HNKNLKKQLTSHVVTRW----------------YRAPELILLQENYTKSIDIWSTGCIFA 243
Query: 336 EMLIGYPPFCSDDPR 350
E+L +D
Sbjct: 244 ELLNMLQSHINDPTN 258
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 77/359 (21%), Positives = 131/359 (36%), Gaps = 91/359 (25%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRA--KTTGEIFAMKKL----KKSEMLKRGQVE-----HVR 154
+E + +GKGA+G V ++ + TGE+ A+KK+ + S +R E +
Sbjct: 9 RKYELVKKLGKGAYGIV--WKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS 66
Query: 155 SERNLLAEVDSRCIVQLFYSFQDSDF--LYLIMEYLPGGDIMTLLMREDILSEDVARFYI 212
N IV L + + +YL+ +Y+ D + ++R +IL ++ +
Sbjct: 67 GHEN---------IVNLLNVLRADNDRDVYLVFDYM-ETD-LHAVIRANILEPVHKQYVV 115
Query: 213 AESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIIN 272
+ + I +H +HRD+KP N++L+ H+K++DFGL + + I
Sbjct: 116 YQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINE 175
Query: 273 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLG 331
+ + + Y V T Y APE+LL Y D WSLG
Sbjct: 176 NTENFDDDQPILTD---------------Y--VATRWYRAPEILLGSTKYTKGIDMWSLG 218
Query: 332 AIMYEMLIGYPPF---------------------------CSDD-----------PRITC 353
I+ E+L G P F S I
Sbjct: 219 CILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQ 278
Query: 354 RKIVNWKTCLKFPEE-----PKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406
+ T K ++EA DL+ LL + R+ + +HP+
Sbjct: 279 SNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRI---SANDALKHPFVSI 334
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 84/339 (24%), Positives = 140/339 (41%), Gaps = 80/339 (23%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRA--KTTGEIFAMKKLK---KSEMLKRGQVEHVRSERNLL 160
DF+ +L+G+GA+G V C A K TGEI A+KK++ K R +R E +L
Sbjct: 11 SDFQLKSLLGEGAYGVV--CSATHKPTGEIVAIKKIEPFDKPLFALRT----LR-EIKIL 63
Query: 161 AEVDSRCIVQL---FYSFQDSDF--LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAES 215
I+ + +F +Y+I E + D + ++ +LS+D +++I ++
Sbjct: 64 KHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTD-LHRVISTQMLSDDHIQYFIYQT 121
Query: 216 VLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQET 275
+ A+ +H N +HRD+KP NL+++ N LK+ DFGL + +++ +
Sbjct: 122 LRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA-----------ADNS 170
Query: 276 VSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIM 334
+ M+ + V T Y APEV+L Y D WS G I+
Sbjct: 171 EPTGQQSGMVE---------------F--VATRWYRAPEVMLTSAKYSRAMDVWSCGCIL 213
Query: 335 YEMLIGYPPFCSDDP-----RIT-----------CRKIVNWKT---CLKFPEEPKI---- 371
E+ + P F D I R I + + P P
Sbjct: 214 AELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEK 273
Query: 372 -----SDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404
+ + DL+ +L D R+ T +E EHP+
Sbjct: 274 MFPRVNPKGIDLLQRMLVFDPAKRI-T--AKEALEHPYL 309
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 55/260 (21%), Positives = 96/260 (36%), Gaps = 64/260 (24%)
Query: 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN--LL 160
+ +D+ + L LIG+G +G V + A+K + ++ +E+N +
Sbjct: 10 LDLDNLKLLELIGRGRYGAV--YKGSLDERPVAVKVFSFANR------QNFINEKNIYRV 61
Query: 161 AEVDSRCIVQLF-----YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAES 215
++ I + + L+MEY P G + L R +A S
Sbjct: 62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCR--LAHS 119
Query: 216 V---LA-IHS------IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265
V LA +H+ ++ HRD+ N+++ +G +SDFGL L
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179
Query: 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL-------LK 318
E+++ E VGT+ YMAPEVL
Sbjct: 180 EEDNAAISE------------------------------VGTIRYMAPEVLEGAVNLRDX 209
Query: 319 KGYGMECDWWSLGAIMYEML 338
+ + D ++LG I +E+
Sbjct: 210 ESALKQVDMYALGLIYWEIF 229
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 64/346 (18%), Positives = 114/346 (32%), Gaps = 90/346 (26%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAK-TTGEIFAMKKLKKSEMLKRGQV--EHVRS------E 156
+ I G++G V C + G A+K++ + R E
Sbjct: 22 SPYTVQRFISSGSYGAV--CAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE 79
Query: 157 RNLLAEVDSRCIVQL---FYSFQDSDF--LYLIMEYLPGGDIMTLL-MREDILSEDVARF 210
LL I+ L F F++ LYL+ E + D+ ++ + ++S ++
Sbjct: 80 IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQY 138
Query: 211 YIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 270
++ +L +H +H+ VHRD+ P N++L N + + DF L +
Sbjct: 139 FMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR---------------- 182
Query: 271 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWS 329
+ Y V Y APE++++ KG+ D WS
Sbjct: 183 ------EDTADANKTH---------------Y--VTHRWYRAPELVMQFKGFTKLVDMWS 219
Query: 330 LGAIMYEMLIGYPPFCSDDP--------------------RITCRKIVNW-KTCLKFPEE 368
G +M EM F + ++ + L
Sbjct: 220 AGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPA 279
Query: 369 -------PKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406
P A DLI +L + + R+ E+ HP+F
Sbjct: 280 RAWTAVVPTADPVALDLIAKMLEFNPQRRI---STEQALRHPYFES 322
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 52/263 (19%), Positives = 85/263 (32%), Gaps = 60/263 (22%)
Query: 107 DFEQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV 163
+ L IGKG FGEV R K GE A+K E + +E +
Sbjct: 40 IARTIVLQESIGKGRFGEV--WRGKWRGEEVAVKIFSSREE----RSWFREAEIYQTVML 93
Query: 164 DSRCIVQLFYSFQDSDF----LYLIMEYLPGGDIMTLLMREDILSEDVARF--YIAESVL 217
I+ + + L+L+ +Y G + L R + E + + A +
Sbjct: 94 RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLA 153
Query: 218 AIHSIHQHNY-----VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIIN 272
+H HRD+K N+++ KNG ++D GL + +I +
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP----- 208
Query: 273 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG------YGMECD 326
VGT YMAPEVL D
Sbjct: 209 -----------------------------NHRVGTKRYMAPEVLDDSINMKHFESFKRAD 239
Query: 327 WWSLGAIMYEMLIGYPPFCSDDP 349
+++G + +E+ +
Sbjct: 240 IYAMGLVFWEIARRCSIGGIHED 262
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 52/252 (20%), Positives = 90/252 (35%), Gaps = 60/252 (23%)
Query: 108 FEQLTLIGKGAFGEVRLCR-AKTTGEIFAMKKLKKS---EMLKRGQVEHVRSERNLLAEV 163
+E I G G + L G +K L S E +ER LAEV
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAM-----AMAERQFLAEV 136
Query: 164 DSRCIVQLFYSFQDSD-----FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLA 218
IVQ+F + +D Y++MEY+ G + ++ L A Y+ E + A
Sbjct: 137 VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK--LPVAEAIAYLLEILPA 194
Query: 219 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 278
+ +H V+ D+KP+N++L + LKL D G + + + +
Sbjct: 195 LSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRI-NSFGYL--------------- 237
Query: 279 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338
GT + APE+ ++ G + D +++G + +
Sbjct: 238 --------------------------YGTPGFQAPEI-VRTGPTVATDIYTVGRTLAALT 270
Query: 339 IGYPPFCSDDPR 350
+ P
Sbjct: 271 LDLPTRNGRYVD 282
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 77/339 (22%), Positives = 128/339 (37%), Gaps = 90/339 (26%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKL----KKSEMLKRGQVEHVRSERNLLA 161
+ ++ L+ +G GA+G V TG A+KKL + KR R E LL
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YR-ELRLLK 83
Query: 162 EVDSRCIVQLF------YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAES 215
+ ++ L S ++ + +YL+ + G D + +++ L++D +F I +
Sbjct: 84 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GAD-LNNIVKCQKLTDDHVQFLIYQI 141
Query: 216 VLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQET 275
+ + IH + +HRD+KP NL ++++ LK+ DFGL + D
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD----------------- 184
Query: 276 VSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIM 334
M V T Y APE++L Y D WS+G IM
Sbjct: 185 --------EMTGY----------------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 220
Query: 335 YEMLIGYPPFCSDDP-----RIT----------CRKIVNWKT---CLKFPEEPKI----- 371
E+L G F D I +KI + + PK+
Sbjct: 221 AELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV 280
Query: 372 ----SDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 405
+ A DL+ +L D + R+ + H +F
Sbjct: 281 FIGANPLAVDLLEKMLVLDSDKRI---TAAQALAHAYFA 316
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 50/265 (18%), Positives = 88/265 (33%), Gaps = 60/265 (22%)
Query: 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE 162
+ L + +G FG V +A+ E A+K + Q E L
Sbjct: 21 FQSMPLQLLEVKARGRFGCV--WKAQLLNEYVAVKIFPIQD----KQSWQNEYEVYSLPG 74
Query: 163 VDSRCIVQLF----YSFQDSDFLYLIMEYLPGGDIMTLLMREDI-------LSEDVAR-- 209
+ I+Q L+LI + G + L + ++E +AR
Sbjct: 75 MKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGL 134
Query: 210 FYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDED 269
Y+ E + + H+ HRDIK N++L N ++DFGL + +
Sbjct: 135 AYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL--------ALKFEAGKS 186
Query: 270 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL-----LKKGYGME 324
+ + VGT YMAPEVL ++ +
Sbjct: 187 AGD-----------THGQ-----------------VGTRRYMAPEVLEGAINFQRDAFLR 218
Query: 325 CDWWSLGAIMYEMLIGYPPFCSDDP 349
D +++G +++E+
Sbjct: 219 IDMYAMGLVLWELASRCTAADGPVD 243
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 78/336 (23%), Positives = 127/336 (37%), Gaps = 82/336 (24%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLK---KSEMLKRGQVEHVRSERNLLAE 162
+ L+ IG+GA+G V A+KK+ +R +R E +L
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT----LR-EIKILLR 81
Query: 163 VDSRCIVQL---FYSFQDSDF--LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVL 217
I+ + + +Y++ + + D + L++ LS D +++ + +
Sbjct: 82 FRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETD-LYKLLKTQHLSNDHICYFLYQILR 139
Query: 218 AIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVS 277
+ IH N +HRD+KP NL+L+ LK+ DFGL + D D + ++
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA----------DPDHDHTGFLT 189
Query: 278 EAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYE 336
E Y V T Y APE++L KGY D WS+G I+ E
Sbjct: 190 E-----------------------Y--VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAE 224
Query: 337 MLIGYPPFCSDDP-----RIT----------CRKIVNWKT---CLKFPEEPKI------- 371
ML P F I I+N K L P + K+
Sbjct: 225 MLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFP 284
Query: 372 --SDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404
+A DL+ +L + R+ VE+ HP+
Sbjct: 285 NADSKALDLLDKMLTFNPHKRI---EVEQALAHPYL 317
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 82/338 (24%), Positives = 126/338 (37%), Gaps = 90/338 (26%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKL----KKSEMLKRGQVEHVRSERNLLA 161
+ L +G GA+G V TG A+KKL + KR R E LL
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA----YR-ELRLLK 79
Query: 162 EVDSRCIVQLF------YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAES 215
+ ++ L + D YL+M ++ G D + LM+ + L ED +F + +
Sbjct: 80 HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTD-LGKLMKHEKLGEDRIQFLVYQM 137
Query: 216 VLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQET 275
+ + IH +HRD+KP NL ++++ LK+ DFGL + + + +
Sbjct: 138 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG------------- 184
Query: 276 VSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIM 334
Y V T Y APEV+L Y D WS+G IM
Sbjct: 185 --------------------------Y--VVTRWYRAPEVILNWMRYTQTVDIWSVGCIM 216
Query: 335 YEMLIGYPPFCSDDP-----RIT----------CRKIVNWKT---CLKFPEEPKI----- 371
EM+ G F D I +++ + + PE K
Sbjct: 217 AEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASI 276
Query: 372 ----SDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404
S A +L+ +L D E R+ E HP+F
Sbjct: 277 LTNASPLAVNLLEKMLVLDAEQRV---TAGEALAHPYF 311
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 4e-23
Identities = 49/263 (18%), Positives = 84/263 (31%), Gaps = 60/263 (22%)
Query: 107 DFEQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV 163
+Q+ + IGKG +GEV K GE A+K +E +E +
Sbjct: 35 IAKQIQMVKQIGKGRYGEV--WMGKWRGEKVAVKVFFTTEE----ASWFRETEIYQTVLM 88
Query: 164 DSRCIVQLFYSFQDSDF----LYLIMEYLPGGDIMTLLMREDILSEDVARF--YIAESVL 217
I+ + LYLI +Y G + L + ++ + + +
Sbjct: 89 RHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLC 148
Query: 218 AIHS-----IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIIN 272
+H+ + HRD+K N+++ KNG ++D GL
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV------------------ 190
Query: 273 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL------LKKGYGMECD 326
+ + VGT YM PEVL + D
Sbjct: 191 ----------------KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMAD 234
Query: 327 WWSLGAIMYEMLIGYPPFCSDDP 349
+S G I++E+ +
Sbjct: 235 MYSFGLILWEVARRCVSGGIVEE 257
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 5e-23
Identities = 54/263 (20%), Positives = 85/263 (32%), Gaps = 64/263 (24%)
Query: 109 EQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
+TL +GKG +GEV R GE A+K + + +E +
Sbjct: 8 RDITLLECVGKGRYGEV--WRGSWQGENVAVKIFSSRDE----KSWFRETELYNTVMLRH 61
Query: 166 RCIVQLF----YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESV---LA 218
I+ S S L+LI Y G + L + + R I S+ LA
Sbjct: 62 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLR--IVLSIASGLA 119
Query: 219 -IHSIHQHNY-----VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIIN 272
+H HRD+K N+++ KNG ++D GL + + + +
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN----- 174
Query: 273 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL------LKKGYGMECD 326
VGT YMAPEVL D
Sbjct: 175 -----------------------------NPRVGTKRYMAPEVLDETIQVDCFDSYKRVD 205
Query: 327 WWSLGAIMYEMLIGYPPFCSDDP 349
W+ G +++E+ +
Sbjct: 206 IWAFGLVLWEVARRMVSNGIVED 228
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 72/344 (20%), Positives = 121/344 (35%), Gaps = 94/344 (27%)
Query: 108 FEQLTLIGKGAFGEVRLCRA--KTTGEIFAMKKL--KKSEMLKRGQVEHVRSERNLLAEV 163
+ L +G G G V A + A+KK+ + +K +R E ++ +
Sbjct: 13 YMDLKPLGCGGNGLV--FSAVDNDCDKRVAIKKIVLTDPQSVKHA----LR-EIKIIRRL 65
Query: 164 DSRCIVQLF--------------YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVAR 209
D IV++F S + + +Y++ EY+ D + ++ + L E+ AR
Sbjct: 66 DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETD-LANVLEQGPLLEEHAR 123
Query: 210 FYIAESVLAIHSIHQHNYVHRDIKPDNLILD-KNGHLKLSDFGLCKPLEDKYSSILLEDE 268
++ + + + IH N +HRD+KP NL ++ ++ LK+ DFGL + ++ YS
Sbjct: 124 LFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS------- 176
Query: 269 DIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDW 327
+ + T Y +P +LL Y D
Sbjct: 177 -----------HKGHLSE---------------G--LVTKWYRSPRLLLSPNNYTKAIDM 208
Query: 328 WSLGAIMYEMLIGYPPFCSDDPRITCRKIVNW-----------------KTCLKFPEEPK 370
W+ G I EML G F + I+ EP
Sbjct: 209 WAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPH 268
Query: 371 I---------SDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404
S EA D + +L RL EE HP+
Sbjct: 269 KPLTQLLPGISREAVDFLEQILTFSPMDRL---TAEEALSHPYM 309
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 83/343 (24%), Positives = 130/343 (37%), Gaps = 97/343 (28%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKL----KKSEMLKRGQVEHVRSERNLLA 161
+ T +G GA+G V K +GE A+KKL + KR R E LL
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRA----YR-ELLLLK 78
Query: 162 EVDSRCIVQL---------FYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYI 212
+ ++ L +F D YL+M ++ D+ ++ + SE+ ++ +
Sbjct: 79 HMQHENVIGLLDVFTPASSLRNFYD---FYLVMPFM-QTDLQKIMGLK--FSEEKIQYLV 132
Query: 213 AESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIIN 272
+ + + IH VHRD+KP NL ++++ LK+ DFGL + + +
Sbjct: 133 YQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE------------- 179
Query: 273 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLG 331
M Y V T Y APEV+L Y D WS+G
Sbjct: 180 -----------MTG---------------Y--VVTRWYRAPEVILSWMHYNQTVDIWSVG 211
Query: 332 AIMYEMLIGYPPFCSDDP-----RIT----------CRKIVNWKT---CLKFPEEPKI-- 371
IM EML G F D +I +K+ + P+ P+
Sbjct: 212 CIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDF 271
Query: 372 -------SDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406
S +A DL+ +L DV+ RL + HP+F
Sbjct: 272 TQLFPRASPQAADLLEKMLELDVDKRL---TAAQALTHPFFEP 311
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 76/348 (21%), Positives = 122/348 (35%), Gaps = 99/348 (28%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKL----KKSEMLKRGQVEHVRSERNLLA 161
++ L IG GA G V A+KKL + KR R E L+
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA----YR-ELVLMK 79
Query: 162 EVDSRCIVQLF------YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAES 215
V+ + I+ L S ++ +Y++ME + ++ ++ E L + + + +
Sbjct: 80 CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMSYLLYQM 136
Query: 216 VLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQET 275
+ I +H +HRD+KP N+++ + LK+ DFGL +
Sbjct: 137 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG------------------ 178
Query: 276 VSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 335
M P Y V T Y APEV+L GY D WS+G IM
Sbjct: 179 ----TSFMMTP---------------Y--VVTRYYRAPEVILGMGYKENVDIWSVGCIMG 217
Query: 336 EMLIGYPPFCSDDP-----RIT-----------------CRKIV---------------- 357
EM+ G F D ++ R V
Sbjct: 218 EMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFP 277
Query: 358 NWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404
+ + +ARDL+ +L D R+ V+E +HP+
Sbjct: 278 DVLFPADSEHNKLKASQARDLLSKMLVIDASKRI---SVDEALQHPYI 322
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 2e-22
Identities = 74/348 (21%), Positives = 122/348 (35%), Gaps = 99/348 (28%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKL----KKSEMLKRGQVEHVRSERNLLA 161
++ L IG GA G V A+KKL + KR R E L+
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA----YR-ELVLMK 116
Query: 162 EVDSRCIVQLF------YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAES 215
V+ + I+ L + ++ +YL+ME + ++ ++ E L + + + +
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMSYLLYQM 173
Query: 216 VLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQET 275
+ I +H +HRD+KP N+++ + LK+ DFGL +
Sbjct: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG------------------ 215
Query: 276 VSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 335
M P Y V T Y APEV+L GY D WS+G IM
Sbjct: 216 ----TSFMMTP---------------Y--VVTRYYRAPEVILGMGYKENVDIWSVGCIMG 254
Query: 336 EMLIGYPPFCSDDPRITCRKIVN-----------------WKTCLKFPEEPKIS------ 372
EM+ F D K++ P+ ++
Sbjct: 255 EMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFP 314
Query: 373 ---------------DEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404
+ARDL+ +L D R+ V++ +HP+
Sbjct: 315 DSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI---SVDDALQHPYI 359
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 3e-22
Identities = 70/378 (18%), Positives = 129/378 (34%), Gaps = 118/378 (31%)
Query: 96 MRLQRRKIGIDDFEQLTL-IGKGAFGEVRLCRAK--TTGEIFAMKKLKKSEMLKRGQVEH 152
+ +R ++ D FE +G+G +G V + K + +A+K+++ + + E
Sbjct: 11 LSSERERV-EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREI 69
Query: 153 VRSERNLLAEVDSRCIVQL---FYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVAR 209
LL E+ ++ L F S D ++L+ +Y D+ ++ +
Sbjct: 70 -----ALLRELKHPNVISLQKVFLSHADRK-VWLLFDYAEH-DLWHIIKFHRASKANKKP 122
Query: 210 FYIAESVL---------AIHSIHQHNYVHRDIKPDNLIL----DKNGHLKLSDFGL---- 252
+ ++ IH +H + +HRD+KP N+++ + G +K++D G
Sbjct: 123 VQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182
Query: 253 CKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMA 312
PL+ + + V T Y A
Sbjct: 183 NSPLK-PLADLDPV--------------------------------------VVTFWYRA 203
Query: 313 PEVLL-KKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCR---------KIV----- 357
PE+LL + Y D W++G I E+L P F I +I
Sbjct: 204 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 263
Query: 358 ----NWKTCLKFPE-------------------------EPKISDEARDLICHLLC-DVE 387
+W+ K PE + K +A L+ LL D
Sbjct: 264 PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPI 323
Query: 388 TRLGTRGVEELKEHPWFR 405
R+ E+ + P+F
Sbjct: 324 KRI---TSEQAMQDPYFL 338
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 6e-22
Identities = 53/243 (21%), Positives = 103/243 (42%), Gaps = 48/243 (19%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLK-KSEMLKRGQVE-HVRSERNLLAEVDS 165
+E L +IGKG+FG+V + A+K ++ + ++ E + + ++
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI--LSEDVARFYIAESVLAIHSIH 223
++ + +F + + + E L ++ L+ + S + R + + + ++H
Sbjct: 159 MNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 224 QHNYVHRDIKPDNLILDKNGH--LKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 281
++ +H D+KP+N++L + G +K+ DFG S E + +
Sbjct: 218 KNRIIHCDLKPENILLKQQGRSGIKVIDFG----------SSCYEHQRV----------- 256
Query: 282 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341
Y+ + + Y APEV+L YGM D WSLG I+ E+L GY
Sbjct: 257 --------------------YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
Query: 342 PPF 344
P
Sbjct: 297 PLL 299
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 6e-19
Identities = 63/246 (25%), Positives = 102/246 (41%), Gaps = 52/246 (21%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLK-KSEMLKRGQVE-HVRSERNLLAEVDS 165
+E +LIGKG+FG+V + E A+K +K K L + Q+E + N
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI--LSEDVARFY---IAESVLAIH 220
IV L F + L L+ E L ++ LL + +S ++ R + + ++L +
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174
Query: 221 SIHQHNYVHRDIKPDNLIL--DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 278
+ + + +H D+KP+N++L K +K+ DFG S + I
Sbjct: 175 T-PELSIIHCDLKPENILLCNPKRSAIKIVDFG----------SSCQLGQRI-------- 215
Query: 279 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338
Y + + Y +PEVLL Y + D WSLG I+ EM
Sbjct: 216 -----------------------YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMH 252
Query: 339 IGYPPF 344
G P F
Sbjct: 253 TGEPLF 258
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 8e-19
Identities = 18/155 (11%), Positives = 44/155 (28%), Gaps = 7/155 (4%)
Query: 111 LTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQ 170
L G + A+ + +L ++ S L+ +D + +
Sbjct: 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 171 LFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVL-AIHSIHQHNYVH 229
+ ++ E++ GG + + R +S+ A + H+
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA-DTSPSPVGAIR--AMQSLAAAADAAHRAGVAL 152
Query: 230 RDIKPDNLILDKNGHLKLSDFGLCKPLE---DKYS 261
P + + +G + L+ D
Sbjct: 153 SIDHPSRVRVSIDGDVVLAYPATMPDANPQDDIRG 187
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 8e-19
Identities = 50/250 (20%), Positives = 95/250 (38%), Gaps = 40/250 (16%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLK-KSEMLKRGQVEHVRSERNL-LAEVDS 165
F + +G G FG V LC+ + +A+K ++ + + ++E + + ++++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE-ADILKKIQNDDINN 95
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI--LSEDVARFYIAESVLAIHSIH 223
IV+ F D + LI E L G + ++ R + + + Y E + A++ +
Sbjct: 96 NNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR 154
Query: 224 QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI---------INQE 274
+ + H D+KP+N++LD K K + I +
Sbjct: 155 KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD 214
Query: 275 TVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIM 334
S + T Y APEV+L G+ + D WS G ++
Sbjct: 215 YH-------------------------GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL 249
Query: 335 YEMLIGYPPF 344
E+ G F
Sbjct: 250 AELYTGSLLF 259
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 46/262 (17%), Positives = 98/262 (37%), Gaps = 62/262 (23%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLK-KSEMLKRGQVE-----HVRSERNLLA 161
+ + +G G F V L + AMK ++ + + E V N
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 162 E-VDSRCIVQLFYSFQ----DSDFLYLIMEYLPGGDIMTLLMREDI--LSEDVARFYIAE 214
+ + + I++L F + + ++ E L G +++ L+ + + + + +
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQ 139
Query: 215 SVLAIHSIH-QHNYVHRDIKPDNLILD------KNGHLKLSDFGLCKPLEDKYSSILLED 267
+L + +H + +H DIKP+N++++ +K++D G + D
Sbjct: 140 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG----------NACWYD 189
Query: 268 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDW 327
E +++ T +Y +PEVLL +G D
Sbjct: 190 EHY-------------------------------TNSIQTREYRSPEVLLGAPWGCGADI 218
Query: 328 WSLGAIMYEMLIGYPPFCSDDP 349
WS +++E++ G F D+
Sbjct: 219 WSTACLIFELITGDFLFEPDEG 240
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 58/242 (23%), Positives = 93/242 (38%), Gaps = 53/242 (21%)
Query: 109 EQLTL---IGKGAFGEVRLCRAK----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA 161
L +G+G FG+V L TGE+ A+K LK + + E ++L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQ--HRSGWKQEIDILR 88
Query: 162 EVDSRCIVQLF--YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFY--IAESVL 217
+ I++ + L L+MEY+P G + L R I + F I E
Sbjct: 89 TLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICE--- 145
Query: 218 AIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVS 277
+ +H +Y+HRD+ N++LD + +K+ DFGL K + + +
Sbjct: 146 GMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE--------GHE----YYRV 193
Query: 278 EAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 336
+G P W APE L + + D WS G +YE
Sbjct: 194 REDGDS--PVF-----W-----------------YAPECLKEYKFYYASDVWSFGVTLYE 229
Query: 337 ML 338
+L
Sbjct: 230 LL 231
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 61/247 (24%), Positives = 91/247 (36%), Gaps = 62/247 (25%)
Query: 109 EQLTL---IGKGAFGEVRLCRAK----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA 161
L +GKG FG V +CR TGE+ A+KKL+ S + E +L
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE---EHLRDFEREIEILK 97
Query: 162 EVDSRCIVQLF--YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAI 219
+ IV+ L LIMEYLP G L D L + R + +
Sbjct: 98 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS---LR---DYLQKHKERIDHIKLLQYT 151
Query: 220 HSI-------HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIIN 272
I Y+HRD+ N++++ +K+ DFGL K L D++
Sbjct: 152 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ--------DKE--- 200
Query: 273 QETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLG 331
+ G+ P W APE L + + + D WS G
Sbjct: 201 -YYKVKEPGES--PIF-----W-----------------YAPESLTESKFSVASDVWSFG 235
Query: 332 AIMYEML 338
++YE+
Sbjct: 236 VVLYELF 242
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 61/247 (24%), Positives = 91/247 (36%), Gaps = 62/247 (25%)
Query: 109 EQLTL---IGKGAFGEVRLCRAK----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA 161
L +GKG FG V +CR TGE+ A+KKL+ S + E +L
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE---EHLRDFEREIEILK 66
Query: 162 EVDSRCIVQLF--YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAI 219
+ IV+ L LIMEYLP G L D L + R + +
Sbjct: 67 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS---LR---DYLQKHKERIDHIKLLQYT 120
Query: 220 HSI-------HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIIN 272
I Y+HRD+ N++++ +K+ DFGL K L D++
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ--------DKE--- 169
Query: 273 QETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLG 331
+ G+ P W APE L + + + D WS G
Sbjct: 170 -FFKVKEPGES--PIF-----W-----------------YAPESLTESKFSVASDVWSFG 204
Query: 332 AIMYEML 338
++YE+
Sbjct: 205 VVLYELF 211
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 84.6 bits (209), Expect = 7e-18
Identities = 63/364 (17%), Positives = 105/364 (28%), Gaps = 78/364 (21%)
Query: 111 LTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLL---AEVDS-- 165
+ +G G F V L + AMK +K +E E E LL D
Sbjct: 42 IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPND 97
Query: 166 ---RCIVQLFYSFQ----DSDFLYLIMEYLPGGDIMTLLMR--EDILSEDVARFYIAESV 216
+VQL F+ + + ++ E L G ++ +++ L + I + +
Sbjct: 98 PNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVL 156
Query: 217 LAIHSIHQH-NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQET 275
+ +H +H DIKP+N++L N + + +
Sbjct: 157 QGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPP-SGSAVSTAPA 215
Query: 276 VSEAEGQWMMPKERLQQWKRNRRALAYSTVG---------TLDYMAPEVLLKKGYGMECD 326
+ + + ++ K L + T Y + EVL+ GY D
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPAD 275
Query: 327 WWSLGAIMYEMLIGYPPFCSDDPRITCRK------------------IVNWKTCLKF--- 365
WS + +E+ G F R IV K +F
Sbjct: 276 IWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTK 335
Query: 366 -------------------PEEPKISDEARDLICHLLC-----DVETRLGTRGVEELKEH 401
E+ + S E L E R E H
Sbjct: 336 KGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAA---ECLRH 392
Query: 402 PWFR 405
PW
Sbjct: 393 PWLN 396
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 55/251 (21%), Positives = 93/251 (37%), Gaps = 69/251 (27%)
Query: 109 EQLTL---IGKGAFGEVRLCRAKT----TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA 161
L +G+G FG+V LCR TGE A+K LK + ++ E +L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN--HIADLKKEIEILR 78
Query: 162 EVDSRCIVQLF--YSFQDSDFLYLIMEYLPGGDIMTLLMRED---------ILSEDVAR- 209
+ IV+ + + + LIME+LP G + L + + + +
Sbjct: 79 NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKG 138
Query: 210 -FYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDE 268
Y+ YVHRD+ N++++ +K+ DFGL K +E D+
Sbjct: 139 MDYLGS----------RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET--------DK 180
Query: 269 DIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDW 327
+ + P W APE L++ + + D
Sbjct: 181 EYY------TVKDDRDSPVF-----W-----------------YAPECLMQSKFYIASDV 212
Query: 328 WSLGAIMYEML 338
WS G ++E+L
Sbjct: 213 WSFGVTLHELL 223
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 5e-17
Identities = 49/261 (18%), Positives = 93/261 (35%), Gaps = 66/261 (25%)
Query: 108 FEQLTLIGKGAFGEVRLCR-AKTTGEIFAMKKLK-KSEMLKRGQVE-HVRSERNLLAEVD 164
+E + +G+G FG+V C A+K ++ + + ++E +V + + +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 165 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI--LSEDVARFYIAESVLAIHSI 222
V + F + + E L G + L + R + A+ +
Sbjct: 81 KFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFL 139
Query: 223 HQHNYVHRDIKPDNLIL-------------------DKNGHLKLSDFGLCKPLEDKYSSI 263
H++ H D+KP+N++ KN ++++DFG S+
Sbjct: 140 HENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG---------SAT 190
Query: 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGM 323
+ E + V T Y PEV+L+ G+
Sbjct: 191 F-DHEHH-------------------------------TTIVATRHYRPPEVILELGWAQ 218
Query: 324 ECDWWSLGAIMYEMLIGYPPF 344
CD WS+G I++E G+ F
Sbjct: 219 PCDVWSIGCILFEYYRGFTLF 239
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 6e-17
Identities = 64/251 (25%), Positives = 94/251 (37%), Gaps = 70/251 (27%)
Query: 109 EQLTL---IGKGAFGEVRLCRAKT----TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA 161
L +GKG FG V LCR TG + A+K+L+ S Q + E +L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD---QQRDFQREIQILK 79
Query: 162 EVDSRCIVQLF--YSFQDSDFLYLIMEYLPGGDIMTLLMRED---------ILSEDVAR- 209
+ S IV+ L L+MEYLP G + L R + S + +
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 139
Query: 210 -FYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDE 268
Y+ VHRD+ N++++ H+K++DFGL K +L D+
Sbjct: 140 MEYLGS----------RRCVHRDLAARNILVESEAHVKIADFGLAK--------LLPLDK 181
Query: 269 DIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDW 327
D V GQ P W APE L + + D
Sbjct: 182 D----YYVVREPGQS--PIF-----W-----------------YAPESLSDNIFSRQSDV 213
Query: 328 WSLGAIMYEML 338
WS G ++YE+
Sbjct: 214 WSFGVVLYELF 224
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 7e-17
Identities = 54/264 (20%), Positives = 102/264 (38%), Gaps = 69/264 (26%)
Query: 99 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIF----AMKKLKKSEMLKRGQVEHVR 154
R + +F+++ ++G GAFG V GE A+K+L+++ K + +
Sbjct: 8 LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEIL 65
Query: 155 SERNLLAEVDSRCIVQLF-YSFQDSDFLYLIMEYLPGGDIMTLLMRED---------ILS 204
E ++A VD+ + +L + + LI + +P G ++ +
Sbjct: 66 DEAYVMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC 123
Query: 205 EDVAR--FYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 262
+A+ Y+ + VHRD+ N+++ H+K++DFGL K L
Sbjct: 124 VQIAKGMNYLED----------RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA---- 169
Query: 263 ILLEDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY 321
++ G+ P K W MA E +L + Y
Sbjct: 170 ---------EEKEYHAEGGKV--PIK-----W-----------------MALESILHRIY 196
Query: 322 GMECDWWSLGAIMYEML-IGYPPF 344
+ D WS G ++E++ G P+
Sbjct: 197 THQSDVWSYGVTVWELMTFGSKPY 220
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 8e-17
Identities = 50/251 (19%), Positives = 93/251 (37%), Gaps = 46/251 (18%)
Query: 108 FEQLTLIGKGAFGEVRLCR-AKTTGEIFAMKKLK-KSEMLKRGQVE-HVRSERNLLAEVD 164
+E + +G+GAFG+V C K G A+K +K + + E V N
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 165 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI--LSEDVARFYIAESVLAIHSI 222
+ VQ+ F+ + ++ E L G + D R + +++ +
Sbjct: 76 TFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFL 134
Query: 223 HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL---------LEDEDIINQ 273
H + H D+KP+N++ ++ + + + + + + + +DE
Sbjct: 135 HSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH--- 191
Query: 274 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 333
+ V T Y APEV+L G+ CD WS+G I
Sbjct: 192 ----------------------------STLVSTRHYRAPEVILALGWSQPCDVWSIGCI 223
Query: 334 MYEMLIGYPPF 344
+ E +G+ F
Sbjct: 224 LIEYYLGFTVF 234
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 61/341 (17%), Positives = 125/341 (36%), Gaps = 67/341 (19%)
Query: 24 LDPDVSVSSPVTRQKAAAAKQFIENHYKNYLQGLQDRKERRRALQMRAQQAAVSNEEQEE 83
+DP R++A+ A + L G+ +E +L +A + +
Sbjct: 4 IDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANT 63
Query: 84 MLRNLERRETEYMRLQRRKIGIDDFEQLTL---IGKGAFGEVRLCRAKTTGEIF---AMK 137
+ +L E ++ + + + IG+G FG V A+K
Sbjct: 64 VHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK 123
Query: 138 KLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLF-YSFQDSDFLYLIMEYLPGGDIMTL 196
L + + +V +E ++ + ++ L + +++ Y+ GD+
Sbjct: 124 SLNRITDIG--EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF 181
Query: 197 LMRE-------DILS--EDVAR--FYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHL 245
+ E D++ VA+ ++A +VHRD+ N +LD+ +
Sbjct: 182 IRNETHNPTVKDLIGFGLQVAKGMKFLAS----------KKFVHRDLAARNCMLDEKFTV 231
Query: 246 KLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYST 304
K++DFGL + + D++ + + A +P K W
Sbjct: 232 KVADFGL---------ARDMYDKEFDSVHNKTGA----KLPVK-----W----------- 262
Query: 305 VGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML-IGYPPF 344
MA E L + + + D WS G +++E++ G PP+
Sbjct: 263 ------MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 297
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 8e-16
Identities = 61/256 (23%), Positives = 102/256 (39%), Gaps = 66/256 (25%)
Query: 107 DFEQLTL----IGKGAFGEVR--LCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLL 160
D + LTL +G G FG V+ + K + A+K LK + E + E N++
Sbjct: 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA-EANVM 72
Query: 161 AEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSE--------DVAR--F 210
++D+ IV++ +++ L+ME G + L + + + V+
Sbjct: 73 QQLDNPYIVRM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 131
Query: 211 YIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 270
Y+ E N+VHRD+ N++L + K+SDFGL S L DE+
Sbjct: 132 YLEE----------SNFVHRDLAARNVLLVTQHYAKISDFGL--------SKALRADEN- 172
Query: 271 INQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWS 329
++ G+W P K W APE + + + D WS
Sbjct: 173 ---YYKAQTHGKW--PVK-----W-----------------YAPECINYYKFSSKSDVWS 205
Query: 330 LGAIMYEML-IGYPPF 344
G +M+E G P+
Sbjct: 206 FGVLMWEAFSYGQKPY 221
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 9e-16
Identities = 67/309 (21%), Positives = 119/309 (38%), Gaps = 67/309 (21%)
Query: 48 NHYKNYLQGLQDRKERRRALQMRAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDD 107
+H+ ++ G ++ + + + + + EE R+ R ++ +I I+
Sbjct: 2 HHHHHHSSGRENLYFQGKLPEPQFYAEPHTYEEPGRAGRSFTRE------IEASRIHIEK 55
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIF---AMKKLKKSEMLKRGQVEHVRSERNLLAEVD 164
+IG G GEV R + G+ A+K LK + Q SE +++ + D
Sbjct: 56 -----IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER--QRRDFLSEASIMGQFD 108
Query: 165 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSI-- 222
I++L ++ EY+ G + T L D +F I + V + +
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD------GQFTIMQLVGMLRGVGA 162
Query: 223 -----HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVS 277
YVHRD+ N+++D N K+SDFGL + LED + +
Sbjct: 163 GMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED-------------DPDAAY 209
Query: 278 EAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 336
G +P + W APE + + + D WS G +M+E
Sbjct: 210 TTTGG-KIPIR-----W-----------------TAPEAIAFRTFSSASDVWSFGVVMWE 246
Query: 337 ML-IGYPPF 344
+L G P+
Sbjct: 247 VLAYGERPY 255
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 53/242 (21%), Positives = 90/242 (37%), Gaps = 42/242 (17%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
+D IG+G FGEV R + + A+K +++ E +L +
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPD--LKAKFLQEARILKQYSH 171
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL-MREDILSEDVARFYIAESVLAIHSIHQ 224
IV+L +Y++ME + GGD +T L L + ++ + +
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 225 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 284
+HRD+ N ++ + LK+SDFG+ + D + + G
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD---------------GVYAASGGLRQ 276
Query: 285 MP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML-IGYP 342
+P K W APE L Y E D WS G +++E +G
Sbjct: 277 VPVK-----W-----------------TAPEALNYGRYSSESDVWSFGILLWETFSLGAS 314
Query: 343 PF 344
P+
Sbjct: 315 PY 316
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 58/255 (22%), Positives = 102/255 (40%), Gaps = 63/255 (24%)
Query: 107 DFEQLTL---IGKGAFGEVRLCRAKTTGEIF---AMKKLKKSEMLKRGQVEHVRSERNLL 160
D +++ +G G FGEV R K + A+K LK K Q E +++
Sbjct: 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK--QRRDFLGEASIM 100
Query: 161 AEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIH 220
+ D I++L S + ++ EY+ G + + L + D A+F + + V +
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD------AQFTVIQLVGMLR 154
Query: 221 SI-------HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 273
I YVHRD+ N++++ N K+SDFGL + LED +
Sbjct: 155 GIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA----------- 203
Query: 274 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGT---LDYMAPEVLLKKGYGMECDWWSL 330
AY+T G + + +PE + + + D WS
Sbjct: 204 ---------------------------AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSY 236
Query: 331 GAIMYEML-IGYPPF 344
G +++E++ G P+
Sbjct: 237 GIVLWEVMSYGERPY 251
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 2e-15
Identities = 60/257 (23%), Positives = 90/257 (35%), Gaps = 74/257 (28%)
Query: 109 EQLTL---IGKGAFGEVRLCRAKTTGEIF---AMKKLKKSEMLKRGQVEHVRSERNLLAE 162
E + L +G+G FGEV A+K KK L E SE ++
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD--NKEKFMSEAVIMKN 69
Query: 163 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED---------ILSEDVAR--FY 211
+D IV+L + + ++IME P G++ L R + S + + Y
Sbjct: 70 LDHPHIVKL-IGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAY 128
Query: 212 IAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDII 271
+ N VHRDI N+++ +KL DFGL S +EDED
Sbjct: 129 LES----------INCVHRDIAVRNILVASPECVKLGDFGL---------SRYIEDED-- 167
Query: 272 NQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTL---DYMAPEVLLKKGYGMECDWW 328
Y T +M+PE + + + D W
Sbjct: 168 -----------------------------YYKASVTRLPIKWMSPESINFRRFTTASDVW 198
Query: 329 SLGAIMYEML-IGYPPF 344
M+E+L G PF
Sbjct: 199 MFAVCMWEILSFGKQPF 215
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 77.7 bits (191), Expect = 3e-15
Identities = 65/265 (24%), Positives = 106/265 (40%), Gaps = 66/265 (24%)
Query: 94 EYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIF--AMKKLKKSEMLKRGQVE 151
+ + L+R + I D E +G G FG VR + + A+K LK+ E
Sbjct: 328 KKLFLKRDNLLIADIE----LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTE 381
Query: 152 HVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM--REDILSEDVAR 209
+ E ++ ++D+ IV+L ++ L L+ME GG + L+ RE+I +VA
Sbjct: 382 EMMREAQIMHQLDNPYIVRL-IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE 440
Query: 210 F---------YIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 260
Y+ E N+VHR++ N++L + K+SDFGL
Sbjct: 441 LLHQVSMGMKYLEE----------KNFVHRNLAARNVLLVNRHYAKISDFGL-------- 482
Query: 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG 320
S L D+ + + G+W + W APE + +
Sbjct: 483 SKALGADDS----YYTARSAGKWPLK------W-----------------YAPECINFRK 515
Query: 321 YGMECDWWSLGAIMYEML-IGYPPF 344
+ D WS G M+E L G P+
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKPY 540
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 3e-15
Identities = 53/255 (20%), Positives = 91/255 (35%), Gaps = 62/255 (24%)
Query: 99 QRRKIGIDDFEQLTLIGKGAFGEVR--LCRAKTTGEIF-AMKKLKKSEMLKRGQVEHVRS 155
IG D L +G G+FG VR A + + A+K LK + + ++
Sbjct: 11 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIR 70
Query: 156 ERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED---------ILSED 206
E N + +D R +++L Y + + ++ E P G ++ L + +
Sbjct: 71 EVNAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 129
Query: 207 VAR--FYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264
VA Y+ ++HRD+ NL+L +K+ DFGL L
Sbjct: 130 VAEGMGYLES----------KRFIHRDLAARNLLLATRDLVKIGDFGL--------MRAL 171
Query: 265 LEDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGM 323
+++D V + + P W APE L + +
Sbjct: 172 PQNDD----HYVMQEHRKV--PFA-----W-----------------CAPESLKTRTFSH 203
Query: 324 ECDWWSLGAIMYEML 338
D W G ++EM
Sbjct: 204 ASDTWMFGVTLWEMF 218
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 59/260 (22%), Positives = 94/260 (36%), Gaps = 72/260 (27%)
Query: 107 DFEQLTL---IGKGAFGEVRLCRAKTTGEIF----AMKKLKKSEMLKRGQVEHVRSERNL 159
+T IG G FGEV KT+ A+K LK K Q E +
Sbjct: 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK--QRVDFLGEAGI 99
Query: 160 LAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED---------ILSEDVAR- 209
+ + I++L + +I EY+ G + L +D + +A
Sbjct: 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 159
Query: 210 -FYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDE 268
Y+A NYVHRD+ N++++ N K+SDFGL + LED +
Sbjct: 160 MKYLAN----------MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA------ 203
Query: 269 DIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGT---LDYMAPEVLLKKGYGMEC 325
Y+T G + + APE + + +
Sbjct: 204 --------------------------------TYTTSGGKIPIRWTAPEAISYRKFTSAS 231
Query: 326 DWWSLGAIMYEML-IGYPPF 344
D WS G +M+E++ G P+
Sbjct: 232 DVWSFGIVMWEVMTYGERPY 251
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 4e-15
Identities = 56/252 (22%), Positives = 99/252 (39%), Gaps = 69/252 (27%)
Query: 109 EQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
E L L +G+G FGEV + T + A+K LK M E E ++ ++
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSP----EAFLQEAQVMKKLRH 321
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED----------ILSEDVAR--FYIA 213
+VQL+ + Y++ EY+ G ++ L E ++ +A Y+
Sbjct: 322 EKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 380
Query: 214 ESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 273
NYVHRD++ N+++ +N K++DFGL + +ED
Sbjct: 381 R----------MNYVHRDLRAANILVGENLVCKVADFGLARLIED--------------N 416
Query: 274 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 333
E + ++ + +W APE L + ++ D WS G +
Sbjct: 417 EYTARQGAKFPI------KW-----------------TAPEAALYGRFTIKSDVWSFGIL 453
Query: 334 MYEML-IGYPPF 344
+ E+ G P+
Sbjct: 454 LTELTTKGRVPY 465
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 5e-15
Identities = 55/254 (21%), Positives = 94/254 (37%), Gaps = 69/254 (27%)
Query: 107 DFEQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV 163
D +LT IG G FG V L ++ A+K +++ M E E ++ ++
Sbjct: 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAM----SEEDFIEEAEVMMKL 60
Query: 164 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED---------ILSEDVAR--FYI 212
+VQL+ + + L+ E++ G + L + + DV Y+
Sbjct: 61 SHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120
Query: 213 AESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIIN 272
E +HRD+ N ++ +N +K+SDFG+ + + D +
Sbjct: 121 EE----------ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-------------D 157
Query: 273 QETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLG 331
Q T S P K W +PEV Y + D WS G
Sbjct: 158 QYTSSTGT---KFPVK-----W-----------------ASPEVFSFSRYSSKSDVWSFG 192
Query: 332 AIMYEML-IGYPPF 344
+M+E+ G P+
Sbjct: 193 VLMWEVFSEGKIPY 206
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 5e-15
Identities = 40/166 (24%), Positives = 69/166 (41%), Gaps = 41/166 (24%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE--------VDS 165
IG+G+FG + + A+K E RS+ L +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKF------------EPRRSDAPQLRDEYRTYKLLAGC 65
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVL-------- 217
I ++Y Q+ L+++ L G + ED+L +F + ++V
Sbjct: 66 TGIPNVYYFGQEGLHNVLVIDLL-GPSL------EDLLDLCGRKFSV-KTVAMAAKQMLA 117
Query: 218 AIHSIHQHNYVHRDIKPDNLIL----DKNGH-LKLSDFGLCKPLED 258
+ SIH+ + V+RDIKPDN ++ KN + + + DFG+ K D
Sbjct: 118 RVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 7e-15
Identities = 54/264 (20%), Positives = 102/264 (38%), Gaps = 69/264 (26%)
Query: 99 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIF----AMKKLKKSEMLKRGQVEHVR 154
R + +F+++ ++G GAFG V GE A+K+L+++ K + +
Sbjct: 8 LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEIL 65
Query: 155 SERNLLAEVDSRCIVQLF-YSFQDSDFLYLIMEYLPGGDIMTLLMRED---------ILS 204
E ++A VD+ + +L + + LI + +P G ++ +
Sbjct: 66 DEAYVMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC 123
Query: 205 EDVAR--FYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 262
+A+ Y+ + VHRD+ N+++ H+K++DFGL K L
Sbjct: 124 VQIAKGMNYLED----------RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA---- 169
Query: 263 ILLEDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY 321
++ G+ P K W MA E +L + Y
Sbjct: 170 ---------EEKEYHAEGGKV--PIK-----W-----------------MALESILHRIY 196
Query: 322 GMECDWWSLGAIMYEML-IGYPPF 344
+ D WS G ++E++ G P+
Sbjct: 197 THQSDVWSYGVTVWELMTFGSKPY 220
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 8e-15
Identities = 41/163 (25%), Positives = 70/163 (42%), Gaps = 37/163 (22%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSER-NLLAEV-------DS 165
IG G+FG++ L GE A+K E V+++ L E
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL------------ECVKTKHPQLHIESKIYKMMQGG 64
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARF------YIAESVLA- 218
I + + + D+ ++ME L G + ED+ + +F +A+ +++
Sbjct: 65 VGIPTIRWCGAEGDYNVMVMELL-GPSL------EDLFNFCSRKFSLKTVLLLADQMISR 117
Query: 219 IHSIHQHNYVHRDIKPDNLILDKNGH---LKLSDFGLCKPLED 258
I IH N++HRD+KPDN ++ + + DFGL K D
Sbjct: 118 IEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 8e-15
Identities = 53/257 (20%), Positives = 86/257 (33%), Gaps = 74/257 (28%)
Query: 109 EQLTL---IGKGAFGEVRLCRAKTTGEIF---AMKKLKKSEMLKRGQVEHVRSERNLLAE 162
E++ L IG+G FG+V + A+K K E E + +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS--VREKFLQEALTMRQ 447
Query: 163 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED---------ILSEDVAR--FY 211
D IV+L + +++IME G++ + L + + ++ Y
Sbjct: 448 FDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAY 506
Query: 212 IAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDII 271
+ +VHRDI N+++ N +KL DFGL S +ED
Sbjct: 507 LES----------KRFVHRDIAARNVLVSSNDCVKLGDFGL---------SRYMEDST-- 545
Query: 272 NQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTL---DYMAPEVLLKKGYGMECDWW 328
Y +MAPE + + + D W
Sbjct: 546 -----------------------------YYKASKGKLPIKWMAPESINFRRFTSASDVW 576
Query: 329 SLGAIMYEML-IGYPPF 344
G M+E+L G PF
Sbjct: 577 MFGVCMWEILMHGVKPF 593
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 48/252 (19%), Positives = 94/252 (37%), Gaps = 64/252 (25%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
D +G G +GEV K A+K LK+ M +VE E ++ E+
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKH 275
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL--MREDILSE--------DVAR--FYIA 213
+VQL Y+I E++ G+++ L +S ++ Y+
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 335
Query: 214 ESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 273
+ N++HR++ N ++ +N +K++DFGL + +
Sbjct: 336 K----------KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG--------------D 371
Query: 274 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 333
+ A ++ + +W APE L + ++ D W+ G +
Sbjct: 372 TYTAHAGAKFPI------KW-----------------TAPESLAYNKFSIKSDVWAFGVL 408
Query: 334 MYEML-IGYPPF 344
++E+ G P+
Sbjct: 409 LWEIATYGMSPY 420
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 57/252 (22%), Positives = 101/252 (40%), Gaps = 69/252 (27%)
Query: 109 EQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
E L L +G+G FGEV + T + A+K LK M E E ++ ++
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSP----EAFLQEAQVMKKLRH 238
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED----------ILSEDVAR--FYIA 213
+VQL Y+ + +Y++ EY+ G ++ L E ++ +A Y+
Sbjct: 239 EKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 297
Query: 214 ESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 273
NYVHRD++ N+++ +N K++DFGL + +ED
Sbjct: 298 R----------MNYVHRDLRAANILVGENLVCKVADFGLARLIED--------------N 333
Query: 274 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 333
E + ++ + +W APE L + ++ D WS G +
Sbjct: 334 EYTARQGAKFPI------KW-----------------TAPEAALYGRFTIKSDVWSFGIL 370
Query: 334 MYEML-IGYPPF 344
+ E+ G P+
Sbjct: 371 LTELTTKGRVPY 382
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 65/262 (24%), Positives = 102/262 (38%), Gaps = 68/262 (25%)
Query: 98 LQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIF--AMKKLKKSEMLKRGQVEHVRS 155
L+R + I D E +G G FG VR + + A+K LK+ E +
Sbjct: 6 LKRDNLLIADIE----LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMR 59
Query: 156 ERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED---------ILSED 206
E ++ ++D+ IV+L ++ L L+ME GG + L+ + L
Sbjct: 60 EAQIMHQLDNPYIVRL-IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118
Query: 207 VAR--FYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264
V+ Y+ E N+VHRD+ N++L + K+SDFGL S L
Sbjct: 119 VSMGMKYLEE----------KNFVHRDLAARNVLLVNRHYAKISDFGL--------SKAL 160
Query: 265 LEDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGM 323
D+ + + G+W P K W APE + + +
Sbjct: 161 GADDS----YYTARSAGKW--PLK-----W-----------------YAPECINFRKFSS 192
Query: 324 ECDWWSLGAIMYEML-IGYPPF 344
D WS G M+E L G P+
Sbjct: 193 RSDVWSYGVTMWEALSYGQKPY 214
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 37/160 (23%), Positives = 64/160 (40%), Gaps = 20/160 (12%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLK---------KSEM--LKRGQVEHVRSERNLLA 161
IG G FG + L E A +K SE+ +R + +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 162 EVDSRCIVQLFYS----FQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVL 217
++D I + S F+ + +++ME L G D+ + + + + +L
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTV-LQLGIRML 161
Query: 218 -AIHSIHQHNYVHRDIKPDNLILD--KNGHLKLSDFGLCK 254
+ IH++ YVH DIK NL+L + L+D+GL
Sbjct: 162 DVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 38/162 (23%), Positives = 66/162 (40%), Gaps = 41/162 (25%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE--------VDS 165
IG G FGE+RL + T E A+K +E ++S L
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIK------------LEPMKSRAPQLHLEYRFYKQLGSG 64
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVL-------- 217
I Q++Y + +++E L G + ED+ F + ++VL
Sbjct: 65 DGIPQVYYFGPCGKYNAMVLELL-GPSL------EDLFDLCDRTFSL-KTVLMIAIQLIS 116
Query: 218 AIHSIHQHNYVHRDIKPDNLILDKNGHLK-----LSDFGLCK 254
+ +H N ++RD+KP+N ++ + G+ + DF L K
Sbjct: 117 RMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 2e-14
Identities = 51/256 (19%), Positives = 99/256 (38%), Gaps = 73/256 (28%)
Query: 107 DFEQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV 163
E++TL +G G FG V+L + K ++ A+K +K+ M + E + ++
Sbjct: 6 KREEITLLKELGSGQFGVVKLGKWKGQYDV-AVKMIKEGSM----SEDEFFQEAQTMMKL 60
Query: 164 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED---------ILSEDVAR--FYI 212
+V+ + +Y++ EY+ G ++ L + DV ++
Sbjct: 61 SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 213 AESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIIN 272
H ++HRD+ N ++D++ +K+SDFG+ + + D+
Sbjct: 121 ES----------HQFIHRDLAARNCLVDRDLCVKVSDFGM---------TRYVLDDQ--- 158
Query: 273 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTL---DYMAPEVLLKKGYGMECDWWS 329
S+VGT + APEV Y + D W+
Sbjct: 159 ----------------------------YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWA 190
Query: 330 LGAIMYEML-IGYPPF 344
G +M+E+ +G P+
Sbjct: 191 FGILMWEVFSLGKMPY 206
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 53/268 (19%), Positives = 94/268 (35%), Gaps = 82/268 (30%)
Query: 109 EQLTL---IGKGAFGEVRLCRAKTTGEIF---AMKKLKKSEMLKRGQVEHVRSERNLLAE 162
+Q TL +GKG FG VR + K F A+K LK + +E E + E
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASS-DIEEFLREAACMKE 81
Query: 163 VDSRCIVQLF------YSFQDSDFLYLIMEYLPGGDIMTLLMR------------EDILS 204
D + +L + +I+ ++ GD+ L+ + ++
Sbjct: 82 FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141
Query: 205 --EDVAR--FYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK- 259
D+A Y++ N++HRD+ N +L ++ + ++DFGL + +
Sbjct: 142 FMVDIACGMEYLSS----------RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
Query: 260 -YSSILLEDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLL 317
Y +P K W +A E L
Sbjct: 192 YY-----------------RQGCASKLPVK-----W-----------------LALESLA 212
Query: 318 KKGYGMECDWWSLGAIMYEML-IGYPPF 344
Y + D W+ G M+E++ G P+
Sbjct: 213 DNLYTVHSDVWAFGVTMWEIMTRGQTPY 240
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 41/164 (25%), Positives = 70/164 (42%), Gaps = 39/164 (23%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSE-RNLLAEV-------DS 165
IG G+FGE+ L T E A+K E+V+++ LL E
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKL------------ENVKTKHPQLLYESKIYRILQGG 62
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVL-------- 217
I + + + D+ L+M+ L G + ED+ + + + ++VL
Sbjct: 63 TGIPNVRWFGVEGDYNVLVMDLL-GPSL------EDLFNFCSRKLSL-KTVLMLADQMIN 114
Query: 218 AIHSIHQHNYVHRDIKPDNLILDKNGH---LKLSDFGLCKPLED 258
+ +H +++HRDIKPDN ++ + + DFGL K D
Sbjct: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 7e-14
Identities = 56/248 (22%), Positives = 98/248 (39%), Gaps = 64/248 (25%)
Query: 114 IGKGAFGEVRLCRAKTTGEIF---AMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQ 170
IGKG FG V + A+K L + ++ QVE E L+ ++ ++
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQ--QVEAFLREGLLMRGLNHPNVLA 86
Query: 171 LF-YSFQDSDFLYLIMEYLPGGDIMTLLMRE-------DILS--EDVAR--FYIAESVLA 218
L ++++ Y+ GD++ + D++S VAR Y+AE
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE---- 142
Query: 219 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 278
+VHRD+ N +LD++ +K++DFGL + + D + + +
Sbjct: 143 ------QKFVHRDLAARNCMLDESFTVKVADFGL---------ARDILDREYYSVQQHRH 187
Query: 279 AEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337
A +P K W A E L + + D WS G +++E+
Sbjct: 188 A----RLPVK-----W-----------------TALESLQTYRFTTKSDVWSFGVLLWEL 221
Query: 338 L-IGYPPF 344
L G PP+
Sbjct: 222 LTRGAPPY 229
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 8e-14
Identities = 53/259 (20%), Positives = 86/259 (33%), Gaps = 74/259 (28%)
Query: 107 DFEQLTL---IGKGAFGEVRLCRAKTTGEIF---AMKKLKKSEMLKRGQVEHVRSERNLL 160
E++ L IG+G FG+V + A+K K E E +
Sbjct: 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREKFLQEALTM 70
Query: 161 AEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED---------ILSEDVAR-- 209
+ D IV+L + +++IME G++ + L + + ++
Sbjct: 71 RQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 129
Query: 210 FYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDED 269
Y+ +VHRDI N+++ N +KL DFGL S +ED
Sbjct: 130 AYLES----------KRFVHRDIAARNVLVSSNDCVKLGDFGL---------SRYMEDST 170
Query: 270 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTL---DYMAPEVLLKKGYGMECD 326
Y +MAPE + + + D
Sbjct: 171 Y-------------------------------YKASKGKLPIKWMAPESINFRRFTSASD 199
Query: 327 WWSLGAIMYEML-IGYPPF 344
W G M+E+L G PF
Sbjct: 200 VWMFGVCMWEILMHGVKPF 218
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 50/248 (20%), Positives = 95/248 (38%), Gaps = 64/248 (25%)
Query: 114 IGKGAFGEVRLCRAKTTGEIF---AMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQ 170
IG+G FG V A+K L + + +V +E ++ + ++
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNVLS 90
Query: 171 LF-YSFQDSDFLYLIMEYLPGGDIMTLLMRE-------DILS--EDVAR--FYIAESVLA 218
L + +++ Y+ GD+ + E D++ VA+ Y+A
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---- 146
Query: 219 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 278
+VHRD+ N +LD+ +K++DFGL + + D++ + +
Sbjct: 147 ------KKFVHRDLAARNCMLDEKFTVKVADFGL---------ARDMYDKEYYSVHNKTG 191
Query: 279 AEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337
A +P K W MA E L + + + D WS G +++E+
Sbjct: 192 A----KLPVK-----W-----------------MALESLQTQKFTTKSDVWSFGVLLWEL 225
Query: 338 L-IGYPPF 344
+ G PP+
Sbjct: 226 MTRGAPPY 233
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 53/253 (20%), Positives = 103/253 (40%), Gaps = 72/253 (28%)
Query: 109 EQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
E L L +G G FGEV + ++ A+K +K M VE +E N++ +
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQH 242
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED----------ILSEDVAR--FYIA 213
+V+L ++ + +Y+I E++ G ++ L ++ S +A +I
Sbjct: 243 DKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 301
Query: 214 ESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 273
+ NY+HRD++ N+++ + K++DFGL + +ED
Sbjct: 302 Q----------RNYIHRDLRAANILVSASLVCKIADFGLARVIEDN-------------- 337
Query: 274 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 333
E + ++ + +W APE + + ++ D WS G +
Sbjct: 338 EYTAREGAKFPI------KW-----------------TAPEAINFGSFTIKSDVWSFGIL 374
Query: 334 MYEML----IGYP 342
+ E++ I YP
Sbjct: 375 LMEIVTYGRIPYP 387
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 2e-13
Identities = 51/256 (19%), Positives = 99/256 (38%), Gaps = 73/256 (28%)
Query: 107 DFEQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV 163
D + LT +G G FG V+ + + ++ A+K +K+ M + E ++ +
Sbjct: 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSM----SEDEFIEEAKVMMNL 76
Query: 164 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED---------ILSEDVAR--FYI 212
+VQL+ +++I EY+ G ++ L + +DV Y+
Sbjct: 77 SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 136
Query: 213 AESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIIN 272
++HRD+ N +++ G +K+SDFGL S + D++
Sbjct: 137 ES----------KQFLHRDLAARNCLVNDQGVVKVSDFGL---------SRYVLDDE--- 174
Query: 273 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTL---DYMAPEVLLKKGYGMECDWWS 329
S+VG+ + PEVL+ + + D W+
Sbjct: 175 ----------------------------YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 206
Query: 330 LGAIMYEML-IGYPPF 344
G +M+E+ +G P+
Sbjct: 207 FGVLMWEIYSLGKMPY 222
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 33/168 (19%), Positives = 62/168 (36%), Gaps = 33/168 (19%)
Query: 113 LIGKGAFGEVRLCRAKT-----TGEIFAMKKLKK--------SEMLKRGQVEHVRSERNL 159
IG+G FG + L + + +K + +R +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 160 LAEVDSRCIVQLFYS----FQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARF----- 210
++ + + + S + ++IM+ G D+ + I + RF
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDL------QKIYEANAKRFSRKTV 154
Query: 211 -YIAESVL-AIHSIHQHNYVHRDIKPDNLILD--KNGHLKLSDFGLCK 254
++ +L + IH+H YVH DIK NL+L+ + L D+GL
Sbjct: 155 LQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 43/271 (15%), Positives = 92/271 (33%), Gaps = 83/271 (30%)
Query: 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIF-------AMKKLKKSEMLKRGQVEHVR 154
KI +D +G+G F ++ + G+ +K L K+ E
Sbjct: 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS---ESFF 60
Query: 155 SERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED---------ILSE 205
++++++ + +V + D L+ E++ G + T L + +++
Sbjct: 61 EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK 120
Query: 206 DVAR--FYIAESVLAIHSIHQHNYVHRDI--------KPDNLILDKNGHLKLSDFGLCKP 255
+A ++ E + +H ++ + ++ +KLSD G+
Sbjct: 121 QLAAAMHFLEE----------NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI--- 167
Query: 256 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEV 315
SI + +DI+ +ER+ W + PE
Sbjct: 168 ------SITVLPKDIL---------------QERI-PW-----------------VPPEC 188
Query: 316 LL-KKGYGMECDWWSLGAIMYEML-IGYPPF 344
+ K + D WS G ++E+ G P
Sbjct: 189 IENPKNLNLATDKWSFGTTLWEICSGGDKPL 219
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 49/256 (19%), Positives = 89/256 (34%), Gaps = 70/256 (27%)
Query: 109 EQLTL---IGKGAFGEVRLCRAKTTGEIF----AMKKLKKSEMLKRGQVEHVRSERNLLA 161
+L +G G FG V GE +K ++ + + V +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ--SFQAVTDHMLAIG 70
Query: 162 EVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMT-LLMREDILSE--------DVAR--F 210
+D IV+L L L+ +YLP G ++ + L +A+ +
Sbjct: 71 SLDHAHIVRL-LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMY 129
Query: 211 YIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 270
Y+ E H VHR++ N++L ++++DFG+ L
Sbjct: 130 YLEE----------HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP------------ 167
Query: 271 INQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWS 329
+ + + +E + P K W MA E + Y + D WS
Sbjct: 168 -DDKQLLYSEAKT--PIK-----W-----------------MALESIHFGKYTHQSDVWS 202
Query: 330 LGAIMYEML-IGYPPF 344
G ++E++ G P+
Sbjct: 203 YGVTVWELMTFGAEPY 218
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 4e-13
Identities = 48/248 (19%), Positives = 91/248 (36%), Gaps = 68/248 (27%)
Query: 107 DFEQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV 163
+ +T+ +G G +GEV K A+K LK+ M +VE E ++ E+
Sbjct: 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEI 66
Query: 164 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDIL----------SEDVAR--FY 211
+VQL Y+I E++ G+++ L + + ++ Y
Sbjct: 67 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126
Query: 212 IAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDII 271
+ + N++HRD+ N ++ +N +K++DFGL + +
Sbjct: 127 LEK----------KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----------- 165
Query: 272 NQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSL 330
A P K W APE L + ++ D W+
Sbjct: 166 -----YTAHAGAKFPIK-----W-----------------TAPESLAYNKFSIKSDVWAF 198
Query: 331 GAIMYEML 338
G +++E+
Sbjct: 199 GVLLWEIA 206
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 6e-13
Identities = 54/267 (20%), Positives = 93/267 (34%), Gaps = 81/267 (30%)
Query: 109 EQLTL---IGKGAFGEVRLCRAKTTGEIF---AMKKLKKSEMLKRGQVEHVRSERNLLAE 162
L L +G+G FG V K A+K +K +R ++E SE + +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQR-EIEEFLSEAACMKD 92
Query: 163 VDSRCIVQLF-----YSFQDSDFLYLIMEYLPGGDIMTLLMR------------EDILS- 204
+++L S Q +I+ ++ GD+ T L+ + +L
Sbjct: 93 FSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKF 152
Query: 205 -EDVAR--FYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK-- 259
D+A Y++ N++HRD+ N +L + + ++DFGL K +
Sbjct: 153 MVDIALGMEYLSN----------RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDY 202
Query: 260 YSSILLEDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLK 318
Y MP K W +A E L
Sbjct: 203 Y-----------------RQGRIAKMPVK-----W-----------------IAIESLAD 223
Query: 319 KGYGMECDWWSLGAIMYEML-IGYPPF 344
+ Y + D W+ G M+E+ G P+
Sbjct: 224 RVYTSKSDVWAFGVTMWEIATRGMTPY 250
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 7e-13
Identities = 26/167 (15%), Positives = 53/167 (31%), Gaps = 33/167 (19%)
Query: 114 IGKGAFGEVRL--------CRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNL------ 159
+ G + C + + F++K K L Q R+ + L
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 160 -LAEVDSRCIVQLFYS-FQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVL 217
L I + +L++ L G + + L SVL
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSL------QSALDVSPKHVLSERSVL 162
Query: 218 --------AIHSIHQHNYVHRDIKPDNLIL--DKNGHLKLSDFGLCK 254
A+ +H++ YVH ++ +N+ + + + L+ +G
Sbjct: 163 QVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 52/245 (21%), Positives = 100/245 (40%), Gaps = 68/245 (27%)
Query: 109 EQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
E L L +G G FGEV + ++ A+K LK+ M + +E NL+ ++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQLQH 67
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED----------ILSEDVAR--FYIA 213
+ +V+L Y+ + +Y+I EY+ G ++ L ++ +A +I
Sbjct: 68 QRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 214 ESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 273
E NY+HRD++ N+++ K++DFGL + +ED
Sbjct: 127 E----------RNYIHRDLRAANILVSDTLSCKIADFGLARLIED--------------N 162
Query: 274 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 333
E + ++ + +W APE + + ++ D WS G +
Sbjct: 163 EYTAREGAKFPI------KW-----------------TAPEAINYGTFTIKSDVWSFGIL 199
Query: 334 MYEML 338
+ E++
Sbjct: 200 LTEIV 204
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-12
Identities = 55/255 (21%), Positives = 93/255 (36%), Gaps = 65/255 (25%)
Query: 109 EQLTL---IGKGAFGEVRLCRAKTTGEIF-----AMKKLKKSEMLKRGQVEHVRSERNLL 160
+ L +G+GAFG+V L A+K LK + R + + E LL
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR---KDFQREAELL 71
Query: 161 AEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM--REDILSEDVARFYIAESVLA 218
+ IV+ + D D L ++ EY+ GD+ L D + + A+ L
Sbjct: 72 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 219 IHSIHQ--------------HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264
+ + ++VHRD+ N ++ N +K+ DFG+ S
Sbjct: 132 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGM---------SRD 182
Query: 265 LEDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGM 323
+ D G M+P + W M PE ++ + +
Sbjct: 183 VYSTDYY------RVGGHTMLPIR-----W-----------------MPPESIMYRKFTT 214
Query: 324 ECDWWSLGAIMYEML 338
E D WS G I++E+
Sbjct: 215 ESDVWSFGVILWEIF 229
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 4e-12
Identities = 47/268 (17%), Positives = 101/268 (37%), Gaps = 83/268 (30%)
Query: 109 EQLTL---IGKGAFGEVRLCRAKTTGEIF-----AMKKLKKSEMLKRGQVEHVRSERNLL 160
E++T+ +G+G+FG V AK + A+K + ++ ++ + +E +++
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVM 82
Query: 161 AEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR----------------EDILS 204
E + +V+L +IME + GD+ + L ++
Sbjct: 83 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 205 --EDVAR--FYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL--ED 258
++A Y+ + +VHRD+ N ++ ++ +K+ DFG+ + + D
Sbjct: 143 MAGEIADGMAYLNA----------NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 192
Query: 259 KYSSILLEDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLL 317
Y G+ ++P + W M+PE L
Sbjct: 193 YY-----------------RKGGKGLLPVR-----W-----------------MSPESLK 213
Query: 318 KKGYGMECDWWSLGAIMYEML-IGYPPF 344
+ D WS G +++E+ + P+
Sbjct: 214 DGVFTTYSDVWSFGVVLWEIATLAEQPY 241
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 8e-12
Identities = 55/256 (21%), Positives = 97/256 (37%), Gaps = 66/256 (25%)
Query: 109 EQLTL---IGKGAFGEVRLCRAK-----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLL 160
++L L +G+GAFG+V A T A+K LK+ + + SE +L
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 84
Query: 161 AEVDS-RCIVQLF-YSFQDSDFLYLIMEYLPGGDIMTLLM--REDILSEDVARFYIAESV 216
+ +V L + L +I+E+ G++ T L R + + VA + +
Sbjct: 85 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 217 LAIHSIHQ--------------HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 262
L + + +HRD+ N++L + +K+ DFGL +
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR-------- 196
Query: 263 ILLEDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY 321
DI +G +P K W MAPE + + Y
Sbjct: 197 ------DIYKDP-DYVRKGDARLPLK-----W-----------------MAPETIFDRVY 227
Query: 322 GMECDWWSLGAIMYEM 337
++ D WS G +++E+
Sbjct: 228 TIQSDVWSFGVLLWEI 243
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 1e-11
Identities = 60/270 (22%), Positives = 107/270 (39%), Gaps = 81/270 (30%)
Query: 107 DFEQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV 163
+ ++L L IGKG FG+V G A+K +K + +E +++ ++
Sbjct: 19 NMKELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCIKNDAT-----AQAFLAEASVMTQL 71
Query: 164 DSRCIVQLF-YSFQDSDFLYLIMEYLPGGDIMT--------LLMREDIL--SEDVAR--F 210
+VQL ++ LY++ EY+ G ++ +L + +L S DV
Sbjct: 72 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 131
Query: 211 YIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 270
Y+ +N+VHRD+ N+++ ++ K+SDFGL K +
Sbjct: 132 YLEG----------NNFVHRDLAARNVLVSEDNVAKVSDFGLTK---EAS---------- 168
Query: 271 INQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWS 329
+ +P K W APE L +K + + D WS
Sbjct: 169 -------STQDTGKLPVK-----W-----------------TAPEALREKKFSTKSDVWS 199
Query: 330 LGAIMYEML-IGYPPFCSDDPRITCRKIVN 358
G +++E+ G P+ PRI + +V
Sbjct: 200 FGILLWEIYSFGRVPY----PRIPLKDVVP 225
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 52/254 (20%), Positives = 96/254 (37%), Gaps = 64/254 (25%)
Query: 109 EQLTL---IGKGAFGEVRLCRAK----TTGEIF-AMKKLKKSEMLKRGQVEHVRSERNLL 160
+ L +G+GAFG+V L ++ A+K LK++ R + + E LL
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR---QDFQREAELL 97
Query: 161 AEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL-MREDILSEDVARFYIAESVLAI 219
+ + IV+ F + L ++ EY+ GD+ L +A L +
Sbjct: 98 TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157
Query: 220 HSIHQ--------------HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265
+ ++VHRD+ N ++ + +K+ DFG+ +
Sbjct: 158 GQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----------- 206
Query: 266 EDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGME 324
DI + + G+ M+P + W M PE +L + + E
Sbjct: 207 ---DIYSTDYY-RVGGRTMLPIR-----W-----------------MPPESILYRKFTTE 240
Query: 325 CDWWSLGAIMYEML 338
D WS G +++E+
Sbjct: 241 SDVWSFGVVLWEIF 254
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 46/255 (18%), Positives = 79/255 (30%), Gaps = 64/255 (25%)
Query: 109 EQLTL---IGKGAFGEVRLCRAKTTGEIF-----AMKKLKKSEMLKRGQVEHVRSERNLL 160
+ +G+ FG+V A+K LK E R E L
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGP--LREEFRHEAMLR 66
Query: 161 AEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL--MREDILSEDVARFYIAESVLA 218
A + +V L L +I Y GD+ L +S L
Sbjct: 67 ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126
Query: 219 IHSIHQ--------------HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264
H+ VH+D+ N+++ ++K+SD GL
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGL---------FRE 177
Query: 265 LEDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGM 323
+ D + G ++P + W MAPE ++ + +
Sbjct: 178 VYAADYY------KLLGNSLLPIR-----W-----------------MAPEAIMYGKFSI 209
Query: 324 ECDWWSLGAIMYEML 338
+ D WS G +++E+
Sbjct: 210 DSDIWSYGVVLWEVF 224
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 57/266 (21%), Positives = 99/266 (37%), Gaps = 79/266 (29%)
Query: 109 EQLTL---IGKGAFGEVRLCRAKTTGEIF-----AMKKLKKSEMLKRGQVEHVRSERNLL 160
+ +TL +G GAFGEV + A+K L + + E ++
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ--DELDFLMEALII 87
Query: 161 AEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR-------------EDILS--E 205
++ + + IV+ S +++ME + GGD+ + L D+L
Sbjct: 88 SKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147
Query: 206 DVAR--FYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH---LKLSDFGLCKPLEDKY 260
D+A Y+ E ++++HRDI N +L G K+ DFG+ +
Sbjct: 148 DIACGCQYLEE----------NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------ 191
Query: 261 SSILLEDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK 319
DI G M+P K W M PE ++
Sbjct: 192 --------DIYRASY-YRKGGCAMLPVK-----W-----------------MPPEAFMEG 220
Query: 320 GYGMECDWWSLGAIMYEML-IGYPPF 344
+ + D WS G +++E+ +GY P+
Sbjct: 221 IFTSKTDTWSFGVLLWEIFSLGYMPY 246
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 3e-11
Identities = 59/264 (22%), Positives = 101/264 (38%), Gaps = 72/264 (27%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEH-VRSERNLLAEVDSRCIVQL 171
+G+G FG V + A+KKL + +++ E ++A+ +V+L
Sbjct: 38 KMGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 172 F-YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDV--------ARFYIAESV---LAI 219
+S D L+ Y+P G +L D LS R IA+ +
Sbjct: 96 LGFSSDGDDLC-LVYVYMPNG---SL---LDRLSCLDGTPPLSWHMRCKIAQGAANGINF 148
Query: 220 HSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEA 279
+H+++++HRDIK N++LD+ K+SDFGL + E Q ++
Sbjct: 149 --LHENHHIHRDIKSANILLDEAFTAKISDFGLAR---------ASEKFA---QTVMTSR 194
Query: 280 EGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPE----VLLKKGYGMECDWWSLGAIMY 335
VGT YMAPE + K D +S G ++
Sbjct: 195 ------------------------IVGTTAYMAPEALRGEITPK-----SDIYSFGVVLL 225
Query: 336 EMLIGYPPFCSDDPRITCRKIVNW 359
E++ G P D + +++
Sbjct: 226 EIITGLPAV---DEHREPQLLLDI 246
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 3e-11
Identities = 58/257 (22%), Positives = 96/257 (37%), Gaps = 67/257 (26%)
Query: 109 EQLTL---IGKGAFGEVRLCRA----KTTGEIF-AMKKLKKSEMLKRGQVEHVRSERNLL 160
+L+ +G GAFG+V A K+ + A+K LK S L + E + SE +L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVL 80
Query: 161 AEVDS-RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL--MREDILSEDVARFYIAESVL 217
+ + + IV L + +I EY GD++ L R+ + + + + L
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 218 AIHS----------------IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261
A+ + N +HRD+ N++L K+ DFGL +
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLAR------- 193
Query: 262 SILLEDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG 320
I ++ +G +P K W MAPE +
Sbjct: 194 --------DIKNDSNYVVKGNARLPVK-----W-----------------MAPESIFNCV 223
Query: 321 YGMECDWWSLGAIMYEM 337
Y E D WS G ++E+
Sbjct: 224 YTFESDVWSYGIFLWEL 240
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 61/261 (23%), Positives = 111/261 (42%), Gaps = 67/261 (25%)
Query: 109 EQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
++L L IGKG FG+V G A+K +K + +E +++ ++
Sbjct: 193 KELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCIKNDAT-----AQAFLAEASVMTQLRH 245
Query: 166 RCIVQLF-YSFQDSDFLYLIMEYLPGGDIMTLL---MREDILSEDVARFY--IAESVLAI 219
+VQL ++ LY++ EY+ G ++ L R + + + +F + E A+
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE---AM 302
Query: 220 HSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEA 279
+ +N+VHRD+ N+++ ++ K+SDFGL K + S ++
Sbjct: 303 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASS---------------TQD 344
Query: 280 EGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338
G+ P K W APE L +K + + D WS G +++E+
Sbjct: 345 TGKL--PVK-----W-----------------TAPEALREKKFSTKSDVWSFGILLWEIY 380
Query: 339 -IGYPPFCSDDPRITCRKIVN 358
G P+ PRI + +V
Sbjct: 381 SFGRVPY----PRIPLKDVVP 397
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 56/266 (21%), Positives = 99/266 (37%), Gaps = 79/266 (29%)
Query: 109 EQLTL---IGKGAFGEVRLCRAKTTGEIF-----AMKKLKKSEMLKRGQVEHVRSERNLL 160
+ +TL +G GAFGEV + A+K L + + E ++
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ--DELDFLMEALII 128
Query: 161 AEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR-------------EDILS--E 205
++ + + IV+ S ++++E + GGD+ + L D+L
Sbjct: 129 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188
Query: 206 DVAR--FYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH---LKLSDFGLCKPLEDKY 260
D+A Y+ E ++++HRDI N +L G K+ DFG+ +
Sbjct: 189 DIACGCQYLEE----------NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------ 232
Query: 261 SSILLEDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK 319
DI G M+P K W M PE ++
Sbjct: 233 --------DIYRAGYY-RKGGCAMLPVK-----W-----------------MPPEAFMEG 261
Query: 320 GYGMECDWWSLGAIMYEML-IGYPPF 344
+ + D WS G +++E+ +GY P+
Sbjct: 262 IFTSKTDTWSFGVLLWEIFSLGYMPY 287
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 63/331 (19%), Positives = 112/331 (33%), Gaps = 81/331 (24%)
Query: 49 HYKNYLQGLQDRKERRRALQMRAQQAAVSNEEQEEMLRNLERRET---------EYMRLQ 99
H+ + K +R R + + L R T +
Sbjct: 7 HHHHSQDPPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVS 66
Query: 100 RRKIGIDDF-----EQLTL---IGKGAFGEVRLCRAKTTGEIF-------AMKKLKKSEM 144
++ D ++LTL +G+G FG+V + A + A+K LK
Sbjct: 67 EYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 126
Query: 145 LKRGQVEHVRSERNLLAEVDSRC-IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM--RED 201
K + + SE ++ + I+ L + LY+I+EY G++ L R
Sbjct: 127 EK--DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 184
Query: 202 ILSEDVARFYIAESVLAIHSIHQ--------------HNYVHRDIKPDNLILDKNGHLKL 247
+ + E + + +HRD+ N+++ +N +K+
Sbjct: 185 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 244
Query: 248 SDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVG 306
+DFGL + DI N + + +P K W
Sbjct: 245 ADFGLAR--------------DINNID-YYKKTTNGRLPVK-----W------------- 271
Query: 307 TLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337
MAPE L + Y + D WS G +M+E+
Sbjct: 272 ----MAPEALFDRVYTHQSDVWSFGVLMWEI 298
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 59/253 (23%), Positives = 95/253 (37%), Gaps = 63/253 (24%)
Query: 109 EQLTL---IGKGAFGEVRLCRA----KTTGEIF-AMKKLKKSEMLKRGQVEHVRSERNLL 160
L +G GAFG+V A K + A+K LK + + E + SE ++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD--EKEALMSELKIM 103
Query: 161 AEVDS-RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAI 219
+ + IV L + + +I EY GD++ L R+ + E F IA S +
Sbjct: 104 SHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163
Query: 220 HSIHQ--------------HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265
+ N +HRD+ N++L K+ DFGL +
Sbjct: 164 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR----------- 212
Query: 266 EDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGME 324
DI+N +G +P K W MAPE + Y ++
Sbjct: 213 ---DIMNDS-NYIVKGNARLPVK-----W-----------------MAPESIFDCVYTVQ 246
Query: 325 CDWWSLGAIMYEM 337
D WS G +++E+
Sbjct: 247 SDVWSYGILLWEI 259
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 61/275 (22%), Positives = 103/275 (37%), Gaps = 68/275 (24%)
Query: 106 DDFEQLTLIGKGAFGEV---RLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE 162
++F+ LIG G FG+V L G A+K+ +G E +E L+
Sbjct: 39 NNFDHKFLIGHGVFGKVYKGVL----RDGAKVALKRRTPES--SQGIEE-FETEIETLSF 91
Query: 163 VDSRCIVQLF-YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSED---VARFYIA-ESVL 217
+V L + + ++ + LI +Y+ G++ L D+ + R I +
Sbjct: 92 CRHPHLVSLIGFCDERNEMI-LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 218 AIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVS 277
+H +H +HRD+K N++LD+N K++DFG+ K D+ +
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK-------KGTELDQTHL------ 197
Query: 278 EAEGQWMMPKERLQQWKRNRRALAYSTV--GTLDYMAPE-----VLLKKGYGMECDWWSL 330
STV GTL Y+ PE L +K D +S
Sbjct: 198 -------------------------STVVKGTLGYIDPEYFIKGRLTEK-----SDVYSF 227
Query: 331 GAIMYEMLIGYPPFCSDDPRITCRKIVNW-KTCLK 364
G +++E+L PR + W
Sbjct: 228 GVVLFEVLCARSAIVQSLPR-EMVNLAEWAVESHN 261
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 52/254 (20%), Positives = 92/254 (36%), Gaps = 65/254 (25%)
Query: 107 DFEQLTL---IGKGAFGEVRLCRAKTTGEIF--AMKKLKKSEMLKRGQVEHVRSERNLLA 161
D+ + IG+G FG+V R K G A+K++K+ E +L
Sbjct: 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD--DHRDFAGELEVLC 80
Query: 162 EVDS-RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL--MREDILSEDVARFYIAESVLA 218
++ I+ L + + +LYL +EY P G+++ L R A S L+
Sbjct: 81 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140
Query: 219 IHSIHQ--------------HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264
+ ++HRD+ N+++ +N K++DFGL + ++ Y
Sbjct: 141 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG-QEVY---- 195
Query: 265 LEDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGM 323
+ +P + W MA E L Y
Sbjct: 196 -------------VKKTMGRLPVR-----W-----------------MAIESLNYSVYTT 220
Query: 324 ECDWWSLGAIMYEM 337
D WS G +++E+
Sbjct: 221 NSDVWSYGVLLWEI 234
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 56/257 (21%), Positives = 97/257 (37%), Gaps = 67/257 (26%)
Query: 109 EQLTL---IGKGAFGEVRLCRAKTTGEIF-------AMKKLKKSEMLKRGQVEHVRSERN 158
++LTL +G+GAFG+V + A + A+K LK K + + SE
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEME 92
Query: 159 LLAEVDSRC-IVQLFYSFQDSDFLYLIMEYLPGGDIMTLL--MREDILSEDVARFYIAES 215
++ + I+ L + LY+I+EY G++ L R + + E
Sbjct: 93 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 216 VLAIHSIHQ--------------HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261
+ + +HRD+ N+++ +N +K++DFGL +
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR------- 205
Query: 262 SILLEDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG 320
DI N + + +P K W MAPE L +
Sbjct: 206 -------DINNID-YYKKTTNGRLPVK-----W-----------------MAPEALFDRV 235
Query: 321 YGMECDWWSLGAIMYEM 337
Y + D WS G +M+E+
Sbjct: 236 YTHQSDVWSFGVLMWEI 252
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 3e-10
Identities = 54/262 (20%), Positives = 96/262 (36%), Gaps = 72/262 (27%)
Query: 109 EQLTL---IGKGAFGEVRLCRA----KTTGEIF-AMKKLKKSEMLKRGQVEHVRSERNLL 160
+ L L +G+G FG+V A G A+K LK++ ++ + SE N+L
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS--ELRDLLSEFNVL 80
Query: 161 AEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR-----EDILSEDVARFYIAES 215
+V+ +++L+ + L LI+EY G + L L +R +
Sbjct: 81 KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 216 VLAIHSIH-------------------QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 256
++ + VHRD+ N+++ + +K+SDFGL +
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR-- 198
Query: 257 EDKYSSILLEDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEV 315
D+ ++ Q +P K W MA E
Sbjct: 199 ------------DVYEED-SYVKRSQGRIPVK-----W-----------------MAIES 223
Query: 316 LLKKGYGMECDWWSLGAIMYEM 337
L Y + D WS G +++E+
Sbjct: 224 LFDHIYTTQSDVWSFGVLLWEI 245
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 60.7 bits (146), Expect = 3e-10
Identities = 35/203 (17%), Positives = 63/203 (31%), Gaps = 48/203 (23%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKL-----KKSEMLKRGQVEHVRSERNLL 160
+ ++ IG+G FGEV + A+K + + E + E +
Sbjct: 20 EKLQRCEKIGEGVFGEV--FQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 161 AEVD-----------------SRCIVQLFY----------------------SFQDSDFL 181
E+ S VQ Y F D L
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 182 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILD 240
++++E+ GG + MR + S A+ + + ++ + HRD+ N++L
Sbjct: 138 FIVLEFEFGGIDL-EQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK 196
Query: 241 KNGHLKLSDFGLCKPLEDKYSSI 263
K KL K +
Sbjct: 197 KTSLKKLHYTLNGKSSTIPSCGL 219
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 55/257 (21%), Positives = 97/257 (37%), Gaps = 67/257 (26%)
Query: 109 EQLTL---IGKGAFGEVRLCRAKTTGEIF-------AMKKLKKSEMLKRGQVEHVRSERN 158
++L L +G+GAFG+V L A + A+K LK K + + SE
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEME 126
Query: 159 LLAEVDSRC-IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM--REDILSEDVARFYIAES 215
++ + I+ L + LY+I+EY G++ L R L + E
Sbjct: 127 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 216 VLAIHSIHQ--------------HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261
L+ + +HRD+ N+++ ++ +K++DFGL +
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR------- 239
Query: 262 SILLEDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG 320
DI + + + +P K W MAPE L +
Sbjct: 240 -------DIHHIDYY-KKTTNGRLPVK-----W-----------------MAPEALFDRI 269
Query: 321 YGMECDWWSLGAIMYEM 337
Y + D WS G +++E+
Sbjct: 270 YTHQSDVWSFGVLLWEI 286
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 65/297 (21%), Positives = 108/297 (36%), Gaps = 77/297 (25%)
Query: 79 EEQEEMLRNLERRETEYMRLQRRKIGIDDF-----EQLTL---IGKGAFGEVRLCRAKTT 130
E Q +M++ + EY + R+ D E L +G GAFG+V A
Sbjct: 10 ESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGI 69
Query: 131 GEIF-----AMKKLKKSEMLKRGQVEHVRSERNLLAEVDS-RCIVQLFYSFQDSDFLYLI 184
+ A+K LK+ + E + SE ++ ++ S IV L + S +YLI
Sbjct: 70 SKTGVSIQVAVKMLKEKADSS--EREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI 127
Query: 185 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHS----------------------- 221
EY GD++ L + + Y + L
Sbjct: 128 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF 187
Query: 222 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 281
+ + VHRD+ N+++ +K+ DFGL + DI++ G
Sbjct: 188 LEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR--------------DIMSDS-NYVVRG 232
Query: 282 QWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337
+P K W MAPE L + Y ++ D WS G +++E+
Sbjct: 233 NARLPVK-----W-----------------MAPESLFEGIYTIKSDVWSYGILLWEI 267
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 54/265 (20%), Positives = 90/265 (33%), Gaps = 76/265 (28%)
Query: 109 EQLTL---IGKGAFGEVRLCRAK----TTGEIF-AMKKLKKSEMLKRGQVEHVRSERNLL 160
+ IG+GAFG V RA A+K LK+ + E L+
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQADFQREAALM 104
Query: 161 AEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIH 220
AE D+ IV+L + L+ EY+ GD+ L + + +
Sbjct: 105 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164
Query: 221 SIH------------------------QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 256
S + +VHRD+ N ++ +N +K++DFGL + +
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 224
Query: 257 --EDKYSSILLEDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAP 313
D Y +A+G +P + W M P
Sbjct: 225 YSADYY-----------------KADGNDAIPIR-----W-----------------MPP 245
Query: 314 EVLLKKGYGMECDWWSLGAIMYEML 338
E + Y E D W+ G +++E+
Sbjct: 246 ESIFYNRYTTESDVWAYGVVLWEIF 270
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 3e-09
Identities = 60/265 (22%), Positives = 102/265 (38%), Gaps = 85/265 (32%)
Query: 106 DDFEQLTLIGKGAFGEV---RLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE 162
D+F ++G+G FG+V RL G + A+K+LK+ +R Q E E
Sbjct: 30 DNFSNKNILGRGGFGKVYKGRL----ADGTLVAVKRLKE----ERTQ----GGELQFQTE 77
Query: 163 VDS------RCIVQLF-YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDV----ARFY 211
V+ R +++L + ++ L L+ Y+ G + + L RE S+ R
Sbjct: 78 VEMISMAVHRNLLRLRGFCMTPTERL-LVYPYMANGSVASCL-RERPESQPPLDWPKRQR 135
Query: 212 IAESV---LA-IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLED 267
IA LA +H +HRD+K N++LD+ + DFGL K ++ K + +
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV---- 191
Query: 268 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYST--VGTLDYMAPEVLLKKGYGME- 324
+T GT+ ++APE Y
Sbjct: 192 -----------------------------------TTAVRGTIGHIAPE------YLSTG 210
Query: 325 -----CDWWSLGAIMYEMLIGYPPF 344
D + G ++ E++ G F
Sbjct: 211 KSSEKTDVFGYGVMLLELITGQRAF 235
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 57.6 bits (138), Expect = 8e-09
Identities = 84/585 (14%), Positives = 166/585 (28%), Gaps = 136/585 (23%)
Query: 15 LKPAAREFDLDPDVSVSSPVTR----------QKAAAAKQFIEN-HYKNY---LQGLQDR 60
K + ++D + V+ ++ ++F+E NY + ++
Sbjct: 42 PKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTE 101
Query: 61 KERRRALQMR---AQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKG 117
+R+ ++ R Q+ + N+ Q N+ R + Y++L++ + + + + + G
Sbjct: 102 -QRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQ-PYLKLRQALLELRPAKNVLIDGVL 159
Query: 118 AFGEVRL----CRAKTT-----GEIF--AMKKLKKSE-MLKRGQVEHVRSERNLLAEVDS 165
G+ + C + +IF +K E +L+ Q + + N + D
Sbjct: 160 GSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDH 219
Query: 166 RC-IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVAR-FYIAESVLAIHSIH 223
I +S Q L + LL+ ++ + F ++ +L
Sbjct: 220 SSNIKLRIHSIQAELRRLLKSKPYENC----LLVLLNVQNAKAWNAFNLSCKILLT---- 271
Query: 224 QHNYVHRDIK-PDNLILDKNGHLKLSDFGLCKPLEDKYS-SILLEDEDIINQETVSEAEG 281
R + D L H+ L L S+LL+ D Q+ E
Sbjct: 272 -----TRFKQVTDFLSAATTTHISLDHHS--MTLTPDEVKSLLLKYLDCRPQDLPREVLT 324
Query: 282 QWMMP-------------KERLQQWKR-NRRALAYSTVGTLDYMAPEVLLKKGYGMECDW 327
P WK N L +L+ + P +K +
Sbjct: 325 --TNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPA-EYRKMF------ 375
Query: 328 WSLGAIMYEMLIGYPPFC---SDDPRITCRKIVN--WKTCL--KFPEEPKIS--DEARDL 378
L I D + +VN K L K P+E IS +L
Sbjct: 376 DRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLEL 435
Query: 379 ICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKL--------------YEMEAAYKPTVN 424
+ E L V+ + D L + ++
Sbjct: 436 KVK--LENEYALHRSIVDHYNIP---KTFDSDDLIPPYLDQYFYSHIGHHLKNIEH---- 486
Query: 425 GELDTQNFEKFPEV-------------DGPPSEIPS--------VGPWRKMLTSKDTNFI 463
+ F V D + ++ + D
Sbjct: 487 ----PERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPK-- 540
Query: 464 GYTFKKSDVLKSLENSGTDMRSNGSSKVPSLISLLGMIYYIFYYN 508
Y + +L L ++ SK L+ + M +
Sbjct: 541 -YERLVNAILDFLPKIEENLI---CSKYTDLLRIALMAEDEAIFE 581
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 8e-08
Identities = 64/429 (14%), Positives = 122/429 (28%), Gaps = 102/429 (23%)
Query: 3 GRDDTVRLGALNLKPAAREFDLD----PDVSVSSPVTRQKAAAAKQ--FIENHYKNYLQG 56
++ L+ + D + D S + + A + Y+N L
Sbjct: 190 KNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLV 249
Query: 57 L---QDRKE--------------RRRALQMRAQQAAVSNEEQEEMLRNLERRETEYMRLQ 99
L Q+ K R + + A ++ + L E + L
Sbjct: 250 LLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVK--SLL 307
Query: 100 RRKIGIDDFE-----------QLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEM-LKR 147
+ + + +L++I L + K E L
Sbjct: 308 LKYLDCRPQDLPREVLTTNPRRLSIIA--ESIRDGLATWDNWKHVNCDKLTTIIESSL-- 363
Query: 148 GQVEHVRSERNLLAEVDSRCIVQLFYS---FQDS--------DFLYLIMEYLPGGDIMTL 196
N+L + R ++F F S ++ + ++
Sbjct: 364 ----------NVLEPAEYR---KMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNK 410
Query: 197 LMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPD--NLILDK-NGHLKLSDFGLC 253
L + ++ + I+ I SI+ V + + I+D N L
Sbjct: 411 LHKYSLVEKQPKESTIS-----IPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLI 465
Query: 254 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAP 313
P D+Y + G + E ++ R LD+
Sbjct: 466 PPYLDQYFYSHI---------------GHHLKNIEHPERMTLFRMVF-------LDF--- 500
Query: 314 EVLLKKGYGMECDWWSLGAIMYEM--LIGYPPF-CSDDPRITCRKIVNWKTCLKFPEEPK 370
L +K W + G+I+ + L Y P+ C +DP+ R + L EE
Sbjct: 501 RFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYE-RLVNAILDFLPKIEENL 559
Query: 371 ISDEARDLI 379
I + DL+
Sbjct: 560 ICSKYTDLL 568
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 5e-06
Identities = 55/280 (19%), Positives = 96/280 (34%), Gaps = 51/280 (18%)
Query: 109 EQLTL---IGKGAFGEVRLCRAK-----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLL 160
++L L +G+GAFG+V A T A+K LK+ + + SE +L
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 79
Query: 161 AEVDS-RCIVQLF-YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLA 218
+ +V L + L +I+E+ G++ T L + + Y +
Sbjct: 80 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK----RNEFVPYKTKGARF 135
Query: 219 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE--DKYSSILLEDEDIINQETV 276
+ D+K + + S F K L ++ + +D + E +
Sbjct: 136 RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHL 195
Query: 277 SEAEGQWMMPKERLQQWKRNRRALAYSTV--------------------GTLDY------ 310
Q E L K R LA + DY
Sbjct: 196 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255
Query: 311 ------MAPEVLLKKGYGMECDWWSLGAIMYEML-IGYPP 343
MAPE + + Y ++ D WS G +++E+ +G P
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 33/153 (21%), Positives = 57/153 (37%), Gaps = 16/153 (10%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIF---AMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIV 169
LIGKGA +++ I K + + + + E LA V I
Sbjct: 343 LIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIP 402
Query: 170 QLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVH 229
+ D D ++M Y+ G ++ ++ + + +H+++ +H
Sbjct: 403 APYIFDVDLDNKRIMMSYINGKLAKDVIEDNLDIAYKIGE--------IVGKLHKNDVIH 454
Query: 230 RDIKPDNLILDKNGHLKLSDFGLCK---PLEDK 259
D+ N I D L + DFGL K EDK
Sbjct: 455 NDLTTSNFIFD--KDLYIIDFGLGKISNLDEDK 485
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 510 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.95 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.88 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.78 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.45 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.34 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.23 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.2 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.91 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.72 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.64 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.53 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.51 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.32 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.32 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.23 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.01 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.86 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.73 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.55 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.5 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.46 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.44 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.43 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.38 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.37 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.21 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.96 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.96 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.74 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.04 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.22 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 83.3 | |
| 3ls8_A | 614 | Phosphatidylinositol 3-kinase catalytic subunit ty | 80.5 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-74 Score=575.51 Aligned_cols=279 Identities=34% Similarity=0.654 Sum_probs=254.3
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceE
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 181 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~ 181 (510)
+...+||++++.||+|+||+||+|+++.+|+.||||++.+..+......+.+.+|+++|+.++|||||+++++|++++++
T Consensus 28 ~~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 107 (311)
T 4aw0_A 28 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 107 (311)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 45568999999999999999999999999999999999988777777788999999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 182 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
|||||||+||||.++|.+.+.++|..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+.....
T Consensus 108 yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999997643211
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~ 341 (510)
...+.+.||||.|||||++.+.+|+.++|||||||+||||++|.
T Consensus 188 ------------------------------------~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~ 231 (311)
T 4aw0_A 188 ------------------------------------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 231 (311)
T ss_dssp ------------------------------------CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSS
T ss_pred ------------------------------------cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 11234689999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC---ChHHhhcCCCcCCCCchhhhcccC
Q 010463 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR---GVEELKEHPWFRGIQWDKLYEMEA 417 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~---~~~eil~HpfF~~i~~~~l~~~~~ 417 (510)
+||.+.+..+++.+|.+. .+.+|. .+|++++|||++||+ ||++|++.. +..+|++||||+++||+.|.+..|
T Consensus 232 ~PF~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~~~p 307 (311)
T 4aw0_A 232 PPFRAGNEGLIFAKIIKL--EYDFPE--KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 307 (311)
T ss_dssp CSSCCSSHHHHHHHHHHT--CCCCCT--TCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCC
T ss_pred CCCCCCCHHHHHHHHHcC--CCCCCc--ccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcCCCC
Confidence 999999999999999984 356664 799999999999998 999999652 334589999999999999998877
Q ss_pred CCc
Q 010463 418 AYK 420 (510)
Q Consensus 418 p~~ 420 (510)
|.+
T Consensus 308 P~l 310 (311)
T 4aw0_A 308 PKL 310 (311)
T ss_dssp CCC
T ss_pred CCC
Confidence 753
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-72 Score=562.15 Aligned_cols=279 Identities=41% Similarity=0.751 Sum_probs=243.7
Q ss_pred hcccCCCCceeeeeeecCCCeEEEEEEEc---CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEee
Q 010463 100 RRKIGIDDFEQLTLIGKGAFGEVRLCRAK---TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ 176 (510)
Q Consensus 100 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~---~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 176 (510)
..++..++|++++.||+|+||+||+|++. .+++.||||++++..... .+...+.+|+.+|+.++|||||+++++|+
T Consensus 18 ~~~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 96 (304)
T 3ubd_A 18 HEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV-RDRVRTKMERDILVEVNHPFIVKLHYAFQ 96 (304)
T ss_dssp CCCCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE-EECC------CCCCCCCCTTEECEEEEEE
T ss_pred cccCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh-HHHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence 34566789999999999999999999984 478899999998765433 23346888999999999999999999999
Q ss_pred cCceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccC
Q 010463 177 DSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 256 (510)
Q Consensus 177 ~~~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~ 256 (510)
+++.+|||||||+||||.++|.+.+.++|..++.|++||+.||+|||++|||||||||+|||++.+|++||+|||+|+..
T Consensus 97 ~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 97 TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp ETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred ECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999865
Q ss_pred ccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHH
Q 010463 257 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 336 (510)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyE 336 (510)
.... ....+.||||.|||||++.+.+|+.++|||||||+|||
T Consensus 177 ~~~~--------------------------------------~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilye 218 (304)
T 3ubd_A 177 IDHE--------------------------------------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFE 218 (304)
T ss_dssp ------------------------------------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHH
T ss_pred cCCC--------------------------------------ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHH
Confidence 3321 11346799999999999999999999999999999999
Q ss_pred HhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CChHHhhcCCCcCCCCchhhh
Q 010463 337 MLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLY 413 (510)
Q Consensus 337 ml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~--~~~~eil~HpfF~~i~~~~l~ 413 (510)
|++|.+||.+.+..+++.+|.+. .+.+|. .+|+++++||++||+ ||++||++ .+++||++||||+++||+.+.
T Consensus 219 mltG~~PF~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~ 294 (304)
T 3ubd_A 219 MLTGTLPFQGKDRKETMTMILKA--KLGMPQ--FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLY 294 (304)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHC--CCCCCT--TSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHH
T ss_pred HHhCCCCCCCcCHHHHHHHHHcC--CCCCCC--cCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHH
Confidence 99999999999999999999874 355664 799999999999998 99999986 358999999999999999996
Q ss_pred --cccCCCcc
Q 010463 414 --EMEAAYKP 421 (510)
Q Consensus 414 --~~~~p~~p 421 (510)
+++|||+|
T Consensus 295 ~~~~~pP~~P 304 (304)
T 3ubd_A 295 RREIHPPFKP 304 (304)
T ss_dssp TTCSCCSSCC
T ss_pred hCCCCcCcCC
Confidence 47899998
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-70 Score=598.95 Aligned_cols=289 Identities=35% Similarity=0.640 Sum_probs=256.8
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHH---HhcCCCCeeeEeEEeec
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLL---AEVDSRCIVQLFYSFQD 177 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL---~~l~hp~Iv~l~~~~~~ 177 (510)
..++++||+++++||+|+||+||+|+++.||+.||||++.+..+........+.+|+.++ +.++|||||+++++|++
T Consensus 184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263 (689)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence 468899999999999999999999999999999999999998877666677777776555 45689999999999999
Q ss_pred CceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCc
Q 010463 178 SDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 257 (510)
Q Consensus 178 ~~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~ 257 (510)
++++|||||||+||||.++|.+.+.|+|..+++|++||+.||+|||++|||||||||+||||+.+|+|||+|||+|+.+.
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998764
Q ss_pred cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHH
Q 010463 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYE 336 (510)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyE 336 (510)
.. .+.+.||||.|||||++.+ .+|+.++|||||||||||
T Consensus 344 ~~----------------------------------------~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYE 383 (689)
T 3v5w_A 344 KK----------------------------------------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFK 383 (689)
T ss_dssp SC----------------------------------------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHH
T ss_pred CC----------------------------------------CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHH
Confidence 32 1346799999999999974 689999999999999999
Q ss_pred HhhCCCCCCCCCh---hhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CChHHhhcCCCcCCCCch
Q 010463 337 MLIGYPPFCSDDP---RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWD 410 (510)
Q Consensus 337 ml~G~~PF~~~~~---~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~--~~~~eil~HpfF~~i~~~ 410 (510)
||+|.+||.+.+. ..+...+.. ..+.+| ..+|++++|||.+||+ ||.+|+|. .+++||++||||+++||+
T Consensus 384 mLtG~~PF~~~~~~~~~~i~~~i~~--~~~~~p--~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~ 459 (689)
T 3v5w_A 384 LLRGHSPFRQHKTKDKHEIDRMTLT--MAVELP--DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ 459 (689)
T ss_dssp HHHSSCTTCGGGCCCHHHHHHHHHH--CCCCCC--TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHH
T ss_pred HHhCCCCCCCCChHHHHHHHHhhcC--CCCCCC--ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHH
Confidence 9999999987543 344555555 335555 4799999999999999 99999985 579999999999999999
Q ss_pred hhh--cccCCCccccCCCccCCCCC
Q 010463 411 KLY--EMEAAYKPTVNGELDTQNFE 433 (510)
Q Consensus 411 ~l~--~~~~p~~p~~~~~~d~~~f~ 433 (510)
.|. .+.|||+|.+.+..++++||
T Consensus 460 ~l~~~~~~pP~~P~~~~~~~~~~fD 484 (689)
T 3v5w_A 460 MVFLQKYPPPLIPPRGEVNAADAFD 484 (689)
T ss_dssp HHHTTCSCCSCCCCTTCSSTTBCCC
T ss_pred HHHcCCCCcCccCCCCCCCcCCCCC
Confidence 997 47899999998888777776
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-67 Score=548.78 Aligned_cols=342 Identities=42% Similarity=0.773 Sum_probs=283.8
Q ss_pred HHHHhhcccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEE
Q 010463 95 YMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYS 174 (510)
Q Consensus 95 ~~~~~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 174 (510)
..++.+.++..++|++++.||+|+||+||+|+++.+|+.||||++.+.......+..++.+|+.+|..++||||++++++
T Consensus 50 ~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 129 (412)
T 2vd5_A 50 VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA 129 (412)
T ss_dssp HHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred hhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 44566677888999999999999999999999999999999999998776666677789999999999999999999999
Q ss_pred eecCceEEEEEeccCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCc
Q 010463 175 FQDSDFLYLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLC 253 (510)
Q Consensus 175 ~~~~~~~~lVmEy~~gG~L~~~L~~~~-~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla 253 (510)
|++.+.+|+||||++||+|.++|.+.+ .+++..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|
T Consensus 130 ~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla 209 (412)
T 2vd5_A 130 FQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSC 209 (412)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhh
Confidence 999999999999999999999998764 7999999999999999999999999999999999999999999999999999
Q ss_pred ccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc-------cCCCCcccc
Q 010463 254 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-------KKGYGMECD 326 (510)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-------~~~y~~~~D 326 (510)
+.+..... ....+.+||+.|+|||++. ...|+.++|
T Consensus 210 ~~~~~~~~-------------------------------------~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~D 252 (412)
T 2vd5_A 210 LKLRADGT-------------------------------------VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECD 252 (412)
T ss_dssp EECCTTSC-------------------------------------EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHH
T ss_pred eeccCCCc-------------------------------------cccceeccccCcCCHHHHhhcccCcCCCCCChHHh
Confidence 87643210 0112468999999999998 356899999
Q ss_pred ccchhhHHHHHhhCCCCCCCCChhhhHHHHhhccccccCCC-CCCCCHHHHHHHHHhhcCccccCCCCChHHhhcCCCcC
Q 010463 327 WWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPE-EPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFR 405 (510)
Q Consensus 327 iwSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~-~~~~s~~~~dlI~~lL~dp~~R~~~~~~~eil~HpfF~ 405 (510)
||||||++|||++|.+||.+.+..+++.+|+++...+.+|. ...+|+++++||++||++|.+|+|+.+++||++||||+
T Consensus 253 iwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~~p~~Rlgr~~~~ei~~Hpff~ 332 (412)
T 2vd5_A 253 WWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFF 332 (412)
T ss_dssp HHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSSCGGGCTTTTTHHHHHTSGGGT
T ss_pred hhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcCChhhcCCCCCHHHHhcCCCcC
Confidence 99999999999999999999999999999998765666664 24799999999999999999999888999999999999
Q ss_pred CCCchhhhcccCCCccccCCCccCCCCCCCCCCCCCCCC--CCCCCcc-cccCCCcCCcccCceeeCCccc
Q 010463 406 GIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSE--IPSVGPW-RKMLTSKDTNFIGYTFKKSDVL 473 (510)
Q Consensus 406 ~i~~~~l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~--~~~~~~~-~~~~~~~~~~f~~~~~~~~~~~ 473 (510)
+++|+.+....|||+|.+.+..|++||+.+.+....... .+..... .......+..|.||||.+....
T Consensus 333 ~i~w~~l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~~~~ 403 (412)
T 2vd5_A 333 GLDWDGLRDSVPPFTPDFEGATDTCNFDLVEDGLTAMVSGGGETLSDIREGAPLGVHLPFVGYSYSCMALR 403 (412)
T ss_dssp TCCSTTSTTSCCSCCCC-----CCSSCC--CCCCCTTSSSSSCCTTTC-----CCTTGGGTTCCBSCCCCC
T ss_pred CCCHHHHhhcCCCCCCcCCCcccccccCcccccccccccccCCCcccccCCCccccCCCCCCCcccCcccc
Confidence 999999999999999999999999999975432211100 0000000 0111234568999999987544
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-67 Score=547.10 Aligned_cols=336 Identities=44% Similarity=0.819 Sum_probs=288.2
Q ss_pred HHhhcccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEee
Q 010463 97 RLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ 176 (510)
Q Consensus 97 ~~~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 176 (510)
.+...++..++|++++.||+|+||+||+|+++.+|+.||||++.+.......+...+.+|+.+|..++|||||+++++|+
T Consensus 60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 34556778899999999999999999999999999999999999877666666777899999999999999999999999
Q ss_pred cCceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccC
Q 010463 177 DSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 256 (510)
Q Consensus 177 ~~~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~ 256 (510)
+.+.+|+|||||+||+|.+++.+ ..+++..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~ 218 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 218 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred ECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEee
Confidence 99999999999999999999865 56999999999999999999999999999999999999999999999999999866
Q ss_pred ccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCC----CCccccccchhh
Q 010463 257 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG----YGMECDWWSLGA 332 (510)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~----y~~~~DiwSlGv 332 (510)
..... ..+.+.+||+.|+|||++.+.+ |+.++|||||||
T Consensus 219 ~~~~~-------------------------------------~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGv 261 (410)
T 3v8s_A 219 NKEGM-------------------------------------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGV 261 (410)
T ss_dssp CTTSE-------------------------------------EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHH
T ss_pred ccCCc-------------------------------------ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchH
Confidence 43210 0123578999999999998766 889999999999
Q ss_pred HHHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhcCccccCCCCChHHhhcCCCcCCCCchhh
Q 010463 333 IMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKL 412 (510)
Q Consensus 333 ilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~dp~~R~~~~~~~eil~HpfF~~i~~~~l 412 (510)
++|||++|.+||.+.+...++.+|+++...+.+|....+|+++++||++||+++.+|+|+.+++||++||||++++|+.+
T Consensus 262 ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~ 341 (410)
T 3v8s_A 262 FLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWE 341 (410)
T ss_dssp HHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCST
T ss_pred HHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHH
Confidence 99999999999999999999999998777788888778999999999999996666666668999999999999998765
Q ss_pred --hcccCCCccccCCCccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCcccCceeeCCcccc
Q 010463 413 --YEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLK 474 (510)
Q Consensus 413 --~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~ 474 (510)
++..|||+|.++++.|++||+.+.+...+....+. + ......+..|.||||.+.....
T Consensus 342 ~~~~~~~p~~p~~~~~~d~~~fd~~~~~~~~~~~~~~--~--~~~~~~~~~f~~f~~~~~~~~~ 401 (410)
T 3v8s_A 342 TLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPI--P--KAFVGNQLPFVGFTYYSNRRYL 401 (410)
T ss_dssp TGGGSCCSCCCCCSSTTCCTTSCCCCSCCSCCCCCCC--C--SSCCCTTGGGTTCCEECC----
T ss_pred hhcccCCCCCCcCCCccchhhcCCccccccccccCCC--c--hhhcccccccccceEeCccccc
Confidence 46889999999999999999987655433222211 1 1122346789999999886653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-66 Score=549.14 Aligned_cols=339 Identities=46% Similarity=0.835 Sum_probs=286.0
Q ss_pred HhhcccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec
Q 010463 98 LQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 177 (510)
Q Consensus 98 ~~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 177 (510)
....++..++|+++++||+|+||+||+|+++.+|+.||||++.+.......+...+.+|+.+|..++|||||+++++|++
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 44556788999999999999999999999999999999999998766666666779999999999999999999999999
Q ss_pred CceEEEEEeccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccC
Q 010463 178 SDFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 256 (510)
Q Consensus 178 ~~~~~lVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~ 256 (510)
.+.+|+|||||+||+|.++|.+ .+.+++..+++|++||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~ 225 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL 225 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhc
Confidence 9999999999999999999987 578999999999999999999999999999999999999999999999999999865
Q ss_pred ccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc-----cCCCCccccccchh
Q 010463 257 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDWWSLG 331 (510)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-----~~~y~~~~DiwSlG 331 (510)
..... ......+||+.|+|||++. ...|+.++||||||
T Consensus 226 ~~~~~-------------------------------------~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlG 268 (437)
T 4aw2_A 226 MEDGT-------------------------------------VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLG 268 (437)
T ss_dssp CTTSC-------------------------------------EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHH
T ss_pred ccCCC-------------------------------------cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHH
Confidence 43211 0112468999999999997 46689999999999
Q ss_pred hHHHHHhhCCCCCCCCChhhhHHHHhhccccccCCCC-CCCCHHHHHHHHHhhcCccccCCCCChHHhhcCCCcCCCCch
Q 010463 332 AIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEE-PKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWD 410 (510)
Q Consensus 332 vilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~-~~~s~~~~dlI~~lL~dp~~R~~~~~~~eil~HpfF~~i~~~ 410 (510)
|++|||++|.+||.+.+..+++.+|+++...+.+|.. ..+|+++++||++||+.+.+|+++.+++||++||||++++|+
T Consensus 269 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~ 348 (437)
T 4aw2_A 269 VCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWD 348 (437)
T ss_dssp HHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTT
T ss_pred HHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHH
Confidence 9999999999999999999999999987666777764 469999999999999955666666689999999999999999
Q ss_pred hhhcccCCCccccCCCccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCcccCceeeCCccccc
Q 010463 411 KLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKS 475 (510)
Q Consensus 411 ~l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~ 475 (510)
.+.+.+|||+|.+.++.|++||+...+........+. +......+.+..|.||||.++..+..
T Consensus 349 ~l~~~~~p~~P~~~~~~d~~~fd~~~~~~~~~~~~~~--~~~~~~~~~~~~f~~~~~~~~~~~~~ 411 (437)
T 4aw2_A 349 NIRNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETMPP--PTHTAFSGHHLPFVGFTYTSSCVLSD 411 (437)
T ss_dssp TGGGSCCSCCCCCSSTTCCTTSCCC--------------------CCTTGGGTTCCEESSCTTST
T ss_pred HHhhCCCCCCCcCCCccchhhcCCcccccccccCCCC--CccccccccCccccCCCcCCchhhcc
Confidence 9999999999999999999999875432221111111 11111234567899999999876644
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-66 Score=530.60 Aligned_cols=256 Identities=28% Similarity=0.511 Sum_probs=230.3
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
+.|++++.||+|+||+||+|+++.||+.||||++.+... ...+.+.+|+.+|+.++|||||+++++|++++.+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC---SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 569999999999999999999999999999999987643 23456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
|||+||+|.+++.+ +.++|.+++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+....
T Consensus 151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~----- 224 (346)
T 4fih_A 151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV----- 224 (346)
T ss_dssp CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-----
T ss_pred eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC-----
Confidence 99999999998865 579999999999999999999999999999999999999999999999999998764321
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCC
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~ 345 (510)
....+.||||.|||||++.+.+|+.++|||||||+||||++|.+||.
T Consensus 225 ---------------------------------~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 271 (346)
T 4fih_A 225 ---------------------------------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF 271 (346)
T ss_dssp ---------------------------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ---------------------------------CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 11236799999999999999999999999999999999999999999
Q ss_pred CCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 346 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 346 ~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
+.+..+.+.+|... ....++.+..+|++++|||.+||+ ||++|+ +++|+++||||+..
T Consensus 272 ~~~~~~~~~~i~~~-~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~---ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 272 NEPPLKAMKMIRDN-LPPRLKNLHKVSPSLKGFLDRLLVRDPAQRA---TAAELLKHPFLAKA 330 (346)
T ss_dssp TSCHHHHHHHHHHS-SCCCCSCGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHTTCGGGGGC
T ss_pred CcCHHHHHHHHHcC-CCCCCCccccCCHHHHHHHHHHcCCChhHCc---CHHHHhcCHhhcCC
Confidence 99999888888763 223444456899999999999999 999999 78999999999853
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-66 Score=515.28 Aligned_cols=255 Identities=31% Similarity=0.565 Sum_probs=217.5
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
+++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+|+.++|||||+++++|++++.+|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 57999999999999999999999999999999999987766666678899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 185 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
|||| +|+|.++|.+.+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+......
T Consensus 92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---- 166 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---- 166 (275)
T ss_dssp EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC----
Confidence 9999 78999999999999999999999999999999999999999999999999999999999999998654321
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCC-CccccccchhhHHHHHhhCCCC
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEMLIGYPP 343 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiwSlGvilyEml~G~~P 343 (510)
...+.+|||.|||||++.+..| +.++|||||||+||||++|++|
T Consensus 167 -----------------------------------~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~P 211 (275)
T 3hyh_A 167 -----------------------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLP 211 (275)
T ss_dssp -------------------------------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred -----------------------------------ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCC
Confidence 1235799999999999999887 6899999999999999999999
Q ss_pred CCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 344 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 344 F~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
|.+.+...++.+|.+. ...+| ..+|+++++||.+||. ||++|| +++|+++||||+.
T Consensus 212 F~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~li~~~L~~dP~~R~---s~~eil~hpw~k~ 268 (275)
T 3hyh_A 212 FDDESIPVLFKNISNG--VYTLP--KFLSPGAAGLIKRMLIVNPLNRI---SIHEIMQDDWFKV 268 (275)
T ss_dssp SCCSSHHHHHHHHHHT--CCCCC--TTSCHHHHHHHHHHSCSSGGGSC---CHHHHHHCHHHHT
T ss_pred CCCCCHHHHHHHHHcC--CCCCC--CCCCHHHHHHHHHHccCChhHCc---CHHHHHcCccccc
Confidence 9999999999999874 34555 4799999999999998 999999 7999999999973
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-66 Score=530.48 Aligned_cols=258 Identities=28% Similarity=0.509 Sum_probs=227.0
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEE
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l 183 (510)
.+++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|+.++|||||+++++|++++.+||
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi 100 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI 100 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 45799999999999999999999999999999999987654 34567889999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 184 IMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
|||||+||||.++|... ..++|..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+....
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 179 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV- 179 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence 99999999999999754 457999999999999999999999999999999999999999999999999999764320
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~ 341 (510)
..+.+.||||.|||||++.+.+|+.++|||||||+||||++|+
T Consensus 180 -------------------------------------~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~ 222 (350)
T 4b9d_A 180 -------------------------------------ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222 (350)
T ss_dssp -------------------------------------HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred -------------------------------------ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 0123578999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
+||.+.+..+++.+|++.... |....+|+++++||.+||. ||++|| +++|+++||||+.
T Consensus 223 ~PF~~~~~~~~~~~i~~~~~~---~~~~~~s~~~~~li~~~L~~dP~~R~---s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 223 HAFEAGSMKNLVLKIISGSFP---PVSLHYSYDLRSLVSQLFKRNPRDRP---SVNSILEKGFIAK 282 (350)
T ss_dssp CSCCCSSHHHHHHHHHHTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHTSHHHHT
T ss_pred CCCCCcCHHHHHHHHHcCCCC---CCCccCCHHHHHHHHHHccCChhHCc---CHHHHhcCHHhhc
Confidence 999999999999999875321 2235799999999999998 999999 7999999999975
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-65 Score=526.27 Aligned_cols=325 Identities=33% Similarity=0.659 Sum_probs=274.4
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCc
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSD 179 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~ 179 (510)
.++..++|++++.||+|+||+||+|+++.+|+.||||++.+...........+..|+.+|..+ +|||||+++++|++.+
T Consensus 18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 97 (353)
T 3txo_A 18 NRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD 97 (353)
T ss_dssp -----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence 456789999999999999999999999999999999999987776777788899999999988 7999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 180 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
.+|+|||||+||+|..++.+.+.+++..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999854321
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~ 339 (510)
. ....+.+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 178 ~--------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 219 (353)
T 3txo_A 178 G--------------------------------------VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLC 219 (353)
T ss_dssp ----------------------------------------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHH
T ss_pred C--------------------------------------ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHh
Confidence 0 01235789999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC---CChHHhhcCCCcCCCCchhhh--
Q 010463 340 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT---RGVEELKEHPWFRGIQWDKLY-- 413 (510)
Q Consensus 340 G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~---~~~~eil~HpfF~~i~~~~l~-- 413 (510)
|.+||.+.+..+++.+|.+. .+.+|. .+++++++||++||+ ||.+|+++ .+++||++||||++++|+.+.
T Consensus 220 G~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~ 295 (353)
T 3txo_A 220 GHAPFEAENEDDLFEAILND--EVVYPT--WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHR 295 (353)
T ss_dssp SSCSSCCSSHHHHHHHHHHC--CCCCCT--TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTT
T ss_pred CCCCCCCCCHHHHHHHHHcC--CCCCCC--CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcC
Confidence 99999999999999999874 355664 799999999999999 99999976 456999999999999999986
Q ss_pred cccCCCccccCCCccCCCCCC-CCCCCCCCCCCCCCCcccccCCCcCCcccCceeeCCc
Q 010463 414 EMEAAYKPTVNGELDTQNFEK-FPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSD 471 (510)
Q Consensus 414 ~~~~p~~p~~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~ 471 (510)
++.|||+|.+++..|++||+. |.... +.. .+.... .+....+..|.||+|..+.
T Consensus 296 ~~~~p~~p~~~~~~~~~~f~~~~~~~~-~~~-~~~~~~--~~~~~~~~~f~~f~~~~~~ 350 (353)
T 3txo_A 296 QIEPPFRPRIKSREDVSNFDPDFIKEE-PVL-TPIDEG--HLPMINQDEFRNFEYVSPE 350 (353)
T ss_dssp CSCCSCCCCCCSTTCCTTSCHHHHTSC-CCC-CCCCTT--SGGGSCGGGGTTCCEECC-
T ss_pred cCCCCccCCCCCcccccccCcccccCC-CcC-CCcccc--ccCcccccccCCceeeCcc
Confidence 478999999999999999985 32221 111 111000 1111234579999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-65 Score=520.64 Aligned_cols=327 Identities=37% Similarity=0.650 Sum_probs=277.7
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceE
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 181 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~ 181 (510)
++..++|++++.||+|+||+||+|+++.+|+.||||++.+.......+..++.+|+.+|..++||||++++++|++.+.+
T Consensus 1 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 80 (337)
T 1o6l_A 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL 80 (337)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred CCChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEE
Confidence 35678999999999999999999999999999999999987766677788899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 182 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
|+||||++||+|..++.+.+.+++..+++|++||+.||+|||++||+||||||+||||+.+|++||+|||+|+......
T Consensus 81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 159 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG- 159 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC-
Confidence 9999999999999999998999999999999999999999999999999999999999999999999999998643210
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~ 341 (510)
....+.+||+.|+|||++.+..|+.++|||||||++|||++|.
T Consensus 160 -------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 202 (337)
T 1o6l_A 160 -------------------------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202 (337)
T ss_dssp -------------------------------------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSS
T ss_pred -------------------------------------CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCC
Confidence 0123578999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CChHHhhcCCCcCCCCchhhhc--cc
Q 010463 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLYE--ME 416 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~--~~~~eil~HpfF~~i~~~~l~~--~~ 416 (510)
+||.+.+....+..|... .+.+|. .+|+++++||.+||. ||.+|||. .+++||++||||++++|+.+.. +.
T Consensus 203 ~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~~ 278 (337)
T 1o6l_A 203 LPFYNQDHERLFELILME--EIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLL 278 (337)
T ss_dssp CSSCCSSHHHHHHHHHHC--CCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred CCCCCCCHHHHHHHHHcC--CCCCCC--CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCCC
Confidence 999999998888888863 455664 799999999999998 99999975 3799999999999999999974 78
Q ss_pred CCCccccCCCccCCCCCC-CCCCCCCCCCCCCCCccccc---CCCcCCcccCceeeCC
Q 010463 417 AAYKPTVNGELDTQNFEK-FPEVDGPPSEIPSVGPWRKM---LTSKDTNFIGYTFKKS 470 (510)
Q Consensus 417 ~p~~p~~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~f~~~~~~~~ 470 (510)
|||+|.+.++.|+++|+. |........+.........+ ....+..|.||+|.+.
T Consensus 279 pp~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~ 336 (337)
T 1o6l_A 279 PPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQREEQEMFEDFDYIAD 336 (337)
T ss_dssp CSCCCCCSSTTCCTTSCHHHHTSCCC--------------------CCTTTTCCEECC
T ss_pred CCCCCCCCCcchhhcccchhccCccCcCCCcccccccccccccccccccCCCceecCC
Confidence 999999999999999985 33322111110000011111 1113468999999764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-65 Score=531.95 Aligned_cols=327 Identities=31% Similarity=0.649 Sum_probs=271.2
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCc
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSD 179 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~ 179 (510)
..+..++|+++++||+|+||+||+|+++.+++.||||++++...........+..|+.+|..+ +|||||+++++|++.+
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 126 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence 356788999999999999999999999999999999999988766666777899999999877 8999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 180 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
.+|+||||++||+|..++.+.+.+++..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999853221
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~ 339 (510)
. ....+.+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 207 ~--------------------------------------~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~ 248 (396)
T 4dc2_A 207 G--------------------------------------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 248 (396)
T ss_dssp T--------------------------------------CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred C--------------------------------------CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHh
Confidence 0 11235799999999999999999999999999999999999
Q ss_pred CCCCCCCC---------ChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC---CChHHhhcCCCcCC
Q 010463 340 GYPPFCSD---------DPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT---RGVEELKEHPWFRG 406 (510)
Q Consensus 340 G~~PF~~~---------~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~---~~~~eil~HpfF~~ 406 (510)
|.+||.+. .....+..|.. ..+.+|. .+|+++++||++||+ ||.+||++ .+++||++||||++
T Consensus 249 G~~Pf~~~~~~~~~~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 249 GRSPFDIVGSSDNPDQNTEDYLFQVILE--KQIRIPR--SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp SSCSSTTTTC------CCHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred CCCCCcccccccccchhhHHHHHHHHhc--cccCCCC--cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 99999643 22334556665 3455664 799999999999998 99999986 35799999999999
Q ss_pred CCchhhhc--ccCCCccccCCCccCCCCCC-CCCCCCCCCCCCCCCcccccCCCcCCcccCceeeCCccc
Q 010463 407 IQWDKLYE--MEAAYKPTVNGELDTQNFEK-FPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVL 473 (510)
Q Consensus 407 i~~~~l~~--~~~p~~p~~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~ 473 (510)
++|+.+.. ..|||+|.++++.|++||+. |..... ...+. .. ..+....+..|.||+|.++..+
T Consensus 325 i~w~~l~~~~~~pp~~p~~~~~~d~~~fd~~~~~~~~--~~~~~-~~-~~~~~~~~~~f~~f~~~~~~~~ 390 (396)
T 4dc2_A 325 VDWDMMEQKQVVPPFKPNISGEFGLDNFDSQFTNEPV--QLTPD-DD-DIVRKIDQSEFEGFEYINPLLM 390 (396)
T ss_dssp CCHHHHHTTCSCCSCCCCCCSSTTGGGSCHHHHTSCC--CCCCC-CH-HHHTTSCGGGGTTCCEECC---
T ss_pred CCHHHHHcCCCCCCCcCCCCCccchhhcChhhccCCC--ccCCC-cc-hhhccccccccCCcEeECcccc
Confidence 99999974 78999999999999999996 333211 11111 11 0111223457999999998665
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-65 Score=531.40 Aligned_cols=256 Identities=28% Similarity=0.511 Sum_probs=230.3
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
+.|++++.||+|+||+||+|+++.+|+.||||++.+... ...+.+.+|+.+|+.++|||||+++++|++++.+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC---SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 569999999999999999999999999999999987543 23456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
|||+||+|.+++.. +.++|.+++.|+.||+.||+|||++|||||||||+||||+.+|+|||+|||+|+.+....
T Consensus 228 Ey~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~----- 301 (423)
T 4fie_A 228 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV----- 301 (423)
T ss_dssp ECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-----
T ss_pred eCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC-----
Confidence 99999999998854 569999999999999999999999999999999999999999999999999998764321
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCC
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~ 345 (510)
....+.||||.|||||++.+..|+.++|||||||+||||++|.+||.
T Consensus 302 ---------------------------------~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 348 (423)
T 4fie_A 302 ---------------------------------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF 348 (423)
T ss_dssp ---------------------------------CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ---------------------------------ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 11236799999999999999999999999999999999999999999
Q ss_pred CCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 346 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 346 ~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
+.+....+..|... ....++....+|++++|||.+||+ ||++|+ +++|||+||||+..
T Consensus 349 ~~~~~~~~~~i~~~-~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~---ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 349 NEPPLKAMKMIRDN-LPPRLKNLHKVSPSLKGFLDRLLVRDPAQRA---TAAELLKHPFLAKA 407 (423)
T ss_dssp TSCHHHHHHHHHHS-CCCCCSCTTSSCHHHHHHHHHHSCSSTTTSC---CHHHHTTCGGGGGC
T ss_pred CcCHHHHHHHHHcC-CCCCCcccccCCHHHHHHHHHHcCCChhHCc---CHHHHhcCHHhcCC
Confidence 99999888888764 223444456899999999999998 999999 78999999999863
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-65 Score=524.99 Aligned_cols=327 Identities=35% Similarity=0.646 Sum_probs=277.7
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCc
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSD 179 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~ 179 (510)
.++..++|++++.||+|+||+||+|+++.+|+.||||++.+.........+++..|+.+|..+ +||||++++++|++.+
T Consensus 15 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 94 (353)
T 2i0e_A 15 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 94 (353)
T ss_dssp ----CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred CCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence 356789999999999999999999999999999999999988766667788899999999887 8999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 180 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
.+|+||||++||+|.+++.+.+.+++..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999999864321
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~ 339 (510)
. ....+.+||+.|+|||++.+.+|+.++|||||||++|||++
T Consensus 175 ~--------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 216 (353)
T 2i0e_A 175 G--------------------------------------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 216 (353)
T ss_dssp T--------------------------------------CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHH
T ss_pred C--------------------------------------cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHc
Confidence 0 01235789999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CChHHhhcCCCcCCCCchhhh--c
Q 010463 340 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLY--E 414 (510)
Q Consensus 340 G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~--~~~~eil~HpfF~~i~~~~l~--~ 414 (510)
|.+||.+.+..+++.+|... .+.+|. .+|+++++||++||+ ||.+||+. .++++|++||||++++|+.+. +
T Consensus 217 G~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~ 292 (353)
T 2i0e_A 217 GQAPFEGEDEDELFQSIMEH--NVAYPK--SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKE 292 (353)
T ss_dssp SSCSSCCSSHHHHHHHHHHC--CCCCCT--TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTC
T ss_pred CCCCCCCCCHHHHHHHHHhC--CCCCCC--CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCC
Confidence 99999999999999999874 455664 799999999999998 99999976 368999999999999999996 4
Q ss_pred ccCCCccccCCCccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCcccCceeeCCccc
Q 010463 415 MEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVL 473 (510)
Q Consensus 415 ~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~ 473 (510)
+.|||+|.+.+. |++||+.+.....+... +. .. .......+..|.||+|.+++.+
T Consensus 293 ~~~p~~p~~~~~-~~~~f~~~~~~~~~~~~-~~-~~-~~~~~~~~~~f~~f~~~~~~~~ 347 (353)
T 2i0e_A 293 IQPPYKPKACGR-NAENFDRFFTRHPPVLT-PP-DQ-EVIRNIDQSEFEGFSFVNSEFL 347 (353)
T ss_dssp SCCSCCCCCCCC---CHHHHHHHHSCCCCC-CC-CH-HHHHHSCTTTTCSCCEECTTCC
T ss_pred CCCCcCCCCCCc-chhhccchhccCCcccC-Cc-cc-cccccccccccCCCeeeCcccc
Confidence 789999999998 99999863222211111 11 00 0011124468999999988664
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-64 Score=515.61 Aligned_cols=325 Identities=35% Similarity=0.642 Sum_probs=252.5
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCc
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSD 179 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~ 179 (510)
.++..++|++++.||+|+||+||+|+++.+|+.||||++++...........+..|+.+|..+ +||||++++++|++.+
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 456789999999999999999999999999999999999987766666778899999999877 9999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 180 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
.+|+||||++||+|.+++.+.+.+++..+++|++||+.||+|||++||+||||||+||||+.+|++||+|||+|+.....
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999999864321
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~ 339 (510)
. ....+.+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 172 ~--------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 213 (345)
T 1xjd_A 172 D--------------------------------------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLI 213 (345)
T ss_dssp T--------------------------------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred C--------------------------------------CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhc
Confidence 0 01235789999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchhhh--ccc
Q 010463 340 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLY--EME 416 (510)
Q Consensus 340 G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l~--~~~ 416 (510)
|.+||.+.+...++.+|... ...+|. .+|+++++||.+||+ ||.+||+.. ++|++||||++++|+.+. ++.
T Consensus 214 g~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~lL~~dp~~R~~~~--~~i~~hp~f~~~~w~~l~~~~~~ 287 (345)
T 1xjd_A 214 GQSPFHGQDEEELFHSIRMD--NPFYPR--WLEKEAKDLLVKLFVREPEKRLGVR--GDIRQHPLFREINWEELERKEID 287 (345)
T ss_dssp SSCSSCCSSHHHHHHHHHHC--CCCCCT--TSCHHHHHHHHHHSCSSGGGSBTTB--SCGGGSGGGTTCCHHHHHTTCSC
T ss_pred CCCCCCCCCHHHHHHHHHhC--CCCCCc--ccCHHHHHHHHHHhcCCHhHcCCCh--HHHHcCccccCCCHHHHhhCCCC
Confidence 99999999999999998874 345553 799999999999998 999999542 399999999999999996 478
Q ss_pred CCCccccCCCccCCCCCC-CCCCCCCCCCCCCCCcccccCCCcCCcccCceeeCCccc
Q 010463 417 AAYKPTVNGELDTQNFEK-FPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVL 473 (510)
Q Consensus 417 ~p~~p~~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~ 473 (510)
|||+|.++++.|++||+. |.+...... +. .. .......+..|.||+|.++...
T Consensus 288 ~p~~p~~~~~~d~~~f~~~~~~~~~~~~--~~-~~-~~~~~~~~~~f~~f~~~~~~~~ 341 (345)
T 1xjd_A 288 PPFRPKVKSPFDCSNFDKEFLNEKPRLS--FA-DR-ALINSMDQNMFRNFSFMNPGME 341 (345)
T ss_dssp C------------------------------------------CCTTTTCCC------
T ss_pred CCcCCCCCCcchhhhcchhhcccCccCC--cc-cc-cccccccccccCCCeeeChhhh
Confidence 999999999999999996 443221111 10 00 0011123468999999877543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-64 Score=521.23 Aligned_cols=329 Identities=38% Similarity=0.665 Sum_probs=246.9
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHH-HHhcCCCCeeeEeEEeecCc
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNL-LAEVDSRCIVQLFYSFQDSD 179 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~i-L~~l~hp~Iv~l~~~~~~~~ 179 (510)
..+..++|++++.||+|+||+||+|+++.+++.||||++.+..+....+..++..|+.+ ++.++|||||+++++|++.+
T Consensus 33 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~ 112 (373)
T 2r5t_A 33 PHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD 112 (373)
T ss_dssp TTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred CCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence 45677899999999999999999999999999999999998877666777788889888 47789999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 180 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
.+|+||||++||+|.+++.+.+.+++..+++|++||+.||+|||++||+||||||+||||+.+|++||+|||+|+.....
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 99999999999999999999899999999999999999999999999999999999999999999999999999853221
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~ 339 (510)
. ....+.+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 193 ~--------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 234 (373)
T 2r5t_A 193 N--------------------------------------STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLY 234 (373)
T ss_dssp C--------------------------------------CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred C--------------------------------------CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHc
Confidence 0 11235789999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC-CChHHhhcCCCcCCCCchhhh--cc
Q 010463 340 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT-RGVEELKEHPWFRGIQWDKLY--EM 415 (510)
Q Consensus 340 G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~-~~~~eil~HpfF~~i~~~~l~--~~ 415 (510)
|.+||.+.+..+++.+|++. .+.+| +.+++++++||.+||+ ||.+|++. .++++|++||||++++|+.+. .+
T Consensus 235 G~~Pf~~~~~~~~~~~i~~~--~~~~~--~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~~~~ 310 (373)
T 2r5t_A 235 GLPPFYSRNTAEMYDNILNK--PLQLK--PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKI 310 (373)
T ss_dssp SSCTTCCSBHHHHHHHHHHS--CCCCC--SSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHTTCS
T ss_pred CCCCCCCCCHHHHHHHHHhc--ccCCC--CCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHHhCCC
Confidence 99999999999999999874 34555 4799999999999998 99999987 467899999999999999996 47
Q ss_pred cCCCccccCCCccCCCCCC-CCCCCCCCCCCCCC--CcccccCCCcCCcccCceeeCCc
Q 010463 416 EAAYKPTVNGELDTQNFEK-FPEVDGPPSEIPSV--GPWRKMLTSKDTNFIGYTFKKSD 471 (510)
Q Consensus 416 ~~p~~p~~~~~~d~~~f~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~f~~~~~~~~~ 471 (510)
.|||+|.+.++.|++||+. |.+...+....... ..........+..|.||||.++.
T Consensus 311 ~pp~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~ 369 (373)
T 2r5t_A 311 TPPFNPNVSGPNDLRHFDPEFTEEPVPNAIGKAPDSVLVTASVKEAAEAFLGFSYAPPT 369 (373)
T ss_dssp CCSCCCSCCC-------------------------------------------------
T ss_pred CCCCCCCCCCcchhhhcCcccccccccccccCCccccccccccccccccCCCCcccCch
Confidence 8999999999999999995 44332221110000 00001111234579999998764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-63 Score=498.18 Aligned_cols=253 Identities=22% Similarity=0.393 Sum_probs=219.4
Q ss_pred Cc-eeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec----CceE
Q 010463 107 DF-EQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD----SDFL 181 (510)
Q Consensus 107 ~f-~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~----~~~~ 181 (510)
+| ++.+.||+|+||+||+|+++.+|..||+|++.+... .....+.+.+|+.+|+.++|||||+++++|++ ++.+
T Consensus 26 r~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 104 (290)
T 3fpq_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence 44 677889999999999999999999999999987654 34456789999999999999999999999975 4579
Q ss_pred EEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCC--eEEeecCCCCeeecC-CCceeecccCCcccCcc
Q 010463 182 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHN--YVHRDIKPDNLILDK-NGHLKLSDFGLCKPLED 258 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~g--iiHRDLKP~NILld~-~g~vkL~DFGla~~~~~ 258 (510)
|||||||+||+|.++|.+.+.+++..++.|+.||+.||+|||++| ||||||||+||||+. +|++||+|||+|+....
T Consensus 105 ~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 999999999999999999999999999999999999999999998 999999999999984 89999999999985432
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHh
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml 338 (510)
. .+.+.||||.|||||++.+ +|+.++|||||||+||||+
T Consensus 185 ~----------------------------------------~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyell 223 (290)
T 3fpq_A 185 S----------------------------------------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMA 223 (290)
T ss_dssp T----------------------------------------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHH
T ss_pred C----------------------------------------ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHH
Confidence 1 1235799999999999864 6999999999999999999
Q ss_pred hCCCCCCCCCh-hhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 339 IGYPPFCSDDP-RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 339 ~G~~PF~~~~~-~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
+|.+||.+.+. ...+..+.....+..++ ..+|+++++||.+||. ||++|| +++|+++||||++
T Consensus 224 tg~~Pf~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~R~---s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 224 TSEYPYSECQNAAQIYRRVTSGVKPASFD--KVAIPEVKEIIEGCIRQNKDERY---SIKDLLNHAFFQE 288 (290)
T ss_dssp HSSCTTTTCSSHHHHHHHHTTTCCCGGGG--GCCCHHHHHHHHHHSCSSGGGSC---CHHHHHTSGGGC-
T ss_pred HCCCCCCCCCcHHHHHHHHHcCCCCCCCC--ccCCHHHHHHHHHHccCChhHCc---CHHHHhcCccccC
Confidence 99999986544 44555565543333333 4689999999999998 999999 7899999999975
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-63 Score=500.81 Aligned_cols=292 Identities=42% Similarity=0.853 Sum_probs=255.6
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEE
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~ 182 (510)
+..++|++++.||+|+||+||+|+++.+|+.||||++.+.......+.+++.+|+.+|+.++||||++++++|++.+.+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 56789999999999999999999999999999999999876666667888999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccc
Q 010463 183 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 262 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 262 (510)
+||||++||+|.+++.+.+.+++..++.+++||+.||.|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--- 159 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 159 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc---
Confidence 99999999999999999899999999999999999999999999999999999999999999999999999865331
Q ss_pred ccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCC
Q 010463 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 342 (510)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~ 342 (510)
..+.+||+.|+|||++.+..|+.++|||||||++|||++|.+
T Consensus 160 --------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 201 (318)
T 1fot_A 160 --------------------------------------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 201 (318)
T ss_dssp --------------------------------------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred --------------------------------------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCC
Confidence 124689999999999999999999999999999999999999
Q ss_pred CCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CChHHhhcCCCcCCCCchhhhc--ccC
Q 010463 343 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLYE--MEA 417 (510)
Q Consensus 343 PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~--~~~~eil~HpfF~~i~~~~l~~--~~~ 417 (510)
||.+.+....+.+|.+. .+.+| ..+++++++||++||+ ||.+|++. .++++|++||||++++|+.+.. ..|
T Consensus 202 pf~~~~~~~~~~~i~~~--~~~~p--~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~ 277 (318)
T 1fot_A 202 PFYDSNTMKTYEKILNA--ELRFP--PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIET 277 (318)
T ss_dssp TTCCSSHHHHHHHHHHC--CCCCC--TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCC
T ss_pred CCCCCCHHHHHHHHHhC--CCCCC--CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHhCCCCC
Confidence 99999999999999874 35566 3799999999999998 99999975 3799999999999999999974 789
Q ss_pred CCccccC-CCccCCCCCCCCCCC
Q 010463 418 AYKPTVN-GELDTQNFEKFPEVD 439 (510)
Q Consensus 418 p~~p~~~-~~~d~~~f~~~~~~~ 439 (510)
||+|.+. +..|+++|+.+++..
T Consensus 278 p~~p~~~~~~~d~~~f~~~~~~~ 300 (318)
T 1fot_A 278 PYEPPIQQGQGDTSQFDKYPEED 300 (318)
T ss_dssp SCCCCC----------------C
T ss_pred CCCCCcCCCccchhhcCCCCccc
Confidence 9999998 589999999876543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-64 Score=508.11 Aligned_cols=250 Identities=27% Similarity=0.386 Sum_probs=218.7
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEE
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l 183 (510)
..++|++.+.||+|+||+||+|+++.+|+.||||++++... ..+|+.+|+.++|||||+++++|++++.+||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45679999999999999999999999999999999986533 2369999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCC-ceeecccCCcccCcccccc
Q 010463 184 IMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG-HLKLSDFGLCKPLEDKYSS 262 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g-~vkL~DFGla~~~~~~~~~ 262 (510)
|||||+||+|.++|.+.+.+++..++.|+.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+.+......
T Consensus 128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 999999999999999999999999999999999999999999999999999999999998 6999999999976532100
Q ss_pred ccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCC
Q 010463 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 342 (510)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~ 342 (510)
. ......++||||.|||||++.+.+|+.++|||||||+||||++|.+
T Consensus 208 ~---------------------------------~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~ 254 (336)
T 4g3f_A 208 K---------------------------------SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254 (336)
T ss_dssp ---------------------------------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred c---------------------------------ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcC
Confidence 0 0001234689999999999999999999999999999999999999
Q ss_pred CCCCCChhhhHHHHhhccccc-cCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhh
Q 010463 343 PFCSDDPRITCRKIVNWKTCL-KFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 399 (510)
Q Consensus 343 PF~~~~~~~~~~~I~~~~~~~-~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil 399 (510)
||.+.+...++.+|.+....+ .+| +.+|+++++||.+||. ||.+|| ++.||+
T Consensus 255 Pf~~~~~~~~~~~i~~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~~R~---sa~el~ 308 (336)
T 4g3f_A 255 PWTQYFRGPLCLKIASEPPPIREIP--PSCAPLTAQAIQEGLRKEPVHRA---SAMELR 308 (336)
T ss_dssp SSTTTCCSCCHHHHHHSCCGGGGSC--TTSCHHHHHHHHHHTCSSGGGSC---CHHHHH
T ss_pred CCCCCCHHHHHHHHHcCCCCchhcC--ccCCHHHHHHHHHHccCCHhHCc---CHHHHH
Confidence 999999888999998754332 234 4899999999999998 999999 678874
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-62 Score=503.03 Aligned_cols=294 Identities=38% Similarity=0.784 Sum_probs=269.9
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCce
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 180 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 180 (510)
.....++|++++.||+|+||.||+|+++.+|+.||||++.+.......+.+++.+|+.+|..++||||++++++|++.+.
T Consensus 36 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 115 (350)
T 1rdq_E 36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN 115 (350)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cCCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 44677899999999999999999999999999999999998876666778889999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccc
Q 010463 181 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 260 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~ 260 (510)
+|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.....
T Consensus 116 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 9999999999999999999889999999999999999999999999999999999999999999999999999865432
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhC
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 340 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G 340 (510)
..+.+||+.|+|||++.+..|+.++|||||||++|||++|
T Consensus 195 ----------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 234 (350)
T 1rdq_E 195 ----------------------------------------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234 (350)
T ss_dssp ----------------------------------------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred ----------------------------------------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhC
Confidence 1246899999999999999999999999999999999999
Q ss_pred CCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CChHHhhcCCCcCCCCchhhh--cc
Q 010463 341 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLY--EM 415 (510)
Q Consensus 341 ~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~--~~~~eil~HpfF~~i~~~~l~--~~ 415 (510)
.+||.+.+....+.+|... .+.+|. .+|+++++||.+||+ ||.+|++. .++++|++||||++++|+.+. ..
T Consensus 235 ~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~ 310 (350)
T 1rdq_E 235 YPPFFADQPIQIYEKIVSG--KVRFPS--HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKV 310 (350)
T ss_dssp SCSSCCSSHHHHHHHHHHC--CCCCCT--TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCS
T ss_pred CCCCCCCCHHHHHHHHHcC--CCCCCC--CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhhccC
Confidence 9999999999999999874 355564 799999999999998 99999973 458999999999999999997 47
Q ss_pred cCCCccccCCCccCCCCCCCCCCC
Q 010463 416 EAAYKPTVNGELDTQNFEKFPEVD 439 (510)
Q Consensus 416 ~~p~~p~~~~~~d~~~f~~~~~~~ 439 (510)
.|||+|.++++.|+++|+.+++..
T Consensus 311 ~~p~~p~~~~~~~~~~f~~~~~~~ 334 (350)
T 1rdq_E 311 EAPFIPKFKGPGDTSNFDDYEEEE 334 (350)
T ss_dssp CCSCCCCCCSTTCCTTSCCCCCCC
T ss_pred CCCCCCCCCCcccccccccccccc
Confidence 899999999999999999776543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-63 Score=507.11 Aligned_cols=324 Identities=32% Similarity=0.656 Sum_probs=273.7
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCc
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSD 179 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~ 179 (510)
..+..++|++++.||+|+||.||+|+++.+|+.||||++.+...........+.+|+.+|..+ +|||||+++++|++.+
T Consensus 4 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 83 (345)
T 3a8x_A 4 DPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 83 (345)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC
Confidence 346778999999999999999999999999999999999988776677788899999999887 8999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 180 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
.+|+||||++||+|..++.+.+.+++..++.|++||+.||+|||++||+||||||+||||+.+|++||+|||+|+.....
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999999864321
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~ 339 (510)
. ....+.+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 164 ~--------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 205 (345)
T 3a8x_A 164 G--------------------------------------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 205 (345)
T ss_dssp T--------------------------------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred C--------------------------------------CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHh
Confidence 0 01235789999999999999999999999999999999999
Q ss_pred CCCCCCC---------CChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC---CChHHhhcCCCcCC
Q 010463 340 GYPPFCS---------DDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT---RGVEELKEHPWFRG 406 (510)
Q Consensus 340 G~~PF~~---------~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~---~~~~eil~HpfF~~ 406 (510)
|.+||.. .+....+..|... .+.+|. .+|+++++||.+||. ||.+||++ .+++||++||||++
T Consensus 206 g~~pf~~~~~~~~~~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 206 GRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRIPR--SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp SSCTTTTTTC-------CHHHHHHHHHHC--CCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred CCCCcCCcccccccccccHHHHHHHHHcC--CCCCCC--CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 9999975 2334455566653 355664 799999999999998 99999986 25799999999999
Q ss_pred CCchhhhc--ccCCCccccCCCccCCCCCC-CCCCCCCCCCCCCCCcccccCCCcCCcccCceeeCC
Q 010463 407 IQWDKLYE--MEAAYKPTVNGELDTQNFEK-FPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKS 470 (510)
Q Consensus 407 i~~~~l~~--~~~p~~p~~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~ 470 (510)
++|+.+.+ ..|||+|.+.+..|+++|+. +....... .+. .. .......+..|.||+|.++
T Consensus 282 ~~w~~~~~~~~~~p~~p~~~~~~~~~~~~~~~~~~~~~~--~~~-~~-~~~~~~~~~~f~~f~~~~~ 344 (345)
T 3a8x_A 282 VDWDMMEQKQVVPPFKPNISGEFGLDNFDSQFTNEPVQL--TPD-DD-DIVRKIDQSEFEGFEYINP 344 (345)
T ss_dssp CCHHHHHTTCSCCSCCCCCCTTTCGGGSCHHHHTSCSSC--CCC-CH-HHHTTSCGGGGTTCCEECC
T ss_pred CCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccCcccC--CCc-cc-cccccccccccCCCEeeCC
Confidence 99999964 78999999999999999985 33322111 111 10 0011223457999999875
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-63 Score=546.87 Aligned_cols=327 Identities=35% Similarity=0.643 Sum_probs=282.1
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCc
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSD 179 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~ 179 (510)
..+..++|+++++||+|+||+||+|+++.+|+.||||++++.........+.+..|+.+|..+ +||||++++++|++.+
T Consensus 336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~ 415 (674)
T 3pfq_A 336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415 (674)
T ss_dssp ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence 456789999999999999999999999999999999999987766677788899999999887 7999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 180 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
.+||||||++||+|..+|.+.+.+++..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred EEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 99999999999999999999899999999999999999999999999999999999999999999999999999854321
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~ 339 (510)
. ....+.+||+.|+|||++.+..|+.++|||||||+||||++
T Consensus 496 ~--------------------------------------~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyellt 537 (674)
T 3pfq_A 496 G--------------------------------------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 537 (674)
T ss_dssp T--------------------------------------CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHH
T ss_pred C--------------------------------------cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHc
Confidence 0 01235789999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CChHHhhcCCCcCCCCchhhh--c
Q 010463 340 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLY--E 414 (510)
Q Consensus 340 G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~--~~~~eil~HpfF~~i~~~~l~--~ 414 (510)
|.+||.+.+..+++.+|+.. .+.+|. .+|+++++||++||. ||.+||+. .+++||++||||+++||+.+. +
T Consensus 538 G~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~ 613 (674)
T 3pfq_A 538 GQAPFEGEDEDELFQSIMEH--NVAYPK--SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKE 613 (674)
T ss_dssp SSCSSCCSSHHHHHHHHHSS--CCCCCT--TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTC
T ss_pred CCCCCCCCCHHHHHHHHHhC--CCCCCc--cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCC
Confidence 99999999999999999874 456664 799999999999999 99999975 457999999999999999997 4
Q ss_pred ccCCCccccCCCccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCcccCceeeCCccc
Q 010463 415 MEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVL 473 (510)
Q Consensus 415 ~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~ 473 (510)
+.|||+|.+.+ .|++|||.+.....+..+.+. . ..+....+..|.||+|.++..+
T Consensus 614 ~~pp~~p~~~~-~~~~~f~~~~~~~~~~~~~~~--~-~~~~~~~~~~f~~f~~~~~~~~ 668 (674)
T 3pfq_A 614 IQPPYKPKASG-RNAENFDRFFTRHPPVLTPPD--Q-EVIRNIDQSEFEGFSFVNSEFL 668 (674)
T ss_dssp SCCSCCCBCCG-GGHHHHTTTTTSSCSSCCCCC--H-HHHTTCCGGGGTTCCEECSSCC
T ss_pred CCCCCCCcCCC-CchhhcCchhccCCCccCCCc--h-hhhhcccccccCCCcccChhhh
Confidence 78999999998 899999986544332211111 1 1111223468999999998765
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-61 Score=505.22 Aligned_cols=264 Identities=23% Similarity=0.405 Sum_probs=226.1
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec------Cc
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD------SD 179 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~------~~ 179 (510)
++|++++.||+|+||+||+|+++.||+.||||++++... .....+.+.+|+.+|+.++|||||++++++.+ .+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 579999999999999999999999999999999976543 34456778899999999999999999998764 46
Q ss_pred eEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 180 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
.+|||||||+ |+|.++|.+.+.+++..++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.+...
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 8999999995 689999999999999999999999999999999999999999999999999999999999999876432
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC-CCCccccccchhhHHHHHh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiwSlGvilyEml 338 (510)
... ......+.|||+.|||||++.+. .|+.++||||||||+|||+
T Consensus 212 ~~~----------------------------------~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell 257 (398)
T 4b99_A 212 PAE----------------------------------HQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEML 257 (398)
T ss_dssp --------------------------------------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred ccc----------------------------------cccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHH
Confidence 100 01123467999999999999875 5699999999999999999
Q ss_pred hCCCCCCCCChhhhHHHHhhcccccc------------------CCC---------CCCCCHHHHHHHHHhhc-CccccC
Q 010463 339 IGYPPFCSDDPRITCRKIVNWKTCLK------------------FPE---------EPKISDEARDLICHLLC-DVETRL 390 (510)
Q Consensus 339 ~G~~PF~~~~~~~~~~~I~~~~~~~~------------------~p~---------~~~~s~~~~dlI~~lL~-dp~~R~ 390 (510)
+|++||.+.+..+++.+|......+. +|. .+.+|++++|||++||+ ||.+|+
T Consensus 258 ~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ 337 (398)
T 4b99_A 258 ARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARI 337 (398)
T ss_dssp HTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSC
T ss_pred HCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCc
Confidence 99999999999988888875322111 111 13579999999999999 999999
Q ss_pred CCCChHHhhcCCCcCCCC
Q 010463 391 GTRGVEELKEHPWFRGIQ 408 (510)
Q Consensus 391 ~~~~~~eil~HpfF~~i~ 408 (510)
+++|+|+||||+...
T Consensus 338 ---ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 338 ---SAAAALRHPFLAKYH 352 (398)
T ss_dssp ---CHHHHTTSGGGTTTC
T ss_pred ---CHHHHhcCHhhCcCC
Confidence 799999999999764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-62 Score=487.84 Aligned_cols=267 Identities=24% Similarity=0.412 Sum_probs=205.1
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc------
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD------ 179 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~------ 179 (510)
+||++++.||+|+||+||+|+++.+|+.||||++++.. .....+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 57999999999999999999999999999999997653 3344567899999999999999999999997644
Q ss_pred ------eEEEEEeccCCCCHHHHHHhccC---CCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeeccc
Q 010463 180 ------FLYLIMEYLPGGDIMTLLMREDI---LSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDF 250 (510)
Q Consensus 180 ------~~~lVmEy~~gG~L~~~L~~~~~---l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DF 250 (510)
++|+|||||+||+|.+++..... .++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence 48999999999999999987654 455678999999999999999999999999999999999999999999
Q ss_pred CCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccch
Q 010463 251 GLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSL 330 (510)
Q Consensus 251 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSl 330 (510)
|+|+.+......... .+. ........+.||||.|||||++.+..|+.++|||||
T Consensus 163 Gla~~~~~~~~~~~~----------~~~----------------~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSl 216 (299)
T 4g31_A 163 GLVTAMDQDEEEQTV----------LTP----------------MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSL 216 (299)
T ss_dssp CCC----------------------------------------------------CCCTTSCHHHHTTCCCCTHHHHHHH
T ss_pred ccceecCCCcccccc----------ccc----------------cccccccCCcccCccccCHHHHcCCCCCCHHHHHHH
Confidence 999977543111000 000 000011235799999999999999999999999999
Q ss_pred hhHHHHHhhCCCCCCCCChh-hhHHHHhhccccccCCC-CCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 331 GAIMYEMLIGYPPFCSDDPR-ITCRKIVNWKTCLKFPE-EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 331 GvilyEml~G~~PF~~~~~~-~~~~~I~~~~~~~~~p~-~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
||+||||++ ||.+.... .....+.+ ..+|. ....++.+.+||++||. ||.+|| ++.||++||||+++
T Consensus 217 Gvilyell~---Pf~~~~~~~~~~~~~~~----~~~p~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~eil~h~~~~~~ 286 (299)
T 4g31_A 217 GLILFELLY---PFSTQMERVRTLTDVRN----LKFPPLFTQKYPCEYVMVQDMLSPSPMERP---EAINIIENAVFEDL 286 (299)
T ss_dssp HHHHHHHHS---CCSSHHHHHHHHHHHHT----TCCCHHHHHHCHHHHHHHHHHTCSSGGGSC---CHHHHHTSGGGCCC
T ss_pred HHHHHHHcc---CCCCccHHHHHHHHHhc----CCCCCCCcccCHHHHHHHHHHcCCChhHCc---CHHHHhcCHhhCCC
Confidence 999999996 88654322 22333333 23332 13567889999999998 999999 78999999999999
Q ss_pred Cch
Q 010463 408 QWD 410 (510)
Q Consensus 408 ~~~ 410 (510)
+|.
T Consensus 287 ~~p 289 (299)
T 4g31_A 287 DFP 289 (299)
T ss_dssp ---
T ss_pred CCC
Confidence 984
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-60 Score=520.13 Aligned_cols=264 Identities=30% Similarity=0.512 Sum_probs=237.7
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
+++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+.+.+|+.+|+.++|||||+|+++|++++.+|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 478999999999999999999999999999999997653 33456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCC--CceeecccCCcccCccccc
Q 010463 185 MEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN--GHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 185 mEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~--g~vkL~DFGla~~~~~~~~ 261 (510)
||||+||+|.++|.+ .+.++|.+++.|++||+.||.|||++|||||||||+||||+.+ |++||+|||+|+.+....
T Consensus 233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~- 311 (573)
T 3uto_A 233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 311 (573)
T ss_dssp EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-
T ss_pred EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-
Confidence 999999999999964 4689999999999999999999999999999999999999854 899999999999765421
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~ 341 (510)
...+.||||.|||||++.+.+|+.++|||||||+|||||+|.
T Consensus 312 --------------------------------------~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~ 353 (573)
T 3uto_A 312 --------------------------------------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL 353 (573)
T ss_dssp --------------------------------------EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSC
T ss_pred --------------------------------------ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 123579999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchhhh
Q 010463 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLY 413 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l~ 413 (510)
+||.+.+..+++.+|......+..+....+|++++|||++||+ ||.+|| +++|+|+||||+..+|....
T Consensus 354 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~---t~~e~l~Hpw~~~~~~~~~~ 423 (573)
T 3uto_A 354 SPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM---TIHQALEHPWLTPGNAPGRD 423 (573)
T ss_dssp CSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSTTTSCCCCTTTT
T ss_pred CCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCc---CHHHHhcCcCcCCCCCCCch
Confidence 9999999999999998755444333446899999999999999 999999 78999999999999987654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-60 Score=488.26 Aligned_cols=282 Identities=28% Similarity=0.412 Sum_probs=213.1
Q ss_pred CCceeeeeeecCCCeEEEEEEEc---CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCceE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAK---TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFL 181 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~---~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~ 181 (510)
+.|++++.||+|+||+||+|+++ .+++.||||++.+.. ...++.+|+.+|..+ +|||||+++++|++.+++
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 67999999999999999999886 467899999986542 345678899999988 699999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCC-CceeecccCCcccCcccc
Q 010463 182 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN-GHLKLSDFGLCKPLEDKY 260 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~-g~vkL~DFGla~~~~~~~ 260 (510)
|||||||+||+|.+++. .+++.+++.|+.||+.||+|||++|||||||||+||||+.+ |++||+|||+|+......
T Consensus 96 ~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp EEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred EEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 99999999999999983 59999999999999999999999999999999999999977 899999999998765432
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC-CCCccccccchhhHHHHHhh
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiwSlGvilyEml~ 339 (510)
................+.. .......++....+.||||.|||||++.+. .|+.++||||+|||+|||++
T Consensus 173 ~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~ 242 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQN----------KCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS 242 (361)
T ss_dssp CGGGGGC------------------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccc----------cccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence 1110000000000000000 000000112233467999999999999875 58999999999999999999
Q ss_pred CCCCCCCC-ChhhhHHHHhhccc--------------------------------------------------cccCCCC
Q 010463 340 GYPPFCSD-DPRITCRKIVNWKT--------------------------------------------------CLKFPEE 368 (510)
Q Consensus 340 G~~PF~~~-~~~~~~~~I~~~~~--------------------------------------------------~~~~p~~ 368 (510)
|++||.+. +......+|....+ ....+.+
T Consensus 243 G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 322 (361)
T 4f9c_A 243 GRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGW 322 (361)
T ss_dssp TCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------C
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccc
Confidence 99999654 44444444432100 0011223
Q ss_pred CCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCC
Q 010463 369 PKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 408 (510)
Q Consensus 369 ~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~ 408 (510)
..+|++++|||++||+ ||++|+ +++|+|+||||++++
T Consensus 323 ~~is~~a~DLl~~lL~~dP~~R~---ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 323 NEVPDEAYDLLDKLLDLNPASRI---TAEEALLHPFFKDMS 360 (361)
T ss_dssp TTCCHHHHHHHHHHTCSCTTTSC---CHHHHHTSGGGTTC-
T ss_pred ccCCHHHHHHHHHHCcCChhHCc---CHHHHhcCcccCCCC
Confidence 5789999999999999 999999 789999999999875
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-58 Score=496.08 Aligned_cols=285 Identities=34% Similarity=0.620 Sum_probs=252.7
Q ss_pred hhcccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC
Q 010463 99 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 178 (510)
Q Consensus 99 ~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 178 (510)
....+..++|+++++||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+|..++|||||+++++|++.
T Consensus 178 ~~~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 257 (543)
T 3c4z_A 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK 257 (543)
T ss_dssp HTSCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hcccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC
Confidence 34567889999999999999999999999999999999999987766666778899999999999999999999999999
Q ss_pred ceEEEEEeccCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcc
Q 010463 179 DFLYLIMEYLPGGDIMTLLMRE----DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCK 254 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~----~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~ 254 (510)
+.+|+||||++||+|..++... ..+++..+++|++||+.||.|||++|||||||||+||||+.+|++||+|||+|+
T Consensus 258 ~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~ 337 (543)
T 3c4z_A 258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV 337 (543)
T ss_dssp SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceee
Confidence 9999999999999999999764 369999999999999999999999999999999999999999999999999998
Q ss_pred cCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHH
Q 010463 255 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIM 334 (510)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvil 334 (510)
.+..... ...+.+||+.|+|||++.+..|+.++|||||||++
T Consensus 338 ~~~~~~~--------------------------------------~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvil 379 (543)
T 3c4z_A 338 ELKAGQT--------------------------------------KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTL 379 (543)
T ss_dssp ECCTTCC--------------------------------------CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHH
T ss_pred eccCCCc--------------------------------------ccccccCCccccChhhhcCCCCChHHhcCcchHHH
Confidence 7643210 12246899999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCC----hhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC--ChHHhhcCCCcCCC
Q 010463 335 YEMLIGYPPFCSDD----PRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR--GVEELKEHPWFRGI 407 (510)
Q Consensus 335 yEml~G~~PF~~~~----~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~--~~~eil~HpfF~~i 407 (510)
|||++|.+||.+.+ .......|... ...+| ..+|+++++||++||+ ||.+||+.. ++++|++||||+++
T Consensus 380 yelltG~~PF~~~~~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 380 YEMIAARGPFRARGEKVENKELKQRVLEQ--AVTYP--DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp HHHHHSSCSSCCTTCCCCHHHHHHHHHHC--CCCCC--TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred HHHHhCCCCCCCCccchhHHHHHHHHhhc--ccCCC--cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 99999999998764 34556666653 34555 4799999999999998 999999863 57999999999999
Q ss_pred Cchhhhc--ccCCCccccCC
Q 010463 408 QWDKLYE--MEAAYKPTVNG 425 (510)
Q Consensus 408 ~~~~l~~--~~~p~~p~~~~ 425 (510)
+|+.+.. ..|||+|....
T Consensus 456 ~w~~l~~~~~~pp~~P~~~~ 475 (543)
T 3c4z_A 456 SWRQLEAGMLTPPFVPDSRT 475 (543)
T ss_dssp CHHHHHTTCSCCSCCCCSSS
T ss_pred CHHHHHcCCCCCCCCCCccc
Confidence 9999984 78999998753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-58 Score=478.13 Aligned_cols=281 Identities=30% Similarity=0.642 Sum_probs=248.5
Q ss_pred hcccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc
Q 010463 100 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 179 (510)
Q Consensus 100 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 179 (510)
...+..++|++++.||+|+||.||+|+++.+|+.||||++.+...........+.+|+.+|+.++|||||+++++|++.+
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 88 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE 88 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 35677899999999999999999999999999999999999887667777888999999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 180 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
.+|+||||++||+|..++.....+++..++.|++||+.||.|||+.|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 99999999999999999999889999999999999999999999999999999999999999999999999999865432
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc---CCCCccccccchhhHHHH
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK---KGYGMECDWWSLGAIMYE 336 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~---~~y~~~~DiwSlGvilyE 336 (510)
. ...+.+||+.|+|||++.+ .+|+.++|||||||++||
T Consensus 169 ~---------------------------------------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~e 209 (384)
T 4fr4_A 169 T---------------------------------------QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYE 209 (384)
T ss_dssp C---------------------------------------CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHH
T ss_pred C---------------------------------------ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHH
Confidence 1 1235789999999999974 468999999999999999
Q ss_pred HhhCCCCCCCCCh---hhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchhh
Q 010463 337 MLIGYPPFCSDDP---RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKL 412 (510)
Q Consensus 337 ml~G~~PF~~~~~---~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l 412 (510)
|++|.+||.+.+. ......+.. ....+| ..+|+++.+||.+||. ||.+||+ +++++++||||++++|+.+
T Consensus 210 lltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~p--~~~s~~~~~li~~lL~~dP~~R~s--~~~~l~~hp~f~~~~w~~~ 283 (384)
T 4fr4_A 210 LLRGRRPYHIRSSTSSKEIVHTFET--TVVTYP--SAWSQEMVSLLKKLLEPNPDQRFS--QLSDVQNFPYMNDINWDAV 283 (384)
T ss_dssp HHHSSCSSCCCTTSCHHHHHHHHHH--CCCCCC--TTSCHHHHHHHHHHSCSSGGGSCC--SHHHHHTSGGGTTCCHHHH
T ss_pred HHhCCCCCCCCCCccHHHHHHHHhh--cccCCC--CcCCHHHHHHHHHHhcCCHhHhcc--cHHHHHcChhhhcCCHHHH
Confidence 9999999975433 333444443 234455 4799999999999998 9999996 3899999999999999999
Q ss_pred hc--ccCCCccccCC
Q 010463 413 YE--MEAAYKPTVNG 425 (510)
Q Consensus 413 ~~--~~~p~~p~~~~ 425 (510)
.. ..|||+|....
T Consensus 284 ~~~~~~p~~~p~~~~ 298 (384)
T 4fr4_A 284 FQKRLIPGFIPNKGR 298 (384)
T ss_dssp HTTCSCCCCCCSCCS
T ss_pred HhCCCCCCCCCCCCC
Confidence 74 78999998653
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-58 Score=490.81 Aligned_cols=293 Identities=41% Similarity=0.737 Sum_probs=251.9
Q ss_pred hcccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc
Q 010463 100 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 179 (510)
Q Consensus 100 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 179 (510)
...+..++|++++.||+|+||.||+|+++.+|+.||||++.+..........++.+|+.+|..++||||++++++|.+.+
T Consensus 142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 221 (446)
T 4ejn_A 142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD 221 (446)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT
T ss_pred ccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC
Confidence 44567789999999999999999999999999999999998876656666778889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhh-CCeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 180 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~-~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
.+|+||||++||+|..++.+.+.+++..++.++.||+.||+|||+ .|||||||||+||||+.+|++||+|||+|+....
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 999999999999999999998999999999999999999999998 9999999999999999999999999999986432
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHh
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml 338 (510)
... ...+.+||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 302 ~~~--------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 343 (446)
T 4ejn_A 302 DGA--------------------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 343 (446)
T ss_dssp -------------------------------------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHH
T ss_pred CCc--------------------------------------ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHh
Confidence 210 112468999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CChHHhhcCCCcCCCCchhhhc-
Q 010463 339 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLYE- 414 (510)
Q Consensus 339 ~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~--~~~~eil~HpfF~~i~~~~l~~- 414 (510)
+|.+||.+.+.......|... .+.+|. .+++++++||.+||. ||.+||+. .+++|+++||||++++|+.+..
T Consensus 344 ~g~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~ 419 (446)
T 4ejn_A 344 CGRLPFYNQDHEKLFELILME--EIRFPR--TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEK 419 (446)
T ss_dssp HSSCSSCCSSHHHHHHHHHHC--CCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTT
T ss_pred hCCCCCCCCCHHHHHHHHHhC--CCCCCc--cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhC
Confidence 999999999998888888863 355563 799999999999999 99999964 3799999999999999999874
Q ss_pred -ccCCCccccCCCccCCCCCC
Q 010463 415 -MEAAYKPTVNGELDTQNFEK 434 (510)
Q Consensus 415 -~~~p~~p~~~~~~d~~~f~~ 434 (510)
..|||+|.+.++.|+++|++
T Consensus 420 ~~~pp~~p~~~~~~~~~~~~~ 440 (446)
T 4ejn_A 420 KLSPPFKPQVTSETDTRYFDE 440 (446)
T ss_dssp CSCCSCCCSCSSTTCCTTC--
T ss_pred cCCCCccCCCCCccchhhcch
Confidence 78999999999999999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-58 Score=500.20 Aligned_cols=284 Identities=35% Similarity=0.675 Sum_probs=251.8
Q ss_pred HhhcccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec
Q 010463 98 LQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 177 (510)
Q Consensus 98 ~~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 177 (510)
+.+..+..++|++++.||+|+||.||+|+++.+|+.||||++.+..+........+.+|+.+|..++|||||+++++|++
T Consensus 176 l~~~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 255 (576)
T 2acx_A 176 LERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET 255 (576)
T ss_dssp HHTSCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhcCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee
Confidence 44566888999999999999999999999999999999999998877666677889999999999999999999999999
Q ss_pred CceEEEEEeccCCCCHHHHHHhccC--CCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCccc
Q 010463 178 SDFLYLIMEYLPGGDIMTLLMREDI--LSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 255 (510)
Q Consensus 178 ~~~~~lVmEy~~gG~L~~~L~~~~~--l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~ 255 (510)
.+.+|+||||++||+|.+++...+. +++..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.
T Consensus 256 ~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 256 KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVH 335 (576)
T ss_dssp SSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEeccccee
Confidence 9999999999999999999987544 99999999999999999999999999999999999999999999999999987
Q ss_pred CccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHH
Q 010463 256 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 335 (510)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvily 335 (510)
+.... ...+.+||+.|+|||++.+..|+.++|||||||++|
T Consensus 336 ~~~~~---------------------------------------~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvily 376 (576)
T 2acx_A 336 VPEGQ---------------------------------------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLY 376 (576)
T ss_dssp CCTTC---------------------------------------CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHH
T ss_pred cccCc---------------------------------------cccccCCCccccCHHHHcCCCCCccchHHHHHHHHH
Confidence 64321 012468999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCCh----hhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC--ChHHhhcCCCcCCCC
Q 010463 336 EMLIGYPPFCSDDP----RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR--GVEELKEHPWFRGIQ 408 (510)
Q Consensus 336 Eml~G~~PF~~~~~----~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~--~~~eil~HpfF~~i~ 408 (510)
||++|.+||.+.+. ......+... ...+| ..+|+++++||++||+ ||.+|||.. +++||++||||++++
T Consensus 377 eLltG~~PF~~~~~~~~~~~i~~~i~~~--~~~~p--~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~ 452 (576)
T 2acx_A 377 EMIAGQSPFQQRKKKIKREEVERLVKEV--PEEYS--ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452 (576)
T ss_dssp HHHHSSCSSSCSSSCCCHHHHHHHHHHC--CCCCC--TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCC
T ss_pred HHHhCCCCCcccccchhHHHHHHHhhcc--cccCC--ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCC
Confidence 99999999987643 3444555542 34445 4799999999999999 999999764 689999999999999
Q ss_pred chhhhc--ccCCCccccC
Q 010463 409 WDKLYE--MEAAYKPTVN 424 (510)
Q Consensus 409 ~~~l~~--~~~p~~p~~~ 424 (510)
|+.+.. ..|||+|...
T Consensus 453 w~~l~~~~~~pp~~p~~~ 470 (576)
T 2acx_A 453 FKRLGAGMLEPPFKPDPQ 470 (576)
T ss_dssp HHHHHTTCSCCSCCCCCC
T ss_pred HHHHhcCCCCCCCCCCcc
Confidence 999984 7899999865
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-58 Score=466.90 Aligned_cols=292 Identities=43% Similarity=0.813 Sum_probs=239.5
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEc---CCCCEEEEEEeechhhcc-hhhHHHHHHHHHHHHhcCCCCeeeEeEEee
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAK---TTGEIFAMKKLKKSEMLK-RGQVEHVRSERNLLAEVDSRCIVQLFYSFQ 176 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~---~tg~~vAiK~i~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 176 (510)
..+..++|++++.||+|+||.||+|++. .+|+.||||++.+..... ......+.+|+.+|+.++||||++++++|.
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 91 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ 91 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence 4567789999999999999999999985 689999999998764332 234567889999999999999999999999
Q ss_pred cCceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccC
Q 010463 177 DSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 256 (510)
Q Consensus 177 ~~~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~ 256 (510)
+.+.+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||+.||+||||||+||||+.+|++||+|||+++..
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 99999999999999999999999899999999999999999999999999999999999999999999999999999754
Q ss_pred ccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHH
Q 010463 257 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 336 (510)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyE 336 (510)
.... ......+||+.|+|||++.+..++.++|||||||++||
T Consensus 172 ~~~~--------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 213 (327)
T 3a62_A 172 IHDG--------------------------------------TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYD 213 (327)
T ss_dssp ---------------------------------------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHH
T ss_pred ccCC--------------------------------------ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHH
Confidence 3210 01224689999999999999999999999999999999
Q ss_pred HhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC--ChHHhhcCCCcCCCCchhhh
Q 010463 337 MLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR--GVEELKEHPWFRGIQWDKLY 413 (510)
Q Consensus 337 ml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~--~~~eil~HpfF~~i~~~~l~ 413 (510)
|++|.+||.+.+......+|... .+.+| +.+++++++||.+||. ||.+||+.. +++|+++||||++++|+.+.
T Consensus 214 l~~g~~pf~~~~~~~~~~~i~~~--~~~~p--~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~ 289 (327)
T 3a62_A 214 MLTGAPPFTGENRKKTIDKILKC--KLNLP--PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELL 289 (327)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHT--CCCCC--TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHH
T ss_pred HHHCCCCCCCCCHHHHHHHHHhC--CCCCC--CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHh
Confidence 99999999999988888888874 34455 4789999999999998 999999875 79999999999999999987
Q ss_pred c--ccCCCccccCCCccCCCCCC
Q 010463 414 E--MEAAYKPTVNGELDTQNFEK 434 (510)
Q Consensus 414 ~--~~~p~~p~~~~~~d~~~f~~ 434 (510)
. ..|||+|.+.+..|.++|+.
T Consensus 290 ~~~~~~p~~p~~~~~~~~~~~~~ 312 (327)
T 3a62_A 290 ARKVEPPFKPLLQSEEDVSQFDS 312 (327)
T ss_dssp TTCSCCSCCCC------------
T ss_pred hccCCCCCCCCcCChhhhhhcch
Confidence 4 67999999999999999985
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-58 Score=464.94 Aligned_cols=257 Identities=21% Similarity=0.379 Sum_probs=220.8
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEc-----CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEee
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAK-----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ 176 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~-----~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 176 (510)
.+..++|.+.+.||+|+||+||+|++. .+|..||||+++.. .....+.+.+|+.+|++++|||||+++++|.
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 85 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCV 85 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 456689999999999999999999875 36889999999754 3445677999999999999999999999999
Q ss_pred cCceEEEEEeccCCCCHHHHHHhc-------------cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCC
Q 010463 177 DSDFLYLIMEYLPGGDIMTLLMRE-------------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG 243 (510)
Q Consensus 177 ~~~~~~lVmEy~~gG~L~~~L~~~-------------~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g 243 (510)
+++.+|||||||+||+|.++|.+. ..+++.++..++.||+.||.|||+++||||||||+||||++++
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence 999999999999999999999764 3699999999999999999999999999999999999999999
Q ss_pred ceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCc
Q 010463 244 HLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGM 323 (510)
Q Consensus 244 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~ 323 (510)
++||+|||+|+........ ......+||+.|||||++.+..|+.
T Consensus 166 ~~Ki~DFGla~~~~~~~~~------------------------------------~~~~~~~gt~~ymAPE~~~~~~~~~ 209 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYY------------------------------------RVGGHTMLPIRWMPPESIMYRKFTT 209 (299)
T ss_dssp CEEECCCSCHHHHTGGGCE------------------------------------EETTTEEECGGGCCHHHHHHCCCCH
T ss_pred cEEECCcccceecCCCCce------------------------------------eecCceecChhhcCHHHHcCCCCCc
Confidence 9999999999865332110 1122457999999999999999999
Q ss_pred cccccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 324 ECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 324 ~~DiwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
++|||||||+||||+| |++||.+.+..+....|.... .+..| ..+|+++.+||.+||. ||++|| ++.+| |
T Consensus 210 k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~-~~~~p--~~~~~~~~~li~~cl~~dP~~RP---s~~~i--~ 281 (299)
T 4asz_A 210 ESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR-VLQRP--RTCPQEVYELMLGCWQREPHMRK---NIKGI--H 281 (299)
T ss_dssp HHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHH--H
T ss_pred hhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CCCCC--ccchHHHHHHHHHHcCCChhHCc---CHHHH--H
Confidence 9999999999999998 999999999988888888743 23444 4799999999999998 999999 67888 4
Q ss_pred CCcC
Q 010463 402 PWFR 405 (510)
Q Consensus 402 pfF~ 405 (510)
+|++
T Consensus 282 ~~L~ 285 (299)
T 4asz_A 282 TLLQ 285 (299)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 5554
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-58 Score=464.62 Aligned_cols=256 Identities=21% Similarity=0.347 Sum_probs=216.0
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEc-----CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEe
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAK-----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSF 175 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~-----~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 175 (510)
..+..++|.+.+.||+|+||+||+|+++ .++..||||+++.. .....+.+.+|+.+|+.++|||||+++++|
T Consensus 36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~ 112 (329)
T 4aoj_A 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVC 112 (329)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 3456678999999999999999999875 36889999999754 344567799999999999999999999999
Q ss_pred ecCceEEEEEeccCCCCHHHHHHhc---------------cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeec
Q 010463 176 QDSDFLYLIMEYLPGGDIMTLLMRE---------------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD 240 (510)
Q Consensus 176 ~~~~~~~lVmEy~~gG~L~~~L~~~---------------~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld 240 (510)
.+.+.+|||||||+||+|.++|.+. +.+++.++..|+.||+.||.|||+++||||||||+||||+
T Consensus 113 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 113 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG 192 (329)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence 9999999999999999999999753 3589999999999999999999999999999999999999
Q ss_pred CCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCC
Q 010463 241 KNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG 320 (510)
Q Consensus 241 ~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~ 320 (510)
.++++||+|||+|+.+...... ....+.+||+.|||||++.+..
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~------------------------------------~~~~~~~gt~~ymAPE~~~~~~ 236 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYY------------------------------------RVGGRTMLPIRWMPPESILYRK 236 (329)
T ss_dssp TTTEEEECCCC----------------------------------------------------CCCCGGGCCHHHHTTCC
T ss_pred CCCcEEEcccccceeccCCCcc------------------------------------eecCcccccccccChhhhcCCC
Confidence 9999999999999865432100 0122468999999999999999
Q ss_pred CCccccccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHh
Q 010463 321 YGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEEL 398 (510)
Q Consensus 321 y~~~~DiwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~ei 398 (510)
|+.++|||||||+||||+| |++||.+.+..+....|.... .+..| ..+++++.+||.+||. ||++|| ++.||
T Consensus 237 ~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~-~~~~p--~~~~~~~~~li~~cl~~dP~~RP---s~~ei 310 (329)
T 4aoj_A 237 FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR-ELERP--RACPPEVYAIMRGCWQREPQQRH---SIKDV 310 (329)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTC-CCCCC--TTCCHHHHHHHHHHCCSSTTTSC---CHHHH
T ss_pred CCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CCCCc--ccccHHHHHHHHHHcCcChhHCc---CHHHH
Confidence 9999999999999999999 999999999888888887643 34445 4799999999999998 999999 67888
Q ss_pred hcC
Q 010463 399 KEH 401 (510)
Q Consensus 399 l~H 401 (510)
+++
T Consensus 311 ~~~ 313 (329)
T 4aoj_A 311 HAR 313 (329)
T ss_dssp HHH
T ss_pred HHH
Confidence 754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-57 Score=457.62 Aligned_cols=256 Identities=21% Similarity=0.276 Sum_probs=209.3
Q ss_pred hcccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc
Q 010463 100 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 179 (510)
Q Consensus 100 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 179 (510)
.+++..+++++.+.||+|+||+||+|+++. .||||+++.... .....+.+.+|+.+|++++|||||++++++.+ +
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~ 104 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-D 104 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-C
Confidence 457888999999999999999999998653 599999975432 44567889999999999999999999998764 5
Q ss_pred eEEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 180 FLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
.+|||||||+||+|.++|... ..+++..+..++.||+.||+|||++|||||||||+||||++++++||+|||+|+....
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 689999999999999999764 5799999999999999999999999999999999999999999999999999986543
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc---CCCCccccccchhhHHH
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK---KGYGMECDWWSLGAIMY 335 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~---~~y~~~~DiwSlGvily 335 (510)
.... ....+.+||+.|||||++.+ ..|+.++|||||||+||
T Consensus 185 ~~~~------------------------------------~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~ 228 (307)
T 3omv_A 185 WSGS------------------------------------QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLY 228 (307)
T ss_dssp ---------------------------------------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHH
T ss_pred CCcc------------------------------------eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHH
Confidence 2100 11235689999999999974 35899999999999999
Q ss_pred HHhhCCCCCCCCChhhhHHHHhhcc-ccccCC-CCCCCCHHHHHHHHHhhc-CccccCCCCChHHhh
Q 010463 336 EMLIGYPPFCSDDPRITCRKIVNWK-TCLKFP-EEPKISDEARDLICHLLC-DVETRLGTRGVEELK 399 (510)
Q Consensus 336 Eml~G~~PF~~~~~~~~~~~I~~~~-~~~~~p-~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil 399 (510)
||+||++||.+.+.......++... .....+ ....+++++.+||.+||. ||++|| ++.||+
T Consensus 229 Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~ei~ 292 (307)
T 3omv_A 229 ELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERP---LFPQIL 292 (307)
T ss_dssp HHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSC---CHHHHH
T ss_pred HHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCc---CHHHHH
Confidence 9999999999877665555554321 112222 124789999999999998 999999 556554
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-57 Score=458.89 Aligned_cols=257 Identities=21% Similarity=0.339 Sum_probs=220.6
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEc-----CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEe
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAK-----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSF 175 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~-----~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 175 (510)
.++..+++++++.||+|+||+||+|+.. .+++.||||+++... .....+.+.+|+.+|++++|||||+++++|
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 98 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVV 98 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence 3567788999999999999999999864 467899999997542 334457799999999999999999999999
Q ss_pred ecCceEEEEEeccCCCCHHHHHHhc----------------cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeee
Q 010463 176 QDSDFLYLIMEYLPGGDIMTLLMRE----------------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL 239 (510)
Q Consensus 176 ~~~~~~~lVmEy~~gG~L~~~L~~~----------------~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILl 239 (510)
.+++.+|||||||+||||.++|... ..+++..+..++.||+.||+|||+++||||||||+||||
T Consensus 99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV 178 (308)
T ss_dssp CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence 9999999999999999999999653 358999999999999999999999999999999999999
Q ss_pred cCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC
Q 010463 240 DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK 319 (510)
Q Consensus 240 d~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~ 319 (510)
++++++||+|||+|+.+...... ....+.+||+.|||||++.++
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~------------------------------------~~~~~~~gt~~ymAPE~l~~~ 222 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYY------------------------------------KLLGNSLLPIRWMAPEAIMYG 222 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCB------------------------------------CSSSSSCBCGGGCCHHHHHHC
T ss_pred CCCCCEEECCcccceeccCCCce------------------------------------eEecccccCCcccCHHHHhCC
Confidence 99999999999999865432110 112346899999999999999
Q ss_pred CCCccccccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHH
Q 010463 320 GYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEE 397 (510)
Q Consensus 320 ~y~~~~DiwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~e 397 (510)
.|+.++|||||||+||||+| |.+||.+.+..+....|.+.. .+..| ..+++++.+||.+||. ||++|| ++.|
T Consensus 223 ~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~-~~~~p--~~~~~~~~~li~~C~~~dP~~RP---s~~e 296 (308)
T 4gt4_A 223 KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQ-VLPCP--DDCPAWVYALMIECWNEFPSRRP---RFKD 296 (308)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHH
T ss_pred CCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCc--ccchHHHHHHHHHHcCCChhHCc---CHHH
Confidence 99999999999999999998 899999999988888887643 23344 4799999999999998 999999 6778
Q ss_pred hhcC
Q 010463 398 LKEH 401 (510)
Q Consensus 398 il~H 401 (510)
|+++
T Consensus 297 i~~~ 300 (308)
T 4gt4_A 297 IHSR 300 (308)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-57 Score=460.98 Aligned_cols=259 Identities=22% Similarity=0.344 Sum_probs=220.3
Q ss_pred hcccCCCCceeeeeeecCCCeEEEEEEEcCCC-----CEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC-CCeeeEeE
Q 010463 100 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTG-----EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS-RCIVQLFY 173 (510)
Q Consensus 100 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg-----~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~ 173 (510)
++++..++|++++.||+|+||+||+|+++.++ +.||||++.... ...+.+.+.+|+.+|..++| ||||++++
T Consensus 58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 45678899999999999999999999987643 689999997643 33456779999999999966 89999999
Q ss_pred Eeec-CceEEEEEeccCCCCHHHHHHhc----------------cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCC
Q 010463 174 SFQD-SDFLYLIMEYLPGGDIMTLLMRE----------------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDN 236 (510)
Q Consensus 174 ~~~~-~~~~~lVmEy~~gG~L~~~L~~~----------------~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~N 236 (510)
+|.+ .+.+|||||||+||+|.++|.+. ..+++..+..|+.||+.||+|||+++||||||||+|
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~N 215 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 215 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccc
Confidence 9865 46799999999999999999753 348999999999999999999999999999999999
Q ss_pred eeecCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhh
Q 010463 237 LILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL 316 (510)
Q Consensus 237 ILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl 316 (510)
|||++++++||+|||+|+.+...... ....+.+||+.|||||++
T Consensus 216 ILl~~~~~vKi~DFGlar~~~~~~~~------------------------------------~~~~~~~gt~~ymAPE~l 259 (353)
T 4ase_A 216 ILLSEKNVVKICDFGLARDIYKDPDY------------------------------------VRKGDARLPLKWMAPETI 259 (353)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTS------------------------------------EEETTEEECGGGCCHHHH
T ss_pred eeeCCCCCEEECcchhhhhcccCCCc------------------------------------eeeccccccccccCHHHH
Confidence 99999999999999999876432110 012246899999999999
Q ss_pred ccCCCCccccccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCC
Q 010463 317 LKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRG 394 (510)
Q Consensus 317 ~~~~y~~~~DiwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~ 394 (510)
.+..|+.++|||||||+||||+| |.+||.+.+..+.+.+++.....+..| ..+|+++.+||.+||. ||++|| +
T Consensus 260 ~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p--~~~~~~~~~li~~c~~~dP~~RP---t 334 (353)
T 4ase_A 260 FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP--DYTTPEMYQTMLDCWHGEPSQRP---T 334 (353)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---C
T ss_pred hcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCC--ccCCHHHHHHHHHHcCcChhHCc---C
Confidence 99999999999999999999998 999999877655555555433445555 4789999999999998 999999 6
Q ss_pred hHHhhcC
Q 010463 395 VEELKEH 401 (510)
Q Consensus 395 ~~eil~H 401 (510)
+.||++|
T Consensus 335 ~~eil~~ 341 (353)
T 4ase_A 335 FSELVEH 341 (353)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 8999887
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-55 Score=453.15 Aligned_cols=268 Identities=29% Similarity=0.484 Sum_probs=237.4
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcch---hhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR---GQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 181 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~---~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~ 181 (510)
.+.|++++.||+|+||.||+|+++.+|+.||+|++.+...... ...+.+.+|+.+|..++||||++++++|.+.+.+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 3679999999999999999999999999999999987643221 1356789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCC----ceeecccCCcccCc
Q 010463 182 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG----HLKLSDFGLCKPLE 257 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g----~vkL~DFGla~~~~ 257 (510)
|+||||++||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++ ++||+|||+++.+.
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~ 170 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence 99999999999999999888999999999999999999999999999999999999998877 89999999998764
Q ss_pred cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHH
Q 010463 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337 (510)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEm 337 (510)
... ...+.+||+.|+|||++.+..|+.++|||||||++|+|
T Consensus 171 ~~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~l 211 (361)
T 2yab_A 171 DGV---------------------------------------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 211 (361)
T ss_dssp TTC---------------------------------------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred CCC---------------------------------------ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHH
Confidence 321 11246899999999999999999999999999999999
Q ss_pred hhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchhhhc
Q 010463 338 LIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYE 414 (510)
Q Consensus 338 l~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l~~ 414 (510)
++|.+||.+.+..+.+.+|......+..+.+..+|+++++||.+||+ ||.+|| +++|+++||||++++|.....
T Consensus 212 l~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---t~~e~l~hp~~~~~~~~~~~~ 286 (361)
T 2yab_A 212 LSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRL---TIQEALRHPWITPVDTQQAMV 286 (361)
T ss_dssp HHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSC---CHHHHHTSTTTSCSSHHHHHH
T ss_pred HhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCc---CHHHHhcCcCcCCCchhhhhh
Confidence 99999999999999999888743222211235789999999999999 999999 789999999999999987653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-55 Score=449.71 Aligned_cols=291 Identities=41% Similarity=0.756 Sum_probs=242.1
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEc---CCCCEEEEEEeechhhcc-hhhHHHHHHHHHHHHhc-CCCCeeeEeEEe
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAK---TTGEIFAMKKLKKSEMLK-RGQVEHVRSERNLLAEV-DSRCIVQLFYSF 175 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~---~tg~~vAiK~i~k~~~~~-~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~ 175 (510)
..+..++|++++.||+|+||.||+|++. .+|+.||||++++..... ....+.+.+|+.+|..+ +||||+++++++
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 128 (355)
T 1vzo_A 49 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 128 (355)
T ss_dssp CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred ccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence 3456689999999999999999999984 589999999997654321 22345577899999999 799999999999
Q ss_pred ecCceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCccc
Q 010463 176 QDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 255 (510)
Q Consensus 176 ~~~~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~ 255 (510)
.+.+.+|+||||++||+|.+++.....+++..++.++.||+.||.|||+.||+||||||+||||+.+|++||+|||+++.
T Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 129 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 99999999999999999999999888999999999999999999999999999999999999999999999999999986
Q ss_pred CccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc--CCCCccccccchhhH
Q 010463 256 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK--KGYGMECDWWSLGAI 333 (510)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiwSlGvi 333 (510)
+..... ......+||+.|+|||++.+ ..++.++|||||||+
T Consensus 209 ~~~~~~-------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~i 251 (355)
T 1vzo_A 209 FVADET-------------------------------------ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVL 251 (355)
T ss_dssp CCGGGG-------------------------------------GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHH
T ss_pred cccCCC-------------------------------------CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHH
Confidence 543210 01224689999999999986 457899999999999
Q ss_pred HHHHhhCCCCCCCCChhh----hHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC--ChHHhhcCCCcCC
Q 010463 334 MYEMLIGYPPFCSDDPRI----TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR--GVEELKEHPWFRG 406 (510)
Q Consensus 334 lyEml~G~~PF~~~~~~~----~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~--~~~eil~HpfF~~ 406 (510)
+|||++|..||...+... ....+... ...+| ..+++.+++||.+||. ||.+||+.. +++|+++||||..
T Consensus 252 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~--~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 252 MYELLTGASPFTVDGEKNSQAEISRRILKS--EPPYP--QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp HHHHHHSSCTTSCTTSCCCHHHHHHHHHHC--CCCCC--TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HHHHHHCCCCCccCCccchHHHHHHHHhcc--CCCCC--cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 999999999997654333 33333332 22333 4789999999999998 999999753 7999999999999
Q ss_pred CCchhhhc--ccCCCccccCCCccCCCC
Q 010463 407 IQWDKLYE--MEAAYKPTVNGELDTQNF 432 (510)
Q Consensus 407 i~~~~l~~--~~~p~~p~~~~~~d~~~f 432 (510)
++|+.+.. ..+||.|.+++..|.+||
T Consensus 328 ~~~~~l~~~~~~~p~~p~~~~~~d~~~~ 355 (355)
T 1vzo_A 328 INWDDLAAKKVPAPFKPVIRDELDVSNF 355 (355)
T ss_dssp CCHHHHHTTCSCCSCCCCCCC-CCC---
T ss_pred CChhHhhhccCCCCCCCccccccccccC
Confidence 99999985 678999999999999887
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-54 Score=439.39 Aligned_cols=260 Identities=29% Similarity=0.496 Sum_probs=234.1
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceE
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 181 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~ 181 (510)
....++|++++.||+|+||.||+|++..+|+.||||++.+... .....+.+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 89 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTL 89 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence 3456899999999999999999999999999999999987643 445567789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 182 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
|+||||++||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||+++......
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 168 (328)
T 3fe3_A 90 YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG- 168 (328)
T ss_dssp EEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-
T ss_pred EEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-
Confidence 9999999999999999998999999999999999999999999999999999999999999999999999997654321
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCC-ccccccchhhHHHHHhhC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYG-MECDWWSLGAIMYEMLIG 340 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~-~~~DiwSlGvilyEml~G 340 (510)
.....+||+.|+|||++.+..+. .++|||||||++|||++|
T Consensus 169 --------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 210 (328)
T 3fe3_A 169 --------------------------------------KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210 (328)
T ss_dssp --------------------------------------GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHS
T ss_pred --------------------------------------ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhC
Confidence 01246899999999999988874 899999999999999999
Q ss_pred CCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCC
Q 010463 341 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 408 (510)
Q Consensus 341 ~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~ 408 (510)
.+||.+.+......++... ...+|. .+|+++.+||++||. ||.+|| +++||++||||+...
T Consensus 211 ~~pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~~L~~dP~~R~---t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 211 SLPFDGQNLKELRERVLRG--KYRIPF--YMSTDCENLLKRFLVLNPIKRG---TLEQIMKDRWINAGH 272 (328)
T ss_dssp SCSSCCSSHHHHHHHHHHC--CCCCCT--TSCHHHHHHHHHHCCSSTTTSC---CHHHHTTCTTTTTTC
T ss_pred CCCCCCCCHHHHHHHHHhC--CCCCCC--CCCHHHHHHHHHHCCCChhHCc---CHHHHhcCHhhcCCC
Confidence 9999999999888888874 344553 789999999999999 999999 799999999998644
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-53 Score=435.99 Aligned_cols=258 Identities=31% Similarity=0.547 Sum_probs=231.3
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++|++++.||+|+||.||+|.++.+|+.||+|++.+... .....+.+.+|+.+|+.++|||||+++++|.+.+..|+||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 579999999999999999999999999999999987643 3445678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCC---ceeecccCCcccCcccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG---HLKLSDFGLCKPLEDKYSS 262 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g---~vkL~DFGla~~~~~~~~~ 262 (510)
||++||+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++.......
T Consensus 108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~-- 185 (362)
T 2bdw_A 108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-- 185 (362)
T ss_dssp CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC--
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc--
Confidence 9999999999999888999999999999999999999999999999999999998654 59999999998664321
Q ss_pred ccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCC
Q 010463 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 342 (510)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~ 342 (510)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|.+
T Consensus 186 -------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~ 228 (362)
T 2bdw_A 186 -------------------------------------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 228 (362)
T ss_dssp -------------------------------------SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred -------------------------------------ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCC
Confidence 0124689999999999999999999999999999999999999
Q ss_pred CCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 343 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 343 PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
||.+.+....+..|......+..+.+..+|+++++||.+||. ||.+|| ++.++++||||..
T Consensus 229 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 229 PFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI---TADQALKVPWICN 290 (362)
T ss_dssp SSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSC---CHHHHTTSHHHHT
T ss_pred CCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCc---CHHHHhcCcccCC
Confidence 999999888888888754444344445789999999999998 999999 7899999999975
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-53 Score=446.72 Aligned_cols=259 Identities=31% Similarity=0.554 Sum_probs=232.3
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++|++++.||+|+||+||+|.++.+|+.||+|++.+... .....+.+.+|+.+|+.++|||||+++++|.+.+..|+||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 579999999999999999999999999999999987543 3445677899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeec---CCCceeecccCCcccCcccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD---KNGHLKLSDFGLCKPLEDKYSS 262 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld---~~g~vkL~DFGla~~~~~~~~~ 262 (510)
|||+||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.......
T Consensus 90 E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~- 168 (444)
T 3soa_A 90 DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ- 168 (444)
T ss_dssp CCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC-
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc-
Confidence 9999999999999999999999999999999999999999999999999999998 468899999999986643211
Q ss_pred ccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCC
Q 010463 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 342 (510)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~ 342 (510)
...+.+||+.|+|||++.+..|+.++|||||||++|+|++|.+
T Consensus 169 -------------------------------------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~ 211 (444)
T 3soa_A 169 -------------------------------------AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYP 211 (444)
T ss_dssp -------------------------------------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred -------------------------------------eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCC
Confidence 1124689999999999999999999999999999999999999
Q ss_pred CCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 343 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 343 PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
||.+.+....+..|......+..|.+..+|+++++||.+||. ||.+|| ++.|+++||||++
T Consensus 212 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---ta~e~L~hp~~~~ 273 (444)
T 3soa_A 212 PFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRI---TAAEALKHPWISH 273 (444)
T ss_dssp SCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSC---CHHHHHHSCTTHH
T ss_pred CCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCC---CHHHHhcCccccC
Confidence 999999999999998865555555567899999999999998 999999 7899999999975
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-53 Score=427.19 Aligned_cols=266 Identities=26% Similarity=0.471 Sum_probs=233.7
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcch---hhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR---GQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~---~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~ 182 (510)
+.|++.+.||+|+||.||+|+++.+|+.||+|++.+...... ...+.+.+|+.+|+.++||||++++++|.+...+|
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 469999999999999999999999999999999987543221 13567899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCC----ceeecccCCcccCcc
Q 010463 183 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG----HLKLSDFGLCKPLED 258 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g----~vkL~DFGla~~~~~ 258 (510)
+||||++||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++ ++||+|||+++.+..
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~ 170 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170 (326)
T ss_dssp EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCT
T ss_pred EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCC
Confidence 9999999999999998888999999999999999999999999999999999999999888 899999999987643
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHh
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml 338 (510)
.. .....+||+.|+|||++.+..|+.++|||||||++|+|+
T Consensus 171 ~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 211 (326)
T 2y0a_A 171 GN---------------------------------------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 211 (326)
T ss_dssp TS---------------------------------------CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred CC---------------------------------------ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHH
Confidence 21 012467999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchhhh
Q 010463 339 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLY 413 (510)
Q Consensus 339 ~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l~ 413 (510)
+|.+||.+.+.......+......+..+....+|+.+++||.+||. ||.+|| +++|+++||||++.+|....
T Consensus 212 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~e~l~hp~~~~~~~~~~~ 284 (326)
T 2y0a_A 212 SGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM---TIQDSLQHPWIKPKDTQQAL 284 (326)
T ss_dssp HSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSC---CHHHHHHSTTTSCCSHHHHH
T ss_pred HCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCC---CHHHHhcCCCccCCcchhhh
Confidence 9999999998888888777643222111124789999999999998 999999 78999999999999987654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-53 Score=433.91 Aligned_cols=268 Identities=31% Similarity=0.584 Sum_probs=228.4
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCceEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~~lV 184 (510)
++|++++.||+|+||+||+|+++.+|+.||||++.+... ...+|+.+|..+ +||||++++++|++.+.+|+|
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 579999999999999999999999999999999987532 134688888777 799999999999999999999
Q ss_pred EeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecC-CC---ceeecccCCcccCcccc
Q 010463 185 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK-NG---HLKLSDFGLCKPLEDKY 260 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~-~g---~vkL~DFGla~~~~~~~ 260 (510)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||+.||+||||||+|||+.. ++ ++||+|||+|+.+....
T Consensus 95 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 95 TELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp ECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 999999999999999899999999999999999999999999999999999999843 33 59999999998654321
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhC
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 340 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G 340 (510)
. ...+.+||+.|+|||++.+.+|+.++|||||||++|||++|
T Consensus 175 ~--------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 216 (342)
T 2qr7_A 175 G--------------------------------------LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216 (342)
T ss_dssp C--------------------------------------CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHS
T ss_pred C--------------------------------------ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcC
Confidence 0 12246899999999999998899999999999999999999
Q ss_pred CCCCCC---CChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchhhhc--
Q 010463 341 YPPFCS---DDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYE-- 414 (510)
Q Consensus 341 ~~PF~~---~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l~~-- 414 (510)
.+||.+ .+..+....|......+..+.+..+|+++++||++||. ||.+|| ++.++++||||. +|+.+..
T Consensus 217 ~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---t~~~il~hp~~~--~~~~~~~~~ 291 (342)
T 2qr7_A 217 YTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRL---TAALVLRHPWIV--HWDQLPQYQ 291 (342)
T ss_dssp SCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSC---CHHHHTTSHHHH--TGGGSCCSC
T ss_pred CCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCc---CHHHHhcCCeec--Ccccccccc
Confidence 999986 35556677776644333333345799999999999998 999999 689999999994 5877753
Q ss_pred ccCCCcccc
Q 010463 415 MEAAYKPTV 423 (510)
Q Consensus 415 ~~~p~~p~~ 423 (510)
+.+|+.|..
T Consensus 292 ~~~~~~p~~ 300 (342)
T 2qr7_A 292 LNRQDAPHL 300 (342)
T ss_dssp CCCCCCHHH
T ss_pred CCCccchhh
Confidence 456666653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-53 Score=427.42 Aligned_cols=256 Identities=27% Similarity=0.434 Sum_probs=227.5
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
.++|++++.||+|+||.||+|+++.+|+.||+|++... ......+.+|+.+|..++||||++++++|.+.+.+|+|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 47899999999999999999999999999999998743 23456688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecC--CCceeecccCCcccCccccc
Q 010463 185 MEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK--NGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~--~g~vkL~DFGla~~~~~~~~ 261 (510)
|||++||+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+++.+.....
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~ 159 (321)
T 1tki_A 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence 9999999999999765 47999999999999999999999999999999999999997 89999999999987643210
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~ 341 (510)
....+|||.|+|||++.+..++.++|||||||++|||++|.
T Consensus 160 ---------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~ 200 (321)
T 1tki_A 160 ---------------------------------------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI 200 (321)
T ss_dssp ---------------------------------------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSS
T ss_pred ---------------------------------------cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 12357999999999999988999999999999999999999
Q ss_pred CCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
+||.+.+.......+.+....+..+.++.+|+++++||.+||. ||.+|| ++.|+++||||+.
T Consensus 201 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp---t~~e~l~hp~~~~ 263 (321)
T 1tki_A 201 NPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM---TASEALQHPWLKQ 263 (321)
T ss_dssp CTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSHHHHS
T ss_pred CCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCc---CHHHHhcChhhcc
Confidence 9999999988888888744322222235789999999999998 999999 7899999999975
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-53 Score=431.06 Aligned_cols=257 Identities=30% Similarity=0.532 Sum_probs=228.1
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEE
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~ 182 (510)
..+++|.+++.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 85 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIV 85 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 34679999999999999999999999999999999998765544444567899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccc
Q 010463 183 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 262 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 262 (510)
+||||+ +|+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||++.......
T Consensus 86 lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~-- 162 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-- 162 (336)
T ss_dssp EEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB--
T ss_pred EEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc--
Confidence 999999 78999999998999999999999999999999999999999999999999999999999999998654321
Q ss_pred ccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCC-CccccccchhhHHHHHhhCC
Q 010463 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiwSlGvilyEml~G~ 341 (510)
...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|.
T Consensus 163 -------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~ 205 (336)
T 3h4j_B 163 -------------------------------------FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205 (336)
T ss_dssp -------------------------------------TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSS
T ss_pred -------------------------------------ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCC
Confidence 1124689999999999998877 78999999999999999999
Q ss_pred CCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
+||.+.+......++... ...+| ..+|+++++||++||. ||.+|| +++||++||||+.
T Consensus 206 ~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~li~~~L~~dP~~Rp---t~~eil~hp~~~~ 264 (336)
T 3h4j_B 206 LPFDDEFIPNLFKKVNSC--VYVMP--DFLSPGAQSLIRRMIVADPMQRI---TIQEIRRDPWFNV 264 (336)
T ss_dssp CSSBCSSSTTCBCCCCSS--CCCCC--TTSCHHHHHHHHTTSCSSGGGSC---CHHHHTTCHHHHT
T ss_pred CCCCCccHHHHHHHHHcC--CCCCc--ccCCHHHHHHHHHHcCCChhHCc---CHHHHHhChhhcc
Confidence 999988776666665542 23344 4789999999999998 999999 7999999999975
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-52 Score=417.13 Aligned_cols=257 Identities=30% Similarity=0.504 Sum_probs=225.7
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
.++|++++.||+|+||+||+|++..+|+.||+|++.... ....+.+.+|+.+++.++||||++++++|.+.+.+|+|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG---CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 467999999999999999999999999999999997653 23346688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 185 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
|||++||+|.+++.+. .+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||+|........
T Consensus 96 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 171 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--- 171 (297)
T ss_dssp EECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC---
T ss_pred EECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc---
Confidence 9999999999998764 699999999999999999999999999999999999999999999999999986643211
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCC
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 344 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF 344 (510)
.....+||+.|+|||++.+..|+.++|||||||++|||++|.+||
T Consensus 172 -----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 216 (297)
T 3fxz_A 172 -----------------------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216 (297)
T ss_dssp -----------------------------------CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred -----------------------------------ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 112468999999999999999999999999999999999999999
Q ss_pred CCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 345 CSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 345 ~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
.+.+.......+.... ...++....+++.+++||.+||. ||.+|| +++|+++||||+..
T Consensus 217 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~ell~h~~~~~~ 276 (297)
T 3fxz_A 217 LNENPLRALYLIATNG-TPELQNPEKLSAIFRDFLNRCLEMDVEKRG---SAKELLQHQFLKIA 276 (297)
T ss_dssp TTSCHHHHHHHHHHHC-SCCCSCGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHTTCGGGGGC
T ss_pred CCCCHHHHHHHHHhCC-CCCCCCccccCHHHHHHHHHHccCChhHCc---CHHHHhhChhhccc
Confidence 9988777666665422 22233335799999999999999 999999 78999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-52 Score=417.05 Aligned_cols=265 Identities=28% Similarity=0.488 Sum_probs=220.7
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceE
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 181 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~ 181 (510)
..-.++|++++.||+|+||+||+|+++ +|+.||+|++..... .......+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 94 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL 94 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEE
Confidence 345689999999999999999999986 599999999976432 334456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccc
Q 010463 182 YLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 260 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~ 260 (510)
|+||||++| +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||+|+......
T Consensus 95 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 95 TLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp EEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred EEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 999999985 788877664 459999999999999999999999999999999999999999999999999998654321
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHhh
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml~ 339 (510)
. .....+||+.|+|||++.+ ..|+.++|||||||++|||++
T Consensus 174 ~--------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~ 215 (311)
T 3niz_A 174 R--------------------------------------SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT 215 (311)
T ss_dssp C-----------------------------------------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHH
T ss_pred c--------------------------------------cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHh
Confidence 1 0123579999999999986 568999999999999999999
Q ss_pred CCCCCCCCChhhhHHHHhhccccccCC--------------------------CCCCCCHHHHHHHHHhhc-CccccCCC
Q 010463 340 GYPPFCSDDPRITCRKIVNWKTCLKFP--------------------------EEPKISDEARDLICHLLC-DVETRLGT 392 (510)
Q Consensus 340 G~~PF~~~~~~~~~~~I~~~~~~~~~p--------------------------~~~~~s~~~~dlI~~lL~-dp~~R~~~ 392 (510)
|.+||.+.+......++.......... ..+.+++++.+||++||+ ||.+||
T Consensus 216 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-- 293 (311)
T 3niz_A 216 GKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRI-- 293 (311)
T ss_dssp SSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSC--
T ss_pred CCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCC--
Confidence 999999888777776665421111000 013578999999999999 999999
Q ss_pred CChHHhhcCCCcCCCCch
Q 010463 393 RGVEELKEHPWFRGIQWD 410 (510)
Q Consensus 393 ~~~~eil~HpfF~~i~~~ 410 (510)
+++|+++||||++++++
T Consensus 294 -t~~ell~hp~f~~~~~~ 310 (311)
T 3niz_A 294 -SARDAMNHPYFKDLDPQ 310 (311)
T ss_dssp -CHHHHHTSGGGTTSCTT
T ss_pred -CHHHHhcCcccccCCcc
Confidence 78999999999998864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-52 Score=442.68 Aligned_cols=261 Identities=28% Similarity=0.532 Sum_probs=235.8
Q ss_pred hcccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc
Q 010463 100 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 179 (510)
Q Consensus 100 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 179 (510)
...+..++|.+++.||+|+||.||+|+++.+|+.||||++.+...........+.+|+.+|+.++||||+++++++.+.+
T Consensus 10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 89 (476)
T 2y94_A 10 DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS 89 (476)
T ss_dssp CSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 34566789999999999999999999999999999999998876555556778999999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 180 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
.+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||+++.....
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999999865432
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCC-CccccccchhhHHHHHh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEML 338 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiwSlGvilyEml 338 (510)
. ...+.+||+.|+|||++.+..+ +.++|||||||++|||+
T Consensus 170 ~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell 210 (476)
T 2y94_A 170 E---------------------------------------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALL 210 (476)
T ss_dssp C---------------------------------------CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHH
T ss_pred c---------------------------------------cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHh
Confidence 1 1224689999999999998876 78999999999999999
Q ss_pred hCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 339 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 339 ~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
+|.+||.+.+....+.+|... ....| ..+++++.+||++||. ||.+|| +++||++||||+.
T Consensus 211 tG~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~Li~~~L~~dP~~Rp---t~~eil~hp~~~~ 272 (476)
T 2y94_A 211 CGTLPFDDDHVPTLFKKICDG--IFYTP--QYLNPSVISLLKHMLQVDPMKRA---TIKDIREHEWFKQ 272 (476)
T ss_dssp HSSCSSCCSSSHHHHHHHHTT--CCCCC--TTCCHHHHHHHHHHTCSSTTTSC---CHHHHHTCHHHHT
T ss_pred hCCCCCCCCCHHHHHHHHhcC--CcCCC--ccCCHHHHHHHHHHcCCCchhCc---CHHHHHhCHHhhh
Confidence 999999999888888888864 23444 4789999999999998 999999 7899999999986
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=410.77 Aligned_cols=260 Identities=28% Similarity=0.487 Sum_probs=217.7
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
+++|++++.||+|+||+||+|+++.+|+.||+|++..... .......+.+|+.+|+.++||||+++++++.+++.+|+|
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 3689999999999999999999999999999999976542 344557788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHH-hccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccc
Q 010463 185 MEYLPGGDIMTLLM-REDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 263 (510)
Q Consensus 185 mEy~~gG~L~~~L~-~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 263 (510)
|||++| +|...+. ..+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||+++.......
T Consensus 80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 156 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-- 156 (292)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS--
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc--
Confidence 999986 5555544 467899999999999999999999999999999999999999999999999999986543211
Q ss_pred cchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCC-CCccccccchhhHHHHHhhCCC
Q 010463 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG-YGMECDWWSLGAIMYEMLIGYP 342 (510)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~-y~~~~DiwSlGvilyEml~G~~ 342 (510)
.....+||+.|+|||++.+.. |+.++|||||||++|||++|..
T Consensus 157 ------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~ 200 (292)
T 3o0g_A 157 ------------------------------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200 (292)
T ss_dssp ------------------------------------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSC
T ss_pred ------------------------------------cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCC
Confidence 112457999999999998765 8999999999999999998776
Q ss_pred C-CCCCChhhhHHHHhhcccccc---------------CC----------CCCCCCHHHHHHHHHhhc-CccccCCCCCh
Q 010463 343 P-FCSDDPRITCRKIVNWKTCLK---------------FP----------EEPKISDEARDLICHLLC-DVETRLGTRGV 395 (510)
Q Consensus 343 P-F~~~~~~~~~~~I~~~~~~~~---------------~p----------~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~ 395 (510)
| |.+.+.......+........ ++ ..+.+++++++||++||. ||++|| ++
T Consensus 201 p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---t~ 277 (292)
T 3o0g_A 201 PLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI---SA 277 (292)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSC---CH
T ss_pred CCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCC---CH
Confidence 6 566666666666543111100 00 113588999999999999 999999 79
Q ss_pred HHhhcCCCcCCC
Q 010463 396 EELKEHPWFRGI 407 (510)
Q Consensus 396 ~eil~HpfF~~i 407 (510)
+|+++||||+++
T Consensus 278 ~e~l~hp~f~~~ 289 (292)
T 3o0g_A 278 EEALQHPYFSDF 289 (292)
T ss_dssp HHHHTSGGGTTC
T ss_pred HHHhcCcccccC
Confidence 999999999874
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-52 Score=428.04 Aligned_cols=262 Identities=30% Similarity=0.532 Sum_probs=223.9
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcch--hhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR--GQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~--~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l 183 (510)
+.|++++.||+|+||+||+|+++.+|+.||||++.+...... ...+.+.+|+.+|+.++|||||+++++|.+.+.+|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 469999999999999999999999999999999986543322 245778999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCc---eeecccCCcccC
Q 010463 184 IMEYLPGGDIMTLLMRE----DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH---LKLSDFGLCKPL 256 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~~----~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~---vkL~DFGla~~~ 256 (510)
|||||+||+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++..
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 99999999999888653 25899999999999999999999999999999999999987665 999999999876
Q ss_pred ccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHH
Q 010463 257 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 336 (510)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyE 336 (510)
..... .....+||+.|+|||++.+..|+.++|||||||++||
T Consensus 184 ~~~~~--------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ 225 (351)
T 3c0i_A 184 GESGL--------------------------------------VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFI 225 (351)
T ss_dssp CTTSC--------------------------------------BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHH
T ss_pred cCCCe--------------------------------------eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHH
Confidence 43210 1124689999999999999999999999999999999
Q ss_pred HhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCc
Q 010463 337 MLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQW 409 (510)
Q Consensus 337 ml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~ 409 (510)
|++|.+||.+. ....+..+.........+.+..+|+++++||.+||. ||.+|| ++.|+++||||++.++
T Consensus 226 ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~e~l~hp~~~~~~~ 295 (351)
T 3c0i_A 226 LLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERI---TVYEALNHPWLKERDR 295 (351)
T ss_dssp HHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSC---CHHHHHTSHHHHTHHH
T ss_pred HHHCCCCCCCc-HHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCc---CHHHHhcChhhcCCcc
Confidence 99999999875 345666666543222211224789999999999998 999999 7899999999987654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=421.00 Aligned_cols=251 Identities=21% Similarity=0.262 Sum_probs=190.8
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc----eE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD----FL 181 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~----~~ 181 (510)
.+|.+.+.||+|+||+||+|++ +|+.||||+++.... .......|+.++..++|||||++++++.+++ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 3688899999999999999987 589999999975421 1122234555567889999999999998654 68
Q ss_pred EEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhC--------CeEEeecCCCCeeecCCCceeecccCCc
Q 010463 182 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH--------NYVHRDIKPDNLILDKNGHLKLSDFGLC 253 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~--------giiHRDLKP~NILld~~g~vkL~DFGla 253 (510)
|||||||+||+|.++|.+ ..++++.+..++.|++.||.|||+. |||||||||+|||||.+|++||+|||+|
T Consensus 77 ~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 999999999999999976 4689999999999999999999987 9999999999999999999999999999
Q ss_pred ccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC------CCCccccc
Q 010463 254 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK------GYGMECDW 327 (510)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~------~y~~~~Di 327 (510)
+......... .....+.+||+.|||||++.+. .|+.++||
T Consensus 156 ~~~~~~~~~~----------------------------------~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DV 201 (303)
T 3hmm_A 156 VRHDSATDTI----------------------------------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI 201 (303)
T ss_dssp EEEETTTTEE----------------------------------SCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHH
T ss_pred ccccCCCCce----------------------------------eeecccccccccccCHHHhcccccccCCccChhHhh
Confidence 8654321110 0011246899999999999764 36789999
Q ss_pred cchhhHHHHHhhCCCCCCCCCh---------------hhhHHHHhhccccccCCCC---CCCCHHHHHHHHHhhc-Cccc
Q 010463 328 WSLGAIMYEMLIGYPPFCSDDP---------------RITCRKIVNWKTCLKFPEE---PKISDEARDLICHLLC-DVET 388 (510)
Q Consensus 328 wSlGvilyEml~G~~PF~~~~~---------------~~~~~~I~~~~~~~~~p~~---~~~s~~~~dlI~~lL~-dp~~ 388 (510)
|||||+||||+||.+||..... ......+......+.+|.. ...+..+.+||.+||. ||++
T Consensus 202 wS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~ 281 (303)
T 3hmm_A 202 YAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAA 281 (303)
T ss_dssp HHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGG
T ss_pred hhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhH
Confidence 9999999999999887643221 1222233332222333321 1233578899999998 9999
Q ss_pred cCCCCChHHhhc
Q 010463 389 RLGTRGVEELKE 400 (510)
Q Consensus 389 R~~~~~~~eil~ 400 (510)
|| ++.||++
T Consensus 282 RP---t~~ei~~ 290 (303)
T 3hmm_A 282 RL---TALRIKK 290 (303)
T ss_dssp SC---CHHHHHH
T ss_pred Cc---CHHHHHH
Confidence 99 6777765
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=429.17 Aligned_cols=260 Identities=29% Similarity=0.528 Sum_probs=228.9
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
.++|++++.||+|+||.||+|.++.+|+.||+|++.+.. ......+.+|+.+|..++|||||+++++|.+...+|+|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 368999999999999999999999999999999997653 23345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecC--CCceeecccCCcccCccccc
Q 010463 185 MEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK--NGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~~-~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~--~g~vkL~DFGla~~~~~~~~ 261 (510)
|||++||+|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++. ++++||+|||+++.+....
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~- 205 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 205 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc-
Confidence 99999999999997654 7999999999999999999999999999999999999984 5789999999998764321
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~ 341 (510)
.....+||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 206 --------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~ 247 (387)
T 1kob_A 206 --------------------------------------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL 247 (387)
T ss_dssp --------------------------------------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSC
T ss_pred --------------------------------------ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCC
Confidence 012357999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCc
Q 010463 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQW 409 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~ 409 (510)
+||.+.+......++......+..+....+|+++++||.+||. ||.+|| +++|+++||||++..+
T Consensus 248 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---t~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 248 SPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL---TVHDALEHPWLKGDHS 313 (387)
T ss_dssp CSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHTSTTTSSCCT
T ss_pred CCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCc---CHHHHhhCccccCCcc
Confidence 9999998888888887644333333345789999999999998 999999 7899999999998654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-52 Score=429.69 Aligned_cols=281 Identities=26% Similarity=0.446 Sum_probs=214.0
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEeEEeecCc--eE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSD--FL 181 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~--~~ 181 (510)
.++|++++.||+|+||.||+|.++.+|+.||||++.+. .........+.+|+.+|..+. |||||+++++|..++ .+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc-ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 46899999999999999999999999999999999754 234455677889999999997 999999999998544 79
Q ss_pred EEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 182 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
|+|||||+ |+|..++.. +.+++..++.++.||+.||+|||+.||+||||||+||||+.+|++||+|||+|+.+.....
T Consensus 87 ~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164 (388)
T ss_dssp EEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred EEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence 99999997 589988865 5799999999999999999999999999999999999999999999999999987643211
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHhhC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIG 340 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml~G 340 (510)
... .......... ..+ ........+.+||+.|+|||++.+ ..|+.++|||||||++|||++|
T Consensus 165 ~~~--------~~~~~~~~~~--------~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g 227 (388)
T 3oz6_A 165 VTN--------NIPLSINENT--------ENF-DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227 (388)
T ss_dssp CCC--------CGGGCCC------------------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHS
T ss_pred ccc--------cccccccccc--------ccc-ccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhC
Confidence 000 0000000000 000 000111235789999999999987 6799999999999999999999
Q ss_pred CCCCCCCChhhhHHHHhhcccccc-------------------------------------------CCCCCCCCHHHHH
Q 010463 341 YPPFCSDDPRITCRKIVNWKTCLK-------------------------------------------FPEEPKISDEARD 377 (510)
Q Consensus 341 ~~PF~~~~~~~~~~~I~~~~~~~~-------------------------------------------~p~~~~~s~~~~d 377 (510)
.+||.+.+....+.+|+....... .+....+++++.+
T Consensus 228 ~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 307 (388)
T 3oz6_A 228 KPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALD 307 (388)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHH
Confidence 999999998888877764211000 0011267999999
Q ss_pred HHHHhhc-CccccCCCCChHHhhcCCCcCCCC
Q 010463 378 LICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 408 (510)
Q Consensus 378 lI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~ 408 (510)
||.+||+ ||.+|| +++|+++||||+.+.
T Consensus 308 ll~~~L~~dP~~R~---t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 308 LLDKLLQFNPNKRI---SANDALKHPFVSIFH 336 (388)
T ss_dssp HHHHHCCSSGGGSC---CHHHHTTSTTTTTTC
T ss_pred HHHHhhccCcccCC---CHHHHhCCHHHHHhc
Confidence 9999999 999999 789999999998654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=428.79 Aligned_cols=275 Identities=21% Similarity=0.317 Sum_probs=225.4
Q ss_pred cCCCCceeeeeeecC--CCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCce
Q 010463 103 IGIDDFEQLTLIGKG--AFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 180 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G--~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 180 (510)
...++|++++.||+| +||.||+|+++.+|+.||||++.+... .......+.+|+.+|+.++|||||+++++|.+.+.
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence 345789999999999 999999999999999999999987543 34567788999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 181 LYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
+|+|||||+||+|.+++... ..+++..++.++.||+.||.|||+.|||||||||+||||+.+|++||+|||++.....
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999999875 6799999999999999999999999999999999999999999999999999876533
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc--CCCCccccccchhhHHHH
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK--KGYGMECDWWSLGAIMYE 336 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiwSlGvilyE 336 (510)
...... .........+||+.|+|||++.+ ..|+.++|||||||++||
T Consensus 181 ~~~~~~-------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~e 229 (389)
T 3gni_B 181 HGQRQR-------------------------------VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACE 229 (389)
T ss_dssp TTEECS-------------------------------CBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHH
T ss_pred cccccc-------------------------------ccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHH
Confidence 211000 00001123589999999999987 679999999999999999
Q ss_pred HhhCCCCCCCCChhhhHHHHhhcccc------------------------------------------ccCCCCCCCCHH
Q 010463 337 MLIGYPPFCSDDPRITCRKIVNWKTC------------------------------------------LKFPEEPKISDE 374 (510)
Q Consensus 337 ml~G~~PF~~~~~~~~~~~I~~~~~~------------------------------------------~~~p~~~~~s~~ 374 (510)
|++|.+||.+.+.......++..... ...+....+|++
T Consensus 230 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 309 (389)
T 3gni_B 230 LANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPH 309 (389)
T ss_dssp HHHSSCTTTTCCSTTHHHHC--------------------------------------------------------CCHH
T ss_pred HHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHH
Confidence 99999999987766665554432110 011122468999
Q ss_pred HHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchhh
Q 010463 375 ARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKL 412 (510)
Q Consensus 375 ~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l 412 (510)
+.+||.+||. ||.+|| +++|+++||||+.+.|...
T Consensus 310 ~~~li~~~L~~dP~~Rp---ta~ell~hp~f~~~~~~~~ 345 (389)
T 3gni_B 310 FHHFVEQCLQRNPDARP---SASTLLNHSFFKQIKRRAS 345 (389)
T ss_dssp HHHHHHHHTCSCTTTSC---CHHHHTTSGGGGGC---CC
T ss_pred HHHHHHHHhhcCcccCC---CHHHHhcCHHHHHHhhcch
Confidence 9999999999 999999 7899999999999887543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-51 Score=403.14 Aligned_cols=264 Identities=30% Similarity=0.530 Sum_probs=235.6
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
.++|++++.||+|+||.||+|.++.+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 4789999999999999999999999999999999986543 444567789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCc---eeecccCCcccCccccc
Q 010463 185 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH---LKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~---vkL~DFGla~~~~~~~~ 261 (510)
|||++||+|.+.+.....+++..+..++.|++.||.|||+.||+||||||+|||++.++. +||+|||++........
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence 999999999999999899999999999999999999999999999999999999987665 99999999976543210
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~ 341 (510)
....+||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 164 ---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 204 (284)
T 3kk8_A 164 ---------------------------------------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGY 204 (284)
T ss_dssp ---------------------------------------CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred ---------------------------------------ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCC
Confidence 12357999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchh
Q 010463 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDK 411 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~ 411 (510)
+||.+.+.......+.........+....+++++.+||.+||. ||.+|| +++|+++||||++..+..
T Consensus 205 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~~l~h~~~~~~~~~~ 272 (284)
T 3kk8_A 205 PPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI---TADQALKVPWICNRERVA 272 (284)
T ss_dssp CSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSC---CHHHHTTSHHHHSCCCGG
T ss_pred CCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCC---CHHHHhcCccccCChhHH
Confidence 9999999888888887755444445556899999999999999 999999 789999999998876543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-52 Score=438.57 Aligned_cols=292 Identities=24% Similarity=0.363 Sum_probs=209.3
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec-----Cc
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD-----SD 179 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-----~~ 179 (510)
.++|++++.||+|+||+||+|+++.+|+.||||++.+. .......+.+.+|+.+|..++|||||+++++|.+ ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECST-TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 47899999999999999999999999999999999754 2344556789999999999999999999999943 36
Q ss_pred eEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 180 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
.+|+||||+ +|+|..++.....+++..++.++.||+.||.|||+.|||||||||+||||+.+|++||+|||+|+.....
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred eEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 799999998 5799999988888999999999999999999999999999999999999999999999999999976533
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHH--HhhcccccccccccCCCcchHhhc-cCCCCccccccchhhHHHH
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQW--KRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYE 336 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~GT~~Y~APEvl~-~~~y~~~~DiwSlGvilyE 336 (510)
........ ...... . .....+ ...........+||+.|+|||++. +..|+.++|||||||||||
T Consensus 210 ~~~~~~~~-----~~~~~~--~------~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~e 276 (458)
T 3rp9_A 210 ENGNSQLP-----ISPRED--D------MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAE 276 (458)
T ss_dssp TTCCCCCC----------------------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred cccccccc-----cCcccc--c------cccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHH
Confidence 11100000 000000 0 000000 000111234578999999999874 5679999999999999999
Q ss_pred Hhh-----------CCCCCCCCCh--------------------hhhHHHHhhcccc------------------ccCC-
Q 010463 337 MLI-----------GYPPFCSDDP--------------------RITCRKIVNWKTC------------------LKFP- 366 (510)
Q Consensus 337 ml~-----------G~~PF~~~~~--------------------~~~~~~I~~~~~~------------------~~~p- 366 (510)
|++ |.+||.+.+. ......|.+.-.. ..+|
T Consensus 277 lltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~ 356 (458)
T 3rp9_A 277 LLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPK 356 (458)
T ss_dssp HHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCC
T ss_pred HHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCC
Confidence 999 7888877542 1222222210000 0000
Q ss_pred --------CCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchhhhc
Q 010463 367 --------EEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYE 414 (510)
Q Consensus 367 --------~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l~~ 414 (510)
..+.+|+++.|||++||. ||.+|| +++|+++||||++++|..+..
T Consensus 357 ~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~---t~~e~L~Hp~f~~~~~~~~e~ 410 (458)
T 3rp9_A 357 REGTDLAERFPASSADAIHLLKRMLVFNPNKRI---TINECLAHPFFKEVRIAEVET 410 (458)
T ss_dssp CCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSC---CHHHHHHSGGGTTTCCGGGCC
T ss_pred CCCCCHHHHCCCCCHHHHHHHHHHhccCccccC---CHHHHhcCHhhhhcCCCccCC
Confidence 124679999999999999 999999 789999999999999987753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=405.70 Aligned_cols=260 Identities=35% Similarity=0.586 Sum_probs=231.9
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCce
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 180 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 180 (510)
.....++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 83 (279)
T 3fdn_A 4 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR 83 (279)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence 35678899999999999999999999999999999999987665555556778999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccc
Q 010463 181 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 260 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~ 260 (510)
.|+||||++||+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||++.......
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence 99999999999999999988899999999999999999999999999999999999999999999999999986543220
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhC
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 340 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G 340 (510)
....+||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 164 ----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 203 (279)
T 3fdn_A 164 ----------------------------------------RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 203 (279)
T ss_dssp --------------------------------------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred ----------------------------------------ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHC
Confidence 1135799999999999999999999999999999999999
Q ss_pred CCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 341 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 341 ~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
.+||.+.+.......+... ...+| ..+++++++||.+||. ||.+|| +++|+++||||++.
T Consensus 204 ~~p~~~~~~~~~~~~~~~~--~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 204 KPPFEANTYQETYKRISRV--EFTFP--DFVTEGARDLISRLLKHNPSQRP---MLREVLEHPWITAN 264 (279)
T ss_dssp SCTTCCSSHHHHHHHHHHT--CCCCC--TTSCHHHHHHHHHHCCSSGGGSC---CHHHHHHCHHHHHH
T ss_pred CCCCCCCcHHHHHHHHHhC--CCCCC--CcCCHHHHHHHHHHhccChhhCC---CHHHHhhCccccCC
Confidence 9999999888888887763 33444 3789999999999998 999999 78999999999763
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-51 Score=405.76 Aligned_cols=262 Identities=36% Similarity=0.629 Sum_probs=233.6
Q ss_pred hhcccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC
Q 010463 99 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 178 (510)
Q Consensus 99 ~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 178 (510)
....+..++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 86 (284)
T 2vgo_A 7 PKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR 86 (284)
T ss_dssp ---CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred CccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC
Confidence 34567788999999999999999999999999999999999876554444567789999999999999999999999999
Q ss_pred ceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 179 DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
+.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||++.....
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 87 KRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 99999999999999999999888999999999999999999999999999999999999999999999999999875432
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHh
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml 338 (510)
.. ....+||+.|+|||++.+..++.++|+|||||++|+|+
T Consensus 167 ~~----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 206 (284)
T 2vgo_A 167 LR----------------------------------------RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFL 206 (284)
T ss_dssp SC----------------------------------------BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHH
T ss_pred cc----------------------------------------cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHH
Confidence 10 12357999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 339 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 339 ~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
+|.+||.+.+.......+... ...+| ..+++++++||.+||. ||.+|| +++++++||||+..
T Consensus 207 ~g~~pf~~~~~~~~~~~~~~~--~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 207 VGMPPFDSPSHTETHRRIVNV--DLKFP--PFLSDGSKDLISKLLRYHPPQRL---PLKGVMEHPWVKAN 269 (284)
T ss_dssp HSSCTTCCSSHHHHHHHHHTT--CCCCC--TTSCHHHHHHHHHHSCSSGGGSC---CHHHHHTCHHHHHH
T ss_pred HCCCCCCCCCHhHHHHHHhcc--ccCCC--CcCCHHHHHHHHHHhhcCHhhCC---CHHHHhhCHHHHhh
Confidence 999999998888888777763 34455 4789999999999998 999999 78999999999753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=417.92 Aligned_cols=260 Identities=25% Similarity=0.456 Sum_probs=220.7
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
.++|++++.||+|+||+||+|+++.+|+.||||++..... ....+.+.+|+.+++.++|||||++++++.+.+..|+|
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 5799999999999999999999999999999999975432 22235688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 185 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
|||++||+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++.+......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-- 161 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-- 161 (323)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE--
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc--
Confidence 999999999999988888999999999999999999999999999999999999999999999999999865432100
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCC-CccccccchhhHHHHHhhCCCC
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEMLIGYPP 343 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiwSlGvilyEml~G~~P 343 (510)
......+||+.|+|||++.+..+ +.++|||||||++|||++|.+|
T Consensus 162 ----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p 207 (323)
T 3tki_A 162 ----------------------------------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207 (323)
T ss_dssp ----------------------------------CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred ----------------------------------cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCC
Confidence 11224689999999999988776 7899999999999999999999
Q ss_pred CCCCChhh-hHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 344 FCSDDPRI-TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 344 F~~~~~~~-~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
|.+.+... .+..+... ....+....+++++.+||.+||. ||.+|| +++|+++||||+..
T Consensus 208 f~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---t~~eil~h~~~~~~ 268 (323)
T 3tki_A 208 WDQPSDSCQEYSDWKEK--KTYLNPWKKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYNKP 268 (323)
T ss_dssp CSSSCTTSHHHHHHHTT--CTTSTTGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHTTCTTTTCC
T ss_pred CCCCchHHHHHHHHhcc--cccCCccccCCHHHHHHHHHHccCChhhCc---CHHHHhhChhhccc
Confidence 98765543 23333322 22233345799999999999998 999999 78999999999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-52 Score=443.77 Aligned_cols=264 Identities=32% Similarity=0.591 Sum_probs=237.0
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
.++|++++.||+|+||.||+|+++.+|+.||||++.+...........+.+|+.+|+.++|||||+++++|.+.+.+|+|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 35799999999999999999999999999999999877655556678899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeee---cCCCceeecccCCcccCccccc
Q 010463 185 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL---DKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILl---d~~g~vkL~DFGla~~~~~~~~ 261 (510)
|||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+.+.....
T Consensus 105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 184 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184 (484)
T ss_dssp ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc
Confidence 9999999999999998999999999999999999999999999999999999999 5678999999999986543210
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~ 341 (510)
..+.+||+.|+|||++.+ .|+.++|||||||++|+|++|.
T Consensus 185 ---------------------------------------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~ 224 (484)
T 3nyv_A 185 ---------------------------------------MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGC 224 (484)
T ss_dssp ---------------------------------------HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSS
T ss_pred ---------------------------------------cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCC
Confidence 113579999999999976 6999999999999999999999
Q ss_pred CCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchh
Q 010463 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDK 411 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~ 411 (510)
+||.+.+......++......+..|.+..+|+++++||++||. ||.+|| +++|+++||||+...+..
T Consensus 225 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---s~~e~l~h~~~~~~~~~~ 292 (484)
T 3nyv_A 225 PPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRI---SARDALDHEWIQTYTKEQ 292 (484)
T ss_dssp CSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSC---CHHHHHTSHHHHHHTC--
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCc---CHHHHhhChhhccccccc
Confidence 9999999999999998866556666667899999999999999 999999 789999999998765543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=412.27 Aligned_cols=259 Identities=34% Similarity=0.647 Sum_probs=220.4
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcch-----------------------hhHHHHHHHHHH
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR-----------------------GQVEHVRSERNL 159 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~-----------------------~~~~~~~~E~~i 159 (510)
+..++|++++.||+|+||.||+|+++.+|+.||||++.+...... ...+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 456899999999999999999999999999999999987543221 224568899999
Q ss_pred HHhcCCCCeeeEeEEeec--CceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCe
Q 010463 160 LAEVDSRCIVQLFYSFQD--SDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNL 237 (510)
Q Consensus 160 L~~l~hp~Iv~l~~~~~~--~~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NI 237 (510)
|+.++||||+++++++.+ .+.+|+||||++||+|.+++. ...+++..++.++.||+.||.|||+.||+||||||+||
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 999999999999999987 568999999999999988754 45799999999999999999999999999999999999
Q ss_pred eecCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc
Q 010463 238 ILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL 317 (510)
Q Consensus 238 Lld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~ 317 (510)
|++.+|++||+|||+++....... .....+||+.|+|||++.
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~~--------------------------------------~~~~~~gt~~y~aPE~~~ 210 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSDA--------------------------------------LLSNTVGTPAFMAPESLS 210 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSSC--------------------------------------EECCCCSCGGGCCGGGCC
T ss_pred EECCCCCEEEecCCCccccccccc--------------------------------------cccCCcCCccccChhhhc
Confidence 999999999999999986543210 012457999999999998
Q ss_pred cCC---CCccccccchhhHHHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC
Q 010463 318 KKG---YGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR 393 (510)
Q Consensus 318 ~~~---y~~~~DiwSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~ 393 (510)
+.. ++.++|||||||++|||++|.+||.+.+.......+... ...+|..+.+++++++||.+||. ||.+||
T Consensus 211 ~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~R~--- 285 (298)
T 2zv2_A 211 ETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQ--ALEFPDQPDIAEDLKDLITRMLDKNPESRI--- 285 (298)
T ss_dssp TTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCSSSCCCHHHHHHHHHHTCSCTTTSC---
T ss_pred cCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcc--cCCCCCccccCHHHHHHHHHHhhcChhhCC---
Confidence 765 378899999999999999999999988877777777653 35556656899999999999998 999999
Q ss_pred ChHHhhcCCCcC
Q 010463 394 GVEELKEHPWFR 405 (510)
Q Consensus 394 ~~~eil~HpfF~ 405 (510)
++.|+++||||+
T Consensus 286 s~~e~l~hp~~~ 297 (298)
T 2zv2_A 286 VVPEIKLHPWVT 297 (298)
T ss_dssp CHHHHTTCHHHH
T ss_pred CHHHHhcCcccc
Confidence 789999999995
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=415.62 Aligned_cols=265 Identities=30% Similarity=0.528 Sum_probs=234.0
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcch---hhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR---GQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~---~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~ 182 (510)
++|++++.||+|+||.||+|+++.+|+.||+|++.+...... ...+.+.+|+.+|..++||||+++++++.+.+.+|
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 569999999999999999999999999999999987543221 13567899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCC----ceeecccCCcccCcc
Q 010463 183 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG----HLKLSDFGLCKPLED 258 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g----~vkL~DFGla~~~~~ 258 (510)
+||||++||+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++ ++||+|||+++....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~ 171 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171 (321)
T ss_dssp EEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCT
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCc
Confidence 9999999999999999888899999999999999999999999999999999999999888 899999999986543
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHh
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml 338 (510)
... ....+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 172 ~~~---------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 212 (321)
T 2a2a_A 172 GVE---------------------------------------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 212 (321)
T ss_dssp TCC---------------------------------------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred ccc---------------------------------------ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHH
Confidence 210 12357999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhhHHHHhhccccccCCC--CCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchhhhc
Q 010463 339 IGYPPFCSDDPRITCRKIVNWKTCLKFPE--EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYE 414 (510)
Q Consensus 339 ~G~~PF~~~~~~~~~~~I~~~~~~~~~p~--~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l~~ 414 (510)
+|..||.+.+.......+.... ..++. ...+|+.+++||.+||. ||.+|| +++|+++||||.+++|.....
T Consensus 213 ~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~e~l~hp~~~~~~~~~~~~ 286 (321)
T 2a2a_A 213 SGASPFLGDTKQETLANITSVS--YDFDEEFFSHTSELAKDFIRKLLVKETRKRL---TIQEALRHPWITPVDNQQAMV 286 (321)
T ss_dssp HSCCSSCCSSHHHHHHHHHTTC--CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSC---CHHHHHHSTTTSCSSHHHHHH
T ss_pred HCCCCCCCCCHHHHHHHHHhcc--cccChhhhcccCHHHHHHHHHHcCCChhhCc---CHHHHhcCccccCCCcccccc
Confidence 9999999998888888877633 22221 14789999999999998 999999 789999999999999877643
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-52 Score=419.85 Aligned_cols=266 Identities=29% Similarity=0.443 Sum_probs=217.7
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceE
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 181 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~ 181 (510)
....++|++++.||+|+||+||+|+++.+|+.||||++..... .......+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL 108 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence 3456899999999999999999999999999999999976532 233455678899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeec-----CCCceeecccCCcccC
Q 010463 182 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD-----KNGHLKLSDFGLCKPL 256 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld-----~~g~vkL~DFGla~~~ 256 (510)
|+||||++| +|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+|||+|+..
T Consensus 109 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 109 HLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred EEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 999999975 9999999988999999999999999999999999999999999999994 4556999999999765
Q ss_pred ccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC-CCCccccccchhhHHH
Q 010463 257 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMY 335 (510)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiwSlGvily 335 (510)
..... .....+||+.|+|||++.+. .|+.++|||||||++|
T Consensus 188 ~~~~~--------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 229 (329)
T 3gbz_A 188 GIPIR--------------------------------------QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWA 229 (329)
T ss_dssp C-------------------------------------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHH
T ss_pred CCccc--------------------------------------ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHH
Confidence 32100 01235799999999999874 5899999999999999
Q ss_pred HHhhCCCCCCCCChhhhHHHHhhcccccc---------CCCC-----------------CCCCHHHHHHHHHhhc-Cccc
Q 010463 336 EMLIGYPPFCSDDPRITCRKIVNWKTCLK---------FPEE-----------------PKISDEARDLICHLLC-DVET 388 (510)
Q Consensus 336 Eml~G~~PF~~~~~~~~~~~I~~~~~~~~---------~p~~-----------------~~~s~~~~dlI~~lL~-dp~~ 388 (510)
||++|.+||.+.+......++........ .+.+ ..+++++.+||.+||. ||.+
T Consensus 230 ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 309 (329)
T 3gbz_A 230 EMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVK 309 (329)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGG
T ss_pred HHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhh
Confidence 99999999999888877777764211110 0000 1278999999999999 9999
Q ss_pred cCCCCChHHhhcCCCcCCCCch
Q 010463 389 RLGTRGVEELKEHPWFRGIQWD 410 (510)
Q Consensus 389 R~~~~~~~eil~HpfF~~i~~~ 410 (510)
|| +++|+++||||++++|+
T Consensus 310 R~---t~~e~l~hp~f~~~~~~ 328 (329)
T 3gbz_A 310 RI---SAKNALEHPYFSHNDFD 328 (329)
T ss_dssp SC---CHHHHHTSGGGSSSCSC
T ss_pred CC---CHHHHhCCcccCCCCCC
Confidence 99 78999999999999996
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=420.07 Aligned_cols=259 Identities=32% Similarity=0.518 Sum_probs=213.5
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEE
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l 183 (510)
..+.|++.+.||+|+||.||+|+++.+++.||||++.+.. ..+.+.+|+.+|..++||||++++++|.+.+.+|+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 125 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL 125 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence 3467999999999999999999999999999999997642 23567889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecC---CCceeecccCCcccCcccc
Q 010463 184 IMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK---NGHLKLSDFGLCKPLEDKY 260 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~---~g~vkL~DFGla~~~~~~~ 260 (510)
||||++||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+++......
T Consensus 126 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 205 (349)
T 2w4o_A 126 VLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205 (349)
T ss_dssp EECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence 9999999999999998889999999999999999999999999999999999999975 8999999999998653320
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhC
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 340 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G 340 (510)
...+.+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 206 ---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 246 (349)
T 2w4o_A 206 ---------------------------------------LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246 (349)
T ss_dssp ----------------------------------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred ---------------------------------------ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhC
Confidence 01246799999999999999999999999999999999999
Q ss_pred CCCCCCCChhh-hHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCc
Q 010463 341 YPPFCSDDPRI-TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQW 409 (510)
Q Consensus 341 ~~PF~~~~~~~-~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~ 409 (510)
..||.+..... .+..+.+.......|....++.++++||.+||. ||++|| ++.|+++||||.+..+
T Consensus 247 ~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 247 FEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRL---TTFQALQHPWVTGKAA 314 (349)
T ss_dssp SCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSTTTTSTTC
T ss_pred CCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCc---CHHHHhcCcccCCCcc
Confidence 99998766544 666777654333334446799999999999998 999999 7899999999987654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=414.01 Aligned_cols=262 Identities=28% Similarity=0.482 Sum_probs=209.0
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
.++|++++.||+|+||.||+|+++.+|+.||+|++.... .......+.+|+.+|+.++|||||++++++.+++.+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 468999999999999999999999999999999997653 223345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc------cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 185 MEYLPGGDIMTLLMRE------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~------~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
|||++ |+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++....
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 99998 5999998764 3589999999999999999999999999999999999999999999999999986543
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHH
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEM 337 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEm 337 (510)
... .....+||+.|+|||++.+ ..|+.++|||||||++|||
T Consensus 161 ~~~--------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 202 (317)
T 2pmi_A 161 PVN--------------------------------------TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEM 202 (317)
T ss_dssp CCC--------------------------------------CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred Ccc--------------------------------------cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHH
Confidence 210 0124579999999999986 4689999999999999999
Q ss_pred hhCCCCCCCCChhhhHHHHhhccccc---------cCC---------------------CCCCCCHHHHHHHHHhhc-Cc
Q 010463 338 LIGYPPFCSDDPRITCRKIVNWKTCL---------KFP---------------------EEPKISDEARDLICHLLC-DV 386 (510)
Q Consensus 338 l~G~~PF~~~~~~~~~~~I~~~~~~~---------~~p---------------------~~~~~s~~~~dlI~~lL~-dp 386 (510)
++|.+||.+.+.......|....... ..+ ....+++++.+||.+||+ ||
T Consensus 203 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 282 (317)
T 2pmi_A 203 ITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNP 282 (317)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSG
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCc
Confidence 99999999988887777765421100 000 012578999999999999 99
Q ss_pred cccCCCCChHHhhcCCCcCCCCch
Q 010463 387 ETRLGTRGVEELKEHPWFRGIQWD 410 (510)
Q Consensus 387 ~~R~~~~~~~eil~HpfF~~i~~~ 410 (510)
.+|| +++|+++||||++..|.
T Consensus 283 ~~Rp---t~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 283 DMRL---SAKQALHHPWFAEYYHH 303 (317)
T ss_dssp GGSC---CHHHHTTSGGGGGGCC-
T ss_pred ccCC---CHHHHhCChhhhcccch
Confidence 9999 78999999999987654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=422.21 Aligned_cols=258 Identities=33% Similarity=0.522 Sum_probs=212.8
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEE
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~ 182 (510)
...++|++++.||+|+||+||+|+++.+|+.||||++.+.... .+.+.+|+.+++.++|||||++++++.+.+.+|
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 3457899999999999999999999999999999999765322 245789999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCc--eeecccCCcccCcccc
Q 010463 183 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH--LKLSDFGLCKPLEDKY 260 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~--vkL~DFGla~~~~~~~ 260 (510)
+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||+|+......
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence 99999999999999998889999999999999999999999999999999999999987775 9999999997432210
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCcc-ccccchhhHHHHHhh
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGME-CDWWSLGAIMYEMLI 339 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~-~DiwSlGvilyEml~ 339 (510)
...+.+||+.|+|||++.+..++.+ +|||||||++|||++
T Consensus 173 ---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 213 (361)
T 3uc3_A 173 ---------------------------------------QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLV 213 (361)
T ss_dssp -----------------------------------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHH
T ss_pred ---------------------------------------CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHh
Confidence 0124679999999999998888655 899999999999999
Q ss_pred CCCCCCCCChhhhHHHHhhc--cccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 340 GYPPFCSDDPRITCRKIVNW--KTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 340 G~~PF~~~~~~~~~~~I~~~--~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
|.+||.+.+....+.+++.. .....+|....+|+++++||.+||. ||.+|| +++||++||||..
T Consensus 214 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---s~~ell~hp~f~~ 280 (361)
T 3uc3_A 214 GAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRI---SIPEIKTHSWFLK 280 (361)
T ss_dssp SSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSC---CHHHHHTSHHHHT
T ss_pred CCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCc---CHHHHHhCcchhc
Confidence 99999876554433333221 1234556656799999999999998 999999 7899999999954
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=440.63 Aligned_cols=260 Identities=32% Similarity=0.598 Sum_probs=232.9
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|+.++|||||++++++.+...+|+||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHH-BCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 579999999999999999999999999999999987543 3345677899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeec---CCCceeecccCCcccCcccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD---KNGHLKLSDFGLCKPLEDKYSS 262 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld---~~g~vkL~DFGla~~~~~~~~~ 262 (510)
|||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++......
T Consensus 101 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~-- 178 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-- 178 (486)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC---
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC--
Confidence 9999999999999989999999999999999999999999999999999999995 55689999999998654321
Q ss_pred ccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCC
Q 010463 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 342 (510)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~ 342 (510)
.....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+
T Consensus 179 -------------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~ 220 (486)
T 3mwu_A 179 -------------------------------------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTP 220 (486)
T ss_dssp ----------------------------------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSC
T ss_pred -------------------------------------ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCC
Confidence 0124689999999999975 59999999999999999999999
Q ss_pred CCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCc
Q 010463 343 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQW 409 (510)
Q Consensus 343 PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~ 409 (510)
||.+.+..+...++......+..|.+..+|+++++||.+||. ||.+|| ++.++++||||+....
T Consensus 221 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 221 PFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRI---TATQCLEHPWIQKYSS 285 (486)
T ss_dssp SSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSC---CHHHHHHCHHHHHTCC
T ss_pred CCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCc---CHHHHhcCHhhccCcc
Confidence 999999999999998876666666667899999999999999 999999 7899999999987643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-51 Score=407.13 Aligned_cols=260 Identities=28% Similarity=0.448 Sum_probs=215.6
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
+++|++++.||+|+||+||+|++ .+|+.||+|++..... .......+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 36899999999999999999998 6799999999976432 223346688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccc
Q 010463 185 MEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 263 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 263 (510)
|||++| +|.+++... +.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++.......
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 155 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-- 155 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc--
Confidence 999986 899988764 6799999999999999999999999999999999999999999999999999875432100
Q ss_pred cchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHhhCCC
Q 010463 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYP 342 (510)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml~G~~ 342 (510)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|.+
T Consensus 156 ------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 199 (288)
T 1ob3_A 156 ------------------------------------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTP 199 (288)
T ss_dssp ------------------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ------------------------------------ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 0123579999999999976 458999999999999999999999
Q ss_pred CCCCCChhhhHHHHhhccccc---------cCC----------------CCCCCCHHHHHHHHHhhc-CccccCCCCChH
Q 010463 343 PFCSDDPRITCRKIVNWKTCL---------KFP----------------EEPKISDEARDLICHLLC-DVETRLGTRGVE 396 (510)
Q Consensus 343 PF~~~~~~~~~~~I~~~~~~~---------~~p----------------~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~ 396 (510)
||.+.+......++....... ..+ ....+++++.+||++||. ||.+|| +++
T Consensus 200 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~ 276 (288)
T 1ob3_A 200 LFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI---TAK 276 (288)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSC---CHH
T ss_pred CCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCC---CHH
Confidence 999988777766665311100 000 013589999999999999 999999 789
Q ss_pred HhhcCCCcCCCC
Q 010463 397 ELKEHPWFRGIQ 408 (510)
Q Consensus 397 eil~HpfF~~i~ 408 (510)
|+++||||++.+
T Consensus 277 e~l~hp~f~~~n 288 (288)
T 1ob3_A 277 QALEHAYFKENN 288 (288)
T ss_dssp HHHTSGGGGC--
T ss_pred HHhcCcchhhcC
Confidence 999999998753
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-51 Score=438.57 Aligned_cols=260 Identities=33% Similarity=0.603 Sum_probs=226.5
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
+.|++++.||+|+||+||+|+++.++..||+|++.+.... ......+.+|+.+|+.++|||||+++++|.+...+|+||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS-TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 3699999999999999999999999999999999876432 233567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecC---CCceeecccCCcccCcccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK---NGHLKLSDFGLCKPLEDKYSS 262 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~---~g~vkL~DFGla~~~~~~~~~ 262 (510)
|||+||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+......
T Consensus 116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~-- 193 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK-- 193 (494)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB--
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc--
Confidence 99999999999999899999999999999999999999999999999999999976 4559999999998664321
Q ss_pred ccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCC
Q 010463 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 342 (510)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~ 342 (510)
...+.+||+.|+|||++. ..|+.++|||||||++|+|++|.+
T Consensus 194 -------------------------------------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~ 235 (494)
T 3lij_A 194 -------------------------------------KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYP 235 (494)
T ss_dssp -------------------------------------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred -------------------------------------cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCC
Confidence 112468999999999986 569999999999999999999999
Q ss_pred CCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCc
Q 010463 343 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQW 409 (510)
Q Consensus 343 PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~ 409 (510)
||.+.+..+...++......+..|.+..+|+++++||++||. ||.+|| +++|+++||||+...+
T Consensus 236 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---s~~e~l~hp~~~~~~~ 300 (494)
T 3lij_A 236 PFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRI---SAQQALEHPWIKEMCS 300 (494)
T ss_dssp SSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSC---CHHHHHTCHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCc---cHHHHhcCcccccCcc
Confidence 999999999999998865555555556899999999999999 999999 7899999999987543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-51 Score=438.38 Aligned_cols=261 Identities=35% Similarity=0.610 Sum_probs=227.8
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcch----------hhHHHHHHHHHHHHhcCCCCeeeEeEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR----------GQVEHVRSERNLLAEVDSRCIVQLFYS 174 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~----------~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 174 (510)
.++|.+++.||+|+||+||+|+++.+++.||+|++.+...... ...+.+.+|+.+|+.++|||||+++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 4689999999999999999999999999999999987643321 345678999999999999999999999
Q ss_pred eecCceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCC---ceeecccC
Q 010463 175 FQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG---HLKLSDFG 251 (510)
Q Consensus 175 ~~~~~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g---~vkL~DFG 251 (510)
|.+...+|+|||||+||+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+| .+||+|||
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 194 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG 194 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCT
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECC
Confidence 999999999999999999999999989999999999999999999999999999999999999999876 69999999
Q ss_pred CcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchh
Q 010463 252 LCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLG 331 (510)
Q Consensus 252 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlG 331 (510)
+|+...... .....+||+.|+|||++. ..|+.++||||||
T Consensus 195 ~a~~~~~~~---------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG 234 (504)
T 3q5i_A 195 LSSFFSKDY---------------------------------------KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCG 234 (504)
T ss_dssp TCEECCTTS---------------------------------------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHH
T ss_pred CCEEcCCCC---------------------------------------ccccccCCcCCCCHHHhc-cCCCchHHHHHHH
Confidence 998664321 012468999999999986 5699999999999
Q ss_pred hHHHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCC
Q 010463 332 AIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 408 (510)
Q Consensus 332 vilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~ 408 (510)
|++|+|++|.+||.+.+.......|......+..+.+..+|+++++||++||. ||.+|| +++|+++||||+...
T Consensus 235 ~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 235 VIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRC---TAEEALNSRWIKKYA 309 (504)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSC---CHHHHHTSHHHHHTC
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCC---CHHHHhcCHhhhhch
Confidence 99999999999999999999999988755444444446899999999999999 999999 789999999998643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-51 Score=426.25 Aligned_cols=253 Identities=33% Similarity=0.518 Sum_probs=211.2
Q ss_pred CCCCceee-eeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHH-HhcCCCCeeeEeEEeec----
Q 010463 104 GIDDFEQL-TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLL-AEVDSRCIVQLFYSFQD---- 177 (510)
Q Consensus 104 ~~~~f~~~-~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL-~~l~hp~Iv~l~~~~~~---- 177 (510)
..++|.++ +.||+|+||+||+|+++.+|+.||||++.+. ..+.+|+.++ ...+||||++++++|.+
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~ 130 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG 130 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence 35688887 7899999999999999999999999999643 2366788887 45589999999999875
Q ss_pred CceEEEEEeccCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecC---CCceeecccCC
Q 010463 178 SDFLYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK---NGHLKLSDFGL 252 (510)
Q Consensus 178 ~~~~~lVmEy~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~---~g~vkL~DFGl 252 (510)
...+|+|||||+||+|.+++...+ .+++..++.++.||+.||.|||+.|||||||||+||||+. +|.+||+|||+
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 678999999999999999998753 5999999999999999999999999999999999999997 78999999999
Q ss_pred cccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhh
Q 010463 253 CKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGA 332 (510)
Q Consensus 253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGv 332 (510)
++...... ...+.+||+.|+|||++.+..|+.++|||||||
T Consensus 211 a~~~~~~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 251 (400)
T 1nxk_A 211 AKETTSHN---------------------------------------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 251 (400)
T ss_dssp CEECC--------------------------------------------------CTTCCGGGSCCCCSSSHHHHHHHHH
T ss_pred ccccCCCC---------------------------------------ccccCCCCCCccCHhhcCCCCCCCcccHHHHHH
Confidence 98654220 012468999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCChhh----hHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 333 IMYEMLIGYPPFCSDDPRI----TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 333 ilyEml~G~~PF~~~~~~~----~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
++|||++|.+||.+.+... ...++......+..+.+..+|+++++||++||. ||.+|| +++||++||||..
T Consensus 252 il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---t~~eil~hp~~~~ 327 (400)
T 1nxk_A 252 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM---TITEFMNHPWIMQ 327 (400)
T ss_dssp HHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSHHHHT
T ss_pred HHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCc---CHHHHhcCccccC
Confidence 9999999999998765432 445555544334444456799999999999998 999999 7899999999975
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=401.01 Aligned_cols=268 Identities=30% Similarity=0.514 Sum_probs=231.6
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhh------cchhhHHHHHHHHHHHHhcC-CCCeeeEeEEee
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEM------LKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQ 176 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~------~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~ 176 (510)
-.++|++++.||+|+||.||+|+++.+|+.||||++..... ......+.+.+|+.+|..+. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 45899999999999999999999999999999999975431 11233567889999999995 999999999999
Q ss_pred cCceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccC
Q 010463 177 DSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 256 (510)
Q Consensus 177 ~~~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~ 256 (510)
+.+..|+||||++||+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++...
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 174 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence 99999999999999999999998889999999999999999999999999999999999999999999999999999865
Q ss_pred ccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc------cCCCCccccccch
Q 010463 257 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL------KKGYGMECDWWSL 330 (510)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~------~~~y~~~~DiwSl 330 (510)
.... .....+||+.|+|||++. ...++.++|+|||
T Consensus 175 ~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~sl 215 (298)
T 1phk_A 175 DPGE---------------------------------------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 215 (298)
T ss_dssp CTTC---------------------------------------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHH
T ss_pred CCCc---------------------------------------ccccccCCccccCHHHhccccccccccCCcccccHhH
Confidence 4321 012457999999999996 4568999999999
Q ss_pred hhHHHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCc
Q 010463 331 GAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQW 409 (510)
Q Consensus 331 GvilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~ 409 (510)
||++|||++|..||.+.+.......+.........|....+++.+.+||.+||. ||.+|| +++|+++||||++..|
T Consensus 216 G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~h~~~~~~~~ 292 (298)
T 1phk_A 216 GVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY---TAEEALAHPFFQQYVV 292 (298)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSC---CHHHHTTSGGGCTTC-
T ss_pred HHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCC---CHHHHHhChHhhhccc
Confidence 999999999999999988888888887754444444445789999999999998 999999 7899999999999988
Q ss_pred hhhh
Q 010463 410 DKLY 413 (510)
Q Consensus 410 ~~l~ 413 (510)
+.++
T Consensus 293 ~~~~ 296 (298)
T 1phk_A 293 EEVR 296 (298)
T ss_dssp ----
T ss_pred hhhc
Confidence 7764
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=411.57 Aligned_cols=266 Identities=28% Similarity=0.474 Sum_probs=229.4
Q ss_pred CCceee-eeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCceEEE
Q 010463 106 DDFEQL-TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 106 ~~f~~~-~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~~l 183 (510)
+.|.+. +.||+|+||.||+|+++.+|+.||+|++.+... .......+.+|+.++..+ +||||++++++|.+.+.+|+
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 346666 899999999999999999999999999986543 233456788999999998 56999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecC---CCceeecccCCcccCcc
Q 010463 184 IMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK---NGHLKLSDFGLCKPLED 258 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~---~g~vkL~DFGla~~~~~ 258 (510)
||||++||+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++. +|.+||+|||+++....
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 99999999999998653 67999999999999999999999999999999999999997 89999999999986543
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHh
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml 338 (510)
... ....+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 187 ~~~---------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 227 (327)
T 3lm5_A 187 ACE---------------------------------------LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLL 227 (327)
T ss_dssp ----------------------------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred ccc---------------------------------------cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHH
Confidence 210 12357999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchhhhc
Q 010463 339 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYE 414 (510)
Q Consensus 339 ~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l~~ 414 (510)
+|.+||.+.+.......+.........+....+++.+.+||.+||. ||.+|| +++++++||||++++|+.+..
T Consensus 228 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~~ll~h~~~~~~~~~~~~~ 301 (327)
T 3lm5_A 228 THTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRP---TAEICLSHSWLQQWDFENLFH 301 (327)
T ss_dssp HSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSC---CHHHHTTCGGGCCCCTTCC--
T ss_pred hCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCc---CHHHHhCCHhhcccccccccC
Confidence 9999999999888888887654444444445799999999999998 999999 789999999999999987753
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=436.12 Aligned_cols=256 Identities=27% Similarity=0.433 Sum_probs=212.4
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC------
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS------ 178 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~------ 178 (510)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+.+|+.++|||||+++++|.+.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 478999999999999999999999999999999998653 3445567889999999999999999999999765
Q ss_pred ceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 179 DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
..+|+||||++| +|...+.. .+++..++.++.||+.||+|||+.||+||||||+||||+.+|++||+|||+|+....
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred CeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 467999999976 46666643 489999999999999999999999999999999999999999999999999986543
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHh
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml 338 (510)
.. .....+||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 217 ~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 257 (464)
T 3ttj_A 217 SF---------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257 (464)
T ss_dssp CC---------------------------------------CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred Cc---------------------------------------ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHH
Confidence 21 112468999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhhHHHHhhccccc-----------------cCCCCC---------------------CCCHHHHHHHH
Q 010463 339 IGYPPFCSDDPRITCRKIVNWKTCL-----------------KFPEEP---------------------KISDEARDLIC 380 (510)
Q Consensus 339 ~G~~PF~~~~~~~~~~~I~~~~~~~-----------------~~p~~~---------------------~~s~~~~dlI~ 380 (510)
+|++||.+.+....+.+|+..-... ..|... ..+++++|||.
T Consensus 258 ~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~ 337 (464)
T 3ttj_A 258 RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS 337 (464)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHH
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHH
Confidence 9999999999888887776521110 000000 01578999999
Q ss_pred Hhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 381 HLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 381 ~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
+||. ||.+|| +++|+++||||+.
T Consensus 338 ~mL~~dP~~R~---ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 338 KMLVIDPAKRI---SVDDALQHPYINV 361 (464)
T ss_dssp HHSCSSTTTSC---CHHHHHTSTTTGG
T ss_pred HHcCCChhhCC---CHHHHhcChhhhh
Confidence 9999 999999 7999999999984
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=424.87 Aligned_cols=289 Identities=27% Similarity=0.425 Sum_probs=218.7
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC-----c
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS-----D 179 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----~ 179 (510)
.++|++++.||+|+||.||+|+++.+|+.||||++.+.. ......+.+.+|+.+|+.++||||+++++++.+. .
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 478999999999999999999999999999999997542 3445567899999999999999999999999876 5
Q ss_pred eEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 180 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
.+|+||||+. |+|.+++.....+++..++.++.||+.||.|||+.||+||||||+||||+.+|++||+|||+|+.....
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred eEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence 7999999986 599999988888999999999999999999999999999999999999999999999999999976543
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhh-ccCCCCccccccchhhHHHHHh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL-LKKGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl-~~~~y~~~~DiwSlGvilyEml 338 (510)
......... ....... ......+....+.+||+.|+|||++ ....|+.++|||||||++|||+
T Consensus 183 ~~~~~~~~~--------~~~~~~~--------~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell 246 (432)
T 3n9x_A 183 KDTNIVNDL--------EENEEPG--------PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246 (432)
T ss_dssp --------------------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred ccccccccc--------ccccccc--------ccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHH
Confidence 211100000 0000000 0000011123467999999999997 4567999999999999999999
Q ss_pred h-----------CCCCCCCCCh-----------------hhhHHHHhhccc----------------------cccCCC-
Q 010463 339 I-----------GYPPFCSDDP-----------------RITCRKIVNWKT----------------------CLKFPE- 367 (510)
Q Consensus 339 ~-----------G~~PF~~~~~-----------------~~~~~~I~~~~~----------------------~~~~p~- 367 (510)
+ |.++|.+.+. ......|.+.-+ ....+.
T Consensus 247 ~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (432)
T 3n9x_A 247 NMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPIN 326 (432)
T ss_dssp TTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCC
T ss_pred hcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCC
Confidence 8 5556655431 112222221000 000010
Q ss_pred ----CCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchhhhc
Q 010463 368 ----EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYE 414 (510)
Q Consensus 368 ----~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l~~ 414 (510)
.+.+|+++.+||.+||. ||.+|| +++|+++||||++++|.....
T Consensus 327 ~~~~~~~~s~~~~dLl~~mL~~dP~~R~---ta~e~L~Hp~f~~~~~~~~e~ 375 (432)
T 3n9x_A 327 LKQKYPSISDDGINLLESMLKFNPNKRI---TIDQALDHPYLKDVRKKKLEN 375 (432)
T ss_dssp HHHHSTTSCHHHHHHHHHHSCSSTTTSC---CHHHHHTCGGGTTTCCTTTC-
T ss_pred HHHHCCCCCHHHHHHHHHHhcCCcccCC---CHHHHhcChhhhhccCcccCc
Confidence 14689999999999999 999999 799999999999999987653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-51 Score=422.76 Aligned_cols=257 Identities=29% Similarity=0.517 Sum_probs=220.9
Q ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEeccCC
Q 010463 111 LTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPG 190 (510)
Q Consensus 111 ~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy~~g 190 (510)
.+.||+|+||.||+|+++.+|+.||+|++..... ...+.+.+|+.+|..++|||||+++++|.+.+.+|+||||++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 6789999999999999999999999999986532 3456789999999999999999999999999999999999999
Q ss_pred CCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeee--cCCCceeecccCCcccCccccccccchh
Q 010463 191 GDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL--DKNGHLKLSDFGLCKPLEDKYSSILLED 267 (510)
Q Consensus 191 G~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILl--d~~g~vkL~DFGla~~~~~~~~~~~~~~ 267 (510)
|+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++.+....
T Consensus 171 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~------- 243 (373)
T 2x4f_A 171 GELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE------- 243 (373)
T ss_dssp CEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-------
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-------
Confidence 9999988654 469999999999999999999999999999999999999 577899999999998764321
Q ss_pred hhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCCC
Q 010463 268 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSD 347 (510)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~~ 347 (510)
.....+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.
T Consensus 244 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 291 (373)
T 2x4f_A 244 --------------------------------KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD 291 (373)
T ss_dssp --------------------------------BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred --------------------------------ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 012357999999999999999999999999999999999999999999
Q ss_pred ChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchhh
Q 010463 348 DPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKL 412 (510)
Q Consensus 348 ~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l 412 (510)
+......+|......+..+....+++++++||.+||. ||.+|| +++|+++||||.+..|...
T Consensus 292 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp---s~~e~l~hp~~~~~~~~~~ 354 (373)
T 2x4f_A 292 NDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRI---SASEALKHPWLSDHKLHSR 354 (373)
T ss_dssp SHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSHHHHCHHHHHH
T ss_pred CHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCC---CHHHHhcCcCcCCCchhhh
Confidence 9888888888754333322335789999999999999 999999 7899999999998776543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-51 Score=416.62 Aligned_cols=267 Identities=29% Similarity=0.515 Sum_probs=227.3
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhc--chhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML--KRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l 183 (510)
++|++++.||+|+||.||+|+++.+++.||+|++.+.... .....+.+.+|+.+|+.++|||||+++++|.+.+.+|+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 4699999999999999999999999999999999876432 34556789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHh----------------------------------------ccCCCHHHHHHHHHHHHHHHHhhh
Q 010463 184 IMEYLPGGDIMTLLMR----------------------------------------EDILSEDVARFYIAESVLAIHSIH 223 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~----------------------------------------~~~l~e~~~~~~~~qi~~aL~~lH 223 (510)
||||++||+|.+++.. ...+++..++.++.||+.||.|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999852 112468888999999999999999
Q ss_pred hCCeEEeecCCCCeeecCCC--ceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhccccc
Q 010463 224 QHNYVHRDIKPDNLILDKNG--HLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALA 301 (510)
Q Consensus 224 ~~giiHRDLKP~NILld~~g--~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (510)
+.||+||||||+|||++.++ .+||+|||+++.+....... ....
T Consensus 186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~----------------------------------~~~~ 231 (345)
T 3hko_A 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE----------------------------------YYGM 231 (345)
T ss_dssp HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC---------------------------------------
T ss_pred HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccc----------------------------------cccc
Confidence 99999999999999998777 89999999998653321000 0001
Q ss_pred ccccccCCCcchHhhcc--CCCCccccccchhhHHHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHH
Q 010463 302 YSTVGTLDYMAPEVLLK--KGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLI 379 (510)
Q Consensus 302 ~s~~GT~~Y~APEvl~~--~~y~~~~DiwSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI 379 (510)
.+.+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+.......+......+..|....+++++++||
T Consensus 232 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 311 (345)
T 3hko_A 232 TTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLL 311 (345)
T ss_dssp ---CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHH
T ss_pred cccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHH
Confidence 24679999999999975 6789999999999999999999999999999888888887655555554456899999999
Q ss_pred HHhhc-CccccCCCCChHHhhcCCCcCCCCc
Q 010463 380 CHLLC-DVETRLGTRGVEELKEHPWFRGIQW 409 (510)
Q Consensus 380 ~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~ 409 (510)
.+||. ||.+|| ++.++++||||+++.|
T Consensus 312 ~~~l~~~p~~Rp---s~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 312 SNLLNRNVDERF---DAMRALQHPWISQFSD 339 (345)
T ss_dssp HHHSCSCTTTSC---CHHHHHHSHHHHTTSS
T ss_pred HHHcCCChhHCC---CHHHHhcChhhccChH
Confidence 99998 999999 7899999999998765
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=403.76 Aligned_cols=266 Identities=29% Similarity=0.440 Sum_probs=220.5
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
.++|++++.||+|+||+||+|+++.+|+.||+|++.... ......+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 468999999999999999999999999999999986653 2333456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 185 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
|||++|++|..++...+.+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++........
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 157 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD--- 157 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc---
Confidence 99999999999998888899999999999999999999999999999999999999999999999999986543210
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHhhCCCC
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYPP 343 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml~G~~P 343 (510)
.....+||+.|+|||++.+ ..++.++|+|||||++|+|++|.+|
T Consensus 158 -----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p 202 (311)
T 4agu_A 158 -----------------------------------YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPL 202 (311)
T ss_dssp -------------------------------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred -----------------------------------ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCC
Confidence 0123579999999999986 6789999999999999999999999
Q ss_pred CCCCChhhhHHHHhhccc-----------------cccCCC----------CCCCCHHHHHHHHHhhc-CccccCCCCCh
Q 010463 344 FCSDDPRITCRKIVNWKT-----------------CLKFPE----------EPKISDEARDLICHLLC-DVETRLGTRGV 395 (510)
Q Consensus 344 F~~~~~~~~~~~I~~~~~-----------------~~~~p~----------~~~~s~~~~dlI~~lL~-dp~~R~~~~~~ 395 (510)
|.+.+.......+..... ....|. .+.+|+++.+||++||. ||.+|| ++
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~ 279 (311)
T 4agu_A 203 WPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERL---TC 279 (311)
T ss_dssp CCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSC---CH
T ss_pred CCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcC---CH
Confidence 999887766655543110 011111 14689999999999999 999999 78
Q ss_pred HHhhcCCCcCCCCchhh
Q 010463 396 EELKEHPWFRGIQWDKL 412 (510)
Q Consensus 396 ~eil~HpfF~~i~~~~l 412 (510)
+|+++||||+++.|...
T Consensus 280 ~ell~hp~f~~~~~~~~ 296 (311)
T 4agu_A 280 EQLLHHPYFENIREIED 296 (311)
T ss_dssp HHHHTSGGGTTCC----
T ss_pred HHHhcChHHHhccCHHH
Confidence 99999999999876543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=404.85 Aligned_cols=262 Identities=26% Similarity=0.426 Sum_probs=215.4
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhc--chhhHHHHHHHHHHHHhc---CCCCeeeEeEEeec
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML--KRGQVEHVRSERNLLAEV---DSRCIVQLFYSFQD 177 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~--~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~~~~ 177 (510)
+..++|++++.||+|+||+||+|+++.+|+.||||++...... .......+.+|+.+++.+ +||||++++++|.+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3457999999999999999999999999999999999754321 111123466777777665 59999999999987
Q ss_pred Cc-----eEEEEEeccCCCCHHHHHHhccC--CCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeeccc
Q 010463 178 SD-----FLYLIMEYLPGGDIMTLLMREDI--LSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDF 250 (510)
Q Consensus 178 ~~-----~~~lVmEy~~gG~L~~~L~~~~~--l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DF 250 (510)
.. .+++||||+. |+|.+++..... +++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 65 5899999997 599999987654 999999999999999999999999999999999999999999999999
Q ss_pred CCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccch
Q 010463 251 GLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSL 330 (510)
Q Consensus 251 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSl 330 (510)
|+|+...... .....+||+.|+|||++.+..|+.++|||||
T Consensus 165 g~a~~~~~~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 205 (308)
T 3g33_A 165 GLARIYSYQM---------------------------------------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSV 205 (308)
T ss_dssp SCTTTSTTCC---------------------------------------CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHH
T ss_pred ccccccCCCc---------------------------------------ccCCccccccccCchHHcCCCCCchHHHHHH
Confidence 9998654321 0124689999999999999999999999999
Q ss_pred hhHHHHHhhCCCCCCCCChhhhHHHHhhcccccc--------------CCC---------CCCCCHHHHHHHHHhhc-Cc
Q 010463 331 GAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLK--------------FPE---------EPKISDEARDLICHLLC-DV 386 (510)
Q Consensus 331 GvilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~--------------~p~---------~~~~s~~~~dlI~~lL~-dp 386 (510)
||++|||++|.+||.+.+......++........ ++. .+.+++++.+||.+||. ||
T Consensus 206 G~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 285 (308)
T 3g33_A 206 GCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNP 285 (308)
T ss_dssp HHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSST
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCC
Confidence 9999999999999999998888877764211110 000 13688999999999999 99
Q ss_pred cccCCCCChHHhhcCCCcCCC
Q 010463 387 ETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 387 ~~R~~~~~~~eil~HpfF~~i 407 (510)
.+|| ++.|+++||||+..
T Consensus 286 ~~R~---t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 286 HKRI---SAFRALQHSYLHKD 303 (308)
T ss_dssp TTSC---CHHHHHTSTTC---
T ss_pred ccCC---CHHHHhcCccccCC
Confidence 9999 78999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-51 Score=412.79 Aligned_cols=253 Identities=32% Similarity=0.528 Sum_probs=198.1
Q ss_pred Cceee---eeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEeEEeecCceEE
Q 010463 107 DFEQL---TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 107 ~f~~~---~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~~~ 182 (510)
+|++. +.||+|+||.||+|+++.+|+.||||++.+. ....+.+|+.+|..+. ||||++++++|.+....|
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~ 82 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTF 82 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEE
Confidence 35554 7899999999999999999999999999754 2355778999999997 999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCC---ceeecccCCcccCccc
Q 010463 183 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG---HLKLSDFGLCKPLEDK 259 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g---~vkL~DFGla~~~~~~ 259 (510)
+||||++||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||+++.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 83 LVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp EEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred EEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 9999999999999999999999999999999999999999999999999999999998766 8999999999865432
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~ 339 (510)
.. ...+.+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 163 ~~--------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~ 204 (325)
T 3kn6_A 163 NQ--------------------------------------PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLS 204 (325)
T ss_dssp -----------------------------------------------------------CCCCHHHHHHHHHHHHHHHHH
T ss_pred CC--------------------------------------cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHh
Confidence 10 0124679999999999999999999999999999999999
Q ss_pred CCCCCCCCCh-------hhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 340 GYPPFCSDDP-------RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 340 G~~PF~~~~~-------~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
|.+||.+.+. .+...++......+..+.+..+|+++++||.+||. ||.+|| +++|+++||||++
T Consensus 205 g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---t~~ell~h~w~~~ 276 (325)
T 3kn6_A 205 GQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRL---KMSGLRYNEWLQD 276 (325)
T ss_dssp SSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCC---CTTTSTTCGGGCT
T ss_pred CCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCC---CHHHHhcChhhcc
Confidence 9999987543 34555555533222222224689999999999998 999999 6889999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-51 Score=411.49 Aligned_cols=261 Identities=26% Similarity=0.477 Sum_probs=214.4
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
+++|.+++.||+|+||+||+|+++.+|+.||+|++..... ......+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 3689999999999999999999999999999999975431 11112345799999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccc
Q 010463 185 MEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 263 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 263 (510)
|||++ |+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++.......
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-- 155 (324)
T 3mtl_A 79 FEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-- 155 (324)
T ss_dssp EECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred ecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc--
Confidence 99997 4898888765 4599999999999999999999999999999999999999999999999999986532210
Q ss_pred cchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHhhCCC
Q 010463 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYP 342 (510)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml~G~~ 342 (510)
.....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+
T Consensus 156 ------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 199 (324)
T 3mtl_A 156 ------------------------------------TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRP 199 (324)
T ss_dssp -------------------------------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ------------------------------------ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 0123579999999999986 678999999999999999999999
Q ss_pred CCCCCChhhhHHHHhhcccccc-----------------CC---------CCCCCCHHHHHHHHHhhc-CccccCCCCCh
Q 010463 343 PFCSDDPRITCRKIVNWKTCLK-----------------FP---------EEPKISDEARDLICHLLC-DVETRLGTRGV 395 (510)
Q Consensus 343 PF~~~~~~~~~~~I~~~~~~~~-----------------~p---------~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~ 395 (510)
||.+.+..+....+........ +| ..+.+++++.+||.+||. ||.+|| ++
T Consensus 200 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---t~ 276 (324)
T 3mtl_A 200 LFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRI---SA 276 (324)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSC---CH
T ss_pred CCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCC---CH
Confidence 9999988877776654211110 11 013578999999999999 999999 79
Q ss_pred HHhhcCCCcCCCCc
Q 010463 396 EELKEHPWFRGIQW 409 (510)
Q Consensus 396 ~eil~HpfF~~i~~ 409 (510)
+|+++||||.++..
T Consensus 277 ~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 277 EDAMKHPFFLSLGE 290 (324)
T ss_dssp HHHTTSGGGGGGCS
T ss_pred HHHhcChhhhhccc
Confidence 99999999998653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=397.98 Aligned_cols=259 Identities=33% Similarity=0.596 Sum_probs=203.9
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEE
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l 183 (510)
..++|++.+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.++..++||||+++++++.+.+..|+
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 45789999999999999999999999999999999987655445556789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccc
Q 010463 184 IMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 262 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 262 (510)
||||+++|+|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||++.+|++||+|||++........
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 167 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE- 167 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC-
Confidence 99999999999999875 6799999999999999999999999999999999999999999999999999986543210
Q ss_pred ccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCC
Q 010463 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 342 (510)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~ 342 (510)
.....+||+.|+|||++.+..++.++|+|||||++|||++|.+
T Consensus 168 -------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 210 (278)
T 3cok_A 168 -------------------------------------KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRP 210 (278)
T ss_dssp -------------------------------------------------------------CTHHHHHHHHHHHHHHSSC
T ss_pred -------------------------------------cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 0123579999999999999999999999999999999999999
Q ss_pred CCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 343 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 343 PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
||...+......++... ....| ..++.++.+||.+||. ||.+|| +++++++||||...
T Consensus 211 p~~~~~~~~~~~~~~~~--~~~~~--~~~~~~~~~li~~~l~~dp~~Rp---s~~~~l~h~~~~~~ 269 (278)
T 3cok_A 211 PFDTDTVKNTLNKVVLA--DYEMP--SFLSIEAKDLIHQLLRRNPADRL---SLSSVLDHPFMSRN 269 (278)
T ss_dssp SSCCCSCC-----CCSS--CCCCC--TTSCHHHHHHHHHHSCSSGGGSC---CHHHHTTSTTTC--
T ss_pred CCCChhHHHHHHHHhhc--ccCCc--cccCHHHHHHHHHHcccCHhhCC---CHHHHhcCccccCC
Confidence 99887766666655542 23334 4789999999999998 999999 78999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=415.29 Aligned_cols=259 Identities=29% Similarity=0.450 Sum_probs=216.2
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc-----
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD----- 179 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~----- 179 (510)
.++|++++.||+|+||.||+|.++.+|+.||||++.+.. ......+.+.+|+.+|+.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 468999999999999999999999999999999996542 23445677899999999999999999999998763
Q ss_pred -eEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 180 -FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 180 -~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
.+|+||||+ |++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||+++....
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 469999999 8899999876 6799999999999999999999999999999999999999999999999999986532
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHH
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEM 337 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEm 337 (510)
. ....+||+.|+|||++.+ ..|+.++|||||||++|||
T Consensus 181 ~-----------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 219 (367)
T 1cm8_A 181 E-----------------------------------------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEM 219 (367)
T ss_dssp S-----------------------------------------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHH
T ss_pred c-----------------------------------------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHH
Confidence 1 124689999999999987 7899999999999999999
Q ss_pred hhCCCCCCCCChhhhHHHHhhccccc------------------cCC---------CCCCCCHHHHHHHHHhhc-Ccccc
Q 010463 338 LIGYPPFCSDDPRITCRKIVNWKTCL------------------KFP---------EEPKISDEARDLICHLLC-DVETR 389 (510)
Q Consensus 338 l~G~~PF~~~~~~~~~~~I~~~~~~~------------------~~p---------~~~~~s~~~~dlI~~lL~-dp~~R 389 (510)
++|.+||.+.+....+..|....... .+| ..+.+++++.+||.+||+ ||.+|
T Consensus 220 l~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R 299 (367)
T 1cm8_A 220 ITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQR 299 (367)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTS
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHC
Confidence 99999999988877777765421110 000 013679999999999999 99999
Q ss_pred CCCCChHHhhcCCCcCCCCch
Q 010463 390 LGTRGVEELKEHPWFRGIQWD 410 (510)
Q Consensus 390 ~~~~~~~eil~HpfF~~i~~~ 410 (510)
+ +++|+++||||+.+.+.
T Consensus 300 ~---t~~e~l~hp~f~~~~~~ 317 (367)
T 1cm8_A 300 V---TAGEALAHPYFESLHDT 317 (367)
T ss_dssp C---CHHHHHHSGGGTTTC--
T ss_pred C---CHHHHhcChHHHhhcCC
Confidence 9 78999999999987643
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=408.07 Aligned_cols=267 Identities=29% Similarity=0.532 Sum_probs=214.4
Q ss_pred CCceee-eeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCceEEE
Q 010463 106 DDFEQL-TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 106 ~~f~~~-~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~~l 183 (510)
+.|++. +.||+|+||.||+|+++.+|+.||||++.+.. ......+.+|+.+|..+ +||||+++++++.+.+.+|+
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 578885 78999999999999999999999999997652 33456788999999884 79999999999999999999
Q ss_pred EEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCc---eeecccCCcccCcccc
Q 010463 184 IMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH---LKLSDFGLCKPLEDKY 260 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~---vkL~DFGla~~~~~~~ 260 (510)
||||++||+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++. +||+|||++.......
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 168 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168 (316)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred EEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence 9999999999999999889999999999999999999999999999999999999998876 9999999998654221
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-----CCCCccccccchhhHHH
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-----KGYGMECDWWSLGAIMY 335 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-----~~y~~~~DiwSlGvily 335 (510)
..... ........+||+.|+|||++.+ ..++.++|||||||++|
T Consensus 169 ~~~~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~ 217 (316)
T 2ac3_A 169 DCSPI-------------------------------STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY 217 (316)
T ss_dssp --------------------------------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHH
T ss_pred ccccc-------------------------------cccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHH
Confidence 00000 0001124579999999999975 56899999999999999
Q ss_pred HHhhCCCCCCCCCh---------------hhhHHHHhhccccccCCC--CCCCCHHHHHHHHHhhc-CccccCCCCChHH
Q 010463 336 EMLIGYPPFCSDDP---------------RITCRKIVNWKTCLKFPE--EPKISDEARDLICHLLC-DVETRLGTRGVEE 397 (510)
Q Consensus 336 Eml~G~~PF~~~~~---------------~~~~~~I~~~~~~~~~p~--~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~e 397 (510)
||++|.+||.+.+. ......+... ...+|. ...+++++++||++||. ||.+|| +++|
T Consensus 218 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~e 292 (316)
T 2ac3_A 218 ILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEG--KYEFPDKDWAHISCAAKDLISKLLVRDAKQRL---SAAQ 292 (316)
T ss_dssp HHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHC--CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSC---CHHH
T ss_pred HHHHCCCCCcccccccccccccccchhHHHHHHHHHhcc--CcccCchhcccCCHHHHHHHHHHhhCChhhCC---CHHH
Confidence 99999999987643 2344555543 233332 24689999999999998 999999 7899
Q ss_pred hhcCCCcCCCCchh
Q 010463 398 LKEHPWFRGIQWDK 411 (510)
Q Consensus 398 il~HpfF~~i~~~~ 411 (510)
+++||||++..|..
T Consensus 293 ~l~hp~~~~~~~~~ 306 (316)
T 2ac3_A 293 VLQHPWVQGCAPEN 306 (316)
T ss_dssp HHHSTTCC------
T ss_pred HhcChhhcCCCCcc
Confidence 99999999877653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=396.52 Aligned_cols=253 Identities=32% Similarity=0.562 Sum_probs=225.4
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++|++.+.||+|+||.||+|+++.++..||+|++.+.. ....+.+.+|+.+|+.++||||++++++|.+.+..|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF---VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG---CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc---cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 46999999999999999999999999999999998653 234567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeee---cCCCceeecccCCcccCcccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL---DKNGHLKLSDFGLCKPLEDKYSS 262 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILl---d~~g~vkL~DFGla~~~~~~~~~ 262 (510)
||++||+|.+++.....+++..++.++.|++.||.|||+.||+||||||+|||+ +.++.+||+|||++.......
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~-- 163 (277)
T 3f3z_A 86 ELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-- 163 (277)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS--
T ss_pred eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc--
Confidence 999999999999998999999999999999999999999999999999999999 888999999999998654321
Q ss_pred ccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCC
Q 010463 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 342 (510)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~ 342 (510)
.....+||+.|+|||++.+. ++.++|+|||||++|||++|.+
T Consensus 164 -------------------------------------~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~ 205 (277)
T 3f3z_A 164 -------------------------------------MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYP 205 (277)
T ss_dssp -------------------------------------CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSC
T ss_pred -------------------------------------chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCC
Confidence 01245799999999998654 9999999999999999999999
Q ss_pred CCCCCChhhhHHHHhhccccccCCC--CCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 343 PFCSDDPRITCRKIVNWKTCLKFPE--EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 343 PF~~~~~~~~~~~I~~~~~~~~~p~--~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
||.+.+......++.... ..+|. ...+++++.+||.+||. ||.+|| ++.++++||||+.
T Consensus 206 p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~---s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 206 PFSAPTDSEVMLKIREGT--FTFPEKDWLNVSPQAESLIRRLLTKSPKQRI---TSLQALEHEWFEK 267 (277)
T ss_dssp SSCCSSHHHHHHHHHHCC--CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSC---CHHHHTTSHHHHH
T ss_pred CCCCCCHHHHHHHHHhCC--CCCCchhhhcCCHHHHHHHHHHccCChhhCc---CHHHHhcCHHHhc
Confidence 999998888888887643 33332 23789999999999998 999999 7899999999975
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=396.33 Aligned_cols=260 Identities=32% Similarity=0.493 Sum_probs=233.2
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEE
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l 183 (510)
..++|.+.+.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 45689999999999999999999999999999999988766566677889999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccc
Q 010463 184 IMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 263 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 263 (510)
||||++||+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++........
T Consensus 93 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-- 170 (294)
T 2rku_A 93 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-- 170 (294)
T ss_dssp EEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc--
Confidence 999999999999998888999999999999999999999999999999999999999999999999999986542210
Q ss_pred cchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCC
Q 010463 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 343 (510)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~P 343 (510)
.....+||+.|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus 171 ------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p 214 (294)
T 2rku_A 171 ------------------------------------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214 (294)
T ss_dssp ------------------------------------CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred ------------------------------------ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 01235799999999999999999999999999999999999999
Q ss_pred CCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCC
Q 010463 344 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 408 (510)
Q Consensus 344 F~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~ 408 (510)
|.+.+..+.+..+... ...+| ..+++.+.+||.+||. ||.+|| +++|+++||||....
T Consensus 215 ~~~~~~~~~~~~~~~~--~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~~ll~~~~~~~~~ 273 (294)
T 2rku_A 215 FETSCLKETYLRIKKN--EYSIP--KHINPVAASLIQKMLQTDPTARP---TINELLNDEFFTSGY 273 (294)
T ss_dssp TCCSSHHHHHHHHHTT--CCCCC--TTSCHHHHHHHHHHTCSSGGGSC---CGGGGGGSHHHHTSC
T ss_pred CCCCCHHHHHHHHhhc--cCCCc--cccCHHHHHHHHHHcccChhhCc---CHHHHhhChheecCC
Confidence 9998888777777653 33444 3789999999999998 999999 789999999997643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-50 Score=401.32 Aligned_cols=256 Identities=34% Similarity=0.605 Sum_probs=226.3
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++|.+++.||+|+||.||+|+++.+|+.||+|++.+... .....+.+|+.+|..++||||+++++++.+.+.+|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 579999999999999999999999999999999986532 23356889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeee---cCCCceeecccCCcccCcccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL---DKNGHLKLSDFGLCKPLEDKYSS 262 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILl---d~~g~vkL~DFGla~~~~~~~~~ 262 (510)
||++||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++......
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~-- 163 (304)
T 2jam_A 86 QLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-- 163 (304)
T ss_dssp CCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT--
T ss_pred EcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc--
Confidence 999999999999988899999999999999999999999999999999999999 788999999999997543220
Q ss_pred ccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCC
Q 010463 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 342 (510)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~ 342 (510)
....+||+.|+|||++.+..++.++|+|||||++|||++|.+
T Consensus 164 --------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 205 (304)
T 2jam_A 164 --------------------------------------MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYP 205 (304)
T ss_dssp --------------------------------------THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSC
T ss_pred --------------------------------------cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCC
Confidence 113579999999999999999999999999999999999999
Q ss_pred CCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 343 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 343 PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
||.+.+.......+.........+....+++++.+||.+||. ||.+|| +++++++||||.+.
T Consensus 206 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~~l~h~~~~~~ 268 (304)
T 2jam_A 206 PFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERY---TCEKALSHPWIDGN 268 (304)
T ss_dssp TTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSC---CHHHHHTSHHHHSS
T ss_pred CCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCc---CHHHHhcCccccCC
Confidence 999988888888887754433334445789999999999998 999999 78999999999863
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-50 Score=412.78 Aligned_cols=258 Identities=33% Similarity=0.569 Sum_probs=226.1
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhc-----chhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCc
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML-----KRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSD 179 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~-----~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~ 179 (510)
++|++.+.||+|+||.||+|+++.+|+.||||++...... .....+.+.+|+.++..+ +||||+++++++.+.+
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 4699999999999999999999999999999999764311 112245688999999999 8999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 180 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
..|+||||++||+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++..+...
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~ 253 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG 253 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCC
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999999876432
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc------CCCCccccccchhhH
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK------KGYGMECDWWSLGAI 333 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~------~~y~~~~DiwSlGvi 333 (510)
. .....+||+.|+|||++.+ ..|+.++|||||||+
T Consensus 254 ~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~i 294 (365)
T 2y7j_A 254 E---------------------------------------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVI 294 (365)
T ss_dssp C---------------------------------------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHH
T ss_pred c---------------------------------------ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHH
Confidence 1 0124689999999999974 368999999999999
Q ss_pred HHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcC
Q 010463 334 MYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 405 (510)
Q Consensus 334 lyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~ 405 (510)
+|||++|.+||.+.+.......+.........|.+..+++.+.+||.+||. ||.+|| +++++++||||+
T Consensus 295 l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~ell~hp~f~ 364 (365)
T 2y7j_A 295 LFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARL---TAEQALQHPFFE 364 (365)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSC---CHHHHHHSGGGC
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCc---CHHHHhcCcccC
Confidence 999999999999988888888887654333333345789999999999998 999999 789999999996
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-50 Score=403.98 Aligned_cols=256 Identities=30% Similarity=0.509 Sum_probs=224.4
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEe
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 186 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmE 186 (510)
.|+..+.||+|+||.||+|+++.+|+.||||++.... ....+.+.+|+.+|+.++||||+++++++.+.+.+|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 3788889999999999999999999999999997643 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccch
Q 010463 187 YLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 266 (510)
Q Consensus 187 y~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~ 266 (510)
|++||+|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++..+.....
T Consensus 123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~----- 196 (321)
T 2c30_A 123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP----- 196 (321)
T ss_dssp CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-----
T ss_pred cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-----
Confidence 9999999998865 5699999999999999999999999999999999999999999999999999986643211
Q ss_pred hhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCC
Q 010463 267 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCS 346 (510)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~ 346 (510)
.....+||+.|+|||++.+..++.++|||||||++|||++|.+||.+
T Consensus 197 ---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~ 243 (321)
T 2c30_A 197 ---------------------------------KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS 243 (321)
T ss_dssp ---------------------------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ---------------------------------ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 01246899999999999999999999999999999999999999999
Q ss_pred CChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCC
Q 010463 347 DDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 408 (510)
Q Consensus 347 ~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~ 408 (510)
.+.......+.... ...++....+++++.+||.+||. ||.+|| +++|+++||||....
T Consensus 244 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~ell~hp~~~~~~ 302 (321)
T 2c30_A 244 DSPVQAMKRLRDSP-PPKLKNSHKVSPVLRDFLERMLVRDPQERA---TAQELLDHPFLLQTG 302 (321)
T ss_dssp SCHHHHHHHHHHSS-CCCCTTGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHHTSGGGGGCC
T ss_pred CCHHHHHHHHhcCC-CCCcCccccCCHHHHHHHHHHccCChhhCc---CHHHHhcChhhccCC
Confidence 88887777776532 22233334789999999999998 999999 789999999998654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=412.18 Aligned_cols=259 Identities=30% Similarity=0.552 Sum_probs=220.9
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcch-----hhHHHHHHHHHHHHhcCCCCeeeEeEEeecCce
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR-----GQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 180 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~-----~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 180 (510)
++|++++.||+|+||.||+|+++.+|+.||||++.+...... .....+.+|+.+|+.++||||++++++|.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 579999999999999999999999999999999987643221 133457789999999999999999999999999
Q ss_pred EEEEEeccCCC-CHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 181 LYLIMEYLPGG-DIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 181 ~~lVmEy~~gG-~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
+|+||||+.+| +|..++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++.+...
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 183 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG 183 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCC
Confidence 99999999777 99999998889999999999999999999999999999999999999999999999999999866432
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCC-CccccccchhhHHHHHh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEML 338 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiwSlGvilyEml 338 (510)
. ...+.+||+.|+|||++.+..+ +.++|||||||++|||+
T Consensus 184 ~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~ 224 (335)
T 3dls_A 184 K---------------------------------------LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224 (335)
T ss_dssp C---------------------------------------CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHH
T ss_pred C---------------------------------------ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHH
Confidence 1 1124689999999999998887 88999999999999999
Q ss_pred hCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC------CCchh
Q 010463 339 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG------IQWDK 411 (510)
Q Consensus 339 ~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~------i~~~~ 411 (510)
+|..||..... +.. .....| ..+|+++.+||.+||. ||.+|| +++++++||||+. .+|+.
T Consensus 225 ~g~~pf~~~~~------~~~--~~~~~~--~~~~~~l~~li~~~L~~dP~~Rp---s~~ell~hp~~~~~~~~~~~~~~~ 291 (335)
T 3dls_A 225 FEENPFCELEE------TVE--AAIHPP--YLVSKELMSLVSGLLQPVPERRT---TLEKLVTDPWVTQPVNLADYTWEE 291 (335)
T ss_dssp HSSCSCSSGGG------GTT--TCCCCS--SCCCHHHHHHHHHHTCSSGGGSC---CHHHHHHCTTTTCCCCGGGCCHHH
T ss_pred hCCCchhhHHH------HHh--hccCCC--cccCHHHHHHHHHHccCChhhCc---CHHHHhcCccccCCccccccCHHH
Confidence 99999975321 121 112223 3689999999999998 999999 7899999999965 56666
Q ss_pred hhccc
Q 010463 412 LYEME 416 (510)
Q Consensus 412 l~~~~ 416 (510)
+....
T Consensus 292 ~~~~~ 296 (335)
T 3dls_A 292 VFRVN 296 (335)
T ss_dssp HC---
T ss_pred Hhhhc
Confidence 65543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=399.62 Aligned_cols=264 Identities=30% Similarity=0.520 Sum_probs=228.0
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcch---hhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR---GQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~---~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~ 182 (510)
++|++++.||+|+||.||+|+++.+|+.||+|++.+...... ...+.+.+|+.+|+.++||||+++++++.+.+..|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 469999999999999999999999999999999987543221 13577899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCC----ceeecccCCcccCcc
Q 010463 183 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG----HLKLSDFGLCKPLED 258 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g----~vkL~DFGla~~~~~ 258 (510)
+||||++||+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++.....
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~ 164 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence 9999999999999999888999999999999999999999999999999999999999887 899999999986543
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHh
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml 338 (510)
... ....+||+.|+|||++.+..++.++|+|||||++|+|+
T Consensus 165 ~~~---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 205 (283)
T 3bhy_A 165 GNE---------------------------------------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 205 (283)
T ss_dssp ----------------------------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred CCc---------------------------------------ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHH
Confidence 210 11357999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchh
Q 010463 339 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDK 411 (510)
Q Consensus 339 ~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~ 411 (510)
+|..||.+.+.......+.........+....+++.+.+||.+||. ||.+|| ++.++++||||+.+.|..
T Consensus 206 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~~l~h~~~~~~~~~~ 276 (283)
T 3bhy_A 206 SGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRM---TIAQSLEHSWIKAIRRRN 276 (283)
T ss_dssp HSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSC---CHHHHHHCHHHHHHHHCC
T ss_pred HCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCc---CHHHHHhCHHHHHHHHHh
Confidence 9999999988888777776533222111124789999999999998 999999 789999999999876543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=414.92 Aligned_cols=272 Identities=26% Similarity=0.421 Sum_probs=216.6
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc-----
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD----- 179 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~----- 179 (510)
.++|++++.||+|+||.||+|+++.+|+.||||++.+.. ........+.+|+.+|+.++||||++++++|.+.+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 478999999999999999999999999999999997643 23445677889999999999999999999998765
Q ss_pred -eEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 180 -FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 180 -~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
.+|+||||++| +|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred cceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 78999999975 7888875 4589999999999999999999999999999999999999999999999999986532
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHh
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml 338 (510)
.. .....+||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 180 ~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 220 (371)
T 2xrw_A 180 SF---------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 220 (371)
T ss_dssp -------------------------------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred cc---------------------------------------ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHH
Confidence 20 012468999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhhHHHHhhccccc----------------------------------cCCCC----CCCCHHHHHHHH
Q 010463 339 IGYPPFCSDDPRITCRKIVNWKTCL----------------------------------KFPEE----PKISDEARDLIC 380 (510)
Q Consensus 339 ~G~~PF~~~~~~~~~~~I~~~~~~~----------------------------------~~p~~----~~~s~~~~dlI~ 380 (510)
+|.+||.+.+....+.+++...... .+|.. ...++++++||+
T Consensus 221 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 300 (371)
T 2xrw_A 221 KGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLS 300 (371)
T ss_dssp HSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHH
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHH
Confidence 9999999988877777776421100 00100 012578999999
Q ss_pred Hhhc-CccccCCCCChHHhhcCCCcCCCCchhhhcccCCCccc
Q 010463 381 HLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPT 422 (510)
Q Consensus 381 ~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l~~~~~p~~p~ 422 (510)
+||+ ||.+|| +++|+++||||+...........+|..|.
T Consensus 301 ~mL~~dP~~R~---t~~e~l~hp~~~~~~~~~~~~~~~~~~~~ 340 (371)
T 2xrw_A 301 KMLVIDASKRI---SVDEALQHPYINVWYDPSEAEAPPPKIPD 340 (371)
T ss_dssp HHSCSSGGGSC---CHHHHHHSHHHHTTCCHHHHTCCCCCCCT
T ss_pred HHCcCChhhCC---CHHHHhCCcchhhhcCccccCCCCCCCCC
Confidence 9999 999999 78999999999864333333344555544
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=403.15 Aligned_cols=259 Identities=32% Similarity=0.497 Sum_probs=233.1
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEE
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l 183 (510)
..++|.+++.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 34689999999999999999999999999999999988766566677889999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccc
Q 010463 184 IMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 263 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 263 (510)
||||++|++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++.......
T Consensus 119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-- 196 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-- 196 (335)
T ss_dssp EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc--
Confidence 999999999999998888999999999999999999999999999999999999999999999999999986543210
Q ss_pred cchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCC
Q 010463 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 343 (510)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~P 343 (510)
.....+||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 197 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 240 (335)
T 2owb_A 197 ------------------------------------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240 (335)
T ss_dssp ------------------------------------CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred ------------------------------------cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCC
Confidence 01235799999999999999999999999999999999999999
Q ss_pred CCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 344 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 344 F~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
|.+.+..+.+..+... ...+| ..+++++.+||.+||. ||.+|| +++|+++||||...
T Consensus 241 f~~~~~~~~~~~~~~~--~~~~~--~~~~~~~~~li~~~l~~dp~~Rp---s~~ell~~~~~~~~ 298 (335)
T 2owb_A 241 FETSCLKETYLRIKKN--EYSIP--KHINPVAASLIQKMLQTDPTARP---TINELLNDEFFTSG 298 (335)
T ss_dssp TCCSSHHHHHHHHHHT--CCCCC--TTSCHHHHHHHHHHTCSSGGGSC---CGGGGGGSHHHHTS
T ss_pred CCCCCHHHHHHHHhcC--CCCCC--ccCCHHHHHHHHHHccCChhHCc---CHHHHhcCccccCC
Confidence 9998888777777653 33444 3789999999999998 999999 78999999999864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=395.91 Aligned_cols=255 Identities=28% Similarity=0.522 Sum_probs=218.0
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++|.+.+.||+|+||.||+|+++.+|..||+|++.+.. .....+.+.+|+.+|+.++||||+++++++.+...+|+||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc--cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 57999999999999999999999999999999998754 2334677899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeee---cCCCceeecccCCcccCcc
Q 010463 186 EYLPGGDIMTLLMRE----DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL---DKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~----~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILl---d~~g~vkL~DFGla~~~~~ 258 (510)
||++||+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++.....
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence 999999999998643 679999999999999999999999999999999999999 4568899999999986543
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHh
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml 338 (510)
... ....+||+.|+|||++. ..++.++|||||||++|||+
T Consensus 180 ~~~---------------------------------------~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll 219 (285)
T 3is5_A 180 DEH---------------------------------------STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLL 219 (285)
T ss_dssp ----------------------------------------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHH
T ss_pred ccc---------------------------------------CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHH
Confidence 210 12357999999999985 57899999999999999999
Q ss_pred hCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 339 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 339 ~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
+|..||.+.+.......+......... ....+++++.+||.+||. ||.+|| ++.|+++||||+.
T Consensus 220 ~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rp---s~~e~l~hp~f~~ 284 (285)
T 3is5_A 220 TGCLPFTGTSLEEVQQKATYKEPNYAV-ECRPLTPQAVDLLKQMLTKDPERRP---SAAQVLHHEWFKQ 284 (285)
T ss_dssp HSSCSSCCSSHHHHHHHHHHCCCCCCC---CCCCHHHHHHHHHHTCSCTTTSC---CHHHHHTSGGGGC
T ss_pred hCCCCCCCCCHHHHHhhhccCCccccc-ccCcCCHHHHHHHHHHccCChhhCc---CHHHHhcCHHhhc
Confidence 999999998887777666553322222 223589999999999998 999999 7899999999975
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=408.58 Aligned_cols=264 Identities=24% Similarity=0.385 Sum_probs=220.4
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc----e
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD----F 180 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~----~ 180 (510)
.++|++++.||+|+||.||+|+++.+|+.||||++.............+.+|+.++..++||||+++++++.+.. .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 478999999999999999999999999999999998765545556678899999999999999999999988655 3
Q ss_pred EEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccc
Q 010463 181 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 260 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~ 260 (510)
+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.+....
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 170 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccc
Confidence 59999999999999999988899999999999999999999999999999999999999999999999999998664321
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhC
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 340 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G 340 (510)
... ......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 171 ~~~-----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g 215 (311)
T 3ork_A 171 NSV-----------------------------------TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215 (311)
T ss_dssp ----------------------------------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred ccc-----------------------------------ccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhC
Confidence 100 011246799999999999999999999999999999999999
Q ss_pred CCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 341 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 341 ~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
.+||.+.+.......+..............+|+++.+||.+||. ||.+|| +..+++.|+|++.
T Consensus 216 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~---~~~~~l~~~l~~~ 279 (311)
T 3ork_A 216 EPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRY---QTAAEMRADLVRV 279 (311)
T ss_dssp SCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSC---SSHHHHHHHHHHH
T ss_pred CCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhCh---hhHHHHHHHHHHH
Confidence 99999988877776666532222111234689999999999998 999999 5688999999863
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=425.32 Aligned_cols=264 Identities=30% Similarity=0.573 Sum_probs=214.2
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcc-----hhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCce
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLK-----RGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 180 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~-----~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 180 (510)
++|.+.+.||+|+||+||+|.++.+++.||||++.+..... ......+.+|+.+|+.++|||||++++++.. +.
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~ 213 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-ED 213 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SE
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-Cc
Confidence 68999999999999999999999999999999998764321 1223357899999999999999999999865 45
Q ss_pred EEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCC---ceeecccCCcccCc
Q 010463 181 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG---HLKLSDFGLCKPLE 257 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g---~vkL~DFGla~~~~ 257 (510)
.|+||||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus 214 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~ 293 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 293 (419)
T ss_dssp EEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC
T ss_pred eEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecC
Confidence 899999999999999998888999999999999999999999999999999999999997554 59999999998764
Q ss_pred cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc---CCCCccccccchhhHH
Q 010463 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK---KGYGMECDWWSLGAIM 334 (510)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~---~~y~~~~DiwSlGvil 334 (510)
... ...+.+||+.|+|||++.+ ..|+.++|||||||++
T Consensus 294 ~~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il 334 (419)
T 3i6u_A 294 ETS---------------------------------------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334 (419)
T ss_dssp --------------------------------------------------CTTCCTTTTC----CTTHHHHHHHHHHHHH
T ss_pred CCc---------------------------------------cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHH
Confidence 321 1124689999999999864 6788999999999999
Q ss_pred HHHhhCCCCCCCCChhhhH-HHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchhh
Q 010463 335 YEMLIGYPPFCSDDPRITC-RKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKL 412 (510)
Q Consensus 335 yEml~G~~PF~~~~~~~~~-~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l 412 (510)
|||++|.+||.+....... ..+.........+.+..+++.+.+||.+||. ||.+|| +++|+++||||++.+|...
T Consensus 335 ~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~e~l~hp~~~~~~~~~~ 411 (419)
T 3i6u_A 335 FICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARF---TTEEALRHPWLQDEDMKRK 411 (419)
T ss_dssp HHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSC---CHHHHHHSGGGCCHHHHHH
T ss_pred HHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCc---CHHHHhCCcccCChhHHHH
Confidence 9999999999876554443 3343322111111124789999999999998 999999 7899999999999887654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=412.04 Aligned_cols=267 Identities=27% Similarity=0.414 Sum_probs=227.9
Q ss_pred hcccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc
Q 010463 100 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 179 (510)
Q Consensus 100 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 179 (510)
...+..++|++++.||+|+||.||+|+++.+|+.||+|++.... .......+.+|+.+|..++||||+++++++.+.+
T Consensus 27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 104 (360)
T 3eqc_A 27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG 104 (360)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT
T ss_pred ccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC
Confidence 34566789999999999999999999999999999999997642 3445677899999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhC-CeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 180 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH-NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~-giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
.+|+||||++||+|.+++...+.+++..++.++.|++.||.|||+. ||+||||||+|||++.+|++||+|||++.....
T Consensus 105 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 105 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 9999999999999999999988999999999999999999999996 999999999999999999999999999875422
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHh
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml 338 (510)
. .....+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 185 ~----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 224 (360)
T 3eqc_A 185 S----------------------------------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 224 (360)
T ss_dssp H----------------------------------------C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHH
T ss_pred c----------------------------------------cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHH
Confidence 1 112468999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhhHH------------------------------------------HHhhccccccCCCCCCCCHHHH
Q 010463 339 IGYPPFCSDDPRITCR------------------------------------------KIVNWKTCLKFPEEPKISDEAR 376 (510)
Q Consensus 339 ~G~~PF~~~~~~~~~~------------------------------------------~I~~~~~~~~~p~~~~~s~~~~ 376 (510)
+|..||.+.+...... .+.+. .....+ ...+|.++.
T Consensus 225 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~ 302 (360)
T 3eqc_A 225 VGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNE-PPPKLP-SGVFSLEFQ 302 (360)
T ss_dssp HTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHS-CCCCCC-TTTSCHHHH
T ss_pred hCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhcc-CCCCCC-cccccHHHH
Confidence 9999998766543322 12221 111122 235799999
Q ss_pred HHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchhhh
Q 010463 377 DLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLY 413 (510)
Q Consensus 377 dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l~ 413 (510)
+||.+||. ||.+|| +++|+++||||++.+|+.+.
T Consensus 303 ~li~~~L~~dP~~Rp---t~~ell~hp~~~~~~~~~~~ 337 (360)
T 3eqc_A 303 DFVNKCLIKNPAERA---DLKQLMVHAFIKRSDAEEVD 337 (360)
T ss_dssp HHHHHHHCSSTTTSC---CHHHHHTSHHHHHHHHSCCC
T ss_pred HHHHHHhhcChhhCC---CHHHHhhChHhhcchHhhhh
Confidence 99999998 999999 78999999999987776553
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=393.10 Aligned_cols=260 Identities=28% Similarity=0.522 Sum_probs=224.0
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCce
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 180 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 180 (510)
..+..++|.+.+.||+|+||.||+|+++.+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD 85 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence 34667899999999999999999999999999999999987655445566789999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccc
Q 010463 181 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 260 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~ 260 (510)
.|+||||++||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++.......
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 99999999999999999988899999999999999999999999999999999999999999999999999998654321
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCC-CccccccchhhHHHHHhh
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiwSlGvilyEml~ 339 (510)
. ....+||+.|+|||++.+..+ +.++|+|||||++|+|++
T Consensus 166 ~---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~ 206 (276)
T 2h6d_A 166 F---------------------------------------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLC 206 (276)
T ss_dssp --------------------------------------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHH
T ss_pred c---------------------------------------eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHh
Confidence 0 113579999999999988776 689999999999999999
Q ss_pred CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 340 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 340 G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
|..||.+.+.......+... ...+| ..++.++.+||.+||. ||.+|| +++++++||||+.
T Consensus 207 g~~p~~~~~~~~~~~~~~~~--~~~~~--~~~~~~l~~li~~~l~~~p~~Rp---s~~~~l~h~~~~~ 267 (276)
T 2h6d_A 207 GTLPFDDEHVPTLFKKIRGG--VFYIP--EYLNRSVATLLMHMLQVDPLKRA---TIKDIREHEWFKQ 267 (276)
T ss_dssp SSCSSCCSSHHHHHHHHHHC--CCCCC--TTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHSHHHHT
T ss_pred CCCCCCCCcHHHHHHHhhcC--cccCc--hhcCHHHHHHHHHHccCChhhCC---CHHHHHhChhhcc
Confidence 99999988887777777653 23344 3789999999999998 999999 7899999999975
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=406.13 Aligned_cols=259 Identities=24% Similarity=0.419 Sum_probs=219.7
Q ss_pred HhhcccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-----CCCeeeEe
Q 010463 98 LQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-----SRCIVQLF 172 (510)
Q Consensus 98 ~~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~-----hp~Iv~l~ 172 (510)
.....+-.++|++++.||+|+||+||+|++..+|+.||||++.+. ......+..|..+|..+. |||||+++
T Consensus 27 ~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 27 WKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp CCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 344445568999999999999999999999999999999999743 233456778999999986 99999999
Q ss_pred EEeecCceEEEEEeccCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecC---------
Q 010463 173 YSFQDSDFLYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK--------- 241 (510)
Q Consensus 173 ~~~~~~~~~~lVmEy~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~--------- 241 (510)
++|.+.+.+|+||||+ ||+|.+++.... .+++..++.++.||+.||.|||+.|||||||||+||||+.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~ 181 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLIT 181 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEE
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccc
Confidence 9999999999999999 999999998754 5999999999999999999999999999999999999975
Q ss_pred ----------------CCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhccccccccc
Q 010463 242 ----------------NGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTV 305 (510)
Q Consensus 242 ----------------~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 305 (510)
++.+||+|||+|+..... ..+.+
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----------------------------------------~~~~~ 220 (360)
T 3llt_A 182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----------------------------------------HGSII 220 (360)
T ss_dssp EECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----------------------------------------CCSCC
T ss_pred hhcccccccccccccCCCCEEEEeccCceecCCC-----------------------------------------CcCcc
Confidence 889999999999864321 12468
Q ss_pred ccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCCCChhhhHHHHhhccccc----------------------
Q 010463 306 GTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCL---------------------- 363 (510)
Q Consensus 306 GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~~---------------------- 363 (510)
||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+.......+......+
T Consensus 221 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 300 (360)
T 3llt_A 221 NTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDEL 300 (360)
T ss_dssp SCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTT
T ss_pred CcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccc
Confidence 9999999999999999999999999999999999999999888776666554321110
Q ss_pred --cCCCC------------------CCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcC
Q 010463 364 --KFPEE------------------PKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 405 (510)
Q Consensus 364 --~~p~~------------------~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~ 405 (510)
.+|.. ...++.+.+||.+||+ ||.+|| ++.|+++||||+
T Consensus 301 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp---ta~elL~hp~f~ 360 (360)
T 3llt_A 301 KLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRP---SPAELLKHKFLE 360 (360)
T ss_dssp EECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSC---CHHHHTTSGGGC
T ss_pred eecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCC---CHHHHhcCcccC
Confidence 11110 0124778899999999 999999 789999999995
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-50 Score=408.00 Aligned_cols=267 Identities=27% Similarity=0.385 Sum_probs=220.1
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec------
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD------ 177 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~------ 177 (510)
..++|++++.||+|+||.||+|+++.+|+.||||++..... .......+.+|+.+|+.++||||+++++++.+
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 35789999999999999999999999999999999876543 22334567789999999999999999999987
Q ss_pred --CceEEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcc
Q 010463 178 --SDFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCK 254 (510)
Q Consensus 178 --~~~~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~ 254 (510)
.+.+|+||||++| +|.+.+... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||+|+
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 4579999999986 777776553 679999999999999999999999999999999999999999999999999998
Q ss_pred cCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhH
Q 010463 255 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAI 333 (510)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvi 333 (510)
.+....... .......+||+.|+|||++.+ ..|+.++|||||||+
T Consensus 173 ~~~~~~~~~----------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~i 218 (351)
T 3mi9_A 173 AFSLAKNSQ----------------------------------PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCI 218 (351)
T ss_dssp ECCCCSSSS----------------------------------CCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHH
T ss_pred ccccccccc----------------------------------ccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHH
Confidence 764321100 001224689999999999986 568999999999999
Q ss_pred HHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCC----------------------------CCHHHHHHHHHhhc-
Q 010463 334 MYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPK----------------------------ISDEARDLICHLLC- 384 (510)
Q Consensus 334 lyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~----------------------------~s~~~~dlI~~lL~- 384 (510)
+|||++|.+||.+.+.......+......+.....+. .++++.+||.+||.
T Consensus 219 l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 298 (351)
T 3mi9_A 219 MAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL 298 (351)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCS
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcC
Confidence 9999999999999988877777765322221111111 27889999999999
Q ss_pred CccccCCCCChHHhhcCCCcCCCCc
Q 010463 385 DVETRLGTRGVEELKEHPWFRGIQW 409 (510)
Q Consensus 385 dp~~R~~~~~~~eil~HpfF~~i~~ 409 (510)
||.+|| +++|+++||||.+..+
T Consensus 299 dP~~R~---t~~e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 299 DPAQRI---DSDDALNHDFFWSDPM 320 (351)
T ss_dssp SGGGSC---CHHHHHTSGGGGSSSC
T ss_pred ChhhCC---CHHHHhCCCCcCCCCC
Confidence 999999 7899999999987554
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=392.23 Aligned_cols=255 Identities=22% Similarity=0.376 Sum_probs=218.7
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec----Cce
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD----SDF 180 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~----~~~ 180 (510)
...|.+.+.||+|+||.||+|.+..++..||+|++..... .......+.+|..+|+.++||||++++++|.+ ...
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 3458999999999999999999999999999999986543 44567789999999999999999999998875 467
Q ss_pred EEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCC--eEEeecCCCCeeec-CCCceeecccCCcccCc
Q 010463 181 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHN--YVHRDIKPDNLILD-KNGHLKLSDFGLCKPLE 257 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~g--iiHRDLKP~NILld-~~g~vkL~DFGla~~~~ 257 (510)
+|+||||++||+|.+++...+.+++..++.++.||+.||.|||+.| |+||||||+|||++ .+|.+||+|||++....
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 9999999999999999998889999999999999999999999999 99999999999998 89999999999997543
Q ss_pred cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHH
Q 010463 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337 (510)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEm 337 (510)
... ....+||+.|+|||++. ..++.++|+|||||++|+|
T Consensus 184 ~~~----------------------------------------~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l 222 (290)
T 1t4h_A 184 ASF----------------------------------------AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEM 222 (290)
T ss_dssp TTS----------------------------------------BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHH
T ss_pred ccc----------------------------------------cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHH
Confidence 221 12457999999999886 4599999999999999999
Q ss_pred hhCCCCCCCCCh-hhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 338 LIGYPPFCSDDP-RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 338 l~G~~PF~~~~~-~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
++|..||.+... ......+........++ ...++++.+||.+||. ||.+|| +++|+++||||++
T Consensus 223 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~~ell~h~~f~~ 288 (290)
T 1t4h_A 223 ATSEYPYSECQNAAQIYRRVTSGVKPASFD--KVAIPEVKEIIEGCIRQNKDERY---SIKDLLNHAFFQE 288 (290)
T ss_dssp HHSSCTTTTCSSHHHHHHHHTTTCCCGGGG--GCCCHHHHHHHHHHSCSSGGGSC---CHHHHHTSGGGC-
T ss_pred HhCCCCCCCcCcHHHHHHHHhccCCccccC--CCCCHHHHHHHHHHccCChhhCC---CHHHHhhCccccc
Confidence 999999987544 44444444432222333 3678999999999999 999999 7899999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=405.40 Aligned_cols=255 Identities=27% Similarity=0.368 Sum_probs=222.8
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
+.|++++.||+|+||.||+|++..+|+.||||++...........+.+.+|+.+|+.++|||||+++++|.+.+..|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 35999999999999999999999999999999997654444555677899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHH-hccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 186 EYLPGGDIMTLLM-REDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 186 Ey~~gG~L~~~L~-~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
||+. |+|.+++. ....+++..++.++.|++.||.|||+.||+||||||+|||++.+|++||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~----- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-----
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-----
Confidence 9997 57888775 4567999999999999999999999999999999999999999999999999999865321
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc---cCCCCccccccchhhHHHHHhhCC
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~---~~~y~~~~DiwSlGvilyEml~G~ 341 (510)
.+.+||+.|+|||++. ...++.++|||||||++|||++|.
T Consensus 208 -------------------------------------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~ 250 (348)
T 1u5q_A 208 -------------------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250 (348)
T ss_dssp -------------------------------------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred -------------------------------------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 1357999999999995 567899999999999999999999
Q ss_pred CCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCC
Q 010463 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 408 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~ 408 (510)
+||.+.+.......+........ ....+++.+++||.+||. ||.+|| +++++++||||....
T Consensus 251 ~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rp---s~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 251 PPLFNMNAMSALYHIAQNESPAL--QSGHWSEYFRNFVDSCLQKIPQDRP---TSEVLLKHRFVLRER 313 (348)
T ss_dssp CTTTTSCHHHHHHHHHHSCCCCC--CCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHTTCHHHHSCC
T ss_pred CCCCCCChHHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHcccChhhCc---CHHHHhhChhhhccC
Confidence 99998887777777765432221 224789999999999998 999999 789999999997643
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=406.66 Aligned_cols=266 Identities=28% Similarity=0.446 Sum_probs=217.2
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcc--hhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceE
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLK--RGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 181 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~--~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~ 181 (510)
..++|++++.||+|+||.||+|+++.+|+.||||++....... ......+.+|+.+|..++||||++++++|.+.+.+
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3578999999999999999999999999999999997643221 11124678899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccc
Q 010463 182 YLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 260 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~ 260 (510)
|+||||++| +|..++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++.+....
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence 999999986 888888764 469999999999999999999999999999999999999999999999999998764321
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHhh
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml~ 339 (510)
. .....+||+.|+|||++.+ ..|+.++|||||||++|||++
T Consensus 167 ~--------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 208 (346)
T 1ua2_A 167 R--------------------------------------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLL 208 (346)
T ss_dssp C--------------------------------------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHH
T ss_pred c--------------------------------------cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHH
Confidence 0 1124689999999999976 458999999999999999999
Q ss_pred CCCCCCCCChhhhHHHHhhccccc---------cCCC---------------CCCCCHHHHHHHHHhhc-CccccCCCCC
Q 010463 340 GYPPFCSDDPRITCRKIVNWKTCL---------KFPE---------------EPKISDEARDLICHLLC-DVETRLGTRG 394 (510)
Q Consensus 340 G~~PF~~~~~~~~~~~I~~~~~~~---------~~p~---------------~~~~s~~~~dlI~~lL~-dp~~R~~~~~ 394 (510)
|.+||.+.+....+.+|....... ..|. ...+++++++||.+||. ||.+|| +
T Consensus 209 g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t 285 (346)
T 1ua2_A 209 RVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI---T 285 (346)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSC---C
T ss_pred CCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCC---C
Confidence 999999998888887776521111 0000 13568999999999998 999999 7
Q ss_pred hHHhhcCCCcCCCCchh
Q 010463 395 VEELKEHPWFRGIQWDK 411 (510)
Q Consensus 395 ~~eil~HpfF~~i~~~~ 411 (510)
++|+++||||.+..|..
T Consensus 286 ~~ell~h~~f~~~~~~~ 302 (346)
T 1ua2_A 286 ATQALKMKYFSNRPGPT 302 (346)
T ss_dssp HHHHHTSGGGTSSSCCC
T ss_pred HHHHhcChhhhcCCCCC
Confidence 89999999999866543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=418.55 Aligned_cols=261 Identities=21% Similarity=0.223 Sum_probs=203.8
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc--CCCCeeeEeE-------Eee
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV--DSRCIVQLFY-------SFQ 176 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l--~hp~Iv~l~~-------~~~ 176 (510)
.+|.+++.||+|+||.||+|+++.+|+.||||++.+.........+.+++|..++..+ +||||++++. ++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 4599999999999999999999999999999999987655556677888896655544 6999888663 333
Q ss_pred cC-----------------ceEEEEEeccCCCCHHHHHHhcc-CCCHHHH------HHHHHHHHHHHHhhhhCCeEEeec
Q 010463 177 DS-----------------DFLYLIMEYLPGGDIMTLLMRED-ILSEDVA------RFYIAESVLAIHSIHQHNYVHRDI 232 (510)
Q Consensus 177 ~~-----------------~~~~lVmEy~~gG~L~~~L~~~~-~l~e~~~------~~~~~qi~~aL~~lH~~giiHRDL 232 (510)
.+ ..+|+|||||+ |+|.+++...+ .+++... ..++.||+.||.|||++|||||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi 220 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence 22 44899999998 89999998743 3444444 455699999999999999999999
Q ss_pred CCCCeeecCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcc
Q 010463 233 KPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMA 312 (510)
Q Consensus 233 KP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~A 312 (510)
||+||||+.+|++||+|||+|+...... ....||+.|+|
T Consensus 221 kp~NIll~~~~~~kL~DFG~a~~~~~~~-----------------------------------------~~~~~t~~y~a 259 (371)
T 3q60_A 221 TPDNLFIMPDGRLMLGDVSALWKVGTRG-----------------------------------------PASSVPVTYAP 259 (371)
T ss_dssp SGGGEEECTTSCEEECCGGGEEETTCEE-----------------------------------------EGGGSCGGGCC
T ss_pred CHHHEEECCCCCEEEEecceeeecCCCc-----------------------------------------cCccCCcCCcC
Confidence 9999999999999999999998654320 12467799999
Q ss_pred hHhhcc--CCCCccccccchhhHHHHHhhCCCCCCCCChhh--hHHH---HhhccccccCCCCCCCCHHHHHHHHHhhc-
Q 010463 313 PEVLLK--KGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI--TCRK---IVNWKTCLKFPEEPKISDEARDLICHLLC- 384 (510)
Q Consensus 313 PEvl~~--~~y~~~~DiwSlGvilyEml~G~~PF~~~~~~~--~~~~---I~~~~~~~~~p~~~~~s~~~~dlI~~lL~- 384 (510)
||++.+ ..|+.++|||||||+||||++|.+||.+.++.. .+.. +......+.+|..+.+++++.+||.+||.
T Consensus 260 PE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 339 (371)
T 3q60_A 260 REFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNF 339 (371)
T ss_dssp HHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCS
T ss_pred hhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCC
Confidence 999987 789999999999999999999999998775432 1111 11222344555556899999999999998
Q ss_pred CccccCCCCChHHhhcCCCcCCCCchh
Q 010463 385 DVETRLGTRGVEELKEHPWFRGIQWDK 411 (510)
Q Consensus 385 dp~~R~~~~~~~eil~HpfF~~i~~~~ 411 (510)
||++|| +++++++||||+++.|..
T Consensus 340 dP~~Rp---t~~e~l~hp~f~~~~~~~ 363 (371)
T 3q60_A 340 DRRRRL---LPLEAMETPEFLQLQNEI 363 (371)
T ss_dssp STTTCC---CHHHHTTSHHHHHHHHHH
T ss_pred ChhhCC---CHHHHhcCHHHHHHHHHH
Confidence 999999 789999999999988754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=410.12 Aligned_cols=258 Identities=27% Similarity=0.435 Sum_probs=204.7
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC------
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS------ 178 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~------ 178 (510)
.++|++++.||+|+||.||+|.++.+|+.||||++.+.. ........+.+|+.+|+.++||||++++++|...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 378999999999999999999999999999999997542 2344567788999999999999999999999764
Q ss_pred ceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 179 DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
..+|+||||+ |++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++....
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp CCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred CeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 5689999999 7899998865 6799999999999999999999999999999999999999999999999999986432
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHH
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEM 337 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEm 337 (510)
. ....+||+.|+|||++.+ ..|+.++|||||||++|||
T Consensus 185 ~-----------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 223 (367)
T 2fst_X 185 E-----------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 223 (367)
T ss_dssp -----------------------------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHH
T ss_pred c-----------------------------------------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHH
Confidence 1 113589999999999987 6789999999999999999
Q ss_pred hhCCCCCCCCChhhhHHHHhhccccc---------------------cCCC------CCCCCHHHHHHHHHhhc-Ccccc
Q 010463 338 LIGYPPFCSDDPRITCRKIVNWKTCL---------------------KFPE------EPKISDEARDLICHLLC-DVETR 389 (510)
Q Consensus 338 l~G~~PF~~~~~~~~~~~I~~~~~~~---------------------~~p~------~~~~s~~~~dlI~~lL~-dp~~R 389 (510)
++|.+||.+.+.......|....... ..|. .+.+++++.+||.+||+ ||.+|
T Consensus 224 l~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R 303 (367)
T 2fst_X 224 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 303 (367)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGS
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccC
Confidence 99999999988877777665421110 0110 13578999999999999 99999
Q ss_pred CCCCChHHhhcCCCcCCCCc
Q 010463 390 LGTRGVEELKEHPWFRGIQW 409 (510)
Q Consensus 390 ~~~~~~~eil~HpfF~~i~~ 409 (510)
| +++|+++||||+....
T Consensus 304 ~---t~~e~L~hp~~~~~~~ 320 (367)
T 2fst_X 304 I---TAAQALAHAYFAQYHD 320 (367)
T ss_dssp C---CHHHHHTSGGGTTTCC
T ss_pred c---CHHHHhcChhhhhccC
Confidence 9 7899999999997654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=389.20 Aligned_cols=259 Identities=25% Similarity=0.461 Sum_probs=222.3
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++|++++.||+|+||.||+|+++.+|+.||+|++..... ....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 579999999999999999999999999999999976532 334577899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
||++||+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++.........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~--- 161 (276)
T 2yex_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE--- 161 (276)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE---
T ss_pred EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch---
Confidence 99999999999988888999999999999999999999999999999999999999999999999999865432100
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCC-CccccccchhhHHHHHhhCCCCC
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEMLIGYPPF 344 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiwSlGvilyEml~G~~PF 344 (510)
......+||+.|+|||++.+..+ +.++|||||||++|||++|..||
T Consensus 162 ---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 208 (276)
T 2yex_A 162 ---------------------------------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208 (276)
T ss_dssp ---------------------------------CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCC
T ss_pred ---------------------------------hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCC
Confidence 11224679999999999988775 78999999999999999999999
Q ss_pred CCCChhh-hHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 345 CSDDPRI-TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 345 ~~~~~~~-~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
.+.+... .+..+.... ...+....+++.+.+||.+||. ||.+|| +++|+++||||+..
T Consensus 209 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~~~~~~~~ 268 (276)
T 2yex_A 209 DQPSDSCQEYSDWKEKK--TYLNPWKKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYNKP 268 (276)
T ss_dssp SCSCTTSHHHHHHHTTC--TTSTTGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHTTCTTTTCC
T ss_pred CCCchHHHHHHHhhhcc--cccCchhhcCHHHHHHHHHHCCCCchhCC---CHHHHhcCccccCh
Confidence 8765442 333333321 2223335789999999999998 999999 78999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=402.49 Aligned_cols=265 Identities=23% Similarity=0.401 Sum_probs=210.6
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc------
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD------ 179 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~------ 179 (510)
++|++++.||+|+||.||+|+++.+|+.||||++.... .....+.+.+|+.+|+.++|||||+++++|.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 57999999999999999999999999999999997643 3345677999999999999999999999986543
Q ss_pred ---------------------------------------------------eEEEEEeccCCCCHHHHHHhcc---CCCH
Q 010463 180 ---------------------------------------------------FLYLIMEYLPGGDIMTLLMRED---ILSE 205 (510)
Q Consensus 180 ---------------------------------------------------~~~lVmEy~~gG~L~~~L~~~~---~l~e 205 (510)
.+|+|||||+||+|.+++.+.. ..++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 3899999999999999998754 3566
Q ss_pred HHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCC
Q 010463 206 DVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 285 (510)
Q Consensus 206 ~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (510)
..++.++.||+.||.|||+.||+||||||+||||+.+|.+||+|||+++........... ..
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~----------~~-------- 225 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV----------LT-------- 225 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------------------
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccc----------cc--------
Confidence 678999999999999999999999999999999999999999999999876543111000 00
Q ss_pred hHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCCCChhhhHHHHhhccccccC
Q 010463 286 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKF 365 (510)
Q Consensus 286 ~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~ 365 (510)
...........+||+.|+|||++.+..++.++|||||||++|||++|..|+... ......+.. ..+
T Consensus 226 --------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~----~~~ 291 (332)
T 3qd2_B 226 --------PMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVRN----LKF 291 (332)
T ss_dssp --------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHT----TCC
T ss_pred --------cccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhc----cCC
Confidence 000001123468999999999999999999999999999999999998876321 122222222 222
Q ss_pred CC-CCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 366 PE-EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 366 p~-~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
|. ....++++.+||.+||. ||.+|| +++|+++||||+++
T Consensus 292 ~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 292 PLLFTQKYPQEHMMVQDMLSPSPTERP---EATDIIENAIFENL 332 (332)
T ss_dssp CHHHHHHCHHHHHHHHHHHCSSGGGSC---CHHHHHHSTTCCCC
T ss_pred CcccccCChhHHHHHHHHccCCCCcCC---CHHHHhhchhhhcC
Confidence 21 12567889999999998 999999 78999999999875
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-49 Score=397.80 Aligned_cols=256 Identities=27% Similarity=0.425 Sum_probs=212.2
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEeEEeec--CceE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQD--SDFL 181 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~--~~~~ 181 (510)
.++|++++.||+|+||+||+|+++.+|+.||||++... ..+.+.+|+.+|..+. ||||+++++++.+ ....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 46899999999999999999999999999999998643 2356889999999997 9999999999998 6789
Q ss_pred EEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCC-ceeecccCCcccCcccc
Q 010463 182 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG-HLKLSDFGLCKPLEDKY 260 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g-~vkL~DFGla~~~~~~~ 260 (510)
++||||++||+|..++. .+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||+|+......
T Consensus 109 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp EEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred EEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 99999999999999884 489999999999999999999999999999999999999777 89999999998654321
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHhh
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml~ 339 (510)
. ....+||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 186 ~---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~ 226 (330)
T 3nsz_A 186 E---------------------------------------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 226 (330)
T ss_dssp C---------------------------------------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH
T ss_pred c---------------------------------------cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHh
Confidence 0 124579999999999987 678999999999999999999
Q ss_pred CCCCCCCC-ChhhhHHHHhhc---------------------------------cccccCCCCCCCCHHHHHHHHHhhc-
Q 010463 340 GYPPFCSD-DPRITCRKIVNW---------------------------------KTCLKFPEEPKISDEARDLICHLLC- 384 (510)
Q Consensus 340 G~~PF~~~-~~~~~~~~I~~~---------------------------------~~~~~~p~~~~~s~~~~dlI~~lL~- 384 (510)
|..||... +.......+... ...........+++++.+||.+||.
T Consensus 227 g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 306 (330)
T 3nsz_A 227 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRY 306 (330)
T ss_dssp TCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCS
T ss_pred CCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcC
Confidence 99999543 332222222210 0000111112389999999999999
Q ss_pred CccccCCCCChHHhhcCCCcCCCCchh
Q 010463 385 DVETRLGTRGVEELKEHPWFRGIQWDK 411 (510)
Q Consensus 385 dp~~R~~~~~~~eil~HpfF~~i~~~~ 411 (510)
||.+|| +++|+++||||+++.|+.
T Consensus 307 dP~~Rp---ta~e~l~hp~f~~~~~~~ 330 (330)
T 3nsz_A 307 DHQSRL---TAREAMEHPYFYTVVKDQ 330 (330)
T ss_dssp SGGGSC---CHHHHHTSGGGTTCC---
T ss_pred CcccCC---CHHHHhcCccHhhhccCC
Confidence 999999 799999999999998763
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=398.73 Aligned_cols=251 Identities=27% Similarity=0.387 Sum_probs=205.8
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHH-hcCCCCeeeEeEEeecCceEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA-EVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~-~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
++|++++.||+|+||+||+|+++.+|+.||||++........ .......|...+. ..+|||||+++++|.+.+.+|+|
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPK-DRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChH-HHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 569999999999999999999999999999999865432222 3333444555554 44999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccc
Q 010463 185 MEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 263 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 263 (510)
|||+ +|+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||||+.+|++||+|||++.......
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~--- 211 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG--- 211 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC---
Confidence 9999 66898888765 469999999999999999999999999999999999999999999999999988654321
Q ss_pred cchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCC
Q 010463 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 343 (510)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~P 343 (510)
.....+||+.|+|||++.+ .++.++|||||||++|||++|..|
T Consensus 212 ------------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~ 254 (311)
T 3p1a_A 212 ------------------------------------AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMEL 254 (311)
T ss_dssp ---------------------------------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCC
T ss_pred ------------------------------------CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence 0123579999999999876 799999999999999999999777
Q ss_pred CCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 344 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 344 F~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
|.+.. ....+........++ ..+++++.+||.+||. ||++|| +++|+++||||+.
T Consensus 255 ~~~~~---~~~~~~~~~~~~~~~--~~~~~~l~~li~~~L~~dP~~Rp---t~~ell~hp~~~~ 310 (311)
T 3p1a_A 255 PHGGE---GWQQLRQGYLPPEFT--AGLSSELRSVLVMMLEPDPKLRA---TAEALLALPVLRQ 310 (311)
T ss_dssp CSSHH---HHHHHTTTCCCHHHH--TTSCHHHHHHHHHHSCSSTTTSC---CHHHHHTSGGGSC
T ss_pred CCCcc---HHHHHhccCCCcccc--cCCCHHHHHHHHHHcCCChhhCc---CHHHHHhCccccC
Confidence 76533 233343322222222 3789999999999999 999999 7899999999975
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-49 Score=392.83 Aligned_cols=261 Identities=24% Similarity=0.371 Sum_probs=218.5
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEE
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l 183 (510)
-.++|++++.||+|+||.||+|++..+++.||+|++...........+.+.+|+.++..++||||+++++++.+.+.+|+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 35789999999999999999999999999999999976555455667789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccc
Q 010463 184 IMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 263 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 263 (510)
||||++||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||+++.......
T Consensus 89 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 166 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-- 166 (294)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc--
Confidence 999999999999999989999999999999999999999999999999999999999999999999999987643210
Q ss_pred cchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCC
Q 010463 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 343 (510)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~P 343 (510)
......+||+.|+|||++.+..++.++|||||||++|||++|.+|
T Consensus 167 -----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p 211 (294)
T 4eqm_A 167 -----------------------------------TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211 (294)
T ss_dssp -------------------------------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred -----------------------------------cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCC
Confidence 001235799999999999999999999999999999999999999
Q ss_pred CCCCChhhhHHHHhhcccc-ccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 344 FCSDDPRITCRKIVNWKTC-LKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 344 F~~~~~~~~~~~I~~~~~~-~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
|.+.+......+++..... ......+.+++.+.++|.+||. ||.+||+. ++++ .+.|.
T Consensus 212 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~--~~~l-~~~l~ 271 (294)
T 4eqm_A 212 FNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKT--IQEM-KDDLS 271 (294)
T ss_dssp SCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSS--HHHH-HHHHH
T ss_pred CCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHcccc--HHHH-HHHHH
Confidence 9998877666555542211 1111124789999999999998 99999952 4444 44443
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-51 Score=421.09 Aligned_cols=249 Identities=18% Similarity=0.207 Sum_probs=209.0
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHH---HHHhcCCCCeeeEe-------EE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN---LLAEVDSRCIVQLF-------YS 174 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~---iL~~l~hp~Iv~l~-------~~ 174 (510)
.++|++.+.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+. +|+.++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 468999999999999999999999999999999998765556667788999994 55566899999998 66
Q ss_pred eecCc-----------------eEEEEEeccCCCCHHHHHHhccCCCH-------HHHHHHHHHHHHHHHhhhhCCeEEe
Q 010463 175 FQDSD-----------------FLYLIMEYLPGGDIMTLLMREDILSE-------DVARFYIAESVLAIHSIHQHNYVHR 230 (510)
Q Consensus 175 ~~~~~-----------------~~~lVmEy~~gG~L~~~L~~~~~l~e-------~~~~~~~~qi~~aL~~lH~~giiHR 230 (510)
+.+.+ ..|+||||+ +|+|.+++...+.+++ ..+..++.||+.||+|||+.||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 66553 389999999 6899999988766666 7777899999999999999999999
Q ss_pred ecCCCCeeecCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCC
Q 010463 231 DIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDY 310 (510)
Q Consensus 231 DLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y 310 (510)
||||+||||+.+|.+||+|||+|+..... ..+.+| +.|
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~~-----------------------------------------~~~~~g-~~y 268 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGAR-----------------------------------------VVSSVS-RGF 268 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTCE-----------------------------------------EECCCC-TTC
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCCc-----------------------------------------ccCCCC-cCc
Confidence 99999999999999999999999854321 124678 999
Q ss_pred cchHhhccC-----------CCCccccccchhhHHHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHH
Q 010463 311 MAPEVLLKK-----------GYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLI 379 (510)
Q Consensus 311 ~APEvl~~~-----------~y~~~~DiwSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI 379 (510)
+|||++.+. .|+.++|||||||++|||++|.+||.+.+.......+... ...+++++.+||
T Consensus 269 ~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~li 340 (377)
T 3byv_A 269 EPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRS--------CKNIPQPVRALL 340 (377)
T ss_dssp CCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGGSS--------CCCCCHHHHHHH
T ss_pred cChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhhhh--------ccCCCHHHHHHH
Confidence 999999988 8999999999999999999999999887766655555431 147899999999
Q ss_pred HHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 380 CHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 380 ~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
.+||. ||.+|| ++.|+++||||+++
T Consensus 341 ~~~L~~dp~~Rp---t~~e~l~hp~f~~~ 366 (377)
T 3byv_A 341 EGFLRYPKEDRL---LPLQAMETPEYEQL 366 (377)
T ss_dssp HHHTCSSGGGCC---CHHHHHTSHHHHHH
T ss_pred HHHcCCCchhCC---CHHHHhhChHHHHH
Confidence 99999 999999 78999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=412.75 Aligned_cols=257 Identities=29% Similarity=0.434 Sum_probs=211.5
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC------c
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS------D 179 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~------~ 179 (510)
.+|++++.||+|+||+||+|+++.+++ ||+|++.+.... ..+|+.+|+.++|||||+++++|... .
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 469999999999999999999988776 788877543211 23699999999999999999999543 3
Q ss_pred eEEEEEeccCCCCHHHHH---HhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeec-CCCceeecccCCccc
Q 010463 180 FLYLIMEYLPGGDIMTLL---MREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD-KNGHLKLSDFGLCKP 255 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L---~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld-~~g~vkL~DFGla~~ 255 (510)
.+|+||||++++.+..+. .....+++..++.++.||+.||.|||+.||+||||||+||||+ .+|++||+|||+|+.
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 589999999875443332 2356799999999999999999999999999999999999999 899999999999987
Q ss_pred CccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC-CCCccccccchhhHH
Q 010463 256 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIM 334 (510)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiwSlGvil 334 (510)
+..... ..+.+||+.|+|||++.+. .|+.++|||||||++
T Consensus 192 ~~~~~~---------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il 232 (394)
T 4e7w_A 192 LIAGEP---------------------------------------NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVM 232 (394)
T ss_dssp CCTTCC---------------------------------------CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred ccCCCC---------------------------------------CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHH
Confidence 543211 1246899999999999764 589999999999999
Q ss_pred HHHhhCCCCCCCCChhhhHHHHhhccc---------------cccCCC----------CCCCCHHHHHHHHHhhc-Cccc
Q 010463 335 YEMLIGYPPFCSDDPRITCRKIVNWKT---------------CLKFPE----------EPKISDEARDLICHLLC-DVET 388 (510)
Q Consensus 335 yEml~G~~PF~~~~~~~~~~~I~~~~~---------------~~~~p~----------~~~~s~~~~dlI~~lL~-dp~~ 388 (510)
|||++|.+||.+.+.......|+.... ...+|. .+.+++++.+||.+||. ||.+
T Consensus 233 ~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (394)
T 4e7w_A 233 AELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSA 312 (394)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhh
Confidence 999999999999988777776654211 011111 13589999999999999 9999
Q ss_pred cCCCCChHHhhcCCCcCCCCchhh
Q 010463 389 RLGTRGVEELKEHPWFRGIQWDKL 412 (510)
Q Consensus 389 R~~~~~~~eil~HpfF~~i~~~~l 412 (510)
|| ++.|+++||||+++.|...
T Consensus 313 R~---t~~e~l~hp~f~~~~~~~~ 333 (394)
T 4e7w_A 313 RL---TAIEALCHPFFDELRTGEA 333 (394)
T ss_dssp SC---CHHHHHTSGGGSTTTSSCC
T ss_pred CC---CHHHHhcChhhhhhccccc
Confidence 99 7899999999999887654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-49 Score=413.39 Aligned_cols=256 Identities=30% Similarity=0.478 Sum_probs=212.5
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec------Cc
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD------SD 179 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~------~~ 179 (510)
.+|++++.||+|+||+||+|+++.+|+.||||++.+... ...+|+.+|+.++|||||+++++|.. ..
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 369999999999999999999999999999999875421 13469999999999999999998843 33
Q ss_pred eEEEEEeccCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCC-CceeecccCCcc
Q 010463 180 FLYLIMEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN-GHLKLSDFGLCK 254 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~-g~vkL~DFGla~ 254 (510)
++++||||+++ +|..++.. ...+++..++.++.||+.||.|||+.||+||||||+||||+.+ +.+||+|||+|+
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 58899999986 66665542 4679999999999999999999999999999999999999965 578999999998
Q ss_pred cCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC-CCCccccccchhhH
Q 010463 255 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAI 333 (510)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiwSlGvi 333 (510)
.+..... ..+.+||+.|+|||++.+. .|+.++|||||||+
T Consensus 206 ~~~~~~~---------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~i 246 (420)
T 1j1b_A 206 QLVRGEP---------------------------------------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCV 246 (420)
T ss_dssp ECCTTCC---------------------------------------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred hcccCCC---------------------------------------ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHH
Confidence 6543210 1246899999999999764 79999999999999
Q ss_pred HHHHhhCCCCCCCCChhhhHHHHhhcc---------------ccccCCC----------CCCCCHHHHHHHHHhhc-Ccc
Q 010463 334 MYEMLIGYPPFCSDDPRITCRKIVNWK---------------TCLKFPE----------EPKISDEARDLICHLLC-DVE 387 (510)
Q Consensus 334 lyEml~G~~PF~~~~~~~~~~~I~~~~---------------~~~~~p~----------~~~~s~~~~dlI~~lL~-dp~ 387 (510)
||||++|++||.+.+....+.+|+..- ..+.+|. .+.+++++.+||++||. ||.
T Consensus 247 l~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~ 326 (420)
T 1j1b_A 247 LAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 326 (420)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGG
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChh
Confidence 999999999999988877777665421 0112221 13578999999999999 999
Q ss_pred ccCCCCChHHhhcCCCcCCCCchh
Q 010463 388 TRLGTRGVEELKEHPWFRGIQWDK 411 (510)
Q Consensus 388 ~R~~~~~~~eil~HpfF~~i~~~~ 411 (510)
+|+ ++.|+++||||+++.+..
T Consensus 327 ~R~---t~~e~l~hp~f~~~~~~~ 347 (420)
T 1j1b_A 327 ARL---TPLEACAHSFFDELRDPN 347 (420)
T ss_dssp GSC---CHHHHHTSGGGGGGGCTT
T ss_pred HCC---CHHHHhCCHhhccccccc
Confidence 999 789999999998876543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=402.28 Aligned_cols=267 Identities=30% Similarity=0.476 Sum_probs=224.2
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEE
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l 183 (510)
..++|++++.||+|+||.||+|+++.+|+.||+|++..... .....+.+.+|+.+|+.++||||+++++++.+.+.+|+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 46789999999999999999999999999999999876532 33345668899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccc
Q 010463 184 IMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 263 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 263 (510)
||||++|++|..++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++.+.....
T Consensus 102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 179 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-- 179 (331)
T ss_dssp EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc--
Confidence 999999999999888788899999999999999999999999999999999999999999999999999986543210
Q ss_pred cchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC-CCCccccccchhhHHHHHhhCCC
Q 010463 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEMLIGYP 342 (510)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiwSlGvilyEml~G~~ 342 (510)
.....+||+.|+|||++.+. .++.++|||||||++|||++|.+
T Consensus 180 ------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~ 223 (331)
T 4aaa_A 180 ------------------------------------VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEP 223 (331)
T ss_dssp ----------------------------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ------------------------------------ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCC
Confidence 01235799999999999875 78999999999999999999999
Q ss_pred CCCCCChhhhHHHHhhcccc-----------------ccCCC----------CCCCCHHHHHHHHHhhc-CccccCCCCC
Q 010463 343 PFCSDDPRITCRKIVNWKTC-----------------LKFPE----------EPKISDEARDLICHLLC-DVETRLGTRG 394 (510)
Q Consensus 343 PF~~~~~~~~~~~I~~~~~~-----------------~~~p~----------~~~~s~~~~dlI~~lL~-dp~~R~~~~~ 394 (510)
||.+.+.......+...... ...|. .+.+|+++.+||.+||. ||.+|| +
T Consensus 224 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp---t 300 (331)
T 4aaa_A 224 LFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRP---F 300 (331)
T ss_dssp SCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSC---C
T ss_pred CCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCC---C
Confidence 99998877766655431110 11111 13679999999999999 999999 6
Q ss_pred hHHhhcCCCcCCCCchhh
Q 010463 395 VEELKEHPWFRGIQWDKL 412 (510)
Q Consensus 395 ~~eil~HpfF~~i~~~~l 412 (510)
+.|+++||||+..+|...
T Consensus 301 ~~ell~hp~f~~~~~~~~ 318 (331)
T 4aaa_A 301 CAELLHHDFFQMDGFAER 318 (331)
T ss_dssp GGGGGGSHHHHGGGHHHH
T ss_pred HHHHhcCchhccCChhhh
Confidence 899999999998776543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=402.49 Aligned_cols=260 Identities=27% Similarity=0.437 Sum_probs=219.6
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC-----ce
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS-----DF 180 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----~~ 180 (510)
++|++++.||+|+||.||+|++..+++.||||++.... .......+.+|+.+|..++||||+++++++... ..
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 58999999999999999999999999999999997532 344457788999999999999999999999765 47
Q ss_pred EEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccc
Q 010463 181 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 260 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~ 260 (510)
+|+||||+. |+|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++......
T Consensus 105 ~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 999999997 599998865 569999999999999999999999999999999999999999999999999998664321
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHhh
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml~ 339 (510)
.. .......+||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 183 ~~-----------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 227 (364)
T 3qyz_A 183 DH-----------------------------------TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227 (364)
T ss_dssp CB-----------------------------------CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHH
T ss_pred Cc-----------------------------------cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHH
Confidence 10 011224689999999998765 558999999999999999999
Q ss_pred CCCCCCCCChhhhHHHHhhccccc------------------cCCC---------CCCCCHHHHHHHHHhhc-CccccCC
Q 010463 340 GYPPFCSDDPRITCRKIVNWKTCL------------------KFPE---------EPKISDEARDLICHLLC-DVETRLG 391 (510)
Q Consensus 340 G~~PF~~~~~~~~~~~I~~~~~~~------------------~~p~---------~~~~s~~~~dlI~~lL~-dp~~R~~ 391 (510)
|.+||.+.+.......|....... ..|. .+.+++++.+||.+||. ||.+||
T Consensus 228 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~- 306 (364)
T 3qyz_A 228 NRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI- 306 (364)
T ss_dssp SSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSC-
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCC-
Confidence 999999988887777765311110 0110 13679999999999999 999999
Q ss_pred CCChHHhhcCCCcCCC
Q 010463 392 TRGVEELKEHPWFRGI 407 (510)
Q Consensus 392 ~~~~~eil~HpfF~~i 407 (510)
+++|+++||||+..
T Consensus 307 --t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 307 --EVEQALAHPYLEQY 320 (364)
T ss_dssp --CHHHHHTSGGGTTT
T ss_pred --CHHHHhcCcchhhc
Confidence 78999999999875
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=402.07 Aligned_cols=259 Identities=27% Similarity=0.446 Sum_probs=215.4
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC--CCeeeEeEEeecCce
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS--RCIVQLFYSFQDSDF 180 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~h--p~Iv~l~~~~~~~~~ 180 (510)
+..+.|++++.||+|+||.||+|.+. +++.||||++..... .....+.+.+|+.+|..++| |||+++++++.+.+.
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 45678999999999999999999874 689999999976542 34456778999999999977 999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccc
Q 010463 181 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 260 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~ 260 (510)
+|+||| +.+|+|.+++.....+++..++.++.||+.||.|||+.||+||||||+||||+ +|.+||+|||+|+.+....
T Consensus 84 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 84 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp EEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred EEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 999999 56889999999999999999999999999999999999999999999999997 6899999999998764321
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-----------CCCCccccccc
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-----------KGYGMECDWWS 329 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-----------~~y~~~~DiwS 329 (510)
.. ....+.+||+.|+|||++.+ ..|+.++||||
T Consensus 162 ~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Diws 205 (343)
T 3dbq_A 162 TS------------------------------------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWS 205 (343)
T ss_dssp --------------------------------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHH
T ss_pred cc------------------------------------ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHH
Confidence 10 01124689999999999975 67899999999
Q ss_pred hhhHHHHHhhCCCCCCCCCh-hhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 330 LGAIMYEMLIGYPPFCSDDP-RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 330 lGvilyEml~G~~PF~~~~~-~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
|||++|||++|.+||.+... ......++.......+| ...+.++.+||.+||. ||.+|| ++.|+++||||+.
T Consensus 206 lG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~L~~dp~~Rp---t~~e~l~hp~~~~ 279 (343)
T 3dbq_A 206 LGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP--DIPEKDLQDVLKCCLKRDPKQRI---SIPELLAHPYVQI 279 (343)
T ss_dssp HHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC--CCSCHHHHHHHHHHTCSSTTTSC---CHHHHHTSHHHHS
T ss_pred HHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCc--ccCCHHHHHHHHHHcCCChhHCC---CHHHHHhCccccc
Confidence 99999999999999986433 34445555433344455 3678899999999998 999999 7899999999974
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=392.67 Aligned_cols=261 Identities=32% Similarity=0.596 Sum_probs=229.8
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++|++++.||+|+||.||+|+++.+|+.||+|++.+... .......+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB-SSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 579999999999999999999999999999999976543 3345677899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCC---CceeecccCCcccCcccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN---GHLKLSDFGLCKPLEDKYSS 262 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~---g~vkL~DFGla~~~~~~~~~ 262 (510)
||++||+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+ +.+||+|||++........
T Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~- 179 (287)
T 2wei_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK- 179 (287)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS-
T ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc-
Confidence 999999999999888899999999999999999999999999999999999999764 4799999999986543210
Q ss_pred ccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCC
Q 010463 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 342 (510)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~ 342 (510)
....+||+.|+|||++.+ .++.++|+|||||++|+|++|.+
T Consensus 180 --------------------------------------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~ 220 (287)
T 2wei_A 180 --------------------------------------MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTP 220 (287)
T ss_dssp --------------------------------------CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred --------------------------------------cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCC
Confidence 113469999999999875 48999999999999999999999
Q ss_pred CCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCch
Q 010463 343 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWD 410 (510)
Q Consensus 343 PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~ 410 (510)
||.+.+.......+.........|....+|+++.+||.+||. ||.+|| +++++++||||+..+|+
T Consensus 221 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~ell~hp~~~~~~~~ 286 (287)
T 2wei_A 221 PFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRI---TATQCLEHPWIQKYSSE 286 (287)
T ss_dssp SSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHSHHHHHHCCC
T ss_pred CCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCc---CHHHHhcCHHHhccccC
Confidence 999988888888887755444445446789999999999998 999999 78999999999876654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=398.05 Aligned_cols=274 Identities=28% Similarity=0.456 Sum_probs=221.1
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC-----c
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS-----D 179 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----~ 179 (510)
.++|++.+.||+|+||.||+|+++.+|+.||||++.... .......+.+|+.+|+.++||||+++++++... .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 478999999999999999999999999999999996432 334456788999999999999999999988754 6
Q ss_pred eEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 180 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
..|+||||+. |+|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++.+...
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred eEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 8999999997 589998866 57999999999999999999999999999999999999999999999999999876542
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml 338 (510)
....... ..........+||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 166 ~~~~~~~----------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 217 (353)
T 2b9h_A 166 AADNSEP----------------------------TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217 (353)
T ss_dssp ------------------------------------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHH
T ss_pred cccccCc----------------------------cccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHH
Confidence 1110000 000011224689999999999875 67899999999999999999
Q ss_pred hCCCCCCCCChhhhHHHHhhccccc----------------------cCCC------CCCCCHHHHHHHHHhhc-Ccccc
Q 010463 339 IGYPPFCSDDPRITCRKIVNWKTCL----------------------KFPE------EPKISDEARDLICHLLC-DVETR 389 (510)
Q Consensus 339 ~G~~PF~~~~~~~~~~~I~~~~~~~----------------------~~p~------~~~~s~~~~dlI~~lL~-dp~~R 389 (510)
+|.+||.+.+.......+....... ..+. .+.+++++.+||.+||. ||.+|
T Consensus 218 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 297 (353)
T 2b9h_A 218 LRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKR 297 (353)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGS
T ss_pred hCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccC
Confidence 9999999888766555544211100 0110 13689999999999998 99999
Q ss_pred CCCCChHHhhcCCCcCCCCchhhh
Q 010463 390 LGTRGVEELKEHPWFRGIQWDKLY 413 (510)
Q Consensus 390 ~~~~~~~eil~HpfF~~i~~~~l~ 413 (510)
| +++|+++||||+.+.|....
T Consensus 298 p---t~~ell~hp~~~~~~~~~~~ 318 (353)
T 2b9h_A 298 I---TAKEALEHPYLQTYHDPNDE 318 (353)
T ss_dssp C---CHHHHHTSGGGTTTCCTTSS
T ss_pred C---CHHHHhcCccccccCCcccc
Confidence 9 78999999999988765543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-49 Score=406.99 Aligned_cols=256 Identities=27% Similarity=0.458 Sum_probs=212.6
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEee------
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ------ 176 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~------ 176 (510)
...++|++++.||+|+||+||+|++..+|+.||||++..... ...+|+.+|+.++|||||+++++|.
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 345789999999999999999999999999999999875421 1336999999999999999999984
Q ss_pred --------------------------------cCceEEEEEeccCCCCHHHHHH----hccCCCHHHHHHHHHHHHHHHH
Q 010463 177 --------------------------------DSDFLYLIMEYLPGGDIMTLLM----REDILSEDVARFYIAESVLAIH 220 (510)
Q Consensus 177 --------------------------------~~~~~~lVmEy~~gG~L~~~L~----~~~~l~e~~~~~~~~qi~~aL~ 220 (510)
+..++++||||++| +|.+.+. ....+++..++.++.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 34459999999985 7766664 3578999999999999999999
Q ss_pred hhhhCCeEEeecCCCCeeec-CCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhccc
Q 010463 221 SIHQHNYVHRDIKPDNLILD-KNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRA 299 (510)
Q Consensus 221 ~lH~~giiHRDLKP~NILld-~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (510)
|||+.||+||||||+|||++ .+|.+||+|||+|+.+.....
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~-------------------------------------- 197 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP-------------------------------------- 197 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--------------------------------------
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--------------------------------------
Confidence 99999999999999999998 689999999999986543211
Q ss_pred ccccccccCCCcchHhhccC-CCCccccccchhhHHHHHhhCCCCCCCCChhhhHHHHhhccc---------------cc
Q 010463 300 LAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKT---------------CL 363 (510)
Q Consensus 300 ~~~s~~GT~~Y~APEvl~~~-~y~~~~DiwSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~---------------~~ 363 (510)
..+.+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+..+....|+.... ..
T Consensus 198 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~ 276 (383)
T 3eb0_A 198 -SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEV 276 (383)
T ss_dssp -CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--C
T ss_pred -CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccc
Confidence 1246799999999999875 489999999999999999999999999988887777764211 11
Q ss_pred cCCC----------CCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCC
Q 010463 364 KFPE----------EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 408 (510)
Q Consensus 364 ~~p~----------~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~ 408 (510)
.+|. ...+|+++.+||.+||. ||.+|| ++.|+++||||+++.
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 277 RFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI---NPYEAMAHPFFDHLR 329 (383)
T ss_dssp CCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC---CHHHHHTSGGGHHHH
T ss_pred cCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCC---CHHHHhcCHHHHHHH
Confidence 1111 13589999999999999 999999 789999999998753
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=409.27 Aligned_cols=260 Identities=27% Similarity=0.446 Sum_probs=217.8
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC--CCCeeeEeEEeecCce
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD--SRCIVQLFYSFQDSDF 180 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~--hp~Iv~l~~~~~~~~~ 180 (510)
+...+|++++.||+|+||+||+|.+.. |+.||||++.+... .....+.+.+|+.+|..+. |||||++++++.+.+.
T Consensus 53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~ 130 (390)
T 2zmd_A 53 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 130 (390)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred ccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCE
Confidence 344569999999999999999998865 99999999976543 3455678999999999996 5999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccc
Q 010463 181 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 260 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~ 260 (510)
+|+||| +.+|+|.+++.....+++..++.++.||+.||.|||+.|||||||||+||||+ +|.+||+|||+++.+....
T Consensus 131 ~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 131 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred EEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 999999 67889999999988999999999999999999999999999999999999995 6899999999998764321
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-----------CCCCccccccc
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-----------KGYGMECDWWS 329 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-----------~~y~~~~DiwS 329 (510)
.. ....+.+||+.|+|||++.+ ..|+.++||||
T Consensus 209 ~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwS 252 (390)
T 2zmd_A 209 TS------------------------------------VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWS 252 (390)
T ss_dssp -----------------------------------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHH
T ss_pred cc------------------------------------ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHH
Confidence 10 01124689999999999975 46899999999
Q ss_pred hhhHHHHHhhCCCCCCCCCh-hhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 330 LGAIMYEMLIGYPPFCSDDP-RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 330 lGvilyEml~G~~PF~~~~~-~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
|||+||||++|.+||.+... ......++.......+|. ..+.++.+||.+||. ||.+|| ++.|+++||||+..
T Consensus 253 lGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rp---s~~ell~hp~~~~~ 327 (390)
T 2zmd_A 253 LGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD--IPEKDLQDVLKCCLKRDPKQRI---SIPELLAHPYVQIQ 327 (390)
T ss_dssp HHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCC--CSCHHHHHHHHHHTCSSTTTSC---CHHHHHTSHHHHSC
T ss_pred HHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCc--cchHHHHHHHHHHcccChhhCC---CHHHHhhCcCcccc
Confidence 99999999999999987543 345556665444444553 568999999999998 999999 78999999999753
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=404.60 Aligned_cols=266 Identities=26% Similarity=0.488 Sum_probs=230.6
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhh--------------HHHHHHHHHHHHhcCCCC
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ--------------VEHVRSERNLLAEVDSRC 167 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~--------------~~~~~~E~~iL~~l~hp~ 167 (510)
....++|++++.||+|+||.||+|++ +|+.||+|++.......... .+.+.+|+.++..++|||
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 104 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY 104 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTT
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCC
Confidence 34568999999999999999999998 89999999998765432221 267899999999999999
Q ss_pred eeeEeEEeecCceEEEEEeccCCCCHHHH------HHh--ccCCCHHHHHHHHHHHHHHHHhhhh-CCeEEeecCCCCee
Q 010463 168 IVQLFYSFQDSDFLYLIMEYLPGGDIMTL------LMR--EDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLI 238 (510)
Q Consensus 168 Iv~l~~~~~~~~~~~lVmEy~~gG~L~~~------L~~--~~~l~e~~~~~~~~qi~~aL~~lH~-~giiHRDLKP~NIL 238 (510)
|+++++++.+.+.+|+||||++||+|.++ +.. ...+++..++.++.||+.||.|||+ .||+||||||+|||
T Consensus 105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184 (348)
T ss_dssp BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence 99999999999999999999999999998 665 5779999999999999999999999 99999999999999
Q ss_pred ecCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc
Q 010463 239 LDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK 318 (510)
Q Consensus 239 ld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~ 318 (510)
++.+|++||+|||++....... ....+||+.|+|||++.+
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~~----------------------------------------~~~~~~~~~y~aPE~~~~ 224 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDKK----------------------------------------IKGSRGTYEFMPPEFFSN 224 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTTE----------------------------------------ECSSCSCGGGCCGGGGSS
T ss_pred EcCCCcEEEecccccccccccc----------------------------------------ccCCCCCcCccCchhhcC
Confidence 9999999999999998654320 123579999999999988
Q ss_pred C-CCCc-cccccchhhHHHHHhhCCCCCCCCCh-hhhHHHHhhccccccCCCC-----------------CCCCHHHHHH
Q 010463 319 K-GYGM-ECDWWSLGAIMYEMLIGYPPFCSDDP-RITCRKIVNWKTCLKFPEE-----------------PKISDEARDL 378 (510)
Q Consensus 319 ~-~y~~-~~DiwSlGvilyEml~G~~PF~~~~~-~~~~~~I~~~~~~~~~p~~-----------------~~~s~~~~dl 378 (510)
. .++. ++|||||||++|||++|.+||.+.+. ......+... ...+|.. ..+++++.+|
T Consensus 225 ~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 302 (348)
T 2pml_X 225 ESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTK--NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDF 302 (348)
T ss_dssp CCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSC--CCCCCCSSSSSTTTTCC--------CCCHHHHHH
T ss_pred CCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhcc--CcCCccchhhhhccccccccccchhhcCHHHHHH
Confidence 7 6766 99999999999999999999998776 6666666653 2334421 4689999999
Q ss_pred HHHhhc-CccccCCCCChHHhhcCCCcCCCCchhhhc
Q 010463 379 ICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYE 414 (510)
Q Consensus 379 I~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l~~ 414 (510)
|.+||+ ||.+|| +++|+++||||++++|..+..
T Consensus 303 i~~~L~~dP~~Rp---s~~e~l~hp~f~~~~~~~~~~ 336 (348)
T 2pml_X 303 LKLFLRKNPAERI---TSEDALKHEWLADTNIEDLRE 336 (348)
T ss_dssp HHHHCCSSGGGSC---CHHHHHTSGGGTTCCHHHHHH
T ss_pred HHHHccCChhhCC---CHHHHhcCccccCCCHHHHHH
Confidence 999999 999999 789999999999999998765
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=401.04 Aligned_cols=262 Identities=31% Similarity=0.601 Sum_probs=216.5
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhc-----chhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCce
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML-----KRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 180 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~-----~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 180 (510)
++|++++.||+|+||.||+|+++.+|+.||||++.+.... .......+.+|+.+|+.++||||+++++++.+..
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 5799999999999999999999999999999999765431 1223345889999999999999999999998765
Q ss_pred EEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCc---eeecccCCcccCc
Q 010463 181 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH---LKLSDFGLCKPLE 257 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~---vkL~DFGla~~~~ 257 (510)
.|+||||++||+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++. +||+|||+++...
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 168 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECC
T ss_pred eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecc
Confidence 8999999999999999988889999999999999999999999999999999999999987665 9999999998654
Q ss_pred cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc---cCCCCccccccchhhHH
Q 010463 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMECDWWSLGAIM 334 (510)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~---~~~y~~~~DiwSlGvil 334 (510)
.... ....+||+.|+|||++. ...++.++|||||||++
T Consensus 169 ~~~~---------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il 209 (322)
T 2ycf_A 169 ETSL---------------------------------------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209 (322)
T ss_dssp CCHH---------------------------------------HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHH
T ss_pred cccc---------------------------------------cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHH
Confidence 3200 11357999999999985 46789999999999999
Q ss_pred HHHhhCCCCCCCCChhhh-HHHHhhccccccCC--CCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCch
Q 010463 335 YEMLIGYPPFCSDDPRIT-CRKIVNWKTCLKFP--EEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWD 410 (510)
Q Consensus 335 yEml~G~~PF~~~~~~~~-~~~I~~~~~~~~~p--~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~ 410 (510)
|||++|.+||.+...... ...+.... ..++ ....+++++.+||.+||. ||.+|| +++++++||||++.+|.
T Consensus 210 ~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp---s~~~~l~h~~~~~~~~~ 284 (322)
T 2ycf_A 210 FICLSGYPPFSEHRTQVSLKDQITSGK--YNFIPEVWAEVSEKALDLVKKLLVVDPKARF---TTEEALRHPWLQDEDMK 284 (322)
T ss_dssp HHHHHSSCSSCSTTCSSCHHHHHHHTC--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSC---CHHHHHTSGGGCCHHHH
T ss_pred HHHHhCCCCCcccchHHHHHHHHHhCc--cccCchhhhhcCHHHHHHHHHHcccCHhhCC---CHHHHhhCcCcCCHHHH
Confidence 999999999987655433 33343321 1111 124689999999999998 999999 78999999999988775
Q ss_pred hh
Q 010463 411 KL 412 (510)
Q Consensus 411 ~l 412 (510)
.-
T Consensus 285 ~~ 286 (322)
T 2ycf_A 285 RK 286 (322)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=393.78 Aligned_cols=265 Identities=28% Similarity=0.439 Sum_probs=223.7
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEE
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~ 182 (510)
...+.|++++.||+|+||.||+|+++.+|+.||+|++... .....+.+.+|+.+|..++||||+++++++.+.+.+|
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 92 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLW 92 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC---CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEE
Confidence 3456899999999999999999999999999999998754 2345677889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 183 LIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
+||||++||+|..++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++.......
T Consensus 93 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 171 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL- 171 (302)
T ss_dssp EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred EEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence 99999999999999876 4679999999999999999999999999999999999999999999999999876321110
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc-----cCCCCccccccchhhHHHH
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDWWSLGAIMYE 336 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-----~~~y~~~~DiwSlGvilyE 336 (510)
......+||+.|+|||++. +..++.++|+|||||++||
T Consensus 172 -------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~ 214 (302)
T 2j7t_A 172 -------------------------------------QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIE 214 (302)
T ss_dssp -------------------------------------HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHH
T ss_pred -------------------------------------cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHH
Confidence 0012357999999999994 6678999999999999999
Q ss_pred HhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchhh
Q 010463 337 MLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKL 412 (510)
Q Consensus 337 ml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l 412 (510)
|++|.+||.+.+.......+..... ...+....++.++.+||.+||. ||.+|| +++++++||||+++.|...
T Consensus 215 l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~h~~~~~~~~~~~ 287 (302)
T 2j7t_A 215 MAQIEPPHHELNPMRVLLKIAKSDP-PTLLTPSKWSVEFRDFLKIALDKNPETRP---SAAQLLEHPFVSSITSNKA 287 (302)
T ss_dssp HHHSSCTTTTSCHHHHHHHHHHSCC-CCCSSGGGSCHHHHHHHHHHSCSCTTTSC---CHHHHTTSTTTTTCCCCHH
T ss_pred HhcCCCCCccCCHHHHHHHHhccCC-cccCCccccCHHHHHHHHHHcccChhhCC---CHHHHhcChHHhhhccchh
Confidence 9999999998888777777665322 1222234789999999999998 999999 7899999999999988654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-49 Score=395.76 Aligned_cols=277 Identities=22% Similarity=0.338 Sum_probs=206.8
Q ss_pred HhhcccCCCCceeeeeeecCCCeEEEEEEEcCCCC---EEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEE
Q 010463 98 LQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGE---IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYS 174 (510)
Q Consensus 98 ~~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~---~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 174 (510)
+....+..++|++++.||+|+||.||+|+++.++. .||||++..... .....+.+.+|+.+++.++||||++++++
T Consensus 15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 93 (323)
T 3qup_A 15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFDHPHVAKLVGV 93 (323)
T ss_dssp -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEE
T ss_pred hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCCCCceehhhce
Confidence 34455777899999999999999999999887775 899999976533 34456789999999999999999999999
Q ss_pred eecCceE------EEEEeccCCCCHHHHHHhcc------CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCC
Q 010463 175 FQDSDFL------YLIMEYLPGGDIMTLLMRED------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN 242 (510)
Q Consensus 175 ~~~~~~~------~lVmEy~~gG~L~~~L~~~~------~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~ 242 (510)
+.+.... |+||||++||+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.+
T Consensus 94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED 173 (323)
T ss_dssp EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT
T ss_pred eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCC
Confidence 9887665 99999999999999997643 59999999999999999999999999999999999999999
Q ss_pred CceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCC
Q 010463 243 GHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYG 322 (510)
Q Consensus 243 g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~ 322 (510)
|.+||+|||+++........ .......||+.|+|||++.+..++
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~ 217 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYY------------------------------------RQGCASKLPVKWLALESLADNLYT 217 (323)
T ss_dssp SCEEECCCCC-----------------------------------------------------CCGGGCCHHHHHHCCCC
T ss_pred CCEEEeeccccccccccccc------------------------------------cccccccCcccccCchhhcCCCCC
Confidence 99999999999865432100 001134578999999999999999
Q ss_pred ccccccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC----ChH
Q 010463 323 MECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR----GVE 396 (510)
Q Consensus 323 ~~~DiwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~----~~~ 396 (510)
.++|||||||++|||++ |.+||.+.+.......+.... .... .+.+++++.+||.+||. ||.+||+.. .++
T Consensus 218 ~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 294 (323)
T 3qup_A 218 VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN-RLKQ--PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELE 294 (323)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCC--CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred CccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC-CCCC--CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 99999999999999999 999999988888888777643 2223 35789999999999998 999999421 278
Q ss_pred HhhcCCCcCCCCchhhhc
Q 010463 397 ELKEHPWFRGIQWDKLYE 414 (510)
Q Consensus 397 eil~HpfF~~i~~~~l~~ 414 (510)
+++.|||+.+..++.+..
T Consensus 295 ~~l~~~~~~~~~~~pl~~ 312 (323)
T 3qup_A 295 NILGHLSVLSTSQDPLYI 312 (323)
T ss_dssp HHHHC-------------
T ss_pred HHHHHhhhcCCCCCCCCC
Confidence 899999999877665543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=385.51 Aligned_cols=250 Identities=22% Similarity=0.335 Sum_probs=211.1
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCceEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~~lV 184 (510)
++|++++.||+|+||.||+|+++.+|+.||+|++.+... .......+.+|+.++..+ +||||+++++++.+.+.+|+|
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA-GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT-TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 579999999999999999999999999999999986532 233456688899999888 999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCC-----------------
Q 010463 185 MEYLPGGDIMTLLMRE----DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG----------------- 243 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~----~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g----------------- 243 (510)
|||++||+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 9999999999999765 6799999999999999999999999999999999999998544
Q ss_pred --ceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC-C
Q 010463 244 --HLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-G 320 (510)
Q Consensus 244 --~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~ 320 (510)
.+||+|||++...... ...+||+.|+|||++.+. .
T Consensus 170 ~~~~kl~Dfg~~~~~~~~------------------------------------------~~~~gt~~y~aPE~~~~~~~ 207 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSP------------------------------------------QVEEGDSRFLANEVLQENYT 207 (289)
T ss_dssp CCCEEECCCTTCEETTCS------------------------------------------CCCCCCGGGCCHHHHTTCCT
T ss_pred ceEEEEcccccccccCCc------------------------------------------cccCCCccccChhHhcCCCC
Confidence 7999999999865432 124699999999999876 5
Q ss_pred CCccccccchhhHHHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhh
Q 010463 321 YGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 399 (510)
Q Consensus 321 y~~~~DiwSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil 399 (510)
++.++|||||||++|||++|.+|+...+ ....+.... ...+| ..+++++.+||.+||. ||.+|| ++.|++
T Consensus 208 ~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~dp~~Rp---s~~~ll 278 (289)
T 1x8b_A 208 HLPKADIFALALTVVCAAGAEPLPRNGD---QWHEIRQGR-LPRIP--QVLSQEFTELLKVMIHPDPERRP---SAMALV 278 (289)
T ss_dssp THHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHHHTTC-CCCCS--SCCCHHHHHHHHHHTCSSGGGSC---CHHHHH
T ss_pred CCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHHHcCC-CCCCC--cccCHHHHHHHHHHhCCCcccCC---CHHHHh
Confidence 6789999999999999999998886543 334444321 22333 4789999999999998 999999 789999
Q ss_pred cCCCcCCC
Q 010463 400 EHPWFRGI 407 (510)
Q Consensus 400 ~HpfF~~i 407 (510)
+||||.+.
T Consensus 279 ~h~~~~~~ 286 (289)
T 1x8b_A 279 KHSVLLSA 286 (289)
T ss_dssp TCTTC---
T ss_pred hChHhhhh
Confidence 99999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-49 Score=388.69 Aligned_cols=259 Identities=27% Similarity=0.452 Sum_probs=205.1
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceE
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 181 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~ 181 (510)
++..++|++++.||+|+||+||+|+++.+|+.||+|++..... .......+..+...++.++||||+++++++.+.+..
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 4567899999999999999999999999999999999976432 233344455566668889999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHhhhhC-CeEEeecCCCCeeecCCCceeecccCCcccC
Q 010463 182 YLIMEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQH-NYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 256 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~lH~~-giiHRDLKP~NILld~~g~vkL~DFGla~~~ 256 (510)
|+||||++| +|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++++||+|||+++..
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999999975 88777653 46799999999999999999999998 9999999999999999999999999999865
Q ss_pred ccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhh----ccCCCCccccccchhh
Q 010463 257 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL----LKKGYGMECDWWSLGA 332 (510)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl----~~~~y~~~~DiwSlGv 332 (510)
..... ....+||+.|+|||++ .+..++.++|||||||
T Consensus 161 ~~~~~---------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~ 201 (290)
T 3fme_A 161 VDDVA---------------------------------------KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGI 201 (290)
T ss_dssp ------------------------------------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHH
T ss_pred ccccc---------------------------------------ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHH
Confidence 43210 1134799999999997 4667899999999999
Q ss_pred HHHHHhhCCCCCCC-CChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 333 IMYEMLIGYPPFCS-DDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 333 ilyEml~G~~PF~~-~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
++|||++|..||.+ .........+.... ....+ ...+++++.+||.+||. ||.+|| +++|+++||||+.
T Consensus 202 il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp---t~~e~l~hp~f~~ 272 (290)
T 3fme_A 202 TMIELAILRFPYDSWGTPFQQLKQVVEEP-SPQLP-ADKFSAEFVDFTSQCLKKNSKERP---TYPELMQHPFFTL 272 (290)
T ss_dssp HHHHHHHTSCSSCCCSCHHHHHHHHHHSC-CCCCC-TTTSCHHHHHHHHHHTCSSGGGSC---CHHHHTTSHHHHH
T ss_pred HHHHHHHCCCCccccCchHHHHHHHhccC-CCCcc-cccCCHHHHHHHHHHhhcChhhCc---CHHHHHhCccccc
Confidence 99999999999986 34444444444422 22222 24789999999999999 999999 7899999999974
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=403.57 Aligned_cols=257 Identities=30% Similarity=0.454 Sum_probs=217.2
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceE----
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL---- 181 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~---- 181 (510)
++|.+.+.||+|+||.||+|+++.+|+.||||++.+.. ........+.+|+.+|+.++||||++++++|.+.+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 68999999999999999999999999999999997643 2344567788999999999999999999999987765
Q ss_pred --EEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 182 --YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 182 --~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
|+||||+. |+|..++. ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||+++.....
T Consensus 121 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 197 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 197 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred eEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC
Confidence 99999997 58888874 34999999999999999999999999999999999999999999999999999864321
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml 338 (510)
....+||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 198 -----------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~ 236 (371)
T 4exu_A 198 -----------------------------------------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML 236 (371)
T ss_dssp -------------------------------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHH
T ss_pred -----------------------------------------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHH
Confidence 124679999999999987 78999999999999999999
Q ss_pred hCCCCCCCCChhhhHHHHhhccccc---------------------cCCC------CCCCCHHHHHHHHHhhc-CccccC
Q 010463 339 IGYPPFCSDDPRITCRKIVNWKTCL---------------------KFPE------EPKISDEARDLICHLLC-DVETRL 390 (510)
Q Consensus 339 ~G~~PF~~~~~~~~~~~I~~~~~~~---------------------~~p~------~~~~s~~~~dlI~~lL~-dp~~R~ 390 (510)
+|.+||.+.+..+....+....... ..+. .+.+++++.+||.+||+ ||.+||
T Consensus 237 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 316 (371)
T 4exu_A 237 TGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRL 316 (371)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSC
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcC
Confidence 9999999988777777665421100 0000 13679999999999999 999999
Q ss_pred CCCChHHhhcCCCcCCCCch
Q 010463 391 GTRGVEELKEHPWFRGIQWD 410 (510)
Q Consensus 391 ~~~~~~eil~HpfF~~i~~~ 410 (510)
+++|+++||||+.+...
T Consensus 317 ---t~~ell~hp~f~~~~~~ 333 (371)
T 4exu_A 317 ---TAAQALTHPFFEPFRDP 333 (371)
T ss_dssp ---CHHHHHTSGGGTTTCCG
T ss_pred ---CHHHHhcCcccccCCCc
Confidence 78999999999986544
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=410.28 Aligned_cols=254 Identities=25% Similarity=0.454 Sum_probs=215.2
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc------CCCCeeeEeEEeecC
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV------DSRCIVQLFYSFQDS 178 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l------~hp~Iv~l~~~~~~~ 178 (510)
..+|++++.||+|+||+||+|++..+++.||||++... ......+.+|+.+|..+ +|+||++++++|...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 35799999999999999999999999999999999754 23345677888888877 678999999999999
Q ss_pred ceEEEEEeccCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCc--eeecccCCcc
Q 010463 179 DFLYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH--LKLSDFGLCK 254 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~--vkL~DFGla~ 254 (510)
+.+|+||||+. |+|.+++.... .+++..++.++.||+.||.|||+.|||||||||+||||+.+|. +||+|||+|+
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999999996 59999987754 4999999999999999999999999999999999999999988 9999999997
Q ss_pred cCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHH
Q 010463 255 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIM 334 (510)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvil 334 (510)
..... ..+.+||+.|+|||++.+..|+.++|||||||+|
T Consensus 251 ~~~~~-----------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 289 (429)
T 3kvw_A 251 YEHQR-----------------------------------------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCIL 289 (429)
T ss_dssp ETTCC-----------------------------------------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHH
T ss_pred ecCCc-----------------------------------------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHH
Confidence 54321 1246899999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCChhhhHHHHhhccccc------------------cCC-----------------------------C
Q 010463 335 YEMLIGYPPFCSDDPRITCRKIVNWKTCL------------------KFP-----------------------------E 367 (510)
Q Consensus 335 yEml~G~~PF~~~~~~~~~~~I~~~~~~~------------------~~p-----------------------------~ 367 (510)
|||++|.+||.+.+.......++...... .+| .
T Consensus 290 ~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (429)
T 3kvw_A 290 AELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPE 369 (429)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTT
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCcc
Confidence 99999999999988877766665310000 000 0
Q ss_pred --------CCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 368 --------EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 368 --------~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
....++++.+||++||+ ||.+|| +++|+++||||+..
T Consensus 370 ~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rp---ta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 370 SREWGNALKGCDDPLFLDFLKQCLEWDPAVRM---TPGQALRHPWLRRR 415 (429)
T ss_dssp CSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSC---CHHHHHTSTTTC--
T ss_pred chhhHhhccccchHHHHHHHHHHCCCChhhCC---CHHHHhCChhhccC
Confidence 01247889999999999 999999 78999999999863
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=388.55 Aligned_cols=261 Identities=25% Similarity=0.435 Sum_probs=221.1
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcc-hhhHHHHHHHHHHHHhcCCCCeeeEeEEe--ecCceE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLK-RGQVEHVRSERNLLAEVDSRCIVQLFYSF--QDSDFL 181 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~--~~~~~~ 181 (510)
.++|++++.||+|+||.||+|.++.+++.||+|++.+..... ......+.+|+.++..++||||+++++++ .+...+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999999999999999998764432 34567799999999999999999999998 455689
Q ss_pred EEEEeccCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 182 YLIMEYLPGGDIMTLLMR--EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~--~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
|+||||+++| |.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++......
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999999887 7777765 457999999999999999999999999999999999999999999999999999865432
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCC--CccccccchhhHHHHH
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY--GMECDWWSLGAIMYEM 337 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y--~~~~DiwSlGvilyEm 337 (510)
... .......||+.|+|||++.+... +.++|||||||++|||
T Consensus 163 ~~~------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l 206 (305)
T 2wtk_C 163 AAD------------------------------------DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNI 206 (305)
T ss_dssp CSS------------------------------------CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHH
T ss_pred ccc------------------------------------cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHH
Confidence 100 01124579999999999986543 7899999999999999
Q ss_pred hhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCc
Q 010463 338 LIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQW 409 (510)
Q Consensus 338 l~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~ 409 (510)
++|..||.+.+.......+... ...+| ..+++.+.+||.+||. ||.+|| +++|+++||||+....
T Consensus 207 ~~g~~p~~~~~~~~~~~~i~~~--~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 207 TTGLYPFEGDNIYKLFENIGKG--SYAIP--GDCGPPLSDLLKGMLEYEPAKRF---SIRQIRQHSWFRKKHP 272 (305)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHC--CCCCC--SSSCHHHHHHHHHHTCSSTTTSC---CHHHHHHSHHHHSCCC
T ss_pred HhCCCCCCCchHHHHHHHHhcC--CCCCC--CccCHHHHHHHHHHccCChhhCC---CHHHHhcCcccccCCC
Confidence 9999999998888888777763 23344 4789999999999998 999999 7899999999987553
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-49 Score=409.45 Aligned_cols=262 Identities=24% Similarity=0.381 Sum_probs=196.9
Q ss_pred CCcee-eeeeecCCCeEEEEEEEc--CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEee--cCce
Q 010463 106 DDFEQ-LTLIGKGAFGEVRLCRAK--TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ--DSDF 180 (510)
Q Consensus 106 ~~f~~-~~~IG~G~fG~V~~~~~~--~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~--~~~~ 180 (510)
+.|++ .++||+|+||+||+|+++ .+++.||||++..... ...+.+|+.+|+.++|||||+++++|. +...
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 34666 457999999999999977 4688999999975432 235788999999999999999999994 5779
Q ss_pred EEEEEeccCCCCHHHHHHhc---------cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeee----cCCCceee
Q 010463 181 LYLIMEYLPGGDIMTLLMRE---------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL----DKNGHLKL 247 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~---------~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILl----d~~g~vkL 247 (510)
+|+||||+.| +|.+++... ..+++..++.++.||+.||.|||+.|||||||||+|||| +.+|.+||
T Consensus 95 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 95 VWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999999964 888887532 249999999999999999999999999999999999999 77899999
Q ss_pred cccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC-CCCcccc
Q 010463 248 SDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECD 326 (510)
Q Consensus 248 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~D 326 (510)
+|||+|+.+....... ....+.+||+.|+|||++.+. .|+.++|
T Consensus 174 ~Dfg~a~~~~~~~~~~-----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~D 218 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPL-----------------------------------ADLDPVVVTFWYRAPELLLGARHYTKAID 218 (405)
T ss_dssp CCTTCCC---------------------------------------------------CCCTTCCHHHHTTCCSCCHHHH
T ss_pred EECCCceecCCCCccc-----------------------------------ccCCCceecCcccCchhhcCCCcccchhh
Confidence 9999998764321100 011246899999999999874 5899999
Q ss_pred ccchhhHHHHHhhCCCCCCCCChh---------hhHHHHhhccccccCCC------------------------------
Q 010463 327 WWSLGAIMYEMLIGYPPFCSDDPR---------ITCRKIVNWKTCLKFPE------------------------------ 367 (510)
Q Consensus 327 iwSlGvilyEml~G~~PF~~~~~~---------~~~~~I~~~~~~~~~p~------------------------------ 367 (510)
||||||++|||++|.+||.+.+.. .....|+..-.......
T Consensus 219 iwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (405)
T 3rgf_A 219 IWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKY 298 (405)
T ss_dssp HHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHH
T ss_pred hHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhh
Confidence 999999999999999999876542 33344432111000000
Q ss_pred ----CCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchh
Q 010463 368 ----EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDK 411 (510)
Q Consensus 368 ----~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~ 411 (510)
....++++.+||.+||+ ||.+|| +++|+++||||.+..|..
T Consensus 299 ~~~~~~~~~~~~~~Ll~~~L~~dP~~R~---ta~e~L~hp~f~~~~~~~ 344 (405)
T 3rgf_A 299 MEKHKVKPDSKAFHLLQKLLTMDPIKRI---TSEQAMQDPYFLEDPLPT 344 (405)
T ss_dssp HHTTTCCTTSHHHHHHHHHSCSSGGGSC---CHHHHHTSGGGTSSSCCC
T ss_pred HhhcCCCCCHHHHHHHHHHccCCcccCC---CHHHHhcChhhccCCCCc
Confidence 01237899999999999 999999 789999999999876544
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=390.80 Aligned_cols=256 Identities=23% Similarity=0.343 Sum_probs=214.0
Q ss_pred hhcccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC
Q 010463 99 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 178 (510)
Q Consensus 99 ~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 178 (510)
....+..++|++.+.||+|+||+||+|++ +|+.||||++.+... .....+.+.+|+.+|+.++||||+++++++.+.
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 34456778999999999999999999976 588999999976543 344567789999999999999999999999999
Q ss_pred ceEEEEEeccCCCCHHHHHHhccC---CCHHHHHHHHHHHHHHHHhhhhCC--eEEeecCCCCeeecCCCceeecccCCc
Q 010463 179 DFLYLIMEYLPGGDIMTLLMREDI---LSEDVARFYIAESVLAIHSIHQHN--YVHRDIKPDNLILDKNGHLKLSDFGLC 253 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~~~---l~e~~~~~~~~qi~~aL~~lH~~g--iiHRDLKP~NILld~~g~vkL~DFGla 253 (510)
+.+|+||||++||+|.+++.+.+. +++..+..++.||+.||.|||+.| |+||||||+|||++.+|.+||+|||++
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 999999999999999999987543 999999999999999999999999 999999999999999999999999999
Q ss_pred ccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhH
Q 010463 254 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 333 (510)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvi 333 (510)
+....... ...+.+||+.|+|||++.+..++.++|||||||+
T Consensus 187 ~~~~~~~~--------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 228 (309)
T 3p86_A 187 RLKASTFL--------------------------------------SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVI 228 (309)
T ss_dssp -----------------------------------------------------CCTTSCHHHHTTCCCCTTHHHHHHHHH
T ss_pred cccccccc--------------------------------------ccccCCCCccccChhhhcCCCCCchhhHHHHHHH
Confidence 75432210 0124579999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 334 MYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 334 lyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
+|||++|..||.+.+.......+........+| ..+++++.+||.+||. ||.+|| ++.++++
T Consensus 229 l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rp---s~~~ll~ 291 (309)
T 3p86_A 229 LWELATLQQPWGNLNPAQVVAAVGFKCKRLEIP--RNLNPQVAAIIEGCWTNEPWKRP---SFATIMD 291 (309)
T ss_dssp HHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCC--TTSCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--ccCCHHHHHHHHHHccCChhhCc---CHHHHHH
Confidence 999999999999988887777775544445555 4799999999999998 999999 6778775
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=388.55 Aligned_cols=263 Identities=29% Similarity=0.479 Sum_probs=222.1
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEE
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l 183 (510)
..++|++++.||+|+||.||+|.++.+|+.||+|++.... ....+.+|+.+|..++||||+++++++.+.+.+|+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 3578999999999999999999999999999999997542 23568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHH-hccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccc
Q 010463 184 IMEYLPGGDIMTLLM-REDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 262 (510)
Q Consensus 184 VmEy~~gG~L~~~L~-~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 262 (510)
||||++||+|.+++. ....+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||++........
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~- 180 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA- 180 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-
Confidence 999999999999997 456799999999999999999999999999999999999999999999999999986543210
Q ss_pred ccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCC
Q 010463 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 342 (510)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~ 342 (510)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 181 -------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 223 (314)
T 3com_A 181 -------------------------------------KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKP 223 (314)
T ss_dssp -------------------------------------CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred -------------------------------------ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCC
Confidence 0124579999999999999999999999999999999999999
Q ss_pred CCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchhhh
Q 010463 343 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLY 413 (510)
Q Consensus 343 PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l~ 413 (510)
||.+.+.......+.... ...+.....+++.+.+||.+||. ||.+|| +++++++||||++..+....
T Consensus 224 p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---t~~~ll~~~~~~~~~~~~~~ 291 (314)
T 3com_A 224 PYADIHPMRAIFMIPTNP-PPTFRKPELWSDNFTDFVKQCLVKSPEQRA---TATQLLQHPFVRSAKGVSIL 291 (314)
T ss_dssp TTTTSCHHHHHHHHHHSC-CCCCSSGGGSCHHHHHHHHHHTCSCTTTSC---CHHHHTTSHHHHTCCCGGGG
T ss_pred CCCCCChHHHHHHHhcCC-CcccCCcccCCHHHHHHHHHHccCChhhCc---CHHHHHhCHHHhcCCcchHH
Confidence 998877666555444321 22222234689999999999998 999999 78999999999998776554
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=391.32 Aligned_cols=266 Identities=29% Similarity=0.475 Sum_probs=220.7
Q ss_pred hcccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeec-
Q 010463 100 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQD- 177 (510)
Q Consensus 100 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~- 177 (510)
......++|++++.||+|+||.||+|++..+|+.||+|++.... .....+.+|+.++..+ +||||+++++++.+
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 34455689999999999999999999999999999999997542 2345688999999998 89999999999987
Q ss_pred -----CceEEEEEeccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeeccc
Q 010463 178 -----SDFLYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDF 250 (510)
Q Consensus 178 -----~~~~~lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DF 250 (510)
.+.+|+||||++||+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Df 173 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF 173 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeC
Confidence 56899999999999999999764 57999999999999999999999999999999999999999999999999
Q ss_pred CCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc-----cCCCCccc
Q 010463 251 GLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMEC 325 (510)
Q Consensus 251 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-----~~~y~~~~ 325 (510)
|++........ .....+||+.|+|||++. +..++.++
T Consensus 174 g~~~~~~~~~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~ 215 (326)
T 2x7f_A 174 GVSAQLDRTVG--------------------------------------RRNTFIGTPYWMAPEVIACDENPDATYDFKS 215 (326)
T ss_dssp TTTC---------------------------------------------------CCGGGCCHHHHC--------CCTTH
T ss_pred cCceecCcCcc--------------------------------------ccccccCCccccChhhhccccccCcCCCccc
Confidence 99986543210 012357999999999997 56789999
Q ss_pred cccchhhHHHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 326 DWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 326 DiwSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
|||||||++|+|++|.+||.+.+.......+...... ......+++.+.+||.+||. ||.+|| +++++++||||
T Consensus 216 Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~hp~~ 290 (326)
T 2x7f_A 216 DLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP--RLKSKKWSKKFQSFIESCLVKNHSQRP---ATEQLMKHPFI 290 (326)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC--CCSCSCSCHHHHHHHHHHCCSSGGGSC---CHHHHHTSHHH
T ss_pred hHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc--cCCccccCHHHHHHHHHHhccChhhCC---CHHHHhhChHH
Confidence 9999999999999999999988877666666543221 11234789999999999998 999999 78999999999
Q ss_pred CCCCchhh
Q 010463 405 RGIQWDKL 412 (510)
Q Consensus 405 ~~i~~~~l 412 (510)
++..+...
T Consensus 291 ~~~~~~~~ 298 (326)
T 2x7f_A 291 RDQPNERQ 298 (326)
T ss_dssp HCCTTHHH
T ss_pred hhCccccc
Confidence 98877553
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=394.87 Aligned_cols=258 Identities=29% Similarity=0.445 Sum_probs=216.7
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCce----
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF---- 180 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~---- 180 (510)
.++|.+.+.||+|+||.||+|+++.+|+.||||++.+.. ........+.+|+.+|+.++||||+++++++.+.+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 368999999999999999999999999999999997643 234456778899999999999999999999987754
Q ss_pred --EEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 181 --LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 181 --~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
+|+||||+. |+|.+++.. .+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||+++....
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred eeEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 499999997 588888743 599999999999999999999999999999999999999999999999999986432
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHH
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEM 337 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEm 337 (510)
. ....+||+.|+|||++.+ ..++.++|||||||++|||
T Consensus 179 ~-----------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el 217 (353)
T 3coi_A 179 E-----------------------------------------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEM 217 (353)
T ss_dssp ----------------------------------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHH
T ss_pred C-----------------------------------------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHH
Confidence 1 113579999999999987 6789999999999999999
Q ss_pred hhCCCCCCCCChhhhHHHHhhcccc--------------------------ccCC-CCCCCCHHHHHHHHHhhc-Ccccc
Q 010463 338 LIGYPPFCSDDPRITCRKIVNWKTC--------------------------LKFP-EEPKISDEARDLICHLLC-DVETR 389 (510)
Q Consensus 338 l~G~~PF~~~~~~~~~~~I~~~~~~--------------------------~~~p-~~~~~s~~~~dlI~~lL~-dp~~R 389 (510)
++|.+||.+.+.......+...... ..++ ..+.+++++.+||.+||+ ||.+|
T Consensus 218 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 297 (353)
T 3coi_A 218 LTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKR 297 (353)
T ss_dssp HHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTS
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccC
Confidence 9999999998877666665431100 0011 123679999999999999 99999
Q ss_pred CCCCChHHhhcCCCcCCCCch
Q 010463 390 LGTRGVEELKEHPWFRGIQWD 410 (510)
Q Consensus 390 ~~~~~~~eil~HpfF~~i~~~ 410 (510)
| +++++++||||+.+...
T Consensus 298 p---t~~e~l~hp~f~~~~~~ 315 (353)
T 3coi_A 298 L---TAAQALTHPFFEPFRDP 315 (353)
T ss_dssp C---CHHHHHTSGGGTTTCCG
T ss_pred C---CHHHHhcCcchhhccCc
Confidence 9 78999999999976543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=398.75 Aligned_cols=258 Identities=31% Similarity=0.470 Sum_probs=202.7
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc-----
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD----- 179 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~----- 179 (510)
.++|++++.||+|+||.||+|+++.+|+.||||++.+.... ......|...+..++||||++++++|.+.+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 57899999999999999999999999999999998664322 234566788888999999999999996543
Q ss_pred --eEEEEEeccCCCCHHHH----HHhccCCCHHHHHHHHHHHHHHHHhhh--hCCeEEeecCCCCeeecC-CCceeeccc
Q 010463 180 --FLYLIMEYLPGGDIMTL----LMREDILSEDVARFYIAESVLAIHSIH--QHNYVHRDIKPDNLILDK-NGHLKLSDF 250 (510)
Q Consensus 180 --~~~lVmEy~~gG~L~~~----L~~~~~l~e~~~~~~~~qi~~aL~~lH--~~giiHRDLKP~NILld~-~g~vkL~DF 250 (510)
.+|+||||++|+ |... +.....+++..++.++.||+.||.||| +.||+||||||+||||+. +|++||+||
T Consensus 98 ~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Df 176 (360)
T 3e3p_A 98 DIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176 (360)
T ss_dssp CEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCC
T ss_pred ceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeC
Confidence 389999999875 4333 335677999999999999999999999 999999999999999996 899999999
Q ss_pred CCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCC-CCccccccc
Q 010463 251 GLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG-YGMECDWWS 329 (510)
Q Consensus 251 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~-y~~~~DiwS 329 (510)
|+++.+..... ....+||+.|+|||++.+.. ++.++||||
T Consensus 177 g~a~~~~~~~~---------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~s 217 (360)
T 3e3p_A 177 GSAKKLSPSEP---------------------------------------NVAYICSRYYRAPELIFGNQHYTTAVDIWS 217 (360)
T ss_dssp TTCBCCCTTSC---------------------------------------CCSTTSCGGGCCHHHHTTCSSCCTHHHHHH
T ss_pred CCceecCCCCC---------------------------------------cccccCCcceeCHHHHcCCCCCCcHHHHHH
Confidence 99987643211 12457999999999997654 899999999
Q ss_pred hhhHHHHHhhCCCCCCCCChhhhHHHHhhccccc---------------c------------CC-CCCCCCHHHHHHHHH
Q 010463 330 LGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCL---------------K------------FP-EEPKISDEARDLICH 381 (510)
Q Consensus 330 lGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~~---------------~------------~p-~~~~~s~~~~dlI~~ 381 (510)
|||++|||++|.+||.+.+.......+....... . ++ .....++++.+||.+
T Consensus 218 lG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 297 (360)
T 3e3p_A 218 VGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSA 297 (360)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHH
Confidence 9999999999999999988887777775421100 0 00 012367899999999
Q ss_pred hhc-CccccCCCCChHHhhcCCCcCCCCc
Q 010463 382 LLC-DVETRLGTRGVEELKEHPWFRGIQW 409 (510)
Q Consensus 382 lL~-dp~~R~~~~~~~eil~HpfF~~i~~ 409 (510)
||+ ||.+|| ++.|+++||||+++.+
T Consensus 298 ~L~~dP~~Rp---t~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 298 LLQYLPEERM---KPYEALCHPYFDELHD 323 (360)
T ss_dssp HTCSSGGGSC---CHHHHTTSGGGGGGGC
T ss_pred HhccCccccC---CHHHHhcCccccccCC
Confidence 999 999999 7899999999998653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-48 Score=389.55 Aligned_cols=262 Identities=27% Similarity=0.422 Sum_probs=219.2
Q ss_pred CCCceeeeeeecCCCeEEEEEEEc-CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc---CCCCeeeEeEEee----
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAK-TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV---DSRCIVQLFYSFQ---- 176 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~-~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~~~---- 176 (510)
.++|++++.||+|+||.||+|++. .+|+.||+|++..... .......+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBC-TTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcc-cccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 478999999999999999999995 6889999999976432 112223456777777666 8999999999987
Q ss_pred -cCceEEEEEeccCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCc
Q 010463 177 -DSDFLYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLC 253 (510)
Q Consensus 177 -~~~~~~lVmEy~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla 253 (510)
+...+|+||||++ |+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence 6678999999998 59999997753 4999999999999999999999999999999999999999999999999999
Q ss_pred ccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhH
Q 010463 254 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 333 (510)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvi 333 (510)
+...... .....+||+.|+|||++.+..++.++|||||||+
T Consensus 168 ~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 208 (326)
T 1blx_A 168 RIYSFQM---------------------------------------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCI 208 (326)
T ss_dssp CCCCGGG---------------------------------------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHH
T ss_pred ccccCCC---------------------------------------CccccccccceeCHHHHhcCCCCcchhHHHHHHH
Confidence 8654321 0124679999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCChhhhHHHHhhccc---------cccCC--------------CCCCCCHHHHHHHHHhhc-Ccccc
Q 010463 334 MYEMLIGYPPFCSDDPRITCRKIVNWKT---------CLKFP--------------EEPKISDEARDLICHLLC-DVETR 389 (510)
Q Consensus 334 lyEml~G~~PF~~~~~~~~~~~I~~~~~---------~~~~p--------------~~~~~s~~~~dlI~~lL~-dp~~R 389 (510)
+|||++|.+||.+.+......+++.... ....+ ....+++.+++||.+||. ||.+|
T Consensus 209 l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 288 (326)
T 1blx_A 209 FAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKR 288 (326)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTS
T ss_pred HHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccC
Confidence 9999999999999888777777764211 00000 014689999999999998 99999
Q ss_pred CCCCChHHhhcCCCcCCCCch
Q 010463 390 LGTRGVEELKEHPWFRGIQWD 410 (510)
Q Consensus 390 ~~~~~~~eil~HpfF~~i~~~ 410 (510)
| ++.|+++||||+++++.
T Consensus 289 p---t~~e~l~hp~~~~~~~~ 306 (326)
T 1blx_A 289 I---SAYSALSHPYFQDLERC 306 (326)
T ss_dssp C---CHHHHHTSGGGTTCCCC
T ss_pred C---CHHHHhcCccccccchh
Confidence 9 78999999999988764
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=403.90 Aligned_cols=254 Identities=23% Similarity=0.364 Sum_probs=208.6
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC--------CCCeeeEeEEe
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD--------SRCIVQLFYSF 175 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~--------hp~Iv~l~~~~ 175 (510)
-.++|++++.||+|+||+||+|++..+|+.||||++.+. ....+.+.+|+.+|+.+. ||||++++++|
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~ 110 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence 357899999999999999999999999999999999754 234567889999999885 78899999999
Q ss_pred e----cCceEEEEEeccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhC-CeEEeecCCCCeeecCCC-----
Q 010463 176 Q----DSDFLYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQH-NYVHRDIKPDNLILDKNG----- 243 (510)
Q Consensus 176 ~----~~~~~~lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~-giiHRDLKP~NILld~~g----- 243 (510)
. +...+|+||||+ +|+|.+.+... ..+++..++.++.||+.||.|||++ |||||||||+||||+.+|
T Consensus 111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 111 KISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp EEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHH
T ss_pred eecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhh
Confidence 8 667899999999 66777776554 5699999999999999999999998 999999999999999876
Q ss_pred --------------------------------------------ceeecccCCcccCccccccccchhhhhhcccccccc
Q 010463 244 --------------------------------------------HLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEA 279 (510)
Q Consensus 244 --------------------------------------------~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (510)
.+||+|||+++.....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-------------------- 249 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-------------------- 249 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--------------------
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--------------------
Confidence 7999999999865432
Q ss_pred cccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCCCChh------hhH
Q 010463 280 EGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPR------ITC 353 (510)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~~~~~------~~~ 353 (510)
....+||+.|+|||++.+..|+.++|||||||+||||++|.+||.+.+.. ...
T Consensus 250 ---------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 308 (397)
T 1wak_A 250 ---------------------FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHI 308 (397)
T ss_dssp ---------------------SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHH
T ss_pred ---------------------CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHH
Confidence 12357999999999999999999999999999999999999999875532 222
Q ss_pred HHHhhccccc--------------------------------------cCCCCCCCCHHHHHHHHHhhc-CccccCCCCC
Q 010463 354 RKIVNWKTCL--------------------------------------KFPEEPKISDEARDLICHLLC-DVETRLGTRG 394 (510)
Q Consensus 354 ~~I~~~~~~~--------------------------------------~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~ 394 (510)
..+....... .++.....++++.+||.+||+ ||.+|| +
T Consensus 309 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t 385 (397)
T 1wak_A 309 ALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRA---T 385 (397)
T ss_dssp HHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSC---C
T ss_pred HHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcC---C
Confidence 2222110000 000012345678999999999 999999 7
Q ss_pred hHHhhcCCCcCC
Q 010463 395 VEELKEHPWFRG 406 (510)
Q Consensus 395 ~~eil~HpfF~~ 406 (510)
++|+++||||++
T Consensus 386 ~~e~l~hp~~~~ 397 (397)
T 1wak_A 386 AAECLRHPWLNS 397 (397)
T ss_dssp HHHHHTSGGGGC
T ss_pred HHHHhhCccccC
Confidence 899999999974
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=383.56 Aligned_cols=254 Identities=30% Similarity=0.453 Sum_probs=223.5
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
+.|++++.||+|+||.||+|+++.+|+.||+|++..... ....+.+.+|+.++..++||||+++++++.+...+|+||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 569999999999999999999999999999999976542 345678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
||++||+|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++..+.....
T Consensus 100 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~---- 174 (303)
T 3a7i_A 100 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI---- 174 (303)
T ss_dssp ECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC----
T ss_pred EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccc----
Confidence 99999999999865 5799999999999999999999999999999999999999999999999999986543210
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCC
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~ 345 (510)
.....+||+.|+|||++.+..++.++|+|||||++|||++|.+||.
T Consensus 175 ----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 220 (303)
T 3a7i_A 175 ----------------------------------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHS 220 (303)
T ss_dssp ----------------------------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ----------------------------------ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCC
Confidence 0124579999999999999999999999999999999999999999
Q ss_pred CCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 346 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 346 ~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
+.+.......+.... ...++ ..++..+.+||.+||. ||.+|| +++++++||||..
T Consensus 221 ~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~~~~~~~ 276 (303)
T 3a7i_A 221 ELHPMKVLFLIPKNN-PPTLE--GNYSKPLKEFVEACLNKEPSFRP---TAKELLKHKFILR 276 (303)
T ss_dssp TSCHHHHHHHHHHSC-CCCCC--SSCCHHHHHHHHHHCCSSGGGSC---CHHHHTTCHHHHH
T ss_pred CcCHHHHHHHhhcCC-CCCCc--cccCHHHHHHHHHHcCCChhhCc---CHHHHhhChhhhc
Confidence 887776666655432 22222 4789999999999998 999999 7899999999964
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=382.30 Aligned_cols=258 Identities=33% Similarity=0.549 Sum_probs=222.2
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEee--cCceE
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ--DSDFL 181 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~--~~~~~ 181 (510)
..++|++++.||+|+||.||+|+++.+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++. +...+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 35789999999999999999999999999999999986543 3445678999999999999999999999884 46789
Q ss_pred EEEEeccCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHhhhhCC-----eEEeecCCCCeeecCCCceeecccCC
Q 010463 182 YLIMEYLPGGDIMTLLMRED----ILSEDVARFYIAESVLAIHSIHQHN-----YVHRDIKPDNLILDKNGHLKLSDFGL 252 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~----~l~e~~~~~~~~qi~~aL~~lH~~g-----iiHRDLKP~NILld~~g~vkL~DFGl 252 (510)
|+||||++||+|.+++.... .+++..++.++.||+.||.|||+.| |+||||||+|||++.+|++||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 99999999999999997643 4999999999999999999999999 99999999999999999999999999
Q ss_pred cccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhh
Q 010463 253 CKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGA 332 (510)
Q Consensus 253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGv 332 (510)
++....... .....+||+.|+|||++.+..++.++|||||||
T Consensus 163 ~~~~~~~~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 204 (279)
T 2w5a_A 163 ARILNHDTS--------------------------------------FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGC 204 (279)
T ss_dssp HHHC---CH--------------------------------------HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHH
T ss_pred heeeccccc--------------------------------------cccccCCCccccChHHhccCCCCchhhHHHHHH
Confidence 876543210 011357999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 333 IMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 333 ilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
++|+|++|.+||.+.+.......+..... ..+| ..+++++.+||.+||. ||.+|| +++||++|||+.+
T Consensus 205 il~~l~~g~~p~~~~~~~~~~~~i~~~~~-~~~~--~~~~~~l~~li~~~l~~~p~~Rp---s~~~ll~~~~~~~ 273 (279)
T 2w5a_A 205 LLYELCALMPPFTAFSQKELAGKIREGKF-RRIP--YRYSDELNEIITRMLNLKDYHRP---SVEEILENPLILE 273 (279)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHTCC-CCCC--TTSCHHHHHHHHHHTCSSGGGSC---CHHHHHTSTTCCG
T ss_pred HHHHHHHCCCCCcccCHHHHHHHHhhccc-ccCC--cccCHHHHHHHHHHcCCCcccCC---CHHHHHhChhhhh
Confidence 99999999999999888777777766432 2333 3789999999999998 999999 7999999999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=389.34 Aligned_cols=274 Identities=26% Similarity=0.426 Sum_probs=200.7
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCce
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 180 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 180 (510)
..+..++|++++.||+|+||.||+|++..+|+.||+|++..... ......+.+|+.++..++||||+++++++.+.+.
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 45677899999999999999999999999999999999875432 2345678899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHh--------ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCC
Q 010463 181 LYLIMEYLPGGDIMTLLMR--------EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGL 252 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~--------~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGl 252 (510)
.|+||||++||+|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999999874 45699999999999999999999999999999999999999999999999999
Q ss_pred cccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchh
Q 010463 253 CKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLG 331 (510)
Q Consensus 253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlG 331 (510)
+.......... ........+||+.|+|||++.+ ..++.++|+||||
T Consensus 168 ~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG 214 (303)
T 2vwi_A 168 SAFLATGGDIT---------------------------------RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFG 214 (303)
T ss_dssp HHHCC------------------------------------------------CCCTTCCHHHHHHHHCCCTHHHHHHHH
T ss_pred hheeccCCCcc---------------------------------chhhhcccCCCccccCHHHhccccCCCchhhHHHHH
Confidence 87654321000 0001124579999999999976 6789999999999
Q ss_pred hHHHHHhhCCCCCCCCChhhhHHHHhhcccc-cc-----CCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 332 AIMYEMLIGYPPFCSDDPRITCRKIVNWKTC-LK-----FPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 332 vilyEml~G~~PF~~~~~~~~~~~I~~~~~~-~~-----~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
|++|||++|..||.+.+.............. .. ......+++++.+||.+||. ||.+|| ++.++++||||
T Consensus 215 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~ll~h~~~ 291 (303)
T 2vwi_A 215 ITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP---TAAELLRHKFF 291 (303)
T ss_dssp HHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSC---CHHHHHTSTTC
T ss_pred HHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCc---CHHHHhhChhh
Confidence 9999999999999987766655544432111 00 01124688999999999998 999999 78999999999
Q ss_pred CCCCchhh
Q 010463 405 RGIQWDKL 412 (510)
Q Consensus 405 ~~i~~~~l 412 (510)
+...+..+
T Consensus 292 ~~~~~~~~ 299 (303)
T 2vwi_A 292 QKAKNKEF 299 (303)
T ss_dssp --------
T ss_pred hcCCCCcc
Confidence 98776544
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=396.87 Aligned_cols=256 Identities=20% Similarity=0.333 Sum_probs=219.2
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEc-------CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeE
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAK-------TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFY 173 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~-------~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~ 173 (510)
.+..++|++.+.||+|+||.||+|++. .++..||||+++... .....+.+.+|+.+|..+ +|||||++++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 456689999999999999999999975 345679999997642 345567899999999999 8999999999
Q ss_pred EeecCceEEEEEeccCCCCHHHHHHhcc----------------CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCe
Q 010463 174 SFQDSDFLYLIMEYLPGGDIMTLLMRED----------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNL 237 (510)
Q Consensus 174 ~~~~~~~~~lVmEy~~gG~L~~~L~~~~----------------~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NI 237 (510)
+|.+.+.+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++|||||||||+||
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 234 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 234 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence 9999999999999999999999998653 479999999999999999999999999999999999
Q ss_pred eecCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc
Q 010463 238 ILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL 317 (510)
Q Consensus 238 Lld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~ 317 (510)
||+.+|++||+|||+|+.+...... .......||+.|+|||++.
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~------------------------------------~~~~~~~~t~~y~aPE~~~ 278 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYY------------------------------------KKTTNGRLPVKWMAPEALF 278 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTT------------------------------------CTTTTTTSCGGGCCHHHHH
T ss_pred EECCCCCEEEccccCCcccCcccce------------------------------------ecccCCCcccceECHhHhc
Confidence 9999999999999999865432110 0012346889999999999
Q ss_pred cCCCCccccccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCh
Q 010463 318 KKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGV 395 (510)
Q Consensus 318 ~~~y~~~~DiwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~ 395 (510)
+..|+.++|||||||++|||++ |.+||.+.+..+....+.... ....| ..+++++.+||.+||. ||.+|| ++
T Consensus 279 ~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dP~~Rp---t~ 352 (370)
T 2psq_A 279 DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH-RMDKP--ANCTNELYMMMRDCWHAVPSQRP---TF 352 (370)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-CCCCC--TTSCHHHHHHHHHHTCSSGGGSC---CH
T ss_pred CCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-CCCCC--CCCCHHHHHHHHHHcCCChhhCc---CH
Confidence 9999999999999999999999 999999988887777666532 23333 4789999999999998 999999 67
Q ss_pred HHhhcC
Q 010463 396 EELKEH 401 (510)
Q Consensus 396 ~eil~H 401 (510)
.|++++
T Consensus 353 ~ell~~ 358 (370)
T 2psq_A 353 KQLVED 358 (370)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 888753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=394.00 Aligned_cols=256 Identities=20% Similarity=0.312 Sum_probs=212.3
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCE----EEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEee
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEI----FAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ 176 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~----vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 176 (510)
..+..++|++++.||+|+||+||+|++..+|+. ||+|++.... .......+.+|+.++..++||||+++++++.
T Consensus 8 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 85 (325)
T 3kex_A 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP 85 (325)
T ss_dssp CBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence 345678999999999999999999999988887 6666664332 1223345778999999999999999999987
Q ss_pred cCceEEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCccc
Q 010463 177 DSDFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 255 (510)
Q Consensus 177 ~~~~~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~ 255 (510)
.+..++||||++||+|.+++... +.+++..+..++.||+.||.|||+.||+||||||+|||++.+|++||+|||+|+.
T Consensus 86 -~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 86 -GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp -BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred -CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccc
Confidence 45699999999999999999774 5799999999999999999999999999999999999999999999999999987
Q ss_pred CccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHH
Q 010463 256 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 335 (510)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvily 335 (510)
+...... .......||+.|+|||++.+..++.++|||||||++|
T Consensus 165 ~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 208 (325)
T 3kex_A 165 LPPDDKQ------------------------------------LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVW 208 (325)
T ss_dssp SCCCTTC------------------------------------CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred cCccccc------------------------------------ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHH
Confidence 6443111 0112356889999999999999999999999999999
Q ss_pred HHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 336 EMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 336 Eml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
||++ |.+||.+.+.......+... .....| ..+++++.+||.+||. ||.+|| ++.++++|
T Consensus 209 el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~dp~~Rp---s~~el~~~ 270 (325)
T 3kex_A 209 ELMTFGAEPYAGLRLAEVPDLLEKG-ERLAQP--QICTIDVYMVMVKCWMIDENIRP---TFKELANE 270 (325)
T ss_dssp HHHTTSCCTTTTSCTTHHHHHHHTT-CBCCCC--TTBCTTTTHHHHHHTCSCTTTSC---CHHHHHHH
T ss_pred HHHhCCCCCccccCHHHHHHHHHcC-CCCCCC--CcCcHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 9999 99999988877776666653 223333 4688899999999998 999999 67777765
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=399.50 Aligned_cols=258 Identities=29% Similarity=0.421 Sum_probs=214.0
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CC-----CeeeEeEEee
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SR-----CIVQLFYSFQ 176 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~-hp-----~Iv~l~~~~~ 176 (510)
.-.++|++++.||+|+||+||+|+++.+|+.||||++... ......+..|+.++..+. |+ +|++++++|.
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 3457999999999999999999999999999999999753 233456778899988875 44 4999999999
Q ss_pred cCceEEEEEeccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhh--hCCeEEeecCCCCeeec--CCCceeeccc
Q 010463 177 DSDFLYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIH--QHNYVHRDIKPDNLILD--KNGHLKLSDF 250 (510)
Q Consensus 177 ~~~~~~lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH--~~giiHRDLKP~NILld--~~g~vkL~DF 250 (510)
+.+.+|+||||++| +|.+++... ..+++..++.++.||+.||.||| +.|||||||||+||||+ .++.+||+||
T Consensus 127 ~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 127 FRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp ETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred cCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 99999999999965 999999775 46999999999999999999999 57999999999999995 5788999999
Q ss_pred CCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccch
Q 010463 251 GLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSL 330 (510)
Q Consensus 251 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSl 330 (510)
|+|+..... ....+||+.|+|||++.+..|+.++|||||
T Consensus 206 G~a~~~~~~-----------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 244 (382)
T 2vx3_A 206 GSSCQLGQR-----------------------------------------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSL 244 (382)
T ss_dssp TTCEETTCC-----------------------------------------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred cCceecccc-----------------------------------------cccccCCccccChHHHcCCCCCcHHHHHHH
Confidence 999865432 124689999999999999999999999999
Q ss_pred hhHHHHHhhCCCCCCCCChhhhHHHHhhccccc----------------cCCC-------------------CCC-----
Q 010463 331 GAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCL----------------KFPE-------------------EPK----- 370 (510)
Q Consensus 331 GvilyEml~G~~PF~~~~~~~~~~~I~~~~~~~----------------~~p~-------------------~~~----- 370 (510)
||++|||++|.+||.+.+......+|+...... .+|. ...
T Consensus 245 G~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 324 (382)
T 2vx3_A 245 GCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNIL 324 (382)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHH
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHh
Confidence 999999999999999988887777766421100 0000 000
Q ss_pred --------------------CCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCc
Q 010463 371 --------------------ISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQW 409 (510)
Q Consensus 371 --------------------~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~ 409 (510)
.++++++||.+||. ||++|| +++|+++||||++..|
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rp---ta~e~L~hp~f~~~~~ 381 (382)
T 2vx3_A 325 GVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRI---QPYYALQHSFFKKTAD 381 (382)
T ss_dssp TTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSC---CHHHHTTSGGGCC---
T ss_pred hccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCC---CHHHHhcCcccccCCC
Confidence 01478999999999 999999 7899999999987654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=388.86 Aligned_cols=264 Identities=27% Similarity=0.433 Sum_probs=214.2
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEee--------
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ-------- 176 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-------- 176 (510)
.++|++++.||+|+||.||+|+++.+|+.||+|++... .....+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 46899999999999999999999999999999998754 3455677899999999999999999999874
Q ss_pred ------cCceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeec-CCCceeecc
Q 010463 177 ------DSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD-KNGHLKLSD 249 (510)
Q Consensus 177 ------~~~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld-~~g~vkL~D 249 (510)
+...+|+||||++ |+|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+|
T Consensus 87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp ----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred ccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 4468999999997 599999864 6799999999999999999999999999999999999997 567999999
Q ss_pred cCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCcccccc
Q 010463 250 FGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWW 328 (510)
Q Consensus 250 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~Diw 328 (510)
||+++........ ........||+.|+|||++.+ ..++.++|||
T Consensus 165 fg~~~~~~~~~~~-----------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~ 209 (320)
T 2i6l_A 165 FGLARIMDPHYSH-----------------------------------KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMW 209 (320)
T ss_dssp CTTCBCC-------------------------------------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHH
T ss_pred CccccccCCCccc-----------------------------------ccccccccccccccCcHHhcCcccCCchhhhH
Confidence 9999876432110 001123578999999999876 7789999999
Q ss_pred chhhHHHHHhhCCCCCCCCChhhhHHHHhhcccc--------------------ccCCC------CCCCCHHHHHHHHHh
Q 010463 329 SLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTC--------------------LKFPE------EPKISDEARDLICHL 382 (510)
Q Consensus 329 SlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~--------------------~~~p~------~~~~s~~~~dlI~~l 382 (510)
||||++|||++|.+||.+.+.......+...... ...+. .+.+++++++||.+|
T Consensus 210 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 289 (320)
T 2i6l_A 210 AAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQI 289 (320)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTT
T ss_pred hHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHH
Confidence 9999999999999999998887777666542110 00010 136899999999999
Q ss_pred hc-CccccCCCCChHHhhcCCCcCCCCchh
Q 010463 383 LC-DVETRLGTRGVEELKEHPWFRGIQWDK 411 (510)
Q Consensus 383 L~-dp~~R~~~~~~~eil~HpfF~~i~~~~ 411 (510)
|. ||.+|| +++|+++||||+..+|..
T Consensus 290 L~~dP~~Rp---t~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 290 LTFSPMDRL---TAEEALSHPYMSIYSFPM 316 (320)
T ss_dssp SCSSGGGSC---CHHHHHTSHHHHTTCC--
T ss_pred cCCCccccC---CHHHHhCCcccccccCcc
Confidence 98 999999 789999999999888753
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=389.87 Aligned_cols=258 Identities=26% Similarity=0.443 Sum_probs=215.9
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEE-cCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCC------CeeeEeEE
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRA-KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR------CIVQLFYS 174 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~-~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp------~Iv~l~~~ 174 (510)
.+-.++|++++.||+|+||.||+|.+ +.+|+.||+|++... ....+.+.+|+.++..++|+ +|++++++
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~ 85 (339)
T 1z57_A 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEW 85 (339)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEE
T ss_pred CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecc
Confidence 34457999999999999999999998 568999999999753 23456688899999888665 59999999
Q ss_pred eecCceEEEEEeccCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecC-----------
Q 010463 175 FQDSDFLYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK----------- 241 (510)
Q Consensus 175 ~~~~~~~~lVmEy~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~----------- 241 (510)
|.+.+.+|+||||+ +|+|.+++...+ .+++..++.++.||+.||+|||+.||+||||||+|||++.
T Consensus 86 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 86 FEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC---
T ss_pred cccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcc
Confidence 99999999999999 889999998765 6899999999999999999999999999999999999987
Q ss_pred --------CCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcch
Q 010463 242 --------NGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAP 313 (510)
Q Consensus 242 --------~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~AP 313 (510)
++.+||+|||+++..... ..+.+||+.|+||
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~-----------------------------------------~~~~~gt~~y~aP 203 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH-----------------------------------------HSTLVSTRHYRAP 203 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC-----------------------------------------CCSSCSCGGGCCH
T ss_pred ccccccccCCCceEeeCcccccCccc-----------------------------------------cccccCCccccCh
Confidence 678999999999864321 1245799999999
Q ss_pred HhhccCCCCccccccchhhHHHHHhhCCCCCCCCChhhhHHHHhhccccc-------------------cC---------
Q 010463 314 EVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCL-------------------KF--------- 365 (510)
Q Consensus 314 Evl~~~~y~~~~DiwSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~~-------------------~~--------- 365 (510)
|++.+..++.++|||||||++|||++|.+||.+.+..+....+......+ .+
T Consensus 204 E~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (339)
T 1z57_A 204 EVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRY 283 (339)
T ss_dssp HHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHH
T ss_pred HHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccch
Confidence 99999999999999999999999999999999887766554443211000 00
Q ss_pred ------------CCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCC
Q 010463 366 ------------PEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 408 (510)
Q Consensus 366 ------------p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~ 408 (510)
......++++.+||.+||. ||.+|| ++.|+++||||+.+.
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp---t~~ell~hp~f~~~~ 336 (339)
T 1z57_A 284 VSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI---TLREALKHPFFDLLK 336 (339)
T ss_dssp HHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC---CHHHHTTSGGGGGGG
T ss_pred hhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc---CHHHHhcCHHHHHHh
Confidence 0011335788999999999 999999 789999999998653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=390.23 Aligned_cols=257 Identities=27% Similarity=0.414 Sum_probs=213.0
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc--e
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD--F 180 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~--~ 180 (510)
...++|.+.+.||+|+||+||+|+++.+|+.||||++.+... ....+.+.+|+.+|+.++||||+++++++.+.. .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence 345689999999999999999999999999999999986543 233566789999999999999999999998765 8
Q ss_pred EEEEEeccCCCCHHHHHHhccC---CCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeee----cCCCceeecccCCc
Q 010463 181 LYLIMEYLPGGDIMTLLMREDI---LSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL----DKNGHLKLSDFGLC 253 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~~~---l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILl----d~~g~vkL~DFGla 253 (510)
+|+||||++||+|.+++..... +++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 8999999999999999986543 9999999999999999999999999999999999999 88889999999999
Q ss_pred ccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc--------cCCCCccc
Q 010463 254 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL--------KKGYGMEC 325 (510)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~--------~~~y~~~~ 325 (510)
+...... ...+.+||+.|+|||++. +..++.++
T Consensus 164 ~~~~~~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~ 204 (319)
T 4euu_A 164 RELEDDE---------------------------------------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATV 204 (319)
T ss_dssp EECCTTC---------------------------------------CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTH
T ss_pred eecCCCC---------------------------------------ceeecccCCCccCHHHhhhccccccccCCCCcHH
Confidence 8764321 012467999999999997 57789999
Q ss_pred cccchhhHHHHHhhCCCCCCCCCh----hhhHHHHhhcccc-----------------ccCCCC----CCCCHHHHHHHH
Q 010463 326 DWWSLGAIMYEMLIGYPPFCSDDP----RITCRKIVNWKTC-----------------LKFPEE----PKISDEARDLIC 380 (510)
Q Consensus 326 DiwSlGvilyEml~G~~PF~~~~~----~~~~~~I~~~~~~-----------------~~~p~~----~~~s~~~~dlI~ 380 (510)
|||||||++|||++|.+||..... .....+++..... ..+|.. ..+++.+.+||+
T Consensus 205 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~ 284 (319)
T 4euu_A 205 DLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA 284 (319)
T ss_dssp HHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHH
Confidence 999999999999999999975432 3334444432210 011211 234568899999
Q ss_pred Hhhc-CccccCCCCChHHhhcCCC
Q 010463 381 HLLC-DVETRLGTRGVEELKEHPW 403 (510)
Q Consensus 381 ~lL~-dp~~R~~~~~~~eil~Hpf 403 (510)
+||. ||++|+ +++|+++||=
T Consensus 285 ~~L~~dP~~R~---s~~ell~h~~ 305 (319)
T 4euu_A 285 NILEADQEKCW---GFDQFFAETS 305 (319)
T ss_dssp HHSCCCTTTSC---CHHHHHHHHH
T ss_pred HhccCChhhhc---cHHHhhhccH
Confidence 9998 999999 7899999974
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=390.39 Aligned_cols=266 Identities=21% Similarity=0.252 Sum_probs=213.7
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCceEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~~l 183 (510)
.++|++++.||+|+||+||+|+++.+|+.||||++..... ...+.+|+.+++.+ +||||+++++++.+.+..|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 82 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM 82 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence 4789999999999999999999999999999999875432 23478899999999 99999999999999999999
Q ss_pred EEeccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCc-----eeecccCCcccCc
Q 010463 184 IMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH-----LKLSDFGLCKPLE 257 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~-----vkL~DFGla~~~~ 257 (510)
||||+ ||+|.+++.. ...+++..++.++.||+.||+|||+.||+||||||+|||++.+|+ +||+|||+|+.+.
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred EEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99999 9999999986 467999999999999999999999999999999999999999988 9999999998764
Q ss_pred cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHH
Q 010463 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337 (510)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEm 337 (510)
........ ......+.+||+.|+|||++.+..++.++|||||||++|||
T Consensus 162 ~~~~~~~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el 210 (330)
T 2izr_A 162 DPETKKHI-------------------------------PYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYF 210 (330)
T ss_dssp CTTTCCBC-------------------------------CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cCCCCccc-------------------------------cccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHH
Confidence 43111000 00012356899999999999999999999999999999999
Q ss_pred hhCCCCCCCCCh---hhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc----------CCC
Q 010463 338 LIGYPPFCSDDP---RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE----------HPW 403 (510)
Q Consensus 338 l~G~~PF~~~~~---~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~----------Hpf 403 (510)
++|.+||.+.+. .+.+.++.........+......+++.+||..||. ||.+||+ +++|++ .++
T Consensus 211 l~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~~~li~~~l~~~p~~RP~---~~~l~~~l~~~~~~~~~~~ 287 (330)
T 2izr_A 211 LRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFPEMATYLRYVRRLDFFEKPD---YDYLRKLFTDLFDRKGYMF 287 (330)
T ss_dssp HHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCHHHHHHHHHHHHCCTTCCCC---HHHHHHHHHHHHHHTTCCC
T ss_pred hcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccChHHHHHHHHHHhCCCCCCCC---HHHHHHHHHHHHHHcCCCC
Confidence 999999988543 34455554322111111001223399999999998 9999995 444443 345
Q ss_pred cCCCCch
Q 010463 404 FRGIQWD 410 (510)
Q Consensus 404 F~~i~~~ 410 (510)
...++|+
T Consensus 288 ~~~~dw~ 294 (330)
T 2izr_A 288 DYEYDWI 294 (330)
T ss_dssp SCCCTTT
T ss_pred CCCccCC
Confidence 5567887
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=402.43 Aligned_cols=265 Identities=18% Similarity=0.269 Sum_probs=222.8
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEE-----EcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEee
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCR-----AKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ 176 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~-----~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 176 (510)
.+..++|++++.||+|+||+||+|+ ...+++.||||++.... .......+.+|+.+|+.++|||||++++++.
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 144 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL 144 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 4566889999999999999999999 44578899999996432 3444567889999999999999999999999
Q ss_pred cCceEEEEEeccCCCCHHHHHHhcc-------CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCc---ee
Q 010463 177 DSDFLYLIMEYLPGGDIMTLLMRED-------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH---LK 246 (510)
Q Consensus 177 ~~~~~~lVmEy~~gG~L~~~L~~~~-------~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~---vk 246 (510)
+....|+||||++||+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||||+.+|. +|
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 9999999999999999999998753 4899999999999999999999999999999999999996664 99
Q ss_pred ecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCcccc
Q 010463 247 LSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECD 326 (510)
Q Consensus 247 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 326 (510)
|+|||+|+.+...... ......+||+.|+|||++.+..|+.++|
T Consensus 225 L~DFG~a~~~~~~~~~------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~D 268 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYY------------------------------------RKGGCAMLPVKWMPPEAFMEGIFTSKTD 268 (367)
T ss_dssp ECCCHHHHHHHHHSSC------------------------------------TTCCGGGSCGGGCCHHHHHHCCCCHHHH
T ss_pred ECCCcccccccccccc------------------------------------ccCCCcCCcccEECHHHhcCCCCCcHHH
Confidence 9999999754221000 0112457899999999999999999999
Q ss_pred ccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 327 WWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 327 iwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
||||||++|||++ |.+||.+.+.......+.... ....| ..+++.+.+||.+||. ||.+|| ++.+|++|.++
T Consensus 269 vwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~-~~~~~--~~~~~~l~~li~~~l~~dP~~Rp---s~~eil~~l~~ 342 (367)
T 3l9p_A 269 TWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG-RMDPP--KNCPGPVYRIMTQCWQHQPEDRP---NFAIILERIEY 342 (367)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCC--ccCCHHHHHHHHHHcCCCHhHCc---CHHHHHHHHHH
Confidence 9999999999998 999999998888888777643 22223 4789999999999998 999999 78999999887
Q ss_pred CCCCch
Q 010463 405 RGIQWD 410 (510)
Q Consensus 405 ~~i~~~ 410 (510)
-.-+.+
T Consensus 343 ~~~~~~ 348 (367)
T 3l9p_A 343 CTQDPD 348 (367)
T ss_dssp HHHCHH
T ss_pred HhhChh
Confidence 544433
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=391.31 Aligned_cols=261 Identities=24% Similarity=0.403 Sum_probs=217.4
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCC-CEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCC------eeeEeEEee
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTG-EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC------IVQLFYSFQ 176 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg-~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~------Iv~l~~~~~ 176 (510)
-.++|++++.||+|+||+||+|+++.++ +.||+|++.+. ....+.+.+|+.+|+.+.|++ ++.+++++.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence 3578999999999999999999998877 68999999753 234466888999999887655 999999999
Q ss_pred cCceEEEEEeccCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeee---------------
Q 010463 177 DSDFLYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL--------------- 239 (510)
Q Consensus 177 ~~~~~~lVmEy~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILl--------------- 239 (510)
..+.+|+||||+ +|+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||||
T Consensus 93 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 93 FHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred eCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccc
Confidence 999999999999 667777776653 69999999999999999999999999999999999999
Q ss_pred ----cCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHh
Q 010463 240 ----DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEV 315 (510)
Q Consensus 240 ----d~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEv 315 (510)
+.++.+||+|||+++..... ....+||+.|+|||+
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~-----------------------------------------~~~~~gt~~y~aPE~ 210 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH-----------------------------------------HTTIVATRHYRPPEV 210 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC-----------------------------------------CCSSCSCGGGCCHHH
T ss_pred cccccCCCcEEEeecCcccccccc-----------------------------------------ccCCcCCCcccCCee
Confidence 67889999999999764321 123579999999999
Q ss_pred hccCCCCccccccchhhHHHHHhhCCCCCCCCChhhhHHHHhhccccc-------------------c------------
Q 010463 316 LLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCL-------------------K------------ 364 (510)
Q Consensus 316 l~~~~y~~~~DiwSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~~-------------------~------------ 364 (510)
+.+..++.++|||||||++|||++|.+||.+.+.......+....... .
T Consensus 211 ~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (355)
T 2eu9_A 211 ILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVK 290 (355)
T ss_dssp HTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHH
T ss_pred eecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhcccc
Confidence 999999999999999999999999999999887766554443211100 0
Q ss_pred ---------CCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchhhh
Q 010463 365 ---------FPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLY 413 (510)
Q Consensus 365 ---------~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l~ 413 (510)
.......++++.+||.+||. ||.+|| +++|+++||||++++|+...
T Consensus 291 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp---t~~e~l~hp~f~~~~~~~~~ 346 (355)
T 2eu9_A 291 ENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI---TLAEALLHPFFAGLTPEERS 346 (355)
T ss_dssp HHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC---CHHHHTTSGGGGGCCHHHHC
T ss_pred ccCCcccccccccchhHHHHHHHHHHHhcCChhhCc---CHHHHhcChhhcCCChhhcc
Confidence 00111235688999999998 999999 78999999999999987654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=395.72 Aligned_cols=259 Identities=22% Similarity=0.338 Sum_probs=218.6
Q ss_pred hcccCCCCceeeeeeecCCCeEEEEEE-----EcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeE
Q 010463 100 RRKIGIDDFEQLTLIGKGAFGEVRLCR-----AKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFY 173 (510)
Q Consensus 100 ~~~~~~~~f~~~~~IG~G~fG~V~~~~-----~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~ 173 (510)
...+..++|++++.||+|+||.||+|+ ...+++.||||++.+.. .....+.+.+|+.+|..+ +|||||++++
T Consensus 16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~ 93 (359)
T 3vhe_A 16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG 93 (359)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence 345677899999999999999999999 55677899999997642 344567789999999999 7899999999
Q ss_pred EeecCc-eEEEEEeccCCCCHHHHHHhccC--------------------------------------------------
Q 010463 174 SFQDSD-FLYLIMEYLPGGDIMTLLMREDI-------------------------------------------------- 202 (510)
Q Consensus 174 ~~~~~~-~~~lVmEy~~gG~L~~~L~~~~~-------------------------------------------------- 202 (510)
++.+.+ .+|+||||++||+|.+++.....
T Consensus 94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (359)
T 3vhe_A 94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173 (359)
T ss_dssp EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence 998765 49999999999999999976543
Q ss_pred ----------------CCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccch
Q 010463 203 ----------------LSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 266 (510)
Q Consensus 203 ----------------l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~ 266 (510)
+++..++.++.||+.||.|||+.||+||||||+||||+.++++||+|||+++.+......
T Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~---- 249 (359)
T 3vhe_A 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY---- 249 (359)
T ss_dssp ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC----
T ss_pred chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc----
Confidence 899999999999999999999999999999999999999999999999999865432110
Q ss_pred hhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh-CCCCCC
Q 010463 267 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPFC 345 (510)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~-G~~PF~ 345 (510)
.......||+.|+|||++.+..|+.++|||||||++|||++ |.+||.
T Consensus 250 --------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 297 (359)
T 3vhe_A 250 --------------------------------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 297 (359)
T ss_dssp --------------------------------EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred --------------------------------hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCC
Confidence 00123579999999999999999999999999999999998 999999
Q ss_pred CCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 346 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 346 ~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
+.+........+........| ..+++++.+||.+||. ||.+|| ++.|+++|
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rp---s~~ell~~ 349 (359)
T 3vhe_A 298 GVKIDEEFCRRLKEGTRMRAP--DYTTPEMYQTMLDCWHGEPSQRP---TFSELVEH 349 (359)
T ss_dssp TCCCSHHHHHHHHHTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred ccchhHHHHHHHHcCCCCCCC--CCCCHHHHHHHHHHccCChhhCC---CHHHHHHH
Confidence 877665555555433334444 4789999999999998 999999 68888876
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=387.69 Aligned_cols=257 Identities=23% Similarity=0.340 Sum_probs=219.0
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCC---EEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGE---IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 177 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~---~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 177 (510)
..+..++|++.+.||+|+||.||+|+++.+|+ .||||++.... .....+.+.+|+.+|..++||||+++++++.+
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 45677899999999999999999999987665 49999997542 34456778999999999999999999999999
Q ss_pred CceEEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccC
Q 010463 178 SDFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 256 (510)
Q Consensus 178 ~~~~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~ 256 (510)
.+.+|+||||++||+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||||+.+|.+||+|||+++..
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999999999654 57999999999999999999999999999999999999999999999999999876
Q ss_pred ccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHH
Q 010463 257 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 336 (510)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyE 336 (510)
....... .......||+.|+|||++.+..++.++|||||||++||
T Consensus 202 ~~~~~~~-----------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~e 246 (325)
T 3kul_A 202 EDDPDAA-----------------------------------YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWE 246 (325)
T ss_dssp C----CC-----------------------------------EECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHH
T ss_pred ccCccce-----------------------------------eeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHH
Confidence 4421100 00112457889999999999999999999999999999
Q ss_pred Hhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 337 MLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 337 ml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
|++ |..||.+.+.......+... ...+....+++++.+||.+||. ||.+|| ++.+|++
T Consensus 247 ll~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~eil~ 306 (325)
T 3kul_A 247 VLAYGERPYWNMTNRDVISSVEEG---YRLPAPMGCPHALHQLMLDCWHKDRAQRP---RFSQIVS 306 (325)
T ss_dssp HHTTSCCTTTTSCHHHHHHHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHcCCCCCcccCCHHHHHHHHHcC---CCCCCCCCcCHHHHHHHHHHccCChhhCc---CHHHHHH
Confidence 999 99999998888888777753 2333445899999999999998 999999 5677764
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=392.48 Aligned_cols=260 Identities=25% Similarity=0.378 Sum_probs=210.4
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhh--------cchhhHHHHHHHHHHHHhcCCCCeeeEeEEe
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEM--------LKRGQVEHVRSERNLLAEVDSRCIVQLFYSF 175 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~--------~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 175 (510)
..++|.+++.||+|+||.||+|.+.. |+.||||++.+... ......+.+.+|+.+|+.++||||++++++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 45789999999999999999998865 99999999865322 1222347799999999999999999999998
Q ss_pred e-----cCceEEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecc
Q 010463 176 Q-----DSDFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSD 249 (510)
Q Consensus 176 ~-----~~~~~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~D 249 (510)
. ....+|+||||++ |+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp EECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred EeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 4 3447999999998 5888887654 4799999999999999999999999999999999999999999999999
Q ss_pred cCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCcccccc
Q 010463 250 FGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWW 328 (510)
Q Consensus 250 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~Diw 328 (510)
||+++...... .....+||+.|+|||++.+ ..++.++|||
T Consensus 178 fg~~~~~~~~~---------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 218 (362)
T 3pg1_A 178 FNLAREDTADA---------------------------------------NKTHYVTHRWYRAPELVMQFKGFTKLVDMW 218 (362)
T ss_dssp TTC------------------------------------------------------CGGGCCHHHHTTCTTCCTHHHHH
T ss_pred cCccccccccc---------------------------------------ccceecccceecCcHHhcCCCCCCcHhHHH
Confidence 99997543221 0123579999999999987 7789999999
Q ss_pred chhhHHHHHhhCCCCCCCCChhhhHHHHhhccccc----------------------cCCC------CCCCCHHHHHHHH
Q 010463 329 SLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCL----------------------KFPE------EPKISDEARDLIC 380 (510)
Q Consensus 329 SlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~~----------------------~~p~------~~~~s~~~~dlI~ 380 (510)
||||++|+|++|.+||.+.+......++....... ..|. .+.+++.+.+||.
T Consensus 219 slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 298 (362)
T 3pg1_A 219 SAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIA 298 (362)
T ss_dssp HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHH
T ss_pred hHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHH
Confidence 99999999999999999988777777665321110 0111 1367899999999
Q ss_pred Hhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 381 HLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 381 ~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
+||. ||.+|| +++|+++||||+++
T Consensus 299 ~~L~~dP~~Rp---t~~ell~hp~f~~~ 323 (362)
T 3pg1_A 299 KMLEFNPQRRI---STEQALRHPYFESL 323 (362)
T ss_dssp HHTCSSGGGSC---CHHHHHTSGGGTTT
T ss_pred HHhcCChhhCC---CHHHHHcCchhhhc
Confidence 9999 999999 78999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=383.08 Aligned_cols=262 Identities=21% Similarity=0.342 Sum_probs=213.4
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEE
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~ 182 (510)
+..++|.+.+.||+|+||+||+|.++.+|+.||+|++.+. .....+.+.+|+.+|..++||||+++++++.+++.+|
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence 4568999999999999999999999999999999998653 3455678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 183 LIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
+||||++||+|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.+|++||+|||+++.......
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999999999999987 56799999999999999999999999999999999999999999999999999987654311
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~ 341 (510)
.... .............+.+||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 164 ~~~~------------------------~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~ 219 (310)
T 3s95_A 164 QPEG------------------------LRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRV 219 (310)
T ss_dssp ----------------------------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTC
T ss_pred cccc------------------------cccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCC
Confidence 1000 0000000111223578999999999999999999999999999999999999
Q ss_pred CCCCCCChhhh-----HHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 342 PPFCSDDPRIT-----CRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 342 ~PF~~~~~~~~-----~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
.||........ ...... ...| +.+++.+.+||.+||. ||++|| ++.++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~----~~~~--~~~~~~l~~li~~~l~~dP~~Rp---s~~~l~~ 275 (310)
T 3s95_A 220 NADPDYLPRTMDFGLNVRGFLD----RYCP--PNCPPSFFPITVRCCDLDPEKRP---SFVKLEH 275 (310)
T ss_dssp CSSTTTSCBCTTSSBCHHHHHH----HTCC--TTCCTTHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred CCCcchhhhHHHHhhhhhcccc----ccCC--CCCCHHHHHHHHHHccCChhhCc---CHHHHHH
Confidence 99976443221 111111 1123 4788999999999998 999999 6778775
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=373.47 Aligned_cols=253 Identities=20% Similarity=0.308 Sum_probs=218.9
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCce
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 180 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 180 (510)
..+..++|++++.||+|+||.||+|++. +++.||+|++.+... ..+.+.+|+.+|+.++||||+++++++.+.+.
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 79 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 79 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred EEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc----CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCc
Confidence 4567789999999999999999999987 577799999976532 23568899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 181 LYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
+|+||||++||+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 99999999999999999654 56899999999999999999999999999999999999999999999999999865432
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~ 339 (510)
.. .......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 160 ~~-------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~ 202 (269)
T 4hcu_A 160 QY-------------------------------------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 202 (269)
T ss_dssp HH-------------------------------------HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred cc-------------------------------------ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhc
Confidence 10 00123568889999999999999999999999999999999
Q ss_pred -CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 340 -GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 340 -G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
|.+||.+.+.......+.... ..+....+++++.+||.+||. ||.+|| ++.++++|
T Consensus 203 ~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~ll~~ 260 (269)
T 4hcu_A 203 EGKIPYENRSNSEVVEDISTGF---RLYKPRLASTHVYQIMNHCWRERPEDRP---AFSRLLRQ 260 (269)
T ss_dssp TSCCTTTTCCHHHHHHHHHTTC---CCCCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHhcCc---cCCCCCcCCHHHHHHHHHHccCCcccCc---CHHHHHHH
Confidence 999999998888888777532 222234689999999999998 999999 67888865
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=376.83 Aligned_cols=261 Identities=30% Similarity=0.473 Sum_probs=214.8
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceE
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 181 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~ 181 (510)
....++|....+||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 18 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 94 (295)
T 2clq_A 18 DYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFI 94 (295)
T ss_dssp EECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcE
Confidence 345566777779999999999999999999999999997642 33456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecC-CCceeecccCCcccCc
Q 010463 182 YLIMEYLPGGDIMTLLMRE---DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK-NGHLKLSDFGLCKPLE 257 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~---~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~-~g~vkL~DFGla~~~~ 257 (510)
|+||||++||+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++. +|.+||+|||+++...
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~ 174 (295)
T 2clq_A 95 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174 (295)
T ss_dssp EEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred EEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence 9999999999999999765 25679999999999999999999999999999999999997 8999999999998654
Q ss_pred cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCC--CCccccccchhhHHH
Q 010463 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG--YGMECDWWSLGAIMY 335 (510)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~--y~~~~DiwSlGvily 335 (510)
.... .....+||+.|+|||++.+.. ++.++|||||||++|
T Consensus 175 ~~~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~ 216 (295)
T 2clq_A 175 GINP--------------------------------------CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTII 216 (295)
T ss_dssp C-------------------------------------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHH
T ss_pred CCCC--------------------------------------cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHH
Confidence 3210 012357999999999998654 899999999999999
Q ss_pred HHhhCCCCCCCCChh-hhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCC
Q 010463 336 EMLIGYPPFCSDDPR-ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 408 (510)
Q Consensus 336 Eml~G~~PF~~~~~~-~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~ 408 (510)
||++|..||.+.+.. ..............+| ..+++++.+||.+||. ||++|| +++++++||||+...
T Consensus 217 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rp---s~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 217 EMATGKPPFYELGEPQAAMFKVGMFKVHPEIP--ESMSAEAKAFILKCFEPDPDKRA---CANDLLVDEFLKVSS 286 (295)
T ss_dssp HHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCC--TTSCHHHHHHHHHTTCSSTTTSC---CHHHHHTSGGGCC--
T ss_pred HHHHCCCCccCCCchhHHHHhhcccccccccc--ccCCHHHHHHHHHHccCChhhCC---CHHHHhcChhhhhcc
Confidence 999999999764332 2222222212223333 4789999999999998 999999 789999999998643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=386.87 Aligned_cols=259 Identities=22% Similarity=0.342 Sum_probs=217.5
Q ss_pred hcccCCCCceeeeeeecCCCeEEEEEEEc-----CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeE
Q 010463 100 RRKIGIDDFEQLTLIGKGAFGEVRLCRAK-----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFY 173 (510)
Q Consensus 100 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~-----~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~ 173 (510)
...+..++|++.+.||+|+||.||+|++. .++..||+|++.... .....+.+.+|+.+|..+ +||||+++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 34567789999999999999999999973 466789999997543 233456789999999999 9999999999
Q ss_pred EeecCceEEEEEeccCCCCHHHHHHhcc-----------------------CCCHHHHHHHHHHHHHHHHhhhhCCeEEe
Q 010463 174 SFQDSDFLYLIMEYLPGGDIMTLLMRED-----------------------ILSEDVARFYIAESVLAIHSIHQHNYVHR 230 (510)
Q Consensus 174 ~~~~~~~~~lVmEy~~gG~L~~~L~~~~-----------------------~l~e~~~~~~~~qi~~aL~~lH~~giiHR 230 (510)
++.+.+.+|+||||++||+|.+++.... .+++..++.++.||+.||.|||+.||+||
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 9999999999999999999999997653 37999999999999999999999999999
Q ss_pred ecCCCCeeecCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCC
Q 010463 231 DIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDY 310 (510)
Q Consensus 231 DLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y 310 (510)
||||+||||+.+|++||+|||++..+...... .......||+.|
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~------------------------------------~~~~~~~~t~~y 240 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNY------------------------------------VVRGNARLPVKW 240 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTS------------------------------------EEETTEEECGGG
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccc------------------------------------eeccCccCccCc
Confidence 99999999999999999999999865432110 001235689999
Q ss_pred cchHhhccCCCCccccccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-Cccc
Q 010463 311 MAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVET 388 (510)
Q Consensus 311 ~APEvl~~~~y~~~~DiwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~ 388 (510)
+|||++.+..++.++|||||||++|||++ |.+||.+.+.......++........| ..+++++.+||.+||. ||.+
T Consensus 241 ~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~ 318 (344)
T 1rjb_A 241 MAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQP--FYATEEIYIIMQSCWAFDSRK 318 (344)
T ss_dssp CCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCC--TTCCHHHHHHHHHHTCSSGGG
T ss_pred cCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCC--CCCCHHHHHHHHHHcCCCchh
Confidence 99999999999999999999999999998 999999887766666666533333333 4789999999999998 9999
Q ss_pred cCCCCChHHhhcC
Q 010463 389 RLGTRGVEELKEH 401 (510)
Q Consensus 389 R~~~~~~~eil~H 401 (510)
|| ++.++++|
T Consensus 319 Rp---s~~~l~~~ 328 (344)
T 1rjb_A 319 RP---SFPNLTSF 328 (344)
T ss_dssp SC---CHHHHHHH
T ss_pred Cc---CHHHHHHH
Confidence 99 67888875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=381.52 Aligned_cols=259 Identities=21% Similarity=0.320 Sum_probs=221.8
Q ss_pred hhcccCCCCceeeeeeecCCCeEEEEEEEc-----CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeE
Q 010463 99 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAK-----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 173 (510)
Q Consensus 99 ~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~-----~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~ 173 (510)
....+..++|.+.+.||+|+||.||+|.+. .+++.||+|++.... .....+.+.+|+.+|+.++||||+++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 93 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYG 93 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEE
Confidence 445667789999999999999999999983 456899999997542 3456678999999999999999999999
Q ss_pred EeecCceEEEEEeccCCCCHHHHHHhccC------------------------CCHHHHHHHHHHHHHHHHhhhhCCeEE
Q 010463 174 SFQDSDFLYLIMEYLPGGDIMTLLMREDI------------------------LSEDVARFYIAESVLAIHSIHQHNYVH 229 (510)
Q Consensus 174 ~~~~~~~~~lVmEy~~gG~L~~~L~~~~~------------------------l~e~~~~~~~~qi~~aL~~lH~~giiH 229 (510)
++.+.+.+|+||||++||+|.+++..... +++..++.++.||+.||.|||+.||+|
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH 173 (314)
T 2ivs_A 94 ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVH 173 (314)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred EEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence 99999999999999999999999986543 899999999999999999999999999
Q ss_pred eecCCCCeeecCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCC
Q 010463 230 RDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLD 309 (510)
Q Consensus 230 RDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~ 309 (510)
|||||+|||++.+|++||+|||+++........ .......||+.
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~ 217 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSY------------------------------------VKRSQGRIPVK 217 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCE------------------------------------ECSSCCCSCGG
T ss_pred cccchheEEEcCCCCEEEccccccccccccccc------------------------------------eeccCCCCccc
Confidence 999999999999999999999999865432110 00113468899
Q ss_pred CcchHhhccCCCCccccccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-Ccc
Q 010463 310 YMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVE 387 (510)
Q Consensus 310 Y~APEvl~~~~y~~~~DiwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~ 387 (510)
|+|||++.+..++.++|||||||++|||++ |.+||.+.+.......+.... ....| ..+++++.+||.+||. ||.
T Consensus 218 y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~dp~ 294 (314)
T 2ivs_A 218 WMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGH-RMERP--DNCSEEMYRLMLQCWKQEPD 294 (314)
T ss_dssp GCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGG
T ss_pred ccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCC-cCCCC--ccCCHHHHHHHHHHccCChh
Confidence 999999999999999999999999999999 999999988877777666532 22333 4789999999999998 999
Q ss_pred ccCCCCChHHhhcC
Q 010463 388 TRLGTRGVEELKEH 401 (510)
Q Consensus 388 ~R~~~~~~~eil~H 401 (510)
+|| ++.++++|
T Consensus 295 ~Rp---s~~~l~~~ 305 (314)
T 2ivs_A 295 KRP---VFADISKD 305 (314)
T ss_dssp GSC---CHHHHHHH
T ss_pred hCc---CHHHHHHH
Confidence 999 67888764
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=377.26 Aligned_cols=272 Identities=27% Similarity=0.485 Sum_probs=211.3
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec--------
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD-------- 177 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-------- 177 (510)
++|++++.||+|+||.||+|+++.+|+.||||++... ......+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 4799999999999999999999999999999999653 3455778999999999999999999998865
Q ss_pred -----CceEEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccC
Q 010463 178 -----SDFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFG 251 (510)
Q Consensus 178 -----~~~~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFG 251 (510)
.+.+|+||||++||+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 46799999999999999999854 468899999999999999999999999999999999999999999999999
Q ss_pred CcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC-CCCccccccch
Q 010463 252 LCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSL 330 (510)
Q Consensus 252 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiwSl 330 (510)
++.............. ... ..........+||+.|+|||++.+. .++.++|||||
T Consensus 162 ~~~~~~~~~~~~~~~~------~~~------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 217 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDS------QNL------------------PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSL 217 (303)
T ss_dssp CCSCTTC-------------------------------------------------CTTSCHHHHTSCSCCCTHHHHHHH
T ss_pred chhhcccccchhcccc------ccc------------------cccccccccCCCcccccCcccccCCCCCcchhhHHHH
Confidence 9987643211000000 000 0000112246799999999999865 68999999999
Q ss_pred hhHHHHHhhCCCCCCCC-ChhhhHHHHhhccccccCCC--CCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 331 GAIMYEMLIGYPPFCSD-DPRITCRKIVNWKTCLKFPE--EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 331 GvilyEml~G~~PF~~~-~~~~~~~~I~~~~~~~~~p~--~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
||++|||++ ||... +.......+... ...+|. ....++.+++||.+||. ||.+|| +++++++||||..
T Consensus 218 G~il~~l~~---p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~ll~h~~~~~ 289 (303)
T 1zy4_A 218 GIIFFEMIY---PFSTGMERVNILKKLRSV--SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP---GARTLLNSGWLPV 289 (303)
T ss_dssp HHHHHHHHS---CCSSHHHHHHHHHHHHST--TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSC---CHHHHHHSSCSCC
T ss_pred HHHHHHHHh---ccCCchhHHHHHHhcccc--ccccCccccccchHHHHHHHHHHHhcCcccCc---CHHHHhCCCCcCC
Confidence 999999998 55432 333344444432 222332 24677889999999998 999999 7899999999998
Q ss_pred CCchhhh
Q 010463 407 IQWDKLY 413 (510)
Q Consensus 407 i~~~~l~ 413 (510)
..++...
T Consensus 290 ~~~~~~~ 296 (303)
T 1zy4_A 290 KHQDEVI 296 (303)
T ss_dssp CCHHHHH
T ss_pred CChHHHH
Confidence 8776543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=390.41 Aligned_cols=253 Identities=32% Similarity=0.532 Sum_probs=186.4
Q ss_pred CCCCceeee-eeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec----C
Q 010463 104 GIDDFEQLT-LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD----S 178 (510)
Q Consensus 104 ~~~~f~~~~-~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~----~ 178 (510)
-.++|.+++ +||+|+||+||+|+++.+|+.||||++.... .........+..+.||||++++++|.+ .
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 98 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYENMHHGK 98 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence 347899965 6999999999999999999999999996532 112223334677899999999999986 5
Q ss_pred ceEEEEEeccCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecC---CCceeecccCCc
Q 010463 179 DFLYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK---NGHLKLSDFGLC 253 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~---~g~vkL~DFGla 253 (510)
..+|+||||++||+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred ceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 56999999999999999998764 6999999999999999999999999999999999999986 456999999999
Q ss_pred ccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhH
Q 010463 254 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 333 (510)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvi 333 (510)
+...... ....+||+.|+|||++.+..++.++|||||||+
T Consensus 179 ~~~~~~~----------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i 218 (336)
T 3fhr_A 179 KETTQNA----------------------------------------LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 218 (336)
T ss_dssp EEC--------------------------------------------------------------CHHHHHHHHHHHHHH
T ss_pred eeccccc----------------------------------------cccCCCCcCccChhhhCCCCCCchhhHHHHHHH
Confidence 8653220 113579999999999998899999999999999
Q ss_pred HHHHhhCCCCCCCCChhhh----HHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 334 MYEMLIGYPPFCSDDPRIT----CRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 334 lyEml~G~~PF~~~~~~~~----~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
+|+|++|.+||.+.+.... ...+.........+....+++++++||.+||. ||.+|| +++|+++||||+.
T Consensus 219 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~ell~hp~~~~ 293 (336)
T 3fhr_A 219 MYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERL---TITQFMNHPWINQ 293 (336)
T ss_dssp HHHHHHSSCCC---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSC---CHHHHHHSHHHHT
T ss_pred HHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCc---CHHHHhcCccccc
Confidence 9999999999987665443 22233222233334445799999999999998 999999 7899999999975
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=369.75 Aligned_cols=252 Identities=21% Similarity=0.316 Sum_probs=217.6
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceE
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 181 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~ 181 (510)
.+..++|++++.||+|+||.||+|+++ ++..||+|++..... ..+.+.+|+.++..++||||+++++++.+.+.+
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM----SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC----cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 456789999999999999999999876 567799999976532 235688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccc
Q 010463 182 YLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 260 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~-~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~ 260 (510)
|+||||++||+|.+++...+ .+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++.......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 99999999999999998754 59999999999999999999999999999999999999999999999999998654321
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh-
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI- 339 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~- 339 (510)
.. ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 159 ~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~ 201 (268)
T 3sxs_A 159 YV-------------------------------------SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSL 201 (268)
T ss_dssp EE-------------------------------------ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTT
T ss_pred hh-------------------------------------cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcC
Confidence 10 0113467889999999999999999999999999999999
Q ss_pred CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 340 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 340 G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
|.+||.+.+......++.... ....| ..+++.+.+||.+||. ||.+|| ++.++++|
T Consensus 202 g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rp---s~~~ll~~ 258 (268)
T 3sxs_A 202 GKMPYDLYTNSEVVLKVSQGH-RLYRP--HLASDTIYQIMYSCWHELPEKRP---TFQQLLSS 258 (268)
T ss_dssp TCCTTTTSCHHHHHHHHHTTC-CCCCC--TTSCHHHHHHHHHTTCSSGGGSC---CHHHHHHH
T ss_pred CCCCccccChHHHHHHHHcCC-CCCCC--CcChHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 999999888887777776532 22223 4689999999999998 999999 67888865
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=390.72 Aligned_cols=255 Identities=23% Similarity=0.407 Sum_probs=208.7
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-----------CCCeee
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-----------SRCIVQ 170 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~-----------hp~Iv~ 170 (510)
.+..++|++++.||+|+||+||+|+++.+|+.||||++.+.. .....+.+|+.++..+. ||||++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~ 90 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 90 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence 345679999999999999999999999999999999997542 23456788999998876 899999
Q ss_pred EeEEeecCc----eEEEEEeccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhC-CeEEeecCCCCeeec---
Q 010463 171 LFYSFQDSD----FLYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQH-NYVHRDIKPDNLILD--- 240 (510)
Q Consensus 171 l~~~~~~~~----~~~lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~-giiHRDLKP~NILld--- 240 (510)
+++++.+.+ .+++||||+ ||+|.+++... ..+++..++.++.||+.||.|||+. ||+||||||+||||+
T Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccC
Confidence 999998654 899999999 89999999763 4599999999999999999999998 999999999999995
Q ss_pred ---CCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc
Q 010463 241 ---KNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL 317 (510)
Q Consensus 241 ---~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~ 317 (510)
..+.+||+|||+++..... ....+||+.|+|||++.
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~-----------------------------------------~~~~~~t~~y~aPE~~~ 208 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEH-----------------------------------------YTNSIQTREYRSPEVLL 208 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBC-----------------------------------------CCSCCSCGGGCCHHHHH
T ss_pred CCcCcceEEEcccccccccCCC-----------------------------------------CCCCCCCccccCcHHHh
Confidence 4448999999999865432 11357999999999999
Q ss_pred cCCCCccccccchhhHHHHHhhCCCCCCCCCh------hhhHHHHhhccc------------------------------
Q 010463 318 KKGYGMECDWWSLGAIMYEMLIGYPPFCSDDP------RITCRKIVNWKT------------------------------ 361 (510)
Q Consensus 318 ~~~y~~~~DiwSlGvilyEml~G~~PF~~~~~------~~~~~~I~~~~~------------------------------ 361 (510)
+..++.++|||||||++|||++|.+||.+.+. ......+.....
T Consensus 209 ~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (373)
T 1q8y_A 209 GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLK 288 (373)
T ss_dssp TCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCC
T ss_pred CCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhccccccc
Confidence 99999999999999999999999999986542 222222221000
Q ss_pred ----------cccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 362 ----------CLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 362 ----------~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
...+| ..+++++.+||.+||. ||.+|| +++|+++||||++.
T Consensus 289 ~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rp---t~~ell~hp~f~~~ 340 (373)
T 1q8y_A 289 FWPLEDVLTEKYKFS--KDEAKEISDFLSPMLQLDPRKRA---DAGGLVNHPWLKDT 340 (373)
T ss_dssp BCCHHHHHHHTTCCC--HHHHHHHHHHHGGGGCSSTTTCB---CHHHHHTCGGGTTC
T ss_pred ccchhhhhhhcccCC--cchHHHHHHHHHHHhccCccccC---CHHHHhhChhhhcc
Confidence 01111 2456789999999999 999999 78999999999874
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=382.38 Aligned_cols=267 Identities=19% Similarity=0.267 Sum_probs=225.3
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEc-----CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEe
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAK-----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSF 175 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~-----~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 175 (510)
..+..++|++.+.||+|+||.||+|+++ .+++.||+|++.... .......+.+|+.+|+.++||||+++++++
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 4556678999999999999999999887 467889999997543 334456788999999999999999999999
Q ss_pred ecCceEEEEEeccCCCCHHHHHHhc----------cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCce
Q 010463 176 QDSDFLYLIMEYLPGGDIMTLLMRE----------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHL 245 (510)
Q Consensus 176 ~~~~~~~lVmEy~~gG~L~~~L~~~----------~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~v 245 (510)
.+.+..|+||||++||+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|++
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeE
Confidence 9999999999999999999999753 356999999999999999999999999999999999999999999
Q ss_pred eecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccc
Q 010463 246 KLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMEC 325 (510)
Q Consensus 246 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 325 (510)
||+|||+++........ ......+||+.|+|||++.+..++.++
T Consensus 178 kl~Dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~ 221 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYY------------------------------------RKGGKGLLPVRWMSPESLKDGVFTTYS 221 (322)
T ss_dssp EECCTTCCCGGGGGGCE------------------------------------EGGGSSEECGGGCCHHHHHHCCCCHHH
T ss_pred EECcCcccccccccccc------------------------------------ccccCCCCCCCccChhhhccCCCCchh
Confidence 99999999865432100 001234689999999999999999999
Q ss_pred cccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC--
Q 010463 326 DWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH-- 401 (510)
Q Consensus 326 DiwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H-- 401 (510)
|||||||++|||++ |.+||.+.+.......+.... ....| ..+++.+.+||.+||. ||.+|| ++.|+++|
T Consensus 222 Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~~e~l~~L~ 295 (322)
T 1p4o_A 222 DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG-LLDKP--DNCPDMLFELMRMCWQYNPKMRP---SFLEIISSIK 295 (322)
T ss_dssp HHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHHHG
T ss_pred hHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC-cCCCC--CCCCHHHHHHHHHHcCCCcccCc---CHHHHHHHHH
Confidence 99999999999999 899999988887777776532 22223 4789999999999998 999999 67788775
Q ss_pred ----CCcCCCCchh
Q 010463 402 ----PWFRGIQWDK 411 (510)
Q Consensus 402 ----pfF~~i~~~~ 411 (510)
|+|+.++|..
T Consensus 296 ~~~~~~~~~~~~~~ 309 (322)
T 1p4o_A 296 EEMEPGFREVSFYY 309 (322)
T ss_dssp GGSCTTHHHHCSTT
T ss_pred HhhccCCccccccc
Confidence 6766665543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=384.48 Aligned_cols=257 Identities=22% Similarity=0.316 Sum_probs=220.3
Q ss_pred hcccCCCCceeeeeeecCCCeEEEEEEEc-----CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEE
Q 010463 100 RRKIGIDDFEQLTLIGKGAFGEVRLCRAK-----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYS 174 (510)
Q Consensus 100 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~-----~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 174 (510)
...+..++|++++.||+|+||.||+|+++ .+++.||+|++.+.. .....+.+.+|+.+|+.++||||++++++
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 34567789999999999999999999997 456899999997643 34456778999999999999999999999
Q ss_pred eecCceEEEEEeccCCCCHHHHHHhc------------------------cCCCHHHHHHHHHHHHHHHHhhhhCCeEEe
Q 010463 175 FQDSDFLYLIMEYLPGGDIMTLLMRE------------------------DILSEDVARFYIAESVLAIHSIHQHNYVHR 230 (510)
Q Consensus 175 ~~~~~~~~lVmEy~~gG~L~~~L~~~------------------------~~l~e~~~~~~~~qi~~aL~~lH~~giiHR 230 (510)
+.+.+.+|+||||++||+|.+++... ..+++..++.++.||+.||.|||+.||+||
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 198 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 99999999999999999999999764 569999999999999999999999999999
Q ss_pred ecCCCCeeecCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCC
Q 010463 231 DIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDY 310 (510)
Q Consensus 231 DLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y 310 (510)
||||+|||++.+|.+||+|||+++........ .......||+.|
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~------------------------------------~~~~~~~~t~~y 242 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYY------------------------------------KADGNDAIPIRW 242 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCB------------------------------------C----CCBCGGG
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccc------------------------------------cccCCCccccee
Confidence 99999999999999999999999764322100 001135789999
Q ss_pred cchHhhccCCCCccccccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-Cccc
Q 010463 311 MAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVET 388 (510)
Q Consensus 311 ~APEvl~~~~y~~~~DiwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~ 388 (510)
+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+.... ....| ..+++++.+||.+||. ||.+
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~ 319 (343)
T 1luf_A 243 MPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN-ILACP--ENCPLELYNLMRLCWSKLPAD 319 (343)
T ss_dssp CCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGG
T ss_pred cChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCC-cCCCC--CCCCHHHHHHHHHHcccCccc
Confidence 99999999999999999999999999999 999999988888877776542 22333 4789999999999998 9999
Q ss_pred cCCCCChHHhhc
Q 010463 389 RLGTRGVEELKE 400 (510)
Q Consensus 389 R~~~~~~~eil~ 400 (510)
|| ++.++++
T Consensus 320 Rp---s~~~~~~ 328 (343)
T 1luf_A 320 RP---SFCSIHR 328 (343)
T ss_dssp SC---CHHHHHH
T ss_pred CC---CHHHHHH
Confidence 99 6777765
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=373.33 Aligned_cols=255 Identities=20% Similarity=0.336 Sum_probs=217.8
Q ss_pred hhcccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC
Q 010463 99 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 178 (510)
Q Consensus 99 ~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 178 (510)
....+..++|++++.||+|+||.||+|.++ ++..||+|++..... ..+.+.+|+.+|..++||||+++++++.+.
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 91 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC----CHHHHHHHHHHHhcCCCCCEeeEEEEEecC
Confidence 455677889999999999999999999876 677899999976532 235688999999999999999999999999
Q ss_pred ceEEEEEeccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCc
Q 010463 179 DFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 257 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~ 257 (510)
+.+|+||||++||+|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||+++...
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred CCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 999999999999999999977 5679999999999999999999999999999999999999999999999999998654
Q ss_pred cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHH
Q 010463 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337 (510)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEm 337 (510)
..... ......||+.|+|||++.+..++.++|||||||++|||
T Consensus 172 ~~~~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l 214 (283)
T 3gen_A 172 DDEYT-------------------------------------SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEI 214 (283)
T ss_dssp CHHHH-------------------------------------STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHH
T ss_pred ccccc-------------------------------------cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHH
Confidence 32100 01134688999999999999999999999999999999
Q ss_pred hh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 338 LI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 338 l~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
++ |.+||.+.+.......+.... ..+....+++.+.+||.+||. ||.+|| ++.++++|
T Consensus 215 ~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~ll~~ 274 (283)
T 3gen_A 215 YSLGKMPYERFTNSETAEHIAQGL---RLYRPHLASEKVYTIMYSCWHEKADERP---TFKILLSN 274 (283)
T ss_dssp HTTTCCTTTTSCHHHHHHHHHTTC---CCCCCTTCCHHHHHHHHHTTCSSGGGSC---CHHHHHHH
T ss_pred HhCCCCCccccChhHHHHHHhccc---CCCCCCcCCHHHHHHHHHHccCChhHCc---CHHHHHHH
Confidence 98 999999988888888777532 222224789999999999998 999999 67888865
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=370.28 Aligned_cols=252 Identities=25% Similarity=0.395 Sum_probs=206.6
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcc-hhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCce
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLK-RGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 180 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 180 (510)
.+..++|++.+.||+|+||.||+|++. |+.||+|++....... ....+.+.+|..+++.++||||+++++++.+.+.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 456789999999999999999999874 8899999987643222 2335778999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCC---eEEeecCCCCeeecC--------CCceeecc
Q 010463 181 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHN---YVHRDIKPDNLILDK--------NGHLKLSD 249 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~g---iiHRDLKP~NILld~--------~g~vkL~D 249 (510)
.|+||||++||+|.+++. ...+++..++.++.|++.||.|||+.| |+||||||+|||++. ++.+||+|
T Consensus 81 ~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred eEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999999999885 457999999999999999999999999 999999999999986 78899999
Q ss_pred cCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccc
Q 010463 250 FGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWS 329 (510)
Q Consensus 250 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwS 329 (510)
||+++...... ..+..||+.|+|||++.+..++.++|+||
T Consensus 160 fg~~~~~~~~~----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 199 (271)
T 3dtc_A 160 FGLAREWHRTT----------------------------------------KMSAAGAYAWMAPEVIRASMFSKGSDVWS 199 (271)
T ss_dssp CCC-----------------------------------------------------CCGGGSCHHHHHHCCCSHHHHHHH
T ss_pred CCccccccccc----------------------------------------ccCCCCccceeCHHHhccCCCCchhhHHH
Confidence 99998654320 11357999999999999999999999999
Q ss_pred hhhHHHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 330 LGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 330 lGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
|||++|+|++|..||.+.+.......+.........| ..+++.+.+||.+||. ||.+|| ++.|+++|
T Consensus 200 lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~e~l~~ 267 (271)
T 3dtc_A 200 YGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP--STCPEPFAKLMEDCWNPDPHSRP---SFTNILDQ 267 (271)
T ss_dssp HHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCC--cccCHHHHHHHHHHhcCCcccCc---CHHHHHHH
Confidence 9999999999999999988777777666543333333 5889999999999998 999999 67888764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=392.25 Aligned_cols=256 Identities=22% Similarity=0.331 Sum_probs=218.3
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCce
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 180 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 180 (510)
..+..++|++.+.||+|+||.||+|+++.+|+.||||++.... .......+.+|+.+|+.++|||||++++++.+.+.
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 186 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP 186 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC
Confidence 4466789999999999999999999999999999999987542 33445568899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 181 LYLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~~-~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
+|+||||++||+|.+++...+ .+++..+..++.||+.||+|||+.||+||||||+|||++.+|.+||+|||+++.....
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 999999999999999998754 6999999999999999999999999999999999999999999999999999864332
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~ 339 (510)
.... ......+|+.|+|||++.+..++.++|||||||++|||++
T Consensus 267 ~~~~------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t 310 (377)
T 3cbl_A 267 VYAA------------------------------------SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310 (377)
T ss_dssp EEEC------------------------------------CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHT
T ss_pred ceee------------------------------------cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHh
Confidence 1100 0012346888999999999999999999999999999998
Q ss_pred -CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 340 -GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 340 -G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
|.+||.+.+.......+... ..+..| ..+++++.+||.+||. ||.+|| ++++|++
T Consensus 311 ~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~cl~~dP~~Rp---s~~~i~~ 367 (377)
T 3cbl_A 311 LGASPYPNLSNQQTREFVEKG-GRLPCP--ELCPDAVFRLMEQCWAYEPGQRP---SFSTIYQ 367 (377)
T ss_dssp TSCCSSTTSCHHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcCCCchhCc---CHHHHHH
Confidence 99999988877776666543 223333 4789999999999998 999999 5677764
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=383.46 Aligned_cols=257 Identities=28% Similarity=0.451 Sum_probs=219.7
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcch---hhHHHHHHHHHHHHhcC--CCCeeeEeEEee
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR---GQVEHVRSERNLLAEVD--SRCIVQLFYSFQ 176 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~---~~~~~~~~E~~iL~~l~--hp~Iv~l~~~~~ 176 (510)
....++|++++.||+|+||.||+|+++.+|+.||||++.+...... .....+.+|+.++..+. ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 3456789999999999999999999999999999999987643321 12244677999999996 599999999999
Q ss_pred cCceEEEEEeccCC-CCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeec-CCCceeecccCCcc
Q 010463 177 DSDFLYLIMEYLPG-GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD-KNGHLKLSDFGLCK 254 (510)
Q Consensus 177 ~~~~~~lVmEy~~g-G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld-~~g~vkL~DFGla~ 254 (510)
+.+..++||||+.+ ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++ .+|.+||+|||+++
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 99999999999976 89999999889999999999999999999999999999999999999999 78999999999998
Q ss_pred cCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCC-CccccccchhhH
Q 010463 255 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAI 333 (510)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiwSlGvi 333 (510)
...... ....+||+.|+|||++.+..+ +.++|||||||+
T Consensus 199 ~~~~~~----------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~i 238 (320)
T 3a99_A 199 LLKDTV----------------------------------------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 238 (320)
T ss_dssp ECCSSC----------------------------------------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHH
T ss_pred cccccc----------------------------------------ccCCCCCccCCChHHhccCCCCCccchHHhHHHH
Confidence 664321 123579999999999988776 788999999999
Q ss_pred HHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchh
Q 010463 334 MYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDK 411 (510)
Q Consensus 334 lyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~ 411 (510)
+|||++|..||...+ .+... ...++ ..+++++.+||.+||. ||.+|| ++++|++||||+++.+..
T Consensus 239 l~el~~g~~pf~~~~------~~~~~--~~~~~--~~~~~~~~~li~~~l~~dp~~Rp---s~~~ll~hp~~~~~~~~~ 304 (320)
T 3a99_A 239 LYDMVCGDIPFEHDE------EIIRG--QVFFR--QRVSSECQHLIRWCLALRPSDRP---TFEEIQNHPWMQDVLLPQ 304 (320)
T ss_dssp HHHHHHSSCSCCSHH------HHHHC--CCCCS--SCCCHHHHHHHHHHTCSSGGGSC---CHHHHHTSGGGSSCCCHH
T ss_pred HHHHHHCCCCCCChh------hhhcc--ccccc--ccCCHHHHHHHHHHccCChhhCc---CHHHHhcCHhhcCccCcc
Confidence 999999999996532 22321 22333 4789999999999998 999999 789999999999987653
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=387.45 Aligned_cols=258 Identities=21% Similarity=0.330 Sum_probs=221.6
Q ss_pred hcccCCCCceeeeeeecCCCeEEEEEEEcCC-------CCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeE
Q 010463 100 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTT-------GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQL 171 (510)
Q Consensus 100 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t-------g~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l 171 (510)
...+..++|.+.+.||+|+||.||+|++..+ +..||+|++.... .......+.+|+.+++.+ +|||||++
T Consensus 63 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~ 140 (382)
T 3tt0_A 63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINL 140 (382)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhh
Confidence 3456678999999999999999999997643 3579999997652 345567899999999999 99999999
Q ss_pred eEEeecCceEEEEEeccCCCCHHHHHHhcc----------------CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCC
Q 010463 172 FYSFQDSDFLYLIMEYLPGGDIMTLLMRED----------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPD 235 (510)
Q Consensus 172 ~~~~~~~~~~~lVmEy~~gG~L~~~L~~~~----------------~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~ 235 (510)
++++.+.+.+|+||||++||+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+
T Consensus 141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 220 (382)
T 3tt0_A 141 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 220 (382)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcc
Confidence 999999999999999999999999998754 4999999999999999999999999999999999
Q ss_pred CeeecCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHh
Q 010463 236 NLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEV 315 (510)
Q Consensus 236 NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEv 315 (510)
||||+.+|.+||+|||+|+........ .......||+.|+|||+
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~------------------------------------~~~~~~~~t~~y~aPE~ 264 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYY------------------------------------KKTTNGRLPVKWMAPEA 264 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTT------------------------------------CCCTTCCCGGGGSCHHH
T ss_pred eEEEcCCCcEEEcccCccccccccccc------------------------------------ccccCCCCCcceeCHHH
Confidence 999999999999999999876432110 00123468999999999
Q ss_pred hccCCCCccccccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC
Q 010463 316 LLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR 393 (510)
Q Consensus 316 l~~~~y~~~~DiwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~ 393 (510)
+.+..++.++|||||||++|||++ |..||.+.+..+....+.... ....| ..+++++.+||.+||. ||.+||
T Consensus 265 ~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dP~~Rp--- 338 (382)
T 3tt0_A 265 LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH-RMDKP--SNCTNELYMMMRDCWHAVPSQRP--- 338 (382)
T ss_dssp HHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-CCCCC--SSCCHHHHHHHHHHTCSSGGGSC---
T ss_pred hcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCC--ccCCHHHHHHHHHHcCCChhhCc---
Confidence 999999999999999999999999 999999988887777776532 23333 4789999999999998 999999
Q ss_pred ChHHhhcC
Q 010463 394 GVEELKEH 401 (510)
Q Consensus 394 ~~~eil~H 401 (510)
++.|+++|
T Consensus 339 s~~ell~~ 346 (382)
T 3tt0_A 339 TFKQLVED 346 (382)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 68888874
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=377.57 Aligned_cols=258 Identities=22% Similarity=0.303 Sum_probs=219.4
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEE-----cCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEE
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRA-----KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYS 174 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~-----~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~ 174 (510)
..+..++|++.+.||+|+||.||+|++ ..+++.||+|++.... .....+.+.+|+.+|..+ +||||++++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 456668999999999999999999985 4578899999997653 234457789999999999 99999999999
Q ss_pred eecCceEEEEEeccCCCCHHHHHHhcc------------------CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCC
Q 010463 175 FQDSDFLYLIMEYLPGGDIMTLLMRED------------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDN 236 (510)
Q Consensus 175 ~~~~~~~~lVmEy~~gG~L~~~L~~~~------------------~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~N 236 (510)
+.+.+..|+||||++||+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 175 (313)
T 1t46_A 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (313)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence 999999999999999999999997654 48999999999999999999999999999999999
Q ss_pred eeecCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhh
Q 010463 237 LILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL 316 (510)
Q Consensus 237 ILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl 316 (510)
||++.++.+||+|||+++........ .......||+.|+|||++
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~ 219 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNY------------------------------------VVKGNARLPVKWMAPESI 219 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTS------------------------------------EECSSSEECGGGCCHHHH
T ss_pred EEEcCCCCEEEccccccccccccccc------------------------------------eeccCCCCcceeeChHHh
Confidence 99999999999999999876543110 001235689999999999
Q ss_pred ccCCCCccccccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCC
Q 010463 317 LKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRG 394 (510)
Q Consensus 317 ~~~~y~~~~DiwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~ 394 (510)
.+..++.++|||||||++|||++ |.+||.+.........++.... ..+....+++++.+||.+||. ||.+|| +
T Consensus 220 ~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s 294 (313)
T 1t46_A 220 FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGF--RMLSPEHAPAEMYDIMKTCWDADPLKRP---T 294 (313)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTC--CCCCCTTSCHHHHHHHHHHTCSSGGGSC---C
T ss_pred cCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCC--CCCCcccCCHHHHHHHHHHcCCCchhCc---C
Confidence 99999999999999999999999 9999998776666665554322 222335789999999999998 999999 6
Q ss_pred hHHhhcC
Q 010463 395 VEELKEH 401 (510)
Q Consensus 395 ~~eil~H 401 (510)
+.+++++
T Consensus 295 ~~ell~~ 301 (313)
T 1t46_A 295 FKQIVQL 301 (313)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 7888754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=378.17 Aligned_cols=262 Identities=27% Similarity=0.417 Sum_probs=203.6
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCce
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 180 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 180 (510)
.....++|++++.||+|+||.||+|+++.+|+.||||++..... .......+..+..++..++||||+++++++.+.+.
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~ 98 (318)
T 2dyl_A 20 YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD 98 (318)
T ss_dssp EECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Confidence 34567899999999999999999999999999999999976532 22233445555667888899999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhC-CeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 181 LYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQH-NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~-giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
+|+||||+ ++.+..++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.+|++||+|||++..+..
T Consensus 99 ~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 99 VFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp EEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 99999999 5566655544 46799999999999999999999995 999999999999999999999999999976543
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc-----cCCCCccccccchhhH
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDWWSLGAI 333 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-----~~~y~~~~DiwSlGvi 333 (510)
... ....+||+.|+|||++. ...++.++|||||||+
T Consensus 178 ~~~---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~i 218 (318)
T 2dyl_A 178 DKA---------------------------------------KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGIS 218 (318)
T ss_dssp ------------------------------------------------CCTTCCHHHHC--------CCTHHHHHHHHHH
T ss_pred Ccc---------------------------------------ccccCCCccccChhhcccccccccCCccccchhhHHHH
Confidence 210 11357999999999994 5678999999999999
Q ss_pred HHHHhhCCCCCCCC-ChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 334 MYEMLIGYPPFCSD-DPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 334 lyEml~G~~PF~~~-~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
+|||++|..||... +.......+... ....+|....+++++.+||.+||. ||.+|| ++++|++||||+..
T Consensus 219 l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 219 LVELATGQFPYKNCKTDFEVLTKVLQE-EPPLLPGHMGFSGDFQSFVKDCLTKDHRKRP---KYNKLLEHSFIKRY 290 (318)
T ss_dssp HHHHHHSSCTTTTCCSHHHHHHHHHHS-CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSC---CHHHHTTSHHHHHH
T ss_pred HHHHHhCCCCCCCCCccHHHHHHHhcc-CCCCCCccCCCCHHHHHHHHHHccCChhHCc---CHHHHhhCHHHHhc
Confidence 99999999999873 444555556543 233445445789999999999998 999999 78999999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=376.64 Aligned_cols=258 Identities=22% Similarity=0.315 Sum_probs=208.5
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEE
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~ 182 (510)
...++|++++.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.++..++||||+++++++.+++.+|
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 34689999999999999999999999999999999998765444555678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccc
Q 010463 183 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 262 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 262 (510)
+||||++||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++.........
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 190 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT 190 (309)
T ss_dssp EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence 99999999999999998889999999999999999999999999999999999999999999999999999865432100
Q ss_pred ccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCC
Q 010463 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 342 (510)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~ 342 (510)
.....+||+.|+|||++.+..++.++|||||||++|||++|.+
T Consensus 191 -------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 233 (309)
T 2h34_A 191 -------------------------------------QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSP 233 (309)
T ss_dssp -------------------------------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSC
T ss_pred -------------------------------------cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCC
Confidence 0123579999999999999999999999999999999999999
Q ss_pred CCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 343 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 343 PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
||.+.+.......+.... .......+.+++++.+||.+||. ||++||+ +++++++
T Consensus 234 pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~--s~~~l~~ 289 (309)
T 2h34_A 234 PYQGDQLSVMGAHINQAI-PRPSTVRPGIPVAFDAVIARGMAKNPEDRYV--TCGDLSA 289 (309)
T ss_dssp SSCSCHHHHHHHHHHSCC-CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCS--SHHHHHH
T ss_pred CCCCchHHHHHHHhccCC-CCccccCCCCCHHHHHHHHHhccCCHHHHHH--hHHHHHH
Confidence 998877654444333221 11111234789999999999998 9999995 3566653
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=373.82 Aligned_cols=247 Identities=19% Similarity=0.283 Sum_probs=209.5
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcCCC-------CEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEE
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTG-------EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYS 174 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg-------~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 174 (510)
++..++|.+.+.||+|+||.||+|+++.++ ..||+|++.+. .....+.+.+|+.+|+.++||||++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---HRNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG---GGGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc---cHHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 456689999999999999999999999887 46999999764 34455778999999999999999999999
Q ss_pred eecCceEEEEEeccCCCCHHHHHHhccC-CCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCc--------e
Q 010463 175 FQDSDFLYLIMEYLPGGDIMTLLMREDI-LSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH--------L 245 (510)
Q Consensus 175 ~~~~~~~~lVmEy~~gG~L~~~L~~~~~-l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~--------v 245 (510)
+.+.+..|+||||++||+|.+++..... +++..++.++.||+.||.|||+.||+||||||+|||++.++. +
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 9999999999999999999999987654 999999999999999999999999999999999999999887 9
Q ss_pred eecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCcc
Q 010463 246 KLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGME 324 (510)
Q Consensus 246 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~ 324 (510)
||+|||++...... ....||+.|+|||++.+ ..++.+
T Consensus 161 kl~Dfg~~~~~~~~------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~ 198 (289)
T 4fvq_A 161 KLSDPGISITVLPK------------------------------------------DILQERIPWVPPECIENPKNLNLA 198 (289)
T ss_dssp EECCCCSCTTTSCH------------------------------------------HHHHHTTTTSCHHHHHCGGGCCHH
T ss_pred eeccCcccccccCc------------------------------------------cccCCcCcccCHHHhCCCCCCCch
Confidence 99999998765321 12468999999999987 779999
Q ss_pred ccccchhhHHHHHhhC-CCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 325 CDWWSLGAIMYEMLIG-YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 325 ~DiwSlGvilyEml~G-~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
+|||||||++|||++| .+||...+.... ..+.. ....+| ...++++.+||.+||. ||.+|| ++.++++|
T Consensus 199 ~DiwslG~il~el~~g~~~~~~~~~~~~~-~~~~~--~~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~~ 269 (289)
T 4fvq_A 199 TDKWSFGTTLWEICSGGDKPLSALDSQRK-LQFYE--DRHQLP--APKAAELANLINNCMDYEPDHRP---SFRAIIRD 269 (289)
T ss_dssp HHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HHHHH--TTCCCC--CCSSCTTHHHHHHHSCSSGGGSC---CHHHHHHH
T ss_pred hHHHHHHHHHHHHHcCCCCCccccchHHH-HHHhh--ccCCCC--CCCCHHHHHHHHHHcCCChhHCc---CHHHHHHH
Confidence 9999999999999995 455555444333 33333 223334 3568899999999998 999999 68888865
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=371.86 Aligned_cols=255 Identities=25% Similarity=0.350 Sum_probs=207.3
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCC---CCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTT---GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 177 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t---g~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 177 (510)
..+..++|++.+.||+|+||.||+|++..+ +..||+|++.... .....+.+.+|..+++.++||||+++++++.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 86 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 86 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence 456678999999999999999999998754 4579999986542 3445677899999999999999999999985
Q ss_pred CceEEEEEeccCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccC
Q 010463 178 SDFLYLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 256 (510)
Q Consensus 178 ~~~~~lVmEy~~gG~L~~~L~~~~-~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~ 256 (510)
++..|+||||++||+|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.+|++||+|||+++..
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccccc
Confidence 567899999999999999997654 6999999999999999999999999999999999999999999999999999876
Q ss_pred ccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHH
Q 010463 257 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 336 (510)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyE 336 (510)
...... ......||+.|+|||++.+..++.++|||||||++||
T Consensus 167 ~~~~~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~e 209 (281)
T 1mp8_A 167 EDSTYY-------------------------------------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWE 209 (281)
T ss_dssp -------------------------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHH
T ss_pred Cccccc-------------------------------------ccccCCCcccccChhhcccCCCCCccCchHHHHHHHH
Confidence 432100 0112457899999999999999999999999999999
Q ss_pred Hhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 337 MLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 337 ml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
|++ |.+||.+.+.......+.... ...+ .+.+++++.+||.+||. ||.+|| ++.+++++
T Consensus 210 ll~~g~~pf~~~~~~~~~~~i~~~~-~~~~--~~~~~~~l~~li~~~l~~~p~~Rp---s~~~l~~~ 270 (281)
T 1mp8_A 210 ILMHGVKPFQGVKNNDVIGRIENGE-RLPM--PPNCPPTLYSLMTKCWAYDPSRRP---RFTELKAQ 270 (281)
T ss_dssp HHTTSCCTTTTCCGGGHHHHHHTTC-CCCC--CTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHhcCCCCCCcCCHHHHHHHHHcCC-CCCC--CCCCCHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 996 999999988888877776542 2223 35899999999999998 999999 67787753
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=370.74 Aligned_cols=258 Identities=19% Similarity=0.219 Sum_probs=210.5
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCce
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDF 180 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~ 180 (510)
.+..++|++++.||+|+||.||+|++..+|+.||+|++..... ...+.+|+.++..+ +||+|+++++++.+...
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~ 80 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 80 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence 3456789999999999999999999999999999999875432 23477899999999 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCc-----eeecccCCcc
Q 010463 181 LYLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH-----LKLSDFGLCK 254 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~~-~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~-----vkL~DFGla~ 254 (510)
.|+||||+ ||+|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.+|. +||+|||+++
T Consensus 81 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 81 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred eEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99999999 999999998754 5999999999999999999999999999999999999988876 9999999998
Q ss_pred cCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHH
Q 010463 255 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIM 334 (510)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvil 334 (510)
........... ........+||+.|+|||++.+..++.++|||||||++
T Consensus 160 ~~~~~~~~~~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 208 (298)
T 1csn_A 160 FYRDPVTKQHI-------------------------------PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVF 208 (298)
T ss_dssp ESBCTTTCCBC-------------------------------CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred ccccccccccc-------------------------------cccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHH
Confidence 76543111000 00012346899999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCC---hhhhHHHHhhccccccCC-CCCCCCHHHHHHHHHhhc-CccccCCCCChHHhh
Q 010463 335 YEMLIGYPPFCSDD---PRITCRKIVNWKTCLKFP-EEPKISDEARDLICHLLC-DVETRLGTRGVEELK 399 (510)
Q Consensus 335 yEml~G~~PF~~~~---~~~~~~~I~~~~~~~~~p-~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil 399 (510)
|||++|.+||.+.+ ....+..+.........+ ....+++++.+||.+||. ||.+||+ +++|+
T Consensus 209 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~---~~~l~ 275 (298)
T 1csn_A 209 MYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPD---YDYLQ 275 (298)
T ss_dssp HHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCC---HHHHH
T ss_pred HHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCC---HHHHH
Confidence 99999999998743 334444444322111111 113789999999999998 9999994 55554
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=368.51 Aligned_cols=249 Identities=17% Similarity=0.231 Sum_probs=216.1
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC--
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS-- 178 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-- 178 (510)
..+..++|++++.||+|+||.||+|+++ |+.||+|++..... .....+.+.+|+.+|+.++||||+++++++.+.
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA 81 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence 4567789999999999999999999985 88999999976532 344556799999999999999999999999987
Q ss_pred ceEEEEEeccCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHhhhhCC--eEEeecCCCCeeecCCCceeecccCCcc
Q 010463 179 DFLYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHN--YVHRDIKPDNLILDKNGHLKLSDFGLCK 254 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~lH~~g--iiHRDLKP~NILld~~g~vkL~DFGla~ 254 (510)
..+|+||||++||+|.+++.... .+++..++.++.||+.||.|||+.| |+||||||+|||++.+|.++|+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecccee
Confidence 78999999999999999998765 4899999999999999999999999 9999999999999999999999999876
Q ss_pred cCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCc---cccccchh
Q 010463 255 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGM---ECDWWSLG 331 (510)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~---~~DiwSlG 331 (510)
.... ...+||+.|+|||++.+..++. ++||||||
T Consensus 162 ~~~~-------------------------------------------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG 198 (271)
T 3kmu_A 162 SFQS-------------------------------------------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFA 198 (271)
T ss_dssp TTSC-------------------------------------------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHH
T ss_pred eecc-------------------------------------------cCccCCccccChhhhccCCCCCCCchhhHHHHH
Confidence 4322 1357999999999998766544 79999999
Q ss_pred hHHHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 332 AIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 332 vilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
|++|||++|..||.+.+.......+........+| ..+++++.+||.+||. ||.+|| +++++++
T Consensus 199 ~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~ 263 (271)
T 3kmu_A 199 VLLWELVTREVPFADLSNMEIGMKVALEGLRPTIP--PGISPHVSKLMKICMNEDPAKRP---KFDMIVP 263 (271)
T ss_dssp HHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 99999999999999988887777776544444444 4799999999999998 999999 6777764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=371.89 Aligned_cols=254 Identities=20% Similarity=0.340 Sum_probs=221.0
Q ss_pred hcccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc
Q 010463 100 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 179 (510)
Q Consensus 100 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 179 (510)
...+..++|++.+.||+|+||.||+|.++.++..||+|++... ....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 82 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 4556778999999999999999999999999999999999753 335677899999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCc
Q 010463 180 FLYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 257 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~ 257 (510)
.+|+||||++||+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++....
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 999999999999999999864 459999999999999999999999999999999999999999999999999998765
Q ss_pred cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHH
Q 010463 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337 (510)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEm 337 (510)
..... ......||+.|+|||++.+..++.++|||||||++|+|
T Consensus 163 ~~~~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 205 (288)
T 3kfa_A 163 GDTYT-------------------------------------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205 (288)
T ss_dssp SSSSE-------------------------------------EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CCccc-------------------------------------cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHH
Confidence 33111 01134689999999999999999999999999999999
Q ss_pred hh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 338 LI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 338 l~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
++ |.+||.+.+.......+... ...+....+++.+.+||.+||. ||.+|| +++++++
T Consensus 206 l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~~~~ 264 (288)
T 3kfa_A 206 ATYGMSPYPGIDLSQVYELLEKD---YRMERPEGCPEKVYELMRACWQWNPSDRP---SFAEIHQ 264 (288)
T ss_dssp HTTSCCSSTTCCGGGHHHHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HhCCCCCCCCCCHHHHHHHHhcc---CCCCCCCCCCHHHHHHHHHHhCCChhhCc---CHHHHHH
Confidence 99 99999988877777666542 2223335789999999999999 999999 5677764
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=378.63 Aligned_cols=258 Identities=21% Similarity=0.324 Sum_probs=219.5
Q ss_pred hcccCCCCceeeeeeecCCCeEEEEEEEcCCCC-----EEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeE
Q 010463 100 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGE-----IFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFY 173 (510)
Q Consensus 100 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~-----~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~ 173 (510)
...+..++|++.+.||+|+||.||+|.+..+++ .||+|++.... .....+.+.+|+.+|..+ +||||+++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 117 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLG 117 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 345677899999999999999999999987665 79999997643 334567789999999999 8999999999
Q ss_pred EeecCceEEEEEeccCCCCHHHHHHhc--------------cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeee
Q 010463 174 SFQDSDFLYLIMEYLPGGDIMTLLMRE--------------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL 239 (510)
Q Consensus 174 ~~~~~~~~~lVmEy~~gG~L~~~L~~~--------------~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILl 239 (510)
++.+.+.+|+||||++||+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||+
T Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL 197 (333)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence 999999999999999999999999753 357999999999999999999999999999999999999
Q ss_pred cCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC
Q 010463 240 DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK 319 (510)
Q Consensus 240 d~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~ 319 (510)
+.++++||+|||+++........ .......||+.|+|||++.+.
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~~~~ 241 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNY------------------------------------IVKGNARLPVKWMAPESIFDC 241 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTS------------------------------------EECSSCEECGGGSCHHHHHHC
T ss_pred CCCCeEEECccccccccccccce------------------------------------eecCCCCCCccccCHHHhccC
Confidence 99999999999999865432110 011235689999999999999
Q ss_pred CCCccccccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHH
Q 010463 320 GYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEE 397 (510)
Q Consensus 320 ~y~~~~DiwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~e 397 (510)
.++.++|||||||++|||++ |.+||.+.........++........| ..+++.+.+||.+||. ||.+|| ++.+
T Consensus 242 ~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rp---s~~~ 316 (333)
T 2i1m_A 242 VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQP--AFAPKNIYSIMQACWALEPTHRP---TFQQ 316 (333)
T ss_dssp CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHH
T ss_pred CCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCCCC--CCCCHHHHHHHHHHhccChhhCc---CHHH
Confidence 99999999999999999998 999999877766666666533333333 4789999999999998 999999 6788
Q ss_pred hhc
Q 010463 398 LKE 400 (510)
Q Consensus 398 il~ 400 (510)
+++
T Consensus 317 l~~ 319 (333)
T 2i1m_A 317 ICS 319 (333)
T ss_dssp HHH
T ss_pred HHH
Confidence 875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=383.80 Aligned_cols=266 Identities=26% Similarity=0.455 Sum_probs=198.1
Q ss_pred hcccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHH-HHHhcCCCCeeeEeEEeecC
Q 010463 100 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN-LLAEVDSRCIVQLFYSFQDS 178 (510)
Q Consensus 100 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~-iL~~l~hp~Iv~l~~~~~~~ 178 (510)
...+..++|++++.||+|+||.||+|.++.+|+.||||++.... .......+..|.. +++.++||||+++++++.+.
T Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~ 93 (327)
T 3aln_A 16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE 93 (327)
T ss_dssp EECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS
T ss_pred hcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC
Confidence 34577899999999999999999999999999999999997642 2223344555555 67778999999999999999
Q ss_pred ceEEEEEeccCCCCHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHhhhhC-CeEEeecCCCCeeecCCCceeecccCC
Q 010463 179 DFLYLIMEYLPGGDIMTLLMR-----EDILSEDVARFYIAESVLAIHSIHQH-NYVHRDIKPDNLILDKNGHLKLSDFGL 252 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~-----~~~l~e~~~~~~~~qi~~aL~~lH~~-giiHRDLKP~NILld~~g~vkL~DFGl 252 (510)
+..|+||||++| +|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+|||++.+|.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 172 (327)
T 3aln_A 94 GDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGI 172 (327)
T ss_dssp SEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred CceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCC
Confidence 999999999986 78777763 56799999999999999999999998 999999999999999999999999999
Q ss_pred cccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhh----ccCCCCcccccc
Q 010463 253 CKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL----LKKGYGMECDWW 328 (510)
Q Consensus 253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl----~~~~y~~~~Diw 328 (510)
++....... ....+||+.|+|||++ .+..++.++|||
T Consensus 173 ~~~~~~~~~---------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~ 213 (327)
T 3aln_A 173 SGQLVDSIA---------------------------------------KTRDAGCRPYMAPERIDPSASRQGYDVRSDVW 213 (327)
T ss_dssp SCC---------------------------------------------------------------------CCSHHHHH
T ss_pred ceecccccc---------------------------------------cccCCCCccccCceeeccccCcCCCCchhhHH
Confidence 986543210 1124799999999999 466789999999
Q ss_pred chhhHHHHHhhCCCCCCCCChh-hhHHHHhhccccccCC--CCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 329 SLGAIMYEMLIGYPPFCSDDPR-ITCRKIVNWKTCLKFP--EEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 329 SlGvilyEml~G~~PF~~~~~~-~~~~~I~~~~~~~~~p--~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
||||++|||++|..||.+.+.. .....+.... ...++ ....+++++.+||.+||. ||.+|| ++.+|++||||
T Consensus 214 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~ell~hp~~ 289 (327)
T 3aln_A 214 SLGITLYELATGRFPYPKWNSVFDQLTQVVKGD-PPQLSNSEEREFSPSFINFVNLCLTKDESKRP---KYKELLKHPFI 289 (327)
T ss_dssp HHHHHHHHHHHSCCCSSCC-------CCCCCSC-CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSC---CHHHHTTSHHH
T ss_pred HHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCC-CCCCCCcccccCCHHHHHHHHHHhhCChhhCc---CHHHHHhChHH
Confidence 9999999999999999864432 2333333221 11222 224689999999999998 999999 78999999999
Q ss_pred CCCCchh
Q 010463 405 RGIQWDK 411 (510)
Q Consensus 405 ~~i~~~~ 411 (510)
....+..
T Consensus 290 ~~~~~~~ 296 (327)
T 3aln_A 290 LMYEERA 296 (327)
T ss_dssp HHHHHSC
T ss_pred HHhHhhH
Confidence 8765543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=377.46 Aligned_cols=264 Identities=27% Similarity=0.444 Sum_probs=216.2
Q ss_pred HhhcccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC--CCCeeeEeEEe
Q 010463 98 LQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD--SRCIVQLFYSF 175 (510)
Q Consensus 98 ~~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~--hp~Iv~l~~~~ 175 (510)
.+...+..++|++++.||+|+||.||+|++. +|+.||+|++..... .......+.+|+.+|..+. ||||+++++++
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 3444566678999999999999999999886 589999999976532 3445678899999999997 59999999999
Q ss_pred ecCceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCccc
Q 010463 176 QDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 255 (510)
Q Consensus 176 ~~~~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~ 255 (510)
.+.+.+|+||| +.+|+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++ +|.+||+|||+++.
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ 175 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccccc
Confidence 99999999999 66889999999988999999999999999999999999999999999999996 58999999999987
Q ss_pred CccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-----------CCCCcc
Q 010463 256 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-----------KGYGME 324 (510)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-----------~~y~~~ 324 (510)
+...... ......+||+.|+|||++.+ ..++.+
T Consensus 176 ~~~~~~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~ 219 (313)
T 3cek_A 176 MQPDTTS------------------------------------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPK 219 (313)
T ss_dssp --------------------------------------------------CCGGGCCHHHHTTCC----------CCCHH
T ss_pred ccCcccc------------------------------------ccccCCCCCCCcCCHHHHhhcccccccccccccCCch
Confidence 6432110 00123579999999999975 478999
Q ss_pred ccccchhhHHHHHhhCCCCCCCCCh-hhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCC
Q 010463 325 CDWWSLGAIMYEMLIGYPPFCSDDP-RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHP 402 (510)
Q Consensus 325 ~DiwSlGvilyEml~G~~PF~~~~~-~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~Hp 402 (510)
+|||||||++|||++|..||..... ......+........+| ...+.++.+||.+||. ||.+|| ++.|+++||
T Consensus 220 ~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~~ell~h~ 294 (313)
T 3cek_A 220 SDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP--DIPEKDLQDVLKCCLKRDPKQRI---SIPELLAHP 294 (313)
T ss_dssp HHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC--CCSCHHHHHHHHHHTCSSTTTSC---CHHHHHTSH
T ss_pred HHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCc--ccchHHHHHHHHHHccCCcccCc---CHHHHhcCc
Confidence 9999999999999999999976543 33444455433333444 3668999999999998 999999 789999999
Q ss_pred CcCC
Q 010463 403 WFRG 406 (510)
Q Consensus 403 fF~~ 406 (510)
||+.
T Consensus 295 ~~~~ 298 (313)
T 3cek_A 295 YVQI 298 (313)
T ss_dssp HHHC
T ss_pred cccC
Confidence 9975
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=381.31 Aligned_cols=254 Identities=22% Similarity=0.357 Sum_probs=207.4
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEE----EEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIF----AMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 178 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~v----AiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 178 (510)
+..++|++++.||+|+||+||+|++..+|+.+ |+|.+.... .......+.+|+.+|+.++|||||++++++.+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 55678999999999999999999998888765 666665332 334457789999999999999999999999876
Q ss_pred ceEEEEEeccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCc
Q 010463 179 DFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 257 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~ 257 (510)
. .++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||+|+.+.
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 5 7899999999999999987 4679999999999999999999999999999999999999999999999999998654
Q ss_pred cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHH
Q 010463 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337 (510)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEm 337 (510)
..... .......||+.|+|||++.+..|+.++|||||||++|||
T Consensus 169 ~~~~~------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el 212 (327)
T 3poz_A 169 AEEKE------------------------------------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 212 (327)
T ss_dssp TTCC-------------------------------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CCccc------------------------------------ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHH
Confidence 32110 001134678999999999999999999999999999999
Q ss_pred hh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 338 LI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 338 l~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
++ |.+||.+.+.......+... ...+....++.++.+||.+||. ||.+|| ++.++++|
T Consensus 213 lt~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~ell~~ 272 (327)
T 3poz_A 213 MTFGSKPYDGIPASEISSILEKG---ERLPQPPICTIDVYMIMVKCWMIDADSRP---KFRELIIE 272 (327)
T ss_dssp HTTSCCTTTTCCGGGHHHHHHTT---CCCCCCTTBCHHHHHHHHHHTCSCGGGSC---CHHHHHHH
T ss_pred HhcCCCCccCCCHHHHHHHHHcC---CCCCCCccCCHHHHHHHHHHcCCChhhCC---CHHHHHHH
Confidence 99 99999988777666655542 2233335789999999999999 999999 67888865
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=368.72 Aligned_cols=252 Identities=23% Similarity=0.355 Sum_probs=210.6
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhh----HHHHHHHHHHHHhcCCCCeeeEeEEee
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ----VEHVRSERNLLAEVDSRCIVQLFYSFQ 176 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~----~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 176 (510)
..+..++|++.+.||+|+||.||+|++..+++.||+|++.......... .+.+.+|+.+++.++||||+++++++.
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (287)
T 4f0f_A 14 PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH 93 (287)
T ss_dssp CBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred hhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence 3466789999999999999999999999999999999997644322222 267889999999999999999999998
Q ss_pred cCceEEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCC--eEEeecCCCCeeecCCCc-----eeec
Q 010463 177 DSDFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHN--YVHRDIKPDNLILDKNGH-----LKLS 248 (510)
Q Consensus 177 ~~~~~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~g--iiHRDLKP~NILld~~g~-----vkL~ 248 (510)
+.. ++||||++||+|.+++... ..+++..++.++.|++.||.|||+.| |+||||||+|||++.++. +||+
T Consensus 94 ~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 94 NPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp TTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred CCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 766 6999999999999888654 57999999999999999999999999 999999999999998887 9999
Q ss_pred ccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc--cCCCCcccc
Q 010463 249 DFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL--KKGYGMECD 326 (510)
Q Consensus 249 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~--~~~y~~~~D 326 (510)
|||+++..... ....+||+.|+|||++. ...++.++|
T Consensus 172 Dfg~~~~~~~~-----------------------------------------~~~~~g~~~y~aPE~~~~~~~~~~~~~D 210 (287)
T 4f0f_A 172 DFGLSQQSVHS-----------------------------------------VSGLLGNFQWMAPETIGAEEESYTEKAD 210 (287)
T ss_dssp CCTTCBCCSSC-----------------------------------------EECCCCCCTTSCGGGSSCSSCEECHHHH
T ss_pred CCCcccccccc-----------------------------------------ccccCCCccccCchhhccCCCCcCchhh
Confidence 99999854321 12357999999999994 456789999
Q ss_pred ccchhhHHHHHhhCCCCCCCCChhhh--HHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 327 WWSLGAIMYEMLIGYPPFCSDDPRIT--CRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 327 iwSlGvilyEml~G~~PF~~~~~~~~--~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
||||||++|||++|..||.+.+.... ...+........+| ..+++++.+||.+||. ||.+|| +++++++
T Consensus 211 i~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~ 282 (287)
T 4f0f_A 211 TYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP--EDCPPRLRNVIELCWSGDPKKRP---HFSYIVK 282 (287)
T ss_dssp HHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCC--TTSCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCC--cccCHHHHHHHHHHhcCChhhCc---CHHHHHH
Confidence 99999999999999999987654433 33344332233333 4789999999999998 999999 6777764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=378.87 Aligned_cols=252 Identities=23% Similarity=0.405 Sum_probs=214.7
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEE--EEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCc
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIF--AMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSD 179 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~v--AiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~ 179 (510)
+..++|++.+.||+|+||.||+|+++.+|..+ |+|.+.... .......+.+|+.+|..+ +||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 56689999999999999999999999999865 999987532 334456788999999999 9999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhcc----------------CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCC
Q 010463 180 FLYLIMEYLPGGDIMTLLMRED----------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG 243 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~~----------------~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g 243 (510)
.+|+||||++||+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.+|
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 9999999999999999997654 699999999999999999999999999999999999999999
Q ss_pred ceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCc
Q 010463 244 HLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGM 323 (510)
Q Consensus 244 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~ 323 (510)
.+||+|||+++....... .....||+.|+|||++.+..++.
T Consensus 180 ~~kL~Dfg~~~~~~~~~~---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~ 220 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYVK---------------------------------------KTMGRLPVRWMAIESLNYSVYTT 220 (327)
T ss_dssp CEEECCTTCEESSCEECC---------------------------------------C----CCTTTCCHHHHHHCEECH
T ss_pred eEEEcccCcCcccccccc---------------------------------------ccCCCCCccccChhhhccccCCc
Confidence 999999999875432100 11245889999999999999999
Q ss_pred cccccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 324 ECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 324 ~~DiwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
++|||||||++|||++ |.+||.+.+.......+... ...+....+++++.+||.+||. ||.+|| +++++++|
T Consensus 221 ~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~ell~~ 294 (327)
T 1fvr_A 221 NSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YRLEKPLNCDDEVYDLMRQCWREKPYERP---SFAQILVS 294 (327)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT---CCCCCCTTBCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred hhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC---CCCCCCCCCCHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 9999999999999998 99999998888877777653 2222234789999999999998 999999 68888875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=376.71 Aligned_cols=258 Identities=22% Similarity=0.339 Sum_probs=216.6
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEE-----cCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEE
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRA-----KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYS 174 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~-----~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~ 174 (510)
..+..++|++.+.||+|+||.||+|++ ..+++.||+|++.+.. .......+.+|+.+|..+ +||||++++++
T Consensus 22 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 22 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred eecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 346678999999999999999999985 4577899999997653 334556789999999999 78999999999
Q ss_pred eecCc-eEEEEEeccCCCCHHHHHHhccC----------------CCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCe
Q 010463 175 FQDSD-FLYLIMEYLPGGDIMTLLMREDI----------------LSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNL 237 (510)
Q Consensus 175 ~~~~~-~~~lVmEy~~gG~L~~~L~~~~~----------------l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NI 237 (510)
+.+.+ .+|+||||++||+|.+++..... +++..++.++.||+.||.|||+.||+||||||+||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni 179 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence 88754 59999999999999999987543 89999999999999999999999999999999999
Q ss_pred eecCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc
Q 010463 238 ILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL 317 (510)
Q Consensus 238 Lld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~ 317 (510)
|++.+|++||+|||+++........ .......||+.|+|||++.
T Consensus 180 l~~~~~~~kl~Dfg~~~~~~~~~~~------------------------------------~~~~~~~~t~~y~aPE~~~ 223 (316)
T 2xir_A 180 LLSEKNVVKICDFGLARDIYKDPDY------------------------------------VRKGDARLPLKWMAPETIF 223 (316)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTS------------------------------------EEETTEEECGGGCCHHHHH
T ss_pred EECCCCCEEECCCccccccccCccc------------------------------------eeccCCCcceeecCchhhc
Confidence 9999999999999999865432110 0012357899999999999
Q ss_pred cCCCCccccccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCh
Q 010463 318 KKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGV 395 (510)
Q Consensus 318 ~~~y~~~~DiwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~ 395 (510)
+..++.++|||||||++|||++ |.+||.+.+........+........| ..+++++.++|.+||. ||.+|| ++
T Consensus 224 ~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~ 298 (316)
T 2xir_A 224 DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP--DYTTPEMYQTMLDCWHGEPSQRP---TF 298 (316)
T ss_dssp HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CH
T ss_pred cccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCCCC--CCCCHHHHHHHHHHcCCChhhCc---CH
Confidence 9999999999999999999998 999998877555554444332333334 4789999999999998 999999 68
Q ss_pred HHhhcC
Q 010463 396 EELKEH 401 (510)
Q Consensus 396 ~eil~H 401 (510)
.++++|
T Consensus 299 ~ell~~ 304 (316)
T 2xir_A 299 SELVEH 304 (316)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 888876
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=372.32 Aligned_cols=255 Identities=24% Similarity=0.396 Sum_probs=206.9
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEE----EcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCR----AKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 177 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~----~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 177 (510)
.+..++|++++.||+|+||+||+|+ +..+|+.||||++... .....+.+.+|+.+|..++||||+++++++.+
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 4566899999999999999999998 5678999999999754 34456778999999999999999999999865
Q ss_pred --CceEEEEEeccCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcc
Q 010463 178 --SDFLYLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCK 254 (510)
Q Consensus 178 --~~~~~lVmEy~~gG~L~~~L~~~~-~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~ 254 (510)
...+|+||||++||+|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.+|++||+|||+++
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 356999999999999999997754 59999999999999999999999999999999999999999999999999998
Q ss_pred cCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHH
Q 010463 255 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIM 334 (510)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvil 334 (510)
......... .......||+.|+|||++.+..++.++|||||||++
T Consensus 163 ~~~~~~~~~-----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 207 (295)
T 3ugc_A 163 VLPQDKEFF-----------------------------------KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVL 207 (295)
T ss_dssp ------------------------------------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred cccCCccee-----------------------------------eeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHH
Confidence 764321100 001134688899999999999999999999999999
Q ss_pred HHHhhCCCCCCCCChh----------------hhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHH
Q 010463 335 YEMLIGYPPFCSDDPR----------------ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEE 397 (510)
Q Consensus 335 yEml~G~~PF~~~~~~----------------~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~e 397 (510)
|||++|..||...... .....+. .....+....+++++.+||.+||. ||.+|| ++.|
T Consensus 208 ~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~e 281 (295)
T 3ugc_A 208 YELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK---NNGRLPRPDGCPDEIYMIMTECWNNNVNQRP---SFRD 281 (295)
T ss_dssp HHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHH---TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSC---CHHH
T ss_pred HHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHh---ccCcCCCCcCcCHHHHHHHHHHcCCChhhCC---CHHH
Confidence 9999999998653221 1111111 122333345899999999999998 999999 5777
Q ss_pred hhc
Q 010463 398 LKE 400 (510)
Q Consensus 398 il~ 400 (510)
+++
T Consensus 282 l~~ 284 (295)
T 3ugc_A 282 LAL 284 (295)
T ss_dssp HHH
T ss_pred HHH
Confidence 764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=386.07 Aligned_cols=257 Identities=21% Similarity=0.325 Sum_probs=207.8
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEc---CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAK---TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 177 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~---~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 177 (510)
..+..++|++.+.||+|+||.||+|+++ .++..||||+++... .....+.+.+|+.+|..++||||+++++++.+
T Consensus 40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 117 (373)
T 2qol_A 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117 (373)
T ss_dssp CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 4566779999999999999999999887 467789999997542 34456779999999999999999999999999
Q ss_pred CceEEEEEeccCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccC
Q 010463 178 SDFLYLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 256 (510)
Q Consensus 178 ~~~~~lVmEy~~gG~L~~~L~~~~-~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~ 256 (510)
.+.+|+||||++||+|.+++.+.+ .+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++..
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 999999999999999999997754 6999999999999999999999999999999999999999999999999999876
Q ss_pred ccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHH
Q 010463 257 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 336 (510)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyE 336 (510)
....... .......||+.|+|||++.+..++.++|||||||++||
T Consensus 198 ~~~~~~~-----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~e 242 (373)
T 2qol_A 198 EDDPEAA-----------------------------------YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWE 242 (373)
T ss_dssp ---------------------------------------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred ccCCccc-----------------------------------eeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHH
Confidence 4321100 00112346889999999999999999999999999999
Q ss_pred Hhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 337 MLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 337 ml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
|++ |..||.+.+.......+... ...|....++..+.+||.+||. ||.+|| ++.+|++
T Consensus 243 llt~g~~P~~~~~~~~~~~~i~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~RP---s~~~i~~ 302 (373)
T 2qol_A 243 VMSYGERPYWEMSNQDVIKAVDEG---YRLPPPMDCPAALYQLMLDCWQKDRNNRP---KFEQIVS 302 (373)
T ss_dssp HHTTC-CTTTTCCHHHHHHHHHTT---EECCCCTTCBHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcC---CCCCCCccccHHHHHHHHHHhCcChhhCc---CHHHHHH
Confidence 998 99999998887777766643 2334445789999999999998 999999 5667664
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=363.36 Aligned_cols=253 Identities=21% Similarity=0.308 Sum_probs=218.2
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCce
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 180 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 180 (510)
..+..++|++++.||+|+||.||+|.+. +++.||+|++.+... ..+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 77 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 77 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred eEEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3466789999999999999999999987 677899999976532 23568899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 181 LYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
+|+||||++||+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 78 ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 99999999999999999765 56899999999999999999999999999999999999999999999999999865432
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~ 339 (510)
.. .......||+.|+|||++.+..++.++|+|||||++|||++
T Consensus 158 ~~-------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 200 (267)
T 3t9t_A 158 QY-------------------------------------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200 (267)
T ss_dssp HH-------------------------------------HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred cc-------------------------------------cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhc
Confidence 00 00123568899999999999999999999999999999999
Q ss_pred -CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 340 -GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 340 -G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
|.+||.+.+.......+.... ....| ..+++.+.+||.+||. ||.+|| ++.+++++
T Consensus 201 ~g~~p~~~~~~~~~~~~i~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rp---s~~~ll~~ 258 (267)
T 3t9t_A 201 EGKIPYENRSNSEVVEDISTGF-RLYKP--RLASTHVYQIMNHCWRERPEDRP---AFSRLLRQ 258 (267)
T ss_dssp TSCCTTTTCCHHHHHHHHHTTC-CCCCC--TTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHhcCC-cCCCC--ccCcHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 999999988888877776532 12223 4689999999999998 999999 67888754
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=376.09 Aligned_cols=252 Identities=29% Similarity=0.475 Sum_probs=207.4
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcch---hhHHHHHHHHHHHHhc----CCCCeeeEeEEee
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR---GQVEHVRSERNLLAEV----DSRCIVQLFYSFQ 176 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~---~~~~~~~~E~~iL~~l----~hp~Iv~l~~~~~ 176 (510)
-.++|++++.||+|+||.||+|+++.+|+.||+|++........ .....+.+|+.++..+ +||||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 34789999999999999999999999999999999976543221 1223456789999888 8999999999999
Q ss_pred cCceEEEEEec-cCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeec-CCCceeecccCCcc
Q 010463 177 DSDFLYLIMEY-LPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD-KNGHLKLSDFGLCK 254 (510)
Q Consensus 177 ~~~~~~lVmEy-~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld-~~g~vkL~DFGla~ 254 (510)
+.+..++|||| +.||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++ .+|.+||+|||++.
T Consensus 109 ~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~ 188 (312)
T 2iwi_A 109 TQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGA 188 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCE
T ss_pred cCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhh
Confidence 99999999999 79999999999888999999999999999999999999999999999999999 89999999999998
Q ss_pred cCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCC-CccccccchhhH
Q 010463 255 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAI 333 (510)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiwSlGvi 333 (510)
...... ....+||+.|+|||++.+..+ +.++|||||||+
T Consensus 189 ~~~~~~----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~i 228 (312)
T 2iwi_A 189 LLHDEP----------------------------------------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGIL 228 (312)
T ss_dssp ECCSSC----------------------------------------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHH
T ss_pred hcccCc----------------------------------------ccccCCcccccCceeeecCCCCCccchHHHHHHH
Confidence 664321 123579999999999988776 458999999999
Q ss_pred HHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCC
Q 010463 334 MYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 408 (510)
Q Consensus 334 lyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~ 408 (510)
+|||++|..||.+.. .+.. ....++ ..+++++.+||.+||. ||++|| +++|+++||||+...
T Consensus 229 l~~l~~g~~pf~~~~------~~~~--~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 229 LYDMVCGDIPFERDQ------EILE--AELHFP--AHVSPDCCALIRRCLAPKPSSRP---SLEEILLDPWMQTPA 291 (312)
T ss_dssp HHHHHHSSCSCCSHH------HHHH--TCCCCC--TTSCHHHHHHHHHHTCSSTTTSC---CHHHHHHSTTTCC--
T ss_pred HHHHHHCCCCCCChH------HHhh--hccCCc--ccCCHHHHHHHHHHccCChhhCc---CHHHHhcChhhcCch
Confidence 999999999996532 2332 223444 4789999999999998 999999 789999999998753
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=375.25 Aligned_cols=259 Identities=20% Similarity=0.332 Sum_probs=219.3
Q ss_pred hhcccCCCCceeeeeeecCCCeEEEEEEEc-------CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeee
Q 010463 99 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAK-------TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQ 170 (510)
Q Consensus 99 ~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~-------~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~ 170 (510)
....+..++|++.+.||+|+||.||+|++. .++..||+|++.... .......+.+|+.+|..+ +||||++
T Consensus 28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~ 105 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIIN 105 (334)
T ss_dssp TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEee
Confidence 344566789999999999999999999986 467789999997542 344567789999999999 9999999
Q ss_pred EeEEeecCceEEEEEeccCCCCHHHHHHhcc----------------CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCC
Q 010463 171 LFYSFQDSDFLYLIMEYLPGGDIMTLLMRED----------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKP 234 (510)
Q Consensus 171 l~~~~~~~~~~~lVmEy~~gG~L~~~L~~~~----------------~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP 234 (510)
+++++.+.+.+|+||||++||+|.+++.... .+++..++.++.||+.||.|||+.||+||||||
T Consensus 106 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 185 (334)
T 2pvf_A 106 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 185 (334)
T ss_dssp EEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred EEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCcc
Confidence 9999999999999999999999999997654 389999999999999999999999999999999
Q ss_pred CCeeecCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchH
Q 010463 235 DNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPE 314 (510)
Q Consensus 235 ~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APE 314 (510)
+|||++.+|++||+|||+++........ .......||+.|+|||
T Consensus 186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE 229 (334)
T 2pvf_A 186 RNVLVTENNVMKIADFGLARDINNIDYY------------------------------------KKTTNGRLPVKWMAPE 229 (334)
T ss_dssp GGEEECTTCCEEECCCTTCEECTTTSSE------------------------------------ECCSCCCCCGGGCCHH
T ss_pred ceEEEcCCCCEEEccccccccccccccc------------------------------------cccCCCCcccceeChH
Confidence 9999999999999999999865432110 0011346889999999
Q ss_pred hhccCCCCccccccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC
Q 010463 315 VLLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT 392 (510)
Q Consensus 315 vl~~~~y~~~~DiwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~ 392 (510)
++.+..++.++|||||||++|||++ |.+||.+.+..+....+.... ....| ..+++++.+||.+||. ||.+||
T Consensus 230 ~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dp~~Rp-- 304 (334)
T 2pvf_A 230 ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH-RMDKP--ANCTNELYMMMRDCWHAVPSQRP-- 304 (334)
T ss_dssp HHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC--
T ss_pred HhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCC-CCCCC--ccCCHHHHHHHHHHccCChhhCc--
Confidence 9999999999999999999999999 999999988877777766532 22333 4789999999999998 999999
Q ss_pred CChHHhhcC
Q 010463 393 RGVEELKEH 401 (510)
Q Consensus 393 ~~~~eil~H 401 (510)
++.+++++
T Consensus 305 -s~~ell~~ 312 (334)
T 2pvf_A 305 -TFKQLVED 312 (334)
T ss_dssp -CHHHHHHH
T ss_pred -CHHHHHHH
Confidence 67888764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=368.86 Aligned_cols=255 Identities=28% Similarity=0.481 Sum_probs=204.8
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEE
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~ 182 (510)
...++|++++.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 34578999999999999999999999999999999998755555666778999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 183 LIMEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
+||||++||+|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++.....
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999999864 45699999999999999999999999999999999999999999999999999886543
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHh
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml 338 (510)
... ......||+.|+|||++.+..++.++|+|||||++|||+
T Consensus 189 ~~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~ 230 (310)
T 2wqm_A 189 KTT--------------------------------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 230 (310)
T ss_dssp ------------------------------------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred CCc--------------------------------------cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHH
Confidence 210 012357999999999999999999999999999999999
Q ss_pred hCCCCCCCCCh--hhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 339 IGYPPFCSDDP--RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 339 ~G~~PF~~~~~--~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
+|..||.+... ......+..... ...+ ...+++++.+||.+||. ||.+|| ++.++++
T Consensus 231 ~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~l~~li~~~l~~dp~~Rp---s~~~il~ 290 (310)
T 2wqm_A 231 ALQSPFYGDKMNLYSLCKKIEQCDY-PPLP-SDHYSEELRQLVNMCINPDPEKRP---DVTYVYD 290 (310)
T ss_dssp HSSCTTC---CCHHHHHHHHHTTCS-CCCC-TTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred hCCCCCcccchhHHHHHHHhhcccC-CCCc-ccccCHHHHHHHHHHcCCChhhCC---CHHHHHH
Confidence 99999976532 233444443211 1111 24789999999999998 999999 6788875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=388.93 Aligned_cols=248 Identities=23% Similarity=0.401 Sum_probs=213.3
Q ss_pred hhcccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC
Q 010463 99 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 178 (510)
Q Consensus 99 ~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 178 (510)
....+..++|++++.||+|+||.||+|..+ |+.||||+++... ..+.+.+|+.+|+.++|||||++++++.+.
T Consensus 186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 258 (450)
T 1k9a_A 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 258 (450)
T ss_dssp TTCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECT
T ss_pred cccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcC
Confidence 345678899999999999999999999875 7799999997542 345688999999999999999999998765
Q ss_pred c-eEEEEEeccCCCCHHHHHHhccC--CCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCccc
Q 010463 179 D-FLYLIMEYLPGGDIMTLLMREDI--LSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 255 (510)
Q Consensus 179 ~-~~~lVmEy~~gG~L~~~L~~~~~--l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~ 255 (510)
. .+|+|||||+||+|.+++.+.+. +++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.
T Consensus 259 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 338 (450)
T ss_dssp TSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence 5 79999999999999999987653 79999999999999999999999999999999999999999999999999985
Q ss_pred CccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHH
Q 010463 256 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 335 (510)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvily 335 (510)
.... .....+|+.|+|||++.+..++.++|||||||+||
T Consensus 339 ~~~~-----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~ 377 (450)
T 1k9a_A 339 ASST-----------------------------------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLW 377 (450)
T ss_dssp CC-----------------------------------------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHH
T ss_pred cccc-----------------------------------------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHH
Confidence 4321 01235889999999999999999999999999999
Q ss_pred HHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 336 EMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 336 Eml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
||++ |.+||.+.+..+....+.... .+..| ..+++++.+||.+||. ||.+|| ++.+|+.
T Consensus 378 el~t~g~~P~~~~~~~~~~~~i~~~~-~~~~p--~~~~~~l~~li~~cl~~dp~~Rp---t~~~l~~ 438 (450)
T 1k9a_A 378 EIYSFGRVPYPRIPLKDVVPRVEKGY-KMDAP--DGCPPAVYDVMKNCWHLDAATRP---TFLQLRE 438 (450)
T ss_dssp HHHTTTCCSSTTSCTTTHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCC--CcCCHHHHHHHHHHcCCChhHCc---CHHHHHH
Confidence 9998 999999888877777776532 23333 4789999999999998 999999 5666653
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=398.57 Aligned_cols=263 Identities=24% Similarity=0.373 Sum_probs=203.8
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCc
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSD 179 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~ 179 (510)
..++..+|.+.++||+|+||+|+. +...+|+.||||++.+... ..+.+|+.+|+.+ +|||||++++++.+..
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 91 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQ 91 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETT
T ss_pred EEEccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence 345556799999999999999764 4566899999999975432 1256799999998 8999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecC---CC--ceeecccCCc
Q 010463 180 FLYLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK---NG--HLKLSDFGLC 253 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~~-~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~---~g--~vkL~DFGla 253 (510)
.+|+|||||+ |+|.+++.... .+++..+..++.||+.||.|||+.|||||||||+||||+. +| .+||+|||+|
T Consensus 92 ~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 92 FQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 9999999996 59999997654 4666677889999999999999999999999999999953 33 5779999999
Q ss_pred ccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc---cCCCCccccccch
Q 010463 254 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMECDWWSL 330 (510)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~---~~~y~~~~DiwSl 330 (510)
+.+....... ......+||+.|+|||++. ...++.++|||||
T Consensus 171 ~~~~~~~~~~-----------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSl 215 (432)
T 3p23_A 171 KKLAVGRHSF-----------------------------------SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSA 215 (432)
T ss_dssp ECC-----------------------------------------------CCSCTTSCCGGGTSCC---CCCTHHHHHHH
T ss_pred eeccCCCcce-----------------------------------eeccccCCCcCccChhhhhcccccCCCcHHHHHHH
Confidence 8764321100 0112468999999999998 4567889999999
Q ss_pred hhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCC
Q 010463 331 GAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 408 (510)
Q Consensus 331 GvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~ 408 (510)
||++|||++ |.+||...........+... .....+.....+..+++||.+||. ||.+|| +++++++||||.+++
T Consensus 216 G~il~ellt~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~evl~hp~f~~~~ 291 (432)
T 3p23_A 216 GCVFYYVISEGSHPFGKSLQRQANILLGAC-SLDCLHPEKHEDVIARELIEKMIAMDPQKRP---SAKHVLKHPFFWSLE 291 (432)
T ss_dssp HHHHHHHHTTSCBTTBSTTTHHHHHHTTCC-CCTTSCTTCHHHHHHHHHHHHHSCSSGGGSC---CHHHHHTSTTTCCHH
T ss_pred HHHHHHHHcCCCCCcchhhHHHHHHHhccC-CccccCccccccHHHHHHHHHHHhCCHhhCC---CHHHHHhCccccChH
Confidence 999999999 99999665444333222211 111111123456779999999999 999999 789999999999988
Q ss_pred ch
Q 010463 409 WD 410 (510)
Q Consensus 409 ~~ 410 (510)
|.
T Consensus 292 ~~ 293 (432)
T 3p23_A 292 KQ 293 (432)
T ss_dssp HH
T ss_pred HH
Confidence 83
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=384.55 Aligned_cols=261 Identities=17% Similarity=0.184 Sum_probs=201.5
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCC-----CCEEEEEEeechhhcchhh--------HHHHHHHHHHHHhcCCCCee
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTT-----GEIFAMKKLKKSEMLKRGQ--------VEHVRSERNLLAEVDSRCIV 169 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t-----g~~vAiK~i~k~~~~~~~~--------~~~~~~E~~iL~~l~hp~Iv 169 (510)
+..++|++++.||+|+||.||+|.++.+ ++.||||++.........+ ...+..|...+..++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 3456899999999999999999999775 5889999987643111111 12234455667778899999
Q ss_pred eEeEEeecC----ceEEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeec--CC
Q 010463 170 QLFYSFQDS----DFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD--KN 242 (510)
Q Consensus 170 ~l~~~~~~~----~~~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld--~~ 242 (510)
++++++.+. ..+||||||+ ||+|.+++... ..+++..++.++.||+.||.|||+.|||||||||+||||+ .+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence 999999865 5699999999 99999999876 6799999999999999999999999999999999999999 89
Q ss_pred CceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCC
Q 010463 243 GHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYG 322 (510)
Q Consensus 243 g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~ 322 (510)
+++||+|||+|+.+......... ........+||+.|+|||++.+..++
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~ 239 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAY-------------------------------AADPKRCHDGTIEFTSIDAHNGVAPS 239 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCS-------------------------------SCCSSCCCCCCTTTCCHHHHTTCCCC
T ss_pred CeEEEEECCcceecccCCccccc-------------------------------ccCcccccCCCCCccCHHHhCCCCCC
Confidence 99999999999876543111000 00011246799999999999999999
Q ss_pred ccccccchhhHHHHHhhCCCCCCCCChhhhHHHHhhcc--cc------ccCCCCCCCCHHHHHHHHHhhc-CccccCCCC
Q 010463 323 MECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWK--TC------LKFPEEPKISDEARDLICHLLC-DVETRLGTR 393 (510)
Q Consensus 323 ~~~DiwSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~--~~------~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~ 393 (510)
.++|||||||++|||++|..||.+.............. .. ..++ ...+++++.+||..||. ||.+||+
T Consensus 240 ~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~~p~~RP~-- 316 (364)
T 3op5_A 240 RRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFP-AANAPGEIAKYMETVKLLDYTEKPL-- 316 (364)
T ss_dssp HHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSC-TTCCCHHHHHHHHHHHTCCTTCCCC--
T ss_pred chhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcc-cccCHHHHHHHHHHHhcCCCCCCCC--
Confidence 99999999999999999999998644333322221100 00 0111 14789999999999998 9999995
Q ss_pred ChHHhh
Q 010463 394 GVEELK 399 (510)
Q Consensus 394 ~~~eil 399 (510)
+++|+
T Consensus 317 -~~~l~ 321 (364)
T 3op5_A 317 -YENLR 321 (364)
T ss_dssp -HHHHH
T ss_pred -HHHHH
Confidence 45544
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=374.62 Aligned_cols=253 Identities=22% Similarity=0.354 Sum_probs=208.5
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEE----EEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIF----AMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 178 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~v----AiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 178 (510)
+..++|++++.||+|+||.||+|++..+|+.| |+|.+... ........+.+|+.+|+.++||||+++++++.+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC--SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc--cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 56789999999999999999999999988876 55554332 1334567789999999999999999999999876
Q ss_pred ceEEEEEeccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCc
Q 010463 179 DFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 257 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~ 257 (510)
. .++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||+++...
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 5 8899999999999999976 4579999999999999999999999999999999999999999999999999998764
Q ss_pred cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHH
Q 010463 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337 (510)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEm 337 (510)
..... .......||+.|+|||++.+..|+.++|||||||++|||
T Consensus 169 ~~~~~------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el 212 (327)
T 3lzb_A 169 AEEKE------------------------------------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 212 (327)
T ss_dssp -----------------------------------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred Ccccc------------------------------------ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHH
Confidence 32110 001134688999999999999999999999999999999
Q ss_pred hh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 338 LI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 338 l~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
++ |.+||.+.+.......+... ...+....++.++.+||.+||. ||.+|| ++.|+++
T Consensus 213 l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~ell~ 271 (327)
T 3lzb_A 213 MTFGSKPYDGIPASEISSILEKG---ERLPQPPICTIDVYMIMRKCWMIDADSRP---KFRELII 271 (327)
T ss_dssp HTTSCCTTTTCCGGGHHHHHHTT---CCCCCCTTBCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHCCCCCCCCCCHHHHHHHHHcC---CCCCCCccCCHHHHHHHHHHcCCChhHCc---CHHHHHH
Confidence 99 99999988877776666543 2233345789999999999998 999999 6788876
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=397.26 Aligned_cols=253 Identities=20% Similarity=0.336 Sum_probs=218.6
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCce
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 180 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 180 (510)
..+..++|++.+.||+|+||.||+|+++.++..||||+++... ...+.+.+|+.+|+.++|||||++++++.+.+.
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 290 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 290 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc----cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 4456678999999999999999999999999999999997643 235678999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 181 LYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
+|+|||||+||+|.++|... ..+++..+..++.||+.||.|||++|||||||||+||||+.++.+||+|||+++....
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 99999999999999999864 4589999999999999999999999999999999999999999999999999987643
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHh
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml 338 (510)
.... ......||+.|+|||++.+..|+.++|||||||+||||+
T Consensus 371 ~~~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~ 413 (495)
T 1opk_A 371 DTYT-------------------------------------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 413 (495)
T ss_dssp CCEE-------------------------------------CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred Ccee-------------------------------------ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHH
Confidence 2110 011345788999999999999999999999999999999
Q ss_pred h-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 339 I-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 339 ~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
+ |.+||.+.+.......+... ..+..| ..+++++.+||.+||. ||.+|| ++.+|++
T Consensus 414 t~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~cl~~dP~~RP---s~~el~~ 471 (495)
T 1opk_A 414 TYGMSPYPGIDLSQVYELLEKD-YRMERP--EGCPEKVYELMRACWQWNPSDRP---SFAEIHQ 471 (495)
T ss_dssp TTSCCSSTTCCGGGHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred hCCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcCcChhHCc---CHHHHHH
Confidence 9 99999998887777666542 223333 4789999999999998 999999 5677664
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=376.85 Aligned_cols=254 Identities=22% Similarity=0.230 Sum_probs=200.7
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc-
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD- 179 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~- 179 (510)
..+..++|++++.||+|+||+||+|++. |+.||||++.... ........|+.+|..++|||||++++++.+..
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 92 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS 92 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred cccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCC
Confidence 3466789999999999999999999875 7899999997542 23344566888899999999999999998744
Q ss_pred ---eEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhC----------CeEEeecCCCCeeecCCCcee
Q 010463 180 ---FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH----------NYVHRDIKPDNLILDKNGHLK 246 (510)
Q Consensus 180 ---~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~----------giiHRDLKP~NILld~~g~vk 246 (510)
.+|+||||++||+|.+++.. ..+++..++.++.||+.||.|||+. ||+||||||+|||++.++++|
T Consensus 93 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 93 VDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred CCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence 47999999999999999966 4599999999999999999999999 999999999999999999999
Q ss_pred ecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-----CCC
Q 010463 247 LSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-----KGY 321 (510)
Q Consensus 247 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-----~~y 321 (510)
|+|||+|+.+...... ......+||+.|+|||++.+ ..+
T Consensus 172 L~DFg~a~~~~~~~~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 215 (322)
T 3soc_A 172 IADFGLALKFEAGKSA------------------------------------GDTHGQVGTRRYMAPEVLEGAINFQRDA 215 (322)
T ss_dssp ECCCTTCEEECTTSCC------------------------------------CCCTTCCCCGGGCCHHHHTTCCCCCHHH
T ss_pred EccCCcccccccccCc------------------------------------cccccCccCccccCHhhcccccccCcCC
Confidence 9999999865432110 01124689999999999987 355
Q ss_pred CccccccchhhHHHHHhhCCCCCCCCChh----------------hhHHHHhhccccccCCC---CCCCCHHHHHHHHHh
Q 010463 322 GMECDWWSLGAIMYEMLIGYPPFCSDDPR----------------ITCRKIVNWKTCLKFPE---EPKISDEARDLICHL 382 (510)
Q Consensus 322 ~~~~DiwSlGvilyEml~G~~PF~~~~~~----------------~~~~~I~~~~~~~~~p~---~~~~s~~~~dlI~~l 382 (510)
+.++|||||||++|||++|.+||.+.... .....+.........+. ....++++.+||.+|
T Consensus 216 ~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 295 (322)
T 3soc_A 216 FLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEEC 295 (322)
T ss_dssp HHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHH
T ss_pred CccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHH
Confidence 67899999999999999999999765321 11112222111111111 012245699999999
Q ss_pred hc-CccccCCCCChHHhhc
Q 010463 383 LC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 383 L~-dp~~R~~~~~~~eil~ 400 (510)
|. ||++|| ++.|+++
T Consensus 296 l~~dP~~Rp---s~~ell~ 311 (322)
T 3soc_A 296 WDHDAEARL---SAGCVGE 311 (322)
T ss_dssp TCSSGGGSC---CHHHHHH
T ss_pred ccCChhhCc---CHHHHHH
Confidence 98 999999 5777764
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=366.27 Aligned_cols=259 Identities=21% Similarity=0.308 Sum_probs=214.8
Q ss_pred hhcccCCCCceeee-eeecCCCeEEEEEEE--cCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEe
Q 010463 99 QRRKIGIDDFEQLT-LIGKGAFGEVRLCRA--KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSF 175 (510)
Q Consensus 99 ~~~~~~~~~f~~~~-~IG~G~fG~V~~~~~--~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 175 (510)
....+..++|.+.+ .||+|+||.||+|.. +.+++.||+|++.... ......+.+.+|+.+++.++||||+++++++
T Consensus 9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 87 (291)
T 1xbb_A 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC 87 (291)
T ss_dssp --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 34456667899998 999999999999954 5678899999997653 2334467799999999999999999999999
Q ss_pred ecCceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCccc
Q 010463 176 QDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 255 (510)
Q Consensus 176 ~~~~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~ 255 (510)
..+..|+||||++||+|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++..
T Consensus 88 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 88 -EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp -ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred -CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 5677899999999999999999888899999999999999999999999999999999999999999999999999987
Q ss_pred CccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHH
Q 010463 256 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 335 (510)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvily 335 (510)
........ .......||+.|+|||++.+..++.++|||||||++|
T Consensus 167 ~~~~~~~~-----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 211 (291)
T 1xbb_A 167 LRADENYY-----------------------------------KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMW 211 (291)
T ss_dssp CCTTCSEE-----------------------------------EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHH
T ss_pred eccCCCcc-----------------------------------cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHH
Confidence 64321100 0011235789999999999999999999999999999
Q ss_pred HHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 336 EMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 336 Eml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
||++ |.+||.+.+.......+.... ....| ..+++++.+||.+||. ||.+|| ++.++++
T Consensus 212 ~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~~~l~~ 272 (291)
T 1xbb_A 212 EAFSYGQKPYRGMKGSEVTAMLEKGE-RMGCP--AGCPREMYDLMNLCWTYDVENRP---GFAAVEL 272 (291)
T ss_dssp HHHTTTCCSSTTCCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSTTTSC---CHHHHHH
T ss_pred HHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 9999 999999988877776666532 23333 4789999999999998 999999 5667664
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=363.77 Aligned_cols=255 Identities=25% Similarity=0.302 Sum_probs=213.3
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcC---CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKT---TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 177 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~---tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 177 (510)
..+..++|++.+.||+|+||.||+|++.. ++..||+|++.+.. .....+.+.+|+.+|+.++||||+++++++.+
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE 84 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence 34567899999999999999999998754 34569999997653 33456778999999999999999999999876
Q ss_pred CceEEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccC
Q 010463 178 SDFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 256 (510)
Q Consensus 178 ~~~~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~ 256 (510)
+ ..|+||||++||+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|++||+|||++...
T Consensus 85 ~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 85 E-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp S-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred C-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 4 568999999999999999765 45999999999999999999999999999999999999999999999999999865
Q ss_pred ccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHH
Q 010463 257 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 336 (510)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyE 336 (510)
...... ......||+.|+|||++.+..++.++|||||||++||
T Consensus 164 ~~~~~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 206 (281)
T 3cc6_A 164 EDEDYY-------------------------------------KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWE 206 (281)
T ss_dssp ----------------------------------------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred cccccc-------------------------------------ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHH
Confidence 432100 0113468899999999999999999999999999999
Q ss_pred Hhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 337 MLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 337 ml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
|++ |.+||...+.......+.... .. +....+++.+.+||.+||. ||.+|| ++.|++++
T Consensus 207 llt~g~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~ell~~ 267 (281)
T 3cc6_A 207 ILSFGKQPFFWLENKDVIGVLEKGD-RL--PKPDLCPPVLYTLMTRCWDYDPSDRP---RFTELVCS 267 (281)
T ss_dssp HHTTTCCTTTTSCGGGHHHHHHHTC-CC--CCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHhCCCCCcccCChHHHHHHHhcCC-CC--CCCCCCCHHHHHHHHHHccCCchhCc---CHHHHHHH
Confidence 998 999998877777766665432 22 3334789999999999998 999999 67888764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=365.11 Aligned_cols=257 Identities=24% Similarity=0.349 Sum_probs=217.1
Q ss_pred ccCCCCceeee-eeecCCCeEEEEEEEc--CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC
Q 010463 102 KIGIDDFEQLT-LIGKGAFGEVRLCRAK--TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 178 (510)
Q Consensus 102 ~~~~~~f~~~~-~IG~G~fG~V~~~~~~--~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 178 (510)
.+..++|.++. .||+|+||.||+|..+ .++..||+|++.... .....+.+.+|+.+|..++||||+++++++. .
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~ 81 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-A 81 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-S
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEec-C
Confidence 45567888887 9999999999999864 467889999997642 3455678999999999999999999999995 5
Q ss_pred ceEEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCc
Q 010463 179 DFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 257 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~ 257 (510)
+.+|+||||++||+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++....
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 5699999999999999999654 569999999999999999999999999999999999999999999999999998764
Q ss_pred cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHH
Q 010463 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337 (510)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEm 337 (510)
...... .......||+.|+|||++.+..++.++|||||||++|||
T Consensus 162 ~~~~~~-----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 206 (287)
T 1u59_A 162 ADDSYY-----------------------------------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEA 206 (287)
T ss_dssp TCSCEE-----------------------------------CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHH
T ss_pred cCccee-----------------------------------eccccccccccccCHHHhccCCCCchhhHHHHHHHHHHH
Confidence 321100 001234689999999999999999999999999999999
Q ss_pred hh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCC
Q 010463 338 LI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHP 402 (510)
Q Consensus 338 l~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~Hp 402 (510)
++ |.+||.+.+.......+.... ...+| ..+++++.+||.+||. ||.+|| ++.++++|.
T Consensus 207 lt~g~~p~~~~~~~~~~~~i~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rp---s~~~l~~~l 267 (287)
T 1u59_A 207 LSYGQKPYKKMKGPEVMAFIEQGK-RMECP--PECPPELYALMSDCWIYKWEDRP---DFLTVEQRM 267 (287)
T ss_dssp HTTSCCTTTTCCTHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHTTCSSGGGSC---CHHHHHHHH
T ss_pred HcCCCCCcccCCHHHHHHHHhcCC-cCCCC--CCcCHHHHHHHHHHcCCChhhCc---CHHHHHHHH
Confidence 98 999999888777777776532 23334 4789999999999998 999999 678888763
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=375.83 Aligned_cols=261 Identities=18% Similarity=0.269 Sum_probs=216.3
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEE-----EcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEee
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCR-----AKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ 176 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~-----~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 176 (510)
.+..++|++++.||+|+||.||+|+ ...++..||||++.... .......+.+|+.+|..++||||+++++++.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL 103 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence 4566899999999999999999999 56688899999996432 3445567889999999999999999999999
Q ss_pred cCceEEEEEeccCCCCHHHHHHhcc-------CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCC---Ccee
Q 010463 177 DSDFLYLIMEYLPGGDIMTLLMRED-------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN---GHLK 246 (510)
Q Consensus 177 ~~~~~~lVmEy~~gG~L~~~L~~~~-------~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~---g~vk 246 (510)
+....|+||||++||+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.+ +.+|
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 9999999999999999999998753 48999999999999999999999999999999999999954 4699
Q ss_pred ecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCcccc
Q 010463 247 LSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECD 326 (510)
Q Consensus 247 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 326 (510)
|+|||++......... .......||+.|+|||++.+..++.++|
T Consensus 184 l~Dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~D 227 (327)
T 2yfx_A 184 IGDFGMARDIYRASYY------------------------------------RKGGCAMLPVKWMPPEAFMEGIFTSKTD 227 (327)
T ss_dssp ECCCHHHHHHHC------------------------------------------CCGGGSCGGGCCHHHHHHCCCCHHHH
T ss_pred ECcccccccccccccc------------------------------------ccCCCcCCCcceeCHhHhcCCCCCchhh
Confidence 9999998754321000 0012357899999999999999999999
Q ss_pred ccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 327 WWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 327 iwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
||||||++|||++ |.+||.+.+.......+.... ....+ ..+++.+.+||.+||. ||.+|| ++.++++|+|+
T Consensus 228 i~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~~l~~ 301 (327)
T 2yfx_A 228 TWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG-RMDPP--KNCPGPVYRIMTQCWQHQPEDRP---NFAIILERIEY 301 (327)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHHHHH
T ss_pred HHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC-CCCCC--CCCCHHHHHHHHHHhcCChhhCc---CHHHHHHHHHH
Confidence 9999999999998 999999888877777776532 22223 4789999999999998 999999 78999999886
Q ss_pred CC
Q 010463 405 RG 406 (510)
Q Consensus 405 ~~ 406 (510)
-.
T Consensus 302 ~~ 303 (327)
T 2yfx_A 302 CT 303 (327)
T ss_dssp HH
T ss_pred Hh
Confidence 43
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=366.41 Aligned_cols=258 Identities=21% Similarity=0.364 Sum_probs=209.2
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcC-CCC--EEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKT-TGE--IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 178 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~-tg~--~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 178 (510)
.+..++|++++.||+|+||.||+|++.. +++ .||+|++...........+.+.+|+.++..++||||+++++++.++
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 4556789999999999999999998654 333 6999999876544555678899999999999999999999999876
Q ss_pred ceEEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCc
Q 010463 179 DFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 257 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~ 257 (510)
. .++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++....
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 5 89999999999999999764 679999999999999999999999999999999999999999999999999998764
Q ss_pred cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHH
Q 010463 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337 (510)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEm 337 (510)
...... .......||+.|+|||++.+..++.++|||||||++|||
T Consensus 173 ~~~~~~-----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 217 (291)
T 1u46_A 173 QNDDHY-----------------------------------VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEM 217 (291)
T ss_dssp C-CCEE-----------------------------------EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHH
T ss_pred ccccch-----------------------------------hhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHH
Confidence 321110 001134688999999999999999999999999999999
Q ss_pred hh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 338 LI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 338 l~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
++ |.+||.+.+.......+...... .+....+++++.++|.+||. ||.+|| ++.++++
T Consensus 218 ~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~l~~ 277 (291)
T 1u46_A 218 FTYGQEPWIGLNGSQILHKIDKEGER--LPRPEDCPQDIYNVMVQCWAHKPEDRP---TFVALRD 277 (291)
T ss_dssp HTTSCCTTTTCCHHHHHHHHHTSCCC--CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HhCCCCCcccCCHHHHHHHHHccCCC--CCCCcCcCHHHHHHHHHHccCCcccCc---CHHHHHH
Confidence 99 99999999888888887764333 33345899999999999998 999999 6788875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=371.69 Aligned_cols=258 Identities=22% Similarity=0.310 Sum_probs=213.1
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCC----CEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEee
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTG----EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ 176 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg----~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 176 (510)
..+..++|++.+.||+|+||.||+|.++.++ ..||+|++.... .......+.+|+.++..++||||+++++++.
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 116 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 116 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 4567789999999999999999999987654 359999997542 3345567889999999999999999999999
Q ss_pred cCceEEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCccc
Q 010463 177 DSDFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 255 (510)
Q Consensus 177 ~~~~~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~ 255 (510)
+.+.+|+||||++||+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++.
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 999999999999999999999765 6799999999999999999999999999999999999999999999999999987
Q ss_pred CccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHH
Q 010463 256 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 335 (510)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvily 335 (510)
........ .......||+.|+|||++.+..++.++|||||||++|
T Consensus 197 ~~~~~~~~-----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 241 (333)
T 1mqb_A 197 LEDDPEAT-----------------------------------YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMW 241 (333)
T ss_dssp -------------------------------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHH
T ss_pred hccccccc-----------------------------------cccCCCCccccccCchhcccCCCCchhhhHHHHHHHH
Confidence 64321100 0011235788999999999999999999999999999
Q ss_pred HHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 336 EMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 336 Eml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
||++ |..||.+.+.......+... ...|....+++.+.+||.+||. ||.+|| ++.+++++
T Consensus 242 ellt~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~l~~~ 303 (333)
T 1mqb_A 242 EVMTYGERPYWELSNHEVMKAINDG---FRLPTPMDCPSAIYQLMMQCWQQERARRP---KFADIVSI 303 (333)
T ss_dssp HHHTTSCCTTTTCCHHHHHHHHHTT---CCCCCCTTCBHHHHHHHHHHTCSSTTTSC---CHHHHHHH
T ss_pred HHHcCCCCCcccCCHHHHHHHHHCC---CcCCCcccCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 9998 99999988887777777653 2233345789999999999998 999999 57777653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=375.16 Aligned_cols=258 Identities=23% Similarity=0.334 Sum_probs=210.5
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCce
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 180 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 180 (510)
.....++|++.+.||+|+||.||+|+++ +|+.||+|++... .....+.+.+|+.+|+.++||||+++++++.+.+.
T Consensus 34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 34 LEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPE---SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSC---CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred HHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEeccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 3345689999999999999999999864 6899999998754 33456778999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccC
Q 010463 181 LYLIMEYLPGGDIMTLLMRED----ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 256 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~~----~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~ 256 (510)
+|+||||++||+|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.+|++||+|||+++..
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKG 189 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 999999999999999986543 5899999999999999999999999999999999999999999999999999864
Q ss_pred ccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHH
Q 010463 257 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 336 (510)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyE 336 (510)
...... ......+||+.|+|||++.+..++.++|||||||++||
T Consensus 190 ~~~~~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e 233 (321)
T 2qkw_B 190 TELDQT------------------------------------HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFE 233 (321)
T ss_dssp SSSSCC------------------------------------CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHH
T ss_pred cccccc------------------------------------ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHH
Confidence 322100 01123579999999999999999999999999999999
Q ss_pred HhhCCCCCCCCChhhhHHHHh-----hccccc------cC--CCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 337 MLIGYPPFCSDDPRITCRKIV-----NWKTCL------KF--PEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 337 ml~G~~PF~~~~~~~~~~~I~-----~~~~~~------~~--p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
|++|.+||.+..+......+. .....+ .. ...+..+..+.+||.+||. ||++|| ++.|+++|
T Consensus 234 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp---s~~ell~~ 309 (321)
T 2qkw_B 234 VLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRP---SMGDVLWK 309 (321)
T ss_dssp HHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCc---CHHHHHHH
Confidence 999999998765543221110 000000 00 0112345778999999998 999999 68888865
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=389.84 Aligned_cols=251 Identities=21% Similarity=0.359 Sum_probs=215.0
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCce
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 180 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 180 (510)
..+..++|++.+.||+|+||+||+|.++ ++..||||+++... ...+.+.+|+.+|+.++|||||++++++. .+.
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~ 256 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEP 256 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred eeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCc
Confidence 4566788999999999999999999986 46789999997643 23567899999999999999999999987 567
Q ss_pred EEEEEeccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 181 LYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
+|+|||||+||+|.++|... ..+++..+..++.||+.||.|||++|||||||||+||||+.++++||+|||+|+....
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 99999999999999999754 3689999999999999999999999999999999999999999999999999986543
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHh
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml 338 (510)
.... ......+|+.|+|||++....|+.++|||||||+||||+
T Consensus 337 ~~~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~ 379 (454)
T 1qcf_A 337 NEYT-------------------------------------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 379 (454)
T ss_dssp HHHH-------------------------------------TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred Ccee-------------------------------------ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHH
Confidence 2100 011245788999999999999999999999999999999
Q ss_pred h-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 339 I-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 339 ~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
+ |.+||.+.+..+....+... ...|....+++++.+||.+||. ||++|| ++++|+.
T Consensus 380 t~g~~P~~~~~~~~~~~~i~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~RP---t~~~i~~ 437 (454)
T 1qcf_A 380 TYGRIPYPGMSNPEVIRALERG---YRMPRPENCPEELYNIMMRCWKNRPEERP---TFEYIQS 437 (454)
T ss_dssp TTSCCSSTTCCHHHHHHHHHHT---CCCCCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred hCCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCCHHHHHHHHHHccCChhHCc---CHHHHHH
Confidence 9 99999998888887777653 2333345799999999999998 999999 5666653
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=365.61 Aligned_cols=256 Identities=23% Similarity=0.385 Sum_probs=206.9
Q ss_pred cCCCCceeeeeeecCCCeEEEEEE----EcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCR----AKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 178 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~----~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 178 (510)
+....|++++.||+|+||.||+|+ +..+|+.||+|++.... .......+.+|+.+|..++||||+++++++.+.
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 344569999999999999999999 56789999999997653 334567789999999999999999999999877
Q ss_pred --ceEEEEEeccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCccc
Q 010463 179 --DFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 255 (510)
Q Consensus 179 --~~~~lVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~ 255 (510)
..+|+||||++||+|.+++.. ...+++..++.++.||+.||+|||+.||+||||||+|||++.+|++||+|||++..
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccc
Confidence 679999999999999999955 46799999999999999999999999999999999999999999999999999987
Q ss_pred CccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHH
Q 010463 256 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 335 (510)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvily 335 (510)
........ .......||+.|+|||++.+..++.++|+|||||++|
T Consensus 176 ~~~~~~~~-----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 220 (302)
T 4e5w_A 176 IETDKEYY-----------------------------------TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLH 220 (302)
T ss_dssp CCTTCCEE-----------------------------------ECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHH
T ss_pred ccCCCcce-----------------------------------eccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHH
Confidence 65431100 0112357899999999999999999999999999999
Q ss_pred HHhhCCCCCCCCC--------------hhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 336 EMLIGYPPFCSDD--------------PRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 336 Eml~G~~PF~~~~--------------~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
||++|..|+.... ........+.. ....+....+++++.+||.+||. ||.+|| ++.++++
T Consensus 221 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~ 295 (302)
T 4e5w_A 221 ELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKE--GKRLPCPPNCPDEVYQLMRKCWEFQPSNRT---SFQNLIE 295 (302)
T ss_dssp HHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHT--TCCCCCCTTCCHHHHHHHHHTTCSSGGGSC---CHHHHHH
T ss_pred HHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhc--cCCCCCCCCCCHHHHHHHHHHcCCCCCCCC---CHHHHHH
Confidence 9999999864321 11111222221 22333335899999999999999 999999 5677764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=367.73 Aligned_cols=260 Identities=20% Similarity=0.291 Sum_probs=209.9
Q ss_pred hhcccCCCCceeeeeeecCCCeEEEEEEEcC---CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEe
Q 010463 99 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKT---TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSF 175 (510)
Q Consensus 99 ~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~---tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 175 (510)
....+..++|.+.+.||+|+||.||+|.... ++..||+|++..... .....+.+.+|+.+++.++||||+++++++
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 3445667899999999999999999998765 556899999975432 344567789999999999999999999999
Q ss_pred ecCc-----eEEEEEeccCCCCHHHHHHh------ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCc
Q 010463 176 QDSD-----FLYLIMEYLPGGDIMTLLMR------EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH 244 (510)
Q Consensus 176 ~~~~-----~~~lVmEy~~gG~L~~~L~~------~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~ 244 (510)
.+.+ ..|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.+|+
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc
Confidence 8765 45999999999999999843 356999999999999999999999999999999999999999999
Q ss_pred eeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCcc
Q 010463 245 LKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGME 324 (510)
Q Consensus 245 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~ 324 (510)
+||+|||+++........ .......||+.|+|||++.+..++.+
T Consensus 186 ~kl~Dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~ 229 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYY------------------------------------RQGRIAKMPVKWIAIESLADRVYTSK 229 (313)
T ss_dssp EEECSCSCC----------------------------------------------------CCGGGSCHHHHHSSCCCHH
T ss_pred EEEeecCcceeccccccc------------------------------------CcccccCCCccccCchhhcCCCccch
Confidence 999999999865432100 00112468899999999999999999
Q ss_pred ccccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 325 CDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 325 ~DiwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
+|||||||++|||++ |.+||.+.+.......+.... ....| ..+++++.+||.+||. ||.+|| ++.++++|
T Consensus 230 ~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~~~l~~~ 302 (313)
T 3brb_A 230 SDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH-RLKQP--EDCLDELYEIMYSCWRTDPLDRP---TFSVLRLQ 302 (313)
T ss_dssp HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-CCCCB--TTCCHHHHHHHHHTTCSSGGGSC---CHHHHHHH
T ss_pred hhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC-CCCCC--ccccHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 999999999999999 999999988888877776532 22333 4789999999999998 999999 67888764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=358.98 Aligned_cols=252 Identities=21% Similarity=0.341 Sum_probs=214.0
Q ss_pred hcccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc
Q 010463 100 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 179 (510)
Q Consensus 100 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 179 (510)
...+..++|++++.||+|+||.||+|.+. ++..||+|++.... ...+.+.+|+.+|+.++||||+++++++.+ +
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~ 80 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc----ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-C
Confidence 34566789999999999999999999875 56789999997643 234668899999999999999999999874 5
Q ss_pred eEEEEEeccCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCc
Q 010463 180 FLYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 257 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~ 257 (510)
..|+||||++||+|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++....
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 6899999999999999997643 79999999999999999999999999999999999999999999999999998764
Q ss_pred cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHH
Q 010463 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337 (510)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEm 337 (510)
..... ......||+.|+|||++.+..++.++|||||||++|||
T Consensus 161 ~~~~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 203 (279)
T 1qpc_A 161 DNEYT-------------------------------------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 203 (279)
T ss_dssp SSCEE-------------------------------------CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHH
T ss_pred Ccccc-------------------------------------cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHH
Confidence 32110 01134688999999999989999999999999999999
Q ss_pred hh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 338 LI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 338 l~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
++ |.+||.+.+..+....+.... .... ...+++++.+||.+||. ||++|| +++++++
T Consensus 204 ~~~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~l~~li~~~l~~~p~~Rp---s~~~l~~ 262 (279)
T 1qpc_A 204 VTHGRIPYPGMTNPEVIQNLERGY-RMVR--PDNCPEELYQLMRLCWKERPEDRP---TFDYLRS 262 (279)
T ss_dssp HTTTCCSSTTCCHHHHHHHHHTTC-CCCC--CTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HhCCCCCCcccCHHHHHHHHhccc-CCCC--cccccHHHHHHHHHHhccChhhCC---CHHHHHH
Confidence 99 999999988877777776532 2222 34789999999999998 999999 5677664
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=387.35 Aligned_cols=260 Identities=25% Similarity=0.382 Sum_probs=197.2
Q ss_pred cccCCCCc-eeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecC
Q 010463 101 RKIGIDDF-EQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDS 178 (510)
Q Consensus 101 ~~~~~~~f-~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~ 178 (510)
......++ .+.+.||+|+||+||.+ ...+|+.||||++.... .+.+.+|+.+|..+ +|||||++++++.+.
T Consensus 9 ~~~~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~ 81 (434)
T 2rio_A 9 FEQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTD 81 (434)
T ss_dssp CSCSCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred hhhhhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 33444554 45688999999999875 55689999999986532 34577899999876 899999999999999
Q ss_pred ceEEEEEeccCCCCHHHHHHhccCCC-------HHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCC---------
Q 010463 179 DFLYLIMEYLPGGDIMTLLMREDILS-------EDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN--------- 242 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~~~l~-------e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~--------- 242 (510)
+.+|+|||||+ |+|.+++....... +..+..++.||+.||.|||++|||||||||+||||+.+
T Consensus 82 ~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~ 160 (434)
T 2rio_A 82 RFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQT 160 (434)
T ss_dssp SEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTT
T ss_pred CeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccccccc
Confidence 99999999995 69999997764432 33456799999999999999999999999999999764
Q ss_pred ----CceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc
Q 010463 243 ----GHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK 318 (510)
Q Consensus 243 ----g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~ 318 (510)
+++||+|||+|+.+....... .......+||+.|+|||++.+
T Consensus 161 ~~~~~~~kL~DFG~a~~~~~~~~~~----------------------------------~~~~~~~~gt~~y~aPE~~~~ 206 (434)
T 2rio_A 161 GAENLRILISDFGLCKKLDSGQSSF----------------------------------RTNLNNPSGTSGWRAPELLEE 206 (434)
T ss_dssp CCCSCEEEECCCTTCEECCC------------------------------------------------CCTTSCHHHHSC
T ss_pred CCCceEEEEcccccceecCCCCccc----------------------------------eeeecCCCCCCCccCHHHhcc
Confidence 489999999998765431100 001124589999999999976
Q ss_pred -------CCCCccccccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccC---CCCCCCCHHHHHHHHHhhc-Cc
Q 010463 319 -------KGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKF---PEEPKISDEARDLICHLLC-DV 386 (510)
Q Consensus 319 -------~~y~~~~DiwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~---p~~~~~s~~~~dlI~~lL~-dp 386 (510)
..++.++|||||||++|||++ |.+||.+..... ..++........ .....+++++.+||.+||. ||
T Consensus 207 ~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 284 (434)
T 2rio_A 207 SNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDP 284 (434)
T ss_dssp CCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSG
T ss_pred ccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCCh
Confidence 678999999999999999999 999997654433 334432211111 1112456899999999998 99
Q ss_pred cccCCCCChHHhhcCCCcCCC
Q 010463 387 ETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 387 ~~R~~~~~~~eil~HpfF~~i 407 (510)
.+|| ++.++++||||.+.
T Consensus 285 ~~Rp---s~~eil~hp~f~~~ 302 (434)
T 2rio_A 285 LKRP---TAMKVLRHPLFWPK 302 (434)
T ss_dssp GGSC---CHHHHHTSGGGSCH
T ss_pred hhCC---CHHHHHhCCccCCc
Confidence 9999 78999999999754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=373.44 Aligned_cols=255 Identities=25% Similarity=0.424 Sum_probs=210.9
Q ss_pred cCCCCceeeeeeecCCCeEEEEEE----EcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEee--
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCR----AKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ-- 176 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~----~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-- 176 (510)
+..++|++++.||+|+||.||+|+ +..+++.||+|++.+. .....+.+.+|+.+|+.++||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 556799999999999999999999 4678999999999764 3445567899999999999999999999886
Q ss_pred cCceEEEEEeccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCccc
Q 010463 177 DSDFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 255 (510)
Q Consensus 177 ~~~~~~lVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~ 255 (510)
+...+|+||||++||+|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++..
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence 55679999999999999999977 45699999999999999999999999999999999999999999999999999987
Q ss_pred CccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHH
Q 010463 256 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 335 (510)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvily 335 (510)
........ .......||+.|+|||++.+..++.++|||||||++|
T Consensus 177 ~~~~~~~~-----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 221 (327)
T 3lxl_A 177 LPLDKDYY-----------------------------------VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLY 221 (327)
T ss_dssp CCTTCSEE-----------------------------------ECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHH
T ss_pred cccCCccc-----------------------------------eeeccCCccccccCHHHhccCCCChHHhHHHHHHHHH
Confidence 64321110 0112356899999999999999999999999999999
Q ss_pred HHhhCCCCCCCCChhh--------------hHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 336 EMLIGYPPFCSDDPRI--------------TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 336 Eml~G~~PF~~~~~~~--------------~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
+|++|..||....... .....+.. ....+....+++++.+||.+||. ||.+|| ++.++++
T Consensus 222 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp---s~~ell~ 296 (327)
T 3lxl_A 222 ELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE--GQRLPAPPACPAEVHELMKLCWAPSPQDRP---SFSALGP 296 (327)
T ss_dssp HHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc--ccCCCCCCcccHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 9999999997543321 11112221 12233345899999999999998 999999 5666654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=377.55 Aligned_cols=261 Identities=18% Similarity=0.193 Sum_probs=202.1
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcC---CCCEEEEEEeechhhc--------chhhHHHHHHHHHHHHhcCCCCeeeE
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKT---TGEIFAMKKLKKSEML--------KRGQVEHVRSERNLLAEVDSRCIVQL 171 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~---tg~~vAiK~i~k~~~~--------~~~~~~~~~~E~~iL~~l~hp~Iv~l 171 (510)
+..++|++++.||+|+||.||+|+++. ++..||+|++.+.... .......+.+|..++..++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 345689999999999999999999987 8889999998764311 11112346678888999999999999
Q ss_pred eEEeec----CceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCC--ce
Q 010463 172 FYSFQD----SDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG--HL 245 (510)
Q Consensus 172 ~~~~~~----~~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g--~v 245 (510)
++++.+ ...+|+||||+ ||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence 999988 78999999999 999999998888999999999999999999999999999999999999999888 99
Q ss_pred eecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccc
Q 010463 246 KLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMEC 325 (510)
Q Consensus 246 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 325 (510)
||+|||+|+.+......... ........+||+.|+|||++.+..++.++
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 241 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQY-------------------------------QENPRKGHNGTIEFTSLDAHKGVALSRRS 241 (345)
T ss_dssp EECCCTTCEESSGGGCCCCC-------------------------------CCCGGGCSCSCTTTCCHHHHHTCCCCHHH
T ss_pred EEEeCCCceecccccccccc-------------------------------hhccccccCCCccccCHHHhcCCCCCchh
Confidence 99999999876532110000 00011246899999999999999999999
Q ss_pred cccchhhHHHHHhhCCCCCCCCC--hhhhHHHHhhccccccCCC-------CCCCCHHHHHHHHHhhc-CccccCCCCCh
Q 010463 326 DWWSLGAIMYEMLIGYPPFCSDD--PRITCRKIVNWKTCLKFPE-------EPKISDEARDLICHLLC-DVETRLGTRGV 395 (510)
Q Consensus 326 DiwSlGvilyEml~G~~PF~~~~--~~~~~~~I~~~~~~~~~p~-------~~~~s~~~~dlI~~lL~-dp~~R~~~~~~ 395 (510)
|||||||++|||++|..||.+.. .......... ....+|. ...+++++.+||.+||. ||.+|| ++
T Consensus 242 Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~ 316 (345)
T 2v62_A 242 DVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTN--LLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKP---NY 316 (345)
T ss_dssp HHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHH--HHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCC---CH
T ss_pred hHHHHHHHHHHHHhCCCCccccccccHHHHHHHHh--hcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCC---CH
Confidence 99999999999999999996532 2222211111 1111221 12789999999999998 999999 56
Q ss_pred HHhhc
Q 010463 396 EELKE 400 (510)
Q Consensus 396 ~eil~ 400 (510)
++|++
T Consensus 317 ~~l~~ 321 (345)
T 2v62_A 317 QALKK 321 (345)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 67664
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=360.17 Aligned_cols=252 Identities=21% Similarity=0.294 Sum_probs=209.3
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCC---EEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceE-E
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGE---IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL-Y 182 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~---~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~-~ 182 (510)
.|.+.+.||+|+||+||+|++..++. .||+|++... ......+.+.+|+.+|+.++||||+++++++.+.+.. +
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 46667999999999999999876655 7999998753 2445667889999999999999999999999877665 9
Q ss_pred EEEeccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 183 LIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
+||||+.||+|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+|||++.+|++||+|||+++.+.....
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 99999999999999976 45689999999999999999999999999999999999999999999999999986643211
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh-C
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-G 340 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~-G 340 (510)
.. ........||+.|+|||++.+..++.++|||||||++|||++ |
T Consensus 180 ~~----------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 225 (298)
T 3pls_A 180 YS----------------------------------VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRG 225 (298)
T ss_dssp GC----------------------------------SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTS
T ss_pred cc----------------------------------cccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCC
Confidence 00 001123578999999999999999999999999999999999 5
Q ss_pred CCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 341 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 341 ~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
.+||.+.+.......+.... ..+....+++.+.+||.+||. ||.+|| ++.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~ll~ 280 (298)
T 3pls_A 226 APPYRHIDPFDLTHFLAQGR---RLPQPEYCPDSLYQVMQQCWEADPAVRP---TFRVLVG 280 (298)
T ss_dssp CCTTTTSCGGGHHHHHHTTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred CCCCccCCHHHHHHHhhcCC---CCCCCccchHHHHHHHHHHccCChhhCc---CHHHHHH
Confidence 66666666666666655432 223335789999999999998 999999 5777764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=384.54 Aligned_cols=254 Identities=27% Similarity=0.418 Sum_probs=208.2
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc--e
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD--F 180 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~--~ 180 (510)
...+.|.+.+.||+|+||+||+|+++.+|+.||||++.+... ....+.+.+|+.+|+.++||||+++++++.+.+ .
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 83 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence 345689999999999999999999999999999999986543 233566789999999999999999999998765 7
Q ss_pred EEEEEeccCCCCHHHHHHhccC---CCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeee----cCCCceeecccCCc
Q 010463 181 LYLIMEYLPGGDIMTLLMREDI---LSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL----DKNGHLKLSDFGLC 253 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~~~---l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILl----d~~g~vkL~DFGla 253 (510)
+|+||||++||+|.+++..... +++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 8999999999999999976543 9999999999999999999999999999999999999 78888999999999
Q ss_pred ccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc--------CCCCccc
Q 010463 254 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK--------KGYGMEC 325 (510)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~--------~~y~~~~ 325 (510)
+...... ...+.+||+.|+|||++.+ ..|+.++
T Consensus 164 ~~~~~~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~ 204 (396)
T 4eut_A 164 RELEDDE---------------------------------------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATV 204 (396)
T ss_dssp EECCCGG---------------------------------------GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHH
T ss_pred eEccCCC---------------------------------------ccccccCCccccCHHHhhccccccccccCCCcHH
Confidence 8764321 0124679999999999975 5678999
Q ss_pred cccchhhHHHHHhhCCCCCCCC----ChhhhHHHHhhccccc-----------------cCCCCC----CCCHHHHHHHH
Q 010463 326 DWWSLGAIMYEMLIGYPPFCSD----DPRITCRKIVNWKTCL-----------------KFPEEP----KISDEARDLIC 380 (510)
Q Consensus 326 DiwSlGvilyEml~G~~PF~~~----~~~~~~~~I~~~~~~~-----------------~~p~~~----~~s~~~~dlI~ 380 (510)
|||||||++|||++|.+||.+. ...+...+++...... .+|... .+++.+.+||.
T Consensus 205 DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~ 284 (396)
T 4eut_A 205 DLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA 284 (396)
T ss_dssp HHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHH
Confidence 9999999999999999999653 2334444554422110 112212 34567889999
Q ss_pred Hhhc-CccccCCCCChHHhhc
Q 010463 381 HLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 381 ~lL~-dp~~R~~~~~~~eil~ 400 (510)
+||. ||++|+ +++++++
T Consensus 285 ~~L~~dP~~R~---s~~e~l~ 302 (396)
T 4eut_A 285 NILEADQEKCW---GFDQFFA 302 (396)
T ss_dssp HHSCCCTTTSC---CHHHHHH
T ss_pred HhhccChhhhc---cHHHHHH
Confidence 9998 999999 5677644
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=360.44 Aligned_cols=266 Identities=20% Similarity=0.271 Sum_probs=208.6
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeE-EeecCceEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY-SFQDSDFLYL 183 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~-~~~~~~~~~l 183 (510)
.++|++++.||+|+||.||+|++..+|+.||||++...... ..+.+|..++..+.|++++..++ ++.+.+..|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 36899999999999999999999999999999987654322 24778999999998877665555 4577888999
Q ss_pred EEeccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeee---cCCCceeecccCCcccCccc
Q 010463 184 IMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL---DKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILl---d~~g~vkL~DFGla~~~~~~ 259 (510)
||||+ ||+|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 99999 9999999975 4679999999999999999999999999999999999999 79999999999999876543
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~ 339 (510)
...... .-......+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 162 ~~~~~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 210 (296)
T 4hgt_A 162 RTHQHI-------------------------------PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNL 210 (296)
T ss_dssp TTCCBC-------------------------------CCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred ccCccC-------------------------------CCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhc
Confidence 111000 0001124689999999999999999999999999999999999
Q ss_pred CCCCCCCCChh---hhHHHHhhccccccCCC---CCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc----------CC
Q 010463 340 GYPPFCSDDPR---ITCRKIVNWKTCLKFPE---EPKISDEARDLICHLLC-DVETRLGTRGVEELKE----------HP 402 (510)
Q Consensus 340 G~~PF~~~~~~---~~~~~I~~~~~~~~~p~---~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~----------Hp 402 (510)
|.+||.+.+.. .....+.... ...|. ...+++++.+||.+||. ||++||+ ++++++ .+
T Consensus 211 g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~l~~~l~~~~~~~~~~ 285 (296)
T 4hgt_A 211 GSLPWQGLKAATKRQKYERISEKK--MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPD---YSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp SSCTTSSCCCSSSSSHHHHHHHHH--HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCC---HHHHHHHHHHHHHHHTCC
T ss_pred CCCCCcccchhhhhhhhhhhhccc--ccchhhhhhccCCHHHHHHHHHHHhcCCCCCCC---HHHHHHHHHHHHHHhCCC
Confidence 99999875433 3333333321 22221 13689999999999998 9999994 555554 45
Q ss_pred CcCCCCchhh
Q 010463 403 WFRGIQWDKL 412 (510)
Q Consensus 403 fF~~i~~~~l 412 (510)
|-..+||+.+
T Consensus 286 ~~~~~dw~~~ 295 (296)
T 4hgt_A 286 YDYVFDWNML 295 (296)
T ss_dssp TTCCCGGGGC
T ss_pred ccCccchhhc
Confidence 6666777765
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=368.74 Aligned_cols=262 Identities=22% Similarity=0.365 Sum_probs=209.6
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEee----c
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ----D 177 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~----~ 177 (510)
.+..++|++++.||+|+||.||+|+++.+|+.||||++... .....+.+.+|+.+++.++||||+++++++. .
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA 101 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence 34567899999999999999999999999999999998654 3445677899999999999999999999987 3
Q ss_pred CceEEEEEeccCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCc
Q 010463 178 SDFLYLIMEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLC 253 (510)
Q Consensus 178 ~~~~~lVmEy~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla 253 (510)
....|+||||++||+|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++
T Consensus 102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 4589999999999999999976 467999999999999999999999999999999999999999999999999998
Q ss_pred ccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCC---CCccccccch
Q 010463 254 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG---YGMECDWWSL 330 (510)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~---y~~~~DiwSl 330 (510)
........... ....... .....||+.|+|||++.+.. ++.++|||||
T Consensus 182 ~~~~~~~~~~~---------------------~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~sl 232 (317)
T 2buj_A 182 NQACIHVEGSR---------------------QALTLQD--------WAAQRCTISYRAPELFSVQSHCVIDERTDVWSL 232 (317)
T ss_dssp EESCEEEESHH---------------------HHHHHHH--------HHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHH
T ss_pred hhccccccccc---------------------ccccccc--------cccccCCcccCCHhHhccCCCcCCCchhhHHHH
Confidence 86543211000 0000000 11346899999999997654 6899999999
Q ss_pred hhHHHHHhhCCCCCCCCC--hhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 331 GAIMYEMLIGYPPFCSDD--PRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 331 GvilyEml~G~~PF~~~~--~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
||++|||++|..||.... .......+.. ...+|..+.+++++.+||.+||. ||.+|| ++.++++|
T Consensus 233 G~il~el~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~~ 300 (317)
T 2buj_A 233 GCVLYAMMFGEGPYDMVFQKGDSVALAVQN---QLSIPQSPRHSSALWQLLNSMMTVDPHQRP---HIPLLLSQ 300 (317)
T ss_dssp HHHHHHHHHSSCTTHHHHHTTSCHHHHHHC---C--CCCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHHHHHhCCCChhhhhcccchhhHHhhc---cCCCCccccCCHHHHHHHHHHhhcChhhCC---CHHHHHHH
Confidence 999999999999995421 1112222222 34455556899999999999998 999999 68898875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=359.65 Aligned_cols=247 Identities=23% Similarity=0.391 Sum_probs=205.8
Q ss_pred hcccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC-
Q 010463 100 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS- 178 (510)
Q Consensus 100 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~- 178 (510)
...+..++|++++.||+|+||.||+|++ +|+.||+|++.... ..+.+.+|+.+++.++||||+++++++.+.
T Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (278)
T 1byg_A 15 GWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 87 (278)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred cccCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 3456778999999999999999999987 48899999987532 456788999999999999999999987554
Q ss_pred ceEEEEEeccCCCCHHHHHHhccC--CCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccC
Q 010463 179 DFLYLIMEYLPGGDIMTLLMREDI--LSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 256 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~~~--l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~ 256 (510)
+.+|+||||++||+|.+++.+.+. +++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++...
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 167 (278)
T 1byg_A 88 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 167 (278)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred CceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccc
Confidence 579999999999999999977543 899999999999999999999999999999999999999999999999998754
Q ss_pred ccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHH
Q 010463 257 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 336 (510)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyE 336 (510)
.... ....||+.|+|||++.+..++.++|||||||++||
T Consensus 168 ~~~~-----------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 206 (278)
T 1byg_A 168 SSTQ-----------------------------------------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWE 206 (278)
T ss_dssp -------------------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred cccc-----------------------------------------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHH
Confidence 3210 12468999999999999999999999999999999
Q ss_pred Hhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 337 MLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 337 ml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
|++ |.+||.+.+.......+.... ....| ..+++.+.+||.+||. ||.+|| ++.++++
T Consensus 207 l~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rp---s~~~l~~ 266 (278)
T 1byg_A 207 IYSFGRVPYPRIPLKDVVPRVEKGY-KMDAP--DGCPPAVYEVMKNCWHLDAAMRP---SFLQLRE 266 (278)
T ss_dssp HHTTSCCSCTTSCGGGHHHHHTTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHhCCCCCCCCCCHHHHHHHHhcCC-CCCCc--ccCCHHHHHHHHHHhcCChhhCC---CHHHHHH
Confidence 998 999999888777777666431 22333 4789999999999998 999999 5666654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=360.26 Aligned_cols=242 Identities=25% Similarity=0.426 Sum_probs=207.7
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec--------
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD-------- 177 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-------- 177 (510)
.+|++++.||+|+||.||+|+++.+|+.||+|++.... +.+.+|+.++..++||||+++++++.+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 47999999999999999999999999999999997542 236789999999999999999998865
Q ss_pred --------CceEEEEEeccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceee
Q 010463 178 --------SDFLYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKL 247 (510)
Q Consensus 178 --------~~~~~lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL 247 (510)
...+|+||||++||+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence 45689999999999999999754 57999999999999999999999999999999999999999999999
Q ss_pred cccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccc
Q 010463 248 SDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDW 327 (510)
Q Consensus 248 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 327 (510)
+|||++........ ....+||+.|+|||++.+..++.++|+
T Consensus 164 ~Dfg~~~~~~~~~~---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di 204 (284)
T 2a19_B 164 GDFGLVTSLKNDGK---------------------------------------RTRSKGTLRYMSPEQISSQDYGKEVDL 204 (284)
T ss_dssp CCCTTCEESSCCSC---------------------------------------CCCCCSCCTTSCHHHHHCSCCCTHHHH
T ss_pred Ccchhheecccccc---------------------------------------ccccCCcccccChhhhccCCCcchhhh
Confidence 99999987643210 123579999999999999999999999
Q ss_pred cchhhHHHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 328 WSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 328 wSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
|||||++|||++|..||... ......+.. ..++ ..+++++++||.+||. ||.+|| ++.|+++|++.
T Consensus 205 ~slG~il~~l~~~~~~~~~~--~~~~~~~~~----~~~~--~~~~~~~~~li~~~l~~dp~~Rp---s~~e~l~~l~~ 271 (284)
T 2a19_B 205 YALGLILAELLHVCDTAFET--SKFFTDLRD----GIIS--DIFDKKEKTLLQKLLSKKPEDRP---NTSEILRTLTV 271 (284)
T ss_dssp HHHHHHHHHHHSCCSSHHHH--HHHHHHHHT----TCCC--TTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCcchhH--HHHHHHhhc----cccc--ccCCHHHHHHHHHHccCChhhCc---CHHHHHHHHHH
Confidence 99999999999999998532 222223322 1223 3689999999999998 999999 78999999775
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=362.14 Aligned_cols=242 Identities=25% Similarity=0.414 Sum_probs=197.8
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEE
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~ 182 (510)
+..++|++.+.||+|+||.||+|++. ++.||+|++... ...+.+.+|+.+|+.++||||+++++++.+ ..|
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 75 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC 75 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence 55678999999999999999999874 788999998643 345678899999999999999999999875 489
Q ss_pred EEEeccCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHhhhh---CCeEEeecCCCCeeecCCCc-eeecccCCccc
Q 010463 183 LIMEYLPGGDIMTLLMRED---ILSEDVARFYIAESVLAIHSIHQ---HNYVHRDIKPDNLILDKNGH-LKLSDFGLCKP 255 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~~---~l~e~~~~~~~~qi~~aL~~lH~---~giiHRDLKP~NILld~~g~-vkL~DFGla~~ 255 (510)
+||||++||+|.+++.... .+++..+..++.||+.||.|||+ .||+||||||+|||++.+|. +||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 9999999999999998654 47899999999999999999999 89999999999999999887 79999999975
Q ss_pred CccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHH
Q 010463 256 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 335 (510)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvily 335 (510)
.... .....||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~-----------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 194 (307)
T 2eva_A 156 IQTH-----------------------------------------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILW 194 (307)
T ss_dssp --------------------------------------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHH
T ss_pred cccc-----------------------------------------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHH
Confidence 4321 01246999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCChh--hhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 336 EMLIGYPPFCSDDPR--ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 336 Eml~G~~PF~~~~~~--~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
||++|..||...... .....+... ..... ...+++.+.+||.+||. ||.+|| +++++++
T Consensus 195 el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~l~~li~~~l~~dp~~Rp---s~~ell~ 256 (307)
T 2eva_A 195 EVITRRKPFDEIGGPAFRIMWAVHNG-TRPPL--IKNLPKPIESLMTRCWSKDPSQRP---SMEEIVK 256 (307)
T ss_dssp HHHHTCCTTTTTCSSHHHHHHHHHTT-CCCCC--BTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHCCCCchhhCccHHHHHHHHhcC-CCCCc--ccccCHHHHHHHHHHhcCChhhCc---CHHHHHH
Confidence 999999999764332 222223221 11222 24789999999999998 999999 6777776
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=374.91 Aligned_cols=240 Identities=18% Similarity=0.242 Sum_probs=196.9
Q ss_pred ccCCCCceeeeeeecCCCeEEEEE-----EEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC---CCCeeeEeE
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLC-----RAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD---SRCIVQLFY 173 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~-----~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~---hp~Iv~l~~ 173 (510)
.+..++|.+.+.||+|+||+||+| .+..+++.||||++... ....+..|..++..+. |+||+++++
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------NPWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------CHHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------ChhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 456678999999999999999999 46778999999999754 2345777888888886 899999999
Q ss_pred EeecCceEEEEEeccCCCCHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecC-------
Q 010463 174 SFQDSDFLYLIMEYLPGGDIMTLLMR-----EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK------- 241 (510)
Q Consensus 174 ~~~~~~~~~lVmEy~~gG~L~~~L~~-----~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~------- 241 (510)
++.+.+..|+|||||+||+|.+++.. ...+++..++.++.||+.||+|||+.|||||||||+||||+.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC--
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccc
Confidence 99999999999999999999999974 457999999999999999999999999999999999999998
Q ss_pred ----CCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc
Q 010463 242 ----NGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL 317 (510)
Q Consensus 242 ----~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~ 317 (510)
++++||+|||+|+.+...... ....+.+||+.|+|||++.
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~------------------------------------~~~~~~~gt~~y~aPE~~~ 258 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKG------------------------------------TIFTAKCETSGFQCVEMLS 258 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTT------------------------------------EEECCSSCTTSCCCHHHHT
T ss_pred cccccCCEEEeeCchhhhhhccCCC------------------------------------ceeeeecCCCCCCChHHhc
Confidence 899999999999754321000 0123468999999999999
Q ss_pred cCCCCccccccchhhHHHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCC
Q 010463 318 KKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLG 391 (510)
Q Consensus 318 ~~~y~~~~DiwSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~ 391 (510)
+..|+.++|||||||++|||++|.+||......... ....++. ...++...+++..||. +|.+|+.
T Consensus 259 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-------~~~~~~~-~~~~~~~~~~~~~~l~~~p~~r~~ 325 (365)
T 3e7e_A 259 NKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK-------PEGLFRR-LPHLDMWNEFFHVMLNIPDCHHLP 325 (365)
T ss_dssp TCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE-------ECSCCTT-CSSHHHHHHHHHHHHCCCCTTCCC
T ss_pred CCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee-------echhccc-cCcHHHHHHHHHHHcCCCCCCcch
Confidence 999999999999999999999999999654332110 1111121 1357789999999998 9999974
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=360.35 Aligned_cols=254 Identities=19% Similarity=0.282 Sum_probs=209.3
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCC---CEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEe-ecCce
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTG---EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSF-QDSDF 180 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg---~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-~~~~~ 180 (510)
...|++.+.||+|+||.||+|++..++ ..||+|++... ......+.+.+|..+++.++||||+++++++ .+++.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 346999999999999999999976433 36899998753 2445567899999999999999999999985 56678
Q ss_pred EEEEEeccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 181 LYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
.|+||||++||+|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+|||++.+|++||+|||+++.....
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 9999999999999999976 356899999999999999999999999999999999999999999999999999876543
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~ 339 (510)
..... .......||+.|+|||++.+..++.++|+|||||++|||++
T Consensus 182 ~~~~~----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 227 (298)
T 3f66_A 182 EYYSV----------------------------------HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227 (298)
T ss_dssp GGCBC---------------------------------------CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred chhcc----------------------------------ccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHh
Confidence 11100 00123578999999999999999999999999999999999
Q ss_pred -CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 340 -GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 340 -G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
|.+||.+.+.......+..... ...| ..+++.+.+||.+||. ||.+|| ++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~l~~li~~~l~~~p~~Rp---s~~ell~ 284 (298)
T 3f66_A 228 RGAPPYPDVNTFDITVYLLQGRR-LLQP--EYCPDPLYEVMLKCWHPKAEMRP---SFSELVS 284 (298)
T ss_dssp TSCCSSTTSCTTTHHHHHHTTCC-CCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred CCCCCCccCCHHHHHHHHhcCCC-CCCC--ccCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 7788888777777777665432 2223 4789999999999998 999999 5777764
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=389.54 Aligned_cols=248 Identities=18% Similarity=0.232 Sum_probs=196.1
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhc-----chhhHHHHHHHHHHHHhcC---------CCCe
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML-----KRGQVEHVRSERNLLAEVD---------SRCI 168 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~-----~~~~~~~~~~E~~iL~~l~---------hp~I 168 (510)
+..++|++++.||+|+||+||+|++ +|+.||||++.+.... .....+.+.+|+.+|+.++ ||||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 3456799999999999999999987 7899999999875421 2334577889999998886 6666
Q ss_pred eeEeEE-----------------eec-------------CceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHH
Q 010463 169 VQLFYS-----------------FQD-------------SDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLA 218 (510)
Q Consensus 169 v~l~~~-----------------~~~-------------~~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~a 218 (510)
|++.++ |.+ .+.+|+|||||+||++.+.+.+ ..+++..++.++.||+.|
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence 555554 443 7899999999999988777755 678999999999999999
Q ss_pred HHhhh-hCCeEEeecCCCCeeecCCC--------------------ceeecccCCcccCccccccccchhhhhhcccccc
Q 010463 219 IHSIH-QHNYVHRDIKPDNLILDKNG--------------------HLKLSDFGLCKPLEDKYSSILLEDEDIINQETVS 277 (510)
Q Consensus 219 L~~lH-~~giiHRDLKP~NILld~~g--------------------~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~ 277 (510)
|.||| ++|||||||||+||||+.+| ++||+|||+|+.....
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------------------ 235 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------------------ 235 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------------------
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------------------
Confidence 99999 99999999999999999987 9999999999865321
Q ss_pred cccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhH-HHHHhhCCCCCCCCCh-hhhHHH
Q 010463 278 EAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI-MYEMLIGYPPFCSDDP-RITCRK 355 (510)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvi-lyEml~G~~PF~~~~~-~~~~~~ 355 (510)
..+||+.|||||++.+.. +.++||||||++ .++++.|..||.+... ......
T Consensus 236 -------------------------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~ 289 (336)
T 2vuw_A 236 -------------------------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDK 289 (336)
T ss_dssp -------------------------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHH
T ss_pred -------------------------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHh
Confidence 358999999999998776 999999998777 8889999999954211 112233
Q ss_pred HhhccccccCC---CCCCCCHHHHHHHHHhhc-CccccCCCCChHHhh-cCCCcC
Q 010463 356 IVNWKTCLKFP---EEPKISDEARDLICHLLC-DVETRLGTRGVEELK-EHPWFR 405 (510)
Q Consensus 356 I~~~~~~~~~p---~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil-~HpfF~ 405 (510)
+.........+ ..+.+|+++++||++||+ | +++|++ +||||+
T Consensus 290 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d--------sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 290 MLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS--------SATDLLCQHSLFK 336 (336)
T ss_dssp HHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS--------SHHHHHHHCGGGC
T ss_pred hhhhhccCcccchhhhhhcCHHHHHHHHHHhccC--------CHHHHHhcCCCcC
Confidence 33211111111 123578999999999997 4 689999 999995
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=360.67 Aligned_cols=258 Identities=19% Similarity=0.297 Sum_probs=200.8
Q ss_pred hhcccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC
Q 010463 99 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 178 (510)
Q Consensus 99 ~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 178 (510)
...++..++|++.+.||+|+||.||+|++. ..||+|++.... ......+.+.+|+.+|+.++||||+++++++ ..
T Consensus 17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~ 91 (289)
T 3og7_A 17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA 91 (289)
T ss_dssp -CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS
T ss_pred CCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cC
Confidence 445677889999999999999999999764 359999997543 2445667899999999999999999999955 56
Q ss_pred ceEEEEEeccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCc
Q 010463 179 DFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 257 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~ 257 (510)
...++||||++||+|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++...
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccc
Confidence 678999999999999999964 4569999999999999999999999999999999999999999999999999998653
Q ss_pred cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc---cCCCCccccccchhhHH
Q 010463 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMECDWWSLGAIM 334 (510)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~---~~~y~~~~DiwSlGvil 334 (510)
..... ......+||+.|+|||++. +..++.++|||||||++
T Consensus 172 ~~~~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il 215 (289)
T 3og7_A 172 RWSGS------------------------------------HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVL 215 (289)
T ss_dssp ------------------------------------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHH
T ss_pred ccccc------------------------------------ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHH
Confidence 21100 0012357999999999997 56789999999999999
Q ss_pred HHHhhCCCCCCCCChhhhHHHHhhcc-ccccCCC-CCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 335 YEMLIGYPPFCSDDPRITCRKIVNWK-TCLKFPE-EPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 335 yEml~G~~PF~~~~~~~~~~~I~~~~-~~~~~p~-~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
|||++|..||.+.+.......++... .....+. ...+++++.+||.+||. ||.+|| ++.++++
T Consensus 216 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~ell~ 281 (289)
T 3og7_A 216 YELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERP---SFPRILA 281 (289)
T ss_dssp HHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCC---CHHHHHH
Confidence 99999999998866655554444321 1111111 23688999999999998 999999 6777764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=362.69 Aligned_cols=252 Identities=25% Similarity=0.332 Sum_probs=198.4
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHh--cCCCCeeeEeEEeec---
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE--VDSRCIVQLFYSFQD--- 177 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~--l~hp~Iv~l~~~~~~--- 177 (510)
+..++|++++.||+|+||+||+|++ +|+.||||++... ....+..|.+++.. ++||||+++++++.+
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~ 76 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR------DEKSWFRETELYNTVMLRHENILGFIASDMTSRH 76 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccC
Confidence 4567899999999999999999987 6899999998654 23446677888776 799999999998654
Q ss_pred -CceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhh--------hCCeEEeecCCCCeeecCCCceeec
Q 010463 178 -SDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIH--------QHNYVHRDIKPDNLILDKNGHLKLS 248 (510)
Q Consensus 178 -~~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH--------~~giiHRDLKP~NILld~~g~vkL~ 248 (510)
...+|+||||++||+|.+++.. ..+++..+..++.||+.||.||| +.||+||||||+|||++.++++||+
T Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 77 SSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp TEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred CCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence 4579999999999999999954 57999999999999999999999 9999999999999999999999999
Q ss_pred ccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC------CCC
Q 010463 249 DFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK------GYG 322 (510)
Q Consensus 249 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~------~y~ 322 (510)
|||+|+......... .......+||+.|+|||++.+. .++
T Consensus 156 Dfg~a~~~~~~~~~~----------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 201 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQL----------------------------------DVGNNPRVGTKRYMAPEVLDETIQVDCFDSY 201 (301)
T ss_dssp CCTTCEEEETTTTEE----------------------------------ECCCCCCCCCGGGCCHHHHTTCCCTTCHHHH
T ss_pred eCCCeeecccccccc----------------------------------cccccccccccceeChhhhcCcCCCCcccCC
Confidence 999997654321100 0011235899999999999876 455
Q ss_pred ccccccchhhHHHHHhhC----------CCCCCCCChh----hhHHHHhh-ccccccCCC---CCCCCHHHHHHHHHhhc
Q 010463 323 MECDWWSLGAIMYEMLIG----------YPPFCSDDPR----ITCRKIVN-WKTCLKFPE---EPKISDEARDLICHLLC 384 (510)
Q Consensus 323 ~~~DiwSlGvilyEml~G----------~~PF~~~~~~----~~~~~I~~-~~~~~~~p~---~~~~s~~~~dlI~~lL~ 384 (510)
.++|||||||++|||++| .+||...... ....++.. .......|. ...+++++.+||.+||.
T Consensus 202 ~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 281 (301)
T 3q4u_A 202 KRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWY 281 (301)
T ss_dssp HHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCC
T ss_pred chhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhh
Confidence 799999999999999999 8999654322 22222222 111122221 01255789999999998
Q ss_pred -CccccCCCCChHHhhc
Q 010463 385 -DVETRLGTRGVEELKE 400 (510)
Q Consensus 385 -dp~~R~~~~~~~eil~ 400 (510)
||.+|| ++.+|++
T Consensus 282 ~dP~~Rp---s~~~i~~ 295 (301)
T 3q4u_A 282 QNPSARL---TALRIKK 295 (301)
T ss_dssp SSGGGSC---CHHHHHH
T ss_pred cChhhCC---CHHHHHH
Confidence 999999 6777764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=370.58 Aligned_cols=261 Identities=21% Similarity=0.282 Sum_probs=207.3
Q ss_pred hcccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc
Q 010463 100 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 179 (510)
Q Consensus 100 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 179 (510)
...+..++|++.+.||+|+||.||+|+.+ +|+.||||++...... .....+.+|+.+++.++||||+++++++.+.+
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 100 (326)
T 3uim_A 24 ELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 100 (326)
T ss_dssp HHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSS
T ss_pred HHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCc--hHHHHHHHHHHHHHhccCCCccceEEEEecCC
Confidence 34466789999999999999999999754 6899999999765322 12235889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHhhhhC---CeEEeecCCCCeeecCCCceeecccCC
Q 010463 180 FLYLIMEYLPGGDIMTLLMRED----ILSEDVARFYIAESVLAIHSIHQH---NYVHRDIKPDNLILDKNGHLKLSDFGL 252 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~~----~l~e~~~~~~~~qi~~aL~~lH~~---giiHRDLKP~NILld~~g~vkL~DFGl 252 (510)
..++||||++||+|.+++.... .+++..+..++.|++.||.|||+. ||+||||||+|||++.++++||+|||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 180 (326)
T 3uim_A 101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180 (326)
T ss_dssp CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSS
T ss_pred ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcc
Confidence 9999999999999999997643 499999999999999999999999 999999999999999999999999999
Q ss_pred cccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhh
Q 010463 253 CKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGA 332 (510)
Q Consensus 253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGv 332 (510)
++........ .....+||+.|+|||++.+..++.++|||||||
T Consensus 181 ~~~~~~~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 223 (326)
T 3uim_A 181 AKLMDYKDTH-------------------------------------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGV 223 (326)
T ss_dssp CEECCSSSSC-------------------------------------EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHH
T ss_pred ccccCccccc-------------------------------------ccccccCCcCccCHHHhccCCCCccccchhHHH
Confidence 9876432110 112356999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCC----CChhhhHHHHhhc-ccccc----------CCCCCCCCHHHHHHHHHhhc-CccccCCCCChH
Q 010463 333 IMYEMLIGYPPFCS----DDPRITCRKIVNW-KTCLK----------FPEEPKISDEARDLICHLLC-DVETRLGTRGVE 396 (510)
Q Consensus 333 ilyEml~G~~PF~~----~~~~~~~~~I~~~-~~~~~----------~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~ 396 (510)
++|||++|.+||.. ..........+.. ..... .+.....+..+.+||.+||. ||.+|| ++.
T Consensus 224 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp---s~~ 300 (326)
T 3uim_A 224 MLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERP---KMS 300 (326)
T ss_dssp HHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSC---CHH
T ss_pred HHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCC---CHH
Confidence 99999999999952 1111111111110 00000 00011234789999999998 999999 688
Q ss_pred HhhcCCC
Q 010463 397 ELKEHPW 403 (510)
Q Consensus 397 eil~Hpf 403 (510)
|+++|-.
T Consensus 301 ell~~L~ 307 (326)
T 3uim_A 301 EVVRMLE 307 (326)
T ss_dssp HHHHHHH
T ss_pred HHHHHhc
Confidence 9988754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=383.18 Aligned_cols=251 Identities=24% Similarity=0.408 Sum_probs=210.3
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCce
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 180 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 180 (510)
..+..++|++.+.||+|+||.||+|.++. +..||||+++.... ..+.+.+|+.+|+.++||||+++++++.+ +.
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~ 252 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 252 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc
Confidence 44666789999999999999999999875 45699999976432 24568999999999999999999999876 67
Q ss_pred EEEEEeccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 181 LYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
+|+||||++||+|.++|... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 99999999999999999753 5699999999999999999999999999999999999999999999999999986543
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHh
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml 338 (510)
.... ......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 333 ~~~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~ 375 (452)
T 1fmk_A 333 NEYT-------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 375 (452)
T ss_dssp -----------------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred Ccee-------------------------------------cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHH
Confidence 2100 011245788999999999999999999999999999999
Q ss_pred h-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 339 I-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 339 ~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
+ |.+||.+.+..+....+... ...|....+++.+.+||.+||. ||++|| ++++|++
T Consensus 376 t~g~~P~~~~~~~~~~~~i~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rp---t~~~l~~ 433 (452)
T 1fmk_A 376 TKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLHDLMCQCWRKEPEERP---TFEYLQA 433 (452)
T ss_dssp TTTCCSSTTCCHHHHHHHHHTT---CCCCCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred hCCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCCHHHHHHHHHHccCChhhCc---CHHHHHH
Confidence 9 99999998888877777653 2233335789999999999998 999999 5777765
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=361.28 Aligned_cols=231 Identities=33% Similarity=0.561 Sum_probs=191.2
Q ss_pred CCCceee-eeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHH-HhcCCCCeeeEeEEeec----C
Q 010463 105 IDDFEQL-TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLL-AEVDSRCIVQLFYSFQD----S 178 (510)
Q Consensus 105 ~~~f~~~-~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL-~~l~hp~Iv~l~~~~~~----~ 178 (510)
.++|.++ +.||+|+||.||+|.++.+|+.||+|++... ..+.+|+.++ +.++||||++++++|.+ .
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 4678888 7899999999999999999999999999643 2366788887 66799999999999987 7
Q ss_pred ceEEEEEeccCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecC---CCceeecccCCc
Q 010463 179 DFLYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK---NGHLKLSDFGLC 253 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~---~g~vkL~DFGla 253 (510)
..+|+||||++||+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred ceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 78999999999999999998764 6999999999999999999999999999999999999998 889999999998
Q ss_pred ccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhH
Q 010463 254 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 333 (510)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvi 333 (510)
.... +..|+.++|||||||+
T Consensus 168 ~~~~------------------------------------------------------------~~~~~~~~DiwslG~i 187 (299)
T 3m2w_A 168 KETT------------------------------------------------------------GEKYDKSCDMWSLGVI 187 (299)
T ss_dssp EECT------------------------------------------------------------TCGGGGHHHHHHHHHH
T ss_pred cccc------------------------------------------------------------cccCCchhhHHHHHHH
Confidence 6432 1346778999999999
Q ss_pred HHHHhhCCCCCCCCChhhhHHHHhhcc--ccccCCC--CCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 334 MYEMLIGYPPFCSDDPRITCRKIVNWK--TCLKFPE--EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 334 lyEml~G~~PF~~~~~~~~~~~I~~~~--~~~~~p~--~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
+|||++|.+||.+.+.......+.... ....+|. ...+++++.+||.+||. ||.+|| +++|+++||||.+
T Consensus 188 l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp---s~~e~l~hp~~~~ 262 (299)
T 3m2w_A 188 MYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM---TITEFMNHPWIMQ 262 (299)
T ss_dssp HHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSC---CHHHHHTSHHHHT
T ss_pred HHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCC---CHHHHhcChhhcc
Confidence 999999999998766544332222111 1112221 14689999999999998 999999 7899999999976
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=384.30 Aligned_cols=273 Identities=20% Similarity=0.224 Sum_probs=218.0
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC-CCeeeEeEEeecCceEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS-RCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~~~~~~~~~l 183 (510)
.++|++++.||+|+||.||+|++..+|+.||||++...... ..+..|..++..+.| ++|+.+..++.+.+..||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 47899999999999999999999999999999998754321 237789999999977 667777777788889999
Q ss_pred EEeccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeee---cCCCceeecccCCcccCccc
Q 010463 184 IMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL---DKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILl---d~~g~vkL~DFGla~~~~~~ 259 (510)
||||+ ||+|.+++.. ...+++..++.++.||+.||.|||++|||||||||+|||| +.++++||+|||+|+.+...
T Consensus 81 vme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99999 9999999975 5679999999999999999999999999999999999999 68999999999999876543
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~ 339 (510)
...... .-......+||+.|+|||++.+..++.++|||||||+||||++
T Consensus 160 ~~~~~~-------------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~ellt 208 (483)
T 3sv0_A 160 STHQHI-------------------------------PYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLR 208 (483)
T ss_dssp TTCCBC-------------------------------CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccc-------------------------------ccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHh
Confidence 111000 0001124689999999999999999999999999999999999
Q ss_pred CCCCCCCCCh---hhhHHHHhhccccccCC-CCCCCCHHHHHHHHHhhc-CccccCCCCCh-------HHhhcCCCcCCC
Q 010463 340 GYPPFCSDDP---RITCRKIVNWKTCLKFP-EEPKISDEARDLICHLLC-DVETRLGTRGV-------EELKEHPWFRGI 407 (510)
Q Consensus 340 G~~PF~~~~~---~~~~~~I~~~~~~~~~p-~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~-------~eil~HpfF~~i 407 (510)
|..||.+... ...+.++.........+ ....+++++.+||..||. ||.+||+...+ .+.+.|+|+..+
T Consensus 209 G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~ 288 (483)
T 3sv0_A 209 GSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVF 288 (483)
T ss_dssp SSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCC
T ss_pred CCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCc
Confidence 9999987543 33344443321111000 013679999999999998 99999954322 122348999999
Q ss_pred Cchhhhc
Q 010463 408 QWDKLYE 414 (510)
Q Consensus 408 ~~~~l~~ 414 (510)
||+.+..
T Consensus 289 dW~~~~~ 295 (483)
T 3sv0_A 289 DWTILKY 295 (483)
T ss_dssp HHHHHTC
T ss_pred Cchhhcc
Confidence 9998864
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=365.26 Aligned_cols=262 Identities=21% Similarity=0.323 Sum_probs=192.4
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEeEEe----
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSF---- 175 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~---- 175 (510)
..+...+|++.+.||+|+||.||+|+++.+|+.||||++.+. .......+.+|+.+|..+. ||||+++++++
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 99 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK 99 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence 345556899999999999999999999999999999998654 2344567889999999995 99999999998
Q ss_pred ----ecCceEEEEEeccCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHhhhhCC--eEEeecCCCCeeecCCCcee
Q 010463 176 ----QDSDFLYLIMEYLPGGDIMTLLMR---EDILSEDVARFYIAESVLAIHSIHQHN--YVHRDIKPDNLILDKNGHLK 246 (510)
Q Consensus 176 ----~~~~~~~lVmEy~~gG~L~~~L~~---~~~l~e~~~~~~~~qi~~aL~~lH~~g--iiHRDLKP~NILld~~g~vk 246 (510)
.+...+|+||||+. |+|.+++.. .+.+++..++.++.||+.||.|||+.| |+||||||+||||+.+|++|
T Consensus 100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 100 EESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp TTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEE
T ss_pred cccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEE
Confidence 44557999999996 699998865 467999999999999999999999999 99999999999999999999
Q ss_pred ecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhh---ccCCCCc
Q 010463 247 LSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL---LKKGYGM 323 (510)
Q Consensus 247 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl---~~~~y~~ 323 (510)
|+|||+++............. ...........+||+.|+|||++ .+..++.
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~ 232 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQ--------------------------RRALVEEEITRNTTPMYRTPEIIDLYSNFPIGE 232 (337)
T ss_dssp BCCCTTCBCCSSCC---------------------------------------------------------CCTTSCSSH
T ss_pred EecCccceeccccCccccccc--------------------------ccccchhhccccCCCCcCChhhhhccccCCCCh
Confidence 999999987654311100000 00000011245799999999999 5677899
Q ss_pred cccccchhhHHHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 324 ECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 324 ~~DiwSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
++|||||||++|||++|..||.+......... ....+.....++.+.+||.+||. ||.+|| ++.|+++|
T Consensus 233 ~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~e~l~~ 302 (337)
T 3ll6_A 233 KQDIWALGCILYLLCFRQHPFEDGAKLRIVNG------KYSIPPHDTQYTVFHSLIRAMLQVNPEERL---SIAEVVHQ 302 (337)
T ss_dssp HHHHHHHHHHHHHHHHSSCCC------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSC---CHHHHHHH
T ss_pred HHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC------cccCCcccccchHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 99999999999999999999976554332222 22334445788899999999999 999999 68899887
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=354.84 Aligned_cols=254 Identities=20% Similarity=0.269 Sum_probs=204.7
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeE-EeecCceEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY-SFQDSDFLYL 183 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~-~~~~~~~~~l 183 (510)
.++|++++.||+|+||.||+|+++.+|+.||||++..... ...+.+|..++..+.|++++..+. ++.+....|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 4789999999999999999999999999999999875432 234788999999999877655554 4567788999
Q ss_pred EEeccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeee---cCCCceeecccCCcccCccc
Q 010463 184 IMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL---DKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILl---d~~g~vkL~DFGla~~~~~~ 259 (510)
||||+ ||+|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99999 9999999974 4579999999999999999999999999999999999999 58899999999999876543
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~ 339 (510)
...... ........+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 162 ~~~~~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 210 (296)
T 3uzp_A 162 RTHQHI-------------------------------PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNL 210 (296)
T ss_dssp TTCCBC-------------------------------CCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccc-------------------------------ccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHh
Confidence 111000 0001124689999999999999999999999999999999999
Q ss_pred CCCCCCCCC---hhhhHHHHhhccccccCCC---CCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 340 GYPPFCSDD---PRITCRKIVNWKTCLKFPE---EPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 340 G~~PF~~~~---~~~~~~~I~~~~~~~~~p~---~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
|..||.+.+ ....+..+.... ...|. ...+|+++.+||.+||. ||.+|| +++++++
T Consensus 211 g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~l~~ 273 (296)
T 3uzp_A 211 GSLPWQGLKAATKRQKYERISEKK--MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKP---DYSYLRQ 273 (296)
T ss_dssp SSCTTSSCCCSSSSSHHHHHHHHH--HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCC---CHHHHHH
T ss_pred CCCCCCCcCchhhhhhhhhhcccc--cCCchHHHHhhCCHHHHHHHHHHHhcCcCcCC---CHHHHHH
Confidence 999998743 334444444321 22221 14789999999999998 999999 4555553
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=374.29 Aligned_cols=253 Identities=20% Similarity=0.285 Sum_probs=202.2
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCC---CEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEee-cCceEE
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTG---EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ-DSDFLY 182 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg---~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-~~~~~~ 182 (510)
.|++.+.||+|+||+||+|+...++ ..||+|.+... ......+.+.+|..+|+.++|||||++++++. +++..|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 4788999999999999999876443 46899998653 23456778999999999999999999999864 556899
Q ss_pred EEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 183 LIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
+||||++||+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|++||+|||+++.+.....
T Consensus 168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence 999999999999999765 4589999999999999999999999999999999999999999999999999986543211
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh-C
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-G 340 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~-G 340 (510)
.. ........||+.|+|||++.+..++.++|||||||++|||++ |
T Consensus 248 ~~----------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~ 293 (373)
T 3c1x_A 248 DS----------------------------------VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 293 (373)
T ss_dssp --------------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred cc----------------------------------ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCc
Confidence 00 000113468899999999999999999999999999999999 7
Q ss_pred CCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 341 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 341 ~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
.+||.+.+..+....+.... ....| ..+++.+.+||.+||. ||.+|| ++.+++++
T Consensus 294 ~~p~~~~~~~~~~~~~~~~~-~~~~p--~~~~~~l~~li~~cl~~dp~~RP---s~~ell~~ 349 (373)
T 3c1x_A 294 APPYPDVNTFDITVYLLQGR-RLLQP--EYCPDPLYEVMLKCWHPKAEMRP---SFSELVSR 349 (373)
T ss_dssp CCSCTTSCSSCHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHcCC-CCCCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 88998887777776666543 22233 4789999999999998 999999 67787753
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=395.70 Aligned_cols=246 Identities=22% Similarity=0.332 Sum_probs=206.7
Q ss_pred eeeecCCCeEEEEEEE--cCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEeccC
Q 010463 112 TLIGKGAFGEVRLCRA--KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLP 189 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~--~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy~~ 189 (510)
+.||+|+||+||+|.+ +.+++.||||+++... ......+.+.+|+.+|..++|||||++++++.+ +.+|+|||||+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence 4799999999999954 4577899999997653 234456789999999999999999999999975 45899999999
Q ss_pred CCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhh
Q 010463 190 GGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDED 269 (510)
Q Consensus 190 gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~ 269 (510)
||+|.++|.....+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.+.......
T Consensus 453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~------ 526 (635)
T 4fl3_A 453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY------ 526 (635)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----------
T ss_pred CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc------
Confidence 99999999988899999999999999999999999999999999999999999999999999998764321100
Q ss_pred hhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh-CCCCCCCCC
Q 010463 270 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDD 348 (510)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~-G~~PF~~~~ 348 (510)
.......||+.|+|||++.+..|+.++|||||||+||||++ |.+||.+.+
T Consensus 527 -----------------------------~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~ 577 (635)
T 4fl3_A 527 -----------------------------KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 577 (635)
T ss_dssp -------------------------------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred -----------------------------ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 00112457899999999999999999999999999999998 999999998
Q ss_pred hhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 349 PRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 349 ~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
..+....+.... ....| ..+++++.+||.+||. ||++|| ++++|++
T Consensus 578 ~~~~~~~i~~~~-~~~~p--~~~~~~l~~li~~cl~~dP~~RP---s~~~l~~ 624 (635)
T 4fl3_A 578 GSEVTAMLEKGE-RMGCP--AGCPREMYDLMNLCWTYDVENRP---GFAAVEL 624 (635)
T ss_dssp HHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSTTTSC---CHHHHHH
T ss_pred HHHHHHHHHcCC-CCCCC--CCCCHHHHHHHHHHcCCCHhHCc---CHHHHHH
Confidence 888877776542 23344 4799999999999998 999999 5666653
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=393.05 Aligned_cols=261 Identities=24% Similarity=0.349 Sum_probs=212.2
Q ss_pred cCCCCceeee-eeecCCCeEEEEEEEcC--CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc
Q 010463 103 IGIDDFEQLT-LIGKGAFGEVRLCRAKT--TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 179 (510)
Q Consensus 103 ~~~~~f~~~~-~IG~G~fG~V~~~~~~~--tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 179 (510)
+..+++.+.. .||+|+||.||+|..+. ++..||||++++.. .....+.+.+|+.+|+.++|||||++++++.+ +
T Consensus 332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~ 408 (613)
T 2ozo_A 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 408 (613)
T ss_dssp CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S
T ss_pred ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C
Confidence 3445666666 89999999999998764 56679999997652 34456789999999999999999999999987 5
Q ss_pred eEEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 180 FLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
.+|+|||||+||+|.++|... ..+++..+..++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+..
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 699999999999999999754 5699999999999999999999999999999999999999999999999999987643
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHh
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml 338 (510)
..... .......||+.|+|||++.+..|+.++|||||||+||||+
T Consensus 489 ~~~~~-----------------------------------~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ell 533 (613)
T 2ozo_A 489 DDSYY-----------------------------------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 533 (613)
T ss_dssp ------------------------------------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred CCcee-----------------------------------eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHH
Confidence 21100 0011235779999999999999999999999999999999
Q ss_pred h-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 339 I-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 339 ~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
+ |.+||.+.+..+....|.... .+..| ..+++++.+||.+||. ||.+||+...+.+.+++.|+
T Consensus 534 t~G~~Pf~~~~~~~~~~~i~~~~-~~~~p--~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 534 SYGQKPYKKMKGPEVMAFIEQGK-RMECP--PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp TTSCCTTTTCCSHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HCCCCCCCCCCHHHHHHHHHcCC-CCCCC--CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 8 999999988888887777643 33444 4799999999999998 99999954333334455443
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=368.53 Aligned_cols=253 Identities=15% Similarity=0.206 Sum_probs=202.1
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCC--------CCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeee------
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTT--------GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQ------ 170 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~t--------g~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~------ 170 (510)
.++|++.+.||+|+||.||+|+++.+ ++.||+|++.+. +.+.+|+.++..++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 47899999999999999999999884 889999999754 24778999999999999988
Q ss_pred ---------EeEEeec-CceEEEEEeccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCee
Q 010463 171 ---------LFYSFQD-SDFLYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLI 238 (510)
Q Consensus 171 ---------l~~~~~~-~~~~~lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NIL 238 (510)
+++++.. ...+|+||||+ ||+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 5666665 78899999999 99999999876 78999999999999999999999999999999999999
Q ss_pred ecCCC--ceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhh
Q 010463 239 LDKNG--HLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL 316 (510)
Q Consensus 239 ld~~g--~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl 316 (510)
++.++ .+||+|||+++.+......... ........+||+.|+|||++
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~-------------------------------~~~~~~~~~gt~~y~aPE~~ 240 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAY-------------------------------VEGSRSPHEGDLEFISMDLH 240 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCC-------------------------------CTTSSCTTCSCTTTCCHHHH
T ss_pred EcCCCCceEEEecCcceeeccCCCccccc-------------------------------cccccccccCCccccCHHHH
Confidence 99998 9999999999876543111000 00011245899999999999
Q ss_pred ccCCCCccccccchhhHHHHHhhCCCCCCCCC--hhhhHHHHhhcc-ccccCCC----CCCCCHHHHHHHHHhhc-Cccc
Q 010463 317 LKKGYGMECDWWSLGAIMYEMLIGYPPFCSDD--PRITCRKIVNWK-TCLKFPE----EPKISDEARDLICHLLC-DVET 388 (510)
Q Consensus 317 ~~~~y~~~~DiwSlGvilyEml~G~~PF~~~~--~~~~~~~I~~~~-~~~~~p~----~~~~s~~~~dlI~~lL~-dp~~ 388 (510)
.+..++.++|||||||++|||++|..||.+.. .......+.... ....++. +..+++++.+||.+||. ||.+
T Consensus 241 ~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 320 (352)
T 2jii_A 241 KGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEE 320 (352)
T ss_dssp TTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTC
T ss_pred ccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhh
Confidence 99999999999999999999999999998754 222222222111 1111111 13579999999999998 9999
Q ss_pred cCCCCChHHhhc
Q 010463 389 RLGTRGVEELKE 400 (510)
Q Consensus 389 R~~~~~~~eil~ 400 (510)
|| ++++|++
T Consensus 321 Rp---s~~~l~~ 329 (352)
T 2jii_A 321 KP---PYAMLRN 329 (352)
T ss_dssp CC---CHHHHHH
T ss_pred CC---CHHHHHH
Confidence 99 5666654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=361.62 Aligned_cols=251 Identities=24% Similarity=0.372 Sum_probs=204.7
Q ss_pred CceeeeeeecCCCeEEEEEEE----cCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec--Cce
Q 010463 107 DFEQLTLIGKGAFGEVRLCRA----KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD--SDF 180 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~----~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~ 180 (510)
.|++++.||+|+||+||+|.. ..+|+.||||++.+.. .......+.+|+.+|+.++||||+++++++.+ ...
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 359999999999999988764 4578999999997652 34456779999999999999999999999987 468
Q ss_pred EEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccc
Q 010463 181 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 260 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~ 260 (510)
+|+||||++||+|.+++.+. .+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++.......
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 188 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTC
T ss_pred EEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccc
Confidence 99999999999999999665 49999999999999999999999999999999999999999999999999998765431
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhC
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 340 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G 340 (510)
... .......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 189 ~~~-----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g 233 (318)
T 3lxp_A 189 EYY-----------------------------------RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTH 233 (318)
T ss_dssp SEE-----------------------------------EC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTT
T ss_pred ccc-----------------------------------ccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhC
Confidence 100 001235689999999999999999999999999999999999
Q ss_pred CCCCCCCChhh--------------hHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 341 YPPFCSDDPRI--------------TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 341 ~~PF~~~~~~~--------------~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
..||....... .....+.. ....+....+++++.+||++||. ||.+|| +++++++
T Consensus 234 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp---s~~ell~ 303 (318)
T 3lxp_A 234 CDSSQSPPTKFLELIGIAQGQMTVLRLTELLER--GERLPRPDKCPAEVYHLMKNCWETEASFRP---TFENLIP 303 (318)
T ss_dssp TCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred CCcccccchhhhhhhcccccchhHHHHHHHHhc--ccCCCCCccccHHHHHHHHHHcCCCcccCc---CHHHHHH
Confidence 99997543211 11122221 12233335799999999999998 999999 6777764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=385.92 Aligned_cols=251 Identities=24% Similarity=0.408 Sum_probs=214.5
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCce
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 180 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 180 (510)
..+..++|++.+.||+|+||+||+|.++. +..||||+++.... ..+.+.+|+.+|+.++|||||++++++.+ +.
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~ 335 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 335 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred eecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-cc
Confidence 45667789999999999999999999875 45699999976532 24568999999999999999999999876 67
Q ss_pred EEEEEeccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 181 LYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
+|+|||||+||+|.++|... ..+++..+..++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+..
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 99999999999999999753 5699999999999999999999999999999999999999999999999999987643
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHh
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml 338 (510)
.... ......||+.|+|||++.+..|+.++|||||||+||||+
T Consensus 416 ~~~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~ 458 (535)
T 2h8h_A 416 NEYT-------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 458 (535)
T ss_dssp HHHH-------------------------------------TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred Ccee-------------------------------------cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHH
Confidence 2100 011245788999999999999999999999999999999
Q ss_pred h-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 339 I-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 339 ~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
+ |..||.+.+..+....+... ...+....+++++.+||.+||. ||++|| ++++|++
T Consensus 459 t~g~~P~~~~~~~~~~~~i~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RP---t~~~l~~ 516 (535)
T 2h8h_A 459 TKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLHDLMCQCWRKEPEERP---TFEYLQA 516 (535)
T ss_dssp TTTCCSSTTCCHHHHHHHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred hCCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCCHHHHHHHHHHcCCChhHCc---CHHHHHH
Confidence 9 99999998888877777653 2233335789999999999998 999999 5677764
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=364.88 Aligned_cols=258 Identities=23% Similarity=0.325 Sum_probs=192.7
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHH--HhcCCCCeeeEeEEee--
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLL--AEVDSRCIVQLFYSFQ-- 176 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL--~~l~hp~Iv~l~~~~~-- 176 (510)
..+..++|++++.||+|+||.||+|+. +|+.||||++.... ...+..|..++ ..++||||+++++.+.
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheeccccc
Confidence 457789999999999999999999976 68999999997542 23344455554 4589999999997543
Q ss_pred ---cCceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhC---------CeEEeecCCCCeeecCCCc
Q 010463 177 ---DSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH---------NYVHRDIKPDNLILDKNGH 244 (510)
Q Consensus 177 ---~~~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~---------giiHRDLKP~NILld~~g~ 244 (510)
....+|+||||++||+|.+++.... +++..+..++.||+.||.|||+. ||+||||||+||||+.+|.
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence 3447899999999999999996654 58999999999999999999999 9999999999999999999
Q ss_pred eeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc------
Q 010463 245 LKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK------ 318 (510)
Q Consensus 245 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~------ 318 (510)
+||+|||+|+.+......... .......+.+||+.|+|||++.+
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 208 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPG------------------------------EEDNAAISEVGTIRYMAPEVLEGAVNLRD 208 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------------------------------------CCTTSCGGGCCHHHHTTCCCGGG
T ss_pred EEEeeccceeecccccccCcc------------------------------ccccccccCCCccceeCchhhcCCccccc
Confidence 999999999876542110000 00011224689999999999987
Q ss_pred -CCCCccccccchhhHHHHHhhCCCCCCCCCh-hh-----------------hHHHHhhccccccCCC----CCCCCHHH
Q 010463 319 -KGYGMECDWWSLGAIMYEMLIGYPPFCSDDP-RI-----------------TCRKIVNWKTCLKFPE----EPKISDEA 375 (510)
Q Consensus 319 -~~y~~~~DiwSlGvilyEml~G~~PF~~~~~-~~-----------------~~~~I~~~~~~~~~p~----~~~~s~~~ 375 (510)
..++.++|||||||++|||++|..||..... .. ....+........+|. ...+++++
T Consensus 209 ~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (336)
T 3g2f_A 209 XESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSL 288 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHH
T ss_pred ccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHH
Confidence 4567899999999999999999766643221 11 0111111111222332 12245689
Q ss_pred HHHHHHhhc-CccccCCCCChHHhhc
Q 010463 376 RDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 376 ~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
.+||.+||. ||.+|| ++.|+++
T Consensus 289 ~~li~~cl~~dP~~Rp---s~~e~l~ 311 (336)
T 3g2f_A 289 KETIEDCWDQDAEARL---TAQXAEE 311 (336)
T ss_dssp HHHHHHHSCSSGGGSC---CHHHHHH
T ss_pred HHHHHHHhcCChhhCc---chHHHHH
Confidence 999999999 999999 5677743
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=356.19 Aligned_cols=252 Identities=23% Similarity=0.316 Sum_probs=202.2
Q ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhh-cchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEe
Q 010463 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEM-LKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 186 (510)
Q Consensus 108 f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~-~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmE 186 (510)
|...+.||+|+||.||+|.. +++.||+|++..... ......+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 33448999999999999975 688999999875432 233446779999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccc
Q 010463 187 YLPGGDIMTLLMR---EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 263 (510)
Q Consensus 187 y~~gG~L~~~L~~---~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 263 (510)
|++||+|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++........
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~- 189 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT- 189 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC-
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccc-
Confidence 9999999999874 346999999999999999999999999999999999999999999999999999865432110
Q ss_pred cchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCC
Q 010463 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 343 (510)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~P 343 (510)
......+||+.|+|||++.+ .++.++|||||||++|+|++|.+|
T Consensus 190 -----------------------------------~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p 233 (307)
T 2nru_A 190 -----------------------------------VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPA 233 (307)
T ss_dssp -----------------------------------EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCS
T ss_pred -----------------------------------ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCC
Confidence 01123579999999999865 589999999999999999999999
Q ss_pred CCCCChhhhHHHHhhc----ccc------ccCC-CCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 344 FCSDDPRITCRKIVNW----KTC------LKFP-EEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 344 F~~~~~~~~~~~I~~~----~~~------~~~p-~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
|.+.........+... ... ...+ .....+..+.+||.+||. ||.+|| ++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp---s~~~l~~~ 300 (307)
T 2nru_A 234 VDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRP---DIKKVQQL 300 (307)
T ss_dssp BCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSC---CHHHHHHH
T ss_pred cccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCc---CHHHHHHH
Confidence 9876554433333211 000 0011 112345788999999998 999999 67787753
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=358.13 Aligned_cols=251 Identities=25% Similarity=0.358 Sum_probs=196.0
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc--CCCCeeeEeEEeecC----
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV--DSRCIVQLFYSFQDS---- 178 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l--~hp~Iv~l~~~~~~~---- 178 (510)
.++|++++.||+|+||.||+|+++ |+.||||++.... ......|.+++..+ +||||+++++++.+.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 368999999999999999999875 8999999986542 23345566666554 999999999999877
Q ss_pred ceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhC--------CeEEeecCCCCeeecCCCceeeccc
Q 010463 179 DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH--------NYVHRDIKPDNLILDKNGHLKLSDF 250 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~--------giiHRDLKP~NILld~~g~vkL~DF 250 (510)
..+|+||||++||+|.+++.. ..+++..+..++.|++.||.|||+. ||+||||||+|||++.+|++||+||
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 789999999999999999965 4699999999999999999999998 9999999999999999999999999
Q ss_pred CCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCcc------
Q 010463 251 GLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGME------ 324 (510)
Q Consensus 251 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~------ 324 (510)
|+|+.+....... .....+.+||+.|+|||++.+..++..
T Consensus 187 g~a~~~~~~~~~~----------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 232 (337)
T 3mdy_A 187 GLAVKFISDTNEV----------------------------------DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIM 232 (337)
T ss_dssp TTCEECC-------------------------------------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHH
T ss_pred CCceeeccccccc----------------------------------cCCCCCCccCcceeChhhcccccCCccccCccc
Confidence 9998654321100 000124589999999999988777665
Q ss_pred ccccchhhHHHHHhhC----------CCCCCCCChh----hhHHHHhh-ccccccCCC---CCCCCHHHHHHHHHhhc-C
Q 010463 325 CDWWSLGAIMYEMLIG----------YPPFCSDDPR----ITCRKIVN-WKTCLKFPE---EPKISDEARDLICHLLC-D 385 (510)
Q Consensus 325 ~DiwSlGvilyEml~G----------~~PF~~~~~~----~~~~~I~~-~~~~~~~p~---~~~~s~~~~dlI~~lL~-d 385 (510)
+|||||||++|||++| ..||...... .....+.. ......+|. ...+++++.+||.+||. |
T Consensus 233 ~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 312 (337)
T 3mdy_A 233 ADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHN 312 (337)
T ss_dssp HHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSS
T ss_pred cchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhC
Confidence 9999999999999999 7777653221 12222221 111122221 12456779999999998 9
Q ss_pred ccccCCCCChHHhhcC
Q 010463 386 VETRLGTRGVEELKEH 401 (510)
Q Consensus 386 p~~R~~~~~~~eil~H 401 (510)
|.+|| ++.++++|
T Consensus 313 P~~Rp---s~~ell~~ 325 (337)
T 3mdy_A 313 PASRL---TALRVKKT 325 (337)
T ss_dssp GGGSC---CHHHHHHH
T ss_pred hhhCC---CHHHHHHH
Confidence 99999 67888865
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=359.08 Aligned_cols=256 Identities=24% Similarity=0.409 Sum_probs=208.3
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEE----EcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCR----AKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 177 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~----~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 177 (510)
.+..++|++++.||+|+||.||+|+ ...+|+.||+|++... .....+.+.+|+.+|+.++||||+++++++.+
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 113 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 113 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Confidence 4556789999999999999999998 4668999999999764 34456778999999999999999999999876
Q ss_pred Cc--eEEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcc
Q 010463 178 SD--FLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCK 254 (510)
Q Consensus 178 ~~--~~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~ 254 (510)
.+ .+|+||||++||+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++.
T Consensus 114 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 114 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred cCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 54 789999999999999999875 469999999999999999999999999999999999999999999999999998
Q ss_pred cCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHH
Q 010463 255 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIM 334 (510)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvil 334 (510)
......... .......||+.|+|||++.+..++.++|||||||++
T Consensus 194 ~~~~~~~~~-----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 238 (326)
T 2w1i_A 194 VLPQDKEYY-----------------------------------KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVL 238 (326)
T ss_dssp ECCSSCSEE-----------------------------------ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHH
T ss_pred hcccccccc-----------------------------------ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHH
Confidence 764431100 001134688899999999999999999999999999
Q ss_pred HHHhhCCCCCCCCChh------------hh---HHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHh
Q 010463 335 YEMLIGYPPFCSDDPR------------IT---CRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEEL 398 (510)
Q Consensus 335 yEml~G~~PF~~~~~~------------~~---~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~ei 398 (510)
|||++|..||...... .. ....+... ...|....+++++.+||.+||. ||.+|| ++.++
T Consensus 239 ~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~Rp---s~~el 313 (326)
T 2w1i_A 239 YELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN--GRLPRPDGCPDEIYMIMTECWNNNVNQRP---SFRDL 313 (326)
T ss_dssp HHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT--CCCCCCTTCCHHHHHHHHHHSCSSGGGSC---CHHHH
T ss_pred HHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcC--CCCCCCCcccHHHHHHHHHHcCCChhhCc---CHHHH
Confidence 9999999998643111 00 11111111 2233335789999999999998 999999 57777
Q ss_pred hc
Q 010463 399 KE 400 (510)
Q Consensus 399 l~ 400 (510)
++
T Consensus 314 ~~ 315 (326)
T 2w1i_A 314 AL 315 (326)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=379.39 Aligned_cols=250 Identities=18% Similarity=0.192 Sum_probs=198.8
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC-CCe----------e----
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS-RCI----------V---- 169 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~h-p~I----------v---- 169 (510)
..+|...+.||+|+||+||+|++..+|+.||||++...........+.+.+|..++..+.| +++ +
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 3458889999999999999999999999999999985443344446778999999999877 211 1
Q ss_pred -------eEeEEeec-----CceEEEEEeccCCCCHHHHHHh-------ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEe
Q 010463 170 -------QLFYSFQD-----SDFLYLIMEYLPGGDIMTLLMR-------EDILSEDVARFYIAESVLAIHSIHQHNYVHR 230 (510)
Q Consensus 170 -------~l~~~~~~-----~~~~~lVmEy~~gG~L~~~L~~-------~~~l~e~~~~~~~~qi~~aL~~lH~~giiHR 230 (510)
.+...+.. ...++++|+++ +|+|.+++.. ...+++..+..++.||+.||.|||++|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr 235 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 11111221 22467888876 6799998842 3457788888889999999999999999999
Q ss_pred ecCCCCeeecCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCC
Q 010463 231 DIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDY 310 (510)
Q Consensus 231 DLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y 310 (510)
||||+||||+.+|.+||+|||+++..... ..+.+| +.|
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~-----------------------------------------~~~~~g-~~y 273 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----------------------------------------AVSPIG-RGF 273 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTEE-----------------------------------------ECCCCC-TTT
T ss_pred CcccceEEEecCCeEEEEeccceeecCCc-----------------------------------------cccCCC-Cce
Confidence 99999999999999999999998865332 124678 999
Q ss_pred cchHhh----------ccCCCCccccccchhhHHHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHH
Q 010463 311 MAPEVL----------LKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLIC 380 (510)
Q Consensus 311 ~APEvl----------~~~~y~~~~DiwSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~ 380 (510)
+|||++ .+..|+.++|||||||++|||++|+.||.+.+.......+.. ....+|+++.+||.
T Consensus 274 ~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~li~ 345 (413)
T 3dzo_A 274 APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFR--------SCKNIPQPVRALLE 345 (413)
T ss_dssp CCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGS--------SCCCCCHHHHHHHH
T ss_pred eCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHh--------hcccCCHHHHHHHH
Confidence 999999 555688999999999999999999999998776665555543 22368899999999
Q ss_pred Hhhc-CccccCCCCChHHhhcCCCcCCCC
Q 010463 381 HLLC-DVETRLGTRGVEELKEHPWFRGIQ 408 (510)
Q Consensus 381 ~lL~-dp~~R~~~~~~~eil~HpfF~~i~ 408 (510)
+||. ||.+|| ++.++++||||+.+.
T Consensus 346 ~~l~~dP~~Rp---t~~~~l~~~~~~~~~ 371 (413)
T 3dzo_A 346 GFLRYPKEDRL---LPLQAMETPEYEQLR 371 (413)
T ss_dssp HHTCSSGGGSC---CHHHHTTSHHHHHHH
T ss_pred HHccCChhhCc---CHHHHHhCHHHHHHH
Confidence 9998 999999 789999999998753
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=399.87 Aligned_cols=265 Identities=26% Similarity=0.425 Sum_probs=212.1
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec------
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD------ 177 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~------ 177 (510)
..++|++++.||+|+||.||+|.++.+|+.||||++... ......+.+.+|+.+|..++||||+++++++.+
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 357899999999999999999999999999999998754 234556778999999999999999999999866
Q ss_pred CceEEEEEeccCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCc---eeecccC
Q 010463 178 SDFLYLIMEYLPGGDIMTLLMRED---ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH---LKLSDFG 251 (510)
Q Consensus 178 ~~~~~lVmEy~~gG~L~~~L~~~~---~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~---vkL~DFG 251 (510)
.+..|+||||++||+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.+|. +||+|||
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 678899999999999999998754 6999999999999999999999999999999999999998775 9999999
Q ss_pred CcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchh
Q 010463 252 LCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLG 331 (510)
Q Consensus 252 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlG 331 (510)
++....... .....+||+.|+|||++.+..++.++||||||
T Consensus 170 ~a~~~~~~~---------------------------------------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLG 210 (676)
T 3qa8_A 170 YAKELDQGE---------------------------------------LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFG 210 (676)
T ss_dssp CCCBTTSCC---------------------------------------CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHH
T ss_pred ccccccccc---------------------------------------ccccccCCcccCChHHhccCCCCchhHHHHHH
Confidence 998764321 11246899999999999999999999999999
Q ss_pred hHHHHHhhCCCCCCCCChhhhHHHHh------------------hccccccCCC--CCCCCHHHHHHHHHhhc-CccccC
Q 010463 332 AIMYEMLIGYPPFCSDDPRITCRKIV------------------NWKTCLKFPE--EPKISDEARDLICHLLC-DVETRL 390 (510)
Q Consensus 332 vilyEml~G~~PF~~~~~~~~~~~I~------------------~~~~~~~~p~--~~~~s~~~~dlI~~lL~-dp~~R~ 390 (510)
|++|||++|..||.+......+...+ .+...+..|. ...+++.+.+||.+||. ||.+||
T Consensus 211 viLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRP 290 (676)
T 3qa8_A 211 TLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRG 290 (676)
T ss_dssp HHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---
T ss_pred HHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCc
Confidence 99999999999997654322211110 0001111111 12467899999999999 999999
Q ss_pred CCCChHHhhcCCCcCCCCchhhhc
Q 010463 391 GTRGVEELKEHPWFRGIQWDKLYE 414 (510)
Q Consensus 391 ~~~~~~eil~HpfF~~i~~~~l~~ 414 (510)
++.++++||||+. ++.+..
T Consensus 291 ---Ta~elL~hp~F~~--l~~iL~ 309 (676)
T 3qa8_A 291 ---TDPQNPNVGCFQA--LDSILS 309 (676)
T ss_dssp ---CCTTCCCCTTHHH--HHHHHC
T ss_pred ---CHHHHhcCHHHHH--HHHHHh
Confidence 6789999999987 444443
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=361.25 Aligned_cols=260 Identities=21% Similarity=0.288 Sum_probs=211.2
Q ss_pred HhhcccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec
Q 010463 98 LQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 177 (510)
Q Consensus 98 ~~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 177 (510)
.....+..++|++.+.||+|+||.||+|+++. .||+|++..... .....+.+.+|+.++..++||||+++++++.+
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 100 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence 45567888999999999999999999998864 499999876432 22334557789999999999999999999999
Q ss_pred CceEEEEEeccCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccC
Q 010463 178 SDFLYLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 256 (510)
Q Consensus 178 ~~~~~lVmEy~~gG~L~~~L~~~~-~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~ 256 (510)
.+.+|+||||++||+|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++ +|.+||+|||+++..
T Consensus 101 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 101 PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp SSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred CCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 999999999999999999997754 699999999999999999999999999999999999998 789999999998765
Q ss_pred ccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc---------CCCCccccc
Q 010463 257 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK---------KGYGMECDW 327 (510)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~---------~~y~~~~Di 327 (510)
...... ..........||+.|+|||++.+ ..++.++||
T Consensus 180 ~~~~~~---------------------------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di 226 (319)
T 2y4i_B 180 GVLQAG---------------------------------RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDV 226 (319)
T ss_dssp -----------------------------------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHH
T ss_pred cccccc---------------------------------ccccccccCCCcccccChHHhhhccccccccccCCCchhhH
Confidence 321100 00011223579999999999975 457999999
Q ss_pred cchhhHHHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 328 WSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 328 wSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
|||||++|||++|..||.+.+.......+....... .....++.++.+||.+||. ||.+|| ++.++++
T Consensus 227 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~l~~ 295 (319)
T 2y4i_B 227 FALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN--LSQIGMGKEISDILLFCWAFEQEERP---TFTKLMD 295 (319)
T ss_dssp HHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC--CCCSSCCTTHHHHHHHHHCSSTTTSC---CHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC--CCcCCCCHHHHHHHHHHhcCChhhCc---CHHHHHH
Confidence 999999999999999999988887777776532211 1223688999999999998 999999 6777775
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=387.79 Aligned_cols=253 Identities=26% Similarity=0.365 Sum_probs=213.0
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcCC---CCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTT---GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 178 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t---g~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 178 (510)
.+..++|++.+.||+|+||.||+|.++.+ +..||+|++.... .....+.+.+|+.+|+.++|||||++++++. +
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 45567899999999999999999998654 4579999986532 3444577899999999999999999999985 4
Q ss_pred ceEEEEEeccCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCc
Q 010463 179 DFLYLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 257 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~~-~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~ 257 (510)
+.+|+||||++||+|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+|||++.+|++||+|||+++...
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 66899999999999999997654 68999999999999999999999999999999999999999999999999998764
Q ss_pred cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHH
Q 010463 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337 (510)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEm 337 (510)
..... ......||+.|+|||++.+..++.++|||||||++|||
T Consensus 543 ~~~~~-------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el 585 (656)
T 2j0j_A 543 DSTYY-------------------------------------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 585 (656)
T ss_dssp C-----------------------------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CCcce-------------------------------------eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHH
Confidence 32110 01124678999999999999999999999999999999
Q ss_pred hh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 338 LI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 338 l~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
++ |.+||.+.+.......+.... ....| +.+++.+.+||.+||. ||.+|| ++.+|++
T Consensus 586 lt~g~~Pf~~~~~~~~~~~i~~~~-~~~~~--~~~~~~l~~li~~~l~~dP~~RP---s~~el~~ 644 (656)
T 2j0j_A 586 LMHGVKPFQGVKNNDVIGRIENGE-RLPMP--PNCPPTLYSLMTKCWAYDPSRRP---RFTELKA 644 (656)
T ss_dssp HTTSCCTTTTCCHHHHHHHHHHTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHcCCCCCCCCCHHHHHHHHHcCC-CCCCC--ccccHHHHHHHHHHcCCChhHCc---CHHHHHH
Confidence 97 999999988888888777642 23333 4799999999999998 999999 6777764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=354.36 Aligned_cols=250 Identities=21% Similarity=0.295 Sum_probs=200.4
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHh--cCCCCeeeEeEEeecCc----
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE--VDSRCIVQLFYSFQDSD---- 179 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~--l~hp~Iv~l~~~~~~~~---- 179 (510)
++|++.+.||+|+||.||+|++ +|+.||||++.+. ....+.+|.+++.. ++||||+++++++.+..
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 5799999999999999999987 5899999998653 23457789999887 79999999999999876
Q ss_pred eEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhh--------hCCeEEeecCCCCeeecCCCceeecccC
Q 010463 180 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIH--------QHNYVHRDIKPDNLILDKNGHLKLSDFG 251 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH--------~~giiHRDLKP~NILld~~g~vkL~DFG 251 (510)
.+|+||||++||+|.+++.+ ..+++..++.++.||+.||.||| +.||+||||||+||||+.+|++||+|||
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 192 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 192 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCT
T ss_pred eeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECC
Confidence 89999999999999999965 46899999999999999999999 8999999999999999999999999999
Q ss_pred CcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCC------CCccc
Q 010463 252 LCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG------YGMEC 325 (510)
Q Consensus 252 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~------y~~~~ 325 (510)
++.......... .......+||+.|+|||++.+.. ++.++
T Consensus 193 ~~~~~~~~~~~~----------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~ 238 (342)
T 1b6c_B 193 LAVRHDSATDTI----------------------------------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRA 238 (342)
T ss_dssp TCEEEETTTTEE----------------------------------EECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHH
T ss_pred Cceecccccccc----------------------------------ccccccCCcCcccCCHhhhcccccccccccCCcc
Confidence 998654321100 00112457999999999998753 34789
Q ss_pred cccchhhHHHHHhhC----------CCCCCCCCh-----hhhHHHHhhccccccCCC---CCCCCHHHHHHHHHhhc-Cc
Q 010463 326 DWWSLGAIMYEMLIG----------YPPFCSDDP-----RITCRKIVNWKTCLKFPE---EPKISDEARDLICHLLC-DV 386 (510)
Q Consensus 326 DiwSlGvilyEml~G----------~~PF~~~~~-----~~~~~~I~~~~~~~~~p~---~~~~s~~~~dlI~~lL~-dp 386 (510)
|||||||++|||++| ..||..... ......+........+|. ...+++.+.+||.+||. ||
T Consensus 239 Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 318 (342)
T 1b6c_B 239 DIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANG 318 (342)
T ss_dssp HHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSG
T ss_pred cHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccCh
Confidence 999999999999999 789976532 223333333222222332 11344678999999998 99
Q ss_pred cccCCCCChHHhhcC
Q 010463 387 ETRLGTRGVEELKEH 401 (510)
Q Consensus 387 ~~R~~~~~~~eil~H 401 (510)
.+|| ++++|++|
T Consensus 319 ~~Rp---s~~~i~~~ 330 (342)
T 1b6c_B 319 AARL---TALRIKKT 330 (342)
T ss_dssp GGSC---CHHHHHHH
T ss_pred hhCC---CHHHHHHH
Confidence 9999 67888765
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=340.74 Aligned_cols=227 Identities=13% Similarity=0.094 Sum_probs=188.5
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEE
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~ 182 (510)
+..++|++++.||+|+||.||+|++..+|+.||||++.............+.+|..++..++||||+++++++.+.+..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 33477999999999999999999999999999999998765444556678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccc
Q 010463 183 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 262 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 262 (510)
+||||++||+|.+++.+ + ..+..+..++.||+.||.|||+.||+||||||+||||+.+|.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 99999999999999854 3 4666788899999999999999999999999999999999999998554
Q ss_pred ccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCC
Q 010463 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 342 (510)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~ 342 (510)
|++ .++.++|||||||++|||++|..
T Consensus 175 -----------------------------------------------~~~-------~~~~~~Di~slG~il~elltg~~ 200 (286)
T 3uqc_A 175 -----------------------------------------------TMP-------DANPQDDIRGIGASLYALLVNRW 200 (286)
T ss_dssp -----------------------------------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEE
T ss_pred -----------------------------------------------ccC-------CCCchhHHHHHHHHHHHHHHCCC
Confidence 222 37889999999999999999999
Q ss_pred CCCCCChhhhHH---HHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 343 PFCSDDPRITCR---KIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 343 PF~~~~~~~~~~---~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
||.+.+...... ++............+.+++++.+||.+||. ||.+| + +.|+++
T Consensus 201 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s---~~el~~ 258 (286)
T 3uqc_A 201 PLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-S---ASTLLN 258 (286)
T ss_dssp CSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-C---HHHHHH
T ss_pred CCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-C---HHHHHH
Confidence 999877644321 222211110000124789999999999998 99999 4 677764
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=384.42 Aligned_cols=241 Identities=23% Similarity=0.282 Sum_probs=199.1
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcC-CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCce--
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKT-TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF-- 180 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~-tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~-- 180 (510)
-.++|++++.||+|+||.||+|.++. +|+.||||++.... .......+.+|+.+|..++|||||+++++|.+.+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 34789999999999999999999986 79999999986532 23445678899999999999999999999987665
Q ss_pred ---EEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCc
Q 010463 181 ---LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 257 (510)
Q Consensus 181 ---~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~ 257 (510)
.|+||||++||+|.+++.. .+++..++.++.||+.||.|||+.|||||||||+||||+.+ .+||+|||+++...
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp CEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred CceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 7999999999999988755 79999999999999999999999999999999999999875 99999999998654
Q ss_pred cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHH
Q 010463 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337 (510)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEm 337 (510)
.. ...+||+.|+|||++.+. ++.++|||||||++|||
T Consensus 233 ~~------------------------------------------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l 269 (681)
T 2pzi_A 233 SF------------------------------------------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAAL 269 (681)
T ss_dssp CC------------------------------------------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHH
T ss_pred cC------------------------------------------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHH
Confidence 31 135799999999999765 58999999999999999
Q ss_pred hhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcC
Q 010463 338 LIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 405 (510)
Q Consensus 338 l~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~ 405 (510)
++|.+||.+....... ........++.+.+||.+||. ||.+||+ ..+.+.|+|+.
T Consensus 270 ~~g~~~~~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~R~~---~~~~l~~~l~~ 325 (681)
T 2pzi_A 270 TLDLPTRNGRYVDGLP----------EDDPVLKTYDSYGRLLRRAIDPDPRQRFT---TAEEMSAQLTG 325 (681)
T ss_dssp HSCCCEETTEECSSCC----------TTCHHHHHCHHHHHHHHHHTCSSGGGSCS---SHHHHHHHHHH
T ss_pred HhCCCCCccccccccc----------ccccccccCHHHHHHHhhhccCChhhCCC---HHHHHHHHHHH
Confidence 9999999753211100 000001356889999999998 9999994 56777888874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=334.19 Aligned_cols=189 Identities=15% Similarity=0.196 Sum_probs=139.8
Q ss_pred eecCCCeEEEEEEEcCCCCEEEEEEeechhhc-------chhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecCceEEEEE
Q 010463 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML-------KRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 114 IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~-------~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
.+.|++|.+..++....|+.||+|++.+.... .....+.+.+|+++|+++ .|+||+++++++++++.+||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 56778888888888889999999999865321 123356799999999999 7999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
|||+||+|.++|.+.+.+++. .++.||+.||+|+|++|||||||||+||||+.+|++||+|||+|+......
T Consensus 322 Eyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~----- 393 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC----- 393 (569)
T ss_dssp ECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--------
T ss_pred ecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC-----
Confidence 999999999999999999875 478999999999999999999999999999999999999999998764321
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCC
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 344 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF 344 (510)
....+.||||.|||||++.+ .+...+|+||+|+++++|++|..||
T Consensus 394 ---------------------------------~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 394 ---------------------------------SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ---------------------------------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred ---------------------------------ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 11235789999999999975 4678899999999999988876654
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.9e-31 Score=282.80 Aligned_cols=192 Identities=19% Similarity=0.193 Sum_probs=148.8
Q ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhc-----chhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 111 LTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML-----KRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 111 ~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~-----~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
.+.||+|+||+||+| +..+..+|+|+....... .....+.+.+|+.+|+.++||||+++..++.+.+..||||
T Consensus 341 ~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 341 EHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp -------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 458999999999999 446788999987543221 1223456899999999999999996655555677789999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
||++||+|.+++.. +..++.||+.||.|||++||+||||||+|||++. ++||+|||+|+.........
T Consensus 419 E~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~-- 486 (540)
T 3en9_A 419 SYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA-- 486 (540)
T ss_dssp ECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH--
T ss_pred ECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc--
Confidence 99999999999876 5688999999999999999999999999999998 99999999999765421100
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc--CCCCccccccchhhHHHHHhhCCCC
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK--KGYGMECDWWSLGAIMYEMLIGYPP 343 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiwSlGvilyEml~G~~P 343 (510)
. . ......+.+||+.|||||++.. .+|+..+|+||.++-..+.+.++.+
T Consensus 487 ------------------------~-~----~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~r 537 (540)
T 3en9_A 487 ------------------------V-D----LIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRAR 537 (540)
T ss_dssp ------------------------H-H----HHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSC
T ss_pred ------------------------c-c----hhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccc
Confidence 0 0 0001125789999999999987 7899999999999999988888777
Q ss_pred CC
Q 010463 344 FC 345 (510)
Q Consensus 344 F~ 345 (510)
|.
T Consensus 538 Y~ 539 (540)
T 3en9_A 538 YV 539 (540)
T ss_dssp CC
T ss_pred cC
Confidence 63
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-28 Score=241.85 Aligned_cols=132 Identities=14% Similarity=0.125 Sum_probs=108.2
Q ss_pred eeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcch---------------hhHHHHHHHHHHHHhcCCCCeeeEeEE
Q 010463 110 QLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR---------------GQVEHVRSERNLLAEVDSRCIVQLFYS 174 (510)
Q Consensus 110 ~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~---------------~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 174 (510)
+.+.||+|+||.||+|++ .+|+.||||+++....... .....+.+|..+|+.++ | ++++++
T Consensus 94 ~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~ 169 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKV 169 (282)
T ss_dssp EEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCE
T ss_pred ecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeE
Confidence 349999999999999999 8899999999975422111 23567889999999998 4 556555
Q ss_pred eecCceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcc
Q 010463 175 FQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCK 254 (510)
Q Consensus 175 ~~~~~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~ 254 (510)
+.. +..|+||||++||+|.+ +.. ..+..++.|++.||.|||+.|||||||||+|||++ +|++||+|||+|+
T Consensus 170 ~~~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~ 240 (282)
T 1zar_A 170 YAW-EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 240 (282)
T ss_dssp EEE-ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCE
T ss_pred Eec-cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCe
Confidence 543 56799999999999988 421 23457899999999999999999999999999999 9999999999986
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=7.3e-23 Score=200.50 Aligned_cols=143 Identities=16% Similarity=0.114 Sum_probs=111.4
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCE--EEEEEeechhhcc---------------------hhhHHHHHHHHHHHHhc
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEI--FAMKKLKKSEMLK---------------------RGQVEHVRSERNLLAEV 163 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~--vAiK~i~k~~~~~---------------------~~~~~~~~~E~~iL~~l 163 (510)
-|++.+.||+|+||.||+|.+..+|+. ||||+++...... ......+.+|..+|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378899999999999999999788999 9999975432110 01123678899999999
Q ss_pred CCCCe--eeEeEEeecCceEEEEEeccCC-C----CHHHHHHhccCCCHHHHHHHHHHHHHHHHhhh-hCCeEEeecCCC
Q 010463 164 DSRCI--VQLFYSFQDSDFLYLIMEYLPG-G----DIMTLLMREDILSEDVARFYIAESVLAIHSIH-QHNYVHRDIKPD 235 (510)
Q Consensus 164 ~hp~I--v~l~~~~~~~~~~~lVmEy~~g-G----~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH-~~giiHRDLKP~ 235 (510)
.|++| +.++.. +..+|||||+.+ | +|.+++.. .++..+..++.||+.||.||| +.|||||||||+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~ 200 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY 200 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence 88754 344432 357899999942 4 66665432 245677889999999999999 999999999999
Q ss_pred CeeecCCCceeecccCCcccCcc
Q 010463 236 NLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 236 NILld~~g~vkL~DFGla~~~~~ 258 (510)
|||++. .++|+|||+|.....
T Consensus 201 NILl~~--~~~liDFG~a~~~~~ 221 (258)
T 1zth_A 201 NIMYID--KVYFIDMGQAVTLRH 221 (258)
T ss_dssp SEEESS--SEEECCCTTCEETTS
T ss_pred HEEEcC--cEEEEECcccccCCC
Confidence 999998 999999999987643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.78 E-value=3.5e-20 Score=190.41 Aligned_cols=139 Identities=11% Similarity=0.141 Sum_probs=101.3
Q ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhc-----------chhhHH--------HHHHHHHHHHhcCCCCe
Q 010463 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML-----------KRGQVE--------HVRSERNLLAEVDSRCI 168 (510)
Q Consensus 108 f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~-----------~~~~~~--------~~~~E~~iL~~l~hp~I 168 (510)
|.+...||+|+||.||+|.+. +|+.||||+++..... ...... ....|...|..+.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 889999999999999999875 6999999998643211 000011 12346666666654443
Q ss_pred e--eEeEEeecCceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCC---
Q 010463 169 V--QLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG--- 243 (510)
Q Consensus 169 v--~l~~~~~~~~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g--- 243 (510)
. ..+.. ...+|||||++|+.|..++ ..+.+..++.||+.+|.+||+.|||||||||.||||+.+|
T Consensus 176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 176 PVPEPIAQ----SRHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp SCCCEEEE----ETTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCCeeeec----cCceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 2 22221 1237999999999886553 2234566789999999999999999999999999999887
Q ss_pred -------ceeecccCCcccCc
Q 010463 244 -------HLKLSDFGLCKPLE 257 (510)
Q Consensus 244 -------~vkL~DFGla~~~~ 257 (510)
.+.|+||+-+....
T Consensus 246 d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp CTTSEEEEEEECCCTTCEETT
T ss_pred cccccccceEEEEeCCcccCC
Confidence 38999999887543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=2e-13 Score=132.80 Aligned_cols=141 Identities=13% Similarity=0.098 Sum_probs=111.6
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEeEEeecCceEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~~~lV 184 (510)
+.|++...+|.|+.+.||++.. .|..|++|+...... .....+.+|..+|..+. +..+.++++++.+.+..|+|
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~---~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC---CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 5788999999999999998864 468899999875321 11234888999999884 67788999999999999999
Q ss_pred EeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhh----------------------------------------
Q 010463 185 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ---------------------------------------- 224 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~---------------------------------------- 224 (510)
|||++|.+|...+. +......++.++..+|..||+
T Consensus 89 ~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 89 MSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 99999999876531 222234567788888888888
Q ss_pred -------------------CCeEEeecCCCCeeecCCCceeecccCCcccC
Q 010463 225 -------------------HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 256 (510)
Q Consensus 225 -------------------~giiHRDLKP~NILld~~g~vkL~DFGla~~~ 256 (510)
.+++|+|++|.|||++.++.+.|+||+.+...
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence 45999999999999987666679999988643
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.34 E-value=1.7e-12 Score=125.30 Aligned_cols=137 Identities=12% Similarity=0.119 Sum_probs=100.5
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCC--eeeEeEEeecCceEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC--IVQLFYSFQDSDFLY 182 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~--Iv~l~~~~~~~~~~~ 182 (510)
..++.+..+.+.|+.+.||++.. .+|..|++|+.... ....+..|..+|+.+.+.+ +.++++++.+.+..|
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~ 91 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW 91 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCE
Confidence 45666655555677799999854 46778999997543 1234778999998885444 566888888888899
Q ss_pred EEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCC------------------------------------
Q 010463 183 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHN------------------------------------ 226 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~g------------------------------------ 226 (510)
+||||++|.+|. . ...+. ..++.++..+|..||+..
T Consensus 92 ~v~e~i~G~~l~--~---~~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 92 LLLGEVPGQDLL--S---SHLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp EEEECCSSEETT--T---SCCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EEEEecCCcccC--c---CcCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 999999998883 2 11222 234566666777777643
Q ss_pred ----------------------eEEeecCCCCeeecCCCceeecccCCcccC
Q 010463 227 ----------------------YVHRDIKPDNLILDKNGHLKLSDFGLCKPL 256 (510)
Q Consensus 227 ----------------------iiHRDLKP~NILld~~g~vkL~DFGla~~~ 256 (510)
++|+|++|.|||++.++.+.|+|||.|...
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 999999999999987766779999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.23 E-value=2.5e-11 Score=123.79 Aligned_cols=143 Identities=17% Similarity=0.220 Sum_probs=107.6
Q ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEee--chhhcchhhHHHHHHHHHHHHhcC--CCCeeeEeEEeecC---ce
Q 010463 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLK--KSEMLKRGQVEHVRSERNLLAEVD--SRCIVQLFYSFQDS---DF 180 (510)
Q Consensus 108 f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~--k~~~~~~~~~~~~~~E~~iL~~l~--hp~Iv~l~~~~~~~---~~ 180 (510)
...++.|+.|.++.||++... +..+++|+.. ..... .....+.+|..+|+.+. +..+++++.++.+. +.
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~ 115 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR 115 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence 345778999999999987653 4678899875 33211 12345778999999886 45688899888876 45
Q ss_pred EEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhh------------------------------------
Q 010463 181 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ------------------------------------ 224 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~------------------------------------ 224 (510)
.|+||||++|..+.+.. ...+++.....++.+++.+|..||+
T Consensus 116 ~~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 116 AFYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp CEEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred eEEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 89999999998775421 1346788888889999999999996
Q ss_pred ----------------------CCeEEeecCCCCeeecCCCc--eeecccCCcccC
Q 010463 225 ----------------------HNYVHRDIKPDNLILDKNGH--LKLSDFGLCKPL 256 (510)
Q Consensus 225 ----------------------~giiHRDLKP~NILld~~g~--vkL~DFGla~~~ 256 (510)
.++||+|++|.|||++.++. +.|+||+.|...
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 46999999999999998764 689999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.20 E-value=1.8e-11 Score=121.88 Aligned_cols=134 Identities=18% Similarity=0.237 Sum_probs=97.5
Q ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCC--eeeEeEEeecCc---eEEEE
Q 010463 111 LTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRC--IVQLFYSFQDSD---FLYLI 184 (510)
Q Consensus 111 ~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~--Iv~l~~~~~~~~---~~~lV 184 (510)
++.++.|....||++. ..+++|+.... .....+.+|..+|..+ .+.. +.+++....+.+ ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 4568999999999763 45889986432 2345688999999887 3322 445555544433 45899
Q ss_pred EeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhh----------------------------------------
Q 010463 185 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ---------------------------------------- 224 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~---------------------------------------- 224 (510)
|++++|..|..... ..++..+...++.+++..|..||+
T Consensus 95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99999988865432 346676777777777777777775
Q ss_pred ------------------CCeEEeecCCCCeeecC--CCceeecccCCcccC
Q 010463 225 ------------------HNYVHRDIKPDNLILDK--NGHLKLSDFGLCKPL 256 (510)
Q Consensus 225 ------------------~giiHRDLKP~NILld~--~g~vkL~DFGla~~~ 256 (510)
..++|+|++|.|||++. ++.+.|+||+.+...
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 24799999999999998 456889999998754
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.72 E-value=2e-07 Score=92.77 Aligned_cols=136 Identities=16% Similarity=0.195 Sum_probs=90.9
Q ss_pred eeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCC---CeeeEeEEee-cCceEEEEE
Q 010463 110 QLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR---CIVQLFYSFQ-DSDFLYLIM 185 (510)
Q Consensus 110 ~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp---~Iv~l~~~~~-~~~~~~lVm 185 (510)
-++.++.|....||++ |..+++|+-.. ......+..|..+|..+.+. .|.+.+.+.. ..+..|+||
T Consensus 23 ~v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~ 92 (306)
T 3tdw_A 23 SVESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGY 92 (306)
T ss_dssp CEEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEE
T ss_pred eeeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEE
Confidence 3566899999999987 56788998532 22346788999999998652 3556666664 456789999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhh------------------------------------------
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIH------------------------------------------ 223 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH------------------------------------------ 223 (510)
||++|..|..... ..++......++.++...|..||
T Consensus 93 e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 93 RKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp ECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred eccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 9999987765311 11233333333333333333333
Q ss_pred ------------------hCCeEEeecCCCCeeecC---CCce-eecccCCcccCc
Q 010463 224 ------------------QHNYVHRDIKPDNLILDK---NGHL-KLSDFGLCKPLE 257 (510)
Q Consensus 224 ------------------~~giiHRDLKP~NILld~---~g~v-kL~DFGla~~~~ 257 (510)
...++|+|++|.|||++. ++.+ .|+||+.+....
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 235799999999999997 4665 899999887543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.64 E-value=3.2e-07 Score=89.00 Aligned_cols=134 Identities=19% Similarity=0.168 Sum_probs=92.2
Q ss_pred eeecCCCe-EEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEeEEeecCceEEEEEeccCC
Q 010463 113 LIGKGAFG-EVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSDFLYLIMEYLPG 190 (510)
Q Consensus 113 ~IG~G~fG-~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~~~lVmEy~~g 190 (510)
.+..|..| .||.......+..+.+|+-... ....+.+|..+|..+. +--|.+++.++.+.+..|+|||+++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 34556555 6998877777788999986533 3455788999998774 22367888889999999999999999
Q ss_pred CCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhh----------------------------------------------
Q 010463 191 GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ---------------------------------------------- 224 (510)
Q Consensus 191 G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~---------------------------------------------- 224 (510)
.++.+...... .....+..++...|..||.
T Consensus 105 ~~~~~~~~~~~----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 105 KTAFQVLEEYP----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp EEHHHHHHHCG----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccccccCCH----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 87766543211 1111122233333333331
Q ss_pred ------------CCeEEeecCCCCeeecCCCceeecccCCcccC
Q 010463 225 ------------HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 256 (510)
Q Consensus 225 ------------~giiHRDLKP~NILld~~g~vkL~DFGla~~~ 256 (510)
..++|+|+.|.|||++.++.+-|+||+.+...
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 12799999999999998777789999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.51 E-value=2.1e-07 Score=95.91 Aligned_cols=80 Identities=19% Similarity=0.226 Sum_probs=51.2
Q ss_pred eeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhh-cc---hhhHHHHHHHHHHHHhcCC--CC-eeeEeEEeecCceEE
Q 010463 110 QLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEM-LK---RGQVEHVRSERNLLAEVDS--RC-IVQLFYSFQDSDFLY 182 (510)
Q Consensus 110 ~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~-~~---~~~~~~~~~E~~iL~~l~h--p~-Iv~l~~~~~~~~~~~ 182 (510)
.++.||.|.++.||++....+++.|++|....... .. ......+..|..+|..+.. |. +.+++.+ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 46789999999999997666678899998653211 00 0123456779999887732 43 4455543 344568
Q ss_pred EEEeccCCC
Q 010463 183 LIMEYLPGG 191 (510)
Q Consensus 183 lVmEy~~gG 191 (510)
+||||++|.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.32 E-value=4.4e-06 Score=83.41 Aligned_cols=138 Identities=10% Similarity=0.134 Sum_probs=79.1
Q ss_pred eeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC--CCCeeeEeE------EeecCceE
Q 010463 110 QLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD--SRCIVQLFY------SFQDSDFL 181 (510)
Q Consensus 110 ~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~--hp~Iv~l~~------~~~~~~~~ 181 (510)
-++.|+.|..+.||++... +..|++|+.... . ..+..|..++..+. .-.+.+++. +..+.+..
T Consensus 36 ~~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~----~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~ 106 (346)
T 2q83_A 36 KIDVIQGNQMALVWKVHTD--SGAVCLKRIHRP----E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFL 106 (346)
T ss_dssp EEEECC----CEEEEEEET--TEEEEEEEECSC----H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEE
T ss_pred EeeeccccccCcEEEEEeC--CCCEEEEecCCC----H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEE
Confidence 4456777889999998753 335899998652 1 22334555554442 112333332 12346778
Q ss_pred EEEEeccCCCCHH--------------HHHHhc-cCC--C-----------HH--------H------------------
Q 010463 182 YLIMEYLPGGDIM--------------TLLMRE-DIL--S-----------ED--------V------------------ 207 (510)
Q Consensus 182 ~lVmEy~~gG~L~--------------~~L~~~-~~l--~-----------e~--------~------------------ 207 (510)
|+||+|++|..+. ..|... ..+ + .. .
T Consensus 107 ~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 186 (346)
T 2q83_A 107 FVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQ 186 (346)
T ss_dssp EEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHH
T ss_pred EEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHH
Confidence 9999999996432 111110 101 0 00 0
Q ss_pred -----HHHHHHHHHHHHHhhh-------------hCCeEEeecCCCCeeecCCCceeecccCCcccC
Q 010463 208 -----ARFYIAESVLAIHSIH-------------QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 256 (510)
Q Consensus 208 -----~~~~~~qi~~aL~~lH-------------~~giiHRDLKP~NILld~~g~vkL~DFGla~~~ 256 (510)
...++..+..++.+|+ ..+++|+|++|.|||++.++.+.|+||+.|...
T Consensus 187 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g 253 (346)
T 2q83_A 187 LYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSFD 253 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcccC
Confidence 0111122333455554 368999999999999988889999999998643
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=4.8e-06 Score=84.18 Aligned_cols=87 Identities=9% Similarity=0.066 Sum_probs=56.6
Q ss_pred ceeeeee-ecCCCeEEEEEEEc---C---CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC---CCeeeEeEEeec
Q 010463 108 FEQLTLI-GKGAFGEVRLCRAK---T---TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS---RCIVQLFYSFQD 177 (510)
Q Consensus 108 f~~~~~I-G~G~fG~V~~~~~~---~---tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~h---p~Iv~l~~~~~~ 177 (510)
...++.| +.|..+.+|++... . ++..+++|+..............+.+|..+|..+.. -.+.+++.+..+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3445778 88889999987653 1 156789998654320000001346778888877732 357778887766
Q ss_pred C---ceEEEEEeccCCCCHH
Q 010463 178 S---DFLYLIMEYLPGGDIM 194 (510)
Q Consensus 178 ~---~~~~lVmEy~~gG~L~ 194 (510)
. +..|+||||++|..+.
T Consensus 102 ~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp STTTSSCEEEEECCCCBCCC
T ss_pred CCccCCceEEEEecCCCChh
Confidence 5 3578999999986643
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.01 E-value=2.6e-05 Score=80.87 Aligned_cols=34 Identities=9% Similarity=0.197 Sum_probs=29.9
Q ss_pred hhCCeEEeecCCCCeeecCCCceeecccCCcccCc
Q 010463 223 HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 257 (510)
Q Consensus 223 H~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~ 257 (510)
+...++|+|++|.|||++.++ ++|+||+.|....
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~ 263 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGP 263 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEEC
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCc
Confidence 567899999999999999877 9999999987543
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.86 E-value=0.00011 Score=73.30 Aligned_cols=77 Identities=17% Similarity=0.148 Sum_probs=60.6
Q ss_pred eeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC---CCCeeeEeEEeecCceEEEEE
Q 010463 109 EQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD---SRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 109 ~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~---hp~Iv~l~~~~~~~~~~~lVm 185 (510)
.-++.|+.|....||++.. ++..|++|+.... ....+..|...|+.+. ...+++++.+..+.+..|+||
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvm 110 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLL 110 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEE
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEE
Confidence 3467789999999998764 5678899987643 2456788988888773 367888888888888999999
Q ss_pred eccCCCCH
Q 010463 186 EYLPGGDI 193 (510)
Q Consensus 186 Ey~~gG~L 193 (510)
||++|..+
T Consensus 111 e~l~G~~~ 118 (312)
T 3jr1_A 111 EALNKSKN 118 (312)
T ss_dssp ECCCCCCC
T ss_pred EeccCCCC
Confidence 99999754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.73 E-value=6.4e-05 Score=74.09 Aligned_cols=135 Identities=10% Similarity=0.008 Sum_probs=75.6
Q ss_pred eeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCe-eeEeEEeecCceEEEEEec
Q 010463 109 EQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCI-VQLFYSFQDSDFLYLIMEY 187 (510)
Q Consensus 109 ~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~I-v~l~~~~~~~~~~~lVmEy 187 (510)
.-++.|+.|....+|++ ..|.+|+...... . .-....|..++..+....+ .++++.+ .+.-++|+||
T Consensus 21 ~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~---~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~ 88 (301)
T 3dxq_A 21 TGPLERLGGLTNLVFRA------GDLCLRIPGKGTE---E-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRY 88 (301)
T ss_dssp CSCEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEEC
T ss_pred cceeEcCCcccccccee------eeEEEECCCCCcc---c-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEee
Confidence 33788999999999988 4588898764311 0 0112457777766632222 4566554 3345789999
Q ss_pred c-CCCCHHH---------------HHH---hcc-CC----C-HHHHHHHHHH--------------HHHHHH----hh--
Q 010463 188 L-PGGDIMT---------------LLM---RED-IL----S-EDVARFYIAE--------------SVLAIH----SI-- 222 (510)
Q Consensus 188 ~-~gG~L~~---------------~L~---~~~-~l----~-e~~~~~~~~q--------------i~~aL~----~l-- 222 (510)
+ +|-.|.. .|. ... .+ . ......+... +...+. .+
T Consensus 89 i~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~ 168 (301)
T 3dxq_A 89 IAGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAA 168 (301)
T ss_dssp CTTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHS
T ss_pred cCCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHh
Confidence 9 6644421 010 100 01 0 1111111111 111111 11
Q ss_pred --hhCCeEEeecCCCCeeecCCCceeecccCCcccC
Q 010463 223 --HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 256 (510)
Q Consensus 223 --H~~giiHRDLKP~NILld~~g~vkL~DFGla~~~ 256 (510)
....++|+|+.|.||| ..+|.+.|+||..|...
T Consensus 169 ~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 169 HPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp SCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred cCCCceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 1235899999999999 66778999999988753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00011 Score=72.95 Aligned_cols=143 Identities=13% Similarity=0.071 Sum_probs=79.2
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCC--eeeEeEE------eec
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC--IVQLFYS------FQD 177 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~--Iv~l~~~------~~~ 177 (510)
....-++.|+.|....||++... +| .|++|+..... .. ..+..|..++..+.... +.+++.. ...
T Consensus 22 ~~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~--~~---~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~ 94 (322)
T 2ppq_A 22 GSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV--EK---NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL 94 (322)
T ss_dssp CCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----C---CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE
T ss_pred CcceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC--CH---HHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEE
Confidence 34455677888999999998753 33 68899886521 11 23556777776653211 3333321 122
Q ss_pred CceEEEEEeccCCCCHHH--------------HHHhc-cCC--------CHHHHHH---------------HHHHHHHHH
Q 010463 178 SDFLYLIMEYLPGGDIMT--------------LLMRE-DIL--------SEDVARF---------------YIAESVLAI 219 (510)
Q Consensus 178 ~~~~~lVmEy~~gG~L~~--------------~L~~~-~~l--------~e~~~~~---------------~~~qi~~aL 219 (510)
.+..++||+|++|..+.. .+... ..+ ....-.. +...+...+
T Consensus 95 ~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~ 174 (322)
T 2ppq_A 95 SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEI 174 (322)
T ss_dssp TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHH
T ss_pred CCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHH
Confidence 456799999999864310 11110 001 1000000 001122334
Q ss_pred Hhhh-------hCCeEEeecCCCCeeecCCCceeecccCCccc
Q 010463 220 HSIH-------QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 255 (510)
Q Consensus 220 ~~lH-------~~giiHRDLKP~NILld~~g~vkL~DFGla~~ 255 (510)
..++ ..++||+|+.|.|||++.++.+.|+||+.+..
T Consensus 175 ~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 175 DYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 4443 24799999999999999876668999998874
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00037 Score=69.22 Aligned_cols=137 Identities=10% Similarity=0.129 Sum_probs=79.2
Q ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCC--CeeeEeEE-----eecCceEEE
Q 010463 111 LTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR--CIVQLFYS-----FQDSDFLYL 183 (510)
Q Consensus 111 ~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp--~Iv~l~~~-----~~~~~~~~l 183 (510)
+..|+ |....||++.. .+|+.|++|+...... ....+..|..++..+... .+++++.. ....+..++
T Consensus 31 ~~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~ 104 (328)
T 1zyl_A 31 LTPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFA 104 (328)
T ss_dssp CEEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEE
T ss_pred EEeec-CcccceEEEEc-CCCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEE
Confidence 34566 88889998654 3466799999863311 234466788887766321 24444433 122456789
Q ss_pred EEeccCCCCHH-----------HH---HHh---c------cCCCHHHH----------------------HHHHHHHHHH
Q 010463 184 IMEYLPGGDIM-----------TL---LMR---E------DILSEDVA----------------------RFYIAESVLA 218 (510)
Q Consensus 184 VmEy~~gG~L~-----------~~---L~~---~------~~l~e~~~----------------------~~~~~qi~~a 218 (510)
||+|++|..+. .. +.. . ..++.... ...+.+++..
T Consensus 105 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 184 (328)
T 1zyl_A 105 VFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAA 184 (328)
T ss_dssp EEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHH
T ss_pred EEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHH
Confidence 99999985431 01 111 0 01111100 0111122222
Q ss_pred HHhh----hhCCeEEeecCCCCeeecCCCceeecccCCccc
Q 010463 219 IHSI----HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 255 (510)
Q Consensus 219 L~~l----H~~giiHRDLKP~NILld~~g~vkL~DFGla~~ 255 (510)
+..+ ....++|+|++|.|||++ + .+.|+||+.|..
T Consensus 185 l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 185 VTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 2222 345689999999999999 4 899999998864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00038 Score=72.39 Aligned_cols=74 Identities=18% Similarity=0.258 Sum_probs=50.3
Q ss_pred eeeeeecCCCeEEEEEEEcC-------CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEeEEeecCceE
Q 010463 110 QLTLIGKGAFGEVRLCRAKT-------TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSDFL 181 (510)
Q Consensus 110 ~~~~IG~G~fG~V~~~~~~~-------tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~~ 181 (510)
.++.|+.|....||++.... ++..|.+|+..... ....+..|..++..+. +....++++.+.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-----TESHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-----cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 35678889899999998653 35789999874311 1134557888888774 3334677777653
Q ss_pred EEEEeccCCCC
Q 010463 182 YLIMEYLPGGD 192 (510)
Q Consensus 182 ~lVmEy~~gG~ 192 (510)
.+||||++|-.
T Consensus 148 g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 GRLEEYIPSRP 158 (429)
T ss_dssp EEEECCCCEEE
T ss_pred CEEEEEeCCcc
Confidence 28999998743
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00031 Score=71.87 Aligned_cols=141 Identities=15% Similarity=0.178 Sum_probs=84.5
Q ss_pred CCceeeeeeecCCCeEEEEEEEcC-------CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEeEEeec
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKT-------TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQD 177 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~-------tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~ 177 (510)
++++ ++.|..|-...+|++.... +++.|.+|+.... ......+.+|..+++.+. +.-..++++.+.+
T Consensus 51 ~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~ 125 (379)
T 3feg_A 51 EELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI----LQGVDSLVLESVMFAILAERSLGPQLYGVFPE 125 (379)
T ss_dssp GGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT
T ss_pred CceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc----cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC
Confidence 4444 3567778888999987642 3578999986331 112345668999987773 3334677777654
Q ss_pred CceEEEEEeccCCCCHHH--------------HHH---hc-----cCC--CHHHHHHHHHHHHH----------------
Q 010463 178 SDFLYLIMEYLPGGDIMT--------------LLM---RE-----DIL--SEDVARFYIAESVL---------------- 217 (510)
Q Consensus 178 ~~~~~lVmEy~~gG~L~~--------------~L~---~~-----~~l--~e~~~~~~~~qi~~---------------- 217 (510)
.+||||++|..|.. .|. .. ... -..++..|+.++-.
T Consensus 126 ----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
T 3feg_A 126 ----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYS 201 (379)
T ss_dssp ----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTT
T ss_pred ----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHH
Confidence 29999999854421 111 11 011 13455555544321
Q ss_pred ---HHHh----hh----hCCeEEeecCCCCeeecCC----CceeecccCCccc
Q 010463 218 ---AIHS----IH----QHNYVHRDIKPDNLILDKN----GHLKLSDFGLCKP 255 (510)
Q Consensus 218 ---aL~~----lH----~~giiHRDLKP~NILld~~----g~vkL~DFGla~~ 255 (510)
.+.. |. ...++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 202 l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 202 LKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 1222 22 2369999999999999876 7899999999875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00039 Score=69.33 Aligned_cols=137 Identities=16% Similarity=0.152 Sum_probs=72.1
Q ss_pred eeeeecCCCeE-EEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC--CCeeeEeEEeecCceEEEEEec
Q 010463 111 LTLIGKGAFGE-VRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS--RCIVQLFYSFQDSDFLYLIMEY 187 (510)
Q Consensus 111 ~~~IG~G~fG~-V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~h--p~Iv~l~~~~~~~~~~~lVmEy 187 (510)
++.|+.|+... +|++.. .+|..|++|...... . ..+..|..++..+.. -.+.+++.+..+.+ ++|||+
T Consensus 23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~---~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~ 93 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE---G---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIED 93 (333)
T ss_dssp ECC--------CCEEEEC-TTCCEEEEEECCTTT---T---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECC
T ss_pred eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCC---C---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEee
Confidence 45676665555 666542 236677777654321 0 224556777666532 23556666533333 789999
Q ss_pred cCCCCHHHHHHhc--------------------------cCCCHHHHH--------HHH------------HHHHHHHHh
Q 010463 188 LPGGDIMTLLMRE--------------------------DILSEDVAR--------FYI------------AESVLAIHS 221 (510)
Q Consensus 188 ~~gG~L~~~L~~~--------------------------~~l~e~~~~--------~~~------------~qi~~aL~~ 221 (510)
+.|..+.+.+... ..++..... .+. ..+...+..
T Consensus 94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~ 173 (333)
T 3csv_A 94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ 173 (333)
T ss_dssp CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 9876665433211 112221110 011 011111222
Q ss_pred h------hhCCeEEeecCCCCeeecCC----CceeecccCCcccC
Q 010463 222 I------HQHNYVHRDIKPDNLILDKN----GHLKLSDFGLCKPL 256 (510)
Q Consensus 222 l------H~~giiHRDLKP~NILld~~----g~vkL~DFGla~~~ 256 (510)
+ +...++|+|+.|.|||++.+ +.+.|+||+.|...
T Consensus 174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 2 34579999999999999875 68999999998754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00031 Score=71.24 Aligned_cols=75 Identities=17% Similarity=0.102 Sum_probs=44.7
Q ss_pred eeeeeecCCCeEEEEEEEcC--------CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCC-eeeEeEEeecCce
Q 010463 110 QLTLIGKGAFGEVRLCRAKT--------TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC-IVQLFYSFQDSDF 180 (510)
Q Consensus 110 ~~~~IG~G~fG~V~~~~~~~--------tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~-Iv~l~~~~~~~~~ 180 (510)
.++.|+.|....||++.... .+..|.+|+..... ........|..+|..+.... +.++++.+.
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~---- 108 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV----DELYNTISEFEVYKTMSKYKIAPQLLNTFN---- 108 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG----GGTSCHHHHHHHHHHHHHTTSSCCEEEEET----
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc----cceecHHHHHHHHHHHHhcCCCCceEEecC----
Confidence 35677888889999987653 13678999875421 11111356888887764333 456666552
Q ss_pred EEEEEeccCCCC
Q 010463 181 LYLIMEYLPGGD 192 (510)
Q Consensus 181 ~~lVmEy~~gG~ 192 (510)
-++||||++|..
T Consensus 109 ~~~v~e~i~G~~ 120 (369)
T 3c5i_A 109 GGRIEEWLYGDP 120 (369)
T ss_dssp TEEEEECCCSEE
T ss_pred CcEEEEEecCCc
Confidence 268999999854
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.37 E-value=0.0014 Score=64.02 Aligned_cols=79 Identities=15% Similarity=0.005 Sum_probs=54.6
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-C--CCeeeEeEEeecCceEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-S--RCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~-h--p~Iv~l~~~~~~~~~~~ 182 (510)
....-+..+|.|..+.||+++. .+|+.|.+|+-.... ......+..|...|+.+. . --+.+.+... .-+
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~---~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~ 86 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDA---PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRT 86 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTC---CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTE
T ss_pred CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCC---cchhhHHHHHHHHHHHHHhhCCCCcceEEecc----Cce
Confidence 3456678899999999999875 468899999865432 111234778999998873 2 2345555442 237
Q ss_pred EEEeccCCCC
Q 010463 183 LIMEYLPGGD 192 (510)
Q Consensus 183 lVmEy~~gG~ 192 (510)
+||||++++.
T Consensus 87 lv~e~l~~~~ 96 (288)
T 3f7w_A 87 LAMEWVDERP 96 (288)
T ss_dssp EEEECCCCCC
T ss_pred EEEEeecccC
Confidence 8999998764
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0014 Score=65.85 Aligned_cols=32 Identities=16% Similarity=0.225 Sum_probs=28.7
Q ss_pred CCeEEeecCCCCeeecCCCceeecccCCcccC
Q 010463 225 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 256 (510)
Q Consensus 225 ~giiHRDLKP~NILld~~g~vkL~DFGla~~~ 256 (510)
.+++|+|+.|.|||++.++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 47999999999999998889999999988753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0042 Score=65.04 Aligned_cols=76 Identities=11% Similarity=0.210 Sum_probs=49.0
Q ss_pred eeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCe-eeEeEEeecCceEEEEEecc
Q 010463 110 QLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCI-VQLFYSFQDSDFLYLIMEYL 188 (510)
Q Consensus 110 ~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~I-v~l~~~~~~~~~~~lVmEy~ 188 (510)
.++.|+.|-...||++....++..|.+|+..... ...+. -..|..+|..+...++ .++++.+. + .+||||+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~---~~~id-R~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT---DEIIN-REREKKISCILYNKNIAKKIYVFFT--N--GRIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C---CSCSC-HHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh---hhhcC-HHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEee
Confidence 4567888999999998876545788999875421 11111 2578888888864444 67777773 2 2599999
Q ss_pred CCCCH
Q 010463 189 PGGDI 193 (510)
Q Consensus 189 ~gG~L 193 (510)
+|-.|
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 98443
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0043 Score=57.99 Aligned_cols=120 Identities=19% Similarity=0.135 Sum_probs=78.4
Q ss_pred CHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhh-hCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhh
Q 010463 192 DIMTLLMR-EDILSEDVARFYIAESVLAIHSIH-QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDED 269 (510)
Q Consensus 192 ~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH-~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~ 269 (510)
+|.++|.. ..+++|+++|.++.|.+.+|.-+- ...-..+=+-|..|+|..+|.|-+.+ +.+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------- 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------- 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc---------------
Confidence 78888875 468999999999999999988762 11111233457899999999998774 2111
Q ss_pred hhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCCCCCh
Q 010463 270 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDP 349 (510)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~~~~~ 349 (510)
.....+.|||... .+.+.+.=|||||+++|.-|-=.
T Consensus 98 -----------------------------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg-------- 133 (229)
T 2yle_A 98 -----------------------------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG-------- 133 (229)
T ss_dssp --------------------------------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTT--------
T ss_pred -----------------------------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC--------
Confidence 0122345676652 34456778999999999876411
Q ss_pred hhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc
Q 010463 350 RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC 384 (510)
Q Consensus 350 ~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~ 384 (510)
+.-..++.+|+.+.+||..|..
T Consensus 134 -------------L~e~eE~eLS~~LE~LL~~Mt~ 155 (229)
T 2yle_A 134 -------------LKENEERELSPPLEQLIDHMAN 155 (229)
T ss_dssp -------------CCTTEEECCCHHHHHHHHHHTT
T ss_pred -------------CCcccchhhCHHHHHHHHHHHh
Confidence 1111225899999999999975
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.04 E-value=0.013 Score=60.76 Aligned_cols=75 Identities=11% Similarity=0.083 Sum_probs=48.2
Q ss_pred eeeeeecCCCeEEEEEEEcCC-------CCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEeEEeecCceE
Q 010463 110 QLTLIGKGAFGEVRLCRAKTT-------GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSDFL 181 (510)
Q Consensus 110 ~~~~IG~G~fG~V~~~~~~~t-------g~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~~ 181 (510)
-++.|..|-...+|++..... +..|.+++..... .. .-...+|..+++.+. +.-..++++.+. -
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~ 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GK-FYDSKVELDVFRYLSNINIAPNIIADFP----E 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----T
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---ch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----C
Confidence 356677788899999887521 5789999864421 11 111346888877763 333556666543 2
Q ss_pred EEEEeccCCCC
Q 010463 182 YLIMEYLPGGD 192 (510)
Q Consensus 182 ~lVmEy~~gG~ 192 (510)
++||||++|..
T Consensus 146 ~~I~efI~G~~ 156 (424)
T 3mes_A 146 GRIEEFIDGEP 156 (424)
T ss_dssp EEEEECCCSEE
T ss_pred CEEEEEeCCcc
Confidence 78999999865
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.22 E-value=0.32 Score=49.57 Aligned_cols=31 Identities=26% Similarity=0.423 Sum_probs=26.4
Q ss_pred CeEEeecCCCCeee------cCCCceeecccCCcccC
Q 010463 226 NYVHRDIKPDNLIL------DKNGHLKLSDFGLCKPL 256 (510)
Q Consensus 226 giiHRDLKP~NILl------d~~g~vkL~DFGla~~~ 256 (510)
.++|.|+.+.|||+ +.++.+.++||-.|..-
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 36899999999999 45678999999998753
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=83.30 E-value=0.089 Score=55.00 Aligned_cols=64 Identities=5% Similarity=-0.052 Sum_probs=17.8
Q ss_pred eeeeeeecCCCeEEEEEEEcCCCCEEEE------EEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEee
Q 010463 109 EQLTLIGKGAFGEVRLCRAKTTGEIFAM------KKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ 176 (510)
Q Consensus 109 ~~~~~IG~G~fG~V~~~~~~~tg~~vAi------K~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 176 (510)
.+.+.|| ||+||++..+.....||+ |.++...+ .......+.+|..++..++|||+++.+.+-.
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~-~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGV-SEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccc-cccccccccccccccccccccccCCCcceEE
Confidence 3445666 999999988765567888 66543332 3444556778889999999999999887643
|
| >3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A | Back alignment and structure |
|---|
Probab=80.50 E-value=15 Score=39.27 Aligned_cols=81 Identities=25% Similarity=0.302 Sum_probs=48.8
Q ss_pred eeEeEEeecCceEEEEEeccCCCCHHHHHHhcc----------C-------CCHHHHHHHHHHHHH--HHHhhhhCCeEE
Q 010463 169 VQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED----------I-------LSEDVARFYIAESVL--AIHSIHQHNYVH 229 (510)
Q Consensus 169 v~l~~~~~~~~~~~lVmEy~~gG~L~~~L~~~~----------~-------l~e~~~~~~~~qi~~--aL~~lH~~giiH 229 (510)
++.|.+.......-+ +|++++.++.+.+.+.+ + ...+....|+..++. .+.|+=..|
T Consensus 402 i~~Y~Vipls~~~Gl-IE~V~~~tl~~il~~~~~l~~~f~~~~~~~~~~~~~~~~a~~nF~~S~A~ySvv~YILGig--- 477 (614)
T 3ls8_A 402 LTPYKVLATSTKHGF-MQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVG--- 477 (614)
T ss_dssp CCCCCEEESSSSEEE-EECCCCEEHHHHHHHTSSHHHHHHHHSBCTTSGGGBCHHHHHHHHHHHHHHHHHHHHHTCC---
T ss_pred eeccEEEEecCCCce-EEEeCCccHHHHHHccChHHHHHHHhCCCccccccccHHHHHHHHHHHHHHhHhheeeecc---
Confidence 445555555544443 57887755555543221 1 112334445544332 344544443
Q ss_pred eecCCCCeeecCCCceeecccCCcc
Q 010463 230 RDIKPDNLILDKNGHLKLSDFGLCK 254 (510)
Q Consensus 230 RDLKP~NILld~~g~vkL~DFGla~ 254 (510)
|=.++|||||.+|++.=+|||.+-
T Consensus 478 -DRH~~NILld~tG~v~HIDFG~~f 501 (614)
T 3ls8_A 478 -DRHLDNLLLTKTGKLFHIDFGYIL 501 (614)
T ss_dssp -CCCTTSEEECTTSCEEECCCSSCT
T ss_pred -CCCCcceeEcCCCCEeeeehHHhh
Confidence 778999999999999999999984
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 510 | ||||
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-88 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-87 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-85 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-83 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-78 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-78 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-76 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-75 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-72 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-72 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-71 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-71 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-71 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-70 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-69 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-69 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-67 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-67 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-66 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-64 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-62 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-60 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-59 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-57 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-57 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-56 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-55 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-53 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-53 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-53 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-52 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-52 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-52 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-52 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-51 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-51 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-50 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-50 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-49 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-49 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-49 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-49 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-48 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-48 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-48 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-47 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-46 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-46 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-45 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-45 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-45 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-44 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-44 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-43 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-42 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-42 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-39 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-38 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-36 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-30 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-13 |
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 269 bits (689), Expect = 9e-88
Identities = 97/327 (29%), Positives = 165/327 (50%), Gaps = 44/327 (13%)
Query: 99 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN 158
Q RK +DF+ ++G+G+F V L R T +A+K L+K ++K +V +V ER+
Sbjct: 1 QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 60
Query: 159 LLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLA 218
+++ +D V+L+++FQD + LY + Y G+++ + + E RFY AE V A
Sbjct: 61 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 120
Query: 219 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 278
+ +H +HRD+KP+N++L+++ H++++DFG K
Sbjct: 121 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAK------------------------ 156
Query: 279 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338
+++A A S VGT Y++PE+L +K D W+LG I+Y+++
Sbjct: 157 ------------VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 204
Query: 339 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLG---TRG 394
G PPF + + + +KI+ + FPE K +ARDL+ LL D RLG G
Sbjct: 205 AGLPPFRAGNEYLIFQKIIKLE--YDFPE--KFFPKARDLVEKLLVLDATKRLGCEEMEG 260
Query: 395 VEELKEHPWFRGIQWDKLYEMEAAYKP 421
LK HP+F + W+ L++
Sbjct: 261 YGPLKAHPFFESVTWENLHQQTPPKLT 287
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 268 bits (687), Expect = 6e-87
Identities = 122/375 (32%), Positives = 184/375 (49%), Gaps = 51/375 (13%)
Query: 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA 161
K+ ++DF+ L L+GKG FG+V L R K TG +AMK L+K ++ + +V H +E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 162 EVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHS 221
+ L Y+FQ D L +MEY GG++ L RE + +E+ ARFY AE V A+
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 222 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 281
+H + V+RDIK +NL+LDK+GH+K++DFGLCK ++
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT------------------- 161
Query: 282 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341
+ GT +Y+APEVL YG DWW LG +MYEM+ G
Sbjct: 162 -------------------MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
Query: 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEEL 398
PF + D I+ + ++FP +S EA+ L+ LL D + RLG +E+
Sbjct: 203 LPFYNQDHERLFELILMEE--IRFP--RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV 258
Query: 399 KEHPWFRGIQWDKLY--EMEAAYKPTVNGELDTQNFEKF----PEVDGPPSEIPSVGPWR 452
EH +F I W + ++ +KP V E+DT+ F+ PP S+G
Sbjct: 259 MEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLE 318
Query: 453 KMLTSKDTNFIGYTF 467
+ F + +
Sbjct: 319 LDQREEQEMFEDFDY 333
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 264 bits (676), Expect = 2e-85
Identities = 123/356 (34%), Positives = 194/356 (54%), Gaps = 52/356 (14%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 164
+ DF+ L +G G+FG V L R++ G +AMK LKK +++ QVEH ER +L+ V
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62
Query: 165 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ 224
I++++ +FQD+ +++IM+Y+ GG++ +LL + VA+FY AE LA+ +H
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122
Query: 225 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 284
+ ++RD+KP+N++LDKNGH+K++DFG K + D
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT------------------------ 158
Query: 285 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 344
Y+ GT DY+APEV+ K Y DWWS G ++YEML GY PF
Sbjct: 159 -----------------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 201
Query: 345 CSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR--GVEELKEH 401
+ T KI+N + L+FP P +++ +DL+ L+ D+ RLG G E++K H
Sbjct: 202 YDSNTMKTYEKILNAE--LRFP--PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257
Query: 402 PWFRGIQWDKLY--EMEAAYKPTV-NGELDTQNFEKFPEVDGPPSEIPSVGPWRKM 454
PWF+ + W+KL +E Y+P + G+ DT F+K+PE D + P+ +
Sbjct: 258 PWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDKYPEED-INYGVQGEDPYADL 312
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 258 bits (661), Expect = 4e-83
Identities = 118/369 (31%), Positives = 179/369 (48%), Gaps = 55/369 (14%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV- 163
I+DF ++GKG+FG+V L K T + FA+K LKK +L VE E+ +L+
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 164 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIH 223
+ + +F +FQ + L+ +MEYL GGD+M + A FY AE +L + +H
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120
Query: 224 QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQW 283
V+RD+K DN++LDK+GH+K++DFG+CK +
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT-------------------- 160
Query: 284 MMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 343
+ GT DY+APE+LL + Y DWWS G ++YEMLIG P
Sbjct: 161 ------------------NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 202
Query: 344 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHP 402
F D I +P + EA+DL+ L + E RLG RG ++++HP
Sbjct: 203 FHGQDEEELFHSIRMDN--PFYPR--WLEKEAKDLLVKLFVREPEKRLGVRG--DIRQHP 256
Query: 403 WFRGIQWDKLY--EMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGP-WRKMLTSKD 459
FR I W++L E++ ++P V D NF+K +E P + R ++ S D
Sbjct: 257 LFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFL-----NEKPRLSFADRALINSMD 311
Query: 460 TN-FIGYTF 467
N F ++F
Sbjct: 312 QNMFRNFSF 320
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 247 bits (632), Expect = 1e-78
Identities = 117/375 (31%), Positives = 197/375 (52%), Gaps = 54/375 (14%)
Query: 74 AAVSNEEQEEMLRNLERRETEYMR----LQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKT 129
AA EQE + L + + ++++ + +D F+++ +G G+FG V L + K
Sbjct: 5 AAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKE 64
Query: 130 TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLP 189
+G +AMK L K +++K Q+EH +E+ +L V+ +V+L +SF+D+ LY++MEY+
Sbjct: 65 SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 190 GGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSD 249
GG++ + L R SE ARFY A+ VL +H + ++RD+KP+NL++D+ G+++++D
Sbjct: 125 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTD 184
Query: 250 FGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLD 309
FG K ++ + ++ GT +
Sbjct: 185 FGFAKRVKGRTWTL-----------------------------------------CGTPE 203
Query: 310 YMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEP 369
+APE++L KGY DWW+LG ++YEM GYPPF +D P KI ++FP
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI--VSGKVRFP--S 259
Query: 370 KISDEARDLICHLLC-DVETRLGTR--GVEELKEHPWFRGIQWDKLY--EMEAAYKPTVN 424
S + +DL+ +LL D+ R G GV ++K H WF W +Y ++EA + P
Sbjct: 260 HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFK 319
Query: 425 GELDTQNFEKFPEVD 439
G DT NF+ + E +
Sbjct: 320 GPGDTSNFDDYEEEE 334
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 244 bits (624), Expect = 2e-78
Identities = 90/307 (29%), Positives = 139/307 (45%), Gaps = 48/307 (15%)
Query: 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLL 160
R+ ++DFE +GKG FG V L R K + I A+K L K+++ K G +R E +
Sbjct: 1 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 60
Query: 161 AEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIH 220
+ + I++L+ F D+ +YLI+EY P G + L + E YI E A+
Sbjct: 61 SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 120
Query: 221 SIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAE 280
H +HRDIKP+NL+L G LK++DFG
Sbjct: 121 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--------------------- 159
Query: 281 GQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 340
+ GTLDY+ PE++ + + + D WSLG + YE L+G
Sbjct: 160 -------------------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 200
Query: 341 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 399
PPF ++ + T ++I ++F +++ ARDLI LL + R + E+
Sbjct: 201 KPPFEANTYQETYKRISR----VEFTFPDFVTEGARDLISRLLKHNPSQRP---MLREVL 253
Query: 400 EHPWFRG 406
EHPW
Sbjct: 254 EHPWITA 260
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 241 bits (616), Expect = 4e-76
Identities = 90/366 (24%), Positives = 150/366 (40%), Gaps = 53/366 (14%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 164
+D ++ +G GAFG V + TG FA K + E VR E ++ +
Sbjct: 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLR 81
Query: 165 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIH 223
+V L +F+D + + +I E++ GG++ + E +SED A Y+ + + +H
Sbjct: 82 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 141
Query: 224 QHNYVHRDIKPDNLIL--DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 281
++NYVH D+KP+N++ ++ LKL DFGL L+ K S
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS-------------------- 181
Query: 282 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341
T GT ++ APEV K G D WS+G + Y +L G
Sbjct: 182 -------------------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL 222
Query: 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400
PF ++ T R + + + IS++ +D I LL D TR+ + + E
Sbjct: 223 SPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM---TIHQALE 279
Query: 401 HPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRK----MLT 456
HPW + + T + ++ +PE P I + RK +
Sbjct: 280 HPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKHRPQEYS 339
Query: 457 SKDTNF 462
+D +
Sbjct: 340 IRDAFW 345
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 238 bits (609), Expect = 6e-75
Identities = 108/384 (28%), Positives = 167/384 (43%), Gaps = 61/384 (15%)
Query: 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN---L 159
+ ++DF +IG+G FGEV CR TG+++AMK L K + + +ER L
Sbjct: 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60
Query: 160 LAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAI 219
++ D IV + Y+F D L I++ + GGD+ L + + SE RFY AE +L +
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 120
Query: 220 HSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEA 279
+H V+RD+KP N++LD++GH+++SD GL K
Sbjct: 121 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP------------------ 162
Query: 280 EGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEML 338
+++VGT YMAPEVL K Y DW+SLG +++++L
Sbjct: 163 ----------------------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 200
Query: 339 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGV 395
G+ PF + +I + S E R L+ LL DV RLG RG
Sbjct: 201 RGHSPFRQHKTKDK-HEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGA 259
Query: 396 EELKEHPWFRGIQWDKLY--EMEAAYKPTVNGELDTQNF--EKFPEVDGPPSEIPSVGPW 451
+E+KE P+FR + W ++ + P F F E D I
Sbjct: 260 QEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEED--TKGIK----- 312
Query: 452 RKMLTSKDTNFIGYTFKKSDVLKS 475
+L S + + S+ +
Sbjct: 313 --LLDSDQELYRNFPLTISERWQQ 334
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 232 bits (593), Expect = 1e-72
Identities = 82/354 (23%), Positives = 150/354 (42%), Gaps = 50/354 (14%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 164
D ++ L +G GAFG V C K TG +F K + L + V++E +++ ++
Sbjct: 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLH 84
Query: 165 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI-LSEDVARFYIAESVLAIHSIH 223
++ L +F+D + LI+E+L GG++ + ED +SE Y+ ++ + +H
Sbjct: 85 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 144
Query: 224 QHNYVHRDIKPDNLILD--KNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 281
+H+ VH DIKP+N++ + K +K+ DFGL L
Sbjct: 145 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD---------------------- 182
Query: 282 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341
+ T T ++ APE++ ++ G D W++G + Y +L G
Sbjct: 183 -----------------EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL 225
Query: 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400
PF +D T + + +S EA+D I +LL + RL V + E
Sbjct: 226 SPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL---TVHDALE 282
Query: 401 HPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKM 454
HPW +G + + ++ + ++ + + +P I + RK
Sbjct: 283 HPWLKGDHSNLTSRIPSSRYNKIRQKIK-EKYADWPAPQPAIGRIANFSSLRKH 335
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (584), Expect = 2e-72
Identities = 68/303 (22%), Positives = 127/303 (41%), Gaps = 44/303 (14%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 164
++D++ + +G+GA+GEV+L + T E A+K + + E+++ E + ++
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 61
Query: 165 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ 224
+V+ + ++ + YL +EY GG++ + + + E A+ + + + + +H
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 225 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 284
HRDIKP+NL+LD+ +LK+SDFGL
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN------------------------- 156
Query: 285 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEMLIGYPP 343
NR L GTL Y+APE+L ++ + D WS G ++ ML G P
Sbjct: 157 -----------NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 205
Query: 344 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHP 402
+ K KI L+ +L + R+ + ++K+
Sbjct: 206 WDQPSDSCQEYSDWKEK-KTYLNPWKKIDSAPLALLHKILVENPSARI---TIPDIKKDR 261
Query: 403 WFR 405
W+
Sbjct: 262 WYN 264
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (583), Expect = 1e-71
Identities = 117/348 (33%), Positives = 185/348 (53%), Gaps = 49/348 (14%)
Query: 93 TEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCR---AKTTGEIFAMKKLKKSEMLKRGQ 149
T + K+GI++FE L ++G GA+G+V L R TG+++AMK LKK+ ++++ +
Sbjct: 11 TANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAK 70
Query: 150 -VEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDV 207
EH R+ER +L + S +V L Y+FQ L+LI++Y+ GG++ T L + + +E
Sbjct: 71 TTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE 130
Query: 208 ARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLED 267
+ Y+ E VLA+ +H+ ++RDIK +N++LD NGH+ L+DFGL K +
Sbjct: 131 VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER---- 186
Query: 268 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL--KKGYGMEC 325
AY GT++YMAP+++ G+
Sbjct: 187 ---------------------------------AYDFCGTIEYMAPDIVRGGDSGHDKAV 213
Query: 326 DWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC- 384
DWWSLG +MYE+L G PF D + + +I + P ++S A+DLI LL
Sbjct: 214 DWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMK 273
Query: 385 DVETRLGT--RGVEELKEHPWFRGIQWDKLY--EMEAAYKPTVNGELD 428
D + RLG R +E+KEH +F+ I WD L ++ A +KP + ELD
Sbjct: 274 DPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELD 321
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (575), Expect = 7e-71
Identities = 73/322 (22%), Positives = 133/322 (41%), Gaps = 52/322 (16%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
D +E + +G GAFG+V + K T + A K + ++E E ++LA D
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDH 68
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQ 224
IV+L +F + L++++E+ GG + +++ E L+E + +++ A++ +H
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 128
Query: 225 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 284
+ +HRD+K N++ +G +KL+DFG+
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR---------------------- 166
Query: 285 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDWWSLGAIMYEMLI 339
S +GT +MAPEV++ + Y + D WSLG + EM
Sbjct: 167 ----------------RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE 210
Query: 340 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEEL 398
PP +P KI + + + S +D + L +V+ R +L
Sbjct: 211 IEPPHHELNPMRVLLKIAKSEP-PTLAQPSRWSSNFKDFLKKCLEKNVDARW---TTSQL 266
Query: 399 KEHPWFRGIQWDKLYEMEAAYK 420
+HP+ + E+ A K
Sbjct: 267 LQHPFVTVDSNKPIRELIAEAK 288
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 225 bits (574), Expect = 8e-71
Identities = 80/314 (25%), Positives = 133/314 (42%), Gaps = 56/314 (17%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLK------RGQVEHVRSERNL 159
+++E ++G+G VR C K T + +A+K + + + E E ++
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 160 LAEVDS-RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLA 218
L +V I+QL +++ + F +L+ + + G++ L + LSE R + +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 219 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 278
I ++H+ N VHRD+KP+N++LD + ++KL+DFG L+
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---------------- 166
Query: 279 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL------KKGYGMECDWWSLGA 332
GT Y+APE++ GYG E D WS G
Sbjct: 167 -----------------------REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 203
Query: 333 IMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLG 391
IMY +L G PPF + R I++ PE SD +DL+ L + R
Sbjct: 204 IMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY- 262
Query: 392 TRGVEELKEHPWFR 405
EE HP+F+
Sbjct: 263 --TAEEALAHPFFQ 274
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 224 bits (572), Expect = 3e-70
Identities = 88/334 (26%), Positives = 146/334 (43%), Gaps = 51/334 (15%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
D ++ ++G GAF EV L K T ++ A+K + K + G+ + +E +L ++
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKH 66
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 225
IV L ++ LYLIM+ + GG++ ++ + +E A I + + A+ +H
Sbjct: 67 PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126
Query: 226 NYVHRDIKPDNLIL---DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 282
VHRD+KP+NL+ D++ + +SDFGL K +
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---------------------- 164
Query: 283 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 342
+ + GT Y+APEVL +K Y D WS+G I Y +L GYP
Sbjct: 165 -----------------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP 207
Query: 343 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401
PF ++ +I+ + P ISD A+D I HL+ D E R E+ +H
Sbjct: 208 PFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRF---TCEQALQH 264
Query: 402 PWFRG-IQWDKLYEMEAAYKPTVNGELDTQNFEK 434
PW G DK + + + +++
Sbjct: 265 PWIAGDTALDK--NIHQSVSEQIKKNFAKSKWKQ 296
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 1e-69
Identities = 70/348 (20%), Positives = 128/348 (36%), Gaps = 87/348 (25%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
DDFE+++ +G G G V K +G + A K + +K + E +L E +S
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNS 63
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ- 224
IV + +F + + ME++ GG + +L + + E + + + + +
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 225 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 284
H +HRD+KP N++++ G +KL DFG+ L D +
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----------------------- 160
Query: 285 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 344
S VGT YM+PE L Y ++ D WS+G + EM +G P
Sbjct: 161 -----------------NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203
Query: 345 CSDD--------------------------------------PRITCRKIVNWKTCLKFP 366
D P + +++++ P
Sbjct: 204 PPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPP 263
Query: 367 EEP--KISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDK 411
+ P S E +D + L + R +++L H + + ++
Sbjct: 264 KLPSGVFSLEFQDFVNKCLIKNPAERA---DLKQLMVHAFIKRSDAEE 308
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 3e-69
Identities = 83/319 (26%), Positives = 140/319 (43%), Gaps = 51/319 (15%)
Query: 92 ETEYMRLQRRKIGIDD----FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR 147
+ E + R + + D + + IG+GA G V TG+ A++++ + K+
Sbjct: 2 DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 61
Query: 148 GQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDV 207
E + +E ++ E + IV S+ D L+++MEYL GG + ++ + E
Sbjct: 62 ---ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQ 117
Query: 208 ARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLED 267
E + A+ +H + +HRDIK DN++L +G +KL+DFG C + + S
Sbjct: 118 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK----- 172
Query: 268 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDW 327
+ VGT +MAPEV+ +K YG + D
Sbjct: 173 ---------------------------------RSTMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 328 WSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DV 386
WSLG + EM+ G PP+ +++P I T + K+S RD + L DV
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSAIFRDFLNRCLDMDV 258
Query: 387 ETRLGTRGVEELKEHPWFR 405
E R +EL +H + +
Sbjct: 259 EKRG---SAKELLQHQFLK 274
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 2e-67
Identities = 88/311 (28%), Positives = 137/311 (44%), Gaps = 59/311 (18%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
+D+E L IG G++G + R K+ G+I K+L M + + + SE NLL E+
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKH 62
Query: 166 RCIVQLFYSFQD--SDFLYLIMEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAI 219
IV+ + D + LY++MEY GGD+ +++ + L E+ + + LA+
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 220 HSIHQ-----HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQE 274
H+ H +HRD+KP N+ LD ++KL DFGL + L S
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS------------- 169
Query: 275 TVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIM 334
A + VGT YM+PE + + Y + D WSLG ++
Sbjct: 170 -------------------------FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLL 204
Query: 335 YEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEP-KISDEARDLICHLLC-DVETRLGT 392
YE+ PPF + + KI KF P + SDE ++I +L R
Sbjct: 205 YELCALMPPFTAFSQKELAGKIREG----KFRRIPYRYSDELNEIITRMLNLKDYHRP-- 258
Query: 393 RGVEELKEHPW 403
VEE+ E+P
Sbjct: 259 -SVEEILENPL 268
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 216 bits (552), Expect = 4e-67
Identities = 72/337 (21%), Positives = 118/337 (35%), Gaps = 51/337 (15%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
F L IG G+FG V R E+ A+KK+ S + + + E L ++
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 225
+Q + +L+MEY G L + + L E ++ + +H H
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 226 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 285
N +HRD+K N++L + G +KL DFG +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--------------------------- 167
Query: 286 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMECDWWSLGAIMYEMLIGYP 342
A S VGT +MAPEV+L + Y + D WSLG E+ P
Sbjct: 168 ---------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212
Query: 343 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401
P + + I + + S+ R+ + L + R E L +H
Sbjct: 213 PLFNMNAMSALYHIAQNE--SPALQSGHWSEYFRNFVDSCLQKIPQDRP---TSEVLLKH 267
Query: 402 PWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEV 438
+ + + ELD + K ++
Sbjct: 268 RFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKI 304
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (542), Expect = 7e-66
Identities = 71/324 (21%), Positives = 137/324 (42%), Gaps = 52/324 (16%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ---VEHVRSERNLLAE 162
D ++ +G G F V+ CR K+TG +A K +KK + E + E ++L E
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 163 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSI 222
+ ++ L +++ + LI+E + GG++ L ++ L+E+ A ++ + + ++ +
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129
Query: 223 HQHNYVHRDIKPDNLILDKNG----HLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 278
H H D+KP+N++L +K+ DFGL ++
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---------------- 173
Query: 279 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338
+ GT +++APE++ + G+E D WS+G I Y +L
Sbjct: 174 -----------------------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 210
Query: 339 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEE 397
G PF D + T + + S A+D I LL D + R+ +++
Sbjct: 211 SGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM---TIQD 267
Query: 398 LKEHPWFRGIQWDKLYEMEAAYKP 421
+HPW + + + +A+
Sbjct: 268 SLQHPWIKPKDTQQA--LSSAWSH 289
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 2e-64
Identities = 68/304 (22%), Positives = 120/304 (39%), Gaps = 50/304 (16%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
+ + +G+G FG V C ++ + + K +K V+ E ++L
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARH 60
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI-LSEDVARFYIAESVLAIHSIHQ 224
R I+ L SF+ + L +I E++ G DI + L+E Y+ + A+ +H
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 225 HNYVHRDIKPDNLILD--KNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 282
HN H DI+P+N+I ++ +K+ +FG + L+ +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--------------------- 159
Query: 283 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 342
+Y APEV D WSLG ++Y +L G
Sbjct: 160 ------------------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN 201
Query: 343 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401
PF ++ + I+N + +IS EA D + LL + ++R+ E +H
Sbjct: 202 PFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM---TASEALQH 258
Query: 402 PWFR 405
PW +
Sbjct: 259 PWLK 262
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 5e-62
Identities = 56/301 (18%), Positives = 115/301 (38%), Gaps = 56/301 (18%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 173
IG+G+F V T A +L+ ++ K + + + E +L + IV+ +
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 174 SFQDS----DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY-- 227
S++ + + L+ E + G + T L R ++ V R + + + + +H
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPI 135
Query: 228 VHRDIKPDN-LILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMP 286
+HRD+K DN I G +K+ D GL ++
Sbjct: 136 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK------------------------ 171
Query: 287 KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC- 345
+ +GT ++MAPE+ ++ Y D ++ G M EM P+
Sbjct: 172 ----------------AVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSE 214
Query: 346 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404
+ R++ + F + E +++I + + + R +++L H +F
Sbjct: 215 CQNAAQIYRRVTSGVKPASFDKV--AIPEVKEIIEGCIRQNKDERY---SIKDLLNHAFF 269
Query: 405 R 405
+
Sbjct: 270 Q 270
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 196 bits (500), Expect = 6e-60
Identities = 66/305 (21%), Positives = 116/305 (38%), Gaps = 43/305 (14%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
D +E ++G G EV L R A+K L+ R E A ++
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 166 RCIVQLFYSFQDSD----FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHS 221
IV ++ + + Y++MEY+ G + ++ E ++ A IA++ A++
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 222 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 281
HQ+ +HRD+KP N+++ +K+ DFG+ + + D
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG--------------------- 165
Query: 282 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341
N + +GT Y++PE D +SLG ++YE+L G
Sbjct: 166 --------------NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 211
Query: 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400
PPF D P + V +S + ++ L + E R T E++
Sbjct: 212 PPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQT--AAEMR- 268
Query: 401 HPWFR 405
R
Sbjct: 269 ADLVR 273
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 6e-59
Identities = 87/359 (24%), Positives = 142/359 (39%), Gaps = 72/359 (20%)
Query: 96 MRLQRRKIGIDDFEQLT-LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVR 154
+++++ I IDD++ + ++G G G+V K T E FA+K L+ + R
Sbjct: 2 LQIKKNAI-IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR-------R 53
Query: 155 SERNLLAEVDSRCIVQLFYSFQDS----DFLYLIMEYLPGGDIMTLLMR--EDILSEDVA 208
IV++ +++ L ++ME L GG++ + + + +E A
Sbjct: 54 EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA 113
Query: 209 RFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK---NGHLKLSDFGLCKPLEDKYSSILL 265
+ AI +H N HRD+KP+NL+ N LKL+DFG K S
Sbjct: 114 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--- 170
Query: 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMEC 325
+ T Y+APEVL + Y C
Sbjct: 171 ------------------------------------TTPCYTPYYVAPEVLGPEKYDKSC 194
Query: 326 DWWSLGAIMYEMLIGYPPFCSDDPRITC----RKIVNWKTCLKFPEEPKISDEARDLICH 381
D WSLG IMY +L GYPPF S+ +I + PE ++S+E + LI +
Sbjct: 195 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 254
Query: 382 LLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVD 439
LL + R+ + E HPW + P + ++ E++ +V
Sbjct: 255 LLKTEPTQRM---TITEFMNHPWIMQ-------STKVPQTPLHTSRVLKEDKERWEDVK 303
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 1e-57
Identities = 77/311 (24%), Positives = 124/311 (39%), Gaps = 62/311 (19%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEH---VRSERNLLAE 162
++ L+G G FG V + A+K ++K + G++ + V E LL +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 163 VDSRC--IVQLFYSFQDSDFLYLIMEYL-PGGDIMTLLMREDILSEDVARFYIAESVLAI 219
V S +++L F+ D LI+E P D+ + L E++AR + + + A+
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 220 HSIHQHNYVHRDIKPDNLILDKN-GHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 278
H +HRDIK +N+++D N G LKL DFG L+D +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT---------------- 167
Query: 279 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEM 337
GT Y PE + Y G WSLG ++Y+M
Sbjct: 168 ------------------------DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 203
Query: 338 LIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVE 396
+ G PF D+ I + + F ++S E + LI L R E
Sbjct: 204 VCGDIPFEHDEEIIRGQ--------VFFR--QRVSSECQHLIRWCLALRPSDRP---TFE 250
Query: 397 ELKEHPWFRGI 407
E++ HPW + +
Sbjct: 251 EIQNHPWMQDV 261
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 2e-57
Identities = 75/325 (23%), Positives = 122/325 (37%), Gaps = 69/325 (21%)
Query: 109 EQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEM--LKRGQVEHVRSERNLLAEVDSR 166
E+L +G+G F V R K T +I A+KK+K K G E LL E+
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 167 CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHN 226
I+ L +F + L+ +++ + + +L+ + Y+ ++ + +HQH
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 227 YVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMP 286
+HRD+KP+NL+LD+NG LKL+DFGL K +
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY----------------------- 157
Query: 287 KERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYPPFC 345
V T Y APE+L + YG+ D W++G I+ E+L+ P
Sbjct: 158 ---------------THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP 202
Query: 346 SDDPRITCRKIVN---------WKTCLKFPEE---------------PKISDEARDLICH 381
D +I W P+ D+ DLI
Sbjct: 203 GDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQG 262
Query: 382 LLC-DVETRLGTRGVEELKEHPWFR 405
L + R+ + + +F
Sbjct: 263 LFLFNPCARI---TATQALKMKYFS 284
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 1e-56
Identities = 62/317 (19%), Positives = 117/317 (36%), Gaps = 48/317 (15%)
Query: 98 LQRRKIGIDDFEQLTLIGKGAFGEVRLC--RAKTTGEIFAMKKLKKSEMLKRGQVEHVRS 155
L R+ + ++D E +G G FG V+ + K + A+K LK E + + +
Sbjct: 3 LDRKLLTLEDKE----LGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLA 57
Query: 156 ERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAES 215
E N++ ++D+ IV++ +++ L+ME G + L + + + + +
Sbjct: 58 EANVMQQLDNPYIVRM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 116
Query: 216 VLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQET 275
+ + + + N+VHRD+ N++L + K+SDFGL K L
Sbjct: 117 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE--------------- 161
Query: 276 VSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 335
N + + APE + + + D WS G +M+
Sbjct: 162 --------------------NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMW 201
Query: 336 EML-IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR 393
E G P+ + + + E DL+ DVE R G
Sbjct: 202 EAFSYGQKPYRGMKGSEVTAMLEKGE---RMGCPAGCPREMYDLMNLCWTYDVENRPGFA 258
Query: 394 GVEELKEHPWFRGIQWD 410
VE + ++ +
Sbjct: 259 AVELRLRNYYYDVVNEG 275
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 7e-55
Identities = 67/314 (21%), Positives = 115/314 (36%), Gaps = 50/314 (15%)
Query: 96 MRLQRRKIGIDDFEQLTLIGKGAFGEVRLC--RAKTTGEIFAMKKLKKSEMLKRGQVEHV 153
+ L+R + I D E +G G FG VR R + A+K LK+ ++ E +
Sbjct: 3 LFLKRDNLLIADIE----LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEM 56
Query: 154 RSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM-REDILSEDVARFYI 212
E ++ ++D+ IV+L Q L L+ME GG + L+ + + + +
Sbjct: 57 MREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 115
Query: 213 AESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIIN 272
+ + + + + N+VHRD+ N++L + K+SDFGL K L
Sbjct: 116 HQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA-------------- 161
Query: 273 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGA 332
+ + L + APE + + + D WS G
Sbjct: 162 ---------------------DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGV 200
Query: 333 IMYEML-IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRL 390
M+E L G P+ I K + P+ E L+ E R
Sbjct: 201 TMWEALSYGQKPYKKMKGPEVMAFIEQGK---RMECPPECPPELYALMSDCWIYKWEDRP 257
Query: 391 GTRGVEELKEHPWF 404
VE+ ++
Sbjct: 258 DFLTVEQRMRACYY 271
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 1e-53
Identities = 76/331 (22%), Positives = 127/331 (38%), Gaps = 70/331 (21%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 164
+++F+++ IG+G +G V R K TGE+ A+KK++ + G E +LL E++
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELN 59
Query: 165 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI-LSEDVARFYIAESVLAIHSIH 223
IV+L + LYL+ E+L + + + + Y+ + + + H
Sbjct: 60 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 224 QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQW 283
H +HRD+KP NL+++ G +KL+DFGL + +
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-------------------- 159
Query: 284 MMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEMLIGYP 342
V TL Y APE+LL Y D WSLG I EM+
Sbjct: 160 ------------------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 201
Query: 343 PFCSDDPRITCRKIVN---------WKTCLKFPEE----------------PKISDEARD 377
F D +I W P+ P + ++ R
Sbjct: 202 LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRS 261
Query: 378 LICHLLC-DVETRLGTRGVEELKEHPWFRGI 407
L+ +L D R+ + HP+F+ +
Sbjct: 262 LLSQMLHYDPNKRI---SAKAALAHPFFQDV 289
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 3e-53
Identities = 52/294 (17%), Positives = 104/294 (35%), Gaps = 48/294 (16%)
Query: 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE 162
I IG G+FG V + A+K L + + Q++ ++E +L +
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQ-QLQAFKNEVGVLRK 60
Query: 163 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI-LSEDVARFYIAESVLAIHS 221
I+ LF + + L ++ ++ G + L + ++ +
Sbjct: 61 TRHVNIL-LFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 119
Query: 222 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 281
+H + +HRD+K +N+ L ++ +K+ DFGL S E
Sbjct: 120 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE--------------- 164
Query: 282 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMECDWWSLGAIMYEML 338
G++ +MAPEV+ K Y + D ++ G ++YE++
Sbjct: 165 ---------------------QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 203
Query: 339 IGYPPFCSDDPRITCRKIVNWKTCLKFPEE--PKISDEARDLICHLLC-DVETR 389
G P+ + + R +V + + L+ L + R
Sbjct: 204 TGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDER 257
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 7e-53
Identities = 79/362 (21%), Positives = 125/362 (34%), Gaps = 75/362 (20%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
+ L+ IG+GA+G V A+KK+ E + + E +L
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRH 65
Query: 166 RCIVQLFYSFQDSDF----LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHS 221
I+ + + ++ +L G D+ LL + LS D +++ + + +
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKY 124
Query: 222 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 281
IH N +HRD+KP NL+L+ LK+ DFGL + +
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP----------------------- 161
Query: 282 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEMLIG 340
+ V T Y APE++L GY D WS+G I+ EML
Sbjct: 162 ------------DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 209
Query: 341 YPPFCSDDPRITCRKIVN------------------WKTCLKFPEE---------PKISD 373
P F I+ L P + P
Sbjct: 210 RPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADS 269
Query: 374 EARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNF 432
+A DL+ +L + R+ VE+ HP+ +D E A + ELD
Sbjct: 270 KALDLLDKMLTFNPHKRI---EVEQALAHPYLEQY-YDPSDEPIAEAPFKFDMELDDLPK 325
Query: 433 EK 434
EK
Sbjct: 326 EK 327
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 1e-52
Identities = 70/339 (20%), Positives = 117/339 (34%), Gaps = 76/339 (22%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 164
+ +E+L IG+G FGEV R + TG+ A+KK+ K G E +L +
Sbjct: 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLK 67
Query: 165 SRCIVQLFYSFQDSDF--------LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESV 216
+V L + +YL+ ++ L + + + +
Sbjct: 68 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 127
Query: 217 LAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETV 276
++ IH++ +HRD+K N+++ ++G LKL+DFGL +
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLA----------------- 170
Query: 277 SEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMY 335
K ++ + V TL Y PE+LL ++ YG D W G IM
Sbjct: 171 -----------------KNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMA 213
Query: 336 EMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKI------------------------ 371
EM P + + I + P +
Sbjct: 214 EMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLK 273
Query: 372 ----SDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 405
A DLI LL D R+ ++ H +F
Sbjct: 274 AYVRDPYALDLIDKLLVLDPAQRI---DSDDALNHDFFW 309
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 4e-52
Identities = 78/344 (22%), Positives = 123/344 (35%), Gaps = 86/344 (25%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
+ +IG G+FG V + +GE+ A+KK+ + + K E ++ ++D
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-------NRELQIMRKLDH 72
Query: 166 RCIVQLFYSFQDSD------FLYLIMEYLPGG---DIMTLLMREDILSEDVARFYIAESV 216
IV+L Y F S +L L+++Y+P + L + Y+ +
Sbjct: 73 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 217 LAIHSIHQHNYVHRDIKPDNLILDKNG-HLKLSDFGLCKPLEDKYSSILLEDEDIINQET 275
++ IH HRDIKP NL+LD + LKL DFG K L +
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN------------- 179
Query: 276 VSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIM 334
S + + Y APE++ Y D WS G ++
Sbjct: 180 --------------------------VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 213
Query: 335 YEMLIGYPPFCSDDPRITCRKIVN---------------WKTCLKFPE----------EP 369
E+L+G P F D +I+ T KFP+ P
Sbjct: 214 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 273
Query: 370 KISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKL 412
+ EA L LL RL E H +F ++ +
Sbjct: 274 RTPPEAIALCSRLLEYTPTARL---TPLEACAHSFFDELRDPNV 314
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 4e-52
Identities = 52/293 (17%), Positives = 97/293 (33%), Gaps = 44/293 (15%)
Query: 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTT---GEIFAMKKLKKSEMLKRGQVEHVRSERNL 159
IG D L +G G+FG VR A+K LK + + ++ E N
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 160 LAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI-LSEDVARFYIAESVLA 218
+ +D R +++L+ + ++ E P G ++ L + Y +
Sbjct: 65 MHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 219 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 278
+ + ++HRD+ NL+L +K+ DFGL + L ++++
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE----------- 172
Query: 279 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338
+ APE L + + D W G ++EM
Sbjct: 173 ------------------------HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 208
Query: 339 -IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETR 389
G P+ + KI + P + +++ E R
Sbjct: 209 TYGQEPWIGLNGSQILHKIDKEG--ERLPRPEDCPQDIYNVMVQCWAHKPEDR 259
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 5e-52
Identities = 56/308 (18%), Positives = 112/308 (36%), Gaps = 60/308 (19%)
Query: 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE 162
+ + + + L IGKG FG+V G A+K +K + +E +++ +
Sbjct: 4 LNMKELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCIKNDAT-----AQAFLAEASVMTQ 56
Query: 163 VDSRCIVQLF-YSFQDSDFLYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAI 219
+ +VQL ++ LY++ EY+ G ++ L +L D + + A+
Sbjct: 57 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116
Query: 220 HSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEA 279
+ +N+VHRD+ N+++ ++ K+SDFGL K
Sbjct: 117 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD------------------ 158
Query: 280 EGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML- 338
+ + + APE L +K + + D WS G +++E+
Sbjct: 159 -----------------------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 195
Query: 339 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGV-- 395
G P+ + ++ K +++ + D R +
Sbjct: 196 FGRVPYPRIPLKDVVPRVEK---GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252
Query: 396 --EELKEH 401
E +K H
Sbjct: 253 QLEHIKTH 260
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 175 bits (443), Expect = 1e-51
Identities = 74/327 (22%), Positives = 121/327 (37%), Gaps = 70/327 (21%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
+ + L IG+G +G V + GE FA+KK++ E G E ++L E+
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRL-EKEDEGIPSTTIREISILKELKH 59
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 225
IV+L+ L L+ E+L L + E L A+ ++ + + I H
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 226 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 285
+HRD+KP NL++++ G LK++DFGL +
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK----------------------- 156
Query: 286 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG-YGMECDWWSLGAIMYEMLIGYPPF 344
+ TL Y AP+VL+ Y D WS+G I EM+ G P F
Sbjct: 157 ---------------YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF 201
Query: 345 CSDDPRITCRKIV---------NWKTCLKFPEE----------------PKISDEARDLI 379
+I NW + P+ + + DL+
Sbjct: 202 PGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLL 261
Query: 380 CHLLC-DVETRLGTRGVEELKEHPWFR 405
+L D R+ ++ EH +F+
Sbjct: 262 SKMLKLDPNQRI---TAKQALEHAYFK 285
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 174 bits (442), Expect = 3e-51
Identities = 64/313 (20%), Positives = 113/313 (36%), Gaps = 48/313 (15%)
Query: 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGE---IFAMKKLKKSEMLKRGQVEHVRSER 157
++I I + +IG G FGEV K G+ A+K LK Q SE
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEA 78
Query: 158 NLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESV 216
+++ + D ++ L S + +I E++ G + + L + D + +
Sbjct: 79 SIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIA 138
Query: 217 LAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETV 276
+ + NYVHRD+ N++++ N K+SDFGL + LED S T
Sbjct: 139 AGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS-----------DPTY 187
Query: 277 SEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 336
+ A G + + APE + + + D WS G +M+E
Sbjct: 188 TSALGGK----------------------IPIRWTAPEAIQYRKFTSASDVWSYGIVMWE 225
Query: 337 ML-IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRG 394
++ G P+ + I + P L+ D R
Sbjct: 226 VMSYGERPYWDMTNQDVINAIEQ---DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQ 282
Query: 395 V----EELKEHPW 403
+ +++ +P
Sbjct: 283 IVNTLDKMIRNPN 295
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 1e-50
Identities = 74/340 (21%), Positives = 125/340 (36%), Gaps = 75/340 (22%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCR-AKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNL--LA 161
+E + IG+GA+G+V R K G A+K+++ + + +R L L
Sbjct: 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 65
Query: 162 EVDSRCIVQLFYSFQDSDF-----LYLIMEYLPGGDIMTLLM-REDILSEDVARFYIAES 215
+ +V+LF S L L+ E++ L E + + + + +
Sbjct: 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125
Query: 216 VLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQET 275
+ + +H H VHRD+KP N+++ +G +KL+DFGL + + +
Sbjct: 126 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL------------- 172
Query: 276 VSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 335
S V TL Y APEVLL+ Y D WS+G I
Sbjct: 173 --------------------------TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFA 206
Query: 336 EMLIGYPPFCSDDPRITCRKIVN---------WKTCLKFPEE--------------PKIS 372
EM P F KI++ W + P + I
Sbjct: 207 EMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDID 266
Query: 373 DEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDK 411
+ +DL+ L + R+ HP+F+ ++ K
Sbjct: 267 ELGKDLLLKCLTFNPAKRI---SAYSALSHPYFQDLERCK 303
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 170 bits (431), Expect = 8e-50
Identities = 49/283 (17%), Positives = 102/283 (36%), Gaps = 45/283 (15%)
Query: 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE 162
+ D +G G +GEV K A+K LK+ M +VE E ++ E
Sbjct: 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKE 69
Query: 163 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM--REDILSEDVARFYIAESVLAIH 220
+ +VQL Y+I E++ G+++ L +S V + + A+
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 129
Query: 221 SIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAE 280
+ + N++HRD+ N ++ +N +K++DFGL + +
Sbjct: 130 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---------------------- 167
Query: 281 GQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 340
+ + + APE L + ++ D W+ G +++E+
Sbjct: 168 ---------------DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 212
Query: 341 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLL 383
+++ ++ PE ++ +L+
Sbjct: 213 GMSPYPGIDLSQVYELLEKDYRMERPEG--CPEKVYELMRACW 253
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 170 bits (430), Expect = 4e-49
Identities = 77/381 (20%), Positives = 134/381 (35%), Gaps = 98/381 (25%)
Query: 70 RAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKT 129
RA+ N + + E E+ DD++ + +G+G + EV T
Sbjct: 6 RARVYTDVNTHRPREYWDYESHVVEW-------GNQDDYQLVRKLGRGKYSEVFEAINIT 58
Query: 130 TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQD--SDFLYLIME 186
E +K LK + + ++ E +L + I+ L +D S L+ E
Sbjct: 59 NNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112
Query: 187 YLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD-KNGHL 245
++ D L L++ RFY+ E + A+ H +HRD+KP N+++D ++ L
Sbjct: 113 HVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKL 169
Query: 246 KLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTV 305
+L D+GL + + P + V
Sbjct: 170 RLIDWGLAE----------------------------FYHPGQEYNVR-----------V 190
Query: 306 GTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYPPFC-SDDPRITCRKIVN----- 358
+ + PE+L+ + Y D WSLG ++ M+ PF D +I
Sbjct: 191 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 250
Query: 359 ----------------------------WKTCLKFPEEPKISDEARDLICHLLC-DVETR 389
W+ + + +S EA D + LL D ++R
Sbjct: 251 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 310
Query: 390 LGTRGVEELKEHPWFRGIQWD 410
L E EHP+F + D
Sbjct: 311 L---TAREAMEHPYFYTVVKD 328
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 4e-49
Identities = 49/283 (17%), Positives = 101/283 (35%), Gaps = 47/283 (16%)
Query: 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE 162
I D L +G G FG V+ + + A+K +K+ M + + E ++
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSE----DEFIEEAKVMMN 55
Query: 163 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM-REDILSEDVARFYIAESVLAIHS 221
+ +VQL+ +++I EY+ G ++ L + A+
Sbjct: 56 LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 115
Query: 222 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 281
+ ++HRD+ N +++ G +K+SDFGL + + D
Sbjct: 116 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD----------------------- 152
Query: 282 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML-IG 340
+ + + + + PEVL+ + + D W+ G +M+E+ +G
Sbjct: 153 --------------DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLG 198
Query: 341 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLL 383
P+ T I L+ S++ ++
Sbjct: 199 KMPYERFTNSETAEHIAQ---GLRLYRPHLASEKVYTIMYSCW 238
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (426), Expect = 6e-49
Identities = 54/326 (16%), Positives = 101/326 (30%), Gaps = 47/326 (14%)
Query: 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA 161
++G + + IG G+FG++ L GE A+K + + E +
Sbjct: 4 RVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ-----LHIESKIYK 57
Query: 162 EVDSR-CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIH 220
+ I + + + D+ ++ME L S + + I
Sbjct: 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIE 117
Query: 221 SIHQHNYVHRDIKPDNLI---LDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVS 277
IH N++HRD+KPDN + K + + DFGL K D +
Sbjct: 118 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH--------------- 162
Query: 278 EAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337
+ + GT Y + L D SLG ++
Sbjct: 163 ----------------QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYF 206
Query: 338 LIGYPPFCSDDPRITCRKIVNWKTC-LKFPEE---PKISDEARDLICHLLC-DVETRLGT 392
+G P+ +K + P E E + + +
Sbjct: 207 NLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDY 266
Query: 393 RGVEELKEHPWFR-GIQWDKLYEMEA 417
+ +L + + R G +D +++
Sbjct: 267 SYLRQLFRNLFHRQGFSYDYVFDWNM 292
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 6e-49
Identities = 48/282 (17%), Positives = 98/282 (34%), Gaps = 45/282 (15%)
Query: 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE 162
I + + IG G FG V L + A+K +++ M + E E ++ +
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSE----EDFIEEAEVMMK 56
Query: 163 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVL-AIHS 221
+ +VQL+ + + L+ E++ G + L + L + V +
Sbjct: 57 LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 116
Query: 222 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 281
+ + +HRD+ N ++ +N +K+SDFG+ + + D +
Sbjct: 117 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS------------------ 158
Query: 282 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341
+ T + + +PEV Y + D WS G +M+E+
Sbjct: 159 -------------------STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 199
Query: 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLL 383
+ + ++ L P S ++ H
Sbjct: 200 KIPYENRSNSEVVEDISTGFRLYKPRL--ASTHVYQIMNHCW 239
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 1e-48
Identities = 62/310 (20%), Positives = 116/310 (37%), Gaps = 51/310 (16%)
Query: 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE 162
I + +G+G FGEV + T + A+K LK M E E ++ +
Sbjct: 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKK 68
Query: 163 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIH 220
+ +VQL Y+ + +Y++ EY+ G ++ L E L A+ +
Sbjct: 69 LRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 127
Query: 221 SIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAE 280
+ + NYVHRD++ N+++ +N K++DFGL + +ED +
Sbjct: 128 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR---------------- 171
Query: 281 GQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI- 339
+ + APE L + ++ D WS G ++ E+
Sbjct: 172 ---------------------QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 210
Query: 340 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEEL 398
G P+ R ++ + P P+ + DL+C + E R ++
Sbjct: 211 GRVPYPGMVNREVLDQVER---GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAF 267
Query: 399 KEHPWFRGIQ 408
+F +
Sbjct: 268 L-EDYFTSTE 276
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 5e-48
Identities = 63/350 (18%), Positives = 127/350 (36%), Gaps = 79/350 (22%)
Query: 79 EEQEEMLRNLERRETEYMRLQRRK--------IGIDDFEQLTLIGKGAFGEVRLCRAKTT 130
E Q +M++ + EY + R+ ++ E ++G GAFG+V A
Sbjct: 2 ESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGI 61
Query: 131 GEI-----FAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS-RCIVQLFYSFQDSDFLYLI 184
+ A+K LK+ + E + SE ++ ++ S IV L + S +YLI
Sbjct: 62 SKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI 119
Query: 185 MEYLPGGDIMTLLMRE-----------------------DILSEDVARFYIAESVLAIHS 221
EY GD++ L + ++L+ + + + +
Sbjct: 120 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF 179
Query: 222 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 281
+ + VHRD+ N+++ +K+ DFGL + + + +
Sbjct: 180 LEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV------------------ 221
Query: 282 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML-IG 340
+ + + +MAPE L + Y ++ D WS G +++E+ +G
Sbjct: 222 ------------------VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 263
Query: 341 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETR 389
P+ K++ K + ++E ++ D R
Sbjct: 264 VNPYPGIPVDANFYKLIQNG--FKMDQPFYATEEIYIIMQSCWAFDSRKR 311
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 8e-48
Identities = 78/343 (22%), Positives = 123/343 (35%), Gaps = 86/343 (25%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
+ L +G GA+G V TG A+KKL + + E LL +
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMRH 76
Query: 166 RCIVQLFYSFQDSDFL------YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAI 219
++ L F + L YL+M ++ G + LM+ + L ED +F + + + +
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGL 134
Query: 220 HSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEA 279
IH +HRD+KP NL ++++ LK+ DFGL + + + +
Sbjct: 135 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY---------------- 178
Query: 280 EGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEML 338
V T Y APEV+L Y D WS+G IM EM+
Sbjct: 179 -------------------------VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI 213
Query: 339 IGYPPFCSDDPRITCRKIVNWKTCLKFPEE-----------------------------P 369
G F D ++I+ K P E
Sbjct: 214 TGKTLFKGSDHLDQLKEIM--KVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILT 271
Query: 370 KISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDK 411
S A +L+ +L D E R+ E HP+F + +
Sbjct: 272 NASPLAVNLLEKMLVLDAEQRV---TAGEALAHPYFESLHDTE 311
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 9e-47
Identities = 75/328 (22%), Positives = 124/328 (37%), Gaps = 70/328 (21%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
+E+L IG+G +G V + + T EI A+K+++ + G E LL E+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKH 60
Query: 166 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 225
+ IV+L L L+ E+ L ++ + ++ + + + H
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 226 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 285
N +HRD+KP NL++++NG LKL++FGL +
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC----------------------- 157
Query: 286 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG-YGMECDWWSLGAIMYEMLIG-YPP 343
+ V TL Y P+VL Y D WS G I E+ P
Sbjct: 158 ---------------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
Query: 344 FCSDDPRITCRKIVN---------WKTCLKFPEE----------------PKISDEARDL 378
F +D ++I W + K P+ PK++ RDL
Sbjct: 203 FPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDL 262
Query: 379 ICHLLC-DVETRLGTRGVEELKEHPWFR 405
+ +LL + R+ EE +HP+F
Sbjct: 263 LQNLLKCNPVQRI---SAEEALQHPYFS 287
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 2e-46
Identities = 55/304 (18%), Positives = 113/304 (37%), Gaps = 50/304 (16%)
Query: 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE 162
+ + + + +G G FGEV + ++ A+K LK+ M + +E NL+ +
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQ 64
Query: 163 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIH 220
+ + +V+L Y+ + +Y+I EY+ G ++ L L+ + A+ +
Sbjct: 65 LQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 221 SIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAE 280
I + NY+HRD++ N+++ K++DFGL + +ED
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED---------------------- 161
Query: 281 GQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML-I 339
N + + APE + + ++ D WS G ++ E++
Sbjct: 162 ---------------NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTH 206
Query: 340 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEEL 398
G P+ + + + +E L+ E R + +
Sbjct: 207 GRIPYPGMTNPEVIQNLERG---YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSV 263
Query: 399 KEHP 402
E
Sbjct: 264 LEDF 267
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 4e-46
Identities = 56/300 (18%), Positives = 104/300 (34%), Gaps = 60/300 (20%)
Query: 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA 161
+ +D + +IG+G FG+V R K G + E + E +L
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 65
Query: 162 EV-DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI----------------LS 204
++ I+ L + + +LYL +EY P G+++ L + + LS
Sbjct: 66 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125
Query: 205 EDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264
+ A+ + + Q ++HRD+ N+++ +N K++DFGL + E
Sbjct: 126 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK-- 183
Query: 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGME 324
+ +MA E L Y
Sbjct: 184 -------------------------------------TMGRLPVRWMAIESLNYSVYTTN 206
Query: 325 CDWWSLGAIMYEML-IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLL 383
D WS G +++E++ +G P+C K+ + + DE DL+
Sbjct: 207 SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY---RLEKPLNCDDEVYDLMRQCW 263
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 2e-45
Identities = 63/302 (20%), Positives = 102/302 (33%), Gaps = 52/302 (17%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTT---GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE 162
+ E IG+G FG+V + A+K K E E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQ 64
Query: 163 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI-LSEDVARFYIAESVLAIHS 221
D IV+L + + +++IME G++ + L L Y + A+
Sbjct: 65 FDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 222 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 281
+ +VHRDI N+++ N +KL DFGL + +ED
Sbjct: 124 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED----------------------- 160
Query: 282 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-G 340
+ A + +MAPE + + + D W G M+E+L+ G
Sbjct: 161 --------------STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 206
Query: 341 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 399
PF +I N + + P P L+ D R ELK
Sbjct: 207 VKPFQGVKNNDVIGRIENGE---RLPMPPNCPPTLYSLMTKCWAYDPSRRP---RFTELK 260
Query: 400 EH 401
Sbjct: 261 AQ 262
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 5e-45
Identities = 53/351 (15%), Positives = 117/351 (33%), Gaps = 46/351 (13%)
Query: 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKK--SEMLKRGQVEHVRSERN 158
R + +F+++ ++G GAFG V GE + K E + + E
Sbjct: 4 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 159 LLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLA 218
++A VD+ + +L S + G + + +D + + +
Sbjct: 64 VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123
Query: 219 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 278
++ + VHRD+ N+++ H+K++DFGL K L
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA-------------------- 163
Query: 279 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338
+ A + +MA E +L + Y + D WS G ++E++
Sbjct: 164 ----------------EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 207
Query: 339 -IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVE 396
G P+ + + + P+ P + + ++ D ++R
Sbjct: 208 TFGSKPYDGIPASEISSILEKGE---RLPQPPICTIDVYMIMVKCWMIDADSRP---KFR 261
Query: 397 ELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPS 447
EL + ++ + + D+ + + + + +
Sbjct: 262 ELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDA 312
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 9e-45
Identities = 76/375 (20%), Positives = 128/375 (34%), Gaps = 93/375 (24%)
Query: 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 164
+ ++ L IG GA G V A+KKL + + + E L+ V+
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 74
Query: 165 SRCIVQLFYSF------QDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLA 218
+ I+ L F ++ +YL+ME + + M D + + + + +
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD---HERMSYLLYQMLCG 131
Query: 219 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 278
I +H +HRD+KP N+++ + LK+ DFGL + +
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF------------------ 173
Query: 279 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338
+ V T Y APEV+L GY D WS+G IM EM+
Sbjct: 174 ---------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
Query: 339 IGYPPFCSDDPRITCRKIVN-------------WKTCLKFPEE----------------- 368
F D K++ T + E
Sbjct: 213 RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL 272
Query: 369 --------PKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAY 419
+ +ARDL+ +L D R+ V++ +HP+ W E+EA
Sbjct: 273 FPADSEHNKLKASQARDLLSKMLVIDPAKRI---SVDDALQHPYIN--VWYDPAEVEAPP 327
Query: 420 KPTVNGELDTQNFEK 434
+ +LD +
Sbjct: 328 PQIYDKQLDEREHTI 342
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (397), Expect = 1e-44
Identities = 58/317 (18%), Positives = 104/317 (32%), Gaps = 71/317 (22%)
Query: 97 RLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAK-----TTGEIFAMKKLKKSEMLKRGQVE 151
+L + ++ E + IG+GAFG V RA + A+K LK+
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQA 61
Query: 152 HVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED---------- 201
+ E L+AE D+ IV+L + L+ EY+ GD+ L
Sbjct: 62 DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 121
Query: 202 --------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKL 247
LS + + + + +VHRD+ N ++ +N +K+
Sbjct: 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKI 181
Query: 248 SDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGT 307
+DFGL + + + +
Sbjct: 182 ADFGLSRNIYSA------------------------------------DYYKADGNDAIP 205
Query: 308 LDYMAPEVLLKKGYGMECDWWSLGAIMYEML-IGYPPFCSDDPRITCRKIVNWKTCLKFP 366
+ +M PE + Y E D W+ G +++E+ G P+ + + L P
Sbjct: 206 IRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI-LACP 264
Query: 367 EEPKISDEARDLICHLL 383
E E +L+
Sbjct: 265 EN--CPLELYNLMRLCW 279
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 2e-44
Identities = 58/311 (18%), Positives = 101/311 (32%), Gaps = 49/311 (15%)
Query: 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGE----IFAMKKLKKSEMLKRGQVEHVRSER 157
+I + +IG G FGEV KT+ A+K LK Q E
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEA 60
Query: 158 NLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESV 216
++ + I++L + +I EY+ G + L +D S +
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120
Query: 217 LAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETV 276
+ + NYVHRD+ N++++ N K+SDFGL + LED +
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS--------- 171
Query: 277 SEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 336
+ + APE + + + D WS G +M+E
Sbjct: 172 --------------------------GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWE 205
Query: 337 MLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGV 395
++ + K +N + P L+ + R +
Sbjct: 206 VMTYGERPYWELSNHEVMKAINDG--FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADI 263
Query: 396 ----EELKEHP 402
++L P
Sbjct: 264 VSILDKLIRAP 274
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 154 bits (391), Expect = 6e-44
Identities = 50/319 (15%), Positives = 101/319 (31%), Gaps = 48/319 (15%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR- 166
++ IG+G+FG + + A+K + R +R E +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGCT 61
Query: 167 CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHN 226
I ++Y Q+ L+++ L L + S + + + SIH+ +
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 227 YVHRDIKPDNLILDK-----NGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 281
V+RDIKPDN ++ + + + DFG+ K D +
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT-------------------- 161
Query: 282 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341
K+ + ++ + GT YM+ L + D +LG + L G
Sbjct: 162 -----KQHIPYREKK------NLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 210
Query: 342 PPFCSDDPRITCRKIVNWKTCLKFPE----EPKISDEARDLICHLLC-DVETRLGTRGVE 396
P+ +K + +E + + + ++
Sbjct: 211 LPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270
Query: 397 ELKEHPWFR-GIQWDKLYE 414
L R D+ ++
Sbjct: 271 GLFSKVLERLNTTEDENFD 289
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 2e-43
Identities = 70/334 (20%), Positives = 124/334 (37%), Gaps = 80/334 (23%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 165
+ ++ L+ +G GA+G V TG A+KKL + + E LL +
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 76
Query: 166 RCIVQLFYSFQDSDFL-----YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIH 220
++ L F + L ++ +L G D+ + ++ L++D +F I + + +
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 135
Query: 221 SIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAE 280
IH + +HRD+KP NL ++++ LK+ DFGL + +D+
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------------------- 175
Query: 281 GQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG-YGMECDWWSLGAIMYEMLI 339
V T Y APE++L Y D WS+G IM E+L
Sbjct: 176 ---------------------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214
Query: 340 GYPPFCSDDPRITCRKIVN---------------------WKTCLKFPEE------PKIS 372
G F D + I+ ++ + P+ +
Sbjct: 215 GRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGAN 274
Query: 373 DEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 405
A DL+ +L D + R+ + H +F
Sbjct: 275 PLAVDLLEKMLVLDSDKRI---TAAQALAHAYFA 305
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 2e-42
Identities = 49/325 (15%), Positives = 109/325 (33%), Gaps = 61/325 (18%)
Query: 103 IGIDDFEQLTLIGKGAFGEVRLCRAKT-----TGEIFAMKKLKKSEMLKRGQVEHVRSER 157
+ + +G+G+FG V AK A+K + ++ ++ + +E
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEA 74
Query: 158 NLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED----------ILSEDV 207
+++ E + +V+L +IME + GD+ + L S
Sbjct: 75 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 208 ARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLED 267
E + ++ + +VHRD+ N ++ ++ +K+ DFG+ + + +
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET-------- 186
Query: 268 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDW 327
+ + + +M+PE L + D
Sbjct: 187 ----------------------------DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDV 218
Query: 328 WSLGAIMYEMLIG-YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-D 385
WS G +++E+ P+ R ++ + D +L+ +
Sbjct: 219 WSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL---LDKPDNCPDMLFELMRMCWQYN 275
Query: 386 VETRLGTRGV-EELKE--HPWFRGI 407
+ R + +KE P FR +
Sbjct: 276 PKMRPSFLEIISSIKEEMEPGFREV 300
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 3e-42
Identities = 47/284 (16%), Positives = 99/284 (34%), Gaps = 46/284 (16%)
Query: 113 LIGKGAFGEV---RLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIV 169
+IG+G FG V L A+K L + G+V +E ++ + ++
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 170 QLF-YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIA-ESVLAIHSIHQHNY 227
L + +++ Y+ GD+ + E + + + +
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF 151
Query: 228 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 287
VHRD+ N +LD+ +K++DFGL + + DK
Sbjct: 152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDK---------------------------- 183
Query: 288 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPFCS 346
+ + + +MA E L + + + D WS G +++E++ G PP+
Sbjct: 184 ------EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 237
Query: 347 DDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETR 389
+ ++ + + + D +++ E R
Sbjct: 238 VNTFDITVYLLQGR---RLLQPEYCPDPLYEVMLKCWHPKAEMR 278
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 5e-42
Identities = 60/313 (19%), Positives = 104/313 (33%), Gaps = 66/313 (21%)
Query: 103 IGIDDFEQLTLIGKGAFGEVRLCRA-----KTTGEIFAMKKLKKSEMLKRGQVEHVRSER 157
+ +G GAFG+V A A+K LK S L + E + SE
Sbjct: 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSEL 77
Query: 158 NLLAEV-DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR----------------- 199
+L+ + + IV L + +I EY GD++ L R
Sbjct: 78 KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 200 -EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258
E L + + + + + N +HRD+ N++L K+ DFGL + +++
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK 318
+ + + + +MAPE +
Sbjct: 198 D------------------------------------SNYVVKGNARLPVKWMAPESIFN 221
Query: 319 KGYGMECDWWSLGAIMYEML-IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARD 377
Y E D WS G ++E+ +G P+ K++ + PE E D
Sbjct: 222 CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEH--APAEMYD 279
Query: 378 LICHLLC-DVETR 389
++ D R
Sbjct: 280 IMKTCWDADPLKR 292
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 2e-39
Identities = 49/305 (16%), Positives = 104/305 (34%), Gaps = 64/305 (20%)
Query: 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGE-------IFAMKKLKKSEMLKRGQVEHVRS 155
+ D +G+GAFG+V L A + A+K LK + ++ + +
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS-DATEKDLSDLISE 68
Query: 156 ERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR---------------- 199
+ + I+ L + LY+I+EY G++ L
Sbjct: 69 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 200 EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259
E+ LS + + + +HRD+ N+++ ++ +K++DFGL + +
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK 319
+ + + +MAPE L +
Sbjct: 189 ------------------------------------DYYKKTTNGRLPVKWMAPEALFDR 212
Query: 320 GYGMECDWWSLGAIMYEML-IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDL 378
Y + D WS G +++E+ +G P+ + + K + + ++E +
Sbjct: 213 IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL---KEGHRMDKPSNCTNELYMM 269
Query: 379 ICHLL 383
+
Sbjct: 270 MRDCW 274
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-38
Identities = 57/320 (17%), Positives = 110/320 (34%), Gaps = 66/320 (20%)
Query: 106 DDFEQLTLIGKGAFGEVRLCRA-----KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLL 160
D + +G+GAFG+V A T A+K LK+ + + L+
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-HRALMSELKILI 71
Query: 161 AEVDSRCIVQLF-YSFQDSDFLYLIMEYLPGGDIMTLL----------------MREDIL 203
+V L + L +I+E+ G++ T L + +D L
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 204 SEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 263
+ + Y + + + +HRD+ N++L + +K+ DFGL +
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR--------D 183
Query: 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGM 323
+ +D D + + L +MAPE + + Y +
Sbjct: 184 IYKDPDYVRKGDA----------------------------RLPLKWMAPETIFDRVYTI 215
Query: 324 ECDWWSLGAIMYEMLIGY-PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHL 382
+ D WS G +++E+ P+ + + T ++ P+ + E +
Sbjct: 216 QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD--YTTPEMYQTMLDC 273
Query: 383 LC-DVETRLGTRGVEELKEH 401
+ R EL EH
Sbjct: 274 WHGEPSQRP---TFSELVEH 290
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 5e-36
Identities = 51/263 (19%), Positives = 84/263 (31%), Gaps = 57/263 (21%)
Query: 114 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 173
IGKG FGEV R K GE A+K E + +E + I+
Sbjct: 11 IGKGRFGEV--WRGKWRGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIA 64
Query: 174 SFQDSDF----LYLIMEYLPGGDIMTLLMREDILSEDVARFY--IAESVLAIHS-----I 222
+ + L+L+ +Y G + L R + E + + A + +H
Sbjct: 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 223 HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 282
+ HRD+K N+++ KNG ++D GL + +I
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI------------------- 165
Query: 283 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL------KKGYGMECDWWSLGAIMYE 336
VGT YMAPEVL D +++G + +E
Sbjct: 166 ---------------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE 210
Query: 337 MLIGYPPFCSDDPRITCRKIVNW 359
+ + +
Sbjct: 211 IARRCSIGGIHEDYQLPYYDLVP 233
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 120 bits (300), Expect = 1e-30
Identities = 54/362 (14%), Positives = 119/362 (32%), Gaps = 108/362 (29%)
Query: 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNL-------L 160
+ + +G G F V L + AMK ++ ++ + ++ + +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 161 AEVDSRCIVQLFYSFQD--SDFLYLIMEYLPGGDIMTLLMRED---ILSEDVARFYIAES 215
+ + I++L F + ++++M + G+ + L+++ + + +
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 216 VLAIHSIH-QHNYVHRDIKPDNLILDKNG------HLKLSDFGLCKPLEDKYSSILLEDE 268
+L + +H + +H DIKP+N++++ +K++D G ++ Y
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-------- 186
Query: 269 DIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWW 328
+++ T +Y +PEVLL +G D W
Sbjct: 187 ---------------------------------TNSIQTREYRSPEVLLGAPWGCGADIW 213
Query: 329 SLGAIMYEMLIGYPPFCSDD---------------------------------------- 348
S +++E++ G F D+
Sbjct: 214 STACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRG 273
Query: 349 --PRITCRKIVNWKTCL--KFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPW 403
I+ K + L K+ + E D + +L D R L HPW
Sbjct: 274 LLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD---AGGLVNHPW 330
Query: 404 FR 405
+
Sbjct: 331 LK 332
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 67.5 bits (164), Expect = 1e-13
Identities = 21/169 (12%), Positives = 57/169 (33%), Gaps = 28/169 (16%)
Query: 113 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKS---------------EMLKRGQVEHVRSER 157
L+G+G V C ++ +K K + R+E
Sbjct: 7 LMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 158 NLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVL 217
L ++ + +++ + ++ME + ++ + + + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGN----AVLMELIDAKELY-------RVRVENPDEVLDMILE 114
Query: 218 AIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 266
+ + VH D+ N+++ + G + + DF + ++ +LE
Sbjct: 115 EVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILE 162
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 510 | |||
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.58 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.18 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.97 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.21 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.15 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.49 |
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-72 Score=571.64 Aligned_cols=291 Identities=41% Similarity=0.723 Sum_probs=269.0
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceE
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 181 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~ 181 (510)
+++++||++++.||+|+||+||+|+++.+|+.||||++++..+......+++.+|+.+|+.++|||||+++++|++++.+
T Consensus 1 ~i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 80 (337)
T d1o6la_ 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL 80 (337)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred CCchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccc
Confidence 46789999999999999999999999999999999999988777777889999999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 182 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
|+|||||+||+|..++.+.+.++|..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+......
T Consensus 81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~- 159 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG- 159 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999998654321
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~ 341 (510)
....+.||||.|||||++.+.+|+.++|||||||++|||++|+
T Consensus 160 -------------------------------------~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~ 202 (337)
T d1o6la_ 160 -------------------------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202 (337)
T ss_dssp -------------------------------------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSS
T ss_pred -------------------------------------cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCC
Confidence 1123579999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CChHHhhcCCCcCCCCchhhhc--cc
Q 010463 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLYE--ME 416 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~--~~~~eil~HpfF~~i~~~~l~~--~~ 416 (510)
+||.+.+..+++.+|... .+.+|. .+|++++|||++||+ ||.+|++. .+++||++||||++++|+.+.. +.
T Consensus 203 ~pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~ 278 (337)
T d1o6la_ 203 LPFYNQDHERLFELILME--EIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLL 278 (337)
T ss_dssp CSSCCSSHHHHHHHHHHC--CCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred CCCCCcCHHHHHHHHhcC--CCCCCc--cCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHHHHHhCCCC
Confidence 999999999999998874 456664 799999999999999 99999974 3589999999999999999974 78
Q ss_pred CCCccccCCCccCCCCCC
Q 010463 417 AAYKPTVNGELDTQNFEK 434 (510)
Q Consensus 417 ~p~~p~~~~~~d~~~f~~ 434 (510)
|||+|.+.++.|+++|+.
T Consensus 279 ~p~~P~~~~~~~~~~f~~ 296 (337)
T d1o6la_ 279 PPFKPQVTSEVDTRYFDD 296 (337)
T ss_dssp CSCCCCCSSTTCCTTSCH
T ss_pred CCCCCCCCChhhhhhcCc
Confidence 999999999999999985
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-68 Score=545.76 Aligned_cols=293 Identities=38% Similarity=0.787 Sum_probs=269.0
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceE
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 181 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~ 181 (510)
...+++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++|||||+++++|.+...+
T Consensus 37 ~~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 116 (350)
T d1rdqe_ 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccc
Confidence 45568999999999999999999999999999999999987766677788899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 182 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
|+||||+.||+|..++.+.+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999876432
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~ 341 (510)
..+.+||+.|||||++.+.+|+.++|||||||+||||++|.
T Consensus 195 ---------------------------------------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~ 235 (350)
T d1rdqe_ 195 ---------------------------------------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235 (350)
T ss_dssp ---------------------------------------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred ---------------------------------------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCC
Confidence 12468999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CChHHhhcCCCcCCCCchhhhc--cc
Q 010463 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLYE--ME 416 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~--~~~~eil~HpfF~~i~~~~l~~--~~ 416 (510)
+||.+.+....+.+|... .+.+| ..+|+++.+||++||. ||.+|++. .++++|++||||++++|+.+.+ +.
T Consensus 236 ~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~ 311 (350)
T d1rdqe_ 236 PPFFADQPIQIYEKIVSG--KVRFP--SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVE 311 (350)
T ss_dssp CSSCCSSHHHHHHHHHHC--CCCCC--TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred CCCCCcCHHHHHHHHhcC--CCCCC--ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHHHhcCCC
Confidence 999999999999999874 34455 4899999999999998 99999753 4799999999999999999874 68
Q ss_pred CCCccccCCCccCCCCCCCCCCC
Q 010463 417 AAYKPTVNGELDTQNFEKFPEVD 439 (510)
Q Consensus 417 ~p~~p~~~~~~d~~~f~~~~~~~ 439 (510)
|||+|.+.++.|++||+.+++..
T Consensus 312 ~p~~p~~~~~~d~s~~~~~~~~~ 334 (350)
T d1rdqe_ 312 APFIPKFKGPGDTSNFDDYEEEE 334 (350)
T ss_dssp CSCCCCCCSTTCCTTSCCCCCCC
T ss_pred cCccCCCCCcchhhhcCCCCccc
Confidence 99999999999999999876543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-68 Score=539.88 Aligned_cols=290 Identities=42% Similarity=0.855 Sum_probs=254.4
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEE
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l 183 (510)
+++||++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|+.++|||||+++++|++++.+|+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 46799999999999999999999999999999999998776667778899999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccc
Q 010463 184 IMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 263 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 263 (510)
|||||+||+|..++.....+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---- 157 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---- 157 (316)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999876432
Q ss_pred cchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCC
Q 010463 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 343 (510)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~P 343 (510)
..+.+||+.|||||++.+.+|+.++|||||||+||||++|.+|
T Consensus 158 -------------------------------------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~P 200 (316)
T d1fota_ 158 -------------------------------------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 200 (316)
T ss_dssp -------------------------------------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCT
T ss_pred -------------------------------------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCC
Confidence 2257899999999999999999999999999999999999999
Q ss_pred CCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CChHHhhcCCCcCCCCchhhh--cccCC
Q 010463 344 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLY--EMEAA 418 (510)
Q Consensus 344 F~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~--~~~~eil~HpfF~~i~~~~l~--~~~~p 418 (510)
|.+.+..+.+.+|.+. ...+| +.+|+++++||.+||. ||.+|++. .++++|++||||++++|+.+. ..++|
T Consensus 201 f~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~~p 276 (316)
T d1fota_ 201 FYDSNTMKTYEKILNA--ELRFP--PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETP 276 (316)
T ss_dssp TCCSSHHHHHHHHHHC--CCCCC--TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCS
T ss_pred CCCcCHHHHHHHHHcC--CCCCC--CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHHHHHhCCCCcC
Confidence 9999999999999874 34555 4799999999999998 99999864 379999999999999999986 47899
Q ss_pred CccccC-CCccCCCCCCCCCC
Q 010463 419 YKPTVN-GELDTQNFEKFPEV 438 (510)
Q Consensus 419 ~~p~~~-~~~d~~~f~~~~~~ 438 (510)
|+|.+. ...|+++|+.+++.
T Consensus 277 ~~p~~~~~~~d~~~f~~~~~~ 297 (316)
T d1fota_ 277 YEPPIQQGQGDTSQFDKYPEE 297 (316)
T ss_dssp CCCCC----------------
T ss_pred CCCCcCCCcchhhhcCCCccc
Confidence 998864 45789999987654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-68 Score=533.25 Aligned_cols=280 Identities=34% Similarity=0.656 Sum_probs=250.3
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceE
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 181 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~ 181 (510)
+...++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++|||||+++++|++++.+
T Consensus 4 ~~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 83 (288)
T d1uu3a_ 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 83 (288)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEE
T ss_pred CCCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEE
Confidence 44568999999999999999999999999999999999987776677788899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 182 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
|+|||||+||+|.+++...+.+++..++.++.|++.||+|||++|||||||||+||||+.+|++||+|||+|+.+.....
T Consensus 84 ~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999987643211
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~ 341 (510)
. ....+.+||+.|||||++.+..|+.++|||||||+||||++|.
T Consensus 164 ~------------------------------------~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~ 207 (288)
T d1uu3a_ 164 Q------------------------------------ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 207 (288)
T ss_dssp ------------------------------------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred c------------------------------------cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCC
Confidence 0 1123568999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC---ChHHhhcCCCcCCCCchhhhcccC
Q 010463 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR---GVEELKEHPWFRGIQWDKLYEMEA 417 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~---~~~eil~HpfF~~i~~~~l~~~~~ 417 (510)
+||.+.+..+++.+|.+.. +.+|. .+|+++++||++||+ ||.+||++. +...|++||||++++|+.|.+..|
T Consensus 208 ~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~~p 283 (288)
T d1uu3a_ 208 PPFRAGNEYLIFQKIIKLE--YDFPE--KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 283 (288)
T ss_dssp CSSCCSSHHHHHHHHHTTC--CCCCT--TCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCC
T ss_pred CCCCCcCHHHHHHHHHcCC--CCCCc--cCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhcCCC
Confidence 9999999999999998743 55664 799999999999999 999999642 223479999999999999999888
Q ss_pred CCcc
Q 010463 418 AYKP 421 (510)
Q Consensus 418 p~~p 421 (510)
|-.|
T Consensus 284 P~l~ 287 (288)
T d1uu3a_ 284 PKLT 287 (288)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 8655
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-68 Score=538.82 Aligned_cols=315 Identities=36% Similarity=0.650 Sum_probs=250.0
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHH-hcCCCCeeeEeEEeecCceEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA-EVDSRCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~-~l~hp~Iv~l~~~~~~~~~~~l 183 (510)
+++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+..|..++. .++|||||+++++|++++.+||
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 479999999999999999999999999999999999877666677788888888875 6899999999999999999999
Q ss_pred EEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccc
Q 010463 184 IMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 263 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 263 (510)
|||||+||+|.+++.....+++.+++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.......
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~-- 158 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-- 158 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccc--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999986543211
Q ss_pred cchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCC
Q 010463 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 343 (510)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~P 343 (510)
.....+||+.|+|||++.+.+|+.++|||||||++|||++|++|
T Consensus 159 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~P 202 (320)
T d1xjda_ 159 ------------------------------------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 202 (320)
T ss_dssp ------------------------------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ------------------------------------cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCC
Confidence 11246899999999999999999999999999999999999999
Q ss_pred CCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchhhh--cccCCCc
Q 010463 344 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLY--EMEAAYK 420 (510)
Q Consensus 344 F~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l~--~~~~p~~ 420 (510)
|.+.+..+++.+|... .+.+| ..+|+++++||++||+ ||.+||+. ..++++||||++++|+.+. ++.||++
T Consensus 203 F~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~dli~~~L~~dP~~R~s~--~~~l~~hpff~~~~~~~l~~~~~~pp~~ 276 (320)
T d1xjda_ 203 FHGQDEEELFHSIRMD--NPFYP--RWLEKEAKDLLVKLFVREPEKRLGV--RGDIRQHPLFREINWEELERKEIDPPFR 276 (320)
T ss_dssp SCCSSHHHHHHHHHHC--CCCCC--TTSCHHHHHHHHHHSCSSGGGSBTT--BSCGGGSGGGTTCCHHHHHTTCSCC---
T ss_pred CCCCCHHHHHHHHHcC--CCCCC--ccCCHHHHHHHHHhcccCCCCCcCH--HHHHHhCchhccCCHHHHHhcCCCCCCC
Confidence 9999999999999874 34555 3799999999999999 99999953 1489999999999999886 4689999
Q ss_pred cccCCCccCCCCCCCCCCCCCCCCCCCCCcccccCCCc-CCcccCcee
Q 010463 421 PTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSK-DTNFIGYTF 467 (510)
Q Consensus 421 p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~f~~~~~ 467 (510)
|.++++.|++||+.......+.. .. ..+.+..+. +..|.||+|
T Consensus 277 p~~~~~~d~~~f~~~~~~~~~~~-~~---~~~~~~~~~~~~~f~~f~~ 320 (320)
T d1xjda_ 277 PKVKSPFDCSNFDKEFLNEKPRL-SF---ADRALINSMDQNMFRNFSF 320 (320)
T ss_dssp ---------------------------------------CCTTTTCCC
T ss_pred CCCCCccchhhcChHhhhCCccC-CC---CcccccCchhhcccCcCcC
Confidence 99999999999986332211111 00 011223333 456999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.2e-65 Score=524.32 Aligned_cols=289 Identities=35% Similarity=0.619 Sum_probs=239.8
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHH---HHHHHhcCCCCeeeEeEEeecCc
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSE---RNLLAEVDSRCIVQLFYSFQDSD 179 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E---~~iL~~l~hp~Iv~l~~~~~~~~ 179 (510)
+++++|+++++||+|+||+||+|+++.+|+.||||++.+..+........+.+| +.+++.++|||||+++++|.+++
T Consensus 1 lslddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~ 80 (364)
T d1omwa3 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 80 (364)
T ss_dssp CCSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CCHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC
Confidence 467899999999999999999999999999999999987765444444445555 55566678999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 180 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
.+|+|||||+||+|.++|.+...+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999866432
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml 338 (510)
. ....+||+.|||||++.+ ..|+.++|||||||+||||+
T Consensus 161 ~----------------------------------------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyeml 200 (364)
T d1omwa3 161 K----------------------------------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 200 (364)
T ss_dssp C----------------------------------------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHH
T ss_pred c----------------------------------------ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHH
Confidence 1 224689999999999974 67999999999999999999
Q ss_pred hCCCCCCCCChhhhHHHHhh-ccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CChHHhhcCCCcCCCCchhhhc
Q 010463 339 IGYPPFCSDDPRITCRKIVN-WKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLYE 414 (510)
Q Consensus 339 ~G~~PF~~~~~~~~~~~I~~-~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~--~~~~eil~HpfF~~i~~~~l~~ 414 (510)
+|.+||.+.+.......+.. ......+| ..+|+++++||.+||. ||.+||+. .+++||++||||++++|+.+..
T Consensus 201 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~ 278 (364)
T d1omwa3 201 RGHSPFRQHKTKDKHEIDRMTLTMAVELP--DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFL 278 (364)
T ss_dssp HSSCSSCSSCSSCHHHHHHHSSSCCCCCC--SSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHT
T ss_pred hCCCCCCCCCHHHHHHHHHhcccCCCCCC--CCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHHhc
Confidence 99999987665443322111 11223333 4799999999999999 99999974 3489999999999999999874
Q ss_pred --ccCCCccccCCCccCCCCC
Q 010463 415 --MEAAYKPTVNGELDTQNFE 433 (510)
Q Consensus 415 --~~~p~~p~~~~~~d~~~f~ 433 (510)
.+||++|........+.|+
T Consensus 279 ~~~~~p~~p~~~~~~~~~~~d 299 (364)
T d1omwa3 279 QKYPPPLIPPRGEVNAADAFD 299 (364)
T ss_dssp TCSCCSCCCCCC---------
T ss_pred CCCCcCcCCCCCCCCcCCccc
Confidence 6799999776655554444
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-65 Score=502.55 Aligned_cols=257 Identities=35% Similarity=0.595 Sum_probs=237.1
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEE
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~ 182 (510)
..+++|++++.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+.+|+.++|||||+++++|.+++.+|
T Consensus 3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 82 (263)
T d2j4za1 3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 82 (263)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred cchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence 45789999999999999999999999999999999999877666666788999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccc
Q 010463 183 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 262 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 262 (510)
+|||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+......
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-- 160 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-- 160 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC--
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999998664321
Q ss_pred ccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCC
Q 010463 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 342 (510)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~ 342 (510)
....+||+.|||||++.+..|+.++|||||||+||||++|++
T Consensus 161 --------------------------------------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~ 202 (263)
T d2j4za1 161 --------------------------------------RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 202 (263)
T ss_dssp --------------------------------------CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred --------------------------------------ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCC
Confidence 124689999999999999999999999999999999999999
Q ss_pred CCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 343 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 343 PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
||.+.+..+++.+|.+. .+.+|. .+|+++++||.+||. ||++|| +++|+++||||.+
T Consensus 203 Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~~L~~dp~~R~---t~~eil~hp~~~~ 260 (263)
T d2j4za1 203 PFEANTYQETYKRISRV--EFTFPD--FVTEGARDLISRLLKHNPSQRP---MLREVLEHPWITA 260 (263)
T ss_dssp TTCCSSHHHHHHHHHTT--CCCCCT--TSCHHHHHHHHHHTCSSGGGSC---CHHHHHTCHHHHH
T ss_pred CCCCCCHHHHHHHHHcC--CCCCCc--cCCHHHHHHHHHHccCCHhHCc---CHHHHHcCcCcCC
Confidence 99999999999988873 345553 799999999999999 999999 7999999999964
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-64 Score=496.67 Aligned_cols=260 Identities=25% Similarity=0.457 Sum_probs=221.9
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... ....+.+.+|+.+|+.++|||||++++++.+++.+|+|
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence 5789999999999999999999999999999999986542 22345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 185 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
||||+||+|.++|.+.+.+++..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+.....
T Consensus 82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~--- 158 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR--- 158 (271)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE---
T ss_pred EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc---
Confidence 99999999999998888999999999999999999999999999999999999999999999999999987643211
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCC-CccccccchhhHHHHHhhCCCC
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEMLIGYPP 343 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiwSlGvilyEml~G~~P 343 (510)
.....+.+|||.|||||++.+..| +.++|||||||+||||++|++|
T Consensus 159 ---------------------------------~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~p 205 (271)
T d1nvra_ 159 ---------------------------------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 205 (271)
T ss_dssp ---------------------------------ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred ---------------------------------cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCC
Confidence 011235789999999999998886 6789999999999999999999
Q ss_pred CCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 344 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 344 F~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
|.+.+.......+..... ...+....+|+++++||.+||+ ||++|| +++|+++||||+.
T Consensus 206 f~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~---t~~eil~hpwf~~ 265 (271)
T d1nvra_ 206 WDQPSDSCQEYSDWKEKK-TYLNPWKKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYNK 265 (271)
T ss_dssp CSSSSTTSHHHHHHHTTC-TTSTTGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHTTCTTTTC
T ss_pred CCCCChHHHHHHHHhcCC-CCCCccccCCHHHHHHHHHHcCCChhHCc---CHHHHhcCHhhCc
Confidence 987655443333332221 2223345799999999999998 999999 7999999999974
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-63 Score=499.08 Aligned_cols=257 Identities=33% Similarity=0.569 Sum_probs=218.3
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
+.|++++.||+|+||+||+|+++.+|+.||||++.+.... .....+.+|+.+|+.++|||||+++++|++++.+|+||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 5699999999999999999999999999999999876542 23456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeec---CCCceeecccCCcccCcccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD---KNGHLKLSDFGLCKPLEDKYSS 262 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld---~~g~vkL~DFGla~~~~~~~~~ 262 (510)
|||+||+|.++|.+.+.+++..++.|+.||+.||+|||++|||||||||+|||+. .+|++||+|||+|+......
T Consensus 87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~-- 164 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-- 164 (307)
T ss_dssp CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred eccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC--
Confidence 9999999999999999999999999999999999999999999999999999995 57999999999998654321
Q ss_pred ccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCC
Q 010463 263 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 342 (510)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~ 342 (510)
...+.+||+.|||||++.+..|+.++|||||||+||||++|.+
T Consensus 165 -------------------------------------~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~ 207 (307)
T d1a06a_ 165 -------------------------------------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP 207 (307)
T ss_dssp ---------------------------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred -------------------------------------eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCC
Confidence 1224689999999999999999999999999999999999999
Q ss_pred CCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 343 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 343 PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
||.+.+...+..+|......+..|..+.+|+++++||.+||. ||++|| +++|+++||||++
T Consensus 208 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~eil~hp~~~~ 269 (307)
T d1a06a_ 208 PFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRF---TCEQALQHPWIAG 269 (307)
T ss_dssp SCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSC---CHHHHHHSTTTTS
T ss_pred CCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCc---CHHHHhcCHhhCC
Confidence 999999999999999876666666667899999999999999 999999 7899999999986
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-63 Score=491.90 Aligned_cols=255 Identities=31% Similarity=0.508 Sum_probs=226.6
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
++|++++.||+|+||+||+|+++.+|+.||||++.+... ...+.+.+|+.+|+.++|||||+++++|.+++.+|+||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC---hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 469999999999999999999999999999999987643 33467899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 186 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 186 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
|||+||+|.+++.+ +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+.....
T Consensus 97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~---- 171 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---- 171 (293)
T ss_dssp ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC----
T ss_pred EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc----
Confidence 99999999998755 5799999999999999999999999999999999999999999999999999987643211
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCC
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~ 345 (510)
.....+||+.|||||++.+..|+.++|||||||++|||++|.+||.
T Consensus 172 ----------------------------------~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~ 217 (293)
T d1yhwa1 172 ----------------------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL 217 (293)
T ss_dssp ----------------------------------CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ----------------------------------cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCC
Confidence 1224689999999999999999999999999999999999999999
Q ss_pred CCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 346 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 346 ~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
+.+......++.... ...++.+..+|+++++||.+||. ||.+|| +++|+++||||+.
T Consensus 218 ~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 218 NENPLRALYLIATNG-TPELQNPEKLSAIFRDFLNRCLDMDVEKRG---SAKELLQHQFLKI 275 (293)
T ss_dssp TSCHHHHHHHHHHHC-SCCCSSGGGSCHHHHHHHHHHTCSSTTTSC---CHHHHTTCGGGGG
T ss_pred CCCHHHHHHHHHhCC-CCCCCCcccCCHHHHHHHHHHccCChhHCc---CHHHHhcCHhhCC
Confidence 988877777766532 22333335799999999999999 999999 7999999999974
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-63 Score=493.78 Aligned_cols=267 Identities=26% Similarity=0.469 Sum_probs=232.2
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcch---hhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR---GQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~---~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~ 182 (510)
+.|++++.||+|+||+||+|+++.+|+.||||++.+...... ...+.+.+|+.+|+.++|||||+++++|.+++.+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 569999999999999999999999999999999987654322 23677999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCC----ceeecccCCcccCcc
Q 010463 183 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG----HLKLSDFGLCKPLED 258 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g----~vkL~DFGla~~~~~ 258 (510)
||||||+||+|.++|.+.+.+++..++.++.||+.||+|||+.|||||||||+|||++.+| ++||+|||+|+....
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~ 169 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence 9999999999999999989999999999999999999999999999999999999999877 599999999987643
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHh
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml 338 (510)
.. ...+.+||+.|||||++.+..|+.++|||||||++|||+
T Consensus 170 ~~---------------------------------------~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell 210 (293)
T d1jksa_ 170 GN---------------------------------------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 210 (293)
T ss_dssp SC---------------------------------------BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred Cc---------------------------------------cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHH
Confidence 21 112468999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchhhhc
Q 010463 339 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYE 414 (510)
Q Consensus 339 ~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l~~ 414 (510)
+|.+||.+.+..+++.+|......+..+..+.+|+++++||++||+ ||++|| +++||++||||++.+|.....
T Consensus 211 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~eil~hp~~~~~~~~~~l~ 284 (293)
T d1jksa_ 211 SGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM---TIQDSLQHPWIKPKDTQQALS 284 (293)
T ss_dssp HSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSTTTCC--------
T ss_pred cCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCc---CHHHHhcCcccCCCChhHhhc
Confidence 9999999999999999988754332222235799999999999999 999999 799999999999999987754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.2e-62 Score=500.44 Aligned_cols=263 Identities=30% Similarity=0.521 Sum_probs=234.6
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
+++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+.+.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 468999999999999999999999999999999997653 33456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeec--CCCceeecccCCcccCccccc
Q 010463 185 MEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD--KNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 185 mEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld--~~g~vkL~DFGla~~~~~~~~ 261 (510)
||||+||+|.+++.+ .+.+++..++.|+.||+.||.|||++|||||||||+||||+ .+|++||+|||+|+.+....
T Consensus 102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~- 180 (350)
T d1koaa2 102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 180 (350)
T ss_dssp ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-
T ss_pred EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc-
Confidence 999999999999854 56799999999999999999999999999999999999996 46899999999998765421
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~ 341 (510)
...+.+||+.|||||++.+..|+.++|||||||++|||++|.
T Consensus 181 --------------------------------------~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~ 222 (350)
T d1koaa2 181 --------------------------------------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL 222 (350)
T ss_dssp --------------------------------------CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSS
T ss_pred --------------------------------------ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCC
Confidence 122468999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchhh
Q 010463 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKL 412 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l 412 (510)
+||.+.+..+++.+|......+..+..+.+|+++++||++||+ ||++|| +++||++||||+..+|...
T Consensus 223 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---t~~eil~hp~~~~~~~~~~ 291 (350)
T d1koaa2 223 SPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM---TIHQALEHPWLTPGNAPGR 291 (350)
T ss_dssp CSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSC---CHHHHHHSTTTSCTTCCSC
T ss_pred CCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCc---CHHHHhcCcccCCCCCCCc
Confidence 9999999999999998755433333335799999999999999 999999 7999999999998877544
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-62 Score=486.90 Aligned_cols=257 Identities=27% Similarity=0.454 Sum_probs=227.2
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 185 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVm 185 (510)
+.|++++.||+|+||+||+|+++.+|+.||||++.+. .....+.+.+|+.+|+.++|||||+++++|.+++.+|+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 4689999999999999999999999999999999765 3345567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 186 EYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 186 Ey~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
|||+||+|.+++.+ .+.+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+......
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~---- 164 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI---- 164 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH----
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc----
Confidence 99999999999765 4579999999999999999999999999999999999999999999999999998653210
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhc-----cCCCCccccccchhhHHHHHhh
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-----~~~y~~~~DiwSlGvilyEml~ 339 (510)
....+.+||+.|||||++. +.+|+.++|||||||++|||++
T Consensus 165 ----------------------------------~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemlt 210 (288)
T d2jfla1 165 ----------------------------------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE 210 (288)
T ss_dssp ----------------------------------HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHH
T ss_pred ----------------------------------ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhh
Confidence 0012468999999999994 4668999999999999999999
Q ss_pred CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 340 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 340 G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
|.+||.+.+..+.+.+|..... ..++....+|+++++||++||+ ||.+|| +++|+++||||+.-
T Consensus 211 g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~~li~~~L~~dp~~R~---t~~ell~hp~~~~~ 275 (288)
T d2jfla1 211 IEPPHHELNPMRVLLKIAKSEP-PTLAQPSRWSSNFKDFLKKCLEKNVDARW---TTSQLLQHPFVTVD 275 (288)
T ss_dssp SSCTTTTSCGGGHHHHHHHSCC-CCCSSGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHTTSGGGCCC
T ss_pred CCCCCCCCCHHHHHHHHHcCCC-CCCCccccCCHHHHHHHHHHccCChhHCc---CHHHHhcCcccCCC
Confidence 9999999999999888887532 2233335899999999999999 999999 78999999999853
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-63 Score=500.75 Aligned_cols=263 Identities=28% Similarity=0.440 Sum_probs=225.0
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEE
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~ 182 (510)
+..++|++++.||+|+||+||+|+++.+|+.||||++++.. .......+.+|+.+|+.++|||||+++++|.+++.+|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 55689999999999999999999999999999999997642 3444577899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhh-CCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 183 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~-~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||+ .|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 158 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 158 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence 999999999999999999999999999999999999999997 59999999999999999999999999999854321
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~ 341 (510)
...+.+||+.|||||++.+..|+.++|||||||++|||++|+
T Consensus 159 --------------------------------------~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~ 200 (322)
T d1s9ja_ 159 --------------------------------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200 (322)
T ss_dssp --------------------------------------TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSS
T ss_pred --------------------------------------ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 123579999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhHHH------------------------------------------HhhccccccCCCCCCCCHHHHHHH
Q 010463 342 PPFCSDDPRITCRK------------------------------------------IVNWKTCLKFPEEPKISDEARDLI 379 (510)
Q Consensus 342 ~PF~~~~~~~~~~~------------------------------------------I~~~~~~~~~p~~~~~s~~~~dlI 379 (510)
+||.+.+....... +.. ......|. ..+|.+++|||
T Consensus 201 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~s~~~~dli 278 (322)
T d1s9ja_ 201 YPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVN-EPPPKLPS-GVFSLEFQDFV 278 (322)
T ss_dssp CCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHT-SCCCCCCB-TTBCHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhc-cCCccCcc-ccCCHHHHHHH
Confidence 99987654322110 000 00111121 24789999999
Q ss_pred HHhhc-CccccCCCCChHHhhcCCCcCCCCchhh
Q 010463 380 CHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKL 412 (510)
Q Consensus 380 ~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l 412 (510)
.+||+ ||.+|| +++|+++||||+..+|+.+
T Consensus 279 ~~~L~~dP~~R~---ta~e~L~Hpf~~~~~~~~~ 309 (322)
T d1s9ja_ 279 NKCLIKNPAERA---DLKQLMVHAFIKRSDAEEV 309 (322)
T ss_dssp HHHTCSSTTTSC---CHHHHHTSHHHHHHHHSCC
T ss_pred HHHcCCChhHCc---CHHHHhhCHhhCcCCcccc
Confidence 99999 999999 7999999999998777544
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-62 Score=478.69 Aligned_cols=255 Identities=33% Similarity=0.568 Sum_probs=216.9
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec--CceEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD--SDFLY 182 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~~~ 182 (510)
.+||++++.||+|+||+||+|+++.+|+.||+|++.+... ...+.+.+.+|+.+|+.++|||||++++++.+ ++.+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 4789999999999999999999999999999999987654 45567789999999999999999999999965 45799
Q ss_pred EEEeccCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHhhhhCC-----eEEeecCCCCeeecCCCceeecccCCc
Q 010463 183 LIMEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQHN-----YVHRDIKPDNLILDKNGHLKLSDFGLC 253 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~lH~~g-----iiHRDLKP~NILld~~g~vkL~DFGla 253 (510)
+|||||+||+|.+++.+ ...+++..++.++.||+.||+|||++| ||||||||+||||+.+|++||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 99999999999999864 357999999999999999999999876 999999999999999999999999999
Q ss_pred ccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhH
Q 010463 254 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 333 (510)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvi 333 (510)
+.+.... ....+.+|||.|||||++.+..|+.++|||||||+
T Consensus 162 ~~~~~~~--------------------------------------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvi 203 (269)
T d2java1 162 RILNHDT--------------------------------------SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCL 203 (269)
T ss_dssp HHC-------------------------------------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred eecccCC--------------------------------------CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHH
Confidence 8764321 01235789999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 334 MYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 334 lyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
+|||++|.+||.+.+..+...+|.+... ..+| ..+|+++++||.+||. ||.+|| +++||++|||.
T Consensus 204 lyel~tg~~Pf~~~~~~~~~~~i~~~~~-~~~~--~~~s~~l~~li~~~L~~dp~~Rp---s~~ell~hp~i 269 (269)
T d2java1 204 LYELCALMPPFTAFSQKELAGKIREGKF-RRIP--YRYSDELNEIITRMLNLKDYHRP---SVEEILENPLI 269 (269)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHTCC-CCCC--TTSCHHHHHHHHHHTCSSGGGSC---CHHHHHTSTTC
T ss_pred HHHHhhCCCCCCCCCHHHHHHHHHcCCC-CCCC--cccCHHHHHHHHHHcCCChhHCc---CHHHHHhCCcC
Confidence 9999999999999999988888887432 2333 4799999999999998 999999 79999999995
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.3e-61 Score=493.23 Aligned_cols=258 Identities=30% Similarity=0.537 Sum_probs=230.6
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
.++|++++.||+|+||+||+|+++.+|+.||||++++... .....+.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3679999999999999999999999999999999987532 3345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeec--CCCceeecccCCcccCccccc
Q 010463 185 MEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD--KNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~~-~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld--~~g~vkL~DFGla~~~~~~~~ 261 (510)
||||+||+|.+++.+.+ .+++.+++.++.||+.||.|||++|||||||||+||||+ .+|++||+|||+|+.+....
T Consensus 105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~- 183 (352)
T d1koba_ 105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 183 (352)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence 99999999999876654 699999999999999999999999999999999999998 67899999999998765421
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~ 341 (510)
...+.+||+.|||||++.+..|+.++|||||||+||||++|.
T Consensus 184 --------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~ 225 (352)
T d1koba_ 184 --------------------------------------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL 225 (352)
T ss_dssp --------------------------------------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSC
T ss_pred --------------------------------------ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCC
Confidence 123468999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCC
Q 010463 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i 407 (510)
+||.+.+....+.+|.+....+..+..+.+|+++++||++||+ ||.+|| +++|+++||||++.
T Consensus 226 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 226 SPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL---TVHDALEHPWLKGD 289 (352)
T ss_dssp CSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHTSTTTSSC
T ss_pred CCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCc---CHHHHhcCHhhCCC
Confidence 9999999999999998754433333345899999999999999 999999 78999999999874
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-61 Score=486.67 Aligned_cols=253 Identities=26% Similarity=0.359 Sum_probs=229.0
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEe
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 186 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmE 186 (510)
.|+.++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++|||||+++++|.+++.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 39999999999999999999999999999999988766566667889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccch
Q 010463 187 YLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 266 (510)
Q Consensus 187 y~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~ 266 (510)
||+||+|..++...+.+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~------- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------- 168 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-------
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC-------
Confidence 9999999888888889999999999999999999999999999999999999999999999999999865432
Q ss_pred hhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc---CCCCccccccchhhHHHHHhhCCCC
Q 010463 267 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK---KGYGMECDWWSLGAIMYEMLIGYPP 343 (510)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~---~~y~~~~DiwSlGvilyEml~G~~P 343 (510)
.+.+|||.|||||++.+ ..|+.++|||||||++|||++|.+|
T Consensus 169 -----------------------------------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~P 213 (309)
T d1u5ra_ 169 -----------------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213 (309)
T ss_dssp -----------------------------------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred -----------------------------------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCC
Confidence 24689999999999974 4589999999999999999999999
Q ss_pred CCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 344 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 344 F~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
|.+.+......++....... +....+|+++++||.+||. ||.+|| +++|+++||||..
T Consensus 214 f~~~~~~~~~~~i~~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~Rp---t~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 214 LFNMNAMSALYHIAQNESPA--LQSGHWSEYFRNFVDSCLQKIPQDRP---TSEVLLKHRFVLR 272 (309)
T ss_dssp TTTSCHHHHHHHHHHSCCCC--CSCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHTTCHHHHS
T ss_pred CCCCCHHHHHHHHHhCCCCC--CCCCCCCHHHHHHHHHHCcCChhHCc---CHHHHHhCHHhcC
Confidence 99998888888887643322 2235789999999999999 999999 7899999999964
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.1e-60 Score=472.77 Aligned_cols=260 Identities=31% Similarity=0.536 Sum_probs=233.0
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcc------hhhHHHHHHHHHHHHhcC-CCCeeeEeEEeec
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLK------RGQVEHVRSERNLLAEVD-SRCIVQLFYSFQD 177 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~------~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~ 177 (510)
.++|++++.||+|+||+||+|+++.+|+.||||++++..... +...+.+.+|+.+|++++ |||||+++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 378999999999999999999999999999999998764322 223456889999999997 9999999999999
Q ss_pred CceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCc
Q 010463 178 SDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 257 (510)
Q Consensus 178 ~~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~ 257 (510)
++.+|||||||+||||.++|...+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+.
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998765
Q ss_pred cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc------CCCCccccccchh
Q 010463 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK------KGYGMECDWWSLG 331 (510)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~------~~y~~~~DiwSlG 331 (510)
.... ....+||+.|+|||++.+ ..|+.++||||+|
T Consensus 162 ~~~~---------------------------------------~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslG 202 (277)
T d1phka_ 162 PGEK---------------------------------------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG 202 (277)
T ss_dssp TTCC---------------------------------------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHH
T ss_pred CCCc---------------------------------------eeeeeccCCCCCHHHhhccccccCCCCCchheEcccc
Confidence 4211 124689999999999963 4578899999999
Q ss_pred hHHHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 332 AIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 332 vilyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
|++|||++|.+||.+.+......+|.+....+..+..+.+|+++++||++||. ||++|| +++||++||||+.
T Consensus 203 vilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~---s~~eil~h~~~~~ 275 (277)
T d1phka_ 203 VIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY---TAEEALAHPFFQQ 275 (277)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSC---CHHHHTTSGGGCT
T ss_pred hhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCc---CHHHHHcCHHHHH
Confidence 99999999999999999999999998866555555556899999999999999 999999 7899999999985
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-61 Score=486.75 Aligned_cols=292 Identities=39% Similarity=0.721 Sum_probs=249.2
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEE---cCCCCEEEEEEeechhhcc-hhhHHHHHHHHHHHHhcCC-CCeeeEeEEe
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRA---KTTGEIFAMKKLKKSEMLK-RGQVEHVRSERNLLAEVDS-RCIVQLFYSF 175 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~---~~tg~~vAiK~i~k~~~~~-~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~~ 175 (510)
.++++++|++++.||+|+||+||+|++ +.+|+.||||++++..... ....+.+.+|+.+|++++| |||+++++++
T Consensus 19 ~~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~ 98 (322)
T d1vzoa_ 19 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 98 (322)
T ss_dssp CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred cccchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee
Confidence 456789999999999999999999987 4579999999997754322 2334568899999999977 8999999999
Q ss_pred ecCceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCccc
Q 010463 176 QDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 255 (510)
Q Consensus 176 ~~~~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~ 255 (510)
.+...+|+||||+.||+|.+++...+.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.
T Consensus 99 ~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 99 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred ccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999987
Q ss_pred CccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC--CCCccccccchhhH
Q 010463 256 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK--GYGMECDWWSLGAI 333 (510)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~--~y~~~~DiwSlGvi 333 (510)
+...... ...+.+||+.|+|||++.+. .++.++|||||||+
T Consensus 179 ~~~~~~~-------------------------------------~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~i 221 (322)
T d1vzoa_ 179 FVADETE-------------------------------------RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVL 221 (322)
T ss_dssp CCGGGGG-------------------------------------GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHH
T ss_pred hcccccc-------------------------------------cccccccccccchhHHhhcCCcCCCchhhhHHHHHH
Confidence 6432110 12246899999999999864 46889999999999
Q ss_pred HHHHhhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CChHHhhcCCCcCCCCch
Q 010463 334 MYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWD 410 (510)
Q Consensus 334 lyEml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~--~~~~eil~HpfF~~i~~~ 410 (510)
||||++|.+||.+.+.......+.........+....+|+++.+||.+||. ||.+|++. .+++|+++||||++++|+
T Consensus 222 LyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~ 301 (322)
T d1vzoa_ 222 MYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD 301 (322)
T ss_dssp HHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHH
Confidence 999999999999887777766665432222333334799999999999999 99999975 369999999999999999
Q ss_pred hhhc--ccCCCccccCCCccC
Q 010463 411 KLYE--MEAAYKPTVNGELDT 429 (510)
Q Consensus 411 ~l~~--~~~p~~p~~~~~~d~ 429 (510)
.+.. ++||++|.++++.|.
T Consensus 302 ~l~~~~~~~p~~p~~~~~~~~ 322 (322)
T d1vzoa_ 302 DLAAKKVPAPFKPVIRDELDV 322 (322)
T ss_dssp HHHTTCSCCSCCCCCCC-CCC
T ss_pred HHHhCCCCcCCCCCCCCCCCC
Confidence 9984 789999999988763
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-60 Score=469.72 Aligned_cols=251 Identities=22% Similarity=0.393 Sum_probs=218.5
Q ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec----CceEEE
Q 010463 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD----SDFLYL 183 (510)
Q Consensus 108 f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~----~~~~~l 183 (510)
|++.+.||+|+||+||+|+++.+++.||+|++.+... .....+.+.+|+++|+.++|||||+++++|.+ ...+|+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 4677789999999999999999999999999987654 34556789999999999999999999999875 457999
Q ss_pred EEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCC--eEEeecCCCCeeec-CCCceeecccCCcccCcccc
Q 010463 184 IMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHN--YVHRDIKPDNLILD-KNGHLKLSDFGLCKPLEDKY 260 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~g--iiHRDLKP~NILld-~~g~vkL~DFGla~~~~~~~ 260 (510)
|||||+||+|.+++.+...+++..++.++.||+.||+|||++| ||||||||+||||+ .+|++||+|||+|+.....
T Consensus 90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~- 168 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 168 (270)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-
Confidence 9999999999999999999999999999999999999999998 99999999999996 5899999999999854322
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhC
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 340 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G 340 (510)
...+.+|||.|||||++.+ +|+.++|||||||++|||++|
T Consensus 169 ---------------------------------------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g 208 (270)
T d1t4ha_ 169 ---------------------------------------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATS 208 (270)
T ss_dssp ---------------------------------------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHS
T ss_pred ---------------------------------------ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHC
Confidence 1235789999999999865 699999999999999999999
Q ss_pred CCCCCCCC-hhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcC
Q 010463 341 YPPFCSDD-PRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 405 (510)
Q Consensus 341 ~~PF~~~~-~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~ 405 (510)
.+||.+.+ ....+.++........++ ..+++++++||.+||. ||++|| +++|+++||||+
T Consensus 209 ~~Pf~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~R~---s~~ell~Hp~fk 270 (270)
T d1t4ha_ 209 EYPYSECQNAAQIYRRVTSGVKPASFD--KVAIPEVKEIIEGCIRQNKDERY---SIKDLLNHAFFQ 270 (270)
T ss_dssp SCTTTTCSSHHHHHHHHTTTCCCGGGG--GCCCHHHHHHHHHHSCSSGGGSC---CHHHHHTSGGGC
T ss_pred CCCCCCcccHHHHHHHHHcCCCCcccC--ccCCHHHHHHHHHHccCCHhHCc---CHHHHhCCcccC
Confidence 99997654 445566666543333333 3689999999999998 999999 799999999996
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-60 Score=479.19 Aligned_cols=256 Identities=27% Similarity=0.434 Sum_probs=228.2
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. .+...+.+|+.+|+.++|||||+++++|++++.+|||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 578999999999999999999999999999999997653 2335688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCC--CceeecccCCcccCccccc
Q 010463 185 MEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN--GHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~~-~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~--g~vkL~DFGla~~~~~~~~ 261 (510)
||||+||+|.++|...+ .++|.+++.|+.||+.||+|||++|||||||||+|||++.+ +.+||+|||+++......
T Consensus 80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~- 158 (321)
T d1tkia_ 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC-
Confidence 99999999999998765 79999999999999999999999999999999999999854 489999999998754321
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~ 341 (510)
...+.+||+.|+|||++.+..|+.++|||||||++|||++|.
T Consensus 159 --------------------------------------~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~ 200 (321)
T d1tkia_ 159 --------------------------------------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI 200 (321)
T ss_dssp --------------------------------------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSS
T ss_pred --------------------------------------cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCC
Confidence 122468999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
+||.+.+....+.+|.+....+..+.++.+|+++++||.+||. ||.+|| +++|+++||||+.
T Consensus 201 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---s~~eil~hp~~~~ 263 (321)
T d1tkia_ 201 NPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM---TASEALQHPWLKQ 263 (321)
T ss_dssp CTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSHHHHS
T ss_pred CCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCc---CHHHHhcCHhhcc
Confidence 9999999999999998854333222235799999999999999 999999 7999999999974
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-59 Score=466.92 Aligned_cols=259 Identities=28% Similarity=0.428 Sum_probs=218.1
Q ss_pred eeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchh--hHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEe
Q 010463 109 EQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRG--QVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 186 (510)
Q Consensus 109 ~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~--~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmE 186 (510)
+.+++||+|+||+||+|+++.+|+.||||++++....... ..+.+.+|+.+|+.++|||||+++++|.+++++|+|||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 4578999999999999999999999999999765432221 23568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccch
Q 010463 187 YLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 266 (510)
Q Consensus 187 y~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~ 266 (510)
|+.||++..++.....+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.......
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~----- 155 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR----- 155 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-----
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcc-----
Confidence 999998888887788899999999999999999999999999999999999999999999999999987654311
Q ss_pred hhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHhhCCCCCC
Q 010463 267 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYPPFC 345 (510)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml~G~~PF~ 345 (510)
...+.+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.
T Consensus 156 ---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~ 202 (299)
T d1ua2a_ 156 ---------------------------------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP 202 (299)
T ss_dssp ---------------------------------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ---------------------------------cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCC
Confidence 1224689999999999975 468999999999999999999999999
Q ss_pred CCChhhhHHHHhhccccc------------------cCCC------CCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 346 SDDPRITCRKIVNWKTCL------------------KFPE------EPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 346 ~~~~~~~~~~I~~~~~~~------------------~~p~------~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
+.+..++..+|....... .+|. .+.+|++++|||++||+ ||++|| +++|+++
T Consensus 203 ~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~---sa~e~L~ 279 (299)
T d1ua2a_ 203 GDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI---TATQALK 279 (299)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSC---CHHHHHT
T ss_pred CCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCc---CHHHHhC
Confidence 999888888776421110 0010 13678999999999999 999999 7999999
Q ss_pred CCCcCCCC
Q 010463 401 HPWFRGIQ 408 (510)
Q Consensus 401 HpfF~~i~ 408 (510)
||||++..
T Consensus 280 Hp~f~~~p 287 (299)
T d1ua2a_ 280 MKYFSNRP 287 (299)
T ss_dssp SGGGTSSS
T ss_pred CHhhCCCC
Confidence 99998643
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-58 Score=458.48 Aligned_cols=262 Identities=29% Similarity=0.482 Sum_probs=217.8
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
+++|++++.||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+.+|+.++|||||+++++|++++.+|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 4799999999999999999999999999999999976532 333456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccc
Q 010463 185 MEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 263 (510)
Q Consensus 185 mEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 263 (510)
|||+.|+.+...... ...+++..++.++.||+.||+|||++|||||||||+|||++.++++||+|||+|+.......
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~-- 157 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-- 157 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB--
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcc--
Confidence 999976544444333 45699999999999999999999999999999999999999999999999999976533210
Q ss_pred cchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCC-CccccccchhhHHHHHhhCCC
Q 010463 264 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEMLIGYP 342 (510)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiwSlGvilyEml~G~~ 342 (510)
.....+||+.|+|||++....+ +.++|+|||||++|+|++|++
T Consensus 158 ------------------------------------~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~ 201 (298)
T d1gz8a_ 158 ------------------------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 201 (298)
T ss_dssp ------------------------------------CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ------------------------------------cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCC
Confidence 1224689999999999887665 899999999999999999999
Q ss_pred CCCCCChhhhHHHHhhccccc----------------cCCC---------CCCCCHHHHHHHHHhhc-CccccCCCCChH
Q 010463 343 PFCSDDPRITCRKIVNWKTCL----------------KFPE---------EPKISDEARDLICHLLC-DVETRLGTRGVE 396 (510)
Q Consensus 343 PF~~~~~~~~~~~I~~~~~~~----------------~~p~---------~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~ 396 (510)
||.+.+......++.+..... .++. .+.+|++++|||++||+ ||++|| +++
T Consensus 202 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~---t~~ 278 (298)
T d1gz8a_ 202 LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI---SAK 278 (298)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSC---CHH
T ss_pred CCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCc---CHH
Confidence 999988877776665311100 0110 13678999999999999 999999 799
Q ss_pred HhhcCCCcCCCC
Q 010463 397 ELKEHPWFRGIQ 408 (510)
Q Consensus 397 eil~HpfF~~i~ 408 (510)
||++||||++++
T Consensus 279 ell~H~ff~~~~ 290 (298)
T d1gz8a_ 279 AALAHPFFQDVT 290 (298)
T ss_dssp HHHTSGGGTTCC
T ss_pred HHhCCHhhccCC
Confidence 999999998864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-59 Score=473.55 Aligned_cols=253 Identities=33% Similarity=0.527 Sum_probs=211.7
Q ss_pred CCCCceeee-eeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHh-cCCCCeeeEeEEeec----
Q 010463 104 GIDDFEQLT-LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE-VDSRCIVQLFYSFQD---- 177 (510)
Q Consensus 104 ~~~~f~~~~-~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~~~~---- 177 (510)
-+++|+++. +||+|+||+||+|+++.+|+.||||++++. ..+.+|+.++.+ ++|||||+++++|++
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~ 80 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG 80 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence 357999985 699999999999999999999999999754 236779988754 589999999999976
Q ss_pred CceEEEEEeccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecC---CCceeecccCC
Q 010463 178 SDFLYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK---NGHLKLSDFGL 252 (510)
Q Consensus 178 ~~~~~lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~---~g~vkL~DFGl 252 (510)
...+|+|||||+||+|.++|.+. ..++|.+++.|+.||+.||+|||++|||||||||+|||++. ++++||+|||+
T Consensus 81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccce
Confidence 46799999999999999999774 46999999999999999999999999999999999999985 56899999999
Q ss_pred cccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhh
Q 010463 253 CKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGA 332 (510)
Q Consensus 253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGv 332 (510)
|+...... ...+.+|||.|||||++.+..|+.++|||||||
T Consensus 161 a~~~~~~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGv 201 (335)
T d2ozaa1 161 AKETTSHN---------------------------------------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 201 (335)
T ss_dssp CEECCCCC---------------------------------------CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHH
T ss_pred eeeccCCC---------------------------------------ccccccCCcccCCcHHHcCCCCCHHHHHHhhch
Confidence 98764321 122468999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCChhhhHHHHhhcc--ccccCCC--CCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCC
Q 010463 333 IMYEMLIGYPPFCSDDPRITCRKIVNWK--TCLKFPE--EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 333 ilyEml~G~~PF~~~~~~~~~~~I~~~~--~~~~~p~--~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~ 406 (510)
+||||++|++||.+.+.......+.... ....+|. ...+|+++++||++||+ ||++|| +++||++||||..
T Consensus 202 ily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~eil~hp~~~~ 277 (335)
T d2ozaa1 202 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM---TITEFMNHPWIMQ 277 (335)
T ss_dssp HHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSC---CHHHHHHSHHHHT
T ss_pred hHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCc---CHHHHHcCHHhhC
Confidence 9999999999998876655444332211 2233332 34689999999999998 999999 7899999999964
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-58 Score=452.52 Aligned_cols=250 Identities=30% Similarity=0.487 Sum_probs=216.7
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhh---HHHHHHHHHHHHhcC--CCCeeeEeEEeecCce
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ---VEHVRSERNLLAEVD--SRCIVQLFYSFQDSDF 180 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~---~~~~~~E~~iL~~l~--hp~Iv~l~~~~~~~~~ 180 (510)
++|++.+.||+|+||+||+|+++.+|+.||||++.+.......+ ...+.+|+.+|+.++ |||||+++++|.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999999999999999998765433221 233668999999986 8999999999999999
Q ss_pred EEEEEeccCC-CCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecC-CCceeecccCCcccCcc
Q 010463 181 LYLIMEYLPG-GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK-NGHLKLSDFGLCKPLED 258 (510)
Q Consensus 181 ~~lVmEy~~g-G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~-~g~vkL~DFGla~~~~~ 258 (510)
+|+||||+.| +++.+++.+...+++..++.++.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+....
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~ 163 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD 163 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceeccc
Confidence 9999999976 688899988899999999999999999999999999999999999999985 57999999999986543
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCC-CccccccchhhHHHHH
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEM 337 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiwSlGvilyEm 337 (510)
. ...+.+||+.|||||++.+..| +.++|||||||++|||
T Consensus 164 ~----------------------------------------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyel 203 (273)
T d1xwsa_ 164 T----------------------------------------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 203 (273)
T ss_dssp S----------------------------------------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHH
T ss_pred c----------------------------------------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhH
Confidence 2 1124689999999999988775 6789999999999999
Q ss_pred hhCCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCC
Q 010463 338 LIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 408 (510)
Q Consensus 338 l~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~ 408 (510)
++|.+||.+.+ .+... ...++ ..+|+++++||++||. ||++|| +++|+++||||+++.
T Consensus 204 l~g~~Pf~~~~------~i~~~--~~~~~--~~~s~~~~~li~~~L~~dp~~R~---s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 204 VCGDIPFEHDE------EIIRG--QVFFR--QRVSSECQHLIRWCLALRPSDRP---TFEEIQNHPWMQDVL 262 (273)
T ss_dssp HHSSCSCCSHH------HHHHC--CCCCS--SCCCHHHHHHHHHHTCSSGGGSC---CHHHHHTSGGGSSCC
T ss_pred hhCCCCCCCch------HHhhc--ccCCC--CCCCHHHHHHHHHHccCCHhHCc---CHHHHhcCHhhCCCC
Confidence 99999997532 34442 23444 4799999999999998 999999 799999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.8e-57 Score=449.40 Aligned_cols=261 Identities=25% Similarity=0.397 Sum_probs=220.7
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc----eE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD----FL 181 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~----~~ 181 (510)
++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.+|+.++|||||++++++.+.+ .+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 67999999999999999999999999999999998876655666778999999999999999999999998654 48
Q ss_pred EEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 182 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
|+|||||+||+|..++...+.+++.+++.++.||+.||+|||++|||||||||+||||+.++.++|+|||+++.......
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~ 166 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 166 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----
T ss_pred EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999876543211
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 341 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~ 341 (510)
. .....+.+||+.|||||++.+..|+.++|||||||++|||++|.
T Consensus 167 ~-----------------------------------~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~ 211 (277)
T d1o6ya_ 167 S-----------------------------------VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 211 (277)
T ss_dssp -----------------------------------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred c-----------------------------------ccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCC
Confidence 0 01123578999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCc
Q 010463 342 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 404 (510)
Q Consensus 342 ~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF 404 (510)
+||.+.+..+...+++...........+.+|+++++||.+||. ||.+||+ ++++++ |+|.
T Consensus 212 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~--sa~~l~-~~l~ 272 (277)
T d1o6ya_ 212 PPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ--TAAEMR-ADLV 272 (277)
T ss_dssp CSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCS--SHHHHH-HHHH
T ss_pred CCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHh--HHHHHH-HHHH
Confidence 9999999988888888754433333346899999999999999 9999995 366654 5543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-57 Score=453.15 Aligned_cols=263 Identities=27% Similarity=0.397 Sum_probs=217.5
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCC-CCEEEEEEeechhhcchhhHHHHHHHHHHHHhc---CCCCeeeEeEEeec---
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTT-GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV---DSRCIVQLFYSFQD--- 177 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~t-g~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~~~~--- 177 (510)
.++|++++.||+|+||+||+|+++.+ ++.||||++++... .......+.+|+.+|+.+ +|||||+++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBC-TTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhc-cchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 36899999999999999999999765 67899999976432 222233456777777665 89999999999853
Q ss_pred --CceEEEEEeccCCCCHHHHHH-hccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcc
Q 010463 178 --SDFLYLIMEYLPGGDIMTLLM-REDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCK 254 (510)
Q Consensus 178 --~~~~~lVmEy~~gG~L~~~L~-~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~ 254 (510)
...+|++|||+.||++..... ....+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+++
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 457999999999987755443 34679999999999999999999999999999999999999999999999999998
Q ss_pred cCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHH
Q 010463 255 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIM 334 (510)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvil 334 (510)
...... ...+.+||+.|||||++.+.+|+.++|||||||++
T Consensus 165 ~~~~~~---------------------------------------~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il 205 (305)
T d1blxa_ 165 IYSFQM---------------------------------------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIF 205 (305)
T ss_dssp CCCGGG---------------------------------------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred hhcccc---------------------------------------cCCCcccChhhcCcchhcCCCCChhehhhchHHHH
Confidence 654321 12256899999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCChhhhHHHHhhcccc---ccCC--------------------CCCCCCHHHHHHHHHhhc-CccccC
Q 010463 335 YEMLIGYPPFCSDDPRITCRKIVNWKTC---LKFP--------------------EEPKISDEARDLICHLLC-DVETRL 390 (510)
Q Consensus 335 yEml~G~~PF~~~~~~~~~~~I~~~~~~---~~~p--------------------~~~~~s~~~~dlI~~lL~-dp~~R~ 390 (510)
|||++|.+||.+.+..++..+|+..... ..++ ....+|++++|||.+||. ||++||
T Consensus 206 ~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ 285 (305)
T d1blxa_ 206 AEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI 285 (305)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSC
T ss_pred HHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCc
Confidence 9999999999999988888777542100 0000 113689999999999999 999999
Q ss_pred CCCChHHhhcCCCcCCCCch
Q 010463 391 GTRGVEELKEHPWFRGIQWD 410 (510)
Q Consensus 391 ~~~~~~eil~HpfF~~i~~~ 410 (510)
+++|+++||||+++++.
T Consensus 286 ---sa~e~L~Hpff~~i~~~ 302 (305)
T d1blxa_ 286 ---SAYSALSHPYFQDLERC 302 (305)
T ss_dssp ---CHHHHHTSGGGTTCCCC
T ss_pred ---CHHHHhcChhhcCchhh
Confidence 78999999999998753
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-57 Score=454.59 Aligned_cols=258 Identities=22% Similarity=0.347 Sum_probs=219.5
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCC-----EEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEE
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGE-----IFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYS 174 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~-----~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~ 174 (510)
+++..++|++++.||+|+||+||+|+++.+++ .||+|++.+.. .......+.+|+.+|.++ +|||||+++++
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~ 109 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGA 109 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEE
Confidence 45667899999999999999999999987654 69999986543 233456788999999988 89999999999
Q ss_pred eecCceEEEEEeccCCCCHHHHHHhc-----------------------cCCCHHHHHHHHHHHHHHHHhhhhCCeEEee
Q 010463 175 FQDSDFLYLIMEYLPGGDIMTLLMRE-----------------------DILSEDVARFYIAESVLAIHSIHQHNYVHRD 231 (510)
Q Consensus 175 ~~~~~~~~lVmEy~~gG~L~~~L~~~-----------------------~~l~e~~~~~~~~qi~~aL~~lH~~giiHRD 231 (510)
|.+.+.+|+|||||+||+|.++|... ..+++..++.|+.||+.||+|||++||||||
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRD 189 (325)
T d1rjba_ 110 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 189 (325)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 99999999999999999999999754 3589999999999999999999999999999
Q ss_pred cCCCCeeecCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCc
Q 010463 232 IKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYM 311 (510)
Q Consensus 232 LKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~ 311 (510)
|||+|||++.+|++||+|||+|+........ ....+.+||+.||
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~------------------------------------~~~~~~~gt~~y~ 233 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNY------------------------------------VVRGNARLPVKWM 233 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTS------------------------------------EEETTEEECGGGC
T ss_pred CchhccccccCCeEEEeeccccccccCCCce------------------------------------eeeccccCCCccC
Confidence 9999999999999999999999865432110 0112467999999
Q ss_pred chHhhccCCCCccccccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-Ccccc
Q 010463 312 APEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETR 389 (510)
Q Consensus 312 APEvl~~~~y~~~~DiwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R 389 (510)
|||++.+..|+.++|||||||+||||++ |.+||.+.+....+.+++.....+..| ..+|+++++||.+||. ||++|
T Consensus 234 aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p--~~~~~~l~~li~~cl~~dP~~R 311 (325)
T d1rjba_ 234 APESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQP--FYATEEIYIIMQSCWAFDSRKR 311 (325)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCC--TTCCHHHHHHHHHHTCSSGGGS
T ss_pred ChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCC--CcCCHHHHHHHHHHcCCChhHC
Confidence 9999999999999999999999999997 899999988777777777654444444 4899999999999998 99999
Q ss_pred CCCCChHHhhcC
Q 010463 390 LGTRGVEELKEH 401 (510)
Q Consensus 390 ~~~~~~~eil~H 401 (510)
| +++||++|
T Consensus 312 P---t~~ei~~~ 320 (325)
T d1rjba_ 312 P---SFPNLTSF 320 (325)
T ss_dssp C---CHHHHHHH
T ss_pred c---CHHHHHHH
Confidence 9 68898875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.5e-56 Score=444.70 Aligned_cols=259 Identities=27% Similarity=0.434 Sum_probs=219.7
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
.++|++++.||+|+||+||+|+++ +|+.||||++.+... .....+.+.+|+.+|+.++|||||+++++|.+++..|+|
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 378999999999999999999986 789999999976543 344467799999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 185 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
|||+.|+++..+....+.+++..++.++.||+.||+|||+.|||||||||+||||+.+|++||+|||+|........
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--- 155 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--- 155 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc---
Confidence 99999988888888788999999999999999999999999999999999999999999999999999986533210
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC-CCCccccccchhhHHHHHhhCCCC
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEMLIGYPP 343 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiwSlGvilyEml~G~~P 343 (510)
.....+||+.|+|||++.+. .++.++|+|||||++|||++|++|
T Consensus 156 -----------------------------------~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~p 200 (286)
T d1ob3a_ 156 -----------------------------------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL 200 (286)
T ss_dssp -----------------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred -----------------------------------ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCC
Confidence 01245799999999999864 569999999999999999999999
Q ss_pred CCCCChhhhHHHHhhccccc---------cCC----------------CCCCCCHHHHHHHHHhhc-CccccCCCCChHH
Q 010463 344 FCSDDPRITCRKIVNWKTCL---------KFP----------------EEPKISDEARDLICHLLC-DVETRLGTRGVEE 397 (510)
Q Consensus 344 F~~~~~~~~~~~I~~~~~~~---------~~p----------------~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~e 397 (510)
|.+.+..+++.++....... ..+ ..+.+|++++|||++||. ||++|| +++|
T Consensus 201 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~---s~~e 277 (286)
T d1ob3a_ 201 FPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI---TAKQ 277 (286)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSC---CHHH
T ss_pred CCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCc---CHHH
Confidence 99988877777665311110 000 013678999999999999 999999 7899
Q ss_pred hhcCCCcCC
Q 010463 398 LKEHPWFRG 406 (510)
Q Consensus 398 il~HpfF~~ 406 (510)
+++||||++
T Consensus 278 ll~Hp~f~~ 286 (286)
T d1ob3a_ 278 ALEHAYFKE 286 (286)
T ss_dssp HHTSGGGGC
T ss_pred HhcCcccCc
Confidence 999999974
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-56 Score=444.89 Aligned_cols=254 Identities=20% Similarity=0.305 Sum_probs=217.6
Q ss_pred hcccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc
Q 010463 100 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 179 (510)
Q Consensus 100 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 179 (510)
++++..++|++.+.||+|+||+||+|+++.+|+.||||++++.. ...+.+.+|+.+|+.++|||||+++++|.+++
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 86 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc----chHHHHHHHHHHHHhCCCCCEecCCccEeeCC
Confidence 45677889999999999999999999999999999999997643 34567899999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCc
Q 010463 180 FLYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 257 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~ 257 (510)
.+|+|||||++|+|..+|.+. ..+++..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 87 ~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 87 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred eeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecC
Confidence 999999999999999999764 578999999999999999999999999999999999999999999999999998765
Q ss_pred cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHH
Q 010463 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337 (510)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEm 337 (510)
..... ......||+.|||||++.+..|+.++|||||||++|||
T Consensus 167 ~~~~~-------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~el 209 (287)
T d1opja_ 167 GDTYT-------------------------------------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 209 (287)
T ss_dssp SSSSE-------------------------------------EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHH
T ss_pred CCCce-------------------------------------eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHH
Confidence 43111 01234699999999999999999999999999999999
Q ss_pred hhCCCCC-CCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 338 LIGYPPF-CSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 338 l~G~~PF-~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
++|..|| .+.+....+..+.. ...+.+| ..+|+++++||.+||. ||++|| +++||++
T Consensus 210 l~~~~p~~~~~~~~~~~~~i~~-~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rp---s~~ei~~ 268 (287)
T d1opja_ 210 ATYGMSPYPGIDLSQVYELLEK-DYRMERP--EGCPEKVYELMRACWQWNPSDRP---SFAEIHQ 268 (287)
T ss_dssp HTTSCCSSTTCCHHHHHHHHHT-TCCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HhCCCCCCCcchHHHHHHHHhc-CCCCCCC--ccchHHHHHHHHHHcCCCHhHCc---CHHHHHH
Confidence 9966555 45555554444433 3334444 4799999999999999 999999 6788865
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-56 Score=442.23 Aligned_cols=257 Identities=22% Similarity=0.316 Sum_probs=213.4
Q ss_pred eeeecCCCeEEEEEEEcC--CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEEEeccC
Q 010463 112 TLIGKGAFGEVRLCRAKT--TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLP 189 (510)
Q Consensus 112 ~~IG~G~fG~V~~~~~~~--tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lVmEy~~ 189 (510)
+.||+|+||+||+|.++. +++.||||+++... ......+.+.+|+.+|++++|||||+++++|.++ ..|||||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 579999999999998654 56789999997543 3445567899999999999999999999999764 5789999999
Q ss_pred CCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccchhhh
Q 010463 190 GGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDED 269 (510)
Q Consensus 190 gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~ 269 (510)
||+|.+++.+...+++..+..++.||+.||+|||+.|||||||||+||||+.+|++||+|||+|+.+.......
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~------ 164 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY------ 164 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE------
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccc------
Confidence 99999999998999999999999999999999999999999999999999999999999999998764321110
Q ss_pred hhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh-CCCCCCCCC
Q 010463 270 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDD 348 (510)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~-G~~PF~~~~ 348 (510)
.......||+.|||||++.+..|+.++|||||||++|||++ |.+||.+.+
T Consensus 165 -----------------------------~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~ 215 (277)
T d1xbba_ 165 -----------------------------KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 215 (277)
T ss_dssp -----------------------------EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred -----------------------------ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC
Confidence 01123579999999999999999999999999999999998 999999988
Q ss_pred hhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCC
Q 010463 349 PRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 408 (510)
Q Consensus 349 ~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~ 408 (510)
..+....|.+. ..+..| ..+|+++.+||.+||. ||++||+...+.+.|+|+|+.-++
T Consensus 216 ~~~~~~~i~~~-~~~~~p--~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~ 273 (277)
T d1xbba_ 216 GSEVTAMLEKG-ERMGCP--AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 273 (277)
T ss_dssp HHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcC-CCCCCC--cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhcCC
Confidence 88877777764 234444 4799999999999998 999999543334446788775443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-56 Score=439.34 Aligned_cols=262 Identities=24% Similarity=0.353 Sum_probs=220.9
Q ss_pred cCCCCceeeee-eecCCCeEEEEEEEcCC--CCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc
Q 010463 103 IGIDDFEQLTL-IGKGAFGEVRLCRAKTT--GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 179 (510)
Q Consensus 103 ~~~~~f~~~~~-IG~G~fG~V~~~~~~~t--g~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 179 (510)
+..++|.+... ||+|+||+||+|.++.+ +..||||++++.. .....+.+.+|+.+|++++|||||++++++.++
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~- 81 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE- 81 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-
Confidence 44567888885 99999999999987654 4579999997642 445667899999999999999999999999764
Q ss_pred eEEEEEeccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 180 FLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
.+|+|||||+||+|.+++.. ...+++..+..++.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+..
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 58999999999999999865 46799999999999999999999999999999999999999999999999999987654
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHh
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml 338 (510)
..... ......+||+.|||||++.+..|+.++|||||||++|||+
T Consensus 162 ~~~~~-----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~l 206 (285)
T d1u59a_ 162 DDSYY-----------------------------------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 206 (285)
T ss_dssp CSCEE-----------------------------------CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred ccccc-----------------------------------ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHH
Confidence 21110 0112457999999999999999999999999999999999
Q ss_pred h-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcC
Q 010463 339 I-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 405 (510)
Q Consensus 339 ~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~ 405 (510)
+ |.+||.+.+..+....|.++. .+..| +.+|+++.+||.+||. ||++||+..++.+.++|+|+.
T Consensus 207 t~G~~Pf~~~~~~~~~~~i~~~~-~~~~p--~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 207 SYGQKPYKKMKGPEVMAFIEQGK-RMECP--PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp TTSCCTTTTCCTHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hCCCCCCCCCCHHHHHHHHHcCC-CCCCC--CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 8 999999988888888777643 34444 4799999999999998 999999655566668888874
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-55 Score=448.19 Aligned_cols=258 Identities=29% Similarity=0.446 Sum_probs=213.8
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc-----
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD----- 179 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~----- 179 (510)
.+.|++++.||+|+||+||+|+++.+|+.||||++++.. ......+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 478999999999999999999999999999999997653 34556778999999999999999999999998765
Q ss_pred -eEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 180 -FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 180 -~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
.+|+||||| |++|..++ +.+.+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+|+....
T Consensus 96 ~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp CCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC
Confidence 579999999 66777665 556799999999999999999999999999999999999999999999999999986543
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC-CCCccccccchhhHHHHH
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEM 337 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiwSlGvilyEm 337 (510)
. ..+.+||+.|+|||++.+. .++.++|||||||++|||
T Consensus 174 ~-----------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el 212 (346)
T d1cm8a_ 174 E-----------------------------------------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEM 212 (346)
T ss_dssp S-----------------------------------------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHH
T ss_pred c-----------------------------------------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHH
Confidence 2 1246899999999999864 569999999999999999
Q ss_pred hhCCCCCCCCChhhhHHHHhhccccc---------------------cCC------CCCCCCHHHHHHHHHhhc-Ccccc
Q 010463 338 LIGYPPFCSDDPRITCRKIVNWKTCL---------------------KFP------EEPKISDEARDLICHLLC-DVETR 389 (510)
Q Consensus 338 l~G~~PF~~~~~~~~~~~I~~~~~~~---------------------~~p------~~~~~s~~~~dlI~~lL~-dp~~R 389 (510)
++|.+||.+.+.......+....... ... ....+|++++|||++||+ ||.+|
T Consensus 213 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R 292 (346)
T d1cm8a_ 213 ITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQR 292 (346)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTS
T ss_pred HHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHC
Confidence 99999999887766655544311100 000 013689999999999999 99999
Q ss_pred CCCCChHHhhcCCCcCCCCc
Q 010463 390 LGTRGVEELKEHPWFRGIQW 409 (510)
Q Consensus 390 ~~~~~~~eil~HpfF~~i~~ 409 (510)
| +++||++||||+++.+
T Consensus 293 ~---ta~eiL~Hp~f~~~~~ 309 (346)
T d1cm8a_ 293 V---TAGEALAHPYFESLHD 309 (346)
T ss_dssp C---CHHHHHHSGGGTTTC-
T ss_pred c---CHHHHhcChhhCcCCC
Confidence 9 7999999999998764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.5e-55 Score=443.15 Aligned_cols=256 Identities=27% Similarity=0.437 Sum_probs=212.9
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEeEEeec--Cce
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQD--SDF 180 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~--~~~ 180 (510)
..++|++++.||+|+||+||+|+++.+|+.||||++++. ..+.+.+|+.+|..+. ||||++++++|.+ ...
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence 346899999999999999999999999999999999753 2356889999999985 9999999999974 457
Q ss_pred EEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCC-ceeecccCCcccCccc
Q 010463 181 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG-HLKLSDFGLCKPLEDK 259 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g-~vkL~DFGla~~~~~~ 259 (510)
+|+|||||++|+|..+. +.+++..++.++.||+.||.|||++|||||||||+||||+.++ .+||+|||+|+.....
T Consensus 107 ~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 99999999999997764 4699999999999999999999999999999999999999765 5999999999876432
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC-CCCccccccchhhHHHHHh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiwSlGvilyEml 338 (510)
. .....+||+.|+|||++.+. .|+.++|+|||||++|||+
T Consensus 184 ~---------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~ 224 (328)
T d3bqca1 184 Q---------------------------------------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 224 (328)
T ss_dssp C---------------------------------------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred C---------------------------------------cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhc
Confidence 1 11246899999999998865 5799999999999999999
Q ss_pred hCCCCCCCCChh-hhHHHHhh---------------------------------ccccccCCCCCCCCHHHHHHHHHhhc
Q 010463 339 IGYPPFCSDDPR-ITCRKIVN---------------------------------WKTCLKFPEEPKISDEARDLICHLLC 384 (510)
Q Consensus 339 ~G~~PF~~~~~~-~~~~~I~~---------------------------------~~~~~~~p~~~~~s~~~~dlI~~lL~ 384 (510)
+|..||...... .....+.. +......+....+|++++|||++||+
T Consensus 225 ~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~ 304 (328)
T d3bqca1 225 FRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 304 (328)
T ss_dssp HTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSC
T ss_pred cCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHcc
Confidence 999999765432 22222211 00001111223589999999999999
Q ss_pred -CccccCCCCChHHhhcCCCcCCCCch
Q 010463 385 -DVETRLGTRGVEELKEHPWFRGIQWD 410 (510)
Q Consensus 385 -dp~~R~~~~~~~eil~HpfF~~i~~~ 410 (510)
||.+|| +++|+|+||||+++.|+
T Consensus 305 ~dP~~R~---ta~e~L~Hp~F~~v~~~ 328 (328)
T d3bqca1 305 YDHQSRL---TAREAMEHPYFYTVVKD 328 (328)
T ss_dssp SSGGGSC---CHHHHHTSGGGTTSCCC
T ss_pred CChhHCc---CHHHHhcCcccCCCCCC
Confidence 999999 79999999999999996
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-55 Score=436.59 Aligned_cols=257 Identities=19% Similarity=0.257 Sum_probs=210.2
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCce
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 180 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 180 (510)
+++..++|++++.||+|+||+||+|+.+ ..||||+++.... .....+.+.+|+.+|+.++|||||++++++. .+.
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~ 77 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQ 77 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccE
Confidence 4677889999999999999999999754 3599999976543 4456788999999999999999999999865 457
Q ss_pred EEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 181 LYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
+|+|||||+||+|.++|... ..+++..+..++.||+.||+|||++|||||||||+||||+.++++||+|||+|+.....
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 89999999999999999764 56999999999999999999999999999999999999999999999999999875432
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc---CCCCccccccchhhHHHH
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK---KGYGMECDWWSLGAIMYE 336 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~---~~y~~~~DiwSlGvilyE 336 (510)
... ....+.+||+.|||||++.+ ..|+.++|||||||+|||
T Consensus 158 ~~~------------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~e 201 (276)
T d1uwha_ 158 SGS------------------------------------HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYE 201 (276)
T ss_dssp --------------------------------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHH
T ss_pred CCc------------------------------------ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHH
Confidence 110 01224689999999999974 358999999999999999
Q ss_pred HhhCCCCCCCCChhhhHHHHhhcc-ccccCC-CCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 337 MLIGYPPFCSDDPRITCRKIVNWK-TCLKFP-EEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 337 ml~G~~PF~~~~~~~~~~~I~~~~-~~~~~p-~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
|++|+.||.+.+.......++... .....+ ....+++++++||.+||. ||++|| ++.||++|
T Consensus 202 l~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RP---t~~~il~~ 266 (276)
T d1uwha_ 202 LMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERP---LFPQILAS 266 (276)
T ss_dssp HHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCc---CHHHHHHH
Confidence 999999999877665554444321 111111 124789999999999998 999999 68888875
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-55 Score=442.16 Aligned_cols=264 Identities=26% Similarity=0.346 Sum_probs=217.7
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec-------
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD------- 177 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~------- 177 (510)
+++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|+.++||||+++++++.+
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 5789999999999999999999999999999999977543 33445678899999999999999999999865
Q ss_pred -CceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccC
Q 010463 178 -SDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 256 (510)
Q Consensus 178 -~~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~ 256 (510)
.+.+|+||||+.++.+.........+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 3468999999998888777777788999999999999999999999999999999999999999999999999999866
Q ss_pred ccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccC-CCCccccccchhhHHH
Q 010463 257 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMY 335 (510)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiwSlGvily 335 (510)
....... .....+.+||+.|+|||++.+. .|+.++|||||||++|
T Consensus 168 ~~~~~~~----------------------------------~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~ 213 (318)
T d3blha1 168 SLAKNSQ----------------------------------PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMA 213 (318)
T ss_dssp CC---------------------------------------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred ccccccc----------------------------------cccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceee
Confidence 5321110 0112356899999999999865 7899999999999999
Q ss_pred HHhhCCCCCCCCChhhhHHHHhhccccccCCCC----------------------------CCCCHHHHHHHHHhhc-Cc
Q 010463 336 EMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEE----------------------------PKISDEARDLICHLLC-DV 386 (510)
Q Consensus 336 Eml~G~~PF~~~~~~~~~~~I~~~~~~~~~p~~----------------------------~~~s~~~~dlI~~lL~-dp 386 (510)
||++|++||.+.+.......+............ ...+++++|||.+||. ||
T Consensus 214 el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP 293 (318)
T d3blha1 214 EMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDP 293 (318)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSST
T ss_pred eHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCCh
Confidence 999999999998887777766542221111100 0137889999999999 99
Q ss_pred cccCCCCChHHhhcCCCcCC
Q 010463 387 ETRLGTRGVEELKEHPWFRG 406 (510)
Q Consensus 387 ~~R~~~~~~~eil~HpfF~~ 406 (510)
++|+ +++|+++||||+.
T Consensus 294 ~~R~---sa~elL~Hpff~~ 310 (318)
T d3blha1 294 AQRI---DSDDALNHDFFWS 310 (318)
T ss_dssp TTSC---CHHHHHHSGGGSS
T ss_pred hHCc---CHHHHHcChhhcc
Confidence 9999 7999999999975
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-55 Score=446.93 Aligned_cols=252 Identities=30% Similarity=0.461 Sum_probs=211.2
Q ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec------Cce
Q 010463 107 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD------SDF 180 (510)
Q Consensus 107 ~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~------~~~ 180 (510)
+|+.+++||+|+||+||+|+++.+|+.||||++.+.... ..+|+.+|+.++|||||+++++|.. ..+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 699999999999999999999999999999999765321 3469999999999999999999853 446
Q ss_pred EEEEEeccCCCCHHHHH---HhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCC-ceeecccCCcccC
Q 010463 181 LYLIMEYLPGGDIMTLL---MREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG-HLKLSDFGLCKPL 256 (510)
Q Consensus 181 ~~lVmEy~~gG~L~~~L---~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g-~vkL~DFGla~~~ 256 (510)
+|||||||++|.+..+. .....+++..++.++.||+.||+|||++|||||||||+||||+.++ .+||+|||+|+.+
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 89999999876444333 3456799999999999999999999999999999999999999876 8999999999866
Q ss_pred ccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHH
Q 010463 257 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMY 335 (510)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvily 335 (510)
.... ...+.+||+.|+|||++.+ ..|+.++|||||||++|
T Consensus 174 ~~~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~ 214 (350)
T d1q5ka_ 174 VRGE---------------------------------------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214 (350)
T ss_dssp CTTS---------------------------------------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred cCCc---------------------------------------ccccccccccccChHHhhcccCCCcceeecccceEEE
Confidence 4321 1225689999999999875 57899999999999999
Q ss_pred HHhhCCCCCCCCChhhhHHHHhhccc---------------cccCC----------CCCCCCHHHHHHHHHhhc-Ccccc
Q 010463 336 EMLIGYPPFCSDDPRITCRKIVNWKT---------------CLKFP----------EEPKISDEARDLICHLLC-DVETR 389 (510)
Q Consensus 336 Eml~G~~PF~~~~~~~~~~~I~~~~~---------------~~~~p----------~~~~~s~~~~dlI~~lL~-dp~~R 389 (510)
||++|.+||.+.+....+.+|+.... ...+| ..+.+|+++.|||.+||+ ||++|
T Consensus 215 el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R 294 (350)
T d1q5ka_ 215 ELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294 (350)
T ss_dssp HHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGS
T ss_pred ehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHC
Confidence 99999999999888777777653110 11111 124689999999999999 99999
Q ss_pred CCCCChHHhhcCCCcCCC
Q 010463 390 LGTRGVEELKEHPWFRGI 407 (510)
Q Consensus 390 ~~~~~~~eil~HpfF~~i 407 (510)
| ++.|+++||||+++
T Consensus 295 ~---ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 295 L---TPLEACAHSFFDEL 309 (350)
T ss_dssp C---CHHHHHTSGGGGGG
T ss_pred c---CHHHHhcCHhhccc
Confidence 9 78999999999865
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-55 Score=439.59 Aligned_cols=259 Identities=23% Similarity=0.338 Sum_probs=209.4
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCC---EEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGE---IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 177 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~---~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 177 (510)
.++..++|++.+.||+|+||+||+|+++.+|+ .||||++.... ...+.+.+.+|+.+|++++|||||++++++.+
T Consensus 21 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~ 98 (299)
T d1jpaa_ 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK 98 (299)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred hhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 35667899999999999999999999987775 58899886542 34456779999999999999999999999999
Q ss_pred CceEEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccC
Q 010463 178 SDFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 256 (510)
Q Consensus 178 ~~~~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~ 256 (510)
++.+|+|||||+||+|.+++... +.+++.++..++.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+
T Consensus 99 ~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 99 STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp SSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEc
Confidence 99999999999999999988774 57999999999999999999999999999999999999999999999999999876
Q ss_pred ccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHH
Q 010463 257 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 336 (510)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyE 336 (510)
........ ........||+.|||||++.+..|+.++|||||||+|||
T Consensus 179 ~~~~~~~~---------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~e 225 (299)
T d1jpaa_ 179 EDDTSDPT---------------------------------YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWE 225 (299)
T ss_dssp --------------------------------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHH
T ss_pred cCCCCcce---------------------------------eeecccccCCccccCHHHHhcCCCCcccccccchHHHHH
Confidence 54311000 000113468999999999999999999999999999999
Q ss_pred Hhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 337 MLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 337 ml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
|++ |.+||.+.+..+....|... ...|....+++++.+||.+||. ||++|| ++.||++
T Consensus 226 l~t~g~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~l~~li~~cl~~~P~~RP---s~~ei~~ 285 (299)
T d1jpaa_ 226 VMSYGERPYWDMTNQDVINAIEQD---YRLPPPMDCPSALHQLMLDCWQKDRNHRP---KFGQIVN 285 (299)
T ss_dssp HHTTSCCTTTTCCHHHHHHHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSTTTSC---CHHHHHH
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcC---CCCCCCccchHHHHHHHHHHcCCCHhHCc---CHHHHHH
Confidence 998 89999999888888887753 2333345799999999999998 999999 5666654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-55 Score=433.02 Aligned_cols=258 Identities=21% Similarity=0.352 Sum_probs=219.1
Q ss_pred hcccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc
Q 010463 100 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 179 (510)
Q Consensus 100 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 179 (510)
.+++..++|++++.||+|+||+||+|+++ ++..||||++++.. ...+.+.+|+.+|++++|||||++++++.+ +
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~ 80 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc----CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-C
Confidence 34567789999999999999999999986 57789999997643 234568999999999999999999998765 5
Q ss_pred eEEEEEeccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCc
Q 010463 180 FLYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 257 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~ 257 (510)
.+|+|||||++|+|.+++... ..+++..+..++.||+.||.|||+.|||||||||+||||+.++++||+|||+|+.+.
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEcc
Confidence 679999999999999977543 369999999999999999999999999999999999999999999999999998765
Q ss_pred cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHH
Q 010463 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337 (510)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEm 337 (510)
..... ......||+.|||||++.+..|+.++|||||||++|||
T Consensus 161 ~~~~~-------------------------------------~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~el 203 (272)
T d1qpca_ 161 DNEYT-------------------------------------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 203 (272)
T ss_dssp SSCEE-------------------------------------CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHH
T ss_pred CCccc-------------------------------------cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHH
Confidence 43110 11245799999999999999999999999999999999
Q ss_pred hh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc--CCCcCC
Q 010463 338 LI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE--HPWFRG 406 (510)
Q Consensus 338 l~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~--HpfF~~ 406 (510)
+| |.+||...+..+....+..+. .+..| ..+++++.+||.+||. ||++|| ++++|++ |+||..
T Consensus 204 lt~~~~~~~~~~~~~~~~~i~~~~-~~~~p--~~~~~~l~~li~~cl~~~P~~Rp---t~~ei~~~L~~~fts 270 (272)
T d1qpca_ 204 VTHGRIPYPGMTNPEVIQNLERGY-RMVRP--DNCPEELYQLMRLCWKERPEDRP---TFDYLRSVLEDFFTA 270 (272)
T ss_dssp HTTTCCSSTTCCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHHHHHHHHH
T ss_pred HhCCCCCCCCCCHHHHHHHHHhcC-CCCCc--ccChHHHHHHHHHHcCCCHhHCc---CHHHHHHHhhhhhhc
Confidence 99 566777777777777776542 23333 4799999999999998 999999 6888887 788853
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-55 Score=429.76 Aligned_cols=251 Identities=21% Similarity=0.318 Sum_probs=209.0
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEE
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~ 182 (510)
+..++|++++.||+|+||+||+|+++ +++.||||++++... ..+.+.+|+.+|+.++|||||++++++.+++.+|
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 76 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC----cHHHHHHHHHHHHhcCCCCcccccceeccCCceE
Confidence 45689999999999999999999987 567899999976432 2356899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 183 LIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
+|||||++|+|.+++... ..+++..+..++.||+.||+|||+.+|+||||||+|||||.++++||+|||+|+.......
T Consensus 77 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 77 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred EEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 999999999999998754 5689999999999999999999999999999999999999999999999999987643211
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh-C
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-G 340 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~-G 340 (510)
. .....+||+.|||||++.+..|+.++|||||||++|||++ |
T Consensus 157 ~-------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~ 199 (263)
T d1sm2a_ 157 T-------------------------------------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 199 (263)
T ss_dssp ---------------------------------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred e-------------------------------------eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCC
Confidence 0 0123579999999999999999999999999999999999 6
Q ss_pred CCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 341 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 341 ~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
.+||.+.+..+....+.... ....| ..+++++.+||.+||. ||++|| +++||++|
T Consensus 200 ~~~~~~~~~~~~~~~i~~~~-~~~~p--~~~~~~l~~li~~cl~~~p~~Rp---s~~~il~~ 255 (263)
T d1sm2a_ 200 KIPYENRSNSEVVEDISTGF-RLYKP--RLASTHVYQIMNHCWKERPEDRP---AFSRLLRQ 255 (263)
T ss_dssp CCTTCSCCHHHHHHHHHHTC-CCCCC--TTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHhcC-CCCCc--cccCHHHHHHHHHHccCCHhHCc---CHHHHHHH
Confidence 78888888877888777642 23334 4789999999999998 999999 68899876
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=424.58 Aligned_cols=251 Identities=21% Similarity=0.346 Sum_probs=221.3
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEE
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 182 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~ 182 (510)
+..++|++++.||+|+||+||+|+++ +++.||||++++... ..+.+.+|+.+++.++|||||+++++|.+++.+|
T Consensus 1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~ 75 (258)
T d1k2pa_ 1 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF 75 (258)
T ss_dssp CCCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS----CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEE
T ss_pred CChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC----CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceE
Confidence 35689999999999999999999985 778899999987543 2356899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 183 LIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 183 lVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
+||||+++|+|..++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++++||+|||+|+.+.....
T Consensus 76 iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 76 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp EEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred EEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 99999999999999655 46799999999999999999999999999999999999999999999999999986644311
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh-C
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-G 340 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~-G 340 (510)
. .....+||+.|+|||++.+..|+.++|||||||++|||+| |
T Consensus 156 ~-------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g 198 (258)
T d1k2pa_ 156 T-------------------------------------SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLG 198 (258)
T ss_dssp C-------------------------------------CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred e-------------------------------------eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcC
Confidence 1 1123579999999999999999999999999999999998 8
Q ss_pred CCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 341 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 341 ~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
+.||.+.+..++..+|.+.. .+..| ..+++++++||++||. ||++|| ++++|++|
T Consensus 199 ~~Pf~~~~~~~~~~~i~~~~-~~~~p--~~~~~~l~~li~~cl~~dP~~RP---t~~eil~~ 254 (258)
T d1k2pa_ 199 KMPYERFTNSETAEHIAQGL-RLYRP--HLASEKVYTIMYSCWHEKADERP---TFKILLSN 254 (258)
T ss_dssp CCTTTTSCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHTTCSSGGGSC---CHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHhCC-CCCCc--ccccHHHHHHHHHHccCCHhHCc---CHHHHHHH
Confidence 99999999999888888642 33344 4789999999999998 999999 68999987
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-54 Score=426.37 Aligned_cols=261 Identities=28% Similarity=0.455 Sum_probs=223.4
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCceEEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV 184 (510)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. ........+.+|+.+|+.++|||||+++++|.+....++|
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 368999999999999999999999999999999997654 2455678899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcccccccc
Q 010463 185 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 264 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 264 (510)
||++.|++|..++...+.+++..++.++.|++.||+|||++|||||||||+||||+.++++||+|||+|+.......
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~--- 156 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--- 156 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS---
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc---
Confidence 99999999999998889999999999999999999999999999999999999999999999999999987644311
Q ss_pred chhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCC-CCccccccchhhHHHHHhhCCCC
Q 010463 265 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG-YGMECDWWSLGAIMYEMLIGYPP 343 (510)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~-y~~~~DiwSlGvilyEml~G~~P 343 (510)
......+++.|+|||++.+.. ++.++|||||||++|||++|..|
T Consensus 157 -----------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p 201 (292)
T d1unla_ 157 -----------------------------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201 (292)
T ss_dssp -----------------------------------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCC
T ss_pred -----------------------------------cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCC
Confidence 012346889999999998765 69999999999999999999888
Q ss_pred C-CCCChhhhHHHHhhccccc---------cCC----------------CCCCCCHHHHHHHHHhhc-CccccCCCCChH
Q 010463 344 F-CSDDPRITCRKIVNWKTCL---------KFP----------------EEPKISDEARDLICHLLC-DVETRLGTRGVE 396 (510)
Q Consensus 344 F-~~~~~~~~~~~I~~~~~~~---------~~p----------------~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~ 396 (510)
| .+.+..+...++....... ..+ ....+|++++|||++||+ ||.+|| +++
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~---sa~ 278 (292)
T d1unla_ 202 LFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI---SAE 278 (292)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSC---CHH
T ss_pred CCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCc---CHH
Confidence 5 5556666666554311110 000 114678999999999999 999999 799
Q ss_pred HhhcCCCcCCC
Q 010463 397 ELKEHPWFRGI 407 (510)
Q Consensus 397 eil~HpfF~~i 407 (510)
|+|+||||+++
T Consensus 279 e~L~Hp~f~~~ 289 (292)
T d1unla_ 279 EALQHPYFSDF 289 (292)
T ss_dssp HHTTSGGGSSC
T ss_pred HHhcChhhcCC
Confidence 99999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-54 Score=436.82 Aligned_cols=261 Identities=28% Similarity=0.429 Sum_probs=212.7
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc----eE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD----FL 181 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~----~~ 181 (510)
+.|++++.||+|+||+||+|+++.+|+.||||++.+.. .....+.+.+|+.+|+.++|||||++++++..+. ..
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 46999999999999999999999999999999997653 3445677899999999999999999999997654 23
Q ss_pred EEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccc
Q 010463 182 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 261 (510)
Q Consensus 182 ~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 261 (510)
+++|+|+.||+|.+++.. +.+++..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.......
T Consensus 86 ~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 444556779999999965 4699999999999999999999999999999999999999999999999999987644311
Q ss_pred cccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhcc-CCCCccccccchhhHHHHHhhC
Q 010463 262 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIG 340 (510)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiwSlGvilyEml~G 340 (510)
. .......+||+.|+|||++.. ..|+.++||||+||++|||++|
T Consensus 165 ~-----------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g 209 (345)
T d1pmea_ 165 H-----------------------------------TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 209 (345)
T ss_dssp B-----------------------------------CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHS
T ss_pred c-----------------------------------ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhC
Confidence 1 011234689999999999854 5679999999999999999999
Q ss_pred CCCCCCCChhhhHHHHhhcccc------------------ccCCC---------CCCCCHHHHHHHHHhhc-CccccCCC
Q 010463 341 YPPFCSDDPRITCRKIVNWKTC------------------LKFPE---------EPKISDEARDLICHLLC-DVETRLGT 392 (510)
Q Consensus 341 ~~PF~~~~~~~~~~~I~~~~~~------------------~~~p~---------~~~~s~~~~dlI~~lL~-dp~~R~~~ 392 (510)
.+||.+.+...+...+...... ...+. .+.+|+++++||.+||+ ||.+||
T Consensus 210 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-- 287 (345)
T d1pmea_ 210 RPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI-- 287 (345)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSC--
T ss_pred CCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCc--
Confidence 9999988776655554321000 00110 24689999999999999 999999
Q ss_pred CChHHhhcCCCcCCC
Q 010463 393 RGVEELKEHPWFRGI 407 (510)
Q Consensus 393 ~~~~eil~HpfF~~i 407 (510)
+++|+++||||+..
T Consensus 288 -ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 288 -EVEQALAHPYLEQY 301 (345)
T ss_dssp -CHHHHHTSGGGTTT
T ss_pred -CHHHHhcCHhhccC
Confidence 79999999999854
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-54 Score=424.70 Aligned_cols=254 Identities=26% Similarity=0.358 Sum_probs=209.3
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcCCC---CEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTG---EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 178 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg---~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 178 (510)
++..++|++.+.||+|+||+||+|++..++ ..||||+++... .....+.+.+|+.+|+.++|||||++++++. +
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 79 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 79 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 456689999999999999999999987654 468899886432 3455678999999999999999999999996 4
Q ss_pred ceEEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCc
Q 010463 179 DFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 257 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~ 257 (510)
+.+|+||||++||+|..++... ..+++..++.++.||+.||+|||+.|||||||||+|||++.++.+||+|||+|+.+.
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheecc
Confidence 6789999999999999987654 579999999999999999999999999999999999999999999999999998764
Q ss_pred cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHH
Q 010463 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337 (510)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEm 337 (510)
.... ......+||+.|+|||++.+..|+.++|||||||++|||
T Consensus 160 ~~~~-------------------------------------~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~ 202 (273)
T d1mp8a_ 160 DSTY-------------------------------------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 202 (273)
T ss_dssp ------------------------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHH
T ss_pred CCcc-------------------------------------eeccceecCcccchhhHhccCCCCCccccccchHHHHHH
Confidence 3211 011245799999999999999999999999999999999
Q ss_pred hh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 338 LI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 338 l~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
++ |.+||.+.+..+.+.++.+.. .+.+| +.+|+++++||.+||. ||++|| +++||++|
T Consensus 203 lt~g~~P~~~~~~~~~~~~i~~~~-~~~~~--~~~~~~~~~li~~cl~~dp~~Rp---s~~ei~~~ 262 (273)
T d1mp8a_ 203 LMHGVKPFQGVKNNDVIGRIENGE-RLPMP--PNCPPTLYSLMTKCWAYDPSRRP---RFTELKAQ 262 (273)
T ss_dssp HTTSCCTTTTCCGGGHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HhcCCCCCCCCCHHHHHHHHHcCC-CCCCC--CCCCHHHHHHHHHHcCCCHhHCc---CHHHHHHH
Confidence 98 899999999999998888743 23333 5899999999999998 999999 68898876
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-54 Score=425.71 Aligned_cols=259 Identities=24% Similarity=0.397 Sum_probs=214.8
Q ss_pred hcccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc
Q 010463 100 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 179 (510)
Q Consensus 100 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 179 (510)
.+.+..++|++.+.||+|+||+||+|+++.+ +.||||++++... ..+.+.+|+.+|+.++|||||++++++.+ +
T Consensus 11 ~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~ 84 (285)
T d1fmka3 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 84 (285)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC----CHHHHHHHHHHHHhcccCCEeEEEEEEec-C
Confidence 4567778999999999999999999998765 5699999976532 23568999999999999999999999965 5
Q ss_pred eEEEEEeccCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCc
Q 010463 180 FLYLIMEYLPGGDIMTLLMR--EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 257 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~--~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~ 257 (510)
.+|+|||||++|+|..++.. ...+++.++..++.||+.||+|||+.||+||||||+|||||.+|++||+|||+|+...
T Consensus 85 ~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~ 164 (285)
T d1fmka3 85 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 164 (285)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhcc
Confidence 57999999999999998865 3579999999999999999999999999999999999999999999999999998654
Q ss_pred cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHH
Q 010463 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337 (510)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEm 337 (510)
..... ...+.+||+.|+|||++.++.++.++|||||||++|||
T Consensus 165 ~~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el 207 (285)
T d1fmka3 165 DNEYT-------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 207 (285)
T ss_dssp ------------------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CCCce-------------------------------------eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHH
Confidence 32110 01235799999999999999999999999999999999
Q ss_pred hhC-CCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc--CCCcCCC
Q 010463 338 LIG-YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE--HPWFRGI 407 (510)
Q Consensus 338 l~G-~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~--HpfF~~i 407 (510)
++| .+||.+.+..+....+... ...|....+|+++++||.+||. ||++|| ++++|++ |+||...
T Consensus 208 ~t~~~p~~~~~~~~~~~~~i~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rp---s~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 208 TTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLHDLMCQCWRKEPEERP---TFEYLQAFLEDYFTST 275 (285)
T ss_dssp HTTTCCSSTTCCHHHHHHHHHTT---CCCCCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHHHHTTTSCS
T ss_pred HhCCCCCCCCCCHHHHHHHHHhc---CCCCCCcccCHHHHHHHHHHcccCHhHCc---CHHHHHHHHhhhhcCC
Confidence 995 6666777777777777653 2333345899999999999998 999999 6889887 8888763
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-54 Score=441.26 Aligned_cols=268 Identities=26% Similarity=0.409 Sum_probs=212.2
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec------Cc
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD------SD 179 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~------~~ 179 (510)
++|++++.||+|+||+||+|+++.||+.||||++.+... .......+.+|+.+|+.++|||||+++++|.. ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 689999999999999999999999999999999987543 45566789999999999999999999999964 46
Q ss_pred eEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 180 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
.+|+|||||.|| +...+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+++.....
T Consensus 96 ~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence 899999999765 44444 356999999999999999999999999999999999999999999999999998865432
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 339 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~ 339 (510)
. .....+||+.|+|||++.+..|+.++||||+||++|||++
T Consensus 173 ~---------------------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~ 213 (355)
T d2b1pa1 173 F---------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 213 (355)
T ss_dssp -----------------------------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred c---------------------------------------ccccccccccccChhhhcCCCCCCCcccccccchHHHHhh
Confidence 1 1124689999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhhHHHHhhcccc--------------------cc---------C-----CC----CCCCCHHHHHHHHH
Q 010463 340 GYPPFCSDDPRITCRKIVNWKTC--------------------LK---------F-----PE----EPKISDEARDLICH 381 (510)
Q Consensus 340 G~~PF~~~~~~~~~~~I~~~~~~--------------------~~---------~-----p~----~~~~s~~~~dlI~~ 381 (510)
|++||.+.+......+++..... .. + +. ....|++++|||++
T Consensus 214 g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~ 293 (355)
T d2b1pa1 214 HKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK 293 (355)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHH
Confidence 99999998877776666421100 00 0 00 01247789999999
Q ss_pred hhc-CccccCCCCChHHhhcCCCcCCCCchhhhcccCCC
Q 010463 382 LLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAY 419 (510)
Q Consensus 382 lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l~~~~~p~ 419 (510)
||. ||++|| +++|||+||||+..-+..-....+|.
T Consensus 294 mL~~dP~~R~---ta~elL~Hpw~~~~~~~~~~~~~~~~ 329 (355)
T d2b1pa1 294 MLVIDPAKRI---SVDDALQHPYINVWYDPAEVEAPPPQ 329 (355)
T ss_dssp HSCSSTTTSC---CHHHHHTSTTTGGGCCHHHHTCCCC-
T ss_pred HCcCChhHCc---CHHHHhcCcccCCCCCcccccCCCCC
Confidence 999 999999 79999999999975443333344443
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-54 Score=440.05 Aligned_cols=257 Identities=27% Similarity=0.407 Sum_probs=215.9
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC-----c
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS-----D 179 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----~ 179 (510)
.++|++++.||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+.+|+.++|||||+++++|... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 3679999999999999999999999999999999986532 444567789999999999999999999999743 3
Q ss_pred eEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccc
Q 010463 180 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 259 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~ 259 (510)
..++||+|+.||+|.+++.. +.+++..++.++.||+.||.|||++|||||||||+|||++.+|++|++|||+|......
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~ 174 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 174 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGG
T ss_pred ceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCcc
Confidence 45667788889999998854 57999999999999999999999999999999999999999999999999999765432
Q ss_pred cccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCC-CCccccccchhhHHHHHh
Q 010463 260 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG-YGMECDWWSLGAIMYEML 338 (510)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~-y~~~~DiwSlGvilyEml 338 (510)
..+.+||+.|+|||++.+.. ++.++|||||||++|+|+
T Consensus 175 -----------------------------------------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll 213 (348)
T d2gfsa1 175 -----------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 213 (348)
T ss_dssp -----------------------------------------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHH
T ss_pred -----------------------------------------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHH
Confidence 12468999999999987755 589999999999999999
Q ss_pred hCCCCCCCCChhhhHHHHhhccccc---------------------cCCC------CCCCCHHHHHHHHHhhc-CccccC
Q 010463 339 IGYPPFCSDDPRITCRKIVNWKTCL---------------------KFPE------EPKISDEARDLICHLLC-DVETRL 390 (510)
Q Consensus 339 ~G~~PF~~~~~~~~~~~I~~~~~~~---------------------~~p~------~~~~s~~~~dlI~~lL~-dp~~R~ 390 (510)
+|.+||.+.+.......|....... ..+. ...+|++++|||++||+ ||.+|+
T Consensus 214 ~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ 293 (348)
T d2gfsa1 214 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 293 (348)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCc
Confidence 9999999998887777775422111 1110 13689999999999999 999999
Q ss_pred CCCChHHhhcCCCcCCC
Q 010463 391 GTRGVEELKEHPWFRGI 407 (510)
Q Consensus 391 ~~~~~~eil~HpfF~~i 407 (510)
+++|+++||||+..
T Consensus 294 ---ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 294 ---TAAQALAHAYFAQY 307 (348)
T ss_dssp ---CHHHHHTSGGGTTT
T ss_pred ---CHHHHhcCHhhCCC
Confidence 79999999999864
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=426.77 Aligned_cols=259 Identities=22% Similarity=0.332 Sum_probs=207.6
Q ss_pred hcccCCCCceeeeeeecCCCeEEEEEEEcC-----CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeE
Q 010463 100 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKT-----TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFY 173 (510)
Q Consensus 100 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~-----tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~ 173 (510)
++++..++|++++.||+|+||+||+|+++. +++.||||++++.. .....+.+..|..++.++ +|||||.+++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 345667899999999999999999999765 45689999997543 334456677788877766 6899999999
Q ss_pred EeecC-ceEEEEEeccCCCCHHHHHHhc----------------cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCC
Q 010463 174 SFQDS-DFLYLIMEYLPGGDIMTLLMRE----------------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDN 236 (510)
Q Consensus 174 ~~~~~-~~~~lVmEy~~gG~L~~~L~~~----------------~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~N 236 (510)
++.++ ..+|+|||||+||+|.++|... ..+++..+..|+.||+.||+|||++|||||||||+|
T Consensus 85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~N 164 (299)
T d1ywna1 85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 164 (299)
T ss_dssp EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccc
Confidence 87654 5799999999999999999653 348999999999999999999999999999999999
Q ss_pred eeecCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhh
Q 010463 237 LILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL 316 (510)
Q Consensus 237 ILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl 316 (510)
|||+.+|++||+|||+|+........ ....+.+||+.|||||++
T Consensus 165 ILl~~~~~~Kl~DFGla~~~~~~~~~------------------------------------~~~~~~~gt~~y~APE~l 208 (299)
T d1ywna1 165 ILLSEKNVVKICDFGLARDIYKDPDY------------------------------------VRKGDARLPLKWMAPETI 208 (299)
T ss_dssp EEECGGGCEEECC------CCSCTTS------------------------------------CCTTSCCCGGGGCCHHHH
T ss_pred eeECCCCcEEEccCcchhhccccccc------------------------------------cccCceeeCccccchhHh
Confidence 99999999999999999865432110 112246899999999999
Q ss_pred ccCCCCccccccchhhHHHHHhhC-CCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCC
Q 010463 317 LKKGYGMECDWWSLGAIMYEMLIG-YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRG 394 (510)
Q Consensus 317 ~~~~y~~~~DiwSlGvilyEml~G-~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~ 394 (510)
.+..|+.++|||||||++|||++| .+||.+.+....+.+++.....+..| ..+|+++++||.+||+ ||++|| +
T Consensus 209 ~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rp---t 283 (299)
T d1ywna1 209 FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP--DYTTPEMYQTMLDCWHGEPSQRP---T 283 (299)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---C
T ss_pred hcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCC--ccCCHHHHHHHHHHcCCChhHCc---C
Confidence 999999999999999999999986 67898877666666665544444444 4799999999999998 999999 6
Q ss_pred hHHhhcC
Q 010463 395 VEELKEH 401 (510)
Q Consensus 395 ~~eil~H 401 (510)
++||++|
T Consensus 284 ~~eil~~ 290 (299)
T d1ywna1 284 FSELVEH 290 (299)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 8999887
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-53 Score=420.91 Aligned_cols=257 Identities=22% Similarity=0.289 Sum_probs=209.3
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCC----CEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEee
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTG----EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ 176 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg----~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 176 (510)
.++..++|++.++||+|+||+||+|.++.++ ..||||++.... .......+.+|+.+|+.++|||||++++++.
T Consensus 2 ~ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~ 79 (283)
T d1mqba_ 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 79 (283)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CcCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe
Confidence 3567889999999999999999999988765 469999997542 3445567899999999999999999999999
Q ss_pred cCceEEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCccc
Q 010463 177 DSDFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 255 (510)
Q Consensus 177 ~~~~~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~ 255 (510)
+.+.+++|||||.+|++.+++... ..+++..+..++.||+.||+|||+.|||||||||+||||+.+|++||+|||+|+.
T Consensus 80 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 80 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred cCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence 999999999999999999988765 6799999999999999999999999999999999999999999999999999987
Q ss_pred CccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHH
Q 010463 256 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 335 (510)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvily 335 (510)
+....... .......||+.|||||++.++.|+.++|||||||++|
T Consensus 160 ~~~~~~~~-----------------------------------~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~ 204 (283)
T d1mqba_ 160 LEDDPEAT-----------------------------------YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMW 204 (283)
T ss_dssp -------------------------------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHH
T ss_pred ccCCCccc-----------------------------------eEeccCCCCccccCHHHHccCCCCCcccccccHHHHH
Confidence 64321100 0012356999999999999999999999999999999
Q ss_pred HHhhC-CCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 336 EMLIG-YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 336 Eml~G-~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
||++| .+||.+.+..+.+..+... ..+..| ..+++++++||.+||. ||++|| ++.||++
T Consensus 205 el~t~~~~~~~~~~~~~~~~~i~~~-~~~~~~--~~~~~~l~~li~~cl~~~p~~RP---t~~eil~ 265 (283)
T d1mqba_ 205 EVMTYGERPYWELSNHEVMKAINDG-FRLPTP--MDCPSAIYQLMMQCWQQERARRP---KFADIVS 265 (283)
T ss_dssp HHHTTSCCTTTTCCHHHHHHHHHTT-CCCCCC--TTCBHHHHHHHHHHTCSSTTTSC---CHHHHHH
T ss_pred HHHhCCCCccccCCHHHHHHHHhcc-CCCCCc--hhhHHHHHHHHHHHCcCCHhHCc---CHHHHHH
Confidence 99995 5566666666666666543 223333 4799999999999998 999999 5777765
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=430.15 Aligned_cols=255 Identities=22% Similarity=0.340 Sum_probs=211.3
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcCCCC----EEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecC
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGE----IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 178 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~----~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 178 (510)
+..+||+++++||+|+||+||+|+++.+|+ .||+|+++... .....+.+.+|+.+|+.++|||||+++++|.++
T Consensus 6 ~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 83 (317)
T d1xkka_ 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 83 (317)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred CCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 345789999999999999999999998887 47778776432 344567799999999999999999999999875
Q ss_pred ceEEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCc
Q 010463 179 DFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 257 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~ 257 (510)
..++||||+.+|+|.+++... ..+++..++.++.||+.||+|||++|||||||||+||||+.++++||+|||+|+.+.
T Consensus 84 -~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 84 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp -SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred -CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence 578889999999999988764 679999999999999999999999999999999999999999999999999998764
Q ss_pred cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHH
Q 010463 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337 (510)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEm 337 (510)
..... ..+...+||+.|||||++.++.|+.++|||||||+||||
T Consensus 163 ~~~~~------------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el 206 (317)
T d1xkka_ 163 AEEKE------------------------------------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 206 (317)
T ss_dssp TTCC--------------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred ccccc------------------------------------ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHH
Confidence 32111 011235799999999999999999999999999999999
Q ss_pred hh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCC
Q 010463 338 LI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHP 402 (510)
Q Consensus 338 l~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~Hp 402 (510)
+| |.+||.+.+..+....+.++ ..+..| +.+++++.+||.+||. ||.+|| ++.||+.|.
T Consensus 207 ~t~g~~p~~~~~~~~~~~~i~~~-~~~~~p--~~~~~~~~~li~~cl~~dP~~RP---s~~eil~~l 267 (317)
T d1xkka_ 207 MTFGSKPYDGIPASEISSILEKG-ERLPQP--PICTIDVYMIMVKCWMIDADSRP---KFRELIIEF 267 (317)
T ss_dssp HTTSCCTTTTSCGGGHHHHHHHT-CCCCCC--TTBCHHHHHHHHHHTCSSGGGSC---CHHHHHHHH
T ss_pred HHCCCCCCCCCCHHHHHHHHHcC-CCCCCC--cccCHHHHHHHHHhCCCChhhCc---CHHHHHHHH
Confidence 98 89999988887777766653 223333 5799999999999998 999999 689999883
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-53 Score=419.06 Aligned_cols=256 Identities=21% Similarity=0.364 Sum_probs=208.5
Q ss_pred cCCCCceeeeeeecCCCeEEEEEEEcC-CCC--EEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeecCc
Q 010463 103 IGIDDFEQLTLIGKGAFGEVRLCRAKT-TGE--IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 179 (510)
Q Consensus 103 ~~~~~f~~~~~IG~G~fG~V~~~~~~~-tg~--~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 179 (510)
+..+||++++.||+|+||+||+|+.+. +++ .||||++.+.........+.+.+|+.+|+.++|||||+++++|.+ +
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence 456789999999999999999998754 333 689999987766566667889999999999999999999999976 4
Q ss_pred eEEEEEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCcc
Q 010463 180 FLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 258 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~ 258 (510)
.+++|||||++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 678999999999999887654 5799999999999999999999999999999999999999999999999999997654
Q ss_pred ccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHh
Q 010463 259 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 338 (510)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml 338 (510)
..... ......+||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 164 ~~~~~-----------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~eml 208 (273)
T d1u46a_ 164 NDDHY-----------------------------------VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 208 (273)
T ss_dssp -CCEE-----------------------------------EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred CCCcc-----------------------------------eecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHH
Confidence 32110 0112356889999999999999999999999999999999
Q ss_pred h-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhh
Q 010463 339 I-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 399 (510)
Q Consensus 339 ~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil 399 (510)
+ |.+||.+.+..+...+|......+ |....+|+++++||.+||. ||++|| ++.||+
T Consensus 209 t~G~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~RP---t~~ei~ 266 (273)
T d1u46a_ 209 TYGQEPWIGLNGSQILHKIDKEGERL--PRPEDCPQDIYNVMVQCWAHKPEDRP---TFVALR 266 (273)
T ss_dssp TTSCCTTTTCCHHHHHHHHHTSCCCC--CCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHH
T ss_pred hCCCCCCCCcCHHHHHHHHHhCCCCC--CCcccccHHHHHHHHHHcCCChhHCc---CHHHHH
Confidence 8 899999999999999988754433 3335899999999999998 999999 567775
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.6e-53 Score=421.64 Aligned_cols=257 Identities=22% Similarity=0.302 Sum_probs=219.6
Q ss_pred hcccCCCCceeeeeeecCCCeEEEEEEEcC-----CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEE
Q 010463 100 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKT-----TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYS 174 (510)
Q Consensus 100 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~-----tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 174 (510)
..++..++|++++.||+|+||+||+|+.+. +++.||||++++.. .....+.+.+|+.+|+.++||||++++++
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 345667899999999999999999999863 56789999997543 34456779999999999999999999999
Q ss_pred eecCceEEEEEeccCCCCHHHHHHhcc------------------------CCCHHHHHHHHHHHHHHHHhhhhCCeEEe
Q 010463 175 FQDSDFLYLIMEYLPGGDIMTLLMRED------------------------ILSEDVARFYIAESVLAIHSIHQHNYVHR 230 (510)
Q Consensus 175 ~~~~~~~~lVmEy~~gG~L~~~L~~~~------------------------~l~e~~~~~~~~qi~~aL~~lH~~giiHR 230 (510)
+.+.+.+++||||+++|+|.++|.... .+++..+..++.||+.||+|||+.|||||
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHr 164 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 164 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEee
Confidence 999999999999999999999996532 38999999999999999999999999999
Q ss_pred ecCCCCeeecCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCC
Q 010463 231 DIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDY 310 (510)
Q Consensus 231 DLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y 310 (510)
||||+|||||.++++||+|||+|+.+..... .....+.+||+.|
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~------------------------------------~~~~~~~~~~~~y 208 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADY------------------------------------YKADGNDAIPIRW 208 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGC------------------------------------BC----CCBCGGG
T ss_pred EEcccceEECCCCcEEEccchhheeccCCcc------------------------------------ccccCCCCcCcCc
Confidence 9999999999999999999999986533211 0112346899999
Q ss_pred cchHhhccCCCCccccccchhhHHHHHhhC-CCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-Cccc
Q 010463 311 MAPEVLLKKGYGMECDWWSLGAIMYEMLIG-YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVET 388 (510)
Q Consensus 311 ~APEvl~~~~y~~~~DiwSlGvilyEml~G-~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~ 388 (510)
+|||++.+..|+.++|||||||++|||++| .+||.+.+..+...++..+. .+..| ..+++++.+||.+||. ||++
T Consensus 209 ~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~-~~~~p--~~~~~~~~~li~~cl~~~P~~ 285 (301)
T d1lufa_ 209 MPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN-ILACP--ENCPLELYNLMRLCWSKLPAD 285 (301)
T ss_dssp CCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGG
T ss_pred CCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCC-CCCCC--ccchHHHHHHHHHHcCCChhH
Confidence 999999999999999999999999999998 47899999988888887643 23334 4799999999999999 9999
Q ss_pred cCCCCChHHhhc
Q 010463 389 RLGTRGVEELKE 400 (510)
Q Consensus 389 R~~~~~~~eil~ 400 (510)
|| ++.||++
T Consensus 286 RP---t~~ev~~ 294 (301)
T d1lufa_ 286 RP---SFCSIHR 294 (301)
T ss_dssp SC---CHHHHHH
T ss_pred Cc---CHHHHHH
Confidence 99 5777753
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-53 Score=422.14 Aligned_cols=253 Identities=24% Similarity=0.382 Sum_probs=215.9
Q ss_pred ccCCCCceeeeeeecCCCeEEEEEEEcCCCCE--EEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeEEeecC
Q 010463 102 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEI--FAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDS 178 (510)
Q Consensus 102 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~--vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~ 178 (510)
.+..++|++.++||+|+||+||+|+++.+|.. ||||++.+. ......+.+.+|+.+|+.+ +|||||+++++|.+.
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~ 83 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 83 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC
Confidence 35678999999999999999999999998875 667776543 2344566799999999998 799999999999999
Q ss_pred ceEEEEEeccCCCCHHHHHHhc----------------cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCC
Q 010463 179 DFLYLIMEYLPGGDIMTLLMRE----------------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN 242 (510)
Q Consensus 179 ~~~~lVmEy~~gG~L~~~L~~~----------------~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~ 242 (510)
+.+|+||||++||+|.++|.+. ..+++..+..++.||+.||.|||+.|||||||||+|||++.+
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 163 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC
Confidence 9999999999999999999654 569999999999999999999999999999999999999999
Q ss_pred CceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCC
Q 010463 243 GHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYG 322 (510)
Q Consensus 243 g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~ 322 (510)
+.+||+|||+|+....... ....+||+.|+|||++.+..|+
T Consensus 164 ~~~kl~DfG~a~~~~~~~~---------------------------------------~~~~~gt~~y~aPE~l~~~~~~ 204 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYVK---------------------------------------KTMGRLPVRWMAIESLNYSVYT 204 (309)
T ss_dssp GCEEECCTTCEESSCEECC---------------------------------------C----CCTTTCCHHHHHHCEEC
T ss_pred CceEEcccccccccccccc---------------------------------------ccceecCCcccchHHhccCCCC
Confidence 9999999999986543211 1135799999999999999999
Q ss_pred ccccccchhhHHHHHhhC-CCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 323 MECDWWSLGAIMYEMLIG-YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 323 ~~~DiwSlGvilyEml~G-~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
.++|||||||++|||++| .+||.+.+..+.+.+|.++. .+..| ..+++++++||.+||. ||++|| +++||++
T Consensus 205 ~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~-~~~~~--~~~~~~~~~li~~cl~~dP~~RP---s~~eil~ 278 (309)
T d1fvra_ 205 TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-RLEKP--LNCDDEVYDLMRQCWREKPYERP---SFAQILV 278 (309)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC-CCCCC--TTBCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred ccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC-CCCCC--ccCCHHHHHHHHHHcCCChhHCc---CHHHHHH
Confidence 999999999999999996 56898988888888887642 23333 4799999999999998 999999 7899998
Q ss_pred C
Q 010463 401 H 401 (510)
Q Consensus 401 H 401 (510)
|
T Consensus 279 ~ 279 (309)
T d1fvra_ 279 S 279 (309)
T ss_dssp H
T ss_pred H
Confidence 7
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=411.66 Aligned_cols=246 Identities=23% Similarity=0.408 Sum_probs=208.0
Q ss_pred cccCCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec-Cc
Q 010463 101 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD-SD 179 (510)
Q Consensus 101 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~~ 179 (510)
+.+..++|++++.||+|+||.||+|+++ |..||||+++++. ..+.+.+|+.+|++++|||||++++++.+ .+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence 4677889999999999999999999984 7789999997542 34568999999999999999999998854 56
Q ss_pred eEEEEEeccCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCc
Q 010463 180 FLYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 257 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~ 257 (510)
.+|+||||+++|+|.++|.+. ..+++..++.++.||+.||.|||+.+||||||||+|||++.+|++||+|||+++...
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecC
Confidence 789999999999999999764 358999999999999999999999999999999999999999999999999998653
Q ss_pred cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHH
Q 010463 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337 (510)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEm 337 (510)
.. ....+||+.|+|||++.+..|+.++|||||||++|||
T Consensus 155 ~~-----------------------------------------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el 193 (262)
T d1byga_ 155 ST-----------------------------------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 193 (262)
T ss_dssp ------------------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CC-----------------------------------------CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHH
Confidence 32 1135689999999999999999999999999999999
Q ss_pred hh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc
Q 010463 338 LI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 400 (510)
Q Consensus 338 l~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~ 400 (510)
++ |.+||...+..+...+|.+. ..+.+| ..+++++++||++||. ||.+|| ++.+|++
T Consensus 194 ~t~~~~p~~~~~~~~~~~~i~~~-~~~~~~--~~~~~~~~~li~~cl~~dP~~Rp---s~~~l~~ 252 (262)
T d1byga_ 194 YSFGRVPYPRIPLKDVVPRVEKG-YKMDAP--DGCPPAVYEVMKNCWHLDAAMRP---SFLQLRE 252 (262)
T ss_dssp HTTSCCSCTTSCGGGHHHHHTTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHCCCCCCCCCCHHHHHHHHHcC-CCCCCC--ccCCHHHHHHHHHHcccCHhHCc---CHHHHHH
Confidence 98 79999998888888888764 233444 4789999999999998 999999 6777765
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-52 Score=417.10 Aligned_cols=258 Identities=22% Similarity=0.309 Sum_probs=222.3
Q ss_pred hcccCCCCceeeeeeecCCCeEEEEEEEc-----CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEeE
Q 010463 100 RRKIGIDDFEQLTLIGKGAFGEVRLCRAK-----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFY 173 (510)
Q Consensus 100 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~-----~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~ 173 (510)
.+++..++|++.+.||+|+||.||+|+++ .+++.||||++++.. ...+...+.+|..+++.+ +|||||++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g 94 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLG 94 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 45577789999999999999999999864 467789999997653 344566799999999998 7999999999
Q ss_pred EeecCceEEEEEeccCCCCHHHHHHhcc------------------CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCC
Q 010463 174 SFQDSDFLYLIMEYLPGGDIMTLLMRED------------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPD 235 (510)
Q Consensus 174 ~~~~~~~~~lVmEy~~gG~L~~~L~~~~------------------~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~ 235 (510)
++.+...+|+|||||+||+|.++|.+.. .+++..+..|+.||+.||+|||++|||||||||+
T Consensus 95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~ 174 (311)
T d1t46a_ 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (311)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence 9999999999999999999999997643 5899999999999999999999999999999999
Q ss_pred CeeecCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHh
Q 010463 236 NLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEV 315 (510)
Q Consensus 236 NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEv 315 (510)
|||++.++++||+|||+++........ ......+||+.|+|||+
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~------------------------------------~~~~~~~gt~~y~aPE~ 218 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNY------------------------------------VVKGNARLPVKWMAPES 218 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTS------------------------------------EECSSSEECGGGCCHHH
T ss_pred cccccccCcccccccchheeccCCCcc------------------------------------eEeeecccChHHcCHHH
Confidence 999999999999999999876543111 01124689999999999
Q ss_pred hccCCCCccccccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC
Q 010463 316 LLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR 393 (510)
Q Consensus 316 l~~~~y~~~~DiwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~ 393 (510)
+.+..++.++|||||||++|||++ |.+||.+.+....+.+++.....+..| ..+|+++.+||.+||. ||++||
T Consensus 219 ~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~l~~Li~~cl~~dP~~RP--- 293 (311)
T d1t46a_ 219 IFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP--EHAPAEMYDIMKTCWDADPLKRP--- 293 (311)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCC--TTSCHHHHHHHHHHTCSSGGGSC---
T ss_pred hcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCc--ccccHHHHHHHHHHcCCChhHCc---
Confidence 999999999999999999999998 778888877777777777654444444 4789999999999998 999999
Q ss_pred ChHHhhc
Q 010463 394 GVEELKE 400 (510)
Q Consensus 394 ~~~eil~ 400 (510)
++++|++
T Consensus 294 s~~~il~ 300 (311)
T d1t46a_ 294 TFKQIVQ 300 (311)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 6788774
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-52 Score=414.79 Aligned_cols=257 Identities=21% Similarity=0.334 Sum_probs=215.9
Q ss_pred hcccCCCCceeeeeeecCCCeEEEEEEEcCCC-------CEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeE
Q 010463 100 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTG-------EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQL 171 (510)
Q Consensus 100 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~tg-------~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l 171 (510)
++.+..++|++++.||+|+||.||+|+...++ ..||||++++.. .......+.+|..++..+ +|||||++
T Consensus 7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~ 84 (299)
T d1fgka_ 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINL 84 (299)
T ss_dssp TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEec
Confidence 35577789999999999999999999987665 379999997653 344567788898888887 89999999
Q ss_pred eEEeecCceEEEEEeccCCCCHHHHHHhcc----------------CCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCC
Q 010463 172 FYSFQDSDFLYLIMEYLPGGDIMTLLMRED----------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPD 235 (510)
Q Consensus 172 ~~~~~~~~~~~lVmEy~~gG~L~~~L~~~~----------------~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~ 235 (510)
+++|.+++.+|+|||||+||+|.++|.... .+++..+..++.||+.||+|||+.|||||||||+
T Consensus 85 ~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~ 164 (299)
T d1fgka_ 85 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 164 (299)
T ss_dssp EEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccc
Confidence 999999999999999999999999997543 5899999999999999999999999999999999
Q ss_pred CeeecCCCceeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHh
Q 010463 236 NLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEV 315 (510)
Q Consensus 236 NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEv 315 (510)
|||++.+|.+||+|||+++........ ......+||+.|+|||+
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~ 208 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYY------------------------------------KKTTNGRLPVKWMAPEA 208 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTT------------------------------------CCCTTSCCGGGGSCHHH
T ss_pred ceeecCCCCeEeccchhhccccccccc------------------------------------cccccCCCChhhhhhhH
Confidence 999999999999999999876543111 11234689999999999
Q ss_pred hccCCCCccccccchhhHHHHHhh-CCCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC
Q 010463 316 LLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR 393 (510)
Q Consensus 316 l~~~~y~~~~DiwSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~ 393 (510)
+.++.|+.++|||||||++|||++ |.+||.+.+....+..+.+. ..+..| ..+|+++++||.+||. ||.+||
T Consensus 209 l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~-~~~~~p--~~~~~~l~~li~~cl~~dP~~Rp--- 282 (299)
T d1fgka_ 209 LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG-HRMDKP--SNCTNELYMMMRDCWHAVPSQRP--- 282 (299)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CCCCCC--SSCCHHHHHHHHHHTCSSGGGSC---
T ss_pred hcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcC-CCCCCC--ccchHHHHHHHHHHccCCHhHCc---
Confidence 999999999999999999999998 79999988888877777653 334444 5899999999999998 999999
Q ss_pred ChHHhhc
Q 010463 394 GVEELKE 400 (510)
Q Consensus 394 ~~~eil~ 400 (510)
++.||++
T Consensus 283 s~~eil~ 289 (299)
T d1fgka_ 283 TFKQLVE 289 (299)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 6788875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-52 Score=416.57 Aligned_cols=265 Identities=19% Similarity=0.265 Sum_probs=226.3
Q ss_pred hcccCCCCceeeeeeecCCCeEEEEEEEcC-----CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEE
Q 010463 100 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKT-----TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYS 174 (510)
Q Consensus 100 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~-----tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 174 (510)
.+++..++|++++.||+|+||+||+|.++. ++..||||++++.. ...+...+.+|+.+|++++|||||+++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 356777999999999999999999998863 35789999997643 34456678999999999999999999999
Q ss_pred eecCceEEEEEeccCCCCHHHHHHhc----------cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCc
Q 010463 175 FQDSDFLYLIMEYLPGGDIMTLLMRE----------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH 244 (510)
Q Consensus 175 ~~~~~~~~lVmEy~~gG~L~~~L~~~----------~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~ 244 (510)
+..++.+++|||||++|+|.+++... ..+++..+..++.|++.||.|||+++||||||||+|||||.+++
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce
Confidence 99999999999999999999998643 24689999999999999999999999999999999999999999
Q ss_pred eeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCcc
Q 010463 245 LKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGME 324 (510)
Q Consensus 245 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~ 324 (510)
+||+|||+|+.+...... ....+.+||+.|+|||++.+..|+.+
T Consensus 172 ~Kl~DFGla~~~~~~~~~------------------------------------~~~~~~~~t~~y~aPe~l~~~~~~~~ 215 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYY------------------------------------RKGGKGLLPVRWMSPESLKDGVFTTY 215 (308)
T ss_dssp EEECCTTCCCGGGGGGCE------------------------------------EGGGSSEECGGGCCHHHHHHCCCCHH
T ss_pred EEEeecccceeccCCcce------------------------------------eeccceecccccCCHHHHccCCCCcc
Confidence 999999999876443111 01224579999999999999999999
Q ss_pred ccccchhhHHHHHhhC-CCCCCCCChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhc--
Q 010463 325 CDWWSLGAIMYEMLIG-YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE-- 400 (510)
Q Consensus 325 ~DiwSlGvilyEml~G-~~PF~~~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~-- 400 (510)
+|||||||++|||++| .+||.+.+..+.+..+.+.. .+..| ..+++.+.+||.+||. ||++|| ++++|++
T Consensus 216 ~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~-~~~~p--~~~~~~l~~li~~cl~~~P~~RP---s~~~il~~L 289 (308)
T d1p4oa_ 216 SDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG-LLDKP--DNCPDMLFELMRMCWQYNPKMRP---SFLEIISSI 289 (308)
T ss_dssp HHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHHH
T ss_pred cccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC-CCCCc--ccchHHHHHHHHHHcCCChhHCc---CHHHHHHHH
Confidence 9999999999999998 58999999988888888743 23333 4799999999999998 999999 6778876
Q ss_pred ----CCCcCCCC
Q 010463 401 ----HPWFRGIQ 408 (510)
Q Consensus 401 ----HpfF~~i~ 408 (510)
+|+|+.++
T Consensus 290 ~~~~~~~~~~~~ 301 (308)
T d1p4oa_ 290 KEEMEPGFREVS 301 (308)
T ss_dssp GGGSCTTHHHHC
T ss_pred HHhcCCCCcCCC
Confidence 66665443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.3e-51 Score=405.63 Aligned_cols=263 Identities=19% Similarity=0.257 Sum_probs=204.1
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCC-eeeEeEEeecCceEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC-IVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~-Iv~l~~~~~~~~~~~lV 184 (510)
+.|++++.||+|+||+||+|+++.+|+.||||++..... ...+..|..+++.++|++ |+.+++++.+.+..++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 469999999999999999999999999999999876432 123778999999997765 55566777888899999
Q ss_pred EeccCCCCHHHHH-HhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeec---CCCceeecccCCcccCcccc
Q 010463 185 MEYLPGGDIMTLL-MREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD---KNGHLKLSDFGLCKPLEDKY 260 (510)
Q Consensus 185 mEy~~gG~L~~~L-~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld---~~g~vkL~DFGla~~~~~~~ 260 (510)
|||+.| +|...+ .....+++..+..++.|++.||+|||++|||||||||+|||++ .++.+||+|||+|+.+....
T Consensus 82 me~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 82 MELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp EECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 999955 555554 4456899999999999999999999999999999999999876 45579999999999775432
Q ss_pred ccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhC
Q 010463 261 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 340 (510)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G 340 (510)
..... ......+.+||+.|||||++.+.+|+.++|||||||++|||++|
T Consensus 161 ~~~~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg 209 (299)
T d1ckia_ 161 THQHI-------------------------------PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLG 209 (299)
T ss_dssp TCCBC-------------------------------CCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHS
T ss_pred cccce-------------------------------eccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhC
Confidence 11000 00112356899999999999999999999999999999999999
Q ss_pred CCCCCCCChhhhHHHHhhccc-cccCCC---CCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcC
Q 010463 341 YPPFCSDDPRITCRKIVNWKT-CLKFPE---EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 405 (510)
Q Consensus 341 ~~PF~~~~~~~~~~~I~~~~~-~~~~p~---~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~ 405 (510)
.+||.+.........+..... ....|. ...+|+++.+||..||. +|++||+...+.++++|+|.+
T Consensus 210 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 210 SLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp SCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred CCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 999987665544433322111 111111 24789999999999998 999999655566778888764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-49 Score=396.65 Aligned_cols=249 Identities=19% Similarity=0.271 Sum_probs=203.7
Q ss_pred eeeeecCCCeEEEEEEEcCCC---CEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEeEEeec-CceEEEEEe
Q 010463 111 LTLIGKGAFGEVRLCRAKTTG---EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD-SDFLYLIME 186 (510)
Q Consensus 111 ~~~IG~G~fG~V~~~~~~~tg---~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~~~~~lVmE 186 (510)
.++||+|+||+||+|++..++ ..||||++++. ......+.+.+|+++|++++|||||++++++.+ ++.+++|||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 578999999999999987654 36999999753 245667889999999999999999999998764 568999999
Q ss_pred ccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCCcccCccccccccc
Q 010463 187 YLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 265 (510)
Q Consensus 187 y~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 265 (510)
||++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||||++++++||+|||+++.+........
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~- 188 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV- 188 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT-
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc-
Confidence 99999999988754 4577888999999999999999999999999999999999999999999999997654311100
Q ss_pred hhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHHhhCCCCCC
Q 010463 266 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 345 (510)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEml~G~~PF~ 345 (510)
.......||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 189 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~ 235 (311)
T d1r0pa_ 189 ---------------------------------HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 235 (311)
T ss_dssp ---------------------------------TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSC
T ss_pred ---------------------------------eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCC
Confidence 01123579999999999999999999999999999999999766665
Q ss_pred C-CChhhhHHHHhhccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcC
Q 010463 346 S-DDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 401 (510)
Q Consensus 346 ~-~~~~~~~~~I~~~~~~~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~H 401 (510)
. .+..+....+.... .+..| ..+++++.+||.+||. ||++|| ++.||++|
T Consensus 236 ~~~~~~~~~~~i~~g~-~~~~p--~~~~~~l~~li~~cl~~dP~~RP---s~~ei~~~ 287 (311)
T d1r0pa_ 236 PDVNTFDITVYLLQGR-RLLQP--EYCPDPLYEVMLKCWHPKAEMRP---SFSELVSR 287 (311)
T ss_dssp C------CHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred CCCCHHHHHHHHHcCC-CCCCc--ccCcHHHHHHHHHHcCCCHhHCc---CHHHHHHH
Confidence 4 44445556666543 33344 4789999999999998 999999 68899876
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.6e-49 Score=391.54 Aligned_cols=251 Identities=20% Similarity=0.221 Sum_probs=204.5
Q ss_pred CCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC-CCeeeEeEEeecCceEEE
Q 010463 105 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS-RCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 105 ~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~~~~~~~~~l 183 (510)
-++|++++.||+|+||+||+|+++.+|+.||||++.+... ...+.+|.++++.+.| +||+.+++++.+....|+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 3689999999999999999999999999999999865431 2346789999999876 899999999999999999
Q ss_pred EEeccCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecC-----CCceeecccCCcccCc
Q 010463 184 IMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK-----NGHLKLSDFGLCKPLE 257 (510)
Q Consensus 184 VmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~-----~g~vkL~DFGla~~~~ 257 (510)
||||+ ||+|.+++... ..+++..+..++.|++.||+|||++|||||||||+||||+. ++.+||+|||+|+.+.
T Consensus 79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99999 78999988765 47999999999999999999999999999999999999974 6789999999999765
Q ss_pred cccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCCccccccchhhHHHHH
Q 010463 258 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 337 (510)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiwSlGvilyEm 337 (510)
........ ......+.+|||.|||||++.+..|+.++|||||||++|||
T Consensus 158 ~~~~~~~~-------------------------------~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~el 206 (293)
T d1csna_ 158 DPVTKQHI-------------------------------PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYF 206 (293)
T ss_dssp CTTTCCBC-------------------------------CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cCccccce-------------------------------eecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHH
Confidence 43111000 00112357899999999999999999999999999999999
Q ss_pred hhCCCCCCCCChh---hhHHHHhhccccccCCC-CCCCCHHHHHHHHHhhc-CccccCCC
Q 010463 338 LIGYPPFCSDDPR---ITCRKIVNWKTCLKFPE-EPKISDEARDLICHLLC-DVETRLGT 392 (510)
Q Consensus 338 l~G~~PF~~~~~~---~~~~~I~~~~~~~~~p~-~~~~s~~~~dlI~~lL~-dp~~R~~~ 392 (510)
++|.+||.+.+.. ..+.++.........+. .+.+++++.+++..|+. +|++||..
T Consensus 207 ltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y 266 (293)
T d1csna_ 207 LRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDY 266 (293)
T ss_dssp HHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCH
T ss_pred HhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCH
Confidence 9999999865443 33444443222111110 13688999999999998 99999953
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-48 Score=384.36 Aligned_cols=249 Identities=22% Similarity=0.276 Sum_probs=189.4
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHH--HHhcCCCCeeeEeEEeecCc----
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNL--LAEVDSRCIVQLFYSFQDSD---- 179 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~i--L~~l~hp~Iv~l~~~~~~~~---- 179 (510)
.+|.+.+.||+|+||.||+|+. +|+.||||+++... ......|+++ +..++|||||++++++.+++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~------~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc------hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence 4688899999999999999986 68999999996542 2233444444 46789999999999998654
Q ss_pred eEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhh--------CCeEEeecCCCCeeecCCCceeecccC
Q 010463 180 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ--------HNYVHRDIKPDNLILDKNGHLKLSDFG 251 (510)
Q Consensus 180 ~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~--------~giiHRDLKP~NILld~~g~vkL~DFG 251 (510)
.+|+|||||++|+|.++|.+. .+++.....++.|++.||.|+|+ +|||||||||+||||+.+|++||+|||
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 689999999999999999764 68999999999999999999996 599999999999999999999999999
Q ss_pred CcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCC------CCccc
Q 010463 252 LCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG------YGMEC 325 (510)
Q Consensus 252 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~------y~~~~ 325 (510)
+|+......... .......+||+.|||||++.+.. ++.++
T Consensus 154 l~~~~~~~~~~~----------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~ 199 (303)
T d1vjya_ 154 LAVRHDSATDTI----------------------------------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRA 199 (303)
T ss_dssp TCEEEETTTTEE----------------------------------CC----CCSCGGGCCHHHHTTCSCTTCHHHHHHH
T ss_pred ccccccCCCcce----------------------------------eccccceecccCcCChhhccccccccCCCcCcch
Confidence 998764321110 00112468999999999997643 57789
Q ss_pred cccchhhHHHHHhhCCCCCCCCChh--------------hhHHHH-hhccccccCCCC---CCCCHHHHHHHHHhhc-Cc
Q 010463 326 DWWSLGAIMYEMLIGYPPFCSDDPR--------------ITCRKI-VNWKTCLKFPEE---PKISDEARDLICHLLC-DV 386 (510)
Q Consensus 326 DiwSlGvilyEml~G~~PF~~~~~~--------------~~~~~I-~~~~~~~~~p~~---~~~s~~~~dlI~~lL~-dp 386 (510)
|||||||+||||++|.+||...... ....+. ........+|.. ......+.+|+.+||. ||
T Consensus 200 Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp 279 (303)
T d1vjya_ 200 DIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANG 279 (303)
T ss_dssp HHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSG
T ss_pred hhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCH
Confidence 9999999999999999887432211 111112 211111222221 1223458899999998 99
Q ss_pred cccCCCCChHHhhc
Q 010463 387 ETRLGTRGVEELKE 400 (510)
Q Consensus 387 ~~R~~~~~~~eil~ 400 (510)
++|| ++.||++
T Consensus 280 ~~Rp---s~~ei~~ 290 (303)
T d1vjya_ 280 AARL---TALRIKK 290 (303)
T ss_dssp GGSC---CHHHHHH
T ss_pred hHCc---CHHHHHH
Confidence 9999 6788765
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2e-47 Score=390.36 Aligned_cols=273 Identities=22% Similarity=0.365 Sum_probs=207.1
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-----------CCCeeeEeEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-----------SRCIVQLFYS 174 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~-----------hp~Iv~l~~~ 174 (510)
.+|++++.||+|+||+||+|+++.+|+.||||++++... ..+.+.+|+.+|+.++ |||||+++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc----chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 459999999999999999999999999999999986532 2345677888887764 5889999988
Q ss_pred eec--CceEEEEEeccCCCCHHHHH---HhccCCCHHHHHHHHHHHHHHHHhhhh-CCeEEeecCCCCeeecCCCc----
Q 010463 175 FQD--SDFLYLIMEYLPGGDIMTLL---MREDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGH---- 244 (510)
Q Consensus 175 ~~~--~~~~~lVmEy~~gG~L~~~L---~~~~~l~e~~~~~~~~qi~~aL~~lH~-~giiHRDLKP~NILld~~g~---- 244 (510)
+.. ....++||+++.++...... .....+++..++.++.||+.||+|||+ .||+||||||+||||+.+|.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence 764 45778888887665443332 234679999999999999999999997 89999999999999987764
Q ss_pred --eeecccCCcccCccccccccchhhhhhcccccccccccCCChHHHHHHHHhhcccccccccccCCCcchHhhccCCCC
Q 010463 245 --LKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYG 322 (510)
Q Consensus 245 --vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~ 322 (510)
++|+|||.|...... ..+.+||+.|+|||++.+..|+
T Consensus 169 ~~~kl~dfg~s~~~~~~-----------------------------------------~~~~~gt~~y~aPE~~~~~~~~ 207 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH-----------------------------------------YTNSIQTREYRSPEVLLGAPWG 207 (362)
T ss_dssp EEEEECCCTTCEETTBC-----------------------------------------CCSCCSCGGGCCHHHHHTCCCC
T ss_pred ceeeEeecccccccccc-----------------------------------------cccccccccccChhhccccCCC
Confidence 999999998865332 1246899999999999999999
Q ss_pred ccccccchhhHHHHHhhCCCCCCCCChhh------hHHHHhhc------------c----------c-----c-------
Q 010463 323 MECDWWSLGAIMYEMLIGYPPFCSDDPRI------TCRKIVNW------------K----------T-----C------- 362 (510)
Q Consensus 323 ~~~DiwSlGvilyEml~G~~PF~~~~~~~------~~~~I~~~------------~----------~-----~------- 362 (510)
.++|+|||||+++||++|++||.+.+... ....++.. . . .
T Consensus 208 ~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (362)
T d1q8ya_ 208 CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLE 287 (362)
T ss_dssp THHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHH
T ss_pred ccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchh
Confidence 99999999999999999999997543211 11111000 0 0 0
Q ss_pred ----ccCCCCCCCCHHHHHHHHHhhc-CccccCCCCChHHhhcCCCcCCCCchhhhcccCCCccccCCCcc
Q 010463 363 ----LKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELD 428 (510)
Q Consensus 363 ----~~~p~~~~~s~~~~dlI~~lL~-dp~~R~~~~~~~eil~HpfF~~i~~~~l~~~~~p~~p~~~~~~d 428 (510)
.........+++++|||.+||. ||.+|| +++|+|+||||+++.+ ..+...|..|...+..|
T Consensus 288 ~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp---ta~e~L~Hp~f~~~~~--~~~~~~p~~~~~~~~~~ 353 (362)
T d1q8ya_ 288 DVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA---DAGGLVNHPWLKDTLG--MEEIRVPDRELYGSGSD 353 (362)
T ss_dssp HHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB---CHHHHHTCGGGTTCTT--CTTCCCTTSCTTCBSTT
T ss_pred hhcccccccCcccCHHHHHHHHHHCCCChhHCc---CHHHHhcCcccCCCCC--cccCCCCCcccCCCCCC
Confidence 0000112357889999999999 999999 7899999999997653 23355566666554444
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=3.1e-27 Score=218.79 Aligned_cols=137 Identities=14% Similarity=0.155 Sum_probs=108.7
Q ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhc---------------chhhHHHHHHHHHHHHhcCCCCeeeEe
Q 010463 108 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML---------------KRGQVEHVRSERNLLAEVDSRCIVQLF 172 (510)
Q Consensus 108 f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~---------------~~~~~~~~~~E~~iL~~l~hp~Iv~l~ 172 (510)
+.+.+.||+|+||+||+|++. +|+.||||+++..... ..........|...|..+.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 356789999999999999885 6899999987542211 011123456688899999999999988
Q ss_pred EEeecCceEEEEEeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhhhCCeEEeecCCCCeeecCCCceeecccCC
Q 010463 173 YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGL 252 (510)
Q Consensus 173 ~~~~~~~~~~lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH~~giiHRDLKP~NILld~~g~vkL~DFGl 252 (510)
++.. .++||||++++.+.. +++..+..++.|++.||.|||++||+||||||+|||++.+| ++|+|||+
T Consensus 81 ~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~ 148 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQ 148 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTT
T ss_pred EecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCC
Confidence 7642 379999999875532 45666778999999999999999999999999999998655 89999999
Q ss_pred cccCc
Q 010463 253 CKPLE 257 (510)
Q Consensus 253 a~~~~ 257 (510)
|+...
T Consensus 149 a~~~~ 153 (191)
T d1zara2 149 SVEVG 153 (191)
T ss_dssp CEETT
T ss_pred cccCC
Confidence 98654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.58 E-value=1e-07 Score=89.65 Aligned_cols=140 Identities=14% Similarity=0.114 Sum_probs=91.7
Q ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEeEEeecCceEEEE
Q 010463 106 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSDFLYLI 184 (510)
Q Consensus 106 ~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~~~lV 184 (510)
+.|+..+..+.|+.+.||++. .++..+.+|....... .....+.+|..+|..+. +--+.+++++..+++..|+|
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~---~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcc---cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 467777766666668999764 4667788898765432 22334677888887763 33367778888888999999
Q ss_pred EeccCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHhhh-----------------------------------------
Q 010463 185 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIH----------------------------------------- 223 (510)
Q Consensus 185 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~lH----------------------------------------- 223 (510)
|++++|..+........ .... ++.++...+..||
T Consensus 89 ~~~l~G~~~~~~~~~~~--~~~~---~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 89 MSEADGVLCSEEYEDEQ--SPEK---IIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHTTTCS--CHHH---HHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred EEecccccccccccccc--cHHH---HHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence 99999987755432110 0110 1111111111111
Q ss_pred ------------------hCCeEEeecCCCCeeecCCCceeecccCCccc
Q 010463 224 ------------------QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 255 (510)
Q Consensus 224 ------------------~~giiHRDLKP~NILld~~g~vkL~DFGla~~ 255 (510)
...++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12389999999999999877677999999875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.18 E-value=3.4e-06 Score=84.52 Aligned_cols=81 Identities=20% Similarity=0.245 Sum_probs=50.5
Q ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhc-c---hhhHHHHHHHHHHHHhcC-C--CCeeeEeEEeecCceEEE
Q 010463 111 LTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML-K---RGQVEHVRSERNLLAEVD-S--RCIVQLFYSFQDSDFLYL 183 (510)
Q Consensus 111 ~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~-~---~~~~~~~~~E~~iL~~l~-h--p~Iv~l~~~~~~~~~~~l 183 (510)
.+.||.|....||++....+|+.|++|.-...... . .....+...|..+|..+. + ..+.+++++ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 56789999999999988778889999964321110 0 112345667888887662 2 345566544 3445679
Q ss_pred EEeccCCCCH
Q 010463 184 IMEYLPGGDI 193 (510)
Q Consensus 184 VmEy~~gG~L 193 (510)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.97 E-value=1.6e-05 Score=73.81 Aligned_cols=136 Identities=12% Similarity=0.096 Sum_probs=81.4
Q ss_pred eeecCC-CeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC--CCeeeEeEEeecCceEEEEEeccC
Q 010463 113 LIGKGA-FGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS--RCIVQLFYSFQDSDFLYLIMEYLP 189 (510)
Q Consensus 113 ~IG~G~-fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~h--p~Iv~l~~~~~~~~~~~lVmEy~~ 189 (510)
.+..|. -+.||++.. .++..+.+|.-.... ...+..|..+|+.+.. --+.+++.+..+++..++||+|++
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 344454 368898764 456678889765432 2236678888776632 336778888888899999999999
Q ss_pred CCCHHHH--------------HHhcc-------CCC--HHH-----HHHHH---------------HHHHHHHHhhh---
Q 010463 190 GGDIMTL--------------LMRED-------ILS--EDV-----ARFYI---------------AESVLAIHSIH--- 223 (510)
Q Consensus 190 gG~L~~~--------------L~~~~-------~l~--e~~-----~~~~~---------------~qi~~aL~~lH--- 223 (510)
|-++... |.+-. .+. ... ...+. ......+..+.
T Consensus 90 G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 169 (255)
T d1nd4a_ 90 GQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARM 169 (255)
T ss_dssp SEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTC
T ss_pred ccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhC
Confidence 8654321 11100 000 000 00000 00011122222
Q ss_pred ----hCCeEEeecCCCCeeecCCCceeecccCCccc
Q 010463 224 ----QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 255 (510)
Q Consensus 224 ----~~giiHRDLKP~NILld~~g~vkL~DFGla~~ 255 (510)
...+||+|+.|.|||++.++.+-|+||+.+..
T Consensus 170 ~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 170 PDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 12489999999999999877778999999875
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.21 E-value=0.00031 Score=67.79 Aligned_cols=130 Identities=10% Similarity=0.153 Sum_probs=74.1
Q ss_pred CeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCC--eeeEe-----EEeecCceEEEEEeccCCC
Q 010463 119 FGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC--IVQLF-----YSFQDSDFLYLIMEYLPGG 191 (510)
Q Consensus 119 fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~hp~--Iv~l~-----~~~~~~~~~~lVmEy~~gG 191 (510)
--.||+++. .+|..|++|+..... ...+.+..|...|..+.... ++... ..+...+..+.|+++++|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~----~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPER----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCC----CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 368998865 468889999986532 12345777888887763211 11111 1223456789999999873
Q ss_pred CHH--------------HHHHh----------------------------ccCCCHHHHHH---HHHHHHHHHHhhh---
Q 010463 192 DIM--------------TLLMR----------------------------EDILSEDVARF---YIAESVLAIHSIH--- 223 (510)
Q Consensus 192 ~L~--------------~~L~~----------------------------~~~l~e~~~~~---~~~qi~~aL~~lH--- 223 (510)
.+. ..+.. ...++...... .+.+++..+..+-
T Consensus 110 ~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~ 189 (325)
T d1zyla1 110 QFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRED 189 (325)
T ss_dssp ECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSC
T ss_pred CCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhcccc
Confidence 221 00100 01111111112 2233333333221
Q ss_pred -hCCeEEeecCCCCeeecCCCceeecccCCccc
Q 010463 224 -QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 255 (510)
Q Consensus 224 -~~giiHRDLKP~NILld~~g~vkL~DFGla~~ 255 (510)
..++||+|+.|.|||++. | ..++||+-|..
T Consensus 190 ~p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 190 FTVLRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp SCCEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred CCceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence 247999999999999974 3 45899999874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.15 E-value=0.00097 Score=65.90 Aligned_cols=80 Identities=15% Similarity=0.245 Sum_probs=53.0
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcC-------CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEeEEe
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKT-------TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSF 175 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~-------tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~ 175 (510)
..+++++ +.|+.|-.-.+|++.... .++.|.+++.... ...+ ...+|..+++.+. +.-..+++++|
T Consensus 41 ~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~----~~~i-dr~~E~~i~~~ls~~gl~Pkll~~~ 114 (395)
T d1nw1a_ 41 PLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETES-HLVAESVIFTLLSERHLGPKLYGIF 114 (395)
T ss_dssp CGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCHH-HHHHHHHHHHHHHHTTSSSCEEEEE
T ss_pred CccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc----chhh-HHHHHHHHHHHHHhCCCCCeEEEEc
Confidence 3345544 678888899999998753 3456777776532 1122 3557888888774 44456788877
Q ss_pred ecCceEEEEEeccCCCCH
Q 010463 176 QDSDFLYLIMEYLPGGDI 193 (510)
Q Consensus 176 ~~~~~~~lVmEy~~gG~L 193 (510)
.+ .+||||++|-.|
T Consensus 115 ~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 115 SG----GRLEEYIPSRPL 128 (395)
T ss_dssp TT----EEEECCCCEEEC
T ss_pred CC----ceEEEEeccccC
Confidence 54 689999988543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.49 E-value=0.0076 Score=56.96 Aligned_cols=145 Identities=12% Similarity=0.045 Sum_probs=77.3
Q ss_pred CCCCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC-----CCeeeEe---EEe
Q 010463 104 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS-----RCIVQLF---YSF 175 (510)
Q Consensus 104 ~~~~f~~~~~IG~G~fG~V~~~~~~~tg~~vAiK~i~k~~~~~~~~~~~~~~E~~iL~~l~h-----p~Iv~l~---~~~ 175 (510)
++....-++-|..|---+.|++... +| .|++|+..+.. .. +.+..|..+|..+.. |..+... ...
T Consensus 16 ~lg~~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~~--~~---~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~ 88 (316)
T d2ppqa1 16 DVGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV--EK---NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLG 88 (316)
T ss_dssp CCCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----C---CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCE
T ss_pred CCCCceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCCC--CH---HHHHHHHHHHHhhhhccccccccceecCCCcce
Confidence 3445555666777877889987654 34 48999986531 22 234456666665532 2222211 011
Q ss_pred ecCceEEEEEeccCCCCHHH--------------HHHh---------------------------ccCCCHHHHHHHHHH
Q 010463 176 QDSDFLYLIMEYLPGGDIMT--------------LLMR---------------------------EDILSEDVARFYIAE 214 (510)
Q Consensus 176 ~~~~~~~lVmEy~~gG~L~~--------------~L~~---------------------------~~~l~e~~~~~~~~q 214 (510)
.-......++.++.|..... .+.. ............+..
T Consensus 89 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 168 (316)
T d2ppqa1 89 ELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRP 168 (316)
T ss_dssp EETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHH
T ss_pred eeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHH
Confidence 12345677777777643211 0000 000011111122333
Q ss_pred HHHHHHhhh----hCCeEEeecCCCCeeecCCCceeecccCCccc
Q 010463 215 SVLAIHSIH----QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 255 (510)
Q Consensus 215 i~~aL~~lH----~~giiHRDLKP~NILld~~g~vkL~DFGla~~ 255 (510)
+...+...+ ..|+||+|+.++|||++.++..-|+||+.|..
T Consensus 169 ~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 169 EIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp HHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 333333333 35899999999999999888778999999873
|